Citrus Sinensis ID: 012062
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 472 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LFT8 | 505 | Cyclin-dependent kinase C | yes | no | 0.968 | 0.904 | 0.791 | 0.0 | |
| Q8W4P1 | 513 | Cyclin-dependent kinase C | no | no | 0.974 | 0.896 | 0.775 | 0.0 | |
| Q5JK68 | 513 | Cyclin-dependent kinase C | yes | no | 0.987 | 0.908 | 0.782 | 0.0 | |
| Q6I5Y0 | 519 | Cyclin-dependent kinase C | no | no | 0.862 | 0.784 | 0.807 | 0.0 | |
| Q6ZAG3 | 324 | Cyclin-dependent kinase C | no | no | 0.586 | 0.854 | 0.616 | 7e-95 | |
| Q69ZA1 | 1511 | Cyclin-dependent kinase 1 | yes | no | 0.739 | 0.230 | 0.462 | 4e-92 | |
| D2H526 | 1491 | Cyclin-dependent kinase 1 | yes | no | 0.652 | 0.206 | 0.517 | 1e-91 | |
| Q14AX6 | 1484 | Cyclin-dependent kinase 1 | no | no | 0.652 | 0.207 | 0.514 | 7e-91 | |
| B5DE93 | 1239 | Cyclin-dependent kinase 1 | yes | no | 0.652 | 0.248 | 0.514 | 8e-91 | |
| Q9NYV4 | 1490 | Cyclin-dependent kinase 1 | yes | no | 0.652 | 0.206 | 0.514 | 9e-91 |
| >sp|Q9LFT8|CDKC1_ARATH Cyclin-dependent kinase C-1 OS=Arabidopsis thaliana GN=CDKC-1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 738 bits (1905), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 379/479 (79%), Positives = 411/479 (85%), Gaps = 22/479 (4%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
MA+EIKTGEIVALKKIRMDNE+EGFPITAIREIKILKKL HENVI+LKEIVTSPG +RD+
Sbjct: 42 MAKEIKTGEIVALKKIRMDNEREGFPITAIREIKILKKLHHENVIQLKEIVTSPGRDRDD 101
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
QG+PD NKY+G YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL
Sbjct: 102 QGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 161
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 180
HRDIKGSNLLIDNEGNLKLADFGLARS+S+DH LTNRVITLWYRPPELLLGATKYGPA
Sbjct: 162 HRDIKGSNLLIDNEGNLKLADFGLARSYSHDHTGNLTNRVITLWYRPPELLLGATKYGPA 221
Query: 181 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240
+DMWSVGCIFAELL+ KPILPGKNE EQL+KIFELCGSPDE +WPGVSKMP +N+FKP+R
Sbjct: 222 IDMWSVGCIFAELLHAKPILPGKNEQEQLNKIFELCGSPDEKLWPGVSKMPWFNNFKPAR 281
Query: 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYE 300
+KRRVRE FRHFDRHALELLEKML+LDP+QRISAKDALD+EYFWTDPLPCDPKSLP YE
Sbjct: 282 PLKRRVREFFRHFDRHALELLEKMLVLDPAQRISAKDALDAEYFWTDPLPCDPKSLPTYE 341
Query: 301 SSHEYQTKKRRQQQRQHEEATKRQKLHH-PQPHGRLPPIQHAGQSH---HW-SGPNHPMN 355
SSHE+QTKK+RQQQRQ+EEA KRQKL H P H RLPP+QH GQSH HW +GPNHP N
Sbjct: 342 SSHEFQTKKKRQQQRQNEEAAKRQKLQHPPLQHSRLPPLQHGGQSHAAPHWPAGPNHPTN 401
Query: 356 NAPPPVPGGPGHHHYGKPRGPPGGANRY-PSGNQSGGYNNPNRGGQGGGYSNAPYPPQGR 414
NAPP VP GP H+ YGKPRGPP G NRY PSGNQSGGYN GGYS+ YPPQGR
Sbjct: 402 NAPPQVPAGPSHNFYGKPRGPP-GPNRYPPSGNQSGGYNQSR-----GGYSSGSYPPQGR 455
Query: 415 GPPYAGAGMPANGPRGPASG-YGVGPQSYSQSGQYGNSAAGRGPNQMGGSRNQQYGWQQ 472
G PY GPRGP+ G YGVGP +Y+Q GQYG S + + RNQQYGWQQ
Sbjct: 456 GAPYVA------GPRGPSGGPYGVGPPNYTQGGQYGGSGSS---GRGQNQRNQQYGWQQ 505
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 3 |
| >sp|Q8W4P1|CDKC2_ARATH Cyclin-dependent kinase C-2 OS=Arabidopsis thaliana GN=CDKC-2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 714 bits (1844), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/482 (77%), Positives = 406/482 (84%), Gaps = 22/482 (4%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
MA+EIKTGEIVALKKIRMDNE+EGFPITAIREIKILKKL HENVI LKEIVTSPG +RD+
Sbjct: 42 MAKEIKTGEIVALKKIRMDNEREGFPITAIREIKILKKLHHENVIHLKEIVTSPGRDRDD 101
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
QG+PD NKY+G YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL
Sbjct: 102 QGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 161
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 180
HRDIKGSNLLIDNEGNLKLADFGLARS+S+DH LTNRVITLWYRPPELLLGATKYGPA
Sbjct: 162 HRDIKGSNLLIDNEGNLKLADFGLARSYSHDHTGNLTNRVITLWYRPPELLLGATKYGPA 221
Query: 181 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240
+DMWSVGCIFAELLNGKPILPGK E EQL+KI+ELCGSPDE+ WPGVSKMP YN K SR
Sbjct: 222 IDMWSVGCIFAELLNGKPILPGKTENEQLNKIYELCGSPDESNWPGVSKMPWYNQMKSSR 281
Query: 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYE 300
+KRRVRE++RHFDRHALELLEKML+LDPSQRI AKDALD+EYFWTDPLPCDPKSLP YE
Sbjct: 282 PLKRRVREIYRHFDRHALELLEKMLVLDPSQRICAKDALDAEYFWTDPLPCDPKSLPTYE 341
Query: 301 SSHEYQTKKRRQQQRQHEEATKRQKLHHP-QPHGRLPPIQH-AGQSHH---W-SGPNHPM 354
SSHE+QTKK+RQQ R +EEA K+QKL HP Q H RLPP QH GQSH W +GPNHPM
Sbjct: 342 SSHEFQTKKKRQQMRHNEEAAKKQKLQHPQQQHSRLPPQQHGVGQSHAAPLWPAGPNHPM 401
Query: 355 -NNAPPP-VPGGPGHHHYGKPRGPPGGANRY-PSGNQSGGYNNPNRGGQGGGYSNAPYPP 411
NNAPPP +P G GH++ GKPRG NRY PSGNQ+GGYNN +R GGYS+ YPP
Sbjct: 402 NNNAPPPQIPAG-GHYYGGKPRGGAPVPNRYPPSGNQTGGYNNQSR----GGYSSGAYPP 456
Query: 412 QGRGPPYAGAGMPANGPRGPASGYGVGP--QSYSQSGQYGNSAAGRGPNQMGGSRNQQYG 469
QGRG PY GPRGP+ GYGVGP S G+ +GRG N MGG+RNQQYG
Sbjct: 457 QGRGAPYGA------GPRGPSGGYGVGPPNYSQGGGQYGGSGGSGRGQNPMGGARNQQYG 510
Query: 470 WQ 471
WQ
Sbjct: 511 WQ 512
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q5JK68|CDKC2_ORYSJ Cyclin-dependent kinase C-2 OS=Oryza sativa subsp. japonica GN=CDKC-2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 688 bits (1776), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/478 (78%), Positives = 401/478 (83%), Gaps = 12/478 (2%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
MA+E +T EIVALKKIRMDNE+EGFPITAIREIKILKKL H+NVI+LKEIVTSPGPERDE
Sbjct: 41 MAKETETNEIVALKKIRMDNEREGFPITAIREIKILKKLHHQNVIQLKEIVTSPGPERDE 100
Query: 61 QGRP-DGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQV 119
QG+P +GNKY+GS YMVFEYMDHDLTGLADRPG+RFTVPQIKCYM+QLLTGLHYCHVNQV
Sbjct: 101 QGKPIEGNKYKGSIYMVFEYMDHDLTGLADRPGMRFTVPQIKCYMRQLLTGLHYCHVNQV 160
Query: 120 LHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGP 179
LHRDIKGSNLLIDNEGNLKLADFGLARSFS DHN LTNRVITLWYRPPELLLG+T+YGP
Sbjct: 161 LHRDIKGSNLLIDNEGNLKLADFGLARSFSSDHNGNLTNRVITLWYRPPELLLGSTRYGP 220
Query: 180 AVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239
AVDMWSVGCIFAELLNGKPIL GKNE EQLSKIFELCG+PDE IWPGV+KMP YN+FKP
Sbjct: 221 AVDMWSVGCIFAELLNGKPILTGKNEPEQLSKIFELCGTPDELIWPGVTKMPWYNNFKPQ 280
Query: 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKY 299
R MKRRV+E F+HFD+HAL+LLEKML LDPSQRISAKDALD+EYFWTDPLPCDPKSLPKY
Sbjct: 281 RPMKRRVKESFKHFDQHALDLLEKMLTLDPSQRISAKDALDAEYFWTDPLPCDPKSLPKY 340
Query: 300 ESSHEYQTKKRRQQQRQHEEATKRQKLHHPQPHGRLPPIQHAGQSHHWSGPNHPMNNAPP 359
E+SHE+QTKK+RQQQRQ EEA KRQKL HP PH RLPPIQ+ GQ H P PM+NA P
Sbjct: 341 EASHEFQTKKKRQQQRQAEEAAKRQKLQHPPPHSRLPPIQNPGQPHQIR-PGQPMHNA-P 398
Query: 360 PVPGGPGHHHYGKPRGPPGGANRYPSGNQSGGYNNPNRGGQGGGYSNAPYPPQ---GRGP 416
PV GP HHY KPRG PGG NRYP G GGY NPNRGGQGGGY + PYP Q
Sbjct: 399 PVAAGPS-HHYAKPRG-PGGPNRYPQGGNQGGY-NPNRGGQGGGYGSGPYPQQGRGPPPY 455
Query: 417 PYAGAGMPANGPRGPASGYGVGPQSYSQSGQYGNSAAGRGPN-QMGGSRN-QQYG-WQ 471
P G G G SGYGVG +Y Q G YG S GRGPN GGSRN QQYG WQ
Sbjct: 456 PGGGMGGAGGPRGGGGSGYGVGGPNYQQGGPYGASGPGRGPNYNQGGSRNQQQYGNWQ 513
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q6I5Y0|CDKC1_ORYSJ Cyclin-dependent kinase C-1 OS=Oryza sativa subsp. japonica GN=CDKC-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 669 bits (1727), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 332/411 (80%), Positives = 361/411 (87%), Gaps = 4/411 (0%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
MARE +T EIVALKKIRMDNE+EGFPITAIREIKILKKL H+NVI+LKEIVTSPGPERDE
Sbjct: 41 MARETETQEIVALKKIRMDNEREGFPITAIREIKILKKLHHQNVIQLKEIVTSPGPERDE 100
Query: 61 QGRP-DGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQV 119
QG+P GNKY+GS YMVFEYMDHDLTGLADRPG+RFTVPQIKCYMKQLLTGLHYCH+NQV
Sbjct: 101 QGKPIHGNKYKGSIYMVFEYMDHDLTGLADRPGMRFTVPQIKCYMKQLLTGLHYCHINQV 160
Query: 120 LHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGP 179
LHRDIKGSNLLIDNEGNLKLADFGLARSFS DHN LTNRVITLWYRPPELLLG+TKYGP
Sbjct: 161 LHRDIKGSNLLIDNEGNLKLADFGLARSFSNDHNGNLTNRVITLWYRPPELLLGSTKYGP 220
Query: 180 AVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239
AVDMWSVGCIFAELLNGKPILPGKNE EQLSKIF++CG+PDE+ WPGV+KMP YN+FKP
Sbjct: 221 AVDMWSVGCIFAELLNGKPILPGKNEPEQLSKIFDVCGTPDESNWPGVTKMPWYNNFKPP 280
Query: 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKY 299
R +KRRV+E F+HFDR AL+LLEKML LDP+QRISA+DALD+EYFW+DPLPCDPKSLPKY
Sbjct: 281 RQLKRRVKEYFKHFDRLALDLLEKMLTLDPAQRISAQDALDAEYFWSDPLPCDPKSLPKY 340
Query: 300 ESSHEYQTKKRRQQQRQHEEATKRQKLHHPQPHGRLPPIQHAGQSHHWSGPNHPMNNAPP 359
ESSHE+QTKK+RQQ RQ +EA KRQK HPQPHGRLPPIQ GQ H P PMNN
Sbjct: 341 ESSHEFQTKKKRQQMRQADEAAKRQKTQHPQPHGRLPPIQQTGQPHPQIRPGQPMNNPHA 400
Query: 360 PVPGGPGHHHYGKPRGPPGGANRYPS-GNQSGGYNNPNRGGQGGGYSNAPY 409
P+ GPG HHY KPRG PGG++RYP GNQ GGY N G GG Y NAPY
Sbjct: 401 PMAAGPG-HHYAKPRG-PGGSSRYPQGGNQGGGYPNRGGQGGGGSYGNAPY 449
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q6ZAG3|CDKC3_ORYSJ Cyclin-dependent kinase C-3 OS=Oryza sativa subsp. japonica GN=CDKC-1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 348 bits (892), Expect = 7e-95, Method: Compositional matrix adjust.
Identities = 177/287 (61%), Positives = 213/287 (74%), Gaps = 10/287 (3%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A +I TGE ALKKI++D+ KEGFP +REIK+LKKL HEN+I+LKEIV SPG
Sbjct: 44 AMDIITGERAALKKIKLDDGKEGFPRQILREIKLLKKLDHENIIRLKEIVVSPGTAHGAG 103
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVP-QIKCYMKQLLTGLHYCHVNQVL 120
G D YRG YMVFEYMDHDL + L + P Q+K YM+QLL GLHYCHVN VL
Sbjct: 104 G-SDDYMYRGDIYMVFEYMDHDL-----KKVLHHSTPSQVKYYMEQLLKGLHYCHVNNVL 157
Query: 121 HRDIKGSNLLIDNEGNL-KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGP 179
HRDIKG+NLLI G L KLADFGLAR F+ D + TN VITLWYRPPELLLGAT Y
Sbjct: 158 HRDIKGANLLISGGGKLLKLADFGLARPFTRD--GSFTNHVITLWYRPPELLLGATNYAE 215
Query: 180 AVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239
AVD+WSVGCIFAE L KP+ PG+ E EQLSKIFELCG P+E WPGVSK+P Y +P+
Sbjct: 216 AVDIWSVGCIFAEFLLRKPLFPGRTEQEQLSKIFELCGFPNEENWPGVSKLPLYKTIRPT 275
Query: 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286
KRR+R++F +FD HA++L+++ML+L+P++RISA DAL + YF T
Sbjct: 276 TPTKRRLRDIFHNFDSHAVDLIDRMLILNPTERISAHDALCAAYFIT 322
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q69ZA1|CDK13_MOUSE Cyclin-dependent kinase 13 OS=Mus musculus GN=Cdk13 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 338 bits (868), Expect = 4e-92, Method: Compositional matrix adjust.
Identities = 174/376 (46%), Positives = 232/376 (61%), Gaps = 27/376 (7%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
AR+ TGE+VALKK+R+DNEKEGFPITAIREIKIL++L H+++I +KEIVT D++
Sbjct: 722 ARDKDTGEMVALKKVRLDNEKEGFPITAIREIKILRQLTHQSIINMKEIVT------DKE 775
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
D K +G+ Y+VFEYMDHDL GL + + F IK +M+QL+ GL YCH LH
Sbjct: 776 DALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFNENHIKSFMRQLMEGLDYCHKKNFLH 835
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 181
RDIK SN+L++N G +KLADFGLAR +S + + TN+VITLWYRPPELLLG +Y PA+
Sbjct: 836 RDIKCSNILLNNRGQIKLADFGLARLYSSEESRPYTNKVITLWYRPPELLLGEERYTPAI 895
Query: 182 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241
D+WS GCI EL KPI E QL I +CGSP +WP V K+P +N KP +
Sbjct: 896 DVWSCGCILGELFTKKPIFQANQELAQLELISRICGSPCPAVWPDVIKLPYFNTMKPKKQ 955
Query: 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW-TDPLPCDPKSLPKYE 300
+R++RE F AL+L + ML LDPS+R +A+ AL E+ +P P LP ++
Sbjct: 956 YRRKLREEFVFIPAAALDLFDYMLALDPSKRCTAEQALQCEFLRDVEPSKMPPPDLPLWQ 1015
Query: 301 SSHEYQTKKRRQQQRQHEEATKRQKLHHPQ--------------PHGRLPPIQHAGQSHH 346
HE +KKRR +Q+Q + P+ P G LPP Q QS+
Sbjct: 1016 DCHELWSKKRR-RQKQMGMTDDLSTIKAPRKDLSLGLDDSRTNTPQGVLPPAQLKSQSNS 1074
Query: 347 -----WSGPNHPMNNA 357
+GP P+N++
Sbjct: 1075 NVAPVITGPGQPLNHS 1090
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, probably by phosphorylating SRSF1/SF2. Required during hematopoiesis. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|D2H526|CDK12_AILME Cyclin-dependent kinase 12 OS=Ailuropoda melanoleuca GN=CDK12 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 337 bits (863), Expect = 1e-91, Method: Compositional matrix adjust.
Identities = 163/315 (51%), Positives = 213/315 (67%), Gaps = 7/315 (2%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A++ TGE+VALKK+R+DNEKEGFPITAIREIKIL++L H +V+ +KEIVT D+Q
Sbjct: 745 AKDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLIHRSVVNMKEIVT------DKQ 798
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
D K +G+ Y+VFEYMDHDL GL + + F+ IK +MKQL+ GL YCH LH
Sbjct: 799 DALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLMEGLDYCHKKNFLH 858
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 181
RDIK SN+L++N G +KLADFGLAR ++ + + TN+VITLWYRPPELLLG +Y PA+
Sbjct: 859 RDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYTPAI 918
Query: 182 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241
D+WS GCI EL KPI E QL I LCGSP +WP V K+P +N KP +
Sbjct: 919 DVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQ 978
Query: 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP-CDPKSLPKYE 300
+RR+RE F AL+LL+ ML LDPS+R +A+ L S++ L DP LP ++
Sbjct: 979 YRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQSDFLKDVELSKMDPPDLPHWQ 1038
Query: 301 SSHEYQTKKRRQQQR 315
HE +KKRR+Q++
Sbjct: 1039 DCHELWSKKRRRQRQ 1053
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors. Ailuropoda melanoleuca (taxid: 9646) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q14AX6|CDK12_MOUSE Cyclin-dependent kinase 12 OS=Mus musculus GN=Cdk12 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 335 bits (858), Expect = 7e-91, Method: Compositional matrix adjust.
Identities = 162/315 (51%), Positives = 213/315 (67%), Gaps = 7/315 (2%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A++ TGE+VALKK+R+DNEKEGFPITAIREIKIL++L H++V+ +KEIVT D+Q
Sbjct: 740 AKDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLVHQSVVNMKEIVT------DKQ 793
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
D K +G+ Y+VFEYMDHDL GL + + F+ IK +MKQL+ GL YCH LH
Sbjct: 794 DALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLMEGLDYCHKKNFLH 853
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 181
RDIK SN+L++N G +KLADFGLAR ++ + + TN+VITLWYRPPELLLG +Y PA+
Sbjct: 854 RDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYTPAI 913
Query: 182 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241
D+WS GCI EL KPI E QL I LCGSP +WP V K+P +N KP +
Sbjct: 914 DVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQ 973
Query: 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP-CDPKSLPKYE 300
+RR+RE F AL+LL+ ML LDPS+R +A+ L S++ L P LP ++
Sbjct: 974 YRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQSDFLKDVELSKMAPPDLPHWQ 1033
Query: 301 SSHEYQTKKRRQQQR 315
HE +KKRR+Q++
Sbjct: 1034 DCHELWSKKRRRQRQ 1048
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|B5DE93|CDK12_XENTR Cyclin-dependent kinase 12 OS=Xenopus tropicalis GN=cdk12 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 334 bits (857), Expect = 8e-91, Method: Compositional matrix adjust.
Identities = 162/315 (51%), Positives = 213/315 (67%), Gaps = 7/315 (2%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A++ TGE+VALKK+R+DNEKEGFPITAIREIKIL++L H++V+ +KEIVT D+Q
Sbjct: 727 AKDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLIHKSVVNMKEIVT------DKQ 780
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
D K +G+ Y+VFEYMDHDL GL + ++F+ IK +MKQL+ GL YCH LH
Sbjct: 781 DALDFKKDKGAFYLVFEYMDHDLMGLLESGLVQFSEDHIKSFMKQLMEGLEYCHKKNFLH 840
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 181
RDIK SN+L++N G +KLADFGLAR +S + + TN+VITLWYRPPELLLG +Y PA+
Sbjct: 841 RDIKCSNILLNNSGQIKLADFGLARLYSSEESRPYTNKVITLWYRPPELLLGEERYTPAI 900
Query: 182 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241
D+WS GCI EL KPI E QL I LCGSP +WP V K+P +N KP +
Sbjct: 901 DVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQ 960
Query: 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW-TDPLPCDPKSLPKYE 300
+RR+RE F AL+LL+ ML LDPS+R +A+ L S++ D LP ++
Sbjct: 961 YRRRLREEFSFVPTPALDLLDHMLTLDPSKRCTAEQTLQSDFLKDVDVCKMATPDLPHWQ 1020
Query: 301 SSHEYQTKKRRQQQR 315
HE +KKRR+Q++
Sbjct: 1021 DCHELWSKKRRRQRQ 1035
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit rpb1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating srsf1/sf2. Xenopus tropicalis (taxid: 8364) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q9NYV4|CDK12_HUMAN Cyclin-dependent kinase 12 OS=Homo sapiens GN=CDK12 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 334 bits (857), Expect = 9e-91, Method: Compositional matrix adjust.
Identities = 162/315 (51%), Positives = 212/315 (67%), Gaps = 7/315 (2%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A++ TGE+VALKK+R+DNEKEGFPITAIREIKIL++L H +V+ +KEIVT D+Q
Sbjct: 744 AKDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLIHRSVVNMKEIVT------DKQ 797
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
D K +G+ Y+VFEYMDHDL GL + + F+ IK +MKQL+ GL YCH LH
Sbjct: 798 DALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLMEGLEYCHKKNFLH 857
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 181
RDIK SN+L++N G +KLADFGLAR ++ + + TN+VITLWYRPPELLLG +Y PA+
Sbjct: 858 RDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYTPAI 917
Query: 182 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241
D+WS GCI EL KPI E QL I LCGSP +WP V K+P +N KP +
Sbjct: 918 DVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQ 977
Query: 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP-CDPKSLPKYE 300
+RR+RE F AL+LL+ ML LDPS+R +A+ L S++ L P LP ++
Sbjct: 978 YRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQSDFLKDVELSKMAPPDLPHWQ 1037
Query: 301 SSHEYQTKKRRQQQR 315
HE +KKRR+Q++
Sbjct: 1038 DCHELWSKKRRRQRQ 1052
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 472 | ||||||
| 225435987 | 517 | PREDICTED: cyclin-dependent kinase C-1-l | 0.997 | 0.911 | 0.809 | 0.0 | |
| 255553496 | 516 | ATP binding protein, putative [Ricinus c | 0.997 | 0.912 | 0.792 | 0.0 | |
| 15238114 | 505 | cyclin-dependent kinase C-1 [Arabidopsis | 0.968 | 0.904 | 0.791 | 0.0 | |
| 356501366 | 516 | PREDICTED: cyclin-dependent kinase C-2-l | 0.997 | 0.912 | 0.786 | 0.0 | |
| 350537283 | 512 | cyclin dependent kinase C [Solanum lycop | 0.995 | 0.917 | 0.778 | 0.0 | |
| 297794099 | 514 | cyclin-dependent kinase C_2 [Arabidopsis | 0.976 | 0.896 | 0.788 | 0.0 | |
| 297811129 | 505 | cyclin-dependent kinase C_1 [Arabidopsis | 0.970 | 0.906 | 0.778 | 0.0 | |
| 15238314 | 513 | cyclin-dependent kinase C-2 [Arabidopsis | 0.974 | 0.896 | 0.775 | 0.0 | |
| 17064746 | 513 | cdc2-like protein kinase [Arabidopsis th | 0.974 | 0.896 | 0.773 | 0.0 | |
| 356574675 | 520 | PREDICTED: cyclin-dependent kinase C-1-l | 0.997 | 0.905 | 0.779 | 0.0 |
| >gi|225435987|ref|XP_002272429.1| PREDICTED: cyclin-dependent kinase C-1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 740 bits (1911), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/478 (80%), Positives = 419/478 (87%), Gaps = 7/478 (1%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
MAREIKTGEIVALKKIRMDNE+EGFPITAIREIKILKKL HENVIKLKEIVTSPGPE+D+
Sbjct: 41 MAREIKTGEIVALKKIRMDNEREGFPITAIREIKILKKLHHENVIKLKEIVTSPGPEKDD 100
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
QGRPDGNKY+G YMVFEYMDHDLTGLADRPG+RF+VPQIKCYM+QLLTGLHYCHVNQVL
Sbjct: 101 QGRPDGNKYKGGIYMVFEYMDHDLTGLADRPGMRFSVPQIKCYMRQLLTGLHYCHVNQVL 160
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 180
HRDIKGSNLLIDNEGNLKLADFGLARSFS DHN LTNRVITLWYRPPELLLG T+YGPA
Sbjct: 161 HRDIKGSNLLIDNEGNLKLADFGLARSFSNDHNGNLTNRVITLWYRPPELLLGTTRYGPA 220
Query: 181 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240
VDMWSVGCIFAELL+GKPI PGK+E EQL+KIFELCG+PDE WPGVSK+P Y++FKP+R
Sbjct: 221 VDMWSVGCIFAELLHGKPIFPGKDEPEQLNKIFELCGAPDEVNWPGVSKIPWYSNFKPTR 280
Query: 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYE 300
MKRR+REVFRHFDRHALELLE+ML LDPSQRISAKDALD+EYFWTDPLPCDPKSLPKYE
Sbjct: 281 PMKRRLREVFRHFDRHALELLERMLTLDPSQRISAKDALDAEYFWTDPLPCDPKSLPKYE 340
Query: 301 SSHEYQTKKRRQQQRQHEEATKRQKLHHPQPHGRLPPIQHAGQSHHW--SGPNHPMN-NA 357
SSHE+QTKK+RQQQRQH+E KRQKL HPQ H RLPPIQ +GQ H +GPN PM+ +
Sbjct: 341 SSHEFQTKKKRQQQRQHDETAKRQKLQHPQQHARLPPIQQSGQVHAQMRAGPNQPMHGGS 400
Query: 358 PPPVPGGPGHHHYGKPRGPPGGANRYP-SGNQSGGYNNPNR--GGQGGGYSNAPYPPQGR 414
PPV GP HHYGKPRGP GG +RYP SGN SGGYN+PNR G GGGY N P+PPQGR
Sbjct: 401 QPPVAAGPS-HHYGKPRGPSGGPSRYPQSGNPSGGYNHPNRGGQGGGGGYGNGPFPPQGR 459
Query: 415 GPPYAGAGMPANGPRGPASGYGVGPQSYSQSGQYGNSAAGRGPNQMGGSRNQQYGWQQ 472
GPPYA +GMP GPRG SGYGVG +Y Q G Y S AGRG N MGG+RNQ YGWQQ
Sbjct: 460 GPPYASSGMPGAGPRGGGSGYGVGAPNYPQGGPYSGSGAGRGSNMMGGNRNQNYGWQQ 517
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255553496|ref|XP_002517789.1| ATP binding protein, putative [Ricinus communis] gi|223543061|gb|EEF44596.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 739 bits (1907), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/477 (79%), Positives = 411/477 (86%), Gaps = 6/477 (1%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
MAREIKT EIVALKKIRMDNE+EGFPITAIREIKILKKL HENVIKLKEIVTSPG E+DE
Sbjct: 41 MAREIKTNEIVALKKIRMDNEREGFPITAIREIKILKKLHHENVIKLKEIVTSPGSEKDE 100
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
QG+PDGNKY+G YMVFEYMDHDLTGLADRPG++F+VPQIKCYM+QLLTGLHYCHVNQVL
Sbjct: 101 QGKPDGNKYKGGIYMVFEYMDHDLTGLADRPGMKFSVPQIKCYMRQLLTGLHYCHVNQVL 160
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 180
HRDIKGSNLLIDNEGNLKLADFGLARSFS +HN LTNRVITLWYRPPELLLG TKYGPA
Sbjct: 161 HRDIKGSNLLIDNEGNLKLADFGLARSFSNEHNANLTNRVITLWYRPPELLLGTTKYGPA 220
Query: 181 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240
VDMWSVGCIFAELL GKPI PGK+E EQ++KIFELCG+PDE WPGVSKMP YN+FKP+R
Sbjct: 221 VDMWSVGCIFAELLYGKPIFPGKDEPEQINKIFELCGAPDEVNWPGVSKMPWYNNFKPNR 280
Query: 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYE 300
MKRR+R++FR FDRHALELLEKML LDPSQRISAKDALD+EYFWTDPLPCDPKSLPKYE
Sbjct: 281 PMKRRLRDLFRGFDRHALELLEKMLTLDPSQRISAKDALDAEYFWTDPLPCDPKSLPKYE 340
Query: 301 SSHEYQTKKRRQQQRQHEEATKRQKLHHPQPHGRLPPIQHAGQSH--HWSGPNHPMNNAP 358
SSHE+QTKK+RQQQRQHEE KRQKL HPQ HGRLPPIQ +GQ+H SGPN M+++
Sbjct: 341 SSHEFQTKKKRQQQRQHEENAKRQKLQHPQQHGRLPPIQQSGQAHVQMRSGPNQQMHSSQ 400
Query: 359 PPVPGGPGHHHYGKPRGPPGGANRYPSGNQSGGYNNPNR---GGQGGGYSNAPYPPQGRG 415
PV GP HHYGKPRGP GG RYP SGGYN+PNR GG GGGY + PYPPQGR
Sbjct: 401 APVAAGPS-HHYGKPRGPAGGPGRYPPSGTSGGYNHPNRGGGGGGGGGYGSGPYPPQGRA 459
Query: 416 PPYAGAGMPANGPRGPASGYGVGPQSYSQSGQYGNSAAGRGPNQMGGSRNQQYGWQQ 472
PPY +GMP G +SGYGVG +Y Q YG+S AGRG N MGG+RNQQYGWQQ
Sbjct: 460 PPYGSSGMPGAPRGGGSSGYGVGAPNYPQGAPYGSSGAGRGSNMMGGNRNQQYGWQQ 516
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15238114|ref|NP_196589.1| cyclin-dependent kinase C-1 [Arabidopsis thaliana] gi|75334961|sp|Q9LFT8.1|CDKC1_ARATH RecName: Full=Cyclin-dependent kinase C-1; Short=CDKC;1 gi|14030693|gb|AAK53021.1|AF375437_1 AT5g10270/F18D22_40 [Arabidopsis thaliana] gi|8953408|emb|CAB96683.1| cdc2-like protein kinase [Arabidopsis thaliana] gi|21464557|gb|AAM52233.1| AT5g10270/F18D22_40 [Arabidopsis thaliana] gi|332004132|gb|AED91515.1| cyclin-dependent kinase C-1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 738 bits (1905), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 379/479 (79%), Positives = 411/479 (85%), Gaps = 22/479 (4%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
MA+EIKTGEIVALKKIRMDNE+EGFPITAIREIKILKKL HENVI+LKEIVTSPG +RD+
Sbjct: 42 MAKEIKTGEIVALKKIRMDNEREGFPITAIREIKILKKLHHENVIQLKEIVTSPGRDRDD 101
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
QG+PD NKY+G YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL
Sbjct: 102 QGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 161
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 180
HRDIKGSNLLIDNEGNLKLADFGLARS+S+DH LTNRVITLWYRPPELLLGATKYGPA
Sbjct: 162 HRDIKGSNLLIDNEGNLKLADFGLARSYSHDHTGNLTNRVITLWYRPPELLLGATKYGPA 221
Query: 181 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240
+DMWSVGCIFAELL+ KPILPGKNE EQL+KIFELCGSPDE +WPGVSKMP +N+FKP+R
Sbjct: 222 IDMWSVGCIFAELLHAKPILPGKNEQEQLNKIFELCGSPDEKLWPGVSKMPWFNNFKPAR 281
Query: 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYE 300
+KRRVRE FRHFDRHALELLEKML+LDP+QRISAKDALD+EYFWTDPLPCDPKSLP YE
Sbjct: 282 PLKRRVREFFRHFDRHALELLEKMLVLDPAQRISAKDALDAEYFWTDPLPCDPKSLPTYE 341
Query: 301 SSHEYQTKKRRQQQRQHEEATKRQKLHH-PQPHGRLPPIQHAGQSH---HW-SGPNHPMN 355
SSHE+QTKK+RQQQRQ+EEA KRQKL H P H RLPP+QH GQSH HW +GPNHP N
Sbjct: 342 SSHEFQTKKKRQQQRQNEEAAKRQKLQHPPLQHSRLPPLQHGGQSHAAPHWPAGPNHPTN 401
Query: 356 NAPPPVPGGPGHHHYGKPRGPPGGANRY-PSGNQSGGYNNPNRGGQGGGYSNAPYPPQGR 414
NAPP VP GP H+ YGKPRGPP G NRY PSGNQSGGYN GGYS+ YPPQGR
Sbjct: 402 NAPPQVPAGPSHNFYGKPRGPP-GPNRYPPSGNQSGGYNQSR-----GGYSSGSYPPQGR 455
Query: 415 GPPYAGAGMPANGPRGPASG-YGVGPQSYSQSGQYGNSAAGRGPNQMGGSRNQQYGWQQ 472
G PY GPRGP+ G YGVGP +Y+Q GQYG S + + RNQQYGWQQ
Sbjct: 456 GAPYVA------GPRGPSGGPYGVGPPNYTQGGQYGGSGSS---GRGQNQRNQQYGWQQ 505
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356501366|ref|XP_003519496.1| PREDICTED: cyclin-dependent kinase C-2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 731 bits (1888), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/477 (78%), Positives = 406/477 (85%), Gaps = 6/477 (1%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
MA+EIKTGEIVALKKIRMDNE+EGFPITAIREIKILKKL HENVIKLKEIVTS GPE+DE
Sbjct: 41 MAKEIKTGEIVALKKIRMDNEREGFPITAIREIKILKKLHHENVIKLKEIVTSQGPEKDE 100
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
QG+PDGNKY+G YMVFEYMDHDLTGLADRPG+RFTVPQIKCYM+QLLTGLHYCHVNQVL
Sbjct: 101 QGKPDGNKYKGGIYMVFEYMDHDLTGLADRPGMRFTVPQIKCYMRQLLTGLHYCHVNQVL 160
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 180
HRDIKGSNLLIDNEGNLKLADFGLARSFS D N LTNRVITLWYRPPELLLG TKYGPA
Sbjct: 161 HRDIKGSNLLIDNEGNLKLADFGLARSFSNDQNANLTNRVITLWYRPPELLLGTTKYGPA 220
Query: 181 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240
VDMWSVGCIFAELL GKPI PGK+E EQL+KI+ELCG+P+E WPGVSK+P YN F P+R
Sbjct: 221 VDMWSVGCIFAELLQGKPIFPGKDEPEQLNKIYELCGAPNEVNWPGVSKIPYYNKFMPTR 280
Query: 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYE 300
MKRR+R+VFRHFD HALELLEKML LDPSQRI+AKDALD+EYFWTDPLPCDPKSLPKYE
Sbjct: 281 PMKRRLRDVFRHFDHHALELLEKMLTLDPSQRITAKDALDAEYFWTDPLPCDPKSLPKYE 340
Query: 301 SSHEYQTKKRRQQQRQHEEATKRQKLHHPQPHGRLPPIQHAGQ-SHHWSGPNHPMNNAPP 359
SSHE+QTKK+RQQQRQ+EE KRQK+ HPQPH RLPPIQ GQ + SGPN P++ + P
Sbjct: 341 SSHEFQTKKKRQQQRQNEEMAKRQKMQHPQPHTRLPPIQQPGQHAQMRSGPNQPIHGSQP 400
Query: 360 PVPGGPGHHHYGKPRGPPGGANRY-PSGNQSGGYNNPNRGGQ-GGGYSNAPYPPQGRGPP 417
V GP HHYGKPRGP GG RY P+GN GGY++PNR GQ G GY + PYPPQGRG P
Sbjct: 401 QVSAGP-THHYGKPRGPSGGPGRYPPNGNPGGGYSHPNRAGQGGSGYGSGPYPPQGRGAP 459
Query: 418 YAGAGMPANGPRGP-ASGYGVGPQSYSQSGQYGNSAAGRGPNQMGGSRN-QQYGWQQ 472
Y MP GPRG ASGY P Q G YG SAAGRG N MGG+RN QQYGWQQ
Sbjct: 460 YGSNSMPGGGPRGSGASGYVGAPNYPQQGGPYGGSAAGRGSNMMGGNRNQQQYGWQQ 516
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|350537283|ref|NP_001234799.1| cyclin dependent kinase C [Solanum lycopersicum] gi|15215944|emb|CAC51391.1| cyclin dependent kinase C [Solanum lycopersicum] | Back alignment and taxonomy information |
|---|
Score = 731 bits (1886), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 369/474 (77%), Positives = 399/474 (84%), Gaps = 4/474 (0%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
MAR+ +TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKL EIVTS GPE DE
Sbjct: 41 MARDKQTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLLEIVTSQGPEEDE 100
Query: 61 QGR--PDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 118
+ D NKY+G+ YMVFEYMDHDLTGLADRPGLRFT+PQIKCYMKQLLTGLHYCH+NQ
Sbjct: 101 PEKLGIDSNKYKGNIYMVFEYMDHDLTGLADRPGLRFTIPQIKCYMKQLLTGLHYCHINQ 160
Query: 119 VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYG 178
VLHRDIKGSNLLIDNEGNLKLADFGLARSFS DHN LTNRVITLWYRPPELLLGATKYG
Sbjct: 161 VLHRDIKGSNLLIDNEGNLKLADFGLARSFSGDHNANLTNRVITLWYRPPELLLGATKYG 220
Query: 179 PAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238
PAVDMWSVGCIFAELL GKPILPGKNE EQL+KIFELCG+PDE WPGVSK+P Y+ FKP
Sbjct: 221 PAVDMWSVGCIFAELLFGKPILPGKNEPEQLNKIFELCGTPDEINWPGVSKIPWYSKFKP 280
Query: 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPK 298
+R MKRRVREVFRHFDRHAL+LL+KML LDPSQRI AKDALD EYFWTDPLPCDP+SLPK
Sbjct: 281 ARPMKRRVREVFRHFDRHALDLLDKMLNLDPSQRICAKDALDGEYFWTDPLPCDPRSLPK 340
Query: 299 YESSHEYQTKKRRQQQRQHEEATKRQKLHHPQPHGRLPPIQHAGQSHHWSGPNHPMNNAP 358
YESSHE+QTKK+RQQQRQ+EE KR KL HPQ H RLPPIQ G S HW G H M+N+
Sbjct: 341 YESSHEFQTKKKRQQQRQNEEMAKRHKLQHPQQHSRLPPIQQPGHSQHWGGSTHQMSNSQ 400
Query: 359 PPVPGGPGHHHYGKPRGPPGGANRYPSGNQSGGYNNPNRGGQGGGYSNAPYPPQGRGPPY 418
P + G GHH +GKPRG GG+NRYP G GG +RG QGGGYS+ YPPQGR PP+
Sbjct: 401 PAISAGAGHHQFGKPRG-TGGSNRYPPGGNPGGGYYQDRGAQGGGYSSGAYPPQGRAPPF 459
Query: 419 AGAGMPANGPRGPASGYGVGPQSYSQSGQYGNSAAGRGPNQMGGSRNQQYGWQQ 472
G+G+ A SG GP +YSQSGQYG S AGRG NQM G+RNQQYGWQQ
Sbjct: 460 PGSGL-APSGPRGPSGGYGGPPNYSQSGQYGGSGAGRGSNQMSGNRNQQYGWQQ 512
|
Source: Solanum lycopersicum Species: Solanum lycopersicum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297794099|ref|XP_002864934.1| cyclin-dependent kinase C_2 [Arabidopsis lyrata subsp. lyrata] gi|297310769|gb|EFH41193.1| cyclin-dependent kinase C_2 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 730 bits (1884), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/483 (78%), Positives = 411/483 (85%), Gaps = 22/483 (4%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
MA+EIKTGEIVALKKIRMDNE+EGFPITAIREIKILKKL HENVI LKEIVTSPG +RD+
Sbjct: 42 MAKEIKTGEIVALKKIRMDNEREGFPITAIREIKILKKLHHENVIHLKEIVTSPGRDRDD 101
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
QG+PD NKY+G YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL
Sbjct: 102 QGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 161
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 180
HRDIKGSNLLIDNEGNLKLADFGLARSFS+DH+ LTNRVITLWYRPPELLLGATKYGPA
Sbjct: 162 HRDIKGSNLLIDNEGNLKLADFGLARSFSHDHSGNLTNRVITLWYRPPELLLGATKYGPA 221
Query: 181 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240
+DMWSVGCIFAELLNGKPILPGK E+EQL+KI+ELCGSPDE WPGVSKMP Y K SR
Sbjct: 222 IDMWSVGCIFAELLNGKPILPGKTESEQLNKIYELCGSPDENNWPGVSKMPWYGQMKSSR 281
Query: 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYE 300
+KRRVRE++RHFDRHALELLEKML+LDP+QRISAKDALD+EYFWTDPLPCDPKSLP YE
Sbjct: 282 PLKRRVREIYRHFDRHALELLEKMLVLDPAQRISAKDALDAEYFWTDPLPCDPKSLPTYE 341
Query: 301 SSHEYQTKKRRQQQRQHEEATKRQKLHH-PQPHGRLPPIQH-AGQSH---HW-SGPNHPM 354
SSHE+QTKK+RQQ R +EEA K+QKL H PQ H RLPP QH GQSH HW +GPNHPM
Sbjct: 342 SSHEFQTKKKRQQMRHNEEAAKKQKLQHPPQQHSRLPPQQHGVGQSHAAPHWPAGPNHPM 401
Query: 355 -NNAPPP-VP-GGPGHHHYGKPRGPPGGANRY-PSGNQSGGYNNPNRGGQGGGYSNAPYP 410
NNAPPP +P GGPG H+YGKPRG G NRY PSGNQ GGYNN +R GGYSN YP
Sbjct: 402 NNNAPPPQIPAGGPGGHYYGKPRGGAPGQNRYPPSGNQPGGYNNQSR----GGYSNGAYP 457
Query: 411 PQGRGPPYAGAGMPANGPRGPASGYGVGP--QSYSQSGQYGNSAAGRGPNQMGGSRNQQY 468
PQGRG PYA GPRGP+ GYGVGP S G+ +GRG N MGG+RNQQY
Sbjct: 458 PQGRGAPYAA------GPRGPSGGYGVGPPNYSQGGGQYGGSGGSGRGQNPMGGARNQQY 511
Query: 469 GWQ 471
GWQ
Sbjct: 512 GWQ 514
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297811129|ref|XP_002873448.1| cyclin-dependent kinase C_1 [Arabidopsis lyrata subsp. lyrata] gi|297319285|gb|EFH49707.1| cyclin-dependent kinase C_1 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 728 bits (1879), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 372/478 (77%), Positives = 397/478 (83%), Gaps = 20/478 (4%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
MA+EIKTGEIVALKKIRMDNE+EGFPITAIREIKILKKL HENVI+LKEIVTSPG +RD+
Sbjct: 42 MAKEIKTGEIVALKKIRMDNEREGFPITAIREIKILKKLHHENVIQLKEIVTSPGRDRDD 101
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
QG+PD NKY+G YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL
Sbjct: 102 QGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 161
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 180
HRDIKGSNLLIDNEGNLKLADFGLARSFS+DH+ LTNRVITLWYRPPELLLGATKYGPA
Sbjct: 162 HRDIKGSNLLIDNEGNLKLADFGLARSFSHDHSGNLTNRVITLWYRPPELLLGATKYGPA 221
Query: 181 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240
+DMWSVGCIFAELL+ KPILPGKNE EQL+KIFELCGSPDE IWPGVSKMP YN+FKP+R
Sbjct: 222 IDMWSVGCIFAELLHAKPILPGKNEQEQLNKIFELCGSPDENIWPGVSKMPWYNNFKPAR 281
Query: 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYE 300
+KRRVRE FRHFDRHALELLEKML+LDPSQRISAKDALD+EYFWTDPLPCDPKSLP YE
Sbjct: 282 PLKRRVREFFRHFDRHALELLEKMLVLDPSQRISAKDALDAEYFWTDPLPCDPKSLPTYE 341
Query: 301 SSHEYQTKKRRQQQRQHEEATKRQKLHH-PQPHGRLPPIQHAGQSH---HW-SGPNHPMN 355
SSHE+QTKK+RQQQRQ+EEA KRQK+ H PQ H RLPP+QH GQSH HW +GPNHP N
Sbjct: 342 SSHEFQTKKKRQQQRQNEEAAKRQKVQHPPQQHSRLPPLQHGGQSHAAPHWPAGPNHPTN 401
Query: 356 NAPPPVPGGPGHHHYGKPRGPPGGANRY-PSGNQSGGYNNPNRGGQGGGYSNAPYPPQGR 414
NAPP VP GP HH YGKPRGPP G NRY PSGNQSGGYN GGYS+ YPPQGR
Sbjct: 402 NAPPQVPAGPSHHFYGKPRGPP-GPNRYPPSGNQSGGYNQSR-----GGYSSGSYPPQGR 455
Query: 415 GPPYAGAGMPANGPRGPASGYGVGPQSYSQSGQYGNSAAGRGPNQMGGSRNQQYGWQQ 472
G PY GPR G Q G + RNQQYGWQQ
Sbjct: 456 GAPYVA------GPR--GPSGGGYGVGPPNYTQGGQYGGSGSSGRGQNPRNQQYGWQQ 505
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15238314|ref|NP_201301.1| cyclin-dependent kinase C-2 [Arabidopsis thaliana] gi|152013386|sp|Q8W4P1.2|CDKC2_ARATH RecName: Full=Cyclin-dependent kinase C-2; Short=CDKC;2 gi|13430444|gb|AAK25844.1|AF360134_1 putative cdc2 protein kinase [Arabidopsis thaliana] gi|8843760|dbj|BAA97308.1| cdc2-like protein kinase [Arabidopsis thaliana] gi|14532732|gb|AAK64067.1| putative cdc2 protein kinase [Arabidopsis thaliana] gi|332010592|gb|AED97975.1| cyclin-dependent kinase C-2 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 714 bits (1844), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/482 (77%), Positives = 406/482 (84%), Gaps = 22/482 (4%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
MA+EIKTGEIVALKKIRMDNE+EGFPITAIREIKILKKL HENVI LKEIVTSPG +RD+
Sbjct: 42 MAKEIKTGEIVALKKIRMDNEREGFPITAIREIKILKKLHHENVIHLKEIVTSPGRDRDD 101
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
QG+PD NKY+G YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL
Sbjct: 102 QGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 161
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 180
HRDIKGSNLLIDNEGNLKLADFGLARS+S+DH LTNRVITLWYRPPELLLGATKYGPA
Sbjct: 162 HRDIKGSNLLIDNEGNLKLADFGLARSYSHDHTGNLTNRVITLWYRPPELLLGATKYGPA 221
Query: 181 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240
+DMWSVGCIFAELLNGKPILPGK E EQL+KI+ELCGSPDE+ WPGVSKMP YN K SR
Sbjct: 222 IDMWSVGCIFAELLNGKPILPGKTENEQLNKIYELCGSPDESNWPGVSKMPWYNQMKSSR 281
Query: 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYE 300
+KRRVRE++RHFDRHALELLEKML+LDPSQRI AKDALD+EYFWTDPLPCDPKSLP YE
Sbjct: 282 PLKRRVREIYRHFDRHALELLEKMLVLDPSQRICAKDALDAEYFWTDPLPCDPKSLPTYE 341
Query: 301 SSHEYQTKKRRQQQRQHEEATKRQKLHHP-QPHGRLPPIQH-AGQSHH---W-SGPNHPM 354
SSHE+QTKK+RQQ R +EEA K+QKL HP Q H RLPP QH GQSH W +GPNHPM
Sbjct: 342 SSHEFQTKKKRQQMRHNEEAAKKQKLQHPQQQHSRLPPQQHGVGQSHAAPLWPAGPNHPM 401
Query: 355 -NNAPPP-VPGGPGHHHYGKPRGPPGGANRY-PSGNQSGGYNNPNRGGQGGGYSNAPYPP 411
NNAPPP +P G GH++ GKPRG NRY PSGNQ+GGYNN +R GGYS+ YPP
Sbjct: 402 NNNAPPPQIPAG-GHYYGGKPRGGAPVPNRYPPSGNQTGGYNNQSR----GGYSSGAYPP 456
Query: 412 QGRGPPYAGAGMPANGPRGPASGYGVGP--QSYSQSGQYGNSAAGRGPNQMGGSRNQQYG 469
QGRG PY GPRGP+ GYGVGP S G+ +GRG N MGG+RNQQYG
Sbjct: 457 QGRGAPYGA------GPRGPSGGYGVGPPNYSQGGGQYGGSGGSGRGQNPMGGARNQQYG 510
Query: 470 WQ 471
WQ
Sbjct: 511 WQ 512
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|17064746|gb|AAL32527.1| cdc2-like protein kinase [Arabidopsis thaliana] gi|27311919|gb|AAO00925.1| cdc2-like protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 712 bits (1837), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/482 (77%), Positives = 405/482 (84%), Gaps = 22/482 (4%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
MA+EIKTGEIVALKKIRMDNE+EGFPITAIREIKILKKL HENVI LKEIVTSPG +RD+
Sbjct: 42 MAKEIKTGEIVALKKIRMDNEREGFPITAIREIKILKKLHHENVIHLKEIVTSPGRDRDD 101
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
QG+PD NKY+G YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL
Sbjct: 102 QGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 161
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 180
HRDIKGSNLLIDNEGNLKLADFGLAR +S+DH LTNRVITLWYRPPELLLGATKYGPA
Sbjct: 162 HRDIKGSNLLIDNEGNLKLADFGLARPYSHDHTGNLTNRVITLWYRPPELLLGATKYGPA 221
Query: 181 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240
+DMWSVGCIFAELLNGKPILPGK E EQL+KI+ELCGSPDE+ WPGVSKMP YN K SR
Sbjct: 222 IDMWSVGCIFAELLNGKPILPGKTENEQLNKIYELCGSPDESNWPGVSKMPWYNQMKSSR 281
Query: 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYE 300
+KRRVRE++RHFDRHALELLEKML+LDPSQRI AKDALD+EYFWTDPLPCDPKSLP YE
Sbjct: 282 PLKRRVREIYRHFDRHALELLEKMLVLDPSQRICAKDALDAEYFWTDPLPCDPKSLPTYE 341
Query: 301 SSHEYQTKKRRQQQRQHEEATKRQKLHHP-QPHGRLPPIQH-AGQSHH---W-SGPNHPM 354
SSHE+QTKK+RQQ R +EEA K+QKL HP Q H RLPP QH GQSH W +GPNHPM
Sbjct: 342 SSHEFQTKKKRQQMRHNEEAAKKQKLQHPQQQHSRLPPQQHGVGQSHAAPLWPAGPNHPM 401
Query: 355 -NNAPPP-VPGGPGHHHYGKPRGPPGGANRY-PSGNQSGGYNNPNRGGQGGGYSNAPYPP 411
NNAPPP +P G GH++ GKPRG NRY PSGNQ+GGYNN +R GGYS+ YPP
Sbjct: 402 NNNAPPPQIPAG-GHYYGGKPRGGAPVPNRYPPSGNQTGGYNNQSR----GGYSSGAYPP 456
Query: 412 QGRGPPYAGAGMPANGPRGPASGYGVGP--QSYSQSGQYGNSAAGRGPNQMGGSRNQQYG 469
QGRG PY GPRGP+ GYGVGP S G+ +GRG N MGG+RNQQYG
Sbjct: 457 QGRGAPYGA------GPRGPSGGYGVGPPNYSQGGGQYGGSGGSGRGQNPMGGARNQQYG 510
Query: 470 WQ 471
WQ
Sbjct: 511 WQ 512
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356574675|ref|XP_003555471.1| PREDICTED: cyclin-dependent kinase C-1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 698 bits (1802), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/481 (77%), Positives = 403/481 (83%), Gaps = 10/481 (2%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
MAREIKTGEIVALKKIRMDNE+EGFPITAIREIKILKKL HENVI LKEIVTSPGPE+DE
Sbjct: 41 MAREIKTGEIVALKKIRMDNEREGFPITAIREIKILKKLHHENVINLKEIVTSPGPEKDE 100
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
QGRPDGNKY+G YMVFEYMDHDLTGLADRPG+RFTVPQIKCYM+QLLTGLHYCHVNQVL
Sbjct: 101 QGRPDGNKYKGGIYMVFEYMDHDLTGLADRPGMRFTVPQIKCYMRQLLTGLHYCHVNQVL 160
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 180
HRDIKGSNLLIDNEGNLKLADFGLARSFS +HN LTNRVITLWYRPPELLLG T+YGPA
Sbjct: 161 HRDIKGSNLLIDNEGNLKLADFGLARSFSNEHNANLTNRVITLWYRPPELLLGTTRYGPA 220
Query: 181 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240
VDMWSVGCIFAELL+GKPI PGK+E EQL+KIFELCG+PDE WPGVSK P YN FKP+R
Sbjct: 221 VDMWSVGCIFAELLHGKPIFPGKDEPEQLNKIFELCGAPDEVNWPGVSKTPWYNQFKPTR 280
Query: 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYE 300
MKRR+REVFRHFDRHALELLEKML LD +QRI+AKDALD+EYFWTDPLPCDPKSLPKYE
Sbjct: 281 PMKRRLREVFRHFDRHALELLEKMLTLDLAQRITAKDALDAEYFWTDPLPCDPKSLPKYE 340
Query: 301 SSHEYQTKKRRQQQRQHEEATKRQKLHHPQPHGRLPPIQHAGQSH--HWSGPNHPMNNAP 358
SSHE+QTKK+RQQQRQ+EE KR K+ HPQ H RLPPIQ AGQ H GPNHP++ +
Sbjct: 341 SSHEFQTKKKRQQQRQNEENAKRLKMQHPQQHTRLPPIQQAGQQHPQMRQGPNHPIHGSQ 400
Query: 359 PPVPGGPGHHHYGKPRGPPGGANR-YPSGNQSGGYNNPNRGGQ--GGGYSNAPYPPQGRG 415
P V GP HHYGKPRGP GG R GN GGYN+PNR GQ G GY + PYPPQGRG
Sbjct: 401 PAVAAGPS-HHYGKPRGPSGGPGRYPSGGNSGGGYNHPNRAGQGGGSGYGSGPYPPQGRG 459
Query: 416 PPYAGAGMPANGPRGPASGYGVGPQ----SYSQSGQYGNSAAGRGPNQMGGSRNQQYGWQ 471
PY +GMP GP G G G +Y Q YG SAAGRG N MGG+RNQQYGWQ
Sbjct: 460 APYGSSGMPGGPSGGPRGGGGSGYGVGAPNYPQGAPYGGSAAGRGSNMMGGNRNQQYGWQ 519
Query: 472 Q 472
Q
Sbjct: 520 Q 520
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 472 | ||||||
| TAIR|locus:2177744 | 513 | CDKC2 "cyclin dependent kinase | 0.730 | 0.672 | 0.844 | 8.9e-182 | |
| TAIR|locus:2145397 | 505 | CDKC;1 "cyclin-dependent kinas | 0.735 | 0.687 | 0.843 | 1.8e-181 | |
| DICTYBASE|DDB_G0273721 | 694 | cdk9-2 "CDK family protein kin | 0.713 | 0.485 | 0.535 | 6.6e-102 | |
| DICTYBASE|DDB_G0273207 | 694 | cdk9-1 "CDK family protein kin | 0.713 | 0.485 | 0.535 | 6.6e-102 | |
| ZFIN|ZDB-GENE-030131-4975 | 1289 | cdk13 "cyclin-dependent kinase | 0.665 | 0.243 | 0.495 | 1.7e-83 | |
| TAIR|locus:2152740 | 580 | AT5G50860 [Arabidopsis thalian | 0.616 | 0.501 | 0.538 | 1.9e-83 | |
| TAIR|locus:2158715 | 644 | AT5G44290 [Arabidopsis thalian | 0.682 | 0.5 | 0.495 | 3.1e-83 | |
| RGD|621111 | 1484 | Cdk12 "cyclin-dependent kinase | 0.639 | 0.203 | 0.514 | 5.7e-83 | |
| UNIPROTKB|Q3MJK5 | 1484 | Cdk12 "Cyclin-dependent kinase | 0.639 | 0.203 | 0.514 | 5.7e-83 | |
| TAIR|locus:2012643 | 614 | AT1G33770 [Arabidopsis thalian | 0.616 | 0.473 | 0.532 | 1e-82 |
| TAIR|locus:2177744 CDKC2 "cyclin dependent kinase group C2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1570 (557.7 bits), Expect = 8.9e-182, Sum P(2) = 8.9e-182
Identities = 293/347 (84%), Positives = 313/347 (90%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
MA+EIKTGEIVALKKIRMDNE+EGFPITAIREIKILKKL HENVI LKEIVTSPG +RD+
Sbjct: 42 MAKEIKTGEIVALKKIRMDNEREGFPITAIREIKILKKLHHENVIHLKEIVTSPGRDRDD 101
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
QG+PD NKY+G YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL
Sbjct: 102 QGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 161
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 180
HRDIKGSNLLIDNEGNLKLADFGLARS+S+DH LTNRVITLWYRPPELLLGATKYGPA
Sbjct: 162 HRDIKGSNLLIDNEGNLKLADFGLARSYSHDHTGNLTNRVITLWYRPPELLLGATKYGPA 221
Query: 181 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240
+DMWSVGCIFAELLNGKPILPGK E EQL+KI+ELCGSPDE+ WPGVSKMP YN K SR
Sbjct: 222 IDMWSVGCIFAELLNGKPILPGKTENEQLNKIYELCGSPDESNWPGVSKMPWYNQMKSSR 281
Query: 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYE 300
+KRRVRE++RHFDRHALELLEKML+LDPSQRI AKDALD+EYFWTDPLPCDPKSLP YE
Sbjct: 282 PLKRRVREIYRHFDRHALELLEKMLVLDPSQRICAKDALDAEYFWTDPLPCDPKSLPTYE 341
Query: 301 SSHEYQTKKXXXXXXXHEEATKRQKLHHPQP-HGRLPPIQHA-GQSH 345
SSHE+QTKK +EEA K+QKL HPQ H RLPP QH GQSH
Sbjct: 342 SSHEFQTKKKRQQMRHNEEAAKKQKLQHPQQQHSRLPPQQHGVGQSH 388
|
|
| TAIR|locus:2145397 CDKC;1 "cyclin-dependent kinase C;1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1600 (568.3 bits), Expect = 1.8e-181, Sum P(2) = 1.8e-181
Identities = 296/351 (84%), Positives = 319/351 (90%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
MA+EIKTGEIVALKKIRMDNE+EGFPITAIREIKILKKL HENVI+LKEIVTSPG +RD+
Sbjct: 42 MAKEIKTGEIVALKKIRMDNEREGFPITAIREIKILKKLHHENVIQLKEIVTSPGRDRDD 101
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
QG+PD NKY+G YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL
Sbjct: 102 QGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 161
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 180
HRDIKGSNLLIDNEGNLKLADFGLARS+S+DH LTNRVITLWYRPPELLLGATKYGPA
Sbjct: 162 HRDIKGSNLLIDNEGNLKLADFGLARSYSHDHTGNLTNRVITLWYRPPELLLGATKYGPA 221
Query: 181 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240
+DMWSVGCIFAELL+ KPILPGKNE EQL+KIFELCGSPDE +WPGVSKMP +N+FKP+R
Sbjct: 222 IDMWSVGCIFAELLHAKPILPGKNEQEQLNKIFELCGSPDEKLWPGVSKMPWFNNFKPAR 281
Query: 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYE 300
+KRRVRE FRHFDRHALELLEKML+LDP+QRISAKDALD+EYFWTDPLPCDPKSLP YE
Sbjct: 282 PLKRRVREFFRHFDRHALELLEKMLVLDPAQRISAKDALDAEYFWTDPLPCDPKSLPTYE 341
Query: 301 SSHEYQTKKXXXXXXXHEEATKRQKLHHPQ-PHGRLPPIQHAGQSH---HW 347
SSHE+QTKK +EEA KRQKL HP H RLPP+QH GQSH HW
Sbjct: 342 SSHEFQTKKKRQQQRQNEEAAKRQKLQHPPLQHSRLPPLQHGGQSHAAPHW 392
|
|
| DICTYBASE|DDB_G0273721 cdk9-2 "CDK family protein kinase 9" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 974 (347.9 bits), Expect = 6.6e-102, Sum P(2) = 6.6e-102
Identities = 190/355 (53%), Positives = 240/355 (67%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A+ G+IVALKK+ MDNE EGFPITAIREIKILK+L H NV+ LKE+VTS
Sbjct: 226 AKNKSNGDIVALKKVIMDNEVEGFPITAIREIKILKELNHANVVNLKEVVTSKASA---- 281
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVP-QIKCYMKQLLTGLHYCHVNQVL 120
N ++GS YMVFEYMDHDL GL D P ++ P QIKCY+KQLL GL YCH N VL
Sbjct: 282 ----SNNHKGSVYMVFEYMDHDLNGLMDSPAFKYFAPGQIKCYLKQLLEGLDYCHRNNVL 337
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSF-SYDHNNTLTNRVITLWYRPPELLLGATKYGP 179
HRDIKGSNLL+DN G LKLADFGLAR F S + LTNRVITLWYRPPELLLG YGP
Sbjct: 338 HRDIKGSNLLLDNNGILKLADFGLARPFNSSEKKQILTNRVITLWYRPPELLLGTFHYGP 397
Query: 180 AVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239
+DMWSVGCI AELL+ K + PG+N +QL KI+++CGSP+ WP +P ++ KP
Sbjct: 398 EIDMWSVGCIMAELLSKKTLFPGRNSIDQLDKIYQVCGSPNANNWPEAMDLPFWDALKPK 457
Query: 240 RTMKR-RVREVFRH-----FDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDP 293
R +++ ++H F + A +LL+K+L +DP +RI+A +ALD +YFWTDP+P +P
Sbjct: 458 REYNSLSLKDFYQHENPSFFTKEAFDLLDKLLCMDPKKRITASEALDHQYFWTDPMPVNP 517
Query: 294 KSLPKYESSHEYQTKKXXXXXXXHEEATKRQKLHHPQPHGRLPPIQHAGQS--HH 346
K LP+Y S HEY+TKK ++ + Q+ QP + Q+ G + HH
Sbjct: 518 KDLPQYPSCHEYRTKKRLRQQNQNQNQQQNQQQQQQQPQNQHQQSQYQGANVNHH 572
|
|
| DICTYBASE|DDB_G0273207 cdk9-1 "CDK family protein kinase 9" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 974 (347.9 bits), Expect = 6.6e-102, Sum P(2) = 6.6e-102
Identities = 190/355 (53%), Positives = 240/355 (67%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A+ G+IVALKK+ MDNE EGFPITAIREIKILK+L H NV+ LKE+VTS
Sbjct: 226 AKNKSNGDIVALKKVIMDNEVEGFPITAIREIKILKELNHANVVNLKEVVTSKASA---- 281
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVP-QIKCYMKQLLTGLHYCHVNQVL 120
N ++GS YMVFEYMDHDL GL D P ++ P QIKCY+KQLL GL YCH N VL
Sbjct: 282 ----SNNHKGSVYMVFEYMDHDLNGLMDSPAFKYFAPGQIKCYLKQLLEGLDYCHRNNVL 337
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSF-SYDHNNTLTNRVITLWYRPPELLLGATKYGP 179
HRDIKGSNLL+DN G LKLADFGLAR F S + LTNRVITLWYRPPELLLG YGP
Sbjct: 338 HRDIKGSNLLLDNNGILKLADFGLARPFNSSEKKQILTNRVITLWYRPPELLLGTFHYGP 397
Query: 180 AVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239
+DMWSVGCI AELL+ K + PG+N +QL KI+++CGSP+ WP +P ++ KP
Sbjct: 398 EIDMWSVGCIMAELLSKKTLFPGRNSIDQLDKIYQVCGSPNANNWPEAMDLPFWDALKPK 457
Query: 240 RTMKR-RVREVFRH-----FDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDP 293
R +++ ++H F + A +LL+K+L +DP +RI+A +ALD +YFWTDP+P +P
Sbjct: 458 REYNSLSLKDFYQHENPSFFTKEAFDLLDKLLCMDPKKRITASEALDHQYFWTDPMPVNP 517
Query: 294 KSLPKYESSHEYQTKKXXXXXXXHEEATKRQKLHHPQPHGRLPPIQHAGQS--HH 346
K LP+Y S HEY+TKK ++ + Q+ QP + Q+ G + HH
Sbjct: 518 KDLPQYPSCHEYRTKKRLRQQNQNQNQQQNQQQQQQQPQNQHQQSQYQGANVNHH 572
|
|
| ZFIN|ZDB-GENE-030131-4975 cdk13 "cyclin-dependent kinase 13" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 808 (289.5 bits), Expect = 1.7e-83, Sum P(2) = 1.7e-83
Identities = 159/321 (49%), Positives = 210/321 (65%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A++ T E+VALKK+R+DNEKEGFPITAIREIKIL++L H+++I +KEIVT D++
Sbjct: 611 AKDKDTAELVALKKVRLDNEKEGFPITAIREIKILRQLNHKSIINMKEIVT------DKE 664
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
D +G+ Y+VFEYMDHDL GL + + F IK +M+QLL GL YCH LH
Sbjct: 665 DALDFKNDKGAFYLVFEYMDHDLMGLLESGLVHFNESHIKSFMRQLLEGLDYCHKKNFLH 724
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 181
RDIK SN+L++N+G +KLADFGLAR ++ + + TN+VITLWYRPPELLLG +Y PA+
Sbjct: 725 RDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYTPAI 784
Query: 182 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241
D+WS GCI EL KPI E QL I +CGSP +WP V K+P +N KP +
Sbjct: 785 DVWSCGCILGELFTKKPIFQANQELAQLELISRICGSPCPAVWPDVIKLPYFNTMKPKKQ 844
Query: 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW-TDPLPCDPKSLPKYE 300
+RR+RE F AL+L + ML LDPS+R +A+ AL+S++ DP P LP ++
Sbjct: 845 YRRRLREEFAFIPLMALDLFDHMLALDPSKRCTAEQALNSDFLRDVDPAKMPPPDLPLWQ 904
Query: 301 SSHEYQTKKXXXXXXXHEEAT 321
HE +KK EE T
Sbjct: 905 DCHELWSKKRRRQKQMPEELT 925
|
|
| TAIR|locus:2152740 AT5G50860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 836 (299.3 bits), Expect = 1.9e-83, P = 1.9e-83
Identities = 166/308 (53%), Positives = 213/308 (69%)
Query: 2 AREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
A+++ +G+IVALKK+R DN E E A REI +L++L H NVIKL+ +VTS
Sbjct: 131 AKDLLSGKIVALKKVRFDNLEAESVKFMA-REILVLRRLNHPNVIKLQGLVTS------- 182
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
+ S Y+VFEYM+HDL+GLA GL+F +PQ+KC+MKQLL+GL +CH VL
Sbjct: 183 -------RVSCSLYLVFEYMEHDLSGLAATQGLKFDLPQVKCFMKQLLSGLEHCHSRGVL 235
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 180
HRDIKGSNLLIDN+G LK+ADFGLA + T+T+RV+TLWYRPPELLLGAT YG
Sbjct: 236 HRDIKGSNLLIDNDGILKIADFGLATFYDPKQKQTMTSRVVTLWYRPPELLLGATSYGTG 295
Query: 181 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240
VD+WS GCI AELL GKP++PG+ E EQL KIF+LCGSP ++ W ++P FKP
Sbjct: 296 VDLWSAGCIMAELLAGKPVMPGRTEVEQLHKIFKLCGSPSDSYWKKY-RLPNATLFKPQH 354
Query: 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYE 300
KR V E F F ++ L+E +L +DP+ R ++ AL+SE+F T+PLPCDP SLPKY
Sbjct: 355 PYKRCVAEAFNGFTPSSVHLVETLLTIDPADRGTSTSALNSEFFTTEPLPCDPSSLPKYP 414
Query: 301 SSHEYQTK 308
S E K
Sbjct: 415 PSKELNVK 422
|
|
| TAIR|locus:2158715 AT5G44290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 812 (290.9 bits), Expect = 3.1e-83, Sum P(2) = 3.1e-83
Identities = 170/343 (49%), Positives = 220/343 (64%)
Query: 2 AREIKTGEIVALKKIRMD-NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
AR++ +IVALK++R D ++ E A REI ++++L H NV+KL+ ++T+
Sbjct: 154 ARDLTNNKIVALKRVRFDLSDLESVKFMA-REIIVMRRLDHPNVLKLEGLITA------- 205
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
S Y+VFEYMDHDL GLA PG++F+ PQ+KCYM+QLL+GLH+CH VL
Sbjct: 206 -------SVSSSLYLVFEYMDHDLVGLASIPGIKFSEPQVKCYMQQLLSGLHHCHSRGVL 258
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 180
HRDIKGSNLLID+ G LK+ADFGLA F + LT+RV+TLWYRPPELLLGA YG
Sbjct: 259 HRDIKGSNLLIDSNGVLKIADFGLATFFDPQNCVPLTSRVVTLWYRPPELLLGACHYGVG 318
Query: 181 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240
VD+WS GCI EL +GKPIL GK E EQL KIF+LCGSP E W + K+P F+P+
Sbjct: 319 VDLWSTGCILGELYSGKPILAGKTEVEQLHKIFKLCGSPTEDYWRKL-KLPPSAAFRPAL 377
Query: 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYE 300
RRV E+F+ + L LLE +L +DP +R SA AL+SEYF T+P CDP SLPKY
Sbjct: 378 PYGRRVAEMFKDLPTNVLSLLEALLSIDPDRRGSAARALESEYFRTEPFACDPSSLPKYP 437
Query: 301 SSHEYQTKKXXXXXXXH--EEATKRQKLHHPQPHGR--LPPIQ 339
S E K +E +RQ + H R +PP++
Sbjct: 438 PSKEIDAKIRDDAKRQRPTQEKHERQDSQTRRSHERKLIPPVK 480
|
|
| RGD|621111 Cdk12 "cyclin-dependent kinase 12" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 803 (287.7 bits), Expect = 5.7e-83, Sum P(3) = 5.7e-83
Identities = 159/309 (51%), Positives = 207/309 (66%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A++ TGE+VALKK+R+DNEKEGFPITAIREIKIL++L H++V+ +KEIVT D+Q
Sbjct: 740 AKDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLVHQSVVNMKEIVT------DKQ 793
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
D K +G+ Y+VFEYMDHDL GL + + F+ IK +MKQL+ GL YCH LH
Sbjct: 794 DALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLMEGLDYCHKKNFLH 853
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 181
RDIK SN+L++N G +KLADFGLAR ++ + + TN+VITLWYRPPELLLG +Y PA+
Sbjct: 854 RDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYTPAI 913
Query: 182 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241
D+WS GCI EL KPI E QL I LCGSP +WP V K+P +N KP +
Sbjct: 914 DVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQ 973
Query: 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP-CDPKSLPKYE 300
+RR+RE F AL+LL+ ML LDPS+R +A+ L S++ L P LP ++
Sbjct: 974 YRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQSDFLKDVELSKMAPPDLPHWQ 1033
Query: 301 SSHEYQTKK 309
HE +KK
Sbjct: 1034 DCHELWSKK 1042
|
|
| UNIPROTKB|Q3MJK5 Cdk12 "Cyclin-dependent kinase 12" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 803 (287.7 bits), Expect = 5.7e-83, Sum P(3) = 5.7e-83
Identities = 159/309 (51%), Positives = 207/309 (66%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A++ TGE+VALKK+R+DNEKEGFPITAIREIKIL++L H++V+ +KEIVT D+Q
Sbjct: 740 AKDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLVHQSVVNMKEIVT------DKQ 793
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
D K +G+ Y+VFEYMDHDL GL + + F+ IK +MKQL+ GL YCH LH
Sbjct: 794 DALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLMEGLDYCHKKNFLH 853
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 181
RDIK SN+L++N G +KLADFGLAR ++ + + TN+VITLWYRPPELLLG +Y PA+
Sbjct: 854 RDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYTPAI 913
Query: 182 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241
D+WS GCI EL KPI E QL I LCGSP +WP V K+P +N KP +
Sbjct: 914 DVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQ 973
Query: 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP-CDPKSLPKYE 300
+RR+RE F AL+LL+ ML LDPS+R +A+ L S++ L P LP ++
Sbjct: 974 YRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQSDFLKDVELSKMAPPDLPHWQ 1033
Query: 301 SSHEYQTKK 309
HE +KK
Sbjct: 1034 DCHELWSKK 1042
|
|
| TAIR|locus:2012643 AT1G33770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 829 (296.9 bits), Expect = 1.0e-82, P = 1.0e-82
Identities = 164/308 (53%), Positives = 214/308 (69%)
Query: 2 AREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
AR+++TG+IVA+KK+R N + E A REI IL+KL H NV+KL+ +VTS
Sbjct: 158 ARDLETGKIVAMKKVRFANMDPESVRFMA-REINILRKLDHPNVMKLQCLVTS------- 209
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
K GS ++VFEYM+HDL+GLA RPG++FT PQIKC+MKQLL GL +CH +L
Sbjct: 210 -------KLSGSLHLVFEYMEHDLSGLALRPGVKFTEPQIKCFMKQLLCGLEHCHSRGIL 262
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 180
HRDIKGSNLL++N+G LK+ DFGLA + D + LT+RV+TLWYR PELLLG+T+YGPA
Sbjct: 263 HRDIKGSNLLVNNDGVLKIGDFGLASFYKPDQDQPLTSRVVTLWYRAPELLLGSTEYGPA 322
Query: 181 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240
+D+WSVGCI AEL KPI+PG+ E EQ+ KIF+LCGSP E W +K P +KP
Sbjct: 323 IDLWSVGCILAELFVCKPIMPGRTEVEQMHKIFKLCGSPSEEFW-NTTKFPQATSYKPQH 381
Query: 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYE 300
KR + E F++ +L+LL+K+L ++P +R SA L SE+F T+PLPC SLPKY
Sbjct: 382 PYKRVLLETFKNLSSSSLDLLDKLLSVEPEKRCSASSTLLSEFFTTEPLPCHISSLPKYP 441
Query: 301 SSHEYQTK 308
S E K
Sbjct: 442 PSKELDAK 449
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8W4P1 | CDKC2_ARATH | 2, ., 7, ., 1, 1, ., 2, 3 | 0.7759 | 0.9745 | 0.8966 | no | no |
| Q9LFT8 | CDKC1_ARATH | 2, ., 7, ., 1, 1, ., 2, 3 | 0.7912 | 0.9682 | 0.9049 | yes | no |
| Q5JK68 | CDKC2_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 3 | 0.7824 | 0.9872 | 0.9083 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.22 | 0.979 |
| 3rd Layer | 2.7.11.23 | 0.979 |
| 3rd Layer | 2.7.11 | 0.983 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 472 | |||
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 0.0 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-144 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-131 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-128 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-128 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-127 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-127 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-113 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-111 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-104 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-102 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-99 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-95 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-93 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-92 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-91 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-91 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-87 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-87 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-85 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-83 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-82 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-80 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-78 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-73 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-73 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-73 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-72 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-71 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-70 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-69 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-69 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-68 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-68 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-67 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-65 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-65 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-61 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-61 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-60 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-58 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-58 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-58 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-56 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-56 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-56 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-55 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-54 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-54 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-50 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-49 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-48 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-48 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-46 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-43 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-43 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-40 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-40 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-38 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-38 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-37 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-36 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-35 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-34 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-34 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-33 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-32 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-31 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-30 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-30 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-26 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-26 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-25 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-25 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-25 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-24 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-24 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-24 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-22 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-20 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-20 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-19 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-19 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-19 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-19 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-18 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-18 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-18 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-18 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-18 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-17 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-17 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-16 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-16 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-16 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-16 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-16 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-15 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-15 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-15 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-14 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-14 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-14 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-14 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-14 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-14 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-13 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-13 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 9e-13 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-12 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-12 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-12 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-12 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-12 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-11 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-11 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-10 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-10 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-10 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-10 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-09 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-09 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-09 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-09 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-09 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-09 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-09 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 8e-09 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 9e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-08 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-08 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-08 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 9e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-07 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-07 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-07 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-07 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-07 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-06 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-06 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-05 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-05 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-05 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-05 | |
| pfam06682 | 317 | pfam06682, DUF1183, Protein of unknown function (D | 3e-04 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 8e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.001 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 0.001 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.001 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 0.001 | |
| pfam03276 | 582 | pfam03276, Gag_spuma, Spumavirus gag protein | 0.001 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 0.001 | |
| pfam02084 | 239 | pfam02084, Bindin, Bindin | 0.001 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 0.002 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 0.002 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 0.003 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 0.003 | |
| pfam07415 | 489 | pfam07415, Herpes_LMP2, Gammaherpesvirus latent me | 0.003 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 527 bits (1359), Expect = 0.0
Identities = 187/285 (65%), Positives = 218/285 (76%), Gaps = 15/285 (5%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
AR KTGE+VALKKIRM+NEKEGFPITAIREIK+L+KL+H N+++LKEIVTS G
Sbjct: 17 KARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG----- 71
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
+GS YMVFEYMDHDLTGL D P ++FT QIKCYMKQLL GL Y H N +L
Sbjct: 72 ---------KGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGIL 122
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 180
HRDIKGSN+LI+N+G LKLADFGLAR ++ ++ TNRVITLWYRPPELLLGAT+YGP
Sbjct: 123 HRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPE 182
Query: 181 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240
VDMWSVGCI AEL GKPI G E EQL KIFELCGSP + WPGVSK+P + + KP +
Sbjct: 183 VDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKK 242
Query: 241 TMKRRVREVFRHF-DRHALELLEKMLMLDPSQRISAKDALDSEYF 284
KRR+RE F+H D AL+LL+K+L LDP +RISA AL EYF
Sbjct: 243 PYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 414 bits (1066), Expect = e-144
Identities = 137/283 (48%), Positives = 185/283 (65%), Gaps = 18/283 (6%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
AR+ KTGEIVALKKIR+DNE+EG P TA+REI +LK+L+H N++KL +++ +
Sbjct: 18 ARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER------ 71
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
Y+VFEY D DL D+ + IK M QLL GL YCH +++LH
Sbjct: 72 ----------KLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILH 121
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 181
RD+K N+LI+ +G LKLADFGLAR+F T T+ V+TLWYR PE+LLG+ Y AV
Sbjct: 122 RDLKPQNILINRDGVLKLADFGLARAFGIP-LRTYTHEVVTLWYRAPEILLGSKHYSTAV 180
Query: 182 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241
D+WSVGCIFAE++ GKP+ PG +E +QL KIF++ G+P E WPGV+K+P Y P
Sbjct: 181 DIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFP 240
Query: 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
+ + +V D ++LL KML +P++RISAK+AL YF
Sbjct: 241 -PKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 380 bits (979), Expect = e-131
Identities = 140/289 (48%), Positives = 187/289 (64%), Gaps = 25/289 (8%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
AR+ KTGEIVALKK++M+ EKEGFPIT++REI IL KLQH N++ +KE+V
Sbjct: 24 ARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVV--------- 74
Query: 62 GRPDGNKYRGST----YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 117
GS YMV EY++HDL L + F ++KC M QLL+G+ + H N
Sbjct: 75 ---------GSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN 125
Query: 118 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 177
+LHRD+K SNLL++N G LK+ DFGLAR + T V+TLWYR PELLLGA +Y
Sbjct: 126 WILHRDLKTSNLLLNNRGILKICDFGLAREYG-SPLKPYTQLVVTLWYRAPELLLGAKEY 184
Query: 178 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237
A+DMWSVGCIFAELL KP+ PGK+E +QL+KIF+L G+P E IWPG S++P
Sbjct: 185 STAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKT 244
Query: 238 PSRTMKRRVREVFRHF--DRHALELLEKMLMLDPSQRISAKDALDSEYF 284
++ ++R+ F + +LL ++L DP++RISA+DAL YF
Sbjct: 245 FTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 375 bits (964), Expect = e-128
Identities = 147/295 (49%), Positives = 188/295 (63%), Gaps = 22/295 (7%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
AR+IKTG +VALKKI M NEK+GFPITA+REIKILKKL+H NV+ L ++ + +
Sbjct: 27 ARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
RGS YMV YMDHDL+GL + P ++ T QIKCYM QLL G++Y H N +LH
Sbjct: 87 --------RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILH 138
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT------------LTNRVITLWYRPPE 169
RDIK +N+LIDN+G LK+ADFGLAR YD TN V+T WYRPPE
Sbjct: 139 RDIKAANILIDNQGILKIADFGLARP--YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPE 196
Query: 170 LLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 229
LLLG +Y AVD+W +GC+FAE+ +PIL GK++ +QL IF+LCG+P E WPG
Sbjct: 197 LLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRS 256
Query: 230 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
+P R + E F L+LL K+L LDP +R++A DAL+ YF
Sbjct: 257 LPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 372 bits (958), Expect = e-128
Identities = 135/299 (45%), Positives = 185/299 (61%), Gaps = 22/299 (7%)
Query: 2 AREIKTGEIVALKKIRMDNEKE---GFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 58
AR+ +TG IVA+KKI++ KE G TA+REIK+L++L+H N+I L ++
Sbjct: 19 ARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH----- 73
Query: 59 DEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 118
+ + +VFE+M+ DL + + T IK YM L GL Y H N
Sbjct: 74 -----------KSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW 122
Query: 119 VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYG 178
+LHRD+K +NLLI ++G LKLADFGLARSF + +T++V+T WYR PELL GA YG
Sbjct: 123 ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK-MTHQVVTRWYRAPELLFGARHYG 181
Query: 179 PAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238
VDMWSVGCIFAELL P LPG ++ +QL KIFE G+P E WPGV+ +P Y FKP
Sbjct: 182 VGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKP 241
Query: 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLP 297
++++F AL+LL+++L L+P++RI+A+ AL+ YF DP P P LP
Sbjct: 242 FP--PTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPPSQLP 298
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 372 bits (958), Expect = e-127
Identities = 147/288 (51%), Positives = 197/288 (68%), Gaps = 13/288 (4%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
AR KT +IVALKK+ M+NEKEGFPITA+REIKIL+ L+HENV+ L EI +
Sbjct: 31 ARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP---- 86
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
N+Y+GS Y+VFE+ +HDL GL ++FT+ +IK MK LL GL+Y H N++LH
Sbjct: 87 ----YNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILH 142
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHN---NTLTNRVITLWYRPPELLLGATKYG 178
RD+K +N+LI +G LKLADFGLAR+FS N N TNRV+TLWYRPPELLLG YG
Sbjct: 143 RDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYG 202
Query: 179 PAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238
P +DMW GCI AE+ PI+ G E QL+ I +LCGS +WPGV K+ + +
Sbjct: 203 PPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMEL 262
Query: 239 SRTMKRRVREVFRHF--DRHALELLEKMLMLDPSQRISAKDALDSEYF 284
+ KR+V+E + + D HAL+L++K+L+LDP++RI A AL+ ++F
Sbjct: 263 PQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 371 bits (953), Expect = e-127
Identities = 156/282 (55%), Positives = 200/282 (70%), Gaps = 6/282 (2%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
AR+ TGE+VALKK+R+DNEKEGFPITAIREIKIL++L H N++ LKEIVT D+Q
Sbjct: 26 ARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVT------DKQ 79
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
D K +G+ Y+VFEYMDHDL GL + + F+ IK +MKQLL GL+YCH LH
Sbjct: 80 DALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLH 139
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 181
RDIK SN+L++N+G +KLADFGLAR ++ + + TN+VITLWYRPPELLLG +YGPA+
Sbjct: 140 RDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAI 199
Query: 182 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241
D+WS GCI EL KPI E QL I LCGSP +WP V K+P +N KP +
Sbjct: 200 DVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQ 259
Query: 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 283
+RR+RE F AL+LL+ ML LDPS+R +A++AL+S +
Sbjct: 260 YRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 335 bits (861), Expect = e-113
Identities = 142/302 (47%), Positives = 194/302 (64%), Gaps = 23/302 (7%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
AR+ +GEIVALKK+RMDNE++G PI+++REI +L L+H N+++LKE+V G D
Sbjct: 26 ARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVV--GKHLD-- 81
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
S ++V EY + DL L D F+ Q+KC M QLL GL Y H N ++H
Sbjct: 82 ----------SIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIH 131
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 181
RD+K SNLL+ ++G LK+ADFGLAR++ +T +V+TLWYR PELLLG T Y A+
Sbjct: 132 RDLKVSNLLLTDKGCLKIADFGLARTYGL-PAKPMTPKVVTLWYRAPELLLGCTTYTTAI 190
Query: 182 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK---- 237
DMW+VGCI AELL KP+LPGK+E EQL I +L G+P+E+IWPG S +P F
Sbjct: 191 DMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQ 250
Query: 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLP 297
P +K + F L LL +LM DP +R +A++AL+S YF PLPC+P+ +P
Sbjct: 251 PYNNLKHK----FPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEPEMMP 306
Query: 298 KY 299
+
Sbjct: 307 TF 308
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 330 bits (849), Expect = e-111
Identities = 141/286 (49%), Positives = 189/286 (66%), Gaps = 23/286 (8%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
AR+ TGEIVALKKIR++ E EG P TAIREI +LK+L H N+++L ++V S
Sbjct: 18 ARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS-------- 69
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
NK Y+VFE++D DL D P P IK Y+ QLL G+ YCH ++VL
Sbjct: 70 ----ENKL----YLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVL 121
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 180
HRD+K NLLID EG LKLADFGLAR+F T T+ V+TLWYR PE+LLG+ +Y
Sbjct: 122 HRDLKPQNLLIDREGALKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGSRQYSTP 180
Query: 181 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS- 239
VD+WS+GCIFAE++N +P+ PG +E +QL +IF G+PDE +WPGV+ +P Y KP+
Sbjct: 181 VDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY---KPTF 237
Query: 240 -RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
+ ++ + +V + D L+LL KML+ DP++RISAK AL YF
Sbjct: 238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 311 bits (799), Expect = e-104
Identities = 126/289 (43%), Positives = 177/289 (61%), Gaps = 26/289 (8%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
A++ +TGE VALKK+ + + G P A+REIK L+ QH V+KL ++
Sbjct: 18 KAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF--------- 68
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTGL---ADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 117
P G +V EYM DL+ + +RP Q+K YM+ LL G+ Y H N
Sbjct: 69 ---PHG----SGFVLVMEYMPSDLSEVLRDEERP---LPEAQVKSYMRMLLKGVAYMHAN 118
Query: 118 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 177
++HRD+K +NLLI +G LK+ADFGLAR FS + +++V T WYR PELL GA KY
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKY 178
Query: 178 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN--H 235
P VD+W+VGCIFAELLNG P+ PG+N+ EQL+ +F G+P+E WPG++ +P YN
Sbjct: 179 DPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT 238
Query: 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
F S+ + + E+F AL+LL+ +L+ DPS+R+SA +AL YF
Sbjct: 239 FPESKPI--PLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 309 bits (793), Expect = e-102
Identities = 128/321 (39%), Positives = 186/321 (57%), Gaps = 44/321 (13%)
Query: 2 AREIKTGEIVALKKIRMDNEKE------------GFPITAIREIKILKKLQHENVIKLKE 49
A + TG+IVA+KK+++ G T +RE+KI+ +++HEN++ L +
Sbjct: 28 AYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87
Query: 50 IVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLT 109
+ +V + M DL + DR +R T Q+KC + Q+L
Sbjct: 88 VYVE----------------GDFINLVMDIMASDLKKVVDRK-IRLTESQVKCILLQILN 130
Query: 110 GLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD-------------HNNTL 156
GL+ H +HRD+ +N+ I+++G K+ADFGLAR + Y +
Sbjct: 131 GLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEM 190
Query: 157 TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 216
T++V+TLWYR PELL+GA KY AVDMWSVGCIFAELL GKP+ PG+NE +QL +IFEL
Sbjct: 191 TSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELL 250
Query: 217 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAK 276
G+P+E WP K+P Y F P + ++ +F + A++LL+ +L L+P +RISAK
Sbjct: 251 GTPNEDNWPQAKKLPLYTEFTPR--KPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAK 308
Query: 277 DALDSEYFWTDPLPCDPKSLP 297
+AL EYF +DPLPCDP LP
Sbjct: 309 EALKHEYFKSDPLPCDPSQLP 329
|
Length = 335 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 298 bits (765), Expect = 4e-99
Identities = 130/284 (45%), Positives = 171/284 (60%), Gaps = 17/284 (5%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
AR+ TGEIVA+KKI++ E EG P TA+REIK+LK+L H N+IKL ++
Sbjct: 17 KARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH------- 69
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
+G Y+VFE+MD DL L IK Y+ QLL GL +CH + +L
Sbjct: 70 ---------KGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGIL 120
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 180
HRD+K NLLI+ EG LKLADFGLARSF T+ V+T WYR PELLLG Y
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVR-PYTHYVVTRWYRAPELLLGDKGYSTP 179
Query: 181 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240
VD+WSVGCIFAELL+ +P+ PGK+E +QL KIF G+PD +WP + + F +
Sbjct: 180 VDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPK 239
Query: 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
+ ++F + AL+LL +ML DP +RI+A+ AL YF
Sbjct: 240 KAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 289 bits (742), Expect = 1e-95
Identities = 132/286 (46%), Positives = 179/286 (62%), Gaps = 23/286 (8%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
AR TGE+VALKKIR+D E EG P TAIREI +LK+L H N++KL +++ +
Sbjct: 19 ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-------- 70
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLAD-RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
Y+VFE++ DL D P +P IK Y+ QLL GL +CH ++VL
Sbjct: 71 --------ENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVL 122
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 180
HRD+K NLLI+ EG +KLADFGLAR+F T T+ V+TLWYR PE+LLG Y A
Sbjct: 123 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGCKYYSTA 181
Query: 181 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS- 239
VD+WS+GCIFAE++ + + PG +E +QL +IF G+PDE +WPGV+ +P Y KPS
Sbjct: 182 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY---KPSF 238
Query: 240 -RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
+ ++ +V D +LL +ML DP++RISAK AL +F
Sbjct: 239 PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 284 bits (730), Expect = 1e-93
Identities = 116/289 (40%), Positives = 170/289 (58%), Gaps = 25/289 (8%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ---HENVIKLKEIVTSPGPER 58
AR++ TG VALKK+R+ +EG P++ +REI +LK+L+ H N+++L ++ GP
Sbjct: 18 ARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCH--GPRT 75
Query: 59 DEQGRPDGNKYRGSTYMVFEYMDHDLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCH 115
D + +VFE++D DL + PGL IK M+QLL G+ + H
Sbjct: 76 DREL---------KLTLVFEHVDQDLATYLSKCPKPGL--PPETIKDLMRQLLRGVDFLH 124
Query: 116 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT 175
++++HRD+K N+L+ ++G +K+ADFGLAR Y LT+ V+TLWYR PE+LL ++
Sbjct: 125 SHRIVHRDLKPQNILVTSDGQVKIADFGLARI--YSFEMALTSVVVTLWYRAPEVLLQSS 182
Query: 176 KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235
Y VDMWSVGCIFAEL +P+ G +EA+QL KIF++ G P E WP +P +
Sbjct: 183 -YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP-RSS 240
Query: 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
F R + L+LL+KML +P +RISA +AL YF
Sbjct: 241 FPSYTP--RSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 280 bits (717), Expect = 7e-92
Identities = 127/290 (43%), Positives = 182/290 (62%), Gaps = 30/290 (10%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
R KTG+IVA+KKIR+++E+EG P TAIREI +LK+LQH N++ L++++
Sbjct: 19 GRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE------- 71
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLAD--RPGLRFTVPQIKCYMKQLLTGLHYCHVNQV 119
++ Y++FE++ DL D G +K Y+ Q+L G+ +CH +V
Sbjct: 72 -----SR----LYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRV 122
Query: 120 LHRDIKGSNLLIDNEGNLKLADFGLARSFS-----YDHNNTLTNRVITLWYRPPELLLGA 174
LHRD+K NLLIDN+G +KLADFGLAR+F Y H V+TLWYR PE+LLG+
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH------EVVTLWYRAPEVLLGS 176
Query: 175 TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234
+Y VD+WS+G IFAE+ KP+ G +E +QL +IF + G+P E +WPGV+ +P Y
Sbjct: 177 PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236
Query: 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
+ P K +R ++ D L+LLEKML+ DP++RISAK AL+ YF
Sbjct: 237 NTFPKWK-KGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 279 bits (715), Expect = 1e-91
Identities = 129/280 (46%), Positives = 183/280 (65%), Gaps = 21/280 (7%)
Query: 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDG 66
TGEIVALK+I +D E EG P TAIREI ++K+L+HEN+++L +++ +
Sbjct: 24 TGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTE------------ 70
Query: 67 NKYRGSTYMVFEYMDHDLTGLADRPGLRFTVP--QIKCYMKQLLTGLHYCHVNQVLHRDI 124
NK +VFEYMD DL D G+R + +K + QLL G+ +CH N+VLHRD+
Sbjct: 71 NKL----MLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDL 126
Query: 125 KGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMW 184
K NLLI+ G LKLADFGLAR+F NT +N V+TLWYR P++LLG+ Y ++D+W
Sbjct: 127 KPQNLLINKRGELKLADFGLARAFGIP-VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIW 185
Query: 185 SVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 244
SVGCI AE++ G+P+ PG N +QL KIF + G+P E+ WPG+S++P Y P R +
Sbjct: 186 SVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFP-RYPPQ 244
Query: 245 RVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
++++F H D ++LL ++L L+P RISA DAL +F
Sbjct: 245 DLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 278 bits (712), Expect = 6e-91
Identities = 134/285 (47%), Positives = 183/285 (64%), Gaps = 20/285 (7%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
AR+ T E +ALKKIR++ E EG P TAIREI +LK++QH N+++L+++V S E+
Sbjct: 21 ARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS---EK--- 74
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
Y+VFEY+D DL D P IK Y+ Q+L G+ YCH ++VL
Sbjct: 75 ----------RLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVL 124
Query: 121 HRDIKGSNLLIDNEGN-LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGP 179
HRD+K NLLID N LKLADFGLAR+F T T+ V+TLWYR PE+LLG+ Y
Sbjct: 125 HRDLKPQNLLIDRRTNALKLADFGLARAFGIP-VRTFTHEVVTLWYRAPEILLGSRHYST 183
Query: 180 AVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239
VD+WSVGCIFAE++N KP+ PG +E ++L KIF + G+P+E WPGV+ +P Y P
Sbjct: 184 PVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFP- 242
Query: 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
+ + + V + ++LL KML LDPS+RI+A+ AL+ EYF
Sbjct: 243 KWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287
|
Length = 294 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 269 bits (689), Expect = 1e-87
Identities = 120/281 (42%), Positives = 168/281 (59%), Gaps = 21/281 (7%)
Query: 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDG 66
TG++VALK+IR+ +EG P TAIRE +LK L+H N++ L +I+ +
Sbjct: 29 TGQLVALKEIRL-EHEEGAPFTAIREASLLKDLKHANIVTLHDIIHT------------- 74
Query: 67 NKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKG 126
+ + +VFEY+D DL D G ++ ++ ++ QLL GL YCH +VLHRD+K
Sbjct: 75 ---KKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKP 131
Query: 127 SNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSV 186
NLLI G LKLADFGLAR+ S + T +N V+TLWYRPP++LLG+T+Y ++DMW V
Sbjct: 132 QNLLISERGELKLADFGLARAKSVP-SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGV 190
Query: 187 GCIFAELLNGKPILPG-KNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRR 245
GCIF E+ G+P+ PG + +QL KIF + G+P E WPGVS P + + R
Sbjct: 191 GCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRP 250
Query: 246 VREVFRHFDR--HALELLEKMLMLDPSQRISAKDALDSEYF 284
+ DR H EL K L +P +RISA +A+ YF
Sbjct: 251 LINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 268 bits (688), Expect = 2e-87
Identities = 123/289 (42%), Positives = 171/289 (59%), Gaps = 29/289 (10%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A+ +T EIVALK++R+D++ EG P +A+REI +LK+L+H+N+++L +++ S
Sbjct: 19 AKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS-------- 70
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
+VFEY D DL D +K +M QLL GL +CH + VLH
Sbjct: 71 --------DKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLH 122
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSF-----SYDHNNTLTNRVITLWYRPPELLLGATK 176
RD+K NLLI+ G LKLADFGLAR+F Y V+TLWYRPP++L GA
Sbjct: 123 RDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA------EVVTLWYRPPDVLFGAKL 176
Query: 177 YGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235
Y ++DMWS GCIFAEL N G+P+ PG + +QL +IF L G+P E WPGVSK+P Y
Sbjct: 177 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236
Query: 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
+ V V + +LL+ +L+ +P QRISA++AL YF
Sbjct: 237 YPMYPATTSLVNVVPKLNST-GRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 262 bits (673), Expect = 1e-85
Identities = 99/284 (34%), Positives = 147/284 (51%), Gaps = 48/284 (16%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
AR+ KTG++VA+K I+ K+ +REIKILKKL+H N+++L ++
Sbjct: 18 ARDKKTGKLVAIKVIKKKKIKK-DRERILREIKILKKLKHPNIVRLYDVFEDED------ 70
Query: 62 GRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
Y+V EY + DL L + G R + + + Y++Q+L+ L Y H ++
Sbjct: 71 ----------KLYLVMEYCEGGDLFDLLKKRG-RLSEDEARFYLRQILSALEYLHSKGIV 119
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 180
HRD+K N+L+D +G++KLADFGLAR D LT V T Y PE+LLG YG A
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQL--DPGEKLTTFVGTPEYMAPEVLLG-KGYGKA 176
Query: 181 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240
VD+WS+G I ELL GKP PG + QL ++F+ G P P
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDD---QLLELFKKIGKPKPPFPPPEWD----------- 222
Query: 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
A +L+ K+L+ DP +R++A++AL +F
Sbjct: 223 ------------ISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 258 bits (661), Expect = 3e-83
Identities = 123/291 (42%), Positives = 177/291 (60%), Gaps = 24/291 (8%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHEN-VIKLKEIVTSPGPERDE 60
AR+ TG++VALKK R++ ++EG P TA+REI +L+ L +++L ++ ++
Sbjct: 20 ARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHV----EEK 75
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTGLADR----PGLRFTVPQIKCYMKQLLTGLHYCHV 116
G+P S Y+VFEY+D DL D PG IK +M QLL G+ +CH
Sbjct: 76 NGKP-------SLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK 128
Query: 117 NQVLHRDIKGSNLLIDNEGN-LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT 175
+ V+HRD+K NLL+D + LK+AD GL R+FS + T+ ++TLWYR PE+LLG+T
Sbjct: 129 HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK-SYTHEIVTLWYRAPEVLLGST 187
Query: 176 KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235
Y VD+WSVGCIFAE+ +P+ PG +E +QL IF+L G+P E +WPGVSK+ ++
Sbjct: 188 HYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHE 247
Query: 236 FK--PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
F + + R L+LL+KML DP++RISAK AL YF
Sbjct: 248 FPQWKPQDLSR----AVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 257 bits (660), Expect = 2e-82
Identities = 113/293 (38%), Positives = 167/293 (56%), Gaps = 29/293 (9%)
Query: 2 AREIKTGEIVALKKIRM--DNEKEGFPITA---IREIKILKKLQHENVIKLKEIVTSPGP 56
A + +TG VA+KKI D+ I A +REIK+L+ L+HEN+I L +I+ P P
Sbjct: 19 AVDKRTGRKVAIKKISNVFDD-----LIDAKRILREIKLLRHLRHENIIGLLDILRPPSP 73
Query: 57 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 116
E Y+V E M+ DL + + T I+ ++ Q+L GL Y H
Sbjct: 74 EDFN-----------DVYIVTELMETDLHKVI-KSPQPLTDDHIQYFLYQILRGLKYLHS 121
Query: 117 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT--LTNRVITLWYRPPELLLGA 174
V+HRD+K SN+L+++ +LK+ DFGLAR D + LT V+T WYR PELLL +
Sbjct: 122 ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSS 181
Query: 175 TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSP-DETI-WPGVSKMPA 232
++Y A+D+WSVGCIFAELL KP+ PG++ +QL+ I E+ G+P +E + + K
Sbjct: 182 SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARN 241
Query: 233 Y-NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
Y K+ + ++F A++LLEKML+ DP +RI+A +AL Y
Sbjct: 242 YLKSLPKKP--KKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 250 bits (640), Expect = 2e-80
Identities = 94/285 (32%), Positives = 137/285 (48%), Gaps = 44/285 (15%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A+ TG+IVA+K ++ +EK TA REI+IL++L H N+++L +
Sbjct: 18 AKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKD------ 71
Query: 62 GRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
Y+V EY + DL G + + K Q+L GL Y H N ++
Sbjct: 72 ----------HLYLVMEYCEGGDLFDY-LSRGGPLSEDEAKKIALQILRGLEYLHSNGII 120
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 180
HRD+K N+L+D G +K+ADFGLA+ +++LT V T WY PE+LLG YGP
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179
Query: 181 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE-LCGSPDETIWPGVSKMPAYNHFKPS 239
VD+WS+G I ELL GKP G+N +QL I L + S
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEE------- 232
Query: 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
A +L++K L DPS+R +A++ L +F
Sbjct: 233 -----------------AKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 246 bits (631), Expect = 2e-78
Identities = 112/310 (36%), Positives = 166/310 (53%), Gaps = 49/310 (15%)
Query: 6 KTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 64
K G+ A+KK + D E+ G +A REI +L++L+HENV+ L E+
Sbjct: 25 KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFL------------ 72
Query: 65 DGNKYRGSTYMVFEYMDHDLTGLAD--RPGLRFTVPQ--IKCYMKQLLTGLHYCHVNQVL 120
S Y++F+Y +HDL + R R ++P +K + Q+L G+HY H N VL
Sbjct: 73 --EHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVL 130
Query: 121 HRDIKGSNLLIDNEGN----LKLADFGLARSF------SYDHNNTLTNRVITLWYRPPEL 170
HRD+K +N+L+ EG +K+ D GLAR F D + V+T+WYR PEL
Sbjct: 131 HRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV----VVTIWYRAPEL 186
Query: 171 LLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE---------AEQLSKIFELCGSPDE 221
LLGA Y A+D+W++GCIFAELL +PI G+ +QL +IFE+ G+P E
Sbjct: 187 LLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTE 246
Query: 222 TIWPGVSKMPAYNHFKPSRTMKRR-----VREVFRHFDR--HALELLEKMLMLDPSQRIS 274
WP + KMP Y+ K + + +H +LL K+L DP++RI+
Sbjct: 247 KDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRIT 306
Query: 275 AKDALDSEYF 284
A++AL+ YF
Sbjct: 307 AEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 232 bits (595), Expect = 2e-73
Identities = 101/288 (35%), Positives = 153/288 (53%), Gaps = 24/288 (8%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
R TGEIVA+KK + + E TA+RE+K+L++L+HEN++ LKE
Sbjct: 20 CRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAF---------- 69
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
+ +G Y+VFEY++ L L + ++ Y+ QLL + YCH + ++H
Sbjct: 70 ------RRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIH 123
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 181
RDIK N+L+ G LKL DFG AR+ + LT+ V T WYR PELL+G T YG V
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPV 183
Query: 182 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK---- 237
D+W++GCI AELL+G+P+ PG ++ +QL I + G + S P +
Sbjct: 184 DVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEP 243
Query: 238 -PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
+++RR AL+ L+ L +DP +R++ + L YF
Sbjct: 244 SQPESLERRYPGK---VSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 233 bits (597), Expect = 4e-73
Identities = 111/303 (36%), Positives = 165/303 (54%), Gaps = 50/303 (16%)
Query: 2 AREIKTGEIVALKKI------RMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSP 54
A + +T E+VALKKI D ++ REI L++L H N++KL ++
Sbjct: 26 AIDRRTKEVVALKKIFDAFRNATDAQR------TFREIMFLQELGDHPNIVKLLNVI--- 76
Query: 55 GPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 114
+ + +K Y+VFEYM+ DL + R + V + M QLL L Y
Sbjct: 77 --------KAENDK---DIYLVFEYMETDLHAVI-RANILEDV-HKRYIMYQLLKALKYI 123
Query: 115 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS----YDHNNTLTNRVITLWYRPPEL 170
H V+HRD+K SN+L++++ +KLADFGLARS S N LT+ V T WYR PE+
Sbjct: 124 HSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEI 183
Query: 171 LLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSP-DETI------ 223
LLG+T+Y VDMWSVGCI E+L GKP+ PG + QL KI E+ G P E I
Sbjct: 184 LLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSP 243
Query: 224 --WPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281
+ +P+ +P + + E+ AL+LL+K+L+ +P++R++A++AL+
Sbjct: 244 FAATMLDSLPS----RPRKPLD----ELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295
Query: 282 EYF 284
Y
Sbjct: 296 PYV 298
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 232 bits (592), Expect = 4e-73
Identities = 119/285 (41%), Positives = 169/285 (59%), Gaps = 24/285 (8%)
Query: 3 REIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQG 62
R T +VALK+IR+++E EG P TAIRE+ +LK L+H N++ L +I+ + ER
Sbjct: 25 RSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHT---ER---- 76
Query: 63 RPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHR 122
+VFEY+D DL D G ++ +K +M QLL GL YCH ++LHR
Sbjct: 77 ---------CLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHR 127
Query: 123 DIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVD 182
D+K NLLI+ +G LKLADFGLAR+ S T +N V+TLWYRPP++LLG+T+Y +D
Sbjct: 128 DLKPQNLLINEKGELKLADFGLARAKSVP-TKTYSNEVVTLWYRPPDVLLGSTEYSTPID 186
Query: 183 MWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTM 242
MW VGCI E+ G+P+ PG E+L IF L G+P E WPG++ + F+
Sbjct: 187 MWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT---SNEEFRSYLFP 243
Query: 243 KRRVREVFRH---FDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
+ R + + H D ++LL +L+ + RISA+ AL YF
Sbjct: 244 QYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 230 bits (587), Expect = 3e-72
Identities = 121/281 (43%), Positives = 165/281 (58%), Gaps = 24/281 (8%)
Query: 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDG 66
T +VALK+IR+++E EG P TAIRE+ +LK L+H N++ L +I+ +
Sbjct: 30 TDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHT------------- 75
Query: 67 NKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKG 126
S +VFEY+D DL D G + +K ++ QLL GL+YCH +VLHRD+K
Sbjct: 76 ---EKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKP 132
Query: 127 SNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSV 186
NLLI+ G LKLADFGLAR+ S T +N V+TLWYRPP++LLG+T Y +DMW V
Sbjct: 133 QNLLINERGELKLADFGLARAKSIP-TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGV 191
Query: 187 GCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRV 246
GCIF E+ G+P+ PG EQL IF + G+P E WPG+ + FK K R
Sbjct: 192 GCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL---SNEEFKSYNYPKYRA 248
Query: 247 REVFRH---FDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
+ H D ELL K+L + +RISA++A+ YF
Sbjct: 249 DCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 228 bits (583), Expect = 1e-71
Identities = 107/290 (36%), Positives = 157/290 (54%), Gaps = 29/290 (10%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFP----ITAIREIKILKKLQ-HENVIKLKEIVTSPG 55
+AR +TGE+VA+KK M K+ F +RE+K L+KL H N++KLKE+
Sbjct: 17 LARNKETGELVAIKK--M---KKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFR--- 68
Query: 56 PERDEQGRPDGNKYRGSTYMVFEYMDHDLTGL-ADRPGLRFTVPQIKCYMKQLLTGLHYC 114
E DE Y VFEYM+ +L L DR G F+ I+ + Q+L GL +
Sbjct: 69 -ENDE------------LYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 115 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA 174
H + HRD+K NLL+ +K+ADFGLAR T+ V T WYR PE+LL +
Sbjct: 116 HKHGFFHRDLKPENLLVSGPEVVKIADFGLAREI--RSRPPYTDYVSTRWYRAPEILLRS 173
Query: 175 TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234
T Y VD+W++GCI AEL +P+ PG +E +QL KI + G+P + WP K+ +
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233
Query: 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
F+ + + ++ + A++L++ ML DP +R +A AL YF
Sbjct: 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 224 bits (572), Expect = 7e-70
Identities = 120/286 (41%), Positives = 171/286 (59%), Gaps = 24/286 (8%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
R T +VALK+IR+++E EG P TAIRE+ +LK L+H N++ L +IV +
Sbjct: 25 GRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDK------ 77
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
S +VFEY+D DL D G ++ +K ++ Q+L GL YCH +VLH
Sbjct: 78 ----------SLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLH 127
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 181
RD+K NLLI+ G LKLADFGLAR+ S T +N V+TLWYRPP++LLG+++Y +
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSVP-TKTYSNEVVTLWYRPPDVLLGSSEYSTQI 186
Query: 182 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241
DMW VGCIF E+ +G+P+ PG ++L IF L G+P E WPG+S + + FK
Sbjct: 187 DMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS---SNDEFKNYNF 243
Query: 242 MKRRVREVFRH---FDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
K + + + H D +ELL K L + +RISA++A+ YF
Sbjct: 244 PKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 223 bits (569), Expect = 1e-69
Identities = 125/283 (44%), Positives = 168/283 (59%), Gaps = 27/283 (9%)
Query: 8 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 67
G++VALK I M E EG P TAIRE +LK L+H N++ L +I+ +
Sbjct: 30 GQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHT-------------- 74
Query: 68 KYRGSTYMVFEYMDHDLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKG 126
+ + VFEYM DL + PG ++ +M QLL GL Y H +LHRD+K
Sbjct: 75 --KETLTFVFEYMHTDLAQYMIQHPG-GLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKP 131
Query: 127 SNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSV 186
NLLI G LKLADFGLAR+ S + T ++ V+TLWYRPP++LLGAT Y A+D+W
Sbjct: 132 QNLLISYLGELKLADFGLARAKSIP-SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGA 190
Query: 187 GCIFAELLNGKPILPGKNEA-EQLSKIFELCGSPDETIWPGVSKMPAYNH--FKPSRTMK 243
GCIF E+L G+P PG ++ EQL KI+ + G P E WPGVSK+P Y F P +
Sbjct: 191 GCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKP-- 248
Query: 244 RRVREVFRHFDR--HALELLEKMLMLDPSQRISAKDALDSEYF 284
+++R V++ R A +L +MLM+ P RISA+DAL YF
Sbjct: 249 QQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 222 bits (568), Expect = 1e-69
Identities = 115/289 (39%), Positives = 167/289 (57%), Gaps = 25/289 (8%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ---HENVIKLKEIVTSPGPER 58
AR+ +G VALK +R+ ++G P++ +RE+ +LK+L+ H N+++L ++ + +R
Sbjct: 19 ARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDR 78
Query: 59 DEQGRPDGNKYRGSTYMVFEYMDHDLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCH 115
+ + +VFE++D DL D+ PGL IK M+Q L GL + H
Sbjct: 79 ETK-----------VTLVFEHVDQDLRTYLDKVPPPGL--PAETIKDLMRQFLRGLDFLH 125
Query: 116 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT 175
N ++HRD+K N+L+ + G +KLADFGLAR +S LT V+TLWYR PE+LL +T
Sbjct: 126 ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC--QMALTPVVVTLWYRAPEVLLQST 183
Query: 176 KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235
Y VDMWSVGCIFAE+ KP+ G +EA+QL KIF+L G P E WP +P
Sbjct: 184 -YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGA- 241
Query: 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
F P R V+ V + +LL +ML +P +RISA AL +F
Sbjct: 242 FSPRG--PRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 221 bits (566), Expect = 1e-68
Identities = 117/286 (40%), Positives = 163/286 (56%), Gaps = 18/286 (6%)
Query: 2 AREIKTGEIVALKKIR--MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERD 59
A+ +T E VA+KKI DN + +REIK+L+ L HENVI +K+I+ P E
Sbjct: 24 AKNSETNEKVAIKKIANAFDNRIDA--KRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81
Query: 60 EQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQV 119
Y+V+E MD DL + R + + ++ QLL GL Y H V
Sbjct: 82 N-----------DVYIVYELMDTDLHQII-RSSQTLSDDHCQYFLYQLLRGLKYIHSANV 129
Query: 120 LHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGP 179
LHRD+K SNLL++ +LK+ DFGLAR+ S + +T V+T WYR PELLL ++Y
Sbjct: 130 LHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD-FMTEYVVTRWYRAPELLLNCSEYTT 188
Query: 180 AVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP- 238
A+D+WSVGCIFAELL KP+ PGK+ QL I EL GSP E + A + +
Sbjct: 189 AIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSL 248
Query: 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
T ++ +F H + A++LLEKML+ DPS+RI+ ++AL Y
Sbjct: 249 PYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL 294
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 219 bits (561), Expect = 7e-68
Identities = 104/295 (35%), Positives = 158/295 (53%), Gaps = 33/295 (11%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGF--PITA---IREIKILKKLQHENVIKLKEIVTSPGP 56
A + ++G+ VA+KKI F P A +RE+KIL+ +H+N+I +++I+ PG
Sbjct: 24 AIDTRSGKKVAIKKI-----PHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGA 78
Query: 57 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGL--ADRPGLRFTVPQIKCYMKQLLTGLHYC 114
+ Y+V + M+ DL + +D+P T I+ ++ QLL GL Y
Sbjct: 79 DFK------------DVYVVMDLMESDLHHIIHSDQP---LTEEHIRYFLYQLLRGLKYI 123
Query: 115 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR---SFSYDHNNTLTNRVITLWYRPPELL 171
H V+HRD+K SNLL++ + L++ DFG+AR S +H +T V T WYR PELL
Sbjct: 124 HSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELL 183
Query: 172 LGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 231
L +Y A+DMWSVGCIFAE+L + + PGKN QL I + GSP E + +
Sbjct: 184 LSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243
Query: 232 AYNHFK--PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
+ + P + ++F AL+LL +ML DP +RI+ + AL +
Sbjct: 244 VRKYIQNLPRKQ-PVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 219 bits (561), Expect = 1e-67
Identities = 110/304 (36%), Positives = 160/304 (52%), Gaps = 17/304 (5%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A + KTG VA+KK+ + RE+++LK + HENVI L ++ T D Q
Sbjct: 34 AFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
Y+V M DL + + + I+ + Q+L GL Y H ++H
Sbjct: 94 ----------DVYLVTHLMGADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIHSAGIIH 141
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 181
RD+K SN+ ++ + LK+ DFGLAR + +T V T WYR PE++L Y V
Sbjct: 142 RDLKPSNIAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTV 197
Query: 182 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241
D+WSVGCI AELL GK + PG + +QL +I L G+PDE + +S A N+ +
Sbjct: 198 DIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQ 257
Query: 242 MKRR-VREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYE 300
M ++ +EVF + A++LLEKML+LDP +RI+A +AL Y P D P Y+
Sbjct: 258 MPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPVAPPYD 317
Query: 301 SSHE 304
S E
Sbjct: 318 QSFE 321
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 212 bits (543), Expect = 3e-65
Identities = 109/281 (38%), Positives = 163/281 (58%), Gaps = 19/281 (6%)
Query: 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDG 66
TG VA+KKI E + F +REIKIL++ +HEN+I + +I+ RP
Sbjct: 29 TGVKVAIKKIS-PFEHQTFCQRTLREIKILRRFKHENIIGILDII-----------RPPS 76
Query: 67 NKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKG 126
+ Y+V E M+ DL L L + I+ ++ Q+L GL Y H VLHRD+K
Sbjct: 77 FESFNDVYIVQELMETDLYKLIKTQHL--SNDHIQYFLYQILRGLKYIHSANVLHRDLKP 134
Query: 127 SNLLIDNEGNLKLADFGLARSFSYDHNNT--LTNRVITLWYRPPELLLGATKYGPAVDMW 184
SNLL++ +LK+ DFGLAR +H++T LT V T WYR PE++L + Y A+D+W
Sbjct: 135 SNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIW 194
Query: 185 SVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 244
SVGCI AE+L+ +P+ PGK+ QL+ I + G+P + + + A N+ K S K
Sbjct: 195 SVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIK-SLPFKP 253
Query: 245 RV--REVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 283
+V ++F + D AL+LL+KML +P +RI+ ++AL Y
Sbjct: 254 KVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 211 bits (537), Expect = 7e-65
Identities = 119/283 (42%), Positives = 168/283 (59%), Gaps = 27/283 (9%)
Query: 8 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 67
G++VALK IR+ E+EG P TAIRE +LK L+H N++ L +I+ +
Sbjct: 30 GKLVALKVIRL-QEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT-------------- 74
Query: 68 KYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 127
+ + +VFEY+ DL D+ +K ++ QLL GL Y H +LHRD+K
Sbjct: 75 --KETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQ 132
Query: 128 NLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVG 187
NLLI + G LKLADFGLAR+ S ++T +N V+TLWYRPP++LLG+T+Y +DMW VG
Sbjct: 133 NLLISDTGELKLADFGLARAKSVP-SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVG 191
Query: 188 CIFAELLNGKPILPG-KNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTM---K 243
CIF E++ G PG K+ +QL +IF + G+P+E WPGV +P HFKP R
Sbjct: 192 CIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP---HFKPERFTLYSP 248
Query: 244 RRVREVFRHFD--RHALELLEKMLMLDPSQRISAKDALDSEYF 284
+ +R+ + HA +L K+L P R+SA+ AL EYF
Sbjct: 249 KNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 202 bits (516), Expect = 4e-61
Identities = 101/290 (34%), Positives = 154/290 (53%), Gaps = 10/290 (3%)
Query: 11 VALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 70
VA+KKI + + + A+REIKI+++L H+N++K+ E++ P + +
Sbjct: 33 VAVKKIVLTDPQS--VKHALREIKIIRRLDHDNIVKVYEVL-GPSGSDLTEDVGSLTELN 89
Query: 71 GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 130
S Y+V EYM+ DL + ++ + + +M QLL GL Y H VLHRD+K +N+
Sbjct: 90 -SVYIVQEYMETDLANVLEQG--PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVF 146
Query: 131 IDNEG-NLKLADFGLARSFS--YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVG 187
I+ E LK+ DFGLAR Y H L+ ++T WYR P LLL Y A+DMW+ G
Sbjct: 147 INTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAG 206
Query: 188 CIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVR 247
CIFAE+L GKP+ G +E EQ+ I E E + + +R +R
Sbjct: 207 CIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLR 266
Query: 248 EVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCD-PKSL 296
++ + AL+ LE++L +P R++A++AL Y P D P SL
Sbjct: 267 DLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEPVSL 316
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 8e-61
Identities = 106/294 (36%), Positives = 158/294 (53%), Gaps = 24/294 (8%)
Query: 4 EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKL--KEIVTSPGPERDE 60
E E VA+KKI K+ A+RE+K+L+ + H+N+ L +IV
Sbjct: 23 ETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP------- 75
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
+ Y+ E M+ DL + R G T + ++ Q+L GL Y H VL
Sbjct: 76 ------GNFNE-LYLYEELMEADLHQII-RSGQPLTDAHFQSFIYQILCGLKYIHSANVL 127
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT---LTNRVITLWYRPPELLLGATKY 177
HRD+K NLL++ + LK+ DFGLAR FS + +T V T WYR PE++L Y
Sbjct: 128 HRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSY 187
Query: 178 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237
A+D+WSVGCI AELL KP+ GK+ +QL++I ++ G+PDE + A N+ +
Sbjct: 188 TKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIR 247
Query: 238 PSRTM-KRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDP 288
+ K+ +F + + AL+LLEK+L DP++RIS ++AL+ Y W DP
Sbjct: 248 SLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDP 301
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 201 bits (512), Expect = 1e-60
Identities = 113/300 (37%), Positives = 164/300 (54%), Gaps = 44/300 (14%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAI-----REIKILKKLQHENVIKLKEIVTSPGP 56
AR+ TG+ VA+KKI + F + RE+K+LK L+HEN+I L +I SP
Sbjct: 29 ARDQLTGQNVAIKKIM-----KPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP-- 81
Query: 57 ERDEQGRPDGNKYRGSTYMVFEYMDHDL-TGLADRPGLRFTVPQ-IKCYMKQLLTGLHYC 114
Y V E + DL L RP Q I+ ++ Q+L GL Y
Sbjct: 82 -------------LEDIYFVTELLGTDLHRLLTSRP----LEKQFIQYFLYQILRGLKYV 124
Query: 115 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA 174
H V+HRD+K SN+LI+ +LK+ DFGLAR + +T V T +YR PE++L
Sbjct: 125 HSAGVVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRYYRAPEIMLTW 180
Query: 175 TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234
KY VD+WS GCIFAE+L GKP+ PGK+ Q S I +L G+P + + ++ + + N
Sbjct: 181 QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDV---INTICSEN 237
Query: 235 HFKPSRTMKRRVR----EVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDP 288
+ +++ +R E F++ D A++LLEKML+ DP +RISA +AL Y + DP
Sbjct: 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 193 bits (493), Expect = 2e-58
Identities = 104/293 (35%), Positives = 160/293 (54%), Gaps = 38/293 (12%)
Query: 3 REIKTGEIVALKKIRMDNEKEGFPIT---AIREIKILKKLQHENVIKLKEIVTSPGPERD 59
R +TG+IVA+KK E E P+ A+REI++LK+L+H N++ L E+
Sbjct: 21 RNRETGQIVAIKKFV---ESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF-------- 69
Query: 60 EQGRPDGNKYRGSTYMVFEYMDHD-LTGLADRPGLRFTVP--QIKCYMKQLLTGLHYCHV 116
+ + ++VFEY DH L L P VP IK + Q L +++CH
Sbjct: 70 --------RRKRKLHLVFEYCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHK 118
Query: 117 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK 176
+ +HRD+K N+LI +G +KL DFG AR + + T+ V T WYR PELL+G T+
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFARILT-GPGDDYTDYVATRWYRAPELLVGDTQ 177
Query: 177 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236
YGP VD+W++GC+FAELL G+P+ PGK++ +QL I + G + P ++ + N F
Sbjct: 178 YGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGD----LIPRHQQIFSTNQF 233
Query: 237 -----KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
P + + F + AL L+ L +DP++R+S ++ L+ YF
Sbjct: 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 193 bits (491), Expect = 4e-58
Identities = 116/294 (39%), Positives = 175/294 (59%), Gaps = 34/294 (11%)
Query: 2 AREIKTG-EIVALKKIRMDNEKEGFPITAIREIKILKKLQ---HENVIKLKEIVTSPGPE 57
AR++K G VALK++R+ +EG P++ IRE+ +L+ L+ H NV++L ++ T +
Sbjct: 20 ARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79
Query: 58 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADR---PGLRFTVP--QIKCYMKQLLTGLH 112
R+ + +VFE++D DLT D+ PG VP IK M QLL GL
Sbjct: 80 RETK-----------LTLVFEHVDQDLTTYLDKVPEPG----VPTETIKDMMFQLLRGLD 124
Query: 113 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL 172
+ H ++V+HRD+K N+L+ + G +KLADFGLAR +S+ LT+ V+TLWYR PE+LL
Sbjct: 125 FLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRAPEVLL 182
Query: 173 GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 232
++ Y VD+WSVGCIFAE+ KP+ G ++ +QL KI ++ G P E WP +P
Sbjct: 183 QSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 241
Query: 233 YNHF--KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
F K ++ +++ V ++ D +LL K L +P++RISA AL YF
Sbjct: 242 -QAFHSKSAQPIEKFVTDI----DELGKDLLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 192 bits (489), Expect = 7e-58
Identities = 103/294 (35%), Positives = 157/294 (53%), Gaps = 40/294 (13%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDE 60
A+ KTG+ A+K ++ + K + +REI+ L++L H N+++L E++
Sbjct: 18 AQSRKTGKYYAIKCMK-KHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKT---- 72
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQ--IKCYMKQLLTGLHYCHVNQ 118
G +VFE MD +L L G + +P+ +K YM QLL L + H N
Sbjct: 73 ----------GRLALVFELMDMNLYELIK--GRKRPLPEKRVKSYMYQLLKSLDHMHRNG 120
Query: 119 VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYG 178
+ HRDIK N+LI ++ LKLADFG R Y T + T WYR PE LL YG
Sbjct: 121 IFHRDIKPENILIKDD-ILKLADFGSCRGI-YSKP-PYTEYISTRWYRAPECLLTDGYYG 177
Query: 179 PAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238
P +D+W+VGC+F E+L+ P+ PG NE +Q++KI ++ G+PD + F+
Sbjct: 178 PKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV---------LKKFRK 228
Query: 239 SRTM-----KRR---VREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
SR M ++ +R++ + L+LL+K+L DP +RI+AK AL YF
Sbjct: 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 2e-56
Identities = 119/342 (34%), Positives = 173/342 (50%), Gaps = 36/342 (10%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A + TGE VA+KKI E +REIK+L+ L+H +++++K I+ P
Sbjct: 19 AIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR----- 73
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
+++ Y+VFE M+ DL + + T + ++ QLL L Y H V H
Sbjct: 74 -----REFK-DIYVVFELMESDLHQVI-KANDDLTPEHHQFFLYQLLRALKYIHTANVFH 126
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTL--TNRVITLWYRPPELLLGA--TKY 177
RD+K N+L + + LK+ DFGLAR D + T+ V T WYR PEL G+ +KY
Sbjct: 127 RDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC-GSFFSKY 185
Query: 178 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237
PA+D+WS+GCIFAE+L GKP+ PGKN QL I +L G+P V A +
Sbjct: 186 TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLS 245
Query: 238 PSRTMK-RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSL 296
R + + F + D AL LLE++L DP R +A++AL YF K L
Sbjct: 246 SMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYF---------KGL 296
Query: 297 PKYE---SSH-----EYQTKKRRQQQRQHEEATKRQKLH-HP 329
K E S+ E++ ++RR + E R+ L HP
Sbjct: 297 AKVEREPSAQPITKLEFEFERRRLTKEDVRELIYREILEYHP 338
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 189 bits (482), Expect = 4e-56
Identities = 104/309 (33%), Positives = 161/309 (52%), Gaps = 22/309 (7%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A + +TGE VA+KK+ + E F A RE+ +LK +QHENVI L ++ TS + Q
Sbjct: 34 AIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
Y+V YM DL + G + +++ + Q+L GL Y H ++H
Sbjct: 94 ----------DFYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIH 140
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 181
RD+K NL ++ + LK+ DFGLAR + +T V+T WYR PE++L Y V
Sbjct: 141 RDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTV 196
Query: 182 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP-SR 240
D+WSVGCI AE+L GK + GK+ +QL++I ++ G P + A ++ K +
Sbjct: 197 DIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPK 256
Query: 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL--PCDPKSLPK 298
++ +F A++LLEKML LD +R++A +AL+ YF D +
Sbjct: 257 YPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF--DSFRDADEETEQQP 314
Query: 299 YESSHEYQT 307
Y+ S E +
Sbjct: 315 YDDSLENEK 323
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 186 bits (475), Expect = 8e-56
Identities = 99/296 (33%), Positives = 161/296 (54%), Gaps = 44/296 (14%)
Query: 3 REIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQG 62
+ +TG+IVA+KK + + A+REI++LK+L+HEN++ L E+
Sbjct: 21 KHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF----------- 69
Query: 63 RPDGNKYRGSTYMVFEYMDHD-LTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
+ + Y+VFE++DH L L P GL + ++ Y+ Q+L G+ +CH + ++
Sbjct: 70 -----RRKKRLYLVFEFVDHTVLDDLEKYPNGLDESR--VRKYLFQILRGIEFCHSHNII 122
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 180
HRDIK N+L+ G +KL DFG AR+ + T+ V T WYR PELL+G TKYG A
Sbjct: 123 HRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYTDYVATRWYRAPELLVGDTKYGRA 181
Query: 181 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG------------SPDETIWPGVS 228
VD+W+VGC+ E+L G+P+ PG ++ +QL I + G +P ++ G+
Sbjct: 182 VDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP---LFAGM- 237
Query: 229 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
++P +P +++R F L+L ++ L +DP R S+ L E+F
Sbjct: 238 RLPEVKEIEP---LEKR----FPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 5e-55
Identities = 67/194 (34%), Positives = 99/194 (51%), Gaps = 20/194 (10%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
AR+ KTG+ VA+K I+ ++ +REI+ILKKL H N++KL +
Sbjct: 12 ARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENH----- 65
Query: 62 GRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
Y+V EY + L L + + +I + Q+L GL Y H N ++
Sbjct: 66 -----------LYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGII 114
Query: 121 HRDIKGSNLLIDN-EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGP 179
HRD+K N+L+D+ G +KLADFGL++ + + L V T Y PE+LLG Y
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLT-SDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 180 AVDMWSVGCIFAEL 193
D+WS+G I EL
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 3e-54
Identities = 108/291 (37%), Positives = 162/291 (55%), Gaps = 33/291 (11%)
Query: 3 REIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQG 62
R +T EIVA+KK + E E T +RE+K+L+ L+ EN+++LKE
Sbjct: 21 RHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF----------- 69
Query: 63 RPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHR 122
+ RG Y+VFEY++ ++ L + +++ Y+ QL+ +H+CH N ++HR
Sbjct: 70 -----RRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHR 124
Query: 123 DIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVD 182
DIK NLLI + LKL DFG AR+ S N T V T WYR PELLLGA YG AVD
Sbjct: 125 DIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA-PYGKAVD 183
Query: 183 MWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS-PDETI--------WPGVSKMPAY 233
MWSVGCI EL +G+P+ PG++E +QL I ++ G P E + + G+ + PA
Sbjct: 184 MWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL-RFPAV 242
Query: 234 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
NH ++++RR + L+L++ +L L+P+ R + L+ F
Sbjct: 243 NH---PQSLERRYLGILSGV---LLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 5e-54
Identities = 109/322 (33%), Positives = 168/322 (52%), Gaps = 20/322 (6%)
Query: 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPD 65
+TG VA+KK+ + E F A RE+++LK ++HENVI L ++ T PD
Sbjct: 38 RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFT-----------PD 86
Query: 66 GNKYR-GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 124
+ R Y+V +M DL L + + +I+ + Q+L GL Y H ++HRD+
Sbjct: 87 LSLDRFHDFYLVMPFMGTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDL 144
Query: 125 KGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMW 184
K NL ++ + LK+ DFGLAR ++ +T V+T WYR PE++L Y VD+W
Sbjct: 145 KPGNLAVNEDCELKILDFGLARQ----TDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIW 200
Query: 185 SVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP-SRTMK 243
SVGCI AE+L GKP+ G + +QL +I ++ G+P + + A N+ K R K
Sbjct: 201 SVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRK 260
Query: 244 RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSH 303
+ R + + + A+ +LEKML+LD RI+A +AL YF P D P Y+ S
Sbjct: 261 KDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAPPYDDSF 320
Query: 304 EYQTKKRRQQQR-QHEEATKRQ 324
+ + + +R E Q
Sbjct: 321 DEVDQSLEEWKRLTFTEILSFQ 342
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 3e-50
Identities = 99/292 (33%), Positives = 145/292 (49%), Gaps = 38/292 (13%)
Query: 6 KTGEIVALKKIRMDNEKEGFPIT--AIREIKILKKLQHENVIKLKEIVTSPGPERDEQGR 63
+ G+ VALKK M N + RE+K+L +H+NV+ +I+ P + E+
Sbjct: 23 RDGKRVALKK--MPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEE-- 78
Query: 64 PDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 123
Y+V E M DL + P + +K ++ Q+L GL Y H +LHRD
Sbjct: 79 ---------IYVVTELMQSDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLHSAGILHRD 128
Query: 124 IKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDM 183
IK NLL+++ LK+ DFGLAR D + +T V+T +YR PE+L+G+ Y AVD+
Sbjct: 129 IKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDI 188
Query: 184 WSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDET------------IWPGVSKMP 231
WSVGCIFAELL + + ++ +QL I +L G+P I G K P
Sbjct: 189 WSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPP 248
Query: 232 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 283
+ + + A+ LL +ML+ DP +RISA DAL Y
Sbjct: 249 SLP----------VLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 171 bits (434), Expect = 4e-49
Identities = 101/304 (33%), Positives = 160/304 (52%), Gaps = 17/304 (5%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A + + + VA+KK+ + RE+++LK ++HENVI L ++ T P +
Sbjct: 34 AYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFT-PATSIEN- 91
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
Y+V M DL + + + ++ + QLL GL Y H ++H
Sbjct: 92 --------FNEVYLVTNLMGADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIHSAGIIH 141
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 181
RD+K SN+ ++ + L++ DFGLAR ++ +T V T WYR PE++L Y V
Sbjct: 142 RDLKPSNVAVNEDCELRILDFGLARQ----ADDEMTGYVATRWYRAPEIMLNWMHYNQTV 197
Query: 182 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241
D+WSVGCI AELL GK + PG + +QL +I E+ G+P + +S A + +
Sbjct: 198 DIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPH 257
Query: 242 MKRR-VREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYE 300
M ++ ++++FR + A++LLEKML+LD +RISA +AL YF P D Y+
Sbjct: 258 MPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEPEAEPYD 317
Query: 301 SSHE 304
S E
Sbjct: 318 ESPE 321
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 169 bits (428), Expect = 3e-48
Identities = 110/322 (34%), Positives = 162/322 (50%), Gaps = 18/322 (5%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A + KTG VA+KK+ + RE+++LK ++HENVI L ++ T P R +
Sbjct: 36 AFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT---PARSLE 92
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
D Y+V M DL + L T ++ + Q+L GL Y H ++H
Sbjct: 93 EFND-------VYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQILRGLKYIHSADIIH 143
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 181
RD+K SNL ++ + LK+ DFGLAR ++ +T V T WYR PE++L Y V
Sbjct: 144 RDLKPSNLAVNEDCELKILDFGLARH----TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 199
Query: 182 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241
D+WSVGCI AELL G+ + PG + +QL I L G+P + +S A N+ +
Sbjct: 200 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 259
Query: 242 M-KRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYE 300
M K VF + A++LLEKML+LD +RI+A AL YF P D Y+
Sbjct: 260 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYD 319
Query: 301 SSHEYQTKKRRQQQRQ-HEEAT 321
S E + + + ++E
Sbjct: 320 QSFESRDLLIDEWKSLTYDEVI 341
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 167 bits (423), Expect = 8e-48
Identities = 103/304 (33%), Positives = 161/304 (52%), Gaps = 49/304 (16%)
Query: 12 ALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 71
ALK+I E G ++A REI +L++L+H NVI L+++ S +
Sbjct: 32 ALKQI----EGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRK------------- 74
Query: 72 STYMVFEYMDHDL--------TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 123
+++F+Y +HDL A++ ++ +K + Q+L G+HY H N VLHRD
Sbjct: 75 -VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRD 133
Query: 124 IKGSNLLIDNEG----NLKLADFGLARSFSYDHN--NTLTNRVITLWYRPPELLLGATKY 177
+K +N+L+ EG +K+AD G AR F+ L V+T WYR PELLLGA Y
Sbjct: 134 LKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHY 193
Query: 178 GPAVDMWSVGCIFAELLNGKPILPGKNE---------AEQLSKIFELCGSPDETIWPGVS 228
A+D+W++GCIFAELL +PI + E +QL +IF + G P + W +
Sbjct: 194 TKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIR 253
Query: 229 KMPAYNHF-KPSRTMKRRVREVFRHFDRHALE-------LLEKMLMLDPSQRISAKDALD 280
KMP Y K R + ++ ++H ++ LL+K+L +DP++RI+++ AL
Sbjct: 254 KMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313
Query: 281 SEYF 284
YF
Sbjct: 314 DPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 163 bits (413), Expect = 2e-46
Identities = 102/304 (33%), Positives = 160/304 (52%), Gaps = 49/304 (16%)
Query: 12 ALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 71
ALK+I E G ++A REI +L++L+H NVI L+++ S +
Sbjct: 32 ALKQI----EGTGISMSACREIALLRELKHPNVISLQKVFLSHADRK------------- 74
Query: 72 STYMVFEYMDHDL--------TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 123
+++F+Y +HDL A++ ++ +K + Q+L G+HY H N VLHRD
Sbjct: 75 -VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRD 133
Query: 124 IKGSNLLIDNEG----NLKLADFGLARSFSYDHN--NTLTNRVITLWYRPPELLLGATKY 177
+K +N+L+ EG +K+AD G AR F+ L V+T WYR PELLLGA Y
Sbjct: 134 LKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHY 193
Query: 178 GPAVDMWSVGCIFAELLNGKPILPGKNE---------AEQLSKIFELCGSPDETIWPGVS 228
A+D+W++GCIFAELL +PI + E +QL +IF + G P + W +
Sbjct: 194 TKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIK 253
Query: 229 KMPAYNHF-KPSRTMKRRVREVFRHFDRH-------ALELLEKMLMLDPSQRISAKDALD 280
KMP ++ K R + ++ ++H A LL+K+L +DP +RI+++ A+
Sbjct: 254 KMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313
Query: 281 SEYF 284
YF
Sbjct: 314 DPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 1e-43
Identities = 87/278 (31%), Positives = 133/278 (47%), Gaps = 49/278 (17%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAI-REIKILKKLQHENVIKLKEIVTSPGPERDE 60
A + TGE++A+K + + + E + A+ REI+IL LQH N+++ G ERDE
Sbjct: 19 ALDKDTGELMAVKSVELSGDSEEE-LEALEREIRILSSLQHPNIVRYY------GSERDE 71
Query: 61 QGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQV 119
+ N ++ EY+ L+ L + G + P I+ Y +Q+L GL Y H N +
Sbjct: 72 ----EKNTLN--IFL--EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGI 122
Query: 120 LHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLGATKYG 178
+HRDIKG+N+L+D++G +KLADFG A+ T V T ++ PE++ G +YG
Sbjct: 123 VHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG-EEYG 181
Query: 179 PAVDMWSVGCIFAELLNGKPILPGKNEAEQ-LSKIFELCGSPDETIWPGVSKMPAYNHFK 237
A D+WS+GC E+ GKP L KI P+ +P +
Sbjct: 182 RAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPE---------IPEHLS-- 230
Query: 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA 275
E + F L K L DP +R +A
Sbjct: 231 ----------EEAKDF-------LRKCLRRDPKKRPTA 251
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 157 bits (397), Expect = 2e-43
Identities = 79/366 (21%), Positives = 127/366 (34%), Gaps = 48/366 (13%)
Query: 9 EIVALKKIRMD-NEKEGFPITAIREIKILKKLQHE-NVIKLKEIVTSPGPERDEQGRPDG 66
++VALK + K +REI+IL L H N++KL + G
Sbjct: 23 KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSL--------- 73
Query: 67 NKYRGSTYMVFEYMD-HDLTGLADRPG--LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 123
Y+V EY+D L L + G + + + Q+L+ L Y H ++HRD
Sbjct: 74 -------YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRD 126
Query: 124 IKGSNLLIDNEGN-LKLADFGLARSFSYD-----HNNTLTNRVITLWYRPPELLLGAT-- 175
IK N+L+D +G +KL DFGLA+ + V T Y PE+LLG +
Sbjct: 127 IKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLA 186
Query: 176 KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235
+ D+WS+G ELL G P G+ + S+ +
Sbjct: 187 YASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK------------------IIL 228
Query: 236 FKPSRTMKRRVREVFRHFDRHAL-ELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPK 294
P+ ++ + A +LL+K+L DP R+S+ L + L
Sbjct: 229 ELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDL 288
Query: 295 SLPKYESSHEYQTKKRRQQQRQHEEATKRQKLHHPQPHGRLPPIQHAGQSHHWSGPNHPM 354
S + + + S H
Sbjct: 289 SDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNS 348
Query: 355 NNAPPP 360
++
Sbjct: 349 SSLLLS 354
|
Length = 384 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 1e-40
Identities = 95/311 (30%), Positives = 152/311 (48%), Gaps = 47/311 (15%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
A + TG+ VA+KK+ + A RE+ ++K + H+N+I L + T P++
Sbjct: 34 AAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFT---PQKSL 90
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTGLA----DRPGLRFTVPQIKCYMKQLLTGLHYCHV 116
+ D Y+V E MD +L + D + + + Q+ C +K L H
Sbjct: 91 EEFQD-------VYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHL-------HS 136
Query: 117 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK 176
++HRD+K SN+++ ++ LK+ DFGLAR+ +T V+T +YR PE++LG
Sbjct: 137 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILG-MG 193
Query: 177 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDE--------TIWPGVS 228
Y VD+WSVGCI E++ G + PG + +Q +KI E G+P + T+ V
Sbjct: 194 YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVE 253
Query: 229 KMPAYNHFKPSRTMKRRVREVF-----RHFDR----HALELLEKMLMLDPSQRISAKDAL 279
P Y + + +V ++ A +LL KML++DP +RIS DAL
Sbjct: 254 NRPKY----AGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDAL 309
Query: 280 DSEYF--WTDP 288
Y W DP
Sbjct: 310 QHPYINVWYDP 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 2e-40
Identities = 84/290 (28%), Positives = 120/290 (41%), Gaps = 57/290 (19%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKE-IVTSPGPERDE 60
R G++ LK+I + N E A+ E+KILKKL H N+IK E
Sbjct: 19 VRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE-------- 70
Query: 61 QGRPDGNKYRGSTYMVFEYMDH-DLTGL---ADRPGLRFTVPQIKCYMKQLLTGLHYCHV 116
+G +V EY D DL+ + G F QI + QL L Y H
Sbjct: 71 ---------KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS 121
Query: 117 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS--YDHNNTLTNRVITLWYRPPELLLGA 174
++LHRDIK N+ + + G +KL DFG+++ S D T+ V T +Y PEL
Sbjct: 122 RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV---VGTPYYLSPELCQNK 178
Query: 175 TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234
Y D+WS+GC+ EL K G+N E KI L G +P +
Sbjct: 179 -PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI--LKGQYP--------PIP--S 225
Query: 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
+ S ++ L+ +L DP +R S L S +
Sbjct: 226 QY--SSELR---------------NLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 2e-38
Identities = 80/300 (26%), Positives = 131/300 (43%), Gaps = 56/300 (18%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A + TG+ VA+KK+R+ + + I EI I+K +H N++ +
Sbjct: 38 ATDRATGKEVAIKKMRLRKQNKE---LIINEILIMKDCKHPNIVDYYDSY---------- 84
Query: 62 GRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
++V EYMD LT + + +R PQI +++L GL Y H V+
Sbjct: 85 ------LVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVI 138
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTLTNRVITLWYRPPELLLGATKYG 178
HRDIK N+L+ +G++KLADFG A + + + N++ V T ++ PE++ YG
Sbjct: 139 HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV---VGTPYWMAPEVIKR-KDYG 194
Query: 179 PAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238
P VD+WS+G + E+ G+P P E P ++ +K P
Sbjct: 195 PKVDIWSLGIMCIEMAEGEP--PYLRE------------PPLRALFLITTKGI------P 234
Query: 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPK 298
+ F+ F L K L+ DP +R SA++ L + C +
Sbjct: 235 PLKNPEKWSPEFKDF-------LNKCLVKDPEKRPSAEELLQHPFL---KKACPKEEFAP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 142 bits (358), Expect = 4e-38
Identities = 92/302 (30%), Positives = 149/302 (49%), Gaps = 42/302 (13%)
Query: 11 VALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 70
VA+KK+ + + A RE+ +LK + H+N+I L + T P++ + D
Sbjct: 49 VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFT---PQKSLEEFQD----- 100
Query: 71 GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 130
Y+V E MD +L + + ++ + Q+L G+ + H ++HRD+K SN++
Sbjct: 101 --VYLVMELMDANLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 155
Query: 131 IDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIF 190
+ ++ LK+ DFGLAR+ N +T V+T +YR PE++LG Y VD+WSVGCI
Sbjct: 156 VKSDCTLKILDFGLARTACT--NFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIM 212
Query: 191 AELLNGKPILPGKNEAEQLSKIFELCGSPD--------ETIWPGVSKMPAYNHFK----- 237
EL+ G I G + +Q +K+ E G+P T+ V P Y
Sbjct: 213 GELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELF 272
Query: 238 -----PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDPLP 290
PS + + +++ A +LL KML++DP +RIS +AL Y W DP
Sbjct: 273 PDWIFPSESERDKLKT------SQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAE 326
Query: 291 CD 292
+
Sbjct: 327 AE 328
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 4e-37
Identities = 80/280 (28%), Positives = 125/280 (44%), Gaps = 51/280 (18%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
AR +TG+ VA+K I+++++++ I I EI+ILKK +H N++K
Sbjct: 19 ARHKRTGKEVAIKVIKLESKEKKEKI--INEIQILKKCKHPNIVKY-------------- 62
Query: 62 GRPDGNKYRGST-YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQV 119
G+ + ++V E+ L L T QI K+LL GL Y H N +
Sbjct: 63 ---YGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGI 119
Query: 120 LHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGP 179
+HRDIK +N+L+ ++G +KL DFGL+ S V T ++ PE++ G Y
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSAQLS--DTKARNTMVGTPYWMAPEVING-KPYDY 176
Query: 180 AVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239
D+WS+G EL GKP EL P + + A N
Sbjct: 177 KADIWSLGITAIELAEGKP------------PYSEL--PPMKAL-----FKIATNGPPGL 217
Query: 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 279
R + + F+ F L+K L +P +R +A+ L
Sbjct: 218 RN-PEKWSDEFKDF-------LKKCLQKNPEKRPTAEQLL 249
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 9e-36
Identities = 63/197 (31%), Positives = 104/197 (52%), Gaps = 24/197 (12%)
Query: 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 64
++TG+ VA+K+I ++ KE + ++EI +LK L+H N++K + +
Sbjct: 22 LETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET----------- 70
Query: 65 DGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 123
S Y++ EY ++ L + + G F + Y+ Q+L GL Y H V+HRD
Sbjct: 71 -----SDSLYIILEYAENGSLRQIIKKFG-PFPESLVAVYVYQVLQGLAYLHEQGVIHRD 124
Query: 124 IKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL--GATKYGPAV 181
IK +N+L +G +KLADFG+A + + + V T ++ PE++ GA+ A
Sbjct: 125 IKAANILTTKDGVVKLADFGVATKLNDVSKDDASV-VGTPYWMAPEVIEMSGAST---AS 180
Query: 182 DMWSVGCIFAELLNGKP 198
D+WS+GC ELL G P
Sbjct: 181 DIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 8e-35
Identities = 90/309 (29%), Positives = 152/309 (49%), Gaps = 44/309 (14%)
Query: 11 VALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 70
VA+KK+ + + A RE+ ++K + H+N+I L + T P++ + D
Sbjct: 52 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT---PQKSLEEFQD----- 103
Query: 71 GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 130
Y+V E MD +L + + ++ + Q+L G+ + H ++HRD+K SN++
Sbjct: 104 --VYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 158
Query: 131 IDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIF 190
+ ++ LK+ DFGLAR+ +T V+T +YR PE++LG Y VD+WSVGCI
Sbjct: 159 VKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIM 215
Query: 191 AELLNGKPILPGKNEAEQLSKIFELCGSP--------DETIWPGVSKMPAYNHFK----- 237
E++ G + PG + +Q +K+ E G+P T+ V P Y +
Sbjct: 216 GEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLF 275
Query: 238 -----PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDPLP 290
P+ + +++ A +LL KML++D S+RIS +AL Y W DP
Sbjct: 276 PDVLFPADSEHNKLKA------SQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSE 329
Query: 291 CD--PKSLP 297
+ P +P
Sbjct: 330 AEAPPPKIP 338
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 5e-34
Identities = 77/288 (26%), Positives = 122/288 (42%), Gaps = 56/288 (19%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIK-LKEIVTSPGPERDE 60
R G+I+ K+I N E + E+ IL++L+H N+++ I+
Sbjct: 19 VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRII--------- 69
Query: 61 QGRPDGNKYRGSTYMVFEYMDH-DLTGL---ADRPGLRFTVPQIKCYMKQLLTGLHYCHV 116
++ + Y+V EY + DL L + I + QLL L+ CH
Sbjct: 70 ------DRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 117 -----NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELL 171
N VLHRD+K +N+ +D N+KL DFGLA+ +D + T V T +Y PE L
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY-VGTPYYMSPEQL 182
Query: 172 LGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 231
Y D+WS+GC+ EL P +N+ + SKI E G
Sbjct: 183 NHM-SYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE-----------G----- 225
Query: 232 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 279
+ R + + E+++ ML +DP +R S ++ L
Sbjct: 226 -------------KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELL 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 6e-34
Identities = 88/298 (29%), Positives = 150/298 (50%), Gaps = 42/298 (14%)
Query: 11 VALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 70
VA+KK+ + + A RE+ ++K + H+N+I L + T P++ + D
Sbjct: 45 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT---PQKSLEEFQD----- 96
Query: 71 GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 130
Y+V E MD +L + + ++ + Q+L G+ + H ++HRD+K SN++
Sbjct: 97 --VYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 151
Query: 131 IDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIF 190
+ ++ LK+ DFGLAR+ +T V+T +YR PE++LG Y VD+WSVGCI
Sbjct: 152 VKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIM 208
Query: 191 AELLNGKPILPGKNEAEQLSKIFELCGSP--------DETIWPGVSKMPAY--------- 233
E++ K + PG++ +Q +K+ E G+P T+ V P Y
Sbjct: 209 GEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLF 268
Query: 234 -NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDP 288
+ P+ + +++ A +LL KML++DP++RIS +AL Y W DP
Sbjct: 269 PDSLFPADSEHNKLKA------SQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 5e-33
Identities = 99/304 (32%), Positives = 147/304 (48%), Gaps = 33/304 (10%)
Query: 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 64
I T E VA+KK+ D P RE+ I+K L H N+I LK+ + +++E+
Sbjct: 88 IDTSEKVAIKKVLQD------PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141
Query: 65 DGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 124
V +YM H R + +K Y QL L Y H + HRD+
Sbjct: 142 LNVVMEFIPQTVHKYMKH-----YARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDL 196
Query: 125 KGSNLLID-NEGNLKLADFGLA-------RSFSYDHNNTLTNRVITLWYRPPELLLGATK 176
K NLLID N LKL DFG A RS SY + + +YR PEL+LGAT
Sbjct: 197 KPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY---------ICSRFYRAPELMLGATN 247
Query: 177 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236
Y +D+WS+GCI AE++ G PI G++ +QL +I ++ G+P E ++ P Y
Sbjct: 248 YTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMN--PNYADI 305
Query: 237 KPSRTMKRRVREVF-RHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKS 295
K + +++VF + A+ + + L +P +R++ +AL +F PC
Sbjct: 306 KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPC--IK 363
Query: 296 LPKY 299
LPKY
Sbjct: 364 LPKY 367
|
Length = 440 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-32
Identities = 77/288 (26%), Positives = 123/288 (42%), Gaps = 67/288 (23%)
Query: 1 MAREIKTGEIVALK-----KIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 55
+ R+ TG++ A+K KI E E + E IL ++ H ++KL
Sbjct: 11 LVRKKDTGKLYAMKVLKKKKIIKRKEVE----HTLTERNILSRINHPFIVKLH------- 59
Query: 56 PERDEQGRPDGNKY----RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTG 110
Y Y+V EY +L + G RF+ + + Y +++
Sbjct: 60 -------------YAFQTEEKLYLVLEYAPGGELFSHLSKEG-RFSEERARFYAAEIVLA 105
Query: 111 LHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPEL 170
L Y H +++RD+K N+L+D +G++KL DFGLA+ S + + T T T Y PE+
Sbjct: 106 LEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEV 164
Query: 171 LLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 230
LLG YG AVD WS+G + E+L GKP ++ E KI L +
Sbjct: 165 LLGK-GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI--LKDPL---------RF 212
Query: 231 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDA 278
P + A +L+ +L DP++R+ + A
Sbjct: 213 PEF-------------------LSPEARDLISGLLQKDPTKRLGSGGA 241
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 8e-31
Identities = 75/308 (24%), Positives = 120/308 (38%), Gaps = 80/308 (25%)
Query: 1 MAREIKTGEIVALK---K---IRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTS 53
+A+E +T + A+K K I+ K E ++L +L H +IKL T
Sbjct: 19 LAKEKETNKEYAIKILDKRQLIKEKKVKY-----VKIEKEVLTRLNGHPGIIKL--YYTF 71
Query: 54 PGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLH 112
+DE+ + Y V EY + +L + G + Y ++L L
Sbjct: 72 ----QDEE----------NLYFVLEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALE 116
Query: 113 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLW-------- 164
Y H ++HRD+K N+L+D + ++K+ DFG A+ + + T
Sbjct: 117 YLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176
Query: 165 -----------YRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 213
Y PELL G + D+W++GCI ++L GKP G NE KI
Sbjct: 177 RRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL 235
Query: 214 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI 273
+L P +F A +L+EK+L+LDP R+
Sbjct: 236 KLE-----------YSFP-------------------PNFPPDAKDLIEKLLVLDPQDRL 265
Query: 274 SAKDALDS 281
+ D
Sbjct: 266 GVNEGYDE 273
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 74/250 (29%), Positives = 115/250 (46%), Gaps = 48/250 (19%)
Query: 31 REIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLAD 89
+EI +L KLQH N IV G ER+E + Y+ E + L L
Sbjct: 51 QEIALLSKLQHPN------IVQYLGTEREE----------DNLYIFLELVPGGSLAKLLK 94
Query: 90 RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 149
+ G F P I+ Y +Q+L GL Y H +HRDIKG+N+L+D G +KLADFG+A+
Sbjct: 95 KYG-SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153
Query: 150 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQL 209
+ + + ++ PE++ YG A D+WS+GC E+ GKP ++ E +
Sbjct: 154 E--FSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW---SQLEGV 208
Query: 210 SKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDP 269
+ +F++ S + +P + H A + + K L DP
Sbjct: 209 AAVFKIGRSKE---------LP----------------PIPDHLSDEAKDFILKCLQRDP 243
Query: 270 SQRISAKDAL 279
S R +A + L
Sbjct: 244 SLRPTAAELL 253
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 78/285 (27%), Positives = 127/285 (44%), Gaps = 55/285 (19%)
Query: 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERD 59
+A++ TG+I A+K I+ + ++ + E IL + Q V+KL
Sbjct: 11 LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG------ 64
Query: 60 EQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 118
+ + Y+V EY+ DL L + G + Y+ +++ L Y H N
Sbjct: 65 ----------KKNLYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLALEYLHSNG 113
Query: 119 VLHRDIKGSNLLIDNEGNLKLADFGLA------RSFSYDHNNTLTNRVI-TLWYRPPELL 171
++HRD+K N+LID+ G+LKL DFGL+ R + + + R++ T Y PE++
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 172 LGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 231
LG + VD WS+GCI E L G P G+ E I L G + WP +
Sbjct: 174 LG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI--LNGKIE---WP--EDVE 225
Query: 232 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAK 276
+ A++L+ K+L+ DP +R+ AK
Sbjct: 226 VSD---------------------EAIDLISKLLVPDPEKRLGAK 249
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 4e-30
Identities = 89/288 (30%), Positives = 121/288 (42%), Gaps = 55/288 (19%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
R TG+I ALKKI +D ++E F +RE+K L+ + V+K G
Sbjct: 19 KVRHKPTGKIYALKKIHVDGDEE-FRKQLLRELKTLRSCESPYVVKCYGAFYKEG----- 72
Query: 61 QGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH-VNQ 118
+V EYMD L L + G P + +Q+L GL Y H
Sbjct: 73 -----------EISIVLEYMDGGSLADLLKKVGK-IPEPVLAYIARQILKGLDYLHTKRH 120
Query: 119 VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLWYRPPELLLGAT 175
++HRDIK SNLLI+++G +K+ADFG+++ NTL V T+ Y PE + G +
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLE----NTLDQCNTFVGTVTYMSPERIQGES 176
Query: 176 KYGPAVDMWSVGCIFAELLNGK-PILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234
Y A D+WS+G E GK P LP Q S FEL M A
Sbjct: 177 -YSYAADIWSLGLTLLECALGKFPFLP----PGQPS-FFEL--------------MQAIC 216
Query: 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSE 282
P FR F + L DP +R SA + L
Sbjct: 217 DGPPPSLPAEEFSPEFRDF-------ISACLQKDPKKRPSAAELLQHP 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 8e-26
Identities = 56/230 (24%), Positives = 91/230 (39%), Gaps = 53/230 (23%)
Query: 6 KTGEIVALKKIR---MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQG 62
VA+K ++ + + E F +RE +I++KL H N++KL + T P
Sbjct: 26 GKEVEVAVKTLKEDASEQQIEEF----LREARIMRKLDHPNIVKLLGVCTEEEP------ 75
Query: 63 RPDGNKYRGSTYMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
+V EYM DL L ++ + + Q+ G+ Y +
Sbjct: 76 ----------LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFI 125
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITLWYRPPE-LLLGATKYG 178
HRD+ N L+ +K++DFGL+R + D+ ++ W PE L G K+
Sbjct: 126 HRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM-APESLKEG--KFT 182
Query: 179 PAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 228
D+WS G + E IF L P +PG+S
Sbjct: 183 SKSDVWSFGVLLWE-------------------IFTLGEEP----YPGMS 209
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 8e-26
Identities = 51/196 (26%), Positives = 87/196 (44%), Gaps = 29/196 (14%)
Query: 6 KTGEIVALKKIR---MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQG 62
K VA+K ++ + + E F +RE +I++KL H NV+KL + T P
Sbjct: 26 KKKVEVAVKTLKEDASEQQIEEF----LREARIMRKLDHPNVVKLLGVCTEEEP------ 75
Query: 63 RPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
Y+V EYM+ DL + + ++ + + Q+ G+ Y +H
Sbjct: 76 ----------LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIH 125
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITLWYRPPE-LLLGATKYGP 179
RD+ N L+ +K++DFGL+R + D+ ++ W PE L G K+
Sbjct: 126 RDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWM-APESLKEG--KFTS 182
Query: 180 AVDMWSVGCIFAELLN 195
D+WS G + E+
Sbjct: 183 KSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 81/274 (29%), Positives = 124/274 (45%), Gaps = 51/274 (18%)
Query: 1 MAREIKTGEIVALKKIRMDNE-----KEGFPITAIR-EIKILKKLQHENVIKLKEIVTSP 54
+ ++ TG +A+K++ D + KE + A+ EI++LK LQHE IV
Sbjct: 20 LCYDVDTGRELAVKQVPFDPDSPETKKE---VNALECEIQLLKNLQHE------RIVQYY 70
Query: 55 GPERDEQGRPDGNKYRGSTYMVFEYM------DHDLTGLADRPGLRFTVPQIKCYMKQLL 108
G RD + + EYM D L L TV + Y +Q+L
Sbjct: 71 GCLRD----------DETLSIFMEYMPGGSVKDQ----LKAYGALTETV--TRKYTRQIL 114
Query: 109 TGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI--TLWYR 166
G+ Y H N ++HRDIKG+N+L D+ GN+KL DFG ++ ++ + + T ++
Sbjct: 115 EGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174
Query: 167 PPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPG 226
PE++ G YG D+WSVGC E+L KP E E ++ IF++ P P
Sbjct: 175 SPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTNPQLP- 229
Query: 227 VSKMPAYNHFKPSRTMKRRVR------EVFRHFD 254
S + RT + E+ RHF
Sbjct: 230 -SHVSPDARNFLRRTFVENAKKRPSAEELLRHFF 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 3e-25
Identities = 71/295 (24%), Positives = 118/295 (40%), Gaps = 72/295 (24%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A +TG++VA+K + ++ + + I+EI ILK+ ++K
Sbjct: 22 AIHKETGQVVAIKVVPVEEDLQEI----IKEISILKQCDSPYIVKYY------------- 64
Query: 62 GRPDGNKYRGSTYM-VFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 116
G+ ++ + V EY D+ + ++ T +I + Q L GL Y H
Sbjct: 65 ----GSYFKNTDLWIVMEYCGAGSVSDIMKITNK---TLTEEEIAAILYQTLKGLEYLHS 117
Query: 117 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLGAT 175
N+ +HRDIK N+L++ EG KLADFG+ S N VI T ++ PE++
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGV--SGQLTDTMAKRNTVIGTPFWMAPEVIQE-I 174
Query: 176 KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235
Y D+WS+G E+ GKP P Y+
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKP--P-------------------------------YSD 201
Query: 236 FKPSRTM---KRRVREVFRHFDRHALEL---LEKMLMLDPSQRISAKDALDSEYF 284
P R + + ++ + E ++K L+ DP +R SA L +
Sbjct: 202 IHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 72/296 (24%), Positives = 124/296 (41%), Gaps = 76/296 (25%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAI-REIKILKKLQHENVIKLKEIVTSPGPERDE 60
A + +T ++VA+K I ++ ++ I I +EI+ L + + + K
Sbjct: 20 AIDKRTNQVVAIKVIDLEEAED--EIEDIQQEIQFLSQCRSPYITK-------------- 63
Query: 61 QGRPDGNKYRGS------TYMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTG 110
Y GS +++ EY DL +PG + I ++++L G
Sbjct: 64 --------YYGSFLKGSKLWIIMEYCGGGSCLDLL----KPG-KLDETYIAFILREVLLG 110
Query: 111 LHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLWYRP 167
L Y H +HRDIK +N+L+ EG++KLADFG++ + +T++ R V T ++
Sbjct: 111 LEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLT----STMSKRNTFVGTPFWMA 166
Query: 168 PELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 227
PE++ + Y D+WS+G EL G+P L + L I P
Sbjct: 167 PEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI------PKN------ 213
Query: 228 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 283
P + + F+ F + L DP +R SAK+ L ++
Sbjct: 214 ---------NPPSLEGNKFSKPFKDF-------VSLCLNKDPKERPSAKELLKHKF 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 7e-25
Identities = 67/235 (28%), Positives = 124/235 (52%), Gaps = 48/235 (20%)
Query: 7 TGEIVALKKIRMD------NEKEGFPITAI-REIKILKKLQHENVIKLKEIVTSPGPERD 59
+GE++A+K++ + +++ + A+ REI +LK+LQHEN+++
Sbjct: 24 SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQ------------- 70
Query: 60 EQGRPDGNKYRGS----TYMVF--EYM-DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLH 112
Y GS ++ EY+ + L + G F ++ +++Q+L GL+
Sbjct: 71 ---------YLGSSLDADHLNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLN 120
Query: 113 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-----TLWYRP 167
Y H ++HRDIKG+N+L+DN+G +K++DFG+++ + +T TN ++++
Sbjct: 121 YLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 168 PELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG--SPD 220
PE ++ T Y D+WS+GC+ E+L GK P + QL IF++ SP+
Sbjct: 181 PE-VVKQTSYTRKADIWSLGCLVVEMLTGKHPFP---DCTQLQAIFKIGENASPE 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 73/242 (30%), Positives = 125/242 (51%), Gaps = 34/242 (14%)
Query: 1 MAREIKTGEIVALKKIRM----DNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 56
AR++KTG ++A+K++ +E+E +EI+++ +L H ++I++
Sbjct: 18 QARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRML-------- 69
Query: 57 ERDEQGRPDGNKYRGSTYMVF-EYM-DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 114
G S + +F E+M ++ L + G F I Y +QLL GL Y
Sbjct: 70 ---------GATCEDSHFNLFVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYL 119
Query: 115 HVNQVLHRDIKGSNLLIDNEGN-LKLADFGLARSFSYDHNNT--LTNRVI-TLWYRPPEL 170
H NQ++HRD+KG+NLLID+ G L++ADFG A + +++ T+ + PE+
Sbjct: 120 HENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 171 LLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC---GSPD--ETIWP 225
L G +YG + D+WSVGC+ E+ KP + + L+ IF++ +P E + P
Sbjct: 180 LRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238
Query: 226 GV 227
G+
Sbjct: 239 GL 240
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 65/226 (28%), Positives = 113/226 (50%), Gaps = 31/226 (13%)
Query: 1 MAREIKTGEIVALKKIRM-------DNEKEGFPITAIR-EIKILKKLQHENVIKLKEIVT 52
+A + TGE++A+K++ + + ++ + A+R EI+ LK L H N IV
Sbjct: 19 LALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLN------IVQ 72
Query: 53 SPGPERDEQGRPDGNKYRGSTYMVF-EYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGL 111
G E E+ +F EY+ G R RF ++ + +Q+L GL
Sbjct: 73 YLGFETTEE-----------YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGL 121
Query: 112 HYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS--YDHNNTLTNRVITLWYRPPE 169
Y H +LHRD+K NLL+D +G K++DFG+++ YD++ ++ + W P
Sbjct: 122 AYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 170 LLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 215
+ + Y VD+WS+GC+ E+ G+ P +E E ++ +F+L
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRR--PWSDE-EAIAAMFKL 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 57/220 (25%), Positives = 90/220 (40%), Gaps = 37/220 (16%)
Query: 6 KTGEIVALKKIR---MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQG 62
T VA+K ++ + E+E F + E I+KKL H N+++L + T P
Sbjct: 26 GTETKVAVKTLKEGASEEEREEF----LEEASIMKKLSHPNIVRLLGVCTQGEP------ 75
Query: 63 RPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
Y+V EYM DL + G + T+ + Q+ G+ Y +H
Sbjct: 76 ----------LYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNFVH 125
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL------WYRPPELLLGAT 175
RD+ N L+ +K++DFGL+R D R W PE L
Sbjct: 126 RDLAARNCLVTENLVVKISDFGLSR----DIYEDDYYRKRGGGKLPIKWM-APESLK-DG 179
Query: 176 KYGPAVDMWSVGCIFAELL-NGKPILPGKNEAEQLSKIFE 214
K+ D+WS G + E+ G+ PG + E L + +
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLED 219
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 6e-23
Identities = 55/243 (22%), Positives = 98/243 (40%), Gaps = 60/243 (24%)
Query: 1 MAREIKTGEI-VALKKIR---MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 56
+ VA+K ++ + E++ F ++E +++KKL H NV++L + T P
Sbjct: 15 KLKGKDGKTTEVAVKTLKEDASEEERKDF----LKEARVMKKLGHPNVVRLLGVCTEEEP 70
Query: 57 ERDEQGRPDGNKYRGSTYMVFEYMDH-DL-------TGLADRPGL-RFTVPQIKCYMKQL 107
Y+V EYM+ DL + P ++ + + Q+
Sbjct: 71 ----------------LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQI 114
Query: 108 LTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITL-WY 165
G+ Y + +HRD+ N L+ + +K++DFGL+R + D+ T + + W
Sbjct: 115 AKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM 174
Query: 166 RPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWP 225
PE L + D+WS G + E IF L +P +P
Sbjct: 175 -APESLKDG-IFTSKSDVWSFGVLLWE-------------------IFTLGATP----YP 209
Query: 226 GVS 228
G+S
Sbjct: 210 GLS 212
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 1e-22
Identities = 68/292 (23%), Positives = 114/292 (39%), Gaps = 69/292 (23%)
Query: 6 KTGEIVALKKI-RMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 64
T ++ A+K + + ++G + E +IL++L H ++ L
Sbjct: 23 DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW---------------- 66
Query: 65 DGNKYRGSTYMVFEYMDHDLTGLADRPGLR--------FTVPQIKCYMKQLLTGLHYCHV 116
++ M Y+ DL D LR F+ Q+K ++ +++ L Y H
Sbjct: 67 --YSFQDEENM---YLVVDLLLGGD---LRYHLSQKVKFSEEQVKFWICEIVLALEYLHS 118
Query: 117 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK 176
++HRDIK N+L+D +G++ + DF +A + D T+ T Y PE+L
Sbjct: 119 KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT--TSTSGTPGYMAPEVLCRQ-G 175
Query: 177 YGPAVDMWSVGCIFAELLNGKPILPGK--NEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234
Y AVD WS+G E L GK G +Q+ E + D S
Sbjct: 176 YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE---TADVLYPATWST----- 227
Query: 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS--AKDALDSEYF 284
A++ + K+L DP +R+ KD + YF
Sbjct: 228 ---------------------EAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 6e-22
Identities = 66/204 (32%), Positives = 101/204 (49%), Gaps = 31/204 (15%)
Query: 5 IKTGEIVALKKIRM-DNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGR 63
+ TGE++A+K+IR+ DN+ + A E+K+L+ L+H N++K + R++
Sbjct: 22 LDTGELMAVKEIRIQDNDPKTIKEIA-DEMKVLELLKHPNLVKYYGVEV----HREK--- 73
Query: 64 PDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHR 122
Y+ EY L L G I+ Y QLL GL Y H + ++HR
Sbjct: 74 ---------VYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHR 123
Query: 123 DIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT------NRVITLWYRPPELLLGATK 176
DIK +N+ +D+ G +KL DFG A NNT T + T Y PE++ G
Sbjct: 124 DIKPANIFLDHNGVIKLGDFGCAVKLK---NNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 177 --YGPAVDMWSVGCIFAELLNGKP 198
+G A D+WS+GC+ E+ GK
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 2e-21
Identities = 72/297 (24%), Positives = 128/297 (43%), Gaps = 74/297 (24%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKL--KEIVTSPGPER 58
+A + TG VA+KK MD K+ E+ I++ QH N++++ +V
Sbjct: 37 IATDKSTGRQVAVKK--MDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG------ 88
Query: 59 DEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 117
DE ++V E+++ LT + R QI +L L + H
Sbjct: 89 DE------------LWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQ 134
Query: 118 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLWYRPPELLLGA 174
V+HRDIK ++L+ ++G +KL+DFG S + + R V T ++ PE ++
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE----VPRRKSLVGTPYWMAPE-VISR 189
Query: 175 TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234
YG VD+WS+G + E+++G+P P +N
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEP--------------------------------PYFN 217
Query: 235 HFKPSRTMKRRVREVFRHFDRHA-------LELLEKMLMLDPSQRISAKDALDSEYF 284
P + M +R+R+ ++ L++ML+ DP+QR +A + L+ +
Sbjct: 218 E-PPLQAM-KRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 5e-21
Identities = 67/214 (31%), Positives = 94/214 (43%), Gaps = 35/214 (16%)
Query: 2 AREIKTGEIVALK--KIRMDNEKEGFPITAIR-EIKILKKL-QHENVIKLKEIVTSPGPE 57
AR KTG++VA+K I D E+E I+ E IL+K H N+ P
Sbjct: 25 ARHKKTGQLVAIKIMDIIEDEEEE------IKEEYNILRKYSNHPNIATFYGAFIKKNP- 77
Query: 58 RDEQGRPDGNKYRGSTYMVFEYMDH----DLTGLADRPGLRFTVPQIKCYMKQLLTGLHY 113
G D ++V E DL + G R I +++ L GL Y
Sbjct: 78 ---PGNDD------QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAY 128
Query: 114 CHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLL 172
H N+V+HRDIKG N+L+ +KL DFG++ D N I T ++ PE++
Sbjct: 129 LHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL--DSTLGRRNTFIGTPYWMAPEVI- 185
Query: 173 GATKYGPAV------DMWSVGCIFAELLNGKPIL 200
A P D+WS+G EL +GKP L
Sbjct: 186 -ACDEQPDASYDARSDVWSLGITAIELADGKPPL 218
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 6e-21
Identities = 69/283 (24%), Positives = 120/283 (42%), Gaps = 72/283 (25%)
Query: 1 MAREIKTGEIVALKK------IRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSP 54
+ R +G+ ALK +++ + + E +IL+ ++H ++ L
Sbjct: 19 LVRHKGSGKYYALKILSKAKIVKLKQVEH-----VLNEKRILQSIRHPFLVNLY------ 67
Query: 55 GPERDEQGRPDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHY 113
G +D+ + Y+V EY+ +L + G RF P + Y Q++ L Y
Sbjct: 68 GSFQDDS----------NLYLVMEYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEY 116
Query: 114 CHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLW----YRPPE 169
H +++RD+K NLL+D++G +K+ DFG A+ + R TL Y PE
Sbjct: 117 LHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKR--------VKGRTYTLCGTPEYLAPE 168
Query: 170 LLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 229
++L YG AVD W++G + E+L G P P + +I+E I G +
Sbjct: 169 IILS-KGYGKAVDWWALGILIYEMLAGYP--PFF--DDNPIQIYEK-------ILEGKVR 216
Query: 230 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR 272
P F A +L+ +L +D ++R
Sbjct: 217 FP-------------------SFFSPDAKDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 46/212 (21%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
AR+I TGE+VA+K I+++ + F I +EI +LK+ +H N++
Sbjct: 22 ARDIATGELVAIKVIKLE-PGDDFEIIQ-QEISMLKECRHPNIVA--------------- 64
Query: 62 GRPDGNKYRGS------TYMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGL 111
Y GS ++V EY D+ + P + QI ++ L GL
Sbjct: 65 -------YFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP---LSELQIAYVCRETLKGL 114
Query: 112 HYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLWYRPP 168
Y H +HRDIKG+N+L+ +G++KLADFG++ + T+ R + T ++ P
Sbjct: 115 AYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLT----ATIAKRKSFIGTPYWMAP 170
Query: 169 ELLLGATK--YGPAVDMWSVGCIFAELLNGKP 198
E+ K Y D+W++G EL +P
Sbjct: 171 EVAAVERKGGYDGKCDIWALGITAIELAELQP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 2e-20
Identities = 63/211 (29%), Positives = 94/211 (44%), Gaps = 48/211 (22%)
Query: 74 YMVFEYMDH-DLTGLADRPGLRFTVPQ--IKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 130
Y+V EY++ D L G +P+ K Y+ +++ G+ H ++HRDIK NLL
Sbjct: 73 YLVMEYLNGGDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLL 129
Query: 131 IDNEGNLKLADFGLARSFSYDHNNTLTNRVI--TLWYRPPELLLGATKYGPAVDMWSVGC 188
ID G+LKL DFGL+R N L N+ T Y PE +LG D WS+GC
Sbjct: 130 IDQTGHLKLTDFGLSR-------NGLENKKFVGTPDYLAPETILGVGD-DKMSDWWSLGC 181
Query: 189 IFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRV-- 246
+ E L G P AE +F+ + RR+
Sbjct: 182 VIFEFLFGYPPF----HAETPDAVFD-------------------------NILSRRINW 212
Query: 247 -REVFRHFDRHALELLEKMLMLDPSQRISAK 276
EV A++L+ ++L +DP++R+ A
Sbjct: 213 PEEVKEFCSPEAVDLINRLLCMDPAKRLGAN 243
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 3e-20
Identities = 67/228 (29%), Positives = 110/228 (48%), Gaps = 25/228 (10%)
Query: 4 EIKTGEIVALKKIRMDNE--KEGFPITAIR-EIKILKKLQHENVIKLKEIVTSPGPERDE 60
+ TG +A+K+++ D E + + A+ EI++LK L HE +++ + P ER
Sbjct: 23 DADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP-MER-- 79
Query: 61 QGRPDGNKYRGSTYMVF-EYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQV 119
T +F E+M + T + Y +Q+L G+ Y H N +
Sbjct: 80 ------------TLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMI 127
Query: 120 LHRDIKGSNLLIDNEGNLKLADFGLARSFSYD--HNNTLTNRVITLWYRPPELLLGATKY 177
+HRDIKG+N+L D+ GN+KL DFG ++ + + T ++ PE++ G Y
Sbjct: 128 VHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG-EGY 186
Query: 178 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWP 225
G D+WSVGC E+L KP E E ++ IF++ P + P
Sbjct: 187 GRKADIWSVGCTVVEMLTEKPPWA---EFEAMAAIFKIATQPTNPVLP 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 1e-19
Identities = 53/217 (24%), Positives = 91/217 (41%), Gaps = 51/217 (23%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A + E VA+K+I ++ + +E++ + + H NV+K
Sbjct: 20 AICLPNNEKVAIKRIDLEKCQTSVD-ELRKEVQAMSQCNHPNVVK--------------- 63
Query: 62 GRPDGNKYRGS------TYMVFEYMD----HDLTGLADRPGLRFTVPQ-------IKCYM 104
Y S ++V Y+ D+ ++ + P+ I +
Sbjct: 64 -------YYTSFVVGDELWLVMPYLSGGSLLDI--------MKSSYPRGGLDEAIIATVL 108
Query: 105 KQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VI 161
K++L GL Y H N +HRDIK N+L+ +G++K+ADFG++ S + + T R V
Sbjct: 109 KEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVG 168
Query: 162 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKP 198
T + PE++ Y D+WS G EL G
Sbjct: 169 TPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAA 205
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 1e-19
Identities = 69/228 (30%), Positives = 112/228 (49%), Gaps = 25/228 (10%)
Query: 4 EIKTGEIVALKKIRMDNE--KEGFPITAIR-EIKILKKLQHENVIKLKEIVTSPGPERDE 60
++ TG +A K+++ D E + ++A+ EI++LK LQHE +++ G RD
Sbjct: 23 DVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYY------GCLRDR 76
Query: 61 QGRPDGNKYRGSTYMVF-EYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQV 119
+ T +F EYM + T + Y +Q+L G+ Y H N +
Sbjct: 77 AEK---------TLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMI 127
Query: 120 LHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI--TLWYRPPELLLGATKY 177
+HRDIKG+N+L D+ GN+KL DFG ++ + R + T ++ PE++ G Y
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG-EGY 186
Query: 178 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWP 225
G D+WS+GC E+L KP E E ++ IF++ P P
Sbjct: 187 GRKADVWSLGCTVVEMLTEKPPWA---EYEAMAAIFKIATQPTNPQLP 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 2e-19
Identities = 68/289 (23%), Positives = 113/289 (39%), Gaps = 67/289 (23%)
Query: 3 REIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIK-----LKEIVTSPGPE 57
R + +V K++ + E A+ EI IL LQH N+I + +
Sbjct: 20 RRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD-------- 71
Query: 58 RDEQGRPDGNKYRGSTYMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHY 113
+ + EY + +D + + G F + Y+ Q+++ + Y
Sbjct: 72 -------------NTLLIEMEYANGGTLYDK--IVRQKGQLFEEEMVLWYLFQIVSAVSY 116
Query: 114 CHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS--YDHNNTLTNRVITLWYRPPELL 171
H +LHRDIK N+ + G +KL DFG+++ Y T+ V T +Y PEL
Sbjct: 117 IHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV---VGTPYYMSPELC 173
Query: 172 LGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 231
G KY D+W++GC+ ELL K N + KI + +P +++
Sbjct: 174 QGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVY------- 225
Query: 232 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280
S + V +L DP +R +A + LD
Sbjct: 226 -------SSELISLVHS---------------LLQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 2e-19
Identities = 55/200 (27%), Positives = 88/200 (44%), Gaps = 35/200 (17%)
Query: 6 KTGEIVALKKIRMDNEKE---GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQG 62
TGE VA+K + E++ F REI+IL+ L HEN++K K + PG
Sbjct: 31 NTGEQVAVKSLNHSGEEQHRSDFE----REIEILRTLDHENIVKYKGVCEKPG------- 79
Query: 63 RPDGNKYRGSTYMVFEY-----MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 117
S ++ EY + L D+ L ++ + Q+ G+ Y
Sbjct: 80 -------GRSLRLIMEYLPSGSLRDYLQRHRDQINL----KRLLLFSSQICKGMDYLGSQ 128
Query: 118 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLWYRPPELLLGA 174
+ +HRD+ N+L+++E +K++DFGLA+ D + WY P L
Sbjct: 129 RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT-- 186
Query: 175 TKYGPAVDMWSVGCIFAELL 194
+K+ A D+WS G EL
Sbjct: 187 SKFSSASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 55/189 (29%), Positives = 87/189 (46%), Gaps = 34/189 (17%)
Query: 94 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 153
F+ P+ Y ++ GL Y H N++++RD+K NLL+D EG +K+ADFGL +
Sbjct: 97 VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKE-GMGFG 155
Query: 154 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 213
+ + T + PE+L T Y AVD W +G + E+L G+ PG +E E I
Sbjct: 156 DRTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV 214
Query: 214 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI 273
DE +P R R A+ ++ ++L +P +R+
Sbjct: 215 N-----DEVRYP-------------------------RFLSREAISIMRRLLRRNPERRL 244
Query: 274 SA--KDALD 280
+ KDA D
Sbjct: 245 GSGEKDAED 253
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 5e-19
Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 30/205 (14%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
AR++ T +A+K+I + + P+ EI + L+H N+++
Sbjct: 27 ARDLSTQVRIAIKEIPERDSRYVQPLH--EEIALHSYLKHRNIVQYL------------- 71
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTG-----LADRPG-LRFTVPQIKCYMKQLLTGLHYCH 115
G+ + +F M+ G L + G L+ I Y KQ+L GL Y H
Sbjct: 72 ----GSDSENGFFKIF--MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH 125
Query: 116 VNQVLHRDIKGSNLLIDN-EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELL-LG 173
NQ++HRDIKG N+L++ G +K++DFG ++ + + T T TL Y PE++ G
Sbjct: 126 DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTG-TLQYMAPEVIDKG 184
Query: 174 ATKYGPAVDMWSVGCIFAELLNGKP 198
YG D+WS+GC E+ GKP
Sbjct: 185 PRGYGAPADIWSLGCTIVEMATGKP 209
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 8e-19
Identities = 76/302 (25%), Positives = 127/302 (42%), Gaps = 71/302 (23%)
Query: 1 MAREIKTGEIVALKK------IRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSP 54
+ R+ + ALK IR+ E+ E ++LK++ H +I+L
Sbjct: 19 LVRDRISEHYYALKVMAIPEVIRLKQEQH-----VHNEKRVLKEVSHPFIIRLF------ 67
Query: 55 GPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 114
E D++ YM+ EY+ R RF+ Y +++ L Y
Sbjct: 68 WTEHDQR----------FLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYL 117
Query: 115 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA 174
H ++++RD+K N+L+D EG++KL DFG A+ D TL T Y PE ++ +
Sbjct: 118 HSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR-DRTWTLCG---TPEYLAPE-VIQS 172
Query: 175 TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234
+ AVD W++G + E+L G P N KI L G + +P
Sbjct: 173 KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI--LAGKLE---FP--------- 218
Query: 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYF----W 285
RH D +A +L++K+L++D ++R+ A D + +F W
Sbjct: 219 ----------------RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW 262
Query: 286 TD 287
D
Sbjct: 263 DD 264
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 1e-18
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 26/216 (12%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
+ + + ALK++ + + + A+ EI+IL + H N+I KE
Sbjct: 19 VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL--------- 69
Query: 62 GRPDGNKYRGSTYMVFEYMD-HDLT-GLADRPGLRFTVPQ--IKCYMKQLLTGLHYCHVN 117
DGNK +V EY DL+ ++ R R +P+ I QLL GL H
Sbjct: 70 ---DGNKL----CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ 122
Query: 118 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLGATK 176
++LHRD+K +N+L+ +K+ D G+++ + I T Y PE+ G
Sbjct: 123 KILHRDLKSANILLVANDLVKIGDLGISKVLK----KNMAKTQIGTPHYMAPEVWKG-RP 177
Query: 177 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 212
Y D+WS+GC+ E+ P ++ + K+
Sbjct: 178 YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV 213
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 2e-18
Identities = 58/209 (27%), Positives = 89/209 (42%), Gaps = 24/209 (11%)
Query: 8 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 67
+ A+K+I + AI E ++L KL +I+ E
Sbjct: 25 KRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD-------------- 70
Query: 68 KYRGSTYMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 123
+G +V EY + H L L + G Q+ + Q+L GL + H ++LHRD
Sbjct: 71 --KGKLNIVMEYAENGDLHKL--LKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRD 126
Query: 124 IKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDM 183
IK NL +D N+K+ D G+A+ S D+ N V T +Y PE L Y D+
Sbjct: 127 IKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPE-LCEDKPYNEKSDV 184
Query: 184 WSVGCIFAELLNGKPILPGKNEAEQLSKI 212
W++G + E GK N+ + KI
Sbjct: 185 WALGVVLYECCTGKHPFDANNQGALILKI 213
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 69/280 (24%), Positives = 112/280 (40%), Gaps = 62/280 (22%)
Query: 3 REIKTGEIVALKKIRMDNEKE-GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
+ ALK ++ + E G E +IL++ H ++KL +D++
Sbjct: 13 KVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTF------KDKK 66
Query: 62 GRPDGNKYRGSTYMVFEYMD--------HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHY 113
YM+ EY D GL D RF Y+ ++ Y
Sbjct: 67 ----------YIYMLMEYCLGGELWTILRDR-GLFDEYTARF-------YIACVVLAFEY 108
Query: 114 CHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG 173
H +++RD+K NLL+D+ G +KL DFG A+ T T T Y PE++L
Sbjct: 109 LHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL-KSGQKTWT-FCGTPEYVAPEIILN 166
Query: 174 ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 233
Y +VD WS+G + ELL G+P P + E +I+ I G
Sbjct: 167 -KGYDFSVDYWSLGILLYELLTGRP--PFGEDDEDPMEIYND-------ILKGN-----G 211
Query: 234 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI 273
P + D+ A +L++++L +P +R+
Sbjct: 212 KLEFP------------NYIDKAAKDLIKQLLRRNPEERL 239
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 75/291 (25%), Positives = 130/291 (44%), Gaps = 50/291 (17%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
+ARE +G VA+K MD K+ E+ I++ QH+NV+++ + G E
Sbjct: 39 IAREKHSGRQVAVKM--MDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-GEE--- 92
Query: 61 QGRPDGNKYRGSTYMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQV 119
+++ E++ LT + + R QI + +L L Y H V
Sbjct: 93 ------------LWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGV 138
Query: 120 LHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGP 179
+HRDIK ++L+ +G +KL+DFG S D + V T ++ PE ++ T YG
Sbjct: 139 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR-KSLVGTPYWMAPE-VISRTPYGT 196
Query: 180 AVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239
VD+WS+G + E+++G+P + + + ++ + SP P
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD---SP-----------------PPK 236
Query: 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 290
++ V R F LE+ML +P +R +A++ LD + LP
Sbjct: 237 LKNAHKISPVLRDF-------LERMLTREPQERATAQELLDHPFLLQTGLP 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 3e-18
Identities = 77/262 (29%), Positives = 110/262 (41%), Gaps = 36/262 (13%)
Query: 32 EIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGL---- 87
EI L +L HEN++K++EI+ S +TYM+ + D DL
Sbjct: 213 EILALGRLNHENILKIEEILRSEA----------------NTYMITQKYDFDLYSFMYDE 256
Query: 88 ----ADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFG 143
DRP L+ Q + MKQLL + Y H +++HRDIK N+ ++ +G + L DFG
Sbjct: 257 AFDWKDRPLLK----QTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFG 312
Query: 144 LARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILP-- 201
A F + V T+ PE+L G Y D+WS G I ++L+ P
Sbjct: 313 TAMPFEKEREAFDYGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLS-HDFCPIG 370
Query: 202 --GKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHA-L 258
G +QL KI + DE K+ Y V + R+ A
Sbjct: 371 DGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADF 430
Query: 259 EL-LEKMLMLDPSQRISAKDAL 279
E L KML D R A + L
Sbjct: 431 EYPLVKMLTFDWHLRPGAAELL 452
|
Length = 501 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 4e-18
Identities = 70/257 (27%), Positives = 104/257 (40%), Gaps = 51/257 (19%)
Query: 2 AREIKTGEIVALKKIR----MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 57
A + G +VALKK++ MD + ++EI +LK+L H NVIK
Sbjct: 21 AICLLDGRVVALKKVQIFEMMDAKARQ---DCLKEIDLLKQLDHPNVIKYL--------- 68
Query: 58 RDEQGRPDGNKYRGSTYMVFEYMDH-DLTGL---ADRPGLRFTVPQIKCYMKQLLTGLHY 113
+V E D DL+ + + I Y QL + L +
Sbjct: 69 -------ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEH 121
Query: 114 CHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG 173
H +++HRDIK +N+ I G +KL D GL R FS + V T +Y PE +
Sbjct: 122 MHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERIHE 180
Query: 174 ATKYGPAVDMWSVGCIFAEL----------------LNGK------PILPGKNEAEQLSK 211
Y D+WS+GC+ E+ L K P LP + +E+L
Sbjct: 181 -NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRD 239
Query: 212 IFELCGSPDETIWPGVS 228
+ C +PD P +S
Sbjct: 240 LVSRCINPDPEKRPDIS 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 4e-18
Identities = 78/290 (26%), Positives = 123/290 (42%), Gaps = 57/290 (19%)
Query: 5 IKTGEIVALKKIRMDN------EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 58
G+++A+K++ +D EKE + E+ +LK L+H N IV G
Sbjct: 21 TNQGQLIAVKQVELDTSNVLAAEKEYEKLQ--EEVDLLKSLKHVN------IVQYLGTCL 72
Query: 59 DEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 118
D+ S +M F ++ + +R G P Y KQ+L G+ Y H N
Sbjct: 73 DDNTI--------SIFMEF-VPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 119 VLHRDIKGSNLLIDNEGNLKLADFGLAR-----SFSYDHNNTLTNRVITLWYRPPELLLG 173
V+HRDIKG+N+++ G +KL DFG AR H+N L + T ++ PE ++
Sbjct: 123 VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE-VIN 181
Query: 174 ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 233
+ YG D+WS+GC E+ GKP L ++L+ +F I MP
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGKPPL---ASMDRLAAMF--------YIGAHRGLMPRL 230
Query: 234 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 283
F A++ + L D +R SA L ++
Sbjct: 231 PD----------------SFSAAAIDFVTSCLTRDQHERPSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 4e-18
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 46/209 (22%)
Query: 5 IKTGEIVALKKIRMDNEKEGFPITAI-REIKILKKLQH---ENVIKLKEIVTSPGPERDE 60
+ TG +VALK I +D ++ I RE+ +L +L+ N+ K
Sbjct: 23 VPTGRVVALKIINLDTPD--DDVSDIQREVALLSQLRQSQPPNITK-------------- 66
Query: 61 QGRPDGNKYRGSTYM----VFEYMDHDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHY 113
Y GS Y+ ++ M++ G + G I ++++L L Y
Sbjct: 67 --------YYGS-YLKGPRLWIIMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKY 116
Query: 114 CHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL----WYRPPE 169
H V+HRDIK +N+L+ N GN+KL DFG+A N +++ T ++ PE
Sbjct: 117 IHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALL-----NQNSSKRSTFVGTPYWMAPE 171
Query: 170 LLLGATKYGPAVDMWSVGCIFAELLNGKP 198
++ Y D+WS+G E+ G P
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATGNP 200
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 5e-18
Identities = 70/235 (29%), Positives = 116/235 (49%), Gaps = 32/235 (13%)
Query: 4 EIKTGEIVALKKIRMD--NEKEGFPITAIR-EIKILKKLQHENVIKLKEIVTSPGPERDE 60
+ TG +A+K++ D +++ + A+ EI++LK L+H+ IV G RD
Sbjct: 23 DADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHD------RIVQYYGCLRDP 76
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLR----FTVPQIKCYMKQLLTGLHYCHV 116
+ + + EYM G + + L+ T + Y +Q+L G+ Y H
Sbjct: 77 EEK--------KLSIFVEYM----PGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS 124
Query: 117 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS--YDHNNTLTNRVITLWYRPPELLLGA 174
N ++HRDIKG+N+L D+ GN+KL DFG ++ + + T ++ PE++ G
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG- 183
Query: 175 TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWP-GVS 228
YG D+WSV C E+L KP E E ++ IF++ P + + P GVS
Sbjct: 184 EGYGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTKPMLPDGVS 235
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 5e-18
Identities = 56/193 (29%), Positives = 88/193 (45%), Gaps = 26/193 (13%)
Query: 7 TGEIVALKKIRMDNEK--EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 64
TGE+VA+KK++ + F REI+ILK LQH+N++K K + S G
Sbjct: 32 TGEVVAVKKLQHSTAEHLRDFE----REIEILKSLQHDNIVKYKGVCYSAG--------- 78
Query: 65 DGNKYRGSTYMVFEYM-DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 123
R + +V EY+ L + R ++ Y Q+ G+ Y + +HRD
Sbjct: 79 -----RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRD 133
Query: 124 IKGSNLLIDNEGNLKLADFGLARSFSYDHNN---TLTNRVITLWYRPPELLLGATKYGPA 180
+ N+L+++E +K+ DFGL + D WY P L +K+ A
Sbjct: 134 LATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPES--LTESKFSVA 191
Query: 181 VDMWSVGCIFAEL 193
D+WS G + EL
Sbjct: 192 SDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 8e-18
Identities = 67/249 (26%), Positives = 99/249 (39%), Gaps = 64/249 (25%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE---- 57
R+ TG++ A+K +R K ++K+ Q +V ++I+
Sbjct: 20 VRDKDTGQVYAMKVLR----KS----------DMIKRNQIAHVRAERDILADADSPWIVK 65
Query: 58 -----RDEQGRPDGNKYRGSTYMVFEYM-DHDLTGLADRPGLRFTVPQIKCYMKQLLTGL 111
+DE+ Y+V EYM DL L R F + Y+ +L+ L
Sbjct: 66 LYYSFQDEE----------HLYLVMEYMPGGDLMNLLIRKD-VFPEETARFYIAELVLAL 114
Query: 112 HYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF----------SYDHNNTLTNRVI 161
H +HRDIK N+LID +G++KLADFGL + + HN + V+
Sbjct: 115 DSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 162 TLW------------------YRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK 203
Y PE+L G T YG D WS+G I E+L G P
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSD 233
Query: 204 NEAEQLSKI 212
E +KI
Sbjct: 234 TLQETYNKI 242
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 1e-17
Identities = 55/184 (29%), Positives = 83/184 (45%), Gaps = 21/184 (11%)
Query: 12 ALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 71
A+K+IR+ + +E +L K++H N++ KE + G
Sbjct: 29 AMKEIRLPKSSSAVE-DSRKEAVLLAKMKHPNIVAFKESFEA----------------DG 71
Query: 72 STYMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 129
Y+V EY D + + + G F I + Q+ G+ + H +VLHRDIK N+
Sbjct: 72 HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNI 131
Query: 130 LIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCI 189
+ G +KL DFG AR + T V T +Y PPE+ Y D+WS+GCI
Sbjct: 132 FLTQNGKVKLGDFGSARLLTSPGAYACT-YVGTPYYVPPEIWEN-MPYNNKSDIWSLGCI 189
Query: 190 FAEL 193
EL
Sbjct: 190 LYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 73/279 (26%), Positives = 127/279 (45%), Gaps = 50/279 (17%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A ++ TG+ VA+K++ + + + I I EI ++++ +H N++
Sbjct: 38 AIDVATGQEVAIKQMNLQQQPKKELI--INEILVMRENKHPNIVNYL------------- 82
Query: 62 GRPDGNKYRGSTYMVFEYM-DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
D ++V EY+ LT + + QI ++ L L + H NQV+
Sbjct: 83 ---DSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQALEFLHSNQVI 137
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 180
HRDIK N+L+ +G++KL DFG + + + T V T ++ PE++ YGP
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVT-RKAYGPK 195
Query: 181 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240
VD+WS+G + E++ G+P P NE +P ++ + A N P
Sbjct: 196 VDIWSLGIMAIEMVEGEP--PYLNE------------NPLRALY-----LIATNG-TPEL 235
Query: 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 279
++ +FR F L + L +D +R SAK+ L
Sbjct: 236 QNPEKLSAIFRDF-------LNRCLEMDVEKRGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 21/201 (10%)
Query: 94 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 153
+F +P+ Y +++ GL + H +++RD+K N+L+D +G++K+ADFG+ +
Sbjct: 92 KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA 151
Query: 154 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 213
T T T Y PE+LLG KY +VD WS G + E+L G+ G +E E I
Sbjct: 152 KTCT-FCGTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI- 208
Query: 214 ELCGSPDETIWPGVSKMPAYNHF------KPSRTM--KRRVRE--VFRHFDRHALELLEK 263
D +P A + +P R + K +R+ FR D ALE E
Sbjct: 209 ----RMDNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWSALEERE- 263
Query: 264 MLMLDPSQRISAKDALDSEYF 284
++P + K A D F
Sbjct: 264 ---IEPPFKPKVKSANDCSNF 281
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 3e-17
Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 34/207 (16%)
Query: 2 AREIKTGEIVALKKIRM--DNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERD 59
A+ +TG A K I++ + E E F + EI IL + +H N++ L
Sbjct: 24 AQHKETGLFAAAKIIQIESEEELEDF----MVEIDILSECKHPNIVGLY----------- 68
Query: 60 EQGRPDGNKYRGSTYMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 118
+ Y +++ E+ D L + T PQI+ +Q+L L++ H ++
Sbjct: 69 -----EAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK 123
Query: 119 VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLWYRPPELLLGAT 175
V+HRD+K N+L+ +G++KLADFG+ S + +TL R + T ++ PE++ T
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGV----SAKNKSTLQKRDTFIGTPYWMAPEVVACET 179
Query: 176 ----KYGPAVDMWSVGCIFAELLNGKP 198
Y D+WS+G EL +P
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQMEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 4e-17
Identities = 58/198 (29%), Positives = 90/198 (45%), Gaps = 35/198 (17%)
Query: 7 TGEIVALKKIRMDN---EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGR 63
TGE+VA+K ++ + G+ +EI ILK L HEN++K K + G +
Sbjct: 32 TGEMVAVKTLKRECGQQNTSGW----KKEINILKTLYHENIVKYKGCCSEQGGK------ 81
Query: 64 PDGNKYRGSTYMVFEYMDHDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHR 122
++ EY+ L L D P + + Q+ + +Q+ G+ Y H +HR
Sbjct: 82 --------GLQLIMEYVP--LGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHR 131
Query: 123 DIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI------TLWYRPPELLLGATK 176
D+ N+L+DN+ +K+ DFGLA++ H RV WY L K
Sbjct: 132 DLAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFWYAVE--CLKENK 186
Query: 177 YGPAVDMWSVGCIFAELL 194
+ A D+WS G ELL
Sbjct: 187 FSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 5e-17
Identities = 64/217 (29%), Positives = 93/217 (42%), Gaps = 27/217 (12%)
Query: 2 AREIKTGEIVALKKIRMD-NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
TG+I+A+K IR++ NE I +RE+ IL K IV G +
Sbjct: 20 VLHRPTGKIMAVKTIRLEINEAIQKQI--LRELDILHKCNSPY------IVGFYGAFYNN 71
Query: 61 QGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH-VNQ 118
G + EYMD L + R + +L GL Y H ++
Sbjct: 72 ----------GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK 121
Query: 119 VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYG 178
++HRD+K SN+L+++ G +KL DFG++ T V T Y PE + G Y
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF---VGTSSYMAPERIQG-NDYS 177
Query: 179 PAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 215
D+WS+G EL G+ P E + IFEL
Sbjct: 178 VKSDIWSLGLSLIELATGR--FPYPPENDPPDGIFEL 212
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 5e-17
Identities = 52/182 (28%), Positives = 84/182 (46%), Gaps = 32/182 (17%)
Query: 94 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 153
RF P+ + Y +++ GL + H +++RD+K N+L+D+EG++K+ADFG+ +
Sbjct: 92 RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV 151
Query: 154 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 213
T T T Y PE+L YGPAVD W++G + E+L G+ G +E E I
Sbjct: 152 TTST-FCGTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL 209
Query: 214 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI 273
E DE +P R + A +L+ L +P +R+
Sbjct: 210 E-----DEVRYP-------------------------RWLSKEAKSILKSFLTKNPEKRL 239
Query: 274 SA 275
Sbjct: 240 GC 241
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 6e-17
Identities = 74/284 (26%), Positives = 125/284 (44%), Gaps = 50/284 (17%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A ++ TG+ VA+K+I + + + I I EI ++K+L++ N++
Sbjct: 38 AIDVATGQEVAIKQINLQKQPKKELI--INEILVMKELKNPNIVNFL------------- 82
Query: 62 GRPDGNKYRGSTYMVFEYM-DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
D ++V EY+ LT + + QI ++ L L + H NQV+
Sbjct: 83 ---DSFLVGDELFVVMEYLAGGSLTDVVTETCM--DEAQIAAVCRECLQALEFLHANQVI 137
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 180
HRDIK N+L+ +G++KL DFG + + + T V T ++ PE++ YGP
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVT-RKAYGPK 195
Query: 181 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240
VD+WS+G + E++ G+P +N L I A N P
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------------------ATNG-TPEL 235
Query: 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
++ +FR F L + L +D +R SAK+ L +
Sbjct: 236 QNPEKLSPIFRDF-------LNRCLEMDVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 1e-16
Identities = 48/204 (23%), Positives = 87/204 (42%), Gaps = 29/204 (14%)
Query: 16 IRMDNE----KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 71
I+M E ++ F I E K++ KL H N+++L + T P
Sbjct: 33 IKMIREGAMSEDDF----IEEAKVMMKLSHPNLVQLYGVCTKQRP--------------- 73
Query: 72 STYMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 129
++V EYM + L L +R G + + + + Y N +HRD+ N
Sbjct: 74 -IFIVTEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNC 131
Query: 130 LIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCI 189
L+ + +K++DFGLAR D + + + PPE+ +++ D+WS G +
Sbjct: 132 LVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFD-YSRFSSKSDVWSFGVL 190
Query: 190 FAELLN-GKPILPGKNEAEQLSKI 212
E+ + GK + +E + +
Sbjct: 191 MWEVFSEGKMPYERFSNSEVVESV 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 47/189 (24%), Positives = 86/189 (45%), Gaps = 33/189 (17%)
Query: 94 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 153
FT +++ Y+ +++ L + H +++RDIK N+L+D+EG++ L DFGL++ F +
Sbjct: 101 HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160
Query: 154 NTLTNRVITLWYRPPELLLGATK-YGPAVDMWSVGCIFAELLNGKP---ILPGKNEAEQL 209
+ T+ Y PE++ G + + AVD WS+G + ELL G + +N ++
Sbjct: 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI 220
Query: 210 SKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDP 269
S+ P P + A + ++K+L DP
Sbjct: 221 SRRILKSKPP----------FP-------------------KTMSAEARDFIQKLLEKDP 251
Query: 270 SQRISAKDA 278
+R+ A A
Sbjct: 252 KKRLGANGA 260
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 69/229 (30%), Positives = 108/229 (47%), Gaps = 19/229 (8%)
Query: 74 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 132
Y V EY++ DL + G +F PQ Y ++ GL + H +++RD+K N+++D
Sbjct: 77 YFVMEYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLD 135
Query: 133 NEGNLKLADFGLARSFSYDHNNTLTNRVI--TLWYRPPELLLGATKYGPAVDMWSVGCIF 190
+EG++K+ADFG+ + D +T R T Y PE ++ YG +VD W+ G +
Sbjct: 136 SEGHIKIADFGMCKEHMVD---GVTTRTFCGTPDYIAPE-IIAYQPYGKSVDWWAYGVLL 191
Query: 191 AELLNGKPILPGKNEAEQLSKIFELCGS-PDETIWPGVSKMPAYNHFKPSRTM------K 243
E+L G+P G++E E I E S P VS PS+ + +
Sbjct: 192 YEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGE 251
Query: 244 RRVRE--VFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 290
R +RE FR D LE E P ++ K A + + F+T P
Sbjct: 252 RDIREHAFFRRIDWDKLENREIQPPFKP--KVCGKGAENFDKFFTRGQP 298
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 68/280 (24%), Positives = 108/280 (38%), Gaps = 39/280 (13%)
Query: 22 KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81
K G T + E +L+ + H +VI++K+ + T MV +
Sbjct: 97 KIGQKGTTLIEAMLLQNVNHPSVIRMKDTLV----------------SGAITCMVLPHYS 140
Query: 82 HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLAD 141
DL + + Q KQ+L GL Y H +++HRD+K N+ I++ + + D
Sbjct: 141 SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGD 200
Query: 142 FGLARSFSYDHNNT-LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELL------ 194
G A+ L V T PE+L KY D+WS G + E+L
Sbjct: 201 LGAAQFPVVAPAFLGLAGTVET---NAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTI 256
Query: 195 ----NGKPILPGKNEAEQLSKIFELCG-SPDETIWPGVSKMPAYNHFKPSRTMKRRVREV 249
P K+ L KI P+E +P F +++R+
Sbjct: 257 FEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE--FPRDPGSRLVRGFIEYASLERQPYTR 314
Query: 250 FRHFDRHALE-----LLEKMLMLDPSQRISAKDALDSEYF 284
+ F R L L+ KML D + R SA++ L+ F
Sbjct: 315 YPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMF 354
|
Length = 357 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 52/167 (31%), Positives = 76/167 (45%), Gaps = 12/167 (7%)
Query: 72 STYMVFEYM-DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 130
+ Y+V EY DL L +R +F + Y+ +L+ +H H +HRDIK N+L
Sbjct: 75 NLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVL 134
Query: 131 IDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL-----GATKYGPAVDMWS 185
ID G++KLADFG A + + V T Y PE+L G YG D WS
Sbjct: 135 IDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWS 194
Query: 186 VGCIFAELLNGKPILPGKNEAEQLSKIF---ELCGSPDETIWPGVSK 229
+G I E++ G+ A+ + I P++ P VS
Sbjct: 195 LGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPED---PKVSS 238
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 4e-16
Identities = 55/195 (28%), Positives = 91/195 (46%), Gaps = 25/195 (12%)
Query: 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPD 65
TGE VA+K ++ ++ +EI+IL+ L HEN++K K I T ++ G
Sbjct: 31 NTGEQVAVKSLKPESGGNHIA-DLKKEIEILRNLYHENIVKYKGICT------EDGGN-- 81
Query: 66 GNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 124
++ E++ L R + + Q Y Q+ G+ Y Q +HRD+
Sbjct: 82 ------GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDL 135
Query: 125 KGSNLLIDNEGNLKLADFGLARSFSYDH-----NNTLTNRVITLWYRPPELLLGATKYGP 179
N+L+++E +K+ DFGL ++ D + L + V WY P L+ +K+
Sbjct: 136 AARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPV--FWYAPECLI--QSKFYI 191
Query: 180 AVDMWSVGCIFAELL 194
A D+WS G ELL
Sbjct: 192 ASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 85/321 (26%), Positives = 128/321 (39%), Gaps = 78/321 (24%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIK----ILKKLQHENVIKLKEIVTSPGP 56
+A++ TGEIVALK RM + F + +R + IL + E ++KL
Sbjct: 19 LAKKKDTGEIVALK--RM-KKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE- 74
Query: 57 ERDEQGRPDGNKYRGSTYMVFEYM-DHDL------TGLADRPGLRFTVPQIKCYMKQLLT 109
Y+ EY+ D G+ RF YM ++
Sbjct: 75 ---------------YLYLAMEYVPGGDFRTLLNNLGVLSEDHARF-------YMAEMFE 112
Query: 110 GLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPP 168
+ H +HRD+K N LID G++KL DFGL++ T N V+ + Y P
Sbjct: 113 AVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV-----TYANSVVGSPDYMAP 167
Query: 169 ELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 228
E+L G Y VD WS+GC+ E L G P G P+ET
Sbjct: 168 EVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGST--------------PNET------ 206
Query: 229 KMPAYNHFKPSRTMKRRVREVFRHF---DRHALELLEKMLMLDPSQRI-SAKDALDSEYF 284
+ + K + +R F D A +L+ K++ DPS+R S +D + +F
Sbjct: 207 ----WENLKYWKETLQRPVYDDPRFNLSDE-AWDLITKLIN-DPSRRFGSLEDIKNHPFF 260
Query: 285 ----WTDPLPCDPKSLPKYES 301
W + P +P+ ES
Sbjct: 261 KEVDWNELRELKPPFVPELES 281
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 8e-16
Identities = 68/220 (30%), Positives = 104/220 (47%), Gaps = 36/220 (16%)
Query: 2 AREIKTGEIVALKKI----RMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 57
AR+++T E+VA+KK+ + NEK I+E++ L++L+H N I+ K
Sbjct: 34 ARDVRTNEVVAIKKMSYSGKQSNEKWQ---DIIKEVRFLQQLRHPNTIEYK--------- 81
Query: 58 RDEQGRPDGNKYRGST-YMVFEYMDHDLTGLAD--RPGLRFTVPQIKCYMKQLLTGLHYC 114
G R T ++V EY + + + + L+ +I L GL Y
Sbjct: 82 --------GCYLREHTAWLVMEYCLGSASDILEVHKKPLQEV--EIAAICHGALQGLAYL 131
Query: 115 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA 174
H ++ +HRDIK N+L+ G +KLADFG A S N+ V T ++ PE++L
Sbjct: 132 HSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS--PANSF---VGTPYWMAPEVILAM 186
Query: 175 T--KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 212
+Y VD+WS+G EL KP L N L I
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 77/275 (28%), Positives = 116/275 (42%), Gaps = 36/275 (13%)
Query: 32 EIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDL-TGLADR 90
E IL+ + H ++I+LK T Y T ++ DL LA +
Sbjct: 133 EAHILRAINHPSIIQLKGTFT----------------YNKFTCLILPRYKTDLYCYLAAK 176
Query: 91 PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 150
+ I + +L + Y H N+++HRDIK N+ I++ G++ L DFG A F
Sbjct: 177 R--NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFG-AACFPV 233
Query: 151 DHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNG------KPILPGK 203
D N N T+ PE LL YGPAVD+WS G + E+ K L G
Sbjct: 234 DINANKYYGWAGTIATNAPE-LLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGD 292
Query: 204 NEAE-QLSKIFELCGS-PDE-TIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALE- 259
+++ Q+ I G+ P+E I + Y + K R ++ + ++
Sbjct: 293 CDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDL 352
Query: 260 --LLEKMLMLDPSQRISAKDALDSEYFWT--DPLP 290
L+ KML D R SA+ LD F DP P
Sbjct: 353 EYLICKMLAFDAHHRPSAEALLDFAAFQDIPDPYP 387
|
Length = 391 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 67/218 (30%), Positives = 100/218 (45%), Gaps = 32/218 (14%)
Query: 2 AREIKTGEIVALKKI----RMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 57
AR+++T E+VA+KK+ + NEK I+E+K L++++H N I+ K
Sbjct: 44 ARDVRTNEVVAIKKMSYSGKQSNEKWQ---DIIKEVKFLQRIKHPNSIEYK--------- 91
Query: 58 RDEQGRPDGNKYRGST-YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 116
G R T ++V EY + L + +I L GL Y H
Sbjct: 92 --------GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS 143
Query: 117 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT- 175
+ ++HRDIK N+L+ G +KLADFG A S + V T ++ PE++L
Sbjct: 144 HNMIHRDIKAGNILLTEPGQVKLADFGSASIAS-----PANSFVGTPYWMAPEVILAMDE 198
Query: 176 -KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 212
+Y VD+WS+G EL KP L N L I
Sbjct: 199 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 236
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 34/206 (16%)
Query: 1 MAREIKTGEIVALKKI---RMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 56
+ + + G+ +K+I +M E+E + +E+ +L ++H N+++ +E
Sbjct: 18 LVKSKEDGKQYVIKEINISKMSPKERE----ESRKEVAVLSNMKHPNIVQYQESFEE--- 70
Query: 57 ERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLAD-RPGLRFTVPQIKCYMKQLLTGLHYC 114
G+ Y+V +Y + DL + + G+ F QI + Q+ L +
Sbjct: 71 -------------NGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHV 117
Query: 115 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT--LTNRVI-TLWYRPPELL 171
H ++LHRDIK N+ + +G +KL DFG+AR N+T L I T +Y PE+
Sbjct: 118 HDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL----NSTVELARTCIGTPYYLSPEIC 173
Query: 172 LGATKYGPAVDMWSVGCIFAELLNGK 197
Y D+W++GC+ E+ K
Sbjct: 174 EN-RPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 59/220 (26%), Positives = 104/220 (47%), Gaps = 28/220 (12%)
Query: 94 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 153
+F P+ + Y ++ L + H + V++RD+K N+L+D EG+ KLADFG+ + +
Sbjct: 92 KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKE-GILNG 150
Query: 154 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 213
T T T Y PE +L +YGP+VD W++G + E++ G+P NE + I
Sbjct: 151 VTTTTFCGTPDYIAPE-ILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL 209
Query: 214 ELCGSPDETIWP------GVSKMPAY---NHFK-----PSRTMKRRVRE--VFRHFDRHA 257
D+ ++P VS + A+ N K S+ + +++ F+ D
Sbjct: 210 H-----DDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVL 264
Query: 258 LELLEKMLMLDPSQRISAKDA--LDSEYFWTDPL--PCDP 293
LE + P + + +D D ++ +P+ P DP
Sbjct: 265 LEQRKIKPPFKPKIK-TKRDVNNFDQDFTKEEPVLTPVDP 303
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 73/282 (25%), Positives = 124/282 (43%), Gaps = 56/282 (19%)
Query: 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDG 66
+G++VA+KK MD K+ E+ I++ QHENV+++
Sbjct: 44 SGKLVAVKK--MDLRKQQRRELLFNEVVIMRDYQHENVVEMY------------------ 83
Query: 67 NKYR--GSTYMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 123
N Y ++V E+++ LT + R QI +L L H V+HRD
Sbjct: 84 NSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQGVIHRD 141
Query: 124 IKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDM 183
IK ++L+ ++G +KL+DFG S + + V T ++ PE L+ YGP VD+
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR-KSLVGTPYWMAPE-LISRLPYGPEVDI 199
Query: 184 WSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY-NHFKPSRTM 242
WS+G + E+++G+P P NE P + M ++ P
Sbjct: 200 WSLGIMVIEMVDGEP--PYFNE-------------------PPLKAMKMIRDNLPPKLKN 238
Query: 243 KRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
+V + F L+++L+ DP+QR +A + L +
Sbjct: 239 LHKVSPSLKGF-------LDRLLVRDPAQRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 2e-15
Identities = 74/284 (26%), Positives = 124/284 (43%), Gaps = 50/284 (17%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A +I TG+ VA+K++ + + + I I EI ++++ ++ N++
Sbjct: 38 AIDIATGQEVAIKQMNLQQQPKKELI--INEILVMRENKNPNIVNYL------------- 82
Query: 62 GRPDGNKYRGSTYMVFEYM-DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
D ++V EY+ LT + + QI ++ L L + H NQV+
Sbjct: 83 ---DSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALDFLHSNQVI 137
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 180
HRDIK N+L+ +G++KL DFG + + + T V T ++ PE++ YGP
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVT-RKAYGPK 195
Query: 181 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240
VD+WS+G + E++ G+P +N L I A N P
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------------------ATNG-TPEL 235
Query: 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
R+ VFR F L + L +D +R SAK+ L +
Sbjct: 236 QNPERLSAVFRDF-------LNRCLEMDVDRRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 25/222 (11%)
Query: 94 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 153
RF + + Y ++ + L + H +++RD+K N+L+D+EG+ KLADFG+ + ++
Sbjct: 92 RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK 151
Query: 154 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 213
T T T Y PE +L YGP+VD W++G + E+L G +NE + I
Sbjct: 152 TTST-FCGTPDYIAPE-ILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL 209
Query: 214 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVR----------EVFRH--FDRHALELL 261
DE ++P A + K T +R + RH F E L
Sbjct: 210 N-----DEVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKL 264
Query: 262 EKMLMLDP-SQRISAKDAL---DSEYFWTDPL--PCDPKSLP 297
+ + P RI +++ + D ++ DP+ P + LP
Sbjct: 265 NRRQIEPPFRPRIKSREDVSNFDPDFIKEDPVLTPIEESLLP 306
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 3e-15
Identities = 71/281 (25%), Positives = 114/281 (40%), Gaps = 56/281 (19%)
Query: 9 EIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 68
+ LK+I + + A +E ++L KL H ++K + ERD
Sbjct: 29 RLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFH----ASFLERD--------- 75
Query: 69 YRGSTYMVFEYM-DHDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 124
+ ++ EY DL + G + Q+ + QLL G+HY H ++LHRD+
Sbjct: 76 ---AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDL 132
Query: 125 KGSNLLIDNEGNLKLADFGLARSF--SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVD 182
K N+ + N LK+ DFG++R S D T T T +Y PE L Y D
Sbjct: 133 KAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTG---TPYYMSPE-ALKHQGYDSKSD 187
Query: 183 MWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTM 242
+WS+GCI E+ G+N + +I E P+ ++
Sbjct: 188 IWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE----------------------GPTPSL 225
Query: 243 KRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 283
+ R +++ ML DPS R SA + L + +
Sbjct: 226 PET-------YSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 4e-15
Identities = 61/202 (30%), Positives = 92/202 (45%), Gaps = 24/202 (11%)
Query: 31 REIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLAD 89
+E+ +L K++H N++ E GR ++V EY D DL +
Sbjct: 48 KEVILLAKMKHPNIVTFFASF-------QENGR---------LFIVMEYCDGGDLMKRIN 91
Query: 90 RP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL-KLADFGLARS 147
R G+ F+ QI + Q+ GL + H ++LHRDIK N+ + G + KL DFG+AR
Sbjct: 92 RQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ 151
Query: 148 FSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAE 207
+ D V T +Y PE+ Y D+WS+GC+ EL K G N
Sbjct: 152 LN-DSMELAYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEG-NNLH 208
Query: 208 QLSKIFELCGSPDETIWPGVSK 229
QL + ++C I P S+
Sbjct: 209 QL--VLKICQGYFAPISPNFSR 228
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 4e-15
Identities = 78/288 (27%), Positives = 124/288 (43%), Gaps = 56/288 (19%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
+A E TG+ VA+KK MD K+ E+ I++ HENV+ +
Sbjct: 40 IATEKHTGKQVAVKK--MDLRKQQRRELLFNEVVIMRDYHHENVVDMY------------ 85
Query: 61 QGRPDGNKYR--GSTYMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 117
N Y ++V E+++ LT + R QI +L L Y H
Sbjct: 86 ------NSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQ 137
Query: 118 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 177
V+HRDIK ++L+ ++G +KL+DFG S + + V T ++ PE ++ Y
Sbjct: 138 GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR-KSLVGTPYWMAPE-VISRLPY 195
Query: 178 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237
G VD+WS+G + E+++G+P P NE P + M
Sbjct: 196 GTEVDIWSLGIMVIEMIDGEP--PYFNE-------------------PPLQAMRRIRDNL 234
Query: 238 PSRTMK-RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
P R +V V R F L+ ML+ +PSQR +A++ L +
Sbjct: 235 PPRVKDSHKVSSVLRGF-------LDLMLVREPSQRATAQELLQHPFL 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 7e-15
Identities = 46/142 (32%), Positives = 75/142 (52%), Gaps = 4/142 (2%)
Query: 74 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 132
Y V EY++ DL + G +F P Y ++ GL + H +++RD+K N+++D
Sbjct: 77 YFVMEYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD 135
Query: 133 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 192
EG++K+ADFG+ + + T T T Y PE++ YG +VD W+ G + E
Sbjct: 136 AEGHIKIADFGMCKENIFGGKTTRT-FCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYE 193
Query: 193 LLNGKPILPGKNEAEQLSKIFE 214
+L G+P G++E E I E
Sbjct: 194 MLAGQPPFDGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 74.8 bits (183), Expect = 7e-15
Identities = 53/186 (28%), Positives = 86/186 (46%), Gaps = 29/186 (15%)
Query: 99 QIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158
QI ++ L L + H NQV+HRDIK N+L+ +G++KL DFG + + + +
Sbjct: 117 QIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-ST 175
Query: 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS 218
V T ++ PE++ YGP VD+WS+G + E++ G+P +N L I
Sbjct: 176 MVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------ 228
Query: 219 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDA 278
A N P ++ +FR F L + L +D +R SAK+
Sbjct: 229 -------------ATNG-TPELQNPEKLSAIFRDF-------LNRCLDMDVEKRGSAKEL 267
Query: 279 LDSEYF 284
L ++
Sbjct: 268 LQHQFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 8e-15
Identities = 63/223 (28%), Positives = 97/223 (43%), Gaps = 42/223 (18%)
Query: 2 AREIKTGEIVALKKI----RMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 57
AR+++ E+VA+KK+ + NEK I+E++ L+KL+H N I+
Sbjct: 34 ARDVRNSEVVAIKKMSYSGKQSNEKWQ---DIIKEVRFLQKLRHPNTIQ----------- 79
Query: 58 RDEQGRPDGNKYRG------STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGL 111
YRG + ++V EY + L + +I L GL
Sbjct: 80 -----------YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 112 HYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELL 171
Y H + ++HRD+K N+L+ G +KL DFG A + V T ++ PE++
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANXFVGTPYWMAPEVI 183
Query: 172 LGAT--KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 212
L +Y VD+WS+G EL KP L N L I
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 8e-15
Identities = 70/251 (27%), Positives = 108/251 (43%), Gaps = 51/251 (20%)
Query: 8 GEIVALKKIR----MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGR 63
G VALKK++ MD + I+EI +LK+L H NVIK E +E
Sbjct: 27 GVPVALKKVQIFDLMDAKARA---DCIKEIDLLKQLNHPNVIKYYASFI----EDNELN- 78
Query: 64 PDGNKYRGSTYMVFEYMDH-DLTGLADR-PGLRFTVPQ--IKCYMKQLLTGLHYCHVNQV 119
+V E D DL+ + + +P+ + Y QL + L + H +V
Sbjct: 79 -----------IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRV 127
Query: 120 LHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGP 179
+HRDIK +N+ I G +KL D GL R FS + V T +Y PE + Y
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPE-RIHENGYNF 185
Query: 180 AVDMWSVGCIFAELLNGK----------------------PILPGKNEAEQLSKIFELCG 217
D+WS+GC+ E+ + P LP + +E+L ++ +C
Sbjct: 186 KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCI 245
Query: 218 SPDETIWPGVS 228
+PD P ++
Sbjct: 246 NPDPEKRPDIT 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 9e-15
Identities = 58/224 (25%), Positives = 97/224 (43%), Gaps = 39/224 (17%)
Query: 94 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 153
RF + + Y +++ GL + H +++RD+K N+++D +G++K+ADFG+ + + N
Sbjct: 92 RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN 151
Query: 154 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 213
T T Y PE+L G KY +VD WS G + E+L G+ G +E E I
Sbjct: 152 RAST-FCGTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI- 208
Query: 214 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI 273
D +P R + + ++LEK+ DP++R+
Sbjct: 209 ----RVDTPHYP-------------------------RWITKESKDILEKLFERDPTRRL 239
Query: 274 SAKDALDSEYF-----WT--DPLPCDPKSLPKYESSHEYQTKKR 310
+ F WT + DP PK +S +Y R
Sbjct: 240 GVVGNIRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNFDR 283
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 39/221 (17%)
Query: 93 LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 152
RF + + Y +++ GL + H +++RD+K N+L+D +G++K+ADFG+ +
Sbjct: 91 GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE 150
Query: 153 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 212
T T Y PE+L G KY +VD WS G + E+L G+ G++E
Sbjct: 151 GKAST-FCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDE------- 201
Query: 213 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR 272
DE ++ P + P R + A + L K+ DP++R
Sbjct: 202 -------DELFDSILNDRPHF----P------------RWISKEAKDCLSKLFERDPTKR 238
Query: 273 ISAK-DALDSEYF----WT--DPLPCDPKSLPKYESSHEYQ 306
+ D +F W + P PK +S +
Sbjct: 239 LGVDGDIRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDAS 279
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 67/261 (25%), Positives = 110/261 (42%), Gaps = 48/261 (18%)
Query: 95 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 154
F+ + + Y ++++ L Y H V++RD+K NL++D +G++K+ DFGL +
Sbjct: 92 FSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKE-GISDGA 150
Query: 155 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 214
T+ T Y PE +L YG AVD W +G + E++ G+ LP N+ + K+FE
Sbjct: 151 TMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE--KLFE 205
Query: 215 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI- 273
L I + P R A LL +L DP QR+
Sbjct: 206 L-------ILMEEIRFP-------------------RTLSPEAKSLLAGLLKKDPKQRLG 239
Query: 274 ----SAKDALDSEYF----WTDPLPCDPKSLPKYESSHEYQTKKRRQQQRQHEEATKRQ- 324
AK+ ++ +F W D + K P ++ +T R EE T +
Sbjct: 240 GGPEDAKEIMEHRFFASINWQDVV--QKKLEPPFKPQVTSETDTRYFD----EEFTAQSI 293
Query: 325 KLHHPQPHGRLPPIQHAGQSH 345
+ P + L +Q + H
Sbjct: 294 TITPPDRYDSLGLLQLEERPH 314
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 56/211 (26%), Positives = 91/211 (43%), Gaps = 35/211 (16%)
Query: 11 VALKKIR---MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 67
VA+K ++ M E F ++E +I+KKL+H+ +++L + + + P
Sbjct: 33 VAVKTLKPGTMS--PEAF----LQEAQIMKKLRHDKLVQLYAVCS--------EEEP--- 75
Query: 68 KYRGSTYMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIK 125
Y+V EYM L L G + +PQ+ Q+ G+ Y +HRD+
Sbjct: 76 -----IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLA 130
Query: 126 GSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGP---AVD 182
N+L+ K+ADFGLAR D + + PE A YG D
Sbjct: 131 ARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPE----AANYGRFTIKSD 186
Query: 183 MWSVGCIFAELLN-GKPILPGKNEAEQLSKI 212
+WS G + E++ G+ PG E L ++
Sbjct: 187 VWSFGILLTEIVTYGRVPYPGMTNREVLEQV 217
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 74/261 (28%), Positives = 100/261 (38%), Gaps = 34/261 (13%)
Query: 31 REIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADR 90
REI ILK + H +I L +++ + MV DL DR
Sbjct: 135 REIDILKTISHRAIINLI----------------HAYRWKSTVCMVMPKYKCDLFTYVDR 178
Query: 91 PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 150
G + Q ++LL L Y H ++HRD+K N+ +D N L DFG A
Sbjct: 179 SG-PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD- 236
Query: 151 DHNNTLTNR--VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK---NE 205
H +T TL PE LL Y D+WS G + E+ L GK +
Sbjct: 237 AHPDTPQCYGWSGTLETNSPE-LLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSS 295
Query: 206 AEQLSKIFELCGSPDETIWPGVSKMPAYNHFK-------PSRTMKRRVREVFRHFDRHAL 258
+ QL I C +P HFK P T+ +R+ H D
Sbjct: 296 SSQLRSIIR-CMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMD--VE 352
Query: 259 ELLEKMLMLDPSQRISAKDAL 279
L+ KML D R SA+D L
Sbjct: 353 YLIAKMLTFDQEFRPSAQDIL 373
|
Length = 392 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 42/211 (19%)
Query: 2 AREIKTGEIVALKKI--RMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERD 59
A+ +TG + A K I + + E E + + EI IL H N++KL
Sbjct: 24 AQNKETGVLAAAKVIDTKSEEELEDYMV----EIDILASCDHPNIVKLL----------- 68
Query: 60 EQGRPDGNKYRGSTYMVFEY-----MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 114
D Y + +++ E+ +D + L +RP T PQI+ KQ L L+Y
Sbjct: 69 -----DAFYYENNLWILIEFCAGGAVDAVMLEL-ERP---LTEPQIRVVCKQTLEALNYL 119
Query: 115 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLWYRPPELL 171
H N+++HRD+K N+L +G++KLADFG+ S + T+ R + T ++ PE++
Sbjct: 120 HENKIIHRDLKAGNILFTLDGDIKLADFGV----SAKNTRTIQRRDSFIGTPYWMAPEVV 175
Query: 172 LGATK----YGPAVDMWSVGCIFAELLNGKP 198
+ T Y D+WS+G E+ +P
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIEMAQIEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 34/207 (16%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A+ +TG + A K I +E+E + EI+IL H ++KL
Sbjct: 31 AKNKETGALAAAKVIETKSEEE--LEDYMVEIEILATCNHPYIVKLL------------- 75
Query: 62 GRPDGNKYRGSTYMVFEYMDH---DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 118
+ G +++ E+ D L GL T PQI+ +Q+L L Y H +
Sbjct: 76 ---GAFYWDGKLWIMIEFCPGGAVDAIMLELDRGL--TEPQIQVICRQMLEALQYLHSMK 130
Query: 119 VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLWYRPPELLLGAT 175
++HRD+K N+L+ +G++KLADFG+ S + TL R + T ++ PE+++ T
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGV----SAKNVKTLQRRDSFIGTPYWMAPEVVMCET 186
Query: 176 ----KYGPAVDMWSVGCIFAELLNGKP 198
Y D+WS+G E+ +P
Sbjct: 187 MKDTPYDYKADIWSLGITLIEMAQIEP 213
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 47/142 (33%), Positives = 76/142 (53%), Gaps = 4/142 (2%)
Query: 74 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 132
Y V EY++ DL + G RF P Y ++ GL + H +++RD+K N+++D
Sbjct: 77 YFVMEYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD 135
Query: 133 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 192
+EG++K+ADFG+ + +D T T T Y PE ++ YG +VD W+ G + E
Sbjct: 136 SEGHIKIADFGMCKENMWDGVTTKT-FCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYE 193
Query: 193 LLNGKPILPGKNEAEQLSKIFE 214
+L G+ G++E E I E
Sbjct: 194 MLAGQAPFEGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 38/207 (18%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
TG + ALK I N ++ REI+IL+ + H NV+K ++ +
Sbjct: 92 KVIHRPTGRLYALKVI-YGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF--------D 142
Query: 61 QGRPDGNKYRGSTYMVFEYMDH---DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 117
G ++ E+MD + T +AD + +Q+L+G+ Y H
Sbjct: 143 HN--------GEIQVLLEFMDGGSLEGTHIADEQ-------FLADVARQILSGIAYLHRR 187
Query: 118 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTL---TNRVITLWYRPPELL--- 171
++HRDIK SNLLI++ N+K+ADFG++R T+ + V T+ Y PE +
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRIL----AQTMDPCNSSVGTIAYMSPERINTD 243
Query: 172 LGATKY-GPAVDMWSVGCIFAELLNGK 197
L Y G A D+WS+G E G+
Sbjct: 244 LNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 57/189 (30%), Positives = 84/189 (44%), Gaps = 36/189 (19%)
Query: 94 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR--SFSYD 151
RF + + + Y +LL L H V++RD+K N+L+D +G++ L DFGL + D
Sbjct: 89 RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD 148
Query: 152 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSK 211
NT T Y PELLLG Y AVD W++G + E+L G P +N E K
Sbjct: 149 KTNTFCG---TPEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRK 204
Query: 212 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ 271
I + + +P FDR A +LL +L DP++
Sbjct: 205 ILQ-----EPLRFPD-------------------------GFDRDAKDLLIGLLSRDPTR 234
Query: 272 RISAKDALD 280
R+ A +
Sbjct: 235 RLGYNGAQE 243
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 62/225 (27%), Positives = 100/225 (44%), Gaps = 43/225 (19%)
Query: 95 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 154
FT + + Y ++++ L Y H V++RDIK NL++D +G++K+ DFGL + D
Sbjct: 92 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GA 150
Query: 155 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 214
T+ T Y PE+L YG AVD W +G + E++ G+ LP N+ + ++FE
Sbjct: 151 TMKTFCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE--RLFE 205
Query: 215 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI- 273
L +E +P R A LL +L DP QR+
Sbjct: 206 LI-LMEEIRFP-------------------------RTLSPEAKSLLAGLLKKDPKQRLG 239
Query: 274 ----SAKDALDSEYF----WTDPLPCDPKSLPKYESSHEYQTKKR 310
AK+ ++ +F W D + K LP ++ + R
Sbjct: 240 GGPSDAKEVMEHRFFLSINWQDVV--QKKLLPPFKPQVTSEVDTR 282
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 6e-14
Identities = 58/203 (28%), Positives = 82/203 (40%), Gaps = 30/203 (14%)
Query: 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDG 66
TG I ALK I D + +RE++I K + IV G DE
Sbjct: 25 TGMIFALKTITTDPNPD-LQKQILRELEINKSCKSPY------IVKYYGAFLDES----- 72
Query: 67 NKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQL-------LTGLHYCHVNQV 119
S + EY + G D + + K L L GL Y H ++
Sbjct: 73 ---SSSIGIAMEYCE---GGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKI 126
Query: 120 LHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGP 179
+HRDIK SN+L+ +G +KL DFG++ T T T +Y PE + G Y
Sbjct: 127 IHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTG---TSFYMAPERIQGKP-YSI 182
Query: 180 AVDMWSVGCIFAELLNGK-PILP 201
D+WS+G E+ + P P
Sbjct: 183 TSDVWSLGLTLLEVAQNRFPFPP 205
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 6e-14
Identities = 70/274 (25%), Positives = 106/274 (38%), Gaps = 65/274 (23%)
Query: 9 EIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKE---------IVTSPGPERD 59
++V +K+I ++ + + A E ++LK L H N+I+ E IV P
Sbjct: 26 KLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAP--- 82
Query: 60 EQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQV 119
G T + EY+ L D I + Q+L LH+ H +
Sbjct: 83 -----------GGT--LAEYIQKRCNSLLDED-------TILHFFVQILLALHHVHTKLI 122
Query: 120 LHRDIKGSNLLIDNEGN-LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYG 178
LHRD+K N+L+D +K+ DFG+++ S + V T Y PEL G Y
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGISKILS--SKSKAYTVVGTPCYISPELCEG-KPYN 179
Query: 179 PAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238
D+W++GC+ EL + K N + KI F P
Sbjct: 180 QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS-------------------GTFAP 220
Query: 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR 272
+ R R L+ ML LDPS+R
Sbjct: 221 ---ISDRYSPDLRQ-------LILSMLNLDPSKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 9e-14
Identities = 54/194 (27%), Positives = 87/194 (44%), Gaps = 29/194 (14%)
Query: 26 PITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHD-- 83
P + + E +I+KKL+H+ +++L +V+ Y+V EYM
Sbjct: 45 PESFLEEAQIMKKLRHDKLVQLYAVVS-----------------EEPIYIVTEYMSKGSL 87
Query: 84 LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFG 143
L L D G +P + Q+ G+ Y +HRD++ +N+L+ + K+ADFG
Sbjct: 88 LDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFG 147
Query: 144 LARSFSYDHNNTLTNR----VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKP 198
LAR +N T R W P L G ++ D+WS G + EL+ G+
Sbjct: 148 LARLI---EDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRV 202
Query: 199 ILPGKNEAEQLSKI 212
PG N E L ++
Sbjct: 203 PYPGMNNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 51/184 (27%), Positives = 88/184 (47%), Gaps = 32/184 (17%)
Query: 95 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 154
F+ +++ Y +++ L + H +++RDIK N+L+D+EG++ L DFGL++ F +
Sbjct: 102 FSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE 161
Query: 155 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKP--ILPG-KNEAEQLSK 211
+ T+ Y PE++ G +G AVD WS+G + ELL G L G +N ++S+
Sbjct: 162 RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR 221
Query: 212 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ 271
C P P++ + A +LL K+L DP +
Sbjct: 222 RILKCDPP----------FPSFIGPE-------------------AQDLLHKLLRKDPKK 252
Query: 272 RISA 275
R+ A
Sbjct: 253 RLGA 256
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 34/104 (32%), Positives = 59/104 (56%), Gaps = 1/104 (0%)
Query: 94 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 153
RF +++ Y +++ L + H +++RDIK N+L+D+ G++ L DFGL++ F D
Sbjct: 101 RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160
Query: 154 NTLTNRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLNG 196
+ T+ Y P+++ G + AVD WS+G + ELL G
Sbjct: 161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-13
Identities = 53/184 (28%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 11 VALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 70
VA+K I+ + E I E K++ KL HE +++L + T P
Sbjct: 31 VAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYGVCTKQRP-------------- 73
Query: 71 GSTYMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 129
Y+V EYM + L G RF Q+ K + G+ Y Q +HRD+ N
Sbjct: 74 --IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNC 131
Query: 130 LIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCI 189
L+D++G +K++DFGL+R D + + + PPE+LL +K+ D+W+ G +
Sbjct: 132 LVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLL-YSKFSSKSDVWAFGVL 190
Query: 190 FAEL 193
E+
Sbjct: 191 MWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 65/212 (30%), Positives = 95/212 (44%), Gaps = 30/212 (14%)
Query: 7 TGEIVALKKI----RMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQG 62
T E+VA+KK+ + NEK I+E+K L++L+H N I+ K G E
Sbjct: 45 TNEVVAVKKMSYSGKQTNEKWQ---DIIKEVKFLQQLKHPNTIEYK------GCYLKEH- 94
Query: 63 RPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHR 122
+ ++V EY + L + +I L GL Y H + ++HR
Sbjct: 95 ---------TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 145
Query: 123 DIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT--KYGPA 180
DIK N+L+ G +KLADFG A S + V T ++ PE++L +Y
Sbjct: 146 DIKAGNILLTEPGQVKLADFGSASKSS-----PANSFVGTPYWMAPEVILAMDEGQYDGK 200
Query: 181 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 212
VD+WS+G EL KP L N L I
Sbjct: 201 VDVWSLGITCIELAERKPPLFNMNAMSALYHI 232
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 47/189 (24%), Positives = 84/189 (44%), Gaps = 26/189 (13%)
Query: 30 IREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHD--LTGL 87
+ E ++K LQH+ +++L +VT P Y++ EYM L L
Sbjct: 49 LEEANLMKTLQHDKLVRLYAVVTKEEP----------------IYIITEYMAKGSLLDFL 92
Query: 88 ADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS 147
G + +P++ + Q+ G+ Y +HRD++ +N+L+ K+ADFGLAR
Sbjct: 93 KSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARV 152
Query: 148 FSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV---DMWSVGCIFAELLN-GKPILPGK 203
+ + + PE A +G D+WS G + E++ GK PG
Sbjct: 153 IEDNEYTAREGAKFPIKWTAPE----AINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM 208
Query: 204 NEAEQLSKI 212
+ ++ +S +
Sbjct: 209 SNSDVMSAL 217
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 57/180 (31%), Positives = 89/180 (49%), Gaps = 18/180 (10%)
Query: 31 REIKILKKLQHENVIKLKEIVTSPGPER--------DEQGRPDGNKYRGST----YMVFE 78
R I +K L + ++ KE+ + G ER DE G K+ T Y+V +
Sbjct: 18 RRIYAMKVLSKKEIVAKKEVAHTIG-ERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTD 76
Query: 79 YMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 137
YM +L + G RF+ + K Y+ +L+ L + H +++RD+K N+L+D G++
Sbjct: 77 YMSGGELFWHLQKEG-RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHI 135
Query: 138 KLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNG 196
L DFGL+++ D N TN T Y PE+LL Y VD WS+G + E+ G
Sbjct: 136 ALCDFGLSKANLTD--NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 4e-13
Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 11 VALKKIR---MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 67
VA+K ++ MD P + E +I+KKL+H +I+L + T P
Sbjct: 33 VAVKTLKPGTMD------PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEP----------- 75
Query: 68 KYRGSTYMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIK 125
Y+V E M + L L G +PQ+ Q+ +G+ Y +HRD+
Sbjct: 76 -----IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLA 130
Query: 126 GSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWS 185
N+L+ K+ADFGLAR D + + PE L ++ D+WS
Sbjct: 131 ARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAAL-YNRFSIKSDVWS 189
Query: 186 VGCIFAELLN-GKPILPGKNEAEQLSKI 212
G + E++ G+ PG AE L ++
Sbjct: 190 FGILLTEIVTYGRMPYPGMTNAEVLQQV 217
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 4e-13
Identities = 47/187 (25%), Positives = 83/187 (44%), Gaps = 37/187 (19%)
Query: 95 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 154
F + Y Q++ GL + H ++++RD+K N+L+D+ GN++++D GLA
Sbjct: 92 FPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELK--GGK 149
Query: 155 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 214
+ R T Y PE+L G Y +VD +++GC E++ G+ P + E++ K
Sbjct: 150 KIKGRAGTPGYMAPEVLQGE-VYDFSVDWFALGCTLYEMIAGRS--PFRQRKEKVEK--- 203
Query: 215 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREV---FRH-FDRHALELLEKMLMLDPS 270
+KRR E+ + F A +L E +L DP
Sbjct: 204 -------------------------EELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPE 238
Query: 271 QRISAKD 277
+R+ +
Sbjct: 239 KRLGCRG 245
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 5e-13
Identities = 68/248 (27%), Positives = 108/248 (43%), Gaps = 51/248 (20%)
Query: 11 VALKKIR----MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDG 66
VALKK++ MD + ++EI +LK+L H NVIK + E +E
Sbjct: 30 VALKKVQIFEMMDAKARQ---DCVKEIDLLKQLNHPNVIKYLDSFI----EDNELN---- 78
Query: 67 NKYRGSTYMVFEYMDH-DLTGLADR-PGLRFTVPQ--IKCYMKQLLTGLHYCHVNQVLHR 122
+V E D DL+ + + +P+ + Y QL + + + H +V+HR
Sbjct: 79 --------IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHR 130
Query: 123 DIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVD 182
DIK +N+ I G +KL D GL R FS + V T +Y PE + Y D
Sbjct: 131 DIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERI-HENGYNFKSD 188
Query: 183 MWSVGCIFAEL-----------LN-----------GKPILPGKNEAEQLSKIFELCGSPD 220
+WS+GC+ E+ +N P LP ++ +E+L ++ +C PD
Sbjct: 189 IWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPD 248
Query: 221 ETIWPGVS 228
P +
Sbjct: 249 PDQRPDIG 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 61/225 (27%), Positives = 102/225 (45%), Gaps = 43/225 (19%)
Query: 95 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 154
F+ + + Y ++++ L Y H ++++RD+K NL++D +G++K+ DFGL + D
Sbjct: 92 FSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AA 150
Query: 155 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 214
T+ T Y PE +L YG AVD W +G + E++ G+ LP N+ + K+FE
Sbjct: 151 TMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE--KLFE 205
Query: 215 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI- 273
L D K P R A LL +L+ DP++R+
Sbjct: 206 LILMED-------IKFP-------------------RTLSADAKSLLSGLLIKDPNKRLG 239
Query: 274 ----SAKDALDSEYF----WTDPLPCDPKSLPKYESSHEYQTKKR 310
AK+ + +F W D D K +P ++ +T R
Sbjct: 240 GGPDDAKEIMRHSFFTGVNWQDVY--DKKLVPPFKPQVTSETDTR 282
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 53/183 (28%), Positives = 84/183 (45%), Gaps = 32/183 (17%)
Query: 95 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 154
F P+ + Y ++ + L Y H +++RD+K N+L+D++G++ L DFGL + + +HN
Sbjct: 93 FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNG 151
Query: 155 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 214
T + T Y PE +L Y VD W +G + E+L G P +N AE I
Sbjct: 152 TTSTFCGTPEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN 210
Query: 215 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS 274
KP + +K + RH LLE +L D ++R+
Sbjct: 211 ----------------------KPLQ-LKPNITNSARH-------LLEGLLQKDRTKRLG 240
Query: 275 AKD 277
AKD
Sbjct: 241 AKD 243
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-13
Identities = 37/100 (37%), Positives = 58/100 (58%), Gaps = 2/100 (2%)
Query: 99 QIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158
QI +K++L GL Y H + +HRDIK +N+L+ +G++KLADFG+A + D
Sbjct: 102 QIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT-DTQIKRNT 160
Query: 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKP 198
V T ++ PE ++ + Y D+WS+G EL G+P
Sbjct: 161 FVGTPFWMAPE-VIQQSAYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 45/131 (34%), Positives = 60/131 (45%), Gaps = 10/131 (7%)
Query: 74 YMVFEYM-DHDLTGLADRPGLRFTVPQ--IKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 130
YMV EYM DL L + +P+ + Y +++ L H +HRD+K N+L
Sbjct: 119 YMVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML 174
Query: 131 IDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL---GATKYGPAVDMWSVG 187
+D G+LKLADFG + V T Y PE+L G YG D WSVG
Sbjct: 175 LDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234
Query: 188 CIFAELLNGKP 198
E+L G
Sbjct: 235 VFLYEMLVGDT 245
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 8e-13
Identities = 54/232 (23%), Positives = 100/232 (43%), Gaps = 34/232 (14%)
Query: 8 GEIVALKKIRMDNEKEGFPITA--------IREIKILKK-LQHENVIKLKEIVTSPGPER 58
++ALK+I + N G + E+ I+K+ L+H N+++ + E
Sbjct: 26 QNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL----EN 81
Query: 59 DEQGRPDGNKYRGSTYMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 114
D Y+V + ++ + RFT +I Q++ L Y
Sbjct: 82 DR------------LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYL 129
Query: 115 HV-NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG 173
H +++HRD+ +N+++ + + + DFGLA+ + LT+ V T+ Y PE++
Sbjct: 130 HKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ--PESKLTSVVGTILYSCPEIVKN 187
Query: 174 ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSP-DETIW 224
YG D+W+ GCI ++ +P N +KI E P E ++
Sbjct: 188 -EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY 238
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 9e-13
Identities = 74/307 (24%), Positives = 120/307 (39%), Gaps = 49/307 (15%)
Query: 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAI-REIKILKKLQHENVIKLKEIVTSPGPER 58
+A+ T +VA+KKI +D+ KE + +EI ++LQH N++ VTS
Sbjct: 18 LAKHKPTNTLVAVKKINLDSCSKEDL--KLLQQEIITSRQLQHPNILP---YVTS----- 67
Query: 59 DEQGRPDGNKYRGSTYMVFEYMDH----DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 114
Y+V M + DL GL I +K +L L Y
Sbjct: 68 --------FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELA--IAFILKDVLNALDYI 117
Query: 115 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT-------NRVITLWYRP 167
H +HR +K S++L+ +G + L+ + S H + V L +
Sbjct: 118 HSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSM-IKHGKRQRVVHDFPKSSVKNLPWLS 176
Query: 168 PELL----LGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSP---- 219
PE+L G Y D++SVG EL NG +P K+ + ++ G+
Sbjct: 177 PEVLQQNLQG---YNEKSDIYSVGITACELANG--HVPFKDMPATQMLLEKVRGTVPCLL 231
Query: 220 DETIWPGVSKMPAYNHFKPSRTMKRRVREVF--RHFDRHALELLEKMLMLDPSQRISAKD 277
D++ +P + + R + R F H + +E L DP R SA
Sbjct: 232 DKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQ 291
Query: 278 ALDSEYF 284
L+ +F
Sbjct: 292 LLNHSFF 298
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 9e-13
Identities = 46/144 (31%), Positives = 70/144 (48%), Gaps = 5/144 (3%)
Query: 74 YMVFEY-MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 132
Y+V +Y + DL L + R + Y+ +++ +H H +HRDIK N+L+D
Sbjct: 77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLD 136
Query: 133 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL----GATKYGPAVDMWSVGC 188
G+++LADFG + D + V T Y PE+L G KYGP D WS+G
Sbjct: 137 MNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGV 196
Query: 189 IFAELLNGKPILPGKNEAEQLSKI 212
E+L G+ ++ E KI
Sbjct: 197 CMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 36/207 (17%)
Query: 71 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 129
G Y++ EY+ +L +R G+ F Y+ ++ L + H +++RD+K N+
Sbjct: 73 GKLYLILEYLSGGELFMHLEREGI-FMEDTACFYLSEISLALEHLHQQGIIYRDLKPENI 131
Query: 130 LIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLGATKYGPAVDMWSVGC 188
L+D +G++KL DFGL + H T+T+ T+ Y PE+L+ + +G AVD WS+G
Sbjct: 132 LLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEYMAPEILM-RSGHGKAVDWWSLGA 188
Query: 189 IFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVRE 248
+ ++L G P +N + + KI + G +P Y
Sbjct: 189 LMYDMLTGAPPFTAENRKKTIDKILK-----------GKLNLPPY--------------- 222
Query: 249 VFRHFDRHALELLEKMLMLDPSQRISA 275
A +LL+K+L +PS R+ A
Sbjct: 223 ----LTPEARDLLKKLLKRNPSSRLGA 245
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 53/194 (27%), Positives = 85/194 (43%), Gaps = 29/194 (14%)
Query: 26 PITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHD-- 83
P ++E +++KKL+HE +++L +V+ Y+V EYM
Sbjct: 45 PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-----------------PIYIVTEYMSKGSL 87
Query: 84 LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFG 143
L L G +PQ+ Q+ +G+ Y +HRD++ +N+L+ K+ADFG
Sbjct: 88 LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG 147
Query: 144 LARSFSYDHNNTLTNR----VITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL-LNGKP 198
LAR +N T R W P L G ++ D+WS G + EL G+
Sbjct: 148 LARLI---EDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRV 202
Query: 199 ILPGKNEAEQLSKI 212
PG E L ++
Sbjct: 203 PYPGMVNREVLDQV 216
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 51/205 (24%), Positives = 87/205 (42%), Gaps = 23/205 (11%)
Query: 11 VALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 70
VA+K ++ D+ + +E++ LK+L+H+++I L + + G P
Sbjct: 33 VAIKILKSDDLLKQQDFQ--KEVQALKRLRHKHLISLFAVCSV--------GEP------ 76
Query: 71 GSTYMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 128
Y++ E M+ L L G V + Q+ G+ Y +HRD+ N
Sbjct: 77 --VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARN 134
Query: 129 LLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGC 188
+L+ + K+ADFGLAR D + ++ W P G + D+WS G
Sbjct: 135 ILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHG--TFSTKSDVWSFGI 192
Query: 189 IFAELLN-GKPILPGKNEAEQLSKI 212
+ E+ G+ PG N E +I
Sbjct: 193 LLYEMFTYGQVPYPGMNNHEVYDQI 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 43/125 (34%), Positives = 62/125 (49%), Gaps = 5/125 (4%)
Query: 92 GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 151
G R P I + + L GL + HVN+ +HRD+KG+N+L+ EG +KL DFG++ +
Sbjct: 118 GERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 177
Query: 152 HNNTLTNRVITLWYRPP----ELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAE 207
T+ W P E L +T Y D+WS+G EL +G P L +
Sbjct: 178 RLRRNTSVGTPFWMAPEVIACEQQLDST-YDARCDVWSLGITAIELGDGDPPLADLHPMR 236
Query: 208 QLSKI 212
L KI
Sbjct: 237 ALFKI 241
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 37/119 (31%), Positives = 62/119 (52%), Gaps = 2/119 (1%)
Query: 94 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 153
F P+ + Y ++ + L Y H +++RD+K N+L+D++G++ L DFGL + +H+
Sbjct: 92 SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKE-GIEHS 150
Query: 154 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 212
T + T Y PE+L Y VD W +G + E+L G P ++ AE I
Sbjct: 151 KTTSTFCGTPEYLAPEVLR-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 4e-12
Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 39/203 (19%)
Query: 9 EIVA---LKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPD 65
E+VA LK+ ++ ++ F RE ++L QHEN++K + T P
Sbjct: 36 ELVAVKTLKETASNDARKDFE----REAELLTNFQHENIVKFYGVCTEGDP--------- 82
Query: 66 GNKYRGSTYMVFEYMDH-DLTGL-------------ADRPGLRFTVPQIKCYMKQLLTGL 111
MVFEYM+H DL D P T+ Q+ Q+ +G+
Sbjct: 83 -------PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGM 135
Query: 112 HYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITLWYRPPEL 170
Y +HRD+ N L+ + +K+ DFG++R ++ D+ + ++ + + PPE
Sbjct: 136 VYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPES 195
Query: 171 LLGATKYGPAVDMWSVGCIFAEL 193
++ K+ D+WS G + E+
Sbjct: 196 IM-YRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 38/141 (26%), Positives = 54/141 (38%), Gaps = 38/141 (26%)
Query: 95 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 154
FT + + Y+ + + + H +HRDIK NLL+D +G++KL+DFGL H
Sbjct: 98 FTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157
Query: 155 TL---------------------TNRVITLW----------------YRPPELLLGATKY 177
+ R W Y PE+ L T Y
Sbjct: 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGY 216
Query: 178 GPAVDMWSVGCIFAELLNGKP 198
D WS+G I E+L G P
Sbjct: 217 NKECDWWSLGVIMYEMLVGYP 237
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 5e-12
Identities = 31/103 (30%), Positives = 57/103 (55%), Gaps = 3/103 (2%)
Query: 103 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVIT 162
Y ++ GL H ++++RD+K N+L+D+ G+++++D GLA T+ RV T
Sbjct: 107 YAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIP--EGETIRGRVGT 164
Query: 163 LWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE 205
+ Y PE ++ +Y + D W +GC+ E++ GK + E
Sbjct: 165 VGYMAPE-VVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 43/151 (28%), Positives = 75/151 (49%), Gaps = 8/151 (5%)
Query: 90 RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 149
G R I + L GL + H N+++HRD+KG+N+L+ EG +KL DFG++ +
Sbjct: 120 ICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 179
Query: 150 YDHNNTLTNRVITLWYRPPELLLGATKYGPA----VDMWSVGCIFAELLNGKPILPGKNE 205
T+ V T ++ PE++ +Y + D+WS+G EL +G P L +
Sbjct: 180 STRLRRNTS-VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF---D 235
Query: 206 AEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236
+ +F++ +P T+ ++NHF
Sbjct: 236 MHPVKTLFKIPRNPPPTLLHPEKWCRSFNHF 266
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-12
Identities = 39/118 (33%), Positives = 64/118 (54%), Gaps = 2/118 (1%)
Query: 95 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 154
FT +K Y+ +L L + H +++RD+K N+L+D EG++KL DFGL++ S DH
Sbjct: 95 FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEK 153
Query: 155 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 212
+ T+ Y PE ++ + + D WS G + E+L G GK+ E ++ I
Sbjct: 154 KAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 6e-12
Identities = 57/240 (23%), Positives = 104/240 (43%), Gaps = 33/240 (13%)
Query: 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDG 66
TG+ VA+K I+ D + F + E ++ KL H+N+++L ++ G
Sbjct: 28 TGQKVAVKNIKCDVTAQAF----LEETAVMTKLHHKNLVRLLGVILHNG----------- 72
Query: 67 NKYRGSTYMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 124
Y+V E M + L R +V Q+ + + G+ Y +++HRD+
Sbjct: 73 ------LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDL 126
Query: 125 KGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMW 184
N+L+ +G K++DFGLAR S +N+ ++ W P L K+ D+W
Sbjct: 127 AARNILVSEDGVAKVSDFGLARVGSMGVDNS---KLPVKWTAPEALKHK--KFSSKSDVW 181
Query: 185 SVGCIFAELLN-GK---PILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240
S G + E+ + G+ P + K E + K + + P+ M + +P +
Sbjct: 182 SYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM-EPPEGCPADVYVLMTSCWETEPKK 240
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 6e-12
Identities = 48/201 (23%), Positives = 89/201 (44%), Gaps = 29/201 (14%)
Query: 15 KIRMDNEKEGF--PITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 72
K+ + + K+G P + E ++K+LQH +++L +VT +
Sbjct: 32 KVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-----------------QEP 74
Query: 73 TYMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 130
Y++ EYM++ + L G++ T+ ++ Q+ G+ + +HRD++ +N+L
Sbjct: 75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANIL 134
Query: 131 IDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGP---AVDMWSVG 187
+ K+ADFGLAR + + + PE A YG D+WS G
Sbjct: 135 VSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE----AINYGTFTIKSDVWSFG 190
Query: 188 CIFAELLN-GKPILPGKNEAE 207
+ E++ G+ PG E
Sbjct: 191 ILLTEIVTYGRIPYPGMTNPE 211
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 8e-12
Identities = 64/250 (25%), Positives = 100/250 (40%), Gaps = 53/250 (21%)
Query: 75 MVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 133
MV EY++ D L G V + Y + + L Y H ++HRD+K NLLI +
Sbjct: 78 MVMEYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITS 136
Query: 134 EGNLKLADFGLAR-------SFSYDHNNTLTNRVI-------TLWYRPPELLLGATKYGP 179
G++KL DFGL++ + Y+ + R T Y PE++L YG
Sbjct: 137 MGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVIL-RQGYGK 195
Query: 180 AVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWP-GVSKMPAYNHFKP 238
VD W++G I E L G G E ++ D+ WP G +PA
Sbjct: 196 PVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS-----DDIEWPEGDEALPA------ 244
Query: 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD---SEYF----WTDPLPC 291
A +L+ ++L +P +R+ A + +F W L
Sbjct: 245 -----------------DAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLRQ 287
Query: 292 DPKSLPKYES 301
+ +P+ ES
Sbjct: 288 KAEFIPQLES 297
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 9e-12
Identities = 50/204 (24%), Positives = 83/204 (40%), Gaps = 40/204 (19%)
Query: 13 LKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 72
LK ++ + + F ++E I+ L HEN+I+L +V +
Sbjct: 31 LKSDKLSDIMDDF----LKEAAIMHSLDHENLIRLYGVVLTH-----------------P 69
Query: 73 TYMVFEYMDHDLTGLADR---PGLR-FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 128
MV E L L DR L F + + Y Q+ G+ Y + +HRD+ N
Sbjct: 70 LMMVTELAP--LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARN 127
Query: 129 LLIDNEGNLKLADFGLARSF--SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSV 186
+L+ ++ +K+ DFGL R+ + DH + + + PE L + A D+W
Sbjct: 128 ILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE-SLRTRTFSHASDVWMF 186
Query: 187 GCIFAEL----------LNGKPIL 200
G E+ L+G IL
Sbjct: 187 GVTLWEMFTYGEEPWAGLSGSQIL 210
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 36/100 (36%), Positives = 56/100 (56%), Gaps = 2/100 (2%)
Query: 99 QIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158
QI ++++L GL Y H + +HRDIK +N+L+ G +KLADFG+A + D
Sbjct: 102 QIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNT 160
Query: 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKP 198
V T ++ PE ++ + Y D+WS+G EL G+P
Sbjct: 161 FVGTPFWMAPE-VIKQSAYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 44/184 (23%), Positives = 80/184 (43%), Gaps = 27/184 (14%)
Query: 30 IREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHD--LTGL 87
+ E ++K LQH+ ++KL +VT + Y++ E+M L L
Sbjct: 49 LAEANVMKTLQHDKLVKLHAVVT-----------------KEPIYIITEFMAKGSLLDFL 91
Query: 88 ADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS 147
G + +P++ + Q+ G+ + +HRD++ +N+L+ K+ADFGLAR
Sbjct: 92 KSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV 151
Query: 148 FSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV---DMWSVGCIFAELLN-GKPILPGK 203
+ + + PE A +G D+WS G + E++ G+ PG
Sbjct: 152 IEDNEYTAREGAKFPIKWTAPE----AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 207
Query: 204 NEAE 207
+ E
Sbjct: 208 SNPE 211
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 46/129 (35%), Positives = 61/129 (47%), Gaps = 10/129 (7%)
Query: 74 YMVFEYM-DHDLTGLADRPGLRFTVPQ--IKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 130
YMV EYM DL L + VP+ + Y +++ L H +HRD+K N+L
Sbjct: 119 YMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML 174
Query: 131 IDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL---GATKYGPAVDMWSVG 187
+D G+LKLADFG + + V T Y PE+L G YG D WSVG
Sbjct: 175 LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234
Query: 188 CIFAELLNG 196
E+L G
Sbjct: 235 VFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 45/178 (25%), Positives = 83/178 (46%), Gaps = 28/178 (15%)
Query: 103 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVIT 162
Y Q+ G+ + H +++RD+K N+L+D++GN +L+D GLA T+T R T
Sbjct: 100 YSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGT 157
Query: 163 LWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDET 222
Y PE+L Y VD +++GC E++ G+ P K+ E+++K +E
Sbjct: 158 NGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGR--TPFKDHKEKVAK--------EEL 206
Query: 223 IWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280
RT++ V+ ++F + ++ L P R+ +++ D
Sbjct: 207 K---------------RRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKND 249
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 32/103 (31%), Positives = 57/103 (55%), Gaps = 3/103 (2%)
Query: 103 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVIT 162
Y ++L GL H ++RD+K N+L+D+ G+++++D GLA ++ RV T
Sbjct: 107 YAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGT 164
Query: 163 LWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE 205
+ Y PE +L +Y + D W +GC+ E++ G+ G+ E
Sbjct: 165 VGYMAPE-VLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 47/129 (36%), Positives = 60/129 (46%), Gaps = 10/129 (7%)
Query: 74 YMVFEYM-DHDLTGLADRPGLRFTVPQ--IKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 130
YMV EYM DL L + VP+ K Y +++ L H ++HRD+K N+L
Sbjct: 119 YMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNML 174
Query: 131 IDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL---GATKYGPAVDMWSVG 187
+D G+LKLADFG V T Y PE+L G YG D WSVG
Sbjct: 175 LDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234
Query: 188 CIFAELLNG 196
E+L G
Sbjct: 235 VFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 45/145 (31%), Positives = 68/145 (46%), Gaps = 5/145 (3%)
Query: 74 YMVFEY-MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 132
Y+V +Y + DL L + R + Y+ +++ + H +HRDIK N+L+D
Sbjct: 77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD 136
Query: 133 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL----GATKYGPAVDMWSVGC 188
G+++LADFG D + V T Y PE+L G KYGP D WS+G
Sbjct: 137 MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGV 196
Query: 189 IFAELLNGKPILPGKNEAEQLSKIF 213
E+L G+ ++ E KI
Sbjct: 197 CMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 34/102 (33%), Positives = 60/102 (58%), Gaps = 3/102 (2%)
Query: 95 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 154
F+ +++ Y +++ GL + H V++RD+K +N+L+D G+++++D GLA FS +
Sbjct: 94 FSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 153
Query: 155 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNG 196
V T Y PE+L T Y + D +S+GC+ +LL G
Sbjct: 154 A---SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 39/202 (19%)
Query: 10 IVALKKIRMD---NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDG 66
+VA+K +R D + F ++EIKI+ +L++ N+I+L + S P
Sbjct: 46 LVAVKMLRADVTKTARNDF----LKEIKIMSRLKNPNIIRLLGVCVSDDP---------- 91
Query: 67 NKYRGSTYMVFEYMDH-DLTGLADRPGLRFT------VPQIK----CYMK-QLLTGLHYC 114
M+ EYM++ DL + + T +P + YM Q+ +G+ Y
Sbjct: 92 ------LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL 145
Query: 115 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITL-WYRPPELLL 172
+HRD+ N L+ N +K+ADFG++R+ +S D+ V+ + W +LL
Sbjct: 146 ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL 205
Query: 173 GATKYGPAVDMWSVGCIFAELL 194
G K+ A D+W+ G E+
Sbjct: 206 G--KFTTASDVWAFGVTLWEMF 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 48/191 (25%), Positives = 89/191 (46%), Gaps = 27/191 (14%)
Query: 11 VALKKIR---MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 67
VA+K ++ + ++ F + E I+ + H N+I L+ +VT P
Sbjct: 35 VAIKTLKAGYTEKQRRDF----LSEASIMGQFDHPNIIHLEGVVTKSKP----------- 79
Query: 68 KYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKG 126
+V EYM++ L + +FTV Q+ ++ + +G+ Y +HRD+
Sbjct: 80 -----VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAA 134
Query: 127 SNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR--VITLWYRPPELLLGATKYGPAVDMW 184
N+L+++ K++DFGL+R D T R I + + PE + K+ A D+W
Sbjct: 135 RNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE-AIAYRKFTSASDVW 193
Query: 185 SVGCIFAELLN 195
S G + E+++
Sbjct: 194 SYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 35/99 (35%), Positives = 57/99 (57%), Gaps = 2/99 (2%)
Query: 100 IKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159
I ++++L GL Y H + +HRDIK +N+L+ +G++KLADFG+A + D
Sbjct: 103 IATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT-DTQIKRNTF 161
Query: 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKP 198
V T ++ PE ++ + Y D+WS+G EL G+P
Sbjct: 162 VGTPFWMAPE-VIKQSAYDFKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 33/102 (32%), Positives = 59/102 (57%), Gaps = 3/102 (2%)
Query: 95 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 154
F+ +++ Y +++ GL + H V++RD+K +N+L+D G+++++D GLA FS +
Sbjct: 94 FSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 153
Query: 155 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNG 196
V T Y PE+L Y + D +S+GC+ +LL G
Sbjct: 154 A---SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 34/109 (31%), Positives = 62/109 (56%), Gaps = 4/109 (3%)
Query: 89 DRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 148
+ PG F P+ Y Q+++GL + H ++++RD+K N+L+DN+GN++++D GLA
Sbjct: 90 ENPG--FPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVEL 147
Query: 149 SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK 197
+ T T + PELL G +Y +VD +++G E++ +
Sbjct: 148 KDGQSKT-KGYAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 107 LLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYR 166
++ GL Y ++LHRD+K SN+L++ G +KL DFG++ N+ V T Y
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTYVGTNAYM 160
Query: 167 PPELLLGATKYGPAVDMWSVGCIFAELLNGK 197
PE + G +YG D+WS+G F EL G+
Sbjct: 161 APERISG-EQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 4e-11
Identities = 50/201 (24%), Positives = 89/201 (44%), Gaps = 37/201 (18%)
Query: 10 IVALKKIR--MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 67
+VA+K ++ DN ++ F RE ++L LQHE+++K + P
Sbjct: 37 LVAVKTLKDASDNARKDFH----REAELLTNLQHEHIVKFYGVCVEGDP----------- 81
Query: 68 KYRGSTYMVFEYMDH------------DLTGLAD-RPGLRFTVPQIKCYMKQLLTGLHYC 114
MVFEYM H D +A+ T Q+ +Q+ G+ Y
Sbjct: 82 -----LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL 136
Query: 115 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITLWYRPPELLLG 173
+HRD+ N L+ +K+ DFG++R +S D+ + ++ + + PPE ++
Sbjct: 137 ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM- 195
Query: 174 ATKYGPAVDMWSVGCIFAELL 194
K+ D+WS+G + E+
Sbjct: 196 YRKFTTESDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 44/219 (20%)
Query: 10 IVALKKIRMDNE--KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 67
+VA+K ++ +E ++ F RE ++L LQH+++++ + T +GRP
Sbjct: 37 LVAVKALKEASESARQDFQ----REAELLTVLQHQHIVRFYGVCT--------EGRP--- 81
Query: 68 KYRGSTYMVFEYMDHD---------------LTGLADRPGLRFTVPQIKCYMKQLLTGLH 112
MVFEYM H L G D + T+ Q+ Q+ +G+
Sbjct: 82 -----LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMV 136
Query: 113 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITLWYRPPELL 171
Y +HRD+ N L+ +K+ DFG++R +S D+ ++ + + PPE +
Sbjct: 137 YLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI 196
Query: 172 LGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLS 210
L K+ D+WS G + E+ GK QLS
Sbjct: 197 L-YRKFTTESDIWSFGVVLWEIFT-----YGKQPWYQLS 229
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 55/223 (24%), Positives = 92/223 (41%), Gaps = 46/223 (20%)
Query: 95 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 154
F P+ + Y ++ + L Y H +++RD+K N+L+D++G++ L DFGL + ++
Sbjct: 93 FPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSD 151
Query: 155 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 214
T T T Y PE++ Y VD W +G + E+L G P ++ AE I
Sbjct: 152 TTTTFCGTPEYLAPEVIR-KQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH 210
Query: 215 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS 274
+ PG S A +LE++L D +R+
Sbjct: 211 ----KPLVLRPGASLT--------------------------AWSILEELLEKDRQRRLG 240
Query: 275 AKDAL----DSEYF----WTD------PLPCDPKSLPKYESSH 303
AK+ + +F WTD P P +P + S+
Sbjct: 241 AKEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPDDISN 283
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 8e-11
Identities = 49/186 (26%), Positives = 85/186 (45%), Gaps = 25/186 (13%)
Query: 11 VALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 69
VA+K I +E F I E K++ KL H +++L + T Q +P
Sbjct: 31 VAIKAINEGAMSEEDF----IEEAKVMMKLSHPKLVQLYGVCT--------QQKP----- 73
Query: 70 RGSTYMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 127
Y+V E+M++ L L R G + + + + + G+ Y N +HRD+
Sbjct: 74 ---LYIVTEFMENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAAR 129
Query: 128 NLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVG 187
N L+ + G +K++DFG+ R D + + + + PPE+ +KY D+WS G
Sbjct: 130 NCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFN-FSKYSSKSDVWSFG 188
Query: 188 CIFAEL 193
+ E+
Sbjct: 189 VLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 8e-11
Identities = 44/146 (30%), Positives = 70/146 (47%), Gaps = 9/146 (6%)
Query: 74 YMVFEY-MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 132
Y+V +Y + DL L + R + Y+ +++ + H +HRDIK N+L+D
Sbjct: 77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD 136
Query: 133 NEGNLKLADFGLARSFSYDHNNTLTNRVI--TLWYRPPELLL----GATKYGPAVDMWSV 186
G+++LADFG + T+ + V T Y PE+L G +YGP D WS+
Sbjct: 137 KNGHIRLADFG--SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSL 194
Query: 187 GCIFAELLNGKPILPGKNEAEQLSKI 212
G E+L G+ ++ E KI
Sbjct: 195 GVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 9e-11
Identities = 58/209 (27%), Positives = 93/209 (44%), Gaps = 27/209 (12%)
Query: 2 AREIKTGEIVALKKIRM-DNEKEGFPITAIREIKILKKLQHENVIK--LKEIVTSPGPER 58
R +KTG++ A+K + + ++E+E + EI +LKK H I + P
Sbjct: 35 GRHVKTGQLAAIKVMDVTEDEEEEIKL----EINMLKKYSHHRNIATYYGAFIKKSPPGH 90
Query: 59 DEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHV 116
D+Q ++V E+ +T L G I +++L GL + H
Sbjct: 91 DDQ-----------LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA 139
Query: 117 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLL--- 172
++V+HRDIKG N+L+ +KL DFG+ S D N I T ++ PE++
Sbjct: 140 HKVIHRDIKGQNVLLTENAEVKLVDFGV--SAQLDRTVGRRNTFIGTPYWMAPEVIACDE 197
Query: 173 -GATKYGPAVDMWSVGCIFAELLNGKPIL 200
Y D+WS+G E+ G P L
Sbjct: 198 NPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 51/188 (27%), Positives = 84/188 (44%), Gaps = 43/188 (22%)
Query: 90 RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 149
R RF K Y +L+ Y H +++RD+K NLL+DN+G++K+ DFG A+
Sbjct: 110 RKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKK-- 167
Query: 150 YDHNNTLTNRVITLW----YRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE 205
+ +R TL Y PE ++ + +G AVD W++G + E + G P P ++
Sbjct: 168 ------VPDRTFTLCGTPEYLAPE-VIQSKGHGKAVDWWTMGVLLYEFIAGYP--PFFDD 218
Query: 206 AEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKML 265
+I+ E I G K P FD A +L++ +L
Sbjct: 219 TP--FRIY-------EKILAGRLKFP-------------------NWFDGRARDLVKGLL 250
Query: 266 MLDPSQRI 273
D ++R+
Sbjct: 251 QTDHTKRL 258
|
Length = 329 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 49/196 (25%), Positives = 90/196 (45%), Gaps = 30/196 (15%)
Query: 6 KTGEIVALKKIR---MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQG 62
K VA+K ++ D ++ F + E I+ + H N+I+L+ +VT
Sbjct: 30 KKEIDVAIKTLKAGSSDKQRLDF----LTEASIMGQFDHPNIIRLEGVVT---------- 75
Query: 63 RPDGNKYRGSTYM-VFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
+ M + EYM++ L +FTV Q+ ++ + +G+ Y +
Sbjct: 76 -------KSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYV 128
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR--VITLWYRPPELLLGATKYG 178
HRD+ N+L+++ K++DFGL+R D T T + I + + PE + K+
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSR-RLEDSEATYTTKGGKIPIRWTAPE-AIAYRKFT 186
Query: 179 PAVDMWSVGCIFAELL 194
A D+WS G + E++
Sbjct: 187 SASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 41/122 (33%), Positives = 69/122 (56%), Gaps = 7/122 (5%)
Query: 95 FTVPQIKCYMKQLLTGLHYCHVNQ-VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 153
F+ + + Y ++++ L Y H + V++RD+K NL++D +G++K+ DFGL + D
Sbjct: 92 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-G 150
Query: 154 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 213
T+ T Y PE +L YG AVD W +G + E++ G+ LP N+ + K+F
Sbjct: 151 ATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE--KLF 205
Query: 214 EL 215
EL
Sbjct: 206 EL 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 35/206 (16%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
AR + TGE+ A+K I+++ E F + +EI ++K +H N++
Sbjct: 28 ARNVNTGELAAIKVIKLE-PGEDFAVVQ-QEIIMMKDCKHSNIVAYFGSYLR-------- 77
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVP----QIKCYMKQLLTGLHYCHVN 117
R ++ E+ G + + T P QI ++ L GL+Y H
Sbjct: 78 --------RDKLWICMEFCG----GGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK 125
Query: 118 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLWYRPPELLLGA 174
+HRDIKG+N+L+ + G++KLADFG++ + T+ R + T ++ PE+
Sbjct: 126 GKMHRDIKGANILLTDNGHVKLADFGVSAQIT----ATIAKRKSFIGTPYWMAPEVAAVE 181
Query: 175 TK--YGPAVDMWSVGCIFAELLNGKP 198
K Y D+W+VG EL +P
Sbjct: 182 RKGGYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 38/202 (18%)
Query: 10 IVALKKIRMD---NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDG 66
+VA+K +R D N + F ++EIKI+ +L+ N+I+L + + P
Sbjct: 48 LVAVKMLREDANKNARNDF----LKEIKIMSRLKDPNIIRLLAVCITSDP---------- 93
Query: 67 NKYRGSTYMVFEYMD----------HDLTGLADRPGLRFTVPQIKCYMK-QLLTGLHYCH 115
M+ EYM+ H+ A++ + +M Q+ +G+ Y
Sbjct: 94 ------LCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS 147
Query: 116 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITL-WYRPPELLLG 173
+HRD+ N L+ +K+ADFG++R+ +S D+ V+ + W +LLG
Sbjct: 148 SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG 207
Query: 174 ATKYGPAVDMWSVGCIFAELLN 195
K+ A D+W+ G E+L
Sbjct: 208 --KFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 35/206 (16%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
AR + TGE+ A+K I+++ + F + +EI ++K+ +H N++ S
Sbjct: 28 ARNLHTGELAAVKIIKLE-PGDDFSLIQ-QEIFMVKECKHCNIVAYFGSYLS-------- 77
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVP----QIKCYMKQLLTGLHYCHVN 117
R ++ EY G + + T P QI ++ L GL Y H
Sbjct: 78 --------REKLWICMEYCG----GGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK 125
Query: 118 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLWYRPPELLLGA 174
+HRDIKG+N+L+ + G++KLADFG+A + T+ R + T ++ PE+
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKIT----ATIAKRKSFIGTPYWMAPEVAAVE 181
Query: 175 TK--YGPAVDMWSVGCIFAELLNGKP 198
Y D+W+VG EL +P
Sbjct: 182 KNGGYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 45/189 (23%), Positives = 80/189 (42%), Gaps = 28/189 (14%)
Query: 8 GEIVALKKIRMD-NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDG 66
G+ VA+K ++ D + F + E ++ L+H N+++L +V P
Sbjct: 29 GQKVAVKCLKDDSTAAQAF----LAEASVMTTLRHPNLVQLLGVVLQGNP---------- 74
Query: 67 NKYRGSTYMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 124
Y+V EYM + L R T+ Q + + G+ Y +HRD+
Sbjct: 75 ------LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDL 128
Query: 125 KGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMW 184
N+L+ + K++DFGLA+ S + + ++ W P L K+ D+W
Sbjct: 129 AARNVLVSEDLVAKVSDFGLAKEASQGQD---SGKLPVKWTAPEALREK--KFSTKSDVW 183
Query: 185 SVGCIFAEL 193
S G + E+
Sbjct: 184 SFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 62/231 (26%), Positives = 95/231 (41%), Gaps = 34/231 (14%)
Query: 7 TGEIVALKKIRMDNEKEGFPITAI-REIKILKKLQHENVIKLKEIVTSPGPERDEQGRPD 65
TG VA+K +R D +E RE + +L H N++ L D P
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVAL----------LDSGEAPP 51
Query: 66 GNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKC--YMKQLLTGLHYCHVNQVLHRD 123
G + VFEY+ T L + +P + M Q+L L H ++HRD
Sbjct: 52 G-----LLFAVFEYVP-GRT-LREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRD 104
Query: 124 IKGSNLLI---DNEGNLKLADFGLARSFSYDHNN-----TLTNRVI-TLWYRPPELLLGA 174
+K N+++ + K+ DFG+ + T T V+ T Y PE L G
Sbjct: 105 LKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGE 164
Query: 175 TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWP 225
P D+++ G IF E L G+ ++ G + AE L + SP + P
Sbjct: 165 PV-TPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQL----SPVDVSLP 210
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 3e-10
Identities = 52/194 (26%), Positives = 86/194 (44%), Gaps = 29/194 (14%)
Query: 26 PITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHD-- 83
P ++E +I+KKL+H+ ++ L +V+ Y+V E+M
Sbjct: 45 PEAFLQEAQIMKKLRHDKLVPLYAVVSEE-----------------PIYIVTEFMGKGSL 87
Query: 84 LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFG 143
L L + G +PQ+ Q+ G+ Y +HRD++ +N+L+ + K+ADFG
Sbjct: 88 LDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFG 147
Query: 144 LARSFSYDHNNTLTNR----VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKP 198
LAR +N T R W P L G ++ D+WS G + EL+ G+
Sbjct: 148 LARLI---EDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRV 202
Query: 199 ILPGKNEAEQLSKI 212
PG E L ++
Sbjct: 203 PYPGMVNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 30/103 (29%), Positives = 58/103 (56%), Gaps = 3/103 (2%)
Query: 95 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 154
F + Y ++ GL H ++++RD+K N+L+D+ G+++++D GLA
Sbjct: 99 FEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156
Query: 155 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK 197
T+ RV T+ Y PE++ +Y + D W++GC+ E++ G+
Sbjct: 157 TIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 50/168 (29%), Positives = 69/168 (41%), Gaps = 45/168 (26%)
Query: 74 YMVFEYM-DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 132
Y V +Y+ D+ L R G+ F + Y+ +L + H +HRDIK N+LID
Sbjct: 77 YFVMDYIPGGDMMSLLIRLGI-FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID 135
Query: 133 NEGNLKLADFGLARSFSYDHNN-----------------------------TLTNR---- 159
+G++KL DFGL F + H++ L R
Sbjct: 136 RDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQ 195
Query: 160 ---------VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKP 198
V T Y PE+LL T Y D WSVG I E+L G+P
Sbjct: 196 HQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVILYEMLVGQP 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 5e-10
Identities = 57/245 (23%), Positives = 93/245 (37%), Gaps = 52/245 (21%)
Query: 1 MAREIKTGEIVALK---KIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 57
+ R TG++ ALK K M + + E +IL L H + L
Sbjct: 19 LVRLKGTGKLFALKVLDKKEMIKRNKVKRVLT--EQEILATLDHPFLPTL---------- 66
Query: 58 RDEQGRPDGNKYRGSTYMVFEY-MDHDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCH 115
Y +V +Y +L L R PG + + Y ++L L Y H
Sbjct: 67 ---YASFQTETY---LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120
Query: 116 VNQVLHRDIKGSNLLIDNEGNLKLADFGLA---------------RSFSYDHNNTLTNRV 160
+ +++RD+K N+L+ G++ L+DF L+ + N++ +
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET 180
Query: 161 I-------------TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAE 207
T Y PE++ G +G AVD W++G + E+L G G N E
Sbjct: 181 FSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239
Query: 208 QLSKI 212
S I
Sbjct: 240 TFSNI 244
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 6e-10
Identities = 63/285 (22%), Positives = 110/285 (38%), Gaps = 48/285 (16%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
+ R G+ +KK+ + N A +E ++L +L+H N++ +E
Sbjct: 18 LVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE---------SW 68
Query: 61 QGRPDGNKYRGSTYMVFEYMDH-DL-TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 118
+G G Y+V + + DL L ++ G Q+ + Q+ L Y H
Sbjct: 69 EGED------GLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH 122
Query: 119 VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYG 178
+LHRD+K N+ + +K+ D G+AR + + + + T +Y PE L Y
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLIGTPYYMSPE-LFSNKPYN 180
Query: 179 PAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238
D+W++GC E+ K K+ + +I E K+P
Sbjct: 181 YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE-------------GKLP------- 220
Query: 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 283
+ + + EL+ ML P +R S K L Y
Sbjct: 221 ---------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 8e-10
Identities = 44/180 (24%), Positives = 77/180 (42%), Gaps = 34/180 (18%)
Query: 31 REIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGL-- 87
+E +++ LQH N++ L + T P T M+FEY+ H DL
Sbjct: 57 QEAELMSDLQHPNIVCLLGVCTKEQP----------------TCMLFEYLAHGDLHEFLV 100
Query: 88 ----ADRPGLRFTVPQIKCYMK---------QLLTGLHYCHVNQVLHRDIKGSNLLIDNE 134
G +K + Q+ G+ Y + +HRD+ N L+
Sbjct: 101 RNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160
Query: 135 GNLKLADFGLARS-FSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL 193
+K++DFGL+R +S D+ + ++ + + PPE +L K+ D+WS G + E+
Sbjct: 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 41/125 (32%), Positives = 60/125 (48%), Gaps = 22/125 (17%)
Query: 107 LLTGLHYCH-VNQVLHRDIKGSNLLIDNEGNLKLADFG--------LARSFSYDHNNTLT 157
+L GL Y ++++HRD+K SN+L+++ G +KL DFG +A SF
Sbjct: 108 VLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF--------- 158
Query: 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 217
V T Y PE L G T Y D+WS+G E+ G+ +P + E L +F
Sbjct: 159 --VGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-LEAMFGRPV 214
Query: 218 SPDET 222
S E
Sbjct: 215 SEGEA 219
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 31/95 (32%), Positives = 55/95 (57%), Gaps = 2/95 (2%)
Query: 103 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVIT 162
Y ++ L++ H +++RD+K N+L+D EG++KL D+G+ + + T T T
Sbjct: 101 YSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGT 159
Query: 163 LWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK 197
Y PE+L G YG +VD W++G + E++ G+
Sbjct: 160 PNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 46/186 (24%), Positives = 79/186 (42%), Gaps = 25/186 (13%)
Query: 11 VALKKIRMDNEKEGFPITA--IREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 68
VA+K IR EG I E +++ KL H +++L + T P
Sbjct: 31 VAIKTIR-----EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSP------------ 73
Query: 69 YRGSTYMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 127
+VFE+M+H L+ +F+ + + G+ Y + V+HRD+
Sbjct: 74 ----ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAAR 129
Query: 128 NLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVG 187
N L+ +K++DFG+ R D + T + + PE + +KY D+WS G
Sbjct: 130 NCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPE-VFSFSKYSSKSDVWSFG 188
Query: 188 CIFAEL 193
+ E+
Sbjct: 189 VLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 38/111 (34%), Positives = 59/111 (53%), Gaps = 10/111 (9%)
Query: 106 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV----- 160
Q+L +H+ H ++HRDIK +N+L+ + G +KL DFG FS + T+++ V
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG----FSKMYAATVSDDVGRTFC 206
Query: 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSK 211
T +Y PE+ Y DM+S+G + ELL K G+N E + K
Sbjct: 207 GTPYYVAPEIWR-RKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK 256
|
Length = 496 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 30/95 (31%), Positives = 54/95 (56%), Gaps = 3/95 (3%)
Query: 103 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVIT 162
Y +L GL ++++RD+K N+L+D+ G+++++D GLA T+ RV T
Sbjct: 107 YAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIP--EGETVRGRVGT 164
Query: 163 LWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK 197
+ Y PE ++ KY + D W +GC+ E++ G+
Sbjct: 165 VGYMAPE-VINNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 43/174 (24%), Positives = 81/174 (46%), Gaps = 29/174 (16%)
Query: 103 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVIT 162
Y ++ L+Y H +++RD+K N+L+D+EG++KL D+G+ + +T + T
Sbjct: 101 YSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGT 159
Query: 163 LWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS---P 219
Y PE+L G YG +VD W++G + E++ G+ F++ GS P
Sbjct: 160 PNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGR-------------SPFDIVGSSDNP 205
Query: 220 DETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI 273
D+ + ++ + R++ + V + F L DP +R+
Sbjct: 206 DQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSF-----------LNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 60/227 (26%), Positives = 99/227 (43%), Gaps = 36/227 (15%)
Query: 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGP-----ERD 59
K VA+K ++ D+ E + E++++K + +H+N+I L T GP E
Sbjct: 45 KEAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 103
Query: 60 EQG---------RPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTG 110
+G RP G +Y +D+ + D T + Q+ G
Sbjct: 104 SKGNLREYLRARRPPGMEY-----------SYDIARVPDEQ---MTFKDLVSCTYQVARG 149
Query: 111 LHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF-SYDHNNTLTNRVITLWYRPPE 169
+ Y + +HRD+ N+L+ +K+ADFGLAR + D+ TN + + + PE
Sbjct: 150 MEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPE 209
Query: 170 LLLGATKYGPAVDMWSVGCIFAEL--LNGKPILPGKNEAEQLSKIFE 214
L Y D+WS G + E+ L G P PG E+L K+ +
Sbjct: 210 ALFDRV-YTHQSDVWSFGVLMWEIFTLGGSP-YPGI-PVEELFKLLK 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 2e-09
Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 25/208 (12%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIK--LKEIVTSPGPERD 59
R +KTG++ A+K + + ++E +EI +LKK H I + P D
Sbjct: 25 GRHVKTGQLAAIKVMDVTGDEEE---EIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81
Query: 60 EQGRPDGNKYRGSTYMVFEYMDH-DLTGL-ADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 117
+Q ++V E+ +T L + G I +++L GL + H +
Sbjct: 82 DQ-----------LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 130
Query: 118 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLL---- 172
+V+HRDIKG N+L+ +KL DFG+ S D N I T ++ PE++
Sbjct: 131 KVIHRDIKGQNVLLTENAEVKLVDFGV--SAQLDRTVGRRNTFIGTPYWMAPEVIACDEN 188
Query: 173 GATKYGPAVDMWSVGCIFAELLNGKPIL 200
Y D+WS+G E+ G P L
Sbjct: 189 PDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 43/156 (27%), Positives = 61/156 (39%), Gaps = 47/156 (30%)
Query: 103 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN-------- 154
YM + + + H +HRDIK N+LID G++KL+DFGL+ F H++
Sbjct: 106 YMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQ 165
Query: 155 ---------------------TLTNR-VITLW----------------YRPPELLLGATK 176
T++++ I W Y PE+ L
Sbjct: 166 GKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QG 224
Query: 177 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 212
YG D WS+G I E L G P +N E KI
Sbjct: 225 YGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKI 260
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 3e-09
Identities = 43/186 (23%), Positives = 77/186 (41%), Gaps = 41/186 (22%)
Query: 94 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID-NEGNLKLADFGLARSF---- 148
+ + ++K ++QL+ L+ H + ++H DIK N+L D + + L D+GL +
Sbjct: 105 KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS 164
Query: 149 SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ 208
YD TL Y PE + G Y + D W+VG + ELL GK P K
Sbjct: 165 CYDG---------TLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGK--HPFKE---- 208
Query: 209 LSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLD 268
DE + + + K ++ ++A + ++ ML +
Sbjct: 209 ---------DEDEEL--DLESLLKRQQKKLPFI---------KNVSKNANDFVQSMLKYN 248
Query: 269 PSQRIS 274
+ R++
Sbjct: 249 INYRLT 254
|
Length = 267 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 63/260 (24%), Positives = 109/260 (41%), Gaps = 42/260 (16%)
Query: 8 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 67
G VA+K I+ D + F + E ++ +L+H N+++L ++
Sbjct: 29 GNKVAVKCIKNDATAQAF----LAEASVMTQLRHSNLVQLLGVIVEE------------- 71
Query: 68 KYRGSTYMVFEYMDHDLTGLADRPGLR-FTVPQIKCYMK---QLLTGLHYCHVNQVLHRD 123
+G Y+V EYM L D R +V C +K + + Y N +HRD
Sbjct: 72 --KGGLYIVTEYMAKG--SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRD 127
Query: 124 IKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDM 183
+ N+L+ + K++DFGL + S + T ++ W P L K+ D+
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEASSTQD---TGKLPVKWTAPEALR--EKKFSTKSDV 182
Query: 184 WSVGCIFAELLN-GK---PILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239
WS G + E+ + G+ P +P K+ ++ K +++ +PD P V Y+ K
Sbjct: 183 WSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM-DAPDGC--PPV----VYDVMKQC 235
Query: 240 RTMKRRVREVFRHFDRHALE 259
+ R F R LE
Sbjct: 236 WHLDAATRPSFLQL-REQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 62/246 (25%), Positives = 95/246 (38%), Gaps = 66/246 (26%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIR-EIKILKKLQHENVIKLKEIVTSPGPERD 59
+A ++ T + A+K +R + + ++ E IL + +E V+KL
Sbjct: 19 LACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD------ 72
Query: 60 EQGRPDGNKYRGSTYMVFEYM-DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 118
+ + Y V +Y+ D+ L R + F + Y+ +L + H
Sbjct: 73 ----------KDNLYFVMDYIPGGDMMSLLIRMEV-FPEVLARFYIAELTLAIESVHKMG 121
Query: 119 VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN------------------------ 154
+HRDIK N+LID +G++KL DFGL F + HN+
Sbjct: 122 FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVS 181
Query: 155 ---------TLTNR-------------VITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 192
TL R V T Y PE+LL Y D WSVG I E
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWSVGVILFE 240
Query: 193 LLNGKP 198
+L G+P
Sbjct: 241 MLVGQP 246
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 32/105 (30%), Positives = 55/105 (52%), Gaps = 2/105 (1%)
Query: 94 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 153
F P+ + Y ++ + + Y H +++RD+K N+L+D++G++ L DFGL + +
Sbjct: 92 CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKE-GVEPE 150
Query: 154 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKP 198
T + T Y PE +L Y VD W +G + E+L G P
Sbjct: 151 ETTSTFCGTPEYLAPE-VLRKEPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 45/181 (24%), Positives = 76/181 (41%), Gaps = 34/181 (18%)
Query: 31 REIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-------- 82
RE ++L LQHE+++K + P MVFEYM H
Sbjct: 56 REAELLTNLQHEHIVKFYGVCGDGDP----------------LIMVFEYMKHGDLNKFLR 99
Query: 83 ----DLTGLADRPGLR----FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 134
D L D + + Q+ Q+ +G+ Y +HRD+ N L+
Sbjct: 100 AHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159
Query: 135 GNLKLADFGLARS-FSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL 193
+K+ DFG++R +S D+ + ++ + + PPE ++ K+ D+WS G I E+
Sbjct: 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEI 218
Query: 194 L 194
Sbjct: 219 F 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-09
Identities = 47/201 (23%), Positives = 77/201 (38%), Gaps = 34/201 (16%)
Query: 5 IKTGEIVALKKIRMD---NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
+K VA+K R + K F ++E +ILK+ H N++KL + P
Sbjct: 16 LKGNTEVAVKTCRSTLPPDLKRKF----LQEAEILKQYDHPNIVKLIGVCVQKQP----- 66
Query: 62 GRPDGNKYRGSTYMVFEYM-DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
Y+V E + L + R TV ++ G+ Y +
Sbjct: 67 -----------IYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCI 115
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT-----NRVITLWYRPPELLLGAT 175
HRD+ N L+ LK++DFG++R + T ++ W P L G
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRE---EEGGIYTVSDGLKQIPIKWTAPEALNYG-- 170
Query: 176 KYGPAVDMWSVGCIFAELLNG 196
+Y D+WS G + E +
Sbjct: 171 RYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 48/195 (24%), Positives = 91/195 (46%), Gaps = 18/195 (9%)
Query: 10 IVALKKIRMD---NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP-----ERDEQ 61
+VA+K +R D N + F ++E+KIL +L+ N+I+L + P E E
Sbjct: 48 LVAVKILRPDANKNARNDF----LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMEN 103
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
G D N++ S ++ + + + + + Q+ +G+ Y +H
Sbjct: 104 G--DLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITL-WYRPPELLLGATKYGP 179
RD+ N L+ +K+ADFG++R+ ++ D+ V+ + W +L+G K+
Sbjct: 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG--KFTT 219
Query: 180 AVDMWSVGCIFAELL 194
A D+W+ G E+L
Sbjct: 220 ASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 73/300 (24%), Positives = 118/300 (39%), Gaps = 85/300 (28%)
Query: 11 VALKKIRMD-NEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNK 68
VA+K ++ D EK+ + E++++K + +H+N+I L + T GP
Sbjct: 45 VAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP------------ 90
Query: 69 YRGSTYMVFEYMDH-DLTGL--ADRP--------GLRFTVPQIKCY-----MKQLLTGLH 112
Y+V EY H +L A RP R + Q+ G+
Sbjct: 91 ----LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGME 146
Query: 113 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY-DHNNTLTNRVITLWYRPPELL 171
+ + +HRD+ N+L+ + +K+ADFGLAR + D+ TN + + + PE L
Sbjct: 147 FLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEAL 206
Query: 172 LGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 231
Y D+WS G + E IF L GSP +PG+
Sbjct: 207 FDRV-YTHQSDVWSFGVLLWE-------------------IFTLGGSP----YPGIPVEE 242
Query: 232 AYNHFKPSRTMKRRV---REVFRHFDRHALELLEKMLMLD-----PSQRISAK---DALD 280
+ K M++ +E++ LM D PSQR + K + LD
Sbjct: 243 LFKLLKEGYRMEKPQNCTQELY-------------HLMRDCWHEVPSQRPTFKQLVEDLD 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 5e-09
Identities = 43/167 (25%), Positives = 78/167 (46%), Gaps = 22/167 (13%)
Query: 32 EIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LAD 89
E I+ + H N+I+L+ +VT K++ ++ EYM++ L D
Sbjct: 56 EASIMGQFSHHNIIRLEGVVT---------------KFK-PAMIITEYMENGALDKYLRD 99
Query: 90 RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 149
G F+ Q+ ++ + G+ Y +HRD+ N+L+++ K++DFGL+R
Sbjct: 100 HDG-EFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158
Query: 150 YDHNNTLTNR--VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELL 194
D T T I + + PE + K+ A D+WS G + E++
Sbjct: 159 DDPEGTYTTSGGKIPIRWTAPE-AIAYRKFTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 5e-09
Identities = 48/193 (24%), Positives = 84/193 (43%), Gaps = 28/193 (14%)
Query: 6 KTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 64
K VA+K ++ D E E F ++E ++K+++H N+++L + T P
Sbjct: 29 KYSLTVAVKTLKEDTMEVEEF----LKEAAVMKEIKHPNLVQLLGVCTREPP-------- 76
Query: 65 DGNKYRGSTYMVFEYMDHDLTGLAD--RPGLRFTVPQIK-CYM-KQLLTGLHYCHVNQVL 120
Y++ E+M + L D R R V + YM Q+ + + Y +
Sbjct: 77 --------FYIITEFMTYG--NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFI 126
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 180
HRD+ N L+ +K+ADFGL+R + D + + PE L K+
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYNKFSIK 185
Query: 181 VDMWSVGCIFAEL 193
D+W+ G + E+
Sbjct: 186 SDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 6e-09
Identities = 65/287 (22%), Positives = 111/287 (38%), Gaps = 51/287 (17%)
Query: 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 64
I TG ++A K + + K +RE++I+ + + IV+ G
Sbjct: 27 IPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPY------IVSFYG--------- 70
Query: 65 DGNKYRGSTYMVFEYMDHD-LTGLADRPG-LRFTV-PQIKCYMKQLLTGLHYCHVNQVLH 121
+ M E+MD L + + G + + +I + + LT L+ H +++H
Sbjct: 71 -AFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMH 127
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 181
RDIK SN+L+++ G +KL DFG++ +T V T Y PE + G KY
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVSGELINSIADTF---VGTSTYMSPERIQGG-KYTVKS 183
Query: 182 DMWSVGCIFAELLNGKPILPGKNEAEQLS----KIFELCGSPDETIWPGVSKMPAYNHFK 237
D+WS+G EL GK N + I +L +
Sbjct: 184 DVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL--------------LQQIVQEP 229
Query: 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
P R F + ++ L+ DP++R + + F
Sbjct: 230 PPRLPSSD-------FPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 6e-09
Identities = 52/174 (29%), Positives = 84/174 (48%), Gaps = 22/174 (12%)
Query: 22 KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81
K G+ +++ E ++L++L H V+ L ++ R G G T +V
Sbjct: 200 KAGWYASSVHEARLLRRLSHPAVLALLDV------------RVVG----GLTCLVLPKYR 243
Query: 82 HDL-TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLA 140
DL T L R + Q+ +QLL+ + Y H ++HRDIK N+L++ ++ L
Sbjct: 244 SDLYTYLGARLR-PLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLG 302
Query: 141 DFGLARSFSYDHNNTLTNRVI--TLWYRPPELLLGATKYGPAVDMWSVGCIFAE 192
DFG A F+ +T + I T+ PE+L G Y P+VD+WS G + E
Sbjct: 303 DFG-AACFARGSWSTPFHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 7e-09
Identities = 29/95 (30%), Positives = 56/95 (58%), Gaps = 2/95 (2%)
Query: 103 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVIT 162
Y ++ L++ H +++RD+K N+L+D +G++KL D+G+ + +T + T
Sbjct: 101 YAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGDTTSTFCGT 159
Query: 163 LWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK 197
Y PE+L G +YG +VD W++G + E++ G+
Sbjct: 160 PNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 7e-09
Identities = 42/109 (38%), Positives = 61/109 (55%), Gaps = 8/109 (7%)
Query: 107 LLTGLHYC-HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWY 165
+L GL Y +Q++HRD+K SN+L+++ G +KL DFG++ N+ V T Y
Sbjct: 112 VLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSY 168
Query: 166 RPPELLLGATKYGPAVDMWSVGCIFAELLNGK-PILPGKNEAEQLSKIF 213
PE L G T Y D+WS+G EL G+ PI P +A++L IF
Sbjct: 169 MSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPP--PDAKELEAIF 214
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 8e-09
Identities = 70/252 (27%), Positives = 107/252 (42%), Gaps = 47/252 (18%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
+ + +T E K I KE + E+ ++++L+H+N+++ +
Sbjct: 31 LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFL-------- 82
Query: 61 QGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQ---IKCYMKQLLTGLHYCHV 116
NK Y++ E+ D DL+ + F + I +QLL L YCH
Sbjct: 83 ------NKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHN 136
Query: 117 -------NQVLHRDIKGSNLLID-----------NEGNL------KLADFGLARSFSYDH 152
+VLHRD+K N+ + NL K+ DFGL+++ +
Sbjct: 137 LKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE- 195
Query: 153 NNTLTNRVITLWYRPPELLLGATK-YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSK 211
+ + V T +Y PELLL TK Y DMW++GCI EL +GK N QL
Sbjct: 196 -SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQL-- 252
Query: 212 IFELCGSPDETI 223
I EL PD I
Sbjct: 253 ISELKRGPDLPI 264
|
Length = 1021 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 9e-09
Identities = 64/260 (24%), Positives = 101/260 (38%), Gaps = 66/260 (25%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIR-EIKILKKLQHENVIKLKEIVTSPGPERD 59
+AR++ T + A+K +R + + ++ E IL + +E V++L
Sbjct: 19 LARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD------ 72
Query: 60 EQGRPDGNKYRGSTYMVFEYM-DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 118
+ + Y V +Y+ D+ L R G+ F + Y+ +L + H
Sbjct: 73 ----------KDNLYFVMDYIPGGDMMSLLIRMGI-FPEDLARFYIAELTCAVESVHKMG 121
Query: 119 VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT----------------------- 155
+HRDIK N+LID +G++KL DFGL F + H++
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPA 181
Query: 156 ----------LTNR-------------VITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 192
L R V T Y PE+LL T Y D WSVG I E
Sbjct: 182 NCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVILYE 240
Query: 193 LLNGKPILPGKNEAEQLSKI 212
+L G+P + E K+
Sbjct: 241 MLVGQPPFLAQTPLETQMKV 260
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 51/197 (25%), Positives = 80/197 (40%), Gaps = 30/197 (15%)
Query: 13 LKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 71
LK +E+E + E+KI+ L HEN++ L T GP
Sbjct: 73 LKPTAHSSEREAL----MSELKIMSHLGNHENIVNLLGACTIGGP--------------- 113
Query: 72 STYMVFEYMDH-DLTGLADRPGLRF-TVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 129
++ EY + DL R F T+ + + Q+ G+ + +HRD+ N+
Sbjct: 114 -ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNV 172
Query: 130 LIDNEGNLKLADFGLARSFSYDHNNTL--TNRVITLWYRPPELLLGATKYGPAVDMWSVG 187
L+ + +K+ DFGLAR D N + R+ W P + Y D+WS G
Sbjct: 173 LLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV--YTFESDVWSYG 230
Query: 188 CIFAEL--LNGKPILPG 202
+ E+ L P PG
Sbjct: 231 ILLWEIFSLGSNP-YPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 38/110 (34%), Positives = 52/110 (47%), Gaps = 7/110 (6%)
Query: 111 LHYCHVNQ-VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPE 169
LHY V+HRD+K SN+L+D GN+KL DFG++ T + Y PE
Sbjct: 127 LHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAA--YMAPE 184
Query: 170 LLLGAT---KYGPAVDMWSVGCIFAELLNGKPILPG-KNEAEQLSKIFEL 215
+ KY D+WS+G EL G+ K E E L+KI +
Sbjct: 185 RIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE 234
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 44/186 (23%), Positives = 76/186 (40%), Gaps = 40/186 (21%)
Query: 31 REIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLT---- 85
RE ++ + H N++KL + G+P ++FEYM + DL
Sbjct: 57 REAALMAEFDHPNIVKLLGVCA--------VGKP--------MCLLFEYMAYGDLNEFLR 100
Query: 86 -----------------GLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 128
L + + C KQ+ G+ Y + +HRD+ N
Sbjct: 101 HRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160
Query: 129 LLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVG 187
L+ +K+ADFGL+R+ +S D+ N I + + PPE + +Y D+W+ G
Sbjct: 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYG 219
Query: 188 CIFAEL 193
+ E+
Sbjct: 220 VVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 57/237 (24%), Positives = 92/237 (38%), Gaps = 41/237 (17%)
Query: 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDG 66
TG +A+K+IR++ ++ F I E+ IL H+ V IV G E
Sbjct: 25 TGVTMAMKEIRLELDESKFN-QIIMELDIL----HKAVSP--YIVDFYGAFFIE------ 71
Query: 67 NKYRGSTYMVFEYMD----------HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 116
G+ YM EYMD T LR + +K L
Sbjct: 72 ----GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH----- 122
Query: 117 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT- 175
++HRD+K +N+L++ G +KL DFG++ + T + Y PE +
Sbjct: 123 -NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKT---NIGCQSYMAPERIKSGGP 178
Query: 176 ----KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 228
Y D+WS+G E+ G+ P + A +++ + T+ G S
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYS 235
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 58/230 (25%), Positives = 95/230 (41%), Gaps = 51/230 (22%)
Query: 8 GEIVALKKIRMDNEKEGFPITA-----------------IREIKILKKL-QHENVIKLKE 49
G++V + I +D +K P+T + E++++K + +H+N+I L
Sbjct: 26 GQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG 85
Query: 50 IVTSPGP-----ERDEQG---------RPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRF 95
T GP E +G RP G Y T + P +
Sbjct: 86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKL--------------PEEQL 131
Query: 96 TVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF-SYDHNN 154
T + Q+ G+ Y + +HRD+ N+L+ + +K+ADFGLAR + D+
Sbjct: 132 TFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYK 191
Query: 155 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL--LNGKPILPG 202
TN + + + PE L Y D+WS G + E+ L G P PG
Sbjct: 192 KTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSP-YPG 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 61/252 (24%), Positives = 102/252 (40%), Gaps = 59/252 (23%)
Query: 11 VALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKY 69
VA+K ++ D ++ I E++++K + +H+N+I L T GP
Sbjct: 53 VAVKMLKSDATEKDLS-DLISEMEMMKMIGKHKNIINLLGACTQDGP------------- 98
Query: 70 RGSTYMVFEYMD----HDLTGLADRPGLRFT-----VPQIKCYMKQLLT-------GLHY 113
Y++ EY + PG+ + VP+ + K L++ G+ Y
Sbjct: 99 ---LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEY 155
Query: 114 CHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY-DHNNTLTNRVITLWYRPPELLL 172
+ +HRD+ N+L+ + +K+ADFGLAR + D+ TN + + + PE L
Sbjct: 156 LASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF 215
Query: 173 GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 232
Y D+WS G + E IF L GSP +PGV
Sbjct: 216 DRI-YTHQSDVWSFGVLLWE-------------------IFTLGGSP----YPGVPVEEL 251
Query: 233 YNHFKPSRTMKR 244
+ K M +
Sbjct: 252 FKLLKEGHRMDK 263
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 42/169 (24%), Positives = 81/169 (47%), Gaps = 22/169 (13%)
Query: 32 EIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADR 90
E I+ + H N+I L+ +VT P ++ E+M++ L +
Sbjct: 55 EASIMGQFDHPNIIHLEGVVTKSRP----------------VMIITEFMENGALDSFLRQ 98
Query: 91 PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 150
+FTV Q+ ++ + G+ Y +HRD+ N+L+++ K++DFGL+R
Sbjct: 99 NDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158
Query: 151 DHNN-TLTNRV---ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN 195
D ++ T T+ + I + + PE + K+ A D+WS G + E+++
Sbjct: 159 DTSDPTYTSSLGGKIPIRWTAPE-AIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 36/199 (18%)
Query: 11 VALKKIRMD---NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 67
VA+K +R D N +E F ++E+KIL +L N+ +L + T P
Sbjct: 49 VAVKVLRPDASDNAREDF----LKEVKILSRLSDPNIARLLGVCTVDPP----------- 93
Query: 68 KYRGSTYMVFEYMDH-DL-----TGLADRPGLRFTVPQIK----CYM-KQLLTGLHYCHV 116
M+ EYM++ DL +A+ GL + YM Q+ +G+ Y
Sbjct: 94 -----LCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES 148
Query: 117 NQVLHRDIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITLWYRPPELLLGAT 175
+HRD+ N L+ +K+ADFG++R+ +S D+ + + + E +L
Sbjct: 149 LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-G 207
Query: 176 KYGPAVDMWSVGCIFAELL 194
K+ D+W+ G E+L
Sbjct: 208 KFTTKSDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 4e-08
Identities = 42/130 (32%), Positives = 68/130 (52%), Gaps = 10/130 (7%)
Query: 107 LLTGLHYC-HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWY 165
++ GL Y ++++HRD+K SN+L+++ G +KL DFG++ N+ V T Y
Sbjct: 112 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSY 168
Query: 166 RPPELLLGATKYGPAVDMWSVGCIFAELLNGK-PILPGKNEAEQLSKIF--ELCGSPDET 222
PE L G T Y D+WS+G E+ G+ PI P +A++L +F + G P E+
Sbjct: 169 MSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPP--PDAKELELMFGCPVEGDPAES 225
Query: 223 IWPGVSKMPA 232
+ P
Sbjct: 226 ETSPRPRPPG 235
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 13/100 (13%)
Query: 103 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVIT 162
Y Q++ Y +++RD+K NLL+D +G +K+ DFG A+ + R T
Sbjct: 136 YAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK--------VVDTRTYT 187
Query: 163 LWYRP----PELLLGATKYGPAVDMWSVGCIFAELLNGKP 198
L P PE+LL +G A D W++G E+L G P
Sbjct: 188 LCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCP 226
|
Length = 340 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 5e-08
Identities = 36/116 (31%), Positives = 51/116 (43%), Gaps = 19/116 (16%)
Query: 110 GLHYCHVN-QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLW---- 164
L Y H V+HRD+K SN+LI+ G +KL DFG++ L + V
Sbjct: 115 ALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGIS--------GYLVDSVAKTIDAGC 166
Query: 165 --YRPPELLLGATK---YGPAVDMWSVGCIFAELLNGK-PILPGKNEAEQLSKIFE 214
Y PE + Y D+WS+G EL G+ P K +QL ++ E
Sbjct: 167 KPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE 222
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 42/182 (23%), Positives = 69/182 (37%), Gaps = 34/182 (18%)
Query: 13 LKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG----PERDEQGRPDGNK 68
LK+ + K+ F +RE ++ +L H +++L + E G K
Sbjct: 31 LKQEHIAAGKKEF----LREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLGPL--LK 84
Query: 69 YRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 128
Y L R V +K Q+ G+ Y +HRD+ N
Sbjct: 85 Y-----------------LKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARN 125
Query: 129 LLIDNEGNLKLADFGLARSFSYDHN---NTLTNRVITLWYRPPELLLGATKYGPAVDMWS 185
+L+ N K++DFG++R+ + T R WY P + G K+ D+WS
Sbjct: 126 VLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG--KFSSKSDVWS 183
Query: 186 VG 187
G
Sbjct: 184 YG 185
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 6e-08
Identities = 28/74 (37%), Positives = 43/74 (58%), Gaps = 2/74 (2%)
Query: 74 YMVFEYM-DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 132
Y+V EY+ D+ L G F Y+ ++ L Y H + ++HRD+K N+LI
Sbjct: 80 YLVMEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS 138
Query: 133 NEGNLKLADFGLAR 146
NEG++KL DFGL++
Sbjct: 139 NEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 9e-08
Identities = 41/190 (21%), Positives = 80/190 (42%), Gaps = 29/190 (15%)
Query: 11 VALKKIR---MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 67
VA+ +R D ++ GF + E L + H N+++L+ ++T
Sbjct: 36 VAIHTLRAGCSDKQRRGF----LAEALTLGQFDHSNIVRLEGVIT--------------- 76
Query: 68 KYRGSTYM-VFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIK 125
RG+T M V EYM + L + + Q+ + L +G+ Y +H+ +
Sbjct: 77 --RGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLA 134
Query: 126 GSNLLIDNEGNLKLADFG-LARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMW 184
+L++++ K++ F L S T++ + LW P + + A D+W
Sbjct: 135 AHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH--HFSSASDVW 192
Query: 185 SVGCIFAELL 194
S G + E++
Sbjct: 193 SFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 9e-08
Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 34/206 (16%)
Query: 11 VALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGP-----ERDEQG-- 62
VA+K ++ DN + I E++++K + +H+N+I L + T GP E +G
Sbjct: 47 VAVKMLK-DNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNL 105
Query: 63 -------RPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 115
RP G Y D+T + + + + Q+ G+ Y
Sbjct: 106 REFLRARRPPGPDY-----------TFDITKVPEEQ---LSFKDLVSCAYQVARGMEYLE 151
Query: 116 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY-DHNNTLTNRVITLWYRPPELLLGA 174
+ +HRD+ N+L+ + +K+ADFGLAR D+ +N + + + PE L
Sbjct: 152 SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR 211
Query: 175 TKYGPAVDMWSVGCIFAEL--LNGKP 198
Y D+WS G + E+ L G P
Sbjct: 212 V-YTHQSDVWSFGILMWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 32/102 (31%), Positives = 49/102 (48%), Gaps = 13/102 (12%)
Query: 118 QVLHRDIKGSNLLIDNEGNLKLADFG----LARSFSYDHNNTLTNRVITLWYRPPELLL- 172
+++HRD+K SN+L+D GN+KL DFG L S + + Y PE +
Sbjct: 128 KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRP------YMAPERIDP 181
Query: 173 -GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA-EQLSKI 212
Y D+WS+G E+ GK P N +QL+++
Sbjct: 182 SARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQV 223
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 48/183 (26%), Positives = 78/183 (42%), Gaps = 37/183 (20%)
Query: 106 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR----SFSYDHNNTLTNRVI 161
Q++ L H +++HRD+K +N+ + G +KL DFG ++ S S D ++
Sbjct: 177 QIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCG--- 233
Query: 162 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDE 221
T +Y PE L +Y DMWS+G I ELL G ++ E + ++ L G D
Sbjct: 234 TPYYLAPE-LWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV--LYGKYDP 290
Query: 222 TIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281
P S M A LL+ +L +P+ R + + L +
Sbjct: 291 FPCPVSSGMKA---------------------------LLDPLLSKNPALRPTTQQLLHT 323
Query: 282 EYF 284
E+
Sbjct: 324 EFL 326
|
Length = 478 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 56/200 (28%), Positives = 82/200 (41%), Gaps = 31/200 (15%)
Query: 10 IVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 69
+ +L +I E E F ++E I+K H NV+ L I
Sbjct: 28 VKSLNRITDLEEVEQF----LKEGIIMKDFSHPNVLSLLGICLPS--------------- 68
Query: 70 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 128
GS +V YM H DL TV + + Q+ G+ Y + +HRD+ N
Sbjct: 69 EGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARN 128
Query: 129 LLIDNEGNLKLADFGLARSFSYD------HNNTLTNRVITLWYRPPELLLGATKYGPAVD 182
++D +K+ADFGLAR YD HN+T ++ W L K+ D
Sbjct: 129 CMLDESFTVKVADFGLARDI-YDKEYYSVHNHT-GAKLPVKWMALES--LQTQKFTTKSD 184
Query: 183 MWSVGCIFAELLN-GKPILP 201
+WS G + EL+ G P P
Sbjct: 185 VWSFGVLLWELMTRGAPPYP 204
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 40/167 (23%), Positives = 69/167 (41%), Gaps = 23/167 (13%)
Query: 30 IREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLA 88
++E +ILK+ H N+++L + T P Y+V E + D
Sbjct: 41 LQEARILKQYSHPNIVRLIGVCTQKQP----------------IYIVMELVQGGDFLTFL 84
Query: 89 DRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 148
G R V ++ ++ G+ Y +HRD+ N L+ + LK++DFG++R
Sbjct: 85 RTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREE 144
Query: 149 S---YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 192
Y + ++ W P L G +Y D+WS G + E
Sbjct: 145 EDGVYASTGGM-KQIPVKWTAPEALNYG--RYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 35/174 (20%), Positives = 68/174 (39%), Gaps = 28/174 (16%)
Query: 32 EIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGL--A 88
E ++K+ +V++L +V+ G+P T +V E M DL +
Sbjct: 59 EASVMKEFNCHHVVRLLGVVS--------TGQP--------TLVVMELMAKGDLKSYLRS 102
Query: 89 DRPGLRFTVP-------QIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLAD 141
RP + ++ G+ Y + +HRD+ N ++ + +K+ D
Sbjct: 103 RRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGD 162
Query: 142 FGLARSFSY-DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELL 194
FG+ R D+ ++ + + PE L + D+WS G + E+
Sbjct: 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 56/246 (22%), Positives = 96/246 (39%), Gaps = 55/246 (22%)
Query: 12 ALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN---- 67
A ++R+ +K+ I A++ ++ L+ E V ++ ERD DG
Sbjct: 13 AFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIR-------AERDILVEADGAWVVK 65
Query: 68 -----KYRGSTYMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
+ + + Y++ E++ +T L + L + + Y+ + + + H +
Sbjct: 66 MFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTL--SEEATQFYIAETVLAIDAIHQLGFI 123
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDH------------------NNTLTNRVIT 162
HRDIK NLL+D +G++KL+DFGL H N + R
Sbjct: 124 HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAE 183
Query: 163 LW----------------YRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA 206
W Y PE+ + T Y D WS+G I E+L G P +
Sbjct: 184 TWKKNRRQLAYSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242
Query: 207 EQLSKI 212
E K+
Sbjct: 243 ETYRKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 4e-07
Identities = 26/102 (25%), Positives = 51/102 (50%), Gaps = 5/102 (4%)
Query: 99 QIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158
+K + +++ L H ++ RD+ +N+L+D+ G+++L F + ++
Sbjct: 86 CVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWS----EVEDSCDG 141
Query: 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPIL 200
+ Y PE + G ++ A D WS+G I ELL GK ++
Sbjct: 142 EAVENMYCAPE-VGGISEETEACDWWSLGAILFELLTGKTLV 182
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 6e-07
Identities = 50/193 (25%), Positives = 80/193 (41%), Gaps = 31/193 (16%)
Query: 30 IREIKILKKLQHENVIKLKEIVTSPGP-----ERDEQG---------RPDGNKYRGSTYM 75
+ E +LK++ H +VIKL + GP E + G R G Y GS
Sbjct: 51 LSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGN 110
Query: 76 VFEYMDHDLTGLADRPGLR-FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 134
D P R T+ + + Q+ G+ Y +++HRD+ N+L+
Sbjct: 111 RNSSYL-------DNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEG 163
Query: 135 GNLKLADFGLARSFSYDHNNTLT---NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFA 191
+K++DFGL+R Y+ ++ + R+ W L Y D+WS G +
Sbjct: 164 RKMKISDFGLSRDV-YEEDSYVKRSKGRIPVKWMAIESLF--DHIYTTQSDVWSFGVLLW 220
Query: 192 EL--LNGKPILPG 202
E+ L G P PG
Sbjct: 221 EIVTLGGNP-YPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 39/152 (25%), Positives = 59/152 (38%), Gaps = 35/152 (23%)
Query: 95 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH-- 152
T + + Y+ + + + H +HRDIK NLL+D++G++KL+DFGL H
Sbjct: 98 LTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157
Query: 153 ----------------NNTLTNRVITLWYR----------------PPELLLGATKYGPA 180
N + R W R PE+ + T Y
Sbjct: 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-QTGYNKL 216
Query: 181 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 212
D WS+G I E+L G P + E K+
Sbjct: 217 CDWWSLGVIMYEMLIGYPPFCSETPQETYKKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 40/183 (21%), Positives = 79/183 (43%), Gaps = 36/183 (19%)
Query: 31 REIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-------- 82
E + +LQH N++ L +VT P M+F Y H
Sbjct: 57 HEAMMRSRLQHPNIVCLLGVVTKEQP----------------LSMIFSYCSHSDLHEFLV 100
Query: 83 ------DLTGLADRPGLRFTV--PQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 134
D+ D ++ T+ + Q+ G+ + + V+H+D+ N+L+ ++
Sbjct: 101 MRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160
Query: 135 GNLKLADFGLARS-FSYDHNNTLTNRVITL-WYRPPELLLGATKYGPAVDMWSVGCIFAE 192
N+K++D GL R ++ D+ + N ++ + W P ++ G K+ D+WS G + E
Sbjct: 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWE 218
Query: 193 LLN 195
+ +
Sbjct: 219 VFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 8e-07
Identities = 24/91 (26%), Positives = 50/91 (54%), Gaps = 2/91 (2%)
Query: 106 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITLW 164
Q+ G+ Y + +H+D+ N+LI + ++K++D GL+R +S D+ ++ +
Sbjct: 132 QIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIR 191
Query: 165 YRPPELLLGATKYGPAVDMWSVGCIFAELLN 195
+ PPE ++ K+ D+WS G + E+ +
Sbjct: 192 WMPPEAIMYG-KFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 9e-07
Identities = 44/196 (22%), Positives = 80/196 (40%), Gaps = 35/196 (17%)
Query: 31 REIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD-HDLTG--L 87
RE+ + +KL H+NV++L + P YM+ EY D DL
Sbjct: 57 RELDMFRKLSHKNVVRLLGLCREAEPH----------------YMILEYTDLGDLKQFLR 100
Query: 88 ADRPGLR------FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLAD 141
A + + Q Q+ G+ + + +HRD+ N L+ ++ +K++
Sbjct: 101 ATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL 160
Query: 142 FGLAR----SFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-G 196
L++ S Y N L I L + PE + + D+WS G + E+ G
Sbjct: 161 LSLSKDVYNSEYYKLRNAL----IPLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEVFTQG 215
Query: 197 KPILPGKNEAEQLSKI 212
+ G ++ E L+++
Sbjct: 216 ELPFYGLSDEEVLNRL 231
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 47/211 (22%), Positives = 82/211 (38%), Gaps = 31/211 (14%)
Query: 11 VALKKIRMDN----EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDG 66
VA+K +++D E E F + E +K H NV+KL + Q P
Sbjct: 30 VAVKTMKLDIHTYSEIEEF----LSEAACMKDFDHPNVMKLIGVCFE---ASSLQKIP-- 80
Query: 67 NKYRGSTYMVFEYMDH-DL------TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQV 119
++ +M H DL + L P + + + +M + G+ Y
Sbjct: 81 -----KPMVILPFMKHGDLHSFLLYSRLGGLP-EKLPLQTLLKFMVDIALGMEYLSNRNF 134
Query: 120 LHRDIKGSNLLIDNEGNLKLADFGLARS-FSYD-HNNTLTNRVITLWYRPPELLLGATKY 177
+HRD+ N ++ + + +ADFGL++ +S D + ++ W L Y
Sbjct: 135 IHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIES--LADRVY 192
Query: 178 GPAVDMWSVGCIFAELLN-GKPILPGKNEAE 207
D+W+ G E+ G+ PG E
Sbjct: 193 TSKSDVWAFGVTMWEIATRGQTPYPGVENHE 223
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 44/184 (23%), Positives = 75/184 (40%), Gaps = 21/184 (11%)
Query: 11 VALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 70
VA+K + D +E I + E +ILK+ H N++KL + T P
Sbjct: 22 VAVKTCKEDLPQE-LKIKFLSEARILKQYDHPNIVKLIGVCTQRQP-------------- 66
Query: 71 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 129
Y+V E + D + Q+ + G+ Y +HRD+ N
Sbjct: 67 --IYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNC 124
Query: 130 LIDNEGNLKLADFGLARSFSYD-HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGC 188
L+ LK++DFG++R ++++ ++ W P L G +Y D+WS G
Sbjct: 125 LVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYG--RYSSESDVWSYGI 182
Query: 189 IFAE 192
+ E
Sbjct: 183 LLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 60/223 (26%), Positives = 96/223 (43%), Gaps = 43/223 (19%)
Query: 7 TGEI-VALKKIR---MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQG 62
+G I VA+K +R D EK+ F ++E ++ H N++KL + P+
Sbjct: 24 SGPIRVAVKTLRKGATDQEKKEF----LKEAHLMSNFNHPNIVKLLGVCLLNEPQ----- 74
Query: 63 RPDGNKYRGSTYMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLL-------TGLHY 113
Y++ E M+ L+ L D RF P + +K+LL G Y
Sbjct: 75 -----------YIIMELMEGGDLLSYLRDARVERFGPPLLT--LKELLDICLDVAKGCVY 121
Query: 114 CHVNQVLHRDIKGSNLLIDNEGN-----LKLADFGLARS-FSYDHNNTLTNRVITLWYRP 167
+HRD+ N L+ +G +K+ DFGLAR + D+ ++ + +
Sbjct: 122 LEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMA 181
Query: 168 PELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQL 209
PE LL K+ D+WS G + E+L G+ P N E L
Sbjct: 182 PESLLDG-KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL 223
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 1e-06
Identities = 38/103 (36%), Positives = 52/103 (50%), Gaps = 3/103 (2%)
Query: 100 IKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159
IK M+Q+LTGL H ++HRDIK NLL+ +G +K+ DFG A N
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYG 370
Query: 160 VITLWYRPPELLLGATKY--GPAVDMWSVGCIFAELLNGKPIL 200
++ Y PPE L+ PA M ++ FA L G+P L
Sbjct: 371 MLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFA-WLYGRPDL 412
|
Length = 507 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 33/145 (22%), Positives = 59/145 (40%), Gaps = 25/145 (17%)
Query: 11 VALKKIRMDNE---KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 67
VA+K + +E F ++E I+++ H +++KL ++T
Sbjct: 37 VAVKTCKNCTSPSVREKF----LQEAYIMRQFDHPHIVKLIGVITEN------------- 79
Query: 68 KYRGSTYMVFE-YMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKG 126
++V E +L + + Y QL T L Y + +HRDI
Sbjct: 80 ----PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAA 135
Query: 127 SNLLIDNEGNLKLADFGLARSFSYD 151
N+L+ + +KL DFGL+R +
Sbjct: 136 RNVLVSSPDCVKLGDFGLSRYLEDE 160
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 7e-06
Identities = 65/289 (22%), Positives = 120/289 (41%), Gaps = 31/289 (10%)
Query: 5 IKTGEIVALK-KIRMDNEKEG--FPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
+ GE V + I++ NE G + + E I+ + H ++++L + SP + Q
Sbjct: 29 VPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQ 88
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
P G + +Y+ + + L + V Q+ G+ Y +++H
Sbjct: 89 LMPHG--------CLLDYVHEHKDNIGSQLLLNWCV--------QIAKGMMYLEERRLVH 132
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTLTNRVITLWYRPPELLLGATKYGP 179
RD+ N+L+ + ++K+ DFGLAR D N ++ W + K+
Sbjct: 133 RDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE--CIHYRKFTH 190
Query: 180 AVDMWSVGCIFAELLN--GKPI--LPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235
D+WS G EL+ GKP +P + + L K L P TI + + +
Sbjct: 191 QSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMI 250
Query: 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
SR + +E+ F R A + ++ L++ R+ DS++F
Sbjct: 251 DADSRP---KFKELAAEFSRMARD-PQRYLVIQGDDRMKLPSPNDSKFF 295
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 7e-06
Identities = 31/94 (32%), Positives = 45/94 (47%), Gaps = 12/94 (12%)
Query: 106 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITLW 164
Q+ G+ Y H V+H+DI N +ID E +K+ D L+R F D++ N
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNE----- 179
Query: 165 YRP-----PELLLGATKYGPAVDMWSVGCIFAEL 193
RP E L+ +Y A D+WS G + EL
Sbjct: 180 NRPVKWMALESLVN-KEYSSASDVWSFGVLLWEL 212
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 9e-06
Identities = 48/184 (26%), Positives = 72/184 (39%), Gaps = 39/184 (21%)
Query: 95 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 154
T+ + CY Q+ G+ + + +HRD+ N+L+ +K+ DFGLAR D +
Sbjct: 176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 235
Query: 155 TLTNRV-ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 213
+ L + PE + Y D+WS G + E IF
Sbjct: 236 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWE-------------------IF 275
Query: 214 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVRE--VFRHFDRHALELLEKMLML---D 268
L SP +PGV K RR++E R D E+ + ML +
Sbjct: 276 SLGASP----YPGV---------KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE 322
Query: 269 PSQR 272
PSQR
Sbjct: 323 PSQR 326
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 59/246 (23%), Positives = 84/246 (34%), Gaps = 60/246 (24%)
Query: 74 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 133
Y V Y+ + L GL I+ M+Q+L L H ++HRD+K N++
Sbjct: 233 YNVEPYLLGKVQDLP--KGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSE 290
Query: 134 E-GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG------------------- 173
G+ K+ D G A N Y P E LL
Sbjct: 291 GSGSFKIIDLGAAADLRVGIN-----------YIPKEFLLDPRYAAPEQYIMSTQTPSAP 339
Query: 174 ----ATKYGPAV---------DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD 220
AT P + D++S G IF ++ P L + Q ++ +
Sbjct: 340 SAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM--AFPNLRSDSNLIQFNRQLKRND--- 394
Query: 221 ETIWPGVSKMPAYNHFKPSRTMK--RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDA 278
+ A+ R RR EV ELL+ M+ QRISAK A
Sbjct: 395 -------YDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAA 447
Query: 279 LDSEYF 284
L YF
Sbjct: 448 LAHPYF 453
|
Length = 566 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 54/205 (26%), Positives = 79/205 (38%), Gaps = 32/205 (15%)
Query: 108 LTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS-----------YDHNNTL 156
L GL+Y H N +HR+IK S++LI +G + L+ GL+ +S YD
Sbjct: 111 LRGLNYLHQNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFS 168
Query: 157 TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK-PILPGKNEAEQLSKIFEL 215
T+ + W P L Y D++SVG EL G+ P L K+
Sbjct: 169 TS--VLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGP 226
Query: 216 CGSP-DETIWP---------------GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALE 259
SP D T +P G+ + + T +R + F
Sbjct: 227 PYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQN 286
Query: 260 LLEKMLMLDPSQRISAKDALDSEYF 284
L+E L DP +R SA L +F
Sbjct: 287 LVELCLQQDPEKRPSASSLLSHAFF 311
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 31/122 (25%), Positives = 55/122 (45%), Gaps = 3/122 (2%)
Query: 95 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 154
T+ + CY Q+ G+ + + +HRD+ N+L+ +K+ DFGLAR D +
Sbjct: 171 LTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 230
Query: 155 TLT-NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKI 212
+ + L + PE + Y D+WS G + E+ + G PG E+ +
Sbjct: 231 VRKGSARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR 289
Query: 213 FE 214
+
Sbjct: 290 LK 291
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 52/213 (24%), Positives = 92/213 (43%), Gaps = 35/213 (16%)
Query: 11 VALKKIRM----DNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDG 66
VA+K +++ +E E F + E +K+ H NV++L + E +G P
Sbjct: 29 VAVKTMKIAICTRSEMEDF----LSEAVCMKEFDHPNVMRLIGVCLQ-TVES--EGYP-- 79
Query: 67 NKYRGSTYMVFEYMDH-DL------TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQV 119
S ++ +M H DL + L D P T +K +M + +G+ Y
Sbjct: 80 -----SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVK-FMTDIASGMEYLSSKSF 133
Query: 120 LHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELL----LGAT 175
+HRD+ N +++ N+ +ADFGL++ Y+ + R+ + P + + L
Sbjct: 134 IHRDLAARNCMLNENMNVCVADFGLSKKI-YNGDYYRQGRIAKM---PVKWIAIESLADR 189
Query: 176 KYGPAVDMWSVGCIFAELLN-GKPILPGKNEAE 207
Y D+WS G E+ G+ PG +E
Sbjct: 190 VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE 222
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 30/108 (27%), Positives = 50/108 (46%), Gaps = 7/108 (6%)
Query: 96 TVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT 155
TV + M Q+ G+ Y +HRD+ N+L+ N+ K++DFGL+++ D ++
Sbjct: 93 TVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGAD-DSY 151
Query: 156 LTNRVITLW---YRPPELLLGATKYGPAVDMWSVGCIFAELLN--GKP 198
R W + PE + K+ D+WS G E + KP
Sbjct: 152 YKARSAGKWPLKWYAPECIN-FRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 31/106 (29%), Positives = 47/106 (44%), Gaps = 5/106 (4%)
Query: 95 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 154
T Q+ + + TG+ Y Q +HRD+ N+L+ K+ADFGL+R
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKK 175
Query: 155 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL--LNGKP 198
T+ R+ W L + Y D+WS G + E+ L G P
Sbjct: 176 TM-GRLPVRWMAIES--LNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 46/202 (22%), Positives = 75/202 (37%), Gaps = 30/202 (14%)
Query: 16 IRMDNEKEGFPITAIREIK-ILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTY 74
+RMD AI+ +K K H + E++ G + ++RG Y
Sbjct: 33 LRMD--------AAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84
Query: 75 MVFEYMDHD----------------LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 118
+ EY H +A+ + Q+ + + G+ Y Q
Sbjct: 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ 144
Query: 119 VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYG 178
+HRD+ N+L+ K+ADFGL+R T+ R+ W L + Y
Sbjct: 145 FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM-GRLPVRWMAIES--LNYSVYT 201
Query: 179 PAVDMWSVGCIFAEL--LNGKP 198
D+WS G + E+ L G P
Sbjct: 202 TNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 7e-05
Identities = 43/154 (27%), Positives = 71/154 (46%), Gaps = 26/154 (16%)
Query: 4 EIKTGEIVALKKIRMD----NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERD 59
E + + VA+K ++ D ++ E F +RE +K+ H NVIKL +
Sbjct: 23 EDGSFQKVAVKMLKADIFSSSDIEEF----LREAACMKEFDHPNVIKLIGVSL------- 71
Query: 60 EQGRPDGNKYRGSTYMV-FEYMDH-DLTG--LADRPGLR-FTVPQ--IKCYMKQLLTGLH 112
+ R G R MV +M H DL L R G FT+P + +M + +G+
Sbjct: 72 -RSRAKG---RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGME 127
Query: 113 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 146
Y +HRD+ N +++ + +ADFGL++
Sbjct: 128 YLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 34/124 (27%), Positives = 56/124 (45%), Gaps = 8/124 (6%)
Query: 106 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN--RVITL 163
Q+ G+ Y +++HRD+ N+L+ + ++K+ DFGLAR D + +V
Sbjct: 117 QIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK 176
Query: 164 WYRPPELLLGATKYGPAVDMWSVGCIFAELLN--GKPI--LPGKNEAEQLSKIFELCGSP 219
W +L ++ D+WS G EL+ KP +P + + L K L P
Sbjct: 177 WMALESIL--HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPP 234
Query: 220 DETI 223
TI
Sbjct: 235 ICTI 238
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 8e-05
Identities = 42/194 (21%), Positives = 80/194 (41%), Gaps = 30/194 (15%)
Query: 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG----PERDEQ 61
K+ + VA+K ++ DN +RE ++++L + ++++ I + E E
Sbjct: 20 KSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAEL 79
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
G NK+ V + ++T L + Q+ G+ Y +H
Sbjct: 80 GPL--NKFLQKNKHV---TEKNITEL----------------VHQVSMGMKYLEETNFVH 118
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHN---NTLTNRVITLWYRPPELLLGATKYG 178
RD+ N+L+ + K++DFGL+++ D N + WY P + K+
Sbjct: 119 RDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE--CMNYYKFS 176
Query: 179 PAVDMWSVGCIFAE 192
D+WS G + E
Sbjct: 177 SKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|219133 pfam06682, DUF1183, Protein of unknown function (DUF1183) | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 31/106 (29%), Positives = 34/106 (32%), Gaps = 16/106 (15%)
Query: 371 GKPRGPPGGANRYPSGNQSGGYNNPNRGGQGGGYSNAPYPPQGRGPPYAGAGMPANGPRG 430
G GP Y G GG GG GGG P PP + P G
Sbjct: 182 GVRGGPRPERAGYGGGGGGGGG-----GGGGGGSGPGPPPPGFKSSFPP----PYGPGAG 232
Query: 431 PASGYGVGPQSYSQSGQYGNSAAGRGPNQMGG-------SRNQQYG 469
P+SGYG G Q G G G G + N YG
Sbjct: 233 PSSGYGSGGTRSGQGGWGPGFWTGLGAGGALGYLFGSRRNNNSSYG 278
|
This family consists of several eukaryotic proteins of around 360 residues in length. The function of this family is unknown. Length = 317 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 42/187 (22%), Positives = 76/187 (40%), Gaps = 23/187 (12%)
Query: 11 VALKKIRMDNEKEGFPITAI-REIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 69
VA+K +R + + I E ++ + H +V++L I S + Q P G
Sbjct: 39 VAIKVLREETSPKAN--KEILDEAYVMASVDHPHVVRLLGICLSSQVQLITQLMPLGC-- 94
Query: 70 RGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 129
+ +Y+ + + + L + V Q+ G+ Y +++HRD+ N+
Sbjct: 95 ------LLDYVRNHKDNIGSQYLLNWCV--------QIAKGMSYLEEKRLVHRDLAARNV 140
Query: 130 LIDNEGNLKLADFGLARSFSYDHNNTLTN--RVITLWYRPPELLLGATKYGPAVDMWSVG 187
L+ ++K+ DFGLA+ D +V W +L Y D+WS G
Sbjct: 141 LVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHR--IYTHKSDVWSYG 198
Query: 188 CIFAELL 194
EL+
Sbjct: 199 VTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 34/134 (25%), Positives = 52/134 (38%), Gaps = 27/134 (20%)
Query: 96 TVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT 155
T+ + Y Q+ G+ + + +HRD+ N+L+ +K+ DFGLAR D +
Sbjct: 171 TLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV 230
Query: 156 LTN--RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 213
R+ W P + Y D+WS G + E IF
Sbjct: 231 RKGDARLPLKWMAPESIF--DKVYTTQSDVWSFGVLLWE-------------------IF 269
Query: 214 ELCGSPDETIWPGV 227
L SP +PGV
Sbjct: 270 SLGASP----YPGV 279
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 33/128 (25%), Positives = 55/128 (42%), Gaps = 6/128 (4%)
Query: 79 YMDHDLT-GLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 137
Y+D D+T + + L + + Q+ G+ + +HRD+ N+L+ +
Sbjct: 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRIT 253
Query: 138 KLADFGLARSFSYDHNNTLTN--RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN 195
K+ DFGLAR D N + R+ W P + Y D+WS G + E+ +
Sbjct: 254 KICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIF--NCVYTFESDVWSYGILLWEIFS 311
Query: 196 -GKPILPG 202
G PG
Sbjct: 312 LGSSPYPG 319
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 76/343 (22%), Positives = 125/343 (36%), Gaps = 87/343 (25%)
Query: 1 MAREIKTGEIVALKKIRMD---NE--KEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 55
+A + VALKKIR D N K+ F +RE KI L H ++ + I +
Sbjct: 20 LAYDPVCSRRVALKKIREDLSENPLLKKRF----LREAKIAADLIHPGIVPVYSICS--- 72
Query: 56 PERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGL------RFTVPQIKCYMKQLLT 109
G P Y Y+ + L + + L + +V ++
Sbjct: 73 -----DGDP---VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124
Query: 110 GLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS----------FSYD------HN 153
+ Y H VLHRD+K N+L+ G + + D+G A D +
Sbjct: 125 TIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 154 NTLTNRVI-TLWYRPPELLLGATKYGPA---VDMWSVGCIFAELLNGKPILPGKNEAEQL 209
T+ +++ T Y PE LLG PA D++++G I ++L P + + +
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGV----PASESTDIYALGVILYQMLTLS--FPYRRKKGR- 237
Query: 210 SKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDP 269
KI S + I ++ Y RE+ + A+ K L +DP
Sbjct: 238 -KI-----SYRDVI-LSPIEVAPY-------------REIPPFLSQIAM----KALAVDP 273
Query: 270 SQRISAKDAL----------DSEYFWTDPLPCDPKSLPKYESS 302
++R S+ L E+ L KS K+
Sbjct: 274 AERYSSVQELKQDLEPHLQGSPEWTVKATLMTKKKSCWKFYEP 316
|
Length = 932 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 29/100 (29%), Positives = 45/100 (45%), Gaps = 5/100 (5%)
Query: 106 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN--RVITL 163
Q+ G+ + +HRD+ N+L+ + K+ DFGLAR D N + R+
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVK 279
Query: 164 WYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPG 202
W P + Y D+WS G + E+ + GK PG
Sbjct: 280 WMAPESIF--DCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 38/144 (26%), Positives = 60/144 (41%), Gaps = 9/144 (6%)
Query: 59 DEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 118
D + + Y E D + + P L + + + Q+ G+ +
Sbjct: 203 DIESSNYESPYDQYLPSAPERTRRDTL-INESPALSYM--DLVGFSYQVANGMEFLASKN 259
Query: 119 VLHRDIKGSNLLIDNEGNL-KLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATK 176
+HRD+ N+LI EG L K+ DFGLAR D N + + + L + PE +
Sbjct: 260 CVHRDLAARNVLI-CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL- 317
Query: 177 YGPAVDMWSVGCIFAEL--LNGKP 198
Y D+WS G + E+ L G P
Sbjct: 318 YTTLSDVWSFGILLWEIFTLGGTP 341
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 56/211 (26%), Positives = 84/211 (39%), Gaps = 42/211 (19%)
Query: 106 QLLTGLHYCHVN-QVLHRDIKGSNLLIDNEGN----------------LKLADFGLARSF 148
Q L Y H ++H D+K N+L++ +++ D G
Sbjct: 239 QTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG----G 294
Query: 149 SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ 208
D ++ T V T YR PE++LG + + DMWS+GCI EL GK + + E
Sbjct: 295 CCDERHSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH 353
Query: 209 LSKIFE-LCGSPDETIWPGVSKMPA----YN---HFKPSRTMK--------RRVREVFRH 252
L + + L P E W G YN +P K R VREV R
Sbjct: 354 LHLMEKTLGRLPSE--WAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIR- 410
Query: 253 FDRHALELLEKMLMLDPSQRISAKDALDSEY 283
D +L+ +L D +R++A+ Y
Sbjct: 411 -DDLLCDLIYGLLHYDRQKRLNARQMTTHPY 440
|
Length = 467 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 30/119 (25%), Positives = 48/119 (40%), Gaps = 5/119 (4%)
Query: 87 LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 146
L+D T + + Q+ G+ + +HRD+ N+L+ +K+ DFGLAR
Sbjct: 226 LSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLAR 285
Query: 147 SFSYDHNNTLTNRVI--TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPG 202
+D N W P + Y D+WS G + E+ + G PG
Sbjct: 286 DIMHDSNYVSKGSTFLPVKWMAPESIF--DNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 28/91 (30%), Positives = 41/91 (45%), Gaps = 5/91 (5%)
Query: 110 GLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPE 169
G+ Y Q +HRD+ N+L+ K+ADFGL+R T+ R+ W
Sbjct: 124 GMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM-GRLPVRWMAIES 182
Query: 170 LLLGATKYGPAVDMWSVGCIFAEL--LNGKP 198
L + Y D+WS G + E+ L G P
Sbjct: 183 --LNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 19/51 (37%), Positives = 28/51 (54%)
Query: 98 PQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 148
IK MK +LT L Y H + + H DIK N+++D + D+G+A F
Sbjct: 126 KLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHF 176
|
Length = 294 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 34/124 (27%), Positives = 53/124 (42%), Gaps = 8/124 (6%)
Query: 106 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN--RVITL 163
Q+ G++Y +++HRD+ N+L+ ++K+ DFGLA+ D +V
Sbjct: 117 QIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK 176
Query: 164 WYRPPELLLGATKYGPAVDMWSVGCIFAELLN--GKPI--LPGKNEAEQLSKIFELCGSP 219
W +L Y D+WS G EL+ KP +P + L K L P
Sbjct: 177 WMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 234
Query: 220 DETI 223
TI
Sbjct: 235 ICTI 238
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|217469 pfam03276, Gag_spuma, Spumavirus gag protein | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 31/111 (27%), Positives = 35/111 (31%), Gaps = 5/111 (4%)
Query: 359 PPVPGGPGHHHYGKPRGPPGGANRYPSGNQ--SGGYNNPNRGGQGGGYSNAPYPPQGRGP 416
P + + P NR NQ S G N RG G Y PQ G
Sbjct: 462 PQNQRRQQNRGRQSSQPPRQQQNRSNQNNQRQSQGPNQGPRGQGGYNLRPRTYQPQRYG- 520
Query: 417 PYAGAGMPANGPRGPASGYGVGPQSYSQSGQYGNSAAGRGPNQMGGSRNQQ 467
G G N SG G Q Q GN + GP + G R Q
Sbjct: 521 --GGQGRRWNPNPYRQSGQGRSQQQQPQPEARGNQSRTPGPGRGQGGRGNQ 569
|
Length = 582 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 23/92 (25%), Positives = 47/92 (51%), Gaps = 4/92 (4%)
Query: 106 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVIT--L 163
Q+ G++Y ++++HR++ N+L+ ++ +++ADFG+A D + T
Sbjct: 117 QIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK 176
Query: 164 WYRPPELLLGATKYGPAVDMWSVGCIFAELLN 195
W +L G +Y D+WS G E+++
Sbjct: 177 WMALESILFG--RYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|216868 pfam02084, Bindin, Bindin | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 24/84 (28%), Positives = 30/84 (35%), Gaps = 2/84 (2%)
Query: 370 YGKPRGPPGGANRYPSGNQ--SGGYNNPNRGGQGGGYSNAPYPPQGRGPPYAGAGMPANG 427
Y + P G YP+ Q GY N GG GG G P G G + G
Sbjct: 7 YPQAMNPQMGGGNYPAPGQPAQQGYANQGMGGPVGGGGGPGAGGGAPGGPVGGGGGGSGG 66
Query: 428 PRGPASGYGVGPQSYSQSGQYGNS 451
P G G + S+ Y +S
Sbjct: 67 PPGGGEVAGEAEDAMSEFDDYSSS 90
|
Length = 239 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 32/117 (27%), Positives = 53/117 (45%), Gaps = 14/117 (11%)
Query: 104 MKQLLTGLHYCHVNQVLHRDIKGSNLLI----DNEGN---LKLADFGLARSFSYDHNNTL 156
KQL + LHY +++H ++ G N+L+ NEG +KL+D G+ + +
Sbjct: 107 AKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL-----SR 161
Query: 157 TNRVITLWYRPPELL-LGATKYGPAVDMWSVGCIFAELL-NGKPILPGKNEAEQLSK 211
RV + + PE + G A D WS G E+ NG+ L + +E+
Sbjct: 162 EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF 218
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 39/178 (21%), Positives = 78/178 (43%), Gaps = 28/178 (15%)
Query: 27 ITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLT 85
I + E ++K+ +V++L +V+ QG+P T ++ E M DL
Sbjct: 54 IEFLNEASVMKEFNCHHVVRLLGVVS--------QGQP--------TLVIMELMTRGDLK 97
Query: 86 GL--ADRPGLRFTVPQIKCYMKQLLT-------GLHYCHVNQVLHRDIKGSNLLIDNEGN 136
+ RP + Q +K+++ G+ Y + N+ +HRD+ N ++ +
Sbjct: 98 SYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 157
Query: 137 LKLADFGLARS-FSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL 193
+K+ DFG+ R + D+ ++ + + PE L + D+WS G + E+
Sbjct: 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 33/134 (24%), Positives = 57/134 (42%), Gaps = 18/134 (13%)
Query: 75 MVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMK---QLLTGLHYCHVNQVLHRDIKGSNL 129
+V E+ DL L G+ + Q + ++ +GL + H +H D+ N
Sbjct: 72 LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNC 131
Query: 130 LIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITLWYRPPEL-------LLGA--TKYGP 179
+ + ++K+ D+GLA + D+ T + L + PEL LL TK
Sbjct: 132 QLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKS- 190
Query: 180 AVDMWSVGCIFAEL 193
++WS+G EL
Sbjct: 191 --NIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 46/206 (22%), Positives = 88/206 (42%), Gaps = 30/206 (14%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFP--ITAIREIKILKKLQHENVIKLKEIVTSPGPER 58
AR+I GE ++ NE I + E ++K +V++L +V+
Sbjct: 26 NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS------ 79
Query: 59 DEQGRPDGNKYRGSTYMVFEYMDH-DLTGL-------ADRPGLRF--TVPQIKCYMKQLL 108
+G+P T +V E M H DL A+ R T+ ++ ++
Sbjct: 80 --KGQP--------TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 109 TGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITLWYRP 167
G+ Y + + +HRD+ N ++ ++ +K+ DFG+ R + D+ ++ + +
Sbjct: 130 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 168 PELLLGATKYGPAVDMWSVGCIFAEL 193
PE L + + DMWS G + E+
Sbjct: 190 PESLKDGV-FTTSSDMWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|219404 pfam07415, Herpes_LMP2, Gammaherpesvirus latent membrane protein (LMP2) protein | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 26/92 (28%), Positives = 33/92 (35%), Gaps = 9/92 (9%)
Query: 359 PPVPGGPGHHHYGKPRGPPGGANRYPSGNQSGGYNNPNRGGQGGGYSNAPYPPQGRGPPY 418
P GGP H G P G G +N Y + ++ P G P R PPY
Sbjct: 8 PLGAGGPRSH--GGPDGDEGDSNPYYPSSFGSSWDRP-----GPPVPEDYDAPSHRPPPY 60
Query: 419 AGAGMPANGPRGPASGYGVGPQSYSQSGQYGN 450
G+ +G P P Y+ GQ G
Sbjct: 61 GGSNGDRHGGYQPLGQQ--DPSLYAGLGQNGG 90
|
This family consists of several Gammaherpesvirus latent membrane protein (LMP2) proteins. Epstein-Barr virus is a human Gammaherpesvirus that infects and establishes latency in B lymphocytes in vivo. The latent membrane protein 2 (LMP2) gene is expressed in latently infected B cells and encodes two protein isoforms, LMP2A and LMP2B, that are identical except for an additional N-terminal 119 aa cytoplasmic domain which is present in the LMP2A isoform. LMP2A is thought to play a key role in either the establishment or the maintenance of latency and/or the reactivation of productive infection from the latent state. The significance of LMP2B and its role in pathogenesis remain unclear. Length = 489 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 472 | |||
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.94 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.9 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.84 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.79 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.79 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.65 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.59 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.58 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.57 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.55 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.55 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.53 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.49 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.45 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.44 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.44 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.42 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.4 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.35 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.28 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.21 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.21 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.15 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.14 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.06 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.03 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.02 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.98 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.91 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.88 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.73 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.6 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.55 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.54 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.48 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.39 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.19 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.1 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 98.05 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.01 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.0 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.98 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.87 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.79 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.76 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.71 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.69 | |
| KOG1924 | 1102 | consensus RhoA GTPase effector DIA/Diaphanous [Sig | 97.67 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.63 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.61 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.55 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.54 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.36 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.29 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.23 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.23 | |
| KOG0921 | 1282 | consensus Dosage compensation complex, subunit MLE | 97.2 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.19 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.16 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.16 | |
| PLN02236 | 344 | choline kinase | 97.0 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.97 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.77 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 96.76 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.74 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.71 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.6 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 95.99 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.96 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.86 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.56 | |
| KOG0921 | 1282 | consensus Dosage compensation complex, subunit MLE | 95.49 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 95.24 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.06 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.99 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.98 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 94.35 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 93.76 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 93.74 |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-67 Score=516.83 Aligned_cols=306 Identities=66% Similarity=1.128 Sum_probs=293.2
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
.|||..||+.||||+|+.++.++++.....|||+||++|+|||||+|.++..+. ..+.+|||+|||
T Consensus 135 kAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~--------------~~~siYlVFeYM 200 (560)
T KOG0600|consen 135 KARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK--------------LSGSIYLVFEYM 200 (560)
T ss_pred EeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec--------------CCceEEEEEecc
Confidence 489999999999999999999999999999999999999999999999999873 257899999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
++||..++.....+|++.+|++||+||+.||+|||.+||+|||||.+|||||++|++||+|||+|+++.......+++.+
T Consensus 201 dhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rV 280 (560)
T KOG0600|consen 201 DHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRV 280 (560)
T ss_pred cchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCcccccce
Confidence 99999999999999999999999999999999999999999999999999999999999999999999888888899999
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (472)
.|+||++||+|++...|+.++|+||+||||.||++|++.|.+.++.+++.+|+++|++|.+..|+ ..++|.+..+++..
T Consensus 281 vTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~~kLP~~~~~kp~~ 359 (560)
T KOG0600|consen 281 VTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-VSKLPHATIFKPQQ 359 (560)
T ss_pred EEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-cccCCcccccCCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999 99999999999999
Q ss_pred hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCchHHHHHHHHHHHHHHHHH
Q 012062 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHEYQTKKRRQQQRQHEEA 320 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (472)
..++.+.+.+..++..+++||.+||.+||.+|.||.++|+++||+..+++|++..+++|..++++..|+++++.++....
T Consensus 360 ~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~~~p~~Lp~y~~s~E~~~K~r~e~~r~~~~~ 439 (560)
T KOG0600|consen 360 PYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLPCDPSSLPKYPPSHELDAKRRREQKRRNKGG 439 (560)
T ss_pred cccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCCCCcccCCCCCcchhHHHHHHHHHhhccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999888877665543
Q ss_pred H
Q 012062 321 T 321 (472)
Q Consensus 321 ~ 321 (472)
+
T Consensus 440 ~ 440 (560)
T KOG0600|consen 440 A 440 (560)
T ss_pred c
Confidence 3
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-59 Score=440.96 Aligned_cols=288 Identities=49% Similarity=0.860 Sum_probs=262.7
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|+|+.|++.||+|+++++..++++....+|||.+|.+++|||||.+.++..-.+ -+.+|||||||+
T Consensus 95 akdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~--------------~d~iy~VMe~~E 160 (419)
T KOG0663|consen 95 AKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN--------------MDKIYIVMEYVE 160 (419)
T ss_pred eccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc--------------cceeeeeHHHHH
Confidence 789999999999999999999999999999999999999999999999987422 456999999999
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccc
Q 012062 82 HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 161 (472)
Q Consensus 82 g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 161 (472)
.||..++..-..+|...++++++.|+|.||+|||.+.|+|||||++|+|+++.|.+||+|||+|+.+... ...++..+.
T Consensus 161 hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-~k~~T~lVV 239 (419)
T KOG0663|consen 161 HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-LKPYTPLVV 239 (419)
T ss_pred hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC-cccCcceEE
Confidence 9999999987788999999999999999999999999999999999999999999999999999988744 456777889
Q ss_pred cCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchh
Q 012062 162 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241 (472)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (472)
|+||+|||+|++...|+.++|+||+|||+.||+++++.|++..+.+++.+|+++++.|.+.+|+++..++..........
T Consensus 240 TLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~ 319 (419)
T KOG0663|consen 240 TLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEH 319 (419)
T ss_pred EeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCC
Confidence 99999999999998999999999999999999999999999999999999999999999999999999987765554444
Q ss_pred hhhhHHHHhhh--ccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCchH
Q 012062 242 MKRRVREVFRH--FDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHE 304 (472)
Q Consensus 242 ~~~~~~~~~~~--~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~~~~~~~~~~~~~~~~~~ 304 (472)
-...++..|.. +++...+||..+|..||.+|.||+|+|+|.||...+.++++..+|.+....+
T Consensus 320 pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~P~k~~ 384 (419)
T KOG0663|consen 320 PYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPTWPAKSE 384 (419)
T ss_pred CchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCCCccccc
Confidence 44455555544 4599999999999999999999999999999999999999999998876544
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-58 Score=422.25 Aligned_cols=282 Identities=44% Similarity=0.790 Sum_probs=257.6
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+|.+||+.||||+|+..+.+++...+++|||+.|+.++|+|||.++|+|.. .+.+.||+||+
T Consensus 20 ka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~----------------~~~l~lVfEfm 83 (318)
T KOG0659|consen 20 KARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH----------------KSNLSLVFEFM 83 (318)
T ss_pred EEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC----------------CCceEEEEEec
Confidence 58999999999999999999888899999999999999999999999999976 67899999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+.||...++.....++..+++.|+.+++.||+|||++.|+||||||.|+||+.+|.+||+|||+|+.+..... ..+..+
T Consensus 84 ~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~-~~~~~V 162 (318)
T KOG0659|consen 84 PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR-IQTHQV 162 (318)
T ss_pred cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc-ccccce
Confidence 9999999998888899999999999999999999999999999999999999999999999999999875443 344458
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (472)
.|.||+|||.+.|.+.|+..+||||+|||++||+.+.+.|++.++.+++..|++.++.|.+..|+++..+++|..+....
T Consensus 163 ~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P 242 (318)
T KOG0659|consen 163 VTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFP 242 (318)
T ss_pred eeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCC
Confidence 89999999999999999999999999999999999999999999999999999999999999999999999998777322
Q ss_pred hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCC
Q 012062 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYES 301 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~~~~~~~~~~~~~~~ 301 (472)
... ...++...+.++.||+.+||..||.+|+|+.|+|+|+||+..+.++.+..++.-..
T Consensus 243 ~~~--~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~lp~p~~ 301 (318)
T KOG0659|consen 243 KPP--LNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSKLPIPST 301 (318)
T ss_pred CCc--cccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhhCcCCcc
Confidence 211 22277888999999999999999999999999999999999999888887775443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-56 Score=415.96 Aligned_cols=266 Identities=38% Similarity=0.669 Sum_probs=232.1
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
||++.||+.||||++....+++...+.++|||++|++|+|+|+|.++++|.. +..++||+|||+
T Consensus 21 Crnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr----------------krklhLVFE~~d 84 (396)
T KOG0593|consen 21 CRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR----------------KRKLHLVFEYCD 84 (396)
T ss_pred eccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh----------------cceeEEEeeecc
Confidence 7899999999999998777777778889999999999999999999999987 778999999999
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccc
Q 012062 82 HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 161 (472)
Q Consensus 82 g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 161 (472)
.++++.+.+....++...++.|+.|++.|+.|||++++||||||||||||+.+|.+||||||+|+.+.. .....+.++-
T Consensus 85 hTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~YTDYVA 163 (396)
T KOG0593|consen 85 HTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNYTDYVA 163 (396)
T ss_pred hHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC-Ccchhhhhhh
Confidence 999988887666799999999999999999999999999999999999999999999999999988764 4566788899
Q ss_pred cCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC-Cch
Q 012062 162 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK-PSR 240 (472)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 240 (472)
|.||+|||.+.++..|+..+||||+||++.||++|.+.|++.++.+++..|...++.....--.-+..-+.+.-.. +..
T Consensus 164 TRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~ 243 (396)
T KOG0593|consen 164 TRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEP 243 (396)
T ss_pred hhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCC
Confidence 9999999999999999999999999999999999999999999999999999988876532222222222221111 222
Q ss_pred hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
.....+...+.+++.-+.||+++||..||.+|++.+|+|.|+||
T Consensus 244 ~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yF 287 (396)
T KOG0593|consen 244 EHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYF 287 (396)
T ss_pred CCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHH
Confidence 33445667778889999999999999999999999999999999
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-55 Score=429.07 Aligned_cols=268 Identities=37% Similarity=0.640 Sum_probs=238.5
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC-CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
||+.+++++.||||.++..... .....-+||++.|++|+ |||||+|++++.+. +.++|+||||
T Consensus 28 la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~---------------~~~L~fVfE~ 91 (538)
T KOG0661|consen 28 LAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDN---------------DRILYFVFEF 91 (538)
T ss_pred EeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhcc---------------CceEeeeHHh
Confidence 6899999999999999876433 23344579999999999 99999999999873 3389999999
Q ss_pred CCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 80 MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 80 ~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
|+.+|..+++.++..|++..|+.|+.||++||+|+|++|+.||||||||||+.....|||+|||+|+.+. .....+.+
T Consensus 92 Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~--SkpPYTeY 169 (538)
T KOG0661|consen 92 MDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR--SKPPYTEY 169 (538)
T ss_pred hhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc--cCCCcchh
Confidence 9999999999888889999999999999999999999999999999999999988899999999998775 34567788
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
+.|.||+|||+|+....|+.++|||++|||++|+.+-+++|++.++.|++.+|+++++.|....|+.-..+....++...
T Consensus 170 VSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P 249 (538)
T KOG0661|consen 170 VSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFP 249 (538)
T ss_pred hhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCC
Confidence 99999999999999889999999999999999999999999999999999999999999999999975544444445544
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
......+..+...++.++.+||.+||.+||++||||+|+|+|+||..
T Consensus 250 ~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~ 296 (538)
T KOG0661|consen 250 QVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQV 296 (538)
T ss_pred cCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccc
Confidence 44455677777889999999999999999999999999999999954
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-54 Score=414.05 Aligned_cols=243 Identities=33% Similarity=0.485 Sum_probs=201.2
Q ss_pred CceeccCCCEEEEEEeecCCcCC-----CchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEE
Q 012062 1 MAREIKTGEIVALKKIRMDNEKE-----GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYM 75 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i 75 (472)
||.++.|++.||||+|++..... .....+.+|++||++|+|||||+++++|+. ....||
T Consensus 190 la~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~----------------~ds~Ym 253 (475)
T KOG0615|consen 190 LAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV----------------PDSSYM 253 (475)
T ss_pred EEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec----------------CCceEE
Confidence 68999999999999998653221 123446799999999999999999999997 457799
Q ss_pred EEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC---CCeEEeeccceeeeccC
Q 012062 76 VFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE---GNLKLADFGLARSFSYD 151 (472)
Q Consensus 76 VmEy~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~---~~vkL~DFG~a~~~~~~ 151 (472)
||||++| +|.+.+... ..+.+...+.+++|||.||.|||++||+||||||||||++.+ -.+||+|||+|+...
T Consensus 254 VlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g-- 330 (475)
T KOG0615|consen 254 VLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG-- 330 (475)
T ss_pred EEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccc--
Confidence 9999996 666666554 468899999999999999999999999999999999999877 459999999998876
Q ss_pred CCCccccccccCCCCChhhhcCCC--CCCCCcchhhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCCCCCccCC
Q 012062 152 HNNTLTNRVITLWYRPPELLLGAT--KYGPAVDMWSVGCIFAELLNGKPILPGKNEAE-QLSKIFELCGSPDETIWPGVS 228 (472)
Q Consensus 152 ~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~ 228 (472)
....+.++|||+.|.||||+.... .+..++||||||||||.+|+|.+||.+..... ...+|.........
T Consensus 331 ~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p------- 403 (475)
T KOG0615|consen 331 EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGP------- 403 (475)
T ss_pred cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccC-------
Confidence 344566789999999999997632 34558999999999999999999998876554 56666543322222
Q ss_pred CCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCCC
Q 012062 229 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 288 (472)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~~ 288 (472)
..|..+++++++||.+||..||+.|+|+.|+|+||||+..+
T Consensus 404 -------------------~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 404 -------------------LQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred -------------------hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 34557899999999999999999999999999999997543
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-52 Score=396.94 Aligned_cols=275 Identities=47% Similarity=0.834 Sum_probs=247.2
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCC-ccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHEN-VIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
|+++.||+.||||+++.+...++....+++|+.+|++|+|+| ||+++|++..... ..-.+.++|||||+
T Consensus 30 ar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~----------~~~~~~l~lvfe~~ 99 (323)
T KOG0594|consen 30 ARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNN----------HRGIGKLYLVFEFL 99 (323)
T ss_pred EEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccc----------ccccceEEEEEEee
Confidence 789999999999999998877888899999999999999999 9999999987321 11245799999999
Q ss_pred CCChhhhhcCCC---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 81 DHDLTGLADRPG---LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 81 ~g~l~~~~~~~~---~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
+-+|..++.... ..++...++.+++||+.||+|||+++|+||||||.||||+++|.+||+|||+|+.+.-. ....+
T Consensus 100 d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip-~~~yt 178 (323)
T KOG0594|consen 100 DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIP-MRTYT 178 (323)
T ss_pred cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhcCC-ccccc
Confidence 999999888755 35788899999999999999999999999999999999999999999999999876533 33467
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..+.|.+|+|||++++...|+..+||||+|||++||+++++.|++..+.+++.+|++.++.|....|+++..++.+....
T Consensus 179 ~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f 258 (323)
T KOG0594|consen 179 PEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPF 258 (323)
T ss_pred ccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccC
Confidence 77899999999999998889999999999999999999999999999999999999999999999999999999988755
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
+.....+.+....+..+.+..||+.+||+.||.+|.|++.+|.|+||...
T Consensus 259 ~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 259 PKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred cCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 55555667777778888899999999999999999999999999999653
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-52 Score=421.47 Aligned_cols=239 Identities=31% Similarity=0.501 Sum_probs=210.8
Q ss_pred ceeccCCCEEEEEEeecC-CcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 2 AREIKTGEIVALKKIRMD-NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~-~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+++..||+.||+|+|.+. -.+....+.+.+||+|++.|+|||||+|+++|++ .+++|||+|+|
T Consensus 37 ~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED----------------s~nVYivLELC 100 (592)
T KOG0575|consen 37 ARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED----------------SNNVYIVLELC 100 (592)
T ss_pred EEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec----------------CCceEEEEEec
Confidence 678899999999999875 3445567788999999999999999999999998 67899999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
.. .|..+++ ....++|.+++.|++||+.||.|||+++|||||||..||||+++.+|||+|||+|+.+..+... ..+.
T Consensus 101 ~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er-k~Tl 178 (592)
T KOG0575|consen 101 HRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER-KKTL 178 (592)
T ss_pred CCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccc-ccee
Confidence 95 5555555 5568999999999999999999999999999999999999999999999999999988755443 4457
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
|||+.|+||||+.. ..++..+||||+|||||.||+|++||...+-.+.+.+|.......+
T Consensus 179 CGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P------------------- 238 (592)
T KOG0575|consen 179 CGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMP------------------- 238 (592)
T ss_pred cCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccc-------------------
Confidence 99999999999985 6789999999999999999999999999999999999965433322
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL 289 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~~~ 289 (472)
..++.+++|||++||..||.+|||+++||.|+||+..-.
T Consensus 239 -----------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~ 277 (592)
T KOG0575|consen 239 -----------SHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFT 277 (592)
T ss_pred -----------cccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCc
Confidence 257889999999999999999999999999999965433
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-52 Score=397.81 Aligned_cols=273 Identities=40% Similarity=0.681 Sum_probs=232.7
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|+++.||+.||||+|.......-..++.++|+++|+.++|+|||.+++++..+... .-+.+|||+|+|+
T Consensus 41 A~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~-----------~f~DvYiV~elMe 109 (359)
T KOG0660|consen 41 AKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD-----------KFNDVYLVFELME 109 (359)
T ss_pred EEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc-----------ccceeEEehhHHh
Confidence 67899999999999986666666778899999999999999999999999872211 1346999999999
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccC-CCCcccccc
Q 012062 82 HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD-HNNTLTNRV 160 (472)
Q Consensus 82 g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~~~~~ 160 (472)
.||...+.... .+++..++.++.|||.||.|+|+.+|+||||||+|+|++.+..+||||||+|+..... ....++..+
T Consensus 110 tDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYV 188 (359)
T KOG0660|consen 110 TDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYV 188 (359)
T ss_pred hHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCcccchhcce
Confidence 99988887653 4999999999999999999999999999999999999999999999999999987532 234557788
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc--cccCCC
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA--YNHFKP 238 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~--~~~~~~ 238 (472)
-|.||+|||+++....|+.++||||+||||+|||+|++.|++.+..+++..|.+.++.+++..+..+.+... |....+
T Consensus 189 aTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp 268 (359)
T KOG0660|consen 189 ATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLP 268 (359)
T ss_pred eeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCC
Confidence 899999999999888999999999999999999999999999999999999999999998766554442111 111111
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
......+...+++.+..+.|||++||.+||.+|+|++|+|.||||..-
T Consensus 269 -~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 269 -QIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY 316 (359)
T ss_pred -CCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence 122455778888999999999999999999999999999999999543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-51 Score=393.48 Aligned_cols=240 Identities=28% Similarity=0.417 Sum_probs=199.7
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCC-eEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG-STYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~iVmEy 79 (472)
+|+|+.|++.+|+|+|... .++...+++.+|++|+++++|||||++|++|.+ ++ .++|+|||
T Consensus 97 kv~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~----------------~~~~isI~mEY 159 (364)
T KOG0581|consen 97 KVRHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYS----------------NGEEISICMEY 159 (364)
T ss_pred EEEEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe----------------CCceEEeehhh
Confidence 4789999999999999544 344567889999999999999999999999987 44 59999999
Q ss_pred CCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~-~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
|+++.++.+.+.-+++++..+..|+++|++||.|||+ ++||||||||+||||+..|+|||||||.+..+.+. ...+
T Consensus 160 MDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a~t 236 (364)
T KOG0581|consen 160 MDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IANT 236 (364)
T ss_pred cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hccc
Confidence 9975444444444679999999999999999999996 89999999999999999999999999999876544 4466
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCC--ChHHHHHHHHHhcCCCCCCCCccCCCCCccccC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK--NEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (472)
++||..|||||.+.+ ..|+.++||||||++++||++|+.||... +..+.+..+..++..++... |.
T Consensus 237 fvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~l-------P~---- 304 (364)
T KOG0581|consen 237 FVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRL-------PE---- 304 (364)
T ss_pred ccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCC-------Cc----
Confidence 899999999999998 68999999999999999999999999875 22333333333333222211 00
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
..+++++++||..||++||.+|+|++|+|+|||++.
T Consensus 305 --------------~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~ 340 (364)
T KOG0581|consen 305 --------------GEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKK 340 (364)
T ss_pred --------------ccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhh
Confidence 037889999999999999999999999999999964
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-51 Score=372.56 Aligned_cols=282 Identities=51% Similarity=0.920 Sum_probs=248.4
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+|+.||+|++-++++++++.++.++|++||..|+|+||+.+++++...... ....+..+||||++|
T Consensus 35 kAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp--------~~r~r~t~ylVf~~c 106 (376)
T KOG0669|consen 35 KARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP--------TNRDRATFYLVFDFC 106 (376)
T ss_pred HHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCC--------cccccceeeeeHHHh
Confidence 478899999999999999999999999999999999999999999999998764321 122477899999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCC---CCccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH---NNTLT 157 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~---~~~~~ 157 (472)
+.||..++.....+|+..+|+.++++|++||.|+|++.|+|||+|++|+||+.++.+||+|||+++.+.... ....+
T Consensus 107 ehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kpryt 186 (376)
T KOG0669|consen 107 EHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYT 186 (376)
T ss_pred hhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcc
Confidence 999999999888899999999999999999999999999999999999999999999999999998775432 23467
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
+++.|++|+.||.+++...|+.+.|||..|||+.||+++.+.|.++++..++..|..+|++.....||++.+++.+....
T Consensus 187 nrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie 266 (376)
T KOG0669|consen 187 NRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIE 266 (376)
T ss_pred cceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhcc
Confidence 78889999999999999999999999999999999999999999999999999999999999999999999999887664
Q ss_pred Cch---hhhhhHHHHhh--hccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCCCCC
Q 012062 238 PSR---TMKRRVREVFR--HFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 290 (472)
Q Consensus 238 ~~~---~~~~~~~~~~~--~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~~~~ 290 (472)
.+. ...+.+....+ .-++++.|||.+||..||.+|+++.++|+|.|||.++.+
T Consensus 267 ~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 267 LEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred CCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 331 11222222222 125689999999999999999999999999999998876
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=401.42 Aligned_cols=237 Identities=30% Similarity=0.486 Sum_probs=210.0
Q ss_pred CceeccCCCEEEEEEeecC-CcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMD-NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~-~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
||+|.+||+.+|||+|.+. ...+.....+.+||-||+.|.||||+++||+|++ +.++|+|+||
T Consensus 30 lakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~----------------~~~lylvlEy 93 (786)
T KOG0588|consen 30 LAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN----------------KQHLYLVLEY 93 (786)
T ss_pred hhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc----------------CceEEEEEEe
Confidence 7899999999999999876 3444455677899999999999999999999987 7799999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
+.+ .|++++.+. +++.+.+++++|+||+.||.|||..+|+||||||||+|||.++++||+|||+|..-- ....+.+
T Consensus 94 v~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~--~gklLeT 170 (786)
T KOG0588|consen 94 VPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV--PGKLLET 170 (786)
T ss_pred cCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc--CCccccc
Confidence 995 566666655 479999999999999999999999999999999999999999999999999996543 3456677
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
.||++.|.|||++.+..+.+.++||||||||||.||+|+.||.+.+-...+.++.+....++
T Consensus 171 SCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP------------------ 232 (786)
T KOG0588|consen 171 SCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP------------------ 232 (786)
T ss_pred cCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC------------------
Confidence 89999999999999977778999999999999999999999999999999998876544433
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
..++.++.+||++||..||++|+|.+||++|||+..
T Consensus 233 ------------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g 268 (786)
T KOG0588|consen 233 ------------SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSG 268 (786)
T ss_pred ------------CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhc
Confidence 357889999999999999999999999999999854
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=393.93 Aligned_cols=238 Identities=33% Similarity=0.516 Sum_probs=209.7
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
||++++|++.||||++.+.. .++....-+.+|-.+|.+| .||.||+||..|++ +..+|+|||
T Consensus 91 ~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD----------------~~sLYFvLe 154 (604)
T KOG0592|consen 91 LAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD----------------EESLYFVLE 154 (604)
T ss_pred EeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec----------------ccceEEEEE
Confidence 68999999999999997663 3333445567899999999 79999999999998 668999999
Q ss_pred cCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC----
Q 012062 79 YMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN---- 153 (472)
Q Consensus 79 y~~-g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~---- 153 (472)
|+. |+|++++.+-+ .|++..++.|+.+|+.||+|||++|||||||||||||||.++++||+|||.|+.+.....
T Consensus 155 ~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~ 233 (604)
T KOG0592|consen 155 YAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQEN 233 (604)
T ss_pred ecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhccccC
Confidence 998 68999888764 799999999999999999999999999999999999999999999999999987754221
Q ss_pred ------Cc--cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCc
Q 012062 154 ------NT--LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWP 225 (472)
Q Consensus 154 ------~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 225 (472)
.. ...++||..|++||+|.. ...+..+|||+||||||.||.|.+||.+.++..++.+|+++.....
T Consensus 234 ~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp----- 307 (604)
T KOG0592|consen 234 PVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP----- 307 (604)
T ss_pred ccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC-----
Confidence 11 256899999999999876 6789999999999999999999999999999999999988765443
Q ss_pred cCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 226 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
+++++.++|||+++|..||.+|+|+++|.+|+||..
T Consensus 308 -------------------------~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 308 -------------------------EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred -------------------------CCCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 357789999999999999999999999999999944
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-49 Score=340.60 Aligned_cols=266 Identities=44% Similarity=0.833 Sum_probs=244.4
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
||+.+|++.||+|.++.+..+++....+++||.+|+.|+|.|||+++++..+ +..+-+|+|||+
T Consensus 21 arn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs----------------dkkltlvfe~cd 84 (292)
T KOG0662|consen 21 ARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS----------------DKKLTLVFEFCD 84 (292)
T ss_pred cccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc----------------CceeEEeHHHhh
Confidence 6889999999999999999999999999999999999999999999999877 678999999999
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccc
Q 012062 82 HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 161 (472)
Q Consensus 82 g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 161 (472)
.+|..++...++-++.+.++.++.|++.||.|||+++++||||||.|+||+.+|++||+|||+++.|+-... .....+.
T Consensus 85 qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvr-cysaevv 163 (292)
T KOG0662|consen 85 QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR-CYSAEVV 163 (292)
T ss_pred HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE-eeeceee
Confidence 999999999888999999999999999999999999999999999999999999999999999998875433 3334567
Q ss_pred cCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 012062 162 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240 (472)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (472)
|++|++|.++.+.+-|+.+.|+||.|||+.|+.. |++.|++.+-.+++.+|+..++.+.++.|+++.++++|..+.. .
T Consensus 164 tlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~-y 242 (292)
T KOG0662|consen 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPI-Y 242 (292)
T ss_pred eeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCC-c
Confidence 9999999999998889999999999999999985 9999999999999999999999999999999999999876543 3
Q ss_pred hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
+....+.++.+.++..-+||++++|.-+|.+|++++++|+|+||.
T Consensus 243 pattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~ 287 (292)
T KOG0662|consen 243 PATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFS 287 (292)
T ss_pred cccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccc
Confidence 334567777888888999999999999999999999999999994
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-48 Score=389.60 Aligned_cols=238 Identities=34% Similarity=0.508 Sum_probs=207.2
Q ss_pred CceeccCCCEEEEEEeecCCcC---CCchhhHHHHHHHHHhcC-CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEE
Q 012062 1 MAREIKTGEIVALKKIRMDNEK---EGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMV 76 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~---~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iV 76 (472)
+|++..|++.||||++++.... ......+.+|+.++++++ ||||+++++++.. ...+|||
T Consensus 35 ~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t----------------~~~~~iv 98 (370)
T KOG0583|consen 35 LAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT----------------PTKIYIV 98 (370)
T ss_pred EeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec----------------CCeEEEE
Confidence 4788999999999988765222 234556778999999999 9999999999988 5569999
Q ss_pred EecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC-CCeEEeeccceeeeccCCCC
Q 012062 77 FEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE-GNLKLADFGLARSFSYDHNN 154 (472)
Q Consensus 77 mEy~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~-~~vkL~DFG~a~~~~~~~~~ 154 (472)
||||.+ +|++.+.+ ..++.+.+++.+|+||+.||+|||++||+|||||||||||+.+ +++||+|||++.... ....
T Consensus 99 mEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~-~~~~ 176 (370)
T KOG0583|consen 99 MEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP-GEDG 176 (370)
T ss_pred EEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC-CCCC
Confidence 999996 88888888 6789999999999999999999999999999999999999999 999999999998764 3445
Q ss_pred ccccccccCCCCChhhhcCCC-CCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 012062 155 TLTNRVITLWYRPPELLLGAT-KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 233 (472)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (472)
.+.+.|||+.|+|||++.+.. +.+.++||||||||||.|++|+.||...+...++.+|.......+
T Consensus 177 ~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p------------- 243 (370)
T KOG0583|consen 177 LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIP------------- 243 (370)
T ss_pred cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCC-------------
Confidence 677789999999999999865 446899999999999999999999999998888888755322221
Q ss_pred ccCCCchhhhhhHHHHhhhc-cHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 234 NHFKPSRTMKRRVREVFRHF-DRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~-~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
..+ +.++++||++||..||.+|+|+.+++.|+||+.
T Consensus 244 -----------------~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 244 -----------------SYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred -----------------CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 124 778999999999999999999999999999987
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=353.73 Aligned_cols=239 Identities=28% Similarity=0.423 Sum_probs=207.0
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
+.+..||+.+|+|+|+.......-.+.+.+|+.|.++|+||||+++++.+.+ .+..|||+|+|+
T Consensus 30 c~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~----------------~~~~ylvFe~m~ 93 (355)
T KOG0033|consen 30 CVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE----------------ESFHYLVFDLVT 93 (355)
T ss_pred HHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcc----------------cceeEEEEeccc
Confidence 4567899999999998765444456678899999999999999999999876 567899999999
Q ss_pred C-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC---CeEEeeccceeeeccCCCCccc
Q 012062 82 H-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG---NLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 82 g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~---~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
| +|...+... .-+++..+..+++|||++|.|||.++|||||+||+|+||.... -|||+|||+|.... ....-.
T Consensus 94 G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--~g~~~~ 170 (355)
T KOG0033|consen 94 GGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--DGEAWH 170 (355)
T ss_pred chHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC--Cccccc
Confidence 7 565555443 3589999999999999999999999999999999999997554 39999999998887 344455
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
.++||+.|||||++.. .+|+..+|||++|||||-||.|.+||.+++....+.+|.......+...|+
T Consensus 171 G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~------------ 237 (355)
T KOG0033|consen 171 GFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWD------------ 237 (355)
T ss_pred cccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccC------------
Confidence 6789999999999986 689999999999999999999999999999999999998776665554443
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
++++++++||++||..||++|+|+.|+|+|||+..
T Consensus 238 --------------~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 238 --------------TVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred --------------cCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 67789999999999999999999999999999953
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-48 Score=371.73 Aligned_cols=239 Identities=28% Similarity=0.431 Sum_probs=205.8
Q ss_pred CceeccCCCEEEEEEeecCCcC-CCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+++.+.|++.+|+|++++.... .......+.|..||.+++||+||+++..|++ .+.+|||+||
T Consensus 43 ~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt----------------~~kLylVld~ 106 (357)
T KOG0598|consen 43 QVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT----------------EEKLYLVLDY 106 (357)
T ss_pred EEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc----------------CCeEEEEEec
Confidence 4788999999999999877432 2356678899999999999999999999998 6789999999
Q ss_pred CCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 80 MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 80 ~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
+.|+.+.........|+++.++.|+..|+.||.|||++|||||||||||||||.+|+|+|+|||+++....... ...++
T Consensus 107 ~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~-~t~tf 185 (357)
T KOG0598|consen 107 LNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD-ATRTF 185 (357)
T ss_pred cCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC-ccccc
Confidence 99755544445556899999999999999999999999999999999999999999999999999986554333 33448
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
|||+.|||||++.+ ..|+.++|.|||||++|+||+|.+||.+.+......+|.+.....
T Consensus 186 cGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~-------------------- 244 (357)
T KOG0598|consen 186 CGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPL-------------------- 244 (357)
T ss_pred cCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCC--------------------
Confidence 99999999999997 689999999999999999999999999999999999997643111
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCC----CHHHHhcCCCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI----SAKDALDSEYFWT 286 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~----t~~elL~h~~f~~ 286 (472)
....++.++++||+++|..||++|. .+.+|-+|+||..
T Consensus 245 ---------~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 245 ---------PPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKG 286 (357)
T ss_pred ---------CCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCccccc
Confidence 1123778999999999999999996 7899999999943
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=394.79 Aligned_cols=263 Identities=31% Similarity=0.544 Sum_probs=214.0
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC-C-----CCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEE
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-H-----ENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYM 75 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~-h-----pnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i 75 (472)
|.|..|++.||||+|+.. ..+..+...|++||..|+ | -|||+++|+|.. ++++||
T Consensus 205 ~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f----------------r~Hlci 265 (586)
T KOG0667|consen 205 AYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF----------------RNHLCI 265 (586)
T ss_pred EEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc----------------ccceee
Confidence 678999999999999843 346778889999999997 4 389999999975 889999
Q ss_pred EEecCCCChhhhhcCCCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC--CeEEeeccceeeeccCC
Q 012062 76 VFEYMDHDLTGLADRPGL-RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG--NLKLADFGLARSFSYDH 152 (472)
Q Consensus 76 VmEy~~g~l~~~~~~~~~-~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~--~vkL~DFG~a~~~~~~~ 152 (472)
|+|+++-+|.++++.+.. .|+...++.|+.|||.||.+||+++|||+|||||||||.+-+ .|||+|||.|+....
T Consensus 266 VfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q-- 343 (586)
T KOG0667|consen 266 VFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ-- 343 (586)
T ss_pred eehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCC--
Confidence 999999999999987543 499999999999999999999999999999999999997644 599999999987542
Q ss_pred CCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 012062 153 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 232 (472)
Q Consensus 153 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (472)
.....+.+..|+||||+++ .+|+.++||||||||++||++|.++|++.++.+++..|++..+.|+...+....+.-.
T Consensus 344 --~vytYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~k 420 (586)
T KOG0667|consen 344 --RVYTYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHK 420 (586)
T ss_pred --cceeeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccce
Confidence 2225678999999999998 7899999999999999999999999999999999999999999987655443322111
Q ss_pred cccC-------CCchh-------------------------hhhhHHHHhh-hccHHHHHHHHHhhccCCCCCCCHHHHh
Q 012062 233 YNHF-------KPSRT-------------------------MKRRVREVFR-HFDRHALELLEKMLMLDPSQRISAKDAL 279 (472)
Q Consensus 233 ~~~~-------~~~~~-------------------------~~~~~~~~~~-~~~~~~~~ll~~~L~~dP~~R~t~~elL 279 (472)
+... ..+.. ..+.+..... .....+.|||++||.+||.+|+|+.++|
T Consensus 421 ff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal 500 (586)
T KOG0667|consen 421 FFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQAL 500 (586)
T ss_pred ehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHh
Confidence 1000 00000 0111112222 3446689999999999999999999999
Q ss_pred cCCCCCCCC
Q 012062 280 DSEYFWTDP 288 (472)
Q Consensus 280 ~h~~f~~~~ 288 (472)
+|+||....
T Consensus 501 ~Hpfl~~~~ 509 (586)
T KOG0667|consen 501 NHPFLTGTS 509 (586)
T ss_pred cCccccccc
Confidence 999997543
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-48 Score=360.02 Aligned_cols=267 Identities=40% Similarity=0.742 Sum_probs=226.9
Q ss_pred CEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCChhhhh
Q 012062 9 EIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLA 88 (472)
Q Consensus 9 ~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~l~~~~ 88 (472)
+.+|||+|+-..+..++...+.|||.+++.|+|+|||.+..+|.+ ++..++|++||.+.||+.++
T Consensus 54 k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~---------------~d~~v~l~fdYAEhDL~~II 118 (438)
T KOG0666|consen 54 KEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLS---------------HDKKVWLLFDYAEHDLWHII 118 (438)
T ss_pred hhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc---------------cCceEEEEehhhhhhHHHHH
Confidence 378999999887777788889999999999999999999999976 26789999999999999877
Q ss_pred cC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC----CCeEEeeccceeeeccCCCC--cccc
Q 012062 89 DR----PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE----GNLKLADFGLARSFSYDHNN--TLTN 158 (472)
Q Consensus 89 ~~----~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~----~~vkL~DFG~a~~~~~~~~~--~~~~ 158 (472)
.- ....++...++.|++||+.||.|||++-|+||||||.||||..+ |.|||+|||+++.+.+.-.. ....
T Consensus 119 ~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~ 198 (438)
T KOG0666|consen 119 KFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDP 198 (438)
T ss_pred HHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCc
Confidence 63 22347888999999999999999999999999999999999887 88999999999988754322 2334
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCC---------hHHHHHHHHHhcCCCCCCCCccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN---------EAEQLSKIFELCGSPDETIWPGVSK 229 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~---------~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (472)
.+.|.+|+|||+|++...|+.++|||++|||+.|||+-++.|.+.. ..+++.+|+++++.|.+..|++..+
T Consensus 199 VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk 278 (438)
T KOG0666|consen 199 VVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKK 278 (438)
T ss_pred eEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhh
Confidence 5679999999999999999999999999999999999999998753 3679999999999999999999999
Q ss_pred CCccccCCCchh-------hhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCCCCC
Q 012062 230 MPAYNHFKPSRT-------MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 290 (472)
Q Consensus 230 ~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~~~~ 290 (472)
+|++......-. ....+-..++.-++.+.+||.+||+.||.+|+|++++|+|+||.+++++
T Consensus 279 ~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~lp 346 (438)
T KOG0666|consen 279 MPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDPLP 346 (438)
T ss_pred CcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCCCC
Confidence 998843221111 0122333344456779999999999999999999999999999998776
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=381.55 Aligned_cols=237 Identities=29% Similarity=0.528 Sum_probs=205.3
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+++.+++.||||.+.+..... .+.+++|+.+|+.++|+|||++++.|.. ++.+|+|||||
T Consensus 291 ~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv----------------~deLWVVMEym 352 (550)
T KOG0578|consen 291 VARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLV----------------GDELWVVMEYM 352 (550)
T ss_pred eeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcc----------------cceeEEEEeec
Confidence 58899999999999998765443 4568899999999999999999999876 56899999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
+| +|.+++... .++|.+|.+|++.+|.||+|||.+||+|||||.+|||++.+|+|||+||||+..+..... ...+.
T Consensus 353 ~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~Tm 429 (550)
T KOG0578|consen 353 EGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRSTM 429 (550)
T ss_pred CCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC-ccccc
Confidence 97 555555443 499999999999999999999999999999999999999999999999999988775544 45667
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
+||+.|||||++.. ..|++++||||||+++.||+.|++||-.++....+..|.... .+..
T Consensus 430 VGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng-~P~l------------------ 489 (550)
T KOG0578|consen 430 VGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPKL------------------ 489 (550)
T ss_pred cCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcC-CCCc------------------
Confidence 99999999999986 789999999999999999999999999999888888775432 2111
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.....++.+++|||.+||+.|+++|+||.|||+|+||..
T Consensus 490 --------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 490 --------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred --------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 112368889999999999999999999999999999943
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=369.09 Aligned_cols=240 Identities=31% Similarity=0.506 Sum_probs=205.1
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++++++..||||.|.+........+.+..||+||+.|+|||||+|+|+++. .+.+|||||||+
T Consensus 29 g~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~----------------~~~i~lVMEyC~ 92 (429)
T KOG0595|consen 29 GRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED----------------DDFIYLVMEYCN 92 (429)
T ss_pred eEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec----------------CCeEEEEEEeCC
Confidence 7899999999999999886555567788999999999999999999999987 668999999999
Q ss_pred C-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC------CCeEEeeccceeeeccCCCC
Q 012062 82 H-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE------GNLKLADFGLARSFSYDHNN 154 (472)
Q Consensus 82 g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~------~~vkL~DFG~a~~~~~~~~~ 154 (472)
| ||..++.+.. +++++.++.++.||+.||++||+++||||||||.||||+.. -.+||+|||+|+.+.. ..
T Consensus 93 gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~--~~ 169 (429)
T KOG0595|consen 93 GGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP--GS 169 (429)
T ss_pred CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc--hh
Confidence 5 7777766554 79999999999999999999999999999999999999875 3589999999988753 33
Q ss_pred ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 155 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
...+.||++.|||||++.. ..|+.|+|+||+|+|||+|++|+.||...+..+.+..+.+....
T Consensus 170 ~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~---------------- 232 (429)
T KOG0595|consen 170 MAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEI---------------- 232 (429)
T ss_pred HHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccc----------------
Confidence 4556799999999999975 67999999999999999999999999999998888865432111
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCCC
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 288 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~~ 288 (472)
+......++..+.+|+..+|..++.+|.+..+-+.|++++.++
T Consensus 233 -----------~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 233 -----------VPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred -----------cCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 1111223555678999999999999999999999999998765
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=371.88 Aligned_cols=245 Identities=30% Similarity=0.459 Sum_probs=202.9
Q ss_pred CceeccCCCEEEEEEeecCCcCC------------CchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKE------------GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 68 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~------------~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 68 (472)
||++..+++.||||++.+..... .-.+++.+||.||++|.|+|||+|+++..++.
T Consensus 115 Lar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~------------- 181 (576)
T KOG0585|consen 115 LARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPE------------- 181 (576)
T ss_pred EEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcc-------------
Confidence 79999999999999997653221 12357889999999999999999999997754
Q ss_pred cCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeee
Q 012062 69 YRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 148 (472)
Q Consensus 69 ~~~~~~iVmEy~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 148 (472)
...+|||+|||+.+..........-+++.+++.|++.++.||+|||.+|||||||||+|+||+++|+|||+|||.+..+
T Consensus 182 -s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~ 260 (576)
T KOG0585|consen 182 -SDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEF 260 (576)
T ss_pred -cCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccceeeec
Confidence 5689999999996544433333323899999999999999999999999999999999999999999999999999876
Q ss_pred cc----CCCCccccccccCCCCChhhhcCC---CCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC
Q 012062 149 SY----DHNNTLTNRVITLWYRPPELLLGA---TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDE 221 (472)
Q Consensus 149 ~~----~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~ 221 (472)
.. .....+...+||+.|+|||++.+. ...+.+.|||||||+||.|+.|+.||.+....+.+.+|++.--..+.
T Consensus 261 ~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~ 340 (576)
T KOG0585|consen 261 PQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLEFPE 340 (576)
T ss_pred ccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcccCCC
Confidence 22 122334446899999999998762 33577999999999999999999999999999999999764322221
Q ss_pred CCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 222 TIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
. +.+.++++|||.+||.+||++|+++.+|..|+|...+
T Consensus 341 ~----------------------------pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 341 N----------------------------PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred c----------------------------ccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 1 1367789999999999999999999999999998654
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=367.85 Aligned_cols=265 Identities=43% Similarity=0.806 Sum_probs=220.5
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||+++..... .....+.+|+.++++++|+||+++++++.. ...+|+||||++
T Consensus 24 ~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----------------~~~~~lv~e~~~ 86 (288)
T cd07871 24 GRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHT----------------ERCLTLVFEYLD 86 (288)
T ss_pred EEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcC----------------CCeEEEEEeCCC
Confidence 678889999999999765322 234567799999999999999999999976 557899999999
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccc
Q 012062 82 HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 161 (472)
Q Consensus 82 g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 161 (472)
++|.+++......+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...... .......+
T Consensus 87 ~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~~~~~~~~ 165 (288)
T cd07871 87 SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-KTYSNEVV 165 (288)
T ss_pred cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC-ccccCcee
Confidence 99888877665568999999999999999999999999999999999999999999999999997653222 22334567
Q ss_pred cCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchh
Q 012062 162 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241 (472)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (472)
|..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..++...+.+....|+.......+........
T Consensus 166 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (288)
T cd07871 166 TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQY 245 (288)
T ss_pred cccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCcc
Confidence 99999999988756789999999999999999999999999999999999999999998888887665443332221111
Q ss_pred hhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
...........++.+++|||++||..||.+|+|++|+|+|+||
T Consensus 246 ~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 246 RAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred CCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 1222233445678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=365.09 Aligned_cols=263 Identities=36% Similarity=0.626 Sum_probs=216.3
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|+-.++++.||||++-.+..-. -+|++||+++.|||||++..+|...... .+-++.+|||||.
T Consensus 43 ~~~~e~~~~vAIKKv~~d~r~k------nrEl~im~~l~HpNIV~L~~~f~~~~~~-----------d~~~lnlVleymP 105 (364)
T KOG0658|consen 43 AKLRETEEEVAIKKVLQDKRYK------NRELQIMRKLDHPNIVRLLYFFSSSTES-----------DEVYLNLVLEYMP 105 (364)
T ss_pred EEEcCCCceeEEEEecCCCCcC------cHHHHHHHhcCCcCeeeEEEEEEecCCC-----------chhHHHHHHHhch
Confidence 4456789999999997553211 2899999999999999999999874322 1336679999999
Q ss_pred CChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC-CCeEEeeccceeeeccCCCCccc
Q 012062 82 HDLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE-GNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 82 g~l~~~~~~---~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~-~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
.+|...+.. .+.+++.-.++-|++||+.||+|||+.||+||||||.|||+|.+ +.+||||||.|+..... ....
T Consensus 106 ~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~--epni 183 (364)
T KOG0658|consen 106 ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG--EPNI 183 (364)
T ss_pred HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccC--CCce
Confidence 998887763 45678999999999999999999999999999999999999976 88999999999987543 3346
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
...+|..|+|||.+.+.+.|+.++||||+|||++||+.|++.|++.+..+++..|+++++.|......... +.|..+.
T Consensus 184 SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn--~~y~~~~ 261 (364)
T KOG0658|consen 184 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN--PNYTEFK 261 (364)
T ss_pred eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC--ccccccc
Confidence 67899999999999999999999999999999999999999999999999999999999998764332221 2222333
Q ss_pred CchhhhhhHHH-HhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 238 PSRTMKRRVRE-VFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 238 ~~~~~~~~~~~-~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
...-....+.+ +....+.++.||+.++|..+|.+|.|+.|+|.|+||.
T Consensus 262 ~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFd 310 (364)
T KOG0658|consen 262 FPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFD 310 (364)
T ss_pred CcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhH
Confidence 22222223323 5567899999999999999999999999999999994
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-47 Score=351.08 Aligned_cols=235 Identities=29% Similarity=0.420 Sum_probs=204.5
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
|+|++.+|..+|+|++++.. .+-...+...+|..||+.+.||++|+++..|.+ .+.+||||||
T Consensus 62 LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d----------------~~~lymvmey 125 (355)
T KOG0616|consen 62 LVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD----------------NSNLYMVMEY 125 (355)
T ss_pred EEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc----------------CCeEEEEEec
Confidence 68999999999999998663 222345667889999999999999999999987 6789999999
Q ss_pred CCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 80 MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 80 ~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
+.|+.+..+.+...+|++..++.|+.||+.||+|||+++|++|||||||||||.+|.+||+|||+|+.... ..-+.
T Consensus 126 v~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~----rT~Tl 201 (355)
T KOG0616|consen 126 VPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG----RTWTL 201 (355)
T ss_pred cCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC----cEEEe
Confidence 99765554444455899999999999999999999999999999999999999999999999999988653 24457
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
|||+.|+|||++.. +.|+.++|.|||||++|||+.|.+||.+.+...++.+|++..-..
T Consensus 202 CGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~f-------------------- 260 (355)
T KOG0616|consen 202 CGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKF-------------------- 260 (355)
T ss_pred cCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccC--------------------
Confidence 99999999999986 789999999999999999999999999999999999997653322
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 286 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----t~~elL~h~~f~~ 286 (472)
+..++.+++|||+++|+.|-.+|. -..||..|+||..
T Consensus 261 ----------P~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 261 ----------PSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred ----------CcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccc
Confidence 235788999999999999999994 5679999999954
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=346.00 Aligned_cols=238 Identities=28% Similarity=0.486 Sum_probs=204.5
Q ss_pred ceeccCCCEEEEEEeecCCcC---C---CchhhHHHHHHHHHhcC-CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEE
Q 012062 2 AREIKTGEIVALKKIRMDNEK---E---GFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTY 74 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~---~---~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 74 (472)
|.+++|++.+|+|+|...... + ...+..++|+.||+++. ||+||++.|++++ +.-++
T Consensus 36 ci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes----------------~sF~F 99 (411)
T KOG0599|consen 36 CIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES----------------DAFVF 99 (411)
T ss_pred hhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC----------------cchhh
Confidence 457899999999999755322 1 23344568999999995 9999999999998 45679
Q ss_pred EEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC
Q 012062 75 MVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 153 (472)
Q Consensus 75 iVmEy~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 153 (472)
+|+|+|.. .|.+++.. ...+++.+.+.||+||+++++|||.++||||||||+|||++++.++||+|||+|+.+. ..
T Consensus 100 lVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~--~G 176 (411)
T KOG0599|consen 100 LVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE--PG 176 (411)
T ss_pred hhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC--Cc
Confidence 99999994 56666544 4579999999999999999999999999999999999999999999999999998875 34
Q ss_pred CccccccccCCCCChhhhcCC-----CCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCC
Q 012062 154 NTLTNRVITLWYRPPELLLGA-----TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 228 (472)
Q Consensus 154 ~~~~~~~gt~~y~aPE~l~~~-----~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 228 (472)
..+...|||+.|+|||.+.+. ..|+..+|+|++|||+|.||.|.+||......-+++.|.+....+....|.
T Consensus 177 ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWa--- 253 (411)
T KOG0599|consen 177 EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWA--- 253 (411)
T ss_pred hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchh---
Confidence 456678999999999998652 347889999999999999999999999999999999998877766665554
Q ss_pred CCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 229 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
+++..++|||.+||+.||.+|+|++|+|.||||
T Consensus 254 -----------------------dis~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 254 -----------------------DISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred -----------------------hccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 566789999999999999999999999999999
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=361.41 Aligned_cols=268 Identities=41% Similarity=0.763 Sum_probs=215.2
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+++...... ....+.+|+.+++.++|+||+++++++.. ...+||||||+
T Consensus 23 ~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~----------------~~~~~lv~e~~ 85 (303)
T cd07869 23 KGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANIVLLHDIIHT----------------KETLTLVFEYV 85 (303)
T ss_pred EEEECCCCCEEEEEEeccccccc-cchhHHHHHHHHhhCCCCCcCeEEEEEec----------------CCeEEEEEECC
Confidence 36788899999999997654322 34467789999999999999999999986 55789999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
.++|.+++......+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++...... ........
T Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 164 (303)
T cd07869 86 HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP-SHTYSNEV 164 (303)
T ss_pred CcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC-CccCCCCc
Confidence 99998888776667899999999999999999999999999999999999999999999999998754322 22334456
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE-AEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.++ .+.+..++.....+....|+.....+.+......
T Consensus 165 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (303)
T cd07869 165 VTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFT 244 (303)
T ss_pred ccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccccccc
Confidence 799999999987756688999999999999999999999987544 5667777777777777777776554433221111
Q ss_pred hhhhhhHHHHhh--hccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 240 RTMKRRVREVFR--HFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 240 ~~~~~~~~~~~~--~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
..........+. .++..+++||.+||+.||++|+|++|+|+|+||..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~ 293 (303)
T cd07869 245 LYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD 293 (303)
T ss_pred ccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccccc
Confidence 111222223332 24578999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=367.74 Aligned_cols=242 Identities=31% Similarity=0.482 Sum_probs=205.0
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
||+.+.||+++|+|++++.. ...+..+.++.|..||....+++||+||..|++ ..++||||||
T Consensus 159 LarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD----------------~~~LYLiMEy 222 (550)
T KOG0605|consen 159 LARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD----------------KEYLYLIMEY 222 (550)
T ss_pred EEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC----------------CCeeEEEEEe
Confidence 78999999999999998774 334456778899999999999999999999998 6789999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC-----
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN----- 153 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~----- 153 (472)
+.| |+..++.+.+ .|++..++.|+.+++.||+.||++|+|||||||+|+|||..|++||+|||+++.+.....
T Consensus 223 lPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~ 301 (550)
T KOG0605|consen 223 LPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYR 301 (550)
T ss_pred cCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhc
Confidence 995 7777777765 699999999999999999999999999999999999999999999999999864321000
Q ss_pred -----------------C------------------------ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHH
Q 012062 154 -----------------N------------------------TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 192 (472)
Q Consensus 154 -----------------~------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~e 192 (472)
. .....+||+-||||||+++ ..|+..+|.||||||+||
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDwWSLG~ImyE 380 (550)
T KOG0605|consen 302 LDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDWWSLGCIMYE 380 (550)
T ss_pred chhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccccHHHHHHHHHH
Confidence 0 0113488999999999998 569999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCC
Q 012062 193 LLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR 272 (472)
Q Consensus 193 ll~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 272 (472)
||.|.+||.+.+..+.+.+|+.. ......|.. ..++++++|||.+||. ||++|
T Consensus 381 mLvGyPPF~s~tp~~T~rkI~nw---------r~~l~fP~~-----------------~~~s~eA~DLI~rll~-d~~~R 433 (550)
T KOG0605|consen 381 MLVGYPPFCSETPQETYRKIVNW---------RETLKFPEE-----------------VDLSDEAKDLITRLLC-DPENR 433 (550)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHH---------hhhccCCCc-----------------CcccHHHHHHHHHHhc-CHHHh
Confidence 99999999999999999999762 222222211 1356799999999999 99999
Q ss_pred C---CHHHHhcCCCCCCC
Q 012062 273 I---SAKDALDSEYFWTD 287 (472)
Q Consensus 273 ~---t~~elL~h~~f~~~ 287 (472)
+ .++||.+||||+..
T Consensus 434 LG~~G~~EIK~HPfF~~v 451 (550)
T KOG0605|consen 434 LGSKGAEEIKKHPFFKGV 451 (550)
T ss_pred cCcccHHHHhcCCccccC
Confidence 8 59999999999553
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=358.34 Aligned_cols=267 Identities=37% Similarity=0.668 Sum_probs=212.1
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+++.....+.....+.+|+++++.++|+||+++++++.. ++.+||||||+
T Consensus 19 ~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~~ 82 (287)
T cd07848 19 KCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR----------------RGKLYLVFEYV 82 (287)
T ss_pred EEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec----------------CCEEEEEEecC
Confidence 36788899999999998765555556678899999999999999999999976 56899999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
.++++..+......+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++...............
T Consensus 83 ~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 162 (287)
T cd07848 83 EKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV 162 (287)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccccc
Confidence 99887777655557999999999999999999999999999999999999999999999999999876443333334457
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC--C
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK--P 238 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~--~ 238 (472)
+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+......+......+.+.... .
T Consensus 163 ~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (287)
T cd07848 163 ATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPA 241 (287)
T ss_pred cccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCc
Confidence 8999999999986 568899999999999999999999999998888777777665554432222111111110000 0
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
..............++.++++||++||+.||++|+|++|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 242 VNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0000111223344678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-47 Score=348.01 Aligned_cols=229 Identities=29% Similarity=0.434 Sum_probs=195.6
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeE-EeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKE-IVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
|+++.||+.||+|.|..+..+......+++||.+|++|+|||||++++ .|... +..++||||||
T Consensus 38 v~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~---------------~evlnivmE~c 102 (375)
T KOG0591|consen 38 VQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIED---------------NEVLNIVMELC 102 (375)
T ss_pred eeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhcc---------------chhhHHHHHhh
Confidence 678899999999999988777767788999999999999999999998 44431 33489999999
Q ss_pred C-CChhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHH--CC--ccccCCCCCcEEEcCCCCeEEeeccceeeeccCC
Q 012062 81 D-HDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHV--NQ--VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 152 (472)
Q Consensus 81 ~-g~l~~~~~---~~~~~l~~~~i~~i~~Qll~aL~~LH~--~g--iiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 152 (472)
+ |||...++ +....+++..++.++.||+.||.+||. .+ |+||||||.||+|+.+|.|||.|||+++.+....
T Consensus 103 ~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~ 182 (375)
T KOG0591|consen 103 DAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKT 182 (375)
T ss_pred cccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchh
Confidence 9 57776665 355679999999999999999999999 45 9999999999999999999999999998876433
Q ss_pred CCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 012062 153 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 232 (472)
Q Consensus 153 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (472)
..-.+.+||+.||+||++.. ..|+.++|||||||++|||+.-++||.+.+-.+...+|.+...++- |
T Consensus 183 -tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~----------p- 249 (375)
T KOG0591|consen 183 -TFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPL----------P- 249 (375)
T ss_pred -HHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCC----------c-
Confidence 33456799999999999987 7899999999999999999999999999988888888866432211 1
Q ss_pred cccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCH
Q 012062 233 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA 275 (472)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~ 275 (472)
-..+|..+..||..||..|++.||+.
T Consensus 250 -----------------~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 250 -----------------DEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred -----------------HHHhhhHHHHHHHHHccCCcccCCCc
Confidence 02578899999999999999999985
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=362.97 Aligned_cols=239 Identities=30% Similarity=0.507 Sum_probs=215.9
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
||||.=||+.||||+|.+.+.+......++.|+..|+.++|||||+||+++.. ...+|||+|+-
T Consensus 36 LArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT----------------QTKlyLiLELG 99 (864)
T KOG4717|consen 36 LARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT----------------QTKLYLILELG 99 (864)
T ss_pred hhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc----------------cceEEEEEEec
Confidence 78999999999999999888777677788999999999999999999999876 66899999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc-CCCCeEEeeccceeeeccCCCCcccc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID-NEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~-~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
++ +|.+++.+....++++.+++||+||+.|+.|||+..+||||||||||.+. .-|-|||.||||+..|.. ...+++
T Consensus 100 D~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P--G~kL~T 177 (864)
T KOG4717|consen 100 DGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP--GKKLTT 177 (864)
T ss_pred CCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC--cchhhc
Confidence 95 99999999888899999999999999999999999999999999999875 457799999999987753 456778
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
.||++.|-|||+|+++.+..+++||||||||||.|++|++||...++.+.+..|+.+...-
T Consensus 178 sCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtv------------------- 238 (864)
T KOG4717|consen 178 SCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTV------------------- 238 (864)
T ss_pred ccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccC-------------------
Confidence 8999999999999998777889999999999999999999999999999999997654332
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
+.+++.+++|||.+||..||++|.|.+||..++|+...
T Consensus 239 -----------PshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~ 276 (864)
T KOG4717|consen 239 -----------PSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAG 276 (864)
T ss_pred -----------chhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCC
Confidence 23688899999999999999999999999999999643
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-45 Score=353.95 Aligned_cols=250 Identities=25% Similarity=0.394 Sum_probs=205.3
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+.+.++++||||+++.++...+ ...+.+|+..|+.++|||||+++..|.. +..+|+||.||
T Consensus 44 ~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv----------------~~~LWvVmpfM 106 (516)
T KOG0582|consen 44 LARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVV----------------DSELWVVMPFM 106 (516)
T ss_pred eeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEe----------------cceeEEeehhh
Confidence 588899999999999999877764 6788999999999999999999999987 77899999999
Q ss_pred CC-ChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC---c
Q 012062 81 DH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN---T 155 (472)
Q Consensus 81 ~g-~l~~~~~~-~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~---~ 155 (472)
.+ ++++++.. -...|+|..|..|++++|.||.|||.+|.||||||+.||||+.+|.|||+|||.+..+...... .
T Consensus 107 a~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~r 186 (516)
T KOG0582|consen 107 AGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTR 186 (516)
T ss_pred cCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEe
Confidence 95 66666654 1224999999999999999999999999999999999999999999999999987655432221 2
Q ss_pred cccccccCCCCChhhh-cCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 156 LTNRVITLWYRPPELL-LGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l-~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
...+++|++|||||++ .....|+.|+||||||++..||.+|..||.......++....+. .++... +
T Consensus 187 f~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn--~pp~~~---t------- 254 (516)
T KOG0582|consen 187 FNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQN--DPPTLL---T------- 254 (516)
T ss_pred eccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC--CCCCcc---c-------
Confidence 2556899999999995 44456999999999999999999999999998887776554332 221110 0
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
.....+..+.++..++++|..||++||.+|||++++|+|+||+..
T Consensus 255 --------~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 255 --------SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred --------ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 011123334577799999999999999999999999999999653
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=366.59 Aligned_cols=236 Identities=30% Similarity=0.487 Sum_probs=207.4
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
+|.+.|.+.||||.|.+....+.....+.+|++|++.|+|||||.+++.|+. ..++|+|+|||.
T Consensus 21 grrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt----------------~~~~~vVte~a~ 84 (808)
T KOG0597|consen 21 GRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET----------------SAHLWVVTEYAV 84 (808)
T ss_pred cccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc----------------cceEEEEehhhh
Confidence 5788999999999998876666677889999999999999999999999987 778999999999
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccc
Q 012062 82 HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 161 (472)
Q Consensus 82 g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 161 (472)
|+|..++.. +..++++.++.|+.+++.||.|||+++|+|||+||.||||+..+.+|+||||+|+.+.. .....+...|
T Consensus 85 g~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t~vltsikG 162 (808)
T KOG0597|consen 85 GDLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NTSVLTSIKG 162 (808)
T ss_pred hhHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc-CceeeeeccC
Confidence 988777754 45799999999999999999999999999999999999999999999999999988764 3345566679
Q ss_pred cCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchh
Q 012062 162 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241 (472)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (472)
|+.|||||++.+ ..|+..+|+||||||+|||++|++||....-......|.... ..|+
T Consensus 163 tPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~-----v~~p---------------- 220 (808)
T KOG0597|consen 163 TPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDP-----VKPP---------------- 220 (808)
T ss_pred cccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCC-----CCCc----------------
Confidence 999999999986 789999999999999999999999999888777777775432 2222
Q ss_pred hhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
..++..++.||+.+|.+||.+|+|-.+++.|+|.+.
T Consensus 221 ---------~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 221 ---------STASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKG 256 (808)
T ss_pred ---------ccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhh
Confidence 136778999999999999999999999999999754
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=353.73 Aligned_cols=283 Identities=49% Similarity=0.908 Sum_probs=235.7
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||+++...........+.+|+.++++++|+||+++++++.... .+.+||||||++
T Consensus 26 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--------------~~~~~lv~e~~~ 91 (309)
T cd07845 26 ARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH--------------LDSIFLVMEYCE 91 (309)
T ss_pred EEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC--------------CCeEEEEEecCC
Confidence 677889999999999876555545556778999999999999999999987521 346899999999
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccc
Q 012062 82 HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 161 (472)
Q Consensus 82 g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 161 (472)
++|.+++......+++.+++.++.||+.||+|||+++|+||||||+||+++.++.+||+|||++....... ........
T Consensus 92 ~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~ 170 (309)
T cd07845 92 QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-KPMTPKVV 170 (309)
T ss_pred CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc-CCCCcccc
Confidence 98888877655679999999999999999999999999999999999999999999999999998765322 22233345
Q ss_pred cCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchh
Q 012062 162 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241 (472)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (472)
+..|+|||++.+...++.++|||||||++|+|++|+.||...+..+.+..+.+.++.+....|+....++....+.....
T Consensus 171 ~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (309)
T cd07845 171 TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQ 250 (309)
T ss_pred cccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCC
Confidence 78899999987756688999999999999999999999999999999999999999988888887766555443332222
Q ss_pred hhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCC
Q 012062 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKY 299 (472)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~~~~~~~~~~~~~ 299 (472)
........+..++.++.+||.+||..||++|||++|+|.|+||...++++.+..++.+
T Consensus 251 ~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~~~~~~~~ 308 (309)
T cd07845 251 PYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEPEMMPTF 308 (309)
T ss_pred CCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCCCCcCCCC
Confidence 2223344445578899999999999999999999999999999998888887777654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=355.00 Aligned_cols=267 Identities=43% Similarity=0.815 Sum_probs=219.7
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||+++..... .....+.+|+.++++++|+||+++++++.. ++.+||||||++
T Consensus 25 ~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~~~ 87 (309)
T cd07872 25 GRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHT----------------DKSLTLVFEYLD 87 (309)
T ss_pred EEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEee----------------CCeEEEEEeCCC
Confidence 677889999999999865432 234467789999999999999999999976 557899999999
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccc
Q 012062 82 HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 161 (472)
Q Consensus 82 g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 161 (472)
+++...+......+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++....... .......+
T Consensus 88 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~ 166 (309)
T cd07872 88 KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT-KTYSNEVV 166 (309)
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc-cccccccc
Confidence 99988877666668999999999999999999999999999999999999999999999999987644322 22233467
Q ss_pred cCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchh
Q 012062 162 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241 (472)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (472)
|..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+++..+.+....|+.......+........
T Consensus 167 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (309)
T cd07872 167 TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKY 246 (309)
T ss_pred cccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCcc
Confidence 89999999987756788999999999999999999999999999999999999998888888876654322222111111
Q ss_pred hhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
...........++.++++||.+||..||.+|+|+.|+|+|+||..
T Consensus 247 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 291 (309)
T cd07872 247 KPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291 (309)
T ss_pred CCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence 112222344568889999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=353.30 Aligned_cols=243 Identities=31% Similarity=0.511 Sum_probs=194.5
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
|+.++.+|+.+|||.+...+... ...+.+|+.+|++|+|+|||++++...... ...++|+|||+
T Consensus 35 l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~--------------~~~~~i~mEy~ 98 (313)
T KOG0198|consen 35 LATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRE--------------NDEYNIFMEYA 98 (313)
T ss_pred EEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCcccccc--------------CeeeEeeeecc
Confidence 46788889999999998763322 566889999999999999999998744310 12689999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC-CCCeEEeeccceeeecc--CCCCcc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN-EGNLKLADFGLARSFSY--DHNNTL 156 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~-~~~vkL~DFG~a~~~~~--~~~~~~ 156 (472)
.+ +|.+++.+....|++..++.+++||++||+|||++||||||||++||||+. ++.+||+|||+++.... ......
T Consensus 99 ~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~ 178 (313)
T KOG0198|consen 99 PGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSE 178 (313)
T ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccccccc
Confidence 95 677777765557999999999999999999999999999999999999999 69999999999987663 222334
Q ss_pred ccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCCCCCCccCCCCCcccc
Q 012062 157 TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK-NEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235 (472)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (472)
....||+.|||||++........++|||||||++.||+||..||... ...+.+..+......|
T Consensus 179 ~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P---------------- 242 (313)
T KOG0198|consen 179 LSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP---------------- 242 (313)
T ss_pred ccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC----------------
Confidence 45789999999999985223345999999999999999999999873 3333333332211111
Q ss_pred CCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
.+...++.++++||.+||..||++||||+++|+|+|...+
T Consensus 243 ------------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 243 ------------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred ------------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 1223578899999999999999999999999999999654
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=350.35 Aligned_cols=234 Identities=30% Similarity=0.533 Sum_probs=204.7
Q ss_pred CceeccCCCEEEEEEeecCCcCC-CchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEKE-GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++...|+.||||.|+++..+. .....+.+||+||..|+|||||.+|++|++ ++.+.|||||
T Consensus 71 ~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN----------------kdKIvivMEY 134 (668)
T KOG0611|consen 71 LAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN----------------KDKIVIVMEY 134 (668)
T ss_pred ehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC----------------CceEEEEEEe
Confidence 57888999999999999885443 345667899999999999999999999987 6789999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
..+ +|.+++.++. .+++.+++.||+||+.|+.|||.++++|||||.+|||||.++++||+|||++..+. ....+.+
T Consensus 135 aS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~--~~kfLqT 211 (668)
T KOG0611|consen 135 ASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA--DKKFLQT 211 (668)
T ss_pred cCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc--cccHHHH
Confidence 995 6777776654 79999999999999999999999999999999999999999999999999997664 3456788
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
+||++.|.+||++.+..+-++.+|.|||||+||.|+.|..||++.+...++.+|.......+.
T Consensus 212 FCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~----------------- 274 (668)
T KOG0611|consen 212 FCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE----------------- 274 (668)
T ss_pred hcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-----------------
Confidence 999999999999998666689999999999999999999999999998888888654332221
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
-+..+.-||+.||..||++|.|++||..|=|.
T Consensus 275 --------------~PSdA~gLIRwmLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 275 --------------TPSDASGLIRWMLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred --------------CCchHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence 22357899999999999999999999999886
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-44 Score=356.63 Aligned_cols=275 Identities=38% Similarity=0.592 Sum_probs=209.6
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+++...........+.+|+++|++++|+||+++++++...... ....+|||||||
T Consensus 18 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~-----------~~~~~~lv~e~~ 86 (338)
T cd07859 18 SAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR-----------EFKDIYVVFELM 86 (338)
T ss_pred EEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCC-----------CCceEEEEEecC
Confidence 367889999999999975433333345678999999999999999999998753211 134689999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC--Ccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTLTN 158 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~--~~~~~ 158 (472)
+++|.+.+.+.. .+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....... .....
T Consensus 87 ~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~ 165 (338)
T cd07859 87 ESDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 165 (338)
T ss_pred CCCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccC
Confidence 998888776543 689999999999999999999999999999999999999999999999999976432221 12234
Q ss_pred ccccCCCCChhhhcCC-CCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 159 RVITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
.++|..|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+....+..+....+.+....+..+........+.
T Consensus 166 ~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 245 (338)
T cd07859 166 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLS 245 (338)
T ss_pred CCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHH
Confidence 5789999999988642 467899999999999999999999999998888887777766665443332221100000000
Q ss_pred -CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 238 -PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 238 -~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
............+..++..+.+||.+||..||++|||++|+|+|+||...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 246 SMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred hhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 00000111223345677889999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=345.30 Aligned_cols=266 Identities=41% Similarity=0.750 Sum_probs=212.4
Q ss_pred ceecc-CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc---CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEE
Q 012062 2 AREIK-TGEIVALKKIRMDNEKEGFPITAIREIKILKKL---QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVF 77 (472)
Q Consensus 2 a~~~~-tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVm 77 (472)
|++.. +++.||||+++.....+.......+|+.+++.+ +|+||+++++++..... .....+||||
T Consensus 20 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~-----------~~~~~~~lv~ 88 (290)
T cd07862 20 ARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT-----------DRETKLTLVF 88 (290)
T ss_pred EEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccC-----------CCCCcEEEEE
Confidence 56644 468899999987655444555667888888776 69999999999864221 1145689999
Q ss_pred ecCCCChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcc
Q 012062 78 EYMDHDLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTL 156 (472)
Q Consensus 78 Ey~~g~l~~~~~~~-~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 156 (472)
||+.++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 89 e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~ 166 (290)
T cd07862 89 EHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MAL 166 (290)
T ss_pred ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEeccCC--ccc
Confidence 99999888877653 345899999999999999999999999999999999999999999999999999765432 223
Q ss_pred ccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccC
Q 012062 157 TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236 (472)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (472)
....+|..|+|||++.+ ..++.++|||||||++|+|++|++||.+.++.+.+.++.+..+.+....|+....++... +
T Consensus 167 ~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-~ 244 (290)
T cd07862 167 TSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA-F 244 (290)
T ss_pred ccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchh-c
Confidence 34567999999999876 568899999999999999999999999999999999999888777666665543332211 0
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
. .............++..+++||.+||+.||++|||+.|+|+|+||
T Consensus 245 ~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 245 H--SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred c--CCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0 011223444556788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=353.57 Aligned_cols=240 Identities=32% Similarity=0.482 Sum_probs=209.4
Q ss_pred CceeccCCCEEEEEEeecCCcCC-CchhhHHHHHHHHHhcC-CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 1 MAREIKTGEIVALKKIRMDNEKE-GFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~-~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
+|+++.||+.||+|+|.+..... .....+.+|+.||++|. |||||.++++|++ ...+|||||
T Consensus 53 ~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~----------------~~~~~lvmE 116 (382)
T KOG0032|consen 53 LCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED----------------PDSVYLVME 116 (382)
T ss_pred EEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc----------------CCeEEEEEE
Confidence 47889999999999998764332 23567889999999998 9999999999998 558999999
Q ss_pred cCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC----CCeEEeeccceeeeccCCC
Q 012062 79 YMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE----GNLKLADFGLARSFSYDHN 153 (472)
Q Consensus 79 y~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~----~~vkL~DFG~a~~~~~~~~ 153 (472)
+|+| .|.+.+.+. .+++..+..+++||+.+++|||+.||+||||||||||+... +.+|++|||++..... .
T Consensus 117 L~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~--~ 192 (382)
T KOG0032|consen 117 LCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP--G 192 (382)
T ss_pred ecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC--C
Confidence 9996 666666655 39999999999999999999999999999999999999654 3699999999988765 5
Q ss_pred CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 012062 154 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 233 (472)
Q Consensus 154 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (472)
......+||+.|+|||++.. ..|+..+||||+||++|.|++|.+||.+.++...+..|...........|+
T Consensus 193 ~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~-------- 263 (382)
T KOG0032|consen 193 ERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWD-------- 263 (382)
T ss_pred ceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCcc--------
Confidence 56677899999999999986 679999999999999999999999999999999998887766555555554
Q ss_pred ccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 234 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
.++..+++||++||..||.+|+|+.++|+|||+...
T Consensus 264 ------------------~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 264 ------------------DISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred ------------------ccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 567789999999999999999999999999999764
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=363.52 Aligned_cols=237 Identities=25% Similarity=0.414 Sum_probs=205.5
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhcC-CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
||..+.|++.+|||+++++. ..++..+.++.|..|+...+ ||.+++++..|+. +.++|+|||
T Consensus 386 lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT----------------~~~l~fvme 449 (694)
T KOG0694|consen 386 LAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT----------------KEHLFFVME 449 (694)
T ss_pred EEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc----------------CCeEEEEEE
Confidence 57889999999999999884 33455677889999999885 9999999999998 779999999
Q ss_pred cCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 79 YMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 79 y~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
|+.|+....+... ..|++..++.|+..|+.||+|||++|||+||||.+|||||.+|.+||+|||+++.-.... ....+
T Consensus 450 y~~Ggdm~~~~~~-~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g-~~TsT 527 (694)
T KOG0694|consen 450 YVAGGDLMHHIHT-DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG-DRTST 527 (694)
T ss_pred ecCCCcEEEEEec-ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCC-Ccccc
Confidence 9997654444443 479999999999999999999999999999999999999999999999999998644333 34566
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
+|||+.|||||++.+ ..|+.++|.|||||+|||||.|..||++.++++.+..|.......
T Consensus 528 fCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~y------------------- 587 (694)
T KOG0694|consen 528 FCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRY------------------- 587 (694)
T ss_pred ccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC-------------------
Confidence 899999999999987 789999999999999999999999999999999999997532211
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCC-----HHHHhcCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 286 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t-----~~elL~h~~f~~ 286 (472)
+..++.++.+||+++|.+||++|+- +.+|..||||+.
T Consensus 588 -----------P~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~ 629 (694)
T KOG0694|consen 588 -----------PRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRS 629 (694)
T ss_pred -----------CCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCcccc
Confidence 1247789999999999999999984 689999999964
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=342.67 Aligned_cols=267 Identities=41% Similarity=0.743 Sum_probs=214.2
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc---CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEE
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL---QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVF 77 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVm 77 (472)
+|+++.|++.||||+++...........+.+|+.+++.+ +|+||+++++++..... .....+++||
T Consensus 18 ~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~-----------~~~~~~~lv~ 86 (288)
T cd07863 18 KARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRT-----------DRETKVTLVF 86 (288)
T ss_pred EEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccC-----------CCCceEEEEE
Confidence 478899999999999987644444445567788888766 69999999999875321 1145689999
Q ss_pred ecCCCChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcc
Q 012062 78 EYMDHDLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTL 156 (472)
Q Consensus 78 Ey~~g~l~~~~~~~-~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 156 (472)
||+.++|..++.+. ...+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 87 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~--~~~ 164 (288)
T cd07863 87 EHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ--MAL 164 (288)
T ss_pred cccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccCc--ccC
Confidence 99999888777653 335899999999999999999999999999999999999999999999999999765422 222
Q ss_pred ccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccC
Q 012062 157 TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236 (472)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (472)
....+|..|+|||++.+ ..++.++|||||||++|+|++|+++|...+..+.+.+++...+.+....|+.....+... +
T Consensus 165 ~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 242 (288)
T cd07863 165 TPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGA-F 242 (288)
T ss_pred CCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccc-c
Confidence 34567999999999976 568999999999999999999999999999999999998888777766666443322111 1
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
. .............++..+++||.+||+.||++|+|+.|+|.|+||
T Consensus 243 ~--~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 243 S--PRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred C--CCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 111233445556788899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=333.67 Aligned_cols=237 Identities=26% Similarity=0.367 Sum_probs=195.9
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC-CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
|.++.|++.+|||++... .++++|++++-+.+ |+|||.++|+|++. .....++.||||.|
T Consensus 81 C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs------------~~~rkcLLiVmE~m 141 (400)
T KOG0604|consen 81 CVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENS------------YQGRKCLLIVMECM 141 (400)
T ss_pred EEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhh------------ccCceeeEeeeecc
Confidence 578899999999998632 25679999998885 99999999999863 23367899999999
Q ss_pred CCC-hhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC---CCeEEeeccceeeeccCCCCc
Q 012062 81 DHD-LTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE---GNLKLADFGLARSFSYDHNNT 155 (472)
Q Consensus 81 ~g~-l~~~~~~-~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~---~~vkL~DFG~a~~~~~~~~~~ 155 (472)
+|+ |+..+.. .+..|++.++..|++||..||.|||+.+|.||||||||+|...+ ..+||+|||+|+.... ...
T Consensus 142 eGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~--~~~ 219 (400)
T KOG0604|consen 142 EGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE--PGD 219 (400)
T ss_pred cchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCC--Ccc
Confidence 975 5544443 34459999999999999999999999999999999999999754 3599999999976432 445
Q ss_pred cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHhcCCCCCCCCccCCCCC
Q 012062 156 LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE----AEQLSKIFELCGSPDETIWPGVSKMP 231 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (472)
+.+.|.|+.|+|||++.. .+|+..+|+||||||+|.||+|.+||.+..- ..+..+|......+++..
T Consensus 220 L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pE-------- 290 (400)
T KOG0604|consen 220 LMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPE-------- 290 (400)
T ss_pred ccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChh--------
Confidence 666788999999998864 7799999999999999999999999988753 345566655544444443
Q ss_pred ccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 232 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
|..+|++++|||+++|..+|++|+|++|+++|+|+..
T Consensus 291 ------------------Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~ 327 (400)
T KOG0604|consen 291 ------------------WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ 327 (400)
T ss_pred ------------------HhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence 4467889999999999999999999999999999954
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=345.37 Aligned_cols=266 Identities=43% Similarity=0.801 Sum_probs=218.2
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||.++...... ....+.+|+.++++|+|+||+++++++.. .+.+||||||+.
T Consensus 25 ~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~nI~~~~~~~~~----------------~~~~~lv~e~~~ 87 (301)
T cd07873 25 GRSKLTDNLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDIIHT----------------EKSLTLVFEYLD 87 (301)
T ss_pred EEEcCCCcEEEEEEEecccccC-chhHHHHHHHHHHhcCCCCcceEEEEEec----------------CCeEEEEEeccc
Confidence 6778899999999998654332 34467789999999999999999999986 567899999999
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccc
Q 012062 82 HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 161 (472)
Q Consensus 82 g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 161 (472)
++|..++.+....+++..++.++.||+.||+|||+++|+|+||||+|||++.++.+||+|||++....... .......+
T Consensus 88 ~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~ 166 (301)
T cd07873 88 KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYSNEVV 166 (301)
T ss_pred cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-Ccccccce
Confidence 99988877666678999999999999999999999999999999999999999999999999987543222 22233456
Q ss_pred cCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchh
Q 012062 162 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241 (472)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (472)
+..|+|||++.+...++.++|||||||++|+|++|+.||...+..+.+..+......+....|+.......+..+.....
T Consensus 167 ~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (301)
T cd07873 167 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKY 246 (301)
T ss_pred eecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCcc
Confidence 88999999988756688899999999999999999999999999899999988888888877776543322222222111
Q ss_pred hhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
...........++..+++||.+||..||.+|+|++|+|+|+||.
T Consensus 247 ~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~ 290 (301)
T cd07873 247 RADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH 290 (301)
T ss_pred ccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 12223344456788999999999999999999999999999994
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=344.46 Aligned_cols=266 Identities=45% Similarity=0.818 Sum_probs=218.2
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+|+.||+|+++...........+.+|++++++++|+||+++++++.+ ...+|+||||+
T Consensus 18 ~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~ 81 (284)
T cd07839 18 KAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS----------------DKKLTLVFEYC 81 (284)
T ss_pred EEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc----------------CCceEEEEecC
Confidence 36788899999999998765444455677899999999999999999999876 55789999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+++|.+.+.+....+++..++.++.||+.||.|||+++|+||||||+|||++.++++||+|||++..+.... .......
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~ 160 (284)
T cd07839 82 DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-RCYSAEV 160 (284)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-CCcCCCc
Confidence 999988877655679999999999999999999999999999999999999999999999999987654322 2223346
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPI-LPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
++..|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+++.+..+....|+.....+.+..+...
T Consensus 161 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd07839 161 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMY 240 (284)
T ss_pred cccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCC
Confidence 688999999988756678999999999999999998766 6677777888888888887777777666555444322221
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
.....+......++.++++||++||..||.+|||++|+|+|+||
T Consensus 241 -~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 241 -PATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred -CCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 11222344556788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=341.60 Aligned_cols=242 Identities=27% Similarity=0.401 Sum_probs=204.1
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
||+...|+..+|||++.+.. .......++..|.+||+.++||.+.+||..|+. +..+||||||
T Consensus 95 L~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet----------------~~~~cl~mey 158 (459)
T KOG0610|consen 95 LVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET----------------DKYSCLVMEY 158 (459)
T ss_pred EEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec----------------cceeEEEEec
Confidence 68889999999999998763 334456678889999999999999999999998 6689999999
Q ss_pred CCC-ChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeecc-------
Q 012062 80 MDH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY------- 150 (472)
Q Consensus 80 ~~g-~l~~~~~~-~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~------- 150 (472)
|.| +|..++.+ ++..|++..++.|+..|+.||+|||..|||+||||||||||.++|+|.|+||.++.....
T Consensus 159 CpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s 238 (459)
T KOG0610|consen 159 CPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKS 238 (459)
T ss_pred CCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeecc
Confidence 996 67777665 556799999999999999999999999999999999999999999999999998743210
Q ss_pred --------------------------C-C---------------------CCccccccccCCCCChhhhcCCCCCCCCcc
Q 012062 151 --------------------------D-H---------------------NNTLTNRVITLWYRPPELLLGATKYGPAVD 182 (472)
Q Consensus 151 --------------------------~-~---------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~D 182 (472)
. . ......++||-.|+|||++.+ ...+.++|
T Consensus 239 ~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G-~GHgsAVD 317 (459)
T KOG0610|consen 239 SSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG-EGHGSAVD 317 (459)
T ss_pred CCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-CCCCchhh
Confidence 0 0 011234678999999999998 57899999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHH
Q 012062 183 MWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLE 262 (472)
Q Consensus 183 iwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 262 (472)
.|+|||+|||||.|..||.+.+..+.+..|+...-..+.. ..++..++|||+
T Consensus 318 WWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~----------------------------~~vs~~akDLIr 369 (459)
T KOG0610|consen 318 WWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEE----------------------------PEVSSAAKDLIR 369 (459)
T ss_pred HHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCC----------------------------CcchhHHHHHHH
Confidence 9999999999999999999999999999987543222211 135678999999
Q ss_pred HhhccCCCCCCC----HHHHhcCCCCCCC
Q 012062 263 KMLMLDPSQRIS----AKDALDSEYFWTD 287 (472)
Q Consensus 263 ~~L~~dP~~R~t----~~elL~h~~f~~~ 287 (472)
++|.+||++|+. |.||.+||||...
T Consensus 370 ~LLvKdP~kRlg~~rGA~eIK~HpFF~gV 398 (459)
T KOG0610|consen 370 KLLVKDPSKRLGSKRGAAEIKRHPFFEGV 398 (459)
T ss_pred HHhccChhhhhccccchHHhhcCccccCC
Confidence 999999999998 9999999999543
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=351.14 Aligned_cols=237 Identities=27% Similarity=0.420 Sum_probs=195.1
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||+++.... .......+++|+.+|++++|+||+++++++.. .+.+||||||
T Consensus 13 ~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~----------------~~~~~lv~e~ 76 (323)
T cd05571 13 LVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT----------------HDRLCFVMEY 76 (323)
T ss_pred EEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc----------------CCEEEEEEeC
Confidence 467889999999999986532 22334567789999999999999999999986 5689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
+.+ +|...+.+ ...+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++..... ......
T Consensus 77 ~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~ 154 (323)
T cd05571 77 ANGGELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMKT 154 (323)
T ss_pred CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcccc
Confidence 986 55555543 346899999999999999999999999999999999999999999999999998753221 222334
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
.++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+....+..+......
T Consensus 155 ~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~-------------------- 213 (323)
T cd05571 155 FCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR-------------------- 213 (323)
T ss_pred eecCccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC--------------------
Confidence 578999999999876 57899999999999999999999999988776666655321100
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 286 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----t~~elL~h~~f~~ 286 (472)
+...++.++.+||++||..||++|+ ++.++++|+||..
T Consensus 214 ----------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 214 ----------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred ----------CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 1124677899999999999999999 8999999999954
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=358.79 Aligned_cols=274 Identities=34% Similarity=0.515 Sum_probs=212.2
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||++............+.+|+++|+.++|+||+++++++...+. .....+||||||+
T Consensus 18 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----------~~~~~~~lv~e~~ 86 (372)
T cd07853 18 SVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHI-----------DPFEEIYVVTELM 86 (372)
T ss_pred EEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCc-----------cccceEEEEeecc
Confidence 36788899999999997543333344578899999999999999999999976321 1123689999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
.++|...+... ..+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.............+
T Consensus 87 ~~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 165 (372)
T cd07853 87 QSDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEV 165 (372)
T ss_pred ccCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccccCCCCC
Confidence 99888777554 36899999999999999999999999999999999999999999999999999876544444444556
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC-Cc-cccCCC
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM-PA-YNHFKP 238 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~-~~~~~~ 238 (472)
+|..|+|||++.+...++.++||||||||+|+|++|+.||.+.+..+++..+.+..+.+....+...... .. ......
T Consensus 166 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 245 (372)
T cd07853 166 VTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPH 245 (372)
T ss_pred cCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCC
Confidence 7999999999987666889999999999999999999999999999999998887776543222111000 00 000000
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
...............++++.+||.+||..||++|+|+.|+|+|+||..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 293 (372)
T cd07853 246 KPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293 (372)
T ss_pred CCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence 000001111223456789999999999999999999999999999965
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=339.90 Aligned_cols=265 Identities=48% Similarity=0.888 Sum_probs=217.3
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||+++.....+.....+.+|+.+++.++|+||+++++++.. ++.+|+||||+.
T Consensus 19 ~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~~v~e~~~ 82 (285)
T cd07861 19 GRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ----------------ESRLYLIFEFLS 82 (285)
T ss_pred EEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee----------------CCeEEEEEecCC
Confidence 5778899999999998765555455678899999999999999999999986 567899999999
Q ss_pred CChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 82 HDLTGLADRP--GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 82 g~l~~~~~~~--~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
++|.+++... ...+++..++.++.||+.||+|||+++|+|+||||+|||++.++.+||+|||++....... ......
T Consensus 83 ~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~ 161 (285)
T cd07861 83 MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RVYTHE 161 (285)
T ss_pred CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-ccccCC
Confidence 8887776542 2468999999999999999999999999999999999999999999999999987654322 222334
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
.++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+++..+.+....|+....+..+....+.
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (285)
T cd07861 162 VVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPK 241 (285)
T ss_pred cccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccc
Confidence 56889999999877566788999999999999999999999999988888888888877777777766554433221111
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
............++.++++||++||..||++|||+.+|++|+||
T Consensus 242 -~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 242 -WKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred -cCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 11122333445688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=338.67 Aligned_cols=267 Identities=45% Similarity=0.808 Sum_probs=225.5
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||++............+.+|+.++++++|+||+++++++.. ...+|+||||+.
T Consensus 19 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----------------~~~~~~v~e~~~ 82 (286)
T cd07832 19 AKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH----------------GSGFVLVMEYMP 82 (286)
T ss_pred EEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec----------------CCeeEEEecccC
Confidence 6778899999999998765444556678899999999999999999999976 557899999997
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccc
Q 012062 82 HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 161 (472)
Q Consensus 82 g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 161 (472)
++|.+++......+++.+++.++.||+.+|+|||+++|+|+||||+||+++.++.++|+|||++...............+
T Consensus 83 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 162 (286)
T cd07832 83 SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA 162 (286)
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccccC
Confidence 78888876655679999999999999999999999999999999999999999999999999998765443333444577
Q ss_pred cCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchh
Q 012062 162 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241 (472)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (472)
+..|+|||++.+...++.++|||||||++|+|++|.++|.+.++.+.+..+.+....+....|+....+..+........
T Consensus 163 ~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (286)
T cd07832 163 TRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPES 242 (286)
T ss_pred cccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCC
Confidence 99999999987656678999999999999999999999999999999999988888887777877666555443333222
Q ss_pred hhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
....+...+..++..+++||++||..||++|||++++|.|+||
T Consensus 243 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~ 285 (286)
T cd07832 243 KPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285 (286)
T ss_pred CcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCc
Confidence 2333455666788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=344.90 Aligned_cols=261 Identities=37% Similarity=0.696 Sum_probs=201.4
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCChh
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLT 85 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~l~ 85 (472)
.+++.||||+++... ....+.+|+++|++++|+||+++++++.... ...+||||||+.++|.
T Consensus 26 ~~~~~~aiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--------------~~~~~lv~e~~~~~l~ 87 (317)
T cd07868 26 KDDRDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHA--------------DRKVWLLFDYAEHDLW 87 (317)
T ss_pred CCCceEEEEEECCCC----CcHHHHHHHHHHHhcCCCCCcceeeeEecCC--------------CcEEEEEEeccCCCHH
Confidence 578899999987442 2345779999999999999999999987522 4578999999999887
Q ss_pred hhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE----cCCCCeEEeeccceeeeccCCC
Q 012062 86 GLADRP--------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI----DNEGNLKLADFGLARSFSYDHN 153 (472)
Q Consensus 86 ~~~~~~--------~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl----~~~~~vkL~DFG~a~~~~~~~~ 153 (472)
.++... ...+++..++.++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||+++.+.....
T Consensus 88 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~ 167 (317)
T cd07868 88 HIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 167 (317)
T ss_pred HHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCc
Confidence 765421 2358999999999999999999999999999999999999 4556899999999987643221
Q ss_pred --CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHhcCCCCCC
Q 012062 154 --NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE---------AEQLSKIFELCGSPDET 222 (472)
Q Consensus 154 --~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~---------~~~~~~i~~~~~~~~~~ 222 (472)
......++|+.|+|||++.+...++.++|||||||++|+|++|+.||....+ .+++..+++..+.+...
T Consensus 168 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (317)
T cd07868 168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADK 247 (317)
T ss_pred cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChH
Confidence 2233457799999999998766689999999999999999999999976543 46777888888888777
Q ss_pred CCccCCCCCccccCCCc--------hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 223 IWPGVSKMPAYNHFKPS--------RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 223 ~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
.|.....++........ ..............+.++.+||++||..||++|+|++|+|+||||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 248 DWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 77766544432111100 000011111112346679999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=349.84 Aligned_cols=269 Identities=32% Similarity=0.516 Sum_probs=203.9
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+++...........+.+|+.+++.++|+||+++++++...... .....+||||||+
T Consensus 39 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~----------~~~~~~~lv~e~~ 108 (359)
T cd07876 39 AAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL----------EEFQDVYLVMELM 108 (359)
T ss_pred EEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc----------cccceeEEEEeCC
Confidence 367888999999999986644444456778999999999999999999998753211 1134689999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
++++...+.. .+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++..... .......
T Consensus 109 ~~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~ 183 (359)
T cd07876 109 DANLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--FMMTPYV 183 (359)
T ss_pred CcCHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccC--ccCCCCc
Confidence 9988776643 4789999999999999999999999999999999999999999999999998754322 2233457
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC--------CCc
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK--------MPA 232 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--------~~~ 232 (472)
+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+++..+.+....+..... .+.
T Consensus 184 ~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (359)
T cd07876 184 VTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQ 262 (359)
T ss_pred ccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCC
Confidence 7999999999986 5688999999999999999999999999988888877777665544322211100 000
Q ss_pred cccCCCchhh----hhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 233 YNHFKPSRTM----KRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 233 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
+......... ...........+.++++||.+||..||++|+|+.|+|+|+||.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 319 (359)
T cd07876 263 YPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT 319 (359)
T ss_pred CCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhh
Confidence 0000000000 0000011123467899999999999999999999999999995
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=319.66 Aligned_cols=235 Identities=31% Similarity=0.481 Sum_probs=206.7
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
|||.++++-.||||++.+.. .......++.+|++|...|+||||+++|.+|.+ ...+||++||
T Consensus 40 larekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd----------------~~riyLilEy 103 (281)
T KOG0580|consen 40 LAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD----------------SKRIYLILEY 103 (281)
T ss_pred EeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec----------------cceeEEEEEe
Confidence 68999999999999997663 344566788899999999999999999999987 6689999999
Q ss_pred CC-CChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 80 MD-HDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 80 ~~-g~l~~~~~~-~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
.. |.+...+.. ...+|++..+..|++|++.||.|||.++||||||||+|+|++.++.+||+|||.+.... .....
T Consensus 104 a~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---~~kR~ 180 (281)
T KOG0580|consen 104 APRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SNKRK 180 (281)
T ss_pred cCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC---CCCce
Confidence 98 567766653 44569999999999999999999999999999999999999999999999999986643 33455
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
+.|||.-|.+||...+ ..++..+|+|++|++.||+|.|.+||...+..+.+.+|.+.....+
T Consensus 181 tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p----------------- 242 (281)
T KOG0580|consen 181 TLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP----------------- 242 (281)
T ss_pred eeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC-----------------
Confidence 6799999999998887 6789999999999999999999999999999999999976543322
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
..++..+.|||.+||.++|.+|.+..|+++|+|+.
T Consensus 243 -------------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~ 277 (281)
T KOG0580|consen 243 -------------STISGGAADLISRLLVKNPIERLALTEVMDHPWIV 277 (281)
T ss_pred -------------cccChhHHHHHHHHhccCccccccHHHHhhhHHHH
Confidence 25788999999999999999999999999999984
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=345.72 Aligned_cols=269 Identities=36% Similarity=0.620 Sum_probs=209.2
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+++...........+.+|+++|++++|+||++++++|..... ......+|++||++
T Consensus 33 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----------~~~~~~~~~~~~~~ 102 (343)
T cd07878 33 SAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS----------IENFNEVYLVTNLM 102 (343)
T ss_pred EEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc----------ccccCcEEEEeecC
Confidence 36788899999999997654333334567789999999999999999999865321 11234689999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
.++|..++.. ..+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.... .....+
T Consensus 103 ~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~----~~~~~~ 176 (343)
T cd07878 103 GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD----EMTGYV 176 (343)
T ss_pred CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC----CcCCcc
Confidence 8888776653 3589999999999999999999999999999999999999999999999999976543 233457
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc--cccCCC
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA--YNHFKP 238 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~--~~~~~~ 238 (472)
+|..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+....+........ +....+
T Consensus 177 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (343)
T cd07878 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLP 256 (343)
T ss_pred ccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccc
Confidence 899999999998756789999999999999999999999999988888888877666554333222211000 000000
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
..........+...++.+.+||.+||..||++|+|+.|+|+|+||..
T Consensus 257 -~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~ 303 (343)
T cd07878 257 -HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303 (343)
T ss_pred -cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence 00011233444566778999999999999999999999999999965
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=358.16 Aligned_cols=267 Identities=31% Similarity=0.517 Sum_probs=205.3
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||++..+. ....+|+.+|+.++|+|||+++++|....... ......++|||||+.
T Consensus 85 ~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~--------~~~~~~l~lvmE~~~ 150 (440)
T PTZ00036 85 AICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKK--------NEKNIFLNVVMEFIP 150 (440)
T ss_pred EEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeeccccc--------CCCceEEEEEEecCC
Confidence 6778899999999986432 12357999999999999999999886532211 111345789999999
Q ss_pred CChhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC-CeEEeeccceeeeccCCCCccc
Q 012062 82 HDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG-NLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 82 g~l~~~~~---~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~-~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
+++..++. .....+++..++.|+.||+.||+|||+++|+||||||+||||+.++ .+||+|||+|+.+.... ...
T Consensus 151 ~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~--~~~ 228 (440)
T PTZ00036 151 QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ--RSV 228 (440)
T ss_pred ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCCC--Ccc
Confidence 98766553 3445689999999999999999999999999999999999999665 69999999998654322 223
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..++|+.|+|||++.+...++.++||||||||||+|++|.+||.+.+..+.+.++.+.++.+....+.... +.+....
T Consensus 229 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~--~~~~~~~ 306 (440)
T PTZ00036 229 SYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMN--PNYADIK 306 (440)
T ss_pred cCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhc--hhhhccc
Confidence 45779999999998876678999999999999999999999999999999999998887766543322211 1111111
Q ss_pred CchhhhhhHH-HHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 238 PSRTMKRRVR-EVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 238 ~~~~~~~~~~-~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
........+. .+....+.++++||.+||..||.+|+|+.|+|.|+||..
T Consensus 307 ~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 307 FPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356 (440)
T ss_pred CCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence 1111111222 223457889999999999999999999999999999953
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=347.27 Aligned_cols=237 Identities=30% Similarity=0.485 Sum_probs=211.7
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCe-EEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS-TYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~iVmEy 79 (472)
|++++.+.+.|+||+|+.....+.....++.|+.++++++|||||.++++|+. ++. +||||+|
T Consensus 22 lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~----------------~~~~l~Ivm~Y 85 (426)
T KOG0589|consen 22 LVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE----------------DGQLLCIVMEY 85 (426)
T ss_pred hhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc----------------CCceEEEEEee
Confidence 57899999999999999988777677789999999999999999999999987 455 8999999
Q ss_pred CCC-ChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 80 MDH-DLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 80 ~~g-~l~~~~~~~~-~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
|+| ++.+.+.+.. ..|+++.+..|+.||+.||.|||++.|+|||||..|||++.++.|||.|||+|+.+..... ...
T Consensus 86 ~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~-~a~ 164 (426)
T KOG0589|consen 86 CEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS-LAS 164 (426)
T ss_pred cCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchh-hhh
Confidence 996 6777776654 6799999999999999999999999999999999999999999999999999998775542 334
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
+.+||+.||+||++.+ .+|+.++|||||||++|||++-+..|...+......+|+..+..+...
T Consensus 165 tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~--------------- 228 (426)
T KOG0589|consen 165 TVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPS--------------- 228 (426)
T ss_pred eecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCc---------------
Confidence 5689999999998887 789999999999999999999999999999999999998877544332
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
.++.+++.||+.||..+|..||++.+||.+|.+
T Consensus 229 --------------~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l 261 (426)
T KOG0589|consen 229 --------------MYSSELRSLVKSMLRKNPEHRPSALELLRRPHL 261 (426)
T ss_pred --------------cccHHHHHHHHHHhhcCCccCCCHHHHhhChhh
Confidence 467789999999999999999999999999766
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=345.07 Aligned_cols=237 Identities=25% Similarity=0.424 Sum_probs=194.0
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||+++.... .......+.+|+++|+.++|+||+++++++.. .+.+||||||
T Consensus 13 ~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----------------~~~~~lv~Ey 76 (328)
T cd05593 13 LVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT----------------KDRLCFVMEY 76 (328)
T ss_pred EEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc----------------CCEEEEEEeC
Confidence 468889999999999986532 23345567889999999999999999999986 5689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
+.+ +|...+. ....+++.+++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++..... ......
T Consensus 77 ~~~g~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~ 154 (328)
T cd05593 77 VNGGELFFHLS-RERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKT 154 (328)
T ss_pred CCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc-cccccc
Confidence 986 4544443 3446899999999999999999999999999999999999999999999999998653221 222334
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
.++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+.....
T Consensus 155 ~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~--------------------- 212 (328)
T cd05593 155 FCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDI--------------------- 212 (328)
T ss_pred ccCCcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCc---------------------
Confidence 578999999999876 5689999999999999999999999998877666555432110
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 286 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----t~~elL~h~~f~~ 286 (472)
.+...++.++.+||++||..||++|+ ++.|+++|+||..
T Consensus 213 ---------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 213 ---------KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred ---------cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 01124677899999999999999997 8999999999943
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=352.16 Aligned_cols=261 Identities=26% Similarity=0.325 Sum_probs=196.3
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+... ..+.+|+++|++|+|||||+++++|.. ....|+|||++
T Consensus 110 ~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~----------------~~~~~lv~e~~ 165 (391)
T PHA03212 110 ACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTY----------------NKFTCLILPRY 165 (391)
T ss_pred EEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEE----------------CCeeEEEEecC
Confidence 478899999999997542 245789999999999999999999976 55789999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
.++|...+... ..+++.+++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.............+
T Consensus 166 ~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 244 (391)
T PHA03212 166 KTDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA 244 (391)
T ss_pred CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccccccccc
Confidence 98888776554 36899999999999999999999999999999999999999999999999999654333333344567
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCC-------ChHHHHHHHHHhcCCCCCCCCccCCC-CCc
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK-------NEAEQLSKIFELCGSPDETIWPGVSK-MPA 232 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~ 232 (472)
+|+.|+|||++.+ ..++.++||||||||||+|++|..||... +...++..++...+..+......... +..
T Consensus 245 gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~ 323 (391)
T PHA03212 245 GTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDE 323 (391)
T ss_pred CccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHH
Confidence 8999999999876 57899999999999999999999776543 23455666666655543222110000 000
Q ss_pred -ccc---CCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 233 -YNH---FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 233 -~~~---~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
+.. ........+........++.++.+||.+||+.||++|||++|+|+|+||...
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 324 IYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred HHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 000 0000000000011112356789999999999999999999999999999653
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=342.22 Aligned_cols=237 Identities=30% Similarity=0.450 Sum_probs=195.1
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||+++... ........+.+|+.+|++++|+||+++++++.. .+.+||||||
T Consensus 11 ~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~ 74 (312)
T cd05585 11 QVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS----------------PEKLYLVLAF 74 (312)
T ss_pred EEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec----------------CCeEEEEEcC
Confidence 36788999999999997542 222334567789999999999999999999976 5679999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
+.+ +|..++.+ ...+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 75 ~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 152 (312)
T cd05585 75 INGGELFHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT 152 (312)
T ss_pred CCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence 986 56666554 3469999999999999999999999999999999999999999999999999987533221 22334
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
.++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 153 ~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~-------------------- 211 (312)
T cd05585 153 FCGTPEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLR-------------------- 211 (312)
T ss_pred ccCCcccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCC--------------------
Confidence 578999999999986 57899999999999999999999999988877766665432110
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCC---CHHHHhcCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI---SAKDALDSEYFWT 286 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~---t~~elL~h~~f~~ 286 (472)
+...++.++++||.+||..||++|+ ++.|+|.|+||..
T Consensus 212 ----------~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~ 252 (312)
T cd05585 212 ----------FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQ 252 (312)
T ss_pred ----------CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCC
Confidence 1124677899999999999999997 5899999999954
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=345.00 Aligned_cols=234 Identities=26% Similarity=0.405 Sum_probs=194.6
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.+++.||||+++.... .......+.+|+.+|++++|+||+++++++.. .+.+||||||
T Consensus 36 ~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----------------~~~~~lv~e~ 99 (329)
T PTZ00263 36 IAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD----------------ENRVYFLLEF 99 (329)
T ss_pred EEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc----------------CCEEEEEEcC
Confidence 467889999999999976432 22334567899999999999999999999987 5689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
+.+ +|.+.+.+. ..+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++...... ...
T Consensus 100 ~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~----~~~ 174 (329)
T PTZ00263 100 VVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----TFT 174 (329)
T ss_pred CCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC----cce
Confidence 986 666665543 46899999999999999999999999999999999999999999999999999765422 223
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
.++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+.++.+.... +
T Consensus 175 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~-----------~-------- 234 (329)
T PTZ00263 175 LCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLK-----------F-------- 234 (329)
T ss_pred ecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcC-----------C--------
Confidence 578999999999986 56789999999999999999999999988877776666432100 0
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCC-----HHHHhcCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 286 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t-----~~elL~h~~f~~ 286 (472)
...++..+++||++||..||.+|++ ++||++|+||..
T Consensus 235 -----------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 235 -----------PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred -----------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 0125668999999999999999997 799999999954
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=343.44 Aligned_cols=237 Identities=28% Similarity=0.436 Sum_probs=194.6
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||+++.... .......+.+|+++++.++||||++++++|.. .+.+||||||
T Consensus 13 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~----------------~~~~~lv~E~ 76 (323)
T cd05595 13 LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT----------------HDRLCFVMEY 76 (323)
T ss_pred EEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec----------------CCEEEEEEeC
Confidence 467889999999999986532 22234566789999999999999999999986 5679999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
+.+ +|...+.+ ...+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++...... ......
T Consensus 77 ~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~ 154 (323)
T cd05595 77 ANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKT 154 (323)
T ss_pred CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCcccc
Confidence 986 55444433 346899999999999999999999999999999999999999999999999998753222 222334
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
.++|..|+|||++.+ ..++.++|||||||++|+|++|+.||...+....+..+......
T Consensus 155 ~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~-------------------- 213 (323)
T cd05595 155 FCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR-------------------- 213 (323)
T ss_pred ccCCcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC--------------------
Confidence 578999999999876 56899999999999999999999999988877766665432110
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 286 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----t~~elL~h~~f~~ 286 (472)
+...+++++++||++||..||++|+ ++.++++|+||..
T Consensus 214 ----------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 214 ----------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred ----------CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCC
Confidence 1124677899999999999999998 9999999999954
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=335.08 Aligned_cols=268 Identities=51% Similarity=0.899 Sum_probs=220.9
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||.++.....+.....+.+|+.++++++|+||+++++++.... .+.+||||||+.
T Consensus 24 ~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--------------~~~~~lv~e~~~ 89 (293)
T cd07843 24 ARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN--------------LDKIYMVMEYVE 89 (293)
T ss_pred EEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC--------------CCcEEEEehhcC
Confidence 677788999999999876555555566789999999999999999999987621 367999999999
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccc
Q 012062 82 HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 161 (472)
Q Consensus 82 g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 161 (472)
++|.+++......+++.+++.++.||+.||+|||+++|+|+||||+|||++.++.+||+|||++..+.... .......+
T Consensus 90 ~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~ 168 (293)
T cd07843 90 HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL-KPYTQLVV 168 (293)
T ss_pred cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-cccccccc
Confidence 98888776655569999999999999999999999999999999999999999999999999998765432 22233456
Q ss_pred cCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchh
Q 012062 162 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241 (472)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (472)
+..|+|||++.+...++.++|||||||++|+|++|..||...+..+.+.+++..++.+....|+....++..........
T Consensus 169 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (293)
T cd07843 169 TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKY 248 (293)
T ss_pred cccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccc
Confidence 88999999987655578899999999999999999999999999999999999888888887877666554443222222
Q ss_pred hhhhHHHHhhh--ccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 242 MKRRVREVFRH--FDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 242 ~~~~~~~~~~~--~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
........+.. +++.+.+||++||+.||++|||+.|+|.|+||
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 249 PYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 22223333433 48889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=339.02 Aligned_cols=234 Identities=27% Similarity=0.408 Sum_probs=194.0
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||+++.... .......+.+|+++|++++|+||+++++++.+ ...+||||||
T Consensus 19 ~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----------------~~~~~lv~e~ 82 (291)
T cd05612 19 LVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD----------------QRFLYMLMEY 82 (291)
T ss_pred EEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc----------------CCeEEEEEeC
Confidence 367888999999999975432 12234567789999999999999999998876 5689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
+.+ +|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ...
T Consensus 83 ~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~----~~~ 157 (291)
T cd05612 83 VPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWT 157 (291)
T ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC----ccc
Confidence 985 666666543 46899999999999999999999999999999999999999999999999998765321 223
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
.++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+......
T Consensus 158 ~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~-------------------- 216 (291)
T cd05612 158 LCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLE-------------------- 216 (291)
T ss_pred ccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcC--------------------
Confidence 568999999999876 56889999999999999999999999998887777766542111
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCC-----HHHHhcCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 286 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t-----~~elL~h~~f~~ 286 (472)
+...++..+++||++||+.||.+|++ ++|+++|+||..
T Consensus 217 ----------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 217 ----------FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred ----------CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence 01135678999999999999999995 999999999943
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=332.53 Aligned_cols=265 Identities=45% Similarity=0.823 Sum_probs=214.4
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||.++...... ....+.+|++++++++|+||+++++++.. ...+||||||+.
T Consensus 24 ~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~ 86 (291)
T cd07844 24 GRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDIIHT----------------KKTLTLVFEYLD 86 (291)
T ss_pred EEEcCCCcEEEEEEEecccccC-CchhHHHHHHHHhhCCCcceeeEEEEEec----------------CCeEEEEEecCC
Confidence 5777899999999998654322 23456789999999999999999999986 568899999999
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccc
Q 012062 82 HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 161 (472)
Q Consensus 82 g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 161 (472)
++|.+++.+....+++..++.++.||++||.|||+++|+||||||+|||++.++.+||+|||+++...... .......+
T Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~ 165 (291)
T cd07844 87 TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-KTYSNEVV 165 (291)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC-cccccccc
Confidence 99888777655578999999999999999999999999999999999999999999999999986543222 12223346
Q ss_pred cCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 012062 162 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN-EAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240 (472)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (472)
+..|+|||++.+...++.++|||||||++|+|++|+.||...+ ..+.+..+.+....+....|+.......+.......
T Consensus 166 ~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (291)
T cd07844 166 TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPF 245 (291)
T ss_pred ccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccc
Confidence 8889999998765668899999999999999999999998776 567777888888888777777776554443333222
Q ss_pred hhhhhHHHHhhhcc--HHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 241 TMKRRVREVFRHFD--RHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 241 ~~~~~~~~~~~~~~--~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
............++ ..+.+||.+||..||++|||+.|+|.|+||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 246 YPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 22223334444455 789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=333.42 Aligned_cols=277 Identities=56% Similarity=0.978 Sum_probs=228.2
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|+++.+++.||||+++.....+.....+.+|+++++.++|+||+++++++.+..... ...+..+.+||||||++
T Consensus 26 ~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~------~~~~~~~~~~lv~e~~~ 99 (302)
T cd07864 26 ARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL------DFKKDKGAFYLVFEYMD 99 (302)
T ss_pred EEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh------hccccCCcEEEEEcccC
Confidence 567788999999999876555545567788999999999999999999987632100 01112447899999999
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccc
Q 012062 82 HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 161 (472)
Q Consensus 82 g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 161 (472)
+++..++......+++.+++.++.||+.||+|||+++|+|+||||+||++++++.+||+|||++................
T Consensus 100 ~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 179 (302)
T cd07864 100 HDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179 (302)
T ss_pred ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccccccCCccccccccee
Confidence 98888777665579999999999999999999999999999999999999999999999999997665433222333455
Q ss_pred cCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchh
Q 012062 162 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241 (472)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (472)
+..|+|||++.+...++.++|||||||++|+|++|+.||...+..+.+..+.+.++.+....|+.....+.+........
T Consensus 180 ~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (302)
T cd07864 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQ 259 (302)
T ss_pred ccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccc
Confidence 78899999887655678899999999999999999999999999999999999998888888887766665544444444
Q ss_pred hhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
..+.....+..++..+.+||.+||..||++|||+.++++|+||
T Consensus 260 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 260 YRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 4455566666789999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=344.80 Aligned_cols=268 Identities=31% Similarity=0.516 Sum_probs=206.2
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||+++...........+.+|+.+++.++|+||+++++++..... ......+||||||++
T Consensus 43 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~----------~~~~~~~~lv~e~~~ 112 (364)
T cd07875 43 AYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKS----------LEEFQDVYIVMELMD 112 (364)
T ss_pred EEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccc----------ccccCeEEEEEeCCC
Confidence 6788899999999998655444455678899999999999999999999865321 111346899999999
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccc
Q 012062 82 HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 161 (472)
Q Consensus 82 g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 161 (472)
+++...+.. .+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++..... .......+
T Consensus 113 ~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--~~~~~~~~ 187 (364)
T cd07875 113 ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVV 187 (364)
T ss_pred CCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC--CcccCCcc
Confidence 988877653 4788999999999999999999999999999999999999999999999999764322 22334577
Q ss_pred cCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC--------CCcc
Q 012062 162 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK--------MPAY 233 (472)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--------~~~~ 233 (472)
|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+.++.+..+.+....+..... .+.+
T Consensus 188 t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (364)
T cd07875 188 TRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKY 266 (364)
T ss_pred cCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCc
Confidence 999999999987 5789999999999999999999999999999998888887766554332222111 0111
Q ss_pred ccCCCchh----hhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 234 NHFKPSRT----MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 234 ~~~~~~~~----~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
..+..... ............+..+++||.+||..||.+|+|+.|+|+|+||.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~ 322 (364)
T cd07875 267 AGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322 (364)
T ss_pred CCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence 10000000 00000111223456899999999999999999999999999994
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=332.47 Aligned_cols=272 Identities=48% Similarity=0.868 Sum_probs=222.7
Q ss_pred ceeccCCCEEEEEEeecCCcC---CCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 2 AREIKTGEIVALKKIRMDNEK---EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
|++..+++.||||+++..... ......+..|++++++++|+||+++++++.. ...+|+|||
T Consensus 19 ~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----------------~~~~~lv~e 82 (298)
T cd07841 19 ARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH----------------KSNINLVFE 82 (298)
T ss_pred EEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec----------------CCEEEEEEc
Confidence 567889999999999866433 3344566789999999999999999999976 557899999
Q ss_pred cCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 79 YMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 79 y~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
|+.++|..++......+++..++.++.||++||+|||+++|+|+||||+|||++.++.+||+|||+++...... .....
T Consensus 83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~~~ 161 (298)
T cd07841 83 FMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN-RKMTH 161 (298)
T ss_pred ccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC-ccccc
Confidence 99778888876654469999999999999999999999999999999999999999999999999997765332 22233
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
...+..|+|||.+.+...++.++|||||||++|+|++|.++|.+.++.+.+.+++.....+....|+.......+.....
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T cd07841 162 QVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKP 241 (298)
T ss_pred cccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccc
Confidence 35578899999987656678999999999999999999999999998888888888887777777776655544332221
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCD 292 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~~~~~~ 292 (472)
. ........+..++.++++||.+||..||++|+|+.|+|.|+||...+.+..
T Consensus 242 ~--~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~ 293 (298)
T cd07841 242 F--PPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP 293 (298)
T ss_pred c--CCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence 1 122234455677889999999999999999999999999999987766543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=334.21 Aligned_cols=276 Identities=53% Similarity=0.942 Sum_probs=224.2
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||++............+.+|+++++.++|+||+++++++....... ......+|+||||+
T Consensus 26 ~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~--------~~~~~~~~lv~~~~ 97 (311)
T cd07866 26 KARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKS--------KRKRGSVYMVTPYM 97 (311)
T ss_pred EEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccc--------cccCceEEEEEecC
Confidence 3678889999999999876555545556789999999999999999999887633211 12255789999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC------
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN------ 154 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~------ 154 (472)
.+++...+......+++.+++.++.||++||+|||+++|+|+||||+|||++.++.+||+|||++.........
T Consensus 98 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 177 (311)
T cd07866 98 DHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGG 177 (311)
T ss_pred CcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCc
Confidence 99888877766667999999999999999999999999999999999999999999999999998765432211
Q ss_pred ----ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 012062 155 ----TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 230 (472)
Q Consensus 155 ----~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 230 (472)
..+...++..|+|||++.+...++.++||||||||+|+|++|++||.+.+..+....++..+..+....|+.....
T Consensus 178 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (311)
T cd07866 178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSL 257 (311)
T ss_pred ccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhc
Confidence 1123356888999999876556889999999999999999999999999999999999998888877777766655
Q ss_pred CccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 231 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
+..................+..++..+.+||.+||..||++|||+.|+|.|+||
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 258 PGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred ccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 544332222222333444566677889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=333.49 Aligned_cols=265 Identities=49% Similarity=0.893 Sum_probs=215.3
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||+++.+.........+.+|++++++++|+||+++++++.+ .+.+|+||||+.
T Consensus 19 ~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----------------~~~~~~v~e~~~ 82 (284)
T cd07860 19 ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT----------------ENKLYLVFEFLH 82 (284)
T ss_pred EEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc----------------CCcEEEEeeccc
Confidence 6788899999999998765554455678899999999999999999999875 557899999999
Q ss_pred CChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 82 HDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 82 g~l~~~~~~-~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
++|..++.. ....+++..++.++.||+.||+|||+++|+|+||||+||+++.++.+||+|||++..+.... .......
T Consensus 83 ~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~~~~~ 161 (284)
T cd07860 83 QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEV 161 (284)
T ss_pred cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc-ccccccc
Confidence 888776654 33468999999999999999999999999999999999999999999999999987554221 2223345
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (472)
++..|+|||++.+...++.++|||||||++|+|++|+.||...++.+.+.++++..+.+....|+.....+.+....+.
T Consensus 162 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 240 (284)
T cd07860 162 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPK- 240 (284)
T ss_pred ccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhccc-
Confidence 6889999998877555788999999999999999999999999999999999888888777777655443322211111
Q ss_pred hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
............++.++++||.+||..||++|||++|+|+|+||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 241 WARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred ccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 01122333445678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=329.57 Aligned_cols=269 Identities=70% Similarity=1.178 Sum_probs=229.6
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||+++...........+.+|+.++++++|+||+++++++.... .+.+||||||++
T Consensus 18 ~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--------------~~~~~lv~e~~~ 83 (287)
T cd07840 18 ARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG--------------KGSIYMVFEYMD 83 (287)
T ss_pred EEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC--------------CCcEEEEecccc
Confidence 567788999999999877544555667889999999999999999999997621 257899999999
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccc
Q 012062 82 HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 161 (472)
Q Consensus 82 g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 161 (472)
++|..++......+++.+++.++.||+.||+|||+++++|+||||+|||+++++.+||+|||++...............+
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 163 (287)
T cd07840 84 HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI 163 (287)
T ss_pred ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccccccc
Confidence 98888887765679999999999999999999999999999999999999999999999999998765543333344566
Q ss_pred cCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchh
Q 012062 162 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241 (472)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (472)
+..|+|||.+.+...++.++|||||||++|+|++|+.||...+..+.+..+++.+..+....|+....+.....+.....
T Consensus 164 ~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (287)
T cd07840 164 TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKP 243 (287)
T ss_pred ccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhcccccc
Confidence 88999999887655678999999999999999999999999999999999999998888888887777655555555555
Q ss_pred hhhhHHHHhhhc-cHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 242 MKRRVREVFRHF-DRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 242 ~~~~~~~~~~~~-~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
........+... +..+.++|++||..||.+|||++++++|+||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 244 YKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred chhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 555555666665 8999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=331.94 Aligned_cols=276 Identities=53% Similarity=0.934 Sum_probs=218.0
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||++......+.....+.+|++++++++|+||+++++++...... .......+||||||+
T Consensus 30 ~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~--------~~~~~~~~~lv~e~~ 101 (310)
T cd07865 30 KARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP--------YNRYKGSFYLVFEFC 101 (310)
T ss_pred EEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccc--------ccCCCceEEEEEcCC
Confidence 367788999999999987655555556677899999999999999999998764321 122356789999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC---Cccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN---NTLT 157 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~---~~~~ 157 (472)
.+++.+++......+++.+++.++.||+.||+|||+++|+|+||||+|||++.++.+||+|||++..+..... ....
T Consensus 102 ~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 181 (310)
T cd07865 102 EHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181 (310)
T ss_pred CcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCcc
Confidence 9998888877666799999999999999999999999999999999999999999999999999976543221 1222
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
...++..|+|||++.+...++.++|||||||++|+|++|+.+|.+.+....+..+..+++......|+.......+....
T Consensus 182 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (310)
T cd07865 182 NRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKME 261 (310)
T ss_pred CcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhcc
Confidence 34568889999998775557889999999999999999999999999888888888888887777777665433322222
Q ss_pred CchhhhhhHHHHh--hhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 238 PSRTMKRRVREVF--RHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 238 ~~~~~~~~~~~~~--~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
............. ...+..+++||.+||..||++|||++|+|+|+||
T Consensus 262 ~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 262 LPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred CCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 1111111111111 1246778999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=335.43 Aligned_cols=261 Identities=38% Similarity=0.712 Sum_probs=201.1
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCChh
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLT 85 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~l~ 85 (472)
.+++.||+|.++... ....+.+|+++|++++|+||+++++++.... +..+||||||+.++|.
T Consensus 26 ~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--------------~~~~~lv~e~~~~~l~ 87 (317)
T cd07867 26 KDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHS--------------DRKVWLLFDYAEHDLW 87 (317)
T ss_pred CccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccC--------------CCeEEEEEeeeCCcHH
Confidence 467899999987442 2335778999999999999999999986522 4578999999999887
Q ss_pred hhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE----cCCCCeEEeeccceeeeccCCC
Q 012062 86 GLADR--------PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI----DNEGNLKLADFGLARSFSYDHN 153 (472)
Q Consensus 86 ~~~~~--------~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl----~~~~~vkL~DFG~a~~~~~~~~ 153 (472)
.++.. ....+++..++.++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+++.+.....
T Consensus 88 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~ 167 (317)
T cd07867 88 HIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 167 (317)
T ss_pred HHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcc
Confidence 76532 12348899999999999999999999999999999999999 4566899999999987643321
Q ss_pred --CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHhcCCCCCC
Q 012062 154 --NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE---------AEQLSKIFELCGSPDET 222 (472)
Q Consensus 154 --~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~---------~~~~~~i~~~~~~~~~~ 222 (472)
.......+|..|+|||++.+...++.++|||||||++|+|++|+.||....+ .+.+.+++..++.+...
T Consensus 168 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (317)
T cd07867 168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADK 247 (317)
T ss_pred cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChh
Confidence 1223456799999999998756688999999999999999999999976543 45677788888888877
Q ss_pred CCccCCCCCccccCCCch--------hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 223 IWPGVSKMPAYNHFKPSR--------TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
.|......+.+....... .............+..+++||.+||+.||.+|+|++|+|+||||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 248 DWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 777765544332211100 00011111112346779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=340.39 Aligned_cols=242 Identities=26% Similarity=0.398 Sum_probs=197.6
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||+++.... .......+.+|+++++.++|+||+++++++.. .+.+||||||
T Consensus 19 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~----------------~~~~~lv~e~ 82 (333)
T cd05600 19 LAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD----------------DEYLYLAMEY 82 (333)
T ss_pred EEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc----------------CCEEEEEEeC
Confidence 367888999999999986532 22334567889999999999999999999986 5689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
+.+ +|.+++.+ ...+++.+++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||++..... ....
T Consensus 83 ~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~~~~ 157 (333)
T cd05600 83 VPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YANS 157 (333)
T ss_pred CCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc----ccCC
Confidence 986 66666544 34689999999999999999999999999999999999999999999999999876543 2334
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
.++|+.|+|||++.+ ..++.++||||||||+|+|++|..||...+..+.+..+...........+ ..
T Consensus 158 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~---------~~--- 224 (333)
T cd05600 158 VVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVY---------DD--- 224 (333)
T ss_pred cccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCC---------Cc---
Confidence 578999999999987 47899999999999999999999999998887777666442211110000 00
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
....++.++.+||.+||..+|.+|+|+.++++|+||..
T Consensus 225 ----------~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 225 ----------PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred ----------cccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 00246788999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=343.49 Aligned_cols=239 Identities=24% Similarity=0.378 Sum_probs=187.8
Q ss_pred ccCCCEEEEEEeecCC--cCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 5 IKTGEIVALKKIRMDN--EKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~--~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
..+++.||||+++... ........+.+|+++|+.+ +|+||+++++++.. .+.+||||||+.
T Consensus 25 ~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----------------~~~~~lv~e~~~ 88 (332)
T cd05614 25 HDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT----------------EAKLHLILDYVS 88 (332)
T ss_pred CCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec----------------CCEEEEEEeCCC
Confidence 4689999999997542 2223345677899999999 59999999999976 567899999998
Q ss_pred C-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 82 H-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 82 g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+ +|..++.+. ..+++.+++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+...........+
T Consensus 89 ~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~ 167 (332)
T cd05614 89 GGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC 167 (332)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCCcccccc
Confidence 6 666665443 46899999999999999999999999999999999999999999999999999765443333334467
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (472)
+|..|+|||++.+...++.++||||||||||+|++|+.||...........+.........
T Consensus 168 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~------------------- 228 (332)
T cd05614 168 GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDP------------------- 228 (332)
T ss_pred CCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCC-------------------
Confidence 8999999999987556788999999999999999999999754332211112111100000
Q ss_pred hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCCC
Q 012062 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 286 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----t~~elL~h~~f~~ 286 (472)
.+...++..+++||.+||..||++|+ +++++++|+||..
T Consensus 229 -------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 229 -------PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 01123677899999999999999999 8899999999954
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=341.36 Aligned_cols=237 Identities=26% Similarity=0.406 Sum_probs=193.4
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||+++.... .......+.+|+++++.++|+||+++++++.. .+.+||||||
T Consensus 13 ~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~----------------~~~~~lv~E~ 76 (325)
T cd05594 13 LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT----------------HDRLCFVMEY 76 (325)
T ss_pred EEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc----------------CCEEEEEEeC
Confidence 467889999999999986532 22234566789999999999999999999986 5689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~-~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
+.+ +|...+. ....+++.+++.|+.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++..... .....
T Consensus 77 ~~~~~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~ 154 (325)
T cd05594 77 ANGGELFFHLS-RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMK 154 (325)
T ss_pred CCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC-Ccccc
Confidence 996 4544443 33468999999999999999999997 79999999999999999999999999998754322 22233
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..++|..|+|||++.+ ..++.++||||||||||+|++|+.||...+....+..+......
T Consensus 155 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~------------------- 214 (325)
T cd05594 155 TFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR------------------- 214 (325)
T ss_pred cccCCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCC-------------------
Confidence 4568999999999976 56899999999999999999999999988876666655321110
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 286 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----t~~elL~h~~f~~ 286 (472)
+...++.++.+||++||..||++|+ ++.++++|+||..
T Consensus 215 -----------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 215 -----------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred -----------CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCC
Confidence 0123677899999999999999997 9999999999954
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=337.94 Aligned_cols=237 Identities=25% Similarity=0.429 Sum_probs=194.7
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
+|+++.+++.||||+++.+. ..+.....+.+|+.+++.+ +|+||+++++++.. .+.+|||||
T Consensus 13 ~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~----------------~~~~~iv~E 76 (320)
T cd05590 13 LARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT----------------PDRLFFVME 76 (320)
T ss_pred EEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc----------------CCEEEEEEc
Confidence 46788999999999998653 2223445667899999877 69999999999986 567999999
Q ss_pred cCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 79 YMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 79 y~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
|+.+ +|...+.+. ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 77 y~~~g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~~~ 154 (320)
T cd05590 77 FVNGGDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTS 154 (320)
T ss_pred CCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCccc
Confidence 9986 565555443 46999999999999999999999999999999999999999999999999998754322 22233
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+.......
T Consensus 155 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~------------------ 215 (320)
T cd05590 155 TFCGTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY------------------ 215 (320)
T ss_pred ccccCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC------------------
Confidence 4578999999999876 578999999999999999999999999998888777765321110
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCH------HHHhcCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA------KDALDSEYFWT 286 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~------~elL~h~~f~~ 286 (472)
...++.++++||++||+.||++|+++ ++++.|+||..
T Consensus 216 ------------~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 216 ------------PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred ------------CCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence 11356789999999999999999998 99999999953
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=330.57 Aligned_cols=241 Identities=24% Similarity=0.374 Sum_probs=192.8
Q ss_pred CceeccCCCEEEEEEeecCCcC-CCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||+++..... ......+.+|+.++++++|+||+++++++.. .+.+|+||||
T Consensus 18 ~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~----------------~~~~~lv~e~ 81 (285)
T cd05631 18 ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET----------------KDALCLVLTI 81 (285)
T ss_pred EEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc----------------CCeEEEEEEe
Confidence 3678889999999999765322 2233456789999999999999999999976 5579999999
Q ss_pred CCC-ChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 80 MDH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 80 ~~g-~l~~~~~~-~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
+.+ +|...+.. ....+++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++...... ....
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~ 159 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG--ETVR 159 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC--Ceec
Confidence 986 56555443 3346899999999999999999999999999999999999999999999999999765322 2223
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..++|..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+........
T Consensus 160 ~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----------------- 221 (285)
T cd05631 160 GRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ----------------- 221 (285)
T ss_pred CCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc-----------------
Confidence 4578999999999986 5789999999999999999999999988765443333332211110
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCC-----HHHHhcCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 286 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t-----~~elL~h~~f~~ 286 (472)
......++.++.+||++||+.||++|+| ++++++|+||..
T Consensus 222 ---------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 222 ---------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred ---------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 0112346788999999999999999997 899999999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=336.29 Aligned_cols=237 Identities=26% Similarity=0.422 Sum_probs=195.0
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
+|++..+++.||||+++.+.. .......+..|+++++.+ +|+||++++++|+. .+.+|||||
T Consensus 13 ~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~----------------~~~~~lv~E 76 (321)
T cd05591 13 LAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT----------------KDRLFFVME 76 (321)
T ss_pred EEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc----------------CCeEEEEEe
Confidence 467888999999999986532 233345667899999876 79999999999987 567999999
Q ss_pred cCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 79 YMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 79 y~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
|+.+ +|...+.+ ...+++..++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||++....... ....
T Consensus 77 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~ 154 (321)
T cd05591 77 YVNGGDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTT 154 (321)
T ss_pred CCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC-cccc
Confidence 9986 56555543 3468999999999999999999999999999999999999999999999999987543222 2233
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..++|..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+.......
T Consensus 155 ~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~------------------ 215 (321)
T cd05591 155 TFCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLY------------------ 215 (321)
T ss_pred ccccCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC------------------
Confidence 4578999999999876 578999999999999999999999999999888877775421110
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCC-------CHHHHhcCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-------SAKDALDSEYFWT 286 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-------t~~elL~h~~f~~ 286 (472)
...++.++.+||.+||..||++|+ ++.++++|+||..
T Consensus 216 ------------p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 216 ------------PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred ------------CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 012567899999999999999999 9999999999943
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=340.96 Aligned_cols=269 Identities=30% Similarity=0.516 Sum_probs=204.3
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||+++...........+.+|+.+++.++|+||+++++++...... .....+||||||++
T Consensus 36 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~----------~~~~~~~lv~e~~~ 105 (355)
T cd07874 36 AYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL----------EEFQDVYLVMELMD 105 (355)
T ss_pred EEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccc----------cccceeEEEhhhhc
Confidence 67788999999999986654444556778999999999999999999998753211 11346899999999
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccc
Q 012062 82 HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 161 (472)
Q Consensus 82 g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 161 (472)
+++...+.. .+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... ........+
T Consensus 106 ~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~ 180 (355)
T cd07874 106 ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVV 180 (355)
T ss_pred ccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC--ccccCCccc
Confidence 988776653 488999999999999999999999999999999999999999999999999976432 222334578
Q ss_pred cCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCC--------CCCcc
Q 012062 162 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS--------KMPAY 233 (472)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--------~~~~~ 233 (472)
|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+....+.... ..+.+
T Consensus 181 t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (355)
T cd07874 181 TRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKY 259 (355)
T ss_pred cCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCcc
Confidence 999999999976 568999999999999999999999999998888888777766554322221111 00000
Q ss_pred ccCCCchh----hhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 234 NHFKPSRT----MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 234 ~~~~~~~~----~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
........ ............+.++++||.+||..||++|||+.|+|+|+||..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~ 316 (355)
T cd07874 260 AGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV 316 (355)
T ss_pred ccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence 00000000 000001112234668899999999999999999999999999953
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=341.56 Aligned_cols=237 Identities=27% Similarity=0.407 Sum_probs=199.5
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
.|.|.+|++.||||+++.+.... ..+.+.+|+.+|..++++||.++|..+.. ...++|+||||
T Consensus 31 k~~d~~t~k~vAiKii~Le~~~d-eIediqqei~~Ls~~~~~~it~yygsyl~----------------g~~LwiiMey~ 93 (467)
T KOG0201|consen 31 KAIDNKTKKVVAIKIIDLEEAED-EIEDIQQEISVLSQCDSPNITEYYGSYLK----------------GTKLWIIMEYC 93 (467)
T ss_pred eeeeccccceEEEEEechhhcch-hhHHHHHHHHHHHhcCcchHHhhhhheee----------------cccHHHHHHHh
Confidence 37899999999999999886544 46678899999999999999999999876 56789999999
Q ss_pred CCC-hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 81 DHD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 81 ~g~-l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
.|+ +++++.. +..+++.++..++++++.||.|||..+.+|||||..||||..+|.|||+|||++.......... .++
T Consensus 94 ~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~tf 171 (467)
T KOG0201|consen 94 GGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-KTF 171 (467)
T ss_pred cCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcc-ccc
Confidence 974 5555544 4456899999999999999999999999999999999999999999999999998877655544 678
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
+||+.||||||+.+ ..|+.++||||||++++||++|.+||........+..|-+ ..+ |
T Consensus 172 vGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk---~~P----P-------------- 229 (467)
T KOG0201|consen 172 VGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK---SAP----P-------------- 229 (467)
T ss_pred cccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC---CCC----C--------------
Confidence 99999999999996 6899999999999999999999999988776333322211 000 0
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.+-..++..+++||..||.+||+.||||.+||+|.|++.
T Consensus 230 --------~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 230 --------RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred --------ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 011257888999999999999999999999999999965
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=341.76 Aligned_cols=241 Identities=23% Similarity=0.345 Sum_probs=192.4
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.+++.||||+++.... .......+.+|+.++++++|+||+++++.+.+ ...+||||||
T Consensus 19 ~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~----------------~~~~~lv~E~ 82 (363)
T cd05628 19 LVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD----------------KLNLYLIMEF 82 (363)
T ss_pred EEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec----------------CCeEEEEEcC
Confidence 477889999999999976432 22334567789999999999999999999987 5679999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC-----
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN----- 153 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~----- 153 (472)
|.+ +|.+++.+. ..+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+.....
T Consensus 83 ~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~ 161 (363)
T cd05628 83 LPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYR 161 (363)
T ss_pred CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccccc
Confidence 986 666666543 4699999999999999999999999999999999999999999999999999875432110
Q ss_pred -----------------------------CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCC
Q 012062 154 -----------------------------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN 204 (472)
Q Consensus 154 -----------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~ 204 (472)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~Pf~~~~ 240 (363)
T cd05628 162 NLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (363)
T ss_pred cccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCCCCCCC
Confidence 01123578999999999986 578999999999999999999999999988
Q ss_pred hHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCC---CCCCHHHHhcC
Q 012062 205 EAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPS---QRISAKDALDS 281 (472)
Q Consensus 205 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~---~R~t~~elL~h 281 (472)
..+.+.++........ ++. ...+++++++||.+||. ++. .|++++||++|
T Consensus 241 ~~~~~~~i~~~~~~~~---------~p~-----------------~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 241 PQETYKKVMNWKETLI---------FPP-----------------EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN 293 (363)
T ss_pred HHHHHHHHHcCcCccc---------CCC-----------------cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence 8887777754211110 000 01257789999999875 444 45899999999
Q ss_pred CCCCC
Q 012062 282 EYFWT 286 (472)
Q Consensus 282 ~~f~~ 286 (472)
+||..
T Consensus 294 p~f~~ 298 (363)
T cd05628 294 PFFEG 298 (363)
T ss_pred CCCCC
Confidence 99954
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=342.16 Aligned_cols=241 Identities=27% Similarity=0.428 Sum_probs=194.4
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||+++.... .......+.+|+.+|+.++|+||++++++|.+ ...+||||||
T Consensus 19 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~----------------~~~~~lv~E~ 82 (364)
T cd05599 19 LVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD----------------ENYLYLIMEY 82 (364)
T ss_pred EEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc----------------CCeEEEEECC
Confidence 478889999999999986432 22344567789999999999999999999987 5689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC----
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN---- 154 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~---- 154 (472)
|.+ +|.+++.+. ..+++..++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+......
T Consensus 83 ~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 161 (364)
T cd05599 83 LPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYR 161 (364)
T ss_pred CCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccccc
Confidence 986 566665543 46999999999999999999999999999999999999999999999999998754321100
Q ss_pred ---------------------------------ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCC
Q 012062 155 ---------------------------------TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILP 201 (472)
Q Consensus 155 ---------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~ 201 (472)
.....+||+.|+|||++.. ..++.++||||||||+|+|++|..||.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G~~Pf~ 240 (364)
T cd05599 162 ILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVGYPPFC 240 (364)
T ss_pred cccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcCCCCCC
Confidence 1112468999999999876 578999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCC---HHHH
Q 012062 202 GKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS---AKDA 278 (472)
Q Consensus 202 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t---~~el 278 (472)
..+..+.+..+.+..... ..+. ...+++++++||++||. ||.+|++ +.|+
T Consensus 241 ~~~~~~~~~~i~~~~~~~---------~~~~-----------------~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~l 293 (364)
T cd05599 241 SDNPQETYRKIINWKETL---------QFPD-----------------EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEI 293 (364)
T ss_pred CCCHHHHHHHHHcCCCcc---------CCCC-----------------CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHH
Confidence 988877776665321110 0000 01357789999999997 9999998 9999
Q ss_pred hcCCCCCC
Q 012062 279 LDSEYFWT 286 (472)
Q Consensus 279 L~h~~f~~ 286 (472)
|+|+||..
T Consensus 294 l~h~~~~~ 301 (364)
T cd05599 294 KSHPFFKG 301 (364)
T ss_pred hcCCCcCC
Confidence 99999954
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=343.17 Aligned_cols=242 Identities=29% Similarity=0.428 Sum_probs=191.7
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.+++.||||+++... ........+.+|+++|++++|+||+++++++.+ .+.+||||||
T Consensus 19 ~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~----------------~~~~~lv~E~ 82 (381)
T cd05626 19 LACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD----------------KDNLYFVMDY 82 (381)
T ss_pred EEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec----------------CCEEEEEEec
Confidence 47889999999999998653 223345567889999999999999999999986 5689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC-----
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN----- 153 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~----- 153 (472)
|.+ +|.+++.+. ..+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+.....
T Consensus 83 ~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 83 IPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 986 666666543 4689999999999999999999999999999999999999999999999999764321100
Q ss_pred -----------------------------------------CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHH
Q 012062 154 -----------------------------------------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 192 (472)
Q Consensus 154 -----------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~e 192 (472)
......+||+.|+|||++.+ ..++.++||||||||+|+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG~il~e 240 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGVILFE 240 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehhhHHHH
Confidence 00123478999999999976 568999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhcc--CCC
Q 012062 193 LLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLML--DPS 270 (472)
Q Consensus 193 ll~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~--dP~ 270 (472)
|++|+.||...+..+...++....... ..+. ...++.++++||.+||.. ++.
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~---------~~~~-----------------~~~~s~~~~dli~~ll~~~~~~~ 294 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVINWENTL---------HIPP-----------------QVKLSPEAVDLITKLCCSAEERL 294 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHHcccccc---------CCCC-----------------CCCCCHHHHHHHHHHccCccccc
Confidence 999999999888766666554321110 0000 013678899999996654 555
Q ss_pred CCCCHHHHhcCCCCCC
Q 012062 271 QRISAKDALDSEYFWT 286 (472)
Q Consensus 271 ~R~t~~elL~h~~f~~ 286 (472)
.|+|+.|+++|+||..
T Consensus 295 ~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 295 GRNGADDIKAHPFFSE 310 (381)
T ss_pred CCCCHHHHhcCcccCC
Confidence 5999999999999954
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=334.00 Aligned_cols=237 Identities=26% Similarity=0.434 Sum_probs=191.4
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
+|++..+++.||||+++.... .+........|..++..+ +|+||+++++++.. .+.+|||||
T Consensus 13 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~----------------~~~~~lv~e 76 (316)
T cd05592 13 LAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT----------------KEHLFFVME 76 (316)
T ss_pred EEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc----------------CCEEEEEEc
Confidence 467888999999999986532 222344556777777654 89999999999976 568999999
Q ss_pred cCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 79 YMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 79 y~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
|+.+ +|..++.. ...+++.+++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++...... ....
T Consensus 77 ~~~gg~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~ 154 (316)
T cd05592 77 YLNGGDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAS 154 (316)
T ss_pred CCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccc
Confidence 9986 55555544 3469999999999999999999999999999999999999999999999999997643222 2333
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..++|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.......
T Consensus 155 ~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~------------------ 215 (316)
T cd05592 155 TFCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHF------------------ 215 (316)
T ss_pred cccCCccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC------------------
Confidence 4578999999999986 568999999999999999999999999988877776664321110
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCH-HHHhcCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA-KDALDSEYFWT 286 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~-~elL~h~~f~~ 286 (472)
...++.++.+||.+||..||++|+++ .++++|+||..
T Consensus 216 ------------~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 216 ------------PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRG 253 (316)
T ss_pred ------------CCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCC
Confidence 11356789999999999999999986 58889999953
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=339.37 Aligned_cols=243 Identities=26% Similarity=0.372 Sum_probs=198.8
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||+++.... .......+.+|+.+++.++|+||+++++++.+ .+.+||||||
T Consensus 19 ~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~----------------~~~~~lv~e~ 82 (330)
T cd05601 19 VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD----------------KDNLYLVMEY 82 (330)
T ss_pred EEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec----------------CCeEEEEECC
Confidence 367889999999999986532 22344567789999999999999999999976 5679999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
+++ +|.+++.+....+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++..+..........
T Consensus 83 ~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 162 (330)
T cd05601 83 QPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKL 162 (330)
T ss_pred CCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceeeec
Confidence 975 7777776655679999999999999999999999999999999999999999999999999998765433333334
Q ss_pred ccccCCCCChhhhcC-----CCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 012062 159 RVITLWYRPPELLLG-----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 233 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~-----~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (472)
.++|..|+|||++.. ...++.++||||||||+|+|++|+.||...+....+.++........ .+.
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~---------~~~- 232 (330)
T cd05601 163 PVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLK---------FPE- 232 (330)
T ss_pred ccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccC---------CCC-
Confidence 568999999999863 24578899999999999999999999998888777777654311100 000
Q ss_pred ccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 234 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
...++.++++||++||. ||++|+|+.+++.|+||..
T Consensus 233 ----------------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 233 ----------------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred ----------------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 01367789999999998 9999999999999999954
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=338.63 Aligned_cols=233 Identities=25% Similarity=0.339 Sum_probs=192.1
Q ss_pred ceeccCC-CEEEEEEeecCC-cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 2 AREIKTG-EIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 2 a~~~~tg-~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
|++..++ ..||||++.... ........+.+|+.+++.++||||+++++++.. .+.+||||||
T Consensus 49 a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~----------------~~~~~lv~Ey 112 (340)
T PTZ00426 49 ATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD----------------ESYLYLVLEF 112 (340)
T ss_pred EEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe----------------CCEEEEEEeC
Confidence 4444444 689999997543 222345567889999999999999999999987 5689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
+.+ +|..++.+. ..+++..+..++.||+.||+|||+++|+||||||+||||+.++++||+|||+++..... ...
T Consensus 113 ~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~----~~~ 187 (340)
T PTZ00426 113 VIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYT 187 (340)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC----cce
Confidence 985 666666543 46899999999999999999999999999999999999999999999999999765321 234
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
.++|+.|+|||++.+ ..++.++||||||||+|+|++|..||.+.+.......+.......
T Consensus 188 ~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~------------------- 247 (340)
T PTZ00426 188 LCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYF------------------- 247 (340)
T ss_pred ecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC-------------------
Confidence 578999999999976 567899999999999999999999999988877777665322110
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 286 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----t~~elL~h~~f~~ 286 (472)
...++..+++||++||+.||++|+ |++|+++|+||..
T Consensus 248 -----------p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 248 -----------PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred -----------CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 123567899999999999999996 8999999999954
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=343.97 Aligned_cols=241 Identities=27% Similarity=0.403 Sum_probs=191.9
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.+++.||||++.... ........+.+|++++++++|+|||+++++|.+ ...+||||||
T Consensus 19 ~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~----------------~~~~~lv~E~ 82 (377)
T cd05629 19 LVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD----------------AQYLYLIMEF 82 (377)
T ss_pred EEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc----------------CCeeEEEEeC
Confidence 46788999999999997543 223344567789999999999999999999986 5679999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC----
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN---- 154 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~---- 154 (472)
+.+ +|..++.. ...+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+......
T Consensus 83 ~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 161 (377)
T cd05629 83 LPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQ 161 (377)
T ss_pred CCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccccc
Confidence 985 66666654 346899999999999999999999999999999999999999999999999998643211000
Q ss_pred ------------------------------------------ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHH
Q 012062 155 ------------------------------------------TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 192 (472)
Q Consensus 155 ------------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~e 192 (472)
.....+||+.|+|||++.+ ..++.++||||||||||+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~e 240 (377)
T cd05629 162 KLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGAIMFE 240 (377)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecchhhhh
Confidence 0012468999999999976 568999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCC
Q 012062 193 LLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR 272 (472)
Q Consensus 193 ll~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 272 (472)
|++|..||...+..+.+..+....... .++. ...++.++++||.+||. +|.+|
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~---------~~p~-----------------~~~~s~~~~dli~~lL~-~~~~r 293 (377)
T cd05629 241 CLIGWPPFCSENSHETYRKIINWRETL---------YFPD-----------------DIHLSVEAEDLIRRLIT-NAENR 293 (377)
T ss_pred hhcCCCCCCCCCHHHHHHHHHccCCcc---------CCCC-----------------CCCCCHHHHHHHHHHhc-CHhhc
Confidence 999999999988877777665321110 0010 01356789999999998 77765
Q ss_pred ---CCHHHHhcCCCCCC
Q 012062 273 ---ISAKDALDSEYFWT 286 (472)
Q Consensus 273 ---~t~~elL~h~~f~~ 286 (472)
+|+.|++.|+||..
T Consensus 294 ~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 294 LGRGGAHEIKSHPFFRG 310 (377)
T ss_pred CCCCCHHHHhcCCCcCC
Confidence 59999999999953
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=340.60 Aligned_cols=243 Identities=26% Similarity=0.353 Sum_probs=196.8
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.+++.||||+++.... .......+.+|+.+++.++|+||+++++++.. .+.+||||||
T Consensus 61 ~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~----------------~~~~~lv~Ey 124 (370)
T cd05596 61 LVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD----------------DKYLYMVMEY 124 (370)
T ss_pred EEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec----------------CCEEEEEEcC
Confidence 468889999999999975422 22233456789999999999999999999986 5689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
+.+ +|..++.. ..+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||++.............
T Consensus 125 ~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~ 202 (370)
T cd05596 125 MPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT 202 (370)
T ss_pred CCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCCC
Confidence 985 66666543 258899999999999999999999999999999999999999999999999998765333223344
Q ss_pred ccccCCCCChhhhcCC---CCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcccc
Q 012062 159 RVITLWYRPPELLLGA---TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~---~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (472)
.++|+.|+|||++... ..++.++|||||||+||+|++|+.||.+.+....+.++........ ++.
T Consensus 203 ~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~---~~~--------- 270 (370)
T cd05596 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLT---FPD--------- 270 (370)
T ss_pred CCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCC---CCC---------
Confidence 6789999999998653 2478899999999999999999999999888777777754221110 110
Q ss_pred CCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCC--CCCHHHHhcCCCCCCC
Q 012062 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ--RISAKDALDSEYFWTD 287 (472)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~--R~t~~elL~h~~f~~~ 287 (472)
...++.++++||++||..+|++ |+|++|+++|+||+..
T Consensus 271 --------------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 271 --------------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred --------------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 0136778999999999999988 9999999999999653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=325.22 Aligned_cols=265 Identities=47% Similarity=0.903 Sum_probs=217.4
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+++..... .....+.+|+.++++++|+||+++++++.. .+.+||||||+
T Consensus 18 ~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~ 80 (284)
T cd07836 18 KGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHT----------------ENKLMLVFEYM 80 (284)
T ss_pred EEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEee----------------CCcEEEEEecC
Confidence 3678889999999999866432 234567789999999999999999999987 55789999999
Q ss_pred CCChhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 81 DHDLTGLADRPG--LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 81 ~g~l~~~~~~~~--~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
.++|.+++.... ..+++..+..++.||+.||+|||+++|+|+||||+||++++++.+||+|||++..+..... ....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~ 159 (284)
T cd07836 81 DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-TFSN 159 (284)
T ss_pred CccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-cccc
Confidence 998888765433 4589999999999999999999999999999999999999999999999999876543221 2233
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
..++..|++||++.+...++.++|||||||++|+|++|+.||.+.+..+.+.++++....+....|......+.+....+
T Consensus 160 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07836 160 EVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFP 239 (284)
T ss_pred ccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccccc
Confidence 45688999999987655678899999999999999999999999999999999998888887777776665444332222
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
.. .......+...++..++++|.+||+.||.+|+|+.|+++|+||
T Consensus 240 ~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 240 RY-PPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred CC-ChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 11 1223344555678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=343.69 Aligned_cols=241 Identities=29% Similarity=0.458 Sum_probs=193.3
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.+++.||||+++.... .......+.+|++++++++|+|||++++.|.. .+.+||||||
T Consensus 19 ~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~----------------~~~~~lv~E~ 82 (382)
T cd05625 19 LARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD----------------KDNLYFVMDY 82 (382)
T ss_pred EEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe----------------CCEEEEEEeC
Confidence 478899999999999975432 22334567889999999999999999999986 5689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC-----
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN----- 153 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~----- 153 (472)
|.+ +|.+++.+. ..+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++..+.....
T Consensus 83 ~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~ 161 (382)
T cd05625 83 IPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (382)
T ss_pred CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence 985 676666554 4689999999999999999999999999999999999999999999999999754321000
Q ss_pred -----------------------------------------CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHH
Q 012062 154 -----------------------------------------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 192 (472)
Q Consensus 154 -----------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~e 192 (472)
......+||+.|+|||++.+ ..++.++||||||||||+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvil~e 240 (382)
T cd05625 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYE 240 (382)
T ss_pred cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEechHHHHH
Confidence 00123468999999999986 578999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCC
Q 012062 193 LLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR 272 (472)
Q Consensus 193 ll~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 272 (472)
|++|+.||...+..+...++........ .+. ...+++++++||.+|+ .||++|
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~---------~p~-----------------~~~~s~~~~~li~~l~-~~p~~R 293 (382)
T cd05625 241 MLVGQPPFLAQTPLETQMKVINWQTSLH---------IPP-----------------QAKLSPEASDLIIKLC-RGPEDR 293 (382)
T ss_pred HHhCCCCCCCCCHHHHHHHHHccCCCcC---------CCC-----------------cccCCHHHHHHHHHHc-cCHhHc
Confidence 9999999999888777666653211111 000 1236778999999987 599999
Q ss_pred CC---HHHHhcCCCCCC
Q 012062 273 IS---AKDALDSEYFWT 286 (472)
Q Consensus 273 ~t---~~elL~h~~f~~ 286 (472)
++ +.|+++|+||..
T Consensus 294 ~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 294 LGKNGADEIKAHPFFKT 310 (382)
T ss_pred CCCCCHHHHhcCCCcCC
Confidence 97 999999999954
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=333.54 Aligned_cols=237 Identities=25% Similarity=0.422 Sum_probs=191.6
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
+|+++.+++.||||+++.... .+........|+.+++.+ +|+||+++++++.. ++++|||||
T Consensus 13 ~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~----------------~~~~~lv~E 76 (316)
T cd05620 13 LAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT----------------KEHLFFVME 76 (316)
T ss_pred EEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe----------------CCEEEEEEC
Confidence 477889999999999986532 122344567788888765 89999999999986 668999999
Q ss_pred cCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 79 YMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 79 y~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
|+.+ +|..++.. ...+++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 77 ~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~ 154 (316)
T cd05620 77 FLNGGDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRAS 154 (316)
T ss_pred CCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCcee
Confidence 9986 56555544 346899999999999999999999999999999999999999999999999998643211 22234
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..++|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 155 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~------------------- 214 (316)
T cd05620 155 TFCGTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPH------------------- 214 (316)
T ss_pred ccCCCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-------------------
Confidence 4578999999999986 57899999999999999999999999988877666655322100
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCH-HHHhcCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA-KDALDSEYFWT 286 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~-~elL~h~~f~~ 286 (472)
....++.++++||++||..||++|+++ +++++|+||..
T Consensus 215 -----------~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~ 253 (316)
T cd05620 215 -----------YPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKT 253 (316)
T ss_pred -----------CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCC
Confidence 011256789999999999999999998 58889999954
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=322.30 Aligned_cols=266 Identities=35% Similarity=0.639 Sum_probs=205.1
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||++............+.+|++++++++|+||+++++++.. ...+||||||++
T Consensus 20 ~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----------------~~~~~~v~e~~~ 83 (286)
T cd07847 20 CRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR----------------KRKLHLVFEYCD 83 (286)
T ss_pred EEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee----------------CCEEEEEEeccC
Confidence 6778899999999997654444445567899999999999999999999986 557899999999
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccc
Q 012062 82 HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 161 (472)
Q Consensus 82 g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 161 (472)
++++..+......+++.+++.++.||+.+|+|||+++|+|+||||+||+++.++.+||+|||++........ ......+
T Consensus 84 ~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~ 162 (286)
T cd07847 84 HTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DYTDYVA 162 (286)
T ss_pred ccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-cccCccc
Confidence 887776665555799999999999999999999999999999999999999999999999999977643221 2223456
Q ss_pred cCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccC-CCch
Q 012062 162 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF-KPSR 240 (472)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 240 (472)
+..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....................+... .+..
T Consensus 163 ~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (286)
T cd07847 163 TRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEP 242 (286)
T ss_pred ccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCc
Confidence 889999999877566889999999999999999999999988887777666554333211100000000000000 0001
Q ss_pred hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
.........+..++..+.+||.+||..||++|||+.|++.|+||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 243 ETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 11122334456678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=343.65 Aligned_cols=241 Identities=29% Similarity=0.456 Sum_probs=192.6
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.+++.||||+++.... .......+.+|+.+|++++|+||++++++|.. ++.+||||||
T Consensus 19 ~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~----------------~~~~~lv~E~ 82 (376)
T cd05598 19 LVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD----------------KDNLYFVMDY 82 (376)
T ss_pred EEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc----------------CCEEEEEEeC
Confidence 478899999999999975422 22234567789999999999999999999986 6689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC-----
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN----- 153 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~----- 153 (472)
|.+ +|.+++.+. ..+++..++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+|..+.....
T Consensus 83 ~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~ 161 (376)
T cd05598 83 IPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (376)
T ss_pred CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccc
Confidence 985 666666553 4689999999999999999999999999999999999999999999999999854321000
Q ss_pred -------------------------------------CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhC
Q 012062 154 -------------------------------------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNG 196 (472)
Q Consensus 154 -------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G 196 (472)
......+||+.|+|||++.+ ..++.++||||||||||+|++|
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyell~G 240 (376)
T cd05598 162 KGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEMLVG 240 (376)
T ss_pred cccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccceeeehhhC
Confidence 01123478999999999976 5689999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCC---
Q 012062 197 KPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI--- 273 (472)
Q Consensus 197 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~--- 273 (472)
+.||.+.+..+....+........ .+. ...++.++.+||.+|+ .||.+|+
T Consensus 241 ~~Pf~~~~~~~~~~~i~~~~~~~~---------~~~-----------------~~~~s~~~~~li~~l~-~~p~~R~~~~ 293 (376)
T cd05598 241 QPPFLADTPAETQLKVINWETTLH---------IPS-----------------QAKLSREASDLILRLC-CGAEDRLGKN 293 (376)
T ss_pred CCCCCCCCHHHHHHHHhccCcccc---------CCC-----------------CCCCCHHHHHHHHHHh-cCHhhcCCCC
Confidence 999999887776665543211100 000 1136778999999976 5999999
Q ss_pred CHHHHhcCCCCCC
Q 012062 274 SAKDALDSEYFWT 286 (472)
Q Consensus 274 t~~elL~h~~f~~ 286 (472)
|+.|+++|+||..
T Consensus 294 t~~ell~h~~~~~ 306 (376)
T cd05598 294 GADEIKAHPFFKG 306 (376)
T ss_pred CHHHHhCCCCcCC
Confidence 9999999999954
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=324.78 Aligned_cols=265 Identities=45% Similarity=0.759 Sum_probs=207.4
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||+++.... ......+.+|+.+++.++|+||+++++++.. .+..|+||||+.
T Consensus 24 ~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----------------~~~~~lv~e~~~ 86 (291)
T cd07870 24 GISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHT----------------KETLTFVFEYMH 86 (291)
T ss_pred EEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEec----------------CCeEEEEEeccc
Confidence 56778899999999976533 2234466789999999999999999999976 557899999999
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccc
Q 012062 82 HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 161 (472)
Q Consensus 82 g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 161 (472)
++++..+......+.+.+++.++.||+.||.|||+++|+|+||||+|||++.++++||+|||+++...... .......+
T Consensus 87 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~ 165 (291)
T cd07870 87 TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-QTYSSEVV 165 (291)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC-CCCCCccc
Confidence 88888776655568888999999999999999999999999999999999999999999999987543222 12233456
Q ss_pred cCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 012062 162 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE-AEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240 (472)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (472)
+..|+|||++.+...++.++|||||||++|+|++|..||...+. .+.+..+....+.+....|.....++.+.......
T Consensus 166 ~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (291)
T cd07870 166 TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLP 245 (291)
T ss_pred cccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccc
Confidence 89999999987655678899999999999999999999986553 45666676767766666666555544432222111
Q ss_pred hhhhhHHHHhhh--ccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 241 TMKRRVREVFRH--FDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 241 ~~~~~~~~~~~~--~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
.........+.. .+..+.+||.+||..||++|+|+.|+|.|+||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 246 CKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 111222233322 25688999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=332.37 Aligned_cols=232 Identities=28% Similarity=0.400 Sum_probs=191.8
Q ss_pred ccCCCE-EEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-
Q 012062 5 IKTGEI-VALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH- 82 (472)
Q Consensus 5 ~~tg~~-vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g- 82 (472)
.-.|+. ||||++............+.+|+.+|++|+|||||+|++++..+ ...++|||||+.+
T Consensus 61 ~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~---------------~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 61 KWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP---------------PGSLCIVTEYMPGG 125 (362)
T ss_pred EeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC---------------CCceEEEEEeCCCC
Confidence 345667 99999987654443467899999999999999999999999873 1268999999995
Q ss_pred ChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCCCcEEEcCCC-CeEEeeccceeeeccCCCCccccc
Q 012062 83 DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQ-VLHRDIKGSNLLIDNEG-NLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 83 ~l~~~~~~-~~~~l~~~~i~~i~~Qll~aL~~LH~~g-iiHrDLKp~NILl~~~~-~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
+|..++.+ ....++...+..|+.||+.||.|||+++ |||||||++||||+.+. ++||+|||+++...... ...+..
T Consensus 126 sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~~~~~ 204 (362)
T KOG0192|consen 126 SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TSMTSV 204 (362)
T ss_pred cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-ccccCC
Confidence 66666655 3667999999999999999999999999 99999999999999997 99999999998765332 344446
Q ss_pred cccCCCCChhhhcC-CCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 160 VITLWYRPPELLLG-ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 160 ~gt~~y~aPE~l~~-~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
.||..|||||++.+ ...|+.++||||+|+|||||+||+.||.+.........+......+..
T Consensus 205 ~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~----------------- 267 (362)
T KOG0192|consen 205 AGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPI----------------- 267 (362)
T ss_pred CCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC-----------------
Confidence 78999999999985 267999999999999999999999999999986666666543222211
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...++..+.+||.+|+..||++||+..+++.
T Consensus 268 -----------p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 268 -----------PKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred -----------CccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 1125678999999999999999999999874
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=330.83 Aligned_cols=276 Identities=45% Similarity=0.858 Sum_probs=224.2
Q ss_pred CceeccCCCEEEEEEeecCCcCCC------------chhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEG------------FPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 68 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~------------~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 68 (472)
+|++..+++.||||+++....... ....+.+|+++++.++|+||+++++++..
T Consensus 27 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--------------- 91 (335)
T PTZ00024 27 KAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE--------------- 91 (335)
T ss_pred EEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec---------------
Confidence 367788999999999976532210 12246789999999999999999999976
Q ss_pred cCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeee
Q 012062 69 YRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 148 (472)
Q Consensus 69 ~~~~~~iVmEy~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 148 (472)
.+.+|+||||+.++|.+.+... ..+++..+..++.||+.||+|||+++|+|+||||+||+++.++.+||+|||++..+
T Consensus 92 -~~~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~ 169 (335)
T PTZ00024 92 -GDFINLVMDIMASDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRY 169 (335)
T ss_pred -CCcEEEEEeccccCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceeec
Confidence 5578999999999888877543 46899999999999999999999999999999999999999999999999999765
Q ss_pred ccCC-------------CCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 012062 149 SYDH-------------NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 215 (472)
Q Consensus 149 ~~~~-------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~ 215 (472)
.... ........++..|+|||++.+...++.++|||||||++|+|++|..||.+.++.+.+..+++.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~ 249 (335)
T PTZ00024 170 GYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFEL 249 (335)
T ss_pred ccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 4111 112223355888999999877556789999999999999999999999999999999999998
Q ss_pred cCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCCCCCCCCCC
Q 012062 216 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKS 295 (472)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~~~~~~~~~ 295 (472)
...+....|+....++.+..+... ...........++.++.+||.+||..||++|+|++|+|.|+||+....+.+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~~~~~~ 327 (335)
T PTZ00024 250 LGTPNEDNWPQAKKLPLYTEFTPR--KPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLPCDPSQ 327 (335)
T ss_pred hCCCchhhCcchhhcccccccCcC--CcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCCCCccc
Confidence 888888777766655544333222 123344455667889999999999999999999999999999988777655443
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=325.81 Aligned_cols=267 Identities=49% Similarity=0.881 Sum_probs=217.6
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||+++.....+.....+.+|++++++++|+||+++++++.. ...+|+||||++
T Consensus 21 ~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~ 84 (294)
T PLN00009 21 ARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS----------------EKRLYLVFEYLD 84 (294)
T ss_pred EEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec----------------CCeEEEEEeccc
Confidence 5677899999999997665444445677899999999999999999999986 557999999999
Q ss_pred CChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC-CCCeEEeeccceeeeccCCCCccccc
Q 012062 82 HDLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN-EGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 82 g~l~~~~~~~-~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~-~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
+++...+... ...+++..++.++.||+.||+|||+++|+|+||||+||+++. ++.+||+|||++...... .......
T Consensus 85 ~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~-~~~~~~~ 163 (294)
T PLN00009 85 LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-VRTFTHE 163 (294)
T ss_pred ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC-ccccccC
Confidence 8887776543 334688899999999999999999999999999999999985 456999999999755432 2222334
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
.++..|+|||++.+...++.++|||||||++|+|++|+.||...+..+.+.+++...+.+....|.....++.+....+.
T Consensus 164 ~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (294)
T PLN00009 164 VVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPK 243 (294)
T ss_pred ceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhccc
Confidence 56889999999876556788999999999999999999999999999999999998888888888877666655322211
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
............++.++++||.+||..||++||++.++|+|+||..
T Consensus 244 -~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~ 289 (294)
T PLN00009 244 -WPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289 (294)
T ss_pred -CCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence 0112233344567889999999999999999999999999999943
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=333.62 Aligned_cols=233 Identities=26% Similarity=0.435 Sum_probs=190.7
Q ss_pred ccCCCEEEEEEeecCCc--CCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC
Q 012062 5 IKTGEIVALKKIRMDNE--KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH 82 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g 82 (472)
..+++.||||+++.... .......+.+|+.+|+.++|+||++++++|.. ++.+||||||+.+
T Consensus 21 ~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~----------------~~~~~lv~e~~~~ 84 (323)
T cd05584 21 ADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT----------------GGKLYLILEYLSG 84 (323)
T ss_pred CCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec----------------CCeEEEEEeCCCC
Confidence 46889999999986422 12233456789999999999999999999986 5679999999996
Q ss_pred -ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccc
Q 012062 83 -DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 161 (472)
Q Consensus 83 -~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 161 (472)
+|...+.+ ...+.+..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++...... ......++
T Consensus 85 ~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~g 162 (323)
T cd05584 85 GELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVTHTFCG 162 (323)
T ss_pred chHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-CcccccCC
Confidence 55555544 3468899999999999999999999999999999999999999999999999987543222 22233568
Q ss_pred cCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchh
Q 012062 162 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241 (472)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (472)
|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+....+..+......
T Consensus 163 t~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~----------------------- 218 (323)
T cd05584 163 TIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLN----------------------- 218 (323)
T ss_pred CccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-----------------------
Confidence 999999999876 56789999999999999999999999998887776666432111
Q ss_pred hhhhHHHHhhhccHHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCCC
Q 012062 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 286 (472)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----t~~elL~h~~f~~ 286 (472)
+...++.++.+||++||..||++|+ +++++++|+||..
T Consensus 219 -------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 219 -------LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred -------CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCC
Confidence 0123567899999999999999999 8999999999954
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=339.83 Aligned_cols=241 Identities=31% Similarity=0.465 Sum_probs=197.9
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||+++.... .......+.+|+++++.++|+||+++++++.+ .+.+||||||
T Consensus 19 ~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----------------~~~~~lv~e~ 82 (350)
T cd05573 19 LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD----------------EEHLYLVMEY 82 (350)
T ss_pred EEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec----------------CCeEEEEEcC
Confidence 478888999999999986532 22345567889999999999999999999876 5689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCC------
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH------ 152 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~------ 152 (472)
+.+ +|.+++.+. ..+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 83 ~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 161 (350)
T cd05573 83 MPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYL 161 (350)
T ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccc
Confidence 985 677666554 569999999999999999999999999999999999999999999999999997654332
Q ss_pred ----------------------CCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHH
Q 012062 153 ----------------------NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLS 210 (472)
Q Consensus 153 ----------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~ 210 (472)
.......++|+.|+|||++.+ ..++.++||||||||||+|++|+.||...+..+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 240 (350)
T cd05573 162 NDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN 240 (350)
T ss_pred cccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHH
Confidence 112334568999999999987 578999999999999999999999999988777777
Q ss_pred HHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCC-HHHHhcCCCCCC
Q 012062 211 KIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-AKDALDSEYFWT 286 (472)
Q Consensus 211 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t-~~elL~h~~f~~ 286 (472)
++....... ..+. ...++.++++||.+||. ||.+|++ ++|+|+|+||..
T Consensus 241 ~i~~~~~~~---------~~p~-----------------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 241 KIINWKESL---------RFPP-----------------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred HHhccCCcc---------cCCC-----------------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 665421111 0110 01257789999999997 9999999 999999999954
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=325.04 Aligned_cols=242 Identities=23% Similarity=0.336 Sum_probs=190.4
Q ss_pred CceeccCCCEEEEEEeecCCcC-CCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||++...... ......+..|++++++++|+||+++++++.. +..+||||||
T Consensus 11 ~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~----------------~~~~~lv~e~ 74 (280)
T cd05608 11 ACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT----------------KTDLCLVMTI 74 (280)
T ss_pred EEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC----------------CCeEEEEEeC
Confidence 3678889999999999765322 2223456789999999999999999999876 5678999999
Q ss_pred CCC-Chhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCc
Q 012062 80 MDH-DLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT 155 (472)
Q Consensus 80 ~~g-~l~~~~~---~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 155 (472)
+.+ +|...+. .....+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++..+..... .
T Consensus 75 ~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~ 153 (280)
T cd05608 75 MNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-K 153 (280)
T ss_pred CCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-c
Confidence 986 5554442 2344689999999999999999999999999999999999999999999999999976543222 2
Q ss_pred cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcccc
Q 012062 156 LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (472)
.....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.........
T Consensus 154 ~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------- 218 (280)
T cd05608 154 TKGYAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSV-------------- 218 (280)
T ss_pred ccccCCCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCC--------------
Confidence 233567999999999986 57889999999999999999999999876543222222211110000
Q ss_pred CCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCCC
Q 012062 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 286 (472)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----t~~elL~h~~f~~ 286 (472)
.+...++..+.+||.+||+.||++|+ |++++++|+||..
T Consensus 219 ------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 219 ------------TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred ------------CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence 01124677899999999999999999 8899999999953
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=332.27 Aligned_cols=236 Identities=28% Similarity=0.436 Sum_probs=191.1
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHH---HhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEE
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKIL---KKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMV 76 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il---~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iV 76 (472)
+|++..+++.||||+++... ........+.+|++++ +.++|+||+++++++.. .+.+|||
T Consensus 17 ~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~----------------~~~~~lv 80 (324)
T cd05589 17 LAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT----------------EDHVCFV 80 (324)
T ss_pred EEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc----------------CCEEEEE
Confidence 36788899999999998653 2222345566776665 46679999999999986 5689999
Q ss_pred EecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCc
Q 012062 77 FEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT 155 (472)
Q Consensus 77 mEy~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 155 (472)
|||+.+ +|...+.. ..+++.+++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++..... ...
T Consensus 81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~ 157 (324)
T cd05589 81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-GDR 157 (324)
T ss_pred EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC-CCc
Confidence 999996 55444433 36899999999999999999999999999999999999999999999999998653322 222
Q ss_pred cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcccc
Q 012062 156 LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (472)
....++|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.......
T Consensus 158 ~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~---------------- 220 (324)
T cd05589 158 TSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRY---------------- 220 (324)
T ss_pred ccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC----------------
Confidence 334578999999999876 568899999999999999999999999988887777665421110
Q ss_pred CCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCCC
Q 012062 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 286 (472)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----t~~elL~h~~f~~ 286 (472)
...++..+.+||++||..||++|+ ++.++++|+||..
T Consensus 221 --------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 221 --------------PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred --------------CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 123577899999999999999999 7999999999954
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=336.46 Aligned_cols=238 Identities=28% Similarity=0.390 Sum_probs=184.3
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||++..... ......+.+|+++|+.++|+||+++++++.. .+.+|+||||+
T Consensus 92 ~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~~ 154 (353)
T PLN00034 92 KVIHRPTGRLYALKVIYGNHE-DTVRRQICREIEILRDVNHPNVVKCHDMFDH----------------NGEIQVLLEFM 154 (353)
T ss_pred EEEECCCCCEEEEEEEecCCc-HHHHHHHHHHHHHHHhCCCCCcceeeeEecc----------------CCeEEEEEecC
Confidence 367888999999999965432 2345567899999999999999999999976 56789999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+++.+... ..+++..+..|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+.... ......+
T Consensus 155 ~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~ 229 (353)
T PLN00034 155 DGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-DPCNSSV 229 (353)
T ss_pred CCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc-ccccccc
Confidence 97543221 235677889999999999999999999999999999999999999999999997664322 2223457
Q ss_pred ccCCCCChhhhcCC----CCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccC
Q 012062 161 ITLWYRPPELLLGA----TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236 (472)
Q Consensus 161 gt~~y~aPE~l~~~----~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (472)
+|..|+|||++... ...+.++||||||||+|+|++|+.||......+....+.........
T Consensus 230 gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------- 294 (353)
T PLN00034 230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPP--------------- 294 (353)
T ss_pred cCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCC---------------
Confidence 89999999987431 23456899999999999999999999854433222222211111000
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.....++.++++||.+||..||++|+|+.|||+|+||..
T Consensus 295 -----------~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~ 333 (353)
T PLN00034 295 -----------EAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILR 333 (353)
T ss_pred -----------CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCccccc
Confidence 011246778999999999999999999999999999954
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=338.25 Aligned_cols=243 Identities=26% Similarity=0.337 Sum_probs=195.4
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.+++.||+|++++.. ........+.+|+.+++.++|+||+++++++.. ...+||||||
T Consensus 61 ~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~----------------~~~~~lv~Ey 124 (370)
T cd05621 61 LVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD----------------DKYLYMVMEY 124 (370)
T ss_pred EEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc----------------CCEEEEEEcC
Confidence 46888999999999997532 222234456789999999999999999999986 5689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
|.+ +|.+++... .+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++.............
T Consensus 125 ~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~ 202 (370)
T cd05621 125 MPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDT 202 (370)
T ss_pred CCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCceeccc
Confidence 985 677666443 58999999999999999999999999999999999999999999999999998765333323345
Q ss_pred ccccCCCCChhhhcCCC---CCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcccc
Q 012062 159 RVITLWYRPPELLLGAT---KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~---~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (472)
.++|+.|+|||++.+.. .++.++|||||||+||+|++|+.||...+....+.++........ ++.
T Consensus 203 ~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~---~p~--------- 270 (370)
T cd05621 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLN---FPE--------- 270 (370)
T ss_pred CCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccC---CCC---------
Confidence 67899999999987532 378899999999999999999999999888777777754321111 000
Q ss_pred CCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCC--CCCHHHHhcCCCCCCC
Q 012062 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ--RISAKDALDSEYFWTD 287 (472)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~--R~t~~elL~h~~f~~~ 287 (472)
...++..+++||.+||..++.+ |+|+.|+++|+||+..
T Consensus 271 --------------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 271 --------------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred --------------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 0135778999999999866544 8999999999999653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=323.97 Aligned_cols=265 Identities=52% Similarity=0.940 Sum_probs=215.9
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|+++.+|+.||||++..+.........+.+|+++++.++|+||+++++++.. .+..||||||++
T Consensus 18 ~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~----------------~~~~~iv~e~~~ 81 (283)
T cd07835 18 ARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS----------------ENKLYLVFEFLD 81 (283)
T ss_pred EEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc----------------CCeEEEEEeccC
Confidence 5678899999999998765555455678899999999999999999999876 567899999998
Q ss_pred CChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 82 HDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 82 g~l~~~~~~~~-~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
++|.+++.... ..+++..++.++.||+.+|+|||+++++|+||+|+||+++.++.++|+|||++..+.... .......
T Consensus 82 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~ 160 (283)
T cd07835 82 LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-RTYTHEV 160 (283)
T ss_pred cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-cccCccc
Confidence 88887765533 468999999999999999999999999999999999999999999999999987553222 1222335
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (472)
++..|+|||++.+...++.++|||||||++|+|++|+.||...+..+.+.++++....+....|+....++.+....+..
T Consensus 161 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd07835 161 VTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKW 240 (283)
T ss_pred cccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccc
Confidence 68899999988765567889999999999999999999999999988888888888777777776665554432211111
Q ss_pred hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
. ..........++..+.+||.+||+.||++|||++|+++|+||
T Consensus 241 ~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 241 A-RQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred c-ccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0 112233455678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=334.21 Aligned_cols=237 Identities=26% Similarity=0.416 Sum_probs=191.2
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHH-HHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIK-ILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
+|++..+++.||||++..... .......+++|+. +++.++|+||+++++++.. .+.+|||||
T Consensus 13 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~----------------~~~~~lv~e 76 (323)
T cd05575 13 LAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT----------------ADKLYFVLD 76 (323)
T ss_pred EEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe----------------CCEEEEEEc
Confidence 467889999999999976432 2223344556655 5678999999999999986 568899999
Q ss_pred cCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 79 YMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 79 y~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
|+.+ +|...+.+ ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..... ......
T Consensus 77 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~-~~~~~~ 154 (323)
T cd05575 77 YVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE-HSKTTS 154 (323)
T ss_pred CCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc-CCCccc
Confidence 9996 55555544 44689999999999999999999999999999999999999999999999999865322 222334
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..++|..|+|||++.+ ..++.++|||||||++|+|++|..||...+..+.+..+......
T Consensus 155 ~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~------------------- 214 (323)
T cd05575 155 TFCGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLR------------------- 214 (323)
T ss_pred cccCChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC-------------------
Confidence 4578999999999876 56899999999999999999999999998877777666432110
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCH----HHHhcCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA----KDALDSEYFWT 286 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~----~elL~h~~f~~ 286 (472)
....++..+.+||++||+.||++|+++ .|+++|+||..
T Consensus 215 -----------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 215 -----------LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred -----------CCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCC
Confidence 012356789999999999999999988 69999999943
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=331.51 Aligned_cols=237 Identities=28% Similarity=0.466 Sum_probs=193.5
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
+|++..+++.||||+++... ........+.+|+++++.+ +|+||+++++++.. .+.+|||||
T Consensus 13 ~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~----------------~~~~~lv~e 76 (318)
T cd05570 13 LAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT----------------KDRLFFVME 76 (318)
T ss_pred EEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc----------------CCEEEEEEc
Confidence 36788899999999998653 2223345667899999888 69999999999986 568999999
Q ss_pred cCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 79 YMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 79 y~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
|+.+ +|...+.+ ...+++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++....... ....
T Consensus 77 ~~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (318)
T cd05570 77 YVNGGDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTS 154 (318)
T ss_pred CCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cccc
Confidence 9986 55555443 3469999999999999999999999999999999999999999999999999986532221 2223
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..++|..|+|||++.+ ..++.++|||||||++|+|++|+.||...+....+..+......
T Consensus 155 ~~~g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~------------------- 214 (318)
T cd05570 155 TFCGTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVR------------------- 214 (318)
T ss_pred ceecCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC-------------------
Confidence 3568999999999986 57899999999999999999999999988877766665432110
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCH-----HHHhcCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA-----KDALDSEYFWT 286 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~-----~elL~h~~f~~ 286 (472)
+...++..+.+||++||..||++|+|+ .++++|+||..
T Consensus 215 -----------~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~ 257 (318)
T cd05570 215 -----------YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257 (318)
T ss_pred -----------CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 012356789999999999999999999 99999999954
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=322.73 Aligned_cols=266 Identities=49% Similarity=0.842 Sum_probs=218.9
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||+++...........+.+|+++|++++|+||+++++++.. ...+|+||||+.
T Consensus 18 ~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~~~~~~v~e~~~ 81 (283)
T cd05118 18 ARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH----------------KGDLYLVFEFMD 81 (283)
T ss_pred EEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc----------------CCCEEEEEeccC
Confidence 5677899999999998765554456678899999999999999999999876 467899999999
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccc
Q 012062 82 HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 161 (472)
Q Consensus 82 g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 161 (472)
+++...+......+++.++..++.||+.+|.|||+++|+|+||||+||+++.++.+||+|||.+....... .......+
T Consensus 82 ~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~~~~~ 160 (283)
T cd05118 82 TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVV 160 (283)
T ss_pred CCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccccCccC
Confidence 99888877755679999999999999999999999999999999999999999999999999997765433 22333456
Q ss_pred cCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchh
Q 012062 162 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241 (472)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (472)
+..|+|||.+.+...++.++|||||||++|+|++|+.+|...+..+.+.++.+....+....|.....+-..........
T Consensus 161 ~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05118 161 TRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKK 240 (283)
T ss_pred cccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccc
Confidence 88999999988754788999999999999999999999999999999988888877776666665544222221111111
Q ss_pred hhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
...........++.++++||.+||..||.+||++.+++.|+||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 241 AGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred cccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 1222344556788999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=334.88 Aligned_cols=233 Identities=24% Similarity=0.415 Sum_probs=192.4
Q ss_pred ccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-C
Q 012062 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-D 83 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~ 83 (472)
..+++.||||+++...........+.+|+++|++++|+||+++++++.. .+.+||||||+.+ +
T Consensus 21 ~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----------------~~~~~lv~e~~~~~~ 84 (318)
T cd05582 21 PDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT----------------EGKLYLILDFLRGGD 84 (318)
T ss_pred CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc----------------CCEEEEEEcCCCCCc
Confidence 4689999999998654333334456789999999999999999999986 5679999999985 6
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccC
Q 012062 84 LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL 163 (472)
Q Consensus 84 l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~ 163 (472)
|...+.+ ...+++.+++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||++....... ......++|.
T Consensus 85 L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~g~~ 162 (318)
T cd05582 85 LFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYSFCGTV 162 (318)
T ss_pred HHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-CceecccCCh
Confidence 6666544 3468999999999999999999999999999999999999999999999999987654321 2223457899
Q ss_pred CCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhh
Q 012062 164 WYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMK 243 (472)
Q Consensus 164 ~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (472)
.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+......
T Consensus 163 ~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~------------------------- 216 (318)
T cd05582 163 EYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG------------------------- 216 (318)
T ss_pred hhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCC-------------------------
Confidence 9999999876 56789999999999999999999999988887777766432111
Q ss_pred hhHHHHhhhccHHHHHHHHHhhccCCCCCCC-----HHHHhcCCCCCC
Q 012062 244 RRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 286 (472)
Q Consensus 244 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t-----~~elL~h~~f~~ 286 (472)
+...++..+++||++||+.||++|+| +.++++|+||..
T Consensus 217 -----~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 217 -----MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred -----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence 01235678999999999999999999 788999999953
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=322.23 Aligned_cols=267 Identities=37% Similarity=0.710 Sum_probs=211.0
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||+++...........+.+|++++++++|+||+++++++.. .+.+||||||+.
T Consensus 20 ~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~~~~~iv~e~~~ 83 (288)
T cd07833 20 CRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR----------------KGRLYLVFEYVE 83 (288)
T ss_pred EEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE----------------CCEEEEEEecCC
Confidence 6778899999999998765555566778899999999999999999999976 557899999999
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccc
Q 012062 82 HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 161 (472)
Q Consensus 82 g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 161 (472)
++++..+.+....+++.+++.++.||+.+|+|||+++|+|+||||+||+++.++.+||+|||++...............+
T Consensus 84 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~ 163 (288)
T cd07833 84 RTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA 163 (288)
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccCccc
Confidence 88777666555568999999999999999999999999999999999999999999999999987765443323344567
Q ss_pred cCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC-Cch
Q 012062 162 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK-PSR 240 (472)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 240 (472)
+..|+|||++.....++.++|||||||++|+|++|+.||...+..+.+..+....+......+........+.... ...
T Consensus 164 ~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (288)
T cd07833 164 TRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEP 243 (288)
T ss_pred ccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCC
Confidence 8999999999875478899999999999999999999999888888777777666554433222221111111100 000
Q ss_pred hhhhhHHHHh-hhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 241 TMKRRVREVF-RHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 241 ~~~~~~~~~~-~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
.........+ ..++.++++||++||..||++|||++++++|+||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 244 SQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred CCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 1111122222 2358899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=332.36 Aligned_cols=237 Identities=24% Similarity=0.378 Sum_probs=187.4
Q ss_pred CceeccCCCEEEEEEeecCCcC-CCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 1 MAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~-~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
+|++..+++.||||+++..... ......+.+|+.+++.+ +|+||++++++|.. .+.+|||||
T Consensus 13 ~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~----------------~~~~~lv~e 76 (329)
T cd05588 13 LVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT----------------ESRLFFVIE 76 (329)
T ss_pred EEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc----------------CCEEEEEEe
Confidence 4678899999999999865322 22345577899999998 69999999999986 568999999
Q ss_pred cCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 79 YMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 79 y~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
||.+ +|..++.+ ...+++..++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++..... .....
T Consensus 77 ~~~~g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~ 154 (329)
T cd05588 77 FVSGGDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTS 154 (329)
T ss_pred CCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccC-CCccc
Confidence 9986 56555543 346999999999999999999999999999999999999999999999999998643221 22233
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCCh--------HHHH-HHHHHhcCCCCCCCCccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE--------AEQL-SKIFELCGSPDETIWPGVS 228 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~--------~~~~-~~i~~~~~~~~~~~~~~~~ 228 (472)
..++|..|+|||++.+ ..++.++|||||||++|+|++|+.||..... .+.+ ..+....
T Consensus 155 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------------ 221 (329)
T cd05588 155 TFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ------------ 221 (329)
T ss_pred cccCCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC------------
Confidence 4578999999999986 5788999999999999999999999963211 1111 1111100
Q ss_pred CCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCC------HHHHhcCCCCCC
Q 012062 229 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS------AKDALDSEYFWT 286 (472)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t------~~elL~h~~f~~ 286 (472)
..+...++.++.+||++||+.||++|+| ++|+++|+||..
T Consensus 222 ------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 222 ------------------IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred ------------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 0011246778999999999999999987 789999999943
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=336.39 Aligned_cols=239 Identities=24% Similarity=0.340 Sum_probs=191.7
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhc---CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEE
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKL---QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMV 76 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iV 76 (472)
+|+++.+++.||||++..... ..........|..++..+ .|+||++++++|.. ...+|||
T Consensus 11 ~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~----------------~~~~~lv 74 (330)
T cd05586 11 QVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT----------------DSDLYLV 74 (330)
T ss_pred EEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec----------------CCeEEEE
Confidence 468889999999999975422 222334456777887766 69999999999987 5679999
Q ss_pred EecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCc
Q 012062 77 FEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT 155 (472)
Q Consensus 77 mEy~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 155 (472)
|||+.+ +|...+.+ ...+++..++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||++...... ...
T Consensus 75 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~-~~~ 152 (330)
T cd05586 75 TDYMSGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD-NKT 152 (330)
T ss_pred EcCCCCChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC-CCC
Confidence 999986 56555544 446999999999999999999999999999999999999999999999999998653322 222
Q ss_pred cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcccc
Q 012062 156 LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (472)
....++|..|+|||++.+...++.++|||||||++|+|++|..||...+..+.+..+........
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--------------- 217 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFP--------------- 217 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCC---------------
Confidence 33457899999999997655688999999999999999999999998887776665542211000
Q ss_pred CCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCC----CHHHHhcCCCCCC
Q 012062 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI----SAKDALDSEYFWT 286 (472)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~----t~~elL~h~~f~~ 286 (472)
...++.++++||++||..||++|+ ++.++++|+||..
T Consensus 218 --------------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 218 --------------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred --------------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccC
Confidence 012567899999999999999998 7999999999954
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=322.66 Aligned_cols=270 Identities=44% Similarity=0.808 Sum_probs=214.8
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC-CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||+++...........+.+|+.+++++. |+||+++++++...... ....+||||||
T Consensus 19 ~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~-----------~~~~~~lv~e~ 87 (295)
T cd07837 19 KARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKN-----------GKPSLYLVFEY 87 (295)
T ss_pred EEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCC-----------CCceEEEEeec
Confidence 3677889999999999876554445567889999999995 69999999998763211 12358999999
Q ss_pred CCCChhhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC-CCCeEEeeccceeeeccCCCC
Q 012062 80 MDHDLTGLADRP----GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN-EGNLKLADFGLARSFSYDHNN 154 (472)
Q Consensus 80 ~~g~l~~~~~~~----~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~-~~~vkL~DFG~a~~~~~~~~~ 154 (472)
+++++.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++..+.... .
T Consensus 88 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~-~ 166 (295)
T cd07837 88 LDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPV-K 166 (295)
T ss_pred cCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceecCCCc-c
Confidence 999888776542 235899999999999999999999999999999999999998 8899999999987654321 1
Q ss_pred ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 155 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
......++..|+|||++.+...++.++|||||||++|+|++|..||.+.++.+.+.++++....+....|+....+....
T Consensus 167 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (295)
T cd07837 167 SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWH 246 (295)
T ss_pred ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchh
Confidence 22233568889999998765567899999999999999999999999999999888888887777777776555433322
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
..... .........+.++.++.+||.+||..||++|||+.|+|.|+||
T Consensus 247 ~~~~~--~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~ 294 (295)
T cd07837 247 EFPQW--KPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294 (295)
T ss_pred hcCcc--cchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCc
Confidence 11110 1122334445688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=317.17 Aligned_cols=241 Identities=25% Similarity=0.391 Sum_probs=197.3
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC-CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
|.++.|+..||||+|.+.. .-...++++|++++..++ |+||+.|+++|++ +..+|||||-|
T Consensus 97 cv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd----------------d~~FYLVfEKm 158 (463)
T KOG0607|consen 97 CVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFED----------------DTRFYLVFEKM 158 (463)
T ss_pred eeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcc----------------cceEEEEEecc
Confidence 5788999999999998652 234668899999999996 9999999999997 66899999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC---eEEeeccceeeeccC-----
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN---LKLADFGLARSFSYD----- 151 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~---vkL~DFG~a~~~~~~----- 151 (472)
.| .|+..+.+. ..|++.++.++++.|+.||.|||.+||.||||||+|||-...+. ||||||.+...+...
T Consensus 159 ~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 159 RGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred cCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 86 677777654 36999999999999999999999999999999999999865543 899999987543322
Q ss_pred -CCCccccccccCCCCChhhhc----CCCCCCCCcchhhHHHHHHHHHhCCCCCCCCC---------------hHHHHHH
Q 012062 152 -HNNTLTNRVITLWYRPPELLL----GATKYGPAVDMWSVGCIFAELLNGKPILPGKN---------------EAEQLSK 211 (472)
Q Consensus 152 -~~~~~~~~~gt~~y~aPE~l~----~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~---------------~~~~~~~ 211 (472)
....+.+.+|+..||||||.. ....|+.++|+||||+|||.||+|.+||.+.- ....+..
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 223455678999999999863 23568999999999999999999999998642 1234455
Q ss_pred HHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 212 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 212 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
|.+....+++. -|.+++.+++|||..+|..|+.+|.++.+++.|||+...
T Consensus 318 IQEGkYeFPdk--------------------------dWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~ 367 (463)
T KOG0607|consen 318 IQEGKYEFPDK--------------------------DWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC 367 (463)
T ss_pred HhccCCcCChh--------------------------hhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence 54444444433 345788999999999999999999999999999999654
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=330.19 Aligned_cols=264 Identities=24% Similarity=0.339 Sum_probs=194.1
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..++..||+|+++.... ......+.+|+++|++++|+||+++++++.. ++.+||||||+
T Consensus 23 ~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~~ 85 (331)
T cd06649 23 KVQHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYS----------------DGEISICMEHM 85 (331)
T ss_pred EEEECCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE----------------CCEEEEEeecC
Confidence 367888999999999986532 2245578899999999999999999999986 56799999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~-giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
++ +|.+++.+ ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...... ....
T Consensus 86 ~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~ 161 (331)
T cd06649 86 DGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 161 (331)
T ss_pred CCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc---cccc
Confidence 96 66666544 34689999999999999999999986 6999999999999999999999999998765322 2233
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc--cc--
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA--YN-- 234 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~--~~-- 234 (472)
..+|..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+...........+........ ..
T Consensus 162 ~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (331)
T cd06649 162 FVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPV 240 (331)
T ss_pred CCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccc
Confidence 468999999999986 5689999999999999999999999987766554332211111111111111100000 00
Q ss_pred -----cCCCchhhhhhHHHH---------hhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 235 -----HFKPSRTMKRRVREV---------FRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 235 -----~~~~~~~~~~~~~~~---------~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
...+..........+ ...++.++++||++||.+||++|||+.|||+|+||..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 306 (331)
T cd06649 241 SGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKR 306 (331)
T ss_pred cccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhh
Confidence 000000000000000 1136788999999999999999999999999999954
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=348.11 Aligned_cols=260 Identities=22% Similarity=0.326 Sum_probs=195.8
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCC------CccceeEEeeCCCCCCCCCCCCCCCCcCCeEE
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHE------NVIKLKEIVTSPGPERDEQGRPDGNKYRGSTY 74 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hp------nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 74 (472)
+|++..+++.||||+++... ........|+.+++.++|. +|++++++|... ..++|
T Consensus 147 ~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~---------------~~~~~ 208 (467)
T PTZ00284 147 EAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE---------------TGHMC 208 (467)
T ss_pred EEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC---------------CceEE
Confidence 36788899999999997432 1233456788888877654 588888888752 45789
Q ss_pred EEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCC----------------Ce
Q 012062 75 MVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEG----------------NL 137 (472)
Q Consensus 75 iVmEy~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~-~giiHrDLKp~NILl~~~~----------------~v 137 (472)
||||++.++|++++.+. ..+++.+++.|+.||+.||+|||+ .|||||||||+||||+.++ .+
T Consensus 209 iv~~~~g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~v 287 (467)
T PTZ00284 209 IVMPKYGPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRV 287 (467)
T ss_pred EEEeccCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceE
Confidence 99999998888877654 368999999999999999999998 5999999999999998765 49
Q ss_pred EEeeccceeeeccCCCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 012062 138 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 217 (472)
Q Consensus 138 kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~ 217 (472)
||+|||++.... ......++|+.|+|||++.+ ..++.++||||||||||||++|+.||.+.+..+.+..+.+.++
T Consensus 288 kl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g 362 (467)
T PTZ00284 288 RICDLGGCCDER----HSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLG 362 (467)
T ss_pred EECCCCccccCc----cccccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcC
Confidence 999999875422 22345678999999999987 5789999999999999999999999999999998888888877
Q ss_pred CCCCCCCccCCCCCc-------cccCCCchhhhhhHHHHh-------hhccHHHHHHHHHhhccCCCCCCCHHHHhcCCC
Q 012062 218 SPDETIWPGVSKMPA-------YNHFKPSRTMKRRVREVF-------RHFDRHALELLEKMLMLDPSQRISAKDALDSEY 283 (472)
Q Consensus 218 ~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~-------~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~ 283 (472)
.++..++..+. ... .....+.. ....+.... ...+..+.|||.+||.+||++|+|++|||+|||
T Consensus 363 ~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~ 440 (467)
T PTZ00284 363 RLPSEWAGRCG-TEEARLLYNSAGQLRPCT-DPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPY 440 (467)
T ss_pred CCCHHHHhhcc-chhHHHHhhhcccccccC-CHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcc
Confidence 66543222110 000 00000000 000000000 012467889999999999999999999999999
Q ss_pred CCC
Q 012062 284 FWT 286 (472)
Q Consensus 284 f~~ 286 (472)
|..
T Consensus 441 ~~~ 443 (467)
T PTZ00284 441 VLK 443 (467)
T ss_pred ccc
Confidence 964
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=342.74 Aligned_cols=236 Identities=29% Similarity=0.482 Sum_probs=202.7
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
||++..|+..||||+|++..........+.+|+++|+.|+|||||+++.+.+. ...+|+||||+
T Consensus 74 La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t----------------~~~lylV~eya 137 (596)
T KOG0586|consen 74 LARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET----------------EATLYLVMEYA 137 (596)
T ss_pred eeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee----------------cceeEEEEEec
Confidence 78999999999999999886666556668899999999999999999999987 66899999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
.+ .+.+++.+. .++.+..++.+|.|++.||+|||+++|+|||||.+||||+.+.++||+|||++..+. ......++
T Consensus 138 ~~ge~~~yl~~~-gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--~~~~lqt~ 214 (596)
T KOG0586|consen 138 SGGELFDYLVKH-GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD--YGLMLQTF 214 (596)
T ss_pred cCchhHHHHHhc-ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec--cccccccc
Confidence 86 555666554 478889999999999999999999999999999999999999999999999999886 34566778
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
||++.|.|||++.+....++.+|+||||++||.|++|..||++.+-.+.-.+.+...
T Consensus 215 cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk----------------------- 271 (596)
T KOG0586|consen 215 CGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGK----------------------- 271 (596)
T ss_pred CCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeee-----------------------
Confidence 999999999999997777899999999999999999999999877544333322111
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
..+.-.++.++.+||+++|.++|.+|.+++++++|.|..
T Consensus 272 -------~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n 310 (596)
T KOG0586|consen 272 -------YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRN 310 (596)
T ss_pred -------ecccceeechhHHHHHHhhccCccccCCHHHhhhhcccc
Confidence 111123667899999999999999999999999999984
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=329.76 Aligned_cols=237 Identities=25% Similarity=0.448 Sum_probs=192.9
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhcCCC-CccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHE-NVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
+|++..+++.||||+++.+.. .......+..|+.+++.+.|+ +|+++++++.. .+.+|||||
T Consensus 18 ~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~----------------~~~~~lv~E 81 (324)
T cd05587 18 LAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT----------------MDRLYFVME 81 (324)
T ss_pred EEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc----------------CCEEEEEEc
Confidence 467888999999999986532 223345677899999999765 57889988876 567999999
Q ss_pred cCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 79 YMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 79 y~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
|+++ +|...+.. ...+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++...... .....
T Consensus 82 ~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~~~ 159 (324)
T cd05587 82 YVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-GKTTR 159 (324)
T ss_pred CCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC-CCcee
Confidence 9986 56555544 346899999999999999999999999999999999999999999999999998653221 12233
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..++|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+....
T Consensus 160 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~------------------- 219 (324)
T cd05587 160 TFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS------------------- 219 (324)
T ss_pred eecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-------------------
Confidence 4578999999999986 56889999999999999999999999998888777776542111
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCH-----HHHhcCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA-----KDALDSEYFWT 286 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~-----~elL~h~~f~~ 286 (472)
+...++.++++||++||..||++|+++ .++++|+||..
T Consensus 220 -----------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 220 -----------YPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred -----------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 012367789999999999999999976 89999999954
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=320.30 Aligned_cols=265 Identities=52% Similarity=0.926 Sum_probs=221.5
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||+|+++.....+.....+.+|+.++++++|+||+++++++.+ .+.+|+||||+.
T Consensus 18 ~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----------------~~~~~~v~e~~~ 81 (282)
T cd07829 18 ARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT----------------ERKLYLVFEYCD 81 (282)
T ss_pred eeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc----------------CCceEEEecCcC
Confidence 6778889999999998765455556678899999999999999999999876 457899999999
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccc
Q 012062 82 HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 161 (472)
Q Consensus 82 g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 161 (472)
++|.+++.+....+++..++.++.||+.+|+|||+++|+|+||+|+||++++++.+||+|||++........ .......
T Consensus 82 ~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~ 160 (282)
T cd07829 82 MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTHEVV 160 (282)
T ss_pred cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccCcccc
Confidence 998888877645799999999999999999999999999999999999999999999999999876643322 2233455
Q ss_pred cCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchh
Q 012062 162 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241 (472)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (472)
+..|+|||++.....++.++|||||||++|+|++|+.||...+..+.+.++.+.+..+....|+....+..+....+ ..
T Consensus 161 ~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 239 (282)
T cd07829 161 TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP-KF 239 (282)
T ss_pred CcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc-cc
Confidence 78899999987755788999999999999999999999999999999999999999888888877766542221111 11
Q ss_pred hhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
........+..++..+.+||++||..||++||++.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 240 PPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred CccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 1222344455668899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=320.23 Aligned_cols=267 Identities=34% Similarity=0.568 Sum_probs=214.2
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|-|..+++.||+|++-..........++.+|+++++.++|+|||+++.+|+-...... -..+|+|||||+
T Consensus 35 a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~----------~~e~y~v~e~m~ 104 (369)
T KOG0665|consen 35 AFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE----------FQEVYLVMELMD 104 (369)
T ss_pred cchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH----------HHhHHHHHHhhh
Confidence 5677899999999997765555566788999999999999999999999986332211 235899999999
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccc
Q 012062 82 HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 161 (472)
Q Consensus 82 g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 161 (472)
.+|...+. ..++-..+..|+.|++.|++|||+.||+||||||+||++..+..+||+|||+|+....+ ..++..+.
T Consensus 105 ~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--~~mtpyVv 179 (369)
T KOG0665|consen 105 ANLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--FMMTPYVV 179 (369)
T ss_pred hHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc--cccCchhh
Confidence 99887776 34677889999999999999999999999999999999999999999999999765433 46777889
Q ss_pred cCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC-ccccCCCch
Q 012062 162 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP-AYNHFKPSR 240 (472)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 240 (472)
|..|+|||++.+. .|...+||||+||++.||++|+..|++.+..+++.++.+.++.++........... .|....+..
T Consensus 180 tRyyrapevil~~-~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y 258 (369)
T KOG0665|consen 180 TRYYRAPEVILGM-GYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQY 258 (369)
T ss_pred eeeccCchheecc-CCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHh
Confidence 9999999999985 48999999999999999999999999999999999999999998876544322110 000000000
Q ss_pred hhhhhHHHHh------------hhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 241 TMKRRVREVF------------RHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 241 ~~~~~~~~~~------------~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
.. ....+.+ +.-...++||+.+||..||++|.|++++|.||||+
T Consensus 259 ~~-~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 259 QA-ISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred hc-cchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 00 1111111 12235689999999999999999999999999995
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=327.56 Aligned_cols=237 Identities=27% Similarity=0.454 Sum_probs=191.7
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
+|++..+++.||||+++.... .+........|+.+++.+ +||||+++++++.. .+.+|||||
T Consensus 13 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~----------------~~~~~lv~e 76 (316)
T cd05619 13 LAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT----------------KENLFFVME 76 (316)
T ss_pred EEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe----------------CCEEEEEEe
Confidence 467889999999999986532 122344567788888764 89999999999987 567999999
Q ss_pred cCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 79 YMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 79 y~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
|+.+ +|..++... ..+++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++....... ....
T Consensus 77 y~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (316)
T cd05619 77 YLNGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTC 154 (316)
T ss_pred CCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Ccee
Confidence 9985 666665543 468999999999999999999999999999999999999999999999999987532211 1223
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..++|..|+|||++.+ ..++.++|||||||++|+|++|..||...+..+.+..+......
T Consensus 155 ~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~------------------- 214 (316)
T cd05619 155 TFCGTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPC------------------- 214 (316)
T ss_pred eecCCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-------------------
Confidence 4568999999999876 56899999999999999999999999988877666655321100
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHH-HHhcCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAK-DALDSEYFWT 286 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~-elL~h~~f~~ 286 (472)
....++.++++||.+||..||++|+++. ++++|+||..
T Consensus 215 -----------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05619 215 -----------YPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFRE 253 (316)
T ss_pred -----------CCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCC
Confidence 0012567899999999999999999996 8999999955
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=330.79 Aligned_cols=236 Identities=27% Similarity=0.415 Sum_probs=190.6
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHH-HHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIK-ILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
+|+++.+++.||||++..... .......+++|.. +++.++|+||+++++++.. .+.+|||||
T Consensus 13 ~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~----------------~~~~~lv~e 76 (325)
T cd05602 13 LARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT----------------ADKLYFVLD 76 (325)
T ss_pred EEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc----------------CCeEEEEEe
Confidence 478889999999999975432 1222334455554 5688999999999999986 567999999
Q ss_pred cCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 79 YMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 79 y~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
|+.+ +|...+.+ ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++..... .....
T Consensus 77 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~~~ 154 (325)
T cd05602 77 YINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGTTS 154 (325)
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCCcc
Confidence 9997 55555544 446889999999999999999999999999999999999999999999999998754322 22334
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..++|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 155 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~------------------- 214 (325)
T cd05602 155 TFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ------------------- 214 (325)
T ss_pred cccCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcC-------------------
Confidence 4578999999999986 57889999999999999999999999998888777766542111
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHH----HHhcCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAK----DALDSEYFW 285 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~----elL~h~~f~ 285 (472)
....++..+.+||++||+.||.+|+++. ++++|+||.
T Consensus 215 -----------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~ 255 (325)
T cd05602 215 -----------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFS 255 (325)
T ss_pred -----------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccC
Confidence 1124677899999999999999999876 899999994
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=331.82 Aligned_cols=269 Identities=32% Similarity=0.551 Sum_probs=204.5
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||++............+.+|++++++++|+||++++++|...... .....+||||||+
T Consensus 34 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~----------~~~~~~~lv~e~~ 103 (353)
T cd07850 34 AAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSL----------EEFQDVYLVMELM 103 (353)
T ss_pred EEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCc----------cccCcEEEEEecc
Confidence 367888999999999976544444455677899999999999999999998753211 1134689999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
.++|...+... +++.++..++.||+.||+|||++||+||||||+|||++.++++||+|||++...... .......
T Consensus 104 ~~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--~~~~~~~ 178 (353)
T cd07850 104 DANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYV 178 (353)
T ss_pred CCCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCC--CCCCCCc
Confidence 99888877543 899999999999999999999999999999999999999999999999999765432 1223346
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC--------Cc
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM--------PA 232 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--------~~ 232 (472)
++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+.++.+..+.+....+...... +.
T Consensus 179 ~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (353)
T cd07850 179 VTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPK 257 (353)
T ss_pred ccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCC
Confidence 7889999999986 57899999999999999999999999999888888888777666543322221110 00
Q ss_pred cc-----cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 233 YN-----HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 233 ~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
.. ...................+..+++||.+||..||++|||+.|+|+|+||.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~ 315 (353)
T cd07850 258 YAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN 315 (353)
T ss_pred CCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence 00 000000000000001223466789999999999999999999999999983
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=331.83 Aligned_cols=237 Identities=24% Similarity=0.372 Sum_probs=190.3
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHH-HHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIK-ILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
+|++..+++.||||+++.... .......+.+|.. +++.++|+||++++++++. .+.+|||||
T Consensus 13 ~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~----------------~~~~~lv~e 76 (325)
T cd05604 13 LAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT----------------TEKLYFVLD 76 (325)
T ss_pred EEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec----------------CCEEEEEEc
Confidence 467889999999999976422 2223345556665 4678999999999999986 568999999
Q ss_pred cCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 79 YMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 79 y~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
|+.+ +|...+. ....+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... ......
T Consensus 77 ~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~-~~~~~~ 154 (325)
T cd05604 77 FVNGGELFFHLQ-RERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA-QSDTTT 154 (325)
T ss_pred CCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC-CCCCcc
Confidence 9996 4544444 345799999999999999999999999999999999999999999999999999865322 122334
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..++|..|+|||++.+ ..++.++|||||||++|+|++|..||...+..+.+..+......
T Consensus 155 ~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~------------------- 214 (325)
T cd05604 155 TFCGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLV------------------- 214 (325)
T ss_pred cccCChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCcc-------------------
Confidence 4578999999999976 56889999999999999999999999998877776666432100
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCH----HHHhcCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA----KDALDSEYFWT 286 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~----~elL~h~~f~~ 286 (472)
....++..+.+||++||..||.+|+++ .++++|+||..
T Consensus 215 -----------~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 215 -----------LRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred -----------CCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence 011356789999999999999999976 59999999953
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=329.68 Aligned_cols=237 Identities=24% Similarity=0.395 Sum_probs=186.2
Q ss_pred CceeccCCCEEEEEEeecCCcC-CCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 1 MAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~-~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
+|++..+++.||||+++..... ......+.+|+.++.++ +|+||+++++++.. .+.+|||||
T Consensus 13 ~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~----------------~~~~~lv~E 76 (329)
T cd05618 13 LVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT----------------ESRLFFVIE 76 (329)
T ss_pred EEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe----------------CCEEEEEEe
Confidence 4678899999999999865322 22344567899988877 79999999999986 568999999
Q ss_pred cCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 79 YMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 79 y~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
|+.+ +|...+.+ ...+++..++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++..... .....
T Consensus 77 ~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~~~ 154 (329)
T cd05618 77 YVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTS 154 (329)
T ss_pred CCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCccc
Confidence 9996 55554443 346999999999999999999999999999999999999999999999999998753222 12233
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCC--------hHH-HHHHHHHhcCCCCCCCCccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN--------EAE-QLSKIFELCGSPDETIWPGVS 228 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~--------~~~-~~~~i~~~~~~~~~~~~~~~~ 228 (472)
..++|..|+|||++.+ ..++.++|||||||++|+|++|+.||.... ..+ ....+....
T Consensus 155 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~------------ 221 (329)
T cd05618 155 TFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------------ 221 (329)
T ss_pred cccCCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC------------
Confidence 4578999999999986 568899999999999999999999995311 111 111111100
Q ss_pred CCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCC------HHHHhcCCCCCC
Q 012062 229 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS------AKDALDSEYFWT 286 (472)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t------~~elL~h~~f~~ 286 (472)
..+...++..+.+||++||+.||++|+| +.|+++|+||+.
T Consensus 222 ------------------~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 222 ------------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred ------------------CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 0112246778999999999999999998 589999999954
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=328.32 Aligned_cols=245 Identities=24% Similarity=0.351 Sum_probs=195.5
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||++++.. ........+.+|+.+++.++|+||++++++|++ .+++||||||
T Consensus 19 ~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----------------~~~~~lv~e~ 82 (331)
T cd05597 19 VVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD----------------ENNLYLVMDY 82 (331)
T ss_pred EEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec----------------CCeEEEEEec
Confidence 36788899999999997532 222334557789999999999999999999987 5689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
+.+ +|.+++.+....+++..++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||++..+..........
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 162 (331)
T cd05597 83 YVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNV 162 (331)
T ss_pred CCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccccc
Confidence 975 7777776655579999999999999999999999999999999999999999999999999987665433323333
Q ss_pred ccccCCCCChhhhcC----CCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 159 RVITLWYRPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
.++|+.|+|||++.. ...++.++|||||||++|+|++|+.||...+..+.+..+........ ++
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~---------~~--- 230 (331)
T cd05597 163 AVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQ---------FP--- 230 (331)
T ss_pred eeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCccc---------CC---
Confidence 468999999999863 24578899999999999999999999998887777766643211100 00
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCC--CCCHHHHhcCCCCCC
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ--RISAKDALDSEYFWT 286 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~--R~t~~elL~h~~f~~ 286 (472)
.....++..+++||++||..++++ |+++.++++|+||..
T Consensus 231 -------------~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 231 -------------PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred -------------CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 001236788999999999765544 789999999999953
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=317.90 Aligned_cols=264 Identities=36% Similarity=0.617 Sum_probs=205.7
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC-CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
|++..+++.||||+++...... ......+|+.+++++. |+||+++++++.+.. .+.+||||||+
T Consensus 18 ~~~~~~~~~~aik~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~--------------~~~~~lv~e~~ 82 (282)
T cd07831 18 AQSRKTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRK--------------TGRLALVFELM 82 (282)
T ss_pred EEEcCCCcEEEEEEehhccCCc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCC--------------CCcEEEEEecC
Confidence 5677899999999987653222 2234568999999995 999999999998621 25789999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
.+++++.+......+++.+++.++.||+.||+|||+++|+||||||+||+++. +.+||+|||++....... ......
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~--~~~~~~ 159 (282)
T cd07831 83 DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP--PYTEYI 159 (282)
T ss_pred CccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC--CcCCCC
Confidence 99988887765557899999999999999999999999999999999999999 999999999997654322 223345
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (472)
++..|+|||++.....++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+........... ....+....
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 238 (282)
T cd07831 160 STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKS-RHMNYNFPS 238 (282)
T ss_pred CCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccc-ccccccCcc
Confidence 7889999998765456788999999999999999999999999988888888776665554321111110 011111111
Q ss_pred hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
.....+......++.++++||.+||..||++|||+.++|.|+||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 239 KKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 11222334445678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=324.70 Aligned_cols=269 Identities=40% Similarity=0.743 Sum_probs=208.0
Q ss_pred ceecc--CCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 2 AREIK--TGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 2 a~~~~--tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
|++.. +++.||||++.... ..+.....+.+|+.++++++|+||+++++++.... ...+|||||
T Consensus 19 ~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------------~~~~~lv~e 84 (316)
T cd07842 19 AKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHA--------------DKSVYLLFD 84 (316)
T ss_pred EEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCC--------------CceEEEEEe
Confidence 45666 89999999998653 23344567789999999999999999999998631 357999999
Q ss_pred cCCCChhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC----CCCeEEeeccceeeecc
Q 012062 79 YMDHDLTGLADR----PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN----EGNLKLADFGLARSFSY 150 (472)
Q Consensus 79 y~~g~l~~~~~~----~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~----~~~vkL~DFG~a~~~~~ 150 (472)
|+++++.+++.. ....+++..++.++.||+.||+|||+++|+||||||+|||++. ++.+||+|||++..+..
T Consensus 85 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~ 164 (316)
T cd07842 85 YAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA 164 (316)
T ss_pred CCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCC
Confidence 999888776542 2236899999999999999999999999999999999999999 88999999999876543
Q ss_pred CCC--CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChH---------HHHHHHHHhcCCC
Q 012062 151 DHN--NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA---------EQLSKIFELCGSP 219 (472)
Q Consensus 151 ~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~---------~~~~~i~~~~~~~ 219 (472)
... ......+++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+.. +.+..+++.+..+
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 244 (316)
T cd07842 165 PLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTP 244 (316)
T ss_pred CcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCC
Confidence 322 12223466889999999877566889999999999999999999999876543 3566777777777
Q ss_pred CCCCCccCCCCCccccCCC---ch----hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 220 DETIWPGVSKMPAYNHFKP---SR----TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~---~~----~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
....|.....++.+..... .. .........+...+.++.+||.+||..||++|||+.|+++|+||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 245 TEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred chhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 6666655554444332110 00 00111112223678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=333.61 Aligned_cols=243 Identities=26% Similarity=0.327 Sum_probs=194.6
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.+++.||+|+++... ........+.+|+.+++.++|+||+++++++.. ...+||||||
T Consensus 61 ~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~----------------~~~~~lv~Ey 124 (371)
T cd05622 61 LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD----------------DRYLYMVMEY 124 (371)
T ss_pred EEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc----------------CCEEEEEEcC
Confidence 47889999999999997532 222233456789999999999999999999986 5689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
|.+ +|..++... .+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++............
T Consensus 125 ~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~ 202 (371)
T cd05622 125 MPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 202 (371)
T ss_pred CCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccC
Confidence 985 666666443 58999999999999999999999999999999999999999999999999998765433333345
Q ss_pred ccccCCCCChhhhcCCC---CCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcccc
Q 012062 159 RVITLWYRPPELLLGAT---KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~---~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (472)
.++|+.|+|||++.... .++.++|||||||+||+|++|..||...+....+.++........ ++.
T Consensus 203 ~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~---~~~--------- 270 (371)
T cd05622 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT---FPD--------- 270 (371)
T ss_pred cccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc---CCC---------
Confidence 67899999999987532 378899999999999999999999999888777777654221110 000
Q ss_pred CCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCC--CCCHHHHhcCCCCCCC
Q 012062 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ--RISAKDALDSEYFWTD 287 (472)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~--R~t~~elL~h~~f~~~ 287 (472)
...++..+++||.+||..++.+ |++++|+++|+||+..
T Consensus 271 --------------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 271 --------------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred --------------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 1246788999999999844443 7899999999999653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=329.63 Aligned_cols=236 Identities=24% Similarity=0.368 Sum_probs=188.7
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHH-HHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIK-ILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
+|++..+++.||||++..... .......+++|+. +++.++|+||+++++++.. .+.+|||||
T Consensus 13 ~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~----------------~~~~~lv~e 76 (321)
T cd05603 13 LAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT----------------AEKLYFVLD 76 (321)
T ss_pred EEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc----------------CCEEEEEEc
Confidence 478889999999999975432 2223344555654 6788999999999999976 567899999
Q ss_pred cCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 79 YMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 79 y~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
|+.+ +|...+. ....+++.+++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++..... .....
T Consensus 77 ~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~ 154 (321)
T cd05603 77 YVNGGELFFHLQ-RERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETTS 154 (321)
T ss_pred CCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCccc
Confidence 9996 5544443 3446899999999999999999999999999999999999999999999999998753222 22233
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..++|+.|+|||++.+ ..++.++|||||||++|+|++|..||...+....+..+......
T Consensus 155 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~------------------- 214 (321)
T cd05603 155 TFCGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQ------------------- 214 (321)
T ss_pred cccCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCC-------------------
Confidence 4578999999999876 56899999999999999999999999988877666665432100
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCH----HHHhcCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA----KDALDSEYFW 285 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~----~elL~h~~f~ 285 (472)
+....+..+.+||.+||+.||.+|+++ .|+++|+||.
T Consensus 215 -----------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~ 255 (321)
T cd05603 215 -----------LPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFS 255 (321)
T ss_pred -----------CCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcC
Confidence 011346679999999999999999875 5999999994
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=334.91 Aligned_cols=241 Identities=24% Similarity=0.383 Sum_probs=193.3
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.+++.||||+++... ........+.+|+.++..++|+||+++++.+.. .+.+||||||
T Consensus 19 ~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~----------------~~~~~lv~E~ 82 (360)
T cd05627 19 LVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD----------------KRNLYLIMEF 82 (360)
T ss_pred EEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc----------------CCEEEEEEeC
Confidence 46788999999999997543 223345567789999999999999999999986 5689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC-----
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN----- 153 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~----- 153 (472)
|.+ +|.+++.+. ..+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 83 ~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~ 161 (360)
T cd05627 83 LPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYR 161 (360)
T ss_pred CCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccccc
Confidence 986 666666543 4689999999999999999999999999999999999999999999999999865432110
Q ss_pred -----------------------------CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCC
Q 012062 154 -----------------------------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN 204 (472)
Q Consensus 154 -----------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~ 204 (472)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~Pf~~~~ 240 (360)
T cd05627 162 NLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (360)
T ss_pred ccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCCCCCCC
Confidence 01123478999999999986 578999999999999999999999999988
Q ss_pred hHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCC---CHHHHhcC
Q 012062 205 EAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI---SAKDALDS 281 (472)
Q Consensus 205 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~---t~~elL~h 281 (472)
..+.+.++....... ..+. ...++.++++||.+|+. ||.+|+ ++.|+++|
T Consensus 241 ~~~~~~~i~~~~~~~---------~~p~-----------------~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 241 PQETYRKVMNWKETL---------VFPP-----------------EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred HHHHHHHHHcCCCce---------ecCC-----------------CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 877777665321100 0000 01257789999999874 999998 58999999
Q ss_pred CCCCC
Q 012062 282 EYFWT 286 (472)
Q Consensus 282 ~~f~~ 286 (472)
+||..
T Consensus 294 p~f~~ 298 (360)
T cd05627 294 PFFEG 298 (360)
T ss_pred CCCCC
Confidence 99954
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=340.44 Aligned_cols=257 Identities=23% Similarity=0.322 Sum_probs=189.7
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||.... ..+.+|+++|++|+|+|||++++++.. .+..|||||++
T Consensus 187 ~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~----------------~~~~~lv~e~~ 242 (461)
T PHA03211 187 ESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVV----------------GGLTCLVLPKY 242 (461)
T ss_pred EEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEE----------------CCEEEEEEEcc
Confidence 367888999999996432 235689999999999999999999876 56789999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC-ccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN-TLTNR 159 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~ 159 (472)
.++|..++......+++.+++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+...... .....
T Consensus 243 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 322 (461)
T PHA03211 243 RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGI 322 (461)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccccc
Confidence 99998888765557999999999999999999999999999999999999999999999999999865432221 22235
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCC-CCCC------hHHHHHHHHHhcCCCCCCCCccCCCC--
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPIL-PGKN------EAEQLSKIFELCGSPDETIWPGVSKM-- 230 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf-~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~-- 230 (472)
++|..|+|||++.+ ..++.++||||||||||||++|..++ .... ....+.++++....... .++.....
T Consensus 323 ~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~-~~~~~~~~~l 400 (461)
T PHA03211 323 AGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD-EFPQHAGSRL 400 (461)
T ss_pred CCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc-cCCCCcchHH
Confidence 68999999999987 56899999999999999999987544 3221 12344444443222111 11110000
Q ss_pred -Cccc-----cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 231 -PAYN-----HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 231 -~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
..+. ...+. .....+ ..+..++..+.+||.+||+.||++|||+.|||+|+||.
T Consensus 401 ~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~ 459 (461)
T PHA03211 401 VSQYRHRAARNRRPA-YTRPAW-TRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQ 459 (461)
T ss_pred HHHHHhhhhcccCCc-cCCcch-hhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccC
Confidence 0000 00000 000001 11224667899999999999999999999999999995
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=326.40 Aligned_cols=271 Identities=39% Similarity=0.648 Sum_probs=207.7
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||+++.... ......+.+|+.++++++|+||+++++++...... ....+|+||||+.
T Consensus 24 ~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-----------~~~~~~lv~e~~~ 91 (336)
T cd07849 24 ATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFE-----------SFNDVYIVQELME 91 (336)
T ss_pred EEEcCCCCeEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCcCchhheeeccccc-----------ccceEEEEehhcc
Confidence 57888999999999964322 23455678899999999999999999988763221 1346899999999
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC--Cccccc
Q 012062 82 HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTLTNR 159 (472)
Q Consensus 82 g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~--~~~~~~ 159 (472)
+++..++.. ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++........ ......
T Consensus 92 ~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 169 (336)
T cd07849 92 TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEY 169 (336)
T ss_pred cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCc
Confidence 988877654 3589999999999999999999999999999999999999999999999999876543221 122334
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc--cccCC
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA--YNHFK 237 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~--~~~~~ 237 (472)
++|..|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..+......+....+........ +....
T Consensus 170 ~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (336)
T cd07849 170 VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSL 249 (336)
T ss_pred CcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhc
Confidence 6789999999887655688999999999999999999999999888887777777666554433322211000 00000
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
+ .............++.++.+||.+||+.||++|||+.|+++|+||+.-
T Consensus 250 ~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 250 P-FKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred C-cCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 0 000111223344568889999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=315.89 Aligned_cols=238 Identities=26% Similarity=0.401 Sum_probs=203.8
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
|||++.|++.+|||+++++. ..++.....+.|-.+|+..+||.+..+...|+. .+.+|+||||
T Consensus 186 L~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt----------------~drlCFVMey 249 (516)
T KOG0690|consen 186 LCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT----------------QDRLCFVMEY 249 (516)
T ss_pred EEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc----------------CceEEEEEEE
Confidence 68999999999999999874 223344566789999999999999999999987 6689999999
Q ss_pred CCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 80 MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 80 ~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
+.|+.+.........|+++.++.|-..|+.||.|||+++||.||||.+|+|||.+|++||+|||+++.-- .......++
T Consensus 250 anGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-~~g~t~kTF 328 (516)
T KOG0690|consen 250 ANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-KYGDTTKTF 328 (516)
T ss_pred ccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcc-cccceeccc
Confidence 9975544444444569999999999999999999999999999999999999999999999999997533 234456678
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
|||+.|+||||+.. ..|+.++|.|.+|||+|||++|+.||...+....+..|....-
T Consensus 329 CGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~---------------------- 385 (516)
T KOG0690|consen 329 CGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL---------------------- 385 (516)
T ss_pred cCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc----------------------
Confidence 99999999999975 7899999999999999999999999999998888877754321
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 286 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----t~~elL~h~~f~~ 286 (472)
.++..++++++.||.-+|.+||.+|. .+.||.+|+||..
T Consensus 386 --------kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 386 --------KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFAS 429 (516)
T ss_pred --------cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence 22346888999999999999999998 6899999999954
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=326.09 Aligned_cols=273 Identities=36% Similarity=0.643 Sum_probs=213.8
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|+++.+++.||||++............+.+|+.+|++++|+||++++++|..... ....+|+||||+.
T Consensus 24 ~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------------~~~~~~lv~e~~~ 91 (334)
T cd07855 24 AIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGA------------DFKDVYVVMDLME 91 (334)
T ss_pred EEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCC------------CCceEEEEEehhh
Confidence 6788899999999998654444455677889999999999999999998875321 1457899999999
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC---Ccccc
Q 012062 82 HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN---NTLTN 158 (472)
Q Consensus 82 g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~---~~~~~ 158 (472)
++|...+... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++........ .....
T Consensus 92 ~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 170 (334)
T cd07855 92 SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTE 170 (334)
T ss_pred hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCccccc
Confidence 8887777554 3599999999999999999999999999999999999999999999999999976543222 12233
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccC-C
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF-K 237 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-~ 237 (472)
.+++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..+....+.+....+...........+ .
T Consensus 171 ~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~ 250 (334)
T cd07855 171 YVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQN 250 (334)
T ss_pred ccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhh
Confidence 467899999999876556889999999999999999999999999888888888887777665544333211000000 0
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
...............++.++++||++||+.||++|||+++++.|+||..-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~ 300 (334)
T cd07855 251 LPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY 300 (334)
T ss_pred cccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence 00001112234455678999999999999999999999999999999543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=325.68 Aligned_cols=269 Identities=21% Similarity=0.275 Sum_probs=192.7
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..||+.||||+++...........+.+|+.+++.++||||++++++|.. ++.+||||||+
T Consensus 18 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~----------------~~~~~lv~e~~ 81 (327)
T cd08227 18 LARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA----------------DNELWVVTSFM 81 (327)
T ss_pred EEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE----------------CCEEEEEEecc
Confidence 46788999999999998765544455667789999999999999999999987 56789999999
Q ss_pred CC-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC----
Q 012062 81 DH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN---- 154 (472)
Q Consensus 81 ~g-~l~~~~~~~-~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~---- 154 (472)
++ +|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.++|+||+.+.........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 161 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV 161 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccc
Confidence 85 566666432 335899999999999999999999999999999999999999999999999865433211110
Q ss_pred --ccccccccCCCCChhhhcCC-CCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC-CCCCC-Cc----
Q 012062 155 --TLTNRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS-PDETI-WP---- 225 (472)
Q Consensus 155 --~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~-~~~~~-~~---- 225 (472)
......++..|+|||++.+. ..++.++|||||||++|+|++|+.||.................. ..+.. .+
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (327)
T cd08227 162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEEL 241 (327)
T ss_pred ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhc
Confidence 11123457789999998753 35889999999999999999999999876654433333221100 00000 00
Q ss_pred --cCCCC---CccccCCC-----chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 226 --GVSKM---PAYNHFKP-----SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 226 --~~~~~---~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
..... ........ ..............++.++++||++||+.||++|||++|||+|+||.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~ 311 (327)
T cd08227 242 TMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 311 (327)
T ss_pred ccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhh
Confidence 00000 00000000 00000111122345678899999999999999999999999999994
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=318.72 Aligned_cols=266 Identities=35% Similarity=0.657 Sum_probs=205.5
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||++............+.+|+++++.++|+||+++++++.. .+.+||||||+.
T Consensus 20 ~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~ 83 (286)
T cd07846 20 CKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR----------------KKRLYLVFEFVD 83 (286)
T ss_pred EEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc----------------CCeEEEEEecCC
Confidence 5677789999999987654444445667899999999999999999999976 567899999999
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccc
Q 012062 82 HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 161 (472)
Q Consensus 82 g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 161 (472)
++++..+......+++.+++.++.||+.+|+|||+.+|+|+||+|+||+++.++.++|+|||++....... .......+
T Consensus 84 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~ 162 (286)
T cd07846 84 HTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTDYVA 162 (286)
T ss_pred ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-cccCcccc
Confidence 87666555444468999999999999999999999999999999999999999999999999987654332 22334567
Q ss_pred cCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccC-CCch
Q 012062 162 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF-KPSR 240 (472)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 240 (472)
+..|+|||++.+...++.++|||||||++|+|++|+.+|...+..+.+..+..................+..... .+..
T Consensus 163 ~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (286)
T cd07846 163 TRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEV 242 (286)
T ss_pred eeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccc
Confidence 889999999876556788999999999999999999999988887777777665443321110000000000000 0001
Q ss_pred hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
.........++.++..+++||.+||..||++|||+.++++|+||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 243 KEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred cCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 11122334456788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=325.87 Aligned_cols=237 Identities=25% Similarity=0.436 Sum_probs=193.2
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
+|++..+++.||||+++.... ..........|+.++..+ .|++|+++++++.. .+.+|||||
T Consensus 18 ~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~----------------~~~~~lv~E 81 (323)
T cd05616 18 LAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT----------------MDRLYFVME 81 (323)
T ss_pred EEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec----------------CCEEEEEEc
Confidence 467888999999999986532 222344567788888877 58999999999976 567999999
Q ss_pred cCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 79 YMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 79 y~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
|+.+ +|...+... ..+++.++..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++...... ....
T Consensus 82 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-~~~~ 159 (323)
T cd05616 82 YVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-VTTK 159 (323)
T ss_pred CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-Cccc
Confidence 9985 666555443 468999999999999999999999999999999999999999999999999987543222 2233
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.......
T Consensus 160 ~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~------------------ 220 (323)
T cd05616 160 TFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY------------------ 220 (323)
T ss_pred cCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC------------------
Confidence 4578999999999986 678999999999999999999999999988877777765422110
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCC-----HHHHhcCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 286 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t-----~~elL~h~~f~~ 286 (472)
...++.++++||.+||..||++|++ ..++++|+||..
T Consensus 221 ------------p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 221 ------------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred ------------CCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 1135678999999999999999997 489999999953
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=318.34 Aligned_cols=240 Identities=25% Similarity=0.398 Sum_probs=191.9
Q ss_pred ceeccCCCEEEEEEeecCCcC-CCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 2 AREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
|++..+++.||||++...... ......+.+|+.+++.++|+||+++++++.. +..+||||||+
T Consensus 19 ~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~~ 82 (285)
T cd05605 19 CQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET----------------KDALCLVLTLM 82 (285)
T ss_pred EEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC----------------CCeEEEEEecc
Confidence 577889999999999765322 2223456789999999999999999999876 55799999999
Q ss_pred CC-ChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 81 DH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 81 ~g-~l~~~~~~-~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
.+ +|...+.. ....+++.++..++.||+.||.|||+++|+||||||+|||+++++.++|+|||++....... ....
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~~~ 160 (285)
T cd05605 83 NGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE--TIRG 160 (285)
T ss_pred CCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC--cccc
Confidence 85 56555443 23468999999999999999999999999999999999999999999999999987653221 2233
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
.+++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+........
T Consensus 161 ~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------------------ 221 (285)
T cd05605 161 RVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ------------------ 221 (285)
T ss_pred ccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc------------------
Confidence 478999999999976 5688999999999999999999999998766544444432211100
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 286 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----t~~elL~h~~f~~ 286 (472)
......++..+.+||.+||..||++|+ +++++++|+||..
T Consensus 222 --------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 222 --------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred --------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 011224677899999999999999999 9999999999943
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=323.23 Aligned_cols=237 Identities=26% Similarity=0.444 Sum_probs=192.2
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhcC-CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
+|+++.+++.||||+++.+.. .......+..|+.+++.+. |++|+++++++.. .+.+|||||
T Consensus 18 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~----------------~~~~~lv~E 81 (323)
T cd05615 18 LAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT----------------VDRLYFVME 81 (323)
T ss_pred EEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec----------------CCEEEEEEc
Confidence 478899999999999986532 2233456778999998886 5778889999876 557999999
Q ss_pred cCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 79 YMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 79 y~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
|+.+ +|..++.+ ...+++.+++.|+.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 82 y~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-~~~~ 159 (323)
T cd05615 82 YVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-VTTR 159 (323)
T ss_pred CCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-cccc
Confidence 9986 56555544 3469999999999999999999999999999999999999999999999999987543221 1223
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..++|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+......
T Consensus 160 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~------------------- 219 (323)
T cd05615 160 TFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS------------------- 219 (323)
T ss_pred CccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-------------------
Confidence 3468999999999876 56899999999999999999999999998887777766542111
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCC-----HHHHhcCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 286 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t-----~~elL~h~~f~~ 286 (472)
....++.++++||.+||.+||++|++ .+++++|+||..
T Consensus 220 -----------~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~ 262 (323)
T cd05615 220 -----------YPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRR 262 (323)
T ss_pred -----------CCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCC
Confidence 01235678999999999999999997 579999999954
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=324.09 Aligned_cols=238 Identities=22% Similarity=0.386 Sum_probs=187.6
Q ss_pred CceeccCCCEEEEEEeecCCcC-CCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 1 MAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~-~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
+|++..+++.||||+++..... ......+.+|+.+++++ +|+||+++++++.. .+.+|||||
T Consensus 13 ~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----------------~~~~~lv~e 76 (327)
T cd05617 13 LVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT----------------TSRLFLVIE 76 (327)
T ss_pred EEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe----------------CCEEEEEEe
Confidence 4678899999999999865322 23345677899999888 69999999999986 567999999
Q ss_pred cCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 79 YMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 79 y~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
|+.+ +|..++.+. ..+++.+++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++..... .....
T Consensus 77 ~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~ 154 (327)
T cd05617 77 YVNGGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTTS 154 (327)
T ss_pred CCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCcee
Confidence 9986 565555433 46999999999999999999999999999999999999999999999999998753222 12233
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHhcCCCCCCCCccCCCCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN------EAEQLSKIFELCGSPDETIWPGVSKMP 231 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (472)
..++|..|+|||++.+ ..++.++|||||||+||+|++|+.||.... ..+.+.+.... .+
T Consensus 155 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~------------ 219 (327)
T cd05617 155 TFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--KP------------ 219 (327)
T ss_pred cccCCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--CC------------
Confidence 4578999999999976 578999999999999999999999996422 11122222110 00
Q ss_pred ccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCC------HHHHhcCCCCCC
Q 012062 232 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS------AKDALDSEYFWT 286 (472)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t------~~elL~h~~f~~ 286 (472)
..+...++..+.+||++||..||++|++ .+++++|+||..
T Consensus 220 ---------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~ 265 (327)
T cd05617 220 ---------------IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRS 265 (327)
T ss_pred ---------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence 0011246778999999999999999998 579999999954
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=322.23 Aligned_cols=271 Identities=43% Similarity=0.685 Sum_probs=211.1
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||.++...........+.+|+.+++.++|+||+++++++...... ....+||||||+.
T Consensus 24 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~-----------~~~~~~lv~e~~~ 92 (337)
T cd07858 24 AKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHRE-----------AFNDVYIVYELMD 92 (337)
T ss_pred EEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheeccccc-----------ccCcEEEEEeCCC
Confidence 67888999999999976543333345677899999999999999999988753211 1246899999999
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccc
Q 012062 82 HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 161 (472)
Q Consensus 82 g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 161 (472)
++|.+++... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++...... .......+
T Consensus 93 ~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~ 170 (337)
T cd07858 93 TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG-DFMTEYVV 170 (337)
T ss_pred CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc-cccccccc
Confidence 9888777654 469999999999999999999999999999999999999999999999999997654322 22334467
Q ss_pred cCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc--cccCCCc
Q 012062 162 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA--YNHFKPS 239 (472)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 239 (472)
+..|+|||++.....++.++|||||||++|+|++|+.||.+.+....+..+.+..+.+....+........ +.....
T Consensus 171 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 249 (337)
T cd07858 171 TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLP- 249 (337)
T ss_pred ccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcC-
Confidence 88999999987645688999999999999999999999999888888888887777665544422211000 000000
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
..........++.++.++++||++||..||++|||++|+|+|+||..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 250 YTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred cccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 00011223345578899999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=318.86 Aligned_cols=261 Identities=26% Similarity=0.440 Sum_probs=198.4
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCC--CC----ccceeEEeeCCCCCCCCCCCCCCCCcCCeEEE
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQH--EN----VIKLKEIVTSPGPERDEQGRPDGNKYRGSTYM 75 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~h--pn----Iv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i 75 (472)
|.|.+++..||||+|+.- ..+.+.++-||++|.++.+ |+ +|.+.++|. +.+++||
T Consensus 108 c~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd----------------yrghiCi 168 (415)
T KOG0671|consen 108 CWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD----------------YRGHICI 168 (415)
T ss_pred EeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh----------------ccCceEE
Confidence 457788999999999843 2356677889999999942 22 556655554 5899999
Q ss_pred EEecCCCChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC--------------------C
Q 012062 76 VFEYMDHDLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN--------------------E 134 (472)
Q Consensus 76 VmEy~~g~l~~~~~~~-~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~--------------------~ 134 (472)
|+|.++-++.+.+..+ -.+|+.++++.+.+||+++|+|||+++|+|.||||||||+.+ +
T Consensus 169 vfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks 248 (415)
T KOG0671|consen 169 VFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKS 248 (415)
T ss_pred EEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCC
Confidence 9999998888888764 456999999999999999999999999999999999999832 2
Q ss_pred CCeEEeeccceeeeccCCCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 012062 135 GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 214 (472)
Q Consensus 135 ~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~ 214 (472)
-.|||+|||.|+.....+ ...+.|..|+|||++++ ..++..+||||+||||+||.+|..+|...++.+.+.-+..
T Consensus 249 ~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMer 323 (415)
T KOG0671|consen 249 TAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMER 323 (415)
T ss_pred cceEEEecCCcceeccCc----ceeeeccccCCchheec-cCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHH
Confidence 249999999998654333 34567999999999998 7899999999999999999999999999999998888877
Q ss_pred hcCCCCCCCCccCCC--------CCccccC-----CCchhhhhhHHHHhhh---ccHHHHHHHHHhhccCCCCCCCHHHH
Q 012062 215 LCGSPDETIWPGVSK--------MPAYNHF-----KPSRTMKRRVREVFRH---FDRHALELLEKMLMLDPSQRISAKDA 278 (472)
Q Consensus 215 ~~~~~~~~~~~~~~~--------~~~~~~~-----~~~~~~~~~~~~~~~~---~~~~~~~ll~~~L~~dP~~R~t~~el 278 (472)
+++..+........+ +.+-+.. +......+........ -...+.|||++||..||.+|+|+.|+
T Consensus 324 IlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EA 403 (415)
T KOG0671|consen 324 ILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREA 403 (415)
T ss_pred hhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHH
Confidence 888655433222210 0000000 0011111112222211 22458899999999999999999999
Q ss_pred hcCCCCCC
Q 012062 279 LDSEYFWT 286 (472)
Q Consensus 279 L~h~~f~~ 286 (472)
|.|+||..
T Consensus 404 L~HpFF~~ 411 (415)
T KOG0671|consen 404 LSHPFFAR 411 (415)
T ss_pred hcCHHhhc
Confidence 99999954
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=333.30 Aligned_cols=258 Identities=26% Similarity=0.316 Sum_probs=192.1
Q ss_pred ccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCCh
Q 012062 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDL 84 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~l 84 (472)
..+++.||||.+.... ...+|+++|++|+|+|||++++++.. ...+|||||++.++|
T Consensus 116 ~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~~~~~l 172 (392)
T PHA03207 116 DEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRW----------------KSTVCMVMPKYKCDL 172 (392)
T ss_pred CccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEee----------------CCEEEEEehhcCCCH
Confidence 4567889999886431 34589999999999999999999876 567999999999998
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC-CccccccccC
Q 012062 85 TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITL 163 (472)
Q Consensus 85 ~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~ 163 (472)
..++.. ...+++.+++.|+.||+.||.|||+++|+||||||+||||+.++.+||+|||+++.+..... ......++|.
T Consensus 173 ~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~ 251 (392)
T PHA03207 173 FTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTL 251 (392)
T ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccccccccccccc
Confidence 887743 34699999999999999999999999999999999999999999999999999976543222 1223457899
Q ss_pred CCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCCCCCCccCCC-C-CccccCCC
Q 012062 164 WYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN---EAEQLSKIFELCGSPDETIWPGVSK-M-PAYNHFKP 238 (472)
Q Consensus 164 ~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~-~-~~~~~~~~ 238 (472)
.|+|||++.. ..++.++|||||||+||+|++|+.||.+.. ....+..+.+.++............ + ..+..+..
T Consensus 252 ~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (392)
T PHA03207 252 ETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAI 330 (392)
T ss_pred CccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcc
Confidence 9999999876 568899999999999999999999997654 3455666666554332211110000 0 00000000
Q ss_pred chhhhhhHHHHh--hhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 239 SRTMKRRVREVF--RHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 239 ~~~~~~~~~~~~--~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
...........+ ..++.++.+||++||..||++|||+.|+|.|+||...
T Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 331 VLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred cccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 000000000011 2356788999999999999999999999999999653
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=322.80 Aligned_cols=273 Identities=40% Similarity=0.676 Sum_probs=217.4
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||++............+.+|+.+++.++|+||+++++++..... .....+|+||||+
T Consensus 18 ~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-----------~~~~~~~lv~e~~ 86 (330)
T cd07834 18 SAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSP-----------EDFNDVYIVTELM 86 (330)
T ss_pred EEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCc-----------ccccceEEEecch
Confidence 36777889999999998654434455678899999999999999999999876321 0124689999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC--Ccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTLTN 158 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~--~~~~~ 158 (472)
.++|..++.+.. .+++..++.++.||+.||+|||++||+|+||||+||||+.++.++|+|||++........ .....
T Consensus 87 ~~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~ 165 (330)
T cd07834 87 ETDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE 165 (330)
T ss_pred hhhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccc
Confidence 988877776544 799999999999999999999999999999999999999999999999999987654321 22344
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC--CCccccC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK--MPAYNHF 236 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~ 236 (472)
..++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+....|..... ...+...
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (330)
T cd07834 166 YVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKS 245 (330)
T ss_pred cccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhh
Confidence 56789999999998754789999999999999999999999999999999999988877776554442211 1111000
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
........+......++..+.+||++||.+||++|||++++|.|+||..
T Consensus 246 -~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 294 (330)
T cd07834 246 -LPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294 (330)
T ss_pred -cccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence 0111122344455668899999999999999999999999999999954
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=309.60 Aligned_cols=237 Identities=28% Similarity=0.460 Sum_probs=190.1
Q ss_pred ceeccCCCEEEEEEeecCCcCC---CchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 2 AREIKTGEIVALKKIRMDNEKE---GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
|++..+++.||||.++...... .....+.+|++++++++|+||++++++++. ...+|+|||
T Consensus 21 ~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~~~~~~v~e 84 (263)
T cd06625 21 CYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD----------------DETLSIFME 84 (263)
T ss_pred EEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc----------------CCeEEEEEE
Confidence 5678899999999997653322 123467789999999999999999999986 458999999
Q ss_pred cCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcc-
Q 012062 79 YMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTL- 156 (472)
Q Consensus 79 y~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~- 156 (472)
|+.+ +|.+.+... ..+++..++.++.||+.||.|||+++|+|+||||+||+++.+++++|+|||+++..........
T Consensus 85 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~ 163 (263)
T cd06625 85 YMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTG 163 (263)
T ss_pred ECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccccc
Confidence 9986 566655543 3588999999999999999999999999999999999999999999999999876543222111
Q ss_pred -ccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcccc
Q 012062 157 -TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235 (472)
Q Consensus 157 -~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (472)
....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+......++.......
T Consensus 164 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------------- 226 (263)
T cd06625 164 MKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNP---------------- 226 (263)
T ss_pred ccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCC----------------
Confidence 23456889999999987 558899999999999999999999998776655544443211000
Q ss_pred CCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
.+...++..+.+||++||..||++|||+.|+|+|+||
T Consensus 227 ------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 227 ------------QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred ------------CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 0112366789999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=339.62 Aligned_cols=236 Identities=24% Similarity=0.368 Sum_probs=192.9
Q ss_pred ceeccC-CCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 2 AREIKT-GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 2 a~~~~t-g~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
|++..+ ++.||+|++..+... ....+.+|+.+|+.++|+|||+++++|+. .+.+||||||+
T Consensus 86 a~~~~~~~~~vv~K~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~~~~~~~~----------------~~~~~lv~E~~ 147 (478)
T PTZ00267 86 ATRGSDPKEKVVAKFVMLNDER--QAAYARSELHCLAACDHFGIVKHFDDFKS----------------DDKLLLIMEYG 147 (478)
T ss_pred EEEcCCCCeEEEEEEcccCCHH--HHHHHHHHHHHHHhCCCCCEeEEEEEEEE----------------CCEEEEEEECC
Confidence 556666 788999987654322 23456789999999999999999999987 56899999999
Q ss_pred CC-ChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC-Cc
Q 012062 81 DH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-NT 155 (472)
Q Consensus 81 ~g-~l~~~~~~---~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~ 155 (472)
.+ +|.+.+.. ....+++.++..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+..... ..
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~ 227 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDV 227 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccccc
Confidence 85 66655432 344689999999999999999999999999999999999999999999999999987653322 12
Q ss_pred cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcccc
Q 012062 156 LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (472)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+......+
T Consensus 228 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~---------------- 290 (478)
T PTZ00267 228 ASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP---------------- 290 (478)
T ss_pred ccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC----------------
Confidence 334578999999999876 578999999999999999999999999888877777664321110
Q ss_pred CCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
....++.++++||.+||..||++|||+.++|.|+|++
T Consensus 291 -------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~ 327 (478)
T PTZ00267 291 -------------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327 (478)
T ss_pred -------------CCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHH
Confidence 0113567899999999999999999999999999984
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=323.63 Aligned_cols=245 Identities=22% Similarity=0.340 Sum_probs=195.2
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+++++.+++.||||++.... ........+.+|+.+++.++|+||+++++++.+ ...+||||||
T Consensus 19 ~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----------------~~~~~lv~ey 82 (332)
T cd05623 19 VVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD----------------ENNLYLVMDY 82 (332)
T ss_pred EEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec----------------CCEEEEEEec
Confidence 36778899999999997532 222233456789999999999999999999986 5679999999
Q ss_pred CC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~-g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
+. ++|.+++.+....+++..++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||++..+..........
T Consensus 83 ~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~ 162 (332)
T cd05623 83 YVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV 162 (332)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcceecc
Confidence 98 47777776655579999999999999999999999999999999999999999999999999987654333333334
Q ss_pred ccccCCCCChhhhcC----CCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 159 RVITLWYRPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
.++|+.|+|||++.. ...++.++|||||||+||+|++|+.||...+..+.+.++........ ++
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~---~p--------- 230 (332)
T cd05623 163 AVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ---FP--------- 230 (332)
T ss_pred cccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcccc---CC---------
Confidence 578999999999863 34578899999999999999999999999887777776653211100 00
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCC--CCCHHHHhcCCCCCC
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ--RISAKDALDSEYFWT 286 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~--R~t~~elL~h~~f~~ 286 (472)
.....++.++++||++||..++.+ |++++|+++|+||..
T Consensus 231 -------------~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 231 -------------AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred -------------CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 011246788999999999765554 689999999999953
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=329.13 Aligned_cols=258 Identities=24% Similarity=0.317 Sum_probs=187.7
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+.... ....|+.+|++++|+||+++++++.. ....||||||+
T Consensus 84 ~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~~ 139 (357)
T PHA03209 84 VATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVS----------------GAITCMVLPHY 139 (357)
T ss_pred EEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEe----------------CCeeEEEEEcc
Confidence 3677888999999985422 23579999999999999999999986 55789999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
.++|..++......+++.+++.|+.||+.||.|||+++|+||||||+||||+.++.+||+|||+++..... .......
T Consensus 140 ~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~~~~~ 217 (357)
T PHA03209 140 SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PAFLGLA 217 (357)
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC--ccccccc
Confidence 99999888776667999999999999999999999999999999999999999999999999998643221 1223356
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCC-CCCCCCCh---------HHHHHHHHHhcCCCCCCCCccCCC-
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK-PILPGKNE---------AEQLSKIFELCGSPDETIWPGVSK- 229 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~-~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~~~~- 229 (472)
+|..|+|||++.+ ..++.++||||||||+|+|+++. .+|..... ...+.+++...+..+.........
T Consensus 218 gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 296 (357)
T PHA03209 218 GTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR 296 (357)
T ss_pred ccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccH
Confidence 8999999999876 56899999999999999999854 44443221 223333333333222211100000
Q ss_pred -CCccccCCCch--hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 230 -MPAYNHFKPSR--TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 230 -~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
...+..+.... ............++..+.+||.+||+.||++|||+.|||+||||.
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~ 355 (357)
T PHA03209 297 LVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFA 355 (357)
T ss_pred HHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhc
Confidence 00000000000 000000011124667888999999999999999999999999995
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=314.19 Aligned_cols=242 Identities=24% Similarity=0.362 Sum_probs=187.3
Q ss_pred CceeccCCCEEEEEEeecCCcCC-CchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEKE-GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.+++.||+|++....... .....+..|++++++++|+||++++++++. +.++||||||
T Consensus 11 ~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~----------------~~~~~lv~e~ 74 (277)
T cd05607 11 AVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES----------------KTHLCLVMSL 74 (277)
T ss_pred EEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec----------------CCeEEEEEec
Confidence 36788899999999997543222 123345679999999999999999999976 5678999999
Q ss_pred CCC-ChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 80 MDH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 80 ~~g-~l~~~~~~-~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
+.+ +|..++.. ....+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++..+... ....
T Consensus 75 ~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~ 152 (277)
T cd05607 75 MNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTIT 152 (277)
T ss_pred CCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC--ceee
Confidence 986 66555543 3335889999999999999999999999999999999999999999999999998765432 1223
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
...+|..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+........
T Consensus 153 ~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------- 214 (277)
T cd05607 153 QRAGTNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDE----------------- 214 (277)
T ss_pred ccCCCCCccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccc-----------------
Confidence 3467999999999986 4589999999999999999999999976543222122211100000
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCH----HHHhcCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA----KDALDSEYFWT 286 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~----~elL~h~~f~~ 286 (472)
.......++.++++||++||+.||++|+++ ++++.|+||..
T Consensus 215 --------~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 215 --------VKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred --------cccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcC
Confidence 000012467789999999999999999999 67889999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=321.74 Aligned_cols=263 Identities=23% Similarity=0.365 Sum_probs=191.7
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||+|+++.... ......+.+|+++|++++|+||++++++|.+ ++.+||||||+
T Consensus 23 ~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~~ 85 (333)
T cd06650 23 KVSHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYS----------------DGEISICMEHM 85 (333)
T ss_pred EEEECCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHHCCCCcccceeEEEEE----------------CCEEEEEEecC
Confidence 367888999999999886532 2244568899999999999999999999987 56899999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~-giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
.+ +|.+++.+. ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..+... ....
T Consensus 86 ~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---~~~~ 161 (333)
T cd06650 86 DGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 161 (333)
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---cccc
Confidence 86 666666543 4689999999999999999999975 7999999999999999999999999998755322 1223
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC--CCCCCCccCCC-----CC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS--PDETIWPGVSK-----MP 231 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~-----~~ 231 (472)
..+|..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.. .++..... ........... +.
T Consensus 162 ~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (333)
T cd06650 162 FVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE-LMFGCPVEGDPAESETSPRPRPPGRPLS 239 (333)
T ss_pred CCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH-HHhcCcccCCccccccCcccCCccchhh
Confidence 467999999999976 56889999999999999999999999876654332 22211111 00000000000 00
Q ss_pred ccc-cCCCchhhhhhHHHH---------hhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 232 AYN-HFKPSRTMKRRVREV---------FRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 232 ~~~-~~~~~~~~~~~~~~~---------~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.+. ...+..........+ ...++.++++||.+||++||++|||++|++.|+||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 304 (333)
T cd06650 240 SYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 304 (333)
T ss_pred hhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhc
Confidence 000 000000000000000 0135778999999999999999999999999999954
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=311.39 Aligned_cols=236 Identities=23% Similarity=0.420 Sum_probs=198.9
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|.|+++|+.||||.+..+.+ ...+++||.|+.++++++||++|+.+-. ...+|||||||.
T Consensus 52 AIH~EsG~v~AIK~VPV~sD----LQEIIKEISIMQQC~S~yVVKYYGSYFK----------------~sDLWIVMEYCG 111 (502)
T KOG0574|consen 52 AIHRESGHVLAIKKVPVDTD----LQEIIKEISIMQQCKSKYVVKYYGSYFK----------------HSDLWIVMEYCG 111 (502)
T ss_pred HHHhccCcEEEEEecCccch----HHHHHHHHHHHHHcCCchhhhhhhhhcc----------------CCceEeehhhcC
Confidence 67899999999999986543 4568899999999999999999987643 446899999999
Q ss_pred -CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 82 -HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 82 -g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
|+..+++..++..+++.++..+++..|.||+|||...-||||||..||||+.+|..||+|||.|-.+.+... ...+.+
T Consensus 112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-KRNTVI 190 (502)
T KOG0574|consen 112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-KRNTVI 190 (502)
T ss_pred CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH-hhCccc
Confidence 567777776777899999999999999999999999999999999999999999999999999977654333 334468
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (472)
||+.||||||+.. -.|+.++||||||++..||..|++||.+-.. ++.||.+...++..+.
T Consensus 191 GTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHP---MRAIFMIPT~PPPTF~---------------- 250 (502)
T KOG0574|consen 191 GTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHP---MRAIFMIPTKPPPTFK---------------- 250 (502)
T ss_pred cCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcccccc---cceeEeccCCCCCCCC----------------
Confidence 9999999999986 5789999999999999999999999976554 4455555544443221
Q ss_pred hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
....++.++.|||++||.++|++|-|+.++++|+|++.
T Consensus 251 --------KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~Fikn 288 (502)
T KOG0574|consen 251 --------KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKN 288 (502)
T ss_pred --------ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcC
Confidence 12246788999999999999999999999999999965
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=304.25 Aligned_cols=238 Identities=25% Similarity=0.426 Sum_probs=192.9
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+++.+++.||||++..+.........+.+|++++++++|+||+++++.+... +..+|+||||+
T Consensus 18 ~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---------------~~~~~lv~e~~ 82 (257)
T cd08223 18 LVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE---------------DGLLYIVMGFC 82 (257)
T ss_pred EEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC---------------CCEEEEEeccc
Confidence 367888999999999986654444455678899999999999999999887531 34689999999
Q ss_pred CC-ChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 81 DH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 81 ~g-~l~~~~~~-~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
.+ +|.+.+.. ....+++.+++.++.||+.+|++||+++|+|+||||+||+++.++.++|+|||++....... .....
T Consensus 83 ~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~ 161 (257)
T cd08223 83 EGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-DMAST 161 (257)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC-Ccccc
Confidence 85 66665554 23458999999999999999999999999999999999999999999999999998764322 22334
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
..++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+.......
T Consensus 162 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~------------------- 221 (257)
T cd08223 162 LIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP------------------- 221 (257)
T ss_pred ccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC-------------------
Confidence 567899999999876 567889999999999999999999998877666555443321100
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
....++..+.+||.+||+.||++|||+.+++.|+||
T Consensus 222 ----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 222 ----------MPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred ----------CccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 011356789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=322.88 Aligned_cols=244 Identities=24% Similarity=0.345 Sum_probs=195.0
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||+++... ........+.+|+.+++.++|+||+++++++.. .+.+||||||
T Consensus 19 ~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~----------------~~~~~lv~Ey 82 (331)
T cd05624 19 VVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD----------------ENYLYLVMDY 82 (331)
T ss_pred EEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc----------------CCEEEEEEeC
Confidence 46788899999999997532 222234456789999999999999999999986 5689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
+.+ +|..++.+....+++..++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||++..+..........
T Consensus 83 ~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 162 (331)
T cd05624 83 YVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSV 162 (331)
T ss_pred CCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceeecc
Confidence 985 7777776655578999999999999999999999999999999999999999999999999997765433333334
Q ss_pred ccccCCCCChhhhcCC----CCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 159 RVITLWYRPPELLLGA----TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~----~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
.++|+.|+|||++.+. ..++.++|||||||+||+|++|+.||...+..+.+.++........ ++
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~---~p--------- 230 (331)
T cd05624 163 AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---FP--------- 230 (331)
T ss_pred ccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCccc---CC---------
Confidence 5689999999998642 3478899999999999999999999998887777766643211100 00
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCC--CCCHHHHhcCCCCC
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ--RISAKDALDSEYFW 285 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~--R~t~~elL~h~~f~ 285 (472)
.....+++++++||.+||..++++ |.+++++++|+||.
T Consensus 231 -------------~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~ 270 (331)
T cd05624 231 -------------SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFE 270 (331)
T ss_pred -------------CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcC
Confidence 011246778999999999976655 56999999999995
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=323.01 Aligned_cols=273 Identities=37% Similarity=0.623 Sum_probs=211.5
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||++............+.+|+.++++++|+||+++++++...+.. .....+|||+||+
T Consensus 33 ~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~----------~~~~~~~lv~e~~ 102 (343)
T cd07851 33 SAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL----------EDFQDVYLVTHLM 102 (343)
T ss_pred EEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc----------cccccEEEEEecC
Confidence 367788999999999876543333445677899999999999999999988653210 1134589999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
.++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++...... .....
T Consensus 103 ~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~----~~~~~ 176 (343)
T cd07851 103 GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE----MTGYV 176 (343)
T ss_pred CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc----ccCCc
Confidence 8888887765 35899999999999999999999999999999999999999999999999998765422 23346
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC-Cc
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK-PS 239 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 239 (472)
++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+.+..+.+..+............. ..
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (343)
T cd07851 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLP 256 (343)
T ss_pred ccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhcc
Confidence 68899999998764567899999999999999999999999999888888888877666554443332110000000 00
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL 289 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~~~ 289 (472)
..........+..++.++.+||++||..||++|||+.|||.|+||.....
T Consensus 257 ~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~ 306 (343)
T cd07851 257 QMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD 306 (343)
T ss_pred ccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCC
Confidence 00111233444567889999999999999999999999999999965433
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=310.80 Aligned_cols=240 Identities=33% Similarity=0.497 Sum_probs=195.1
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||+|++..............+|+.++++++|+||+++++++.. ...+|+||||+
T Consensus 17 ~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~----------------~~~~~~v~~~~ 80 (260)
T PF00069_consen 17 KAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD----------------DNYLYIVMEYC 80 (260)
T ss_dssp EEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE----------------SSEEEEEEEEE
T ss_pred EEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc----------------ccccccccccc
Confidence 47889999999999999776554444455679999999999999999999987 66889999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
.+ +|.+++. ....+++.++..++.||+.||++||+++|+|+||||+|||++.++.++|+|||++.... .........
T Consensus 81 ~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~~~~ 158 (260)
T PF00069_consen 81 PGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENFNPF 158 (260)
T ss_dssp TTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEBSSS
T ss_pred cccccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence 98 7777666 33468999999999999999999999999999999999999999999999999987642 223344456
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
.+|..|+|||++.....++.++||||||+++|+|++|..||...+..+....+.+....
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~--------------------- 217 (260)
T PF00069_consen 159 VGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKR--------------------- 217 (260)
T ss_dssp SSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHT---------------------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc---------------------
Confidence 77999999999873367899999999999999999999999988544444444332110
Q ss_pred hhhhhhHHHHh---hhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 240 RTMKRRVREVF---RHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 240 ~~~~~~~~~~~---~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
...... ......+.+||++||..||++|||+.++++||||
T Consensus 218 -----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 218 -----PLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp -----HHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred -----cccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 011111 1123789999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=334.65 Aligned_cols=247 Identities=24% Similarity=0.337 Sum_probs=198.4
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+++.....+.....+.+|+.+|..++|+||+++++.+...+... ......++|||||+
T Consensus 50 ~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~--------~~~~~~i~lV~Ey~ 121 (496)
T PTZ00283 50 CAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN--------PENVLMIALVLDYA 121 (496)
T ss_pred EEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC--------cccceEEEEEEeCC
Confidence 3678899999999999876554444566788999999999999999998876532110 11123578999999
Q ss_pred CC-ChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC-Cc
Q 012062 81 DH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-NT 155 (472)
Q Consensus 81 ~g-~l~~~~~~---~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~ 155 (472)
.+ +|.+.+.. ....+++..++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+..... ..
T Consensus 122 ~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~ 201 (496)
T PTZ00283 122 NAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDV 201 (496)
T ss_pred CCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccc
Confidence 85 77766543 234689999999999999999999999999999999999999999999999999977543222 22
Q ss_pred cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcccc
Q 012062 156 LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (472)
....++|+.|+|||++.+ ..++.++|||||||+||+|++|+.||...+..+.+..+......+
T Consensus 202 ~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~---------------- 264 (496)
T PTZ00283 202 GRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP---------------- 264 (496)
T ss_pred cccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC----------------
Confidence 334578999999999986 568999999999999999999999999888777666654321110
Q ss_pred CCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
+...++.++.+||.+||..||++|||+.++|+|+|+.
T Consensus 265 -------------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~ 301 (496)
T PTZ00283 265 -------------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICK 301 (496)
T ss_pred -------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHH
Confidence 1124677899999999999999999999999999974
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=321.40 Aligned_cols=241 Identities=28% Similarity=0.442 Sum_probs=189.0
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC-CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCCh
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDL 84 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~l 84 (472)
.+.+.||+|++.....+.....-+..||.+|.+|+ |.+||.|+||-.. ++.+||||||-+.||
T Consensus 383 s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~----------------d~~lYmvmE~Gd~DL 446 (677)
T KOG0596|consen 383 SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT----------------DGYLYMVMECGDIDL 446 (677)
T ss_pred CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc----------------CceEEEEeecccccH
Confidence 34577888888776666666777889999999996 9999999999765 778999999999999
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC-CccccccccC
Q 012062 85 TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITL 163 (472)
Q Consensus 85 ~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~ 163 (472)
...+.+...-+....++.|.+|+|.||.++|.+||||.||||.|+|+-. |.+||+|||+|..+..+.. -.....+||+
T Consensus 447 ~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~ 525 (677)
T KOG0596|consen 447 NKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIVKDSQVGTV 525 (677)
T ss_pred HHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccCccccceeeccccCcc
Confidence 9988876555555689999999999999999999999999999999865 6799999999987765432 2344568999
Q ss_pred CCCChhhhcCCC----------CCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 012062 164 WYRPPELLLGAT----------KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 233 (472)
Q Consensus 164 ~y~aPE~l~~~~----------~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (472)
.||+||.+.... +.+.++||||||||||+|+.|++||..-. ..+.++..+...-.+..++....
T Consensus 526 NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~aI~~P~~~Iefp~~~~---- 599 (677)
T KOG0596|consen 526 NYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHAITDPNHEIEFPDIPE---- 599 (677)
T ss_pred cccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHhhcCCCccccccCCCC----
Confidence 999999986421 24678999999999999999999996432 23333333322212222222211
Q ss_pred ccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCCCC
Q 012062 234 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL 289 (472)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~~~ 289 (472)
..++.++++.||..||++|+|+.|||+|+|+...+.
T Consensus 600 --------------------~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i 635 (677)
T KOG0596|consen 600 --------------------NDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPI 635 (677)
T ss_pred --------------------chHHHHHHHHHHhcCcccCCCcHHHhcCcccccccc
Confidence 124899999999999999999999999999965443
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=303.27 Aligned_cols=236 Identities=28% Similarity=0.410 Sum_probs=194.6
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.|++|.+............+.+|++++++++|+||+++++++.. .+.+|+||||+.
T Consensus 19 ~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~ 82 (256)
T cd08529 19 VVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD----------------KGKLNIVMEYAE 82 (256)
T ss_pred EEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc----------------CCEEEEEEEeCC
Confidence 5678899999999998654444456678899999999999999999999876 567899999998
Q ss_pred C-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 82 H-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 82 g-~l~~~~~~~-~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
+ +|.+++... ...+++..++.++.||+.||.|||+++|+|+||||+||+++.++.+||+|||++..+..... .....
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-~~~~~ 161 (256)
T cd08529 83 NGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-FANTI 161 (256)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-hhhcc
Confidence 5 676666543 45689999999999999999999999999999999999999999999999999876643222 22334
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
.++..|+|||++.. ..++.++|||||||++++|++|+.||...+..+...++.+.....
T Consensus 162 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------------------- 220 (256)
T cd08529 162 VGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPP-------------------- 220 (256)
T ss_pred ccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--------------------
Confidence 67889999999876 567899999999999999999999999888766666554321100
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
+...++..+.++|++||+.||++||++.++++|+|+
T Consensus 221 ---------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 221 ---------VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ---------CccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 001356789999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=326.60 Aligned_cols=237 Identities=26% Similarity=0.417 Sum_probs=200.1
Q ss_pred CceeccCCCEEEEEEeecC-CcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMD-NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~-~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
.|+|+.|.+.||||++... +...+.-.++++|++.|++|+|||+|.+.++|.. +...||||||
T Consensus 44 fArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr----------------e~TaWLVMEY 107 (948)
T KOG0577|consen 44 FARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR----------------EHTAWLVMEY 107 (948)
T ss_pred EeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec----------------cchHHHHHHH
Confidence 3899999999999999876 3333345678999999999999999999999976 4567999999
Q ss_pred CCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 80 MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 80 ~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
|-|+-.+++.-...++.+.+|..|+.+.|.||+|||+++.||||||..||||++.|.|||+|||.|.... .-..+
T Consensus 108 ClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~-----PAnsF 182 (948)
T KOG0577|consen 108 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA-----PANSF 182 (948)
T ss_pred HhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC-----chhcc
Confidence 9986555555444578999999999999999999999999999999999999999999999999986654 33458
Q ss_pred cccCCCCChhhhcCC--CCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 160 VITLWYRPPELLLGA--TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~--~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
+||++||||||++.. ..|+-++|||||||+..||...++|+...+....+.-|.........
T Consensus 183 vGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLq---------------- 246 (948)
T KOG0577|consen 183 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ---------------- 246 (948)
T ss_pred cCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCC----------------
Confidence 999999999999753 45899999999999999999999999888887777777543211100
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
-..+++.++.||.+||.+-|.+|||.+++|.|+|...
T Consensus 247 ------------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 247 ------------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred ------------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 1247788999999999999999999999999999855
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=311.65 Aligned_cols=241 Identities=24% Similarity=0.393 Sum_probs=189.3
Q ss_pred CceeccCCCEEEEEEeecCCcCC-CchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEKE-GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|.+..+++.||||++....... .....+.+|+.++++++|+||+.+++.+.. ++.+||||||
T Consensus 18 ~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~----------------~~~~~lv~e~ 81 (285)
T cd05630 18 ACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET----------------KDALCLVLTL 81 (285)
T ss_pred EEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec----------------CCEEEEEEEe
Confidence 36788899999999997653322 223456789999999999999999999876 5679999999
Q ss_pred CCC-ChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 80 MDH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 80 ~~g-~l~~~~~~-~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
+.+ +|.+++.. ....+++.++..++.||+.||.|||+++|+||||||+||+++.++.++|+|||++...... ....
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~--~~~~ 159 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--QTIK 159 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC--cccc
Confidence 985 66665543 2335899999999999999999999999999999999999999999999999998764322 1223
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
...+|..|+|||++.+ ..++.++|||||||++|+|++|+.||...................
T Consensus 160 ~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~------------------ 220 (285)
T cd05630 160 GRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV------------------ 220 (285)
T ss_pred CCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh------------------
Confidence 3468999999999976 568999999999999999999999998754322111111110000
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCC-----HHHHhcCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 286 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t-----~~elL~h~~f~~ 286 (472)
.......++.++++||++||+.||++|+| ++|+++|+||..
T Consensus 221 --------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 221 --------QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred --------hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 00112346778999999999999999999 999999999953
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=312.12 Aligned_cols=269 Identities=23% Similarity=0.293 Sum_probs=194.6
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
++++..+++.||||+++...........+.+|+++++.++|+||++++++|.. .+.+|++|||+
T Consensus 18 ~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~----------------~~~~~~~~e~~ 81 (314)
T cd08216 18 LAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV----------------DSELYVVSPLM 81 (314)
T ss_pred EEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec----------------CCeEEEEEecc
Confidence 36778899999999998764444456678899999999999999999999976 55789999999
Q ss_pred CC-ChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC-----
Q 012062 81 DH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN----- 153 (472)
Q Consensus 81 ~g-~l~~~~~~-~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~----- 153 (472)
.+ ++.+++.. ....+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+||+.+........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 82 AYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 95 56565554 234588999999999999999999999999999999999999999999999998875532211
Q ss_pred -CccccccccCCCCChhhhcCC-CCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC--CCCCCccCCC
Q 012062 154 -NTLTNRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSP--DETIWPGVSK 229 (472)
Q Consensus 154 -~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~ 229 (472)
.......++..|+|||++... ..++.++|||||||++|+|++|+.||........+.......... ....++....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence 111223457789999998753 347889999999999999999999998876554433222211100 0000000000
Q ss_pred -CCcc-ccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 230 -MPAY-NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 230 -~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
.... ...................++.++.+||++||..||++|||++++|+|+||.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~ 299 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFK 299 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHh
Confidence 0000 0000000011111122235677899999999999999999999999999995
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=318.61 Aligned_cols=280 Identities=34% Similarity=0.596 Sum_probs=204.2
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||++..... .....+.+|++++++++|+||+++++++......... ..........+|+||||+
T Consensus 23 ~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~lv~e~~ 98 (342)
T cd07854 23 SAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE--DVGSLTELNSVYIVQEYM 98 (342)
T ss_pred EEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc--ccccccccceEEEEeecc
Confidence 367889999999999976543 2345678999999999999999999988764321100 000011134689999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC-CCCeEEeeccceeeeccCCC--Cccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN-EGNLKLADFGLARSFSYDHN--NTLT 157 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~-~~~vkL~DFG~a~~~~~~~~--~~~~ 157 (472)
.++|...+.. ..+++..++.++.||++||.|||++||+||||||+||+++. +..+||+|||++........ ....
T Consensus 99 ~~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 176 (342)
T cd07854 99 ETDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLS 176 (342)
T ss_pred cccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccc
Confidence 9888776654 35899999999999999999999999999999999999985 44689999999876532211 1112
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC-CCccccC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK-MPAYNHF 236 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~ 236 (472)
...++..|+|||++.....++.++|||||||++|+|++|+.||...+..+.+..+...........+..... .+... .
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 255 (342)
T cd07854 177 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFV-R 255 (342)
T ss_pred cccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhh-h
Confidence 235688999999887656688899999999999999999999999888887777765443322211111110 00000 0
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
................++.++++||++||..||++|+|+.|+|.|+||..-
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 256 NDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred hcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 001111222334455688899999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=318.20 Aligned_cols=269 Identities=37% Similarity=0.618 Sum_probs=205.2
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||++............+.+|+.+|++++|+||+++++++...... ..-..+||||||+.
T Consensus 34 ~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~----------~~~~~~~lv~e~~~ 103 (343)
T cd07880 34 ALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL----------DRFHDFYLVMPFMG 103 (343)
T ss_pred EEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc----------cccceEEEEEecCC
Confidence 57788999999999976544444455678999999999999999999998753211 01235799999997
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccc
Q 012062 82 HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 161 (472)
Q Consensus 82 g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 161 (472)
++|..++.. ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++..... ......+
T Consensus 104 ~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~----~~~~~~~ 177 (343)
T cd07880 104 TDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS----EMTGYVV 177 (343)
T ss_pred CCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc----Ccccccc
Confidence 777766654 3589999999999999999999999999999999999999999999999999875432 2223456
Q ss_pred cCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc--cccCCCc
Q 012062 162 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA--YNHFKPS 239 (472)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 239 (472)
+..|+|||++.+...++.++|+|||||++|+|++|+.||...+....+.+++..........+........ +....+
T Consensus 178 ~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 256 (343)
T cd07880 178 TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLP- 256 (343)
T ss_pred CCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhcc-
Confidence 88999999987645578899999999999999999999999888777777776554433222221111000 000000
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
.............++..+.+||.+||..||++|+|+.+++.|+||...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 257 RFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred ccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 001112334456778899999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=322.22 Aligned_cols=237 Identities=24% Similarity=0.351 Sum_probs=201.3
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
+++.+||+.||||+|.+.+........++.|+.||.++.||.||.|.-.|+. .+.+++|||-+.
T Consensus 583 g~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET----------------~ervFVVMEKl~ 646 (888)
T KOG4236|consen 583 GKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET----------------PERVFVVMEKLH 646 (888)
T ss_pred ceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC----------------CceEEEEehhhc
Confidence 5788999999999998776555566788999999999999999999999988 558999999999
Q ss_pred CChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC---CeEEeeccceeeeccCCCCccc
Q 012062 82 HDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG---NLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 82 g~l~~~~~~-~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~---~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
||.++.+.. ...++++...+.++.|||.||.|||.++|+|+|||||||||.+.. ++||||||+|+.+.... ...
T Consensus 647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--FRr 724 (888)
T KOG4236|consen 647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--FRR 724 (888)
T ss_pred chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh--hhh
Confidence 999887765 556899999999999999999999999999999999999997654 59999999999887543 334
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..+||+.|+|||||++ +.|....|+||+|||+|.-|+|..||.... ++-.+|.+...-.+...
T Consensus 725 sVVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~P-------------- 787 (888)
T KOG4236|consen 725 SVVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNP-------------- 787 (888)
T ss_pred hhcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCc--------------
Confidence 4689999999999987 679999999999999999999998886443 34444543333233333
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
|+.++.++.|||..+|+..-.+|.|.+..|.|+|+.
T Consensus 788 ------------W~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq 823 (888)
T KOG4236|consen 788 ------------WSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQ 823 (888)
T ss_pred ------------hhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhh
Confidence 346788999999999999999999999999999984
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=305.00 Aligned_cols=267 Identities=42% Similarity=0.778 Sum_probs=207.1
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc---CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEE
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL---QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVF 77 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVm 77 (472)
+|++..+++.||||+++...........+.+|+.+++++ +|+||+++++++...+.. ....+|+||
T Consensus 17 ~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~-----------~~~~~~l~~ 85 (287)
T cd07838 17 KARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTD-----------RELKLTLVF 85 (287)
T ss_pred EEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCC-----------CCceeEEEe
Confidence 356777899999999986654444445566788888776 599999999999873211 123589999
Q ss_pred ecCCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcc
Q 012062 78 EYMDHDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTL 156 (472)
Q Consensus 78 Ey~~g~l~~~~~~~~-~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 156 (472)
||+.++|.+++.+.. ..+++..++.++.||+.||+|||+++|+|+||||+||+++.++++||+|||++..+.... ..
T Consensus 86 e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~--~~ 163 (287)
T cd07838 86 EHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM--AL 163 (287)
T ss_pred hhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCCc--cc
Confidence 999988877665532 358999999999999999999999999999999999999999999999999987764332 22
Q ss_pred ccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccC
Q 012062 157 TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236 (472)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (472)
....++..|+|||++.+ ..++.++|||||||++|+|++|.++|...+..+.+.++++.........|+......... +
T Consensus 164 ~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 241 (287)
T cd07838 164 TSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSS-F 241 (287)
T ss_pred ccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhh-c
Confidence 23356888999999986 568899999999999999999999999999999998888766555444443222110000 0
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
..............++..+.+||.+||..||++||++.|++.|+||
T Consensus 242 --~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 242 --PSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred --ccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0011122244445677889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=303.94 Aligned_cols=237 Identities=24% Similarity=0.368 Sum_probs=186.8
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||+++..... ....+.+|+.+++.++|+||+++++++.. .+.+|+||||++
T Consensus 28 ~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~~~~l~h~~ii~~~~~~~~----------------~~~~~lv~e~~~ 89 (267)
T cd06645 28 ARNVNTGELAAIKVIKLEPGE--DFAVVQQEIIMMKDCKHSNIVAYFGSYLR----------------RDKLWICMEFCG 89 (267)
T ss_pred EEEcCCCcEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCeeeEEEEEEe----------------CCEEEEEEeccC
Confidence 677889999999999765322 23456789999999999999999999976 567899999998
Q ss_pred C-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 82 H-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 82 g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+ +|.+++.. ...+++.+++.++.||+.+|.|||++||+|+||||+||+++.++.+||+|||++...... ........
T Consensus 90 ~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~ 167 (267)
T cd06645 90 GGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT-IAKRKSFI 167 (267)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc-cccccccc
Confidence 6 66665544 346899999999999999999999999999999999999999999999999998765432 22223456
Q ss_pred ccCCCCChhhhcC--CCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 161 ITLWYRPPELLLG--ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 161 gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
++..|+|||++.. ...++.++|||||||++|+|++|..||........+..+......+. .+..
T Consensus 168 ~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~--~~~~------------ 233 (267)
T cd06645 168 GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP--KLKD------------ 233 (267)
T ss_pred CcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCC--cccc------------
Confidence 7999999998742 24578899999999999999999999876655443333221110000 0000
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 283 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~ 283 (472)
...++..+.+||++||..||++|||++++++|+|
T Consensus 234 -----------~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 234 -----------KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred -----------cCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 0125667899999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=318.01 Aligned_cols=269 Identities=38% Similarity=0.637 Sum_probs=205.3
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
|++..+++.||||++............+.+|+.+++++ +|+||+++++++...+ ...+||||||+
T Consensus 26 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~--------------~~~~~lv~e~~ 91 (337)
T cd07852 26 AIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN--------------DKDIYLVFEYM 91 (337)
T ss_pred EEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCC--------------CceEEEEeccc
Confidence 56778899999999865433322344567899999999 9999999999986521 34689999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC----Ccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN----NTL 156 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~----~~~ 156 (472)
.++|...+... .+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++........ ...
T Consensus 92 ~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~ 169 (337)
T cd07852 92 ETDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVL 169 (337)
T ss_pred ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcch
Confidence 99888777654 678889999999999999999999999999999999999999999999999876543322 123
Q ss_pred ccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccC
Q 012062 157 TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236 (472)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (472)
....+|..|+|||++.+...++.++|||||||++|+|++|+.||.+....+.+.++......+....+...........+
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (337)
T cd07852 170 TDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATML 249 (337)
T ss_pred hcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhh
Confidence 34567899999998876566789999999999999999999999998888888877766554433222211100000000
Q ss_pred -CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 237 -KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 237 -~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
..............+.++.++.+||.+||+.||++|||+.++++|+||..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~ 300 (337)
T cd07852 250 DSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300 (337)
T ss_pred hhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhh
Confidence 00000111223344557889999999999999999999999999999954
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=316.94 Aligned_cols=269 Identities=36% Similarity=0.607 Sum_probs=205.8
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||+++.....+.....+.+|+.++++++|+||+++++++...... .....+|+||||+.
T Consensus 34 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~----------~~~~~~~lv~e~~~ 103 (342)
T cd07879 34 AIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSG----------DEFQDFYLVMPYMQ 103 (342)
T ss_pred EEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccC----------CCCceEEEEecccc
Confidence 56788999999999986544444556678999999999999999999998753211 11245799999998
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccc
Q 012062 82 HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 161 (472)
Q Consensus 82 g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 161 (472)
.++..... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.... ......+
T Consensus 104 ~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~----~~~~~~~ 176 (342)
T cd07879 104 TDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA----EMTGYVV 176 (342)
T ss_pred cCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC----CCCCcee
Confidence 77665542 2589999999999999999999999999999999999999999999999999865422 2233466
Q ss_pred cCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC-Cch
Q 012062 162 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK-PSR 240 (472)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 240 (472)
+..|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..+....+.+....+............. ...
T Consensus 177 ~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (342)
T cd07879 177 TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPK 256 (342)
T ss_pred eecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCC
Confidence 8899999998764567889999999999999999999999998888888887766554433222221100000000 000
Q ss_pred hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
.........+..++.++++||++||+.||++|+|+.|+|.|+||...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 257 YPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred cccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 01122333445678889999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=314.82 Aligned_cols=271 Identities=37% Similarity=0.618 Sum_probs=207.0
Q ss_pred ceeccC--CCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 2 AREIKT--GEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 2 a~~~~t--g~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
|++..+ ++.||||+++...........+.+|+.+++++ +|+||+++++.+.... .....+|++||
T Consensus 19 ~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~------------~~~~~~~~~~e 86 (332)
T cd07857 19 ARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP------------GNFNELYLYEE 86 (332)
T ss_pred EEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc------------ccCCcEEEEEe
Confidence 556666 88999999976544444456778999999999 5999999998765421 01346799999
Q ss_pred cCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC---Cc
Q 012062 79 YMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN---NT 155 (472)
Q Consensus 79 y~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~---~~ 155 (472)
|+.++|...+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+..... ..
T Consensus 87 ~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 165 (332)
T cd07857 87 LMEADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF 165 (332)
T ss_pred cccCCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccccccccc
Confidence 9999888777543 4689999999999999999999999999999999999999999999999999976543221 11
Q ss_pred cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcccc
Q 012062 156 LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (472)
....++|..|+|||++.+...++.++|||||||++|+|++|+.||...+....+..++...+.+....+...........
T Consensus 166 ~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (332)
T cd07857 166 MTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNY 245 (332)
T ss_pred ccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHH
Confidence 23346799999999887655688999999999999999999999999998888888888777665443332221100000
Q ss_pred CCC-chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 236 FKP-SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 236 ~~~-~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
... ...........+..++..+++||.+||+.||++|+|+.|++.|+||.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~ 296 (332)
T cd07857 246 IRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296 (332)
T ss_pred HHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhh
Confidence 000 00000112233345678899999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=307.28 Aligned_cols=264 Identities=37% Similarity=0.637 Sum_probs=210.6
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC-CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
|++..+++.||||++....... ......+|+..+++++ |+||+++++++.. ++.+|+||||+
T Consensus 18 ~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~----------------~~~~~lv~e~~ 80 (283)
T cd07830 18 ARNKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNEHPNIVKLKEVFRE----------------NDELYFVFEYM 80 (283)
T ss_pred EEECCCCcEEEEEEehhhccch-hHHHHHHHHHHHHhccCCCCchhHHHHhhc----------------CCcEEEEEecC
Confidence 5667789999999987553321 2234467999999999 9999999999876 55789999999
Q ss_pred CCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 81 DHDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 81 ~g~l~~~~~~~~-~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
.+++.+.+.... ..+++.+++.++.||+.+|.|||+++|+|+||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--~~~~~ 158 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--PYTDY 158 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC--CcCCC
Confidence 888888776643 468999999999999999999999999999999999999999999999999997654322 22345
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
.++..|+|||++.....++.++|+||||+++++|++|+.+|...+..+.+.++....+.+....|.....+.........
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07830 159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFP 238 (283)
T ss_pred CCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccc
Confidence 67889999999876566789999999999999999999999999999999999888888776666554332221111111
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
..............+..+++||++||..||++|||++|++.|+||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 239 QFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 111122233344457889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=308.04 Aligned_cols=240 Identities=25% Similarity=0.408 Sum_probs=192.6
Q ss_pred ceeccCCCEEEEEEeecCCcC-CCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 2 AREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
|++..+++.||||++...... ......+.+|+.+|++++|+||+++++.+.. ++.+|+||||+
T Consensus 19 ~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~----------------~~~~~lv~e~~ 82 (285)
T cd05632 19 CQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET----------------KDALCLVLTIM 82 (285)
T ss_pred EEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec----------------CCEEEEEEEec
Confidence 677889999999999765322 2233456789999999999999999999876 56789999999
Q ss_pred CC-ChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 81 DH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 81 ~g-~l~~~~~~-~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
.+ +|...+.. ....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++...... .....
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~ 160 (285)
T cd05632 83 NGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--ESIRG 160 (285)
T ss_pred cCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC--CcccC
Confidence 96 56555543 2346999999999999999999999999999999999999999999999999998664322 22234
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
..++..|+|||++.+ ..++.++|||||||++|+|++|..||....+......+..........
T Consensus 161 ~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~---------------- 223 (285)
T cd05632 161 RVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEV---------------- 223 (285)
T ss_pred CCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccc----------------
Confidence 568999999999976 568899999999999999999999998877655544443322111110
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCC-----HHHHhcCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 286 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t-----~~elL~h~~f~~ 286 (472)
....++.++.+||.+||..||++|+| +.+++.|+||..
T Consensus 224 ----------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05632 224 ----------YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRN 266 (285)
T ss_pred ----------cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhc
Confidence 11246678999999999999999999 899999999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=299.48 Aligned_cols=237 Identities=28% Similarity=0.457 Sum_probs=196.7
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
++++..+++.|++|++............+.+|+.++++++|+||+++++++.+ .+.+++||||+
T Consensus 18 ~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----------------~~~~~~~~e~~ 81 (256)
T cd08221 18 LYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD----------------DNTLLIEMEYA 81 (256)
T ss_pred EEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec----------------CCeEEEEEEec
Confidence 36788999999999998665444455678899999999999999999999986 55789999999
Q ss_pred CC-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 81 DH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 81 ~g-~l~~~~~~~-~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
.+ +|.+.+.+. ...+++.++..++.||+.+|.|||+++|+|+||||+||+++.++.+||+|||++........ ....
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~~~~ 160 (256)
T cd08221 82 NGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-MAET 160 (256)
T ss_pred CCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-cccc
Confidence 85 777766553 45689999999999999999999999999999999999999999999999999977643332 2334
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
..++..|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+......+.
T Consensus 161 ~~~~~~y~ape~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~------------------ 221 (256)
T cd08221 161 VVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPV------------------ 221 (256)
T ss_pred cCCCccccCHhhcCC-CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC------------------
Confidence 567999999999876 4578899999999999999999999988877776666643211000
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
...++.++.+||.+||..||++|||++|+|+|+|+
T Consensus 222 -----------~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 222 -----------VSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred -----------ccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 02356789999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=303.13 Aligned_cols=236 Identities=28% Similarity=0.536 Sum_probs=188.8
Q ss_pred ceeccCCCEEEEEEeecCCcCC-------CchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEE
Q 012062 2 AREIKTGEIVALKKIRMDNEKE-------GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTY 74 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~-------~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 74 (472)
|++..+++.||||.+....... .....+.+|+.++++++|+||+++++++.. .+.++
T Consensus 19 a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~ 82 (267)
T cd06628 19 GMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD----------------ADHLN 82 (267)
T ss_pred EEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe----------------CCccE
Confidence 5677889999999987653221 123457789999999999999999999876 55789
Q ss_pred EEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC
Q 012062 75 MVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 153 (472)
Q Consensus 75 iVmEy~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 153 (472)
+||||+.+ +|..++... ..+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||+++.......
T Consensus 83 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06628 83 IFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSL 161 (267)
T ss_pred EEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccccc
Confidence 99999986 565665443 4688999999999999999999999999999999999999999999999999876642211
Q ss_pred -----CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCC
Q 012062 154 -----NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 228 (472)
Q Consensus 154 -----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 228 (472)
.......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+....+..+......
T Consensus 162 ~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------- 230 (267)
T cd06628 162 STKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASP---------- 230 (267)
T ss_pred cCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCC----------
Confidence 11122356889999999876 56788999999999999999999999887665554443221100
Q ss_pred CCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 229 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
.+...++..+.+||++||+.||.+||++.|+++|+||
T Consensus 231 -------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 231 -------------------EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred -------------------cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 0112356789999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=307.99 Aligned_cols=232 Identities=16% Similarity=0.155 Sum_probs=184.5
Q ss_pred eccCCCEEEEEEeecCCcCC-CchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC
Q 012062 4 EIKTGEIVALKKIRMDNEKE-GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH 82 (472)
Q Consensus 4 ~~~tg~~vAlK~i~~~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g 82 (472)
.+.+|+.||||+++...... .....+.+|+.+|++++|+|||++++++.+.. .....++|||||+.+
T Consensus 39 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~------------~~~~~~~lv~Ey~~~ 106 (283)
T PHA02988 39 GIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV------------DDLPRLSLILEYCTR 106 (283)
T ss_pred EEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc------------cCCCceEEEEEeCCC
Confidence 34588999999998654322 22456679999999999999999999986511 013468999999996
Q ss_pred -ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 83 -DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 83 -~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~-giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+|.+++.+ ...+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++..... ....+
T Consensus 107 g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~----~~~~~ 181 (283)
T PHA02988 107 GYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP----PFKNV 181 (283)
T ss_pred CcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc----ccccc
Confidence 56666554 34688999999999999999999984 9999999999999999999999999998754321 12346
Q ss_pred ccCCCCChhhhcCC-CCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 161 ITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 161 gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
+|..|+|||++.+. ..++.++|||||||++|+|++|+.||...+..+.+..+......+..
T Consensus 182 ~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~------------------ 243 (283)
T PHA02988 182 NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKL------------------ 243 (283)
T ss_pred CcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC------------------
Confidence 78999999998652 46899999999999999999999999988877776666432211110
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...++..+++||.+||+.||++|||+.|+++
T Consensus 244 ----------~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 244 ----------PLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred ----------CCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 0135678999999999999999999999985
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=305.57 Aligned_cols=239 Identities=25% Similarity=0.353 Sum_probs=190.9
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
+++..++..||+|.+...... ....+.+|+++++.++|+||+++++++.. .+..|+||||+.
T Consensus 24 ~~~~~~~~~~~~k~~~~~~~~--~~~~~~~e~~~l~~l~h~~ii~~~~~~~~----------------~~~~~~v~e~~~ 85 (282)
T cd06643 24 AQNKETGVLAAAKVIDTKSEE--ELEDYMVEIDILASCDHPNIVKLLDAFYY----------------ENNLWILIEFCA 85 (282)
T ss_pred EEECCCCeEEEEEEeCCCCHH--HHHHHHHHHHHHHHCCCCCeeeEEEEEee----------------CCEEEEEEEecC
Confidence 567788999999998654322 24567789999999999999999999976 557899999999
Q ss_pred CC-hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 82 HD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 82 g~-l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
++ |..++.+....+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++...... ........
T Consensus 86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~ 164 (282)
T cd06643 86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRRDSFI 164 (282)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc-cccccccc
Confidence 64 44555444456899999999999999999999999999999999999999999999999998654322 12223346
Q ss_pred ccCCCCChhhhcC----CCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccC
Q 012062 161 ITLWYRPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236 (472)
Q Consensus 161 gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (472)
++..|+|||++.. ...++.++|||||||++|+|++|+.||...+..+....+........
T Consensus 165 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------- 228 (282)
T cd06643 165 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL---------------- 228 (282)
T ss_pred ccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCC----------------
Confidence 7899999998842 24467899999999999999999999988877666555533211000
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.....++.++++||++||..||.+|||+.++++|+||..
T Consensus 229 -----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 267 (282)
T cd06643 229 -----------AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTV 267 (282)
T ss_pred -----------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEec
Confidence 001135678999999999999999999999999999965
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=296.55 Aligned_cols=239 Identities=24% Similarity=0.344 Sum_probs=197.7
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
++..+||..+|||.+++...++ ..+++++.+.++.+. .+|+||+++++|.. +..++|.||.|
T Consensus 111 ~~~rs~~~iiAVK~M~rt~Nke-e~kRILmDldvv~~s~dcpyIV~c~GyFi~----------------n~dV~IcMelM 173 (391)
T KOG0983|consen 111 MRFRSTGHIIAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVQCFGYFIT----------------NTDVFICMELM 173 (391)
T ss_pred EEEcccceEEEEEeecccCCHH-HHHHHHHhhhHHhhccCCCeeeeeeeEEee----------------CchHHHHHHHH
Confidence 5678899999999998775554 456777788877665 49999999999987 55689999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~-giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
...+..++++....++|..+-++...++.||.||.++ +|+|||+||+|||||..|++||||||++-.+-+. ...+..
T Consensus 174 s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS--kAhtrs 251 (391)
T KOG0983|consen 174 STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS--KAHTRS 251 (391)
T ss_pred HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc--cccccc
Confidence 9877777777666799999999999999999999865 9999999999999999999999999999766433 334445
Q ss_pred cccCCCCChhhhcC--CCCCCCCcchhhHHHHHHHHHhCCCCCCC-CChHHHHHHHHHhcCCCCCCCCccCCCCCccccC
Q 012062 160 VITLWYRPPELLLG--ATKYGPAVDMWSVGCIFAELLNGKPILPG-KNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236 (472)
Q Consensus 160 ~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~ell~G~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (472)
.|.+.|||||.+-- ...|+.++||||||++|+||.||+.||.+ +.+.+++.++.+... +. .+.
T Consensus 252 AGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP--P~--L~~---------- 317 (391)
T KOG0983|consen 252 AGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP--PL--LPG---------- 317 (391)
T ss_pred cCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC--CC--CCc----------
Confidence 78999999999853 24689999999999999999999999997 467888888876321 10 000
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
-..|+..+++|+..||.+|+.+||.-.++|+|+|+..
T Consensus 318 -------------~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 318 -------------HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKR 354 (391)
T ss_pred -------------ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceee
Confidence 0137889999999999999999999999999999853
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=307.58 Aligned_cols=239 Identities=25% Similarity=0.367 Sum_probs=189.7
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||+|++..... .....+.+|+++++.++|+||+++++++.. ++.+|+||||+.
T Consensus 31 ~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~ 92 (292)
T cd06644 31 AKNKETGALAAAKVIETKSE--EELEDYMVEIEILATCNHPYIVKLLGAFYW----------------DGKLWIMIEFCP 92 (292)
T ss_pred EEECCCCceEEEEEeccCCH--HHHHHHHHHHHHHHhCCCCcEeeeEEEEEe----------------CCeEEEEEecCC
Confidence 67788999999999975432 235567789999999999999999999876 557899999999
Q ss_pred CC-hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 82 HD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 82 g~-l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
++ |..++.+....+++.+++.++.||+.+|+|||+++|+||||||+||+++.++++||+|||++...... ........
T Consensus 93 ~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~ 171 (292)
T cd06644 93 GGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQRRDSFI 171 (292)
T ss_pred CCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc-ccccceec
Confidence 75 44455444456899999999999999999999999999999999999999999999999998654322 12223345
Q ss_pred ccCCCCChhhhcC----CCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccC
Q 012062 161 ITLWYRPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236 (472)
Q Consensus 161 gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (472)
++..|+|||++.. ...++.++|||||||++|+|++|..||...+....+.++....... .
T Consensus 172 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------~--------- 235 (292)
T cd06644 172 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-------L--------- 235 (292)
T ss_pred CCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCcc-------C---------
Confidence 7889999998853 2446789999999999999999999998877655554443211000 0
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.....++.++.+||++||..||++||+++|+++|+||..
T Consensus 236 -----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 236 -----------SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred -----------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 001135667999999999999999999999999999943
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=305.78 Aligned_cols=239 Identities=26% Similarity=0.400 Sum_probs=191.6
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||+|+++..... ....+.+|++++++++|+||+++++++.. +..+||||||++
T Consensus 24 ~~~~~~~~~~~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~ 85 (280)
T cd06611 24 AQHKETGLFAAAKIIQIESEE--ELEDFMVEIDILSECKHPNIVGLYEAYFY----------------ENKLWILIEFCD 85 (280)
T ss_pred EEEcCCCcEEEEEEEeeCCHH--HHHHHHHHHHHHHhCCCCceeEEEEEEec----------------CCeEEEEeeccC
Confidence 566778999999999754322 34567789999999999999999999986 557899999999
Q ss_pred C-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 82 H-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 82 g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+ +|..++.+....+++.+++.++.||+.+|.|||+++|+|+||||+||+++.++.++|+|||++....... .......
T Consensus 86 ~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~ 164 (280)
T cd06611 86 GGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-QKRDTFI 164 (280)
T ss_pred CCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc-cccceee
Confidence 7 5666665555579999999999999999999999999999999999999999999999999886543222 1223346
Q ss_pred ccCCCCChhhhcC----CCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccC
Q 012062 161 ITLWYRPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236 (472)
Q Consensus 161 gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (472)
++..|++||++.. ...++.++|||||||++|+|++|+.||...+....+.++....... .
T Consensus 165 ~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------~--------- 228 (280)
T cd06611 165 GTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPT-------L--------- 228 (280)
T ss_pred cchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCC-------c---------
Confidence 7899999999852 2346789999999999999999999998877666555543211000 0
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.....++.++.+||.+||..||.+|||+.++|+|+||..
T Consensus 229 -----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 267 (280)
T cd06611 229 -----------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD 267 (280)
T ss_pred -----------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcc
Confidence 001235678999999999999999999999999999954
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=316.06 Aligned_cols=222 Identities=28% Similarity=0.449 Sum_probs=190.3
Q ss_pred CEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC-CChhhh
Q 012062 9 EIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD-HDLTGL 87 (472)
Q Consensus 9 ~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~-g~l~~~ 87 (472)
..||+|.++.... ....+++|++||++|+|+|||+++++++. ++-+|||||||. |+|+++
T Consensus 231 ~~vavk~ik~~~m---~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~----------------~~piyIVtE~m~~GsLl~y 291 (468)
T KOG0197|consen 231 TKVAVKTIKEGSM---SPEAFLREAQIMKKLRHEKLVKLYGVCTK----------------QEPIYIVTEYMPKGSLLDY 291 (468)
T ss_pred CcccceEEecccc---ChhHHHHHHHHHHhCcccCeEEEEEEEec----------------CCceEEEEEecccCcHHHH
Confidence 3799999986532 34567799999999999999999999986 346999999998 689988
Q ss_pred hcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccCCCC
Q 012062 88 ADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYR 166 (472)
Q Consensus 88 ~~~-~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~ 166 (472)
+.. ....+...+.+.++.||++|++||+++++|||||-..||||+++..+||+|||+|+...++.............|.
T Consensus 292 Lr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWt 371 (468)
T KOG0197|consen 292 LRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWT 371 (468)
T ss_pred hhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceec
Confidence 886 5567999999999999999999999999999999999999999999999999999965555444444444577899
Q ss_pred ChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhh
Q 012062 167 PPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRR 245 (472)
Q Consensus 167 aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (472)
|||++.- ..++.++||||+||+|+||+| |+.||++.+..+.+..+.+...-+..
T Consensus 372 APEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P------------------------ 426 (468)
T KOG0197|consen 372 APEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRP------------------------ 426 (468)
T ss_pred CHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCC------------------------
Confidence 9999976 679999999999999999998 99999999999999988765433322
Q ss_pred HHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHh
Q 012062 246 VREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 279 (472)
Q Consensus 246 ~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL 279 (472)
..+++++.+|+..|+..+|++|||++.+.
T Consensus 427 -----~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 427 -----EGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred -----CCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 24778899999999999999999998765
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=301.01 Aligned_cols=241 Identities=24% Similarity=0.411 Sum_probs=188.4
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
|++..+++.||||+++.... ....+.+|+.+++++ +|+||+++++++...... .....+||||||+
T Consensus 25 ~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~----------~~~~~~~iv~e~~ 91 (272)
T cd06637 25 GRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP----------GMDDQLWLVMEFC 91 (272)
T ss_pred EEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC----------CCCcEEEEEEEcC
Confidence 56788999999999975432 234678899999999 699999999999763221 1135789999999
Q ss_pred CC-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 81 DH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 81 ~g-~l~~~~~~~-~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
.+ +|.+++... ...+++..+..++.||+.||+|||+++|+|+||||+||+++.++.+||+|||++....... .....
T Consensus 92 ~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~ 170 (272)
T cd06637 92 GAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV-GRRNT 170 (272)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceeccccc-ccCCc
Confidence 85 676666542 3468999999999999999999999999999999999999999999999999987654322 22334
Q ss_pred ccccCCCCChhhhcC----CCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 159 RVITLWYRPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
..++..|+|||++.+ ...++.++|||||||++|+|++|..||...........+... ....
T Consensus 171 ~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~---~~~~------------ 235 (272)
T cd06637 171 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PAPR------------ 235 (272)
T ss_pred ccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---CCCC------------
Confidence 567899999999863 235788999999999999999999999766554443333210 0000
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
.....++.++.+||.+||..||.+|||+.|+++|+||
T Consensus 236 -------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 236 -------------LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred -------------CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 0011356689999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=309.22 Aligned_cols=240 Identities=27% Similarity=0.448 Sum_probs=192.0
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||++..... .....+.+|+.++++++|+||+++++.+.. .+.+|+||||+.
T Consensus 41 ~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~----------------~~~~~lv~e~~~ 102 (292)
T cd06658 41 ATEKHTGKQVAVKKMDLRKQ--QRRELLFNEVVIMRDYHHENVVDMYNSYLV----------------GDELWVVMEFLE 102 (292)
T ss_pred EEECCCCCEEEEEEEecchH--HHHHHHHHHHHHHHhCCCCcHHHHHHheec----------------CCeEEEEEeCCC
Confidence 56778999999999875432 234567899999999999999999999876 557899999998
Q ss_pred CC-hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 82 HD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 82 g~-l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
++ |.+++.. ..+++.+++.++.||+.+|+|||+++|+||||||+||+++.++.+||+|||++........ ......
T Consensus 103 ~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~ 179 (292)
T cd06658 103 GGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSLV 179 (292)
T ss_pred CCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCceee
Confidence 75 4444433 3589999999999999999999999999999999999999999999999999875533222 223346
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (472)
++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+....+..+.........
T Consensus 180 ~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------------- 239 (292)
T cd06658 180 GTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVK------------------- 239 (292)
T ss_pred cCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccc-------------------
Confidence 7899999999876 56789999999999999999999999988776665554332111000
Q ss_pred hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCCCCC
Q 012062 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 290 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~~~~ 290 (472)
....++..+.+||.+||..||++|||++|+|+|+||.....+
T Consensus 240 --------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 240 --------DSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred --------cccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence 001356679999999999999999999999999999765443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=314.89 Aligned_cols=231 Identities=22% Similarity=0.383 Sum_probs=177.5
Q ss_pred ccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-
Q 012062 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH- 82 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g- 82 (472)
..+++.||||+++.... ......+++|+.+|+++ +|+|||++++++... .+.+||||||+.+
T Consensus 34 ~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~---------------~~~~~lv~ey~~~g 97 (338)
T cd05102 34 KSSCNTVAVKMLKEGAT-ASEHKALMSELKILIHIGNHLNVVNLLGACTKP---------------NGPLMVIVEFCKYG 97 (338)
T ss_pred cccchhhheeccccccc-hHHHHHHHHHHHHHHHhccCcceeeEEeEecCC---------------CCceEEEEecCCCC
Confidence 35667899999975432 22345688999999999 899999999988652 3468999999985
Q ss_pred ChhhhhcCC-------------------------------------------------------------CCCCCHHHHH
Q 012062 83 DLTGLADRP-------------------------------------------------------------GLRFTVPQIK 101 (472)
Q Consensus 83 ~l~~~~~~~-------------------------------------------------------------~~~l~~~~i~ 101 (472)
+|.+++... ...+++..+.
T Consensus 98 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 177 (338)
T cd05102 98 NLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLI 177 (338)
T ss_pred cHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHHHH
Confidence 666655432 1247788899
Q ss_pred HHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC-ccccccccCCCCChhhhcCCCCCCCC
Q 012062 102 CYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPA 180 (472)
Q Consensus 102 ~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~ 180 (472)
.|+.||+.||+|||+++|+||||||+|||++.++.+||+|||+++........ ......++..|+|||++.+ ..++.+
T Consensus 178 ~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~ 256 (338)
T cd05102 178 CYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFD-KVYTTQ 256 (338)
T ss_pred HHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhc-CCCCcc
Confidence 99999999999999999999999999999999999999999999765322211 1122344678999999976 568999
Q ss_pred cchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHH
Q 012062 181 VDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALE 259 (472)
Q Consensus 181 ~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (472)
+|||||||+||+|++ |..||.+....+.+.......... .....++..+.+
T Consensus 257 sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~ 308 (338)
T cd05102 257 SDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM----------------------------RAPENATPEIYR 308 (338)
T ss_pred cCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC----------------------------CCCCCCCHHHHH
Confidence 999999999999997 999998866544433332211000 001235678999
Q ss_pred HHHHhhccCCCCCCCHHHHhc
Q 012062 260 LLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 260 ll~~~L~~dP~~R~t~~elL~ 280 (472)
||.+||..||++|||+.||++
T Consensus 309 li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred HHHHHccCChhhCcCHHHHHH
Confidence 999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=307.57 Aligned_cols=261 Identities=23% Similarity=0.311 Sum_probs=191.2
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||+|+++.+.. ......+.+|++++++++|+||++++++|.. ++.+||||||+
T Consensus 19 ~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~ey~ 81 (308)
T cd06615 19 KVLHRPSGLIMARKLIHLEIK-PAIRNQIIRELKVLHECNSPYIVGFYGAFYS----------------DGEISICMEHM 81 (308)
T ss_pred EEEEcCCCeEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEee----------------CCEEEEEeecc
Confidence 367788999999999875432 2244567899999999999999999999986 56899999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~-~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
++ +|.+++.+. ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++...... ....
T Consensus 82 ~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~~~~ 157 (308)
T cd06615 82 DGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 157 (308)
T ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc---cccc
Confidence 86 666665543 468999999999999999999997 59999999999999999999999999998654322 1233
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc--ccC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY--NHF 236 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~--~~~ 236 (472)
.+++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..... .++...... ..+......... ...
T Consensus 158 ~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 158 FVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE-AMFGRPVSE--GEAKESHRPVSGHPPDS 233 (308)
T ss_pred CCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH-HhhcCcccc--ccccCCcccccCCCCCc
Confidence 567899999999876 56889999999999999999999999876643332 222211110 000000000000 000
Q ss_pred CCchhhhhhHHHH---------hhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 237 KPSRTMKRRVREV---------FRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 237 ~~~~~~~~~~~~~---------~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
............. ...++.++++||.+||..||++|||+.||+.|+||..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 0000000000000 1136778999999999999999999999999999954
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=305.87 Aligned_cols=233 Identities=28% Similarity=0.445 Sum_probs=192.3
Q ss_pred ceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 2 AREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
|++..+++.||||+++.... .......+.+|++++++++|+||+++++++.. ...+|+||||+
T Consensus 20 ~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~~v~e~~ 83 (290)
T cd05580 20 VRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD----------------DSNLYLVMEYV 83 (290)
T ss_pred EEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc----------------CCeEEEEEecC
Confidence 57788999999999975432 22345567899999999999999999999976 56789999999
Q ss_pred C-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 81 D-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 81 ~-g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
. ++|.+++.+. ..+++..+..++.||+.+|.|||+++|+|+||||+||||+.++.+||+|||++...... ....
T Consensus 84 ~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----~~~~ 158 (290)
T cd05580 84 PGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYTL 158 (290)
T ss_pred CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----CCCC
Confidence 6 5676666554 46899999999999999999999999999999999999999999999999998776433 2234
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
.++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+......++......
T Consensus 159 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------------- 216 (290)
T cd05580 159 CGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVR--------------------- 216 (290)
T ss_pred CCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcc---------------------
Confidence 67899999998876 46788999999999999999999999887766555555421100
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 286 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----t~~elL~h~~f~~ 286 (472)
+...++..+++||++||..||.+|+ +++|+++|+||..
T Consensus 217 ---------~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 259 (290)
T cd05580 217 ---------FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAG 259 (290)
T ss_pred ---------CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCccccc
Confidence 0113467899999999999999999 9999999999943
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=308.40 Aligned_cols=241 Identities=27% Similarity=0.437 Sum_probs=194.3
Q ss_pred CceeccCCCEEEEEEeecCCcCC-CchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEKE-GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||.+....... .....+.+|+++|+.++|+||+++++.+.. ...+||||||
T Consensus 19 ~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~~~~~lv~e~ 82 (316)
T cd05574 19 LVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT----------------ETYLCLVMDY 82 (316)
T ss_pred EEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec----------------CCEEEEEEEe
Confidence 36777899999999998654332 244567889999999999999999999876 5678999999
Q ss_pred CCC-ChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC----
Q 012062 80 MDH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN---- 153 (472)
Q Consensus 80 ~~g-~l~~~~~~-~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~---- 153 (472)
+.+ +|.+++.+ ....+++..++.++.||+.+|+|||+++|+|+||||+||||+.++.++|+|||++........
T Consensus 83 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 162 (316)
T cd05574 83 CPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSK 162 (316)
T ss_pred cCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccccc
Confidence 986 67666654 335689999999999999999999999999999999999999999999999999865432111
Q ss_pred ------------------------CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHH
Q 012062 154 ------------------------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQL 209 (472)
Q Consensus 154 ------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~ 209 (472)
......++|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~ 241 (316)
T cd05574 163 ALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETF 241 (316)
T ss_pred ccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHH
Confidence 01113467889999999976 56789999999999999999999999988877766
Q ss_pred HHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCC----HHHHhcCCCCC
Q 012062 210 SKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS----AKDALDSEYFW 285 (472)
Q Consensus 210 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t----~~elL~h~~f~ 285 (472)
..+...... ++. ...++..+++||++||..||++|+| ++|+|.|+||.
T Consensus 242 ~~~~~~~~~-----~~~-----------------------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~ 293 (316)
T cd05574 242 SNILKKEVT-----FPG-----------------------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293 (316)
T ss_pred HHHhcCCcc-----CCC-----------------------ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhh
Confidence 655421110 000 0115678999999999999999999 99999999996
Q ss_pred C
Q 012062 286 T 286 (472)
Q Consensus 286 ~ 286 (472)
.
T Consensus 294 ~ 294 (316)
T cd05574 294 G 294 (316)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=322.28 Aligned_cols=239 Identities=23% Similarity=0.348 Sum_probs=199.1
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|.+++|+-..|-|+|.... ++..++++-||+||..+.||+||+|++.|.. ++.+||+.|||.
T Consensus 51 A~nket~~lAAaKvIetks--eEELEDylVEIeILa~CdHP~ivkLl~ayy~----------------enkLwiliEFC~ 112 (1187)
T KOG0579|consen 51 AVNKETKLLAAAKVIETKS--EEELEDYLVEIEILAECDHPVIVKLLSAYYF----------------ENKLWILIEFCG 112 (1187)
T ss_pred hhcccchhhhhhhhhcccc--hhHHhhhhhhhhhhhcCCChHHHHHHHHHhc----------------cCceEEEEeecC
Confidence 5677888888999987543 3346788999999999999999999988754 778999999999
Q ss_pred CChhh-hhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 82 HDLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 82 g~l~~-~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
|+-.+ ++...+..|++++|.-+++|+|.||.|||+++|||||||..|||++-+|.|+|+|||.+.... ........++
T Consensus 113 GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t~qkRDsFI 191 (1187)
T KOG0579|consen 113 GGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK-STRQKRDSFI 191 (1187)
T ss_pred CchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccch-hHHhhhcccc
Confidence 86544 555566679999999999999999999999999999999999999999999999999875432 2223445689
Q ss_pred ccCCCCChhhhcC----CCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccC
Q 012062 161 ITLWYRPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236 (472)
Q Consensus 161 gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (472)
||++||||||+.+ +.+|+.++||||||++|.+|..+.+|....+...++-+|.+.... . .
T Consensus 192 GTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePP--T-L------------- 255 (1187)
T KOG0579|consen 192 GTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP--T-L------------- 255 (1187)
T ss_pred CCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCC--c-c-------------
Confidence 9999999999864 467999999999999999999999999988888887777543211 0 0
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
-.+.+++..+.|||.+||.+||..||++.+||+|+||..
T Consensus 256 -----------lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~ 294 (1187)
T KOG0579|consen 256 -----------LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQN 294 (1187)
T ss_pred -----------cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCccccc
Confidence 011356778999999999999999999999999999954
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=313.50 Aligned_cols=269 Identities=22% Similarity=0.266 Sum_probs=191.3
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+++.........+.+.+|+.+++.++|+||++++++|+. .+.+||||||+
T Consensus 18 ~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~----------------~~~~~~v~e~~ 81 (328)
T cd08226 18 LARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT----------------GSWLWVISPFM 81 (328)
T ss_pred EEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec----------------CCceEEEEecc
Confidence 47888999999999998664443345677889999999999999999999987 55789999999
Q ss_pred CC-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCc---
Q 012062 81 DH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT--- 155 (472)
Q Consensus 81 ~g-~l~~~~~~~-~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~--- 155 (472)
.+ ++.+++.+. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.++|+||+.+..........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 85 666665542 2358999999999999999999999999999999999999999999999998653322111100
Q ss_pred ---cccccccCCCCChhhhcCC-CCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC--CCCccCCC
Q 012062 156 ---LTNRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDE--TIWPGVSK 229 (472)
Q Consensus 156 ---~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~ 229 (472)
.....++..|+|||++.+. ..++.++|||||||++|+|++|+.||........+..+.......+. ..++....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES 241 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence 0011235679999998763 34788999999999999999999999887765554444332111000 00000000
Q ss_pred CC---------------ccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 230 MP---------------AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 230 ~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
.. .....................++..+++||++||..||++|||+.|+|+|+||.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~ 312 (328)
T cd08226 242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFK 312 (328)
T ss_pred hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHH
Confidence 00 000000000000001112235678899999999999999999999999999993
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=341.96 Aligned_cols=240 Identities=27% Similarity=0.420 Sum_probs=191.3
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||+|++............++.|+.+|+.|+|+|||+++++|.... ...+||||||+
T Consensus 31 LAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~--------------~~~lyIVMEY~ 96 (1021)
T PTZ00266 31 LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA--------------NQKLYILMEFC 96 (1021)
T ss_pred EEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC--------------CCEEEEEEeCC
Confidence 5788999999999999876555445667889999999999999999999986522 45789999999
Q ss_pred CC-ChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHC-------CccccCCCCCcEEEcC----------------
Q 012062 81 DH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVN-------QVLHRDIKGSNLLIDN---------------- 133 (472)
Q Consensus 81 ~g-~l~~~~~~---~~~~l~~~~i~~i~~Qll~aL~~LH~~-------giiHrDLKp~NILl~~---------------- 133 (472)
.+ +|..++.. ....+++..++.|+.||+.||+|||+. +||||||||+||||+.
T Consensus 97 ~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~n 176 (1021)
T PTZ00266 97 DAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLN 176 (1021)
T ss_pred CCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccC
Confidence 85 77766653 234689999999999999999999985 4999999999999964
Q ss_pred -CCCeEEeeccceeeeccCCCCccccccccCCCCChhhhcCC-CCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 012062 134 -EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSK 211 (472)
Q Consensus 134 -~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~ 211 (472)
...+||+|||++..+.... .....++|+.|+|||++.+. ..++.++||||||||||+|++|..||...+....+..
T Consensus 177 g~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~ 254 (1021)
T PTZ00266 177 GRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLIS 254 (1021)
T ss_pred CCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHH
Confidence 2348999999997654322 22345689999999998653 3578899999999999999999999987766555444
Q ss_pred HHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 212 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 212 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
.+....... ...++.++.+||.+||..||.+|||+.|+|.|+||.
T Consensus 255 ~lk~~p~lp-----------------------------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik 299 (1021)
T PTZ00266 255 ELKRGPDLP-----------------------------IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIK 299 (1021)
T ss_pred HHhcCCCCC-----------------------------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHh
Confidence 332211000 012466899999999999999999999999999995
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=333.93 Aligned_cols=244 Identities=29% Similarity=0.374 Sum_probs=179.0
Q ss_pred hhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCChhhhhcCCC----CCCCHHHHH
Q 012062 26 PITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPG----LRFTVPQIK 101 (472)
Q Consensus 26 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~l~~~~~~~~----~~l~~~~i~ 101 (472)
...+.+|+.+|++|+|+|||++++++.. .+..|||||++.+++..++.... ......+++
T Consensus 207 ~~~~~~Ei~il~~l~HpnIv~l~~~~~~----------------~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~ 270 (501)
T PHA03210 207 AIQLENEILALGRLNHENILKIEEILRS----------------EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTR 270 (501)
T ss_pred HHHHHHHHHHHHhCCCCCcCcEeEEEEE----------------CCeeEEEEeccccCHHHHHhhccccccccccHHHHH
Confidence 4456789999999999999999999987 55789999999998887664422 224567788
Q ss_pred HHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccCCCCChhhhcCCCCCCCCc
Q 012062 102 CYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 181 (472)
Q Consensus 102 ~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~ 181 (472)
.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+...........++|..|+|||++.+ ..++.++
T Consensus 271 ~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~ 349 (501)
T PHA03210 271 AIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEIT 349 (501)
T ss_pred HHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHH
Confidence 999999999999999999999999999999999999999999998775443333445678999999999987 5689999
Q ss_pred chhhHHHHHHHHHhCCCC-CCC--CChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHh--hhccHH
Q 012062 182 DMWSVGCIFAELLNGKPI-LPG--KNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVF--RHFDRH 256 (472)
Q Consensus 182 DiwSlG~il~ell~G~~p-f~~--~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 256 (472)
||||||||||||+++..+ |.. .+....+.+++.........+.....++..+............+...+ ..++..
T Consensus 350 DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 429 (501)
T PHA03210 350 DIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPAD 429 (501)
T ss_pred HHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChH
Confidence 999999999999998754 432 234455555555443322221110000000000000000001111111 236678
Q ss_pred HHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 257 ALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 257 ~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
+.++|.+||..||++|||+.|+|.|+||..
T Consensus 430 ~~~li~kmL~~DP~~Rpsa~elL~hp~f~~ 459 (501)
T PHA03210 430 FEYPLVKMLTFDWHLRPGAAELLALPLFSA 459 (501)
T ss_pred HHHHHHHHhccCcccCcCHHHHhhChhhhc
Confidence 899999999999999999999999999954
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=319.75 Aligned_cols=220 Identities=25% Similarity=0.380 Sum_probs=178.4
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCChh
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLT 85 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~l~ 85 (472)
-.++.||||+++.-+ ..+|+-|++|+|+|||.|+++|.. .-.+|||||||..+-+
T Consensus 145 l~netVAVKKV~elk---------ETdIKHLRkLkH~NII~FkGVCtq----------------sPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 145 LHNETVAVKKVRELK---------ETDIKHLRKLKHPNIITFKGVCTQ----------------SPCYCIIMEFCAQGQL 199 (904)
T ss_pred ccCceehhHHHhhhh---------hhhHHHHHhccCcceeeEeeeecC----------------CceeEEeeeccccccH
Confidence 457889999987321 268999999999999999999986 4578999999995444
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccCCC
Q 012062 86 GLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWY 165 (472)
Q Consensus 86 ~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y 165 (472)
..+.+....++......|.++|+.|+.|||.+.|||||||.-||||..++.|||+|||.++..... .+...++||..|
T Consensus 200 ~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaGTVaW 277 (904)
T KOG4721|consen 200 YEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAGTVAW 277 (904)
T ss_pred HHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhhhHhh
Confidence 444444557899999999999999999999999999999999999999999999999999876543 344568999999
Q ss_pred CChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhh
Q 012062 166 RPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRR 245 (472)
Q Consensus 166 ~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (472)
||||++++ .+.+.|+|||||||||||||||..||.+-+...++--+ +. ....+
T Consensus 278 MAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV----Gs-------NsL~L--------------- 330 (904)
T KOG4721|consen 278 MAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV----GS-------NSLHL--------------- 330 (904)
T ss_pred hCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccchheeEEec----cC-------Ccccc---------------
Confidence 99999987 78999999999999999999999999765543221111 00 00001
Q ss_pred HHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 246 VREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 246 ~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
.+...+++-++-||+.||.-.|..||++.++|.|
T Consensus 331 --pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 331 --PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred --cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 1123467789999999999999999999999987
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=314.10 Aligned_cols=268 Identities=37% Similarity=0.604 Sum_probs=203.9
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||+++...........+.+|+.++++++|+||+++++++..... ......+|+++|++.
T Consensus 36 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~----------~~~~~~~~lv~~~~~ 105 (345)
T cd07877 36 AFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS----------LEEFNDVYLVTHLMG 105 (345)
T ss_pred EEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc----------ccccccEEEEehhcc
Confidence 5678899999999997654333334567789999999999999999999875321 111346899999998
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccc
Q 012062 82 HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 161 (472)
Q Consensus 82 g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 161 (472)
++|.+++... .+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+|||++..... ......+
T Consensus 106 ~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~----~~~~~~~ 179 (345)
T cd07877 106 ADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVA 179 (345)
T ss_pred cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc----ccccccc
Confidence 8887766543 589999999999999999999999999999999999999999999999999875432 2233467
Q ss_pred cCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc--cccCCCc
Q 012062 162 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA--YNHFKPS 239 (472)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 239 (472)
+..|+|||++.+...++.++|||||||++|+|++|+.||...+....+..+......+....+........ +.....
T Consensus 180 ~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 258 (345)
T cd07877 180 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT- 258 (345)
T ss_pred CCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhc-
Confidence 88999999987655688899999999999999999999998888887777777665554433332221000 000000
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
..........+...+.++++||.+||..||.+|+|+.++|.|+||..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~ 305 (345)
T cd07877 259 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 305 (345)
T ss_pred ccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhh
Confidence 00000111222246788999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=297.76 Aligned_cols=236 Identities=25% Similarity=0.464 Sum_probs=193.1
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
+++..+++.||||.++...........+.+|+.++++++|+||++++++++. .+.+||||||+.
T Consensus 19 ~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~~~~~lv~e~~~ 82 (256)
T cd08218 19 VKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE----------------NGNLYIVMDYCE 82 (256)
T ss_pred EEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC----------------CCeEEEEEecCC
Confidence 5677899999999998654333345578899999999999999999999976 568899999998
Q ss_pred C-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 82 H-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 82 g-~l~~~~~~~-~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
+ +|.+.+... ...+++.+++.|+.||+.+|.|||+++++|+||+|+|||++.++.++|+|||++........ .....
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 161 (256)
T cd08218 83 GGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-LARTC 161 (256)
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-hhhhc
Confidence 5 677666543 33588999999999999999999999999999999999999999999999999976543221 12233
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
.++..|+|||++.+ ..++.++|+|||||++|+|++|+.||...+..+....+.......
T Consensus 162 ~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-------------------- 220 (256)
T cd08218 162 IGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPP-------------------- 220 (256)
T ss_pred cCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCC--------------------
Confidence 56888999999876 567889999999999999999999998877776666554321100
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
....++.++.+||.+||+.||++||++.|+|+|+||
T Consensus 221 ---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 221 ---------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred ---------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 012356789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=304.92 Aligned_cols=237 Identities=23% Similarity=0.361 Sum_probs=185.3
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||++..+.. ......+.+|++++++++|+||+++++++.. .+..+|||||+
T Consensus 19 ~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~~ 81 (279)
T cd06619 19 KAYHLLTRRILAVKVIPLDIT-VELQKQIMSELEILYKCDSPYIIGFYGAFFV----------------ENRISICTEFM 81 (279)
T ss_pred EEEEcCCCcEEEEEEEecCCC-hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE----------------CCEEEEEEecC
Confidence 367888999999999976532 2234567899999999999999999999987 55789999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
++..+.... .+++..+..++.||+.||+|||+++|+|+||||+|||++.++.+||+|||++..+... .....+
T Consensus 82 ~~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~~~~~ 154 (279)
T cd06619 82 DGGSLDVYR----KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYV 154 (279)
T ss_pred CCCChHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---cccCCC
Confidence 976554332 4788899999999999999999999999999999999999999999999999765422 223356
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHH---HHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ---LSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
+|..|+|||++.+ ..++.++|||||||++|+|++|+.||......+. .....+.........
T Consensus 155 ~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-------------- 219 (279)
T cd06619 155 GTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV-------------- 219 (279)
T ss_pred CChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCC--------------
Confidence 7999999999876 5688999999999999999999999965322110 011111110000000
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.....++.++++||.+||..||++||+++|+++|+||..
T Consensus 220 ----------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~ 258 (279)
T cd06619 220 ----------LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQ 258 (279)
T ss_pred ----------CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccc
Confidence 001135668999999999999999999999999999954
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=297.18 Aligned_cols=234 Identities=26% Similarity=0.421 Sum_probs=189.2
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||+|.++.... ...+.+|++++++++|+||+++++++.. ...+|+|+||+.
T Consensus 22 ~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~----------------~~~~~l~~e~~~ 81 (256)
T cd06612 22 AIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFK----------------NTDLWIVMEYCG 81 (256)
T ss_pred EEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeec----------------CCcEEEEEecCC
Confidence 56677889999999975432 4578899999999999999999999986 557899999999
Q ss_pred C-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 82 H-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 82 g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+ +|.+++......+++..++.++.||+.+|.|||+++|+|+||+|+||+++.++.+||+|||++........ ......
T Consensus 82 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~ 160 (256)
T cd06612 82 AGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KRNTVI 160 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-cccccc
Confidence 6 66666655555789999999999999999999999999999999999999999999999999876543221 222334
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (472)
++..|+|||++.+ ..++.++||||||||+|+|++|+.||...+.......+.... .. . +
T Consensus 161 ~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~-~------------~---- 219 (256)
T cd06612 161 GTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKP---PP-T------------L---- 219 (256)
T ss_pred CCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCC---CC-C------------C----
Confidence 6889999999876 568899999999999999999999998766554433221100 00 0 0
Q ss_pred hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
.....++.++.+||.+||+.||++|||+.|+|+|+||
T Consensus 220 -------~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 220 -------SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred -------CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 0012356789999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=305.27 Aligned_cols=236 Identities=28% Similarity=0.478 Sum_probs=191.0
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||.+...... ....+.+|+++++.++|+||+++++++.. ...+|+||||+.
T Consensus 38 ~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~~~ 99 (296)
T cd06655 38 AIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLV----------------GDELFVVMEYLA 99 (296)
T ss_pred EEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEec----------------CceEEEEEEecC
Confidence 567889999999999754332 34567889999999999999999999976 557999999998
Q ss_pred C-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 82 H-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 82 g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+ +|..++.. ..+++.++..++.||+.+|+|||+++|+|+||||+||+++.++.+||+|||++........ ......
T Consensus 100 ~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~ 176 (296)
T cd06655 100 GGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KRSTMV 176 (296)
T ss_pred CCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-cCCCcC
Confidence 6 45454443 2589999999999999999999999999999999999999999999999999876543221 223346
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (472)
++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+....+..+.... .+..
T Consensus 177 ~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~------------------- 235 (296)
T cd06655 177 GTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPEL------------------- 235 (296)
T ss_pred CCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-Cccc-------------------
Confidence 7889999998876 567899999999999999999999999888766655443211 0000
Q ss_pred hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.....++..+.+||++||..||++|+|+.+++.|+||..
T Consensus 236 -------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 236 -------QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred -------CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhh
Confidence 001235678999999999999999999999999999954
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=297.23 Aligned_cols=238 Identities=26% Similarity=0.394 Sum_probs=190.5
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||++...... ....+.+|+.++++++|+||+++++++.. ...+||||||+.
T Consensus 22 ~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----------------~~~~~l~~e~~~ 83 (262)
T cd06613 22 ARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLR----------------RDKLWIVMEYCG 83 (262)
T ss_pred eEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEe----------------CCEEEEEEeCCC
Confidence 567788999999999865433 35678899999999999999999999876 567999999999
Q ss_pred C-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 82 H-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 82 g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+ +|..++......+++.+++.++.||+.+|+|||+++|+|+||||+||+++.++.+||+|||++..+.... .......
T Consensus 84 ~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~~~ 162 (262)
T cd06613 84 GGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AKRKSFI 162 (262)
T ss_pred CCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh-hcccccc
Confidence 7 5555555544579999999999999999999999999999999999999999999999999987654321 1223346
Q ss_pred ccCCCCChhhhcCC--CCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 161 ITLWYRPPELLLGA--TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 161 gt~~y~aPE~l~~~--~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
++..|+|||++... ..++.++|||||||++|+|++|..||...+.......+.........
T Consensus 163 ~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~----------------- 225 (262)
T cd06613 163 GTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPK----------------- 225 (262)
T ss_pred CCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCcc-----------------
Confidence 78899999988652 25788999999999999999999999887766555444321100000
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 283 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~ 283 (472)
......++.++.+||++||..||.+|||+.+++.|+|
T Consensus 226 --------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 226 --------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred --------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 0001235667999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=339.69 Aligned_cols=241 Identities=26% Similarity=0.356 Sum_probs=209.1
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
|++++.|++.||+|++++... +......+..|..||-.-+++-|+.++..|.+ +.++||||||
T Consensus 93 lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD----------------~~~LYlVMdY 156 (1317)
T KOG0612|consen 93 LVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD----------------ERYLYLVMDY 156 (1317)
T ss_pred EEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC----------------ccceEEEEec
Confidence 689999999999999987532 23334456779999999999999999999988 7799999999
Q ss_pred CC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~-g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
+. |||+.++.+-. +++++.++.|+..|+.||..||+.|+|||||||+|||||..|+|||+|||.+..+..+..-....
T Consensus 157 ~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~ 235 (1317)
T KOG0612|consen 157 MPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSV 235 (1317)
T ss_pred ccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEecc
Confidence 98 58999998877 89999999999999999999999999999999999999999999999999998888777777788
Q ss_pred ccccCCCCChhhhcC----CCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC--CCCCCCCccCCCCCc
Q 012062 159 RVITLWYRPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG--SPDETIWPGVSKMPA 232 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~ 232 (472)
.+||+-|++||+|.. ...|+..+|.|||||++||||.|..||...+-.+.+.+|+.... .+++.
T Consensus 236 aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~---------- 305 (1317)
T KOG0612|consen 236 AVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDE---------- 305 (1317)
T ss_pred ccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcc----------
Confidence 899999999999853 24689999999999999999999999999999999999976521 11110
Q ss_pred cccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCC---HHHHhcCCCCCCC
Q 012062 233 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS---AKDALDSEYFWTD 287 (472)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t---~~elL~h~~f~~~ 287 (472)
-.+|.++++||+++|. +++.|.. ++|+..||||...
T Consensus 306 ------------------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~ 344 (1317)
T KOG0612|consen 306 ------------------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGI 344 (1317)
T ss_pred ------------------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCC
Confidence 1378899999999876 6888998 9999999999554
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=319.94 Aligned_cols=261 Identities=31% Similarity=0.514 Sum_probs=207.0
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCC------CCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEE
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQH------ENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYM 75 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~h------pnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i 75 (472)
|+|...|..||||||+... ...+.-++|++||++|+. -|+|+|+..|.. .+++||
T Consensus 451 a~D~~r~~~vAiKIIRnNE---~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h----------------knHLCl 511 (752)
T KOG0670|consen 451 ARDQARGQEVAIKIIRNNE---VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH----------------KNHLCL 511 (752)
T ss_pred ccccCCCCeeEEEEeecch---HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh----------------cceeEE
Confidence 6788889999999998543 234566899999999973 478898877754 889999
Q ss_pred EEecCCCChhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC-CeEEeeccceeeeccCC
Q 012062 76 VFEYMDHDLTGLADR--PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG-NLKLADFGLARSFSYDH 152 (472)
Q Consensus 76 VmEy~~g~l~~~~~~--~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~-~vkL~DFG~a~~~~~~~ 152 (472)
|||-+.-+|..++++ .+..|....++.|+.||+.||..|..+||+|.||||+||||++.. .+||||||.|.....
T Consensus 512 VFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~e-- 589 (752)
T KOG0670|consen 512 VFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASE-- 589 (752)
T ss_pred EehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccccc--
Confidence 999999999998886 334588889999999999999999999999999999999999765 489999999976543
Q ss_pred CCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC---
Q 012062 153 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK--- 229 (472)
Q Consensus 153 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--- 229 (472)
...+.+..+..|+|||++++ ..|+...|+||+||+||||.||+..|++.+.-.++..++++.+.++..+...-..
T Consensus 590 -neitPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dq 667 (752)
T KOG0670|consen 590 -NEITPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQ 667 (752)
T ss_pred -ccccHHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhh
Confidence 34555667899999999998 6899999999999999999999999999999999999999888876443321110
Q ss_pred -------CC--------------ccccCCCchhhhhhHHHH------hhhccHHHHHHHHHhhccCCCCCCCHHHHhcCC
Q 012062 230 -------MP--------------AYNHFKPSRTMKRRVREV------FRHFDRHALELLEKMLMLDPSQRISAKDALDSE 282 (472)
Q Consensus 230 -------~~--------------~~~~~~~~~~~~~~~~~~------~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~ 282 (472)
+. ...+.+++..+...+... -..+-..+++||.+||.+||++|.|+.++|.||
T Consensus 668 HFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~Hp 747 (752)
T KOG0670|consen 668 HFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHP 747 (752)
T ss_pred hcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCC
Confidence 00 001122222211111110 112345789999999999999999999999999
Q ss_pred CCC
Q 012062 283 YFW 285 (472)
Q Consensus 283 ~f~ 285 (472)
||.
T Consensus 748 Fi~ 750 (752)
T KOG0670|consen 748 FIT 750 (752)
T ss_pred ccc
Confidence 995
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=299.80 Aligned_cols=236 Identities=25% Similarity=0.392 Sum_probs=191.7
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||+++.+.... ....+.+|+.+++.++|+||+++++++.. ...+|+|+||+.
T Consensus 20 ~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~~v~e~~~ 82 (274)
T cd06609 20 AIDKRTNQVVAIKVIDLEEAED-EIEDIQQEIQFLSQCRSPYITKYYGSFLK----------------GSKLWIIMEYCG 82 (274)
T ss_pred EEECCCCeEEEEEEeeccccch-HHHHHHHHHHHHHHcCCCCeeeeeEEEEE----------------CCeEEEEEEeeC
Confidence 6778899999999998654322 34467789999999999999999999886 457899999998
Q ss_pred C-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 82 H-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 82 g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+ +|.+++... .+++..++.++.||+.+|.|||+++|+|+||+|+||+++.++.++|+|||+++...... .......
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~~~ 159 (274)
T cd06609 83 GGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SKRNTFV 159 (274)
T ss_pred CCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-ccccccc
Confidence 6 666666543 68999999999999999999999999999999999999999999999999998775432 2223346
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (472)
++..|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+..... ... .
T Consensus 160 ~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~--~~~--------~--------- 219 (274)
T cd06609 160 GTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP--PSL--------E--------- 219 (274)
T ss_pred CCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCC--CCC--------c---------
Confidence 7889999999986 4589999999999999999999999987765554443322100 000 0
Q ss_pred hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
...++..+.+||.+||..||++|||++++++|+||..
T Consensus 220 ---------~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~ 256 (274)
T cd06609 220 ---------GNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKK 256 (274)
T ss_pred ---------ccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcC
Confidence 0015668999999999999999999999999999954
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=300.63 Aligned_cols=241 Identities=29% Similarity=0.530 Sum_probs=188.1
Q ss_pred ceeccCCCEEEEEEeecCCcCC----CchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEE
Q 012062 2 AREIKTGEIVALKKIRMDNEKE----GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVF 77 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVm 77 (472)
|++..+++.||||+++...... .....+.+|+++|++++|+||+++++++.. .+.+++||
T Consensus 19 ~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----------------~~~~~~v~ 82 (268)
T cd06630 19 ARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE----------------DSHFNLFV 82 (268)
T ss_pred EEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc----------------CCeEEEEE
Confidence 6778899999999997543221 234567889999999999999999999976 55789999
Q ss_pred ecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC-CeEEeeccceeeeccCCC--
Q 012062 78 EYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG-NLKLADFGLARSFSYDHN-- 153 (472)
Q Consensus 78 Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~-~vkL~DFG~a~~~~~~~~-- 153 (472)
||+.+ +|.+++.+ ...+++..++.++.||+.||+|||+++|+|+||||+||+++.++ .+||+|||++........
T Consensus 83 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (268)
T cd06630 83 EWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGA 161 (268)
T ss_pred eccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccccC
Confidence 99996 55555543 34689999999999999999999999999999999999998776 599999999876543211
Q ss_pred -CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 012062 154 -NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 232 (472)
Q Consensus 154 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (472)
.......++..|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.+.......
T Consensus 162 ~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------- 229 (268)
T cd06630 162 GEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA----------- 229 (268)
T ss_pred CccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCC-----------
Confidence 11122356889999999876 56789999999999999999999999765543333333222110000
Q ss_pred cccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 233 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
..+...++.++.+||.+||..||++|||+.|+++|+||.
T Consensus 230 --------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 230 --------------PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred --------------CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 011124677899999999999999999999999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=304.60 Aligned_cols=236 Identities=26% Similarity=0.468 Sum_probs=189.5
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||++....... ...+.+|+.+++.+.|+||+++++.|.. ...+|+||||+.
T Consensus 39 ~~~~~~~~~v~ik~~~~~~~~~--~~~~~~e~~~l~~~~h~~v~~~~~~~~~----------------~~~~~lv~e~~~ 100 (296)
T cd06654 39 AMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLV----------------GDELWVVMEYLA 100 (296)
T ss_pred EEECCCCcEEEEEEEecCCcch--HHHHHHHHHHHHhCCCCCEeeEEEEEEe----------------CCEEEEeecccC
Confidence 5678899999999998654332 4567899999999999999999999976 557899999998
Q ss_pred C-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 82 H-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 82 g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+ +|.+++.. ..+++.++..++.||+.||+|||+++|+|+||||+|||++.++.+||+|||++....... .......
T Consensus 101 ~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~~~~~~ 177 (296)
T cd06654 101 GGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMV 177 (296)
T ss_pred CCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc-cccCccc
Confidence 6 66666543 258899999999999999999999999999999999999999999999999987643222 1223346
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (472)
++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+....+..+.... .+..
T Consensus 178 ~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~------------------- 236 (296)
T cd06654 178 GTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPEL------------------- 236 (296)
T ss_pred CCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCC-CCCC-------------------
Confidence 7889999998876 567899999999999999999999998877654443332110 0000
Q ss_pred hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.....++..+.+||.+||..||++|||+.|+++|+||..
T Consensus 237 -------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 275 (296)
T cd06654 237 -------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (296)
T ss_pred -------CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhc
Confidence 001235677999999999999999999999999999954
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=322.41 Aligned_cols=223 Identities=26% Similarity=0.436 Sum_probs=181.7
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+.+..|++..++|+|.+... +..+|+.++.+. +|+||+++++.+.+ ..++|+|||++
T Consensus 341 ~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~----------------~~~~~~v~e~l 398 (612)
T KOG0603|consen 341 CESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYED----------------GKEIYLVMELL 398 (612)
T ss_pred eeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecC----------------Cceeeeeehhc
Confidence 46788999999999976521 234678777666 69999999999987 67899999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE-cCCCCeEEeeccceeeeccCCCCccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI-DNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl-~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
.|.++-..+.....+. .++..|+++|+.||.|||++|||||||||+|||+ ++.++++|+|||+++..... ..+.
T Consensus 399 ~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----~~tp 473 (612)
T KOG0603|consen 399 DGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----CDTP 473 (612)
T ss_pred cccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh----hccc
Confidence 9865443333332344 7888899999999999999999999999999999 58889999999999765433 3344
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA-EQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
+-|..|.|||++.. ..|+.++||||||++||+||+|+.||...... +++.++. .+..
T Consensus 474 ~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~----~~~~----------------- 531 (612)
T KOG0603|consen 474 ALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQ----MPKF----------------- 531 (612)
T ss_pred chhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhc----CCcc-----------------
Confidence 66999999999985 78999999999999999999999999887665 3333331 1111
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
...+|+.++|||++||+.||.+|+++.+++.|+||
T Consensus 532 -----------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 532 -----------SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred -----------ccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 03588999999999999999999999999999999
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=298.65 Aligned_cols=238 Identities=26% Similarity=0.414 Sum_probs=191.6
Q ss_pred CceeccCCCEEEEEEeecCCcC-CCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||++...... ......+.+|+++++.++|+||+++++++.. ...+||||||
T Consensus 11 ~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~ 74 (262)
T cd05572 11 LVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD----------------KKYIYMLMEY 74 (262)
T ss_pred EEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc----------------CCccEEEEec
Confidence 3678888999999999765422 2345678899999999999999999999876 5578999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
+.+ +|.+++.+. ..+++..+..++.||+.||+|||+++++|+||||+||+++.++.+||+|||++....... ....
T Consensus 75 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 75 CLGGELWTILRDR-GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred CCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 985 666666543 358999999999999999999999999999999999999999999999999997664332 1223
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHhcCCCCCCCCccCCCCCccccC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN--EAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (472)
..++..|++||++.. ..++.++|+|||||++|+|++|..||...+ ..+.+..+........
T Consensus 152 ~~~~~~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------- 214 (262)
T cd05572 152 FCGTPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLE---------------- 214 (262)
T ss_pred ccCCcCccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCC----------------
Confidence 467889999999875 567899999999999999999999998776 4444444431110000
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCC-----HHHHhcCCCCCC
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 286 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t-----~~elL~h~~f~~ 286 (472)
....++.++++||.+||..||++|+| ++|+++|+||..
T Consensus 215 ------------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 215 ------------FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred ------------CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhC
Confidence 00123568999999999999999999 999999999953
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=299.50 Aligned_cols=237 Identities=25% Similarity=0.351 Sum_probs=183.8
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||+++..... ....+.+|+.++++++|+||+++++++.. ++.+||||||+.
T Consensus 28 ~~~~~~~~~~aik~~~~~~~~--~~~~~~~e~~~l~~~~h~~ii~~~~~~~~----------------~~~~~iv~e~~~ 89 (267)
T cd06646 28 ARNLHTGELAAVKIIKLEPGD--DFSLIQQEIFMVKECKHCNIVAYFGSYLS----------------REKLWICMEYCG 89 (267)
T ss_pred EEECCCCeEEEEEEEecCccc--hHHHHHHHHHHHHhcCCCCeeeeeEEEEe----------------CCEEEEEEeCCC
Confidence 567889999999999754322 23457789999999999999999999976 557899999999
Q ss_pred C-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 82 H-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 82 g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+ +|.+++.+ ...+++.++..++.||+.||+|||+++|+||||||+||+++.++.+||+|||++..+.... .......
T Consensus 90 ~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~~~~~ 167 (267)
T cd06646 90 GGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-AKRKSFI 167 (267)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc-cccCccc
Confidence 6 56555543 3468999999999999999999999999999999999999999999999999997654221 1222346
Q ss_pred ccCCCCChhhhcC--CCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 161 ITLWYRPPELLLG--ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 161 gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
++..|+|||++.. ...++.++|||||||++|+|++|..||...+..+....+......+. .+.
T Consensus 168 ~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~------------- 232 (267)
T cd06646 168 GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPP--KLK------------- 232 (267)
T ss_pred cCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCC--CCc-------------
Confidence 7889999998753 23467899999999999999999999876554333222211100000 000
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 283 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~ 283 (472)
....++..+.+||++||..||++|||+++||+|.|
T Consensus 233 ----------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 233 ----------DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred ----------cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 01135678999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=310.64 Aligned_cols=241 Identities=24% Similarity=0.396 Sum_probs=197.3
Q ss_pred ceeccCCCEEEEEEeecCCcC-CCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 2 AREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
|+-..||+-+|+|++.+...+ ..-..-+++|..||.+++.+.||.+-..|++ ++.+|+||.+|
T Consensus 204 cqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT----------------kd~LClVLtlM 267 (591)
T KOG0986|consen 204 CQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET----------------KDALCLVLTLM 267 (591)
T ss_pred EEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC----------------CCceEEEEEee
Confidence 455789999999999766433 2334557899999999999999999999988 66899999999
Q ss_pred CC-ChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 81 DH-DLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 81 ~g-~l~~~~~~~~-~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
+| ||...+...+ ..|++..++.|+.+|+.||++||+.+||+|||||+|||||+.|+|+|+|+|+|..+.. ......
T Consensus 268 NGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~--g~~~~~ 345 (591)
T KOG0986|consen 268 NGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE--GKPIRG 345 (591)
T ss_pred cCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC--CCcccc
Confidence 96 5655555432 3699999999999999999999999999999999999999999999999999988754 344555
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
++||..|||||++.+ ..|+...|.|||||+||||+.|+.||....+..-...+-+.
T Consensus 346 rvGT~GYMAPEvl~n-e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr----------------------- 401 (591)
T KOG0986|consen 346 RVGTVGYMAPEVLQN-EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRR----------------------- 401 (591)
T ss_pred ccCcccccCHHHHcC-CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHH-----------------------
Confidence 699999999999987 55999999999999999999999999876543333222111
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWTD 287 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----t~~elL~h~~f~~~ 287 (472)
......+....+++++++|.+.+|.+||++|. .+.++.+||||+.-
T Consensus 402 ---~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l 452 (591)
T KOG0986|consen 402 ---TLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL 452 (591)
T ss_pred ---HhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence 01122233457999999999999999999998 67899999999653
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=303.01 Aligned_cols=240 Identities=22% Similarity=0.356 Sum_probs=189.7
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||+|.++..... .....+.+|+.++++++|+||+++++++.. .+.+||||||+.
T Consensus 20 ~~~~~~~~~~a~k~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----------------~~~~~lv~e~~~ 82 (286)
T cd06622 20 VLHRPTGVTMAMKEIRLELDE-SKFNQIIMELDILHKAVSPYIVDFYGAFFI----------------EGAVYMCMEYMD 82 (286)
T ss_pred EEEcCCCcEEEEEEeecccCH-HHHHHHHHHHHHHHhcCCCcHHhhhhheec----------------CCeEEEEEeecC
Confidence 677789999999999754322 223567899999999999999999999876 568999999999
Q ss_pred C-ChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 82 H-DLTGLADRP--GLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 82 g-~l~~~~~~~--~~~l~~~~i~~i~~Qll~aL~~LH~-~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
+ +|..++... ...+++..++.++.||+.+|.|||+ .+|+|+||||+|||++.++.+||+|||++..+... ...
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~~~ 159 (286)
T cd06622 83 AGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS---LAK 159 (286)
T ss_pred CCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC---ccc
Confidence 7 555555442 2368999999999999999999997 59999999999999999999999999998765322 222
Q ss_pred cccccCCCCChhhhcCCC-----CCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 012062 158 NRVITLWYRPPELLLGAT-----KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 232 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~-----~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (472)
...++..|+|||++.+.. .++.++|||||||++|+|++|+.||...+.......+..........
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------- 229 (286)
T cd06622 160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPT---------- 229 (286)
T ss_pred cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCC----------
Confidence 345688999999885422 25789999999999999999999998766555444443322211111
Q ss_pred cccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 233 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
+...++.++.+||.+||..||++||++.++++|+||...
T Consensus 230 ----------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 230 ----------------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred ----------------CCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 112367789999999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=304.37 Aligned_cols=238 Identities=26% Similarity=0.471 Sum_probs=191.4
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||+++..... ....+.+|+.+++.++|+||+++++++.. .+.+|+||||++
T Consensus 40 ~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~----------------~~~~~iv~e~~~ 101 (297)
T cd06659 40 AREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHQNVVEMYKSYLV----------------GEELWVLMEFLQ 101 (297)
T ss_pred EEEcCCCCEEEEEEEEecccc--hHHHHHHHHHHHHhCCCCchhhhhhheee----------------CCeEEEEEecCC
Confidence 567789999999999764332 34567899999999999999999999876 557899999999
Q ss_pred C-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 82 H-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 82 g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+ +|..++.. ..+++..++.++.||+.||+|||+++|+|+||||+|||++.++.+||+|||++..+.... .......
T Consensus 102 ~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~~ 178 (297)
T cd06659 102 GGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSLV 178 (297)
T ss_pred CCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-cccccee
Confidence 6 45554433 358999999999999999999999999999999999999999999999999986544322 1223356
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (472)
++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+.... ...+
T Consensus 179 ~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~----~~~~---------------- 237 (297)
T cd06659 179 GTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP----PPKL---------------- 237 (297)
T ss_pred cCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC----CCCc----------------
Confidence 7899999999876 568899999999999999999999998877666655442211 0000
Q ss_pred hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCCC
Q 012062 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 288 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~~ 288 (472)
.....++..+.++|++||..||++|||++++++|+||....
T Consensus 238 -------~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 238 -------KNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred -------cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 00123567899999999999999999999999999996543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=306.06 Aligned_cols=241 Identities=26% Similarity=0.344 Sum_probs=191.0
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||.++.... .......+.+|+++++.++|+||+++++.+.. ++.+||||||
T Consensus 19 ~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----------------~~~~~lv~e~ 82 (305)
T cd05609 19 LVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET----------------KRHLCMVMEY 82 (305)
T ss_pred EEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec----------------CCEEEEEEec
Confidence 367888999999999976532 12234567789999999999999999999976 5678999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC-----
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN----- 153 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~----- 153 (472)
+++ +|.+++... ..+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.......
T Consensus 83 ~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (305)
T cd05609 83 VEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYE 161 (305)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccc
Confidence 986 565555443 4689999999999999999999999999999999999999999999999998863211100
Q ss_pred ---------CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 012062 154 ---------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 224 (472)
Q Consensus 154 ---------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 224 (472)
.......++..|+|||.+.. ..++.++|||||||++|+|++|..||.+.+..+.+..+..........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-- 238 (305)
T cd05609 162 GHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEG-- 238 (305)
T ss_pred cccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCc--
Confidence 01112356788999999876 568899999999999999999999999887766666554321110000
Q ss_pred ccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCC---HHHHhcCCCCCC
Q 012062 225 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS---AKDALDSEYFWT 286 (472)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t---~~elL~h~~f~~ 286 (472)
...++..+++||++||..||++|+| +.++|+|+||..
T Consensus 239 -------------------------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 239 -------------------------DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred -------------------------cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 0135678999999999999999997 799999999954
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=297.76 Aligned_cols=242 Identities=24% Similarity=0.372 Sum_probs=193.2
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|.+..+++.||||+++...... ....+.+|+++|+.++|+||+++++.+.. ...+|||||++.
T Consensus 20 ~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~~~~~iv~e~~~ 82 (267)
T cd06610 20 AICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVV----------------GDELWLVMPYLS 82 (267)
T ss_pred EEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEee----------------CCEEEEEEeccC
Confidence 4566789999999997654333 45678899999999999999999999876 567899999998
Q ss_pred C-ChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC---c
Q 012062 82 H-DLTGLADRP--GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN---T 155 (472)
Q Consensus 82 g-~l~~~~~~~--~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~---~ 155 (472)
+ +|.+++... ...+++..++.++.||+.||+|||+++|+|+||||+||++++++.+||+|||++..+...... .
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~ 162 (267)
T cd06610 83 GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKV 162 (267)
T ss_pred CCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccc
Confidence 6 566665442 246899999999999999999999999999999999999999999999999998766543222 2
Q ss_pred cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcccc
Q 012062 156 LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (472)
....+++..|++||++.....++.++|+|||||++|+|++|+.||...+....+.++...... .+...
T Consensus 163 ~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~-------- 230 (267)
T cd06610 163 RKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPP----SLETG-------- 230 (267)
T ss_pred cccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCC----CcCCc--------
Confidence 233467889999999876446889999999999999999999999887766555554332100 00000
Q ss_pred CCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
..+..++..+++||.+||..||++|||++||++||||
T Consensus 231 ------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 231 ------------ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ------------cccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 0023467789999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=301.98 Aligned_cols=240 Identities=26% Similarity=0.394 Sum_probs=189.1
Q ss_pred ceeccCCCEEEEEEeecCCcC-CCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 2 AREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
|++..+++.||||++...... ......+.+|+++|+.++|+||++++++++. .+.+||||||+
T Consensus 12 ~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~~~~~lv~e~~ 75 (277)
T cd05577 12 CQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET----------------KDDLCLVMTLM 75 (277)
T ss_pred EEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec----------------CCeEEEEEecC
Confidence 677889999999999764322 2234456789999999999999999999976 56789999999
Q ss_pred CC-ChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 81 DH-DLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 81 ~g-~l~~~~~~~~-~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
++ +|.+.+.+.. ..+++.+++.++.||+.+|.|||+++|+|+||||+||+++.++.+||+|||++..... ......
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--~~~~~~ 153 (277)
T cd05577 76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG--GKKIKG 153 (277)
T ss_pred CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc--CCcccc
Confidence 85 6666654432 3689999999999999999999999999999999999999999999999999876543 222233
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
..++..|++||++.+ ..++.++|||||||++|+|++|+.||...+.......+.+.....
T Consensus 154 ~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------------- 213 (277)
T cd05577 154 RAGTPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEM------------------- 213 (277)
T ss_pred ccCCCCcCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccc-------------------
Confidence 456889999999876 458899999999999999999999998765422222222111000
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 286 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----t~~elL~h~~f~~ 286 (472)
.......++..+.+||++||..||++|+ ++.+++.|+||+.
T Consensus 214 -------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 214 -------AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred -------cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhc
Confidence 0011124677899999999999999999 9999999999953
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=298.08 Aligned_cols=239 Identities=28% Similarity=0.474 Sum_probs=186.0
Q ss_pred ceeccCCCEEEEEEeecCCcCC---CchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 2 AREIKTGEIVALKKIRMDNEKE---GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
|++..+++.||+|+++...... .....+.+|+.+++.++|+||+++++++.... ...+++|||
T Consensus 21 ~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------------~~~~~l~~e 86 (266)
T cd06651 21 CYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRA--------------EKTLTIFME 86 (266)
T ss_pred EEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCC--------------CCEEEEEEe
Confidence 5778899999999997653222 23345778999999999999999999987521 457899999
Q ss_pred cCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCC--CCc
Q 012062 79 YMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH--NNT 155 (472)
Q Consensus 79 y~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~--~~~ 155 (472)
|+.+ +|.+.+... ..+++..++.++.||+.+|+|||+++|+|+||||+||+++.++.+||+|||++....... ...
T Consensus 87 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 165 (266)
T cd06651 87 YMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTG 165 (266)
T ss_pred CCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCc
Confidence 9986 566665543 358999999999999999999999999999999999999999999999999987553211 111
Q ss_pred cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcccc
Q 012062 156 LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (472)
.....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+....+.++......+
T Consensus 166 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------------- 228 (266)
T cd06651 166 IRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNP---------------- 228 (266)
T ss_pred cccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCC----------------
Confidence 222456889999999876 567899999999999999999999998776555444332111000
Q ss_pred CCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
.+...++..+++|| +||..||++|||++||++||||.
T Consensus 229 ------------~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 229 ------------QLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred ------------CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 00123566788998 57778999999999999999994
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=296.86 Aligned_cols=234 Identities=27% Similarity=0.468 Sum_probs=185.6
Q ss_pred cCCCEEEEEEeecCCcCC----CchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 6 KTGEIVALKKIRMDNEKE----GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
.+++.||||+++.+.... .....+.+|+.+|++++|+||+++++++.+ .+.+|+||||+.
T Consensus 22 ~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~~~~~lv~e~~~ 85 (265)
T cd06631 22 NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD----------------DNTISIFMEFVP 85 (265)
T ss_pred cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec----------------CCeEEEEEecCC
Confidence 578999999997653221 123457789999999999999999999986 567899999998
Q ss_pred C-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCC-----CCc
Q 012062 82 H-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH-----NNT 155 (472)
Q Consensus 82 g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-----~~~ 155 (472)
+ +|.+++.+. ..+++..+..++.||+.+|+|||+.+|+|+||||+||+++.++.+||+|||++....... ...
T Consensus 86 ~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 164 (265)
T cd06631 86 GGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNM 164 (265)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccccccccc
Confidence 6 566665443 468999999999999999999999999999999999999999999999999987543211 111
Q ss_pred cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcccc
Q 012062 156 LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (472)
.....++..|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+........
T Consensus 165 ~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------- 228 (265)
T cd06631 165 LKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMP--------------- 228 (265)
T ss_pred ccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCC---------------
Confidence 223457889999999876 5678999999999999999999999987765554433322111100
Q ss_pred CCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
.+...++.++.+||++||..||++|||+.|+|+|+||
T Consensus 229 ------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 229 ------------RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred ------------CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0112467789999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=301.18 Aligned_cols=239 Identities=23% Similarity=0.377 Sum_probs=185.3
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHH-HHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKI-LKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.+++.||||+++.....+ ....+..|+.+ ++.++|+||+++++++.. ++.+|+||||
T Consensus 19 ~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~----------------~~~~~lv~e~ 81 (283)
T cd06617 19 KMRHVPTGTIMAVKRIRATVNSQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFR----------------EGDVWICMEV 81 (283)
T ss_pred EEEEcCCCcEEEEEEEecCCCcH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEec----------------CCcEEEEhhh
Confidence 36788899999999998654332 23455667665 667789999999999976 5578999999
Q ss_pred CCCChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCc
Q 012062 80 MDHDLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT 155 (472)
Q Consensus 80 ~~g~l~~~~~~---~~~~l~~~~i~~i~~Qll~aL~~LH~~-giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 155 (472)
++++|.+++.. ....+++..++.++.||+.||+|||++ +++||||||+|||++.++.+||+|||++..+.... .
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--~ 159 (283)
T cd06617 82 MDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV--A 159 (283)
T ss_pred hcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc--c
Confidence 99987665542 334689999999999999999999997 99999999999999999999999999987653221 2
Q ss_pred cccccccCCCCChhhhcCC---CCCCCCcchhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCCCCCCccCCCCC
Q 012062 156 LTNRVITLWYRPPELLLGA---TKYGPAVDMWSVGCIFAELLNGKPILPGKN-EAEQLSKIFELCGSPDETIWPGVSKMP 231 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~---~~~~~~~DiwSlG~il~ell~G~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (472)
.+...++..|+|||++.+. ..++.++|+|||||++|+|++|+.||.... ..+.+..+..... . .++
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~-------~~~ 229 (283)
T cd06617 160 KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS---P-------QLP 229 (283)
T ss_pred cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC---C-------CCC
Confidence 2234578899999988642 346789999999999999999999996532 2333333322100 0 000
Q ss_pred ccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 232 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
...++.++++||.+||..||++|||+.|+++|+||..
T Consensus 230 ------------------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 266 (283)
T cd06617 230 ------------------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266 (283)
T ss_pred ------------------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhh
Confidence 0136778999999999999999999999999999954
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=299.00 Aligned_cols=237 Identities=25% Similarity=0.460 Sum_probs=191.1
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||+++..... ....+.+|+.+++.++|+||+++++++.. .+..|+|+||+.
T Consensus 38 ~~~~~~~~~~~iK~~~~~~~~--~~~~~~~e~~~l~~~~h~~vv~~~~~~~~----------------~~~~~~v~e~~~ 99 (285)
T cd06648 38 ATDKSTGRQVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHPNIVEMYSSYLV----------------GDELWVVMEFLE 99 (285)
T ss_pred EEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHHcCCCChheEEEEEEc----------------CCeEEEEEeccC
Confidence 566788999999998754322 24557899999999999999999999876 557899999998
Q ss_pred C-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 82 H-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 82 g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+ +|.+++.. .++++.++..++.||+.+|+|||+++|+||||||+||+++.++.++|+|||++........ ......
T Consensus 100 ~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~ 176 (285)
T cd06648 100 GGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKSLV 176 (285)
T ss_pred CCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cccccc
Confidence 6 56555554 4689999999999999999999999999999999999999999999999998865443221 222345
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (472)
++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+....+.++.........
T Consensus 177 ~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~------------------- 236 (285)
T cd06648 177 GTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLK------------------- 236 (285)
T ss_pred CCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCc-------------------
Confidence 7889999999876 56889999999999999999999999887776666655432100000
Q ss_pred hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
....++..+.+||++||..||++|||+.++++|+||...
T Consensus 237 --------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 275 (285)
T cd06648 237 --------NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKA 275 (285)
T ss_pred --------ccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccC
Confidence 001256689999999999999999999999999999653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=307.34 Aligned_cols=264 Identities=40% Similarity=0.638 Sum_probs=204.6
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+++.+++.||||++............+.+|++++++++||||++++++|... ...+|+||||+
T Consensus 28 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---------------~~~~~lv~e~~ 92 (328)
T cd07856 28 SARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP---------------LEDIYFVTELL 92 (328)
T ss_pred EEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC---------------CCcEEEEeehh
Confidence 367888999999999876544444456778999999999999999999998652 34689999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
.++|..++.. ..+++..+..++.||++||+|||+++|+||||||+|||++.++.+||+|||++..... ......
T Consensus 93 ~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~----~~~~~~ 166 (328)
T cd07856 93 GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP----QMTGYV 166 (328)
T ss_pred ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC----CcCCCc
Confidence 8888776654 2578888999999999999999999999999999999999999999999999875432 223345
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC---CccccCC
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM---PAYNHFK 237 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~---~~~~~~~ 237 (472)
++..|+|||++.+...++.++|||||||++|+|++|+.||...+....+..+.+..+.+....+...... .......
T Consensus 167 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (328)
T cd07856 167 STRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLP 246 (328)
T ss_pred ccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhcc
Confidence 6889999998866456889999999999999999999999998887777777766665543332221110 0000000
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
.............++..+++||++||+.||++|+|++++|.|+||...
T Consensus 247 --~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 247 --KREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred --ccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 000112233445678899999999999999999999999999999543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=300.07 Aligned_cols=239 Identities=24% Similarity=0.361 Sum_probs=181.1
Q ss_pred CceeccCCCEEEEEEeecCCcCC-CchhhHHHHHHHHHh---cCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEE
Q 012062 1 MAREIKTGEIVALKKIRMDNEKE-GFPITAIREIKILKK---LQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMV 76 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~-~~~~~~~~Ei~il~~---l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iV 76 (472)
+|++..+++.||||+++...... .......+|..+++. ..|+||+.+++++.. .+.+|+|
T Consensus 12 ~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~----------------~~~~~lv 75 (279)
T cd05633 12 GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT----------------PDKLCFI 75 (279)
T ss_pred EEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec----------------CCeEEEE
Confidence 36788899999999997653322 112233455544444 479999999999986 5578999
Q ss_pred EecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCc
Q 012062 77 FEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT 155 (472)
Q Consensus 77 mEy~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 155 (472)
|||+.+ +|...+.. ...+++..+..|+.||+.||+|||+++|+||||||+|||++.++.++|+|||++.......
T Consensus 76 ~e~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 76 LDLMNGGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 999996 55554443 3469999999999999999999999999999999999999999999999999987554221
Q ss_pred cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcccc
Q 012062 156 LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (472)
.....+|..|+|||++.....++.++|||||||++|+|++|..||......... .+........
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~--------------- 215 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTVN--------------- 215 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhhcCC---------------
Confidence 223467999999999865456789999999999999999999999764322111 1111100000
Q ss_pred CCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCCC
Q 012062 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 286 (472)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----t~~elL~h~~f~~ 286 (472)
..+...++.++++||++||..||++|+ |++|+++|+||..
T Consensus 216 -----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 216 -----------VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred -----------cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence 011124677899999999999999999 6999999999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=295.42 Aligned_cols=238 Identities=31% Similarity=0.468 Sum_probs=192.1
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|.+..+++.||+|+++...........+.+|++++++++|+||+++++++.... ...+|+||||+.
T Consensus 19 ~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--------------~~~~~~~~e~~~ 84 (265)
T cd08217 19 VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRS--------------NQTLYIVMEYCE 84 (265)
T ss_pred eeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCC--------------CCEEEEEehhcc
Confidence 677889999999999865444444566788999999999999999999886522 456899999998
Q ss_pred C-ChhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHH-----HCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCC
Q 012062 82 H-DLTGLADRP---GLRFTVPQIKCYMKQLLTGLHYCH-----VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 152 (472)
Q Consensus 82 g-~l~~~~~~~---~~~l~~~~i~~i~~Qll~aL~~LH-----~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 152 (472)
+ +|.+++.+. ...+++.+++.++.||+.||+||| +.+|+|+||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~ 164 (265)
T cd08217 85 GGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS 164 (265)
T ss_pred CCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCc
Confidence 5 666665432 456899999999999999999999 8999999999999999999999999999998765332
Q ss_pred CCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 012062 153 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 232 (472)
Q Consensus 153 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (472)
. ......++..|++||++.. ..++.++|+|||||++|+|++|+.||...+.......+..... +
T Consensus 165 ~-~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------~------- 228 (265)
T cd08217 165 S-FAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKF-------R------- 228 (265)
T ss_pred c-cccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCC-------C-------
Confidence 2 1233467999999999876 5578899999999999999999999998875544443321100 0
Q ss_pred cccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 233 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
.+...++..+.+||.+||..||++|||+.+||+|||+
T Consensus 229 ---------------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 229 ---------------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ---------------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 0112356789999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=304.08 Aligned_cols=236 Identities=28% Similarity=0.471 Sum_probs=188.3
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||.+...... ....+.+|+.+++.++|+||++++++|.. .+.+|+||||++
T Consensus 38 ~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----------------~~~~~lv~e~~~ 99 (297)
T cd06656 38 AIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV----------------GDELWVVMEYLA 99 (297)
T ss_pred EEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEec----------------CCEEEEeecccC
Confidence 567889999999999765433 23567889999999999999999999986 557899999998
Q ss_pred C-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 82 H-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 82 g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+ +|..++.+ ..+++.++..++.||+.+|.|||+.+|+||||||+|||++.++.+||+|||++....... .......
T Consensus 100 ~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~ 176 (297)
T cd06656 100 GGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMV 176 (297)
T ss_pred CCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc-cCcCccc
Confidence 6 56565543 247899999999999999999999999999999999999999999999999987654322 1223346
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (472)
++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+....+..+... ..+..
T Consensus 177 ~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~-~~~~~------------------- 235 (297)
T cd06656 177 GTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPEL------------------- 235 (297)
T ss_pred CCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccC-CCCCC-------------------
Confidence 7889999999876 56789999999999999999999999876654332221110 00000
Q ss_pred hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.....++..+++||.+||..||++|||++++++|+||..
T Consensus 236 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 274 (297)
T cd06656 236 -------QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKL 274 (297)
T ss_pred -------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcc
Confidence 001235677899999999999999999999999999954
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=299.27 Aligned_cols=242 Identities=24% Similarity=0.389 Sum_probs=187.2
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.+++.||+|++..... ....+..|+.+++++ +|+||+++++++...... .....+||||||
T Consensus 34 ~~~~~~~~~~~a~K~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~----------~~~~~~~iv~e~ 100 (282)
T cd06636 34 KGRHVKTGQLAAIKVMDVTED---EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP----------GHDDQLWLVMEF 100 (282)
T ss_pred EEEEcCCCcEEEEEEEecChH---HHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc----------CCCCEEEEEEEe
Confidence 367888999999999875432 234577899999998 699999999998642211 124578999999
Q ss_pred CCC-ChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 80 MDH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 80 ~~g-~l~~~~~~-~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
+.+ +|.+++.. ....+++..+..++.||+.||+|||+++|+|+||||+||+++.++.++|+|||++....... ....
T Consensus 101 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~-~~~~ 179 (282)
T cd06636 101 CGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV-GRRN 179 (282)
T ss_pred CCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhccc-cCCC
Confidence 986 66666654 23458888999999999999999999999999999999999999999999999987553221 1223
Q ss_pred cccccCCCCChhhhcC----CCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 012062 158 NRVITLWYRPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 233 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (472)
...++..|+|||++.. ...++.++|||||||++|+|++|..||........+..+.... .. .
T Consensus 180 ~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~---~~-------~---- 245 (282)
T cd06636 180 TFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP---PP-------K---- 245 (282)
T ss_pred cccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCC---CC-------C----
Confidence 3567899999998863 2357789999999999999999999997766544333221110 00 0
Q ss_pred ccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 234 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
.....++..+.+||++||..||.+|||+.|||+|+||
T Consensus 246 --------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 246 --------------LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred --------------CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 0012367789999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=298.98 Aligned_cols=239 Identities=23% Similarity=0.341 Sum_probs=181.8
Q ss_pred CceeccCCCEEEEEEeecCCcCC-CchhhHHHHH---HHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEE
Q 012062 1 MAREIKTGEIVALKKIRMDNEKE-GFPITAIREI---KILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMV 76 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~-~~~~~~~~Ei---~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iV 76 (472)
+|++..+++.||||++....... ........|. ++++...|+||+++++++.. ...+|+|
T Consensus 12 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~----------------~~~~~~v 75 (278)
T cd05606 12 GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT----------------PDKLSFI 75 (278)
T ss_pred EEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec----------------CCEEEEE
Confidence 36788899999999997653221 1122233443 34455679999999999987 5578999
Q ss_pred EecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCc
Q 012062 77 FEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT 155 (472)
Q Consensus 77 mEy~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 155 (472)
|||+.+ +|..++. ....+++.+++.|+.||+.||+|||+++|+||||||+|||++.++.+||+|||++..+... .
T Consensus 76 ~e~~~g~~L~~~l~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---~ 151 (278)
T cd05606 76 LDLMNGGDLHYHLS-QHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---K 151 (278)
T ss_pred EecCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc---C
Confidence 999986 4544444 3456999999999999999999999999999999999999999999999999998765322 1
Q ss_pred cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcccc
Q 012062 156 LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (472)
....+++..|+|||++.+...++.++|||||||++|+|++|+.||................ ....
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~-------------- 216 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-TMAV-------------- 216 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh-ccCC--------------
Confidence 2234679999999998754568899999999999999999999998763222111110000 0000
Q ss_pred CCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCCC
Q 012062 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 286 (472)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----t~~elL~h~~f~~ 286 (472)
.....++.++.+||.+||..||++|+ ++.++++|+||..
T Consensus 217 ------------~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~ 260 (278)
T cd05606 217 ------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS 260 (278)
T ss_pred ------------CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccC
Confidence 01123567899999999999999999 9999999999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=303.40 Aligned_cols=236 Identities=28% Similarity=0.426 Sum_probs=191.3
Q ss_pred ceeccCCCEEEEEEeecCCcC-CCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 2 AREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
|++..+++.||||++...... ......+.+|+++++.++|+||+++++++.. .+..||||||+
T Consensus 34 ~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~----------------~~~~~lv~e~~ 97 (307)
T cd06607 34 ARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR----------------EHTAWLVMEYC 97 (307)
T ss_pred EEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe----------------CCeEEEEHHhh
Confidence 567778999999999754322 2233567899999999999999999999986 45789999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
.+++.+++......+++..+..++.||+.+|.|||+++|+|+||+|+||+++.++.+||+|||++...... ....
T Consensus 98 ~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-----~~~~ 172 (307)
T cd06607 98 LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-----NSFV 172 (307)
T ss_pred CCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC-----CCcc
Confidence 99888877655556899999999999999999999999999999999999999999999999998654321 2345
Q ss_pred ccCCCCChhhhcC--CCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 161 ITLWYRPPELLLG--ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 161 gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
++..|+|||++.. ...++.++|||||||++|+|++|+.||...+.......+.... .. ...
T Consensus 173 ~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~--~~--------~~~------- 235 (307)
T cd06607 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND--SP--------TLS------- 235 (307)
T ss_pred CCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCC--CC--------CCC-------
Confidence 6888999998752 2457889999999999999999999998877665544432110 00 000
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
...++..+++||.+||..||++|||+.+++.|+||..
T Consensus 236 -----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 236 -----------SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred -----------chhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 0125668999999999999999999999999999965
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=331.97 Aligned_cols=240 Identities=23% Similarity=0.402 Sum_probs=184.5
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC-CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
||++...+..||||++-.. ++.....+.+||++||+|+ |+|||.++|....... .+.-.-+++|+|||
T Consensus 55 la~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~---------~~~~~~EvllLmEy 123 (738)
T KOG1989|consen 55 LAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS---------SNNGVWEVLLLMEY 123 (738)
T ss_pred EEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc---------CCCceeEEEeehhh
Confidence 5788888899999998755 3345677889999999997 9999999994222110 00002368999999
Q ss_pred CC-CChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEcCCCCeEEeeccceeeeccCC-CC
Q 012062 80 MD-HDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQ--VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH-NN 154 (472)
Q Consensus 80 ~~-g~l~~~~~~-~~~~l~~~~i~~i~~Qll~aL~~LH~~g--iiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~ 154 (472)
|. |+|.+++.. ...+|++.+|++||.++++||++||... |||||||-|||||+.++++||||||.|+-..... ..
T Consensus 124 C~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~ 203 (738)
T KOG1989|consen 124 CKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSA 203 (738)
T ss_pred ccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccH
Confidence 99 588887763 3345999999999999999999999998 9999999999999999999999999986432211 10
Q ss_pred c-------cccccccCCCCChhhhc--CCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCc
Q 012062 155 T-------LTNRVITLWYRPPELLL--GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWP 225 (472)
Q Consensus 155 ~-------~~~~~gt~~y~aPE~l~--~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 225 (472)
. .....-|+.|+|||++- .....+.|+|||+|||+||.|+....||.......++..-+.+
T Consensus 204 ~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~Y~~---------- 273 (738)
T KOG1989|consen 204 QEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGNYSF---------- 273 (738)
T ss_pred HHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEeccccC----------
Confidence 0 01112399999999862 2356899999999999999999999999877554433322211
Q ss_pred cCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCC
Q 012062 226 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 283 (472)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~ 283 (472)
|. ++.++..+++||+.||+.||.+||++-+++.+-+
T Consensus 274 -----P~-----------------~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 274 -----PP-----------------FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred -----CC-----------------CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 10 1257889999999999999999999999987543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=306.45 Aligned_cols=270 Identities=27% Similarity=0.435 Sum_probs=206.9
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC-----C---CCccceeEEeeCCCCCCCCCCCCCCCCcCCe
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-----H---ENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 72 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~-----h---pnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 72 (472)
||.|..+.++||||+++.. +-+.+.++.||++|++++ | ..||+|+|.|...++. ..|
T Consensus 96 LawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN------------G~H 160 (590)
T KOG1290|consen 96 LAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN------------GQH 160 (590)
T ss_pred EEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC------------CcE
Confidence 7899999999999999854 346778999999999994 2 4699999999986654 558
Q ss_pred EEEEEecCCCChhhhhcCCCC-CCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEc------------------
Q 012062 73 TYMVFEYMDHDLTGLADRPGL-RFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLID------------------ 132 (472)
Q Consensus 73 ~~iVmEy~~g~l~~~~~~~~~-~l~~~~i~~i~~Qll~aL~~LH~~-giiHrDLKp~NILl~------------------ 132 (472)
+|||+|++..+|+.++++.+. .++...++.|++|||.||.|||.. ||||.||||+||||.
T Consensus 161 VCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~ 240 (590)
T KOG1290|consen 161 VCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREAGEATT 240 (590)
T ss_pred EEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhhhccccc
Confidence 999999999999999988554 499999999999999999999976 999999999999980
Q ss_pred --------------------------------------------------------------------------------
Q 012062 133 -------------------------------------------------------------------------------- 132 (472)
Q Consensus 133 -------------------------------------------------------------------------------- 132 (472)
T Consensus 241 ~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~ 320 (590)
T KOG1290|consen 241 SLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERST 320 (590)
T ss_pred cCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccchhhcc
Confidence
Q ss_pred -----------------C---------------------------------------------------CCCeEEeeccc
Q 012062 133 -----------------N---------------------------------------------------EGNLKLADFGL 144 (472)
Q Consensus 133 -----------------~---------------------------------------------------~~~vkL~DFG~ 144 (472)
. +-.|||+|||.
T Consensus 321 ~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGN 400 (590)
T KOG1290|consen 321 LEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGN 400 (590)
T ss_pred cccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEEeeccc
Confidence 0 00267888887
Q ss_pred eeeeccCCCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCC------CChHHHHHHHHHhcCC
Q 012062 145 ARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPG------KNEAEQLSKIFELCGS 218 (472)
Q Consensus 145 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~------~~~~~~~~~i~~~~~~ 218 (472)
|+-+ ....+.-+.|..|+||||+++ ..|+..+||||++|++|||+||..+|.- ..+.+.++.|+++++.
T Consensus 401 ACW~----~khFT~DIQTRQYRapEVllG-sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~ 475 (590)
T KOG1290|consen 401 ACWV----HKHFTEDIQTRQYRAPEVLLG-SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGK 475 (590)
T ss_pred hhhh----hhhhchhhhhhhccCcceeec-CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhh
Confidence 7643 234555677999999999998 6799999999999999999999999863 3578899999999988
Q ss_pred CCCCCCccCCCCCcc----------ccC--CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 219 PDETIWPGVSKMPAY----------NHF--KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 219 ~~~~~~~~~~~~~~~----------~~~--~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.+..+...-...-++ ..+ .+..............-..++.|||.-||.++|++|+||.++|+|||+..
T Consensus 476 iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~ 555 (590)
T KOG1290|consen 476 IPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNP 555 (590)
T ss_pred ccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccccC
Confidence 764332211110000 000 11111111111111233466889999999999999999999999999976
Q ss_pred CCCC
Q 012062 287 DPLP 290 (472)
Q Consensus 287 ~~~~ 290 (472)
.+.+
T Consensus 556 ~~~~ 559 (590)
T KOG1290|consen 556 VAGP 559 (590)
T ss_pred CCCC
Confidence 5544
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=297.56 Aligned_cols=234 Identities=28% Similarity=0.447 Sum_probs=189.5
Q ss_pred ceeccCCCEEEEEEeecCCcCC-CchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 2 AREIKTGEIVALKKIRMDNEKE-GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
|++..+++.||+|++....... .....+.+|++++++++|+||+++++++.. ...+|+||||+
T Consensus 19 ~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~ 82 (258)
T cd05578 19 VQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD----------------EENMYLVVDLL 82 (258)
T ss_pred EEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC----------------CCeEEEEEeCC
Confidence 6788899999999998654322 345678899999999999999999999876 55799999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
.+ +|...+... ..+++.++..|+.||+++|.|||+++|+|+||||+||++++++.++|+|||++....... .....
T Consensus 83 ~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 159 (258)
T cd05578 83 LGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTST 159 (258)
T ss_pred CCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--ccccc
Confidence 86 565555444 568999999999999999999999999999999999999999999999999987654322 22334
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE--AEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
.++..|+|||++.. ..++.++|+|||||++|+|++|..||...+. .+.+...... ..
T Consensus 160 ~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~----------------- 218 (258)
T cd05578 160 SGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET---AD----------------- 218 (258)
T ss_pred CCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc---cc-----------------
Confidence 57889999999876 5588999999999999999999999987764 2222222111 00
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCH--HHHhcCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA--KDALDSEYF 284 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~--~elL~h~~f 284 (472)
......++..+.++|++||..||.+|+++ +|+++|+||
T Consensus 219 ---------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 219 ---------VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ---------ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 00112356789999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=297.98 Aligned_cols=236 Identities=28% Similarity=0.454 Sum_probs=189.7
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|+++.+++.||+|++...... .....+.+|+++++.++|+||+++++++.. .+.+||||||+.
T Consensus 20 ~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----------------~~~~~lv~e~~~ 82 (265)
T cd06605 20 VLHRPTGKIMAVKTIRLEINE-AIQKQILRELDILHKCNSPYIVGFYGAFYN----------------NGDISICMEYMD 82 (265)
T ss_pred EEEcCCCcEEEEEEEecccCh-HHHHHHHHHHHHHHHCCCCchhhhheeeec----------------CCEEEEEEEecC
Confidence 677889999999999765433 345667899999999999999999999876 568999999999
Q ss_pred -CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 82 -HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 82 -g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~-~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
++|.+++......+++..+..++.||+.+|+|||+ .+|+|+||||+||+++.++.+||+|||++......... ..
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~---~~ 159 (265)
T cd06605 83 GGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK---TF 159 (265)
T ss_pred CCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh---cc
Confidence 47777766544578999999999999999999999 99999999999999999999999999998665322211 15
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN-----EAEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
.++..|+|||++.+ ..++.++|||||||++|+|++|..||...+ ..+.+..+... ..... +
T Consensus 160 ~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~-------~--- 225 (265)
T cd06605 160 VGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE---PPPRL-------P--- 225 (265)
T ss_pred cCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC---CCCCC-------C---
Confidence 67889999999876 578899999999999999999999997652 22222222211 00000 0
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
...++.++++||.+||..||++|||+.|++.|+||..
T Consensus 226 ---------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 226 ---------------SGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred ---------------hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 0016778999999999999999999999999999953
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=292.60 Aligned_cols=235 Identities=27% Similarity=0.416 Sum_probs=191.5
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||.+............+.+|+++|++++|+||+++++.+.. .+.++|||||+.
T Consensus 19 ~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----------------~~~~~lv~e~~~ 82 (256)
T cd08220 19 CRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE----------------DKALMIVMEYAP 82 (256)
T ss_pred EEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec----------------CCEEEEEEecCC
Confidence 6778899999999998765444456678899999999999999999999875 567899999998
Q ss_pred C-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC-CeEEeeccceeeeccCCCCcccc
Q 012062 82 H-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG-NLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 82 g-~l~~~~~~~-~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~-~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
+ +|.+++... ...+++..++.++.||+.+|+|||+++|+|+||||+||+++.++ .+||+|||++....... ....
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--~~~~ 160 (256)
T cd08220 83 GGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS--KAYT 160 (256)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc--cccc
Confidence 6 676666543 33589999999999999999999999999999999999998654 57999999997664322 2223
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
..++..|+|||++.+ ..++.++|||||||++|+|++|+.+|...+.......+.......
T Consensus 161 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~------------------- 220 (256)
T cd08220 161 VVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP------------------- 220 (256)
T ss_pred cccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCC-------------------
Confidence 467889999999876 567889999999999999999999998877666555543311110
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
+...++..+++||.+||..||++|||+.|+|.||||
T Consensus 221 ----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 221 ----------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred ----------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 011356789999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=296.36 Aligned_cols=242 Identities=25% Similarity=0.466 Sum_probs=187.3
Q ss_pred ceeccCCCEEEEEEeecCCcCC--------CchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeE
Q 012062 2 AREIKTGEIVALKKIRMDNEKE--------GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 73 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~--------~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 73 (472)
|++..+++.||||.++...... ...+.+.+|+.+++.++|+||+++++++.. ...+
T Consensus 20 ~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~ 83 (272)
T cd06629 20 ALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT----------------EEYL 83 (272)
T ss_pred EeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc----------------CCce
Confidence 5677889999999987532111 122356789999999999999999999876 4578
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCC
Q 012062 74 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 152 (472)
Q Consensus 74 ~iVmEy~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 152 (472)
++||||+.+ +|.+++.+. ..+++..++.++.||+.+|.|||+++++|+||||+||+++.++.++|+|||+++......
T Consensus 84 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 162 (272)
T cd06629 84 SIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIY 162 (272)
T ss_pred EEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccccc
Confidence 999999986 566665554 468999999999999999999999999999999999999999999999999987643221
Q ss_pred C-CccccccccCCCCChhhhcCCC-CCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 012062 153 N-NTLTNRVITLWYRPPELLLGAT-KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 230 (472)
Q Consensus 153 ~-~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 230 (472)
. .......++..|+|||++.... .++.++|+|||||++|+|++|..||...+....+..+....... .++
T Consensus 163 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~----- 234 (272)
T cd06629 163 DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAP---PIP----- 234 (272)
T ss_pred cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCC---cCC-----
Confidence 1 1122345688999999987643 37889999999999999999999997665554443332111000 000
Q ss_pred CccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 231 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
......++.++++||.+||..||++|||++|+|+|+||
T Consensus 235 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 235 ----------------PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ----------------ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 01112467789999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=295.89 Aligned_cols=243 Identities=26% Similarity=0.417 Sum_probs=189.5
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.+++.||+|+++.... ....+.+|+.+++++ .|+||+++++++...... .....+||||||
T Consensus 24 ~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~----------~~~~~~~lv~e~ 90 (275)
T cd06608 24 KARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP----------GNDDQLWLVMEL 90 (275)
T ss_pred EEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC----------CcceEEEEEEEc
Confidence 367788899999999876533 235678999999999 699999999999864321 114568999999
Q ss_pred CCC-ChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCc
Q 012062 80 MDH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT 155 (472)
Q Consensus 80 ~~g-~l~~~~~~---~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 155 (472)
+++ +|.+++.. .+..+++..++.++.||+.||.|||+++|+|+||+|+||+++.++.+||+|||++....... ..
T Consensus 91 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~ 169 (275)
T cd06608 91 CGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL-GR 169 (275)
T ss_pred CCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceecccch-hh
Confidence 996 55555443 23578999999999999999999999999999999999999999999999999987654322 22
Q ss_pred cccccccCCCCChhhhcCC----CCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 012062 156 LTNRVITLWYRPPELLLGA----TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 231 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~----~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (472)
.....++..|+|||++... ..++.++|||||||+||+|++|+.||...+....+.++.... ... +
T Consensus 170 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~-------~- 238 (275)
T cd06608 170 RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP---PPT-------L- 238 (275)
T ss_pred hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC---CCC-------C-
Confidence 3345678899999987542 346788999999999999999999998766555554443211 000 0
Q ss_pred ccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 232 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
.....++..+++||++||..||++|||+.|+++|+|+
T Consensus 239 ----------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 239 ----------------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred ----------------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 0011356789999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=294.97 Aligned_cols=269 Identities=35% Similarity=0.620 Sum_probs=217.7
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
+.|..+|+.||+|++..-...-...+.+.+|+++|..++|.||+..+|+...+... +-..+|+|+|+|.
T Consensus 72 VTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~d-----------fFqEiYV~TELmQ 140 (449)
T KOG0664|consen 72 VTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPS-----------FFQELYVLTELMQ 140 (449)
T ss_pred ccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCch-----------HHHHHHHHHHHHH
Confidence 46788999999999875544434456788999999999999999999998875432 2336899999999
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccc
Q 012062 82 HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 161 (472)
Q Consensus 82 g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 161 (472)
.||..++..+. .++.+.++-++.||+.||.|||+.+|+||||||.|+|++.+..+||||||+|+....+....++..+.
T Consensus 141 SDLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVV 219 (449)
T KOG0664|consen 141 SDLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVV 219 (449)
T ss_pred hhhhheeccCC-CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhhHHHHH
Confidence 99998888765 68999999999999999999999999999999999999999999999999999988777788888888
Q ss_pred cCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchh
Q 012062 162 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241 (472)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (472)
|-.|+|||++.+...|+.++||||+|||+.|||..+..|...+..+++..|.++++.+.......... ...+......
T Consensus 220 TQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE--GAk~H~LR~~ 297 (449)
T KOG0664|consen 220 TQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE--GAKNHVLRAG 297 (449)
T ss_pred HHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh--hhHHHhhccC
Confidence 99999999999999999999999999999999999999999999999999999999876432211110 0000000000
Q ss_pred hh-hhHHHHh-----hhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 242 MK-RRVREVF-----RHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 242 ~~-~~~~~~~-----~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
.+ .....++ .+-..+..+++.+||..||.+|++.++++.|+|.
T Consensus 298 ~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 298 LRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred CCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 00 0000000 1234567899999999999999999999999986
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=292.69 Aligned_cols=240 Identities=29% Similarity=0.494 Sum_probs=188.5
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
+++..+++.||||+++...........+.+|+.+++.++|+||+++++++.. .+.+++|+||+.
T Consensus 19 ~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~----------------~~~~~lv~e~~~ 82 (264)
T cd06626 19 AVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH----------------REKVYIFMEYCS 82 (264)
T ss_pred EEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec----------------CCEEEEEEecCC
Confidence 4567789999999998765544466778899999999999999999999875 557899999999
Q ss_pred C-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcc---c
Q 012062 82 H-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTL---T 157 (472)
Q Consensus 82 g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~---~ 157 (472)
+ +|.+++.. ...+++..++.|+.||+.||+|||+++|+|+||||+||+++.++.+||+|||++........... .
T Consensus 83 ~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~ 161 (264)
T cd06626 83 GGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQ 161 (264)
T ss_pred CCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccccc
Confidence 6 55555544 34588999999999999999999999999999999999999999999999999877654332211 1
Q ss_pred cccccCCCCChhhhcCCC--CCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcccc
Q 012062 158 NRVITLWYRPPELLLGAT--KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~--~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (472)
...++..|++||++.+.. .++.++|||||||++|+|++|+.||...+........... ..... ++.
T Consensus 162 ~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~--------~~~--- 229 (264)
T cd06626 162 SLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPP--------IPD--- 229 (264)
T ss_pred CCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCC--------CCc---
Confidence 345688999999987632 2788999999999999999999999766433222221111 10000 000
Q ss_pred CCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
...++..+.+||++||+.||.+|||+.|++.|+|+
T Consensus 230 --------------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 230 --------------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred --------------ccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 11246788999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=300.08 Aligned_cols=242 Identities=21% Similarity=0.324 Sum_probs=186.9
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC-CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+++..+++.||||++...... .....+.+|+.++.++. |+||+++++++.. .+..++||||+
T Consensus 23 ~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~----------------~~~~~~~~e~~ 85 (288)
T cd06616 23 MLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFR----------------EGDCWICMELM 85 (288)
T ss_pred EEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEec----------------CCcEEEEEecc
Confidence 578889999999999865433 23456788999999996 9999999999876 45679999999
Q ss_pred CCChhhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCc
Q 012062 81 DHDLTGLAD----RPGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT 155 (472)
Q Consensus 81 ~g~l~~~~~----~~~~~l~~~~i~~i~~Qll~aL~~LH~~-giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 155 (472)
..++..+.. .....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..+.... .
T Consensus 86 ~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~ 163 (288)
T cd06616 86 DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI--A 163 (288)
T ss_pred cCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC--c
Confidence 876554322 2235689999999999999999999975 99999999999999999999999999987554322 1
Q ss_pred cccccccCCCCChhhhcCC--CCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 012062 156 LTNRVITLWYRPPELLLGA--TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 233 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (472)
.....++..|+|||++... ..++.++|||||||++|+|++|+.||...+. ....+.+..........
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~--------- 232 (288)
T cd06616 164 KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPPILS--------- 232 (288)
T ss_pred cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCCcCC---------
Confidence 2233578899999998764 3688999999999999999999999976542 22222222211110000
Q ss_pred ccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 234 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
......++.++.+||++||..||++|||++||+.|+||..
T Consensus 233 -------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 233 -------------NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred -------------CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 0001236778999999999999999999999999999953
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=293.20 Aligned_cols=232 Identities=23% Similarity=0.356 Sum_probs=182.3
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||+++.... .+....+.+|++++++++|+||+++++++.. ...+||||||+.
T Consensus 14 ~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~ 76 (252)
T cd05084 14 GRLRADNTPVAVKSCRETLP-PDLKAKFLQEARILKQYSHPNIVRLIGVCTQ----------------KQPIYIVMELVQ 76 (252)
T ss_pred EEEecCCceEEEEecCccCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEcC----------------CCCeEEEEeecc
Confidence 57788999999999874432 2345678899999999999999999999876 557899999998
Q ss_pred C-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcc-ccc
Q 012062 82 H-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTL-TNR 159 (472)
Q Consensus 82 g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~-~~~ 159 (472)
+ +|.+++.+....+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++........... ...
T Consensus 77 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 77 GGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 5 67767665555689999999999999999999999999999999999999999999999999865432111110 111
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
..+..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+.......
T Consensus 157 ~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~------------------- 216 (252)
T cd05084 157 QIPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLP------------------- 216 (252)
T ss_pred CCceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCC-------------------
Confidence 22456999998876 568899999999999999997 889998776655544443211000
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....++..+.+||.+||..||++|||+.++++
T Consensus 217 ----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 217 ----------CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred ----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01134668999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=298.39 Aligned_cols=236 Identities=28% Similarity=0.415 Sum_probs=193.1
Q ss_pred ceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 2 AREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
|++..+++.||||++..... ..+....+.+|++++++++|+||+++++++.. ....||||||+
T Consensus 44 ~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~~ 107 (317)
T cd06635 44 ARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR----------------EHTAWLVMEYC 107 (317)
T ss_pred EEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee----------------CCeEEEEEeCC
Confidence 56778999999999976532 22344567889999999999999999999976 45689999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
.+++++++......+++.++..++.||+.+|.|||+++|+|+||||+||+++.++.+||+|||++..... .....
T Consensus 108 ~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-----~~~~~ 182 (317)
T cd06635 108 LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-----ANSFV 182 (317)
T ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC-----ccccc
Confidence 9988887766556789999999999999999999999999999999999999999999999998865332 22345
Q ss_pred ccCCCCChhhhcC--CCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 161 ITLWYRPPELLLG--ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 161 gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
++..|+|||++.. ...++.++|||||||++|+|++|..||...+....+..+.........
T Consensus 183 ~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------------- 245 (317)
T cd06635 183 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ----------------- 245 (317)
T ss_pred CCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCC-----------------
Confidence 7889999998752 245788999999999999999999999887766666555432111000
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
...++..+++||.+||..||.+|||+.++++|+|+..
T Consensus 246 -----------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 246 -----------SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred -----------CccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 0135667999999999999999999999999999955
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=295.72 Aligned_cols=239 Identities=31% Similarity=0.537 Sum_probs=193.2
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||++..+.. .......+.+|++++++++|+||+++++.++. ...+||||||
T Consensus 11 ~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----------------~~~~~lv~e~ 74 (265)
T cd05579 11 LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG----------------KKNLYLVMEY 74 (265)
T ss_pred EEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec----------------CcEEEEEEec
Confidence 367778899999999976532 22345677889999999999999999998876 5678999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC-----
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN----- 153 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~----- 153 (472)
+.+ +|.+++.+.. .+++..+..++.||+.+|+|||+++|+|+||+|+||+++.++.++|+|||++........
T Consensus 75 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 75 LPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 986 6766665543 689999999999999999999999999999999999999999999999999875433211
Q ss_pred --CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 012062 154 --NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 231 (472)
Q Consensus 154 --~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (472)
.......++..|++||++.. ..++.++|||||||++|+|++|..||...+..+.+..+...... |+..
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~---- 223 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIE-----WPED---- 223 (265)
T ss_pred ccccccCcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcC-----CCcc----
Confidence 12233456888999999876 45788999999999999999999999988877666655431110 1100
Q ss_pred ccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCH---HHHhcCCCCC
Q 012062 232 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA---KDALDSEYFW 285 (472)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~---~elL~h~~f~ 285 (472)
..++..+.+||++||+.||++|||+ .|+|+|+||.
T Consensus 224 -------------------~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~ 261 (265)
T cd05579 224 -------------------VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261 (265)
T ss_pred -------------------ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCcccc
Confidence 0146789999999999999999999 9999999995
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=292.09 Aligned_cols=233 Identities=29% Similarity=0.465 Sum_probs=189.1
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+++.+++.||+|.++...... ....+.+|+.+++.++|+||+++++.++. ++.+|+||||+
T Consensus 18 ~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~ 80 (255)
T cd08219 18 LVQHVNSDQKYAMKEIRLPKSSS-AVEDSRKEAVLLAKMKHPNIVAFKESFEA----------------DGHLYIVMEYC 80 (255)
T ss_pred EEEEcCCCceEEEEEEEcCcchH-HHHHHHHHHHHHHhCCCCCcceEEEEEEE----------------CCEEEEEEeeC
Confidence 36788899999999997654322 34567889999999999999999999986 66899999999
Q ss_pred CC-ChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 81 DH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 81 ~g-~l~~~~~~-~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
.+ ++.+++.. ....+++..++.++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++..+..... ....
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 159 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-YACT 159 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-cccc
Confidence 85 67666543 334589999999999999999999999999999999999999999999999999976643222 2233
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
..++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+......+
T Consensus 160 ~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------------- 219 (255)
T cd08219 160 YVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP------------------- 219 (255)
T ss_pred ccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCC-------------------
Confidence 467889999999876 568899999999999999999999999877666555553211110
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
....++..+.+||.+||..||++|||+.+++.-
T Consensus 220 ----------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 ----------LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ----------CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 011356679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=300.10 Aligned_cols=236 Identities=28% Similarity=0.400 Sum_probs=193.1
Q ss_pred ceeccCCCEEEEEEeecCCcC-CCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 2 AREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
|++..+++.||||++...... ......+.+|+.+++.++|+||+++++++.+ ....||||||+
T Consensus 40 ~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~~ 103 (313)
T cd06633 40 ATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK----------------EHTAWLVMEYC 103 (313)
T ss_pred EEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe----------------CCEEEEEEecC
Confidence 567789999999999765322 2233567889999999999999999999986 55789999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
.+++..++......+++.+++.++.||+.+|.|||++||+|+||||+||+++.++.+||+|||++.... ......
T Consensus 104 ~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~-----~~~~~~ 178 (313)
T cd06633 104 LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS-----PANSFV 178 (313)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC-----CCCCcc
Confidence 998888877666678999999999999999999999999999999999999999999999999885422 222346
Q ss_pred ccCCCCChhhhcC--CCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 161 ITLWYRPPELLLG--ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 161 gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
++..|+|||++.. ...++.++|||||||++|+|++|..||...+....+..+...... .
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~--~----------------- 239 (313)
T cd06633 179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP--T----------------- 239 (313)
T ss_pred ccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--C-----------------
Confidence 7889999999852 245788999999999999999999999888766666555322100 0
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.....++..+++||.+||+.||.+|||+.+++.|+||..
T Consensus 240 ---------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~ 278 (313)
T cd06633 240 ---------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRR 278 (313)
T ss_pred ---------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 001135567999999999999999999999999999965
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=284.32 Aligned_cols=242 Identities=25% Similarity=0.392 Sum_probs=184.2
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
|+++.+|++.||+|+|...+.. ..+.+++||++.++++||||++++++...... ......||+++|.
T Consensus 39 LV~~~s~~~~YAlKkI~c~~~~--~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~-----------D~~~~~yll~Pyy 105 (302)
T KOG2345|consen 39 LVKGLSTGHLYALKKILCHSQE--DIEEALREIDNHRKFNSPNVLRLVDHQLREEK-----------DGKHEAYLLLPYY 105 (302)
T ss_pred eecccCcccchhhheeeccchH--HHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc-----------cCceeEEEEeehh
Confidence 5778899999999999876632 46788999999999999999999998765211 1245689999999
Q ss_pred C-CChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC
Q 012062 81 D-HDLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQ--VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 154 (472)
Q Consensus 81 ~-g~l~~~~~~---~~~~l~~~~i~~i~~Qll~aL~~LH~~g--iiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 154 (472)
. |+|++.+.+ .+..+++.++..|+.+|++||++||+.. ++||||||.|||+.+++.++|.|||.++...-.-..
T Consensus 106 ~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~ 185 (302)
T KOG2345|consen 106 KRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEG 185 (302)
T ss_pred ccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccceEeec
Confidence 7 668876654 3346999999999999999999999998 999999999999999999999999998765321111
Q ss_pred --------ccccccccCCCCChhhhcCCC--CCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 012062 155 --------TLTNRVITLWYRPPELLLGAT--KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 224 (472)
Q Consensus 155 --------~~~~~~gt~~y~aPE~l~~~~--~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 224 (472)
......+|..|+|||.+.-.. ..+.++|||||||+||+|+.|..||.. +++.-++..-.+.
T Consensus 186 ~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~---------~~~~GgSlaLAv~ 256 (302)
T KOG2345|consen 186 SRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER---------IYQQGGSLALAVQ 256 (302)
T ss_pred hHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH---------HhhcCCeEEEeee
Confidence 122346799999999875432 357899999999999999999999953 2221111110000
Q ss_pred ccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 225 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
..-.+.|. ...+++.+.+||+.||+.||.+||++.+++.+
T Consensus 257 n~q~s~P~-----------------~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 257 NAQISIPN-----------------SSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred ccccccCC-----------------CCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 00000000 01278899999999999999999999999864
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=292.77 Aligned_cols=238 Identities=28% Similarity=0.463 Sum_probs=186.5
Q ss_pred ceeccCCCEEEEEEeecCCcCC---CchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 2 AREIKTGEIVALKKIRMDNEKE---GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
+++..+++.||||+++.+.... .....+.+|+.++++++|+||+++++++.+.. ...+|+|||
T Consensus 21 ~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--------------~~~~~~v~e 86 (265)
T cd06652 21 CYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM--------------ERTLSIFME 86 (265)
T ss_pred EEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC--------------CceEEEEEE
Confidence 5778899999999987543221 22346778999999999999999999886521 346899999
Q ss_pred cCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC--Cc
Q 012062 79 YMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NT 155 (472)
Q Consensus 79 y~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~--~~ 155 (472)
|+.+ +|.+++.+. ..+++..+..++.||+.+|+|||+++|+|+||||+|||++.++.+||+|||++........ ..
T Consensus 87 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 165 (265)
T cd06652 87 HMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTG 165 (265)
T ss_pred ecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccccccc
Confidence 9986 666665543 3588999999999999999999999999999999999999999999999999876532111 11
Q ss_pred cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcccc
Q 012062 156 LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (472)
.....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+....+.++.. .+...
T Consensus 166 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~~------------- 228 (265)
T cd06652 166 MKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPTNP------------- 228 (265)
T ss_pred cccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCCCC-------------
Confidence 223457889999999876 5678999999999999999999999987655554443321 11100
Q ss_pred CCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
.....++..+.++|++||. +|++|||++|+++|+|+
T Consensus 229 ------------~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~ 264 (265)
T cd06652 229 ------------VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFV 264 (265)
T ss_pred ------------CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCccc
Confidence 0112456789999999995 99999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=345.03 Aligned_cols=241 Identities=27% Similarity=0.436 Sum_probs=195.3
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|.+..||+..|+|.|+...........+.+|.++|..|+|||||++|++-.. +..++|.||||+
T Consensus 1254 avN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH----------------Rekv~IFMEyC~ 1317 (1509)
T KOG4645|consen 1254 AVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH----------------REKVYIFMEYCE 1317 (1509)
T ss_pred eecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec----------------HHHHHHHHHHhc
Confidence 5788999999999998765545555667899999999999999999988654 678999999999
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCC---CCcccc
Q 012062 82 HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH---NNTLTN 158 (472)
Q Consensus 82 g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~---~~~~~~ 158 (472)
++.+..+.....-.++...+.|..|++.||+|||+.|||||||||+||+|+.+|.+|+.|||.|..+.... ......
T Consensus 1318 ~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~ 1397 (1509)
T KOG4645|consen 1318 GGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQS 1397 (1509)
T ss_pred cCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHh
Confidence 75554444444457777888899999999999999999999999999999999999999999998876542 233456
Q ss_pred ccccCCCCChhhhcCCC--CCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccC
Q 012062 159 RVITLWYRPPELLLGAT--KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~--~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (472)
..||+.|||||++.+.. ...-++||||||||+.||+||+.||...+..-++.-.+.....|
T Consensus 1398 ~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~P----------------- 1460 (1509)
T KOG4645|consen 1398 MMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKP----------------- 1460 (1509)
T ss_pred hcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCC-----------------
Confidence 78999999999998754 35668999999999999999999998765443333222222221
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
+++..++.+.+|||..||..||++|+++.|||+|.|-+.
T Consensus 1461 -----------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1461 -----------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred -----------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 112247889999999999999999999999999998743
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=295.74 Aligned_cols=228 Identities=16% Similarity=0.244 Sum_probs=181.1
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Ch
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL 84 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l 84 (472)
.++..||||+++..... .....+.+|+.++++++|+||+++++++.. .+.+||||||+.+ +|
T Consensus 31 ~~~~~vaik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~~~~~~L 93 (266)
T cd05064 31 KRELPVAIHTLRAGCSD-KQRRGFLAEALTLGQFDHSNIVRLEGVITR----------------GNTMMIVTEYMSNGAL 93 (266)
T ss_pred CceeeEEEEecCCCCCH-HHHHHHHHHHHHHhcCCCCCcCeEEEEEec----------------CCCcEEEEEeCCCCcH
Confidence 45678999999865332 234567899999999999999999999976 5578999999996 55
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccCC
Q 012062 85 TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLW 164 (472)
Q Consensus 85 ~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~ 164 (472)
.+++.+....+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||.+...............++..
T Consensus 94 ~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~ 173 (266)
T cd05064 94 DSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL 173 (266)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccchhcccCCCCcee
Confidence 55665545578999999999999999999999999999999999999999999999999875532221111112234678
Q ss_pred CCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhh
Q 012062 165 YRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMK 243 (472)
Q Consensus 165 y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (472)
|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+.+..+.+....+.
T Consensus 174 y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------------- 229 (266)
T cd05064 174 WAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPA----------------------- 229 (266)
T ss_pred ecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCC-----------------------
Confidence 999999876 678999999999999999775 9999998887776666543211100
Q ss_pred hhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 244 RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 244 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...++..+.+|+.+||..||.+|||+++|++
T Consensus 230 ------~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 230 ------PRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred ------CCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 1235668999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=290.44 Aligned_cols=236 Identities=29% Similarity=0.488 Sum_probs=189.3
Q ss_pred ceeccCCCEEEEEEeecCCcC---CCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 2 AREIKTGEIVALKKIRMDNEK---EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
|.+..+++.||||++...... ......+.+|+.+++.++|+||+++++++.. ...+|+|||
T Consensus 19 ~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----------------~~~~~lv~e 82 (258)
T cd06632 19 GLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE----------------EDNLYIFLE 82 (258)
T ss_pred EEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec----------------CCeEEEEEE
Confidence 556778999999999765322 2244567889999999999999999999876 457899999
Q ss_pred cCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 79 YMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 79 y~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
|+.+ +|.+++.+. ..+++..+..++.||+.+|+|||+++|+|+||||+||+++.++.+||+|||++....... ...
T Consensus 83 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--~~~ 159 (258)
T cd06632 83 LVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--FAK 159 (258)
T ss_pred ecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--ccc
Confidence 9986 666666543 358999999999999999999999999999999999999999999999999987654322 223
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
...++..|++||.+.....++.++|+|||||++|+|++|+.||......+....+......+
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------------ 221 (258)
T cd06632 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELP------------------ 221 (258)
T ss_pred ccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCC------------------
Confidence 34578899999998763337899999999999999999999998776555444432211000
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
.+...++..+++||++||..||++|||+.++|.|+|+
T Consensus 222 ----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 222 ----------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred ----------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 0112356789999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=291.50 Aligned_cols=236 Identities=28% Similarity=0.460 Sum_probs=189.8
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
++++.++..||+|.+............+.+|+.++++++|+||+++++++.. .+.+|+|+||+.
T Consensus 19 ~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~----------------~~~~~lv~e~~~ 82 (257)
T cd08225 19 AKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE----------------NGRLFIVMEYCD 82 (257)
T ss_pred EEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc----------------CCeEEEEEecCC
Confidence 5677889999999998754333345567899999999999999999999876 567899999998
Q ss_pred C-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC-eEEeeccceeeeccCCCCcccc
Q 012062 82 H-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN-LKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 82 g-~l~~~~~~~-~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~-vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
+ +|.+++.+. ...+++..++.++.||+.+|+|||+++|+|+||||+||+++.++. +||+|||.+....... .....
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 161 (257)
T cd08225 83 GGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM-ELAYT 161 (257)
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc-ccccc
Confidence 5 676666543 335799999999999999999999999999999999999998864 6999999987654322 12223
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
..++..|+|||++.. ..++.++|+|||||++++|++|..||...+..+....+......
T Consensus 162 ~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------------- 220 (257)
T cd08225 162 CVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA-------------------- 220 (257)
T ss_pred cCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCC--------------------
Confidence 457889999998876 46789999999999999999999999877765555444321100
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
.....++..++++|.+||..||++|||+.|+++|+||
T Consensus 221 ---------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 221 ---------PISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ---------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 0012356789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=299.69 Aligned_cols=235 Identities=22% Similarity=0.302 Sum_probs=177.6
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Ch
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL 84 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l 84 (472)
.++..||||+++..... .....+.+|+++|++++|+||+++++++.. .+.+||||||+.+ +|
T Consensus 44 ~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----------------~~~~~lv~e~~~~~~L 106 (304)
T cd05096 44 GRPLLVAVKILRPDANK-NARNDFLKEVKILSRLKDPNIIRLLGVCVD----------------EDPLCMITEYMENGDL 106 (304)
T ss_pred CcceEEEEEEecCCCCH-HHHHHHHHHHHHHhhcCCCCeeEEEEEEec----------------CCceEEEEecCCCCcH
Confidence 34557999999764322 234567899999999999999999999976 4568999999985 66
Q ss_pred hhhhcCC------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeecccee
Q 012062 85 TGLADRP------------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 146 (472)
Q Consensus 85 ~~~~~~~------------------~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 146 (472)
.+++... ...+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++
T Consensus 107 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~ 186 (304)
T cd05096 107 NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSR 186 (304)
T ss_pred HHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCCccEEECCCccce
Confidence 6655321 1236778899999999999999999999999999999999999999999999997
Q ss_pred eeccCCCC-ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh--CCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 012062 147 SFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN--GKPILPGKNEAEQLSKIFELCGSPDETI 223 (472)
Q Consensus 147 ~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~--G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 223 (472)
.+...... ......++..|+|||++.. ..++.++|||||||++|+|++ +..||...+..+.+..+...........
T Consensus 187 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 265 (304)
T cd05096 187 NLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQV 265 (304)
T ss_pred ecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccc
Confidence 65432211 1122344778999999876 568999999999999999986 5678887776665554433211110000
Q ss_pred CccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 224 WPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
+. .....++..+.+||.+||..||++|||+.||.+
T Consensus 266 ~~----------------------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 266 YL----------------------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred cc----------------------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 00 001235678999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=289.19 Aligned_cols=236 Identities=33% Similarity=0.512 Sum_probs=194.6
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||++............+.+|+++++.++|+||+++++.+.. ...++|||||++
T Consensus 19 ~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~----------------~~~~~lv~e~~~ 82 (258)
T cd08215 19 VRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE----------------KGKLCIVMEYAD 82 (258)
T ss_pred EEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec----------------CCEEEEEEEecC
Confidence 5677789999999998765544456678899999999999999999999876 457899999998
Q ss_pred C-ChhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 82 H-DLTGLADRP---GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 82 g-~l~~~~~~~---~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
+ +|...+.+. ...+++.++..++.+|+.||.|||+++++|+||+|+||+++.+++++|+|||++....... ....
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~ 161 (258)
T cd08215 83 GGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-DLAK 161 (258)
T ss_pred CCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc-ceec
Confidence 6 676666553 3579999999999999999999999999999999999999999999999999997765432 1223
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
...++..|+|||.+.. ..++.++|+||||+++++|++|..||...+..+....+.......
T Consensus 162 ~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------------ 222 (258)
T cd08215 162 TVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP------------------ 222 (258)
T ss_pred ceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCC------------------
Confidence 3467889999998876 567899999999999999999999998877655555443211000
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
....++..+.++|++||..||++|||+.|+|+|+||
T Consensus 223 -----------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 223 -----------IPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred -----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 011356789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=295.10 Aligned_cols=237 Identities=26% Similarity=0.439 Sum_probs=188.8
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC---CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ---HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
|++..+++.||||+++.+... .....+.+|++++++++ |+||+++++++.. ...+|||||
T Consensus 20 ~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~----------------~~~~~lv~e 82 (277)
T cd06917 20 GKHVPTGRVVALKIINLDTPD-DDVSDIQREVALLSQLRQSQPPNITKYYGSYLK----------------GPRLWIIME 82 (277)
T ss_pred EEEcCCCcEEEEEEecCCCCc-hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee----------------CCEEEEEEe
Confidence 677889999999999765332 23456778999999997 9999999999876 557899999
Q ss_pred cCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 79 YMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 79 y~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
|+.+ +|.+++... .+++..++.++.||+.+|.|||+++|+|+||+|+||+++.++.++|+|||++..+.... ....
T Consensus 83 ~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~ 159 (277)
T cd06917 83 YAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-SKRS 159 (277)
T ss_pred cCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-cccc
Confidence 9986 565555432 68999999999999999999999999999999999999999999999999998765433 2223
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
...++..|+|||.+.....++.++|+|||||++|+|++|..||...+.......+... .+.. +.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~--------~~------ 223 (277)
T cd06917 160 TFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPPR--------LE------ 223 (277)
T ss_pred cccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--CCCC--------CC------
Confidence 3467889999999876556788999999999999999999999876554333222110 0000 00
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
...++.++.+||.+||..||++|||+.|++.|+||..
T Consensus 224 ------------~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~ 260 (277)
T cd06917 224 ------------DNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKA 260 (277)
T ss_pred ------------cccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhc
Confidence 0125668999999999999999999999999999954
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=310.64 Aligned_cols=239 Identities=27% Similarity=0.453 Sum_probs=192.2
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|||..|...+|||.|...... +..-+..||.+++.|+|.|||++++.+.. ++.+-|+||-+.
T Consensus 594 ~RD~~tqvrIaIKEIpekdsr--~~QPLhEEIaLH~~LrHkNIVrYLGs~se----------------nGf~kIFMEqVP 655 (1226)
T KOG4279|consen 594 ARDMDTQVRIAIKEIPEKDSR--EVQPLHEEIALHSTLRHKNIVRYLGSVSE----------------NGFFKIFMEQVP 655 (1226)
T ss_pred eccccceeEEEeeecccccch--hhccHHHHHHHHHHHhhHhHHHHhhccCC----------------CCeEEEEeecCC
Confidence 689999999999999754433 35567899999999999999999999876 667889999998
Q ss_pred C-ChhhhhcCCCCCC--CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC-CCCeEEeeccceeeeccCCCCccc
Q 012062 82 H-DLTGLADRPGLRF--TVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN-EGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 82 g-~l~~~~~~~~~~l--~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~-~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
| +|..++...-+++ .+..+..|.+|||+||.|||++.|||||||-+||||+. .|.+||.|||.++.+..-.. ...
T Consensus 656 GGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~TE 734 (1226)
T KOG4279|consen 656 GGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-CTE 734 (1226)
T ss_pred CCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCc-ccc
Confidence 6 5666666554566 78889999999999999999999999999999999974 78899999999987654322 233
Q ss_pred cccccCCCCChhhhcC-CCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCCCCCCccCCCCCcccc
Q 012062 158 NRVITLWYRPPELLLG-ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ-LSKIFELCGSPDETIWPGVSKMPAYNH 235 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~-~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (472)
++.||+.|||||++-. ...|+.++|||||||++.||.||++||........ +.++ .+...
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV-GmyKv----------------- 796 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV-GMYKV----------------- 796 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh-cceec-----------------
Confidence 4678999999999853 35699999999999999999999999986544332 2211 11000
Q ss_pred CCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
-..++..++.+++.||.+|+..||.+|++|.++|.+||+...
T Consensus 797 ----------HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 797 ----------HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred ----------CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 011223578899999999999999999999999999999654
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=295.37 Aligned_cols=241 Identities=26% Similarity=0.382 Sum_probs=187.1
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
|+++.+++.||||++.... .....+.+|+.+++++ +|+||+++++++...+.. ..+.+|+||||+
T Consensus 41 ~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~-----------~~~~~~lv~ey~ 106 (291)
T cd06639 41 VTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL-----------VGGQLWLVLELC 106 (291)
T ss_pred EEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc-----------CCCeeEEEEEEC
Confidence 5677899999999986432 2234667899999999 799999999998753211 135689999999
Q ss_pred CC-ChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcc
Q 012062 81 DH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTL 156 (472)
Q Consensus 81 ~g-~l~~~~~~---~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 156 (472)
.+ +|.+++.. ....+++..++.++.||+.||+|||+++|+|+||||+||+++.++.+||+|||++........ ..
T Consensus 107 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~ 185 (291)
T cd06639 107 NGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL-RR 185 (291)
T ss_pred CCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhcccccc-cc
Confidence 86 66555432 344689999999999999999999999999999999999999999999999999876542221 12
Q ss_pred ccccccCCCCChhhhcCCC----CCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 012062 157 TNRVITLWYRPPELLLGAT----KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 232 (472)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~----~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (472)
....++..|+|||++.... .++.++|||||||++|+|++|+.||...+....+..+.+.... .. .
T Consensus 186 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~---~~----~---- 254 (291)
T cd06639 186 NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPP---TL----L---- 254 (291)
T ss_pred cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCC---CC----C----
Confidence 2345788999999886422 2578999999999999999999999887766655544321100 00 0
Q ss_pred cccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 233 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
....++..+.+||.+||..||++|||+.||++|+||
T Consensus 255 ----------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~ 290 (291)
T cd06639 255 ----------------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFI 290 (291)
T ss_pred ----------------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcCccc
Confidence 001245579999999999999999999999999998
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=291.44 Aligned_cols=230 Identities=21% Similarity=0.308 Sum_probs=183.4
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|.+..+++.||+|+++.+.. ....+.+|+++++.++|+||+++++++.. ++.+++||||+.
T Consensus 25 ~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~ 85 (263)
T cd05052 25 GVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTR----------------EPPFYIITEFMT 85 (263)
T ss_pred EEEecCCceEEEEEecCCch---HHHHHHHHHHHHHhCCCCChhheEEEEcC----------------CCCcEEEEEeCC
Confidence 56778899999999874321 24567899999999999999999999876 557899999997
Q ss_pred C-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 82 H-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 82 g-~l~~~~~~~-~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
+ +|.+++... ...+++..++.++.||+.+|+|||+++|+||||||+|||+++++.+||+|||++..............
T Consensus 86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~ 165 (263)
T cd05052 86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 165 (263)
T ss_pred CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCC
Confidence 4 677666543 34588999999999999999999999999999999999999999999999999876543322222222
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
..+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 166 ~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~-------------------- 224 (263)
T cd05052 166 KFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRM-------------------- 224 (263)
T ss_pred CCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC--------------------
Confidence 33567999998876 567899999999999999998 99999887766655554321100
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
.....++.++.+||.+||..||++|||+.|+++
T Consensus 225 ---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 225 ---------ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred ---------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 001235678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=294.65 Aligned_cols=241 Identities=27% Similarity=0.405 Sum_probs=184.7
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
|++..+++.||||+++.... ....+.+|+.+++++ +|+||+++++++..... ...+.+|+||||+
T Consensus 37 ~~~~~~~~~~~ik~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~-----------~~~~~~~lv~e~~ 102 (286)
T cd06638 37 VLNKKNGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV-----------KNGDQLWLVLELC 102 (286)
T ss_pred EEECCCCceeEEEeeccccc---hHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc-----------CCCCeEEEEEeec
Confidence 57788999999999864321 234567899999999 69999999998854221 1145789999999
Q ss_pred CC-Chhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcc
Q 012062 81 DH-DLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTL 156 (472)
Q Consensus 81 ~g-~l~~~~~---~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 156 (472)
++ +|.+++. .....+++..++.++.||+.||.|||+++|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 103 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~ 181 (286)
T cd06638 103 NGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR-LRR 181 (286)
T ss_pred CCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeecccCC-Ccc
Confidence 86 5555443 233468899999999999999999999999999999999999999999999999987654322 122
Q ss_pred ccccccCCCCChhhhcCC----CCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 012062 157 TNRVITLWYRPPELLLGA----TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 232 (472)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~----~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (472)
....++..|+|||++... ..++.++|||||||++|+|++|+.||...+....+.++..... .. .
T Consensus 182 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~--~~-----~----- 249 (286)
T cd06638 182 NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPP--PT-----L----- 249 (286)
T ss_pred ccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCC--Cc-----c-----
Confidence 334678999999988532 3478899999999999999999999987765444333211100 00 0
Q ss_pred cccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 233 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
.....++..+++||.+||..||++|||+.|||+|+||
T Consensus 250 ---------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 250 ---------------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred ---------------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 0001245679999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=294.60 Aligned_cols=244 Identities=26% Similarity=0.401 Sum_probs=186.7
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||+|++...... .....+.+|++++++++|+||++++++|.+.. .+.+||||||+
T Consensus 19 ~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--------------~~~~~lv~e~~ 83 (287)
T cd06621 19 KCRLKNTGMIFALKTITTDPNP-DLQKQILRELEINKSCKSPYIVKYYGAFLDES--------------SSSIGIAMEYC 83 (287)
T ss_pred EEEECCCCeEEEEEEEecCCch-HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC--------------CCeEEEEEEec
Confidence 3677889999999999865332 34567889999999999999999999986532 45789999999
Q ss_pred CC-Chhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcc
Q 012062 81 DH-DLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTL 156 (472)
Q Consensus 81 ~g-~l~~~~~---~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 156 (472)
++ +|.+++. .....+++..+..++.||+.+|+|||+.+++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--- 160 (287)
T cd06621 84 EGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA--- 160 (287)
T ss_pred CCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccccc---
Confidence 86 6655432 2344589999999999999999999999999999999999999999999999999865432211
Q ss_pred ccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHhcCCCCCCCCccCCCCC
Q 012062 157 TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE-----AEQLSKIFELCGSPDETIWPGVSKMP 231 (472)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~-----~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (472)
....++..|++||.+.+ ..++.++|||||||++|+|++|..||..... .+....+.... .+ . . .
T Consensus 161 ~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~--~----~---~ 229 (287)
T cd06621 161 GTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP-NP--E----L---K 229 (287)
T ss_pred ccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC-ch--h----h---c
Confidence 23356888999998876 5688999999999999999999999986622 22222221100 00 0 0 0
Q ss_pred ccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 232 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.. ...-..+++.+++||.+||..||++|||+.|++.|+||+.
T Consensus 230 ~~-------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 271 (287)
T cd06621 230 DE-------------PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271 (287)
T ss_pred cC-------------CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccc
Confidence 00 0000124567899999999999999999999999999943
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=294.25 Aligned_cols=238 Identities=24% Similarity=0.410 Sum_probs=186.1
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||+|++..... ......+.+|+++++.++|+||+++++++.. .+.+||||||+.
T Consensus 24 ~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~ 86 (284)
T cd06620 24 VKHIPTGTVMAKKVVHIGAK-SSVRKQILRELQIMHECRSPYIVSFYGAFLN----------------ENNICMCMEFMD 86 (284)
T ss_pred EEEcCCCcEEEEEEEEecCc-chHHHHHHHHHHHHHHcCCCCcceEeeeEec----------------CCEEEEEEecCC
Confidence 57788899999999875432 3345678899999999999999999999986 567899999999
Q ss_pred CC-hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 82 HD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 82 g~-l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~-~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
++ |..++.+ ...+++..+..++.+|+.+|.|||+ .+|+||||||+||++++++.++|+|||++....... ....
T Consensus 87 ~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~---~~~~ 162 (284)
T cd06620 87 CGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---ADTF 162 (284)
T ss_pred CCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---cCcc
Confidence 74 5444443 3468999999999999999999997 599999999999999999999999999986543221 1234
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHH--------HHHHHHHhcCCCCCCCCccCCCCC
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAE--------QLSKIFELCGSPDETIWPGVSKMP 231 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--------~~~~i~~~~~~~~~~~~~~~~~~~ 231 (472)
+++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+ ....+.......... ++
T Consensus 163 ~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~ 234 (284)
T cd06620 163 VGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPR-------LP 234 (284)
T ss_pred ccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCC-------CC
Confidence 67999999999876 468899999999999999999999998765421 111111111000000 00
Q ss_pred ccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 232 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
...++.++.+||.+||..||++|||+.|+++|+||..
T Consensus 235 ------------------~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 235 ------------------SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred ------------------chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 0125668999999999999999999999999999954
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=292.68 Aligned_cols=236 Identities=28% Similarity=0.416 Sum_probs=184.7
Q ss_pred ceeccCCCEEEEEEeecCCcC-CCchhhHHHHHHHH-HhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 2 AREIKTGEIVALKKIRMDNEK-EGFPITAIREIKIL-KKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~-~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
|++..+++.||||+++..... .........|..++ +.++|+||++++++++. ++.+||||||
T Consensus 15 a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----------------~~~~~lv~e~ 78 (260)
T cd05611 15 AKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS----------------KDYLYLVMEY 78 (260)
T ss_pred EEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc----------------CCeEEEEEec
Confidence 677889999999999754321 11223344555544 45589999999999986 5679999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
+.+ +|..++... ..+++..+..++.||+.||.|||+++|+|+||+|+|||++.++.+||+|||++..... ...
T Consensus 79 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~ 152 (260)
T cd05611 79 LNGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKK 152 (260)
T ss_pred cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----ccc
Confidence 986 565555443 4689999999999999999999999999999999999999999999999999875432 223
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
..++..|++||.+.+ ..++.++||||||+++|+|++|..||...+....+..+.........
T Consensus 153 ~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------------- 214 (260)
T cd05611 153 FVGTPDYLAPETILG-VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPE----------------- 214 (260)
T ss_pred CCCCcCccChhhhcC-CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCC-----------------
Confidence 456889999999887 45789999999999999999999999988776666655432111000
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCC---HHHHhcCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS---AKDALDSEYFWT 286 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t---~~elL~h~~f~~ 286 (472)
.....++..+.+||.+||+.||++|+| ++|+|+|+||..
T Consensus 215 ---------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 215 ---------EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred ---------cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhc
Confidence 011246778999999999999999994 579999999953
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=292.48 Aligned_cols=237 Identities=27% Similarity=0.438 Sum_probs=182.6
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..++..||+|.+...... ....+.+|+++++.++|+||+++++++.. .+.+|+||||+.
T Consensus 27 ~~~~~~~~~v~~k~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~~~ 88 (268)
T cd06624 27 ARDLSTQVRIAIKEIPERDSR--YVQPLHEEIALHSYLKHRNIVQYLGSDSE----------------NGFFKIFMEQVP 88 (268)
T ss_pred eEecCCCcEEEEEEecCCCHH--HHHHHHHHHHHHHhcCCCCeeeeeeeecc----------------CCEEEEEEecCC
Confidence 567788999999998755322 24567899999999999999999999876 567899999998
Q ss_pred C-ChhhhhcCCCCCC--CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC-CCCeEEeeccceeeeccCCCCccc
Q 012062 82 H-DLTGLADRPGLRF--TVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN-EGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 82 g-~l~~~~~~~~~~l--~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~-~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
+ +|.+.+......+ ++..+..++.||+.||+|||+++|+||||||+||+++. ++.+||+|||++....... ....
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~ 167 (268)
T cd06624 89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN-PCTE 167 (268)
T ss_pred CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC-Cccc
Confidence 5 6666665433344 78889999999999999999999999999999999976 6689999999987653222 1222
Q ss_pred cccccCCCCChhhhcCC-CCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccC
Q 012062 158 NRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (472)
...++..|+|||++... ..++.++|||||||++|+|++|+.||..................
T Consensus 168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------ 229 (268)
T cd06624 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKI------------------ 229 (268)
T ss_pred cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhcc------------------
Confidence 34568899999998653 23788999999999999999999999754432211111000000
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
...+...+++++++||++||..||++|||+.|++.|+||
T Consensus 230 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 230 ---------HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred ---------CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 001112466789999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=297.62 Aligned_cols=237 Identities=26% Similarity=0.408 Sum_probs=191.5
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.+++.||||.+..... .......+.+|+++++.++|+||+++++++.. ....||||||
T Consensus 33 ~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~ 96 (308)
T cd06634 33 FARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR----------------EHTAWLVMEY 96 (308)
T ss_pred EEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc----------------CCeeEEEEEc
Confidence 367788999999999975422 22234567789999999999999999999986 4578999999
Q ss_pred CCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 80 MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 80 ~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
+.+++.+++......+++..+..++.||+.+|.|||+++++||||||+|||++.++.+||+|||++..... ....
T Consensus 97 ~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~-----~~~~ 171 (308)
T cd06634 97 CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANXF 171 (308)
T ss_pred cCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC-----cccc
Confidence 99888877765555689999999999999999999999999999999999999999999999999876532 1234
Q ss_pred cccCCCCChhhhcC--CCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 160 VITLWYRPPELLLG--ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 160 ~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
.++..|+|||++.+ ...++.++|||||||++|+|++|..||...+..+....+...... .
T Consensus 172 ~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~----------------- 233 (308)
T cd06634 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP-A----------------- 233 (308)
T ss_pred cCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCC-C-----------------
Confidence 56889999999853 235788999999999999999999999876655554444321100 0
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.....++..+++||++||..+|++|||+.+++.|+|+..
T Consensus 234 ----------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 234 ----------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred ----------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 001135678999999999999999999999999999965
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=278.40 Aligned_cols=258 Identities=31% Similarity=0.575 Sum_probs=196.8
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC-CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+++..+++.++||+++... .+.+.+||+||..|. |+|||+++++..++. .....||+||+
T Consensus 57 g~~~~~~eK~ViKiLKPVk-----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~--------------SktpaLiFE~v 117 (338)
T KOG0668|consen 57 GINITNNEKCVIKILKPVK-----KKKIKREIKILQNLRGGPNIIKLLDIVKDPE--------------SKTPSLIFEYV 117 (338)
T ss_pred ccccCCCceEEEeeechHH-----HHHHHHHHHHHHhccCCCCeeehhhhhcCcc--------------ccCchhHhhhh
Confidence 4567899999999998543 346789999999998 999999999998754 34568999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC-CeEEeeccceeeeccCCCCcccc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG-NLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~-~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
+. +...+.. .++.-.++.++.+||.||.|||++||+|||+||.|+|||... .++|+|+|+|.++... .....
T Consensus 118 ~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~--~eYnV 191 (338)
T KOG0668|consen 118 NNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG--KEYNV 191 (338)
T ss_pred ccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC--ceeee
Confidence 86 4333332 478889999999999999999999999999999999999765 5999999999776432 23344
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCC-CCCCCCChHHHHHHHHHhcCCCCCCCCcc---CCCCCccc
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK-PILPGKNEAEQLSKIFELCGSPDETIWPG---VSKMPAYN 234 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~---~~~~~~~~ 234 (472)
++-+..|--||++..-..|+.+.|+|||||+|+.|+..+ +.|.+.+..+++.+|.+.++.-+-.-.-. +..-+.+.
T Consensus 192 RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~ 271 (338)
T KOG0668|consen 192 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFE 271 (338)
T ss_pred eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHh
Confidence 566889999999998778999999999999999999876 55678899999999988877632110000 00001111
Q ss_pred cCCCchhhhhhHHHHh----h-hccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 235 HFKPSRTMKRRVREVF----R-HFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~----~-~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
+... +..++.+..+. . ..++++.|||.++|..|-.+|+||+|++.||||.
T Consensus 272 ~i~~-~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~ 326 (338)
T KOG0668|consen 272 DILG-RHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFA 326 (338)
T ss_pred hHhh-ccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHH
Confidence 1000 01111222222 1 2468999999999999999999999999999993
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=309.30 Aligned_cols=229 Identities=22% Similarity=0.367 Sum_probs=177.2
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-C
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-D 83 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~ 83 (472)
.+++.||||+++.....+ ....+.+|+.+++.+ +|+|||++++++.. .+.+|||||||.+ +
T Consensus 66 ~~~~~vavK~~~~~~~~~-~~~~~~~E~~il~~l~~h~nIv~~~~~~~~----------------~~~~~lv~ey~~~g~ 128 (374)
T cd05106 66 DNVLRVAVKMLKASAHTD-EREALMSELKILSHLGQHKNIVNLLGACTH----------------GGPVLVITEYCCYGD 128 (374)
T ss_pred cccceeEEEeccCCCCHH-HHHHHHHHHHHHHhhccCCceeeEeeEecC----------------CCCeEEeHhhccCCc
Confidence 344689999997654322 345678999999999 89999999999876 5578999999985 6
Q ss_pred hhhhhcCC---------------------------------------------------------------------CCC
Q 012062 84 LTGLADRP---------------------------------------------------------------------GLR 94 (472)
Q Consensus 84 l~~~~~~~---------------------------------------------------------------------~~~ 94 (472)
|.+++.+. ...
T Consensus 129 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (374)
T cd05106 129 LLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWP 208 (374)
T ss_pred HHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhccCCCCC
Confidence 66554321 124
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcc-ccccccCCCCChhhhcC
Q 012062 95 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTL-TNRVITLWYRPPELLLG 173 (472)
Q Consensus 95 l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~-~~~~gt~~y~aPE~l~~ 173 (472)
+++.+++.|+.||+.||+|||+++|+||||||+|||+++++.+||+|||+++.......... ....++..|+|||++..
T Consensus 209 l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 288 (374)
T cd05106 209 LDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFD 288 (374)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcC
Confidence 78889999999999999999999999999999999999999999999999976543322111 12234567999999876
Q ss_pred CCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhh
Q 012062 174 ATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRH 252 (472)
Q Consensus 174 ~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (472)
..++.++|||||||++|+|++ |+.||........+.++......+.. ...
T Consensus 289 -~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~----------------------------~~~ 339 (374)
T cd05106 289 -CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSR----------------------------PDF 339 (374)
T ss_pred -CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccC----------------------------CCC
Confidence 568999999999999999997 99999876655444444332111100 012
Q ss_pred ccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 253 FDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 253 ~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
++.++++||.+||..||++|||+.+|++
T Consensus 340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 340 APPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 4678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=289.16 Aligned_cols=226 Identities=22% Similarity=0.302 Sum_probs=179.9
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chh
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLT 85 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~ 85 (472)
+++.+|||+++.... ....+.+|++++++++|+||+++++++.. .+.+|+||||+.+ +|.
T Consensus 27 ~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~~~~~lv~e~~~~~~L~ 87 (256)
T cd05059 27 GKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTK----------------QRPIFIVTEYMANGCLL 87 (256)
T ss_pred CCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcC----------------CCceEEEEecCCCCCHH
Confidence 567899999864322 23467789999999999999999999876 4578999999975 677
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccCCC
Q 012062 86 GLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWY 165 (472)
Q Consensus 86 ~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y 165 (472)
+++......+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+|||+++...............+..|
T Consensus 88 ~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y 167 (256)
T cd05059 88 NYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKW 167 (256)
T ss_pred HHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccCCCCCCccc
Confidence 77765445789999999999999999999999999999999999999999999999999876543222111222234579
Q ss_pred CChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhh
Q 012062 166 RPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 244 (472)
Q Consensus 166 ~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (472)
+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+.......
T Consensus 168 ~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~------------------------- 221 (256)
T cd05059 168 APPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLY------------------------- 221 (256)
T ss_pred cCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCC-------------------------
Confidence 99999876 568899999999999999998 899998877766665553221100
Q ss_pred hHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 245 RVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 245 ~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
....++.++.+|+.+||..+|++|||+.|+++.
T Consensus 222 ----~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 222 ----RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred ----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 001356789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=288.52 Aligned_cols=225 Identities=23% Similarity=0.342 Sum_probs=180.6
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chh
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLT 85 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~ 85 (472)
++..||||.++.... ....+.+|+.+|++++|+||+++++++.. .+.+||||||+.+ +|.
T Consensus 27 ~~~~~a~K~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~iv~e~~~~~~L~ 87 (256)
T cd05114 27 AQIKVAIKAINEGAM---SEEDFIEEAKVMMKLSHPKLVQLYGVCTQ----------------QKPLYIVTEFMENGCLL 87 (256)
T ss_pred cCceEEEEecccCCc---cHHHHHHHHHHHHHCCCCCceeEEEEEcc----------------CCCEEEEEEcCCCCcHH
Confidence 456899998864322 23567889999999999999999999876 5578999999984 677
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccCCC
Q 012062 86 GLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWY 165 (472)
Q Consensus 86 ~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y 165 (472)
+++......+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+|||+++..............++..|
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y 167 (256)
T cd05114 88 NYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKW 167 (256)
T ss_pred HHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhh
Confidence 76655444689999999999999999999999999999999999999999999999999876533222222222345679
Q ss_pred CChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhh
Q 012062 166 RPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 244 (472)
Q Consensus 166 ~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (472)
+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+.+..+.+.......
T Consensus 168 ~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~----------------------- 223 (256)
T cd05114 168 SPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP----------------------- 223 (256)
T ss_pred CChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC-----------------------
Confidence 99999876 568899999999999999999 89999988887777766442211000
Q ss_pred hHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 245 RVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 245 ~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...+..+.+||.+||..||++|||+.|+++
T Consensus 224 ------~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 224 ------KLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred ------CCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 113457899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=293.80 Aligned_cols=235 Identities=27% Similarity=0.408 Sum_probs=189.2
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||+++..... .....+.+|+++++++.|+||+++++++.. ...+||||||+.
T Consensus 23 ~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~ 85 (277)
T cd06640 23 GIDNRTQQVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLK----------------GTKLWIIMEYLG 85 (277)
T ss_pred EEEccCCEEEEEEEEeccccH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEE----------------CCEEEEEEecCC
Confidence 577889999999998754322 234567889999999999999999999986 557999999998
Q ss_pred C-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 82 H-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 82 g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+ +|.+++.. ..+++.++..++.||+.+|+|||+++++|+||+|+||+++.++.++|+|||++..+..... ......
T Consensus 86 ~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~ 162 (277)
T cd06640 86 GGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNTFV 162 (277)
T ss_pred CCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-cccccc
Confidence 6 56665543 3589999999999999999999999999999999999999999999999999976543221 222345
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (472)
++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+.... +
T Consensus 163 ~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~--~--------------------- 218 (277)
T cd06640 163 GTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN--P--------------------- 218 (277)
T ss_pred CcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCC--C---------------------
Confidence 6888999999876 567899999999999999999999998776554443321100 0
Q ss_pred hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
..+...++..+.+||.+||..||++|||+.|++.|+||..
T Consensus 219 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06640 219 ------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVK 258 (277)
T ss_pred ------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhh
Confidence 0011235667899999999999999999999999999954
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=286.12 Aligned_cols=235 Identities=30% Similarity=0.488 Sum_probs=192.4
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||++......+.....+.+|++++++++|+||+++++++.+ .+.+|+||||++
T Consensus 19 ~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~~~~~~v~e~~~ 82 (254)
T cd06627 19 GLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET----------------SDSLYIILEYAE 82 (254)
T ss_pred EEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe----------------CCEEEEEEecCC
Confidence 5677889999999998765444456678899999999999999999999876 557899999998
Q ss_pred C-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 82 H-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 82 g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+ +|.+++.+. ..+++..++.++.||+.+|.|||++||+|+||||+||+++.++.++|+|||++........ ......
T Consensus 83 ~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 160 (254)
T cd06627 83 NGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-DDASVV 160 (254)
T ss_pred CCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-cccccc
Confidence 6 566665544 5689999999999999999999999999999999999999999999999999987654322 123346
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (472)
++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+......++.... ..
T Consensus 161 ~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~~------------------- 217 (254)
T cd06627 161 GTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD---HP------------------- 217 (254)
T ss_pred cchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccC---CC-------------------
Confidence 7889999998876 457899999999999999999999998776554444432110 00
Q ss_pred hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
.+...++..++++|.+||..||++|||+.|++.|+||
T Consensus 218 -------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 218 -------PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred -------CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 0112356789999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=296.12 Aligned_cols=234 Identities=25% Similarity=0.386 Sum_probs=186.5
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|.+..+++.||||+++...... ....+.+|++++++++|+||+++++++.. ...+|+||||+.
T Consensus 23 ~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~ 85 (277)
T cd06642 23 GIDNRTKEVVAIKIIDLEEAED-EIEDIQQEITVLSQCDSPYITRYYGSYLK----------------GTKLWIIMEYLG 85 (277)
T ss_pred EEEcCCCeEEEEEEeccccchH-HHHHHHHHHHHHHcCCCCccHhhhccccc----------------CCceEEEEEccC
Confidence 5677889999999987554332 34567899999999999999999999876 557899999999
Q ss_pred C-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 82 H-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 82 g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+ +|.+++.. ..+++..++.++.||+.||.|||+++|+|+||+|+||+++.++.++|+|||++..+.... .......
T Consensus 86 ~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~~~~ 162 (277)
T cd06642 86 GGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRNTFV 162 (277)
T ss_pred CCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc-hhhhccc
Confidence 6 56555543 358999999999999999999999999999999999999999999999999987654322 1122245
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (472)
++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+.... ++
T Consensus 163 ~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~-------~~--------------- 219 (277)
T cd06642 163 GTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS-------PP--------------- 219 (277)
T ss_pred CcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCC-------CC---------------
Confidence 6889999999876 567889999999999999999999997665544333221100 00
Q ss_pred hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
.....++..+.+||.+||..||++|||+.|++.|+||.
T Consensus 220 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 257 (277)
T cd06642 220 -------TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFIT 257 (277)
T ss_pred -------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHH
Confidence 00113566799999999999999999999999999983
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=289.33 Aligned_cols=229 Identities=20% Similarity=0.291 Sum_probs=182.3
Q ss_pred eccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-
Q 012062 4 EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH- 82 (472)
Q Consensus 4 ~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g- 82 (472)
.+.+++.||||+++...........+.+|+.+++.+.|+||+++++++.. ...+|||||+.+
T Consensus 18 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----------------~~~~lv~e~~~~~ 80 (257)
T cd05116 18 MKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-----------------ESWMLVMELAELG 80 (257)
T ss_pred cCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----------------CCcEEEEecCCCC
Confidence 45688999999997665444455678899999999999999999998753 346899999995
Q ss_pred ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCc--ccccc
Q 012062 83 DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT--LTNRV 160 (472)
Q Consensus 83 ~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~--~~~~~ 160 (472)
+|.+++.+. ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.......... .....
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05116 81 PLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159 (257)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence 566666543 468999999999999999999999999999999999999999999999999987654332211 11223
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
++..|+|||++.. ..++.++|||||||++|||++ |..||...+..+....+.+... ++
T Consensus 160 ~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~-~~------------------- 218 (257)
T cd05116 160 WPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER-ME------------------- 218 (257)
T ss_pred CCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC-CC-------------------
Confidence 3578999998865 567889999999999999998 9999998877666665532110 00
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....++.++.+||.+||+.||++|||+.+|..
T Consensus 219 ---------~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 219 ---------CPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred ---------CCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 01136678999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=294.50 Aligned_cols=237 Identities=26% Similarity=0.455 Sum_probs=189.3
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
+++..+++.||||++..... .....+.+|+.++++++|+||+++++++.. .+..|+||||+.
T Consensus 39 ~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~~~ 100 (292)
T cd06657 39 ATVKSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLV----------------GDELWVVMEFLE 100 (292)
T ss_pred EEEcCCCeEEEEEEecccch--hHHHHHHHHHHHHHhcCCcchhheeeEEEe----------------CCEEEEEEecCC
Confidence 46678999999999864332 234567889999999999999999999986 557899999998
Q ss_pred CC-hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 82 HD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 82 g~-l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+. |.+++.. ..+++..++.++.||+.+|+|||++||+|+||||+||+++.++.++|+|||++....... .......
T Consensus 101 ~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~ 177 (292)
T cd06657 101 GGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLV 177 (292)
T ss_pred CCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccccc
Confidence 74 5444432 358999999999999999999999999999999999999999999999999987654322 1223345
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (472)
++..|++||.+.. ..++.++|+||+||++|+|++|..||...+..+.+..+........ .
T Consensus 178 ~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----~--------------- 237 (292)
T cd06657 178 GTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKL----K--------------- 237 (292)
T ss_pred cCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCccc----C---------------
Confidence 7889999998865 5678999999999999999999999988776665554432211000 0
Q ss_pred hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
....++..+.++|.+||..||.+|+++.++|+|+||...
T Consensus 238 --------~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~ 276 (292)
T cd06657 238 --------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 276 (292)
T ss_pred --------CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhcc
Confidence 011356678999999999999999999999999999654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=306.78 Aligned_cols=231 Identities=23% Similarity=0.344 Sum_probs=178.6
Q ss_pred eccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC
Q 012062 4 EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH 82 (472)
Q Consensus 4 ~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g 82 (472)
+..++..||||+++..... .....+.+|+.+|+.+ +|||||++++++.. .+..|||||||.+
T Consensus 61 ~~~~~~~vavK~l~~~~~~-~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~----------------~~~~~lv~E~~~~ 123 (375)
T cd05104 61 KSDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYLGNHINIVNLLGACTV----------------GGPTLVITEYCCY 123 (375)
T ss_pred cCccceeEEEEeccCCcCc-HHHHHHHHHHHHHHHhcCCcceeeeeeeecc----------------CCcceeeehhccC
Confidence 3457789999999754322 2345678999999999 89999999999976 5568999999985
Q ss_pred -ChhhhhcCCC---------------------------------------------------------------------
Q 012062 83 -DLTGLADRPG--------------------------------------------------------------------- 92 (472)
Q Consensus 83 -~l~~~~~~~~--------------------------------------------------------------------- 92 (472)
+|.+++....
T Consensus 124 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (375)
T cd05104 124 GDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEI 203 (375)
T ss_pred CcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHH
Confidence 6766554321
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCc-cccccccCCCC
Q 012062 93 -----LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT-LTNRVITLWYR 166 (472)
Q Consensus 93 -----~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~-~~~~~gt~~y~ 166 (472)
..+++..++.|+.||+.||+|||+++|+||||||+|||++.++.+||+|||+++......... .....++..|+
T Consensus 204 ~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 283 (375)
T cd05104 204 LEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWM 283 (375)
T ss_pred HhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCccee
Confidence 246788899999999999999999999999999999999999999999999997654332211 11223456799
Q ss_pred ChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhh
Q 012062 167 PPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRR 245 (472)
Q Consensus 167 aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (472)
|||++.+ ..++.++|||||||++|+|++ |..||........+.++........
T Consensus 284 aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~------------------------- 337 (375)
T cd05104 284 APESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML------------------------- 337 (375)
T ss_pred ChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC-------------------------
Confidence 9999976 578999999999999999998 8899987665444444432111000
Q ss_pred HHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 246 VREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 246 ~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
.....+.++++||.+||..||++|||+.||++
T Consensus 338 ---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 369 (375)
T cd05104 338 ---SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369 (375)
T ss_pred ---CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 00124567999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=293.01 Aligned_cols=228 Identities=23% Similarity=0.364 Sum_probs=181.6
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chh
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLT 85 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~ 85 (472)
+.+.||+|.++.... ......+.+|+.++++++|+||+++++++.. .+.+|++|||+.+ +|.
T Consensus 34 ~~~~v~~K~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~----------------~~~~~~~~e~~~~~~L~ 96 (283)
T cd05048 34 SATSVAIKTLKENAE-PKVQQEFRQEAELMSDLQHPNIVCLLGVCTK----------------EQPTCMLFEYLAHGDLH 96 (283)
T ss_pred ceeeEEEEecccCCC-HHHHHHHHHHHHHHHhcCCcccceEEEEEcC----------------CCceEEEEecCCCCcHH
Confidence 346899999875432 2234567889999999999999999999876 4568999999985 676
Q ss_pred hhhcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeecc
Q 012062 86 GLADRPG---------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 150 (472)
Q Consensus 86 ~~~~~~~---------------~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 150 (472)
+++.+.. ..+++..++.++.||+.||+|||+++|+|+||||+|||+++++.+||+|||++.....
T Consensus 97 ~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~ 176 (283)
T cd05048 97 EFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYS 176 (283)
T ss_pred HHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEEECCCcceeeccc
Confidence 6664321 3578899999999999999999999999999999999999999999999999976533
Q ss_pred CCC-CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCC
Q 012062 151 DHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 228 (472)
Q Consensus 151 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 228 (472)
... .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 177 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~~~---------- 245 (283)
T cd05048 177 ADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLL---------- 245 (283)
T ss_pred cccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC----------
Confidence 221 22233456788999999876 568999999999999999998 99999988877766655432100
Q ss_pred CCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 229 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
.....++.++.+|+.+||+.||.+|||+.||+++
T Consensus 246 -------------------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 246 -------------------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred -------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0012467789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=283.26 Aligned_cols=234 Identities=31% Similarity=0.474 Sum_probs=189.9
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.|++|+++.... .....+.+|+.++++++|+||+++++++.. ....++|+||+.
T Consensus 19 ~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~~~~~l~~e~~~ 80 (253)
T cd05122 19 ARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLK----------------KDELWIVMEFCS 80 (253)
T ss_pred EEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEec----------------CCeEEEEEecCC
Confidence 56677899999999986544 245678899999999999999999999986 457899999999
Q ss_pred C-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 82 H-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 82 g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+ +|.+++......+++..+..++.||+.+|++||.++++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 158 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTMV 158 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--cccee
Confidence 5 66666655545789999999999999999999999999999999999999999999999999876653321 23456
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (472)
++..|++||.+.. ..++.++|||||||++|+|++|+.||...+....+..+...... ...+
T Consensus 159 ~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~---------------- 219 (253)
T cd05122 159 GTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPP--GLRN---------------- 219 (253)
T ss_pred cCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCC--CcCc----------------
Confidence 7889999999876 45788999999999999999999999887655544443321100 0000
Q ss_pred hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCC
Q 012062 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 283 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~ 283 (472)
...++..+.+||.+||..||++|||+.|+|+|+|
T Consensus 220 ---------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 220 ---------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ---------ccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 0013668999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=310.52 Aligned_cols=233 Identities=24% Similarity=0.357 Sum_probs=198.1
Q ss_pred cCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCCh
Q 012062 6 KTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDL 84 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~l 84 (472)
.....+|+|++++.. .+....+.+..|..||..++++.||++|..|.+ ..++||+||-|-|+.
T Consensus 443 ~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd----------------~kyvYmLmEaClGGE 506 (732)
T KOG0614|consen 443 SQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD----------------SKYVYMLMEACLGGE 506 (732)
T ss_pred ccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc----------------chhhhhhHHhhcCch
Confidence 333358999998653 334456778899999999999999999999987 668999999997644
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccCC
Q 012062 85 TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLW 164 (472)
Q Consensus 85 ~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~ 164 (472)
+.-+.+..+.|++..++.|+.-+++|++|||++|||+|||||||+||+.+|-+||.|||+|+.+.... ..-++|||+.
T Consensus 507 lWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~--KTwTFcGTpE 584 (732)
T KOG0614|consen 507 LWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR--KTWTFCGTPE 584 (732)
T ss_pred hhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC--ceeeecCCcc
Confidence 44444445679999999999999999999999999999999999999999999999999999876433 3345899999
Q ss_pred CCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhh
Q 012062 165 YRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 244 (472)
Q Consensus 165 y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (472)
|+|||++++ +..+.++|.||||+++||||+|.+||.+.+....+..|.+.+..
T Consensus 585 YVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~-------------------------- 637 (732)
T KOG0614|consen 585 YVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK-------------------------- 637 (732)
T ss_pred cccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh--------------------------
Confidence 999999997 67899999999999999999999999999999999988764321
Q ss_pred hHHHHhhhccHHHHHHHHHhhccCCCCCCC-----HHHHhcCCCCC
Q 012062 245 RVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFW 285 (472)
Q Consensus 245 ~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t-----~~elL~h~~f~ 285 (472)
-.+++.+...+.+||+++..-+|.+|.- +.||.+|.||.
T Consensus 638 --i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~ 681 (732)
T KOG0614|consen 638 --IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFE 681 (732)
T ss_pred --hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhh
Confidence 1233567888999999999999999985 89999999993
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=285.66 Aligned_cols=228 Identities=25% Similarity=0.414 Sum_probs=186.6
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC-CChh
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD-HDLT 85 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~-g~l~ 85 (472)
++..||||+++...... ....+.+|+++++.++|+||+++++++.. ...++|||||+. ++|.
T Consensus 22 ~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----------------~~~~~lv~e~~~~~~L~ 84 (262)
T cd00192 22 KTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTE----------------EEPLYLVLEYMEGGDLL 84 (262)
T ss_pred CCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecC----------------CCceEEEEEeccCCcHH
Confidence 38899999998765433 45678899999999999999999999876 557899999996 5777
Q ss_pred hhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC-Ccc
Q 012062 86 GLADRP--------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-NTL 156 (472)
Q Consensus 86 ~~~~~~--------~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~ 156 (472)
+.+... ...+++.+++.++.||+.||+|||+++|+|+||||+||+++.++.+||+|||.+........ ...
T Consensus 85 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 164 (262)
T cd00192 85 DYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK 164 (262)
T ss_pred HHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccccccc
Confidence 776654 36799999999999999999999999999999999999999999999999999987654321 122
Q ss_pred ccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcccc
Q 012062 157 TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235 (472)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (472)
....++..|+|||++.. ..++.++|||||||++|+|++ |..||...+..+....+......
T Consensus 165 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------------- 226 (262)
T cd00192 165 TGGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL----------------- 226 (262)
T ss_pred cCCCcCccccCHHHhcc-CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-----------------
Confidence 33456889999998876 468899999999999999999 69999988777766665431100
Q ss_pred CCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
.....++.++.++|.+||..||++|||+.|++++
T Consensus 227 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 227 ------------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred ------------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0011346789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=287.90 Aligned_cols=236 Identities=31% Similarity=0.487 Sum_probs=191.0
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+++..... .....+.+|+.++++++|+||+++++++.. .+.+|+||||+
T Consensus 19 ~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~~~~~lv~e~~ 81 (264)
T cd06623 19 KVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYK----------------EGEISIVLEYM 81 (264)
T ss_pred EEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcc----------------CCeEEEEEEec
Confidence 3677889999999999865432 345678899999999999999999999976 56789999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~-~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
.+ +|.+++... ..+++..++.++.||+.+|+|||+ ++++|+||+|+||+++.++.++|+|||++......... ...
T Consensus 82 ~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-~~~ 159 (264)
T cd06623 82 DGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-CNT 159 (264)
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-ccc
Confidence 95 666666543 468999999999999999999999 99999999999999999999999999998766432222 123
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCCCCCCccCCCCCcccc
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN---EAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (472)
..++..|+|||.+.. ..++.++|+||||+++|+|++|+.||...+ ..+....+... ....
T Consensus 160 ~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~------------- 222 (264)
T cd06623 160 FVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG---PPPS------------- 222 (264)
T ss_pred eeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC---CCCC-------------
Confidence 456889999999876 578889999999999999999999998774 23333333211 0000
Q ss_pred CCCchhhhhhHHHHhhh-ccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 236 FKPSRTMKRRVREVFRH-FDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 236 ~~~~~~~~~~~~~~~~~-~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
.... ++..+.+||.+||..+|++|||+.|+++|+||.
T Consensus 223 -------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~ 260 (264)
T cd06623 223 -------------LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIK 260 (264)
T ss_pred -------------CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHH
Confidence 0012 567899999999999999999999999999994
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=290.89 Aligned_cols=228 Identities=26% Similarity=0.402 Sum_probs=181.7
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Ch
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL 84 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l 84 (472)
.+++.||||+++..... .....+.+|+++|++++|+||+++++++.. ...+||||||+.+ +|
T Consensus 33 ~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~~~~~lv~e~~~~~~L 95 (280)
T cd05049 33 NDKELVAVKTLKETASN-DARKDFEREAELLTNFQHENIVKFYGVCTE----------------GDPPIMVFEYMEHGDL 95 (280)
T ss_pred CCcceEEEEeecccCCH-HHHHHHHHHHHHHHhcCCCCchheeeEEec----------------CCCeEEEEecCCCCCH
Confidence 45788999999755332 234678899999999999999999999986 4578999999985 66
Q ss_pred hhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccC
Q 012062 85 TGLADRP-------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 151 (472)
Q Consensus 85 ~~~~~~~-------------~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 151 (472)
.+++... ...+++.++..++.||+.+|+|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 96 ~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~ 175 (280)
T cd05049 96 NKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTT 175 (280)
T ss_pred HHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEECCcccceecccC
Confidence 6655432 234788899999999999999999999999999999999999999999999998754322
Q ss_pred CC-CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 012062 152 HN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 229 (472)
Q Consensus 152 ~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (472)
.. .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+.......
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 244 (280)
T cd05049 176 DYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQ---------- 244 (280)
T ss_pred cceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCC----------
Confidence 21 11223345778999999876 568999999999999999998 999998887776666554211100
Q ss_pred CCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 230 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....++..+++||++||..||++|||+.|+++
T Consensus 245 -------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 245 -------------------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred -------------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 01135678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=289.68 Aligned_cols=228 Identities=24% Similarity=0.396 Sum_probs=178.4
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.+++.+|+|++....... .|+.++..+ +|+||+++++.|.. .+.+||||||
T Consensus 34 ~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~----------------~~~~~iv~e~ 90 (267)
T PHA03390 34 VLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTT----------------LKGHVLIMDY 90 (267)
T ss_pred EEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEec----------------CCeeEEEEEc
Confidence 36788899999999987543221 133333323 69999999999987 5578999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC-CeEEeeccceeeeccCCCCccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG-NLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~-~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
+.+ +|.+++.... .+++.+++.++.||+.||.|||+++|+||||||+||+++.++ .++|+|||++...... .
T Consensus 91 ~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-----~ 164 (267)
T PHA03390 91 IKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-----S 164 (267)
T ss_pred CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-----c
Confidence 975 7777766543 799999999999999999999999999999999999999988 9999999998765422 1
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCCCCCCccCCCCCccccC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ-LSKIFELCGSPDETIWPGVSKMPAYNHF 236 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (472)
...++..|+|||++.+ ..++.++|||||||++|+|++|..||......+. ...+...... ..
T Consensus 165 ~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~--------------- 227 (267)
T PHA03390 165 CYDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK-KL--------------- 227 (267)
T ss_pred cCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc-cC---------------
Confidence 2356889999999976 5688999999999999999999999986544331 1222111100 00
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCC-HHHHhcCCCCC
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-AKDALDSEYFW 285 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t-~~elL~h~~f~ 285 (472)
...+.++..+.+||.+||+.||.+|++ ++|+|+|+||.
T Consensus 228 -----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 228 -----------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred -----------CcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 111247788999999999999999996 59999999994
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=312.36 Aligned_cols=237 Identities=25% Similarity=0.404 Sum_probs=191.8
Q ss_pred ceeccCCCEEEEEEeecCC--cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 2 AREIKTGEIVALKKIRMDN--EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
|.|..+|..||.-.++.+. .......++..|+.+|+.|+|+|||+||++|.+.. +.++.+|+|+
T Consensus 59 a~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~--------------n~~in~iTEL 124 (632)
T KOG0584|consen 59 AFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD--------------NKTINFITEL 124 (632)
T ss_pred ccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC--------------Cceeeeeeec
Confidence 5677888888887776553 23344578899999999999999999999998732 4678999999
Q ss_pred CC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEcC-CCCeEEeeccceeeeccCCCCc
Q 012062 80 MD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ--VLHRDIKGSNLLIDN-EGNLKLADFGLARSFSYDHNNT 155 (472)
Q Consensus 80 ~~-g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~g--iiHrDLKp~NILl~~-~~~vkL~DFG~a~~~~~~~~~~ 155 (472)
+. |+|..++++. .+++...+++|++|||.||.|||++. |||||||-+||+|+. .|.|||.|+|+|+........
T Consensus 125 ~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ak- 202 (632)
T KOG0584|consen 125 FTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAK- 202 (632)
T ss_pred ccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccccc-
Confidence 98 5666666554 47899999999999999999999994 999999999999985 578999999999887644332
Q ss_pred cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCC-CChHHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 156 LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPG-KNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
..+||+.|||||++. ..|+..+||||||+.++||+|+..||.. .+...++.++..... |
T Consensus 203 --svIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiK-P--------------- 262 (632)
T KOG0584|consen 203 --SVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIK-P--------------- 262 (632)
T ss_pred --eeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCC-H---------------
Confidence 368999999999886 5799999999999999999999999964 455555555543211 1
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
..+.+--++++++||.+||.. .++|+|+.|||.|+||..+
T Consensus 263 ------------~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 263 ------------AALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred ------------HHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 011112367899999999999 9999999999999999776
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=310.83 Aligned_cols=242 Identities=29% Similarity=0.479 Sum_probs=198.8
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
||+.+.|...||+|.+++.. ........+.-|..||..-..+-||+||..|.+ ++++|+||||
T Consensus 647 Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD----------------kdnLYFVMdY 710 (1034)
T KOG0608|consen 647 LVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD----------------KDNLYFVMDY 710 (1034)
T ss_pred EEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc----------------CCceEEEEec
Confidence 67888999999999997653 333445566779999999999999999999988 7789999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC----
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN---- 154 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~---- 154 (472)
+.| |+..++++-+ -|.|+.++.|+..|..||++.|..|+|||||||+|||||.+|+|||.|||+++-|...+..
T Consensus 711 IPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq 789 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 789 (1034)
T ss_pred cCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccccccc
Confidence 985 8888888765 5899999999999999999999999999999999999999999999999999866432110
Q ss_pred -------------------------------------ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCC
Q 012062 155 -------------------------------------TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK 197 (472)
Q Consensus 155 -------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~ 197 (472)
.--..+||..|+|||||.. ..|+..+|.||+|||||||+.|+
T Consensus 790 ~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~gvil~em~~g~ 868 (1034)
T KOG0608|consen 790 EGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVGVILYEMLVGQ 868 (1034)
T ss_pred CCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhhHHHHHHhhCC
Confidence 0112478999999999986 67899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCC---C
Q 012062 198 PILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI---S 274 (472)
Q Consensus 198 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~---t 274 (472)
+||...+..+...+++ .|.....++.+ .+++.++.+||.++.. +++.|+ -
T Consensus 869 ~pf~~~tp~~tq~kv~---------nw~~~l~~~~~-----------------~~ls~e~~~li~kLc~-sad~RLGkng 921 (1034)
T KOG0608|consen 869 PPFLADTPGETQYKVI---------NWRNFLHIPYQ-----------------GNLSKEALDLIQKLCC-SADSRLGKNG 921 (1034)
T ss_pred CCccCCCCCcceeeee---------ehhhccccccc-----------------cccCHHHHHHHHHHhc-Chhhhhcccc
Confidence 9999988877665553 35555444432 2477889999988654 677776 5
Q ss_pred HHHHhcCCCCCCC
Q 012062 275 AKDALDSEYFWTD 287 (472)
Q Consensus 275 ~~elL~h~~f~~~ 287 (472)
++||..|+||+..
T Consensus 922 ~d~vKaHpfFkgI 934 (1034)
T KOG0608|consen 922 ADQVKAHPFFKGI 934 (1034)
T ss_pred hhhhhcCcccccc
Confidence 6779999999653
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=286.38 Aligned_cols=239 Identities=26% Similarity=0.448 Sum_probs=188.0
Q ss_pred CceeccCCCEEEEEEeecCCc---CCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEE
Q 012062 1 MAREIKTGEIVALKKIRMDNE---KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVF 77 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~---~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVm 77 (472)
+|++..+++.||||++..+.. .......+.+|++++++++|+||+++++++.+.. ...+++||
T Consensus 20 ~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~--------------~~~~~~v~ 85 (264)
T cd06653 20 LCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE--------------EKKLSIFV 85 (264)
T ss_pred EEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC--------------CCEEEEEE
Confidence 367788999999999865422 1223456778999999999999999999987532 34689999
Q ss_pred ecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCC--CC
Q 012062 78 EYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH--NN 154 (472)
Q Consensus 78 Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~--~~ 154 (472)
||+.+ +|.+++.+. ..+++..++.|+.||+.||.|||+++|+|+||||+||+++.++.++|+|||+++...... ..
T Consensus 86 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (264)
T cd06653 86 EYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGT 164 (264)
T ss_pred EeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccccCc
Confidence 99986 566665543 358899999999999999999999999999999999999999999999999997654211 11
Q ss_pred ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 155 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
......++..|+|||++.+ ..++.++|+|||||++|+|++|+.||...+....+.++.. .+...
T Consensus 165 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~------------ 228 (264)
T cd06653 165 GIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT---QPTKP------------ 228 (264)
T ss_pred cccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc---CCCCC------------
Confidence 2223457889999999876 5678999999999999999999999987766555444421 11100
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
.+...+++.+.++|++||. ++.+|||+.+++.|+|.
T Consensus 229 -------------~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 229 -------------MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred -------------CCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 0112467789999999999 56999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=290.61 Aligned_cols=221 Identities=22% Similarity=0.354 Sum_probs=174.7
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+|..|++.||+|+++.... ..+|...+....|+||+++++++.. ...+||||||+
T Consensus 11 ~~~~~~~~~~~~~K~i~~~~~-------~~~~~~~~~~~~~~~i~~~~~~~~~----------------~~~~~lv~e~~ 67 (237)
T cd05576 11 LVMDTRTQQTFILKGLRKSSE-------YSRERLTIIPHCVPNMVCLHKYIVS----------------EDSVFLVLQHA 67 (237)
T ss_pred EEEEccCCcEEEEEeecchhh-------hhhHHHHHHhcCCCceeehhhheec----------------CCeEEEEEecC
Confidence 578999999999999976431 2345556666789999999999876 55789999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
.+ +|.+++.+. ..+++..+..++.||+.||+|||+++|+||||||+||+++.++.++|+|||++..+... ....
T Consensus 68 ~~~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~ 142 (237)
T cd05576 68 EGGKLWSHISKF-LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGE 142 (237)
T ss_pred CCCCHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccC
Confidence 96 676666543 35899999999999999999999999999999999999999999999999987654322 1223
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
..+..|+|||++.. ..++.++|||||||++|+|++|+.+|...... +. .. ..
T Consensus 143 ~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~------------~~------~~---- 194 (237)
T cd05576 143 AVENMYCAPEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSG-----IN------------TH------TT---- 194 (237)
T ss_pred CcCccccCCcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----cc------------cc------cc----
Confidence 45778999998865 56788999999999999999999776432110 00 00 00
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCH-----HHHhcCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA-----KDALDSEYF 284 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~-----~elL~h~~f 284 (472)
..+...++..+++||++||+.||++|+|+ +|+++||||
T Consensus 195 -------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 195 -------LNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred -------cCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 00112467789999999999999999986 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=285.93 Aligned_cols=225 Identities=26% Similarity=0.396 Sum_probs=179.6
Q ss_pred CCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chhh
Q 012062 8 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTG 86 (472)
Q Consensus 8 g~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~~ 86 (472)
+..||||.++.... ....+.+|+.++++++|+||+++++++.. ...+||||||+.+ +|.+
T Consensus 28 ~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~~~~l~~ 88 (256)
T cd05113 28 QYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTK----------------QRPIYIVTEYMSNGCLLN 88 (256)
T ss_pred CCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEcc----------------CCCcEEEEEcCCCCcHHH
Confidence 44699999875432 23467899999999999999999999876 4467999999985 6777
Q ss_pred hhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccCCCC
Q 012062 87 LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYR 166 (472)
Q Consensus 87 ~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~ 166 (472)
++......+++.+++.++.||+.||+|||+++|+|+||||+|||++.++.+||+|||+++..............++..|+
T Consensus 89 ~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~ 168 (256)
T cd05113 89 YLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 168 (256)
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhC
Confidence 66654446899999999999999999999999999999999999999999999999998765432222222223467799
Q ss_pred ChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhh
Q 012062 167 PPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRR 245 (472)
Q Consensus 167 aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (472)
+||++.+ ..++.++|||||||++|+|++ |..||...+..+....+.+.......
T Consensus 169 ~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------------------ 223 (256)
T cd05113 169 PPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP------------------------ 223 (256)
T ss_pred CHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCC------------------------
Confidence 9999876 468899999999999999998 99999887776666655432211000
Q ss_pred HHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 246 VREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 246 ~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
...+..+++||.+||..||++|||+.+|+++
T Consensus 224 -----~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 224 -----HLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred -----CCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 1245689999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=284.87 Aligned_cols=234 Identities=29% Similarity=0.509 Sum_probs=191.0
Q ss_pred ceeccCCCEEEEEEeecCCcCC-CchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 2 AREIKTGEIVALKKIRMDNEKE-GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
|++..+++.||+|+++...... .....+.+|++++++++|+||+++++.++. +..+|+||||+
T Consensus 12 ~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~~v~e~~ 75 (250)
T cd05123 12 VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT----------------EEKLYLVLEYA 75 (250)
T ss_pred EEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec----------------CCeeEEEEecC
Confidence 5667789999999998664322 244567889999999999999999999876 56789999999
Q ss_pred C-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 81 D-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 81 ~-g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
. ++|.+++.... .+++..+..++.||+.+|.|||+++++|+||||+||+++.++.++|+|||++....... ......
T Consensus 76 ~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~ 153 (250)
T cd05123 76 PGGELFSHLSKEG-RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTF 153 (250)
T ss_pred CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCC
Confidence 5 57777665543 58999999999999999999999999999999999999999999999999987654322 122334
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
.++..|++||.+.+ ...+.++|+|||||++|+|++|..||...+.......+......
T Consensus 154 ~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------------- 211 (250)
T cd05123 154 CGTPEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLR--------------------- 211 (250)
T ss_pred cCCccccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC---------------------
Confidence 56889999999876 45788999999999999999999999887775555555431100
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCH---HHHhcCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA---KDALDSEYF 284 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~---~elL~h~~f 284 (472)
+...++..+.+||++||..||++|+|+ +++++|+||
T Consensus 212 ---------~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 212 ---------FPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred ---------CCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 011246789999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=285.01 Aligned_cols=225 Identities=25% Similarity=0.383 Sum_probs=179.9
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC-CChh
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD-HDLT 85 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~-g~l~ 85 (472)
+++.||||.++.... ....+.+|+.++++++|+||+++++++.. .+.+|+||||+. ++|.
T Consensus 29 ~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~~~~L~ 89 (261)
T cd05068 29 NTTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTL----------------EEPIYIVTELMKYGSLL 89 (261)
T ss_pred CCeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEec----------------CCCeeeeeecccCCcHH
Confidence 457899999875432 24567899999999999999999999876 557899999995 5777
Q ss_pred hhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccCC
Q 012062 86 GLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLW 164 (472)
Q Consensus 86 ~~~~~~-~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~ 164 (472)
+++... ...+++.++..++.||+.||.|||+++|+|+||||+||+++.++.+||+|||+++...............+..
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~ 169 (261)
T cd05068 90 EYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIK 169 (261)
T ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCCcCcee
Confidence 776543 3468999999999999999999999999999999999999999999999999998765322211111222457
Q ss_pred CCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhh
Q 012062 165 YRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMK 243 (472)
Q Consensus 165 y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (472)
|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+....+..+......+.
T Consensus 170 y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~----------------------- 225 (261)
T cd05068 170 WTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPC----------------------- 225 (261)
T ss_pred ccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC-----------------------
Confidence 999998876 568899999999999999999 9999998887766665533211000
Q ss_pred hhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 244 RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 244 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...++..+.+||.+||..||++||++.+|++
T Consensus 226 ------~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 226 ------PPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred ------CCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 0124568999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=291.96 Aligned_cols=235 Identities=31% Similarity=0.495 Sum_probs=191.9
Q ss_pred ceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhcC-CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 2 AREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
|++..+++.||||++..... .......+.+|++++++++ |+||+++++++.. .+.+|+||||
T Consensus 20 ~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~----------------~~~~~lv~e~ 83 (280)
T cd05581 20 AKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD----------------EENLYFVLEY 83 (280)
T ss_pred EEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC----------------CceEEEEEcC
Confidence 56778999999999976432 2223456788999999998 9999999999876 5578999999
Q ss_pred CC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC-----
Q 012062 80 MD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN----- 153 (472)
Q Consensus 80 ~~-g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~----- 153 (472)
+. ++|.+++.+.. .+++..++.|+.||+.+|.|||+++++|+||||+||+++.+++++|+|||++........
T Consensus 84 ~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~ 162 (280)
T cd05581 84 APNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNK 162 (280)
T ss_pred CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCC
Confidence 96 57777766543 699999999999999999999999999999999999999999999999999876643321
Q ss_pred --------------CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 012062 154 --------------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSP 219 (472)
Q Consensus 154 --------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~ 219 (472)
.......++..|++||++.. ..++.++|||||||++++|++|+.||...+....+..+.......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (280)
T cd05581 163 GDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSF 241 (280)
T ss_pred CCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCCC
Confidence 12223456889999998876 557889999999999999999999999888766665554321111
Q ss_pred CCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCH----HHHhcCCCC
Q 012062 220 DETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA----KDALDSEYF 284 (472)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~----~elL~h~~f 284 (472)
...++..+.+||++||..||++|||+ +|+|+|+||
T Consensus 242 ------------------------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 242 ------------------------------PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred ------------------------------CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 11346789999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=290.15 Aligned_cols=237 Identities=31% Similarity=0.513 Sum_probs=191.9
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||+|+++.... ....+.+|+++++.++|+||+++++++.. ...+|+||||++
T Consensus 38 ~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~~~~~lv~e~~~ 98 (286)
T cd06614 38 ATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLV----------------GDELWVVMEYMD 98 (286)
T ss_pred EEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEE----------------CCEEEEEEeccC
Confidence 56677899999999986543 34567899999999999999999999986 567899999999
Q ss_pred -CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 82 -HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 82 -g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
++|.+++......++..++..++.||+.+|+|||++||+|+||||+||+++.++.++|+|||++........ ......
T Consensus 99 ~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 177 (286)
T cd06614 99 GGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-KRNSVV 177 (286)
T ss_pred CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-hhcccc
Confidence 577777766544689999999999999999999999999999999999999999999999998765432211 122234
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (472)
++..|++||++.+ ..++.++|+||||||+|+|++|+.||...+.......+........
T Consensus 178 ~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------- 236 (286)
T cd06614 178 GTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPL-------------------- 236 (286)
T ss_pred CCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--------------------
Confidence 6788999998876 5688999999999999999999999988776655554432110000
Q ss_pred hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.....++..+++||++||+.||.+|||+.++|+|+||..
T Consensus 237 -------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 237 -------KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred -------cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 001135678999999999999999999999999999965
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=325.98 Aligned_cols=254 Identities=27% Similarity=0.396 Sum_probs=188.6
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCC--------------------
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE-------------------- 60 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~-------------------- 60 (472)
+||++-+|+.||||+|.... ......++.+|+++|.+|+|||||++|..|.+...+...
T Consensus 497 kVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~ 575 (1351)
T KOG1035|consen 497 KVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSESRSQSASKYNG 575 (1351)
T ss_pred EEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchhhhcccCCCccc
Confidence 47999999999999999876 444567889999999999999999999877653211000
Q ss_pred --------------------------CCC--C------------------C-----------------------------
Q 012062 61 --------------------------QGR--P------------------D----------------------------- 65 (472)
Q Consensus 61 --------------------------~~~--~------------------~----------------------------- 65 (472)
... . +
T Consensus 576 ~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~~~ess~s~~~~ 655 (1351)
T KOG1035|consen 576 VDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDDTSESSESIPKT 655 (1351)
T ss_pred ceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCcchhhhhhcccc
Confidence 000 0 0
Q ss_pred CCCcC--------CeEEEEEecCCCChhhhhcCCCCCC-CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC
Q 012062 66 GNKYR--------GSTYMVFEYMDHDLTGLADRPGLRF-TVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 136 (472)
Q Consensus 66 ~~~~~--------~~~~iVmEy~~g~l~~~~~~~~~~l-~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~ 136 (472)
.+..+ -.+||-||||+.+++..+++.+... ....++++|++|++||+|+|+.|||||||||.||+|+.++.
T Consensus 656 ~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~ 735 (1351)
T KOG1035|consen 656 ENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNS 735 (1351)
T ss_pred CCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCC
Confidence 00011 3589999999998888777765443 47789999999999999999999999999999999999999
Q ss_pred eEEeeccceeeec-----------------cCCCCccccccccCCCCChhhhcCCC--CCCCCcchhhHHHHHHHHHhCC
Q 012062 137 LKLADFGLARSFS-----------------YDHNNTLTNRVITLWYRPPELLLGAT--KYGPAVDMWSVGCIFAELLNGK 197 (472)
Q Consensus 137 vkL~DFG~a~~~~-----------------~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~~DiwSlG~il~ell~G~ 197 (472)
|||+|||+|+... .......+..+||..|+|||++.+.. .|+.|+||||||||||||+.
T Consensus 736 VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y-- 813 (1351)
T KOG1035|consen 736 VKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY-- 813 (1351)
T ss_pred eeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc--
Confidence 9999999998621 01112456789999999999998765 69999999999999999986
Q ss_pred CCCCCCC-hHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHH
Q 012062 198 PILPGKN-EAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAK 276 (472)
Q Consensus 198 ~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~ 276 (472)
||...- ....+..+.+..-..+.. ++..--..-..+|+.||+.||++||||.
T Consensus 814 -PF~TsMERa~iL~~LR~g~iP~~~~--------------------------f~~~~~~~e~slI~~Ll~hdP~kRPtA~ 866 (1351)
T KOG1035|consen 814 -PFGTSMERASILTNLRKGSIPEPAD--------------------------FFDPEHPEEASLIRWLLSHDPSKRPTAT 866 (1351)
T ss_pred -cCCchHHHHHHHHhcccCCCCCCcc--------------------------cccccchHHHHHHHHHhcCCCccCCCHH
Confidence 354332 222333332111100000 0111112467899999999999999999
Q ss_pred HHhcCCCC
Q 012062 277 DALDSEYF 284 (472)
Q Consensus 277 elL~h~~f 284 (472)
|+|.+.||
T Consensus 867 eLL~s~ll 874 (1351)
T KOG1035|consen 867 ELLNSELL 874 (1351)
T ss_pred HHhhccCC
Confidence 99999998
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=282.79 Aligned_cols=228 Identities=21% Similarity=0.353 Sum_probs=180.8
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Ch
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL 84 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l 84 (472)
.++..||+|+++..... .....+.+|+.++++++|+||+++++++.. .+.+|+||||+.+ +|
T Consensus 17 ~~~~~~a~K~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~~~~L 79 (250)
T cd05085 17 KDKTPVAVKTCKEDLPQ-ELKIKFLSEARILKQYDHPNIVKLIGVCTQ----------------RQPIYIVMELVPGGDF 79 (250)
T ss_pred cCCcEEEEEecCCcCCH-HHHHHHHHHHHHHHhCCCCCcCeEEEEEec----------------CCccEEEEECCCCCcH
Confidence 46889999998755322 234467889999999999999999999976 4568999999985 67
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccCC
Q 012062 85 TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLW 164 (472)
Q Consensus 85 ~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~ 164 (472)
.+++......+++..+..++.||+.+|.|||+++++|+||||+||+++.++.+||+|||++................+..
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK 159 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCccc
Confidence 76665555568999999999999999999999999999999999999999999999999987543222111122233567
Q ss_pred CCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhh
Q 012062 165 YRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMK 243 (472)
Q Consensus 165 y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (472)
|+|||++.. ..++.++|||||||++|+|++ |..||...+.......+......
T Consensus 160 y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~------------------------- 213 (250)
T cd05085 160 WTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM------------------------- 213 (250)
T ss_pred ccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCC-------------------------
Confidence 999999875 567889999999999999998 99999888776655554321100
Q ss_pred hhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 244 RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 244 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
.....++..+.+||.+||..||++|||+.|+++
T Consensus 214 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 214 ----SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred ----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 001135678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=284.92 Aligned_cols=234 Identities=24% Similarity=0.402 Sum_probs=190.6
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|+++.+++.||||++............+.+|++++++++|+||+++++++.. ...+|+||||+.
T Consensus 19 ~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~~~~~~v~e~~~ 82 (256)
T cd08530 19 VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD----------------GNKLCIVMEYAP 82 (256)
T ss_pred EEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc----------------CCEEEEEehhcC
Confidence 5788899999999998765444445667889999999999999999999876 467899999997
Q ss_pred C-ChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 82 H-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 82 g-~l~~~~~~---~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
+ +|...+.+ ....+++..+..++.||+.||+|||+++++|+||||+||+++.++.+||+|||++...... ...
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---~~~ 159 (256)
T cd08530 83 FGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---MAK 159 (256)
T ss_pred CCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---Ccc
Confidence 6 66665543 2345899999999999999999999999999999999999999999999999998766433 222
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
...++..|++||.+.+ ..++.++|+||||+++|+|++|+.||...+..+....+.......
T Consensus 160 ~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------------ 220 (256)
T cd08530 160 TQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPP------------------ 220 (256)
T ss_pred cccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC------------------
Confidence 3456889999999876 567889999999999999999999998887665544442211000
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
....++.+++++|.+||..||++|||+.|++.||++
T Consensus 221 -----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 221 -----------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred -----------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 011356789999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=285.12 Aligned_cols=226 Identities=21% Similarity=0.385 Sum_probs=181.5
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Ch
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL 84 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l 84 (472)
.+++.||+|.+..... ....+.+|+.++++++|+||+++++++.. .+.+||||||+.+ +|
T Consensus 28 ~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~~~~L 88 (261)
T cd05072 28 NNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTK----------------EEPIYIITEYMAKGSL 88 (261)
T ss_pred cCCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcC----------------CCCcEEEEecCCCCcH
Confidence 4567899998865322 24577899999999999999999999875 4568999999974 77
Q ss_pred hhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccC
Q 012062 85 TGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL 163 (472)
Q Consensus 85 ~~~~~~-~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~ 163 (472)
.+++.+ ....+++..++.++.||+.||+|||+++++||||||+||+++.++.+||+|||++...............++.
T Consensus 89 ~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 168 (261)
T cd05072 89 LDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI 168 (261)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceeccCCCccce
Confidence 776654 3446889999999999999999999999999999999999999999999999999876533222222334567
Q ss_pred CCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhh
Q 012062 164 WYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTM 242 (472)
Q Consensus 164 ~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (472)
.|+|||++.. ..++.++|||||||++|+|++ |..||...+..+....+......+
T Consensus 169 ~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~----------------------- 224 (261)
T cd05072 169 KWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMP----------------------- 224 (261)
T ss_pred ecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC-----------------------
Confidence 8999999876 567889999999999999998 999999887777666654321110
Q ss_pred hhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 243 KRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 243 ~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....++.++.+||.+||..||++|||++++++
T Consensus 225 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 225 ------RMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred ------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 00135668999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=285.11 Aligned_cols=229 Identities=23% Similarity=0.347 Sum_probs=184.3
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++.. ++.||+|+++..... ....+.+|+.+++.++|+||+++++++.. ...+|+||||+.
T Consensus 25 ~~~~~-~~~~~~k~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~~~~~lv~e~~~ 85 (261)
T cd05148 25 GLWKN-RVRVAIKILKSDDLL--KQQDFQKEVQALKRLRHKHLISLFAVCSV----------------GEPVYIITELME 85 (261)
T ss_pred eEecC-CCcEEEEeccccchh--hHHHHHHHHHHHhcCCCcchhheeeeEec----------------CCCeEEEEeecc
Confidence 45555 889999999765432 24467889999999999999999999876 456899999998
Q ss_pred C-ChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 82 H-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 82 g-~l~~~~~~-~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
+ +|.+++.+ ....+++.+++.++.||+.||+|||+++|+|+||||+||||++++.+||+|||++........ .....
T Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~-~~~~~ 164 (261)
T cd05148 86 KGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY-LSSDK 164 (261)
T ss_pred cCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc-cccCC
Confidence 5 77777765 334589999999999999999999999999999999999999999999999999876543221 11223
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
.++..|++||++.. ..++.++|||||||++|+|++ |+.||...+..+.+..+......+.
T Consensus 165 ~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------ 225 (261)
T cd05148 165 KIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPC------------------ 225 (261)
T ss_pred CCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCC------------------
Confidence 44677999999876 568899999999999999998 8999998887777666643211100
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...++..+.+||.+||..||++|||+.+|++
T Consensus 226 -----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 226 -----------PAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred -----------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 1135678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=281.76 Aligned_cols=240 Identities=32% Similarity=0.576 Sum_probs=191.0
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.|+||+++...........+.+|++++++++|+||+++++++.... ...+++||||+.
T Consensus 19 ~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--------------~~~~~lv~e~~~ 84 (260)
T cd06606 19 ALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE--------------KNTLNIFLEYVS 84 (260)
T ss_pred EEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC--------------CCeEEEEEEecC
Confidence 567778999999999876544445667889999999999999999999987621 257899999996
Q ss_pred C-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC-ccccc
Q 012062 82 H-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN-TLTNR 159 (472)
Q Consensus 82 g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~ 159 (472)
+ +|.+++.+.. .+++..++.++.||+.+|+|||+++++|+||+|+||+++.++.++|+|||.+......... .....
T Consensus 85 ~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 163 (260)
T cd06606 85 GGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSV 163 (260)
T ss_pred CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCC
Confidence 5 6666665543 7999999999999999999999999999999999999999999999999999876543321 12334
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
.++..|++||.+.. ...+.++|||||||++|+|++|..||...+. ....+........
T Consensus 164 ~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~------------------- 221 (260)
T cd06606 164 RGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMAALYKIGSSGE------------------- 221 (260)
T ss_pred CCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHhccccCC-------------------
Confidence 67889999998876 4578999999999999999999999987762 2222222111000
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
...+...++..+++||.+||..||++|||+.|++.|+||
T Consensus 222 ------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 222 ------PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred ------CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 001112346789999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=298.27 Aligned_cols=232 Identities=21% Similarity=0.362 Sum_probs=178.4
Q ss_pred ccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-
Q 012062 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH- 82 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g- 82 (472)
..|++.||||+++..... .....+.+|+.+++++ +|+||+++++++... ...+++||||+.+
T Consensus 34 ~~~~~~va~K~~~~~~~~-~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~---------------~~~~~~v~ey~~~~ 97 (337)
T cd05054 34 SASCRTVAVKMLKEGATA-SEYKALMTELKILIHIGHHLNVVNLLGACTKP---------------GGPLMVIVEYCKFG 97 (337)
T ss_pred ccccceeeeeeccCCCCH-HHHHHHHHHHHHHHhhccCcchhheeeeEecC---------------CCCEEEEEecCCCC
Confidence 356789999999754322 2345678899999999 899999999988652 3468999999986
Q ss_pred ChhhhhcCC------------------------------------------------------------CCCCCHHHHHH
Q 012062 83 DLTGLADRP------------------------------------------------------------GLRFTVPQIKC 102 (472)
Q Consensus 83 ~l~~~~~~~------------------------------------------------------------~~~l~~~~i~~ 102 (472)
+|.+++... ...+++..+..
T Consensus 98 ~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 177 (337)
T cd05054 98 NLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLIS 177 (337)
T ss_pred CHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHH
Confidence 565554321 12578899999
Q ss_pred HHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC-ccccccccCCCCChhhhcCCCCCCCCc
Q 012062 103 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAV 181 (472)
Q Consensus 103 i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~ 181 (472)
++.||+.||+|||+++|+||||||+||||+.++.+||+|||++..+...... ......++..|+|||++.+ ..++.++
T Consensus 178 ~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~ 256 (337)
T cd05054 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFD-KVYTTQS 256 (337)
T ss_pred HHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcC-CCCCccc
Confidence 9999999999999999999999999999999999999999999765432221 1222344678999999986 6789999
Q ss_pred chhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHH
Q 012062 182 DMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALEL 260 (472)
Q Consensus 182 DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 260 (472)
|||||||+||+|++ |..||.+....+.+........... ....++.++.+|
T Consensus 257 Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~l 308 (337)
T cd05054 257 DVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMR----------------------------APEYATPEIYSI 308 (337)
T ss_pred cHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCC----------------------------CCccCCHHHHHH
Confidence 99999999999997 9999987654444433322110000 011345689999
Q ss_pred HHHhhccCCCCCCCHHHHhcC
Q 012062 261 LEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 261 l~~~L~~dP~~R~t~~elL~h 281 (472)
+.+||+.+|++|||+.||++|
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=285.28 Aligned_cols=228 Identities=21% Similarity=0.359 Sum_probs=182.0
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chh
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLT 85 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~ 85 (472)
+...||||+++.... ......+.+|+.++++++|+||+++++++.. .+.+||||||+.+ +|.
T Consensus 31 ~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~iv~e~~~~~~L~ 93 (266)
T cd05033 31 KEIDVAIKTLKAGSS-DKQRLDFLTEASIMGQFDHPNIIRLEGVVTK----------------SRPVMIITEYMENGSLD 93 (266)
T ss_pred CcceEEEEEcCCCCC-hHHHHHHHHHHHHHHhCCCCCcceEeEEEec----------------CCceEEEEEcCCCCCHH
Confidence 356899999875432 2234567889999999999999999999876 5568999999986 677
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCc-cccccccCC
Q 012062 86 GLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT-LTNRVITLW 164 (472)
Q Consensus 86 ~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~-~~~~~gt~~ 164 (472)
+++......+++.+++.++.||+.||+|||+++|+|+||||+||||+.++.+||+|||+++.+....... .....++..
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 173 (266)
T cd05033 94 KFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR 173 (266)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCcc
Confidence 7776655579999999999999999999999999999999999999999999999999998765222111 112234678
Q ss_pred CCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhh
Q 012062 165 YRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMK 243 (472)
Q Consensus 165 y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (472)
|+|||.+.+ ..++.++|||||||++|+|++ |..||......+....+.+....+.
T Consensus 174 y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------------- 229 (266)
T cd05033 174 WTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPP----------------------- 229 (266)
T ss_pred ccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC-----------------------
Confidence 999998876 568899999999999999997 9999987776666655533211100
Q ss_pred hhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 244 RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 244 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
...++..+.+||.+||..||++||++.|++++
T Consensus 230 ------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 230 ------PMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred ------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 01346679999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=284.46 Aligned_cols=227 Identities=21% Similarity=0.290 Sum_probs=179.2
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Ch
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL 84 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l 84 (472)
.++..||||+++.... ......+.+|+.++++++|+||+++++++.. ..+|+||||+.+ +|
T Consensus 20 ~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-----------------~~~~lv~e~~~~~~L 81 (257)
T cd05115 20 KKQIDVAIKVLKNENE-KSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-----------------EALMLVMEMASGGPL 81 (257)
T ss_pred CCceeEEEEEcccccC-hHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-----------------CCeEEEEEeCCCCCH
Confidence 4566799999875532 2344567899999999999999999998753 357999999985 66
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCc--ccccccc
Q 012062 85 TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT--LTNRVIT 162 (472)
Q Consensus 85 ~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~--~~~~~gt 162 (472)
.+++......+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.......... .....++
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 161 (257)
T cd05115 82 NKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWP 161 (257)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCC
Confidence 66665545578999999999999999999999999999999999999999999999999987554332211 1112235
Q ss_pred CCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchh
Q 012062 163 LWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241 (472)
Q Consensus 163 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (472)
..|+|||++.. ..++.++|||||||++|+|++ |..||...+..+....+..... +.
T Consensus 162 ~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~--------------------- 218 (257)
T cd05115 162 LKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR-LD--------------------- 218 (257)
T ss_pred cccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC-CC---------------------
Confidence 78999998875 567889999999999999996 9999998877766655532210 00
Q ss_pred hhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
.....+.++.+||.+||..||++||++.++++
T Consensus 219 -------~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 219 -------CPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred -------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01135678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=284.33 Aligned_cols=228 Identities=25% Similarity=0.390 Sum_probs=179.6
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+ ..||||+++.... ....+.+|+.++++++|+||+++++++.. ..+|+||||+.
T Consensus 25 ~~~~~~-~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-----------------~~~~lv~e~~~ 83 (262)
T cd05071 25 GTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-----------------EPIYIVTEYMS 83 (262)
T ss_pred EEecCC-ceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEECC-----------------CCcEEEEEcCC
Confidence 455444 4699999975432 23467899999999999999999988743 34699999998
Q ss_pred C-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 82 H-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 82 g-~l~~~~~~~-~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
+ +|.+++.+. ...+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||+++.+...........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~ 163 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 163 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccccccCC
Confidence 5 777777642 33578999999999999999999999999999999999999999999999999976653332222233
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
.++..|+|||++.+ ..++.++|||||||++|+|++ |..||......+.+..+......+
T Consensus 164 ~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~------------------- 223 (262)
T cd05071 164 KFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP------------------- 223 (262)
T ss_pred cccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCC-------------------
Confidence 45678999998875 568999999999999999999 889998887766665553211000
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....++..+.+||.+||+.||++|||+.++++
T Consensus 224 ----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 224 ----------CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred ----------CccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 00135668999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=291.40 Aligned_cols=239 Identities=24% Similarity=0.344 Sum_probs=186.0
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC-CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
|++..+++.||||+++...... ....+.+|+.++.++. |+||+++++++.. ...+|+||||+
T Consensus 34 ~~~~~~~~~~avK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----------------~~~~~~v~e~~ 96 (296)
T cd06618 34 MRFKKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVKCYGYFIT----------------DSDVFICMELM 96 (296)
T ss_pred EEECCCCeEEEEEEEeccCChH-HHHHHHHHHHHHHhccCCCchHhhheeeec----------------CCeEEEEeecc
Confidence 5677789999999997653222 3345667887776665 9999999999986 55789999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~-~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
.+.+..++......+++..+..++.||+.+|+|||+ .+|+||||||+||+++.++.+||+|||++..+..... ....
T Consensus 97 ~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~--~~~~ 174 (296)
T cd06618 97 STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA--KTRS 174 (296)
T ss_pred CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc--ccCC
Confidence 988777776655578999999999999999999997 5999999999999999999999999999876543221 2223
Q ss_pred cccCCCCChhhhcCC---CCCCCCcchhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCCCCCccCCCCCcccc
Q 012062 160 VITLWYRPPELLLGA---TKYGPAVDMWSVGCIFAELLNGKPILPGKNE-AEQLSKIFELCGSPDETIWPGVSKMPAYNH 235 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~---~~~~~~~DiwSlG~il~ell~G~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (472)
.++..|+|||++.+. ..++.++|||||||++|+|++|+.||..... .+.+.++...... . ++.
T Consensus 175 ~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~--~~~--------- 241 (296)
T cd06618 175 AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP--S--LPP--------- 241 (296)
T ss_pred CCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCC--C--CCC---------
Confidence 467889999998753 2378899999999999999999999976432 3333333321100 0 000
Q ss_pred CCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
...++.++.+||.+||..||++|||+.+++.|+||..
T Consensus 242 --------------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 242 --------------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred --------------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence 0135678999999999999999999999999999953
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=282.38 Aligned_cols=231 Identities=23% Similarity=0.339 Sum_probs=181.8
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|.+.. ++.||||+++..... .....+.+|++++++++|+||+++++++.. ....|+||||+.
T Consensus 14 ~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~~~~~~v~e~~~ 75 (251)
T cd05041 14 GVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQ----------------KQPIYIVMELVP 75 (251)
T ss_pred EEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEec----------------CCCeEEEEEcCC
Confidence 44555 899999998765433 234567899999999999999999999876 557899999997
Q ss_pred C-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcc-ccc
Q 012062 82 H-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTL-TNR 159 (472)
Q Consensus 82 g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~-~~~ 159 (472)
+ +|.+++......+++..+..++.+++.+|+|||+++|+||||||+||||+.++.+||+|||++........... ...
T Consensus 76 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 76 GGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 5 67777655555688999999999999999999999999999999999999999999999999875432111111 112
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
..+..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+.......+.......
T Consensus 156 ~~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~------------------- 215 (251)
T cd05041 156 QIPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMP------------------- 215 (251)
T ss_pred cceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCC-------------------
Confidence 23567999998876 568899999999999999998 889998877655554442211000
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....++..+.+||.+||..+|++|||+.|+++
T Consensus 216 ----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 216 ----------APQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred ----------CCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 01135668999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=294.20 Aligned_cols=232 Identities=20% Similarity=0.286 Sum_probs=179.1
Q ss_pred ceeccCCC----EEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEE
Q 012062 2 AREIKTGE----IVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVF 77 (472)
Q Consensus 2 a~~~~tg~----~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVm 77 (472)
|++..+++ .||||+++.... ......+.+|+.+++.++|+||+++++++.. ...++|+
T Consensus 26 ~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~-----------------~~~~~v~ 87 (316)
T cd05108 26 GLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLT-----------------STVQLIT 87 (316)
T ss_pred EEEecCCCccceeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC-----------------CCceeee
Confidence 34444555 389999874322 2245567889999999999999999999864 2357999
Q ss_pred ecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCc-
Q 012062 78 EYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT- 155 (472)
Q Consensus 78 Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~- 155 (472)
||+. ++|.+.+......++...+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+.......
T Consensus 88 e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 167 (316)
T cd05108 88 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYH 167 (316)
T ss_pred ecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCccee
Confidence 9998 57777777655568899999999999999999999999999999999999999999999999998765332211
Q ss_pred cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 156 LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
......+..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+....+.. .++........
T Consensus 168 ~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~------------- 232 (316)
T cd05108 168 AEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQ------------- 232 (316)
T ss_pred ccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCCCCCCC-------------
Confidence 112233678999999876 568999999999999999997 99999877655433 33322111100
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
...++.++.+||.+||..||++|||+.+++.+
T Consensus 233 ---------------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 233 ---------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred ---------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 01244578999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=285.62 Aligned_cols=233 Identities=29% Similarity=0.416 Sum_probs=181.9
Q ss_pred ceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 2 AREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
|++..+++.||||+++.... .......+.+|+++++.++|+||+++++++.. .+.+|+||||+
T Consensus 21 ~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~~v~e~~ 84 (267)
T cd08228 21 ATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE----------------DNELNIVLELA 84 (267)
T ss_pred EEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE----------------CCeEEEEEEec
Confidence 67788999999999875432 23334567889999999999999999999886 55789999999
Q ss_pred CC-Chhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcc
Q 012062 81 DH-DLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTL 156 (472)
Q Consensus 81 ~g-~l~~~~~---~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 156 (472)
.+ +|.+++. .....+++..+..++.||+.||+|||+++|+|+||||+||||+.++.++|+|||++..+.... ...
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~-~~~ 163 (267)
T cd08228 85 DAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-TAA 163 (267)
T ss_pred CCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh-HHH
Confidence 96 6655543 233458899999999999999999999999999999999999999999999999987654322 112
Q ss_pred ccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 157 TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE--AEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
....++..|+|||++.+ ..++.++|||||||++|+|++|+.||..... .+....+ .....+..
T Consensus 164 ~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~------------- 228 (267)
T cd08228 164 HSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI-EQCDYPPL------------- 228 (267)
T ss_pred hcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHH-hcCCCCCC-------------
Confidence 23457889999999876 5678899999999999999999999865432 2222222 21111100
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....++..+.+||.+||..||++|||+.++++
T Consensus 229 --------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 229 --------------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred --------------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 01135678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=287.80 Aligned_cols=228 Identities=21% Similarity=0.344 Sum_probs=176.8
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chh
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLT 85 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~ 85 (472)
+...||+|.++..... .....+.+|+.++++++|+||+++++++.. ....||||||+.+ +|.
T Consensus 35 ~~~~v~ik~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~~~~~lv~e~~~g~~L~ 97 (277)
T cd05036 35 VELQVAVKTLPESCSE-QDESDFLMEALIMSKFNHQNIVRLIGVSFE----------------RLPRFILLELMAGGDLK 97 (277)
T ss_pred CceeEEEEEcCCCCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc----------------CCCcEEEEecCCCCCHH
Confidence 6788999988644322 223567889999999999999999998876 4467999999975 677
Q ss_pred hhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC---CeEEeeccceeeeccCCCC-c
Q 012062 86 GLADRPG------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG---NLKLADFGLARSFSYDHNN-T 155 (472)
Q Consensus 86 ~~~~~~~------~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~---~vkL~DFG~a~~~~~~~~~-~ 155 (472)
+++.+.. ..+++..++.++.||+.+|+|||+++|+||||||+|||++.++ .+||+|||+++........ .
T Consensus 98 ~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~ 177 (277)
T cd05036 98 SFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRK 177 (277)
T ss_pred HHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCccccccCCccceec
Confidence 6665432 2588999999999999999999999999999999999998765 5999999999765322111 1
Q ss_pred cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 156 LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
......+..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+.+..+.... ...
T Consensus 178 ~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~~~-------------- 241 (277)
T cd05036 178 GGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG-RLD-------------- 241 (277)
T ss_pred CCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-cCC--------------
Confidence 112223567999999976 568999999999999999997 999999877766554443211 000
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
....++..+.+||++||+.||++|||+.+||+|
T Consensus 242 --------------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 242 --------------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred --------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 011356689999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=287.06 Aligned_cols=235 Identities=26% Similarity=0.411 Sum_probs=188.3
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||++...... .....+.+|++++++++|+||+++++++.. +..+|+||||++
T Consensus 23 ~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~~~ 85 (277)
T cd06641 23 GIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLK----------------DTKLWIIMEYLG 85 (277)
T ss_pred EEECCCCcEEEEEEeccccch-HHHHHHHHHHHHHHhcCCCCEeEEEEEEEe----------------CCeEEEEEEeCC
Confidence 567788999999998754332 234567889999999999999999999986 557899999998
Q ss_pred C-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 82 H-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 82 g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+ +|..++.. ..+++..+..++.||+.+|.|||+++|+|+||||+||+++.++.++|+|||++..+.... .......
T Consensus 86 ~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~~~~ 162 (277)
T cd06641 86 GGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRNTFV 162 (277)
T ss_pred CCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch-hhhcccc
Confidence 6 55555543 358999999999999999999999999999999999999999999999999987654321 1122345
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (472)
++..|+|||.+.. ..++.++|+|||||++|+|++|..||...+.......+.... . +
T Consensus 163 ~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~-----~--------------- 219 (277)
T cd06641 163 GTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN--P-----P--------------- 219 (277)
T ss_pred CCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCC--C-----C---------------
Confidence 6889999998875 567889999999999999999999998766555444432110 0 0
Q ss_pred hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.+...++.++.++|.+||..||++||++.+++.|+||..
T Consensus 220 -------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~ 258 (277)
T cd06641 220 -------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVR 258 (277)
T ss_pred -------CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhh
Confidence 001135678999999999999999999999999999954
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=284.80 Aligned_cols=240 Identities=18% Similarity=0.249 Sum_probs=181.4
Q ss_pred ceeccCCC--EEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 2 AREIKTGE--IVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 2 a~~~~tg~--~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
|++..+++ .||||.++...........+.+|+.+++.++|+||+++++++...... ......++||||
T Consensus 18 ~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~----------~~~~~~~~v~e~ 87 (272)
T cd05075 18 GQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVES----------EGYPSPVVILPF 87 (272)
T ss_pred eEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcc----------cCCCCcEEEEEe
Confidence 34445554 699999886644444456778899999999999999999987542110 012357999999
Q ss_pred CCC-ChhhhhcC-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC
Q 012062 80 MDH-DLTGLADR-----PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 153 (472)
Q Consensus 80 ~~g-~l~~~~~~-----~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 153 (472)
+.+ +|...+.. ....+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 88 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 167 (272)
T cd05075 88 MKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDY 167 (272)
T ss_pred CCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccccCcccc
Confidence 985 66554421 223488999999999999999999999999999999999999999999999999986543221
Q ss_pred C-ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 012062 154 N-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 231 (472)
Q Consensus 154 ~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (472)
. .......+..|++||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+.+.....
T Consensus 168 ~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~------------ 234 (272)
T cd05075 168 YRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLK------------ 234 (272)
T ss_pred eecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence 1 1112234678999999876 568899999999999999999 889998877766555543211000
Q ss_pred ccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 232 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
....++..+++||.+||..||++|||+.+|+++
T Consensus 235 -----------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 235 -----------------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred -----------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 011356679999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=282.45 Aligned_cols=224 Identities=18% Similarity=0.269 Sum_probs=177.9
Q ss_pred CCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chhh
Q 012062 8 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTG 86 (472)
Q Consensus 8 g~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~~ 86 (472)
+..||||+++..... .....+.+|+++++.+.|+||+++++++.. ..+++||||+.+ +|.+
T Consensus 23 ~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----------------~~~~~v~e~~~~~~L~~ 84 (257)
T cd05060 23 EVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG-----------------EPLMLVMELAPLGPLLK 84 (257)
T ss_pred cceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-----------------CceEEEEEeCCCCcHHH
Confidence 378999999865433 345567899999999999999999998753 357999999985 6777
Q ss_pred hhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc--cccccCC
Q 012062 87 LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT--NRVITLW 164 (472)
Q Consensus 87 ~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~--~~~gt~~ 164 (472)
++.... .+++..+..++.||+.+|+|||.++|+|+||||+|||++.++.+||+|||+++........... ...++..
T Consensus 85 ~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~ 163 (257)
T cd05060 85 YLKKRR-EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLK 163 (257)
T ss_pred HHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCcccccc
Confidence 766543 6899999999999999999999999999999999999999999999999999866433221111 1122467
Q ss_pred CCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhh
Q 012062 165 YRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMK 243 (472)
Q Consensus 165 y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (472)
|+|||++.. ..++.++|||||||++|+|++ |..||...+..+....+......
T Consensus 164 y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~------------------------- 217 (257)
T cd05060 164 WYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL------------------------- 217 (257)
T ss_pred ccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC-------------------------
Confidence 999999876 568999999999999999998 99999887766555544321100
Q ss_pred hhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 244 RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 244 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
.....++..+++||.+||..||++|||+.++++
T Consensus 218 ----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 218 ----PRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 001235668999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=292.46 Aligned_cols=236 Identities=28% Similarity=0.482 Sum_probs=187.4
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
+++..+++.||||.++..... ....+.+|+.++++++|+||+++++++.. .+.+|+||||+.
T Consensus 38 ~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~----------------~~~~~lv~e~~~ 99 (293)
T cd06647 38 AIDVATGQEVAIKQMNLQQQP--KKELIINEILVMRENKHPNIVNYLDSYLV----------------GDELWVVMEYLA 99 (293)
T ss_pred EEEcCCCCEEEEEEeccccch--HHHHHHHHHHHHhhcCCCCeeehhheeee----------------CCcEEEEEecCC
Confidence 456778999999998754322 24567889999999999999999999876 457899999998
Q ss_pred C-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 82 H-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 82 g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+ +|.+++.+. .+++.++..++.||+.||.|||+++|+|+||||+||+++.++.+||+|||++..+.... .......
T Consensus 100 ~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~-~~~~~~~ 176 (293)
T cd06647 100 GGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMV 176 (293)
T ss_pred CCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc-ccccccc
Confidence 6 666666543 47899999999999999999999999999999999999999999999999987654322 2223345
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (472)
++..|++||++.. ..++.++|||||||++|+|++|+.||...+..+.+..+... ..+. +
T Consensus 177 ~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~---~---------------- 235 (293)
T cd06647 177 GTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE---L---------------- 235 (293)
T ss_pred CChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcC-CCCC---C----------------
Confidence 7888999999876 56789999999999999999999999877654433322110 0000 0
Q ss_pred hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.....++..+++||++||..||++||++.+++.|+||..
T Consensus 236 -------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~ 274 (293)
T cd06647 236 -------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKI 274 (293)
T ss_pred -------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 011235668999999999999999999999999999954
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=284.09 Aligned_cols=235 Identities=18% Similarity=0.254 Sum_probs=180.9
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chh
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLT 85 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~ 85 (472)
++..||||+++.+.........+.+|+++++.++|+||+++++++...... ......++||||+.+ +|.
T Consensus 26 ~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~----------~~~~~~~~v~e~~~~~~l~ 95 (273)
T cd05035 26 SQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSL----------QKIPKPMVILPFMKHGDLH 95 (273)
T ss_pred CcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcc----------ccCcccEEEEeccCCCCHH
Confidence 458899999986544333455788999999999999999999987653210 112357999999985 665
Q ss_pred hhhcC-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCc-cccc
Q 012062 86 GLADR-----PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT-LTNR 159 (472)
Q Consensus 86 ~~~~~-----~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~-~~~~ 159 (472)
.++.. ....+++..++.++.||+.||+|||+++|+||||||+||++++++.+||+|||+++.+....... ....
T Consensus 96 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 175 (273)
T cd05035 96 SFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA 175 (273)
T ss_pred HHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccceeeccccccccccccc
Confidence 55432 22358999999999999999999999999999999999999999999999999998654322211 1112
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
..+..|+|||++.. ..++.++|||||||++|||++ |..||.+.+..+.+..+......
T Consensus 176 ~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-------------------- 234 (273)
T cd05035 176 KMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRL-------------------- 234 (273)
T ss_pred cCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------------------
Confidence 33678999998865 568899999999999999999 89999887776665555321100
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
.....++..+.+||.+||+.||++|||+.|++++
T Consensus 235 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 235 ---------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred ---------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0012356789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=281.42 Aligned_cols=225 Identities=25% Similarity=0.421 Sum_probs=179.0
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Ch
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL 84 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l 84 (472)
.++..||+|+++..... ...+.+|+.++++++|+||+++++++.. ..+|+||||+.+ +|
T Consensus 28 ~~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-----------------~~~~lv~e~~~~~~L 87 (260)
T cd05070 28 NGNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSE-----------------EPIYIVTEYMSKGSL 87 (260)
T ss_pred cCCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECC-----------------CCcEEEEEecCCCcH
Confidence 36677999998754332 3467899999999999999999988742 346999999985 77
Q ss_pred hhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccC
Q 012062 85 TGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL 163 (472)
Q Consensus 85 ~~~~~~~-~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~ 163 (472)
.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||+++++.++|+|||++..+............++.
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 167 (260)
T cd05070 88 LDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPI 167 (260)
T ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCCCCCc
Confidence 7766543 345899999999999999999999999999999999999999999999999999776433222222233466
Q ss_pred CCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhh
Q 012062 164 WYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTM 242 (472)
Q Consensus 164 ~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (472)
.|+|||++.. ..++.++|||||||++|+|++ |..||.+.+..+.+..+......+
T Consensus 168 ~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------- 223 (260)
T cd05070 168 KWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMP----------------------- 223 (260)
T ss_pred cccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-----------------------
Confidence 7999998875 568899999999999999999 899998887777666553211000
Q ss_pred hhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 243 KRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 243 ~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....++..+++||.+||..||++|||+.++++
T Consensus 224 ------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 224 ------CPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred ------CCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 01235668999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=288.65 Aligned_cols=238 Identities=23% Similarity=0.391 Sum_probs=185.2
Q ss_pred cCCCEEEEEEeecCCc--CCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC
Q 012062 6 KTGEIVALKKIRMDNE--KEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH 82 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~--~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g 82 (472)
.+|+.||+|+++.... .......+.+|+++|+++ +|+||+++++.++. +..+||||||+.+
T Consensus 26 ~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----------------~~~~~lv~e~~~~ 89 (290)
T cd05613 26 DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT----------------DTKLHLILDYING 89 (290)
T ss_pred CCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec----------------CCeEEEEEecCCC
Confidence 5899999999975432 222345677899999999 59999999999876 5578999999995
Q ss_pred -ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccc
Q 012062 83 -DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 161 (472)
Q Consensus 83 -~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 161 (472)
+|.+.+... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++..+............+
T Consensus 90 ~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 168 (290)
T cd05613 90 GELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCG 168 (290)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccccccccccC
Confidence 666666543 468899999999999999999999999999999999999999999999999997764433333334567
Q ss_pred cCCCCChhhhcCC-CCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 012062 162 TLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240 (472)
Q Consensus 162 t~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (472)
+..|+|||++... ..++.++|||||||++|+|++|..||...........+.+.......
T Consensus 169 ~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~------------------- 229 (290)
T cd05613 169 TIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP------------------- 229 (290)
T ss_pred CcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC-------------------
Confidence 8999999998653 24678999999999999999999999754433222222221110000
Q ss_pred hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCCC
Q 012062 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 286 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----t~~elL~h~~f~~ 286 (472)
.....++..+.+||++||..||++|+ ++++++.|+||..
T Consensus 230 -------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 273 (290)
T cd05613 230 -------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273 (290)
T ss_pred -------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCccccc
Confidence 00123567899999999999999997 8999999999954
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=288.61 Aligned_cols=227 Identities=23% Similarity=0.377 Sum_probs=179.6
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Ch
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL 84 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l 84 (472)
.++..||+|.++.... .....+.+|+.++++++|+||+++++++.. .+.+|+||||+.+ +|
T Consensus 33 ~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~~~~L 94 (288)
T cd05093 33 QDKILVAVKTLKDASD--NARKDFHREAELLTNLQHEHIVKFYGVCVE----------------GDPLIMVFEYMKHGDL 94 (288)
T ss_pred CcceEEEEEecCCcCH--HHHHHHHHHHHHHHhCCCCCcceEEEEEec----------------CCccEEEEEcCCCCCH
Confidence 4566799998875432 234567899999999999999999999976 4578999999985 66
Q ss_pred hhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCC
Q 012062 85 TGLADRP------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 152 (472)
Q Consensus 85 ~~~~~~~------------~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 152 (472)
.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.......
T Consensus 95 ~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 174 (288)
T cd05093 95 NKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD 174 (288)
T ss_pred HHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccCCccccccCCc
Confidence 6665422 1248999999999999999999999999999999999999999999999999987553222
Q ss_pred C-CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 012062 153 N-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 230 (472)
Q Consensus 153 ~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 230 (472)
. .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+.+..+.......
T Consensus 175 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~~----------- 242 (288)
T cd05093 175 YYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQ----------- 242 (288)
T ss_pred eeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcCC-----------
Confidence 1 11122334678999999876 568899999999999999998 999998888777666654321100
Q ss_pred CccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 231 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....++.++.+||.+||..||.+|||+.|+++
T Consensus 243 ------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 243 ------------------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred ------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 01135668999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=283.46 Aligned_cols=232 Identities=22% Similarity=0.349 Sum_probs=182.6
Q ss_pred ceeccCCC---EEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 2 AREIKTGE---IVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 2 a~~~~tg~---~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
|++..+++ .||||+++..... .....+..|++++++++|+||+++++++.. .+.+|+|||
T Consensus 24 ~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e 86 (268)
T cd05063 24 GILKMPGRKEVAVAIKTLKPGYTE-KQRQDFLSEASIMGQFSHHNIIRLEGVVTK----------------FKPAMIITE 86 (268)
T ss_pred EEEecCCCCceEEEEEeccccCCH-HHHHHHHHHHHHHhcCCCCCeeEEEEEEcc----------------CCCcEEEEE
Confidence 44554554 7999998755322 234567889999999999999999999976 456899999
Q ss_pred cCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 79 YMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 79 y~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
|+.+ +|..++......+++.++..++.|++.||+|||+++|+||||||+|||++.++.+||+|||++............
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 166 (268)
T cd05063 87 YMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYT 166 (268)
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccccccee
Confidence 9986 666666555557899999999999999999999999999999999999999999999999998766433222221
Q ss_pred c--ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 158 N--RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 158 ~--~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
. ...+..|+|||++.. ..++.++|||||||++|+|++ |+.||...+..+....+......+.
T Consensus 167 ~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~-------------- 231 (268)
T cd05063 167 TSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPA-------------- 231 (268)
T ss_pred ccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCC--------------
Confidence 1 122457999999876 567899999999999999997 9999988887776666643211110
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...++.++.+||.+||..||++||++.+|++
T Consensus 232 ---------------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 232 ---------------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred ---------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0124567899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=279.89 Aligned_cols=232 Identities=23% Similarity=0.409 Sum_probs=184.8
Q ss_pred ceeccCC----CEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEE
Q 012062 2 AREIKTG----EIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVF 77 (472)
Q Consensus 2 a~~~~tg----~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVm 77 (472)
|++..++ +.||+|+++.....+ ....+..|+.+++.++|+||+++++++.. .+.+|+||
T Consensus 18 ~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~~~~~~i~ 80 (258)
T smart00219 18 GTLKGLSGEKEVEVAVKTLKEDADEQ-QIEEFLREARIMRKLDHPNIVKLLGVCTE----------------EEPLMIVM 80 (258)
T ss_pred EEecCCCCCCCceEEEEEccCCCChH-HHHHHHHHHHHHHhcCCCchheEEEEEcC----------------CCeeEEEE
Confidence 3444444 899999997654332 45678899999999999999999999976 45789999
Q ss_pred ecCCC-ChhhhhcCCCCC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCc
Q 012062 78 EYMDH-DLTGLADRPGLR-FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT 155 (472)
Q Consensus 78 Ey~~g-~l~~~~~~~~~~-l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 155 (472)
||+.+ +|.+.+...... +++.++..++.||+.+|+|||+++|+|+||||+||+++.++.++|+|||++..........
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK 160 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence 99985 676666554333 8999999999999999999999999999999999999999999999999997765432222
Q ss_pred cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 156 LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
.....++..|+|||.+.. ..++.++|||||||++|+|++ |+.||...+..+.+..+........
T Consensus 161 ~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------- 225 (258)
T smart00219 161 KKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPK-------------- 225 (258)
T ss_pred cccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC--------------
Confidence 112235788999998865 668999999999999999998 8899988777666665543211000
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...++.++.++|.+||..||++|||+.|+++
T Consensus 226 ---------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 226 ---------------PENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred ---------------CCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 0125678999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=286.72 Aligned_cols=230 Identities=21% Similarity=0.334 Sum_probs=180.1
Q ss_pred ccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-C
Q 012062 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-D 83 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~ 83 (472)
..+++.||||.++..... .....+.+|+.++++++|+||+++++++.. ....||||||+.+ +
T Consensus 31 ~~~~~~~~ik~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----------------~~~~~lv~e~~~~~~ 93 (283)
T cd05090 31 MDHAQLVAIKTLKDINNP-QQWGEFQQEASLMAELHHPNIVCLLGVVTQ----------------EQPVCMLFEYLNQGD 93 (283)
T ss_pred CCCcceEEEEeccCCCCH-HHHHHHHHHHHHHhhCCCCCeeeEEEEEec----------------CCceEEEEEcCCCCc
Confidence 456789999999754322 233567789999999999999999999876 4568999999985 6
Q ss_pred hhhhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceee
Q 012062 84 LTGLADRP----------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS 147 (472)
Q Consensus 84 l~~~~~~~----------------~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~ 147 (472)
|.+++... ...+++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 94 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~ 173 (283)
T cd05090 94 LHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSRE 173 (283)
T ss_pred HHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEEecccccccc
Confidence 66665321 12478889999999999999999999999999999999999999999999999976
Q ss_pred eccCCC-CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCc
Q 012062 148 FSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWP 225 (472)
Q Consensus 148 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 225 (472)
...... .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..... +.
T Consensus 174 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~----- 246 (283)
T cd05090 174 IYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQL-LP----- 246 (283)
T ss_pred ccCCcceecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc-CC-----
Confidence 533221 11223344677999999876 568899999999999999998 9999988776555554432110 00
Q ss_pred cCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 226 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
....++..+.+||.+||..||++||++.+|+++
T Consensus 247 -----------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 247 -----------------------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred -----------------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 011356789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=286.42 Aligned_cols=229 Identities=19% Similarity=0.297 Sum_probs=177.3
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Ch
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL 84 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l 84 (472)
.+++.||||+++..... .....+.+|+.+++.++|+||+++++++.. ...+++||||+.+ +|
T Consensus 34 ~~~~~~aik~~~~~~~~-~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~----------------~~~~~lv~e~~~~~~L 96 (277)
T cd05062 34 EPETRVAIKTVNEAASM-RERIEFLNEASVMKEFNCHHVVRLLGVVSQ----------------GQPTLVIMELMTRGDL 96 (277)
T ss_pred CceeEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEcC----------------CCCeEEEEecCCCCCH
Confidence 35678999998643221 133457889999999999999999999875 5578999999985 66
Q ss_pred hhhhcCCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC-
Q 012062 85 TGLADRPG---------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN- 154 (472)
Q Consensus 85 ~~~~~~~~---------~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~- 154 (472)
.+++.+.. ..++...+..++.||+.||+|||+++++|+||||+|||++.++.+||+|||+++........
T Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 176 (277)
T cd05062 97 KSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 176 (277)
T ss_pred HHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCCCccccCCcceee
Confidence 66654321 23577889999999999999999999999999999999999999999999998754322111
Q ss_pred ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 012062 155 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 233 (472)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (472)
......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+.+.....
T Consensus 177 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~-------------- 241 (277)
T cd05062 177 KGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLD-------------- 241 (277)
T ss_pred cCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC--------------
Confidence 1112344778999999876 568999999999999999998 789998887766655543321100
Q ss_pred ccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 234 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
....++..+++||.+||+.||++|||+.|++++
T Consensus 242 ---------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 242 ---------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred ---------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 001345679999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=286.30 Aligned_cols=229 Identities=22% Similarity=0.323 Sum_probs=179.8
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Ch
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL 84 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l 84 (472)
.+++.||||+++..... .....+.+|+.+++.++|+||+++++++.. ...+++++||+.+ +|
T Consensus 33 ~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~----------------~~~~~~~~e~~~~~~l 95 (283)
T cd05091 33 EQTQAVAIKTLKDKAEG-PLREEFKHEAMMRSRLQHPNIVCLLGVVTK----------------EQPLSMIFSYCSHSDL 95 (283)
T ss_pred CceeEEEEEEccCCCCH-HHHHHHHHHHHHHhcCCCCCcCeEEEEEcC----------------CCceEEEEEcCCCCcH
Confidence 34678999999854322 234567789999999999999999999976 4568999999985 55
Q ss_pred hhhhcC---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeec
Q 012062 85 TGLADR---------------PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 149 (472)
Q Consensus 85 ~~~~~~---------------~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 149 (472)
..++.. ....+++..++.++.||+.||+|||+++|+||||||+|||+++++.+||+|||+++...
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (283)
T cd05091 96 HEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175 (283)
T ss_pred HHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceEecccccccccc
Confidence 555431 12347888899999999999999999999999999999999999999999999987653
Q ss_pred cCCC-CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 012062 150 YDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGV 227 (472)
Q Consensus 150 ~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 227 (472)
.... .......++..|+|||++.. ..++.++|||||||++|||++ |..||.+.+..+.+..+......+
T Consensus 176 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~-------- 246 (283)
T cd05091 176 AADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLP-------- 246 (283)
T ss_pred cchheeeccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC--------
Confidence 2221 11222345778999999876 568899999999999999998 889998887777666654321110
Q ss_pred CCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 228 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
....++..+.+||.+||+.||++|||+.+|+..
T Consensus 247 ---------------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 247 ---------------------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred ---------------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 012466789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=281.15 Aligned_cols=222 Identities=25% Similarity=0.423 Sum_probs=176.8
Q ss_pred CEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chhhh
Q 012062 9 EIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGL 87 (472)
Q Consensus 9 ~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~~~ 87 (472)
..||||+++.+.. ....+.+|++++++++|+||+++++++.. +..|+||||+.+ +|.++
T Consensus 31 ~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----------------~~~~~v~e~~~~~~L~~~ 90 (260)
T cd05069 31 TKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-----------------EPIYIVTEFMGKGSLLDF 90 (260)
T ss_pred ceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-----------------CCcEEEEEcCCCCCHHHH
Confidence 4699998865432 33567889999999999999999988743 346899999985 77777
Q ss_pred hcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccCCCC
Q 012062 88 ADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYR 166 (472)
Q Consensus 88 ~~~~-~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~ 166 (472)
+... ...+++..+..++.||+.||+|||+++|+|+||||+|||+++++.+||+|||++...............++..|+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~ 170 (260)
T cd05069 91 LKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWT 170 (260)
T ss_pred HhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhC
Confidence 7543 334789999999999999999999999999999999999999999999999999765433222222234567899
Q ss_pred ChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhh
Q 012062 167 PPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRR 245 (472)
Q Consensus 167 aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (472)
|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+......+
T Consensus 171 ~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-------------------------- 223 (260)
T cd05069 171 APEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMP-------------------------- 223 (260)
T ss_pred CHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--------------------------
Confidence 9998876 568899999999999999999 899999888777666553321100
Q ss_pred HHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 246 VREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 246 ~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....++..+++||++||.+||++|||++++++
T Consensus 224 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 224 ---CPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred ---CCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 01135668999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=283.99 Aligned_cols=233 Identities=29% Similarity=0.408 Sum_probs=181.7
Q ss_pred ceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 2 AREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
|++..+++.||||.+..... .......+.+|+.+++.++|+||+++++++.. .+.+++||||+
T Consensus 21 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----------------~~~~~~v~e~~ 84 (267)
T cd08229 21 ATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE----------------DNELNIVLELA 84 (267)
T ss_pred EeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe----------------CCeEEEEEEec
Confidence 56778999999998875432 22234567889999999999999999999976 55789999999
Q ss_pred CC-ChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcc
Q 012062 81 DH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTL 156 (472)
Q Consensus 81 ~g-~l~~~~~~---~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 156 (472)
.+ +|.+++.. ....+++..++.++.||+.+|.|||+++|+|+||||+||+++.++.++|+|||++..+..... ..
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~ 163 (267)
T cd08229 85 DAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-AA 163 (267)
T ss_pred CCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc-cc
Confidence 86 66665542 334589999999999999999999999999999999999999999999999999876543221 22
Q ss_pred ccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 157 TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA--EQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
....++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.... .....+... ..+. .
T Consensus 164 ~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~------~------- 228 (267)
T cd08229 164 HSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-DYPP------L------- 228 (267)
T ss_pred ccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC-CCCC------C-------
Confidence 23467889999999876 56788999999999999999999999765432 111211110 0000 0
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....++..+++||.+||..||++|||+.+|++
T Consensus 229 --------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 229 --------------PSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred --------------CcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 01236778999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=283.47 Aligned_cols=232 Identities=23% Similarity=0.348 Sum_probs=182.2
Q ss_pred ceeccCC---CEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 2 AREIKTG---EIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 2 a~~~~tg---~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
|+++.++ ..||||.++..... .....+.+|+.++++++|+||+++++++.. .+.+|||||
T Consensus 23 ~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e 85 (267)
T cd05066 23 GRLKLPGKREIPVAIKTLKAGYTE-KQRRDFLSEASIMGQFDHPNIIHLEGVVTK----------------SKPVMIVTE 85 (267)
T ss_pred EEEecCCCCceEEEEEECCCCCCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEec----------------CCccEEEEE
Confidence 3444443 37999998754322 234567889999999999999999999875 457899999
Q ss_pred cCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcc-
Q 012062 79 YMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTL- 156 (472)
Q Consensus 79 y~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~- 156 (472)
|+.+ +|.+++.+....+++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++..+........
T Consensus 86 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 165 (267)
T cd05066 86 YMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT 165 (267)
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccceeee
Confidence 9985 67777766555789999999999999999999999999999999999999999999999999976643322111
Q ss_pred -ccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 157 -TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 157 -~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
.....+..|++||++.+ ..++.++|+|||||++|+|++ |..||...+..+....+.+....+.
T Consensus 166 ~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------- 230 (267)
T cd05066 166 TRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPA-------------- 230 (267)
T ss_pred cCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCC--------------
Confidence 11223567999999876 568999999999999999886 9999988777666555543211000
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...++..+.+||.+||+.||.+|||+.++++
T Consensus 231 ---------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 231 ---------------PMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred ---------------CCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 0124668899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=287.27 Aligned_cols=228 Identities=25% Similarity=0.420 Sum_probs=178.4
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Ch
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL 84 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l 84 (472)
+...||+|+++.....+ ....+.+|+.+++++ +|+||+++++++.. .+.+||||||+.+ +|
T Consensus 41 ~~~~~a~k~~~~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~----------------~~~~~li~e~~~~~~L 103 (293)
T cd05053 41 ETSTVAVKMLKDDATEK-DLSDLVSEMEMMKMIGKHKNIINLLGVCTQ----------------EGPLYVVVEYAAHGNL 103 (293)
T ss_pred CceeEEEEEccCCCCHH-HHHHHHHHHHHHHhhcCCCCeeeEEEEEcC----------------CCCeEEEEEeCCCCcH
Confidence 34789999987553322 335678999999999 79999999999876 5578999999985 66
Q ss_pred hhhhcC---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeec
Q 012062 85 TGLADR---------------PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 149 (472)
Q Consensus 85 ~~~~~~---------------~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 149 (472)
..++.. ....+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 104 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 183 (293)
T cd05053 104 RDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIH 183 (293)
T ss_pred HHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeEEeCccccccccc
Confidence 666532 23468899999999999999999999999999999999999999999999999997654
Q ss_pred cCCCC-ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 012062 150 YDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGV 227 (472)
Q Consensus 150 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 227 (472)
..... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+.+..+...... .
T Consensus 184 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~------- 254 (293)
T cd05053 184 HIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRM-E------- 254 (293)
T ss_pred cccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcC-C-------
Confidence 32211 1112234567999998876 568899999999999999997 99999887766665554321100 0
Q ss_pred CCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 228 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
....++..+.+||.+||..||++|||+.|++++
T Consensus 255 ---------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 255 ---------------------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred ---------------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 001245689999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=279.69 Aligned_cols=233 Identities=28% Similarity=0.413 Sum_probs=182.0
Q ss_pred ceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 2 AREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
|.+..+++.||||.++.... .......+.+|++++++++|+||+++++++.. .+.+++||||+
T Consensus 21 ~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~----------------~~~~~lv~e~~ 84 (267)
T cd08224 21 AICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE----------------NNELNIVLELA 84 (267)
T ss_pred EEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec----------------CCeEEEEEecC
Confidence 56777999999999975432 22335678899999999999999999999976 45789999999
Q ss_pred CC-ChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcc
Q 012062 81 DH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTL 156 (472)
Q Consensus 81 ~g-~l~~~~~~---~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 156 (472)
.+ +|..++.. ....+++.+++.++.||+.+|+|||++||+|+||||+||+++.++.++|+|||++..+.... ...
T Consensus 85 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 163 (267)
T cd08224 85 DAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-TAA 163 (267)
T ss_pred CCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC-ccc
Confidence 85 67666542 33458999999999999999999999999999999999999999999999999987654322 122
Q ss_pred ccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 157 TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE--AEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... .+....+..... + ..
T Consensus 164 ~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------~---~~---- 228 (267)
T cd08224 164 HSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY-------P---PL---- 228 (267)
T ss_pred ceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCC-------C---CC----
Confidence 33457889999999876 5688999999999999999999999865432 122222111000 0 00
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....++..+.++|.+||..||++|||+.+|++
T Consensus 229 --------------~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 229 --------------PADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred --------------ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 01135678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=287.41 Aligned_cols=227 Identities=24% Similarity=0.365 Sum_probs=178.5
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Ch
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL 84 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l 84 (472)
.++..|++|.++..... ....+.+|+.++++++|+||+++++++.. ...+++||||+.+ +|
T Consensus 33 ~~~~~~~~k~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~~~~L 94 (291)
T cd05094 33 KDKMLVAVKALKDPTLA--ARKDFQREAELLTNLQHEHIVKFYGVCGD----------------GDPLIMVFEYMKHGDL 94 (291)
T ss_pred CcceeeEEEecCCccHH--HHHHHHHHHHHHhcCCCCCcceEEEEEcc----------------CCceEEEEecCCCCcH
Confidence 45667899988644321 23467899999999999999999999976 4568999999985 66
Q ss_pred hhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeec
Q 012062 85 TGLADRP---------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 149 (472)
Q Consensus 85 ~~~~~~~---------------~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 149 (472)
.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 95 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~ 174 (291)
T cd05094 95 NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVY 174 (291)
T ss_pred HHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEECCCCcccccC
Confidence 6665432 2347899999999999999999999999999999999999999999999999987543
Q ss_pred cCCC-CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 012062 150 YDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGV 227 (472)
Q Consensus 150 ~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 227 (472)
.... .......++..|+|||++.+ ..++.++||||||||+|+|++ |..||...+..+.+..+.......
T Consensus 175 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-------- 245 (291)
T cd05094 175 STDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLE-------- 245 (291)
T ss_pred CCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCCCC--------
Confidence 3221 11223345788999999876 568899999999999999998 999998887776665543211000
Q ss_pred CCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 228 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....++..+.+||.+||..||++|||+.++++
T Consensus 246 ---------------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 246 ---------------------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred ---------------------CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 00124667999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=278.73 Aligned_cols=226 Identities=24% Similarity=0.374 Sum_probs=179.7
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chh
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLT 85 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~ 85 (472)
+++.+|||+++..... ...+.+|++++++++|+||+++++++.. ...+|+||||+.+ +|.
T Consensus 27 ~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~~~~~~v~e~~~~~~L~ 87 (256)
T cd05112 27 EKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTE----------------RSPICLVFEFMEHGCLS 87 (256)
T ss_pred CCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEcc----------------CCceEEEEEcCCCCcHH
Confidence 4678999998754322 3467889999999999999999999876 4578999999986 565
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccCCC
Q 012062 86 GLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWY 165 (472)
Q Consensus 86 ~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y 165 (472)
+++......+++..++.++.||+.+|+|||+++|+|+||||+||+++.++.+||+|||++................+..|
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~ 167 (256)
T cd05112 88 DYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKW 167 (256)
T ss_pred HHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCccchhh
Confidence 66655445689999999999999999999999999999999999999999999999999876543222222223346789
Q ss_pred CChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhh
Q 012062 166 RPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 244 (472)
Q Consensus 166 ~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (472)
+|||++.+ ..++.++|||||||++|+|++ |..||...+..+.+..+.+......
T Consensus 168 ~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------------ 222 (256)
T cd05112 168 SSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK------------------------ 222 (256)
T ss_pred cCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCC------------------------
Confidence 99999876 568889999999999999998 9999988777666665532111000
Q ss_pred hHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 245 RVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 245 ~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
....+..+.+|+.+||..||++|||+.|+++.
T Consensus 223 -----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 223 -----PRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred -----CCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 01245689999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=286.15 Aligned_cols=236 Identities=19% Similarity=0.311 Sum_probs=181.6
Q ss_pred ccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-C
Q 012062 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-D 83 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~ 83 (472)
..++..||+|++...... .....+.+|++++++++|+||+++++++.. ++.+++||||+.+ +
T Consensus 43 ~~~~~~va~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~~~~~lv~e~~~~~~ 105 (296)
T cd05051 43 ADAPVLVAVKVLRPDASD-NAREDFLKEVKILSRLSDPNIARLLGVCTV----------------DPPLCMIMEYMENGD 105 (296)
T ss_pred cCCceeEEEEEecCccCH-HHHHHHHHHHHHHHhcCCCCEeEEEEEEec----------------CCCcEEEEecCCCCC
Confidence 345577999998865433 234567889999999999999999999976 4578999999985 6
Q ss_pred hhhhhcCCC----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC
Q 012062 84 LTGLADRPG----------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 153 (472)
Q Consensus 84 l~~~~~~~~----------~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 153 (472)
|..++.+.. ..+++..++.++.||+.||+|||+++|+||||||+||+++.++.++|+|||++........
T Consensus 106 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 185 (296)
T cd05051 106 LNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY 185 (296)
T ss_pred HHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCCCceEEccccceeecccCcc
Confidence 666654422 2589999999999999999999999999999999999999999999999999876533221
Q ss_pred -CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh--CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 012062 154 -NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN--GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 230 (472)
Q Consensus 154 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~--G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 230 (472)
.......++..|+|||++.+ ..++.++|||||||++|+|++ +..||...+..+.+..+............
T Consensus 186 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~------ 258 (296)
T cd05051 186 YRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIY------ 258 (296)
T ss_pred eeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhcccccccccc------
Confidence 11223345778999999876 568899999999999999998 67888877776666655432211100000
Q ss_pred CccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 231 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
......++.++.+||.+||+.||++|||+.||++
T Consensus 259 ----------------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 259 ----------------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred ----------------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 0001235678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=279.38 Aligned_cols=225 Identities=24% Similarity=0.398 Sum_probs=181.1
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chh
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLT 85 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~ 85 (472)
+++.||||.++.+.. ....+.+|++++++++|+||+++++++.. ...+|+||||+++ +|.
T Consensus 29 ~~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~~v~e~~~~~~L~ 89 (261)
T cd05034 29 GTTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSE----------------EEPIYIVTEYMSKGSLL 89 (261)
T ss_pred CCceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeec----------------CCceEEEEeccCCCCHH
Confidence 457799999875432 24568899999999999999999999875 4568999999985 677
Q ss_pred hhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccCC
Q 012062 86 GLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLW 164 (472)
Q Consensus 86 ~~~~~~~-~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~ 164 (472)
+++.... ..+++..+..++.||+.||+|||+++|+|+||||+||+|+.++.+||+|||++..+.............+..
T Consensus 90 ~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 169 (261)
T cd05034 90 DFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK 169 (261)
T ss_pred HHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhccCCCcc
Confidence 7765532 468999999999999999999999999999999999999999999999999987765322211222234568
Q ss_pred CCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhh
Q 012062 165 YRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMK 243 (472)
Q Consensus 165 y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (472)
|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+....+..+......+..
T Consensus 170 y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------- 226 (261)
T cd05034 170 WTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRP---------------------- 226 (261)
T ss_pred ccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC----------------------
Confidence 999999876 568899999999999999998 99999988877777766432211100
Q ss_pred hhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 244 RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 244 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
..++.++.++|.+||..||++|||++++++
T Consensus 227 -------~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 227 -------PNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred -------CCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 123567999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=301.87 Aligned_cols=229 Identities=20% Similarity=0.292 Sum_probs=187.2
Q ss_pred EEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chhhhh
Q 012062 10 IVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLA 88 (472)
Q Consensus 10 ~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~~~~ 88 (472)
.||||+++.+....+..+.+.+|+.+||+-+|.||+=|.+++..+ .+.||..+|+| +|..++
T Consensus 416 dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p-----------------~~AIiTqwCeGsSLY~hl 478 (678)
T KOG0193|consen 416 DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP-----------------PLAIITQWCEGSSLYTHL 478 (678)
T ss_pred ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC-----------------ceeeeehhccCchhhhhc
Confidence 699999999877766788899999999999999999999999863 34899999998 677777
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccC-CCCccccccccCCCCC
Q 012062 89 DRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD-HNNTLTNRVITLWYRP 167 (472)
Q Consensus 89 ~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~~~~~gt~~y~a 167 (472)
.-...+|.....+.|++||++|+.|||.++|||||||..||+|.+++.|||.|||++...... .........+...|||
T Consensus 479 Hv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmA 558 (678)
T KOG0193|consen 479 HVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMA 558 (678)
T ss_pred cchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhc
Confidence 667778999999999999999999999999999999999999999999999999999765432 2223334456888999
Q ss_pred hhhhcC--CCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhh
Q 012062 168 PELLLG--ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRR 245 (472)
Q Consensus 168 PE~l~~--~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (472)
||+++. ..+|++.+||||+|||+|||++|..||...+.+.++..+=+... ..+
T Consensus 559 PEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l-------------------------~pd 613 (678)
T KOG0193|consen 559 PEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYL-------------------------MPD 613 (678)
T ss_pred HHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccccc-------------------------Ccc
Confidence 999864 35689999999999999999999999995554333322211110 112
Q ss_pred HHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 246 VREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 246 ~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
......+...++++|+..|+.+++++||++.+||.
T Consensus 614 ~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 614 LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 23334467779999999999999999999999986
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=282.99 Aligned_cols=220 Identities=21% Similarity=0.284 Sum_probs=169.5
Q ss_pred CCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCCh-hh
Q 012062 8 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDL-TG 86 (472)
Q Consensus 8 g~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~l-~~ 86 (472)
...||||+++... ......+.+|+.+++.++||||+++++++.. +...+|||||++++. ..
T Consensus 32 ~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~----------------~~~~~lv~e~~~~~~l~~ 93 (262)
T cd05077 32 EIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVR----------------DVENIMVEEFVEFGPLDL 93 (262)
T ss_pred ceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEec----------------CCCCEEEEecccCCCHHH
Confidence 3468899876543 2234567789999999999999999999876 446799999999754 44
Q ss_pred hhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC-------eEEeeccceeeeccCCCCccccc
Q 012062 87 LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN-------LKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 87 ~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~-------vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
++.+....+++..++.|+.||+.||+|||+++|+||||||+||||+.++. +||+|||++..... ....
T Consensus 94 ~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~-----~~~~ 168 (262)
T cd05077 94 FMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS-----RQEC 168 (262)
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccC-----cccc
Confidence 44444456899999999999999999999999999999999999987664 89999999865421 1234
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHH-hCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELL-NGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell-~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
.++..|+|||++.....++.++|||||||++|+|+ .|..||......+.. .+......
T Consensus 169 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~-------------------- 227 (262)
T cd05077 169 VERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCM-------------------- 227 (262)
T ss_pred cccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCcc--------------------
Confidence 56888999998875567889999999999999998 588888765543322 22111000
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
.....+.++.+||.+||..||.+||++.+||++
T Consensus 228 ----------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 228 ----------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ----------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 001134578999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=291.88 Aligned_cols=238 Identities=25% Similarity=0.428 Sum_probs=198.6
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
||..+-|.+.+|||+++++.. ..+-.+-.+.|-++|... +-|.++.++..|+. -+.+|+|||
T Consensus 367 LaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT----------------mDRLyFVME 430 (683)
T KOG0696|consen 367 LAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT----------------MDRLYFVME 430 (683)
T ss_pred eecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh----------------hhheeeEEE
Confidence 577888999999999998842 222334456788888877 47789999999987 557999999
Q ss_pred cCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 79 YMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 79 y~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
|+.|+.+-+.+..-++|.+..+..|+..|+.||-|||++|||.||||.+||||+.+|+|||+|||+++.--.. ..+..+
T Consensus 431 yvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~-~~TTkT 509 (683)
T KOG0696|consen 431 YVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD-GVTTKT 509 (683)
T ss_pred EecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC-Ccceee
Confidence 9997544444445568999999999999999999999999999999999999999999999999998753322 334456
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
+|||+-|+|||++.- .+|+.++|.||+||+|||||.|++||.++++.+.+..|.+..-+
T Consensus 510 FCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvs-------------------- 568 (683)
T KOG0696|consen 510 FCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVS-------------------- 568 (683)
T ss_pred ecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCc--------------------
Confidence 899999999998875 78999999999999999999999999999999999999764322
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCH-----HHHhcCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA-----KDALDSEYFWT 286 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~-----~elL~h~~f~~ 286 (472)
..+.+|.++.++.+.+|.+.|.+|..+ .+|-.|+||+.
T Consensus 569 ----------yPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 569 ----------YPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred ----------CcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhh
Confidence 224578899999999999999999844 78899999954
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=283.45 Aligned_cols=231 Identities=20% Similarity=0.281 Sum_probs=179.3
Q ss_pred ceeccCCC----EEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEE
Q 012062 2 AREIKTGE----IVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVF 77 (472)
Q Consensus 2 a~~~~tg~----~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVm 77 (472)
|++..+++ .||||+++..... .....+.+|+.+++.++|+||+++++++.. ...+++|
T Consensus 26 ~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----------------~~~~l~~ 87 (279)
T cd05109 26 GIWIPDGENVKIPVAIKVLRENTSP-KANKEILDEAYVMAGVGSPYVCRLLGICLT-----------------STVQLVT 87 (279)
T ss_pred EEEecCCCccceEEEEEEecCCCCH-HHHHHHHHHHHHHHhcCCCCCceEEEEEcC-----------------CCcEEEE
Confidence 34455665 4899998754322 234567889999999999999999999864 2368999
Q ss_pred ecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCc-
Q 012062 78 EYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT- 155 (472)
Q Consensus 78 Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~- 155 (472)
||+. ++|.+++......+++..+..++.||+.||+|||+++|+||||||+|||+++++.+||+|||+++.+.......
T Consensus 88 ~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~ 167 (279)
T cd05109 88 QLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH 167 (279)
T ss_pred EcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccceee
Confidence 9998 57777776655579999999999999999999999999999999999999999999999999998764322211
Q ss_pred cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 156 LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
.....++..|+|||++.+ ..++.++|||||||++|||++ |..||...........+.. ......
T Consensus 168 ~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~------------- 232 (279)
T cd05109 168 ADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK-GERLPQ------------- 232 (279)
T ss_pred cCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCcCCC-------------
Confidence 111233678999999876 568899999999999999998 8999987666554443322 111000
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...++.++.+||.+||..||++|||+.|+++
T Consensus 233 ---------------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 233 ---------------PPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred ---------------CccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0135567899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=287.90 Aligned_cols=230 Identities=23% Similarity=0.356 Sum_probs=180.0
Q ss_pred ccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC-C
Q 012062 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD-H 82 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~-g 82 (472)
..++..||||+++..... .....+.+|+++++++ +|+||+++++++.. .+.+||||||+. +
T Consensus 62 ~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~----------------~~~~~lv~e~~~~~ 124 (302)
T cd05055 62 SDAVMKVAVKMLKPTAHS-SEREALMSELKIMSHLGNHENIVNLLGACTI----------------GGPILVITEYCCYG 124 (302)
T ss_pred CCceeEEEEEecCccCCh-HHHHHHHHHHHHHHhccCCCCcceEEEEEec----------------CCceEEEEEcCCCC
Confidence 345668999998754322 2345678899999999 79999999999876 456899999998 4
Q ss_pred ChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC-cccccc
Q 012062 83 DLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN-TLTNRV 160 (472)
Q Consensus 83 ~l~~~~~~~~-~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~ 160 (472)
+|.+++.... ..+++.++..|+.||+.||+|||+++|+|+||||+|||++.++.+||+|||++..+...... ......
T Consensus 125 ~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 204 (302)
T cd05055 125 DLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNAR 204 (302)
T ss_pred cHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCC
Confidence 7777765432 33899999999999999999999999999999999999999999999999998765432211 111234
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+.+.+.........
T Consensus 205 ~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~------------------- 264 (302)
T cd05055 205 LPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA------------------- 264 (302)
T ss_pred cccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCC-------------------
Confidence 4778999999876 567899999999999999998 9999988776555544433111000
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
.....+.++.+||.+||..||++|||+.|+++
T Consensus 265 ---------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 265 ---------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred ---------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 00124668999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=284.22 Aligned_cols=228 Identities=25% Similarity=0.385 Sum_probs=179.5
Q ss_pred ccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-C
Q 012062 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-D 83 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~ 83 (472)
..++..||+|.++.... .....+.+|+++++.++|+||+++++++.. ...+|+||||+.+ +
T Consensus 32 ~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~~~~ 93 (280)
T cd05092 32 EQDKMLVAVKALKEASE--SARQDFQREAELLTVLQHQHIVRFYGVCTE----------------GRPLLMVFEYMRHGD 93 (280)
T ss_pred CCCceEEEEEecCcCCH--HHHHHHHHHHHHHhcCCCCCCceEEEEEec----------------CCceEEEEecCCCCC
Confidence 34677899998874432 234568899999999999999999999876 4568999999985 6
Q ss_pred hhhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeec
Q 012062 84 LTGLADRPG--------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 149 (472)
Q Consensus 84 l~~~~~~~~--------------~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 149 (472)
|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||+++++.+||+|||++....
T Consensus 94 L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 173 (280)
T cd05092 94 LNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY 173 (280)
T ss_pred HHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCceeEcC
Confidence 666654321 247889999999999999999999999999999999999999999999999987553
Q ss_pred cCCC-CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 012062 150 YDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGV 227 (472)
Q Consensus 150 ~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 227 (472)
.... .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||......+.+..+.......
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 244 (280)
T cd05092 174 STDYYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELE-------- 244 (280)
T ss_pred CCceeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCccCC--------
Confidence 2211 11122234678999999876 568899999999999999998 999998877776665553321100
Q ss_pred CCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 228 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....++..+.+||.+||..||.+||++.||++
T Consensus 245 ---------------------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 245 ---------------------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred ---------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 00135678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=299.61 Aligned_cols=228 Identities=22% Similarity=0.345 Sum_probs=175.7
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC-CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Ch
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL 84 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l 84 (472)
++..||||+++.... ......+++|+++|+++. |||||++++++.. .+.+|||||||.+ +|
T Consensus 66 ~~~~vavK~l~~~~~-~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~----------------~~~~~lv~Ey~~~g~L 128 (400)
T cd05105 66 PVMKVAVKMLKPTAR-SSEKQALMSELKIMTHLGPHLNIVNLLGACTK----------------SGPIYIITEYCFYGDL 128 (400)
T ss_pred CceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc----------------CCceEEEEEecCCCcH
Confidence 455799999975432 223457889999999996 9999999999976 5578999999985 66
Q ss_pred hhhhcCC-------------------------------------------------------------------------
Q 012062 85 TGLADRP------------------------------------------------------------------------- 91 (472)
Q Consensus 85 ~~~~~~~------------------------------------------------------------------------- 91 (472)
.+++...
T Consensus 129 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (400)
T cd05105 129 VNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNY 208 (400)
T ss_pred HHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcc
Confidence 5544321
Q ss_pred ----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeec
Q 012062 92 ----------------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 149 (472)
Q Consensus 92 ----------------------~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 149 (472)
...+++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 209 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~ 288 (400)
T cd05105 209 DRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIM 288 (400)
T ss_pred cccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceecc
Confidence 1237788889999999999999999999999999999999999999999999997654
Q ss_pred cCCCC-ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 012062 150 YDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGV 227 (472)
Q Consensus 150 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 227 (472)
..... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||......+.+.........+.
T Consensus 289 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~------- 360 (400)
T cd05105 289 HDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMA------- 360 (400)
T ss_pred ccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCC-------
Confidence 32221 1222345778999999876 568999999999999999997 9999987654443333322110000
Q ss_pred CCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 228 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....++.++.+||.+||..||++|||+.+|.+
T Consensus 361 ---------------------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 361 ---------------------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred ---------------------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 01135678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=288.96 Aligned_cols=231 Identities=25% Similarity=0.336 Sum_probs=176.1
Q ss_pred ceeccCCCE--EEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 2 AREIKTGEI--VALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 2 a~~~~tg~~--vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
|++..++.. +|+|.++... .......+.+|+++++++ +|+||+++++++.. .+.+|+|||
T Consensus 26 a~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~----------------~~~~~lv~e 88 (303)
T cd05088 26 ARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH----------------RGYLYLAIE 88 (303)
T ss_pred EEEccCCceeeEEEEEecccC-CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC----------------CCCceEEEE
Confidence 566667765 4666655322 222345677899999999 89999999999976 557899999
Q ss_pred cCCC-ChhhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeec
Q 012062 79 YMDH-DLTGLADRP---------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADF 142 (472)
Q Consensus 79 y~~g-~l~~~~~~~---------------~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DF 142 (472)
|+.+ +|.+++.+. ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+||
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~df 168 (303)
T cd05088 89 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF 168 (303)
T ss_pred eCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeCcc
Confidence 9985 676666432 125789999999999999999999999999999999999999999999999
Q ss_pred cceeeeccCCCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCC
Q 012062 143 GLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDE 221 (472)
Q Consensus 143 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~ 221 (472)
|++....... .......+..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+....
T Consensus 169 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~----- 240 (303)
T cd05088 169 GLSRGQEVYV--KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY----- 240 (303)
T ss_pred ccCcccchhh--hcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC-----
Confidence 9985322111 1111223567999998876 568899999999999999998 999998877665554432110
Q ss_pred CCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 222 TIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
.+. ....++.++.+||.+||..||++|||+.++|.+
T Consensus 241 -~~~-----------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 241 -RLE-----------------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred -cCC-----------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 001256678999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=278.01 Aligned_cols=224 Identities=21% Similarity=0.349 Sum_probs=180.6
Q ss_pred EEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC-CChhhhh
Q 012062 10 IVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD-HDLTGLA 88 (472)
Q Consensus 10 ~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~-g~l~~~~ 88 (472)
.||||.++.+... .....+.+|+.++++++|+||+++++++.. ..+++||||+. ++|.+.+
T Consensus 25 ~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----------------~~~~~v~e~~~~~~L~~~l 86 (257)
T cd05040 25 PVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-----------------HPLMMVTELAPLGSLLDRL 86 (257)
T ss_pred EEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-----------------CeEEEEEEecCCCcHHHHH
Confidence 6999999876543 456678899999999999999999999863 36799999997 4777776
Q ss_pred cCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC--ccccccccCCC
Q 012062 89 DRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN--TLTNRVITLWY 165 (472)
Q Consensus 89 ~~~~-~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~--~~~~~~gt~~y 165 (472)
.... ..+++..++.++.||+.||+|||+++|+|+||||+|||++.++.+||+|||++..+...... ......++..|
T Consensus 87 ~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y 166 (257)
T cd05040 87 RKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAW 166 (257)
T ss_pred HhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCcee
Confidence 6544 46899999999999999999999999999999999999999999999999999876432211 11123457789
Q ss_pred CChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhh
Q 012062 166 RPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 244 (472)
Q Consensus 166 ~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (472)
+|||.+.. ..++.++|||||||++|+|++ |+.||...+..+.+..+...... +.
T Consensus 167 ~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-----~~------------------- 221 (257)
T cd05040 167 CAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGER-----LE------------------- 221 (257)
T ss_pred cCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCc-----CC-------------------
Confidence 99998875 568899999999999999998 99999888877766666431100 00
Q ss_pred hHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 245 RVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 245 ~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....++..+.+||.+||..+|++|||+.|+++
T Consensus 222 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 222 ----RPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred ----CCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 00124567999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=280.30 Aligned_cols=241 Identities=23% Similarity=0.344 Sum_probs=188.6
Q ss_pred eeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHh-cCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 3 REIKTGEIVALKKIRMDNEKEGFPITAIREIKILKK-LQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 3 ~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
.++.+|+..|||.|+..+. +...++++.|.+...+ -++||||+||++.-. ++..||.||+|+
T Consensus 84 ~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~----------------EGdcWiCMELMd 146 (361)
T KOG1006|consen 84 LHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS----------------EGDCWICMELMD 146 (361)
T ss_pred hcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc----------------CCceeeeHHHHh
Confidence 5789999999999998765 3346678888886654 479999999998755 567899999999
Q ss_pred CChhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcc
Q 012062 82 HDLTGLADR----PGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTL 156 (472)
Q Consensus 82 g~l~~~~~~----~~~~l~~~~i~~i~~Qll~aL~~LH~~-giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 156 (472)
-++..+.+. ...+++|..+-.|..-.+.||.||.+. .||||||||+||||+..|.|||||||++-.+-. +...
T Consensus 147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~--SiAk 224 (361)
T KOG1006|consen 147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD--SIAK 224 (361)
T ss_pred hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHH--HHHh
Confidence 877665543 445689999999999999999999765 999999999999999999999999999865432 2233
Q ss_pred ccccccCCCCChhhhcCCCC-CCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC-CCCCCCCccCCCCCccc
Q 012062 157 TNRVITLWYRPPELLLGATK-YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG-SPDETIWPGVSKMPAYN 234 (472)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~-~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~ 234 (472)
+.-.|...|||||.+..... |+.++|+||||++|||+.||..|+.+-+. ++.++..... .++....+
T Consensus 225 T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l~~~--------- 293 (361)
T KOG1006|consen 225 TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPILLFD--------- 293 (361)
T ss_pred hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCeecCc---------
Confidence 44567899999999975444 89999999999999999999988765433 4444443221 11111000
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
...-+++..++.+|..||.+|-+.||...++++++|++.
T Consensus 294 -------------~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 294 -------------KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRM 332 (361)
T ss_pred -------------ccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhh
Confidence 000146778999999999999999999999999999965
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=278.10 Aligned_cols=225 Identities=22% Similarity=0.401 Sum_probs=179.6
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Ch
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL 84 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l 84 (472)
.+++.||+|.+..... ....+.+|+.++++++|+||+++++++.. +.+|+||||+.+ +|
T Consensus 28 ~~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----------------~~~~~v~e~~~~~~L 87 (260)
T cd05067 28 NGHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVTQ-----------------EPIYIITEYMENGSL 87 (260)
T ss_pred CCCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEcc-----------------CCcEEEEEcCCCCCH
Confidence 4678899999875432 23567899999999999999999998742 357999999975 77
Q ss_pred hhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccC
Q 012062 85 TGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL 163 (472)
Q Consensus 85 ~~~~~~-~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~ 163 (472)
.+++.. ....+++.++..++.||+.||+|||+++|+||||||+||+++.++.++|+|||++...............++.
T Consensus 88 ~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 167 (260)
T cd05067 88 VDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPI 167 (260)
T ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccc
Confidence 776654 3446899999999999999999999999999999999999999999999999999766532222222334567
Q ss_pred CCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhh
Q 012062 164 WYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTM 242 (472)
Q Consensus 164 ~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (472)
.|+|||++.. ..++.++|||||||++|+|++ |+.||.+.+..+....+......+
T Consensus 168 ~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------- 223 (260)
T cd05067 168 KWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP----------------------- 223 (260)
T ss_pred cccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC-----------------------
Confidence 8999998875 567889999999999999998 999999887766655543221110
Q ss_pred hhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 243 KRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 243 ~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....++.++.+||.+||..||++|||++++++
T Consensus 224 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 224 ------RPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred ------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 01135668999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=281.46 Aligned_cols=228 Identities=19% Similarity=0.313 Sum_probs=178.7
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC-CCh
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD-HDL 84 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~-g~l 84 (472)
.++..||||++...... .....+.+|+.+++.++|+||+++++++.. ...+|+||||+. ++|
T Consensus 34 ~~~~~~aik~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----------------~~~~~~v~e~~~~~~L 96 (277)
T cd05032 34 EPETRVAIKTVNENASM-RERIEFLNEASVMKEFNCHHVVRLLGVVST----------------GQPTLVVMELMAKGDL 96 (277)
T ss_pred CcceeEEEEecCCccCH-HHHHHHHHHHHHHHhCCCCceeEEEEEEcC----------------CCCcEEEEecCCCCCH
Confidence 35588999998644322 223467789999999999999999999976 456899999998 467
Q ss_pred hhhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC-C
Q 012062 85 TGLADRP---------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-N 154 (472)
Q Consensus 85 ~~~~~~~---------~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~-~ 154 (472)
.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 97 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~ 176 (277)
T cd05032 97 KSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR 176 (277)
T ss_pred HHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCcccchhhccCcccc
Confidence 6665431 12367889999999999999999999999999999999999999999999999876543221 1
Q ss_pred ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 012062 155 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 233 (472)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (472)
......++..|+|||++.. ..++.++|||||||++|+|++ |..||...+..+.+..+.... ...
T Consensus 177 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~------------- 241 (277)
T cd05032 177 KGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG-HLD------------- 241 (277)
T ss_pred cCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCC-CCC-------------
Confidence 2233445788999999875 568899999999999999998 999998877766655543110 000
Q ss_pred ccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 234 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....++.++.+||.+||..||++|||+.++++
T Consensus 242 ---------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 242 ---------------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred ---------------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00124668999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=282.45 Aligned_cols=219 Identities=18% Similarity=0.255 Sum_probs=170.0
Q ss_pred CEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chhhh
Q 012062 9 EIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGL 87 (472)
Q Consensus 9 ~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~~~ 87 (472)
..||+|++.... ......+..|+.+++.++|+||+++++++.. ....+|||||+.+ +|..+
T Consensus 28 ~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~----------------~~~~~lv~e~~~~g~L~~~ 89 (258)
T cd05078 28 TEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVC----------------GDESIMVQEYVKFGSLDTY 89 (258)
T ss_pred chhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEe----------------CCCcEEEEecCCCCcHHHH
Confidence 348888876432 2234567789999999999999999999976 4467999999986 56667
Q ss_pred hcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC--------eEEeeccceeeeccCCCCccccc
Q 012062 88 ADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN--------LKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 88 ~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~--------vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
+......+++..++.++.||+.||+|||+++|+||||||+|||++.++. ++|+|||++..... ....
T Consensus 90 l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~-----~~~~ 164 (258)
T cd05078 90 LKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP-----KEIL 164 (258)
T ss_pred HhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCC-----chhc
Confidence 6665556899999999999999999999999999999999999987765 69999998865432 1224
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCC-CCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK-PILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
.++..|+|||++.+...++.++|||||||++|+|++|. .||...+...... +......
T Consensus 165 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~-------------------- 223 (258)
T cd05078 165 LERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQ-------------------- 223 (258)
T ss_pred cccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHcccc--------------------
Confidence 56888999999986556789999999999999999985 6666555443322 2211000
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
+....+.++.+||.+||+.||++|||++++++.
T Consensus 224 ----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 224 ----------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred ----------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 011234578999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=316.54 Aligned_cols=237 Identities=25% Similarity=0.328 Sum_probs=181.4
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||+++.+.. .+.....+.+|++++++++||||+++++++.. .+.+|+||||
T Consensus 20 lA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d----------------~~~lyLVMEY 83 (932)
T PRK13184 20 LAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD----------------GDPVYYTMPY 83 (932)
T ss_pred EEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee----------------CCEEEEEEEc
Confidence 467889999999999986532 22344568899999999999999999999976 5578999999
Q ss_pred CCC-ChhhhhcCC----------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeee
Q 012062 80 MDH-DLTGLADRP----------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 148 (472)
Q Consensus 80 ~~g-~l~~~~~~~----------~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 148 (472)
+++ +|.+++... ...++...+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++..
T Consensus 84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i 163 (932)
T PRK13184 84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFK 163 (932)
T ss_pred CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcceec
Confidence 986 666555321 123566778999999999999999999999999999999999999999999999866
Q ss_pred ccCCC-----------------CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 012062 149 SYDHN-----------------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSK 211 (472)
Q Consensus 149 ~~~~~-----------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~ 211 (472)
..... ......+||+.|+|||++.+ ..++.++||||||||+|+|++|+.||...+..+....
T Consensus 164 ~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~ 242 (932)
T PRK13184 164 KLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYR 242 (932)
T ss_pred ccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhh
Confidence 21110 11122468999999999886 5689999999999999999999999987554333221
Q ss_pred HHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 212 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 212 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
. ....+.. ...+..++..+.+++.+||..||++|++..+.|.+
T Consensus 243 ~--~i~~P~~-------------------------~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 243 D--VILSPIE-------------------------VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred h--hccChhh-------------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1 0000000 00112467789999999999999999877665543
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=285.69 Aligned_cols=230 Identities=25% Similarity=0.310 Sum_probs=176.7
Q ss_pred ceeccCCC--EEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 2 AREIKTGE--IVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 2 a~~~~tg~--~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
|++..++. .+++|.++.... ......+.+|+.+++++ +|+||+++++++.. .+.+|+|||
T Consensus 21 ~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~----------------~~~~~lv~e 83 (297)
T cd05089 21 AMIKKDGLKMNAAIKMLKEFAS-ENDHRDFAGELEVLCKLGHHPNIINLLGACEN----------------RGYLYIAIE 83 (297)
T ss_pred EEecCCCCcceeEEEEccccCC-HHHHHHHHHHHHHHHhhcCCCchhheEEEEcc----------------CCcceEEEE
Confidence 44555554 468888763222 22345678899999999 79999999999876 456899999
Q ss_pred cCCC-ChhhhhcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeec
Q 012062 79 YMDH-DLTGLADRPG---------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADF 142 (472)
Q Consensus 79 y~~g-~l~~~~~~~~---------------~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DF 142 (472)
|+.+ +|.+++.+.. ..+++..++.|+.||+.||+|||+++|+||||||+|||++.++.+||+||
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~df 163 (297)
T cd05089 84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADF 163 (297)
T ss_pred ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEECCc
Confidence 9984 6766664321 24788999999999999999999999999999999999999999999999
Q ss_pred cceeeeccCCCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCC
Q 012062 143 GLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDE 221 (472)
Q Consensus 143 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~ 221 (472)
|++....... .......+..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+.+..+.......
T Consensus 164 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~-- 238 (297)
T cd05089 164 GLSRGEEVYV--KKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRME-- 238 (297)
T ss_pred CCCcccccee--ccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC--
Confidence 9985422111 1111122557999999876 568899999999999999997 999999888777666553211000
Q ss_pred CCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 222 TIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....++.++++||.+||..||.+|||++++++
T Consensus 239 ---------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 270 (297)
T cd05089 239 ---------------------------KPRNCDDEVYELMRQCWRDRPYERPPFAQISV 270 (297)
T ss_pred ---------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01236678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=280.31 Aligned_cols=225 Identities=22% Similarity=0.342 Sum_probs=178.6
Q ss_pred CCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chhh
Q 012062 8 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTG 86 (472)
Q Consensus 8 g~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~~ 86 (472)
...||||.+...... ...+.+.+|+.++++++|+||+++++++.. ...||||||+.+ +|.+
T Consensus 34 ~~~v~ik~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----------------~~~~lv~e~~~~~~L~~ 95 (270)
T cd05056 34 KIAVAVKTCKNCTSP-SVREKFLQEAYIMRQFDHPHIVKLIGVITE-----------------NPVWIVMELAPLGELRS 95 (270)
T ss_pred CcceEEEecCCcCCH-HHHHHHHHHHHHHHhCCCCchhceeEEEcC-----------------CCcEEEEEcCCCCcHHH
Confidence 346899988754322 234567889999999999999999998864 246899999984 7777
Q ss_pred hhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccCCCC
Q 012062 87 LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYR 166 (472)
Q Consensus 87 ~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~ 166 (472)
++.+....+++..++.++.||+.||+|||+++++|+||||+|||++.++.+||+|||+++...............+..|+
T Consensus 96 ~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~ 175 (270)
T cd05056 96 YLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWM 175 (270)
T ss_pred HHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccceecCCCCcccccc
Confidence 77665556899999999999999999999999999999999999999999999999998765433221222223356799
Q ss_pred ChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhh
Q 012062 167 PPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRR 245 (472)
Q Consensus 167 aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (472)
|||.+.. ..++.++|||||||++|+|++ |..||...+..+.+..+.......
T Consensus 176 aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~-------------------------- 228 (270)
T cd05056 176 APESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLP-------------------------- 228 (270)
T ss_pred Chhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCC--------------------------
Confidence 9998875 568899999999999999986 999999888776665553211100
Q ss_pred HHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 246 VREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 246 ~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....++.++.+||.+||..||++|||+.++++
T Consensus 229 ---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 229 ---MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred ---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01235678999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=282.47 Aligned_cols=244 Identities=22% Similarity=0.334 Sum_probs=176.3
Q ss_pred eccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-
Q 012062 4 EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH- 82 (472)
Q Consensus 4 ~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g- 82 (472)
+..+++.||||+++..... .....+.+|+++|++++|+||+++++++.... ...+||||||+.+
T Consensus 29 ~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--------------~~~~~lv~e~~~~~ 93 (283)
T cd05080 29 NDGTGEMVAVKTLKRECGQ-QNTSGWKKEINILKTLYHENIVKYKGCCSEQG--------------GKGLQLIMEYVPLG 93 (283)
T ss_pred cCCCCceEEEEEeccccCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--------------CceEEEEecCCCCC
Confidence 3467889999999765322 23456788999999999999999999886521 3468999999996
Q ss_pred ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCc--ccccc
Q 012062 83 DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT--LTNRV 160 (472)
Q Consensus 83 ~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~--~~~~~ 160 (472)
+|.+++... .+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++......... .....
T Consensus 94 ~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 171 (283)
T cd05080 94 SLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171 (283)
T ss_pred CHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCC
Confidence 565555443 58999999999999999999999999999999999999999999999999987654322111 11223
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC-CCCCCCCccCCCCCccccCCCc
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG-SPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
++..|+|||++.+ ..++.++|||||||++|+|++|..||...... +..+..... ......+.....
T Consensus 172 ~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~---------- 238 (283)
T cd05080 172 SPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRLIELLE---------- 238 (283)
T ss_pred CCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhhhhhhhh----------
Confidence 4667999998876 56789999999999999999999988654321 111110000 000000000000
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
..........++.++.+||.+||..||++|||++++++
T Consensus 239 ---~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 239 ---RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred ---cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00000012346678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=283.52 Aligned_cols=232 Identities=18% Similarity=0.292 Sum_probs=179.1
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC-CChh
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD-HDLT 85 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~-g~l~ 85 (472)
++..||||+++...... ....+.+|+.+++.++|+||+++++++.. ...+|+||||+. ++|.
T Consensus 35 ~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~~~~~lv~e~~~~g~L~ 97 (288)
T cd05061 35 AETRVAVKTVNESASLR-ERIEFLNEASVMKGFTCHHVVRLLGVVSK----------------GQPTLVVMELMAHGDLK 97 (288)
T ss_pred cceEEEEEECCCcCCHH-HHHHHHHHHHHHHhCCCCCeeeEEEEEcC----------------CCCcEEEEeCCCCCCHH
Confidence 34589999987543222 23456789999999999999999999876 446799999998 4777
Q ss_pred hhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC-Cc
Q 012062 86 GLADRP---------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-NT 155 (472)
Q Consensus 86 ~~~~~~---------~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~ 155 (472)
+++.+. ...++...+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 98 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~ 177 (288)
T cd05061 98 SYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK 177 (288)
T ss_pred HHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCCccccccccccccc
Confidence 666431 12356778899999999999999999999999999999999999999999999875432211 11
Q ss_pred cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 156 LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
.....++..|+|||.+.+ ..++.++|||||||++|+|++ +..||.+.+..+.+..+...... .
T Consensus 178 ~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~------~--------- 241 (288)
T cd05061 178 GGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL------D--------- 241 (288)
T ss_pred cCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC------C---------
Confidence 122344678999999876 567899999999999999998 78899887776655554321100 0
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc------CCCCC
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD------SEYFW 285 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~------h~~f~ 285 (472)
....++..+++||.+||+.||++|||+.|+++ |+||.
T Consensus 242 --------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~ 284 (288)
T cd05061 242 --------------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 284 (288)
T ss_pred --------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCC
Confidence 00124568999999999999999999999986 78874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=281.25 Aligned_cols=231 Identities=19% Similarity=0.261 Sum_probs=176.7
Q ss_pred ceeccCCC----EEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEE
Q 012062 2 AREIKTGE----IVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVF 77 (472)
Q Consensus 2 a~~~~tg~----~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVm 77 (472)
|+...+++ .|++|++..... ......+..|+.+++++.|+||+++++++.. ..+++||
T Consensus 26 ~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-----------------~~~~~i~ 87 (279)
T cd05111 26 GIWIPEGDSIKIPVAIKTIQDRSG-RQTFQEITDHMLAMGSLDHAYIVRLLGICPG-----------------ASLQLVT 87 (279)
T ss_pred EEEcCCCCceeeEEEEeecccccc-hHHHHHHHHHHHHHhcCCCCCcceEEEEECC-----------------CccEEEE
Confidence 44555666 467777653322 2233566788889999999999999998743 2468999
Q ss_pred ecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC-c
Q 012062 78 EYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN-T 155 (472)
Q Consensus 78 Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~ 155 (472)
||+. ++|.+++......+++..+..|+.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.+...... .
T Consensus 88 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 167 (279)
T cd05111 88 QLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYF 167 (279)
T ss_pred EeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccc
Confidence 9998 5788887665567899999999999999999999999999999999999999999999999999765432221 2
Q ss_pred cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 156 LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
.....++..|++||++.+ ..++.++|||||||++|||++ |..||.+.........+ .....+..
T Consensus 168 ~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~------------- 232 (279)
T cd05111 168 YSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-EKGERLAQ------------- 232 (279)
T ss_pred cCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCcCCC-------------
Confidence 223345678999999876 568999999999999999998 99999887665443333 21111000
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...++.++.+++.+||..||++|||+.|+++
T Consensus 233 ---------------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 233 ---------------PQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred ---------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0113456889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=281.35 Aligned_cols=230 Identities=25% Similarity=0.323 Sum_probs=176.6
Q ss_pred ceeccCCC--EEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 2 AREIKTGE--IVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 2 a~~~~tg~--~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
|++..++. .+|+|.++..... .....+.+|+++++++ +|+||+++++++.. .+.+|+|||
T Consensus 14 ~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~----------------~~~~~lv~e 76 (270)
T cd05047 14 ARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLGHHPNIINLLGACEH----------------RGYLYLAIE 76 (270)
T ss_pred EEEcCCCCeeEEEEEEccccCCH-HHHHHHHHHHHHHHhhccCCCeeeEEEEEec----------------CCCceEEEE
Confidence 45666765 4688887643222 2345678899999999 79999999999976 456899999
Q ss_pred cCC-CChhhhhcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeec
Q 012062 79 YMD-HDLTGLADRPG---------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADF 142 (472)
Q Consensus 79 y~~-g~l~~~~~~~~---------------~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DF 142 (472)
|+. ++|.+++.... ..+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+||
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCC
Confidence 998 47777664321 24788999999999999999999999999999999999999999999999
Q ss_pred cceeeeccCCCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCC
Q 012062 143 GLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDE 221 (472)
Q Consensus 143 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~ 221 (472)
|++....... .......+..|+|||++.. ..++.++|||||||++|+|++ |..||.+.+..+.+..+......
T Consensus 157 gl~~~~~~~~--~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~--- 230 (270)
T cd05047 157 GLSRGQEVYV--KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL--- 230 (270)
T ss_pred CCccccchhh--hccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCC---
Confidence 9985322111 1111223567999998865 568899999999999999997 99999887766655544221000
Q ss_pred CCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 222 TIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
. ....++.++.+||.+||..||.+|||+.|++.
T Consensus 231 ---~-----------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 231 ---E-----------------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred ---C-----------------------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 0 00125567999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=316.96 Aligned_cols=129 Identities=26% Similarity=0.434 Sum_probs=110.8
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||+++.... .......+.+|+.+++.++|+||+++++++.. ...+||||||
T Consensus 22 ~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~----------------~~~~~lVmEy 85 (669)
T cd05610 22 LGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS----------------ANNVYLVMEY 85 (669)
T ss_pred EEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE----------------CCEEEEEEeC
Confidence 467888999999999986432 22334567889999999999999999999876 5689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeecccee
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 146 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 146 (472)
+.+ +|..++... ..+++..++.|+.||+.||+|||.++|+||||||+||||+.++.+||+|||+++
T Consensus 86 ~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 86 LIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 975 666666543 368999999999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=284.22 Aligned_cols=239 Identities=23% Similarity=0.381 Sum_probs=181.8
Q ss_pred ccCCCEEEEEEeecCCc--CCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 5 IKTGEIVALKKIRMDNE--KEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~~--~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
..+++.||||+++.... .......+.+|+++++++ +|+||+++++++.. ...+||||||+.
T Consensus 25 ~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~----------------~~~~~lv~e~~~ 88 (288)
T cd05583 25 HDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT----------------DTKLHLILDYVN 88 (288)
T ss_pred ccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec----------------CCEEEEEEecCC
Confidence 45788999999975422 222345677899999999 59999999999876 557899999998
Q ss_pred C-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 82 H-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 82 g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+ +|...+... ..+++..++.++.||+.+|.|||+.+++|+||||+||+++.++.++|+|||++..+............
T Consensus 89 ~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 167 (288)
T cd05583 89 GGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC 167 (288)
T ss_pred CCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccccccccccc
Confidence 6 666655443 46899999999999999999999999999999999999999999999999998765543322223345
Q ss_pred ccCCCCChhhhcCCC-CCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 161 ITLWYRPPELLLGAT-KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 161 gt~~y~aPE~l~~~~-~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
++..|+|||++.+.. ..+.++||||||+++|+|++|..||...+.......+.+.......
T Consensus 168 ~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------------------ 229 (288)
T cd05583 168 GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP------------------ 229 (288)
T ss_pred CCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC------------------
Confidence 788999999986532 2678999999999999999999999654322221222111000000
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCC---HHHHhcCCCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS---AKDALDSEYFWT 286 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t---~~elL~h~~f~~ 286 (472)
.....++..+.+||.+||+.||++||| +.++|+|+||..
T Consensus 230 --------~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~ 271 (288)
T cd05583 230 --------PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQG 271 (288)
T ss_pred --------CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCccccc
Confidence 001135668999999999999999998 567799999954
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=280.17 Aligned_cols=232 Identities=23% Similarity=0.367 Sum_probs=180.7
Q ss_pred ceeccCCC---EEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 2 AREIKTGE---IVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 2 a~~~~tg~---~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
|+++.+++ .||||+++.... +.....+.+|+.+++.++|+||+++++++.. ...+++|||
T Consensus 23 ~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----------------~~~~~lv~e 85 (269)
T cd05065 23 GRLKLPGKREIFVAIKTLKSGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTK----------------SRPVMIITE 85 (269)
T ss_pred EEEecCCCCceeEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCcCcceEEEEECC----------------CCceEEEEe
Confidence 34455544 699999875432 2234577899999999999999999999876 456899999
Q ss_pred cCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC-cc
Q 012062 79 YMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN-TL 156 (472)
Q Consensus 79 y~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~ 156 (472)
|+.+ +|.+++......+++.+++.++.|++.||+|||+++++|+||||+||+++.++.+||+|||++......... ..
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 165 (269)
T cd05065 86 FMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 165 (269)
T ss_pred cCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCcccccc
Confidence 9986 566666655556899999999999999999999999999999999999999999999999998755332211 11
Q ss_pred cccc---ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 012062 157 TNRV---ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 232 (472)
Q Consensus 157 ~~~~---gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (472)
.... .+..|+|||++.. ..++.++|||||||++|||++ |..||...+..+....+......+.
T Consensus 166 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~------------ 232 (269)
T cd05065 166 TSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPP------------ 232 (269)
T ss_pred ccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCC------------
Confidence 1111 1457999999876 568899999999999999886 9999988877766666532211000
Q ss_pred cccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 233 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...++..+.++|.+||..||.+||++.+|+.
T Consensus 233 -----------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 233 -----------------PMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred -----------------cccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0134567899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=282.12 Aligned_cols=220 Identities=20% Similarity=0.294 Sum_probs=170.0
Q ss_pred CCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCC-hhh
Q 012062 8 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHD-LTG 86 (472)
Q Consensus 8 g~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~-l~~ 86 (472)
...||+|+++.... .....+.+|+.+++.++|+||+++++++.. ....||||||++++ |..
T Consensus 44 ~~~v~~k~~~~~~~--~~~~~~~~~~~~~~~l~h~niv~~~~~~~~----------------~~~~~lv~ey~~~g~L~~ 105 (274)
T cd05076 44 ELRVVLKVLDPSHR--DIALAFFETASLMSQVSHIHLAFVHGVCVR----------------GSENIMVEEFVEHGPLDV 105 (274)
T ss_pred eeeEEEEecChHHH--HHHHHHHHHHHHHhcCCCCCeeeEEEEEEe----------------CCceEEEEecCCCCcHHH
Confidence 34689998864422 234567789999999999999999999976 45679999999975 545
Q ss_pred hhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC-------CeEEeeccceeeeccCCCCccccc
Q 012062 87 LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG-------NLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 87 ~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~-------~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
++.+....+++..+..++.||+.||+|||+++|+||||||+||||+..+ .+||+|||++...... ...
T Consensus 106 ~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~ 180 (274)
T cd05076 106 CLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR-----EER 180 (274)
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc-----ccc
Confidence 5544455789999999999999999999999999999999999997643 3899999987543211 223
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHH-hCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELL-NGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell-~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
.++..|+|||++.+...++.++|||||||++|+|+ +|..||......+... ++......
T Consensus 181 ~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~~------------------- 240 (274)
T cd05076 181 VERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-FYEKKHRL------------------- 240 (274)
T ss_pred ccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-HHHhccCC-------------------
Confidence 46788999999876566889999999999999995 6899998766544332 22111000
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
....+..+.+||.+||..||++|||+.++|++
T Consensus 241 -----------~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 241 -----------PEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred -----------CCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 00123468999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=281.82 Aligned_cols=247 Identities=24% Similarity=0.382 Sum_probs=177.4
Q ss_pred eccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-
Q 012062 4 EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH- 82 (472)
Q Consensus 4 ~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g- 82 (472)
+..+++.||||.++..... .....+.+|+.+++.++|+||+++++++...+ ...+||||||+.+
T Consensus 29 ~~~~~~~va~K~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------------~~~~~lv~e~~~g~ 93 (284)
T cd05079 29 GDNTGEQVAVKSLKPESGG-NHIADLKKEIEILRNLYHENIVKYKGICTEDG--------------GNGIKLIMEFLPSG 93 (284)
T ss_pred CCCccceEEEEEcCccccH-HHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC--------------CCceEEEEEccCCC
Confidence 4578999999998755332 23457889999999999999999999987621 3467999999985
Q ss_pred ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC--cccccc
Q 012062 83 DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN--TLTNRV 160 (472)
Q Consensus 83 ~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~--~~~~~~ 160 (472)
+|.+++.+....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+...... ......
T Consensus 94 ~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 173 (284)
T cd05079 94 SLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLD 173 (284)
T ss_pred CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCC
Confidence 666666554446899999999999999999999999999999999999999999999999998765432211 112334
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCC-CccCCCCCccccCCCc
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETI-WPGVSKMPAYNHFKPS 239 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 239 (472)
++..|+|||++.+ ..++.++|||||||++|+|+++..++..... .+.+. .+...... +.....
T Consensus 174 ~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~~--~~~~~---~~~~~~~~~~~~~~~---------- 237 (284)
T cd05079 174 SPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPMT--LFLKM---IGPTHGQMTVTRLVR---------- 237 (284)
T ss_pred CCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCccccc--hhhhh---cccccccccHHHHHH----------
Confidence 5778999999876 5688999999999999999998765432211 00000 00000000 000000
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
.............++..+.+||.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 238 VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 000000001123467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=277.74 Aligned_cols=228 Identities=23% Similarity=0.310 Sum_probs=174.5
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chh
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLT 85 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~ 85 (472)
+...||||++..... ......+.+|+.+++.++|+||+++++++... ++..|+||||+.+ +|.
T Consensus 22 ~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---------------~~~~~lv~e~~~~~~L~ 85 (262)
T cd05058 22 QKIHCAVKSLNRITD-LEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS---------------EGSPLVVLPYMKHGDLR 85 (262)
T ss_pred ceEEEEEEecCccCC-HHHHHHHHHHHHHHccCCCCCcceEEEEeecC---------------CCCcEEEEecCCCCCHH
Confidence 446799998864322 12345677899999999999999999977542 3457899999984 777
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC---Ccccccccc
Q 012062 86 GLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN---NTLTNRVIT 162 (472)
Q Consensus 86 ~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~---~~~~~~~gt 162 (472)
+++.+....+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....... .......++
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 165 (262)
T cd05058 86 NFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP 165 (262)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCC
Confidence 77665444577888899999999999999999999999999999999999999999999875532211 111122346
Q ss_pred CCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchh
Q 012062 163 LWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241 (472)
Q Consensus 163 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (472)
..|+|||++.. ..++.++|||||||++|+|++ |.+||...+..+....+.......
T Consensus 166 ~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------- 222 (262)
T cd05058 166 VKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLL---------------------- 222 (262)
T ss_pred ccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC----------------------
Confidence 78999998876 568899999999999999999 567787776655554442210000
Q ss_pred hhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....++..+.+|+.+||..||++||++.|+++
T Consensus 223 -------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 223 -------QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred -------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00124567999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=284.91 Aligned_cols=228 Identities=23% Similarity=0.370 Sum_probs=179.3
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Ch
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL 84 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l 84 (472)
++..||||+++..... .....+.+|+.+++.+ +|+||+++++++.. ...+|+||||+.+ +|
T Consensus 46 ~~~~v~iK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~----------------~~~~~lv~e~~~~~~L 108 (304)
T cd05101 46 EAVTVAVKMLKDDATE-KDLSDLVSEMEMMKMIGKHKNIINLLGACTQ----------------DGPLYVIVEYASKGNL 108 (304)
T ss_pred cceeEEeeecccccch-HHHHHHHHHHHHHHhhccCCCchheeEEEec----------------CCceEEEEecCCCCcH
Confidence 4557999998754322 2345678999999999 89999999999976 4578999999985 67
Q ss_pred hhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeec
Q 012062 85 TGLADRP---------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 149 (472)
Q Consensus 85 ~~~~~~~---------------~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 149 (472)
.+++.+. ...++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 109 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~ 188 (304)
T cd05101 109 REYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVN 188 (304)
T ss_pred HHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCCcEEECCCccceecc
Confidence 6666532 2347788899999999999999999999999999999999999999999999998764
Q ss_pred cCCCCc-cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 012062 150 YDHNNT-LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGV 227 (472)
Q Consensus 150 ~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 227 (472)
...... .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+.+..+.......
T Consensus 189 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 259 (304)
T cd05101 189 NIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD-------- 259 (304)
T ss_pred cccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCC--------
Confidence 322211 122334678999999876 568899999999999999998 788998877666655553211000
Q ss_pred CCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 228 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
....++.++++||.+||..+|++|||+.|+++.
T Consensus 260 ---------------------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 260 ---------------------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred ---------------------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 011356789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=283.78 Aligned_cols=232 Identities=21% Similarity=0.332 Sum_probs=175.9
Q ss_pred CEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chhhh
Q 012062 9 EIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGL 87 (472)
Q Consensus 9 ~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~~~ 87 (472)
..||||+++.... ......+.+|++++++++|+||+++++++.. .+.+||||||+.+ +|.++
T Consensus 45 ~~vavK~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~~~~L~~~ 107 (295)
T cd05097 45 VLVAVKMLRADVT-KTARNDFLKEIKIMSRLKNPNIIRLLGVCVS----------------DDPLCMITEYMENGDLNQF 107 (295)
T ss_pred eEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCcCeEEEEEcC----------------CCccEEEEecCCCCcHHHH
Confidence 3589999975432 2234567899999999999999999999976 5578999999985 66665
Q ss_pred hcCCC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC-c
Q 012062 88 ADRPG-----------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN-T 155 (472)
Q Consensus 88 ~~~~~-----------~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~ 155 (472)
+.... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++..+...... .
T Consensus 108 l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 187 (295)
T cd05097 108 LSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRI 187 (295)
T ss_pred HHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCCCcEEecccccccccccCcceec
Confidence 53321 13678889999999999999999999999999999999999999999999998764322211 1
Q ss_pred cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh--CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 012062 156 LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN--GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 233 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~--G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (472)
.....++..|+|||++.. ..++.++|||||||++|+|++ +..||...+..+.+..+.+.........+.
T Consensus 188 ~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 258 (295)
T cd05097 188 QGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYL-------- 258 (295)
T ss_pred cCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccC--------
Confidence 122334678999999876 568999999999999999988 667888877766655543321111000000
Q ss_pred ccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 234 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
.....++..+++||.+||..||++|||+.+|++
T Consensus 259 --------------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 259 --------------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred --------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 001125678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=276.18 Aligned_cols=223 Identities=21% Similarity=0.361 Sum_probs=177.0
Q ss_pred ccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-C
Q 012062 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-D 83 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~ 83 (472)
..+++.||+|.++.+. ....+.+|+.++++++|+||+++++++... .+.+|+||||+.+ +
T Consensus 26 ~~~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---------------~~~~~lv~e~~~~~~ 86 (256)
T cd05082 26 DYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE---------------KGGLYIVTEYMAKGS 86 (256)
T ss_pred EEcCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC---------------CCceEEEEECCCCCc
Confidence 3467889999986432 244678999999999999999999976531 4468999999985 7
Q ss_pred hhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccccc
Q 012062 84 LTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVIT 162 (472)
Q Consensus 84 l~~~~~~~~-~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt 162 (472)
|.+++.+.. ..+++..+..++.||+.+|+|||+++|+||||||+||+++.++.+||+|||++....... .....+
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~ 162 (256)
T cd05082 87 LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLP 162 (256)
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC----CCCccc
Confidence 777765433 348899999999999999999999999999999999999999999999999987543221 122345
Q ss_pred CCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchh
Q 012062 163 LWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241 (472)
Q Consensus 163 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (472)
..|+|||++.. ..++.++|||||||++|+|++ |+.||...+..+....+......
T Consensus 163 ~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------------------- 218 (256)
T cd05082 163 VKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM----------------------- 218 (256)
T ss_pred eeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC-----------------------
Confidence 67999998876 568899999999999999997 99999877765555544321100
Q ss_pred hhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
.....++..+++||.+||..||++|||+.++++
T Consensus 219 ------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 219 ------DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred ------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 001235678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=279.15 Aligned_cols=232 Identities=18% Similarity=0.260 Sum_probs=173.4
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chh
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLT 85 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~ 85 (472)
+...||||.++.... ......+++|+.+++.++|+||+++++.+.. ...+||||||+.+ +|.
T Consensus 21 ~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~----------------~~~~~lv~e~~~~g~L~ 83 (269)
T cd05042 21 SKARVVVKELRASAT-PDEQLLFLQEVQPYRELNHPNVLQCLGQCIE----------------SIPYLLVLEFCPLGDLK 83 (269)
T ss_pred CCeEEEEeecCccCC-hHHHHHHHHHHHHHHhCCCCCcceEEEEECC----------------CCceEEEEEeCCCCcHH
Confidence 445788888764332 2234567889999999999999999999876 4568999999985 676
Q ss_pred hhhcCCC----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC-Ccccccc
Q 012062 86 GLADRPG----LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-NTLTNRV 160 (472)
Q Consensus 86 ~~~~~~~----~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~ 160 (472)
+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++........ .......
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 163 (269)
T cd05042 84 NYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHA 163 (269)
T ss_pred HHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccCCCC
Confidence 6665422 2246778899999999999999999999999999999999999999999999865322111 1112223
Q ss_pred ccCCCCChhhhcC------CCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 012062 161 ITLWYRPPELLLG------ATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 233 (472)
Q Consensus 161 gt~~y~aPE~l~~------~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (472)
++..|+|||++.. ...++.++|||||||++|+|++ |..||....+.+.+..+..........
T Consensus 164 ~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 232 (269)
T cd05042 164 VPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPK----------- 232 (269)
T ss_pred CcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCC-----------
Confidence 4677999998753 1346789999999999999998 788998887777666654432111000
Q ss_pred ccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 234 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
......++..+.+++..|+ .||++|||++||++
T Consensus 233 -------------~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 233 -------------PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred -------------CcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 0011235667889999998 59999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=285.09 Aligned_cols=227 Identities=23% Similarity=0.379 Sum_probs=176.7
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Ch
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL 84 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l 84 (472)
+...||+|+++..... .....+.+|+++++++ +|+||+++++++.. .+.+||||||+.+ +|
T Consensus 43 ~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~----------------~~~~~lv~e~~~~g~L 105 (314)
T cd05099 43 QTVTVAVKMLKDNATD-KDLADLISEMELMKLIGKHKNIINLLGVCTQ----------------EGPLYVIVEYAAKGNL 105 (314)
T ss_pred cceEEEEEecCCCCCh-HHHHHHHHHHHHHHhccCCCCeeeEEEEEcc----------------CCceEEEEecCCCCcH
Confidence 4557999998754322 2345678899999999 69999999999875 4578999999985 66
Q ss_pred hhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeec
Q 012062 85 TGLADRP---------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 149 (472)
Q Consensus 85 ~~~~~~~---------------~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 149 (472)
.+++... ...++..++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 106 ~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~ 185 (314)
T cd05099 106 REFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVH 185 (314)
T ss_pred HHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCCcEEEcccccccccc
Confidence 6666432 2347888999999999999999999999999999999999999999999999997654
Q ss_pred cCCCC-ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 012062 150 YDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGV 227 (472)
Q Consensus 150 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 227 (472)
..... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+.+..+..... .
T Consensus 186 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~-------- 255 (314)
T cd05099 186 DIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHR-M-------- 255 (314)
T ss_pred ccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-C--------
Confidence 22111 1111223467999999876 568899999999999999999 8899988776666655532110 0
Q ss_pred CCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 228 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
.....++.++++||.+||..||++|||+.|+++
T Consensus 256 --------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 256 --------------------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred --------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 001135668999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=275.86 Aligned_cols=223 Identities=23% Similarity=0.379 Sum_probs=179.9
Q ss_pred ccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-C
Q 012062 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-D 83 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~ 83 (472)
...++.||||+++.... ....+.+|+.+++.++|+||+++++++.. ...+|+||||+.+ +
T Consensus 26 ~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------------~~~~~~v~e~~~~~~ 86 (256)
T cd05039 26 DYRGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQ----------------GNPLYIVTEYMAKGS 86 (256)
T ss_pred EecCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcC----------------CCCeEEEEEecCCCc
Confidence 34588999999976543 35678899999999999999999999876 4568999999985 7
Q ss_pred hhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccccc
Q 012062 84 LTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVIT 162 (472)
Q Consensus 84 l~~~~~~~~-~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt 162 (472)
|.+++.... ..+++..++.++.||+.||.|||+++|+|+||||+||+++.++.+||+|||+++....... ....+
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~----~~~~~ 162 (256)
T cd05039 87 LVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD----SGKLP 162 (256)
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc----cCCCc
Confidence 777665433 2589999999999999999999999999999999999999999999999999876532211 22346
Q ss_pred CCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchh
Q 012062 163 LWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241 (472)
Q Consensus 163 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (472)
..|+|||++.. ..++.++|||||||++|+|++ |..||...+..+....+.... ..
T Consensus 163 ~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~---------------------- 218 (256)
T cd05039 163 VKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY-RM---------------------- 218 (256)
T ss_pred ccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC-CC----------------------
Confidence 67999998875 567889999999999999997 999998877666554443210 00
Q ss_pred hhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
.....++..+.+||++||..||++|||+.|+++
T Consensus 219 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 219 ------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred ------CCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 001135678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=279.10 Aligned_cols=226 Identities=23% Similarity=0.360 Sum_probs=176.8
Q ss_pred CCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chhh
Q 012062 8 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTG 86 (472)
Q Consensus 8 g~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~~ 86 (472)
++.||||.+...... .....+.+|+.+++.++|+||+++++++.. .+..|+||||+.+ +|.+
T Consensus 26 ~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~~v~e~~~~~~L~~ 88 (269)
T cd05044 26 PIRVAVKTLRKGATD-QEKKEFLKEAHLMSNFNHPNIVKLLGVCLL----------------NEPQYIIMELMEGGDLLS 88 (269)
T ss_pred ceeehhhhhhcccch-hhHHHHHHHHHHHHhcCCCCeeeEeeeecC----------------CCCeEEEEeccCCCcHHH
Confidence 368999998654322 234567899999999999999999999875 4568999999985 7776
Q ss_pred hhcC------CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC-----CeEEeeccceeeeccCCC-C
Q 012062 87 LADR------PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG-----NLKLADFGLARSFSYDHN-N 154 (472)
Q Consensus 87 ~~~~------~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~-----~vkL~DFG~a~~~~~~~~-~ 154 (472)
++.+ ....+++.++..++.||+.+|+|||+++|+|+||||+|||++.++ .+||+|||++........ .
T Consensus 89 ~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~ 168 (269)
T cd05044 89 YLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR 168 (269)
T ss_pred HHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccc
Confidence 6643 223478899999999999999999999999999999999999877 899999999875432211 1
Q ss_pred ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 012062 155 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 233 (472)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (472)
.......+..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+..... .
T Consensus 169 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~-~-------------- 232 (269)
T cd05044 169 KEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGR-L-------------- 232 (269)
T ss_pred cCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCc-c--------------
Confidence 1122345778999999876 568999999999999999998 9999988777665554421100 0
Q ss_pred ccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 234 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
.....++..+.+||.+||..+|.+|||+.++++
T Consensus 233 --------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 233 --------------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred --------------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 011235678999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=284.54 Aligned_cols=228 Identities=24% Similarity=0.380 Sum_probs=176.6
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Ch
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL 84 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l 84 (472)
+...||+|+++.+.. ......+.+|+++++++ +|+||+++++++.. .+.+||||||+.+ +|
T Consensus 49 ~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~----------------~~~~~lv~e~~~~~~L 111 (307)
T cd05098 49 RVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQ----------------DGPLYVIVEYASKGNL 111 (307)
T ss_pred ccceEEEEeccCCCC-hHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec----------------CCceEEEEecCCCCcH
Confidence 345799999986432 22345678899999999 79999999999976 4578999999985 77
Q ss_pred hhhhcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeec
Q 012062 85 TGLADRPG---------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 149 (472)
Q Consensus 85 ~~~~~~~~---------------~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 149 (472)
.+++.... ..++..+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.+.
T Consensus 112 ~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~ 191 (307)
T cd05098 112 REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 191 (307)
T ss_pred HHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCCcEEECCCccccccc
Confidence 77765421 247888999999999999999999999999999999999999999999999987654
Q ss_pred cCCCCc-cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 012062 150 YDHNNT-LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGV 227 (472)
Q Consensus 150 ~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 227 (472)
...... ......+..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+.... ..
T Consensus 192 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~-------- 261 (307)
T cd05098 192 HIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH-RM-------- 261 (307)
T ss_pred ccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCC-CC--------
Confidence 221111 111223568999999876 567899999999999999998 889998766555444432210 00
Q ss_pred CCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 228 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
.....++.++++||.+||..||++|||+.+++++
T Consensus 262 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 262 --------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred --------------------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 0011356789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=281.27 Aligned_cols=227 Identities=20% Similarity=0.329 Sum_probs=176.0
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chh
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLT 85 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~ 85 (472)
....||+|++....... ....+.+|+.+++.++|+||+++++.+.. ++..|+||||+.+ +|.
T Consensus 29 ~~~~~~~k~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~~~~~~L~ 91 (290)
T cd05045 29 GYTTVAVKMLKENASSS-ELRDLLSEFNLLKQVNHPHVIKLYGACSQ----------------DGPLLLIVEYAKYGSLR 91 (290)
T ss_pred cceeEEEEecCCCCCHH-HHHHHHHHHHHHhhCCCCCEeeEEEEEec----------------CCCcEEEEEecCCCCHH
Confidence 34678999887543222 24567889999999999999999999876 4567999999985 565
Q ss_pred hhhcC-----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeec
Q 012062 86 GLADR-----------------------PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADF 142 (472)
Q Consensus 86 ~~~~~-----------------------~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DF 142 (472)
+++.. ....+++..++.++.||+.||+|||+++|+||||||+||||++++.+||+||
T Consensus 92 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~df 171 (290)
T cd05045 92 SFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDF 171 (290)
T ss_pred HHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccc
Confidence 55432 1134788899999999999999999999999999999999999999999999
Q ss_pred cceeeeccCCCC-ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCC
Q 012062 143 GLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPD 220 (472)
Q Consensus 143 G~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~ 220 (472)
|+++........ ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+.+.....
T Consensus 172 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~- 249 (290)
T cd05045 172 GLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRME- 249 (290)
T ss_pred cccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCC-
Confidence 998765332211 1122234678999998876 568899999999999999998 999998877666554432211000
Q ss_pred CCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 221 ETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....++.++.+||.+||+.||++||++.|+++
T Consensus 250 ----------------------------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 250 ----------------------------RPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred ----------------------------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 01135678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=278.51 Aligned_cols=229 Identities=21% Similarity=0.362 Sum_probs=179.1
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chh
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLT 85 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~ 85 (472)
+.+.||+|.+..... +.....+.+|++++++++|+||+++++++.+ ....||||||+.+ +|.
T Consensus 34 ~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~~~~~~L~ 96 (275)
T cd05046 34 GETLVLVKALQKTKD-ENLQSEFRRELDMFRKLSHKNVVRLLGLCRE----------------AEPHYMILEYTDLGDLK 96 (275)
T ss_pred CcceEEEEccCCccc-hHHHHHHHHHHHHHHhcCCcceeeeEEEECC----------------CCcceEEEEecCCCcHH
Confidence 456799998864322 2245678899999999999999999999876 4567999999985 666
Q ss_pred hhhcCCC--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 86 GLADRPG--------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 86 ~~~~~~~--------~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
+++.... ..+++..+..++.||+.+|+|||+++|+||||||+|||++.++.++|+|||++............
T Consensus 97 ~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~ 176 (275)
T cd05046 97 QFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLR 176 (275)
T ss_pred HHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccccccCcccccccC
Confidence 6665432 15899999999999999999999999999999999999999999999999998654322222233
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (472)
...++..|++||.+.+ ..++.++|||||||++|+|++ |..||........+..+..... .|..
T Consensus 177 ~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~-----~~~~---------- 240 (275)
T cd05046 177 NALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL-----ELPV---------- 240 (275)
T ss_pred CceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCc-----CCCC----------
Confidence 3455778999998876 457889999999999999998 7889987766665554432110 0100
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
...++..+.+||.+||..||++|||+.|+++.
T Consensus 241 -------------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 241 -------------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred -------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 11356789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=280.22 Aligned_cols=228 Identities=22% Similarity=0.359 Sum_probs=177.8
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Ch
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL 84 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l 84 (472)
.++..||||+++..... .....+.+|+.++++++|+||+++++++.. ...+|+||||+.+ +|
T Consensus 33 ~~~~~~aiK~~~~~~~~-~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~~~~~~L 95 (288)
T cd05050 33 EPFTMVAVKMLKEEASA-DMQADFQREAALMAEFDHPNIVKLLGVCAV----------------GKPMCLLFEYMAYGDL 95 (288)
T ss_pred CcceeEEEEecCCCcCH-HHHHHHHHHHHHHHhcCCCchheEEEEEcC----------------CCccEEEEecCCCCCH
Confidence 47889999998754322 234567789999999999999999999876 4467999999985 67
Q ss_pred hhhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeecc
Q 012062 85 TGLADRP---------------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFG 143 (472)
Q Consensus 85 ~~~~~~~---------------------~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG 143 (472)
.+++... ...+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg 175 (288)
T cd05050 96 NEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFG 175 (288)
T ss_pred HHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecCCCceEECccc
Confidence 6665421 1247788899999999999999999999999999999999999999999999
Q ss_pred ceeeeccCCC-CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCC
Q 012062 144 LARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDE 221 (472)
Q Consensus 144 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~ 221 (472)
++........ ........+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~---- 250 (288)
T cd05050 176 LSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNV---- 250 (288)
T ss_pred cceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC----
Confidence 9875432211 11122234667999999876 568899999999999999997 8889988777666555432110
Q ss_pred CCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 222 TIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
++ ....++.++.+||.+||+.||++|||+.||++
T Consensus 251 --~~-----------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 251 --LS-----------------------CPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred --CC-----------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 00 00134568999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=275.69 Aligned_cols=233 Identities=20% Similarity=0.254 Sum_probs=172.8
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Ch
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL 84 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l 84 (472)
.++..||+|.++...... ....+.+|+.++++++|+||+++++++.+ ...+||||||+.+ +|
T Consensus 20 ~~~~~~~~k~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~~~~g~L 82 (269)
T cd05087 20 YTPAQVVVKELRVSASVQ-EQMKFLEEAQPYRSLQHSNLLQCLGQCTE----------------VTPYLLVMEFCPLGDL 82 (269)
T ss_pred CCceEEEEEecCCCCChH-HHHHHHHHHHHHHhCCCCCEeeEEEEEcC----------------CCCcEEEEECCCCCcH
Confidence 456789999987654322 33467889999999999999999999876 4467999999985 66
Q ss_pred hhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC-Cccccc
Q 012062 85 TGLADRP----GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-NTLTNR 159 (472)
Q Consensus 85 ~~~~~~~----~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~~~ 159 (472)
.+++... ...+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+|||+++....... ......
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~ 162 (269)
T cd05087 83 KGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQL 162 (269)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCc
Confidence 6665431 22456778889999999999999999999999999999999999999999999865432211 112233
Q ss_pred cccCCCCChhhhcCC------CCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 012062 160 VITLWYRPPELLLGA------TKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 232 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~------~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (472)
.++..|+|||++.+. ..++.++|||||||++|+|++ |+.||...+..+............... +
T Consensus 163 ~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~------- 233 (269)
T cd05087 163 WVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPK--P------- 233 (269)
T ss_pred CCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCC--C-------
Confidence 567889999988642 135789999999999999996 999998877665544332211000000 0
Q ss_pred cccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 233 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
.....+++.+.+|+++|+ .||++|||++||+.
T Consensus 234 ---------------~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 234 ---------------RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred ---------------ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 000124567889999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=282.80 Aligned_cols=229 Identities=26% Similarity=0.417 Sum_probs=178.2
Q ss_pred ccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC-CC
Q 012062 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD-HD 83 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~-g~ 83 (472)
...+..|+||+++.... ......+++|++++++++|+||+++++++.. .+.++|||||+. ++
T Consensus 25 ~~~~~~V~vk~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~----------------~~~~~lv~e~~~~g~ 87 (259)
T PF07714_consen 25 NDKNQPVAVKILKPSSS-EEEEEEFLNEIQILRKLRHPNIVKLYGFCIE----------------NEPLFLVMEYCPGGS 87 (259)
T ss_dssp TSSEEEEEEEEESTTSS-HHHHHHHHHHHHHHHTHSBTTBE-EEEEEES----------------SSSEEEEEE--TTEB
T ss_pred CCCCEEEEEEEeccccc-cccceeeeecccccccccccccccccccccc----------------ccccccccccccccc
Confidence 35678899999965322 2235678899999999999999999999985 445899999998 47
Q ss_pred hhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC-Cccccccc
Q 012062 84 LTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-NTLTNRVI 161 (472)
Q Consensus 84 l~~~~~~~-~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~g 161 (472)
|.+++... ...++..++..|+.||+.||+|||+++|+|+||+++||||+.++.+||+|||++........ ........
T Consensus 88 L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~ 167 (259)
T PF07714_consen 88 LDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQL 167 (259)
T ss_dssp HHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSES
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 77777665 55799999999999999999999999999999999999999999999999999977632211 11222345
Q ss_pred cCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 012062 162 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240 (472)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (472)
...|+|||++.. ..++.++||||||+++|||++ |+.||...+..+...++.+.....
T Consensus 168 ~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~--------------------- 225 (259)
T PF07714_consen 168 PLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLP--------------------- 225 (259)
T ss_dssp GGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETT---------------------
T ss_pred cccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccce---------------------
Confidence 778999999876 458999999999999999999 789999888887777774332111
Q ss_pred hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....++..+.+||.+||..||++|||+.+|++
T Consensus 226 --------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 226 --------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp --------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred --------eccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11246778999999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=279.18 Aligned_cols=247 Identities=26% Similarity=0.361 Sum_probs=175.7
Q ss_pred eccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC-C
Q 012062 4 EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD-H 82 (472)
Q Consensus 4 ~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~-g 82 (472)
+..+++.||||+++.... .....+.+|++++++++|+||+++++++...+ ...+||||||+. +
T Consensus 29 ~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--------------~~~~~lv~e~~~~~ 92 (284)
T cd05081 29 QDNTGEVVAVKKLQHSTA--EHLRDFEREIEILKSLQHDNIVKYKGVCYSAG--------------RRNLRLVMEYLPYG 92 (284)
T ss_pred cCCCCcEEEEEEeccCCH--HHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC--------------CCceEEEEEecCCC
Confidence 456889999999875432 23456789999999999999999999876422 346899999997 4
Q ss_pred ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcc--cccc
Q 012062 83 DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTL--TNRV 160 (472)
Q Consensus 83 ~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~--~~~~ 160 (472)
+|.+++.+....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++........... ....
T Consensus 93 ~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 172 (284)
T cd05081 93 SLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGE 172 (284)
T ss_pred CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCC
Confidence 77777765555689999999999999999999999999999999999999999999999999986543222111 1112
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (472)
.+..|+|||++.+ ..++.++|||||||++|||+++..++..... .....+..... ... ....... . ..
T Consensus 173 ~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~~~~~~-~~~-~~~~~~~---~--~~--- 240 (284)
T cd05081 173 SPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRMMGNDKQ-GQM-IVYHLIE---L--LK--- 240 (284)
T ss_pred CceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhhcccccc-ccc-chHHHHH---H--Hh---
Confidence 3456999999876 5688999999999999999998766543321 11110000000 000 0000000 0 00
Q ss_pred hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
..........++.++.+||.+||..||++|||+.||++
T Consensus 241 --~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 241 --NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred --cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 00000011346778999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=280.13 Aligned_cols=234 Identities=21% Similarity=0.332 Sum_probs=175.8
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chh
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLT 85 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~ 85 (472)
+...||||+++.... ......+.+|+.+++.++|+||+++++++.. .+.+|+||||+.+ +|.
T Consensus 45 ~~~~~a~K~~~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~----------------~~~~~lv~e~~~~~~L~ 107 (296)
T cd05095 45 QPVLVAVKMLREDAN-KNARNDFLKEIKIMSRLKDPNIIRLLAVCIT----------------SDPLCMITEYMENGDLN 107 (296)
T ss_pred ceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec----------------CCccEEEEEeCCCCcHH
Confidence 455799999875432 2234567899999999999999999999976 4568999999985 776
Q ss_pred hhhcCCC----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCc
Q 012062 86 GLADRPG----------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT 155 (472)
Q Consensus 86 ~~~~~~~----------~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 155 (472)
+++.... ..+++..+..++.||+.||+|||+++|+|+||||+|||++.++.+||+|||+++.+.......
T Consensus 108 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 187 (296)
T cd05095 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYR 187 (296)
T ss_pred HHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCCCCEEeccCcccccccCCccee
Confidence 6654321 236778899999999999999999999999999999999999999999999987653322111
Q ss_pred -cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh--CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 012062 156 -LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN--GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 232 (472)
Q Consensus 156 -~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~--G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (472)
......+..|++||++.+ ..++.++|||||||++|||++ +..||...+..+.+....+......... ..
T Consensus 188 ~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~-- 259 (296)
T cd05095 188 IQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQV-----YL-- 259 (296)
T ss_pred ccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccc-----cC--
Confidence 112233678999998876 568999999999999999998 7788887766655544322110000000 00
Q ss_pred cccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 233 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
.....++..+.+||.+||..||++|||+.||++
T Consensus 260 ---------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 260 ---------------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ---------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 001124567999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=286.09 Aligned_cols=226 Identities=24% Similarity=0.375 Sum_probs=176.6
Q ss_pred CEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chhh
Q 012062 9 EIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTG 86 (472)
Q Consensus 9 ~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~~ 86 (472)
..||+|+++..... .....+.+|+++++++ +|+||+++++++.. .+.+|+||||+.+ +|.+
T Consensus 45 ~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~----------------~~~~~lv~e~~~~g~L~~ 107 (334)
T cd05100 45 VTVAVKMLKDDATD-KDLSDLVSEMEMMKMIGKHKNIINLLGACTQ----------------DGPLYVLVEYASKGNLRE 107 (334)
T ss_pred eeEEEEEcccccCH-HHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc----------------CCceEEEEecCCCCcHHH
Confidence 47899988754322 2345678999999999 79999999999976 4578999999985 6766
Q ss_pred hhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccC
Q 012062 87 LADRP---------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 151 (472)
Q Consensus 87 ~~~~~---------------~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 151 (472)
++.+. ...++..++..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.....
T Consensus 108 ~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 187 (334)
T cd05100 108 YLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNI 187 (334)
T ss_pred HHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCcccceecccc
Confidence 65432 224778889999999999999999999999999999999999999999999999765432
Q ss_pred CCCc-cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 012062 152 HNNT-LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 229 (472)
Q Consensus 152 ~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (472)
.... .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+.......
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 256 (334)
T cd05100 188 DYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMD---------- 256 (334)
T ss_pred cccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC----------
Confidence 2111 111223567999999976 568899999999999999998 889998887766655543211000
Q ss_pred CCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 230 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
....++.++.+||.+||..+|++|||+.|++++
T Consensus 257 -------------------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 257 -------------------KPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred -------------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 011345679999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=292.45 Aligned_cols=231 Identities=23% Similarity=0.325 Sum_probs=178.9
Q ss_pred ccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC-CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-
Q 012062 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH- 82 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g- 82 (472)
..+++.||||+++..... .....+++|+++|.++. |+|||++++++.. .+.+|||||||.+
T Consensus 64 ~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~----------------~~~~~iv~E~~~~g 126 (401)
T cd05107 64 SQSTMKVAVKMLKSTARS-SEKQALMSELKIMSHLGPHLNIVNLLGACTK----------------GGPIYIITEYCRYG 126 (401)
T ss_pred CCCceEEEEEecCCCCCh-hHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc----------------CCCcEEEEeccCCC
Confidence 456678999999865322 23446789999999997 9999999999976 4578999999985
Q ss_pred ChhhhhcCCC----------------------------------------------------------------------
Q 012062 83 DLTGLADRPG---------------------------------------------------------------------- 92 (472)
Q Consensus 83 ~l~~~~~~~~---------------------------------------------------------------------- 92 (472)
+|.+++.+..
T Consensus 127 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (401)
T cd05107 127 DLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIES 206 (401)
T ss_pred cHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhc
Confidence 6666553311
Q ss_pred ---------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccce
Q 012062 93 ---------------------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLA 145 (472)
Q Consensus 93 ---------------------------~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a 145 (472)
..+++..++.|+.||+.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla 286 (401)
T cd05107 207 SNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLA 286 (401)
T ss_pred cCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcc
Confidence 13677788999999999999999999999999999999999999999999999
Q ss_pred eeeccCCC-CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 012062 146 RSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETI 223 (472)
Q Consensus 146 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 223 (472)
+....... .......++..|+|||++.+ ..++.++|||||||++|||++ |..||......+.+...+.....+.
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~--- 362 (401)
T cd05107 287 RDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMA--- 362 (401)
T ss_pred eecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCC---
Confidence 76532221 12223356788999999876 568899999999999999998 8899987665554444332110000
Q ss_pred CccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 224 WPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
....++.++.+||.+||..||.+||++.||++.
T Consensus 363 -------------------------~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 363 -------------------------KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred -------------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 012356789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=275.43 Aligned_cols=235 Identities=28% Similarity=0.429 Sum_probs=182.4
Q ss_pred ceeccCCCEEEEEEeecCC---cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 2 AREIKTGEIVALKKIRMDN---EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~---~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
|++..++..+++|+++... ........+.+|+.++++++|+||+++++++.. ...+|+|||
T Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e 82 (260)
T cd08222 19 VKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE----------------RDAFCIITE 82 (260)
T ss_pred EEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc----------------CCceEEEEE
Confidence 4566666777777765432 222234456789999999999999999999876 456899999
Q ss_pred cCCC-Chhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC
Q 012062 79 YMDH-DLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 154 (472)
Q Consensus 79 y~~g-~l~~~~~---~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 154 (472)
|+.+ +|..++. .....+++.+++.++.||+.||.|||+++|+|+||||+||+++. +.+||+|||++....... .
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~-~ 160 (260)
T cd08222 83 YCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC-D 160 (260)
T ss_pred eCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc-c
Confidence 9986 5555443 23446899999999999999999999999999999999999975 569999999987654322 1
Q ss_pred ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 155 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+.... ..
T Consensus 161 ~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~--~~-------------- 223 (260)
T cd08222 161 LATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGP--TP-------------- 223 (260)
T ss_pred cccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCC--CC--------------
Confidence 2223456888999998865 567889999999999999999999998776655555543211 00
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
.....++.++.+||.+||..||++||++.|+++|+||
T Consensus 224 -------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 224 -------------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred -------------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 0012356789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=287.59 Aligned_cols=232 Identities=22% Similarity=0.380 Sum_probs=174.9
Q ss_pred ccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-
Q 012062 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH- 82 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g- 82 (472)
..+++.||||+++.+... .....+.+|+.+|+++ +|+|||++++++... ...+|||||||++
T Consensus 34 ~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~---------------~~~~~lv~ey~~~g 97 (343)
T cd05103 34 TATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTKP---------------GGPLMVIVEFCKFG 97 (343)
T ss_pred cccceeEEEEEeccCCCh-HHHHHHHHHHHHHHhccCCccHhhhcceeecC---------------CCceEEEEeccCCC
Confidence 467889999999754322 2345678999999999 689999999988652 3467999999985
Q ss_pred ChhhhhcCCC------------------------------------------------------------------CCCC
Q 012062 83 DLTGLADRPG------------------------------------------------------------------LRFT 96 (472)
Q Consensus 83 ~l~~~~~~~~------------------------------------------------------------------~~l~ 96 (472)
+|.+++.... ..++
T Consensus 98 ~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (343)
T cd05103 98 NLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLT 177 (343)
T ss_pred cHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCC
Confidence 6655543211 1367
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC-ccccccccCCCCChhhhcCCC
Q 012062 97 VPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGAT 175 (472)
Q Consensus 97 ~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~ 175 (472)
+..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++..+...... ......++..|+|||++.+ .
T Consensus 178 ~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~ 256 (343)
T cd05103 178 LEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-R 256 (343)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcC-C
Confidence 7888999999999999999999999999999999999999999999998765322111 1112234677999999876 5
Q ss_pred CCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhcc
Q 012062 176 KYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFD 254 (472)
Q Consensus 176 ~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (472)
.++.++|||||||++|+|++ |..||........+........... . ...++
T Consensus 257 ~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---------~-------------------~~~~~ 308 (343)
T cd05103 257 VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR---------A-------------------PDYTT 308 (343)
T ss_pred CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCC---------C-------------------CCCCC
Confidence 68899999999999999997 9999987654333332221110000 0 01245
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 255 RHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 255 ~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
.++.+++.+||..||++|||+.||++|
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=300.34 Aligned_cols=243 Identities=26% Similarity=0.414 Sum_probs=198.8
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
++++.+++.+||||...+.+.+ +.+..|.+||+.+ .|||++.++++|.-.+. ...+.+|||||||
T Consensus 38 ~k~~~~~~~aa~kI~~~~~d~d---eEiE~eynil~~~~~hpnv~~fyg~~~k~~~-----------~~~DqLWLVMEfC 103 (953)
T KOG0587|consen 38 GRHVKTGQLAAIKIMDPTEDEE---EEIELEYNMLKKYSHHPNVATFYGAFIKKDP-----------GNGDQLWLVMEFC 103 (953)
T ss_pred EeeeecCceeeeEeecCCcccc---HHHHHHHHHHHhccCCCCcceEEEEEEEecC-----------CCCCeEEEEeecc
Confidence 6789999999999998765443 3566789999988 59999999999886443 1266899999999
Q ss_pred CC-ChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 81 DH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 81 ~g-~l~~~~~~-~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
.+ +..++++. .+.++.+..|..|++.+|.||.+||.+.++|||||-.||||+.++.|||+|||++....... ....+
T Consensus 104 ~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~-grRnT 182 (953)
T KOG0587|consen 104 GGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTV-GRRNT 182 (953)
T ss_pred CCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeeccc-ccccC
Confidence 96 55555554 35679999999999999999999999999999999999999999999999999998876433 34455
Q ss_pred ccccCCCCChhhhcCCC----CCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 159 RVITLWYRPPELLLGAT----KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~----~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
.+||+.||||||+.+.. .|+..+|+||||++..||.-|.+|+.+......+.+| ...|+..
T Consensus 183 ~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I---pRNPPPk------------ 247 (953)
T KOG0587|consen 183 FIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---PRNPPPK------------ 247 (953)
T ss_pred cCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC---CCCCCcc------------
Confidence 78999999999997643 3677899999999999999999999887775544433 2222211
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
...+++++.++.+||..||.+|-++||+..++|+|||++.
T Consensus 248 ------------Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 248 ------------LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred ------------ccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 1223467889999999999999999999999999999963
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=272.38 Aligned_cols=225 Identities=21% Similarity=0.373 Sum_probs=178.0
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Ch
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL 84 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l 84 (472)
..+..||||+++... .....+.+|++++++++|+||+++++++.. ...|+||||+.+ +|
T Consensus 28 ~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----------------~~~~~v~e~~~~~~L 87 (260)
T cd05073 28 NKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-----------------EPIYIITEFMAKGSL 87 (260)
T ss_pred cCCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-----------------CCeEEEEEeCCCCcH
Confidence 355679999887432 124567889999999999999999998863 357999999984 78
Q ss_pred hhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccC
Q 012062 85 TGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL 163 (472)
Q Consensus 85 ~~~~~~-~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~ 163 (472)
.+++.+ ....+++..+..++.||+.||.|||+++++|+||||+||+++.++.+||+|||++..+............++.
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 167 (260)
T cd05073 88 LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI 167 (260)
T ss_pred HHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCcccc
Confidence 777755 3445788899999999999999999999999999999999999999999999999766432222222233467
Q ss_pred CCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhh
Q 012062 164 WYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTM 242 (472)
Q Consensus 164 ~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (472)
.|+|||++.. ..++.++|||||||++|+|++ |+.||...+..+....+......+
T Consensus 168 ~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~----------------------- 223 (260)
T cd05073 168 KWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP----------------------- 223 (260)
T ss_pred cccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCC-----------------------
Confidence 7999999876 568889999999999999998 999999887766665553211000
Q ss_pred hhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 243 KRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 243 ~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....++.++.+||.+||..||++||++.++++
T Consensus 224 ------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 224 ------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred ------CcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 01235678999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=271.56 Aligned_cols=221 Identities=24% Similarity=0.394 Sum_probs=176.5
Q ss_pred ccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-C
Q 012062 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-D 83 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~ 83 (472)
..+++.||||+++.+. ....+.+|+.++++++|+||+++++++.. +.+|+||||+.+ +
T Consensus 26 ~~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----------------~~~~~v~e~~~~~~ 84 (254)
T cd05083 26 EYTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILH-----------------NGLYIVMELMSKGN 84 (254)
T ss_pred ccCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-----------------CCcEEEEECCCCCC
Confidence 4578899999987542 23467899999999999999999999864 236999999985 7
Q ss_pred hhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccccc
Q 012062 84 LTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVIT 162 (472)
Q Consensus 84 l~~~~~~~-~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt 162 (472)
|.+++... ...+++..++.++.||+.||.|||+++++||||||+|||++.++.+||+|||++...... ......+
T Consensus 85 L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----~~~~~~~ 160 (254)
T cd05083 85 LVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----VDNSKLP 160 (254)
T ss_pred HHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc----CCCCCCC
Confidence 77776543 335889999999999999999999999999999999999999999999999998754321 1122335
Q ss_pred CCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchh
Q 012062 163 LWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241 (472)
Q Consensus 163 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (472)
..|+|||.+.+ ..++.++|||||||++|+|++ |+.||...+..+....+.... .+.
T Consensus 161 ~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~--------------------- 217 (254)
T cd05083 161 VKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY-RME--------------------- 217 (254)
T ss_pred ceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC-CCC---------------------
Confidence 67999998875 568899999999999999997 999998877665554442210 000
Q ss_pred hhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....++..+.+||++||..+|++|||+.++++
T Consensus 218 -------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 218 -------PPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred -------CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00135678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=304.76 Aligned_cols=227 Identities=25% Similarity=0.388 Sum_probs=189.6
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC-CCh
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD-HDL 84 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~-g~l 84 (472)
.+...||||.++.+.+. ....++.+|+++|..|+|+|||+|++++.. ++-+|||+|||. |||
T Consensus 514 ~~~~lVAVK~LKd~a~~-~~~~dF~REaeLla~l~H~nIVrLlGVC~~----------------~~P~~MvFEYm~~GDL 576 (774)
T KOG1026|consen 514 QDEQLVAVKALKDKAEN-QARQDFRREAELLAELQHPNIVRLLGVCRE----------------GDPLCMVFEYMDHGDL 576 (774)
T ss_pred ccceehhHhhhcccccH-HHHHHHHHHHHHHHhccCCCeEEEEEEEcc----------------CCeeEEEEEecccccH
Confidence 35568999999865443 256789999999999999999999999987 556899999999 688
Q ss_pred hhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccC
Q 012062 85 TGLADRP-------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 151 (472)
Q Consensus 85 ~~~~~~~-------------~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 151 (472)
..+++.. ...++..+.+.|+.||+.|+.||-++.+|||||-..|+||.++..|||+|||+++.....
T Consensus 577 ~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYss 656 (774)
T KOG1026|consen 577 HEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSS 656 (774)
T ss_pred HHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEecccccchhhhhh
Confidence 8776531 123888999999999999999999999999999999999999999999999999876433
Q ss_pred CCCc-cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 012062 152 HNNT-LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 229 (472)
Q Consensus 152 ~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (472)
+... .....-...||+||.++- .+|+.++||||+||||||+++ |+.||.+..+.++++.|.+..
T Consensus 657 DYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~------------- 722 (774)
T KOG1026|consen 657 DYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQ------------- 722 (774)
T ss_pred hhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCC-------------
Confidence 3222 223344778999999986 679999999999999999997 999999999999998885421
Q ss_pred CCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHh
Q 012062 230 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 279 (472)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL 279 (472)
+....+.++.++.+|+..|++.+|++|||++||-
T Consensus 723 ----------------lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 723 ----------------LLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred ----------------cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 1122235778999999999999999999999984
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=274.02 Aligned_cols=231 Identities=21% Similarity=0.299 Sum_probs=179.5
Q ss_pred ceeccCCC----EEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEE
Q 012062 2 AREIKTGE----IVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVF 77 (472)
Q Consensus 2 a~~~~tg~----~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVm 77 (472)
|.++.+++ .||+|+++.... ......+.+|+.++++++|+||+++++++.. ..+++||
T Consensus 26 ~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----------------~~~~~v~ 87 (279)
T cd05057 26 GVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-----------------SQVQLIT 87 (279)
T ss_pred EEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----------------CceEEEE
Confidence 34444554 589998875533 2234567889999999999999999999864 3579999
Q ss_pred ecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCc-
Q 012062 78 EYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT- 155 (472)
Q Consensus 78 Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~- 155 (472)
||+. ++|.+++......+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.........
T Consensus 88 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 167 (279)
T cd05057 88 QLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYH 167 (279)
T ss_pred ecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCccccee
Confidence 9998 47777777655569999999999999999999999999999999999999999999999999997654322111
Q ss_pred cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 156 LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
......+..|+|||.+.. ..++.++|||||||++|+|++ |+.||.+.+..+....+......+.
T Consensus 168 ~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------- 232 (279)
T cd05057 168 AEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQ-------------- 232 (279)
T ss_pred cCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCC--------------
Confidence 111223567999998865 567899999999999999998 9999988876665554432110000
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....+..+.++|.+||..||++|||+.++++
T Consensus 233 ---------------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 233 ---------------PPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred ---------------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0124457899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=272.73 Aligned_cols=233 Identities=24% Similarity=0.418 Sum_probs=182.9
Q ss_pred ceecc-CCCEEEEEEeecCCc--------CCCchhhHHHHHHHHHh-cCCCCccceeEEeeCCCCCCCCCCCCCCCCcCC
Q 012062 2 AREIK-TGEIVALKKIRMDNE--------KEGFPITAIREIKILKK-LQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG 71 (472)
Q Consensus 2 a~~~~-tg~~vAlK~i~~~~~--------~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 71 (472)
|++.. +++.||||.++.... .......+.+|+.++++ ++|+||+++++++.. ++
T Consensus 19 ~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~----------------~~ 82 (269)
T cd08528 19 VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE----------------ND 82 (269)
T ss_pred EEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc----------------CC
Confidence 44555 678999999874421 12234456789988875 799999999999976 56
Q ss_pred eEEEEEecCCC-Chhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCCeEEeecccee
Q 012062 72 STYMVFEYMDH-DLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGNLKLADFGLAR 146 (472)
Q Consensus 72 ~~~iVmEy~~g-~l~~~~~---~~~~~l~~~~i~~i~~Qll~aL~~LH~-~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 146 (472)
.+|+||||+.+ +|.+++. .....+++..++.++.||+.+|.|||+ .+|+|+||||+|||++.++.+||+|||++.
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~ 162 (269)
T cd08528 83 RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK 162 (269)
T ss_pred eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEeccccee
Confidence 88999999986 5655542 334568999999999999999999996 689999999999999999999999999997
Q ss_pred eeccCCCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 012062 147 SFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPG 226 (472)
Q Consensus 147 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 226 (472)
...... ......++..|++||++.+ ..++.++|||||||++|+|++|+.||...+.......+.+....+..
T Consensus 163 ~~~~~~--~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 234 (269)
T cd08528 163 QKQPES--KLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP----- 234 (269)
T ss_pred eccccc--ccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCC-----
Confidence 654332 3344567889999999986 56889999999999999999999999877766655555432211100
Q ss_pred CCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 227 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
...++.++.+||++||..||++|||+.|+..+
T Consensus 235 -----------------------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 235 -----------------------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred -----------------------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 01245689999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=271.99 Aligned_cols=216 Identities=23% Similarity=0.307 Sum_probs=167.2
Q ss_pred CEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chhhh
Q 012062 9 EIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGL 87 (472)
Q Consensus 9 ~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~~~ 87 (472)
..|++|+++..... ...+.+|+.++++++|+||+++++++.. ...||||||+.+ +|..+
T Consensus 31 ~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----------------~~~~lv~e~~~~~~L~~~ 90 (259)
T cd05037 31 VSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR-----------------DENIMVEEYVKFGPLDVF 90 (259)
T ss_pred eeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-----------------CCcEEEEEcCCCCcHHHH
Confidence 45888877644322 4677899999999999999999998864 235899999996 56556
Q ss_pred hcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC-------CeEEeeccceeeeccCCCCcccccc
Q 012062 88 ADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG-------NLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 88 ~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~-------~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+......+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||++..... .....
T Consensus 91 l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~ 165 (259)
T cd05037 91 LHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS-----REERV 165 (259)
T ss_pred HHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccccc-----ccccc
Confidence 555444689999999999999999999999999999999999999887 799999999876532 12234
Q ss_pred ccCCCCChhhhcCC-CCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 161 ITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 161 gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
++..|+|||++.+. ..++.++|||||||++|+|++ |..||...+..+..... .... .+ ..
T Consensus 166 ~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~-~~~~-----~~----~~-------- 227 (259)
T cd05037 166 ERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY-QDQH-----RL----PM-------- 227 (259)
T ss_pred cCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHH-hcCC-----CC----CC--------
Confidence 57789999998764 367899999999999999999 57778766533322222 1000 00 00
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
.....+.+||.+||..||.+|||+.|+++
T Consensus 228 -------------~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 228 -------------PDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred -------------CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 01147899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=278.76 Aligned_cols=231 Identities=20% Similarity=0.271 Sum_probs=177.0
Q ss_pred ceeccCCC----EEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEE
Q 012062 2 AREIKTGE----IVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVF 77 (472)
Q Consensus 2 a~~~~tg~----~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVm 77 (472)
|+++.+++ .||+|++..... ......+.+|+.+++.++|+||+++++++.. ...++|+
T Consensus 26 ~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-----------------~~~~~v~ 87 (303)
T cd05110 26 GIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLS-----------------PTIQLVT 87 (303)
T ss_pred EEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-----------------CCceeee
Confidence 45566666 468888764432 2233457889999999999999999999864 1357999
Q ss_pred ecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC-c
Q 012062 78 EYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN-T 155 (472)
Q Consensus 78 Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~ 155 (472)
||+. ++|.+.+......+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.+...... .
T Consensus 88 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 167 (303)
T cd05110 88 QLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN 167 (303)
T ss_pred hhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcccccc
Confidence 9998 5777777665556899999999999999999999999999999999999999999999999999865432221 1
Q ss_pred cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 156 LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
.....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+ ........
T Consensus 168 ~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~------------- 232 (303)
T cd05110 168 ADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL-EKGERLPQ------------- 232 (303)
T ss_pred cCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HCCCCCCC-------------
Confidence 122334678999999876 568899999999999999997 88999876654433332 21110000
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...++..+.+||.+||..||++||++.++++
T Consensus 233 ---------------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~ 263 (303)
T cd05110 233 ---------------PPICTIDVYMVMVKCWMIDADSRPKFKELAA 263 (303)
T ss_pred ---------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0123457899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=272.79 Aligned_cols=236 Identities=19% Similarity=0.269 Sum_probs=179.2
Q ss_pred ccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-C
Q 012062 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-D 83 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~ 83 (472)
..+++.||||+++.+.........+.+|++++++++|+||+++++++....... .....++++||+.+ +
T Consensus 24 ~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~ 93 (273)
T cd05074 24 DGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG----------RLPIPMVILPFMKHGD 93 (273)
T ss_pred CCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC----------cccceEEEEecCCCCc
Confidence 346889999999866544444566789999999999999999999987532110 11245789999984 5
Q ss_pred hhhhhcC-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC-Cccc
Q 012062 84 LTGLADR-----PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-NTLT 157 (472)
Q Consensus 84 l~~~~~~-----~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~ 157 (472)
|..++.. ....+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 94 l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 173 (273)
T cd05074 94 LHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGC 173 (273)
T ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccccccccCCcceecCC
Confidence 5544321 122478899999999999999999999999999999999999999999999999876532221 1112
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (472)
....+..|++||.+.. ..++.++|||||||++|+|++ |+.||...+..+....+.......
T Consensus 174 ~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~----------------- 235 (273)
T cd05074 174 ASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK----------------- 235 (273)
T ss_pred CccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCC-----------------
Confidence 2234578999998876 567889999999999999999 889998877666555443211000
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....++..+.+|+.+||..+|++|||+.|++.
T Consensus 236 ------------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 236 ------------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred ------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00135568999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=272.12 Aligned_cols=230 Identities=17% Similarity=0.280 Sum_probs=171.2
Q ss_pred CEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chhhh
Q 012062 9 EIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGL 87 (472)
Q Consensus 9 ~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~~~ 87 (472)
..+++|.++.... ......+.+|+.+++.++|+||+++++.+.. ...+||||||+.+ +|.++
T Consensus 23 ~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~~~~~~L~~~ 85 (268)
T cd05086 23 ARVVVKELKANAS-SKEQNEFLQQGDPYRILQHPNILQCLGQCVE----------------AIPYLLVFEYCELGDLKSY 85 (268)
T ss_pred ceEEEEEecCCCC-hHHHHHHHHHHHHHhccCCcchhheEEEecC----------------CCccEEEEecCCCCcHHHH
Confidence 3566676654432 2235678899999999999999999999876 4568999999995 77666
Q ss_pred hcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccC-CCCccccccccC
Q 012062 88 ADRP---GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD-HNNTLTNRVITL 163 (472)
Q Consensus 88 ~~~~---~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~~~~~gt~ 163 (472)
+.+. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++...... ........+++.
T Consensus 86 l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 165 (268)
T cd05086 86 LSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPL 165 (268)
T ss_pred HHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcc
Confidence 6542 224667788899999999999999999999999999999999999999999987542211 111223346788
Q ss_pred CCCChhhhcCC------CCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccC
Q 012062 164 WYRPPELLLGA------TKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236 (472)
Q Consensus 164 ~y~aPE~l~~~------~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (472)
.|+|||++... ..++.++|||||||++|+|++ +..||...++.+.+..+....... .+.
T Consensus 166 ~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~---~~~----------- 231 (268)
T cd05086 166 RWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK---LFK----------- 231 (268)
T ss_pred cccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc---cCC-----------
Confidence 99999987531 235678999999999999997 577888877777666654321110 000
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
+ .....+++.+.+||.+|+ .||++|||+++|++
T Consensus 232 -~---------~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 232 -P---------QLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred -C---------ccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 0 001125667899999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=265.06 Aligned_cols=235 Identities=41% Similarity=0.671 Sum_probs=188.5
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||+|++........ ...+.+|++++++++|+||+++++++.. ....++||||+.
T Consensus 8 ~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~----------------~~~~~l~~e~~~ 70 (244)
T smart00220 8 ARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFED----------------EDKLYLVMEYCD 70 (244)
T ss_pred EEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheee----------------CCEEEEEEeCCC
Confidence 56677899999999986543321 5678899999999999999999999876 457899999999
Q ss_pred C-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 82 H-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 82 g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+ +|..++.... .++...+..++.+|+.+|.+||+.+|+|+||+|+||+++.++.++|+|||++....... ......
T Consensus 71 ~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~ 147 (244)
T smart00220 71 GGDLFDLLKKRG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFV 147 (244)
T ss_pred CCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--cccccc
Confidence 7 7777665543 38999999999999999999999999999999999999999999999999998765432 233456
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK-NEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
++..|++||.+.. ..++.++||||||+++++|++|..||... +....+..+.........
T Consensus 148 ~~~~~~~pE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~------------------ 208 (244)
T smart00220 148 GTPEYMAPEVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPP------------------ 208 (244)
T ss_pred CCcCCCCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc------------------
Confidence 7889999999875 56788999999999999999999999874 333333333221111000
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
....++.++.++|.+||..||++||++.++++|+||
T Consensus 209 ---------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 209 ---------PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred ---------ccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 000156689999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=274.09 Aligned_cols=228 Identities=21% Similarity=0.289 Sum_probs=176.7
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC-CChh
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD-HDLT 85 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~-g~l~ 85 (472)
+++.||+|+++... .......+.+|+.++++++|+||+++++++... ....++++||+. ++|.
T Consensus 34 ~~~~v~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---------------~~~~~~~~~~~~~~~L~ 97 (280)
T cd05043 34 KEEEVFVKTVKDHA-SEIQVTLLLQESCLLYGLSHQNILPILHVCIED---------------GEPPFVLYPYMNWGNLK 97 (280)
T ss_pred ceeEEEEEEccCCC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC---------------CCCCEEEEEcCCCCcHH
Confidence 36889999887432 222345678899999999999999999987642 235789999998 4666
Q ss_pred hhhcCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC-ccc
Q 012062 86 GLADRPG-------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN-TLT 157 (472)
Q Consensus 86 ~~~~~~~-------~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~ 157 (472)
.++.... ..+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.+...... ...
T Consensus 98 ~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 177 (280)
T cd05043 98 LFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177 (280)
T ss_pred HHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCC
Confidence 6654321 35889999999999999999999999999999999999999999999999999765332211 112
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (472)
...++..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+.... ... .
T Consensus 178 ~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~-----~---------- 240 (280)
T cd05043 178 NENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY-RLA-----Q---------- 240 (280)
T ss_pred CCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-CCC-----C----------
Confidence 2234678999999876 568899999999999999998 999998877665544433211 000 0
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...++++++++|.+||..||++|||+.|+++
T Consensus 241 -------------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 241 -------------PINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred -------------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0124567999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=273.36 Aligned_cols=235 Identities=25% Similarity=0.407 Sum_probs=178.2
Q ss_pred ccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-C
Q 012062 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-D 83 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~ 83 (472)
..+++.||||+++..... .....+.+|+++++.++|+||+++++++...+ ...+|+||||+.+ +
T Consensus 30 ~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~--------------~~~~~lv~e~~~~~~ 94 (284)
T cd05038 30 DNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPG--------------GRSLRLIMEYLPSGS 94 (284)
T ss_pred CCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCC--------------CCceEEEEecCCCCC
Confidence 346889999999865433 24567889999999999999999999887532 4468999999975 7
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCc--cccccc
Q 012062 84 LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT--LTNRVI 161 (472)
Q Consensus 84 l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~--~~~~~g 161 (472)
|.+++......+++..+..++.||+.||+|||+++|+|+||||+|||++.++.+||+|||++.......... ......
T Consensus 95 l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 174 (284)
T cd05038 95 LRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES 174 (284)
T ss_pred HHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCC
Confidence 777776655568999999999999999999999999999999999999999999999999997765222111 112234
Q ss_pred cCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHH-----------HHHHHHhcCCCCCCCCccCCCC
Q 012062 162 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ-----------LSKIFELCGSPDETIWPGVSKM 230 (472)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~-----------~~~i~~~~~~~~~~~~~~~~~~ 230 (472)
+..|++||.+.. ..++.++|||||||++|+|++|..||........ ...+.+.+.....
T Consensus 175 ~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 244 (284)
T cd05038 175 PIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGER--------- 244 (284)
T ss_pred cccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCc---------
Confidence 567999998876 5688999999999999999999988765332110 1111111100000
Q ss_pred CccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 231 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
......++.++.+|+.+||..||++|||+.||++
T Consensus 245 ----------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 245 ----------------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred ----------------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0001134568999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=278.04 Aligned_cols=245 Identities=24% Similarity=0.393 Sum_probs=190.2
Q ss_pred ceeccCCCEEEEEEeecCCcC-----CCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEE
Q 012062 2 AREIKTGEIVALKKIRMDNEK-----EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMV 76 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~-----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iV 76 (472)
|.|+...++||||+-.....+ +.+.+.+.+|..|++.|.|+.||++||+|... ...+|-|
T Consensus 482 AFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD---------------tdsFCTV 546 (775)
T KOG1151|consen 482 AFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD---------------TDSFCTV 546 (775)
T ss_pred hcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec---------------cccceee
Confidence 567888999999998665433 34566778999999999999999999999862 4568999
Q ss_pred EecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCCCcEEEcC---CCCeEEeeccceeeeccC
Q 012062 77 FEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN--QVLHRDIKGSNLLIDN---EGNLKLADFGLARSFSYD 151 (472)
Q Consensus 77 mEy~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~--giiHrDLKp~NILl~~---~~~vkL~DFG~a~~~~~~ 151 (472)
+|||+|+.+++..+....+++.+++.|+.||+.||.||.+. -|||-||||.||||.+ -|.+||.|||+++.+..+
T Consensus 547 LEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMddd 626 (775)
T KOG1151|consen 547 LEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDD 626 (775)
T ss_pred eeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCC
Confidence 99999966666666666799999999999999999999987 5999999999999854 467999999999988765
Q ss_pred CCC------ccccccccCCCCChhhhcCC---CCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC
Q 012062 152 HNN------TLTNRVITLWYRPPELLLGA---TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDET 222 (472)
Q Consensus 152 ~~~------~~~~~~gt~~y~aPE~l~~~---~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~ 222 (472)
... ......||.||++||++.-. ...+.++||||+|||+|.+|.|+.||..+-....+...-.++... +.
T Consensus 627 Sy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAt-EV 705 (775)
T KOG1151|consen 627 SYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKAT-EV 705 (775)
T ss_pred ccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcce-ec
Confidence 433 12234679999999997532 346889999999999999999999997653322211111010000 00
Q ss_pred CCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 223 IWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
.++ .-+-++.++++||++||...-++|+...+|..|+||.
T Consensus 706 qFP-----------------------~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 706 QFP-----------------------PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL 745 (775)
T ss_pred cCC-----------------------CCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence 000 0023678999999999999999999999999999994
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=268.48 Aligned_cols=237 Identities=23% Similarity=0.390 Sum_probs=189.7
Q ss_pred CceeccCCCEEEEEEeecCCcCCC-chhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEG-FPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~-~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
||+.++|.+.+|+|++++...+++ ...-+..|-.+...- +||.+|-++.+|+. +..+++|.|
T Consensus 268 ~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt----------------esrlffvie 331 (593)
T KOG0695|consen 268 LVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT----------------ESRLFFVIE 331 (593)
T ss_pred heehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc----------------cceEEEEEE
Confidence 578899999999999998743332 233456688888766 69999999999987 668999999
Q ss_pred cCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 79 YMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 79 y~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
|+.| +|.....+. .+++++.++.|...|+.||.|||++|||.||||.+|||||.+|++||.|+|+++.-..+ .....
T Consensus 332 yv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~-gd~ts 409 (593)
T KOG0695|consen 332 YVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP-GDTTS 409 (593)
T ss_pred EecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCC-Ccccc
Confidence 9996 666666554 47999999999999999999999999999999999999999999999999998764433 34455
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCC-------CChHHHHHHHHHhcCCCCCCCCccCCCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPG-------KNEAEQLSKIFELCGSPDETIWPGVSKM 230 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~-------~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 230 (472)
++|||+.|+|||++++ ..|+.++|.|+|||+++||+.|+.||.- .+..+-+.+++-
T Consensus 410 tfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil---------------- 472 (593)
T KOG0695|consen 410 TFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL---------------- 472 (593)
T ss_pred cccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh----------------
Confidence 6899999999999998 6799999999999999999999999962 222222222211
Q ss_pred CccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCC------CHHHHhcCCCCC
Q 012062 231 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI------SAKDALDSEYFW 285 (472)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~------t~~elL~h~~f~ 285 (472)
...-.+.+.++-.+..+|+..|++||.+|. ...++..|+||.
T Consensus 473 -------------ekqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr 520 (593)
T KOG0695|consen 473 -------------EKQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFR 520 (593)
T ss_pred -------------hhcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhh
Confidence 011112234555678899999999999997 468999999995
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=280.85 Aligned_cols=240 Identities=25% Similarity=0.335 Sum_probs=173.8
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCC-eEEEEEecCC-CC
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG-STYMVFEYMD-HD 83 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~iVmEy~~-g~ 83 (472)
.+++.||||.++...... ...+.+|+.+|.+++|+|||+|+++|.+ .+ +.+||+|||. |+
T Consensus 97 ~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e----------------~~~~~~LVYEym~nGs 158 (361)
T KOG1187|consen 97 SDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLE----------------GGEHRLLVYEYMPNGS 158 (361)
T ss_pred CCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEec----------------CCceEEEEEEccCCCC
Confidence 455899999877654332 3458999999999999999999999987 33 5899999998 67
Q ss_pred hhhhhcCCCC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 84 LTGLADRPGL-RFTVPQIKCYMKQLLTGLHYCHVNQ---VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 84 l~~~~~~~~~-~l~~~~i~~i~~Qll~aL~~LH~~g---iiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
|.+.+..... .+++....+|+.+++.||+|||... |||||||++|||||++.+.||+|||+|+..... .......
T Consensus 159 L~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~-~~~~~~~ 237 (361)
T KOG1187|consen 159 LEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG-DTSVSTT 237 (361)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc-ccceeee
Confidence 8777766554 7899999999999999999999864 999999999999999999999999999654321 1112222
Q ss_pred -cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCCCCCCccCCCCCcccc
Q 012062 160 -VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN---EAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235 (472)
Q Consensus 160 -~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (472)
.||..|++||.+.. ...+.++||||+|++|+||++|+.+..... +.....-........ .+..+.
T Consensus 238 ~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~---~~~eii------- 306 (361)
T KOG1187|consen 238 VMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG---KLREIV------- 306 (361)
T ss_pred cCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc---chhhee-------
Confidence 78999999998865 568999999999999999999998777542 111111111111000 000000
Q ss_pred CCCchh-hhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 236 FKPSRT-MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 236 ~~~~~~-~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
++... ...... ..-..+..+..+|+..++.+||++.|+++
T Consensus 307 -D~~l~~~~~~~~----~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 307 -DPRLKEGEYPDE----KEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred -CCCccCCCCChH----HHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 00000 000000 11123778899999999999999999754
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=292.10 Aligned_cols=260 Identities=22% Similarity=0.281 Sum_probs=165.2
Q ss_pred ceeccC----CCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEE
Q 012062 2 AREIKT----GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVF 77 (472)
Q Consensus 2 a~~~~t----g~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVm 77 (472)
|++..+ ++.||||+++..... +....| .++...+.+++.++..|..... ......++|||
T Consensus 151 a~~~~~~~~~~~~vAvK~~~~~~~~----e~~~~e--~l~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~LV~ 214 (566)
T PLN03225 151 ASLVNKQSKKEGKYVLKKATEYGAV----EIWMNE--RVRRACPNSCADFVYGFLEPVS----------SKKEDEYWLVW 214 (566)
T ss_pred EEEcCCccccCcEEEEEEecccchh----HHHHHH--HHHhhchhhHHHHHHhhhcccc----------cccCCceEEEE
Confidence 566777 899999988643211 111111 2223333444444433322110 11255789999
Q ss_pred ecCCC-ChhhhhcCCCCC-------------------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC-CCC
Q 012062 78 EYMDH-DLTGLADRPGLR-------------------FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN-EGN 136 (472)
Q Consensus 78 Ey~~g-~l~~~~~~~~~~-------------------l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~-~~~ 136 (472)
||+.+ +|.+++...... .....+..|+.||+.||+|||+++|+||||||+||||+. ++.
T Consensus 215 ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~~ 294 (566)
T PLN03225 215 RYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGS 294 (566)
T ss_pred EecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCCCCc
Confidence 99986 565555432211 123456789999999999999999999999999999986 578
Q ss_pred eEEeeccceeeeccCCCCccccccccCCCCChhhhcCCC---------------------CCCCCcchhhHHHHHHHHHh
Q 012062 137 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT---------------------KYGPAVDMWSVGCIFAELLN 195 (472)
Q Consensus 137 vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---------------------~~~~~~DiwSlG~il~ell~ 195 (472)
+||+|||+|+.+...........++|+.|+|||.+.... .++.++||||||||||||++
T Consensus 295 ~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~ 374 (566)
T PLN03225 295 FKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAF 374 (566)
T ss_pred EEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHh
Confidence 999999999866443333445567899999999764321 23456799999999999998
Q ss_pred CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCH
Q 012062 196 GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA 275 (472)
Q Consensus 196 G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~ 275 (472)
+.. ...+....+.+++..+.... ..|...... ... .............+..+++||.+||++||++|+|+
T Consensus 375 ~~~--~~~~~~~~~~~~l~~~~~~~-~~~~~~~~~------~~~-~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta 444 (566)
T PLN03225 375 PNL--RSDSNLIQFNRQLKRNDYDL-VAWRKLVEP------RAS-PDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISA 444 (566)
T ss_pred CcC--CCchHHHHHHHHHHhcCCcH-HHHHHhhcc------ccc-hhhhhhhhhccccchHHHHHHHHHccCCcccCCCH
Confidence 654 44445555555544332211 111111000 000 00011112223345567899999999999999999
Q ss_pred HHHhcCCCCCCC
Q 012062 276 KDALDSEYFWTD 287 (472)
Q Consensus 276 ~elL~h~~f~~~ 287 (472)
.|+|+||||...
T Consensus 445 ~e~L~Hpff~~~ 456 (566)
T PLN03225 445 KAALAHPYFDRE 456 (566)
T ss_pred HHHhCCcCcCCC
Confidence 999999999653
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=301.55 Aligned_cols=225 Identities=22% Similarity=0.389 Sum_probs=188.6
Q ss_pred CEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC-CChhhh
Q 012062 9 EIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD-HDLTGL 87 (472)
Q Consensus 9 ~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~-g~l~~~ 87 (472)
..||||.+++..+ +.....+++|..+|++++|||||++++++.+ .+..+|++|||+ |||+.+
T Consensus 723 ~~vaiK~l~~~~~-~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~----------------~~~~~i~leyM~gGDL~sf 785 (1025)
T KOG1095|consen 723 IQVAVKSLKRLSS-EQEVSDFLKEALLMSKFDHPNIVSLIGVCLD----------------SGPPLILLEYMEGGDLLSF 785 (1025)
T ss_pred eEEEEEeccccCC-HHHHHHHHHHHHHHhcCCCcceeeEEEeecC----------------CCCcEEEehhcccCcHHHH
Confidence 3589999886543 3356788999999999999999999999987 446799999999 589998
Q ss_pred hcCC------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc-c
Q 012062 88 ADRP------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR-V 160 (472)
Q Consensus 88 ~~~~------~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~-~ 160 (472)
+.+. ...++..+.+.|+.+|+.|+.||+++.+|||||-..|+||+....|||+|||+|+.+........... .
T Consensus 786 lr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~ 865 (1025)
T KOG1095|consen 786 LRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAM 865 (1025)
T ss_pred HHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccc
Confidence 8876 55689999999999999999999999999999999999999999999999999995543332222222 2
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
-...|||||.+.. ..++.++|||||||+|||+++ |..||.+.+..+++..+.+......
T Consensus 866 lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~------------------- 925 (1025)
T KOG1095|consen 866 LPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDP------------------- 925 (1025)
T ss_pred cceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCC-------------------
Confidence 2467999999986 689999999999999999998 9999999999998886655431111
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
+..+++.+.+|+..|++.||++||++..|++
T Consensus 926 ----------P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 926 ----------PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred ----------CCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 1246778999999999999999999999986
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=290.18 Aligned_cols=189 Identities=30% Similarity=0.425 Sum_probs=156.7
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
+++++||+.||||.++...... -.+...+|++|||+|+|+|||+++++-+.... ......-.||||||.
T Consensus 32 grnketG~~vAvK~~~~~~~~r-~~e~~~~EieilkKLnh~NIVk~f~iee~~~~----------~~~~~~~vlvmEyC~ 100 (732)
T KOG4250|consen 32 GRNKETGRLVAVKTFNKESSLR-PRERWCREIEILKKLNHPNIVKLFDIEETKFL----------GLVTRLPVLVMEYCS 100 (732)
T ss_pred ecccccccchhHHhhhhhcccc-hHHHHHHHHHHHHHcCchhhhhhcccCCcccc----------CcccccceEEEeecC
Confidence 5789999999999998765333 34566799999999999999999988654221 111335689999998
Q ss_pred C-ChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc--CCCC--eEEeeccceeeeccCCCC
Q 012062 82 H-DLTGLADRP--GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID--NEGN--LKLADFGLARSFSYDHNN 154 (472)
Q Consensus 82 g-~l~~~~~~~--~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~--~~~~--vkL~DFG~a~~~~~~~~~ 154 (472)
+ +|...+.++ ...+++.+++.++..|..||.|||++||+||||||+||++. .+|+ .||+|||.|+......
T Consensus 101 gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s-- 178 (732)
T KOG4250|consen 101 GGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS-- 178 (732)
T ss_pred CCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC--
Confidence 5 777777764 34599999999999999999999999999999999999974 3343 7999999999876443
Q ss_pred ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCC
Q 012062 155 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK 203 (472)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~ 203 (472)
..+..+||..|.+||++.....|+..+|.||+||++|+++||..||.-.
T Consensus 179 ~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 179 LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 6778899999999999875578999999999999999999999998643
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=281.71 Aligned_cols=224 Identities=21% Similarity=0.313 Sum_probs=184.7
Q ss_pred EEEEEeecC-CcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chhhhh
Q 012062 11 VALKKIRMD-NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLA 88 (472)
Q Consensus 11 vAlK~i~~~-~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~~~~ 88 (472)
||||..+.+ ...++....+++|.++|++|+|+|||+||++... +.-+|||||+|.| +|.+++
T Consensus 189 VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~----------------~~Pl~ivmEl~~gGsL~~~L 252 (474)
T KOG0194|consen 189 VAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL----------------EEPLMLVMELCNGGSLDDYL 252 (474)
T ss_pred eEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC----------------CCccEEEEEecCCCcHHHHH
Confidence 899999863 2445567788999999999999999999999887 4568999999996 788888
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccCCCCCh
Q 012062 89 DRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPP 168 (472)
Q Consensus 89 ~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aP 168 (472)
.+....++..+...++.+.+.||+|||++++|||||-..|+|++.++.+||+|||+++.-.. .........-...|+||
T Consensus 253 ~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~-~~~~~~~~klPirWLAP 331 (474)
T KOG0194|consen 253 KKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ-YVMKKFLKKLPIRWLAP 331 (474)
T ss_pred HhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcc-eeeccccccCcceecCh
Confidence 88766799999999999999999999999999999999999999999899999999865431 11111111236789999
Q ss_pred hhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHH
Q 012062 169 ELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVR 247 (472)
Q Consensus 169 E~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (472)
|.+.. ..|+.++||||+||++||+++ |..||.+.+..+...+|..........
T Consensus 332 Etl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~------------------------- 385 (474)
T KOG0194|consen 332 ETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP------------------------- 385 (474)
T ss_pred hhhcc-CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC-------------------------
Confidence 99986 589999999999999999998 889999999999999885432221110
Q ss_pred HHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 248 EVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 248 ~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...+.++..++.+|+..||++|+|+.++.+
T Consensus 386 ---~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 386 ---SKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred ---CCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 124567889999999999999999998864
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=264.44 Aligned_cols=241 Identities=17% Similarity=0.162 Sum_probs=169.3
Q ss_pred ceeccC---CCEEEEEEeecCCcCCCch---------hhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCc
Q 012062 2 AREIKT---GEIVALKKIRMDNEKEGFP---------ITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 69 (472)
Q Consensus 2 a~~~~t---g~~vAlK~i~~~~~~~~~~---------~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 69 (472)
|++..+ +..+|+|+........... .....++..++.+.|+||+++++....... .
T Consensus 31 ~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~------------~ 98 (294)
T PHA02882 31 TQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKRC------------R 98 (294)
T ss_pred EEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEecC------------C
Confidence 445555 6677888755433211000 112234445566789999999987654210 0
Q ss_pred CCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeec
Q 012062 70 RGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 149 (472)
Q Consensus 70 ~~~~~iVmEy~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 149 (472)
.-..+++||++..++..++... ..+++..++.|+.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+.+.
T Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~ 177 (294)
T PHA02882 99 MYYRFILLEKLVENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFI 177 (294)
T ss_pred ceEEEEEEehhccCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEcCCceeec
Confidence 1245789998877766655443 236788899999999999999999999999999999999999999999999998764
Q ss_pred cCCC------CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH--hcCCCCC
Q 012062 150 YDHN------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE--LCGSPDE 221 (472)
Q Consensus 150 ~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~--~~~~~~~ 221 (472)
.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..... ......
T Consensus 178 ~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~- 255 (294)
T PHA02882 178 IHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLH- 255 (294)
T ss_pred cCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhh-
Confidence 3211 11223468999999999886 5689999999999999999999999987743222211111 000000
Q ss_pred CCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 222 TIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
.........+..+.++++.|+..||++||+..++++
T Consensus 256 -----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 256 -----------------------EGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred -----------------------hhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 000112235678999999999999999999999875
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=292.74 Aligned_cols=230 Identities=29% Similarity=0.439 Sum_probs=174.4
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCChh
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLT 85 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~l~ 85 (472)
.++.||||.+-.+ +...+.+||..|+.- .|+|||++|..-.+ +..+||++|+|..+|.
T Consensus 532 e~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d----------------~qF~YIalELC~~sL~ 590 (903)
T KOG1027|consen 532 EGREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQD----------------RQFLYIALELCACSLQ 590 (903)
T ss_pred CCceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeeccC----------------CceEEEEehHhhhhHH
Confidence 4667888876532 345678999999988 59999999976554 6689999999999999
Q ss_pred hhhcCC--CCCCCH-HHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC---CC--CeEEeeccceeeeccCCC--Cc
Q 012062 86 GLADRP--GLRFTV-PQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN---EG--NLKLADFGLARSFSYDHN--NT 155 (472)
Q Consensus 86 ~~~~~~--~~~l~~-~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~---~~--~vkL~DFG~a~~~~~~~~--~~ 155 (472)
+++... +..+.. -..+.++.|++.||++||+.+||||||||.||||+. ++ .++|+|||+++.+..... ..
T Consensus 591 dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r 670 (903)
T KOG1027|consen 591 DLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSR 670 (903)
T ss_pred HHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhc
Confidence 988874 111111 345788999999999999999999999999999976 33 589999999998765433 22
Q ss_pred cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 156 LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNG-KPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
.....||..|+|||++... .-+.++||||||||+|+.++| ..||.+.-+.+ ..|....... .
T Consensus 671 ~s~~sGt~GW~APE~L~~~-~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L--------------~ 733 (903)
T KOG1027|consen 671 LSGGSGTSGWQAPEQLRED-RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTL--------------V 733 (903)
T ss_pred ccCCCCcccccCHHHHhcc-ccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccce--------------e
Confidence 4455689999999999874 446799999999999999986 89997654432 2222111000 0
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
... ...+.+++|||.+||..||..||||.++|.||+||..
T Consensus 734 ~L~-------------~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 734 HLE-------------PLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred eec-------------cCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 000 0111279999999999999999999999999999974
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=275.53 Aligned_cols=234 Identities=23% Similarity=0.301 Sum_probs=189.0
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC-CChh
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD-HDLT 85 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~-g~l~ 85 (472)
....||+|+++-+..+. ....+.+||++|.+|+|||||+++++|.. ++-+|||||||+ |+|.
T Consensus 561 g~lkVAVK~Lr~~a~~~-~r~~F~kEIkiLsqLkhPNIveLvGVC~~----------------DePicmI~EYmEnGDLn 623 (807)
T KOG1094|consen 561 GPLKVAVKILRPDATKN-ARNDFLKEIKILSRLKHPNIVELLGVCVQ----------------DDPLCMITEYMENGDLN 623 (807)
T ss_pred CceEEEEeecCcccchh-HHHHHHHHHHHHhccCCCCeeEEEeeeec----------------CCchHHHHHHHhcCcHH
Confidence 35799999999775544 35788999999999999999999999987 567899999999 7888
Q ss_pred hhhcCCCCC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeecc-CCCCccccccccC
Q 012062 86 GLADRPGLR-FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY-DHNNTLTNRVITL 163 (472)
Q Consensus 86 ~~~~~~~~~-l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~-~~~~~~~~~~gt~ 163 (472)
.++.+.... +......+|+.||+.|++||.+.++|||||.+.|+|++.+.++||+|||+++.+.. +........+-..
T Consensus 624 qFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpi 703 (807)
T KOG1094|consen 624 QFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPI 703 (807)
T ss_pred HHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceeeecceeeee
Confidence 888775433 35556677999999999999999999999999999999999999999999985432 2222333345578
Q ss_pred CCCChhhhcCCCCCCCCcchhhHHHHHHHHH--hCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchh
Q 012062 164 WYRPPELLLGATKYGPAVDMWSVGCIFAELL--NGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241 (472)
Q Consensus 164 ~y~aPE~l~~~~~~~~~~DiwSlG~il~ell--~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (472)
.|||+|.++. .+++.++|+|++|+++||++ +...||...++++..+...+..........
T Consensus 704 RwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~----------------- 765 (807)
T KOG1094|consen 704 RWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVV----------------- 765 (807)
T ss_pred eehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCccee-----------------
Confidence 9999999986 67999999999999999986 477999999888887777665443332211
Q ss_pred hhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...+.-++..+.+||.+|+..|-++|||.+++..
T Consensus 766 -----l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 766 -----LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred -----ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 1112346778999999999999999999999854
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-32 Score=240.45 Aligned_cols=195 Identities=23% Similarity=0.361 Sum_probs=161.0
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
.|+..+|+..|+|.|+...... ...+.++|+.+..+. .||.+|+||+..-. ++.++|.||.|
T Consensus 65 mrh~~sg~imAvKri~~tvn~q-~q~r~L~dldi~~r~~~CPf~V~FyGa~~r----------------egdvwIcME~M 127 (282)
T KOG0984|consen 65 MRHIQSGTIMAVKRIRATVNSQ-EQKRLLMDLDIIMRTVDCPFTVHFYGALFR----------------EGDVWICMELM 127 (282)
T ss_pred eeeccCCeEEEEeeehhhcChH-HHHHHHHhhhhhccCCCCCeEEEeehhhhc----------------cccEEEeHHHh
Confidence 4788999999999998764433 456778899877655 69999999997655 66799999999
Q ss_pred CCChhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcc
Q 012062 81 DHDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTL 156 (472)
Q Consensus 81 ~g~l~~~~~---~~~~~l~~~~i~~i~~Qll~aL~~LH~~-giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 156 (472)
+.+|..+.. +.+..++|..+-+|+..++.||.|||++ .|||||+||+||||+.+|+|||||||++-.+.+....
T Consensus 128 ~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk-- 205 (282)
T KOG0984|consen 128 DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK-- 205 (282)
T ss_pred hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHH--
Confidence 987765443 4667899999999999999999999987 8999999999999999999999999998765433222
Q ss_pred ccccccCCCCChhhhcC---CCCCCCCcchhhHHHHHHHHHhCCCCCCC-CChHHHHHHHHHh
Q 012062 157 TNRVITLWYRPPELLLG---ATKYGPAVDMWSVGCIFAELLNGKPILPG-KNEAEQLSKIFEL 215 (472)
Q Consensus 157 ~~~~gt~~y~aPE~l~~---~~~~~~~~DiwSlG~il~ell~G~~pf~~-~~~~~~~~~i~~~ 215 (472)
+-..|.-.|||||.+.. ...|+.++||||||+++.||.+++.||+. .++.+++.++++.
T Consensus 206 t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 206 TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 22346778999998853 23589999999999999999999999874 6788888888764
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=273.65 Aligned_cols=255 Identities=24% Similarity=0.354 Sum_probs=168.3
Q ss_pred cCCCEEEEEEeecCCcC------------CCchhhHHHHHHHHHhcCCCCc-----cceeEEeeCCCCCCCCCCCCCCCC
Q 012062 6 KTGEIVALKKIRMDNEK------------EGFPITAIREIKILKKLQHENV-----IKLKEIVTSPGPERDEQGRPDGNK 68 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~------------~~~~~~~~~Ei~il~~l~hpnI-----v~l~~~~~~~~~~~~~~~~~~~~~ 68 (472)
..++.||||.++.+... ....+..+.|+.++.+++|.++ ++++++|..... +...
T Consensus 184 ~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~--------~g~~ 255 (507)
T PLN03224 184 QKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTA--------DGAF 255 (507)
T ss_pred ccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHhhcccchhhhhhhhhhhcccccc--------cccc
Confidence 45678999999754321 0112234567888888876654 677777765221 1222
Q ss_pred cCCeEEEEEecCCC-ChhhhhcCC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 012062 69 YRGSTYMVFEYMDH-DLTGLADRP-----------------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 124 (472)
Q Consensus 69 ~~~~~~iVmEy~~g-~l~~~~~~~-----------------------~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDL 124 (472)
.++..||||||+.+ +|.+++... ...+++..++.|+.||+.+|.|||+++|+||||
T Consensus 256 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDL 335 (507)
T PLN03224 256 TKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDI 335 (507)
T ss_pred cCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 35678999999985 555554321 112456788999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccCCCCChhhhcCCCC-------------------CC--CCcch
Q 012062 125 KGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK-------------------YG--PAVDM 183 (472)
Q Consensus 125 Kp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-------------------~~--~~~Di 183 (472)
||+|||++.++.+||+|||++..+.............|+.|+|||++..... ++ .+.||
T Consensus 336 Kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~Dv 415 (507)
T PLN03224 336 KPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDS 415 (507)
T ss_pred chHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccch
Confidence 9999999999999999999997654322211122234789999998864211 11 24799
Q ss_pred hhHHHHHHHHHhCCC-CCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHH
Q 012062 184 WSVGCIFAELLNGKP-ILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLE 262 (472)
Q Consensus 184 wSlG~il~ell~G~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 262 (472)
||+|||||+|+++.. +|..........+.+. .+...|...... ... ...+..+++.++|||.
T Consensus 416 wSlGvil~em~~~~l~p~~~~~~f~~~~~~~~----~~~~~~r~~~~~------------~~~-~~~~d~~s~~~~dLi~ 478 (507)
T PLN03224 416 YTAGVLLMQMCVPELRPVANIRLFNTELRQYD----NDLNRWRMYKGQ------------KYD-FSLLDRNKEAGWDLAC 478 (507)
T ss_pred hhHHHHHHHHHhCCCCCccchhhhhhHHhhcc----chHHHHHhhccc------------CCC-cccccccChHHHHHHH
Confidence 999999999999874 6654322111110000 000011111000 000 0123457889999999
Q ss_pred HhhccCC---CCCCCHHHHhcCCCCC
Q 012062 263 KMLMLDP---SQRISAKDALDSEYFW 285 (472)
Q Consensus 263 ~~L~~dP---~~R~t~~elL~h~~f~ 285 (472)
+||..++ .+|+|++|+|+|+||.
T Consensus 479 ~LL~~~~~~~~~RlSa~eaL~Hp~f~ 504 (507)
T PLN03224 479 KLITKRDQANRGRLSVGQALSHRFFL 504 (507)
T ss_pred HHhccCCCCcccCCCHHHHhCCCCcC
Confidence 9999876 6899999999999994
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=261.02 Aligned_cols=256 Identities=30% Similarity=0.492 Sum_probs=187.4
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC-CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCChh
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLT 85 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~l~ 85 (472)
+.++||||.|...... ..+..|+++|..+. +.||+++.+.+.. +++++|||||++++-.
T Consensus 63 ~~~~valk~i~~ts~p----~ri~~El~~L~~~gG~~ni~~~~~~~rn----------------nd~v~ivlp~~~H~~f 122 (418)
T KOG1167|consen 63 KRRYVALKAIYRTSSP----SRILNELEMLYRLGGSDNIIKLNGCFRN----------------NDQVAIVLPYFEHDRF 122 (418)
T ss_pred ccceEeeeecccccCc----hHHHHHHHHHHHhccchhhhcchhhhcc----------------CCeeEEEecccCccCH
Confidence 6789999999876543 46889999999995 9999999999876 6789999999998655
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC-CCCeEEeeccceeeeccC-------------
Q 012062 86 GLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN-EGNLKLADFGLARSFSYD------------- 151 (472)
Q Consensus 86 ~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~-~~~vkL~DFG~a~~~~~~------------- 151 (472)
..+.+ .++..+++.|++.++.||.++|.+|||||||||.|||.+. .+.-.|+|||+|......
T Consensus 123 ~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~ 199 (418)
T KOG1167|consen 123 RDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRH 199 (418)
T ss_pred HHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhccc
Confidence 54444 3678899999999999999999999999999999999985 456899999999621100
Q ss_pred ------------------------------CCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCC-
Q 012062 152 ------------------------------HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPIL- 200 (472)
Q Consensus 152 ------------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf- 200 (472)
......++.||+.|+|||++.....-+.++||||.|+|++.+++++.||
T Consensus 200 ~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 200 ATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFF 279 (418)
T ss_pred CCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccc
Confidence 0001224578999999999998777789999999999999999998765
Q ss_pred CCCChHHHHHHHHHhcCCC--------CCC--CCccC--CCCCc----cccCC-----CchhhhhhHHHHhhhccHHHHH
Q 012062 201 PGKNEAEQLSKIFELCGSP--------DET--IWPGV--SKMPA----YNHFK-----PSRTMKRRVREVFRHFDRHALE 259 (472)
Q Consensus 201 ~~~~~~~~~~~i~~~~~~~--------~~~--~~~~~--~~~~~----~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 259 (472)
...++.+.+..|..+.+.. ... .|... ..+++ +.... ..+..........+.++..+.|
T Consensus 280 ~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~d 359 (418)
T KOG1167|consen 280 KAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLD 359 (418)
T ss_pred cCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHH
Confidence 4555556555554433321 111 33310 01111 11110 0000001112222445668999
Q ss_pred HHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 260 LLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 260 ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
||.+||..||.+|+|++|+|+|+||.
T Consensus 360 lLdk~le~np~kRitAEeALkHpFF~ 385 (418)
T KOG1167|consen 360 LLDKCLELNPQKRITAEDALKHPFFD 385 (418)
T ss_pred HHHHHccCChhhcccHHHHhcCcCCc
Confidence 99999999999999999999999995
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=266.52 Aligned_cols=223 Identities=22% Similarity=0.348 Sum_probs=186.1
Q ss_pred EEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC-CChhhhh
Q 012062 10 IVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD-HDLTGLA 88 (472)
Q Consensus 10 ~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~-g~l~~~~ 88 (472)
.||||..+.+...+ ..+.++.|..+|++++|||||++++++.+ .-+|||||++. |.|..++
T Consensus 420 aVAvKtCK~d~t~d-~tekflqEa~iMrnfdHphIikLIGv~~e-----------------~P~WivmEL~~~GELr~yL 481 (974)
T KOG4257|consen 420 AVAVKTCKTDCTPD-DTEKFLQEASIMRNFDHPHIIKLIGVCVE-----------------QPMWIVMELAPLGELREYL 481 (974)
T ss_pred eeeeehhccCCChh-hHHHHHHHHHHHHhCCCcchhheeeeeec-----------------cceeEEEecccchhHHHHH
Confidence 48889877654443 47789999999999999999999999985 35899999999 6788888
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccCCCCCh
Q 012062 89 DRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPP 168 (472)
Q Consensus 89 ~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aP 168 (472)
..+...++......|+.||+.||+|||+.++|||||-..|||+.....|||+|||+++-+.++.....+.-.-..-||||
T Consensus 482 q~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaP 561 (974)
T KOG4257|consen 482 QQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAP 561 (974)
T ss_pred HhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhhccccccceeecCc
Confidence 88888899999999999999999999999999999999999999999999999999988765543333322235679999
Q ss_pred hhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHH
Q 012062 169 ELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVR 247 (472)
Q Consensus 169 E~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (472)
|.+.- +.++.++|||-|||.+||+|. |..||.+-...+++-.+.+....|-
T Consensus 562 ESINf-RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~--------------------------- 613 (974)
T KOG4257|consen 562 ESINF-RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPC--------------------------- 613 (974)
T ss_pred cccch-hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCC---------------------------
Confidence 98864 678999999999999999986 9999999888777666644322221
Q ss_pred HHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 248 EVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 248 ~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
++++++.+..|+.+|+..||.+||++.||..
T Consensus 614 --P~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 614 --PPNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred --CCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 2356778999999999999999999998864
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=272.24 Aligned_cols=225 Identities=23% Similarity=0.336 Sum_probs=187.1
Q ss_pred CEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC-CChhhh
Q 012062 9 EIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD-HDLTGL 87 (472)
Q Consensus 9 ~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~-g~l~~~ 87 (472)
..||||+++.+.... ....+++|+.+|.+|+|+|+|+||+++.+ .-+.||||++. |+|++.
T Consensus 139 V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-----------------qp~mMV~ELaplGSLldr 200 (1039)
T KOG0199|consen 139 VNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-----------------QPAMMVFELAPLGSLLDR 200 (1039)
T ss_pred EeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-----------------chhhHHhhhcccchHHHH
Confidence 368999999776554 56789999999999999999999999874 24689999999 578877
Q ss_pred hcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC-ccc-cccccCC
Q 012062 88 ADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN-TLT-NRVITLW 164 (472)
Q Consensus 88 ~~~-~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~-~~~gt~~ 164 (472)
+.+ ....|-......|+.||+.|+.||..+++|||||-..||||.....|||+|||+.+.+...... .+. .......
T Consensus 201 Lrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfA 280 (1039)
T KOG0199|consen 201 LRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFA 280 (1039)
T ss_pred HhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCccc
Confidence 766 4456888999999999999999999999999999999999999999999999999887643322 222 2234678
Q ss_pred CCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhh
Q 012062 165 YRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMK 243 (472)
Q Consensus 165 y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (472)
|+|||.|.- ..++.++|||++||+||||++ |+.||.+.....++.+|-+...
T Consensus 281 WCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~er-------------------------- 333 (1039)
T KOG0199|consen 281 WCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGER-------------------------- 333 (1039)
T ss_pred ccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccccc--------------------------
Confidence 999999975 789999999999999999997 8899999999998888742111
Q ss_pred hhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 244 RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 244 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
....+.+++++.+++..|+..+|++|+|+..|.+.
T Consensus 334 ---LpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 334 ---LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred ---CCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 11223578899999999999999999999988643
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=275.49 Aligned_cols=227 Identities=22% Similarity=0.345 Sum_probs=196.9
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC-CChh
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD-HDLT 85 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~-g~l~ 85 (472)
....||||.++.... +....+++.|..||-+++|||||+|.++.+. ..-+.||.|||+ |.|.
T Consensus 656 re~~VAIKTLK~Gyt-ekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk----------------s~PvMIiTEyMENGsLD 718 (996)
T KOG0196|consen 656 REITVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIRLEGVVTK----------------SKPVMIITEYMENGSLD 718 (996)
T ss_pred cceeEEEeeeccCcc-HHHHhhhhhhhhhcccCCCCcEEEEEEEEec----------------CceeEEEhhhhhCCcHH
Confidence 445799999986643 2356789999999999999999999999986 456899999999 6788
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccc--cC
Q 012062 86 GLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI--TL 163 (472)
Q Consensus 86 ~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g--t~ 163 (472)
.+++..+..|+.-++.-+++.|+.|++||-++++|||||-..||||+.+..+|++|||+++.+.++.....++.-| ..
T Consensus 719 sFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPi 798 (996)
T KOG0196|consen 719 SFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPI 798 (996)
T ss_pred HHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccce
Confidence 8888888899999999999999999999999999999999999999999999999999999876655444444333 67
Q ss_pred CCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhh
Q 012062 164 WYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTM 242 (472)
Q Consensus 164 ~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (472)
.|.|||.+.- .+++.++||||+|||+||.++ |+.||.+.++.+++..|.+....|+.-
T Consensus 799 RWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPm-------------------- 857 (996)
T KOG0196|consen 799 RWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPM-------------------- 857 (996)
T ss_pred eecChhHhhh-cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCC--------------------
Confidence 8999999975 689999999999999999886 999999999999999998766555432
Q ss_pred hhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 243 KRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 243 ~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
+++..+.+|+..|+++|-.+||++.||+.
T Consensus 858 ---------DCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 858 ---------DCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred ---------CCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 46778999999999999999999999875
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=292.54 Aligned_cols=210 Identities=18% Similarity=0.183 Sum_probs=151.5
Q ss_pred HHhcCC-CCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 012062 36 LKKLQH-ENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 114 (472)
Q Consensus 36 l~~l~h-pnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~L 114 (472)
++.++| .||++++++|....... .....++++||+++++|..++......+++.+++.|++||+.||+||
T Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l 96 (793)
T PLN00181 26 SKSLSHIDYVRSLLGSHKEGNLDG---------LDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAA 96 (793)
T ss_pred cchhhHHHHHHHhhcccCCccccc---------cccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHH
Confidence 455667 68999999986533221 11346789999999999998876666799999999999999999999
Q ss_pred HHCCccccCCCCCcEEEcCCC-------------------CeEEeeccceeeeccCCC---------------Ccccccc
Q 012062 115 HVNQVLHRDIKGSNLLIDNEG-------------------NLKLADFGLARSFSYDHN---------------NTLTNRV 160 (472)
Q Consensus 115 H~~giiHrDLKp~NILl~~~~-------------------~vkL~DFG~a~~~~~~~~---------------~~~~~~~ 160 (472)
|++||+||||||+||||+..+ .+||+|||+++....... ......+
T Consensus 97 H~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (793)
T PLN00181 97 HSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAM 176 (793)
T ss_pred HhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccC
Confidence 999999999999999996544 455666666543211000 0011235
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (472)
+|+.|||||++.+ ..|+.++||||||||||||+++..+|.... ..+..+..... +..
T Consensus 177 gt~~Y~APE~~~~-~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~-~~~------------------- 233 (793)
T PLN00181 177 EMSWYTSPEEDNG-SSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL-PPQ------------------- 233 (793)
T ss_pred CCcceEChhhhcc-CCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc-Chh-------------------
Confidence 7889999999887 568999999999999999999888765322 12222211100 000
Q ss_pred hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.. .....+.+++.+||..||.+|||+.|||+|+||..
T Consensus 234 --------~~-~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 234 --------IL-LNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINE 270 (793)
T ss_pred --------hh-hcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence 00 01234678899999999999999999999999964
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=261.35 Aligned_cols=222 Identities=21% Similarity=0.306 Sum_probs=180.2
Q ss_pred CEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC-CChhhh
Q 012062 9 EIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD-HDLTGL 87 (472)
Q Consensus 9 ~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~-g~l~~~ 87 (472)
-.||||.++.+ ....+.+++|..||+.++|||+|+|+++|+. +--+|||+|||. |+|+++
T Consensus 293 lTvAVKtLKED---tMeveEFLkEAAvMKeikHpNLVqLLGVCT~----------------EpPFYIiTEfM~yGNLLdY 353 (1157)
T KOG4278|consen 293 LTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH----------------EPPFYIITEFMCYGNLLDY 353 (1157)
T ss_pred eeeehhhhhhc---chhHHHHHHHHHHHHhhcCccHHHHhhhhcc----------------CCCeEEEEecccCccHHHH
Confidence 35788888743 2346788999999999999999999999987 446899999998 799999
Q ss_pred hcCCCCC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccCCCC
Q 012062 88 ADRPGLR-FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYR 166 (472)
Q Consensus 88 ~~~~~~~-l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~ 166 (472)
+.+++.. ++.-.++.++.||..|++||..+++|||||-..|+||.++..|||+|||+++.+..+..+.........-|.
T Consensus 354 LRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWT 433 (1157)
T KOG4278|consen 354 LRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 433 (1157)
T ss_pred HHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCccCccccc
Confidence 9886644 455556677899999999999999999999999999999999999999999988765544444444477899
Q ss_pred ChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhh
Q 012062 167 PPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRR 245 (472)
Q Consensus 167 aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (472)
|||-|.- ..++.++|||+|||+|||+.| |-.||++-+-..++..+.+. ..++
T Consensus 434 APEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg-yRM~------------------------- 486 (1157)
T KOG4278|consen 434 APESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG-YRMD------------------------- 486 (1157)
T ss_pred Ccccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc-cccc-------------------------
Confidence 9998864 568999999999999999997 88999998765555444221 1111
Q ss_pred HHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHh
Q 012062 246 VREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 279 (472)
Q Consensus 246 ~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL 279 (472)
-...+++.+.+|++.|++++|++||++.|+-
T Consensus 487 ---~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 487 ---GPEGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred ---CCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 1135778899999999999999999998874
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=262.71 Aligned_cols=181 Identities=28% Similarity=0.397 Sum_probs=156.6
Q ss_pred CceeccCCCEEEEEEeecCCcC------CCchhhHHHHHHHHHhcC---CCCccceeEEeeCCCCCCCCCCCCCCCCcCC
Q 012062 1 MAREIKTGEIVALKKIRMDNEK------EGFPITAIREIKILKKLQ---HENVIKLKEIVTSPGPERDEQGRPDGNKYRG 71 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~------~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 71 (472)
||.+++....|+||+|.+.+.- +...-++-.||.||..|+ |+||++++++|++ ++
T Consensus 579 lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd----------------dd 642 (772)
T KOG1152|consen 579 LAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED----------------DD 642 (772)
T ss_pred EeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec----------------CC
Confidence 6889999999999999876421 122334557999999997 9999999999998 67
Q ss_pred eEEEEEecCCC--ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeec
Q 012062 72 STYMVFEYMDH--DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 149 (472)
Q Consensus 72 ~~~iVmEy~~g--~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 149 (472)
.+||+||--.. ||.+++... .+++|.+++.||+||+.|+++||+.||||||||-|||+++.+|.+||+|||.|...
T Consensus 643 ~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~- 720 (772)
T KOG1152|consen 643 YYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYT- 720 (772)
T ss_pred eeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhh-
Confidence 89999998874 666666543 47999999999999999999999999999999999999999999999999988543
Q ss_pred cCCCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCC
Q 012062 150 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILP 201 (472)
Q Consensus 150 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~ 201 (472)
.......++||..|.|||++.+..+.+..-|||+||++||.++....||.
T Consensus 721 --ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 721 --KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred --cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 34556678999999999999997778899999999999999999888875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=264.29 Aligned_cols=240 Identities=23% Similarity=0.345 Sum_probs=193.7
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|||+.+++..|+|+|+....+. ...+..||-+++.++|+|||.+++.+.. +..++|+||||+
T Consensus 34 aRd~~s~elaavkvVkLep~dd--~~~iqqei~~~~dc~h~nivay~gsylr----------------~dklwicMEycg 95 (829)
T KOG0576|consen 34 ARDKRSGELAAVKVVKLEPGDD--FSGIQQEIGMLRDCRHPNIVAYFGSYLR----------------RDKLWICMEYCG 95 (829)
T ss_pred hcccccCchhhheeeeccCCcc--ccccccceeeeecCCCcChHHHHhhhhh----------------hcCcEEEEEecC
Confidence 7999999999999999875443 3456789999999999999999998876 567899999999
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccc
Q 012062 82 HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 161 (472)
Q Consensus 82 g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 161 (472)
++.+..+..--..+++.++...++..+.+|+|||+.|-+|||||-.|||+++++.|||+|||.+-.+... ......++|
T Consensus 96 ggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat-i~KrksfiG 174 (829)
T KOG0576|consen 96 GGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT-IAKRKSFIG 174 (829)
T ss_pred CCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh-hhhhhcccC
Confidence 8777766666668999999999999999999999999999999999999999999999999998766532 233456789
Q ss_pred cCCCCChhhhc--CCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 162 TLWYRPPELLL--GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 162 t~~y~aPE~l~--~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
|+.|||||+.. ....|...+|||++|++..|+-.-++|.........+..+-+....++..
T Consensus 175 tpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~l----------------- 237 (829)
T KOG0576|consen 175 TPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTL----------------- 237 (829)
T ss_pred CccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcc-----------------
Confidence 99999999853 23458899999999999999988777766555544444333222221110
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
.. ...+++.+.+|++.+|.++|++|||++.+|.|+|..
T Consensus 238 -kD-------k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs 275 (829)
T KOG0576|consen 238 -KD-------KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVS 275 (829)
T ss_pred -cC-------CccchHHHHHHHHHHhcCCCccCCChhhheeceeec
Confidence 00 013566788999999999999999999999999974
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-29 Score=281.40 Aligned_cols=233 Identities=22% Similarity=0.309 Sum_probs=165.6
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||+++.... ...+|++++++++|||||++++++.. ...+||||||++
T Consensus 709 ~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~----------------~~~~~lv~Ey~~ 766 (968)
T PLN00113 709 GKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRS----------------EKGAYLIHEYIE 766 (968)
T ss_pred EEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEc----------------CCCCEEEEeCCC
Confidence 56678999999999864322 12357899999999999999999986 446799999998
Q ss_pred C-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 82 H-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH---VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 82 g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH---~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
+ +|.+++. .+++.++..|+.||+.||+||| +.+|+||||||+||+++.++..++. |+.+..... ..
T Consensus 767 ~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-----~~ 836 (968)
T PLN00113 767 GKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-----DT 836 (968)
T ss_pred CCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----CC
Confidence 5 6666664 3788899999999999999999 6699999999999999998887775 665433221 12
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCC-CCCCCCccCCCCCcccc
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE-AEQLSKIFELCGS-PDETIWPGVSKMPAYNH 235 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~-~~~~~~i~~~~~~-~~~~~~~~~~~~~~~~~ 235 (472)
...+|..|+|||++.+ ..++.++|||||||++|||++|+.||..... ...+......... .....|-+. ..
T Consensus 837 ~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~-- 909 (968)
T PLN00113 837 KCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDP----SI-- 909 (968)
T ss_pred CccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCc----cc--
Confidence 2367899999999876 5789999999999999999999999854321 1111111111100 000000000 00
Q ss_pred CCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
... .........++.+|+.+||+.||++|||+.|+++.
T Consensus 910 -~~~-------~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 910 -RGD-------VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred -cCC-------CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 000 00001122357899999999999999999999863
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=263.80 Aligned_cols=226 Identities=24% Similarity=0.395 Sum_probs=181.7
Q ss_pred CCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC-CChh
Q 012062 8 GEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD-HDLT 85 (472)
Q Consensus 8 g~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~-g~l~ 85 (472)
...||||+++..... .....+..|+++|+.+ .|+|||.+++.+.. ++.+++|+||+. |+|+
T Consensus 328 ~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~----------------~~~~~~v~Ey~~~G~L~ 390 (609)
T KOG0200|consen 328 YVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ----------------DGPLYVIVEYAEHGDLL 390 (609)
T ss_pred eEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc----------------CCceEEEEEeccCCcHH
Confidence 567999999876554 4567888999999999 59999999999986 567899999998 6888
Q ss_pred hhhcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeecc
Q 012062 86 GLADRPG---------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 150 (472)
Q Consensus 86 ~~~~~~~---------------~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~ 150 (472)
.++.... ..++..+...++.||+.|++||++..+|||||-..||||..+..+||+|||+|+....
T Consensus 391 ~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~ 470 (609)
T KOG0200|consen 391 EFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYN 470 (609)
T ss_pred HHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEccccceeccCC
Confidence 8777654 2488899999999999999999999999999999999999999999999999986544
Q ss_pred CCCCccccccc--cCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCC-hHHHHHHHHHhcCCCCCCCCcc
Q 012062 151 DHNNTLTNRVI--TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKN-EAEQLSKIFELCGSPDETIWPG 226 (472)
Q Consensus 151 ~~~~~~~~~~g--t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~ 226 (472)
..........+ ...|||||.+.. ..|+.++||||+||+||||++ |..||++-. ..+.+..+.+.. .+
T Consensus 471 ~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~-r~------- 541 (609)
T KOG0200|consen 471 KDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGN-RM------- 541 (609)
T ss_pred CCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCC-CC-------
Confidence 33322222222 344999999987 789999999999999999998 889999855 444444332211 11
Q ss_pred CCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 227 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
..+..++.++.+|++.|+..+|++||+..++.+
T Consensus 542 ---------------------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 542 ---------------------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred ---------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 111246778999999999999999999999875
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-27 Score=220.66 Aligned_cols=202 Identities=39% Similarity=0.626 Sum_probs=169.0
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
+++..+++.++||++....... ....+.+|+++++.++|++|+++++++.. ....++|||++.
T Consensus 12 ~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~----------------~~~~~~~~e~~~ 74 (215)
T cd00180 12 ARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFED----------------ENHLYLVMEYCE 74 (215)
T ss_pred EEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeec----------------CCeEEEEEecCC
Confidence 4556679999999998654322 34578899999999999999999999976 457899999999
Q ss_pred -CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC-CCCeEEeeccceeeeccCCCCccccc
Q 012062 82 -HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN-EGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 82 -g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~-~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
.+|..++......++...++.++.+++.+|++||+++++|+||+|.||+++. ++.++|+||+.+........ .....
T Consensus 75 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 75 GGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 5777776654346899999999999999999999999999999999999999 88999999999976643321 12334
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
.....|++||.+.....++.+.|+|+||+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 5688899999887633678899999999999999
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSE 282 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~ 282 (472)
..+.++|.+||..||++|+++.+++++.
T Consensus 188 ---------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1478999999999999999999999763
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-29 Score=264.62 Aligned_cols=226 Identities=28% Similarity=0.431 Sum_probs=179.1
Q ss_pred chhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHH
Q 012062 25 FPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYM 104 (472)
Q Consensus 25 ~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~l~~~~~~~~~~l~~~~i~~i~ 104 (472)
+...+..|+.+-..|+|+||+..++++... ..++-+||||.+||..++.+. ..++..++.+++
T Consensus 364 ~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~----------------~~~~~~mE~~~~Dlf~~~~~~-~~~~~~e~~c~f 426 (601)
T KOG0590|consen 364 YNYNITSEFCIGSSLSHPNIIETLDIVQEI----------------DGILQSMEYCPYDLFSLVMSN-GKLTPLEADCFF 426 (601)
T ss_pred HhhhhhhheeecccccCCchhhhHHHHhhc----------------ccchhhhhcccHHHHHHHhcc-cccchhhhhHHH
Confidence 333466788888999999998888877652 223334999999777777664 468999999999
Q ss_pred HHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC---CccccccccCCCCChhhhcCCCCCCCCc
Q 012062 105 KQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN---NTLTNRVITLWYRPPELLLGATKYGPAV 181 (472)
Q Consensus 105 ~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~ 181 (472)
+||+.||+|||..||.|||||++|++++.++.+||+|||.+..+..... ......+|+..|+|||++.+...-....
T Consensus 427 KqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~v 506 (601)
T KOG0590|consen 427 KQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAV 506 (601)
T ss_pred HHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchh
Confidence 9999999999999999999999999999999999999999998876555 4556678899999999998855445679
Q ss_pred chhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHH
Q 012062 182 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELL 261 (472)
Q Consensus 182 DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll 261 (472)
||||+|+|++.|++|+.||......+... .. ...............++..++.+.+.+|
T Consensus 507 DiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--~~-------------------~~~~~~~~~~~~~~~~~~~lp~~~~~~~ 565 (601)
T KOG0590|consen 507 DVWSCGIIYICMILGRFPWKVAKKSDNSF--KT-------------------NNYSDQRNIFEGPNRLLSLLPRETRIII 565 (601)
T ss_pred hhhhccceEEEEecCCCccccccccccch--hh-------------------hccccccccccChHHHHHhchhhHHHHH
Confidence 99999999999999999997655433221 00 0001111123344566677888999999
Q ss_pred HHhhccCCCCCCCHHHHhcCCCCCCCC
Q 012062 262 EKMLMLDPSQRISAKDALDSEYFWTDP 288 (472)
Q Consensus 262 ~~~L~~dP~~R~t~~elL~h~~f~~~~ 288 (472)
.+||+.||.+|.|+++|++++||....
T Consensus 566 ~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 566 YRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred HHHccCChhheecHHHHhhChHhhhcc
Confidence 999999999999999999999996543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=216.03 Aligned_cols=165 Identities=19% Similarity=0.227 Sum_probs=127.2
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccc
Q 012062 82 HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 161 (472)
Q Consensus 82 g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 161 (472)
|+|.+++......+++.+++.|+.||+.||+|||+++ ||+|||++.++.+|+ ||++....... ..+
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------SRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc------CCC
Confidence 4667777665557999999999999999999999998 999999999999999 99987654321 257
Q ss_pred cCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 012062 162 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAE-QLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240 (472)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (472)
|+.|||||++.+ ..++.++||||||||+|+|++|+.||....... .+..+......... ..
T Consensus 67 ~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~-------------- 128 (176)
T smart00750 67 DPYFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDP---RD-------------- 128 (176)
T ss_pred cccccChHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCc---cc--------------
Confidence 999999999987 578999999999999999999999997655432 23333222111000 00
Q ss_pred hhhhhHHHHhhhccH--HHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 241 TMKRRVREVFRHFDR--HALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~--~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
......++. ++++||++||..||++|||+.|+++|.|+
T Consensus 129 ------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 129 ------RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred ------cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 000112333 68999999999999999999999999887
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=234.38 Aligned_cols=177 Identities=22% Similarity=0.295 Sum_probs=140.6
Q ss_pred ccCCCEEEEEEeecCCcCCCchhhHHHHHHHHH--hcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC-
Q 012062 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILK--KLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD- 81 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~--~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~- 81 (472)
.-+++.||||++.... ...+..|.+|.+ .++|+||++|+..-+... ..+..++||+||..
T Consensus 230 qL~~~~VAVKifp~~~-----kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t------------~~~~eywLVt~fh~k 292 (534)
T KOG3653|consen 230 QLDNRLVAVKIFPEQE-----KQSFQNEKNIYSLPGMKHENILQFIGAEKRGT------------ADRMEYWLVTEFHPK 292 (534)
T ss_pred hccCceeEEEecCHHH-----HHHHHhHHHHHhccCccchhHHHhhchhccCC------------ccccceeEEeeeccC
Confidence 4578999999997542 234556666666 458999999997754321 11457899999998
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CccccCCCCCcEEEcCCCCeEEeeccceeeeccCC
Q 012062 82 HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN---------QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 152 (472)
Q Consensus 82 g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~---------giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 152 (472)
|+|.++++.. .+++.+..+++..|+.||+|||+. .|+|||||..||||.+++...|+|||+|..+....
T Consensus 293 GsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~ 370 (534)
T KOG3653|consen 293 GSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGK 370 (534)
T ss_pred CcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCC
Confidence 6888888765 489999999999999999999963 59999999999999999999999999998886432
Q ss_pred C-CccccccccCCCCChhhhcCCCCCC-----CCcchhhHHHHHHHHHhCCCCC
Q 012062 153 N-NTLTNRVITLWYRPPELLLGATKYG-----PAVDMWSVGCIFAELLNGKPIL 200 (472)
Q Consensus 153 ~-~~~~~~~gt~~y~aPE~l~~~~~~~-----~~~DiwSlG~il~ell~G~~pf 200 (472)
. ......+||..|||||+|.+...+. .++||||+|+|||||++.-..+
T Consensus 371 ~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 371 PQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred CCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 2 2333478999999999998765554 3689999999999999865433
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=215.21 Aligned_cols=195 Identities=37% Similarity=0.582 Sum_probs=158.5
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
+++..+++.||||.+...... .....+.+|++++++++|+||+++++++.. ...+++++|++.
T Consensus 18 ~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~----------------~~~~~~v~e~~~ 80 (225)
T smart00221 18 ARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFED----------------PEPLYLVMEYCE 80 (225)
T ss_pred EEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeec----------------CCceEEEEeccC
Confidence 456667899999999866433 235678889999999999999999999876 457899999999
Q ss_pred C-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 82 H-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 82 g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+ +|.+++......+++..+..++.+++.+|.+||+++++|+||+++||+++.++.++|+|||++..+............
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 160 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVK 160 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccccee
Confidence 7 777776654322889999999999999999999999999999999999999999999999999876543211233456
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCC-CChH-HHHHHHH
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPG-KNEA-EQLSKIF 213 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~-~~~~-~~~~~i~ 213 (472)
++..|++||.+.....++.++|+|+||+++++|++|+.||.. .+.. .+...+.
T Consensus 161 ~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~ 215 (225)
T smart00221 161 GTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWS 215 (225)
T ss_pred ccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHh
Confidence 688899999884335677899999999999999999999977 4444 4444443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-27 Score=221.00 Aligned_cols=236 Identities=23% Similarity=0.310 Sum_probs=171.7
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC-CCCccceeEE-eeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEI-VTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
||+|..+++.++||-+...... ...+.+|..---.|. |.|||.-|++ |+. .+.++++||
T Consensus 42 L~eHr~s~t~ivlKavp~p~tt---~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt----------------~d~YvF~qE 102 (378)
T KOG1345|consen 42 LAEHRQSKTRIVLKAVPRPQTT---QADFVREFHYSFFLSPHQHIIDTYEVAFQT----------------SDAYVFVQE 102 (378)
T ss_pred eeeccCCceEEEeeccCcchhh---HHHHHHHhccceeeccchhhhHHHHHHhhc----------------CceEEEeec
Confidence 7899999999999999765432 456778887665664 8999988875 544 446789999
Q ss_pred cCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC--CCeEEeeccceeeeccCCCCc
Q 012062 79 YMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE--GNLKLADFGLARSFSYDHNNT 155 (472)
Q Consensus 79 y~~-g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~--~~vkL~DFG~a~~~~~~~~~~ 155 (472)
|+. |+|.+.+... .+-+.-.+.++.||++||.|||+++|||||||.+||||-.. -+|||||||+.+..+..-
T Consensus 103 ~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV--- 177 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV--- 177 (378)
T ss_pred cCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCcee---
Confidence 999 6888777664 37888899999999999999999999999999999999543 369999999986543211
Q ss_pred cccccccCCCCChhhhcCC----CCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCCCCCCccCCCC
Q 012062 156 LTNRVITLWYRPPELLLGA----TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ-LSKIFELCGSPDETIWPGVSKM 230 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~----~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~ 230 (472)
....-+..|.+||++.-. -...+.+|||.||+|+|.+|+|..||......+. +....+-. ...
T Consensus 178 -~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~---------~rk-- 245 (378)
T KOG1345|consen 178 -KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWL---------KRK-- 245 (378)
T ss_pred -hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHh---------ccc--
Confidence 112237789999986431 2256789999999999999999999984322211 11111100 000
Q ss_pred CccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCC---CCHHHHhcCCCC
Q 012062 231 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR---ISAKDALDSEYF 284 (472)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R---~t~~elL~h~~f 284 (472)
...+...|+.+++.+..+.++-|..++++| .++++.....|.
T Consensus 246 ------------~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 246 ------------NPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred ------------CccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 012334556788999999999999999999 455554444443
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-27 Score=242.11 Aligned_cols=225 Identities=20% Similarity=0.251 Sum_probs=181.8
Q ss_pred CCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC-CChhh
Q 012062 8 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD-HDLTG 86 (472)
Q Consensus 8 g~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~-g~l~~ 86 (472)
+-.||||++......+ ..+.+++|+-+|.+|.|+|+++|++++... .+.||++|+. |.|++
T Consensus 725 KipVaiKvl~~~t~~~-~s~e~LdeAl~masldHpnl~RLLgvc~~s-----------------~~qlvtq~mP~G~LlD 786 (1177)
T KOG1025|consen 725 KIPVAIKVLIEFTSPK-ASIELLDEALRMASLDHPNLLRLLGVCMLS-----------------TLQLVTQLMPLGCLLD 786 (1177)
T ss_pred cceeEEEEeeccCCch-hhHHHHHHHHHHhcCCCchHHHHhhhcccc-----------------hHHHHHHhcccchHHH
Confidence 3468999987553332 356788999999999999999999999752 3679999999 68999
Q ss_pred hhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc-cccCCC
Q 012062 87 LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR-VITLWY 165 (472)
Q Consensus 87 ~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~-~gt~~y 165 (472)
++......+-....+.|..||++|+.|||.++++||||-..||||..-..|||.|||+++....+........ ...+.|
T Consensus 787 yvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikw 866 (1177)
T KOG1025|consen 787 YVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKW 866 (1177)
T ss_pred HHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHH
Confidence 9988777888899999999999999999999999999999999999999999999999987765544333221 125668
Q ss_pred CChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhh
Q 012062 166 RPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 244 (472)
Q Consensus 166 ~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (472)
||-|.+.. ..|+.++||||+||++||||| |..|+.+....++-..+......
T Consensus 867 male~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRL-------------------------- 919 (1177)
T KOG1025|consen 867 MALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERL-------------------------- 919 (1177)
T ss_pred HHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccC--------------------------
Confidence 99998875 789999999999999999998 99999988766655444322110
Q ss_pred hHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 245 RVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 245 ~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...+..+-++.-++.+||..|+..||+++++..
T Consensus 920 ---sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 920 ---SQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred ---CCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 111235567889999999999999999998753
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.3e-27 Score=227.59 Aligned_cols=233 Identities=22% Similarity=0.311 Sum_probs=163.7
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHH--hcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC-C
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILK--KLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD-H 82 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~--~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~-g 82 (472)
-.|+.||||++....+.. ..+|.+|.. .|+|+||+.|+..-.... ..-..+|||.||.+ |
T Consensus 232 wrGe~VAVKiF~srdE~S-----WfrEtEIYqTvmLRHENILgFIaaD~~~~------------gs~TQLwLvTdYHe~G 294 (513)
T KOG2052|consen 232 WRGEDVAVKIFSSRDERS-----WFRETEIYQTVMLRHENILGFIAADNKDN------------GSWTQLWLVTDYHEHG 294 (513)
T ss_pred ccCCceEEEEecccchhh-----hhhHHHHHHHHHhccchhhhhhhccccCC------------CceEEEEEeeecccCC
Confidence 468999999998654433 346666654 669999999987643211 11336899999999 6
Q ss_pred ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC-
Q 012062 83 DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN--------QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN- 153 (472)
Q Consensus 83 ~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~--------giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~- 153 (472)
+|.+++.+ ..++.....+++..++.||+|||.. .|.|||||..||||..++...|+|||+|.....+..
T Consensus 295 SL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~ 372 (513)
T KOG2052|consen 295 SLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDT 372 (513)
T ss_pred cHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCc
Confidence 88888877 3689999999999999999999953 499999999999999999999999999987765422
Q ss_pred --CccccccccCCCCChhhhcCCCCC-----CCCcchhhHHHHHHHHHhC----------CCCCCCCC----hHHHHHHH
Q 012062 154 --NTLTNRVITLWYRPPELLLGATKY-----GPAVDMWSVGCIFAELLNG----------KPILPGKN----EAEQLSKI 212 (472)
Q Consensus 154 --~~~~~~~gt~~y~aPE~l~~~~~~-----~~~~DiwSlG~il~ell~G----------~~pf~~~~----~~~~~~~i 212 (472)
.....++||..|||||+|-..... -..+||||||+|+||++.. ..||.+-. ..+.+.++
T Consensus 373 idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkV 452 (513)
T KOG2052|consen 373 IDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKV 452 (513)
T ss_pred ccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcc
Confidence 234567999999999998643221 1368999999999999763 34554321 12223222
Q ss_pred HHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHh
Q 012062 213 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 279 (472)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL 279 (472)
+-. ..+++..+...... ..-..+..|++.|+..+|.-|.|+-.+.
T Consensus 453 VCv------------------~~~RP~ipnrW~s~----~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 453 VCV------------------QKLRPNIPNRWKSD----PALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred eee------------------cccCCCCCcccccC----HHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 110 11111111000000 0112466789999999999999986653
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-22 Score=198.20 Aligned_cols=241 Identities=33% Similarity=0.513 Sum_probs=183.7
Q ss_pred CEEEEEEeecCCcCCC-chhhHHHHHHHHHhcCCC-CccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCC-hh
Q 012062 9 EIVALKKIRMDNEKEG-FPITAIREIKILKKLQHE-NVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHD-LT 85 (472)
Q Consensus 9 ~~vAlK~i~~~~~~~~-~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~-l~ 85 (472)
..+|+|.+........ ....+.+|+.+++.+.|+ +|+++++++.. ....++++|++.+. +.
T Consensus 23 ~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----------------~~~~~~~~~~~~~~~l~ 86 (384)
T COG0515 23 KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD----------------EGSLYLVMEYVDGGSLE 86 (384)
T ss_pred cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec----------------CCEEEEEEecCCCCcHH
Confidence 6789999987655443 567788999999999988 79999999955 34589999999974 44
Q ss_pred hhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC-CeEEeeccceeeeccCCCC-----ccc
Q 012062 86 GLADRPG--LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG-NLKLADFGLARSFSYDHNN-----TLT 157 (472)
Q Consensus 86 ~~~~~~~--~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~-~vkL~DFG~a~~~~~~~~~-----~~~ 157 (472)
.++.... ..+....+..++.|++.+|.|+|..+++||||||+||+++..+ .++++|||++..+...... ...
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 166 (384)
T COG0515 87 DLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPS 166 (384)
T ss_pred HHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcccccccccc
Confidence 3433332 2689999999999999999999999999999999999999988 6999999999865543322 345
Q ss_pred cccccCCCCChhhhcCC--CCCCCCcchhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCC-CCCCCccCCCCC
Q 012062 158 NRVITLWYRPPELLLGA--TKYGPAVDMWSVGCIFAELLNGKPILPGKNE---AEQLSKIFELCGSP-DETIWPGVSKMP 231 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~--~~~~~~~DiwSlG~il~ell~G~~pf~~~~~---~~~~~~i~~~~~~~-~~~~~~~~~~~~ 231 (472)
..++|..|++||++.+. ..+....|+||+|+++++++++..||..... .......+...... .....
T Consensus 167 ~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 239 (384)
T COG0515 167 TSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPL------- 239 (384)
T ss_pred ccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccccc-------
Confidence 66889999999999863 4678899999999999999999999888774 33333333322221 00000
Q ss_pred ccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 232 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
... .. ......+.+++.+|+..+|..|.+..+.+.+.|...
T Consensus 240 -----~~~------~~---~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 240 -----SPS------NP---ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred -----Ccc------cc---chhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 000 00 223356889999999999999999999998866543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-24 Score=220.11 Aligned_cols=225 Identities=24% Similarity=0.342 Sum_probs=182.7
Q ss_pred ccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC-CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCC
Q 012062 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHD 83 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~ 83 (472)
...+..+|+|+.++.............|..++..++ |+.+|+++..|+. ++.+++++++..++
T Consensus 19 ~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt----------------~~kl~l~ld~~rgg 82 (612)
T KOG0603|consen 19 ADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT----------------DGKLYLILDFLRGG 82 (612)
T ss_pred ccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc----------------ccchhHhhhhcccc
Confidence 456788999999876544333335567899999997 9999999999987 66889999999974
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccC
Q 012062 84 LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL 163 (472)
Q Consensus 84 l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~ 163 (472)
.+.........+++...+.+...++.+++++|+.+|+|||+|++||+++.+|++++.|||+++.+-.... .|||.
T Consensus 83 ~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-----~cgt~ 157 (612)
T KOG0603|consen 83 DLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-----ACGTY 157 (612)
T ss_pred hhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh-----cccch
Confidence 4433333444688889999999999999999999999999999999999999999999999876543222 28999
Q ss_pred CCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhh
Q 012062 164 WYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMK 243 (472)
Q Consensus 164 ~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (472)
.|||||++.+ ...++|.||+|+++|+|++|..||.. +.+..|...+...
T Consensus 158 eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~------------------------ 206 (612)
T KOG0603|consen 158 EYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEM------------------------ 206 (612)
T ss_pred hhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCC------------------------
Confidence 9999999873 57889999999999999999999988 6666665432221
Q ss_pred hhHHHHhhhccHHHHHHHHHhhccCCCCCCC-----HHHHhcCCCCCCC
Q 012062 244 RRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWTD 287 (472)
Q Consensus 244 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t-----~~elL~h~~f~~~ 287 (472)
...++..+++++..|+..+|..|.- +.|+++|+||+..
T Consensus 207 ------p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i 249 (612)
T KOG0603|consen 207 ------PRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSI 249 (612)
T ss_pred ------chhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheee
Confidence 1246678999999999999999974 4799999999653
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-22 Score=196.30 Aligned_cols=209 Identities=20% Similarity=0.257 Sum_probs=166.1
Q ss_pred hhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC-CChhhhhc-----CC--CCCCCHH
Q 012062 27 ITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD-HDLTGLAD-----RP--GLRFTVP 98 (472)
Q Consensus 27 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~-g~l~~~~~-----~~--~~~l~~~ 98 (472)
..++.|..+|..+.|+|+..+..+..+. ....++++.++. |+|..++. .. ...++..
T Consensus 332 ~~~L~es~lly~~sH~nll~V~~V~ie~---------------~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~ 396 (563)
T KOG1024|consen 332 NLLLQESMLLYGASHPNLLSVLGVSIED---------------YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTI 396 (563)
T ss_pred HHHHHHHHHHhcCcCCCccceeEEEeec---------------cCcceEEEeccCcchHHHHHHHhccCCCccccchhHH
Confidence 4456788888888999999999988762 234578888887 67766655 21 2346777
Q ss_pred HHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc-cccCCCCChhhhcCCCCC
Q 012062 99 QIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR-VITLWYRPPELLLGATKY 177 (472)
Q Consensus 99 ~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~-~gt~~y~aPE~l~~~~~~ 177 (472)
++..++.||..|++|||+.+|||.||-..|++|++.-+|||+|=.+++.+-..+...+... -....||++|.+.+ ..|
T Consensus 397 qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~y 475 (563)
T KOG1024|consen 397 QLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHY 475 (563)
T ss_pred HHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhh-hhh
Confidence 8888999999999999999999999999999999999999999999987544333333222 23677999999986 679
Q ss_pred CCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHH
Q 012062 178 GPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRH 256 (472)
Q Consensus 178 ~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (472)
+.++|+||||++||||++ |+.|+..-++.++..-+.+...... +-+++++
T Consensus 476 ssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQ-----------------------------P~NCPDe 526 (563)
T KOG1024|consen 476 SSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQ-----------------------------PFNCPDE 526 (563)
T ss_pred cchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecC-----------------------------CCCCcHH
Confidence 999999999999999997 9999999998887766643321111 1147789
Q ss_pred HHHHHHHhhccCCCCCCCHHHHhc
Q 012062 257 ALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 257 ~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
+..++..|+..+|++||+.+|+..
T Consensus 527 Lf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 527 LFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred HHHHHHHHHhcCcccCCCHHHHHH
Confidence 999999999999999999999864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-21 Score=193.61 Aligned_cols=234 Identities=23% Similarity=0.193 Sum_probs=170.0
Q ss_pred ceeccCC-CEEEEEEeecCCcCCCchhhHHHHHHHHHhcCC----CCccceeEEee-CCCCCCCCCCCCCCCCcCCeEEE
Q 012062 2 AREIKTG-EIVALKKIRMDNEKEGFPITAIREIKILKKLQH----ENVIKLKEIVT-SPGPERDEQGRPDGNKYRGSTYM 75 (472)
Q Consensus 2 a~~~~tg-~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~h----pnIv~l~~~~~-~~~~~~~~~~~~~~~~~~~~~~i 75 (472)
|.+..++ +.+|+|+......... ..+..|+.+++.+.. .++..+++... . ...-||
T Consensus 37 v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~----------------~~~~~i 98 (322)
T KOG1164|consen 37 VSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRST----------------EDFNFI 98 (322)
T ss_pred EEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCC----------------CceeEE
Confidence 4555554 6789988775533221 156789999999973 68888888874 3 446699
Q ss_pred EEecCCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC-----CCeEEeecccee--e
Q 012062 76 VFEYMDHDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE-----GNLKLADFGLAR--S 147 (472)
Q Consensus 76 VmEy~~g~l~~~~~~~~-~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~-----~~vkL~DFG~a~--~ 147 (472)
||++++.+|.+++.... .+|+...+.+|+.|++.+|++||+.|++||||||+|+++... ..++|+|||+++ .
T Consensus 99 VM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~ 178 (322)
T KOG1164|consen 99 VMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFK 178 (322)
T ss_pred EEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcccc
Confidence 99999999999886543 789999999999999999999999999999999999999865 359999999998 4
Q ss_pred eccCCCC------c-cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 012062 148 FSYDHNN------T-LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD 220 (472)
Q Consensus 148 ~~~~~~~------~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~ 220 (472)
+...... . ...+.||..|+++.+..+ ...+.+.|+|||+.++.+|+.|..||...+......++.+......
T Consensus 179 ~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~ 257 (322)
T KOG1164|consen 179 YVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLL 257 (322)
T ss_pred ccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhc
Confidence 3222211 1 233568999999999987 5679999999999999999999999977665444443333211110
Q ss_pred CCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHh
Q 012062 221 ETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 279 (472)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL 279 (472)
... .....+.++.+++..+-..+...+|....+.
T Consensus 258 ~~~-------------------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~ 291 (322)
T KOG1164|consen 258 TDR-------------------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLA 291 (322)
T ss_pred ccc-------------------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHH
Confidence 000 1112334566666666667777777665554
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-21 Score=185.69 Aligned_cols=191 Identities=23% Similarity=0.314 Sum_probs=156.8
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC-CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+.++.-+++.||||.-.+...- -++..|....+.|. .+.|..+|.+-.. ..+-.||||+
T Consensus 46 ~G~Nl~nne~VAIKfEPrkS~A----PQLrdEYr~YKlL~g~~GIP~vYYFGqe----------------G~~NiLVidL 105 (449)
T KOG1165|consen 46 LGKNLYNNEPVAIKFEPRKSEA----PQLRDEYRTYKLLGGTEGIPQVYYFGQE----------------GKYNILVIDL 105 (449)
T ss_pred cccccccCceEEEEeccccCCc----chHHHHHHHHHHHcCCCCCCceeeeccc----------------cchhhhhhhh
Confidence 3567889999999986554332 36778999999885 7899888866543 3345799999
Q ss_pred CCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC-----CCeEEeeccceeeeccCCCC
Q 012062 80 MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE-----GNLKLADFGLARSFSYDHNN 154 (472)
Q Consensus 80 ~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~-----~~vkL~DFG~a~~~~~~~~~ 154 (472)
+..+|.+++.-++.+|+...+..+++|++.-++|+|++.+|.|||||+|+||..- ..|.|+|||+|+.+.+....
T Consensus 106 LGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~Tk 185 (449)
T KOG1165|consen 106 LGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTK 185 (449)
T ss_pred hCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcccc
Confidence 9999999999999999999999999999999999999999999999999999643 34999999999987654332
Q ss_pred ------ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 012062 155 ------TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 212 (472)
Q Consensus 155 ------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i 212 (472)
......||..||+-...++ ..-+...|+-|||.|++++|.|..||.+........+.
T Consensus 186 qHIPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kY 248 (449)
T KOG1165|consen 186 QHIPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKY 248 (449)
T ss_pred ccCccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHH
Confidence 2344578999999998888 45688999999999999999999999987654443333
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.9e-23 Score=217.81 Aligned_cols=232 Identities=27% Similarity=0.360 Sum_probs=162.7
Q ss_pred ceeccCCCEEEEEEeecCCcC--CCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 2 AREIKTGEIVALKKIRMDNEK--EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
||-+...-.|+||++-+.... -....+.++|++ .+.+++||++.+..+... +...|||-+|
T Consensus 40 ~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t----------------~kAAylvRqy 102 (1431)
T KOG1240|consen 40 ARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVT----------------DKAAYLVRQY 102 (1431)
T ss_pred hhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHh----------------hHHHHHHHHH
Confidence 455556667999998544311 112233456666 677799999998877554 4567999999
Q ss_pred CCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeec--cCCCCccc
Q 012062 80 MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS--YDHNNTLT 157 (472)
Q Consensus 80 ~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~--~~~~~~~~ 157 (472)
+..+|.+.+..+. -+.+-+.+-|+.||+.||..||+.||+|+|||.|||||+.=+.+.|+||...+..- .+.....+
T Consensus 103 vkhnLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~ 181 (1431)
T KOG1240|consen 103 VKHNLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFT 181 (1431)
T ss_pred Hhhhhhhhhccch-HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccce
Confidence 9999988765543 36777888899999999999999999999999999999998889999998654321 12222222
Q ss_pred cccc----cCCCCChhhhcCCC---------C-CCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCC
Q 012062 158 NRVI----TLWYRPPELLLGAT---------K-YGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDET 222 (472)
Q Consensus 158 ~~~g----t~~y~aPE~l~~~~---------~-~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~ 222 (472)
-++- -..|+|||.+.... . .+++.||||+|||++||++ |+++|. ..++.......
T Consensus 182 fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----LSQL~aYr~~~------ 251 (1431)
T KOG1240|consen 182 FFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----LSQLLAYRSGN------ 251 (1431)
T ss_pred EEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----HHHHHhHhccC------
Confidence 2222 34699999986421 1 5678999999999999997 788884 11221111100
Q ss_pred CCccCCCCCccccCCCchhhhhhHHHHhhh-ccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 223 IWPGVSKMPAYNHFKPSRTMKRRVREVFRH-FDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
.......... -+..++.||..|++.||++|.+|++.|+.
T Consensus 252 --------------------~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 252 --------------------ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred --------------------ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0001111111 13368999999999999999999999976
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.2e-22 Score=179.00 Aligned_cols=190 Identities=26% Similarity=0.332 Sum_probs=154.7
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCC-CCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQH-ENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
||.+..+|+.||||+-+.+... -.+..|.++.+.|++ ..|.++..++.+ +.+-.||||+
T Consensus 33 ~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e----------------~~ynvlVMdL 92 (341)
T KOG1163|consen 33 LGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTE----------------KDYNVLVMDL 92 (341)
T ss_pred eeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhccc----------------cccceeeeec
Confidence 5778899999999987654332 257789999999974 567777777665 4456899999
Q ss_pred CCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC---CCCeEEeeccceeeeccCCC---
Q 012062 80 MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN---EGNLKLADFGLARSFSYDHN--- 153 (472)
Q Consensus 80 ~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~---~~~vkL~DFG~a~~~~~~~~--- 153 (472)
+..+|.+++.-+..+|+...++.++-|++.-|+|+|.+++|||||||+|+|+.- -..+.|+|||+|+.+.+...
T Consensus 93 LGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~H 172 (341)
T KOG1163|consen 93 LGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQH 172 (341)
T ss_pred cCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccccc
Confidence 999999998888888999999999999999999999999999999999999853 34599999999998765322
Q ss_pred ---CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 012062 154 ---NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSK 211 (472)
Q Consensus 154 ---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~ 211 (472)
....+..||..|.+-....+ ..-+...|+-|+|.+|..+..|..||.+........+
T Consensus 173 Ipyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK 232 (341)
T KOG1163|consen 173 IPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK 232 (341)
T ss_pred CccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHH
Confidence 23345678999999887776 3457889999999999999999999998765444333
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-21 Score=196.03 Aligned_cols=146 Identities=21% Similarity=0.187 Sum_probs=108.2
Q ss_pred ceecc-CCCEEEEEEeecCCc---CCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEE
Q 012062 2 AREIK-TGEIVALKKIRMDNE---KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVF 77 (472)
Q Consensus 2 a~~~~-tg~~vAlK~i~~~~~---~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVm 77 (472)
|++.. +++.||||++..... .......+.+|+++|++|+|+||+..+..+ +..||||
T Consensus 37 a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-------------------~~~~LVm 97 (365)
T PRK09188 37 GYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-------------------GKDGLVR 97 (365)
T ss_pred EEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-------------------CCcEEEE
Confidence 56665 788889998763311 222345678999999999999998533211 1369999
Q ss_pred ecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC-CCCcEEEcCCCCeEEeeccceeeeccCCCC--
Q 012062 78 EYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI-KGSNLLIDNEGNLKLADFGLARSFSYDHNN-- 154 (472)
Q Consensus 78 Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDL-Kp~NILl~~~~~vkL~DFG~a~~~~~~~~~-- 154 (472)
|||.|..+..+.. .. ...++.|++++|.|||++||+|||| ||+|||++.++++||+|||+|+.+......
T Consensus 98 E~~~G~~L~~~~~----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~ 170 (365)
T PRK09188 98 GWTEGVPLHLARP----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYR 170 (365)
T ss_pred EccCCCCHHHhCc----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhh
Confidence 9999865543321 11 2568899999999999999999999 999999999999999999999876543211
Q ss_pred -----ccccccccCCCCChhhhcC
Q 012062 155 -----TLTNRVITLWYRPPELLLG 173 (472)
Q Consensus 155 -----~~~~~~gt~~y~aPE~l~~ 173 (472)
..++.+++..|+|||.+..
T Consensus 171 ~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 171 IAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred hhhhhhhhhhhccCccCCcccCCh
Confidence 1234567888999998754
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=181.88 Aligned_cols=207 Identities=18% Similarity=0.228 Sum_probs=145.1
Q ss_pred CCCCccceeEEeeCCCCCC----------CCCC-CCCCCCcCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHH
Q 012062 40 QHENVIKLKEIVTSPGPER----------DEQG-RPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLL 108 (472)
Q Consensus 40 ~hpnIv~l~~~~~~~~~~~----------~~~~-~~~~~~~~~~~~iVmEy~~g~l~~~~~~~~~~l~~~~i~~i~~Qll 108 (472)
+|||||+++.+|.+.-... .... ++.+-.....+|+||.-...+|..++.... .+....+-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~--~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH--RSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC--CchHHHHHHHHHHH
Confidence 5999999999998742110 0001 223334456799999999999998887654 56677888999999
Q ss_pred HHHHHHHHCCccccCCCCCcEEEcC--CC--CeEEeeccceeeeccC-----CCCccccccccCCCCChhhhcCCCC---
Q 012062 109 TGLHYCHVNQVLHRDIKGSNLLIDN--EG--NLKLADFGLARSFSYD-----HNNTLTNRVITLWYRPPELLLGATK--- 176 (472)
Q Consensus 109 ~aL~~LH~~giiHrDLKp~NILl~~--~~--~vkL~DFG~a~~~~~~-----~~~~~~~~~gt~~y~aPE~l~~~~~--- 176 (472)
+|+.|||++||.|||||.+||||.- ++ .+.|+|||.+-..... ........-|....||||+......
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 9999999999999999999999853 32 3899999977432210 0111222345777899998753211
Q ss_pred --CCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhcc
Q 012062 177 --YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFD 254 (472)
Q Consensus 177 --~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (472)
--.++|.|++|.+.||++....||.+..+...-.+-++.... ......++
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qL----------------------------Palp~~vp 483 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQL----------------------------PALPSRVP 483 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhC----------------------------CCCcccCC
Confidence 124789999999999999999999885443222222221111 11223467
Q ss_pred HHHHHHHHHhhccCCCCCCCHH
Q 012062 255 RHALELLEKMLMLDPSQRISAK 276 (472)
Q Consensus 255 ~~~~~ll~~~L~~dP~~R~t~~ 276 (472)
..+++||..+|+.||++|+++.
T Consensus 484 p~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 484 PVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred hHHHHHHHHHhcCCccccCCcc
Confidence 7899999999999999999864
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.6e-21 Score=187.81 Aligned_cols=229 Identities=18% Similarity=0.239 Sum_probs=135.6
Q ss_pred ceeccCCCEEEEEEeecCCcC-CCchhhHHHHHHHHHhcC----------CCCccceeEEeeCCCCCCCCCCCCCCCCcC
Q 012062 2 AREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQ----------HENVIKLKEIVTSPGPERDEQGRPDGNKYR 70 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~-~~~~~~~~~Ei~il~~l~----------hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 70 (472)
|+|.+||+.+|||++...... ....+.+.+|.-....+. |-.++..+|+....+.-.... -....
T Consensus 31 v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~~~~~----~~~~~ 106 (288)
T PF14531_consen 31 VTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKPPFFE----RGPGQ 106 (288)
T ss_dssp EEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-SEEE----ECETT
T ss_pred EEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCCccee----cCCCC
Confidence 689999999999999766522 223344455554444432 234555555554322100000 00001
Q ss_pred C-----eEEEEEecCCCChhhhhcC----CCCCCCHH--HHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEE
Q 012062 71 G-----STYMVFEYMDHDLTGLADR----PGLRFTVP--QIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKL 139 (472)
Q Consensus 71 ~-----~~~iVmEy~~g~l~~~~~~----~~~~l~~~--~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL 139 (472)
. ..+++|+-+.++|..++.. ........ ....+..|++..+++||..||+|+||||+||+++.+|.++|
T Consensus 107 ~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~L 186 (288)
T PF14531_consen 107 SIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFL 186 (288)
T ss_dssp EEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE
T ss_pred ccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEE
Confidence 1 2478899998888765432 21111222 22445699999999999999999999999999999999999
Q ss_pred eeccceeeeccCCCCccccccccCCCCChhhhcCC-------CCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 012062 140 ADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA-------TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 212 (472)
Q Consensus 140 ~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-------~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i 212 (472)
.||+.....+..... ...+..|.+||+.... ..++.+.|.|+||+++|.|+|++.||............
T Consensus 187 g~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~~ 262 (288)
T PF14531_consen 187 GDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEWD 262 (288)
T ss_dssp --GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGGG
T ss_pred cChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCcccccccc
Confidence 999987654422111 3346789999987442 24688999999999999999999999765432111100
Q ss_pred HHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCC
Q 012062 213 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR 272 (472)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 272 (472)
|..+ .++++.+++||+.||+.||.+|
T Consensus 263 -----------f~~C-----------------------~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 263 -----------FSRC-----------------------RDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -----------GTTS-----------------------S---HHHHHHHHHHT-SSGGGS
T ss_pred -----------chhc-----------------------CCcCHHHHHHHHHHccCCcccC
Confidence 0000 1467789999999999999988
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.7e-20 Score=170.44 Aligned_cols=127 Identities=19% Similarity=0.189 Sum_probs=94.3
Q ss_pred ceeccCCCEEEEEEeecCCcCCCc------------------------hhhHHHHHHHHHhcCCCCccceeEEeeCCCCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGF------------------------PITAIREIKILKKLQHENVIKLKEIVTSPGPE 57 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~------------------------~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 57 (472)
|++. +|+.||||+++........ .....+|+++|++|.+++|.....+...
T Consensus 16 a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~~p~~~~~~---- 90 (190)
T cd05147 16 ATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIPCPEPILLK---- 90 (190)
T ss_pred EECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCcEEEec----
Confidence 5565 8999999999865321111 1122459999999998887544333211
Q ss_pred CCCCCCCCCCCcCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HHCCccccCCCCCcEEEcCCCC
Q 012062 58 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC-HVNQVLHRDIKGSNLLIDNEGN 136 (472)
Q Consensus 58 ~~~~~~~~~~~~~~~~~iVmEy~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~L-H~~giiHrDLKp~NILl~~~~~ 136 (472)
..+|||||++++.+.........+++..+..++.||+.+|.+| |+.||+||||||+|||++ ++.
T Consensus 91 --------------~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 91 --------------SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred --------------CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence 1289999999854332212234689999999999999999999 799999999999999998 478
Q ss_pred eEEeeccceeee
Q 012062 137 LKLADFGLARSF 148 (472)
Q Consensus 137 vkL~DFG~a~~~ 148 (472)
++|+|||+|...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.8e-20 Score=197.79 Aligned_cols=150 Identities=29% Similarity=0.486 Sum_probs=124.3
Q ss_pred HHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC--------------ccccccccCCCCChhhhcC
Q 012062 108 LTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN--------------TLTNRVITLWYRPPELLLG 173 (472)
Q Consensus 108 l~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~--------------~~~~~~gt~~y~aPE~l~~ 173 (472)
+.+++|||+-+|+|||+||+|+||+.-|++|+.|||+++........ .-...|+|+.|+||||+..
T Consensus 153 vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr 232 (1205)
T KOG0606|consen 153 VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR 232 (1205)
T ss_pred hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhh
Confidence 78999999999999999999999999999999999998754322111 1112378999999999986
Q ss_pred CCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhc
Q 012062 174 ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHF 253 (472)
Q Consensus 174 ~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (472)
..|+..+|.|++|+|+|+++.|..||.+.+.++.+.+++..... |+.-. ..+
T Consensus 233 -qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~-----wpE~d----------------------ea~ 284 (1205)
T KOG0606|consen 233 -QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE-----WPEED----------------------EAL 284 (1205)
T ss_pred -hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc-----ccccC----------------------cCC
Confidence 67999999999999999999999999999999999988775433 32221 135
Q ss_pred cHHHHHHHHHhhccCCCCCC---CHHHHhcCCCCC
Q 012062 254 DRHALELLEKMLMLDPSQRI---SAKDALDSEYFW 285 (472)
Q Consensus 254 ~~~~~~ll~~~L~~dP~~R~---t~~elL~h~~f~ 285 (472)
..+++++|.++|..+|..|. .+-+|..|.||.
T Consensus 285 p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~ 319 (1205)
T KOG0606|consen 285 PPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQ 319 (1205)
T ss_pred CHHHHHHHHHHHHhChHhhcccchhhhhhhcccee
Confidence 67899999999999999996 667888999994
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.4e-19 Score=164.24 Aligned_cols=127 Identities=19% Similarity=0.207 Sum_probs=96.9
Q ss_pred ceeccCCCEEEEEEeecCCcCCCc------------------------hhhHHHHHHHHHhcCCCCccceeEEeeCCCCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGF------------------------PITAIREIKILKKLQHENVIKLKEIVTSPGPE 57 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~------------------------~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 57 (472)
|++. +|+.||||+++........ .....+|++++.++.|++|.....+...
T Consensus 16 a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~---- 90 (190)
T cd05145 16 ARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVPVPEPILLK---- 90 (190)
T ss_pred EEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCCCceEEEec----
Confidence 5665 8999999999865321000 1123579999999999988655544322
Q ss_pred CCCCCCCCCCCcCCeEEEEEecCCCC-hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCC
Q 012062 58 RDEQGRPDGNKYRGSTYMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEG 135 (472)
Q Consensus 58 ~~~~~~~~~~~~~~~~~iVmEy~~g~-l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~-~giiHrDLKp~NILl~~~~ 135 (472)
..||||||+++. +...... ...++..++..++.|++.+|.+||+ +||+||||||+|||++ ++
T Consensus 91 --------------~~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 91 --------------KNVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred --------------CCEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC
Confidence 138999999975 3322222 2457888999999999999999999 9999999999999999 78
Q ss_pred CeEEeeccceeeec
Q 012062 136 NLKLADFGLARSFS 149 (472)
Q Consensus 136 ~vkL~DFG~a~~~~ 149 (472)
.++|+|||+++...
T Consensus 155 ~~~liDFG~a~~~~ 168 (190)
T cd05145 155 KPYIIDVSQAVELD 168 (190)
T ss_pred CEEEEEcccceecC
Confidence 89999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.8e-20 Score=186.79 Aligned_cols=179 Identities=28% Similarity=0.444 Sum_probs=132.2
Q ss_pred CCeEEEEEecCCC-ChhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeecccee
Q 012062 70 RGSTYMVFEYMDH-DLTGLADR--PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 146 (472)
Q Consensus 70 ~~~~~iVmEy~~g-~l~~~~~~--~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 146 (472)
..++||.|++|.. .|.+.+.+ .....+...++.++.|+..+++| ++.+|||+||.||++..+..+||.|||+.+
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~t 404 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT 404 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhhee
Confidence 5578999999996 45555532 23346778899999999999999 999999999999999999999999999998
Q ss_pred eeccCC-----CCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCC
Q 012062 147 SFSYDH-----NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPD 220 (472)
Q Consensus 147 ~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~ 220 (472)
...... ....+..++|.+||+||.+.+ ..|+.++||||||+||+||+. -...|.. ...+..+.
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~r------- 473 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLIQFSTQFER---IATLTDIR------- 473 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHHHhccHHHH---HHhhhhhh-------
Confidence 876554 335566789999999999998 679999999999999999997 2222211 01111111
Q ss_pred CCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 221 ETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
+..|+ ..+..-.+.-.+||..||.+.|.+||++.+.--|.|.
T Consensus 474 ~g~ip----------------------~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 474 DGIIP----------------------PEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred cCCCC----------------------hHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 11111 0111112345689999999999999987776666553
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-20 Score=201.11 Aligned_cols=240 Identities=30% Similarity=0.431 Sum_probs=187.6
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC-CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCC-
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHD- 83 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~- 83 (472)
.+...+|+|.+........+...+..|+.+-+.+. |.|++++++.... ....++++||.++.
T Consensus 44 ~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~----------------~~~~~~~~~~s~g~~ 107 (601)
T KOG0590|consen 44 DPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS----------------PRSYLLSLSYSDGGS 107 (601)
T ss_pred CCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC----------------CcccccccCcccccc
Confidence 34556777877765544455666677999999997 9999999998876 45679999998874
Q ss_pred hhhhhcCCCC-CCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCCCcEEEcCCC-CeEEeeccceeeecc--CCCCcccc
Q 012062 84 LTGLADRPGL-RFTVPQIKCYMKQLLTGLHYCH-VNQVLHRDIKGSNLLIDNEG-NLKLADFGLARSFSY--DHNNTLTN 158 (472)
Q Consensus 84 l~~~~~~~~~-~l~~~~i~~i~~Qll~aL~~LH-~~giiHrDLKp~NILl~~~~-~vkL~DFG~a~~~~~--~~~~~~~~ 158 (472)
+...+...+. .++...+..++.|+..+|.|+| ..++.||||||+|.+++..+ .+++.|||+|+.+.. ........
T Consensus 108 ~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~ 187 (601)
T KOG0590|consen 108 LFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKD 187 (601)
T ss_pred cccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeec
Confidence 4444424444 6788899999999999999999 99999999999999999999 999999999998876 33344556
Q ss_pred ccc-cCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 159 RVI-TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 159 ~~g-t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
.++ ++.|+|||++.+........|+||+|+++..+++|..||......+....- |....
T Consensus 188 ~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~-----------~~~~~--------- 247 (601)
T KOG0590|consen 188 RCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSS-----------WKSNK--------- 247 (601)
T ss_pred ccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccccee-----------ecccc---------
Confidence 688 999999999987656788999999999999999999998765543311100 00000
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.......|..++..+.+++.++|..++..|.+.+++..++|+..
T Consensus 248 -----~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 248 -----GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred -----cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 01112334567788999999999999999999999999999955
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.4e-19 Score=169.32 Aligned_cols=157 Identities=14% Similarity=0.217 Sum_probs=112.8
Q ss_pred CCCEEEEEEeecCCcCC-Cchhh------HHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 7 TGEIVALKKIRMDNEKE-GFPIT------AIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~-~~~~~------~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
++..||||+++...... .+... +.+|+.++.+|.|++|..+.+++..... ....+.+..+|||||
T Consensus 53 ~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~--------~~~~~~~~~~lvmEy 124 (232)
T PRK10359 53 DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER--------KTLRYAHTYIMLIEY 124 (232)
T ss_pred CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc--------ccccccCCeEEEEEE
Confidence 56789999997553322 22223 4689999999999999999999775321 111234568999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
++| +|.+.. .+++ ..+.+|+.+|..||++||+||||||+|||++.++ ++|+|||.......+....
T Consensus 125 i~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~d--- 191 (232)
T PRK10359 125 IEGVELNDMP-----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAKD--- 191 (232)
T ss_pred ECCccHHHhh-----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCCcccccchhhHH---
Confidence 998 454431 1333 3456999999999999999999999999999988 9999999876542211110
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN 195 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~ 195 (472)
..++. ..|+.++|+||||+++..+..
T Consensus 192 ----------~~vle-r~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 192 ----------RIDLE-RHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred ----------HHHHH-hHhcccccccceeEeehHHHH
Confidence 02222 457789999999999877654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.5e-19 Score=160.64 Aligned_cols=172 Identities=15% Similarity=0.033 Sum_probs=119.8
Q ss_pred CCCEEEEEEeecCCcCCC--chhhHHHHHHHHHhcC-CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCC
Q 012062 7 TGEIVALKKIRMDNEKEG--FPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHD 83 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~--~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~ 83 (472)
.+..|+.+.+........ ....+.+|+++|++|. |++|.+++++. ..|++|||+.|.
T Consensus 24 ~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~--------------------~~~lvmeyI~G~ 83 (218)
T PRK12274 24 GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD--------------------GRHLDRSYLAGA 83 (218)
T ss_pred CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc--------------------CEEEEEeeecCc
Confidence 455566565554332111 1124678999999995 58899998762 259999999986
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC-CCCcEEEcCCCCeEEeeccceeeeccCCCC----c---
Q 012062 84 LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI-KGSNLLIDNEGNLKLADFGLARSFSYDHNN----T--- 155 (472)
Q Consensus 84 l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDL-Kp~NILl~~~~~vkL~DFG~a~~~~~~~~~----~--- 155 (472)
.+..... . ....++.|++.+|.+||++||+|||| ||+|||++.++.++|+|||+|......... .
T Consensus 84 ~L~~~~~------~-~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rD 156 (218)
T PRK12274 84 AMYQRPP------R-GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLARED 156 (218)
T ss_pred cHHhhhh------h-hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHH
Confidence 5432211 1 12457889999999999999999999 799999999999999999999865432210 0
Q ss_pred -----cccccccCCCCChhhhcCCCCCC-CCcchhhHHHHHHHHHhCCCCCCCCCh
Q 012062 156 -----LTNRVITLWYRPPELLLGATKYG-PAVDMWSVGCIFAELLNGKPILPGKNE 205 (472)
Q Consensus 156 -----~~~~~gt~~y~aPE~l~~~~~~~-~~~DiwSlG~il~ell~G~~pf~~~~~ 205 (472)
..-...++.|++|+...-....+ ...+.++.|+-+|.++|+..++.+.++
T Consensus 157 l~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 157 LRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 00012377888888654322223 456888999999999999987765543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=8.1e-19 Score=162.31 Aligned_cols=221 Identities=17% Similarity=0.205 Sum_probs=165.4
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC-CChh
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD-HDLT 85 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~-g~l~ 85 (472)
.|..++.|+++...........+..|.-.|+-+.||||+.+++.+.++ -++.++..||. ++|.
T Consensus 212 qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp----------------pnlv~isq~mp~gsly 275 (448)
T KOG0195|consen 212 QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP----------------PNLVIISQYMPFGSLY 275 (448)
T ss_pred cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC----------------CCceEeeeeccchHHH
Confidence 345677788876654444556677899999999999999999999873 36789999998 5777
Q ss_pred hhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEcCCCCeEEe--eccceeeeccCCCCcccccc
Q 012062 86 GLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQ--VLHRDIKGSNLLIDNEGNLKLA--DFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 86 ~~~~~~-~~~l~~~~i~~i~~Qll~aL~~LH~~g--iiHrDLKp~NILl~~~~~vkL~--DFG~a~~~~~~~~~~~~~~~ 160 (472)
.++... +.-++..++.+++..|+.|++|||+.. |.--.|....|+||++...+|. |--++.. ...+.
T Consensus 276 nvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq--------e~gr~ 347 (448)
T KOG0195|consen 276 NVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ--------EVGRA 347 (448)
T ss_pred HHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee--------ccccc
Confidence 766553 334678899999999999999999984 4445688899999998775553 4333321 12234
Q ss_pred ccCCCCChhhhcCCCC--CCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 161 ITLWYRPPELLLGATK--YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~--~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
-.+.||+||.+..... --.++|+|||.++||||.|.+.||......+.-.+|.-.
T Consensus 348 y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkiale----------------------- 404 (448)
T KOG0195|consen 348 YSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALE----------------------- 404 (448)
T ss_pred cCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhc-----------------------
Confidence 4889999999976432 234799999999999999999999988876655554210
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHh
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 279 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL 279 (472)
.....+.+.++..+..|+.-|+..||.+||.+..++
T Consensus 405 -----glrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 405 -----GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred -----cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 111123456888999999999999999999887654
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=8.2e-18 Score=171.98 Aligned_cols=206 Identities=23% Similarity=0.333 Sum_probs=153.3
Q ss_pred HHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 012062 36 LKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 114 (472)
Q Consensus 36 l~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~-g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~L 114 (472)
|+.+.|.|+.+|++++.+ ...+++|.+||. |+|.+.+......++.--...+++.|+.||+||
T Consensus 1 l~~l~h~n~~~f~g~~~~----------------~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~yl 64 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVD----------------GPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYL 64 (484)
T ss_pred CcccchhhhhhheeeEec----------------CCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHH
Confidence 467899999999999987 457899999999 677788777777888888999999999999999
Q ss_pred HHCCc-cccCCCCCcEEEcCCCCeEEeeccceeeeccC-CCCccccccccCCCCChhhhcCCCC------CCCCcchhhH
Q 012062 115 HVNQV-LHRDIKGSNLLIDNEGNLKLADFGLARSFSYD-HNNTLTNRVITLWYRPPELLLGATK------YGPAVDMWSV 186 (472)
Q Consensus 115 H~~gi-iHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~------~~~~~DiwSl 186 (472)
|.--| .|+.|+..|++++....+||.|||+....... .........-...|.|||.+..... .+.+.||||+
T Consensus 65 h~s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~ 144 (484)
T KOG1023|consen 65 HNSPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSF 144 (484)
T ss_pred hcCcceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehH
Confidence 98865 99999999999999999999999997654320 0011111122567999999876321 3667999999
Q ss_pred HHHHHHHHhCCCCCCCCCh----HHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHH
Q 012062 187 GCIFAELLNGKPILPGKNE----AEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLE 262 (472)
Q Consensus 187 G~il~ell~G~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 262 (472)
|++++|+++...||..... .+.+..+.+. ......+.+.. . ..+.+++..+++
T Consensus 145 ~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~---~~~~~rP~i~~-------------------~-~e~~~~l~~l~~ 201 (484)
T KOG1023|consen 145 GIIMYEILFRSGPFDLRNLVEDPDEIILRVKKG---GSNPFRPSIEL-------------------L-NELPPELLLLVA 201 (484)
T ss_pred HHHHHHHHhccCccccccccCChHHHHHHHHhc---CCCCcCcchhh-------------------h-hhcchHHHHHHH
Confidence 9999999999999986432 2334443330 11111111100 0 034457899999
Q ss_pred HhhccCCCCCCCHHHHhc
Q 012062 263 KMLMLDPSQRISAKDALD 280 (472)
Q Consensus 263 ~~L~~dP~~R~t~~elL~ 280 (472)
.|+..+|++||+++++-.
T Consensus 202 ~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 202 RCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred HhcccChhhCccHHHHHh
Confidence 999999999999998853
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2e-17 Score=154.06 Aligned_cols=122 Identities=19% Similarity=0.223 Sum_probs=92.0
Q ss_pred eccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-----CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEE-EEE
Q 012062 4 EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-----QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTY-MVF 77 (472)
Q Consensus 4 ~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-----~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~-iVm 77 (472)
+..+... +||++...... ....+.+|+++++.| .|+||+++++++++... .+.++ +||
T Consensus 21 hp~~~~k-~IKv~~~~~~~--~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g-------------~g~v~~~I~ 84 (210)
T PRK10345 21 HPEDAQR-CIKIVYHRGDG--GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG-------------TGYVYDVIA 84 (210)
T ss_pred CCCCcCe-EEEEEeccccc--hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC-------------CeEEEEEEe
Confidence 4556666 69988764322 345788999999999 57999999999987321 23444 789
Q ss_pred ecCC---CChhhhhcCCCCCCCHHHHHHHHHHHHHHH-HHHHHCCccccCCCCCcEEEcC----CCCeEEeeccce
Q 012062 78 EYMD---HDLTGLADRPGLRFTVPQIKCYMKQLLTGL-HYCHVNQVLHRDIKGSNLLIDN----EGNLKLADFGLA 145 (472)
Q Consensus 78 Ey~~---g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL-~~LH~~giiHrDLKp~NILl~~----~~~vkL~DFG~a 145 (472)
||+. ++|.+++.+. .+++. ..++.|++.++ +|||+++|+||||||+|||++. +.+++|+||+.+
T Consensus 85 e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 85 DFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred cCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 9954 4787877553 46655 46688888888 9999999999999999999974 337999995433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.2e-17 Score=153.65 Aligned_cols=127 Identities=16% Similarity=0.169 Sum_probs=93.0
Q ss_pred ce-eccCCCEEEEEEeecCCcCC-----------C-----------chhhHHHHHHHHHhcCCCCccceeEEeeCCCCCC
Q 012062 2 AR-EIKTGEIVALKKIRMDNEKE-----------G-----------FPITAIREIKILKKLQHENVIKLKEIVTSPGPER 58 (472)
Q Consensus 2 a~-~~~tg~~vAlK~i~~~~~~~-----------~-----------~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 58 (472)
|+ +..+|+.||||+++...... . ....+.+|+.+++++.+. ++.+..++..
T Consensus 47 a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~-~i~~p~~~~~----- 120 (237)
T smart00090 47 ALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEA-GVPVPKPIAW----- 120 (237)
T ss_pred EEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhc-CCCCCeeeEe-----
Confidence 45 56799999999998653210 0 012346899999999753 3443333322
Q ss_pred CCCCCCCCCCcCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCCCcEEEcCCCCe
Q 012062 59 DEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ-VLHRDIKGSNLLIDNEGNL 137 (472)
Q Consensus 59 ~~~~~~~~~~~~~~~~iVmEy~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~g-iiHrDLKp~NILl~~~~~v 137 (472)
. ..||||||++++.+.........+...++..++.||+.+|.+||.+| |+||||||+|||++ ++++
T Consensus 121 -----------~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~~i 187 (237)
T smart00090 121 -----------R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DGKV 187 (237)
T ss_pred -----------c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CCCE
Confidence 1 23899999998544333222334667778899999999999999999 99999999999999 7889
Q ss_pred EEeeccceee
Q 012062 138 KLADFGLARS 147 (472)
Q Consensus 138 kL~DFG~a~~ 147 (472)
+|+|||++..
T Consensus 188 ~LiDFg~a~~ 197 (237)
T smart00090 188 VIIDVSQSVE 197 (237)
T ss_pred EEEEChhhhc
Confidence 9999998854
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.5e-16 Score=167.57 Aligned_cols=172 Identities=20% Similarity=0.266 Sum_probs=132.9
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC---CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ---HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
|.+.. ++.||||+-+-...++-+... +++.+|+ -+.|+++...+.- .+.-+||+|
T Consensus 717 a~~~~-~~~~alK~e~P~~~WEfYI~~-----q~~~RLk~~~~~~~~~~~~a~~~----------------~~~S~lv~e 774 (974)
T KOG1166|consen 717 ATHSN-GKLVALKVEKPPNPWEFYICL-----QVMERLKPQMLPSIMHISSAHVF----------------QNASVLVSE 774 (974)
T ss_pred eecCC-CcEEEEEeecCCCceeeeehH-----HHHHhhchhhhcchHHHHHHHcc----------------CCcceeeee
Confidence 33444 999999998877777644433 3344444 2345555444332 445689999
Q ss_pred cCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC-------CCCeEEeeccceeeecc
Q 012062 79 YMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN-------EGNLKLADFGLARSFSY 150 (472)
Q Consensus 79 y~~-g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~-------~~~vkL~DFG~a~~~~~ 150 (472)
|.+ |+|++++. ...-+++..+..|+.|+|..|++||..+|||+||||+|+||.. +--++|||||.+..+..
T Consensus 775 y~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~l 853 (974)
T KOG1166|consen 775 YSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKL 853 (974)
T ss_pred ccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeE
Confidence 999 68888877 4456999999999999999999999999999999999999842 22399999999976643
Q ss_pred C-CCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCC
Q 012062 151 D-HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK 197 (472)
Q Consensus 151 ~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~ 197 (472)
- ........+.|-.|-++|.+.+ +.++..+|.|.|..+++.||.|+
T Consensus 854 fp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 854 FPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred cCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHH
Confidence 2 2335556677999999998887 78999999999999999999986
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=6.3e-15 Score=136.60 Aligned_cols=119 Identities=22% Similarity=0.233 Sum_probs=87.5
Q ss_pred cCCCEEEEEEeecCCcCC--------------------CchhhHHHHHHHHHhcCCCC--ccceeEEeeCCCCCCCCCCC
Q 012062 6 KTGEIVALKKIRMDNEKE--------------------GFPITAIREIKILKKLQHEN--VIKLKEIVTSPGPERDEQGR 63 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~--------------------~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~~~~~~~~~~ 63 (472)
.+|+.||||+++...... .....+.+|+.++.++.|.+ +..+++.
T Consensus 37 ~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~~~~~------------- 103 (198)
T cd05144 37 PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPKPIDW------------- 103 (198)
T ss_pred CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCceeec-------------
Confidence 489999999987543110 01123567999999998874 3333321
Q ss_pred CCCCCcCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeecc
Q 012062 64 PDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFG 143 (472)
Q Consensus 64 ~~~~~~~~~~~iVmEy~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG 143 (472)
+..+|||||+++..+..+.. ...+..++.+|+.+|.+||+.+|+|+||||+||+|+.++.++|+|||
T Consensus 104 -------~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg 170 (198)
T cd05144 104 -------NRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWP 170 (198)
T ss_pred -------CCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECC
Confidence 13489999999844332221 13466788999999999999999999999999999999999999999
Q ss_pred ceeeecc
Q 012062 144 LARSFSY 150 (472)
Q Consensus 144 ~a~~~~~ 150 (472)
++..+..
T Consensus 171 ~~~~~~~ 177 (198)
T cd05144 171 QMVSTDH 177 (198)
T ss_pred ccccCCC
Confidence 9865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.1e-14 Score=136.18 Aligned_cols=119 Identities=19% Similarity=0.242 Sum_probs=92.4
Q ss_pred CCCEEEEEEeecCCcCCC------chhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 7 TGEIVALKKIRMDNEKEG------FPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~------~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
++..|+||+......... ....+.+|+.++..+.|++|+....++.. ....+|||||+
T Consensus 18 ~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~----------------~~~~~lv~e~~ 81 (211)
T PRK14879 18 LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD----------------PENFIIVMEYI 81 (211)
T ss_pred CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe----------------CCCCEEEEEEe
Confidence 778899998764332211 12356789999999999998877666654 33568999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceee
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS 147 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~ 147 (472)
+| +|.+++... .. ....++.+|+.+|.+||+.+|+|+||+|+|||++ ++.++|+|||++..
T Consensus 82 ~G~~L~~~~~~~----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSN----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhc----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 87 555555432 12 7788999999999999999999999999999999 77899999998753
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=3.9e-15 Score=152.59 Aligned_cols=232 Identities=21% Similarity=0.218 Sum_probs=179.1
Q ss_pred ccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC-CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCC
Q 012062 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHD 83 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~ 83 (472)
.++...+|+|.-+...........-++|+.-.+++. |+|+++.+..++. .+.+||-+|+|+..
T Consensus 140 ~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~----------------~~~lfiqtE~~~~s 203 (524)
T KOG0601|consen 140 SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG----------------SGILFIQTELCGES 203 (524)
T ss_pred ccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc----------------CCcceeeeccccch
Confidence 577888999985544333323344567888888885 9999998888877 66889999999998
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHH----HHHHHHHCCccccCCCCCcEEEcCC-CCeEEeeccceeeeccCCCCc---
Q 012062 84 LTGLADRPGLRFTVPQIKCYMKQLLT----GLHYCHVNQVLHRDIKGSNLLIDNE-GNLKLADFGLARSFSYDHNNT--- 155 (472)
Q Consensus 84 l~~~~~~~~~~l~~~~i~~i~~Qll~----aL~~LH~~giiHrDLKp~NILl~~~-~~vkL~DFG~a~~~~~~~~~~--- 155 (472)
+..+.......+....++.++.+++. ||.++|...|+|-|+||+||++..+ ...+++||++...+....-..
T Consensus 204 l~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~ 283 (524)
T KOG0601|consen 204 LQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFK 283 (524)
T ss_pred hHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEccCCcccccee
Confidence 88888877766899999999999999 9999999999999999999999998 789999999998876543111
Q ss_pred -cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCC--ChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 012062 156 -LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK--NEAEQLSKIFELCGSPDETIWPGVSKMPA 232 (472)
Q Consensus 156 -~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (472)
.....+...|++||++.+ -++.+.||++||.++.+..++...+... +...++...+
T Consensus 284 ~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~------------------- 342 (524)
T KOG0601|consen 284 VSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY------------------- 342 (524)
T ss_pred eeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-------------------
Confidence 112256788999998865 5789999999999999998886554433 1111111110
Q ss_pred cccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 233 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
...++....+.++..++..||..|+..|++++.++++.+..
T Consensus 343 ------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~ 383 (524)
T KOG0601|consen 343 ------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH 383 (524)
T ss_pred ------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc
Confidence 11223344566677799999999999999999999999874
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.5e-14 Score=135.47 Aligned_cols=123 Identities=19% Similarity=0.202 Sum_probs=88.9
Q ss_pred CCCEEEEEEeecCCc-----C------CCchhhHHHHHHHHHhcCCCCc--cceeEEeeCCCCCCCCCCCCCCCCcCCeE
Q 012062 7 TGEIVALKKIRMDNE-----K------EGFPITAIREIKILKKLQHENV--IKLKEIVTSPGPERDEQGRPDGNKYRGST 73 (472)
Q Consensus 7 tg~~vAlK~i~~~~~-----~------~~~~~~~~~Ei~il~~l~hpnI--v~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 73 (472)
.+..++||.++.... . ......+.+|+.++++|.|.+| ++.+.+...... .....
T Consensus 54 ~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~------------~~~~~ 121 (239)
T PRK01723 54 PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG------------LFYRA 121 (239)
T ss_pred CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC------------cceee
Confidence 367889998864211 1 1223567889999999998885 666666443110 01234
Q ss_pred EEEEecCCC--ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceee
Q 012062 74 YMVFEYMDH--DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS 147 (472)
Q Consensus 74 ~iVmEy~~g--~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~ 147 (472)
+||||++++ +|..++... .+++. .+.+|+.+|.+||++||+||||||+|||++.++.++|+|||.+..
T Consensus 122 ~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 122 DILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred eEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 699999996 555555432 35543 357899999999999999999999999999888999999998753
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.55 E-value=2e-14 Score=133.08 Aligned_cols=117 Identities=17% Similarity=0.248 Sum_probs=86.6
Q ss_pred cCCCEEEEEEeecCCcCCC------chhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 6 KTGEIVALKKIRMDNEKEG------FPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~------~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
.++..|+||+......... ...++.+|+++++.+.|.+|....-++.. ....+|||||
T Consensus 15 ~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~----------------~~~~~lv~e~ 78 (199)
T TIGR03724 15 FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD----------------PDNKTIVMEY 78 (199)
T ss_pred cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE----------------CCCCEEEEEE
Confidence 4678899998654321111 12456789999999998876544444332 3346899999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceee
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS 147 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~ 147 (472)
++| +|.+++.... ..++.+|+.+|.+||+.+|+|+||||+|||++ ++.++|+|||++..
T Consensus 79 ~~g~~l~~~~~~~~--------~~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGN--------DELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcH--------HHHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 987 4544443211 17899999999999999999999999999999 78899999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.53 E-value=3.4e-14 Score=130.16 Aligned_cols=123 Identities=22% Similarity=0.250 Sum_probs=83.5
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhh----------------------HHHHHHHHHhcCCCC--ccceeEEeeCCCCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPIT----------------------AIREIKILKKLQHEN--VIKLKEIVTSPGPE 57 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~----------------------~~~Ei~il~~l~hpn--Iv~l~~~~~~~~~~ 57 (472)
|++. +++.||||+++........... ...|..++..+.+.. +.+++.+.
T Consensus 16 a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~------ 88 (187)
T cd05119 16 ALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVPKPIDLN------ 88 (187)
T ss_pred EECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCCceEecC------
Confidence 4554 8999999998764321111111 135666666665433 33333221
Q ss_pred CCCCCCCCCCCcCCeEEEEEecCCCC-hhh-hhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCC
Q 012062 58 RDEQGRPDGNKYRGSTYMVFEYMDHD-LTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNE 134 (472)
Q Consensus 58 ~~~~~~~~~~~~~~~~~iVmEy~~g~-l~~-~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~-~giiHrDLKp~NILl~~~ 134 (472)
..+|||||+.++ +.. .+.... .. .++..++.+++.++.+||. .+|+|+||||+||+++ +
T Consensus 89 --------------~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 89 --------------RHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-D 150 (187)
T ss_pred --------------CCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-C
Confidence 248999999973 211 111111 11 6788999999999999999 9999999999999999 8
Q ss_pred CCeEEeeccceeeec
Q 012062 135 GNLKLADFGLARSFS 149 (472)
Q Consensus 135 ~~vkL~DFG~a~~~~ 149 (472)
+.++|+|||.+....
T Consensus 151 ~~~~liDfg~a~~~~ 165 (187)
T cd05119 151 GKVYIIDVPQAVEID 165 (187)
T ss_pred CcEEEEECccccccc
Confidence 889999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.1e-13 Score=147.55 Aligned_cols=95 Identities=20% Similarity=0.295 Sum_probs=79.1
Q ss_pred hhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHH
Q 012062 27 ITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMK 105 (472)
Q Consensus 27 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~~~~~~~~~~l~~~~i~~i~~ 105 (472)
..+.+|+++++.++|++|+..+.++.. ....+|||||+++ +|.+++. ....++.
T Consensus 381 ~~~~~E~~~l~~l~~~~i~~p~~~~~~----------------~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~ 435 (535)
T PRK09605 381 ERTRAEARLLSEARRAGVPTPVIYDVD----------------PEEKTIVMEYIGGKDLKDVLE---------GNPELVR 435 (535)
T ss_pred HHHHHHHHHHHhhcccCCCeeEEEEEe----------------CCCCEEEEEecCCCcHHHHHH---------HHHHHHH
Confidence 456789999999999999887766654 2345899999987 5544442 4577899
Q ss_pred HHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceee
Q 012062 106 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS 147 (472)
Q Consensus 106 Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~ 147 (472)
+|+.+|.+||+++|+||||||+|||+ .++.++|+|||+++.
T Consensus 436 ~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 436 KVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred HHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999999999999999999 567899999999854
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.45 E-value=5.3e-13 Score=116.49 Aligned_cols=113 Identities=23% Similarity=0.242 Sum_probs=90.8
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCC--CCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCCh
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQH--ENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDL 84 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~l 84 (472)
++..++||.++.... ...+.+|+.+++.+++ .++.+++.++.. .+..|++|||+.+..
T Consensus 20 ~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~----------------~~~~~~v~e~~~g~~ 79 (155)
T cd05120 20 KDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGES----------------DGWSYLLMEWIEGET 79 (155)
T ss_pred cCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC----------------CCccEEEEEecCCee
Confidence 346889998865432 3467899999999986 588888887764 346799999998754
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCCCcEEEcCCCCeEEeecccee
Q 012062 85 TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN---QVLHRDIKGSNLLIDNEGNLKLADFGLAR 146 (472)
Q Consensus 85 ~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~---giiHrDLKp~NILl~~~~~vkL~DFG~a~ 146 (472)
...+ +......++.+++.+|++||.. +++|+|||++|||++..+.++|+||+.+.
T Consensus 80 ~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 80 LDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred cccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 3322 4556777899999999999985 79999999999999998899999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=3.1e-14 Score=135.51 Aligned_cols=237 Identities=18% Similarity=0.177 Sum_probs=151.1
Q ss_pred ceeccCCCEEEEEEeecCCcCC--CchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 2 AREIKTGEIVALKKIRMDNEKE--GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~--~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
|-+.+.|..|+.-.+.....++ ........-+..|-.+.|-|||+++.||.+...+ .+..+.++.||
T Consensus 85 amd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~-----------e~~rviFitey 153 (458)
T KOG1266|consen 85 AMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYE-----------EKPRVIFITEY 153 (458)
T ss_pred HhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccc-----------cccceEEEEec
Confidence 4455566666655554332111 1112222234455666799999999999874322 14567899999
Q ss_pred CC-CChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCCCcEEEcCCCCeEEeeccceeeeccC--
Q 012062 80 MD-HDLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVN--QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD-- 151 (472)
Q Consensus 80 ~~-g~l~~~~~~---~~~~l~~~~i~~i~~Qll~aL~~LH~~--giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-- 151 (472)
|+ +.+...+++ +...+.+...++|+.||+.||.|||+. -|+|.+|..+.|++..++-+||.---.. .+...
T Consensus 154 mssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~ 232 (458)
T KOG1266|consen 154 MSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVN 232 (458)
T ss_pred ccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCcc-ccchhhh
Confidence 98 566555543 445688888999999999999999998 4999999999999998887776532111 11000
Q ss_pred --CCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCCCCCCccCC
Q 012062 152 --HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPI-LPGKNEAEQLSKIFELCGSPDETIWPGVS 228 (472)
Q Consensus 152 --~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 228 (472)
.........+-+.|.+||.-.- ...+-++|||++|...++|..+..- -.+......-..+.+....
T Consensus 233 ~~~~~Ek~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~---------- 301 (458)
T KOG1266|consen 233 STREAEKSVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIG---------- 301 (458)
T ss_pred hhhHhhhhccccCCccccCCcCcc-cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheee----------
Confidence 0001111234567889985432 4556789999999999999877632 2222222211112111100
Q ss_pred CCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 229 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
.-+..-+++|.+||+-.|..|+++.++|.|+.+
T Consensus 302 -----------------------len~lqr~~i~kcl~~eP~~rp~ar~llfHpll 334 (458)
T KOG1266|consen 302 -----------------------LENGLQRGSITKCLEGEPNGRPDARLLLFHPLL 334 (458)
T ss_pred -----------------------ccCccccCcCcccccCCCCCCcchhhhhcCcee
Confidence 001123579999999999999999999999975
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.2e-12 Score=135.78 Aligned_cols=167 Identities=21% Similarity=0.336 Sum_probs=126.8
Q ss_pred eeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC
Q 012062 3 REIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH 82 (472)
Q Consensus 3 ~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g 82 (472)
..+.++.+|.|+..+.... .....+.+-++.||.|+||||+++++.++. ++++|||+|-+..
T Consensus 32 t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~----------------~~~~ylvTErV~P 93 (690)
T KOG1243|consen 32 TRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEE----------------EGTLYLVTERVRP 93 (690)
T ss_pred ceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcc----------------cCceEEEeecccc
Confidence 4578899999999986654 345567788999999999999999999987 6689999999864
Q ss_pred ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccc
Q 012062 83 DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH-VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 161 (472)
Q Consensus 83 ~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH-~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 161 (472)
|..++.+ +....+...+.||+.||.||| +.+++|++|..+.|+|+..|++||.+|.++........ ......-
T Consensus 94 -l~~~lk~----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~ 167 (690)
T KOG1243|consen 94 -LETVLKE----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYL 167 (690)
T ss_pred -HHHHHHH----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchh
Confidence 2222222 335567777999999999997 56899999999999999999999999998865543221 0011111
Q ss_pred cCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhC
Q 012062 162 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNG 196 (472)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G 196 (472)
--.|..|+.+-. -....|.|-|||++++++.|
T Consensus 168 ~~s~~~P~~~~~---s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 168 IESFDDPEEIDP---SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hhcccChhhcCc---cccchhhhhHHHHHHHHhCc
Confidence 234667764432 12567999999999999999
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.42 E-value=9.6e-14 Score=149.32 Aligned_cols=188 Identities=27% Similarity=0.426 Sum_probs=147.5
Q ss_pred CCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeee
Q 012062 70 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 148 (472)
Q Consensus 70 ~~~~~iVmEy~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 148 (472)
....+|||+|+.+ +|...+.... ..+.+-++.++..+..++++||...++|||++|.|+|+..++..++.||+.....
T Consensus 876 rsP~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 876 RSPLPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred CCCcchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccc
Confidence 4567999999985 5555554433 5777788888999999999999999999999999999999999999999843322
Q ss_pred ccC-----C-------------------------CCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCC
Q 012062 149 SYD-----H-------------------------NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKP 198 (472)
Q Consensus 149 ~~~-----~-------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~ 198 (472)
... . .......++|+-|.+||.+.+ ......+|.|++|+++++.++|.+
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-RRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-ccCCCcchhhhhhhhhhhhhcCCC
Confidence 110 0 001222466999999999988 567888999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHH--
Q 012062 199 ILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAK-- 276 (472)
Q Consensus 199 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~-- 276 (472)
||........+..|... +..|+.... ..+.++.+++.++|..++.+|..+.
T Consensus 1034 p~na~tpq~~f~ni~~~-----~~~~p~g~~----------------------~~s~~aq~~~~~ll~~~~~qr~~a~~~ 1086 (1205)
T KOG0606|consen 1034 PFNAETPQQIFENILNR-----DIPWPEGPE----------------------EGSYEAQDLINRLLTEEPTQRLGAKGA 1086 (1205)
T ss_pred CCCCcchhhhhhccccC-----CCCCCCCcc----------------------ccChhhhhhhhhhhccCchhccCcccc
Confidence 99999988877666443 233443322 3566899999999999999999887
Q ss_pred -HHhcCCCCCC
Q 012062 277 -DALDSEYFWT 286 (472)
Q Consensus 277 -elL~h~~f~~ 286 (472)
++-.|+||..
T Consensus 1087 ~e~k~~~~~~~ 1097 (1205)
T KOG0606|consen 1087 AEVKGHPFFQD 1097 (1205)
T ss_pred cccccCCccCC
Confidence 8899999954
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.2e-12 Score=118.31 Aligned_cols=97 Identities=15% Similarity=0.243 Sum_probs=73.6
Q ss_pred HHHHHHHhcCC--CCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCChh-hhhcCCCCCCCHHHHHHHHHHH
Q 012062 31 REIKILKKLQH--ENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLT-GLADRPGLRFTVPQIKCYMKQL 107 (472)
Q Consensus 31 ~Ei~il~~l~h--pnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~l~-~~~~~~~~~l~~~~i~~i~~Ql 107 (472)
+|++.|++|.. -++.+.+++.. -+|||||++++.+ ....+ +..+++.++..++.++
T Consensus 75 kE~r~L~rl~~~Gv~vP~pi~~~~--------------------~~lvME~Ig~~~~~~~~Lk-d~~~~~~~~~~i~~~i 133 (197)
T cd05146 75 KEMHNLKRMQKAGIPCPEVVVLKK--------------------HVLVMSFIGDDQVPAPKLK-DAKLNDEEMKNAYYQV 133 (197)
T ss_pred HHHHHHHHHHHcCCCCCeEEEecC--------------------CEEEEEEcCCCCccchhhh-ccccCHHHHHHHHHHH
Confidence 79999999964 45556665432 2899999987422 11111 2235666778889999
Q ss_pred HHHHHHH-HHCCccccCCCCCcEEEcCCCCeEEeeccceeeec
Q 012062 108 LTGLHYC-HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 149 (472)
Q Consensus 108 l~aL~~L-H~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 149 (472)
+.+|..| |+.||+|+||++.|||+++ +.++|+||+.+....
T Consensus 134 ~~~l~~l~H~~glVHGDLs~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 134 LSMMKQLYKECNLVHADLSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHHHHHHHhCCeecCCCCHHHEEEEC-CcEEEEECCCceeCC
Confidence 9999999 8999999999999999974 679999999986643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.6e-11 Score=122.28 Aligned_cols=211 Identities=18% Similarity=0.232 Sum_probs=153.0
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|....+|..|++|.++-++.. .......-+++++++.|.|||.|.++|..... .+..+++|++|..
T Consensus 295 ~~s~~DG~~YvLkRlhg~r~~--~~nk~t~lve~wkkl~h~NvV~frevf~t~tF------------~D~SlvlvYDYyP 360 (655)
T KOG3741|consen 295 ATSNVDGNAYVLKRLHGDRDQ--STNKDTSLVEAWKKLCHTNVVPFREVFLTYTF------------GDLSLVLVYDYYP 360 (655)
T ss_pred eeeccCCceeeeeeecccccc--CcccchHHHHHHHHhccCceeehhhhhhhhcc------------CcceEEEEEecCC
Confidence 456789999999999544322 12233456788999999999999999984221 2567999999998
Q ss_pred C--ChhhhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccce
Q 012062 82 H--DLTGLADR--------------PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLA 145 (472)
Q Consensus 82 g--~l~~~~~~--------------~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a 145 (472)
+ +|.++... .+...++..+|+|+.||..||.++|+.|+..+-|.+.+||++.+.+++|...|+.
T Consensus 361 ~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~ 440 (655)
T KOG3741|consen 361 SSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIM 440 (655)
T ss_pred CCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccce
Confidence 5 55554322 2234678999999999999999999999999999999999999988999888876
Q ss_pred eeeccCCCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCc
Q 012062 146 RSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWP 225 (472)
Q Consensus 146 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 225 (472)
.....+.. |-+.. -.+-|.=.||.+++.|.||..--..
T Consensus 441 Dvl~~d~~---------------~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~----------------------- 478 (655)
T KOG3741|consen 441 DVLQEDPT---------------EPLES----QQQNDLRDLGLLLLALATGTENSNR----------------------- 478 (655)
T ss_pred eeecCCCC---------------cchhH----HhhhhHHHHHHHHHHHhhccccccc-----------------------
Confidence 54432220 11211 2346899999999999998521000
Q ss_pred cCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 226 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
......-....+...++.+++++|.-+...++++ -++.+++.+
T Consensus 479 ------------~d~~~~s~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 479 ------------TDSTQSSHLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred ------------ccchHHHHHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 0001112234445568889999999999999987 688888865
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.4e-12 Score=133.99 Aligned_cols=227 Identities=21% Similarity=0.179 Sum_probs=160.2
Q ss_pred ccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCC
Q 012062 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHD 83 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~ 83 (472)
..++..|++|.+.............+.|+.+...+ .|.++++++..|.. ....||=.|||++.
T Consensus 288 ~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~----------------~r~~~ip~e~~~~~ 351 (524)
T KOG0601|consen 288 PEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ----------------LRQGYIPLEFCEGG 351 (524)
T ss_pred CCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc----------------cccccCchhhhcCc
Confidence 35667778887765544433344556788888777 49999998887765 34567999999875
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC-CCeEEeeccceeeeccCCCCcccccccc
Q 012062 84 LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE-GNLKLADFGLARSFSYDHNNTLTNRVIT 162 (472)
Q Consensus 84 l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~-~~vkL~DFG~a~~~~~~~~~~~~~~~gt 162 (472)
...+.......+++...+++..|++.++.++|++.++|+|+||+||++.++ +..++.||+.++.+... ......+
T Consensus 352 s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~----~~~~~~~ 427 (524)
T KOG0601|consen 352 SSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS----SGVFHHI 427 (524)
T ss_pred chhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee----ccccccc
Confidence 555444444458888999999999999999999999999999999999986 67899999988653211 1112223
Q ss_pred CCCC-ChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchh
Q 012062 163 LWYR-PPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241 (472)
Q Consensus 163 ~~y~-aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (472)
-.+. ..|++.....+..+.|++||+..+.+.+++...-....... .|... .++
T Consensus 428 ~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~---~i~~~-------------~~p---------- 481 (524)
T KOG0601|consen 428 DRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL---TIRSG-------------DTP---------- 481 (524)
T ss_pred ccccccchhhccccccccccccccccccccccccCcccCcccccce---eeecc-------------ccc----------
Confidence 3444 36666666778899999999999999999874332211100 00000 000
Q ss_pred hhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
........+..+.+.++..|+..|+.+.++..|.-|
T Consensus 482 -------~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 482 -------NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred -------CCCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 001223568889999999999999999999888655
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.21 E-value=5.3e-11 Score=106.94 Aligned_cols=110 Identities=18% Similarity=0.179 Sum_probs=79.0
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCcc-ceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCChh
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVI-KLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLT 85 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~l~ 85 (472)
.++.|+||+...... ......+|+++++.+.+.+++ +++.+... .-++||||++|..+
T Consensus 20 ~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~------------------~~~lv~e~i~G~~l 78 (170)
T cd05151 20 ANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDPE------------------TGVLITEFIEGSEL 78 (170)
T ss_pred CCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeCC------------------CCeEEEEecCCCcc
Confidence 477899998764422 123457899999999765544 45544321 23799999998433
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCc-----cccCCCCCcEEEcCCCCeEEeecccee
Q 012062 86 GLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQV-----LHRDIKGSNLLIDNEGNLKLADFGLAR 146 (472)
Q Consensus 86 ~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~gi-----iHrDLKp~NILl~~~~~vkL~DFG~a~ 146 (472)
.... .....++.+|+.+|+.||..++ +|+|+++.|||++ ++.++|+||+.+.
T Consensus 79 ~~~~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 2210 1123467899999999999985 9999999999999 5679999999863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.21 E-value=9.3e-12 Score=130.70 Aligned_cols=74 Identities=19% Similarity=0.350 Sum_probs=53.0
Q ss_pred CCeEEEEEecCCC-Chhhh--hcCCCC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC----CeEE
Q 012062 70 RGSTYMVFEYMDH-DLTGL--ADRPGL---RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG----NLKL 139 (472)
Q Consensus 70 ~~~~~iVmEy~~g-~l~~~--~~~~~~---~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~----~vkL 139 (472)
...-+|||||++| .+.+. +...+. .+.+..+..++.||+ ..|++|+|+||.||+++.++ ++++
T Consensus 233 st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~l 305 (537)
T PRK04750 233 CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIA 305 (537)
T ss_pred CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEE
Confidence 3455899999998 44332 222221 244445555666665 58999999999999999888 8999
Q ss_pred eeccceeeecc
Q 012062 140 ADFGLARSFSY 150 (472)
Q Consensus 140 ~DFG~a~~~~~ 150 (472)
+|||++..+..
T Consensus 306 lDFGivg~l~~ 316 (537)
T PRK04750 306 LDFGIVGSLNK 316 (537)
T ss_pred EecceEEECCH
Confidence 99999977653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.9e-10 Score=119.18 Aligned_cols=75 Identities=20% Similarity=0.338 Sum_probs=55.0
Q ss_pred eEEEEEecCCCC-hhhhhcCCCCCCCHHHHHHHHHHHHH-HHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeec
Q 012062 72 STYMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLT-GLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 149 (472)
Q Consensus 72 ~~~iVmEy~~g~-l~~~~~~~~~~l~~~~i~~i~~Qll~-aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 149 (472)
.-+|||||++|. +.+........++ ...++..++. .+..+|..|++|+|+||.||+++.+++++|+|||++..+.
T Consensus 232 ~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 232 ERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 358999999974 4333321111122 2345555555 4788999999999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.3e-10 Score=106.26 Aligned_cols=120 Identities=23% Similarity=0.276 Sum_probs=77.5
Q ss_pred cCCCEEEEEEeecCCcC-----------CC-------------chhhHHHHHHHHHhcCCC--CccceeEEeeCCCCCCC
Q 012062 6 KTGEIVALKKIRMDNEK-----------EG-------------FPITAIREIKILKKLQHE--NVIKLKEIVTSPGPERD 59 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~-----------~~-------------~~~~~~~Ei~il~~l~hp--nIv~l~~~~~~~~~~~~ 59 (472)
.+++.||||+.+..... .. ....+.+|.++|.++..- ++.+++++-..
T Consensus 8 ~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~~~------ 81 (188)
T PF01163_consen 8 PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYNRN------ 81 (188)
T ss_dssp CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEETT------
T ss_pred CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEeCC------
Confidence 35779999998743210 00 113346799999999866 46677755432
Q ss_pred CCCCCCCCCcCCeEEEEEecCC--CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHH-HHHCCccccCCCCCcEEEcCCCC
Q 012062 60 EQGRPDGNKYRGSTYMVFEYMD--HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHY-CHVNQVLHRDIKGSNLLIDNEGN 136 (472)
Q Consensus 60 ~~~~~~~~~~~~~~~iVmEy~~--g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~-LH~~giiHrDLKp~NILl~~~~~ 136 (472)
+|||||++ |..+..+.... ++......++.+++..+.. +|..||+|+||.+.|||++.+ .
T Consensus 82 --------------~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~ 144 (188)
T PF01163_consen 82 --------------VIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-K 144 (188)
T ss_dssp --------------EEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-C
T ss_pred --------------EEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-e
Confidence 79999999 64333333221 2244567788889886655 579999999999999999987 7
Q ss_pred eEEeeccceeee
Q 012062 137 LKLADFGLARSF 148 (472)
Q Consensus 137 vkL~DFG~a~~~ 148 (472)
+.|+||+.+...
T Consensus 145 ~~iIDf~qav~~ 156 (188)
T PF01163_consen 145 VYIIDFGQAVDS 156 (188)
T ss_dssp EEE--GTTEEET
T ss_pred EEEEecCcceec
Confidence 999999998654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.2e-09 Score=105.68 Aligned_cols=130 Identities=18% Similarity=0.112 Sum_probs=88.9
Q ss_pred cCCCEEEEEEeecCCcCCC--------c-hhhHHHHHHHHHhcCCCCcc--ceeEEeeCCCCCCCCCCCCCCCCcCCeEE
Q 012062 6 KTGEIVALKKIRMDNEKEG--------F-PITAIREIKILKKLQHENVI--KLKEIVTSPGPERDEQGRPDGNKYRGSTY 74 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~--------~-~~~~~~Ei~il~~l~hpnIv--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 74 (472)
-.|+.|.||........+. . ...+.+|...+.+|..-+|. ..+.+.+... +.....-+
T Consensus 43 ~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~-----------~~~~~~s~ 111 (268)
T PRK15123 43 LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGS-----------NPATRTSF 111 (268)
T ss_pred ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecC-----------CCccceeE
Confidence 3567889996643321110 0 11477999999988644443 3344443210 00022468
Q ss_pred EEEecCCC--ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC-------CCCeEEeeccc
Q 012062 75 MVFEYMDH--DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN-------EGNLKLADFGL 144 (472)
Q Consensus 75 iVmEy~~g--~l~~~~~~~-~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~-------~~~vkL~DFG~ 144 (472)
||||++++ +|.+++... ....+......++.+|+..+.-||.+||+|+||++.||||+. +..+.||||+.
T Consensus 112 LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r 191 (268)
T PRK15123 112 IITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHR 191 (268)
T ss_pred EEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence 99999997 455555321 234567778899999999999999999999999999999975 45799999997
Q ss_pred ee
Q 012062 145 AR 146 (472)
Q Consensus 145 a~ 146 (472)
+.
T Consensus 192 ~~ 193 (268)
T PRK15123 192 AQ 193 (268)
T ss_pred cc
Confidence 64
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.2e-10 Score=121.39 Aligned_cols=160 Identities=23% Similarity=0.288 Sum_probs=115.7
Q ss_pred HHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC--------ccccccccCCCCChh
Q 012062 99 QIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN--------TLTNRVITLWYRPPE 169 (472)
Q Consensus 99 ~i~~i~~Qll~aL~~LH~~-giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~--------~~~~~~gt~~y~aPE 169 (472)
.+..=+.+++.||.|+|.. ++||+.|.|++|.++..+.+||+.|+++......... ...-..-...|.|||
T Consensus 100 ~~f~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE 179 (700)
T KOG2137|consen 100 DGFANLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPE 179 (700)
T ss_pred HhhhhhhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccch
Confidence 3333345666899999976 9999999999999999999999999988654431111 001112266799999
Q ss_pred hhcCCCCCCCCcchhhHHHHHHHHH-hCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHH
Q 012062 170 LLLGATKYGPAVDMWSVGCIFAELL-NGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVRE 248 (472)
Q Consensus 170 ~l~~~~~~~~~~DiwSlG~il~ell-~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (472)
.+.. ...+.++|+|||||++|.+. .|+..|...+.......-....... ...
T Consensus 180 ~~~~-~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~--------------------------~~~ 232 (700)
T KOG2137|consen 180 YLLG-TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAG--------------------------AFG 232 (700)
T ss_pred hhcc-ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccc--------------------------ccc
Confidence 9987 66789999999999999999 6777666654433332221111000 000
Q ss_pred HhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 249 VFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 249 ~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
....++.++++-|.++|..|...|+++.+++..+||.
T Consensus 233 ~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~ 269 (700)
T KOG2137|consen 233 YSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFS 269 (700)
T ss_pred ccccCcHHHHHHHHHHhcCCcccCcchhhhhcccccC
Confidence 1135788999999999999999999999999999984
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=1e-09 Score=97.96 Aligned_cols=93 Identities=20% Similarity=0.344 Sum_probs=70.8
Q ss_pred hhHHHHHHHHHhcCCCC--ccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCChhh-hhcCCCCCCCHHHHHHH
Q 012062 27 ITAIREIKILKKLQHEN--VIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTG-LADRPGLRFTVPQIKCY 103 (472)
Q Consensus 27 ~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~l~~-~~~~~~~~l~~~~i~~i 103 (472)
.+..+|+.++.++.--. +..++++... ...|+|||++|.++. ++... ...+
T Consensus 44 ~Rt~~Earil~~a~~~GV~~P~v~dvD~~------------------~~~I~me~I~G~~lkd~l~~~--------~~~~ 97 (204)
T COG3642 44 ERTRREARILAKAREAGVPVPIVYDVDPD------------------NGLIVMEYIEGELLKDALEEA--------RPDL 97 (204)
T ss_pred HHHHHHHHHHHHHHHcCCCCCeEEEEcCC------------------CCEEEEEEeCChhHHHHHHhc--------chHH
Confidence 34467999999886444 3445554432 347999999997765 44332 2456
Q ss_pred HHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeecccee
Q 012062 104 MKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 146 (472)
Q Consensus 104 ~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 146 (472)
++.|=.-+.-||.+||+|+||.++||++...+ +.++|||++.
T Consensus 98 ~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~ 139 (204)
T COG3642 98 LREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGE 139 (204)
T ss_pred HHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccc
Confidence 77777888899999999999999999998876 9999999985
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.7e-09 Score=96.09 Aligned_cols=128 Identities=18% Similarity=0.188 Sum_probs=86.4
Q ss_pred eccCCCEEEEEEeecCCc-C-----CCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEE
Q 012062 4 EIKTGEIVALKKIRMDNE-K-----EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVF 77 (472)
Q Consensus 4 ~~~tg~~vAlK~i~~~~~-~-----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVm 77 (472)
..-.|+.+.||.-....- - .-...+...|+++|.++.--.|.--.=+|.+. ..-+|+|
T Consensus 26 ~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~----------------~~~~i~M 89 (229)
T KOG3087|consen 26 GSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT----------------YGGQIYM 89 (229)
T ss_pred eccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec----------------CCCeEEE
Confidence 345677777775322211 1 11224456799999998754554333344331 1237999
Q ss_pred ecCCC--ChhhhhcCCCCCCCHHHH-HHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC---eEEeeccceee
Q 012062 78 EYMDH--DLTGLADRPGLRFTVPQI-KCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN---LKLADFGLARS 147 (472)
Q Consensus 78 Ey~~g--~l~~~~~~~~~~l~~~~i-~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~---vkL~DFG~a~~ 147 (472)
||++| ++.+++......-++++. ..+++.|=+.|.-||.++|||+||..+||+|..++. +.|+|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99998 666666553323333343 788999999999999999999999999999987664 58999999743
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.91 E-value=1e-08 Score=96.02 Aligned_cols=124 Identities=19% Similarity=0.228 Sum_probs=87.6
Q ss_pred CCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCC--CccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCChh
Q 012062 8 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHE--NVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLT 85 (472)
Q Consensus 8 g~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~l~ 85 (472)
|+.++||+....... .....+.+|+++++.+.+. ++.+++.+..... ..+..|+||||++|..+
T Consensus 22 g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~-------------~~~~~~~v~e~i~G~~l 87 (223)
T cd05154 22 GRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS-------------VLGTPFYVMERVDGRVL 87 (223)
T ss_pred CcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC-------------ccCCceEEEEEeCCEec
Confidence 578999998654322 1345678999999999764 4566776654311 12356899999998533
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------------
Q 012062 86 GLADRPGLRFTVPQIKCYMKQLLTGLHYCHV------------------------------------------------- 116 (472)
Q Consensus 86 ~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~------------------------------------------------- 116 (472)
...... ..+++.+...++.+++..|..||+
T Consensus 88 ~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (223)
T cd05154 88 RDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEA 166 (223)
T ss_pred CCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHh
Confidence 322211 246777777788888888888873
Q ss_pred -------CCccccCCCCCcEEEcC--CCCeEEeecccee
Q 012062 117 -------NQVLHRDIKGSNLLIDN--EGNLKLADFGLAR 146 (472)
Q Consensus 117 -------~giiHrDLKp~NILl~~--~~~vkL~DFG~a~ 146 (472)
..++|+|+++.|||++. ++.+.|+||+.+.
T Consensus 167 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 167 HLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred hCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 23699999999999998 5668999999774
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.2e-08 Score=93.38 Aligned_cols=109 Identities=20% Similarity=0.228 Sum_probs=82.1
Q ss_pred hhhHHHHHHHHHhcCCCC--ccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC--ChhhhhcCCCCCCCHHHHH
Q 012062 26 PITAIREIKILKKLQHEN--VIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH--DLTGLADRPGLRFTVPQIK 101 (472)
Q Consensus 26 ~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g--~l~~~~~~~~~~l~~~~i~ 101 (472)
..++.+|...+..|..-. +.+.+.+.+.... - ....+||+|++++ +|.+++.... .++.....
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~-----------~-~~~s~lite~l~~~~~L~~~~~~~~-~~~~~~~~ 121 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKG-----------G-GYRSYLITEALPGAQDLRDLLQQWE-QLDPSQRR 121 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCC-----------C-ceeEEEEEEeCCCcccHHHHHHhhc-ccchhhHH
Confidence 346788999998886443 3455555543110 0 1346899999997 5666655422 26677888
Q ss_pred HHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC---CeEEeeccceee
Q 012062 102 CYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG---NLKLADFGLARS 147 (472)
Q Consensus 102 ~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~---~vkL~DFG~a~~ 147 (472)
.++.+|...++-||.+||+|+||++.||||+.++ .+.|+||+.++.
T Consensus 122 ~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 122 ELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999999999999999999999999999887 799999997653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=2.3e-07 Score=92.04 Aligned_cols=129 Identities=12% Similarity=0.120 Sum_probs=96.6
Q ss_pred eEEEEEecCCCC--hhhhhc-----CCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccc
Q 012062 72 STYMVFEYMDHD--LTGLAD-----RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGL 144 (472)
Q Consensus 72 ~~~iVmEy~~g~--l~~~~~-----~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~ 144 (472)
.+-++|..+.+. ...++. +.-..+.+.-+.+..+.|+.+.+.||+.|.+-+|+.++|||+++++.|.|+|-..
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence 378899998862 222211 1122367788999999999999999999999999999999999999999998654
Q ss_pred eeeeccCCCCccccccccCCCCChhhhcCC----CCCCCCcchhhHHHHHHHHHhC-CCCCCC
Q 012062 145 ARSFSYDHNNTLTNRVITLWYRPPELLLGA----TKYGPAVDMWSVGCIFAELLNG-KPILPG 202 (472)
Q Consensus 145 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~~DiwSlG~il~ell~G-~~pf~~ 202 (472)
-... .........++...|.+||.-.-. ..-+...|.|.|++++|+||.| +.||.+
T Consensus 164 fqi~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 164 FQIN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred eeec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 3322 223333445789999999964311 1235678999999999999986 899976
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=2.4e-07 Score=87.64 Aligned_cols=116 Identities=22% Similarity=0.273 Sum_probs=84.5
Q ss_pred CCCEEEEEEeecCCcC--------------------CCchhhHHHHHHHHHhcCCC--CccceeEEeeCCCCCCCCCCCC
Q 012062 7 TGEIVALKKIRMDNEK--------------------EGFPITAIREIKILKKLQHE--NVIKLKEIVTSPGPERDEQGRP 64 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~--------------------~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~~~~~~~~~~~~~~ 64 (472)
.|..+|||.=+..... ......+.+|.++|.+|... .|.+.+++-.
T Consensus 114 ~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~P~~~nR------------ 181 (304)
T COG0478 114 KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPKPIAWNR------------ 181 (304)
T ss_pred CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCCcccccc------------
Confidence 5889999976532110 01234567899999999765 6667665432
Q ss_pred CCCCcCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccc
Q 012062 65 DGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGL 144 (472)
Q Consensus 65 ~~~~~~~~~~iVmEy~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~ 144 (472)
-++||||++|-.+.-+ +++...+..++..|+.-+.-+-..||||+|+..-|||++++|.++|+||=.
T Consensus 182 --------HaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ 248 (304)
T COG0478 182 --------HAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWPQ 248 (304)
T ss_pred --------ceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeCcc
Confidence 3799999998443222 123445666777788877777799999999999999999999999999987
Q ss_pred eee
Q 012062 145 ARS 147 (472)
Q Consensus 145 a~~ 147 (472)
+..
T Consensus 249 ~v~ 251 (304)
T COG0478 249 AVP 251 (304)
T ss_pred ccc
Confidence 644
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.55 E-value=7.1e-07 Score=83.64 Aligned_cols=123 Identities=16% Similarity=0.193 Sum_probs=84.2
Q ss_pred cCCCEEEEEEeecCCcCCC----------------------chhhHHHHHHHHHhcC--CCCccceeEEeeCCCCCCCCC
Q 012062 6 KTGEIVALKKIRMDNEKEG----------------------FPITAIREIKILKKLQ--HENVIKLKEIVTSPGPERDEQ 61 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~----------------------~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~~~~ 61 (472)
.++..||||+++....... ...-..+|+..|+++. +=.+.+-+.++..
T Consensus 70 ~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~~n-------- 141 (268)
T COG1718 70 GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFRNN-------- 141 (268)
T ss_pred CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeecCC--------
Confidence 3578999999985421100 0112246888888885 3344455555432
Q ss_pred CCCCCCCcCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCCeEEe
Q 012062 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGNLKLA 140 (472)
Q Consensus 62 ~~~~~~~~~~~~~iVmEy~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~-~giiHrDLKp~NILl~~~~~vkL~ 140 (472)
.|||||+..+..-.=.-.+..+...++..+..++++.+.-|-. .++||+||..-|||+. ++.+.||
T Consensus 142 ------------VLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iI 208 (268)
T COG1718 142 ------------VLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYII 208 (268)
T ss_pred ------------eEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEE
Confidence 7999999864211101112234444788889999999999877 8999999999999999 7789999
Q ss_pred eccceeeec
Q 012062 141 DFGLARSFS 149 (472)
Q Consensus 141 DFG~a~~~~ 149 (472)
||+.|....
T Consensus 209 D~~QaV~~~ 217 (268)
T COG1718 209 DVSQAVTID 217 (268)
T ss_pred ECccccccC
Confidence 999986544
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.54 E-value=5.1e-07 Score=83.69 Aligned_cols=67 Identities=21% Similarity=0.388 Sum_probs=50.4
Q ss_pred CCeEEEEEecCCCC-hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeecccee
Q 012062 70 RGSTYMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 146 (472)
Q Consensus 70 ~~~~~iVmEy~~g~-l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 146 (472)
....+|||||++|- |.+... +++ .+...|.++|.-||+.|++|+|++|.|+++++++ ++++||+..+
T Consensus 115 ~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 115 TSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred eeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECcccc
Confidence 34567999999984 333221 222 2445677889999999999999999999999765 9999997543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.1e-06 Score=81.21 Aligned_cols=109 Identities=16% Similarity=0.159 Sum_probs=79.5
Q ss_pred hhhHHHHHHHHHhcCCCC--ccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC--ChhhhhcCC-CCCCCHHHH
Q 012062 26 PITAIREIKILKKLQHEN--VIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH--DLTGLADRP-GLRFTVPQI 100 (472)
Q Consensus 26 ~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g--~l~~~~~~~-~~~l~~~~i 100 (472)
..++.+|+..|++|..-+ +.++. ++.... . ...-.-+||+|-+++ +|.+++... -.+.+..+.
T Consensus 63 ~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k---------~--~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k 130 (216)
T PRK09902 63 RPTIVREVAVIKELERAGVIVPKIV-FGEAVK---------I--EGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVR 130 (216)
T ss_pred chHHHHHHHHHHHHHHcCCCCCccc-eeeeec---------c--CCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHH
Confidence 457889999999996433 33333 222100 0 002246899998885 676665442 224677778
Q ss_pred HHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC--eEEeecccee
Q 012062 101 KCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN--LKLADFGLAR 146 (472)
Q Consensus 101 ~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~--vkL~DFG~a~ 146 (472)
..++.+|...|+-||+.|+.|+|+-+.|||++.++. |+++||.-++
T Consensus 131 ~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 131 QAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred HHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 899999999999999999999999999999987777 9999998654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.39 E-value=2.3e-07 Score=96.36 Aligned_cols=210 Identities=17% Similarity=0.133 Sum_probs=138.8
Q ss_pred hHHHHHHHHHhcCCCC-ccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCC--hhhhhcCCCCCCCHHHHHHHH
Q 012062 28 TAIREIKILKKLQHEN-VIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHD--LTGLADRPGLRFTVPQIKCYM 104 (472)
Q Consensus 28 ~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~--l~~~~~~~~~~l~~~~i~~i~ 104 (472)
...-++++|.+++||| .++.++-++. +...+|+|+++++. ...........+.+-+...+.
T Consensus 279 ~~rl~~eLLdK~n~P~~~v~~~~d~~~----------------E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~ 342 (829)
T KOG0576|consen 279 SRRLAIELLDKVNNPNPVVRYLEDYDG----------------EDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPL 342 (829)
T ss_pred hhHHHHHHHHHccCCCCcccccccCCc----------------ccccchhhhhhcCCccccccCChhhHhhhhhhhhhhh
Confidence 3456899999999999 4444433322 56789999999864 333333333345556677778
Q ss_pred HHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccCCCCChhhhcCCCCCCCCcchh
Q 012062 105 KQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMW 184 (472)
Q Consensus 105 ~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~Diw 184 (472)
+.-+.+|++||+.--+||| ||+..+ +..|+.||+....+.... ......+|..++|||+... ..+..+.|.|
T Consensus 343 r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~~~~~~~~~pev~~~-~~~~~~p~~~ 414 (829)
T KOG0576|consen 343 RKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTAIGTPEPLAPEVIQE-NTIDGCPDSG 414 (829)
T ss_pred hhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc--ccccCCCCCCCCCchhhcc-cccccCCCcc
Confidence 8888999999999878998 887766 469999999886654332 3445678999999999876 5678899999
Q ss_pred hHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHh
Q 012062 185 SVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKM 264 (472)
Q Consensus 185 SlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 264 (472)
++++-..+|.-|.+|-...- ... .....-+. .+....+ ..|.... -.++...|
T Consensus 415 ~~~~~~~~~ap~~pPr~~P~---------------~~~--~~~g~~p~----s~~L~~~----~aw~~~~--~~~~~~~~ 467 (829)
T KOG0576|consen 415 SLAVSAIQMAPGLPPRSSPP---------------AVL--PMIGNGPN----SPMLTDK----SAWSPVF--HRDFPAPC 467 (829)
T ss_pred CCCcchhhcCCCCCCCCCCc---------------ccc--CCCCCCCC----ccccchh----hhcCccc--ccCCcccc
Confidence 99987777777766543300 000 00000000 0000000 1111110 11588899
Q ss_pred hccCCCCCCCHHHHhcCCCCCCCC
Q 012062 265 LMLDPSQRISAKDALDSEYFWTDP 288 (472)
Q Consensus 265 L~~dP~~R~t~~elL~h~~f~~~~ 288 (472)
|...|..|.+...++.|.+|..-+
T Consensus 468 ~~g~P~~pkv~mgacfsKvfngCp 491 (829)
T KOG0576|consen 468 LNGLPPTPKVHMGACFSKVFNGCP 491 (829)
T ss_pred cCCCCCCCcchhhHHHHHHhccCc
Confidence 999999999999999999995533
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.19 E-value=3.7e-06 Score=93.01 Aligned_cols=200 Identities=20% Similarity=0.270 Sum_probs=129.9
Q ss_pred HHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCC-eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHH
Q 012062 30 IREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRG-STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQL 107 (472)
Q Consensus 30 ~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~iVmEy~~g-~l~~~~~~~~~~l~~~~i~~i~~Ql 107 (472)
..|++.+.++.|+|++.++.+-...- ..+ .+.+..|+|.. ++..++ ..-..++...++.+..++
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~-------------~~g~~~~v~~~~~s~~~~~~~~-q~v~~i~~~~~r~~~~~~ 295 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERL-------------FRGIVLDVLQEICSKVELRSLL-QSVGSIPLETLRILHQKL 295 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhh-------------cchHHHHHHHhhcCccchHHHH-hhccccCHHHHHHHHHHH
Confidence 45777788889999999998865411 122 23344577776 344443 333468889999999999
Q ss_pred HHHHHHHHHCCccccCCCCC---cEEEcCCCCeEEe--eccceeeeccCCCCccccccccCCCCChhhhcCCCCCC--CC
Q 012062 108 LTGLHYCHVNQVLHRDIKGS---NLLIDNEGNLKLA--DFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYG--PA 180 (472)
Q Consensus 108 l~aL~~LH~~giiHrDLKp~---NILl~~~~~vkL~--DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~--~~ 180 (472)
++||+++|+..+.|.-|.-+ +..++.++.+.+. ||+.+..+..... ......+..+.++|.+.. ..+. ..
T Consensus 296 ~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~--~~~~~~~~~~~~~e~~~~-~~~~~~r~ 372 (1351)
T KOG1035|consen 296 LEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK--SFSDLLAEIRNADEDLKE-NTAKKSRL 372 (1351)
T ss_pred hhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCCccc--chhhcCcccccccccccc-ccchhhhh
Confidence 99999999996555544444 3333445556666 8887765543222 122234666788887654 2333 34
Q ss_pred cchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhh-ccHHHHH
Q 012062 181 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRH-FDRHALE 259 (472)
Q Consensus 181 ~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 259 (472)
.|+|.+|..+..+..+...-.. ...+. .+... ......+
T Consensus 373 ~dL~~lgll~~~~~~~~~i~~~------~~~~~----------------------------------~~l~~~~~~~~~d 412 (1351)
T KOG1035|consen 373 TDLWCLGLLLLQLSQGEDISEK------SAVPV----------------------------------SLLDVLSTSELLD 412 (1351)
T ss_pred hHHHHHHHHHhhhhhcCccccc------ccchh----------------------------------hhhccccchhhhh
Confidence 6999999999999887532110 00000 00111 1125788
Q ss_pred HHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 260 LLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 260 ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
++.+|+..|.++|+++.+++.|+|.+.
T Consensus 413 ~~~~~~~~~~~~Rl~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 413 ALPKCLDEDSEERLSALELLTHPFLRF 439 (1351)
T ss_pred hhhhhcchhhhhccchhhhhhchhccc
Confidence 999999999999999999999999754
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.10 E-value=2.7e-05 Score=73.64 Aligned_cols=28 Identities=29% Similarity=0.381 Sum_probs=25.1
Q ss_pred CccccCCCCCcEEEcCCCCeEEeecccee
Q 012062 118 QVLHRDIKGSNLLIDNEGNLKLADFGLAR 146 (472)
Q Consensus 118 giiHrDLKp~NILl~~~~~vkL~DFG~a~ 146 (472)
.++|+|+.|.||+++.++ +.|+||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 478999999999999888 9999999763
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.05 E-value=2.1e-05 Score=80.50 Aligned_cols=173 Identities=25% Similarity=0.353 Sum_probs=116.5
Q ss_pred hhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHH
Q 012062 27 ITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQ 106 (472)
Q Consensus 27 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~l~~~~~~~~~~l~~~~i~~i~~Q 106 (472)
.+++-...+++.+.|+|.-.++++.+.. .....+|||+++-++.+...... +....
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~---------------~~r~IVV~e~~~~Sled~~~~~~--l~~~s------- 82 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGK---------------HERVIVVMEHYTMSLEDILKTGN--LKDES------- 82 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCc---------------cceEEEEehhhccchHHHHHhcc--cchhh-------
Confidence 4566778899999999999999887642 22378999999988888776543 11111
Q ss_pred HHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccCCCCChhhhcCCCCCCCCcchhhH
Q 012062 107 LLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSV 186 (472)
Q Consensus 107 ll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSl 186 (472)
++ .+++.|- || ++++| -++ .. | | ....+++||||+
T Consensus 83 ~~-------~~~~~~~-----~~-------~~~td-~~~---t~--------------~--~------~~~~pKsdVwsl 117 (725)
T KOG1093|consen 83 LL-------AHGVLHL-----NI-------IYITD-HFL---TK--------------Y--P------SPIGPKSDVWSL 117 (725)
T ss_pred hc-------cccccee-----hh-------hhccc-ccc---cc--------------C--C------CCCCcchhhhhH
Confidence 11 2222222 22 34444 000 00 0 1 112258999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhc
Q 012062 187 GCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLM 266 (472)
Q Consensus 187 G~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 266 (472)
|.|+.++..|...|...+..+.+..+.+....... .........+...++..+++++.+|+.
T Consensus 118 ~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~------------------~~~~a~e~~~~~~~d~~~~~~~~~c~~ 179 (725)
T KOG1093|consen 118 GFIILELYLGISLEAELTESEYLEILLKYYTDDQE------------------LLSTAMEHLIQLLADKKRLPLLKKCLW 179 (725)
T ss_pred HHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchh------------------HHHHHHHHHHHHhhhHhHHHHhccCCc
Confidence 99999999999999888888887777654332211 111222235556678889999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCC
Q 012062 267 LDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 267 ~dP~~R~t~~elL~h~~f~~ 286 (472)
..|..|+...+++++.-|..
T Consensus 180 ~~~~ir~l~~~~~k~~i~~e 199 (725)
T KOG1093|consen 180 LEPIIRPLPMELSKRCSFTE 199 (725)
T ss_pred cccccccchhHHhcCccHHH
Confidence 99999999999999988743
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.01 E-value=2.8e-05 Score=81.71 Aligned_cols=76 Identities=17% Similarity=0.332 Sum_probs=49.8
Q ss_pred eEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeec
Q 012062 72 STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 149 (472)
Q Consensus 72 ~~~iVmEy~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 149 (472)
.-.|+|||++| .+.+........++...+.....++ -+..+=..|++|.|.+|.||+++.++.+.+.|||+...+.
T Consensus 240 ~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 240 RRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred CcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHhcCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 34799999998 3333321111234533332222211 1233344899999999999999999999999999986654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.00 E-value=2.6e-05 Score=71.49 Aligned_cols=99 Identities=25% Similarity=0.191 Sum_probs=78.4
Q ss_pred HHHHHHHHhcCC-CCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chhhhhc--CCCCCCCHHHHHHHHH
Q 012062 30 IREIKILKKLQH-ENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLAD--RPGLRFTVPQIKCYMK 105 (472)
Q Consensus 30 ~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~~~~~--~~~~~l~~~~i~~i~~ 105 (472)
..|.-+|+.|.+ +++.++++++-. ++|.||+.. .+..... ..-...++....+|+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~--------------------~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~ 66 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR--------------------FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIAL 66 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC--------------------EEEEEeecCccccccccccccccccCHHHHHHHHH
Confidence 358899999976 699999999843 689999985 3432110 1112357889999999
Q ss_pred HHHHHHHHHHH---CCccccCCCCCcEEEcCCCCeEEeeccceeee
Q 012062 106 QLLTGLHYCHV---NQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 148 (472)
Q Consensus 106 Qll~aL~~LH~---~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 148 (472)
++++.+.+|+. ..+.-+|++++||.|++++++|++|...+...
T Consensus 67 ~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 67 QLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred HHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 99999999987 35888999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.98 E-value=5.3e-05 Score=72.37 Aligned_cols=28 Identities=25% Similarity=0.262 Sum_probs=25.3
Q ss_pred CccccCCCCCcEEEcCCCCeEEeeccce
Q 012062 118 QVLHRDIKGSNLLIDNEGNLKLADFGLA 145 (472)
Q Consensus 118 giiHrDLKp~NILl~~~~~vkL~DFG~a 145 (472)
.++|+|+.+.|||++++..+.|+||+.+
T Consensus 164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a 191 (244)
T cd05150 164 VVTHGDACLPNIIVDPGKFSGFIDLGRL 191 (244)
T ss_pred EEECCCCCCccEEEeCCcEEEEEEcccc
Confidence 4899999999999999777889999876
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.87 E-value=6e-05 Score=70.70 Aligned_cols=30 Identities=30% Similarity=0.612 Sum_probs=20.8
Q ss_pred CCccccCCCCCcEEEc-CCCCeEEeecccee
Q 012062 117 NQVLHRDIKGSNLLID-NEGNLKLADFGLAR 146 (472)
Q Consensus 117 ~giiHrDLKp~NILl~-~~~~vkL~DFG~a~ 146 (472)
..++|+|+.+.|||++ .++.|.|+||+.+.
T Consensus 166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp EEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred cEEEEeccccccceeeeccceeEEEecccce
Confidence 3699999999999999 56666899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00035 Score=64.51 Aligned_cols=117 Identities=17% Similarity=0.195 Sum_probs=79.5
Q ss_pred eeccCCCEEEEEEeecCC--------------cCCCchhhHHHHHHHHHhcC------CCCccceeEEeeCCCCCCCCCC
Q 012062 3 REIKTGEIVALKKIRMDN--------------EKEGFPITAIREIKILKKLQ------HENVIKLKEIVTSPGPERDEQG 62 (472)
Q Consensus 3 ~~~~tg~~vAlK~i~~~~--------------~~~~~~~~~~~Ei~il~~l~------hpnIv~l~~~~~~~~~~~~~~~ 62 (472)
...-.....+||+++... ..........+|+.-...+. +.+|.+++++.++
T Consensus 18 y~HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT--------- 88 (199)
T PF10707_consen 18 YQHPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVET--------- 88 (199)
T ss_pred EECCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEEEec---------
Confidence 344456667899988665 01112345567777777666 8899999999988
Q ss_pred CCCCCCcCCeEEEEEecCC---C----ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC
Q 012062 63 RPDGNKYRGSTYMVFEYMD---H----DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 135 (472)
Q Consensus 63 ~~~~~~~~~~~~iVmEy~~---g----~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~ 135 (472)
+--+-+|+|.+. | +|.+++... .++. .+...|-+-.+||-++.|+.+||+|.||++....
T Consensus 89 -------~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~ 155 (199)
T PF10707_consen 89 -------NLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRD 155 (199)
T ss_pred -------CCceEEEEEEEECCCCCcCccHHHHHHcC--CccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecC
Confidence 345678888873 3 355555332 3544 3334455667888999999999999999996433
Q ss_pred ----CeEEee
Q 012062 136 ----NLKLAD 141 (472)
Q Consensus 136 ----~vkL~D 141 (472)
.+.|+|
T Consensus 156 ~~~~~lvlID 165 (199)
T PF10707_consen 156 SGEFRLVLID 165 (199)
T ss_pred CCceEEEEEe
Confidence 477777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00024 Score=79.92 Aligned_cols=60 Identities=22% Similarity=0.310 Sum_probs=38.6
Q ss_pred EEEEEEeecCCcCCCchhhHHHHHHHHHhcC-CCCc--cceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCC
Q 012062 10 IVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENV--IKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHD 83 (472)
Q Consensus 10 ~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnI--v~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~ 83 (472)
.++||+....... .....+.+|+++|+.|. |.+| .+++.++.+... .+..||||||++|.
T Consensus 67 ~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v-------------~G~~flVME~v~G~ 129 (822)
T PLN02876 67 RYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV-------------IGTAFYIMEYLEGR 129 (822)
T ss_pred eEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc-------------CCCceEEEEecCCc
Confidence 5666665432211 12346779999999996 6665 677777654211 24568999999985
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00023 Score=63.53 Aligned_cols=108 Identities=23% Similarity=0.227 Sum_probs=75.5
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCcc-ceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Ch
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVI-KLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL 84 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l 84 (472)
+|..+|+|+-+.+.. ...+..|.++|..++-.++- +++.+-+ .++.|||++| .|
T Consensus 44 ~~~~~a~Kvrr~ds~----r~~l~kEakiLeil~g~~~~p~vy~yg~--------------------~~i~me~i~G~~L 99 (201)
T COG2112 44 RGGEVALKVRRRDSP----RRNLEKEAKILEILAGEGVTPEVYFYGE--------------------DFIRMEYIDGRPL 99 (201)
T ss_pred cCceEEEEEecCCcc----hhhHHHHHHHHHHhhhcCCCceEEEech--------------------hhhhhhhhcCcch
Confidence 567899998776543 34788999999999987775 5554433 3677999998 55
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC-CCcEEEcCCCCeEEeecccee
Q 012062 85 TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIK-GSNLLIDNEGNLKLADFGLAR 146 (472)
Q Consensus 85 ~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLK-p~NILl~~~~~vkL~DFG~a~ 146 (472)
....... + +.-+..+++.---|-..||-|..|. |..++|.+++.+.|+||..|+
T Consensus 100 ~~~~~~~----~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 100 GKLEIGG----D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hhhhhcc----c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 4443321 1 2223456666666778899999985 555566566589999999886
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00022 Score=70.59 Aligned_cols=126 Identities=17% Similarity=0.242 Sum_probs=84.7
Q ss_pred ccCCCEEEEEEeecCC----cC--------------------CCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCC
Q 012062 5 IKTGEIVALKKIRMDN----EK--------------------EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~----~~--------------------~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~ 60 (472)
..+|..+||||++... .. .....-+.+|+..|++|+...|.--.-+..
T Consensus 165 ~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP~PePIlL-------- 236 (520)
T KOG2270|consen 165 EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIPCPEPILL-------- 236 (520)
T ss_pred cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCCCCCceee--------
Confidence 3578889999987431 00 011123457999999987655432222221
Q ss_pred CCCCCCCCcCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HHCCccccCCCCCcEEEcCCCCeEE
Q 012062 61 QGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC-HVNQVLHRDIKGSNLLIDNEGNLKL 139 (472)
Q Consensus 61 ~~~~~~~~~~~~~~iVmEy~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~L-H~~giiHrDLKp~NILl~~~~~vkL 139 (472)
++ -.|||+|++.+-+-.=.-.+..++...+..+-.|++.-+.-| |.+++||.||.--|+|+-. |.|.|
T Consensus 237 ---------k~-hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-G~lyi 305 (520)
T KOG2270|consen 237 ---------KN-HVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-GKLYI 305 (520)
T ss_pred ---------ec-ceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-CEEEE
Confidence 11 269999998643322222234577888888888898888888 5679999999999999865 57999
Q ss_pred eeccceeeec
Q 012062 140 ADFGLARSFS 149 (472)
Q Consensus 140 ~DFG~a~~~~ 149 (472)
||.+.+....
T Consensus 306 IDVSQSVE~D 315 (520)
T KOG2270|consen 306 IDVSQSVEHD 315 (520)
T ss_pred EEccccccCC
Confidence 9998875443
|
|
| >KOG1924 consensus RhoA GTPase effector DIA/Diaphanous [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00058 Score=72.23 Aligned_cols=7 Identities=29% Similarity=-0.145 Sum_probs=3.2
Q ss_pred cCCCCCC
Q 012062 267 LDPSQRI 273 (472)
Q Consensus 267 ~dP~~R~ 273 (472)
-|-.-|+
T Consensus 416 nDy~~rp 422 (1102)
T KOG1924|consen 416 NDYYIRP 422 (1102)
T ss_pred hhhhhhH
Confidence 3444444
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00025 Score=67.35 Aligned_cols=29 Identities=28% Similarity=0.405 Sum_probs=24.6
Q ss_pred CccccCCCCCcEEEcCCCCeEEeecccee
Q 012062 118 QVLHRDIKGSNLLIDNEGNLKLADFGLAR 146 (472)
Q Consensus 118 giiHrDLKp~NILl~~~~~vkL~DFG~a~ 146 (472)
.++|+|+.+.|||++++...-|+||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 58999999999999876545799999763
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00038 Score=67.04 Aligned_cols=28 Identities=39% Similarity=0.637 Sum_probs=25.0
Q ss_pred CccccCCCCCcEEEcCCCCeEEeecccee
Q 012062 118 QVLHRDIKGSNLLIDNEGNLKLADFGLAR 146 (472)
Q Consensus 118 giiHrDLKp~NILl~~~~~vkL~DFG~a~ 146 (472)
.++|+|+.+.|||++.++ ++|+||..|.
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 589999999999999877 8999998773
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00069 Score=64.13 Aligned_cols=28 Identities=21% Similarity=0.495 Sum_probs=25.4
Q ss_pred CccccCCCCCcEEEcC-CCCeEEeeccce
Q 012062 118 QVLHRDIKGSNLLIDN-EGNLKLADFGLA 145 (472)
Q Consensus 118 giiHrDLKp~NILl~~-~~~vkL~DFG~a 145 (472)
.++|+|+.+.|||++. ++.+.|+||..|
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a 199 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYA 199 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccC
Confidence 6999999999999998 567999999876
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.54 E-value=1.5e-05 Score=90.07 Aligned_cols=156 Identities=12% Similarity=0.019 Sum_probs=112.3
Q ss_pred HHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC-CChhhhhcCCCC---CCCHHHHHHHH
Q 012062 29 AIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD-HDLTGLADRPGL---RFTVPQIKCYM 104 (472)
Q Consensus 29 ~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~-g~l~~~~~~~~~---~l~~~~i~~i~ 104 (472)
.+.|...++...|.++.+.+.-..... ....|++++|+. |++.+.+.+... .+...-+.+..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~--------------s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~ 1341 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSE--------------STEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRH 1341 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCC--------------ChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHH
Confidence 344555666678999887765443311 334689999998 567777765322 24455566666
Q ss_pred HHHHHHHHHHHHC-----CccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccCCCCChhhhcCCCCCCC
Q 012062 105 KQLLTGLHYCHVN-----QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGP 179 (472)
Q Consensus 105 ~Qll~aL~~LH~~-----giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~ 179 (472)
.+.+.+..-+|.. =.+|++||+-|.+|..+-++|+.++|+.+.. ..........++++.|+.++.... -.++.
T Consensus 1342 kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIk-np~~sf~Gl~l~sp~~v~qli~N~-ik~t~ 1419 (2724)
T KOG1826|consen 1342 KVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIK-NPVLSFFGLELCSPIYVLQLIKNE-IKFTK 1419 (2724)
T ss_pred HHHHhccchhhhcccCCccchhhhhhhhccceecCCccccccccccccc-CchHhhhhhhhCCHHHHHHHHHHH-Hhhhh
Confidence 6667777777754 2789999999999999999999999998732 223334445677888999996654 56777
Q ss_pred CcchhhHHHHHHHHHhCCCCC
Q 012062 180 AVDMWSVGCIFAELLNGKPIL 200 (472)
Q Consensus 180 ~~DiwSlG~il~ell~G~~pf 200 (472)
++|+|..++.+|++..+..+|
T Consensus 1420 rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1420 RSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHHHHHHHHHHhcccHHH
Confidence 899999999999998887655
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.00093 Score=65.94 Aligned_cols=28 Identities=36% Similarity=0.515 Sum_probs=25.5
Q ss_pred CccccCCCCCcEEEcCC----CCeEEeeccce
Q 012062 118 QVLHRDIKGSNLLIDNE----GNLKLADFGLA 145 (472)
Q Consensus 118 giiHrDLKp~NILl~~~----~~vkL~DFG~a 145 (472)
.++|+|+.+.|||++.+ +.++|+||..|
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya 211 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYA 211 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCC
Confidence 68999999999999974 78999999876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0016 Score=60.79 Aligned_cols=29 Identities=38% Similarity=0.676 Sum_probs=20.7
Q ss_pred CccccCCCCCcEEE-cCCCCeEEeecccee
Q 012062 118 QVLHRDIKGSNLLI-DNEGNLKLADFGLAR 146 (472)
Q Consensus 118 giiHrDLKp~NILl-~~~~~vkL~DFG~a~ 146 (472)
-++|.||.+.|||+ +.++.++||||..|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 58999999999999 788889999999874
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0016 Score=64.42 Aligned_cols=29 Identities=31% Similarity=0.466 Sum_probs=26.2
Q ss_pred CCccccCCCCCcEEEcCCCCeEEeeccce
Q 012062 117 NQVLHRDIKGSNLLIDNEGNLKLADFGLA 145 (472)
Q Consensus 117 ~giiHrDLKp~NILl~~~~~vkL~DFG~a 145 (472)
.+++|+|+++.||+++.++.+.|+||+.+
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~ 215 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFA 215 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeecccc
Confidence 58999999999999998876789999976
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0021 Score=63.93 Aligned_cols=30 Identities=27% Similarity=0.389 Sum_probs=25.6
Q ss_pred CCccccCCCCCcEEEcCCCCeEEeecccee
Q 012062 117 NQVLHRDIKGSNLLIDNEGNLKLADFGLAR 146 (472)
Q Consensus 117 ~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 146 (472)
.++||+|+++.|||++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 389999999999999976555899999763
|
|
| >KOG0921 consensus Dosage compensation complex, subunit MLE [Transcription] | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0021 Score=69.54 Aligned_cols=18 Identities=28% Similarity=0.348 Sum_probs=9.3
Q ss_pred CCCCCCCCCCCC-CCCCCC
Q 012062 432 ASGYGVGPQSYS-QSGQYG 449 (472)
Q Consensus 432 ~~~~~~~~~~~~-~~~~~~ 449 (472)
|+|++.+|++++ ++|++|
T Consensus 1239 ggGdyrnpgggyrgsGGfg 1257 (1282)
T KOG0921|consen 1239 GGGDYRNPGGGYRGSGGFG 1257 (1282)
T ss_pred CCCCCCCCCCCccCCCCcC
Confidence 555555555544 444444
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.00052 Score=66.91 Aligned_cols=95 Identities=18% Similarity=0.228 Sum_probs=67.5
Q ss_pred hhHHHHHHHHHhcCC-C-CccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCC-hhhhhcCCCCCCCHHHHHHH
Q 012062 27 ITAIREIKILKKLQH-E-NVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHD-LTGLADRPGLRFTVPQIKCY 103 (472)
Q Consensus 27 ~~~~~Ei~il~~l~h-p-nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~-l~~~~~~~~~~l~~~~i~~i 103 (472)
..+.+|+..|+.|.. - -|.+.+|+. .-|+|||+++|- |.....- ..+..+
T Consensus 155 laa~kEfafmkaL~e~gfpVPkpiD~~--------------------RH~Vvmelv~g~Pl~~v~~v-------~d~~~l 207 (465)
T KOG2268|consen 155 LAATKEFAFMKALYERGFPVPKPIDHN--------------------RHCVVMELVDGYPLRQVRHV-------EDPPTL 207 (465)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCccccc--------------------ceeeHHHhhcccceeeeeec-------CChHHH
Confidence 345689999998853 2 244555443 238999999973 3332211 123445
Q ss_pred HHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeee
Q 012062 104 MKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 148 (472)
Q Consensus 104 ~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 148 (472)
...|+.-+--|..+|+||+|..-=||||++++.+++|||=.....
T Consensus 208 y~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 208 YDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVIDFPQMVST 252 (465)
T ss_pred HHHHHHHHHHHHHcCceecccchheeEEecCCCEEEeechHhhcc
Confidence 566677777889999999999999999999999999999765443
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0024 Score=62.71 Aligned_cols=29 Identities=31% Similarity=0.450 Sum_probs=25.9
Q ss_pred CCccccCCCCCcEEEcCCCCeEEeeccce
Q 012062 117 NQVLHRDIKGSNLLIDNEGNLKLADFGLA 145 (472)
Q Consensus 117 ~giiHrDLKp~NILl~~~~~vkL~DFG~a 145 (472)
.+++|+|+.+.|||+++++.+.|+||+.+
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a 203 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFA 203 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhh
Confidence 47999999999999998776789999876
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0016 Score=68.58 Aligned_cols=73 Identities=22% Similarity=0.339 Sum_probs=49.3
Q ss_pred eEEEEEecCCC---ChhhhhcCCCCCCCHHHHHHHHHHHHHHH-HHHHHCCccccCCCCCcEEEcC----CCCeEEeecc
Q 012062 72 STYMVFEYMDH---DLTGLADRPGLRFTVPQIKCYMKQLLTGL-HYCHVNQVLHRDIKGSNLLIDN----EGNLKLADFG 143 (472)
Q Consensus 72 ~~~iVmEy~~g---~l~~~~~~~~~~l~~~~i~~i~~Qll~aL-~~LH~~giiHrDLKp~NILl~~----~~~vkL~DFG 143 (472)
.-.|+||||+| +.++.+.+.+ ++...+.. -+.++. .-|=..|++|+|=+|.||++.. +.++.|.|||
T Consensus 276 ~RVLtME~~~G~~i~Dl~~i~~~g--i~~~~i~~---~l~~~~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhG 350 (538)
T KOG1235|consen 276 KRVLTMEYVDGIKINDLDAIDKRG--ISPHDILN---KLVEAYLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHG 350 (538)
T ss_pred ceEEEEEecCCccCCCHHHHHHcC--CCHHHHHH---HHHHHHHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEccc
Confidence 35899999998 3334444433 55544433 333332 2233568999999999999984 5679999999
Q ss_pred ceeeec
Q 012062 144 LARSFS 149 (472)
Q Consensus 144 ~a~~~~ 149 (472)
+.....
T Consensus 351 l~~~is 356 (538)
T KOG1235|consen 351 LYAVIS 356 (538)
T ss_pred cccccc
Confidence 986654
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0041 Score=62.72 Aligned_cols=29 Identities=24% Similarity=0.495 Sum_probs=25.4
Q ss_pred CccccCCCCCcEEEcC-CCCeEEeecccee
Q 012062 118 QVLHRDIKGSNLLIDN-EGNLKLADFGLAR 146 (472)
Q Consensus 118 giiHrDLKp~NILl~~-~~~vkL~DFG~a~ 146 (472)
.++|+||++.|||+++ ++.++|+||..|.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 6899999999999986 4679999998773
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.003 Score=62.65 Aligned_cols=71 Identities=24% Similarity=0.310 Sum_probs=57.5
Q ss_pred CeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcCCCCeEEeeccceee
Q 012062 71 GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEGNLKLADFGLARS 147 (472)
Q Consensus 71 ~~~~iVmEy~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~-giiHrDLKp~NILl~~~~~vkL~DFG~a~~ 147 (472)
.+.|++|++-.+.+.... --..+++..|+++.+..++-+..+ .+-||||...||||+ +|+|-|+||-+++.
T Consensus 299 ~y~yl~~kdhgt~is~ik-----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 299 LYLYLHFKDHGTPISIIK-----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred eEEEEEEecCCceeeeee-----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 356888888776544221 135678999999999988888876 799999999999999 99999999999873
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.007 Score=60.64 Aligned_cols=27 Identities=33% Similarity=0.660 Sum_probs=24.2
Q ss_pred ccccCCCCCcEEEcC-CCCeEEeeccce
Q 012062 119 VLHRDIKGSNLLIDN-EGNLKLADFGLA 145 (472)
Q Consensus 119 iiHrDLKp~NILl~~-~~~vkL~DFG~a 145 (472)
++|.||.+.|||++. ++.++|+||..|
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYa 211 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYG 211 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEccccc
Confidence 799999999999975 467999999976
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.0068 Score=55.81 Aligned_cols=124 Identities=23% Similarity=0.248 Sum_probs=75.9
Q ss_pred eccCCCEEEEEEeecC---CcC---C-------------CchhhHHHHHHHHHhc---CCCCc--cceeEEeeCCCCCCC
Q 012062 4 EIKTGEIVALKKIRMD---NEK---E-------------GFPITAIREIKILKKL---QHENV--IKLKEIVTSPGPERD 59 (472)
Q Consensus 4 ~~~tg~~vAlK~i~~~---~~~---~-------------~~~~~~~~Ei~il~~l---~hpnI--v~l~~~~~~~~~~~~ 59 (472)
-.-+|+.||||+++.- ... + .+..-+..|....-+| .+.++ |++++++.-...+..
T Consensus 57 v~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~ 136 (207)
T PF13095_consen 57 VEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQF 136 (207)
T ss_pred EEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHH
Confidence 3557889999995421 110 0 1223345676666555 46677 999999865310000
Q ss_pred CCC--CCCCCCcCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCe
Q 012062 60 EQG--RPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 137 (472)
Q Consensus 60 ~~~--~~~~~~~~~~~~iVmEy~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~v 137 (472)
..- ........-...||.||+...- .++... +.+|++-|..||..||+-+|+|+.|.. .=
T Consensus 137 ~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~~~k~gI~~~Dv~~~ny~-----~G 198 (207)
T PF13095_consen 137 EQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKILHKLGIVPRDVKPRNYR-----GG 198 (207)
T ss_pred HHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHHHHHCCeeeccCcccccc-----CC
Confidence 000 0011112334578999887543 233333 456778888999999999999999997 35
Q ss_pred EEeeccce
Q 012062 138 KLADFGLA 145 (472)
Q Consensus 138 kL~DFG~a 145 (472)
||+|||.+
T Consensus 199 ~lvDfs~~ 206 (207)
T PF13095_consen 199 KLVDFSSS 206 (207)
T ss_pred EEEecccC
Confidence 99999864
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.0067 Score=59.15 Aligned_cols=29 Identities=28% Similarity=0.523 Sum_probs=24.7
Q ss_pred CccccCCCCCcEEEcCCCC-eEEeecccee
Q 012062 118 QVLHRDIKGSNLLIDNEGN-LKLADFGLAR 146 (472)
Q Consensus 118 giiHrDLKp~NILl~~~~~-vkL~DFG~a~ 146 (472)
.++|+|+++.|||++.++. .-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 4899999999999997555 4699999874
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.023 Score=56.09 Aligned_cols=56 Identities=16% Similarity=0.059 Sum_probs=36.0
Q ss_pred EEEEEEeecCCcCCCchhhHHHHHHHHHhcCC---CCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC
Q 012062 10 IVALKKIRMDNEKEGFPITAIREIKILKKLQH---ENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH 82 (472)
Q Consensus 10 ~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~h---pnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g 82 (472)
.+.+|..+... ....+..|...|+.|.- -.|.++++++.... ..+.-+||||++++
T Consensus 39 ~~~~k~~~~~~----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~-------------~~g~~~LVmE~i~G 97 (297)
T PRK10593 39 NPMPLMARSFS----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ-------------SPGPDVLLLERLRG 97 (297)
T ss_pred CEEEEEecccc----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCC-------------cCCCeEEEEeccCC
Confidence 45666643211 12367789999999853 35677777765421 13457999999987
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.02 Score=56.71 Aligned_cols=30 Identities=30% Similarity=0.424 Sum_probs=27.3
Q ss_pred CccccCCCCCcEEEcCCCCeEEeeccceee
Q 012062 118 QVLHRDIKGSNLLIDNEGNLKLADFGLARS 147 (472)
Q Consensus 118 giiHrDLKp~NILl~~~~~vkL~DFG~a~~ 147 (472)
.++|+|+++.||||+.++-+=|+||+++..
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 479999999999999998899999998854
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.99 E-value=0.034 Score=56.91 Aligned_cols=28 Identities=25% Similarity=0.483 Sum_probs=24.5
Q ss_pred CCccccCCCCCcEEEcCCCCeEEeeccce
Q 012062 117 NQVLHRDIKGSNLLIDNEGNLKLADFGLA 145 (472)
Q Consensus 117 ~giiHrDLKp~NILl~~~~~vkL~DFG~a 145 (472)
..++|+|+.+.|||+..+ .++|+||.++
T Consensus 223 ~~l~HgDl~~gni~~~~~-~~~viD~E~a 250 (401)
T PRK09550 223 EALLHGDLHTGSIFVTEE-ETKVIDPEFA 250 (401)
T ss_pred CceeeccCCcccEEeeCC-CcEEEecccc
Confidence 368999999999999876 4999999876
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.96 E-value=0.073 Score=61.32 Aligned_cols=30 Identities=40% Similarity=0.665 Sum_probs=25.6
Q ss_pred CCccccCCCCCcEEEcCCC--CeE-Eeecccee
Q 012062 117 NQVLHRDIKGSNLLIDNEG--NLK-LADFGLAR 146 (472)
Q Consensus 117 ~giiHrDLKp~NILl~~~~--~vk-L~DFG~a~ 146 (472)
.+|||.|+.++|||++.++ ++. |+|||.+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 4799999999999999875 555 99999774
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.86 E-value=0.044 Score=56.01 Aligned_cols=28 Identities=29% Similarity=0.333 Sum_probs=23.9
Q ss_pred CCccccCCCCCcEEEcCCCCeEEeeccce
Q 012062 117 NQVLHRDIKGSNLLIDNEGNLKLADFGLA 145 (472)
Q Consensus 117 ~giiHrDLKp~NILl~~~~~vkL~DFG~a 145 (472)
..++|.||-+.|||++++ .++|+||..|
T Consensus 227 ~VfCHNDL~~gNIL~~~~-~l~lID~EYA 254 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFNQ-GIYFIDFDFA 254 (383)
T ss_pred eeeeeccCCcccEEecCC-CEEEEEeccc
Confidence 468999999999997654 5999999876
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.071 Score=55.55 Aligned_cols=27 Identities=30% Similarity=0.544 Sum_probs=23.5
Q ss_pred CccccCCCCCcEEEcCCCCeEEeeccce
Q 012062 118 QVLHRDIKGSNLLIDNEGNLKLADFGLA 145 (472)
Q Consensus 118 giiHrDLKp~NILl~~~~~vkL~DFG~a 145 (472)
-++|.|+-+.|||++.++ ++|+||..|
T Consensus 285 VfCHNDl~~~NiL~~~~~-l~LIDfEYA 311 (442)
T PTZ00296 285 VFCHNDLQENNIINTNKC-LRLIDFEYS 311 (442)
T ss_pred eEEeCCCCccceeecCCC-EEEEeeccc
Confidence 589999999999987554 999999876
|
|
| >KOG0921 consensus Dosage compensation complex, subunit MLE [Transcription] | Back alignment and domain information |
|---|
Probab=95.49 E-value=0.057 Score=58.92 Aligned_cols=21 Identities=48% Similarity=0.863 Sum_probs=11.9
Q ss_pred CCCCCCCCCCCCCCCCCCCCC
Q 012062 395 PNRGGQGGGYSNAPYPPQGRG 415 (472)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~ 415 (472)
..+||+|+||++++|.--++|
T Consensus 1189 ysgGGYGggys~gGygsGGYG 1209 (1282)
T KOG0921|consen 1189 YSGGGYGGGYSGGGYGSGGYG 1209 (1282)
T ss_pred CCCCCcCCCCCCCCcCCCCCC
Confidence 445666666666655554444
|
|
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.24 E-value=0.063 Score=52.73 Aligned_cols=92 Identities=16% Similarity=0.214 Sum_probs=69.1
Q ss_pred HHHHHHHhc-----CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHH
Q 012062 31 REIKILKKL-----QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMK 105 (472)
Q Consensus 31 ~Ei~il~~l-----~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~l~~~~~~~~~~l~~~~i~~i~~ 105 (472)
+|+..|.++ .+|-+|.+... .|||-|++.+-+-.-+-.+..|+.++.++.-.
T Consensus 334 kEmhNL~RMq~~GlpcP~vV~lkkh-----------------------vLVMsFiGd~~~aAPkLK~v~l~d~E~~~aY~ 390 (531)
T KOG2269|consen 334 KEMHNLSRMQKHGLPCPQVVKLKKH-----------------------VLVMSFIGDQGLAAPKLKNVELTDDERRNAYD 390 (531)
T ss_pred HHHHHHHHHHhcCCCCCceeeeecc-----------------------eEEEEeecCCCCCCccccccccChHHHHHHHH
Confidence 566666665 37788877632 59999998543222222334589999999999
Q ss_pred HHHHHHHHH-HHCCccccCCCCCcEEEcCCCCeEEeecccee
Q 012062 106 QLLTGLHYC-HVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 146 (472)
Q Consensus 106 Qll~aL~~L-H~~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 146 (472)
|++.++.-| |+.-+||-||.--|||+... .|.+||...+.
T Consensus 391 q~~~~M~~lY~Ec~LVHADlSEyN~Lw~~g-Kvw~IDVsQsv 431 (531)
T KOG2269|consen 391 QVQSIMCRLYKECLLVHADLSEYNLLWTPG-KVWVIDVSQSV 431 (531)
T ss_pred HHHHHHHHHHHhhheeecchhhhhheecCC-ceEEEechhcc
Confidence 999999888 67789999999999999875 79999987654
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.06 E-value=0.24 Score=50.78 Aligned_cols=27 Identities=15% Similarity=0.400 Sum_probs=23.9
Q ss_pred CccccCCCCCcEEEcCCCCeEEeeccce
Q 012062 118 QVLHRDIKGSNLLIDNEGNLKLADFGLA 145 (472)
Q Consensus 118 giiHrDLKp~NILl~~~~~vkL~DFG~a 145 (472)
-++|+||.+.|||++.++ .+++|..++
T Consensus 231 ~L~HGDl~~g~i~~~~~~-~~~id~ef~ 257 (418)
T PLN02756 231 ALVHGDLHTGSVMVTPDS-TQVIDPEFA 257 (418)
T ss_pred ceeecCCCCCcEEEcCCC-ceEecchhh
Confidence 589999999999999876 899997765
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.99 E-value=0.043 Score=54.16 Aligned_cols=28 Identities=21% Similarity=0.420 Sum_probs=25.0
Q ss_pred CCccccCCCCCcEEEcCCCCeEEeeccce
Q 012062 117 NQVLHRDIKGSNLLIDNEGNLKLADFGLA 145 (472)
Q Consensus 117 ~giiHrDLKp~NILl~~~~~vkL~DFG~a 145 (472)
.+|+|+|+++.|||++. +.+.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence 47999999999999988 67899999865
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.98 E-value=0.067 Score=49.83 Aligned_cols=84 Identities=19% Similarity=0.300 Sum_probs=56.2
Q ss_pred hHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHH
Q 012062 28 TAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQL 107 (472)
Q Consensus 28 ~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~l~~~~~~~~~~l~~~~i~~i~~Ql 107 (472)
.+..+..|+.++. .|+++.. | ..-.+-+++|+|-.- .. .-..++.-=
T Consensus 104 ~y~nky~v~Armh--GilrL~N---------------D---n~~~yGvIlE~Cy~~------------~i-~~~N~i~ag 150 (308)
T PF07387_consen 104 LYFNKYRVFARMH--GILRLKN---------------D---NNYKYGVILERCYKI------------KI-NFSNFITAG 150 (308)
T ss_pred hhhhhhhHHHHhh--heeEeec---------------C---CCceeEEEEeeccCc------------cc-chhHHHHHh
Confidence 3456788887765 5666651 1 022467999998521 00 112222223
Q ss_pred HHHHHHHHHC--CccccCCCCCcEEEcCCCCeEEeeccc
Q 012062 108 LTGLHYCHVN--QVLHRDIKGSNLLIDNEGNLKLADFGL 144 (472)
Q Consensus 108 l~aL~~LH~~--giiHrDLKp~NILl~~~~~vkL~DFG~ 144 (472)
+..|.-.|+. +.+|+|..|+|||-|..|.+||.|=+.
T Consensus 151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 5677888843 799999999999999999999999764
|
The function of this family is unknown. |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=94.35 E-value=0.056 Score=52.44 Aligned_cols=46 Identities=28% Similarity=0.400 Sum_probs=34.5
Q ss_pred HHHHHHHHHHHHHHHHC--CccccCCCCCcEEEcCCCCeEEeecccee
Q 012062 101 KCYMKQLLTGLHYCHVN--QVLHRDIKGSNLLIDNEGNLKLADFGLAR 146 (472)
Q Consensus 101 ~~i~~Qll~aL~~LH~~--giiHrDLKp~NILl~~~~~vkL~DFG~a~ 146 (472)
...+..+-..+.-++.. =++|.|+.++|+|+++.+.++|+||..|.
T Consensus 135 ~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg 182 (269)
T COG0510 135 RKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAG 182 (269)
T ss_pred HHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCC
Confidence 33444444455545444 59999999999999998999999998773
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=93.76 E-value=0.079 Score=52.43 Aligned_cols=76 Identities=20% Similarity=0.268 Sum_probs=44.4
Q ss_pred EEEEEecCCCChhhh--hc--CCCCCCCHHHHHHHHHHHHHHHHHH---H-HCCccccCCCCCcEEEcCCC---------
Q 012062 73 TYMVFEYMDHDLTGL--AD--RPGLRFTVPQIKCYMKQLLTGLHYC---H-VNQVLHRDIKGSNLLIDNEG--------- 135 (472)
Q Consensus 73 ~~iVmEy~~g~l~~~--~~--~~~~~l~~~~i~~i~~Qll~aL~~L---H-~~giiHrDLKp~NILl~~~~--------- 135 (472)
-.||+.++-++...+ .. +.+...-..-++.++.||+.-.--+ - ....+|-||||+||||-+..
T Consensus 246 nIIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~ 325 (434)
T PF05445_consen 246 NIIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGN 325 (434)
T ss_pred cEEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECC
Confidence 358998876532221 11 1221222334666777775433112 1 34799999999999985433
Q ss_pred ---------CeEEeeccceeee
Q 012062 136 ---------NLKLADFGLARSF 148 (472)
Q Consensus 136 ---------~vkL~DFG~a~~~ 148 (472)
.++|.||.++...
T Consensus 326 ~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 326 RNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred eEEEecccceeeecccCHHHhc
Confidence 2577778777553
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.74 E-value=0.047 Score=49.75 Aligned_cols=26 Identities=38% Similarity=0.641 Sum_probs=0.0
Q ss_pred ccccCCCCCcEEEcCCCCeEEeeccce
Q 012062 119 VLHRDIKGSNLLIDNEGNLKLADFGLA 145 (472)
Q Consensus 119 iiHrDLKp~NILl~~~~~vkL~DFG~a 145 (472)
.+|+|+.|+||++++++ ++|+||+.|
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a 104 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYA 104 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCcc
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 472 | ||||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-81 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-81 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-81 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-80 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-67 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-67 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-67 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-67 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-67 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-67 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-67 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-67 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-67 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-66 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-66 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-66 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-66 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-66 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-66 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-66 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-66 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-66 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-66 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-66 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-66 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-66 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-66 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-66 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-66 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-66 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-66 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-66 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-66 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-66 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-66 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-66 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-66 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-66 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-66 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-63 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-63 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-63 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-62 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-62 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-59 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-57 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-56 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-56 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-56 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-55 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-52 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-52 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-51 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-50 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-50 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-50 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-49 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-44 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 9e-44 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-43 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-43 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-43 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-43 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-43 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-43 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-43 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-43 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-43 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-43 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-43 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-43 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-43 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-43 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-43 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-43 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-43 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-43 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-43 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-43 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-43 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-42 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-42 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-42 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-42 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-42 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-42 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-42 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-42 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-42 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-41 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-41 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-41 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-41 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-41 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-41 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-41 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-41 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-41 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-41 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-41 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-41 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-41 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-41 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-41 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-41 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-41 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-41 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-41 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-41 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-41 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-41 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-41 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-41 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-41 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-41 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-41 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-41 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-41 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-41 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-41 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-41 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-41 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-41 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-41 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-41 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-41 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-41 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-41 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-41 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-41 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-41 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-41 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-41 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-41 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-41 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-41 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-41 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-41 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-41 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-41 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-40 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-40 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-40 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-40 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-40 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-40 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-40 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-40 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-40 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-40 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-39 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-39 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-39 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-38 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-38 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-36 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-35 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-35 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-35 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-35 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-35 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-35 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-35 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-35 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-35 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 9e-35 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-35 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-34 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-34 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-34 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-34 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-34 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-34 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-34 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-33 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-33 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-33 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-33 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-32 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-32 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-31 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-30 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-30 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-30 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-30 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-30 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-30 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-30 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-30 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-30 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-30 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-30 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-30 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-30 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-30 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-30 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-30 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-30 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-30 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-30 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-30 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-29 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-29 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-29 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-29 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-29 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-29 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-29 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-29 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-29 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-29 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-29 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-29 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-28 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-28 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-28 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-27 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 7e-27 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-26 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-25 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-24 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-23 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-23 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 3e-23 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-23 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-23 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-23 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 8e-23 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-23 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-22 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-22 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-22 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-22 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-22 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-22 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-22 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-22 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-22 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-22 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-22 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 5e-22 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-21 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-21 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-21 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-21 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-21 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-21 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-21 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-21 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-20 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-20 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-20 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-20 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 5e-20 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 6e-20 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 6e-20 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 6e-20 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 6e-20 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 6e-20 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 6e-20 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 7e-20 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 7e-20 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-20 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 9e-20 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-20 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-20 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-19 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-19 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-19 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-19 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-19 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-19 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-19 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-19 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-19 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-19 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-19 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-19 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-19 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-19 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-19 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-19 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-19 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-19 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-19 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-19 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-19 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-19 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-19 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-19 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-18 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-18 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-18 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-18 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-18 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-17 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-17 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-17 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-17 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-17 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 8e-17 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 8e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 9e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-17 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-16 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-16 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-16 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-16 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-16 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-16 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-16 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-16 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-16 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-16 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-16 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-16 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 9e-16 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-15 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-15 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-15 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-15 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-15 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-15 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-15 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-15 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-15 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-15 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-14 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-14 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-14 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-14 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-14 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-14 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-14 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-14 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-14 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-14 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-13 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-13 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-13 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-13 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-13 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-13 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-13 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-13 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-13 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-13 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-13 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-13 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-13 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-13 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-13 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-13 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-13 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-13 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-13 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-13 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-13 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-13 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 9e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 9e-13 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-12 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-12 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-12 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-12 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 2e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-12 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-12 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-12 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-12 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-12 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-12 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-12 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-12 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-12 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-12 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-12 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-12 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-12 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-12 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-12 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-12 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-12 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-12 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-12 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-12 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-12 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-12 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-12 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-12 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-12 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-12 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-12 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-12 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 4e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-12 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-12 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-12 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-12 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-12 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-12 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-12 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-12 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-12 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-12 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-12 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-12 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-12 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-12 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-12 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-12 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-12 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-12 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-12 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-12 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 6e-12 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-12 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-12 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-12 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-12 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-12 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-12 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 9e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-12 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 9e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 9e-12 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-11 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-11 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-11 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-11 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-11 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-11 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-11 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-11 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-11 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-11 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-11 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-11 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-11 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-11 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-11 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-11 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-11 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-11 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-11 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-11 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 6e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-10 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-10 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-09 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-09 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-09 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-09 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 5e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-09 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 6e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 6e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-09 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 8e-09 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 9e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-08 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-08 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-08 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-08 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-08 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-08 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-08 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-08 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-08 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-08 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-08 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-08 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-08 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-08 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 8e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 9e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 9e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 9e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-07 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-07 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-07 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-07 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-07 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-07 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-07 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-07 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-07 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-07 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-07 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-06 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-06 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-06 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-06 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-06 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-06 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-06 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-06 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-06 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-06 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-06 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-06 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-06 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-06 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-06 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-06 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 7e-06 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 7e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-06 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 9e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-05 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-05 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-05 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-05 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-05 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-05 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-05 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-05 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-05 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-05 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-05 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-05 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-05 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-05 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-05 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-05 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 6e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-05 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 8e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-04 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 1e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-04 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-04 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-04 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-04 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-04 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-04 |
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 549 bits (1416), Expect = 0.0
Identities = 152/323 (47%), Positives = 209/323 (64%), Gaps = 15/323 (4%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
AR KTG+ VALKK+ M+NEKEGFPITA+REIKIL+ L+HENV+ L EI +
Sbjct: 36 ARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS----- 90
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
N+ +GS Y+VF++ +HDL GL ++FT+ +IK M+ LL GL+Y H N++LH
Sbjct: 91 ---PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILH 147
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSY---DHNNTLTNRVITLWYRPPELLLGATKYG 178
RD+K +N+LI +G LKLADFGLAR+FS N TNRV+TLWYRPPELLLG YG
Sbjct: 148 RDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYG 207
Query: 179 PAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238
P +D+W GCI AE+ PI+ G E QL+ I +LCGS +WP V Y +
Sbjct: 208 PPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLEL 267
Query: 239 SRTMKRRVREVFRHF--DRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSL 296
+ KR+V++ + + D +AL+L++K+L+LDP+QRI + DAL+ ++FW+DP+P D K +
Sbjct: 268 VKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKGM 327
Query: 297 PKYE--SSHEYQTKKRRQQQRQH 317
S EY RR+ H
Sbjct: 328 LSTHLTSMFEYLAPPRRKHHHHH 350
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 503 bits (1297), Expect = e-179
Identities = 128/339 (37%), Positives = 182/339 (53%), Gaps = 28/339 (8%)
Query: 2 AREIKTGEIVALKKIRMDNE---KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 58
AR+ T +IVA+KKI++ + K+G TA+REIK+L++L H N+I L +
Sbjct: 29 ARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH----- 83
Query: 59 DEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 118
+ + +VF++M+ DL + L T IK YM L GL Y H +
Sbjct: 84 -----------KSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 132
Query: 119 VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYG 178
+LHRD+K +NLL+D G LKLADFGLA+SF N T++V+T WYR PELL GA YG
Sbjct: 133 ILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVVTRWYRAPELLFGARMYG 191
Query: 179 PAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238
VDMW+VGCI AELL P LPG ++ +QL++IFE G+P E WP + +P Y FK
Sbjct: 192 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 251
Query: 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPK 298
+ +F L+L++ + + +P RI+A AL +YF P P LP+
Sbjct: 252 FP--GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPR 309
Query: 299 YESSHEYQTKKRRQQQRQHEEATKRQKLHHPQPHGRLPP 337
E ++Q A KR++ + G LP
Sbjct: 310 PNCPVE-----TLKEQSNPALAIKRKRTEALE-QGGLPK 342
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 482 bits (1243), Expect = e-171
Identities = 123/332 (37%), Positives = 173/332 (52%), Gaps = 27/332 (8%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
+ T +VALK+IR+++E EG P TAIRE+ +LK L+H N++ L +I+ +
Sbjct: 20 KGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHT------- 71
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
S +VFEY+D DL D G + +K ++ QLL GL YCH +VL
Sbjct: 72 ---------EKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVL 122
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 180
HRD+K NLLI+ G LKLADFGLAR+ S T N V+TLWYRPP++LLG+T Y
Sbjct: 123 HRDLKPQNLLINERGELKLADFGLARAKS-IPTKTYDNEVVTLWYRPPDILLGSTDYSTQ 181
Query: 181 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240
+DMW VGCIF E+ G+P+ PG EQL IF + G+P E WPG+ + + +
Sbjct: 182 IDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPK 241
Query: 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYE 300
+ D +LL K+L + RISA+DA+ +F + LP
Sbjct: 242 YRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHK--LPDTT 299
Query: 301 SSHEYQTKKRRQQQRQHEEATKRQKLHHPQPH 332
S K+ + Q+ + HH H
Sbjct: 300 SIFA--LKEIQLQKE-----ASLRSAHHHHHH 324
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 470 bits (1212), Expect = e-166
Identities = 115/313 (36%), Positives = 172/313 (54%), Gaps = 24/313 (7%)
Query: 2 AREIK-TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ---HENVIKLKEIVTSPGPE 57
AR++K G VALK++R+ +EG P++ IRE+ +L+ L+ H NV++L ++ T +
Sbjct: 30 ARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89
Query: 58 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHV 116
R+ +VFE++D DLT D+ P IK M QLL GL + H
Sbjct: 90 RE-----------TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138
Query: 117 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK 176
++V+HRD+K N+L+ + G +KLADFGLAR +S LT+ V+TLWYR PE+LL ++
Sbjct: 139 HRVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSVVVTLWYRAPEVLLQSS- 195
Query: 177 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236
Y VD+WSVGCIFAE+ KP+ G ++ +QL KI ++ G P E WP +P
Sbjct: 196 YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFH 255
Query: 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCD--PK 294
S + + + D +LL K L +P++RISA AL YF +
Sbjct: 256 SKS---AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKENLDS 312
Query: 295 SLPKYESSHEYQT 307
LP +++ E T
Sbjct: 313 HLPPSQNTSELNT 325
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 468 bits (1206), Expect = e-166
Identities = 117/290 (40%), Positives = 170/290 (58%), Gaps = 19/290 (6%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A+ +T EIVALK++R+D++ EG P +A+REI +LK+L+H+N+++L +++ S
Sbjct: 21 AKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-------- 72
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
+VFE+ D DL D +K ++ QLL GL +CH VLH
Sbjct: 73 --------DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLH 124
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 181
RD+K NLLI+ G LKLA+FGLAR+F + V+TLWYRPP++L GA Y ++
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 182 DMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240
DMWS GCIFAEL N G+P+ PG + +QL +IF L G+P E WP ++K+P Y + P
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY-PMY 242
Query: 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 290
+ V + +LL+ +L +P QRISA++AL YF P
Sbjct: 243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 464 bits (1196), Expect = e-164
Identities = 118/313 (37%), Positives = 180/313 (57%), Gaps = 29/313 (9%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
TG VALK++++D+E EG P TAIREI ++K+L+HEN+++L +++ +
Sbjct: 24 GLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHT-------- 74
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLR-----FTVPQIKCYMKQLLTGLHYCHV 116
+VFE+MD+DL D + + +K + QLL GL +CH
Sbjct: 75 --------ENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE 126
Query: 117 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK 176
N++LHRD+K NLLI+ G LKL DFGLAR+F NT ++ V+TLWYR P++L+G+
Sbjct: 127 NKILHRDLKPQNLLINKRGQLKLGDFGLARAFG-IPVNTFSSEVVTLWYRAPDVLMGSRT 185
Query: 177 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236
Y ++D+WS GCI AE++ GKP+ PG N+ EQL IF++ G+P+E++WP V+K+P YN
Sbjct: 186 YSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPN 245
Query: 237 KPSRTMKRRVREVFRH-----FDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPC 291
R R +R+V + D + ++ L +L L+P R+SAK AL +F
Sbjct: 246 IQQRP-PRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHA 304
Query: 292 DPKSLPKYESSHE 304
+ H
Sbjct: 305 SMGGSRSHHHHHH 317
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 462 bits (1190), Expect = e-163
Identities = 119/287 (41%), Positives = 176/287 (61%), Gaps = 18/287 (6%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A++ G IVALK+IR+D E EG P TAIREI +LK+L H N++ L +++ S
Sbjct: 40 AKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS-------- 90
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
+VFE+M+ DL + D QIK Y+ QLL G+ +CH +++LH
Sbjct: 91 --------ERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILH 142
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 181
RD+K NLLI+++G LKLADFGLAR+F + T+ V+TLWYR P++L+G+ KY +V
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLARAFG-IPVRSYTHEVVTLWYRAPDVLMGSKKYSTSV 201
Query: 182 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241
D+WS+GCIFAE++ GKP+ PG + +QL KIF + G+P+ WP V ++P +
Sbjct: 202 DIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVF 261
Query: 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 288
K+ + F + ++LL ML DP++RISA+DA++ YF
Sbjct: 262 EKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 458 bits (1180), Expect = e-162
Identities = 121/283 (42%), Positives = 172/283 (60%), Gaps = 19/283 (6%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A+ GE ALKKIR++ E EG P T IREI ILK+L+H N++KL +++ +
Sbjct: 21 AQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-------- 71
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
+ +VFE++D DL L D K ++ QLL G+ YCH +VLH
Sbjct: 72 --------KKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 181
RD+K NLLI+ EG LK+ADFGLAR+F T+ ++TLWYR P++L+G+ KY +
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFG-IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182
Query: 182 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241
D+WSVGCIFAE++NG P+ PG +EA+QL +IF + G+P+ WP V+++P Y+
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242
Query: 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
+ D ++LL KML LDP+QRI+AK AL+ YF
Sbjct: 243 -PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 454 bits (1170), Expect = e-160
Identities = 118/294 (40%), Positives = 175/294 (59%), Gaps = 23/294 (7%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A + T E VA+K+IR+++E+EG P TAIRE+ +LK+LQH N+I+LK ++
Sbjct: 53 AIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH-------- 104
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
+++FEY ++DL D+ ++ IK ++ QL+ G+++CH + LH
Sbjct: 105 --------NHRLHLIFEYAENDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRRCLH 155
Query: 122 RDIKGSNLLID-----NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK 176
RD+K NLL+ LK+ DFGLAR+F T+ +ITLWYRPPE+LLG+
Sbjct: 156 RDLKPQNLLLSVSDASETPVLKIGDFGLARAFG-IPIRQFTHEIITLWYRPPEILLGSRH 214
Query: 177 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236
Y +VD+WS+ CI+AE+L P+ PG +E +QL KIFE+ G PD+T WPGV+ +P +
Sbjct: 215 YSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQS 274
Query: 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 290
P K R + D L+LL ML +DP +RISAK+AL+ YF +
Sbjct: 275 FPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD 328
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 451 bits (1162), Expect = e-159
Identities = 115/300 (38%), Positives = 163/300 (54%), Gaps = 26/300 (8%)
Query: 2 AREIKTGEIVALKKIRMDNEKEG---FPITAIREIKILKKLQ---HENVIKLKEIVTSPG 55
AR+ +G VALK +R+ N G PI+ +RE+ +L++L+ H NV++L ++ +
Sbjct: 28 ARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87
Query: 56 PERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLAD-RPGLRFTVPQIKCYMKQLLTGLHYC 114
+R+ +VFE++D DL D P IK M+Q L GL +
Sbjct: 88 TDRE-----------IKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFL 136
Query: 115 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA 174
H N ++HRD+K N+L+ + G +KLADFGLAR +S + LT V+TLWYR PE+LL +
Sbjct: 137 HANCIVHRDLKPENILVTSGGTVKLADFGLARIYS--YQMALTPVVVTLWYRAPEVLLQS 194
Query: 175 TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234
T Y VDMWSVGCIFAE+ KP+ G +EA+QL KIF+L G P E WP +P
Sbjct: 195 T-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGA 253
Query: 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPK 294
R V+ V + +LL +ML +P +RISA AL Y D P+
Sbjct: 254 FPPRGP---RPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGN--PE 308
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 449 bits (1157), Expect = e-158
Identities = 96/306 (31%), Positives = 149/306 (48%), Gaps = 18/306 (5%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
R TG+IVA+KK + A+REI++LK+L+H N++ L E+
Sbjct: 22 CRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR-------- 73
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
+ ++VFEY DH + DR +K Q L +++CH + +H
Sbjct: 74 --------KRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIH 125
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 181
RD+K N+LI +KL DFG AR + ++ + V T WYR PELL+G T+YGP V
Sbjct: 126 RDVKPENILITKHSVIKLCDFGFARLLT-GPSDYYDDEVATRWYRSPELLVGDTQYGPPV 184
Query: 182 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK-PSR 240
D+W++GC+FAELL+G P+ PGK++ +QL I + G S ++ K P
Sbjct: 185 DVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDP 244
Query: 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYE 300
+ F + AL LL+ L +DP++R++ + L YF D
Sbjct: 245 EDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDLAKEHDKP 304
Query: 301 SSHEYQ 306
+ + Y
Sbjct: 305 AENLYF 310
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 447 bits (1151), Expect = e-157
Identities = 88/304 (28%), Positives = 150/304 (49%), Gaps = 18/304 (5%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
R TG IVA+KK ++ + A+REIK+LK+L+HEN++ L E+
Sbjct: 44 CRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVC---------- 93
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
K + Y+VFE++DH + + ++ Y+ Q++ G+ +CH + ++H
Sbjct: 94 ------KKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIH 147
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 181
RDIK N+L+ G +KL DFG AR+ + + V T WYR PELL+G KYG AV
Sbjct: 148 RDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYDDEVATRWYRAPELLVGDVKYGKAV 206
Query: 182 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK-PSR 240
D+W++GC+ E+ G+P+ PG ++ +QL I G+ +K P + + P
Sbjct: 207 DVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEI 266
Query: 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYE 300
+ + + ++L +K L +DP +R + L ++F D + +
Sbjct: 267 KEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERFSQELQLK 326
Query: 301 SSHE 304
+
Sbjct: 327 VQKD 330
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 423 bits (1089), Expect = e-146
Identities = 112/381 (29%), Positives = 184/381 (48%), Gaps = 63/381 (16%)
Query: 3 REIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQG 62
++ K + ALK+I E G ++A REI +L++L+H NVI L+++ S
Sbjct: 43 KDGKDDKDYALKQI----EGTGISMSACREIALLRELKHPNVISLQKVFLSHADR----- 93
Query: 63 RPDGNKYRGSTYMVFEYMDHDLTGL--------ADRPGLRFTVPQIKCYMKQLLTGLHYC 114
+++F+Y +HDL + A++ ++ +K + Q+L G+HY
Sbjct: 94 ---------KVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 115 HVNQVLHRDIKGSNLLI----DNEGNLKLADFGLARSFSYDHNNTLTN---RVITLWYRP 167
H N VLHRD+K +N+L+ G +K+AD G AR F+ L + V+T WYR
Sbjct: 145 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN-SPLKPLADLDPVVVTFWYRA 203
Query: 168 PELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE---------AEQLSKIFELCGS 218
PELLLGA Y A+D+W++GCIFAELL +PI + E +QL +IF + G
Sbjct: 204 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 263
Query: 219 PDETIWPGVSKMPAYNHFKP--------SRTMKRRVREVFRHFDRHALELLEKMLMLDPS 270
P + W + KMP ++ + ++ + + + D A LL+K+L +DP
Sbjct: 264 PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPI 323
Query: 271 QRISAKDALDSEYFWTDPLPCDPKSLP------------KYESSHEYQTKKRRQQQRQHE 318
+RI+++ A+ YF DPLP + E + K ++QQQ +
Sbjct: 324 KRITSEQAMQDPYFLEDPLPTSDVFAGCQIPYPKREFLTEEEPDDKGDKKNQQQQQGNNH 383
Query: 319 EATKRQKLHHPQPHGRLPPIQ 339
+ H + PP++
Sbjct: 384 TNGTGHPGNQDSSHTQGPPLK 404
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 322 bits (826), Expect = e-106
Identities = 103/374 (27%), Positives = 164/374 (43%), Gaps = 39/374 (10%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A+ +GE+VA+KK+ D + RE++I++KL H N+++L+ S G ++DE
Sbjct: 73 AKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 118
+V +Y+ + +A R V +K YM QL L Y H
Sbjct: 127 ----------YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 176
Query: 119 VLHRDIKGSNLLID-NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 177
+ HRDIK NLL+D + LKL DFG A+ + + + +YR PEL+ GAT Y
Sbjct: 177 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRAPELIFGATDY 234
Query: 178 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237
++D+WS GC+ AELL G+PI PG + +QL +I ++ G+P ++ P Y FK
Sbjct: 235 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFK 292
Query: 238 PSRTMKRRVREVFR-HFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDP---LPC 291
+ +VFR A+ L ++L P+ R++ +A +F DP LP
Sbjct: 293 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPN 352
Query: 292 DPKSLPKYE-SSHEYQTKKRRQQQRQHEEATKRQKLHHPQPHGRLPPIQHAGQSHHWSGP 350
+ + ++ E + A + P S +G
Sbjct: 353 GRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTN--------ATAASDANTGD 404
Query: 351 NHPMNNAPPPVPGG 364
NNA
Sbjct: 405 RGQTNNAASASASN 418
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 316 bits (812), Expect = e-105
Identities = 97/346 (28%), Positives = 160/346 (46%), Gaps = 32/346 (9%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A+ +++ E VA+KK+ D + RE++I++ ++H NV+ LK S G ++DE
Sbjct: 59 AKLVESDE-VAIKKVLQDKRFKN------RELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 118
+V EY+ + + + + IK YM QLL L Y H
Sbjct: 112 ----------FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG 161
Query: 119 VLHRDIKGSNLLID-NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 177
+ HRDIK NLL+D G LKL DFG A+ + + + +YR PEL+ GAT Y
Sbjct: 162 ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYICSRYYRAPELIFGATNY 219
Query: 178 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237
+D+WS GC+ AEL+ G+P+ PG++ +QL +I ++ G+P ++ P Y K
Sbjct: 220 TTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN--PNYMEHK 277
Query: 238 PSRTMKRRVREVFR-HFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDP---LPC 291
+ +VFR A++L+ ++L PS R++A +AL +F +P
Sbjct: 278 FPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPN 337
Query: 292 DPKSLPKYE-SSHEYQTKKRRQQQRQHEEATKRQKLHHPQPHGRLP 336
+ P + + E + + + A H P
Sbjct: 338 GRELPPLFNWTKEELSVRPDLISRLVPQHAEAELLSRGIDVHNFQP 383
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 296 bits (759), Expect = 1e-97
Identities = 85/294 (28%), Positives = 140/294 (47%), Gaps = 36/294 (12%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDE 60
A I E V +K ++ +K+ REIKIL+ L+ N+I L +IV P
Sbjct: 55 AINITNNEKVVVKILKPVKKKK-----IKREIKILENLRGGPNIITLADIVKDPVSRTP- 108
Query: 61 QGRPDGNKYRGSTYMVFEY-MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQV 119
+VFE+ + D L T I+ YM ++L L YCH +
Sbjct: 109 -------------ALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGI 151
Query: 120 LHRDIKGSNLLIDNE-GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYG 178
+HRD+K N++ID+E L+L D+GLA Y RV + +++ PELL+ Y
Sbjct: 152 MHRDVKPHNVMIDHEHRKLRLIDWGLAEF--YHPGQEYNVRVASRYFKGPELLVDYQMYD 209
Query: 179 PAVDMWSVGCIFAELLNGK-PILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237
++DMWS+GC+ A ++ K P G + +QL +I ++ G+ D + + F
Sbjct: 210 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 269
Query: 238 PS--RTMKRRVREVFRHFDRH-----ALELLEKMLMLDPSQRISAKDALDSEYF 284
R ++R ++H AL+ L+K+L D R++A++A++ YF
Sbjct: 270 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 297 bits (762), Expect = 2e-96
Identities = 103/386 (26%), Positives = 160/386 (41%), Gaps = 75/386 (19%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A + +VA+KKI E +REI IL +L H++V+K+ +IV E+ ++
Sbjct: 72 AYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
Y+V E D D L R + T IK + LL G+ Y H +LH
Sbjct: 132 -----------LYVVLEIADSDFKKLF-RTPVYLTELHIKTLLYNLLVGVKYVHSAGILH 179
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN--------------------------T 155
RD+K +N L++ + ++K+ DFGLAR+ Y N
Sbjct: 180 RDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQ 239
Query: 156 LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-----------GKPILPGKN 204
LT V+T WYR PEL+L Y A+D+WS+GCIFAELLN P+ PG +
Sbjct: 240 LTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSS 299
Query: 205 --------------------EAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 244
+QL+ IF + G+P E + K A + + +
Sbjct: 300 CFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREG 359
Query: 245 R-VREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDPLPCDPKSLPKYES 301
+ E F A+ LL++ML+ +P++RI+ + L +F + + K
Sbjct: 360 TDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA-EVETNATEKVRL 418
Query: 302 SHEYQTKKRRQQQRQ--HEEATKRQK 325
Q R +E +
Sbjct: 419 PFNDWMNMDEPQLRYAFVKEIQRYHP 444
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 293 bits (751), Expect = 1e-95
Identities = 90/329 (27%), Positives = 155/329 (47%), Gaps = 40/329 (12%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
+I++G+ ALKK+ D P RE+ I+K L H N+IKL + + G E +
Sbjct: 26 VFDIESGKRFALKKVLQD------PRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79
Query: 62 GRPDGNKYRGST----------------------YMVFEYMDHDLTGLAD---RPGLRFT 96
+P + + ++ EY+ L + R G
Sbjct: 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIP 139
Query: 97 VPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID-NEGNLKLADFGLARSFSYDHNNT 155
+ I Y+ QL + + H + HRDIK NLL++ + LKL DFG A+ +
Sbjct: 140 MNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSV 199
Query: 156 LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 215
+ + +YR PEL+LGAT+Y P++D+WS+GC+F EL+ GKP+ G+ +QL +I ++
Sbjct: 200 --AYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQI 257
Query: 216 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHF-DRHALELLEKMLMLDPSQRIS 274
G+P + ++ P Y + + R++ A++LLE++L +P RI+
Sbjct: 258 MGTPTKEQMIRMN--PHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN 315
Query: 275 AKDALDSEYFWTDPLPCDPKSLPKYESSH 303
+A+ +F D L + +S+
Sbjct: 316 PYEAMAHPFF--DHLR-NSYESEVKNNSN 341
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 291 bits (748), Expect = 1e-95
Identities = 90/311 (28%), Positives = 137/311 (44%), Gaps = 34/311 (10%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL---QHENVIKLKEIVTSPGPER 58
+E TG VA+KK+ D P RE++I++ L H N+++L+ + G
Sbjct: 42 GKEKSTGMSVAIKKVIQD------PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95
Query: 59 DEQGRPDGNKYRGSTYMVFEYMDHDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCH 115
Y +V EY+ L R + IK ++ QL+ + H
Sbjct: 96 RRD------IY---LNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH 146
Query: 116 VN--QVLHRDIKGSNLLIDNE-GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL 172
+ V HRDIK N+L++ G LKL DFG A+ S N + + +YR PEL+
Sbjct: 147 LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV--AYICSRYYRAPELIF 204
Query: 173 GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 232
G Y AVD+WSVGCIFAE++ G+PI G N A QL +I + G P + ++ P+
Sbjct: 205 GNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLN--PS 262
Query: 233 YNHFK----PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WT 286
+ + + A +LL +L P +R+ +AL YF
Sbjct: 263 HTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322
Query: 287 DPLPCDPKSLP 297
DP P +
Sbjct: 323 DPATKLPNNKD 333
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 285 bits (731), Expect = 1e-93
Identities = 101/293 (34%), Positives = 156/293 (53%), Gaps = 13/293 (4%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A + + VA+KKI + + + A+REIKI+++L H+N++K+ EI+ G + +
Sbjct: 30 AVDNDCDKRVAIKKIVLTDPQ--SVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
S Y+V EYM+ DL + ++ L + +M QLL GL Y H VLH
Sbjct: 88 VGSLTEL--NSVYIVQEYMETDLANVLEQGPL--LEEHARLFMYQLLRGLKYIHSANVLH 143
Query: 122 RDIKGSNLLIDNEG-NLKLADFGLARSFS--YDHNNTLTNRVITLWYRPPELLLGATKYG 178
RD+K +NL I+ E LK+ DFGLAR Y H L+ ++T WYR P LLL Y
Sbjct: 144 RDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYT 203
Query: 179 PAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSP-DETIWPGVSKMPAYNHFK 237
A+DMW+ GCIFAE+L GK + G +E EQ+ I E +E +S +P Y
Sbjct: 204 KAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRND 263
Query: 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDP 288
+ + + ++ R A++ LE++L P R++A++AL Y ++ P
Sbjct: 264 MTEP-HKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 285 bits (732), Expect = 3e-93
Identities = 86/296 (29%), Positives = 132/296 (44%), Gaps = 26/296 (8%)
Query: 6 KTGEIVALKKIRMDNEKEGFPIT---------AIREIKILKKLQHENVIKLKEIVTSPGP 56
G VA+K++ +REI++L H N++ L++I
Sbjct: 44 SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEE 103
Query: 57 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 116
+ Y+V E M DL + + + I+ +M +L GLH H
Sbjct: 104 PAMHK-----------LYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE 152
Query: 117 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK 176
V+HRD+ N+L+ + ++ + DF LAR + D N T+ V WYR PEL++
Sbjct: 153 AGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKG 210
Query: 177 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236
+ VDMWS GC+ AE+ N K + G QL+KI E+ G+P S A ++
Sbjct: 211 FTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYL 270
Query: 237 KPSRTMKRRV--REVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDP 288
+ S + V D AL+L+ KML +P +RIS + AL YF DP
Sbjct: 271 RNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP 326
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 283 bits (725), Expect = 4e-92
Identities = 108/308 (35%), Positives = 166/308 (53%), Gaps = 20/308 (6%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A + VA+KKI E + + +REIKIL + +HEN+I + +I+ +P E+ +
Sbjct: 46 AYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
Y+V + M+ DL L L + I ++ Q+L GL Y H VLH
Sbjct: 105 -----------VYIVQDLMETDLYKLLKTQHL--SNDHICYFLYQILRGLKYIHSANVLH 151
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT--LTNRVITLWYRPPELLLGATKYGP 179
RD+K SNLL++ +LK+ DFGLAR DH++T LT V T WYR PE++L + Y
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 180 AVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239
++D+WSVGCI AE+L+ +PI PGK+ +QL+ I + GSP + + + A N+
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL 271
Query: 240 RTMKRR-VREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDPLPCDPKSL 296
+ +F + D AL+LL+KML +P +RI + AL Y + DP +P +
Sbjct: 272 PHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP-SDEPIAE 330
Query: 297 PKYESSHE 304
++ E
Sbjct: 331 APFKFDME 338
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 282 bits (724), Expect = 5e-92
Identities = 106/326 (32%), Positives = 161/326 (49%), Gaps = 40/326 (12%)
Query: 2 AREIKTGEIVALKKIR-MDNEKEGFPITA---IREIKILKKLQHENVIKLKEIVTSPGPE 57
A TGEIVA+KKI D P+ A +REIKILK +HEN+I + I E
Sbjct: 30 ATHKPTGEIVAIKKIEPFDK-----PLFALRTLREIKILKHFKHENIITIFNIQRPDSFE 84
Query: 58 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 117
+ Y++ E M DL + L + I+ ++ Q L + H +
Sbjct: 85 NFNE-----------VYIIQELMQTDLHRVISTQML--SDDHIQYFIYQTLRAVKVLHGS 131
Query: 118 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFS---------YDHNNTLTNRVITLWYRPP 168
V+HRD+K SNLLI++ +LK+ DFGLAR + + V T WYR P
Sbjct: 132 NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAP 191
Query: 169 ELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSP--DETIWPG 226
E++L + KY A+D+WS GCI AEL +PI PG++ QL IF + G+P D +
Sbjct: 192 EVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLR-C 250
Query: 227 VSKMPAYNHFKPSRTMKRR-VREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF- 284
+ A + K + ++F + ++LL++ML+ DP++RI+AK+AL+ Y
Sbjct: 251 IESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ 310
Query: 285 -WTDPL---PCDPKSLPKYESSHEYQ 306
+ DP +P +E H +
Sbjct: 311 TYHDPNDEPEGEPIPPSFFEFDHYKE 336
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 282 bits (723), Expect = 6e-92
Identities = 102/308 (33%), Positives = 163/308 (52%), Gaps = 21/308 (6%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A + ++GE VA+KK+ + E F A RE+ +LK +QHENVI L ++ T R+
Sbjct: 43 AIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
Y+V +M DL + F+ +I+ + Q+L GL Y H V+H
Sbjct: 103 D----------FYLVMPFMQTDLQKIMGLK---FSEEKIQYLVYQMLKGLKYIHSAGVVH 149
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 181
RD+K NL ++ + LK+ DFGLAR + +T V+T WYR PE++L Y V
Sbjct: 150 RDLKPGNLAVNEDCELKILDFGLARHA----DAEMTGYVVTRWYRAPEVILSWMHYNQTV 205
Query: 182 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241
D+WSVGCI AE+L GK + GK+ +QL++I ++ G P ++ A ++ +
Sbjct: 206 DIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQ 265
Query: 242 MKRR-VREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDPLPCDPKSLPK 298
R+ ++F A +LLEKML LD +R++A AL +F + DP + ++
Sbjct: 266 TPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP-EEETEAQQP 324
Query: 299 YESSHEYQ 306
++ S E++
Sbjct: 325 FDDSLEHE 332
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 278 bits (712), Expect = 4e-90
Identities = 100/339 (29%), Positives = 160/339 (47%), Gaps = 36/339 (10%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A + +TG VA+KK+ + E F A RE+++LK ++HENVI L ++ T D
Sbjct: 44 AVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
Y+V +M DL L L +I+ + Q+L GL Y H ++H
Sbjct: 104 D----------FYLVMPFMGTDLGKLMKHEKL--GEDRIQFLVYQMLKGLRYIHAAGIIH 151
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 181
RD+K NL ++ + LK+ DFGLAR + +T V+T WYR PE++L +Y V
Sbjct: 152 RDLKPGNLAVNEDCELKILDFGLARQAD----SEMTGYVVTRWYRAPEVILNWMRYTQTV 207
Query: 182 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241
D+WSVGCI AE++ GK + G + +QL +I ++ G+P + A N+ K
Sbjct: 208 DIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPE 267
Query: 242 MKRR-VREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDPL---PCDP-- 293
++++ + + A+ LLEKML+LD QR++A +AL YF D
Sbjct: 268 LEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYD 327
Query: 294 -----KSLPK-------YESSHEYQTKKRRQQQRQHEEA 320
Y+ ++ ++ + E
Sbjct: 328 DSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETP 366
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 274 bits (703), Expect = 1e-88
Identities = 109/334 (32%), Positives = 163/334 (48%), Gaps = 26/334 (7%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A + KTG VA+KK+ + RE+++LK ++HENVI L ++ T +
Sbjct: 48 AFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
Y+V M DL + L T ++ + Q+L GL Y H ++H
Sbjct: 108 D----------VYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQILRGLKYIHSADIIH 155
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 181
RD+K SNL ++ + LK+ DFGLAR + + +T V T WYR PE++L Y V
Sbjct: 156 RDLKPSNLAVNEDCELKILDFGLARHTA----DEMTGYVATRWYRAPEIMLNWMHYNQTV 211
Query: 182 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241
D+WSVGCI AELL G+ + PG + +QL I L G+P + +S A N+ +
Sbjct: 212 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 271
Query: 242 MKRR-VREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDPLPCDPKSLPK 298
M + VF + A++LLEKML+LD +RI+A AL YF + DP D
Sbjct: 272 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVADP 329
Query: 299 YESSHEYQTKKRRQ-QQRQHEEATKRQKLHHPQP 331
Y+ S E + + + ++E P P
Sbjct: 330 YDQSLESRDLLIDEWKSLTYDEVIS----FVPPP 359
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 267 bits (685), Expect = 3e-85
Identities = 99/405 (24%), Positives = 169/405 (41%), Gaps = 73/405 (18%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A + T + VA+KK+ E +REI IL +L+ + +I+L +++ + ++
Sbjct: 45 AYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
Y+V E D DL L + + T IK + LL G ++ H + ++H
Sbjct: 105 -----------LYIVLEIADSDLKKLF-KTPIFLTEEHIKTILYNLLLGENFIHESGIIH 152
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT---------------------LTNRV 160
RD+K +N L++ + ++K+ DFGLAR+ + + + LT+ V
Sbjct: 153 RDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHV 212
Query: 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNG-----------KPILPG------- 202
+T WYR PEL+L Y ++D+WS GCIFAELLN P+ PG
Sbjct: 213 VTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLS 272
Query: 203 ----------KNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRR-VREVFR 251
K+ +QL+ IF + G+P E ++K + K K +++ +
Sbjct: 273 PDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYP 332
Query: 252 HFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDP---LPCDPKSLPKYESSHEYQ 306
+ LLE ML +P++RI+ ALD Y K + ++
Sbjct: 333 SISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFDDWMVLS 392
Query: 307 TKKRRQQQRQHEEATKRQKLHHPQPHGRLPPIQHAGQSHHWSGPN 351
+ R +E HP+ H ++ P+
Sbjct: 393 ETQLR--YIFLKEVQS----FHPELVIPSVFTIHENNFYNNEKPS 431
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 265 bits (678), Expect = 7e-84
Identities = 97/381 (25%), Positives = 170/381 (44%), Gaps = 34/381 (8%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A + VA+KK+ + + A RE+ ++K + H+N+I L + T + Q
Sbjct: 81 AYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
Y+V E MD +L + ++ + Q+L G+ + H ++H
Sbjct: 141 ----------DVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAGIIH 187
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 181
RD+K SN+++ ++ LK+ DFGLAR+ + +T V+T +YR PE++LG Y V
Sbjct: 188 RDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILG-MGYKENV 244
Query: 182 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDE----TIWPGVSKMPAYNHFK 237
D+WSVGCI E++ K + PG++ +Q +K+ E G+P + P V
Sbjct: 245 DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKY 304
Query: 238 PSRTMKRR--------VREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTD 287
T + E + A +LL KML++DP++RIS DAL Y W D
Sbjct: 305 AGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 364
Query: 288 PLPCDPKSLPKYESSHEYQTKKRRQQQRQ--HEEATK-RQKLHHPQPHGRLPPIQHAGQS 344
P + Y+ + + + ++ ++ ++E +K + G+ P A S
Sbjct: 365 PAEVEAPPPQIYDKQLD-EREHTIEEWKELIYKEVMNSEEKTKNGVVKGQPSPSGAAVNS 423
Query: 345 HHWSGPNHPMNNAPPPVPGGP 365
P+ +N+
Sbjct: 424 SESLPPSSSVNDISSMSTDQT 444
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 261 bits (670), Expect = 1e-83
Identities = 110/373 (29%), Positives = 172/373 (46%), Gaps = 59/373 (15%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDE 60
+ + +TGE+VA+KKI + REI IL +L HEN++ L ++
Sbjct: 28 SIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVL--------- 78
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
R D ++ Y+VF+YM+ DL + L + + QL+ + Y H +L
Sbjct: 79 --RADNDR---DVYLVFDYMETDLHAVIRANIL--EPVHKQYVVYQLIKVIKYLHSGGLL 131
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSY--------------------DHNNTLTNRV 160
HRD+K SN+L++ E ++K+ADFGL+RSF D LT+ V
Sbjct: 132 HRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYV 191
Query: 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSP- 219
T WYR PE+LLG+TKY +DMWS+GCI E+L GKPI PG + QL +I + P
Sbjct: 192 ATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPS 251
Query: 220 DETIW--------------PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRH--ALELLEK 263
+E + ++ N K + ++ D + AL+LL+K
Sbjct: 252 NEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDK 311
Query: 264 MLMLDPSQRISAKDALDSEYF--WTDPLPCDPKSLPKYESSHEYQTKKRRQQQRQ--HEE 319
+L +P++RISA DAL + + +P +P K R + E
Sbjct: 312 LLQFNPNKRISANDALKHPFVSIFHNP-NEEPNCDHIITIPINDNVKHSIDDYRNLVYSE 370
Query: 320 ATKRQKLHHPQPH 332
++R++ H
Sbjct: 371 ISRRKRELISNKH 383
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 260 bits (666), Expect = 3e-83
Identities = 90/348 (25%), Positives = 158/348 (45%), Gaps = 39/348 (11%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A + VA+KK+ + + A RE+ ++K + H+N+I L + T + Q
Sbjct: 44 AYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
Y+V E MD +L + ++ + Q+L G+ + H ++H
Sbjct: 104 D----------VYIVMELMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAGIIH 150
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 181
RD+K SN+++ ++ LK+ DFGLAR+ + +T V+T +YR PE++LG Y V
Sbjct: 151 RDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILG-MGYKENV 207
Query: 182 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS--------KMPAY 233
D+WSVGCI E++ G + PG + +Q +K+ E G+P + P Y
Sbjct: 208 DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKY 267
Query: 234 NHFKPSR----TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTD 287
+ + + E + A +LL KML++D S+RIS +AL Y W D
Sbjct: 268 AGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 327
Query: 288 PL---PCDPKSLPKYESSHEYQTKKRRQQQRQ--HEEATKRQKLHHPQ 330
P P + + + + ++ ++ ++E + HH
Sbjct: 328 PSEAEAPPP---KIPDKQLD-EREHTIEEWKELIYKEVMDLEHHHHHH 371
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 2e-63
Identities = 65/297 (21%), Positives = 108/297 (36%), Gaps = 48/297 (16%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
AR A+KKIR EK T + E+ +L L H+ V++
Sbjct: 25 ARNALDSRYYAIKKIRHTEEKL---STILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81
Query: 62 GRPDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
++ EY + L L L + +Q+L L Y H ++
Sbjct: 82 TAVKKKST---LFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGII 138
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFS-------------YDHNNTLTNRVITLWYRP 167
HRD+K N+ ID N+K+ DFGLA++ ++ LT+ + T Y
Sbjct: 139 HRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVA 198
Query: 168 PELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 227
E+L G Y +DM+S+G IF E++ P G L K+ +
Sbjct: 199 TEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKKLRSVSIEFPPDFDDNK 256
Query: 228 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
K +++ ++ DP++R A+ L+S +
Sbjct: 257 MK--------------------------VEKKIIRLLIDHDPNKRPGARTLLNSGWL 287
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 7e-59
Identities = 71/309 (22%), Positives = 115/309 (37%), Gaps = 60/309 (19%)
Query: 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQH--ENVIKLKEIVTSPGPERDEQGR 63
+ +I A+K + ++ + EI L KLQ + +I+L + +
Sbjct: 50 EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ-------- 101
Query: 64 PDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 123
YMV E + DL + + K Y K +L +H H + ++H D
Sbjct: 102 --------YIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSD 152
Query: 124 IKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLGA-------- 174
+K +N LI + G LKL DFG+A D + + + + T+ Y PPE +
Sbjct: 153 LKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGK 211
Query: 175 --TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDE-TIWPGVSKMP 231
+K P D+WS+GCI + GK P + Q+SK+ + E K
Sbjct: 212 SKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHEIEFPDIPEKD- 268
Query: 232 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPC 291
++L+ L DP QRIS + L Y P
Sbjct: 269 -------------------------LQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 303
Query: 292 DPKSLPKYE 300
+ + E
Sbjct: 304 NQMAKGTTE 312
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 5e-58
Identities = 61/286 (21%), Positives = 112/286 (39%), Gaps = 45/286 (15%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A+ G+ +K+++ +NEK A RE+K L KL H N++ + +
Sbjct: 30 AKHRIDGKTYVIKRVKYNNEK------AEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83
Query: 62 GRPDGNKYRGSTYMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQV 119
+ ++ E+ D L + R G + +Q+ G+ Y H ++
Sbjct: 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKL 143
Query: 120 LHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGP 179
++RD+K SN+ + + +K+ DFGL S ++ T TL Y PE + YG
Sbjct: 144 INRDLKPSNIFLVDTKQVKIGDFGLVTSLK--NDGKRTRSKGTLRYMSPEQISS-QDYGK 200
Query: 180 AVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239
VD++++G I AELL+ ++ + + + +
Sbjct: 201 EVDLYALGLILAELLHVCD--TAFETSKFFTDLRD-------------GIISD------- 238
Query: 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285
FD+ LL+K+L P R + + L + W
Sbjct: 239 ------------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 1e-57
Identities = 74/339 (21%), Positives = 122/339 (35%), Gaps = 61/339 (17%)
Query: 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQH--ENVIKLKEIVTSPGPERDEQGR 63
+ +I A+K + ++ + EI L KLQ + +I+L + E +Q
Sbjct: 31 EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY------EITDQ-- 82
Query: 64 PDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 123
YMV E + DL + + K Y K +L +H H + ++H D
Sbjct: 83 --------YIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSD 133
Query: 124 IKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLG--------- 173
+K +N LI + G LKL DFG+A D + + + + T+ Y PPE +
Sbjct: 134 LKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGK 192
Query: 174 -ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDE-TIWPGVSKMP 231
+K P D+WS+GCI + GK P + Q+SK+ + E K
Sbjct: 193 SKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHEIEFPDIPEK-- 248
Query: 232 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPC 291
++L+ L DP QRIS + L Y P
Sbjct: 249 ------------------------DLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP- 283
Query: 292 DPKSLPKYESSHEYQTKKRRQQQRQHEEATKRQKLHHPQ 330
+ +Y + + + L+
Sbjct: 284 VNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHY 322
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 4e-55
Identities = 73/338 (21%), Positives = 124/338 (36%), Gaps = 59/338 (17%)
Query: 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQH--ENVIKLKEIVTSPGPERDEQGR 63
+ +I A+K + ++ + EI L KLQ + +I+L + E +Q
Sbjct: 78 EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY------EITDQ-- 129
Query: 64 PDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 123
YMV E + DL + + K Y K +L +H H + ++H D
Sbjct: 130 --------YIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSD 180
Query: 124 IKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLGA-------- 174
+K +N LI + G LKL DFG+A D + + + + + Y PPE +
Sbjct: 181 LKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGK 239
Query: 175 --TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 232
+K P D+WS+GCI + GK P + Q+SK+ + E +P
Sbjct: 240 SKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHEIEFP------- 290
Query: 233 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCD 292
++ ++L+ L DP QRIS + L Y P
Sbjct: 291 ------------------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP-V 331
Query: 293 PKSLPKYESSHEYQTKKRRQQQRQHEEATKRQKLHHPQ 330
+ +Y + + + L+
Sbjct: 332 NQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHY 369
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-51
Identities = 67/346 (19%), Positives = 123/346 (35%), Gaps = 57/346 (16%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
+ + G +K+I + + RE+ +L ++H N+++ +E
Sbjct: 43 VKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE-------- 94
Query: 62 GRPDGNKYRGSTYMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQV 119
GS Y+V +Y + DL + + G+ F QI + Q+ L + H ++
Sbjct: 95 --------NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKI 146
Query: 120 LHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGP 179
LHRDIK N+ + +G ++L DFG+AR + + T +Y PE+ Y
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA-CIGTPYYLSPEICEN-KPYNN 204
Query: 180 AVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239
D+W++GC+ EL K + + KI
Sbjct: 205 KSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI--------------------------- 237
Query: 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY-------FWTDPLPCD 292
+ V H+ L+ ++ +P R S L+ + F + L +
Sbjct: 238 --ISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAE 295
Query: 293 PKSLPKYESSHEYQTKKRRQQQRQH-EEATKRQKLHHPQPHGRLPP 337
L + +R Q+ QK+ P +P
Sbjct: 296 EFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAKYGIPL 341
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 3e-51
Identities = 58/302 (19%), Positives = 102/302 (33%), Gaps = 50/302 (16%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAI-REIKILKKLQHENVIKLKEIVTSPGPERDE 60
R KTG++ A+K + P+ RE ++LKKL H+N++KL I
Sbjct: 28 GRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH-- 83
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTG--LADR-----PGLRFTVPQIKCYMKQLLTGLHY 113
++ E+ L + ++ ++ G+++
Sbjct: 84 ------------KVLIMEFC----PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 114 CHVNQVLHRDIKGSNLLI----DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPE 169
N ++HR+IK N++ D + KL DFG AR + + + T Y P+
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSLYGTEEYLHPD 185
Query: 170 LLLGAT-------KYGPAVDMWSVGCIFAELLNGKP----ILPGKNEAEQLSKIFELCGS 218
+ A KYG VD+WS+G F G + E + KI + G
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI--ITGK 243
Query: 219 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDA 278
P I + + + + +L +L D +
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQ---VLLTPVLANILEADQEKCWGFDQF 300
Query: 279 LD 280
Sbjct: 301 FA 302
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 1e-50
Identities = 91/327 (27%), Positives = 145/327 (44%), Gaps = 63/327 (19%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHE------NVIKLKEIVTSPG 55
A + K + VALK +R NEK F A EI+IL+ L+ + NVI + E
Sbjct: 116 AYDHKVHQHVALKMVR--NEKR-FHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF---- 168
Query: 56 PERDEQGRPDGNKYRGSTYMVFEYMDHDL-TGLADRPGLRFTVPQIKCYMKQLLTGLHYC 114
+R M FE + +L + F++P ++ + +L L
Sbjct: 169 ------------TFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216
Query: 115 HVNQVLHRDIKGSNLLIDNEG--NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL 172
H N+++H D+K N+L+ +G +K+ DFG S Y+H + + + +YR PE++L
Sbjct: 217 HKNRIIHCDLKPENILLKQQGRSGIKVIDFG---SSCYEHQ-RVYTYIQSRFYRAPEVIL 272
Query: 173 GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDE----------- 221
GA +YG +DMWS+GCI AELL G P+LPG++E +QL+ + EL G P +
Sbjct: 273 GA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKN 331
Query: 222 -----------TIWPGVSKMPAYNHFKPSRTMK------RRVREVFRHFDRHAL-ELLEK 263
T+ N + R R + D + L++
Sbjct: 332 FVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQ 391
Query: 264 MLMLDPSQRISAKDALDSEYFWTDPLP 290
L DP+ R++ AL + LP
Sbjct: 392 CLEWDPAVRMTPGQALRHPWL-RRRLP 417
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 1e-50
Identities = 64/295 (21%), Positives = 114/295 (38%), Gaps = 59/295 (20%)
Query: 3 REIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQ 61
R + VA+K+I + A RE+++L++ +H NVI+ E+D Q
Sbjct: 43 RGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCT------EKDRQ 91
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
Y+ E L ++ + ++Q +GL + H ++H
Sbjct: 92 ----------FQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVH 141
Query: 122 RDIKGSNLLIDNEGN-----LKLADFGLARSFSYDHN--NTLTNRVITLWYRPPELLLGA 174
RD+K N+LI ++DFGL + + + + + T + PE+L
Sbjct: 142 RDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED 201
Query: 175 TK--YGPAVDMWSVGCIFAELL-NGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 231
K VD++S GC+F ++ G + + +
Sbjct: 202 CKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL----------------GAC 245
Query: 232 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286
+ + P +H D A EL+EKM+ +DP +R SAK L +FW+
Sbjct: 246 SLDCLHPE-----------KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 3e-50
Identities = 67/292 (22%), Positives = 117/292 (40%), Gaps = 54/292 (18%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
R G+I+ K++ + E + E+ +L++L+H N+++ + + D
Sbjct: 25 IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII------DRT 78
Query: 62 GRPDGNKYRGSTYMVFEYMDH-DLTGL---ADRPGLRFTVPQIKCYMKQLLTGLHYCH-- 115
+ Y+V EY + DL + + + M QL L CH
Sbjct: 79 N--------TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 116 ---VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL 172
+ VLHRD+K +N+ +D + N+KL DFGLAR ++D + T V T +Y PE +
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT-FVGTPYYMSPEQMN 189
Query: 173 GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 232
Y D+WS+GC+ EL P ++ E KI
Sbjct: 190 RM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-------------------- 228
Query: 233 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
+ + R + + E++ +ML L R S ++ L++
Sbjct: 229 ---------REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 6e-50
Identities = 83/351 (23%), Positives = 141/351 (40%), Gaps = 87/351 (24%)
Query: 1 MAREIKTGEIVALK-----KIRMDNEKEGFPITAI-REIKILKKLQHENVIKLKEIVTSP 54
+A E KT + VA+K K + + +E P + EI+ILKKL H +IK+K +
Sbjct: 28 LAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87
Query: 55 GPERDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADR---PGLRFTVPQIKCYMKQLLT 109
Y+V E M G L D+ R K Y Q+L
Sbjct: 88 -----------------DYYIVLELM----EGGELFDKVVGNK-RLKEATCKLYFYQMLL 125
Query: 110 GLHYCHVNQVLHRDIKGSNLLIDNEG---NLKLADFGLARSFSYDHNNTLTNRVITLWYR 166
+ Y H N ++HRD+K N+L+ ++ +K+ DFG ++ + + T Y
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTYL 183
Query: 167 PPELLLGATK--YGPAVDMWSVGCIFAELLNGKPILP---GKNEAEQLSKI----FELCG 217
PE+L+ Y AVD WS+G I L+G P P + + +I +
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSLKDQITSGKYNF-- 239
Query: 218 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKD 277
+W VS+ AL+L++K+L++DP R + ++
Sbjct: 240 --IPEVWAEVSE--------------------------KALDLVKKLLVVDPKARFTTEE 271
Query: 278 ALDSEYFWTDPLPCDPKSLPKYESSH--------EYQTKKRRQQQRQHEEA 320
AL + + + + L E+ + T ++R ++ + E A
Sbjct: 272 ALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGA 322
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-49
Identities = 56/306 (18%), Positives = 103/306 (33%), Gaps = 57/306 (18%)
Query: 2 AREIKTGEIVALKKIR---MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 58
A+ A+K+IR + +E +RE+K L KL+H +++ E+
Sbjct: 24 AKNKVDDCNYAIKRIRLPNRELARE----KVMREVKALAKLEHPGIVRYFNAWL----EK 75
Query: 59 DEQGRPDGNKYRGSTYMVFEYMDH-DLTGL--ADRPGLRFTVPQIKCYMKQLLTGLHYCH 115
+ + + + Y+ + +L Q+ + + H
Sbjct: 76 NTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH 135
Query: 116 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-----------NTLTNRVITLW 164
++HRD+K SN+ + +K+ DFGL + D T +V T
Sbjct: 136 SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKL 195
Query: 165 YRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 224
Y PE + G Y VD++S+G I ELL P L+ +
Sbjct: 196 YMSPEQIHG-NSYSHKVDIFSLGLILFELL--YPFSTQMERVRTLTDV------------ 240
Query: 225 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
+ +F +++ ML P +R A + +++ F
Sbjct: 241 -----------------RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVF 283
Query: 285 WTDPLP 290
P
Sbjct: 284 EDLDFP 289
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 2e-49
Identities = 66/329 (20%), Positives = 123/329 (37%), Gaps = 65/329 (19%)
Query: 1 MAREIKTGEIVALK---KIRMDNEKEGFPITAI------------REIKILKKLQHENVI 45
+ + + ALK K ++ +++ E++I+ +++E +
Sbjct: 49 LCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106
Query: 46 KLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD--------HDLTGLADRPGLRFTV 97
+ I+T+ ++ Y+++EYM+ L +
Sbjct: 107 TCEGIITNY------------DEV----YIIYEYMENDSILKFDEYFFVLDKNYTCFIPI 150
Query: 98 PQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTL 156
IKC +K +L Y H + HRD+K SN+L+D G +KL+DFG + + +
Sbjct: 151 QVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV---DKKI 207
Query: 157 TNRVITLWYRPPELLLGATKY-GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 215
T + PPE + Y G VD+WS+G + +P F L
Sbjct: 208 KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV--VP-----------FSL 254
Query: 216 CGSPDET---IWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR 272
S E I + P + ++ ++ L+ L +P++R
Sbjct: 255 KISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAER 314
Query: 273 ISAKDALDSEYF---WTDPLPCDPKSLPK 298
I+++DAL E+ + L K L K
Sbjct: 315 ITSEDALKHEWLADTNIEDLREFSKELYK 343
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 172 bits (436), Expect = 2e-49
Identities = 40/303 (13%), Positives = 81/303 (26%), Gaps = 47/303 (15%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAI-REIKILKKLQHENVIKLKE---------IV 51
R+++ E ALK M E + + +L E+ + ++ V
Sbjct: 81 VRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140
Query: 52 TSPG-PERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADR------PGLRFTVPQIKCYM 104
P + + + ++ DL L + +
Sbjct: 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILT 200
Query: 105 KQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLW 164
QL+ ++H NL I +G L L D + +
Sbjct: 201 AQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWK----VGTRGPASSVPVT 256
Query: 165 YRPPELLLG-ATKYGPAVDMWSVGCIFAELLNGKP--ILPGKNEAEQLSKIFELCGSPDE 221
Y P E L + A++ W +G + L + D
Sbjct: 257 YAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDS 316
Query: 222 TIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281
+ + +P + L+ + L D +R+ +A+++
Sbjct: 317 LAFGSCTPLPDF-----------------------VKTLIGRFLNFDRRRRLLPLEAMET 353
Query: 282 EYF 284
F
Sbjct: 354 PEF 356
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 2e-49
Identities = 78/347 (22%), Positives = 134/347 (38%), Gaps = 72/347 (20%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-----------HENVIKLKE 49
+A+++ VA+K +R + + A EIK+L+++ +++KL
Sbjct: 37 LAKDMVNNTHVAMKIVR---GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL- 92
Query: 50 IVTSPGPERDEQGRPDGNKYRGSTY----MVFEYMDHDLTGLADR-PGLRFTVPQIKCYM 104
D ++G MVFE + +L L + + +K
Sbjct: 93 ---------------DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 137
Query: 105 KQLLTGLHYCHVN-QVLHRDIKGSNLLIDNE------GNLKLADFGLARSFSYDHNNTLT 157
KQLL GL Y H ++H DIK N+L++ +K+AD G A + + T
Sbjct: 138 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWYDEH-YT 193
Query: 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK------NEAEQLSK 211
N + T YR PE+LLGA +G D+WS C+ EL+ G + + + +++
Sbjct: 194 NSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252
Query: 212 IFELCGSPDETIWPGVSKMPAYNHF-------KPSRTMKRRVRE--------VFRHFDRH 256
I EL G + + F + +K E + +
Sbjct: 253 IIELLGELPSYL---LRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKE 309
Query: 257 ALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSH 303
+ L ML LDP +R A ++ + D L + +P E
Sbjct: 310 ISDFLSPMLQLDPRKRADAGGLVNHPWL-KDTLGMEEIRVPDRELYG 355
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 3e-49
Identities = 56/322 (17%), Positives = 112/322 (34%), Gaps = 69/322 (21%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAI-REIKILKKLQHENVIKLKEIVTSPGPERDE 60
E + + K ++ +G + +EI IL +H N++ L E S
Sbjct: 24 CVETSSKKTYMAKFVK----VKGTDQVLVKKEISILNIARHRNILHLHESFESME----- 74
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTG--LADR---PGLRFTVPQIKCYMKQLLTGLHYCH 115
M+FE++ +G + +R +I Y+ Q+ L + H
Sbjct: 75 -----------ELVMIFEFI----SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 116 VNQVLHRDIKGSNLLIDNEGN--LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG 173
+ + H DI+ N++ + +K+ +FG AR + Y PE+
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEYYAPEVHQH 177
Query: 174 ATKYGPAVDMWSVGCIFAELLNGKPILP--GKNEAEQLSKIFELCGSPD--ETIWPGVSK 229
A DMWS+G + LL+G P + + + I + E + +S
Sbjct: 178 -DVVSTATDMWSLGTLVYVLLSGIN--PFLAETNQQIIENI--MNAEYTFDEEAFKEISI 232
Query: 230 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL 289
A++ ++++L+ + R++A +AL +
Sbjct: 233 --------------------------EAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266
Query: 290 PCDPKSLPKYESSHEYQTKKRR 311
K + + Y T ++
Sbjct: 267 RVSTKVIRTLKHRRYYHTLIKK 288
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 3e-49
Identities = 57/286 (19%), Positives = 93/286 (32%), Gaps = 54/286 (18%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERD 59
R + G + A+K+ + E+ +K+ QH ++L++ G
Sbjct: 75 KVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG---- 130
Query: 60 EQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQV 119
Y+ E L + G Q+ Y++ L L + H +
Sbjct: 131 ------------ILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGL 178
Query: 120 LHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLGATKYG 178
+H D+K +N+ + G KL DFGL Y PELL G YG
Sbjct: 179 VHLDVKPANIFLGPRGRCKLGDFGLLVELG---TAGAGEVQEGDPRYMAPELLQG--SYG 233
Query: 179 PAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238
A D++S+G E+ LP + E ++ + G G+S
Sbjct: 234 TAADVFSLGLTILEVACNME-LP--HGGEGWQQLRQ--GYLPPEFTAGLSS--------- 279
Query: 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
+L ML DP R +A+ L
Sbjct: 280 -----------------ELRSVLVMMLEPDPKLRATAEALLALPVL 308
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 3e-49
Identities = 79/288 (27%), Positives = 123/288 (42%), Gaps = 61/288 (21%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
R+ T A+K IR + + E+ +LK L H N++KL +
Sbjct: 56 CRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF---------- 105
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTG--LADRPGLR--FTVPQIKCYMKQLLTGLHYCHVN 117
D Y Y+V E G L D R F +KQ+L+G+ Y H +
Sbjct: 106 --EDKRNY----YLVMEC----YKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155
Query: 118 QVLHRDIKGSNLLIDN---EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA 174
++HRD+K NLL+++ + +K+ DFGL+ F ++ + R+ T +Y PE+L
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF--ENQKKMKERLGTAYYIAPEVLRK- 212
Query: 175 TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD--ETIWPGVSKMPA 232
KY D+WS+G I LL G P G+ + E L K+ G W VS+
Sbjct: 213 -KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV--EKGKYTFDSPEWKNVSE--- 266
Query: 233 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280
A +L+++ML D +RISA+ AL+
Sbjct: 267 -----------------------GAKDLIKQMLQFDSQRRISAQQALE 291
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 173 bits (439), Expect = 3e-49
Identities = 63/318 (19%), Positives = 113/318 (35%), Gaps = 80/318 (25%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDE 60
+ G VA+K++ +D A+ EIK+L + H NVI+ E +
Sbjct: 33 FQGSFQGRPVAVKRMLIDFCD-----IALMEIKLLTESDDHPNVIRYYCS------ETTD 81
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDL------TGLADRPGLRFTVPQIKCYMKQLLTGLHYC 114
+ Y+ E + +L ++D ++Q+ +G+ +
Sbjct: 82 R----------FLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 115 HVNQVLHRDIKGSNLLIDNEG-------------NLKLADFGLARSFSYDH---NNTLTN 158
H +++HRD+K N+L+ + ++DFGL + L N
Sbjct: 132 HSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 159 RVITLWYRPPELLLGAT------KYGPAVDMWSVGCIFAELL-NGKPILPGKNEAEQ--L 209
T +R PELL + + ++D++S+GC+F +L GK K E +
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII 251
Query: 210 SKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDP 269
IF L + A +L+ +M+ DP
Sbjct: 252 RGIFSL-DEMKCLHDRSLIA--------------------------EATDLISQMIDHDP 284
Query: 270 SQRISAKDALDSEYFWTD 287
+R +A L FW
Sbjct: 285 LKRPTAMKVLRHPLFWPK 302
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 8e-49
Identities = 70/376 (18%), Positives = 122/376 (32%), Gaps = 44/376 (11%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAI-REIKILKKLQHENVIKLKEIVTSPGPERDE 60
TGE VA+K+ R + + EI+I+KKL H NV+ +E+
Sbjct: 33 WIHQDTGEQVAIKQCRQELSPK--NRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90
Query: 61 QGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVP--QIKCYMKQLLTGLHYCHVN 117
+ EY + DL ++ + I+ + + + L Y H N
Sbjct: 91 D----------LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 118 QVLHRDIKGSNLLIDNEGN---LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA 174
+++HRD+K N+++ K+ D G A+ D T V TL Y PELL
Sbjct: 141 RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQYLAPELLEQ- 197
Query: 175 TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234
KY VD WS G + E + G + Q + ++ ++ ++
Sbjct: 198 KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFS 257
Query: 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF---------- 284
P+ + L+ MLM QR + + F
Sbjct: 258 SVLPTPNHLSGILAGKLE------RWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311
Query: 285 -----WTDPLPCDPKSLPKYESSHEYQTKKRRQQQRQHEEATKRQKLHHPQPHGRLPPIQ 339
+ + E+ ++ ++ EE Q + P Q
Sbjct: 312 LLSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTGIPEEEQELLQASGLA-LNSAQPLTQ 370
Query: 340 HAGQSHHWSGPNHPMN 355
+ G +
Sbjct: 371 YVIDCTVIDGRQGEGD 386
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 9e-49
Identities = 83/293 (28%), Positives = 132/293 (45%), Gaps = 63/293 (21%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
++ T + A+K I + K T +RE+++LKKL H N++KL EI+ E
Sbjct: 41 CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL--------E- 91
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTG--LADR---PGLRFTVPQIKCYMKQLLTGLHYCHV 116
D + + Y+V E TG L D RF+ +KQ+ +G+ Y H
Sbjct: 92 ---DSSSF----YIVGEL----YTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHK 139
Query: 117 NQVLHRDIKGSNLLIDN---EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG 173
+ ++HRD+K N+L+++ + ++K+ DFGL+ F N + +R+ T +Y PE+L G
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRIGTAYYIAPEVLRG 197
Query: 174 ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD--ETIWPGVSKMP 231
Y D+WS G I LL+G P GKNE + L ++ G W +S
Sbjct: 198 --TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV--ETGKYAFDLPQWRTISD-- 251
Query: 232 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
A +L+ KML PS RI+A L+ +
Sbjct: 252 ------------------------DAKDLIRKMLTFHPSLRITATQCLEHPWI 280
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 1e-48
Identities = 86/293 (29%), Positives = 136/293 (46%), Gaps = 62/293 (21%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAI-REIKILKKLQHENVIKLKEIVTSPGPERDE 60
++ TG+ A+K I K+ ++ RE+++LK+L H N++KL E
Sbjct: 45 CKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF--------- 95
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTG--LADRPGLR--FTVPQIKCYMKQLLTGLHYCHV 116
D + Y+V E TG L D R F+ ++Q+L+G+ Y H
Sbjct: 96 ---EDKGYF----YLVGEV----YTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 144
Query: 117 NQVLHRDIKGSNLLIDN---EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG 173
N+++HRD+K NLL+++ + N+++ DFGL+ F + + + +++ T +Y PE+L G
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKIGTAYYIAPEVLHG 202
Query: 174 ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD--ETIWPGVSKMP 231
Y D+WS G I LL+G P G NE + L K+ G W VS+
Sbjct: 203 --TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV--EKGKYTFELPQWKKVSE-- 256
Query: 232 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
A +L+ KML PS RISA+DALD E+
Sbjct: 257 ------------------------SAKDLIRKMLTYVPSMRISARDALDHEWI 285
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 170 bits (431), Expect = 2e-48
Identities = 66/354 (18%), Positives = 116/354 (32%), Gaps = 56/354 (15%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAI-REIKILKKLQHENVIKLKEIVTSPGPERDE 60
R KTG++ A+K + P+ RE ++LKKL H+N++KL I
Sbjct: 28 GRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH-- 83
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTG--LADR-----PGLRFTVPQIKCYMKQLLTGLHY 113
++ E+ L + ++ ++ G+++
Sbjct: 84 ------------KVLIMEFC----PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 114 CHVNQVLHRDIKGSNLLI----DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPE 169
N ++HR+IK N++ D + KL DFG AR + + + T Y P+
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSLYGTEEYLHPD 185
Query: 170 LLLGAT-------KYGPAVDMWSVGCIFAELLNGKP----ILPGKNEAEQLSKIFELCGS 218
+ A KYG VD+WS+G F G + E + KI S
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 219 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDA 278
+ P + + R +L +L D +
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCS-----LSRGLQVLLTPVLANILEADQEKCWGFDQF 300
Query: 279 LDSEYFWTDPLPCDPKSLPKYES----SHEYQTKKRRQQ--QRQHEEATKRQKL 326
+ SL + + H Y T + +Q + + Q+L
Sbjct: 301 FAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQEL 354
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 3e-48
Identities = 80/328 (24%), Positives = 131/328 (39%), Gaps = 69/328 (21%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHE------NVIKLKEIVTSPG 55
A + E VA+K I+ N K+ F A E+++L+ + ++ LK
Sbjct: 73 AYDRVEQEWVAIKIIK--N-KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM--- 126
Query: 56 PERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLR-FTVPQIKCYMKQLLTGLHYC 114
+R +VFE + ++L L R ++ + + +Q+ T L +
Sbjct: 127 -------------FRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 173
Query: 115 HVN--QVLHRDIKGSNLLIDNEGN--LKLADFGLARSFSYDHNNTLTNRVITLWYRPPEL 170
++H D+K N+L+ N +K+ DFG S + + + +YR PE+
Sbjct: 174 ATPELSIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQ-RIYQYIQSRFYRSPEV 229
Query: 171 LLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD---------- 220
LLG Y A+DMWS+GCI E+ G+P+ G NE +Q++KI E+ G P
Sbjct: 230 LLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA 288
Query: 221 ----------------------ETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHA- 257
E PG K+ + RR E +
Sbjct: 289 RKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLK 348
Query: 258 -LELLEKMLMLDPSQRISAKDALDSEYF 284
+L+ +ML DP RI AL +F
Sbjct: 349 FKDLILRMLDYDPKTRIQPYYALQHSFF 376
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 4e-48
Identities = 81/292 (27%), Positives = 114/292 (39%), Gaps = 69/292 (23%)
Query: 1 MAREIKTGEIVALKKI---RMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 57
+A + T A KKI +++ +EI+I+K L H N+I+L E
Sbjct: 27 IAVQKGTRIRRAAKKIPKYFVEDVDR-----FKQEIEIMKSLDHPNIIRLYETFE----- 76
Query: 58 RDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADR--PGLRFTVPQIKCYMKQLLTGLHY 113
D Y+V E TG L +R F MK +L+ + Y
Sbjct: 77 -------DNTDI----YLVMELC----TGGELFERVVHKRVFRESDAARIMKDVLSAVAY 121
Query: 114 CHVNQVLHRDIKGSNLLIDNEG---NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPEL 170
CH V HRD+K N L + LKL DFGLA F + +V T +Y P++
Sbjct: 122 CHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF--KPGKMMRTKVGTPYYVSPQV 179
Query: 171 LLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD--ETIWPGVS 228
L G YGP D WS G + LL G P ++E + KI G+ E W VS
Sbjct: 180 LEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI--REGTFTFPEKDWLNVS 235
Query: 229 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280
A L+ ++L P QRI++ AL+
Sbjct: 236 P--------------------------QAESLIRRLLTKSPKQRITSLQALE 261
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 7e-48
Identities = 63/323 (19%), Positives = 118/323 (36%), Gaps = 61/323 (18%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
E TG + K I + + + EI I+ +L H +I L +
Sbjct: 70 CVEKATGRVFVAKFINTPYPLDKYTV--KNEISIMNQLHHPKLINLHDAFEDKY------ 121
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTG--LADR---PGLRFTVPQIKCYMKQLLTGLHYCHV 116
++ E++ +G L DR + + ++ YM+Q GL + H
Sbjct: 122 ----------EMVLILEFL----SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 167
Query: 117 NQVLHRDIKGSNLLIDNEGN--LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA 174
+ ++H DIK N++ + + +K+ DFGLA + + + T + PE++
Sbjct: 168 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEIVDR- 224
Query: 175 TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234
G DMW++G + LL+G G+++ E L + DE + VS
Sbjct: 225 EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP----- 279
Query: 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW-TDPLPCDP 293
A + ++ +L +P +R++ DAL+ W
Sbjct: 280 ---------------------EAKDFIKNLLQKEPRKRLTVHDALEHP--WLKGDHSNLT 316
Query: 294 KSLPKYESSHEYQTKKRRQQQRQ 316
+P + Q K +
Sbjct: 317 SRIPSSRYNKIRQKIKEKYADWP 339
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 7e-48
Identities = 80/304 (26%), Positives = 127/304 (41%), Gaps = 74/304 (24%)
Query: 2 AREIKTGEIVALKKI---RMDNEKEGFPITAI--------REIKILKKLQHENVIKLKEI 50
+E A+K I + D + I EI +LK L H N+IKL ++
Sbjct: 55 CKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114
Query: 51 VTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADR---PGLRFTVPQIKCYMK 105
D + Y+V E+ G L ++ +F MK
Sbjct: 115 F------------EDKKYF----YLVTEF----YEGGELFEQIINRH-KFDECDAANIMK 153
Query: 106 QLLTGLHYCHVNQVLHRDIKGSNLLIDN---EGNLKLADFGLARSFSYDHNNTLTNRVIT 162
Q+L+G+ Y H + ++HRDIK N+L++N N+K+ DFGL+ F + L +R+ T
Sbjct: 154 QILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF--SKDYKLRDRLGT 211
Query: 163 LWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD-- 220
+Y PE+L KY D+WS G I LL G P G+N+ + + K+ G
Sbjct: 212 AYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV--EKGKYYFD 267
Query: 221 ETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280
W +S A EL++ ML D ++R +A++AL+
Sbjct: 268 FNDWKNISD--------------------------EAKELIKLMLTYDYNKRCTAEEALN 301
Query: 281 SEYF 284
S +
Sbjct: 302 SRWI 305
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-47
Identities = 74/303 (24%), Positives = 119/303 (39%), Gaps = 62/303 (20%)
Query: 1 MAREIKTGEIVALK---KIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 57
+ T E+ A K K + + ++ EI I + L H++V+
Sbjct: 33 EISDADTKEVFAGKIVPKSLLLKPHQREKMS--MEISIHRSLAHQHVVGFHGFFEDND-- 88
Query: 58 RDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 116
++V E L L R T P+ + Y++Q++ G Y H
Sbjct: 89 --------------FVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHR 133
Query: 117 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI--TLWYRPPELLLGA 174
N+V+HRD+K NL ++ + +K+ DFGLA YD + T Y PE+L
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLSK- 189
Query: 175 TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234
+ VD+WS+GCI LL GKP E +I + +P
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK-----------NEYSIP--- 235
Query: 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPK 294
+H + A L++KML DP+ R + + L+ E+F + + P
Sbjct: 236 ----------------KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI---PA 276
Query: 295 SLP 297
LP
Sbjct: 277 RLP 279
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-47
Identities = 82/289 (28%), Positives = 130/289 (44%), Gaps = 63/289 (21%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
++ T + A+K I + K T +RE+++LKKL H N++KL EI+
Sbjct: 41 CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE--------- 91
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTG--LADR---PGLRFTVPQIKCYMKQLLTGLHYCHV 116
D + + Y+V E TG L D RF+ +KQ+ +G+ Y H
Sbjct: 92 ---DSSSF----YIVGELY----TGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHK 139
Query: 117 NQVLHRDIKGSNLLIDNEG---NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG 173
+ ++HRD+K N+L++++ ++K+ DFGL+ F N + +R+ T +Y PE+L G
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRIGTAYYIAPEVLRG 197
Query: 174 ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD--ETIWPGVSKMP 231
Y D+WS G I LL+G P GKNE + L ++ G W +S
Sbjct: 198 --TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV--ETGKYAFDLPQWRTISD-- 251
Query: 232 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280
A +L+ KML PS RI+A L+
Sbjct: 252 ------------------------DAKDLIRKMLTFHPSLRITATQCLE 276
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-47
Identities = 75/301 (24%), Positives = 118/301 (39%), Gaps = 68/301 (22%)
Query: 1 MAREIKTGEIVALK---KIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 57
A I TG VA+K K M K G E+KI +L+H ++++L
Sbjct: 29 RAESIHTGLEVAIKMIDKKAM--YKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN-- 84
Query: 58 RDEQGRPDGNKYRGSTYMVFEY------MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGL 111
Y+V E + L +R F+ + + +M Q++TG+
Sbjct: 85 --------------YVYLVLEMCHNGEMNRY----LKNRVK-PFSENEARHFMHQIITGM 125
Query: 112 HYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTLTNRVITLWYRPPE 169
Y H + +LHRD+ SNLL+ N+K+ADFGLA H TL T Y PE
Sbjct: 126 LYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCG---TPNYISPE 182
Query: 170 LLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 229
+ + +G D+WS+GC+F LL G+P L+K+ +
Sbjct: 183 IATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL-----------ADYE 230
Query: 230 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL 289
MP A +L+ ++L +P+ R+S LD + +
Sbjct: 231 MP-------------------SFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSS 271
Query: 290 P 290
Sbjct: 272 T 272
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-47
Identities = 72/290 (24%), Positives = 115/290 (39%), Gaps = 64/290 (22%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
TG A K I RE +I +KLQH N+++L + +
Sbjct: 25 CVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES------ 78
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTG--LADRPGLR--FTVPQIKCYMKQLLTGLHYCHVN 117
Y+VF+ + TG L + R ++ ++Q+L + YCH N
Sbjct: 79 ----------FHYLVFDLV----TGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 118 QVLHRDIKGSNLLIDNEGN---LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA 174
++HR++K NLL+ ++ +KLADFGLA + + T Y PE+L
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGFAGTPGYLSPEVLKK- 181
Query: 175 TKYGPAVDMWSVGCIFAELLNGKPILP--GKNEAEQLSKIFELCGSPD--ETIWPGVSKM 230
Y VD+W+ G I LL G P P +++ ++I G+ D W V+
Sbjct: 182 DPYSKPVDIWACGVILYILLVGYP--PFWDEDQHRLYAQI--KAGAYDYPSPEWDTVTP- 236
Query: 231 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280
A L++ ML ++P +RI+A AL
Sbjct: 237 -------------------------EAKSLIDSMLTVNPKKRITADQALK 261
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-47
Identities = 71/294 (24%), Positives = 105/294 (35%), Gaps = 71/294 (24%)
Query: 2 AREIKTGEIVALKKI---RMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 58
E +G +K I R E EI++LK L H N+IK+ E+
Sbjct: 41 VEERSSGLERVIKTINKDRSQVPMEQI----EAEIEVLKSLDHPNIIKIFEVFE------ 90
Query: 59 DEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADR------PGLRFTVPQIKCYMKQLLTG 110
D + Y+V E G L +R G + + MKQ++
Sbjct: 91 ------DYHNM----YIVMETC----EGGELLERIVSAQARGKALSEGYVAELMKQMMNA 136
Query: 111 LHYCHVNQVLHRDIKGSNLLIDN---EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRP 167
L Y H V+H+D+K N+L + +K+ DFGLA F + TN T Y
Sbjct: 137 LAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF--KSDEHSTNAAGTALYMA 194
Query: 168 PELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD-ETIWPG 226
PE+ D+WS G + LL G G + E K P+
Sbjct: 195 PEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA--TYKEPNYAVECRP 250
Query: 227 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280
++ A++LL++ML DP +R SA L
Sbjct: 251 LTP--------------------------QAVDLLKQMLTKDPERRPSAAQVLH 278
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-47
Identities = 69/314 (21%), Positives = 114/314 (36%), Gaps = 63/314 (20%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPIT---AIREIKILKKLQHENVIKLKE--------- 49
A E +T I A+K + + ++ P E++++KKL H N+ +L E
Sbjct: 45 AIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104
Query: 50 IVT---------------SPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLR 94
+V + E ++ + G +
Sbjct: 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFV 164
Query: 95 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI--DNEGNLKLADFGLARSF---S 149
I M+Q+ + LHY H + HRDIK N L + +KL DFGL++ F +
Sbjct: 165 QREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLN 224
Query: 150 YDHNNTLTNRVITLWYRPPELLLGATK-YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ 208
+T + T ++ PE+L + YGP D WS G + LL G PG N+A+
Sbjct: 225 NGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADT 284
Query: 209 LSKIFELCGSPD--ETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLM 266
+S++ L + +S A +LL +L
Sbjct: 285 ISQV--LNKKLCFENPNYNVLSP--------------------------LARDLLSNLLN 316
Query: 267 LDPSQRISAKDALD 280
+ +R A AL
Sbjct: 317 RNVDERFDAMRALQ 330
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-47
Identities = 77/297 (25%), Positives = 120/297 (40%), Gaps = 71/297 (23%)
Query: 2 AREIKTGEIVALKKI--RMDNEKEGFPITAI-REIKILKKLQHENVIKLKEIVTSPGPER 58
+TG+ A+K + G + RE I L+H ++++L E +S G
Sbjct: 43 CINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDG--- 99
Query: 59 DEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADR------PGLRFTVPQIKCYMKQLLTG 110
YMVFE+M G L G ++ YM+Q+L
Sbjct: 100 -------------MLYMVFEFM----DGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 111 LHYCHVNQVLHRDIKGSNLLI---DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRP 167
L YCH N ++HRD+K +L+ +N +KL FG+A + RV T +
Sbjct: 143 LRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL-GESGLVAGGRVGTPHFMA 201
Query: 168 PELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE--LCGSPD--ETI 223
PE++ YG VD+W G I LL+G G E ++FE + G
Sbjct: 202 PEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKMNPRQ 255
Query: 224 WPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280
W +S+ A +L+ +MLMLDP++RI+ +AL+
Sbjct: 256 WSHISE--------------------------SAKDLVRRMLMLDPAERITVYEALN 286
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 5e-47
Identities = 77/301 (25%), Positives = 125/301 (41%), Gaps = 75/301 (24%)
Query: 1 MAREIKTGEIVALK-----KIRMDNEKEGFPITAI-REIKILKKLQHENVIKLKEIVTSP 54
+A E KT + VA++ K + + +E P + EI+ILKKL H +IK+K +
Sbjct: 153 LAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 212
Query: 55 GPERDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADR---PGLRFTVPQIKCYMKQLLT 109
Y+V E M G L D+ R K Y Q+L
Sbjct: 213 -----------------DYYIVLELM----EGGELFDKVVGNK-RLKEATCKLYFYQMLL 250
Query: 110 GLHYCHVNQVLHRDIKGSNLLI---DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYR 166
+ Y H N ++HRD+K N+L+ + + +K+ DFG ++ + + T Y
Sbjct: 251 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTYL 308
Query: 167 PPELLLGATK--YGPAVDMWSVGCIFAELLNGKPILP---GKNEAEQLSKIFELCGSPD- 220
PE+L+ Y AVD WS+G I L+G P P + + +I G +
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSLKDQI--TSGKYNF 364
Query: 221 -ETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 279
+W VS+ AL+L++K+L++DP R + ++AL
Sbjct: 365 IPEVWAEVSE--------------------------KALDLVKKLLVVDPKARFTTEEAL 398
Query: 280 D 280
Sbjct: 399 R 399
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 6e-47
Identities = 71/328 (21%), Positives = 128/328 (39%), Gaps = 67/328 (20%)
Query: 2 AREIKTGEIVALK---KIRMDNEKEGFPITAI-REIKILKKLQHENVIKLKEIVTSPGPE 57
RE TG A K K + + G I RE+ IL+++ H NVI L ++ +
Sbjct: 31 CREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT-- 88
Query: 58 RDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADR--PGLRFTVPQIKCYMKQLLTGLHY 113
++ E + +G L D + + ++KQ+L G++Y
Sbjct: 89 --------------DVVLILELV----SGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 114 CHVNQVLHRDIKGSNLLI----DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPE 169
H ++ H D+K N+++ ++KL DFGLA + N T + PE
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVAPE 188
Query: 170 LLLGATKYGPAVDMWSVGCIFAELLNGKPILP--GKNEAEQLSKIFELCGSPDETIWPGV 227
++ G DMWS+G I LL+G P G + E L+ I + DE +
Sbjct: 189 IVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGDTKQETLANITSVSYDFDEEFFSHT 245
Query: 228 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287
S+ A + + K+L+ + +R++ ++AL W
Sbjct: 246 SE--------------------------LAKDFIRKLLVKETRKRLTIQEALRHP--WIT 277
Query: 288 PLPCDPKSLPKYESSHEYQTKKRRQQQR 315
P+ + + + +K+ ++R
Sbjct: 278 PVDNQQAMVRRESVVNLENFRKQYVRRR 305
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-46
Identities = 69/295 (23%), Positives = 123/295 (41%), Gaps = 69/295 (23%)
Query: 2 AREIKTGEIVALKKI---RMDNEKEGFPITAI-REIKILKKLQHENVIKLKEIVTSPGPE 57
R+ TG+ A K I R+ + + G I RE+ IL++++H N+I L +I +
Sbjct: 24 CRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT-- 81
Query: 58 RDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADR--PGLRFTVPQIKCYMKQLLTGLHY 113
++ E + +G L D T + ++KQ+L G+HY
Sbjct: 82 --------------DVVLILELV----SGGELFDFLAEKESLTEDEATQFLKQILDGVHY 123
Query: 114 CHVNQVLHRDIKGSNLLIDNE----GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPE 169
H ++ H D+K N+++ ++ +KL DFG+A + N N T + PE
Sbjct: 124 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKNIFGTPEFVAPE 181
Query: 170 LLLGATKYGPAVDMWSVGCIFAELLNGKPILP--GKNEAEQLSKIFELCGSPD--ETIWP 225
++ G DMWS+G I LL+G P G+ + E L+ I + D E +
Sbjct: 182 IVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGETKQETLTNI--SAVNYDFDEEYFS 236
Query: 226 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280
S+ A + + ++L+ DP +R++ +L+
Sbjct: 237 NTSE--------------------------LAKDFIRRLLVKDPKRRMTIAQSLE 265
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-46
Identities = 67/300 (22%), Positives = 112/300 (37%), Gaps = 71/300 (23%)
Query: 1 MAREIKTGEIVALKKI-------RMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVT 52
T + A+K I E + ++E+ IL+K+ H N+I+LK+
Sbjct: 35 RCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94
Query: 53 SPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADR---PGLRFTVPQIKCYMKQL 107
+ ++VF+ M L D + + + M+ L
Sbjct: 95 TNT----------------FFFLVFDLM----KKGELFDYLTEKV-TLSEKETRKIMRAL 133
Query: 108 LTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRP 167
L + H ++HRD+K N+L+D++ N+KL DFG + D L T Y
Sbjct: 134 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSYLA 191
Query: 168 PELLLGA-----TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD-- 220
PE++ + YG VDMWS G I LL G P + + L I + G+
Sbjct: 192 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI--MSGNYQFG 249
Query: 221 ETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280
W S +L+ + L++ P +R +A++AL
Sbjct: 250 SPEWDDYSD--------------------------TVKDLVSRFLVVQPQKRYTAEEALA 283
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-46
Identities = 65/330 (19%), Positives = 118/330 (35%), Gaps = 71/330 (21%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHE-----NVIKLKEIVTSPGP 56
+ I + A+K +R N + + +A E ILKK+Q++ N++K
Sbjct: 54 CQHIDNKKYYAVKVVR--N-IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM---- 106
Query: 57 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLR-FTVPQIKCYMKQLLTGLHYCH 115
Y ++FE + L + R F + IK Y ++L L+Y
Sbjct: 107 ------------YYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR 154
Query: 116 VNQVLHRDIKGSN-LLIDNEG------------------------NLKLADFGLARSFSY 150
+ H D+K N LL D +KL DFG ++
Sbjct: 155 KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG---CATF 211
Query: 151 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLS 210
+ + + T YR PE++L + + DMWS GC+ AEL G + E L+
Sbjct: 212 KSDY-HGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLA 269
Query: 211 KIFELCGSPDETIWPGVSKMPAYNHFK---------PSRTMKRRVREVFRHF-------D 254
+ + + + +K + + + ++ V +
Sbjct: 270 MMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKH 329
Query: 255 RHALELLEKMLMLDPSQRISAKDALDSEYF 284
+ L +L +DP+ R S + L ++
Sbjct: 330 ELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-46
Identities = 71/291 (24%), Positives = 117/291 (40%), Gaps = 61/291 (20%)
Query: 2 AREIKTGEIVALKKI---RMDNEKEGFPITAI-REIKILKKLQHENVIKLKEIVTSPGPE 57
RE TG A K I R + + G I RE+ ILK++QH NVI L E+ +
Sbjct: 30 CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT-- 87
Query: 58 RDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADR--PGLRFTVPQIKCYMKQLLTGLHY 113
++ E + G L D T + ++KQ+L G++Y
Sbjct: 88 --------------DVILILELV----AGGELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 114 CHVNQVLHRDIKGSNLLIDNE----GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPE 169
H Q+ H D+K N+++ + +K+ DFGLA D N N T + PE
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPE 187
Query: 170 LLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 229
++ G DMWS+G I LL+G G + E L+ + + ++ + S
Sbjct: 188 IVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 246
Query: 230 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280
A + + ++L+ DP +R++ +D+L
Sbjct: 247 --------------------------LAKDFIRRLLVKDPKKRMTIQDSLQ 271
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-46
Identities = 71/328 (21%), Positives = 128/328 (39%), Gaps = 67/328 (20%)
Query: 2 AREIKTGEIVALKKI---RMDNEKEGFPITAI-REIKILKKLQHENVIKLKEIVTSPGPE 57
RE TG A K I + + G I RE+ IL+++ H N+I L ++ +
Sbjct: 31 CREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT-- 88
Query: 58 RDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADR--PGLRFTVPQIKCYMKQLLTGLHY 113
++ E + +G L D + + ++KQ+L G++Y
Sbjct: 89 --------------DVVLILELV----SGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 114 CHVNQVLHRDIKGSNLLI----DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPE 169
H ++ H D+K N+++ ++KL DFGLA + N T + PE
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVAPE 188
Query: 170 LLLGATKYGPAVDMWSVGCIFAELLNGKPILP--GKNEAEQLSKIFELCGSPDETIWPGV 227
++ G DMWS+G I LL+G P G + E L+ I + DE +
Sbjct: 189 IVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGDTKQETLANITAVSYDFDEEFFSQT 245
Query: 228 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287
S+ A + + K+L+ + +R++ ++AL W
Sbjct: 246 SE--------------------------LAKDFIRKLLVKETRKRLTIQEALRHP--WIT 277
Query: 288 PLPCDPKSLPKYESSHEYQTKKRRQQQR 315
P+ + + + KK+ ++R
Sbjct: 278 PVDTQQAMVRRESVVNLENFKKQYVRRR 305
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 3e-46
Identities = 73/286 (25%), Positives = 115/286 (40%), Gaps = 53/286 (18%)
Query: 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERD 59
+ARE ++ I+ALK + EK G RE++I L+H N+++L
Sbjct: 27 LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH------- 79
Query: 60 EQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 118
D + Y++ EY + + +F + Y+ +L L YCH +
Sbjct: 80 -----DATRV----YLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKR 129
Query: 119 VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYG 178
V+HRDIK NLL+ + G LK+ADFG + L TL Y PPE++ G +
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCG---TLDYLPPEMIEGRM-HD 185
Query: 179 PAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238
VD+WS+G + E L GKP E +I P
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR-----------VEFTFP------- 227
Query: 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
A +L+ ++L +PSQR ++ L+ +
Sbjct: 228 ------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 5e-46
Identities = 76/337 (22%), Positives = 125/337 (37%), Gaps = 76/337 (22%)
Query: 1 MAREIKTGEIVALK---KIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 57
+ T E+ A K K + + ++ EI I + L H++V+
Sbjct: 59 EISDADTKEVFAGKIVPKSLLLKPHQREKMS--MEISIHRSLAHQHVVGFHGFFEDND-- 114
Query: 58 RDEQGRPDGNKYRGSTYMVFEY------MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGL 111
++V E ++ R T P+ + Y++Q++ G
Sbjct: 115 --------------FVFVVLELCRRRSLLEL----HKRRK--ALTEPEARYYLRQIVLGC 154
Query: 112 HYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTLTNRVITLWYRPPE 169
Y H N+V+HRD+K NL ++ + +K+ DFGLA YD L T Y PE
Sbjct: 155 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCG---TPNYIAPE 211
Query: 170 LLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 229
+L + VD+WS+GCI LL GKP E +I +
Sbjct: 212 VLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK-----------NEYS 259
Query: 230 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL 289
+P +H + A L++KML DP+ R + + L+ E+F + +
Sbjct: 260 IP-------------------KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300
Query: 290 PCDPKSLPKYESSHEYQTKKRRQQQRQHEEATKRQKL 326
P LP R + + R+ L
Sbjct: 301 ---PARLP----ITCLTIPPRFSIAPSSLDPSNRKPL 330
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 5e-46
Identities = 76/293 (25%), Positives = 123/293 (41%), Gaps = 73/293 (24%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
++ TG++ ALK I + EI +LKK++HEN++ L++I S
Sbjct: 28 VKQRLTGKLFALKCI--KKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYEST------- 78
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTG--LADR---PGLRFTVPQIKCYMKQLLTGLHYCHV 116
Y Y+V + + +G L DR G +T ++Q+L+ + Y H
Sbjct: 79 -----THY----YLVMQLV----SGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLHE 124
Query: 117 NQVLHRDIKGSNLLI---DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG 173
N ++HRD+K NLL + + + DFGL++ + N ++ T Y PE+L
Sbjct: 125 NGIVHRDLKPENLLYLTPEENSKIMITDFGLSK---MEQNGIMSTACGTPGYVAPEVLAQ 181
Query: 174 ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI------FELCGSPDETIWPGV 227
Y AVD WS+G I LL G P + E++ KI FE SP W +
Sbjct: 182 -KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFE---SPF---WDDI 234
Query: 228 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280
S+ A + + +L DP++R + + AL
Sbjct: 235 SE--------------------------SAKDFICHLLEKDPNERYTCEKALS 261
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 6e-46
Identities = 70/313 (22%), Positives = 114/313 (36%), Gaps = 64/313 (20%)
Query: 2 AREIKTGEIVALKKIRMDN-----EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGP 56
A + G VALKK+++ + + I+EI +LK+L H NVIK
Sbjct: 51 AACLLDGVPVALKKVQIFDLMDAKARA----DCIKEIDLLKQLNHPNVIKYYASFIE--- 103
Query: 57 ERDEQGRPDGNKYRGSTYMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLH 112
+V E D + + + Y QL + L
Sbjct: 104 -------------DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 113 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELL 171
+ H +V+HRDIK +N+ I G +KL D GL R FS T + ++ T +Y PE +
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMSPERI 208
Query: 172 LGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPG-VSKM 230
Y D+WS+GC+ E+ + P + L + + I +
Sbjct: 209 HE-NGYNFKSDIWSLGCLLYEMAALQS--PFYGDKMNLYSLCKK-------IEQCDYPPL 258
Query: 231 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 290
P+ +H+ S ++ +L+ + DP +R D
Sbjct: 259 PS-DHY--SEELR---------------QLVNMCINPDPEKRPDVTYVYDVAKRMH---A 297
Query: 291 CDPKSLPKYESSH 303
C SL + H
Sbjct: 298 CTASSLEHHHHHH 310
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-45
Identities = 70/340 (20%), Positives = 127/340 (37%), Gaps = 71/340 (20%)
Query: 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHE------NVIKLKEIVTSPGPERD 59
+ VALK IR N + A EI +LKK++ + + + +
Sbjct: 43 RGKSQVALKIIR--N-VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN------- 92
Query: 60 EQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLR-FTVPQIKCYMKQLLTGLHYCHVNQ 118
+ G + FE + + + + +P ++ QL L + H NQ
Sbjct: 93 ---------FHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ 143
Query: 119 VLHRDIKGSN-LLIDNEG------------------NLKLADFGLARSFSYDHNNTLTNR 159
+ H D+K N L +++E ++++ADFG S ++DH + T
Sbjct: 144 LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG---SATFDHEH-HTTI 199
Query: 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSP 219
V T YRPPE++L + D+WS+GCI E G + E L + ++ G
Sbjct: 200 VATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPI 258
Query: 220 DETIWPGVSKMPAYNHF--------------KPSRTMKRRVREVFRH---FDRHALELLE 262
+ + + +F + + + ++ +L+
Sbjct: 259 PSHM---IHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMR 315
Query: 263 KMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESS 302
+ML DP+QRI+ +AL +F P + S
Sbjct: 316 RMLEFDPAQRITLAEALLHPFF-AGLTPEERSFHTSRNPS 354
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-45
Identities = 71/288 (24%), Positives = 114/288 (39%), Gaps = 60/288 (20%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
TG A K I RE +I +KLQH N+++L + +
Sbjct: 48 CVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES------ 101
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTG--LADRPGLR--FTVPQIKCYMKQLLTGLHYCHVN 117
Y+VF+ + TG L + R ++ ++Q+L + YCH N
Sbjct: 102 ----------FHYLVFDLV----TGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147
Query: 118 QVLHRDIKGSNLLIDNEGN---LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA 174
++HR++K NLL+ ++ +KLADFGLA + + T Y PE+L
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGFAGTPGYLSPEVLKK- 204
Query: 175 TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD--ETIWPGVSKMPA 232
Y VD+W+ G I LL G P +++ ++I G+ D W V+
Sbjct: 205 DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEWDTVTP--- 259
Query: 233 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280
A L++ ML ++P +RI+A AL
Sbjct: 260 -----------------------EAKSLIDSMLTVNPKKRITADQALK 284
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 1e-45
Identities = 68/326 (20%), Positives = 122/326 (37%), Gaps = 69/326 (21%)
Query: 2 AREIKTG-EIVALKKIRMDNEKEGFPITAIREIKILKKLQHE------NVIKLKEIVTSP 54
+ K G VA+K ++ N + A EI++L+ L +++ E
Sbjct: 33 CIDHKAGGRHVAVKIVK--NVDR-YCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE-- 87
Query: 55 GPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLR-FTVPQIKCYMKQLLTGLHY 113
+ G +VFE + G F + I+ Q+ +++
Sbjct: 88 --------------HHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNF 133
Query: 114 CHVNQVLHRDIKGSNLLIDNEGN-------------------LKLADFGLARSFSYDHNN 154
H N++ H D+K N+L +K+ DFG S +YD +
Sbjct: 134 LHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG---SATYDDEH 190
Query: 155 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 214
+ V T YR PE++L + D+WS+GCI E G + P + E L+ +
Sbjct: 191 -HSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMER 248
Query: 215 LCGSPDETI----------------WPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHAL 258
+ G + + W S Y + + +K +
Sbjct: 249 ILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRY-VSRACKPLKEFML-SQDVEHERLF 306
Query: 259 ELLEKMLMLDPSQRISAKDALDSEYF 284
+L++KML DP++RI+ ++AL +F
Sbjct: 307 DLIQKMLEYDPAKRITLREALKHPFF 332
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 2e-45
Identities = 66/325 (20%), Positives = 121/325 (37%), Gaps = 66/325 (20%)
Query: 2 AREIKTGEIVALKKI--RMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERD 59
E TG A K + +++KE +EI+ + L+H ++ L +
Sbjct: 176 VTERATGNNFAAKFVMTPHESDKETV----RKEIQTMSVLRHPTLVNLHDAFEDDN---- 227
Query: 60 EQGRPDGNKYRGSTYMVFEYMDHDLTG--LADR---PGLRFTVPQIKCYMKQLLTGLHYC 114
M++E+M +G L ++ + + + YM+Q+ GL +
Sbjct: 228 ------------EMVMIYEFM----SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271
Query: 115 HVNQVLHRDIKGSNLLIDN--EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL 172
H N +H D+K N++ LKL DFGL D ++ T + PE+
Sbjct: 272 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTTGTAEFAAPEVAE 329
Query: 173 GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD--ETIWPGVSKM 230
G G DMWSVG + LL+G G+N+ E L + + ++ + G+S+
Sbjct: 330 G-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV--KSCDWNMDDSAFSGISE- 385
Query: 231 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 290
+ + K+L+ DP+ R++ AL+ + P
Sbjct: 386 -------------------------DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 420
Query: 291 CDPKSLPKYESSHEYQTKKRRQQQR 315
+P + + K +
Sbjct: 421 GRDSQIPSSRYTKIRDSIKTKYDAW 445
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 4e-45
Identities = 70/290 (24%), Positives = 118/290 (40%), Gaps = 63/290 (21%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
++ G+ A I RE +I + L+H N+++L + ++
Sbjct: 30 CVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE-------- 81
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTG--LADRPGLR--FTVPQIKCYMKQLLTGLHYCHVN 117
G Y++F+ + TG L + R ++ ++Q+L + +CH
Sbjct: 82 --------EGHHYLIFDLV----TGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 118 QVLHRDIKGSNLLIDNEGN---LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA 174
V+HR++K NLL+ ++ +KLADFGLA + T Y PE+L
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-QQAWFGFAGTPGYLSPEVLRK- 187
Query: 175 TKYGPAVDMWSVGCIFAELLNGKPILP--GKNEAEQLSKIFELCGSPD--ETIWPGVSKM 230
YG VD+W+ G I LL G P P +++ +I G+ D W V+
Sbjct: 188 DPYGKPVDLWACGVILYILLVGYP--PFWDEDQHRLYQQI--KAGAYDFPSPEWDTVTP- 242
Query: 231 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280
A +L+ KML ++PS+RI+A +AL
Sbjct: 243 -------------------------EAKDLINKMLTINPSKRITAAEALK 267
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 6e-45
Identities = 76/303 (25%), Positives = 119/303 (39%), Gaps = 53/303 (17%)
Query: 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERD 59
+ARE + I+ALK + EKEG REI+I L+H N++++
Sbjct: 32 LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK---- 87
Query: 60 EQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 118
Y++ E+ +L + G RF + +M++L LHYCH +
Sbjct: 88 ------------RIYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHERK 134
Query: 119 VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYG 178
V+HRDIK NLL+ +G LK+ADFG + T+ TL Y PPE++ G +
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCG---TLDYLPPEMIEG-KTHD 190
Query: 179 PAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238
VD+W G + E L G P + E +I K P
Sbjct: 191 EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN-----------VDLKFP------- 232
Query: 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPK 298
+ +L+ K+L P QR+ K ++ + + P
Sbjct: 233 ------------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQS 280
Query: 299 YES 301
+S
Sbjct: 281 TQS 283
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 7e-45
Identities = 64/328 (19%), Positives = 114/328 (34%), Gaps = 67/328 (20%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQH-ENVIKLKEIVTSPGPERDE 60
TG+ A K ++ + + EI +L+ + VI L E+ +
Sbjct: 48 CISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS----- 102
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTG------LADRPGLRFTVPQIKCYMKQLLTGLHYC 114
++ EY G + + +KQ+L G++Y
Sbjct: 103 -----------EIILILEYA----AGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 115 HVNQVLHRDIKGSNLLIDNE---GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELL 171
H N ++H D+K N+L+ + G++K+ DFG++R H L + T Y PE+L
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--GHACELREIMGTPEYLAPEIL 205
Query: 172 LGATKYGPAVDMWSVGCIFAELLNGKPILP--GKNEAEQLSKIFELCGSPD--ETIWPGV 227
A DMW++G I LL P G++ E I + D E + V
Sbjct: 206 NY-DPITTATDMWNIGIIAYMLLTHTS--PFVGEDNQETYLNI--SQVNVDYSEETFSSV 260
Query: 228 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287
S+ A + ++ +L+ +P +R +A+ L +
Sbjct: 261 SQ--------------------------LATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294
Query: 288 PLPCDPKSLPKYESSHEYQTKKRRQQQR 315
SS R + +
Sbjct: 295 DFENLFHPEETSSSSQTQDHSVRSSEDK 322
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 7e-45
Identities = 62/293 (21%), Positives = 108/293 (36%), Gaps = 67/293 (22%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDE 60
+TG+ ALK + D+ K A +E+ + +++ + ++
Sbjct: 48 CFHRRTGQKCALKLLY-DSPK------ARQEVDHHWQASGGPHIVCILDVYE-------- 92
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTG------LADRPGLRFTVPQIKCYMKQLLTGLHYC 114
+ + + ++ E M G + +R FT + M+ + T + +
Sbjct: 93 ----NMHHGKRCLLIIMECM----EGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFL 144
Query: 115 HVNQVLHRDIKGSNLLIDNEG---NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELL 171
H + + HRD+K NLL ++ LKL DFG A+ N L T +Y PE+L
Sbjct: 145 HSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET---TQNALQTPCYTPYYVAPEVL 201
Query: 172 LGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE--LCGSPD--ETIWPGV 227
G KY + DMWS+G I LL G P + G W V
Sbjct: 202 -GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEV 260
Query: 228 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280
S+ A +L+ +L DP++R++ ++
Sbjct: 261 SE--------------------------DAKQLIRLLLKTDPTERLTITQFMN 287
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-44
Identities = 53/295 (17%), Positives = 95/295 (32%), Gaps = 61/295 (20%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
+ G ALK+I +++ A RE + + H N+++L + E
Sbjct: 48 VEGLHDGHFYALKRILCHEQQD--REEAQREADMHRLFNHPNILRLVAYCLRERGAKHE- 104
Query: 62 GRPDGNKYRGSTYMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 117
+++ + + G T QI + + GL H
Sbjct: 105 -----------AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK 153
Query: 118 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI--------TLWYRPPE 169
HRD+K +N+L+ +EG L D G + + T+ YR PE
Sbjct: 154 GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE 213
Query: 170 LLLGA--TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDET---IW 224
L D+WS+GC+ ++ G+ P +++ ++
Sbjct: 214 LFSVQSHCVIDERTDVWSLGCVLYAMMFGEG--P-----------YDMVFQKGDSVALAV 260
Query: 225 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 279
+P S + +LL M+ +DP QR L
Sbjct: 261 QNQLSIPQSPRH--SSALW---------------QLLNSMMTVDPHQRPHIPLLL 298
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-44
Identities = 79/319 (24%), Positives = 119/319 (37%), Gaps = 62/319 (19%)
Query: 2 AREIKTGEIVALKKI--RMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERD 59
E TG +A K I R +KE EI ++ +L H N+I+L + S
Sbjct: 108 CEETATGLKLAAKIIKTRGMKDKEEV----KNEISVMNQLDHANLIQLYDAFESKN---- 159
Query: 60 EQGRPDGNKYRGSTYMVFEYMDHDLTG--LADR---PGLRFTVPQIKCYMKQLLTGLHYC 114
+V EY+ G L DR T +MKQ+ G+ +
Sbjct: 160 ------------DIVLVMEYV----DGGELFDRIIDESYNLTELDTILFMKQICEGIRHM 203
Query: 115 HVNQVLHRDIKGSNLLIDN--EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL 172
H +LH D+K N+L N +K+ DFGLAR + L T + PE++
Sbjct: 204 HQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY--KPREKLKVNFGTPEFLAPEVVN 261
Query: 173 GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 232
DMWSVG I LL+G G N+AE L+ I ++ + +S+
Sbjct: 262 Y-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISE--- 317
Query: 233 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCD 292
A E + K+L+ + S RISA +AL + L
Sbjct: 318 -----------------------EAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSR 354
Query: 293 PKSLPKYESSHEYQTKKRR 311
+ K + Q +
Sbjct: 355 LSAQKKKNRGSDAQDFVTK 373
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-43
Identities = 64/298 (21%), Positives = 108/298 (36%), Gaps = 70/298 (23%)
Query: 2 AREIKTGEIVALKKIR------MDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSP 54
TG A+K + + E RE IL+++ H ++I L + S
Sbjct: 113 CVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172
Query: 55 GPERDEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADR---PGLRFTVPQIKCYMKQLLT 109
++VF+ M L D + + + M+ LL
Sbjct: 173 S----------------FMFLVFDLM----RKGELFDYLTEKV-ALSEKETRSIMRSLLE 211
Query: 110 GLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPE 169
+ + H N ++HRD+K N+L+D+ ++L+DFG + + L T Y PE
Sbjct: 212 AVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL--EPGEKLRELCGTPGYLAPE 269
Query: 170 LLLGA-----TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD--ET 222
+L + YG VD+W+ G I LL G P + + L I + G
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI--MEGQYQFSSP 327
Query: 223 IWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280
W S +L+ ++L +DP R++A+ AL
Sbjct: 328 EWDDRSS--------------------------TVKDLISRLLQVDPEARLTAEQALQ 359
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-43
Identities = 73/314 (23%), Positives = 119/314 (37%), Gaps = 78/314 (24%)
Query: 1 MAREIKTGEIVALK---KIRMDNEKEGFPITAI---------------------REIKIL 36
+A A+K K ++ + +EI IL
Sbjct: 31 LAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90
Query: 37 KKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTG-LADRPGL-R 94
KKL H NV+KL E++ P YMVFE ++ G + + P L
Sbjct: 91 KKLDHPNVVKLVEVLDDPN--------------EDHLYMVFELVNQ---GPVMEVPTLKP 133
Query: 95 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 154
+ Q + Y + L+ G+ Y H +++HRDIK SNLL+ +G++K+ADFG++ F +
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK-GSDA 192
Query: 155 TLTNRVITLWYRPPELLLGATK-Y-GPAVDMWSVGCIFAELLNGKPILP--GKNEAEQLS 210
L+N V T + PE L K + G A+D+W++G + G+ P + S
Sbjct: 193 LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ--CPFMDERIMCLHS 250
Query: 211 KIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPS 270
KI + P +L+ +ML +P
Sbjct: 251 KIKS-----------QALEFPDQPDIAED-----------------LKDLITRMLDKNPE 282
Query: 271 QRISAKDALDSEYF 284
RI + +
Sbjct: 283 SRIVVPEIKLHPWV 296
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 7e-43
Identities = 71/312 (22%), Positives = 124/312 (39%), Gaps = 54/312 (17%)
Query: 1 MAREIKTGEIVALKKI--RMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 58
+ +T A+K + + +EI++L++L+H+NVI+L +++ + ++
Sbjct: 23 EVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82
Query: 59 DEQGRPDGNKYRGSTYMVFEYMDHDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVN 117
YMV EY + + D P RF V Q Y QL+ GL Y H
Sbjct: 83 --------------MYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ 128
Query: 118 QVLHRDIKGSNLLIDNEGNLKLADFGLARSF-SYDHNNTLTNRVITLWYRPPELLLGATK 176
++H+DIK NLL+ G LK++ G+A + + ++T + ++PPE+ G
Sbjct: 129 GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDT 188
Query: 177 Y-GPAVDMWSVGCIFAELLNGKPILP--GKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 233
+ G VD+WS G + G P G N + I + G +P
Sbjct: 189 FSGFKVDIWSAGVTLYNITTGL--YPFEGDNIYKLFENIGK-----------GSYAIP-- 233
Query: 234 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD-PLPCD 292
+LL+ ML +P++R S + +F P
Sbjct: 234 -----------------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEA 276
Query: 293 PKSLPKYESSHE 304
P +P + +
Sbjct: 277 PVPIPPSPDTKD 288
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 8e-43
Identities = 65/293 (22%), Positives = 110/293 (37%), Gaps = 66/293 (22%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDE 60
+T E ALK ++ D K RE+++ + +++++ ++
Sbjct: 81 IFNKRTQEKFALKMLQ-DCPKAR------REVELHWRASQCPHIVRIVDVYE-------- 125
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTG------LADRPGLRFTVPQIKCYMKQLLTGLHYC 114
+ R +V E + G + DR FT + MK + + Y
Sbjct: 126 ----NLYAGRKCLLIVMECL----DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 177
Query: 115 HVNQVLHRDIKGSNLLIDNEG---NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELL 171
H + HRD+K NLL ++ LKL DFG A+ +N+LT T +Y PE+L
Sbjct: 178 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET--TSHNSLTTPCYTPYYVAPEVL 235
Query: 172 LGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE--LCGSPD--ETIWPGV 227
G KY + DMWS+G I LL G P + + G + W V
Sbjct: 236 -GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 294
Query: 228 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280
S+ L+ +L +P+QR++ + ++
Sbjct: 295 SE--------------------------EVKMLIRNLLKTEPTQRMTITEFMN 321
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-42
Identities = 72/295 (24%), Positives = 107/295 (36%), Gaps = 74/295 (25%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDE 60
T A+K I EI+IL + QH N+I LK++
Sbjct: 41 CIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGK----- 89
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTG--LADRPGLR--FTVPQIKCYMKQLLTGLHYCHV 116
Y+V E M G L D+ + F+ + + + + Y H
Sbjct: 90 -----------YVYVVTELM----KGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA 134
Query: 117 NQVLHRDIKGSNLLI----DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL 172
V+HRD+K SN+L N ++++ DFG A+ N L T + PE+L
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-AENGLLMTPCYTANFVAPEVLE 193
Query: 173 GATKYGPAVDMWSVGCIFAELLNGKP---ILPGKNEAEQLSKI----FELCGSPDETIWP 225
Y A D+WS+G + +L G P E L++I F L G W
Sbjct: 194 R-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGY----WN 248
Query: 226 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280
VS A +L+ KML +DP QR++A L
Sbjct: 249 SVSD--------------------------TAKDLVSKMLHVDPHQRLTAALVLR 277
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-42
Identities = 83/291 (28%), Positives = 122/291 (41%), Gaps = 69/291 (23%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
++ T + ALK ++ +K+ EI +L +L H N+IKLKEI +P
Sbjct: 72 CKQKGTQKPYALKVLKKTVDKKIV----RTEIGVLLRLSHPNIIKLKEIFETPT------ 121
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTG--LADR---PGLRFTVPQIKCYMKQLLTGLHYCHV 116
+V E + TG L DR G ++ +KQ+L + Y H
Sbjct: 122 ----------EISLVLELV----TGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLHE 166
Query: 117 NQVLHRDIKGSNLLI---DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG 173
N ++HRD+K NLL + LK+ADFGL++ +H + T Y PE+L G
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKTVCGTPGYCAPEILRG 224
Query: 174 ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE--LCGSPD--ETIWPGVSK 229
YGP VDMWSVG I LL G P +E +F L W VS
Sbjct: 225 -CAYGPEVDMWSVGIITYILLCGFE--PFYDERGD-QFMFRRILNCEYYFISPWWDEVSL 280
Query: 230 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280
+A +L+ K+++LDP +R++ AL
Sbjct: 281 --------------------------NAKDLVRKLIVLDPKKRLTTFQALQ 305
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-42
Identities = 73/331 (22%), Positives = 122/331 (36%), Gaps = 73/331 (22%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDE 60
K+ + A+K I E +EI LK + H N++KL E+
Sbjct: 30 CVHKKSNQAFAVKIISKRMEANTQ-----KEITALKLCEGHPNIVKLHEVFHDQL----- 79
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTG--LADRPGLR--FTVPQIKCYMKQLLTGLHYCHV 116
T++V E + G L +R + F+ + M++L++ + + H
Sbjct: 80 -----------HTFLVMELL----NGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124
Query: 117 NQVLHRDIKGSNLLIDNEG---NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG 173
V+HRD+K NLL +E +K+ DFG AR N L TL Y PE LL
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP-PDNQPLKTPCFTLHYAAPE-LLN 182
Query: 174 ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLS---KIFE--LCGSPD--ETIWPG 226
Y + D+WS+G I +L+G+ + + + +I + G W
Sbjct: 183 QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKN 242
Query: 227 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW- 285
VS+ A +L++ +L +DP++R+ +E W
Sbjct: 243 VSQ--------------------------EAKDLIQGLLTVDPNKRLKMSGLRYNE--WL 274
Query: 286 --TDPLPCDPKSLPKYESSHEYQTKKRRQQQ 314
L +P P S +
Sbjct: 275 QDGSQLSSNPLMTPDILGSSGAAVHTCVKAT 305
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 7e-42
Identities = 58/293 (19%), Positives = 98/293 (33%), Gaps = 87/293 (29%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDE 60
+T E ALK ++ D K RE+++ + Q +++++ ++
Sbjct: 37 IFNKRTQEKFALKMLQ-DCPKAR------REVELHWRASQCPHIVRIVDVYE-------- 81
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTG------LADRPGLRFTVPQIKCYMKQLLTGLHYC 114
+ R +V E + G + DR FT + MK + + Y
Sbjct: 82 ----NLYAGRKCLLIVMECL----DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 115 HVNQVLHRDIKGSNLLIDNEG---NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELL 171
H + HRD+K NLL ++ LKL DFG A E
Sbjct: 134 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA----------------------KETT 171
Query: 172 LGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE--LCGSPD--ETIWPGV 227
KY + DMWS+G I LL G P + + G + W V
Sbjct: 172 --GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 229
Query: 228 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280
S+ L+ +L +P+QR++ + ++
Sbjct: 230 SE--------------------------EVKMLIRNLLKTEPTQRMTITEFMN 256
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 7e-41
Identities = 54/293 (18%), Positives = 97/293 (33%), Gaps = 72/293 (24%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
++ +TG A+KK+R++ + E+ L ++ L G R+
Sbjct: 76 RMKDKQTGFQCAVKKVRLEVFRV-------EELVACAGLSSPRIVPLY------GAVREG 122
Query: 61 QGRPDGNKYRGSTYMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 116
+ E ++ L + + Y+ Q L GL Y H
Sbjct: 123 ----------PWVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLEYLHT 168
Query: 117 NQVLHRDIKGSNLLIDNEGNL-KLADFGLARSFSYDHNNTLTNRVITL----WYRPPELL 171
++LH D+K N+L+ ++G+ L DFG A D + + PE++
Sbjct: 169 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228
Query: 172 LGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 231
+G VD+WS C+ +LNG P W + P
Sbjct: 229 MG-KPCDAKVDIWSSCCMMLHMLNGCH--P----------------------WTQYFRGP 263
Query: 232 AY----NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280
+ P R + + +++ L +P R SA +
Sbjct: 264 LCLKIASEPPPIREIPPSCAPLTAQA-------IQEGLRKEPVHRASAMELRR 309
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-40
Identities = 74/306 (24%), Positives = 127/306 (41%), Gaps = 54/306 (17%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
+AR I TG VA+K I RE++I+K L H N++KL E++ +
Sbjct: 33 LARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK----- 87
Query: 61 QGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQV 119
+ Y++ EY ++ G R + + +Q+++ + YCH ++
Sbjct: 88 -----------TLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQKRI 135
Query: 120 LHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGP 179
+HRD+K NLL+D + N+K+ADFG + F+ L Y PEL G GP
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFT--VGGKLDAFCGAPPYAAPELFQGKKYDGP 193
Query: 180 AVDMWSVGCIFAELLNGKPILP--GKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237
VD+WS+G I L++G LP G+N E ++ G ++P
Sbjct: 194 EVDVWSLGVILYTLVSGS--LPFDGQNLKELRERVLR-----------GKYRIP------ 234
Query: 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLP 297
+ LL++ L+L+P +R + + + + + K
Sbjct: 235 -------------FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFV 281
Query: 298 KYESSH 303
+ E
Sbjct: 282 EPELDI 287
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-40
Identities = 80/288 (27%), Positives = 121/288 (42%), Gaps = 57/288 (19%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
R++ +A+K+I + + P+ EI + K L+H+N IV G +
Sbjct: 40 AGRDLSNQVRIAIKEIPERDSRYSQPL--HEEIALHKHLKHKN------IVQYLGSFSEN 91
Query: 61 QGRPDGNKYRGSTYMVFEYMD----HDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCH 115
G + E + L L + G L+ I Y KQ+L GL Y H
Sbjct: 92 ----------GFIKIFMEQVPGGSLSAL--LRSKWGPLKDNEQTIGFYTKQILEGLKYLH 139
Query: 116 VNQVLHRDIKGSNLLIDN-EGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLG 173
NQ++HRDIKG N+LI+ G LK++DFG ++ + N T TL Y PE++
Sbjct: 140 DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA--GINPCTETFTGTLQYMAPEIIDK 197
Query: 174 ATK-YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 232
+ YG A D+WS+GC E+ GKP P E + +F++ G+ K+
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKP--PFYELGEPQAAMFKV----------GMFKVH- 244
Query: 233 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280
P E+ A + K DP +R A D L
Sbjct: 245 -----P---------EIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 5e-40
Identities = 52/306 (16%), Positives = 91/306 (29%), Gaps = 77/306 (25%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDE 60
+ G I A+K+ + A+RE+ L QH +V++
Sbjct: 30 CVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE------- 82
Query: 61 QGRPDGNKYRGSTYMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 116
+ EY + D R F ++K + Q+ GL Y H
Sbjct: 83 ---------DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS 133
Query: 117 NQVLHRDIKGSNLLIDNEGNL-------------------KLADFGLARSFSYDHNNTLT 157
++H DIK SN+ I K+ D G S
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS--SPQVEE 191
Query: 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 217
+ E+L + P D++++ +P LP +Q +I +
Sbjct: 192 G---DSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP-LP--RNGDQWHEIRQ--- 242
Query: 218 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKD 277
++P + + + ELL+ M+ DP +R SA
Sbjct: 243 ----------GRLP----------------RIPQVLSQEFTELLKVMIHPDPERRPSAMA 276
Query: 278 ALDSEY 283
+
Sbjct: 277 LVKHSV 282
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-40
Identities = 87/308 (28%), Positives = 123/308 (39%), Gaps = 67/308 (21%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
+A T E VA+K + M P +EI I K L HENV+K
Sbjct: 25 LAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREG------ 77
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTG--LADR--PGLRFTVPQIKCYMKQLLTGLHYCHV 116
N Y+ EY +G L DR P + P + + QL+ G+ Y H
Sbjct: 78 ------NIQ----YLFLEYC----SGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 117 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLGAT 175
+ HRDIK NLL+D NLK++DFGLA F Y++ L N++ TL Y PELL
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 176 KYGPAVDMWSVGCIFAELLNGKPILP---GKNEAEQLSKIFELCGSPDETIWPGVSKMPA 232
+ VD+WS G + +L G+ LP + ++ S E P
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQEYSDWKE----------KKTYLNP- 230
Query: 233 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCD 292
++ D L LL K+L+ +PS RI+ D ++
Sbjct: 231 -----------------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWY-------- 265
Query: 293 PKSLPKYE 300
K L K
Sbjct: 266 NKPLKKGA 273
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 5e-40
Identities = 57/338 (16%), Positives = 106/338 (31%), Gaps = 88/338 (26%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKE------------ 49
A+ A+K+IR+ N + +RE+K L KL+H +++
Sbjct: 25 AKNKVDDCNYAIKRIRLPNRELARE-KVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83
Query: 50 -----------------------------IVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80
P ++ G+ + + Y+ +
Sbjct: 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLC 143
Query: 81 DH-DLTGLADR--PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 137
+L +R Q+ + + H ++HRD+K SN+ + +
Sbjct: 144 RKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVV 203
Query: 138 KLADFGLARSFSYD-----------HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSV 186
K+ DFGL + D T T +V T Y PE + G Y VD++S+
Sbjct: 204 KVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG-NNYSHKVDIFSL 262
Query: 187 GCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRV 246
G I ELL ++ + +
Sbjct: 263 GLILFELLY--SFSTQMERVRIITDV-----------------------------RNLKF 291
Query: 247 REVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
+F +++ ML P++R A D +++ F
Sbjct: 292 PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-39
Identities = 43/326 (13%), Positives = 97/326 (29%), Gaps = 68/326 (20%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIRE----IKILKKLQHENVIKLK-------EI 50
A + +TGE + I ++E +++L+ ++++ K+ ++
Sbjct: 92 ATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151
Query: 51 VTSPGPERDEQGRPDGNKYR-GSTYMVFEYMDHDLTGLAD------RPGLRFTVPQIKCY 103
V P ++ + R D S + ++ M +L +
Sbjct: 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQL 211
Query: 104 MKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL 163
Q++ L H ++H ++ ++++D G + L F + ++
Sbjct: 212 TLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-----RDGARVVSSVSR 266
Query: 164 WYRPPELL----------LGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 213
+ PPEL T + D W++G + + + IF
Sbjct: 267 GFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIF 326
Query: 214 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI 273
C ++ + LLE L R+
Sbjct: 327 RSC----------------------------------KNIPQPVRALLEGFLRYPKEDRL 352
Query: 274 SAKDALDSEYFWTDPLPCDPKSLPKY 299
A+++ + +LP Y
Sbjct: 353 LPLQAMETPEY-EQLRTELSAALPLY 377
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 5e-39
Identities = 63/314 (20%), Positives = 113/314 (35%), Gaps = 85/314 (27%)
Query: 2 AREIKTGEIVALKKI--RMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPER 58
+ T + A+K I + + + RE+++L + Q H NV++L E
Sbjct: 32 CINLITSQEYAVKIIEKQPGHIRSRV----FREVEMLYQCQGHRNVLELIEFFE------ 81
Query: 59 DEQGRPDGNKYRGSTYMVFEYMDHDLTG--LADRPGLR--FTVPQIKCYMKQLLTGLHYC 114
+ +++ Y+VFE M G + R F + ++ + + L +
Sbjct: 82 ------EEDRF----YLVFEKM----RGGSILSHIHKRRHFNELEASVVVQDVASALDFL 127
Query: 115 HVNQVLHRDIKGSNLLIDNEGN---LKLADFGLARSFSYDH------NNTLTNRVITLWY 165
H + HRD+K N+L ++ +K+ DF L + L + Y
Sbjct: 128 HNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 166 RPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDE 221
PE++ A+ Y D+WS+G I LL+G P G+ ++ E C +
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247
Query: 222 TI---------------WPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLM 266
+ W +S A +L+ K+L+
Sbjct: 248 MLFESIQEGKYEFPDKDWAHISC--------------------------AAKDLISKLLV 281
Query: 267 LDPSQRISAKDALD 280
D QR+SA L
Sbjct: 282 RDAKQRLSAAQVLQ 295
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 9e-39
Identities = 84/292 (28%), Positives = 120/292 (41%), Gaps = 59/292 (20%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
+A T E VA+K + M P +EI I K L HENV+K
Sbjct: 25 LAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREG------ 77
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTG--LADR--PGLRFTVPQIKCYMKQLLTGLHYCHV 116
N Y+ EY +G L DR P + P + + QL+ G+ Y H
Sbjct: 78 ------NIQ----YLFLEYC----SGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 117 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLGAT 175
+ HRDIK NLL+D NLK++DFGLA F Y++ L N++ TL Y PELL
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 176 KYGPAVDMWSVGCIFAELLNGKPILP---GKNEAEQLSKIFELCGSPDETIWPGVSKMPA 232
+ VD+WS G + +L G+ LP + ++ S E P
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQEYSDWKE----------KKTYLNP- 230
Query: 233 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
++ D L LL K+L+ +PS RI+ D ++
Sbjct: 231 -----------------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 265
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-38
Identities = 76/310 (24%), Positives = 128/310 (41%), Gaps = 59/310 (19%)
Query: 1 MAREIKTGEIVALK---KIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 57
+A KT + VALK + + + REI LK L+H ++IKL +++T+P
Sbjct: 27 LATHYKTQQKVALKFISRQLLKKSDMHMRVE--REISYLKLLRHPHIIKLYDVITTPT-- 82
Query: 58 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 117
MV EY +L R T + + + +Q++ + YCH +
Sbjct: 83 --------------DIVMVIEYAGGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRH 127
Query: 118 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 177
+++HRD+K NLL+D+ N+K+ADFGL+ + + L + Y PE++ G
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--FLKTSCGSPNYAAPEVINGKLYA 185
Query: 178 GPAVDMWSVGCIFAELLNGKPILP--GKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235
GP VD+WS G + +L G+ LP + K+ V MP
Sbjct: 186 GPEVDVWSCGIVLYVMLVGR--LPFDDEFIPNLFKKVNS-----------CVYVMP---- 228
Query: 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD-PLPCDPK 294
A L+ +M++ DP QRI+ ++ +F + P P
Sbjct: 229 ---------------DFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPM 273
Query: 295 SLPKYESSHE 304
+ +
Sbjct: 274 EEVQGSYADS 283
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-38
Identities = 52/288 (18%), Positives = 100/288 (34%), Gaps = 49/288 (17%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
+ +T VA +++ + E ++LK LQH N+++ +
Sbjct: 44 KGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWE-------- 95
Query: 61 QGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ- 118
K + +V E M L R + ++ + +Q+L GL + H
Sbjct: 96 ----STVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTP 150
Query: 119 -VLHRDIKGSNLLID-NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK 176
++HRD+K N+ I G++K+ D GLA + + T + PE+ K
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV---IGTPEFMAPEM--YEEK 205
Query: 177 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236
Y +VD+++ G E+ + A Q+ + G +
Sbjct: 206 YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKPASFDKVAI-------- 256
Query: 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
+ +E + + +R S KD L+ +F
Sbjct: 257 -----------PEVKEI-------IEGCIRQNKDERYSIKDLLNHAFF 286
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-38
Identities = 66/344 (19%), Positives = 116/344 (33%), Gaps = 67/344 (19%)
Query: 1 MAREIKTGEIVALK-----KIRMDNEKEGFPITAI-REIKILKKLQHENVIKLKEIVTSP 54
A + + + V +K K+ D E + + EI IL +++H N+IK+ +I +
Sbjct: 42 TAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101
Query: 55 GPERDEQGRPDGNKYRGSTYMVFEYMDH--DLTGLADRPGLRFTVPQIKCYMKQLLTGLH 112
G +V E DL DR R P +QL++ +
Sbjct: 102 G----------------FFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVG 144
Query: 113 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL 172
Y + ++HRDIK N++I + +KL DFG A T+ Y PE+L+
Sbjct: 145 YLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK--LFYTFCGTIEYCAPEVLM 202
Query: 173 GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 232
G GP ++MWS+G L+ + P +L + E P
Sbjct: 203 GNPYRGPELEMWSLGVTLYTLVFEE--NP----FCELEETVE-----------AAIHPP- 244
Query: 233 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD----P 288
+ + L+ +L P +R + + + +
Sbjct: 245 ------------------YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLAD 286
Query: 289 LPCDPKSLPKYESSHEYQTKKRRQQQRQHEEATKRQKLHHPQPH 332
+ S R + + Q+L + H
Sbjct: 287 YTWEEVFRVNKPESGVLSAASLEMGNRSLSDVAQAQELCGGEGH 330
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-37
Identities = 79/290 (27%), Positives = 124/290 (42%), Gaps = 59/290 (20%)
Query: 1 MAREIKTGEIVALK---KIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 57
+ TG VA+K + ++ + I REI+ LK +H ++IKL +++++P
Sbjct: 29 IGEHQLTGHKVAVKILNRQKIRSLDVVGKIK--REIQNLKLFRHPHIIKLYQVISTPT-- 84
Query: 58 RDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 116
+MV EY+ +L + G R + + +Q+L+ + YCH
Sbjct: 85 --------------DFFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHR 129
Query: 117 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK 176
+ V+HRD+K N+L+D N K+ADFGL S L + Y PE++ G
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGL--SNMMSDGEFLRTSCGSPNYAAPEVISGRLY 187
Query: 177 YGPAVDMWSVGCIFAELLNGKPILP--GKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234
GP VD+WS G I LL G LP ++ KI GV +P
Sbjct: 188 AGPEVDIWSCGVILYALLCGT--LPFDDEHVPTLFKKIRG-----------GVFYIP--- 231
Query: 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
+ +R LL ML +DP +R + KD + E+F
Sbjct: 232 ----------------EYLNRSVATLLMHMLQVDPLKRATIKDIREHEWF 265
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 70/292 (23%), Positives = 113/292 (38%), Gaps = 59/292 (20%)
Query: 1 MAREIKTGEIVALK---KIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 57
+ R+ T E+VA+K + +E REI + L+H N+++ KE++ +P
Sbjct: 38 LMRDKLTKELVAVKYIERGAAIDEN------VQREIINHRSLRHPNIVRFKEVILTP--- 88
Query: 58 RDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 116
++ EY +L G RF+ + + + +QLL+G+ YCH
Sbjct: 89 ---------THL----AIIMEYASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHS 134
Query: 117 NQVLHRDIKGSNLLID--NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA 174
Q+ HRD+K N L+D LK+ DFG ++S + V T Y PE+LL
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRQ 192
Query: 175 TKYGPAVDMWSVGCIFAELLNGKPILP--GKNEAEQLSKIFELCGSPDETIWPGVSKMPA 232
G D+WS G +L G P E K + I +P
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGA--YPFEDPEEPRDYRKTI-------QRILSVKYSIPD 243
Query: 233 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
P L+ ++ + DP+ RIS + +F
Sbjct: 244 DIRISPE-----------------CCHLISRIFVADPATRISIPEIKTHSWF 278
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-37
Identities = 89/414 (21%), Positives = 149/414 (35%), Gaps = 82/414 (19%)
Query: 1 MAREIKTGEIVALK---KIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 57
+ + TG VA+K + ++ + I REI+ LK +H ++IKL +++++P
Sbjct: 34 VGKHELTGHKVAVKILNRQKIRSLDVVGKIR--REIQNLKLFRHPHIIKLYQVISTPS-- 89
Query: 58 RDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 116
+MV EY+ +L + G R + + +Q+L+G+ YCH
Sbjct: 90 --------------DIFMVMEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCHR 134
Query: 117 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK 176
+ V+HRD+K N+L+D N K+ADFGL+ S L + Y PE++ G
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRTSCGSPNYAAPEVISGRLY 192
Query: 177 YGPAVDMWSVGCIFAELLNGKPILP--GKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234
GP VD+WS G I LL G LP + KI + G+ P
Sbjct: 193 AGPEVDIWSSGVILYALLCGT--LPFDDDHVPTLFKKICD-----------GIFYTP--- 236
Query: 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPK 294
++ + + LL+ ML +DP +R + KD + E+F D
Sbjct: 237 ----------------QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFP 280
Query: 295 SLPKYESSH----------------EYQTKKRRQQQRQHEEAT-------KRQKLHHPQP 331
P Y S+ E + + + +++ +
Sbjct: 281 EDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLAVAYHLIIDNRRIMNEAK 340
Query: 332 HGRLPPIQHAGQSHHWSGPNHPMNNAPPPVPGGPGHHHYGKPRGPPGGANRYPS 385
L P V P H P ++
Sbjct: 341 DFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQKSKHQGVR 394
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 8e-37
Identities = 68/299 (22%), Positives = 109/299 (36%), Gaps = 65/299 (21%)
Query: 1 MAREIKTGEIVALK---KIRMDNEKEGFPITAI-REIKILKKLQHE--NVIKLKEIVTSP 54
+ VA+K K R+ + E T + E+ +LKK+ VI+L + P
Sbjct: 61 SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120
Query: 55 GPERDEQGRPDGNKYRGSTYMVFEYMDH--DLTGLADRPGLRFTVPQIKCYMKQLLTGLH 112
+ + ++ E + DL G + + Q+L +
Sbjct: 121 ------------DSF----VLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVR 163
Query: 113 YCHVNQVLHRDIKGSNLLID-NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELL 171
+CH VLHRDIK N+LID N G LKL DFG + + T+ T Y PPE +
Sbjct: 164 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWI 220
Query: 172 LGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 231
+G + +WS+G + +++ G +P FE DE I G
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGD--IP-----------FEH----DEEIIRGQVFFR 263
Query: 232 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 290
+ L+ L L PS R + ++ + + LP
Sbjct: 264 -------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 303
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-36
Identities = 67/337 (19%), Positives = 116/337 (34%), Gaps = 69/337 (20%)
Query: 2 AREIKTGEIVALKKI-RMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERD 59
A+++ +G ALK++ + EK I+E+ +KKL H N+++ + E D
Sbjct: 47 AQDVGSGREYALKRLLSNEEEKNR---AIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103
Query: 60 EQGRPDGNKYRGSTYMVFEYMDHDLTGLAD-----RPGLRFTVPQIKCYMKQLLTGLHYC 114
+ L + + + Q + +
Sbjct: 104 -----------TGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 115 HVNQ--VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT-----------NRVI 161
H + ++HRD+K NLL+ N+G +KL DFG A + S+ + + + R
Sbjct: 153 HRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 162 TLWYRPPEL--LLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSP 219
T YR PE+ L G D+W++GCI L + P FE
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH--P-----------FE--DGA 257
Query: 220 DETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 279
I G +P ++ L+ ML ++P +R+S + +
Sbjct: 258 KLRIVNGKYSIPPHDTQ--YTVFHS---------------LIRAMLQVNPEERLSIAEVV 300
Query: 280 DSEYFWTDPLPCDPKSLPKYESSHEYQTKKRRQQQRQ 316
+PKS P E + R
Sbjct: 301 HQLQEIAAARNVNPKS-PITELLEQNGGYGSATLSRG 336
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 64/361 (17%), Positives = 104/361 (28%), Gaps = 59/361 (16%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
AR TGE V +++I ++ E+ + K H N++
Sbjct: 46 ARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP--------------- 90
Query: 62 GRPDGNKYRGS------TYMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGL 111
YR + ++V +M DL + I ++ +L L
Sbjct: 91 -------YRATFIADNELWVVTSFMAYGSAKDL--ICTHFMDGMNELAIAYILQGVLKAL 141
Query: 112 HYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTLTNRVITLWYRP-- 167
Y H +HR +K S++LI +G + L+ S + +
Sbjct: 142 DYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201
Query: 168 --PELLL-GATKYGPAVDMWSVGCIFAELLNGKP-------------IL---PGKNEAEQ 208
PE+L Y D++SVG EL NG L
Sbjct: 202 LSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS 261
Query: 209 LSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLD 268
EL SP ++ R F H +E+ L +
Sbjct: 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRN 321
Query: 269 PSQRISAKDALDSEYFWTDPLPCDPKSLPKY-ESSHEYQTKKRRQQQRQHEEATKRQKLH 327
P R SA L+ +F ++LP+ + Q Q L
Sbjct: 322 PDARPSASTLLNHSFF-KQIKRRASEALPELLRPVTPITNFEGSQSQDHSGIFGLVTNLE 380
Query: 328 H 328
Sbjct: 381 E 381
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-35
Identities = 63/317 (19%), Positives = 105/317 (33%), Gaps = 69/317 (21%)
Query: 1 MAREIKTGEIVALK---KIRMDNEKEGFPITAI-REIKILKKL----QHENVIKLKEIVT 52
+ VA+K + R+ E+ +L K+ H VI+L +
Sbjct: 49 AGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108
Query: 53 SPGPERDEQGRPDGNKYRGSTYMVFEYMDH--DLTGLADRPGLRFTVPQIKCYMKQLLTG 110
+ + +V E DL G +C+ Q++
Sbjct: 109 TQ------------EGF----MLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAA 151
Query: 111 LHYCHVNQVLHRDIKGSNLLIDNE-GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPE 169
+ +CH V+HRDIK N+LID G KL DFG + H+ T+ T Y PPE
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG---ALLHDEPYTDFDGTRVYSPPE 208
Query: 170 LLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 229
+ + +WS+G + +++ G +P FE D+ I
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGD--IP-----------FER----DQEILEAELH 251
Query: 230 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTD 287
P H L+ + L PS R S ++ L + +
Sbjct: 252 FP-------------------AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292
Query: 288 PLPCDPKSLPKYESSHE 304
+P +P +
Sbjct: 293 DVPLNPSKGGPAPLAWS 309
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-33
Identities = 74/291 (25%), Positives = 117/291 (40%), Gaps = 67/291 (23%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A+ +TG + A K I +E+E I EI+IL H ++KL
Sbjct: 38 AKNKETGALAAAKVIETKSEEELEDY--IVEIEILATCDHPYIVKLL------------- 82
Query: 62 GRPDGNKYRGST-YMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 116
G Y +++ E+ + DR T PQI+ +Q+L L++ H
Sbjct: 83 ----GAYYHDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVVCRQMLEALNFLHS 135
Query: 117 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLWYRPPELLLG 173
+++HRD+K N+L+ EG+++LADFG S + TL R + T ++ PE+++
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFG----VSAKNLKTLQKRDSFIGTPYWMAPEVVMC 191
Query: 174 ATK----YGPAVDMWSVGCIFA-ELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 228
T Y D+WS+G I E+ +P N L KI +
Sbjct: 192 ETMKDTPYDYKADIWSLG-ITLIEMAQIEPPHHELNPMRVLLKI---------------A 235
Query: 229 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 279
K P+ + FR F L+ L +P R SA L
Sbjct: 236 KSDP-----PTLLTPSKWSVEFRDF-------LKIALDKNPETRPSAAQLL 274
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-32
Identities = 73/325 (22%), Positives = 135/325 (41%), Gaps = 70/325 (21%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A +TG+IVA+K++ ++++ + I+EI I+++ +V+K
Sbjct: 48 AIHKETGQIVAIKQVPVESDLQEI----IKEISIMQQCDSPHVVKYY------------- 90
Query: 62 GRPDGNKYRGST-YMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 116
G+ ++ + ++V EY D+ L ++ T +I ++ L GL Y H
Sbjct: 91 ----GSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT---LTEDEIATILQSTLKGLEYLHF 143
Query: 117 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLWYRPPELLLG 173
+ +HRDIK N+L++ EG+ KLADFG + +T+ R + T ++ PE++
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFG----VAGQLTDTMAKRNTVIGTPFWMAPEVIQE 199
Query: 174 ATKYGPAVDMWSVGCIFA-ELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 232
Y D+WS+G I A E+ GKP + + I P
Sbjct: 200 IG-YNCVADIWSLG-ITAIEMAEGKPPYADIHPMRAIFMI---------------PTNPP 242
Query: 233 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCD 292
P+ + F F +++ L+ P QR +A L + +
Sbjct: 243 -----PTFRKPELWSDNFTDF-------VKQCLVKSPEQRATATQLLQHPFVRS---AKG 287
Query: 293 PKSL-PKYESSHEYQTKKRRQQQRQ 316
L + + + K++ QQR+
Sbjct: 288 VSILRDLINEAMDVKLKRQESQQRE 312
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 72/327 (22%), Positives = 125/327 (38%), Gaps = 66/327 (20%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAI-REIKILKKLQHENVIKLKEIVTSPGPERDE 60
AR+++ E+VA+KK+ ++ I +E++ L+KL+H N I+ +
Sbjct: 73 ARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR------------ 120
Query: 61 QGRPDGNKYRGST-YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQV 119
G R T ++V EY + L + +I L GL Y H + +
Sbjct: 121 -----GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 175
Query: 120 LHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLWYRPPELLLGATK 176
+HRD+K N+L+ G +KL DFG A + + V T ++ PE++L +
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAPANSFVGTPYWMAPEVILAMDE 227
Query: 177 --YGPAVDMWSVGCIFA-ELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 233
Y VD+WS+G I EL KP L N L I ++
Sbjct: 228 GQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHI---------------AQNE-- 269
Query: 234 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDP 293
E FR+F ++ L P R +++ L + P
Sbjct: 270 ----SPALQSGHWSEYFRNF-------VDSCLQKIPQDRPTSEVLLKHRFVLR---ERPP 315
Query: 294 KSL-PKYESSHEYQTKKRRQQQRQHEE 319
+ + + + + Q R+ ++
Sbjct: 316 TVIMDLIQRTKDAVRELDNLQYRKMKK 342
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 45/325 (13%), Positives = 89/325 (27%), Gaps = 57/325 (17%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIR-EIKILKKLQ----------HENVIKLKEI 50
A + +TGE + I ++ E+ L+ L+ H I ++
Sbjct: 97 ATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156
Query: 51 VTSPGPERDEQGRPDGNKYR-GSTYMVFEYMDHDLTGLAD------RPGLRFTVPQIKCY 103
V P ++ + R D S + ++ M +L +
Sbjct: 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQL 216
Query: 104 MKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL 163
Q++ L H ++H ++ ++++D G + L F + +
Sbjct: 217 TLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPP 276
Query: 164 WYRPPELLLGA----TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSP 219
+L T A D W++G + IF C
Sbjct: 277 ETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSC--- 333
Query: 220 DETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 279
+P LLE L R+ A+
Sbjct: 334 --------KNIPQP-----------------------VRALLEGFLRYPKEDRLLPLQAM 362
Query: 280 DSEYFWTDPLPCDPKSLPKYESSHE 304
++ + +LP Y++ E
Sbjct: 363 ETP-EYEQLRTELSAALPLYQTDGE 386
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-32
Identities = 72/288 (25%), Positives = 127/288 (44%), Gaps = 68/288 (23%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A ++ TG+ VA++++ + + + I I EI ++++ ++ N++
Sbjct: 39 AMDVATGQEVAIRQMNLQQQPKKELI--INEILVMRENKNPNIVN--------------- 81
Query: 62 GRPDGNKYRGSTY------MVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 114
Y S +V EY+ LT + QI ++ L L +
Sbjct: 82 -------YLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFL 132
Query: 115 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTLTNRVITLWYRPPELLL 172
H NQV+HRDIK N+L+ +G++KL DFG + + + +T+ V T ++ PE++
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM---VGTPYWMAPEVVT 189
Query: 173 GATKYGPAVDMWSVGCIFA-ELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 231
YGP VD+WS+G I A E++ G+P P NE L ++ + +
Sbjct: 190 R-KAYGPKVDIWSLG-IMAIEMIEGEP--PYLNE-NPLRALYLIATNG------------ 232
Query: 232 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 279
P ++ +FR F L + L +D +R SAK+ L
Sbjct: 233 -----TPELQNPEKLSAIFRDF-------LNRCLEMDVEKRGSAKELL 268
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 7e-32
Identities = 45/297 (15%), Positives = 101/297 (34%), Gaps = 44/297 (14%)
Query: 3 REIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQG 62
+ K + LK + N E F I + ++ LK +K
Sbjct: 90 NDAKNKQKFVLKVQKPANPWE-FYIG-TQLMERLKPSMQHMFMKFYSAH----------- 136
Query: 63 RPDGNKYRGSTYMVFEYMDHD-----LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 117
++ + +V E + + + P + + ++L + H
Sbjct: 137 -----LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC 191
Query: 118 QVLHRDIKGSNLLI-----------DNEGNLKLADFGLARSFS-YDHNNTLTNRVITLWY 165
+++H DIK N ++ D L L D G + + T + T +
Sbjct: 192 EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGF 251
Query: 166 RPPELLLGATKYGPAVDMWSVGCIFAELLNGKPI-LPGKNEAEQLSKIFELCGSPDETIW 224
+ E+L + +D + V +L G + + + + +F P +W
Sbjct: 252 QCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFR--RLPHLDMW 308
Query: 225 PGVSK----MPAYNHFKPSRTMKRRVREVF-RHFDRHALELLEKMLMLDPSQRISAK 276
+P +H +++++++VF +H+ L ++++L + S K
Sbjct: 309 NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 365
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 72/288 (25%), Positives = 123/288 (42%), Gaps = 68/288 (23%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
ARE +G VA+K + + ++ + E+ I++ QH NV++
Sbjct: 64 AREKHSGRQVAVKMMDLRKQQRRELL--FNEVVIMRDYQHFNVVE--------------- 106
Query: 62 GRPDGNKYRGSTY------MVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 114
S ++ E++ LT + + +R QI + +L L Y
Sbjct: 107 -------MYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYL 157
Query: 115 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTLTNRVITLWYRPPELLL 172
H V+HRDIK ++L+ +G +KL+DFG S D +L V T ++ PE++
Sbjct: 158 HAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL---VGTPYWMAPEVIS 214
Query: 173 GATKYGPAVDMWSVGCIFA-ELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 231
+ Y VD+WS+G I E+++G+P P ++ + + L SP
Sbjct: 215 R-SLYATEVDIWSLG-IMVIEMVDGEP--PYFSD-SPVQAMKRLRDSP------------ 257
Query: 232 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 279
P +V V R F LE+ML+ DP +R +A++ L
Sbjct: 258 -----PPKLKNSHKVSPVLRDF-------LERMLVRDPQERATAQELL 293
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 3e-31
Identities = 70/364 (19%), Positives = 125/364 (34%), Gaps = 103/364 (28%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ--------HENVIKLKEIVT 52
++ +I+ + VA+K ++ E + TA+ EI++LK ++ E V++L +
Sbjct: 55 LSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111
Query: 53 SPGPERDEQGRPDGNKYRGS-TYMVFEYMDHDLTGLADR-PGLRFTVPQIKCYMKQLLTG 110
G G+ MVFE + H L + +P +K ++Q+L G
Sbjct: 112 ISGVN-------------GTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQG 158
Query: 111 LHYCH-VNQVLHRDIKGSNLLIDNE----------------------------------- 134
L Y H +++H DIK N+L+
Sbjct: 159 LDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 135 --------------GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 180
+K+AD G A + T YR E+L+G+ Y
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----TRQYRSLEVLIGS-GYNTP 273
Query: 181 VDMWSVGCIFAELLNGKPILPGKN------EAEQLSKIFELCGSPDETIWPGVSKMPAY- 233
D+WS C+ EL G + + + + ++ I EL G + +
Sbjct: 274 ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFF 333
Query: 234 ---------NHFKPSRTMKRRVREVFRHFDRH----ALELLEKMLMLDPSQRISAKDALD 280
KP + V + + + + L ML L P +R +A + L
Sbjct: 334 TKKGDLKHITKLKPWGLFEVLVEK--YEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391
Query: 281 SEYF 284
+
Sbjct: 392 HPWL 395
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-31
Identities = 63/303 (20%), Positives = 116/303 (38%), Gaps = 46/303 (15%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
+G ++A K I ++ + IRE+++L + ++
Sbjct: 52 VSHKPSGLVMARKLIHLEIKPAIR-NQIIRELQVLHECNSPYIVGFY------------- 97
Query: 62 GRPDGNKYRGST-YMVFEYMDHDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVN 117
G Y + E+MD G D + R + ++ GL Y
Sbjct: 98 ----GAFYSDGEISICMEHMD---GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 150
Query: 118 -QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLGAT 175
+++HRD+K SN+L+++ G +KL DFG++ +++ N + T Y PE L G T
Sbjct: 151 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQG-T 205
Query: 176 KYGPAVDMWSVGCIFAELLNGK-PILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234
Y D+WS+G E+ G+ PI P + +L ++ G ET + N
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265
Query: 235 HFKPSRTMKRRVREVFRH-------------FDRHALELLEKMLMLDPSQRISAKDALDS 281
F + E+ + F + + K L+ +P++R K +
Sbjct: 266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325
Query: 282 EYF 284
+
Sbjct: 326 AFI 328
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 59/301 (19%), Positives = 108/301 (35%), Gaps = 61/301 (20%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A E VA+K+I ++ + ++EI+ + + H N++
Sbjct: 34 AYCAPKKEKVAIKRINLEKCQTSM-DELLKEIQAMSQCHHPNIVS--------------- 77
Query: 62 GRPDGNKYRGS------TYMVFEYMD----HDLTGLADRPGLR----FTVPQIKCYMKQL 107
Y S ++V + + D+ G I ++++
Sbjct: 78 -------YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 108 LTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRP 167
L GL Y H N +HRD+K N+L+ +G++++ADFG++ + + T T P
Sbjct: 131 LEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 168 ----PELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETI 223
PE++ Y D+WS G EL G + L + + ++
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ---NDPPSL 247
Query: 224 WPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 283
GV + S FR + L DP +R +A + L ++
Sbjct: 248 ETGVQDKEMLKKYGKS----------FRKM-------ISLCLQKDPEKRPTAAELLRHKF 290
Query: 284 F 284
F
Sbjct: 291 F 291
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-29
Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 38/206 (18%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
+ +T ++VA+K I ++ ++ +EI +L + V K
Sbjct: 41 GIDNRTQKVVAIKIIDLEEAEDEI-EDIQQEITVLSQCDSPYVTKYY------------- 86
Query: 62 GRPDGNKYRGST-YMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 116
G+ + + +++ EY+ DL PG QI ++++L GL Y H
Sbjct: 87 ----GSYLKDTKLWIIMEYLGGGSALDLL----EPG-PLDETQIATILREILKGLDYLHS 137
Query: 117 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLWYRPPELLLG 173
+ +HRDIK +N+L+ G +KLADFG+A + +T R V T ++ PE++
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT----DTQIKRNTFVGTPFWMAPEVIKQ 193
Query: 174 ATKYGPAVDMWSVGCIFA-ELLNGKP 198
+ Y D+WS+G I A EL G+P
Sbjct: 194 SA-YDSKADIWSLG-ITAIELARGEP 217
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 70/331 (21%), Positives = 123/331 (37%), Gaps = 62/331 (18%)
Query: 8 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 67
+ VA+K+I ++E++ F I E++ L ++ H N++KL +P
Sbjct: 31 AKDVAIKQIESESERKAF----IVELRQLSRVNHPNIVKLYGACLNP------------- 73
Query: 68 KYRGSTYMVFEYMDH-DLTGL--ADRPGLRFTVPQIKCYMKQLLTGLHYCH---VNQVLH 121
+V EY + L + P +T + Q G+ Y H ++H
Sbjct: 74 -----VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 122 RDIKGSNLLIDNEGN-LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 180
RD+K NLL+ G LK+ DFG A D +TN + + PE+ G + Y
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEG-SNYSEK 183
Query: 181 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240
D++S G I E++ + P F+ G P I V +N +P
Sbjct: 184 CDVFSWGIILWEVITRR--KP-----------FDEIGGPAFRIMWAV-----HNGTRP-- 223
Query: 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS-EYFWTDPLPCDPKSLPKY 299
+ ++ + L+ + DPSQR S ++ + + D
Sbjct: 224 -------PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPC 276
Query: 300 ESSHEYQTKKRRQQQRQHEEATKRQKLHHPQ 330
+ S R + E + + H +
Sbjct: 277 QHSLPPGEDGRVEPYVDFAEFYRLWSVDHGE 307
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 8e-29
Identities = 70/331 (21%), Positives = 129/331 (38%), Gaps = 62/331 (18%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDE 60
R +KTG++ A+K + + ++E +EI +LKK H N+ P +
Sbjct: 43 GRHVKTGQLAAIKVMDVTGDEEE---EIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 99
Query: 61 QGRPDGNKYRGSTYMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 116
++V E+ DL + + G I +++L GL + H
Sbjct: 100 D----------QLWLVMEFCGAGSVTDL--IKNTKGNTLKEEWIAYICREILRGLSHLHQ 147
Query: 117 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLWYRPPELLLG 173
++V+HRDIKG N+L+ +KL DFG++ T+ R + T ++ PE++
Sbjct: 148 HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD----RTVGRRNTFIGTPYWMAPEVIAC 203
Query: 174 ATK----YGPAVDMWSVGCIFA-ELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 228
Y D+WS+G I A E+ G P L + L I
Sbjct: 204 DENPDATYDFKSDLWSLG-ITAIEMAEGAPPLCDMHPMRALFLI---------------P 247
Query: 229 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 288
+ P R ++ + F+ F +E L+ + SQR + + + + P
Sbjct: 248 RNP------APRLKSKKWSKKFQSF-------IESCLVKNHSQRPATEQLMKHPFIRDQP 294
Query: 289 LPCDPKSLPKYESSHEYQTKKRRQQQRQHEE 319
+ K + + K+ + + ++E
Sbjct: 295 NERQVRIQLK-DHIDRTKKKRGEKDETEYEY 324
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 65/288 (22%), Positives = 117/288 (40%), Gaps = 57/288 (19%)
Query: 1 MAREIKTGEIVALK---KIRMDNEKEGFPITAIR-EIKILKKLQHENVIKLKEIVTSPGP 56
+ARE+ T A+K K + E + + + E ++ +L H +KL
Sbjct: 48 LARELATSREYAIKILEKRHIIKENK---VPYVTRERDVMSRLDHPFFVKLY------FT 98
Query: 57 ERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 115
+D++ Y Y + +L + G F + Y ++++ L Y H
Sbjct: 99 FQDDE----------KLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH 147
Query: 116 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR-VITLWYRPPELLLGA 174
++HRD+K N+L++ + ++++ DFG A+ S + N V T Y PELL
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE- 206
Query: 175 TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234
+ D+W++GCI +L+ G P NE KI + E +P
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-----LEYDFP--------- 252
Query: 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSE 282
F A +L+EK+L+LD ++R+ ++
Sbjct: 253 ----------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYG 284
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 60/296 (20%), Positives = 100/296 (33%), Gaps = 66/296 (22%)
Query: 1 MAREIKTGEIVALKKIR-----MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 55
+ + +TG++ A+K + E F E +L + +L
Sbjct: 79 VVKMKQTGQVYAMKIMNKWDMLKRGEVSCF----REERDVLVNGDRRWITQLH------- 127
Query: 56 PERDEQGRPDGNKY----RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTG 110
+ Y+V EY DL L + G R + Y+ +++
Sbjct: 128 -------------FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMA 174
Query: 111 LHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPEL 170
+ H +HRDIK N+L+D G+++LADFG D V T Y PE+
Sbjct: 175 IDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEI 234
Query: 171 LLG------ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 224
L YGP D W++G E+ G+ + AE KI +
Sbjct: 235 LQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH---------Y 285
Query: 225 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280
+P + A + +++ L+ P R+ A D
Sbjct: 286 KEHLSLPLVD----------------EGVPEEARDFIQR-LLCPPETRLGRGGAGD 324
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 39/202 (19%), Positives = 82/202 (40%), Gaps = 21/202 (10%)
Query: 11 VALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 70
VA+K + + E+ +L+K +H N++ T+P
Sbjct: 49 VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP---------------- 92
Query: 71 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 129
+V ++ + L +F + ++ +Q G+ Y H ++HRD+K +N+
Sbjct: 93 -QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNI 151
Query: 130 LIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLG--ATKYGPAVDMWSV 186
+ + +K+ DFGLA S + ++ + PE++ + Y D+++
Sbjct: 152 FLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAF 211
Query: 187 GCIFAELLNGKPILPGKNEAEQ 208
G + EL+ G+ N +Q
Sbjct: 212 GIVLYELMTGQLPYSNINNRDQ 233
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 58/289 (20%), Positives = 114/289 (39%), Gaps = 63/289 (21%)
Query: 1 MAREIKTGEIVALKKIR-----MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 55
+ TG++ A KK+ +G A+ E KIL K+ ++ L +
Sbjct: 203 ACQMKATGKLYACKKLNKKRLKKRKGYQG----AMVEKKILAKVHSRFIVSLAYAFETKT 258
Query: 56 PERDEQGRPDGNKYRGSTYMVFEYMD------HDLTGLADRPGLRFTVPQIKCYMKQLLT 109
+V M+ H + + + F P+ Y Q+++
Sbjct: 259 ----------------DLCLVMTIMNGGDIRYH-IYNVDEDNP-GFQEPRAIFYTAQIVS 300
Query: 110 GLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPE 169
GL + H +++RD+K N+L+D++GN++++D GLA T T + PE
Sbjct: 301 GLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-YAGTPGFMAPE 359
Query: 170 LLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 229
LLLG +Y +VD +++G E++ + + E + ++ +
Sbjct: 360 LLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ--------------- 403
Query: 230 MPAYNHFKPSRTMKRRVREVF-RHFDRHALELLEKMLMLDPSQRISAKD 277
R +++ V + F + + E +L DP +R+ +D
Sbjct: 404 ----------RVLEQAVT--YPDKFSPASKDFCEALLQKDPEKRLGFRD 440
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-27
Identities = 57/294 (19%), Positives = 99/294 (33%), Gaps = 69/294 (23%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAI-REIKILKKL-QHENVIK-----LKEIVTSP 54
R KTG ++A+K++R KE I ++ ++ K +++ +
Sbjct: 44 MRFRKTGHVIAVKQMRRSGNKE--ENKRILMDLDVVLKSHDCPYIVQCFGTFITN----- 96
Query: 55 GPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 114
++ E M L R + ++ L+Y
Sbjct: 97 ----------------TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYL 140
Query: 115 H-VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTL--TNRVITLWYRPPE-- 169
+ V+HRD+K SN+L+D G +KL DFG++ + Y PE
Sbjct: 141 KEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV----DDKAKDRSAGCAAYMAPERI 196
Query: 170 --LLLGATKYGPAVDMWSVGCIFAELLNGKPILPG-KNEAEQLSKIFELCGSPDETIWPG 226
Y D+WS+G EL G+ K + E L+K+ + P P
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EEP-----P- 248
Query: 227 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280
+P + F F+ F ++ L D +R L+
Sbjct: 249 --LLPGHMGFSGD----------FQSF-------VKDCLTKDHRKRPKYNKLLE 283
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 55/301 (18%), Positives = 100/301 (33%), Gaps = 74/301 (24%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAI-REIKILKKL-QHENVIKLKEIVTSPGPERD 59
R + +G+I+A+K+IR + + ++ I + +
Sbjct: 26 MRHVPSGQIMAVKRIRATVNSQ--EQKRLLMDLDISMRTVDCPFTVTFY----------- 72
Query: 60 EQGRPDGNKYRGST-YMVFEYMDHDLTGLAD------RPGLRFTVPQIKCYMKQLLTGLH 112
G +R ++ E MD T L G + ++ L
Sbjct: 73 ------GALFREGDVWICMELMD---TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 123
Query: 113 YCHVN-QVLHRDIKGSNLLIDNEGNLKLADFG----LARSFSYDHNNTLTNRVITLWYRP 167
+ H V+HRD+K SN+LI+ G +K+ DFG L + D + Y
Sbjct: 124 HLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID------AGCKPYMA 177
Query: 168 PELLLG---ATKYGPAVDMWSVGCIFAELLNGKPILPG-KNEAEQLSKIFELCGSPDETI 223
PE + Y D+WS+G EL + +QL ++ +
Sbjct: 178 PERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV--VEEPS---- 231
Query: 224 WPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 283
P ++PA + F F F + L + +R + + + +
Sbjct: 232 -P---QLPA-DKFSAE----------FVDF-------TSQCLKKNSKERPTYPELMQHPF 269
Query: 284 F 284
F
Sbjct: 270 F 270
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 48/227 (21%), Positives = 89/227 (39%), Gaps = 41/227 (18%)
Query: 2 AREIKTGEIVALKKIRMD-NEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERD 59
+G+I+A+K+IR +EKE + + ++ ++ + +++
Sbjct: 41 MVHKPSGQIMAVKRIRSTVDEKEQKQL--LMDLDVVMRSSDCPYIVQFY----------- 87
Query: 60 EQGRPDGNKYRGST-YMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 114
G +R ++ E M + + + L++
Sbjct: 88 ------GALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL 141
Query: 115 HVN-QVLHRDIKGSNLLIDNEGNLKLADFG----LARSFSYDHNNTLTNRVITLWYRPPE 169
N +++HRDIK SN+L+D GN+KL DFG L S + T Y PE
Sbjct: 142 KENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA------KTRDAGCRPYMAPE 195
Query: 170 LLLGATK---YGPAVDMWSVGCIFAELLNGKPILPG-KNEAEQLSKI 212
+ + Y D+WS+G EL G+ P + +QL+++
Sbjct: 196 RIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV 242
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-26
Identities = 47/212 (22%), Positives = 88/212 (41%), Gaps = 37/212 (17%)
Query: 7 TGEIVALKKIRMDNEK--EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 64
TGE++ +K++ +E+ F ++E+K+++ L+H NV+K ++
Sbjct: 34 TGEVMVMKELIRFDEETQRTF----LKEVKVMRCLEHPNVLKFIGVLYKDKR-------- 81
Query: 65 DGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 123
+ EY+ L G+ ++ Q + K + +G+ Y H ++HRD
Sbjct: 82 --------LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRD 133
Query: 124 IKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRP-------------PEL 170
+ N L+ N+ +ADFGLAR + R + R PE+
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 171 LLGATKYGPAVDMWSVGCIFAELLNGKPILPG 202
+ G Y VD++S G + E++ P
Sbjct: 194 ING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 1e-25
Identities = 51/322 (15%), Positives = 86/322 (26%), Gaps = 65/322 (20%)
Query: 3 REIKTGEIVALKKIRMDN------EKEGFPITAIREIKILKKLQ---------HENVIKL 47
+ I VA+K I ++ + + EI I K+L E I L
Sbjct: 38 QTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97
Query: 48 KE--IVTSPGPERDEQGRPDGNKYRGS------------TYMVFEYMDHDLTGLADRPGL 93
V P + N +GS ++V E+ L
Sbjct: 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGG-IDLEQMRTK 156
Query: 94 RFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 152
++ K + QL L + + HRD+ N+L+ KL +S +
Sbjct: 157 LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPS 216
Query: 153 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 212
L + Y + +F ++ + + G + + I
Sbjct: 217 CG---------------LQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTG--DGDYQFDI 259
Query: 213 FELCGSPDETIWPGVSKMPAYNHF----------KPSRTMKRRVREVFRHFDRHALELLE 262
+ L + W P N K + + R E
Sbjct: 260 YRLMKKENNNRWGEYH--PYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHR 317
Query: 263 KMLMLDPSQRISAKDALDSEYF 284
ML SA D L
Sbjct: 318 TMLNFS-----SATDLLCQHSL 334
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 39/206 (18%), Positives = 78/206 (37%), Gaps = 36/206 (17%)
Query: 6 KTGEIVALKKIRMDNEKEGFPITAI-----REIKILKKLQHENVIKLKEIVTSPGPERDE 60
K +VA+K + + + + + RE+ I+ L H N++KL ++ +P
Sbjct: 42 KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP------ 95
Query: 61 QGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN-- 117
MV E++ DL M + G+ Y
Sbjct: 96 ------------PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNP 143
Query: 118 QVLHRDIKGSNLLIDNEG-----NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL 172
++HRD++ N+ + + K+ADFGL++ ++++ + + PE +
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQWMAPETIG 199
Query: 173 GATK-YGPAVDMWSVGCIFAELLNGK 197
+ Y D +S I +L G+
Sbjct: 200 AEEESYTEKADTYSFAMILYTILTGE 225
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 58/294 (19%), Positives = 98/294 (33%), Gaps = 64/294 (21%)
Query: 1 MAREIKTGEIVALKKIR-----MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 55
+ + ++ A+K + E F E +L + + L
Sbjct: 92 VVKLKNADKVFAMKILNKWEMLKRAETACF----REERDVLVNGDSKWITTLH------- 140
Query: 56 PERDEQGRPDGNKY----RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTG 110
Y + Y+V +Y DL L + R + Y+ +++
Sbjct: 141 -------------YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIA 187
Query: 111 LHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPEL 170
+ H +HRDIK N+L+D G+++LADFG D + V T Y PE+
Sbjct: 188 IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 247
Query: 171 LL----GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPG 226
L G +YGP D WS+G E+L G+ ++ E KI
Sbjct: 248 LQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN---------HKE 298
Query: 227 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280
+ P +A +L+ + L+ R+ D
Sbjct: 299 RFQFPTQ----------------VTDVSENAKDLIRR-LICSREHRLGQNGIED 335
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 49/207 (23%), Positives = 87/207 (42%), Gaps = 42/207 (20%)
Query: 8 GEIVALKKIRMDNEKEGFPITA--IREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPD 65
G+ VA+K R D +++ +E K+ L+H N+I L+ +
Sbjct: 30 GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN--------- 80
Query: 66 GNKYRGSTYMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH---VNQ 118
+V E+ + + L+ + R + + Q+ G++Y H +
Sbjct: 81 -------LCLVMEFARGGPLNRV--LSGK---RIPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 119 VLHRDIKGSNLLIDNEG--------NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPEL 170
++HRD+K SN+LI + LK+ DFGLAR H T + + PE+
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTTKMSAAGAYAWMAPEV 185
Query: 171 LLGATKYGPAVDMWSVGCIFAELLNGK 197
+ + + D+WS G + ELL G+
Sbjct: 186 IRA-SMFSKGSDVWSYGVLLWELLTGE 211
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 44/243 (18%), Positives = 89/243 (36%), Gaps = 50/243 (20%)
Query: 11 VALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYR 70
VA++ I ++ + E RE+ ++ +HENV+ SP
Sbjct: 58 VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH-------------- 103
Query: 71 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 129
++ L + + V + + ++++ G+ Y H +LH+D+K N+
Sbjct: 104 --LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNV 161
Query: 130 LIDNEGNLKLADFGLAR----SFSYDHNNTLTNRVITLWYRPPELLLGATK--------Y 177
DN G + + DFGL + + L + L + PE++ + +
Sbjct: 162 FYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPF 220
Query: 178 GPAVDMWSVGCIFAELL--------------------NGKPILPGKNEAEQLSKIFELCG 217
D++++G I+ EL KP L +++S I C
Sbjct: 221 SKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCW 280
Query: 218 SPD 220
+ +
Sbjct: 281 AFE 283
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-25
Identities = 53/280 (18%), Positives = 107/280 (38%), Gaps = 58/280 (20%)
Query: 1 MAREIKTGEIVALKKIR-----MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 55
+ TG++ A KK+ + A+ E +IL+K+ V+ L +
Sbjct: 202 ACQVRATGKMYACKKLEKKRIKKRKGEAM----ALNEKQILEKVNSRFVVSLAYAYETKD 257
Query: 56 PERDEQGRPDGNKYRGSTYMVFEYMDH-DL-TGLADRPGLRFTVPQIKCYMKQLLTGLHY 113
+ +V M+ DL + F + Y ++ GL
Sbjct: 258 ----------------ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLED 301
Query: 114 CHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG 173
H ++++RD+K N+L+D+ G+++++D GLA T+ RV T+ Y PE++
Sbjct: 302 LHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTIKGRVGTVGYMAPEVVKN 359
Query: 174 ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 233
+Y + D W++GC+ E++ G+ + + + ++
Sbjct: 360 -ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER------------------- 399
Query: 234 NHFKPSRTMKRRVREVF-RHFDRHALELLEKMLMLDPSQR 272
+ + F A L ++L DP++R
Sbjct: 400 ------LVKEVPEE--YSERFSPQARSLCSQLLCKDPAER 431
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-25
Identities = 29/198 (14%), Positives = 66/198 (33%), Gaps = 30/198 (15%)
Query: 8 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 67
G + +K +++ + E L+ H NV+ + SP P +
Sbjct: 33 GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---------PAPH 83
Query: 68 KYRGSTYMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV--NQVLH 121
++ +M +++ L + Q + + G+ + H +
Sbjct: 84 -----PTLITHWMPYGSLYNV--LHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPR 136
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG--ATKYGP 179
+ +++ID + +++ + SF R+ + PE L
Sbjct: 137 HALNSRSVMIDEDMTARISMADVKFSFQS------PGRMYAPAWVAPEALQKKPEDTNRR 190
Query: 180 AVDMWSVGCIFAELLNGK 197
+ DMWS + EL+ +
Sbjct: 191 SADMWSFAVLLWELVTRE 208
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 59/286 (20%), Positives = 107/286 (37%), Gaps = 66/286 (23%)
Query: 1 MAREIKTGEIVALK-----KIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 55
+ ++ T ++ A+K K NE +E++I++ L+H ++ L
Sbjct: 33 IVQKNDTKKMYAMKYMNKQKCVERNEVRN----VFKELQIMQGLEHPFLVNLW------- 81
Query: 56 PERDEQGRPDGNKY----RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTG 110
Y +MV + + DL + F +K ++ +L+
Sbjct: 82 -------------YSFQDEEDMFMVVDLLLGGDLRYHLQQNV-HFKEETVKLFICELVMA 127
Query: 111 LHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPEL 170
L Y +++HRD+K N+L+D G++ + DF +A + +T T Y PE+
Sbjct: 128 LDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--TQITTMAGTKPYMAPEM 185
Query: 171 LL--GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 228
Y AVD WS+G ELL G+ ++ + +I V
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS-STSSKEIVHT-------FETTVV 237
Query: 229 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS 274
P + + + LL+K+L +P QR S
Sbjct: 238 TYP-------------------SAWSQEMVSLLKKLLEPNPDQRFS 264
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-24
Identities = 50/221 (22%), Positives = 89/221 (40%), Gaps = 39/221 (17%)
Query: 8 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 67
E VA+K + +++ E+ L ++HEN+++ + + +++G
Sbjct: 47 NEYVAVKIFPIQDKQSWQ---NEYEVYSLPGMKHENILQF---IGA-----EKRGTSVDV 95
Query: 68 KYRGSTYMVFEYMDHDLTG-LADRPGLRFTVPQIKCYMKQLLT---GLHYCHVNQ----- 118
+++ + + G L+D L+ V T GL Y H +
Sbjct: 96 DL----WLITAFHEK---GSLSDF--LKANVVSWNELCHIAETMARGLAYLHEDIPGLKD 146
Query: 119 -----VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLL 172
+ HRDIK N+L+ N +ADFGLA F + T+ + T Y PE+L
Sbjct: 147 GHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLE 206
Query: 173 GA----TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQL 209
GA +DM+++G + EL + G + L
Sbjct: 207 GAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-24
Identities = 47/195 (24%), Positives = 81/195 (41%), Gaps = 23/195 (11%)
Query: 8 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 67
G VA+K + + +RE+ I+K+L+H N++ VT P
Sbjct: 60 GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN----------- 108
Query: 68 KYRGSTYMVFEYMDH-DLTGLADRPGLRFTVP--QIKCYMKQLLTGLHYCHVN--QVLHR 122
+V EY+ L L + G R + + + G++Y H ++HR
Sbjct: 109 -----LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHR 163
Query: 123 DIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVD 182
++K NLL+D + +K+ DFGL+R + + T + PE+L D
Sbjct: 164 NLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSD 221
Query: 183 MWSVGCIFAELLNGK 197
++S G I EL +
Sbjct: 222 VYSFGVILWELATLQ 236
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 43/194 (22%), Positives = 76/194 (39%), Gaps = 28/194 (14%)
Query: 8 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 67
G V LK + + A+ E + L ++ H +++++ V D G
Sbjct: 106 GRPVVLKGLVHSGD-AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG----- 159
Query: 68 KYRGSTYMVFEYMDHDLTG--LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIK 125
Y+V EY+ G L G + V + Y+ ++L L Y H +++ D+K
Sbjct: 160 ------YIVMEYVG----GQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLK 209
Query: 126 GSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLGATKYGPAVDMW 184
N+++ E LKL D G + T ++ PE++ A D++
Sbjct: 210 PENIMLTEEQ-LKLIDLGAVSRI------NSFGYLYGTPGFQAPEIVRTGP--TVATDIY 260
Query: 185 SVGCIFAELLNGKP 198
+VG A L P
Sbjct: 261 TVGRTLAALTLDLP 274
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 2e-23
Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 22/200 (11%)
Query: 2 AREIKTGEIVALKKIRMD-NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
A + VA+K I + EKE RE+ +L H+N++ + +E
Sbjct: 30 AEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS----MIDVD---EE 82
Query: 61 QGRPDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQV 119
Y+V EY++ L+ + G +V + Q+L G+ + H ++
Sbjct: 83 DDCY---------YLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHDMRI 132
Query: 120 LHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLGATKYG 178
+HRDIK N+LID+ LK+ DFG+A++ S + + T TN V+ T+ Y PE G
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEAT-D 190
Query: 179 PAVDMWSVGCIFAELLNGKP 198
D++S+G + E+L G+P
Sbjct: 191 ECTDIYSIGIVLYEMLVGEP 210
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 5e-23
Identities = 56/221 (25%), Positives = 80/221 (36%), Gaps = 31/221 (14%)
Query: 1 MAREIKTGEIVALKKIRMD-----NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 55
+ R T ++ A+K + ++ F E I+ V++L
Sbjct: 87 LVRHKSTRKVYAMKLLSKFEMIKRSDSAFF----WEERDIMAFANSPWVVQLFYAFQDDR 142
Query: 56 PERDEQGRPDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 114
YMV EYM DL L + Y +++ L
Sbjct: 143 ----------------YLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAI 184
Query: 115 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL-- 172
H +HRD+K N+L+D G+LKLADFG + + V T Y PE+L
Sbjct: 185 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 244
Query: 173 -GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 212
G YG D WSVG E+L G + SKI
Sbjct: 245 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 285
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-23
Identities = 57/284 (20%), Positives = 105/284 (36%), Gaps = 66/284 (23%)
Query: 1 MAREIKTGEIVALKKIR-----MDNEKEGFPITAIREIKILKKLQHEN---VIKLKEIVT 52
R+ TG++ A+K + M + A+ E +L + + ++ +
Sbjct: 207 GCRKADTGKMYAMKCLDKKRIKMKQGET----LALNERIMLSLVSTGDCPFIVCMSYAFH 262
Query: 53 SPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGL 111
+P + + M+ DL + G F+ ++ Y +++ GL
Sbjct: 263 TPD----------------KLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGL 305
Query: 112 HYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELL 171
+ H V++RD+K +N+L+D G+++++D GLA FS + V T Y PE+L
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA---SVGTHGYMAPEVL 362
Query: 172 LGATKYGPAVDMWSVGCIFAELLNGKP---ILPGKNEAEQLSKIFELCGSPDETIWPGVS 228
Y + D +S+GC+ +LL G K++ E P
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-----MAVELP--- 414
Query: 229 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR 272
F LLE +L D ++R
Sbjct: 415 ----------------------DSFSPELRSLLEGLLQRDVNRR 436
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 66/281 (23%), Positives = 115/281 (40%), Gaps = 66/281 (23%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREI-------KILKKLQHENVIKLKEIVTS 53
+ + ++G A+K + + +++I +IL+ + ++KL+
Sbjct: 59 LVKHKESGNHYAMKILDKQK------VVKLKQIEHTLNEKRILQAVNFPFLVKLE----- 107
Query: 54 PGPERDEQGRPDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLH 112
+D + YMV EY+ ++ R G RF+ P + Y Q++
Sbjct: 108 -FSFKDNS----------NLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFE 155
Query: 113 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL 172
Y H +++RD+K NLLID +G +++ DFG A+ TL T PE++L
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWTLCG---TPEALAPEIIL 211
Query: 173 GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 232
Y AVD W++G + E+ G P P A+Q +I+E I G + P
Sbjct: 212 S-KGYNKAVDWWALGVLIYEMAAGYP--P--FFADQPIQIYEK-------IVSGKVRFP- 258
Query: 233 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI 273
HF +LL +L +D ++R
Sbjct: 259 ------------------SHFSSDLKDLLRNLLQVDLTKRF 281
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 1e-22
Identities = 59/294 (20%), Positives = 96/294 (32%), Gaps = 48/294 (16%)
Query: 8 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 67
GE VA+K E F EI ++HEN++ +
Sbjct: 60 GEKVAVKVFFTTEEASWF---RETEIYQTVLMRHENILGFIAADIKGTGSWTQ------- 109
Query: 68 KYRGSTYMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ----- 118
Y++ +Y + +D L + ++GL + H
Sbjct: 110 -----LYLITDYHENGSLYDY--LKSTT---LDAKSMLKLAYSSVSGLCHLHTEIFSTQG 159
Query: 119 ---VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT---LTNRVITLWYRPPELLL 172
+ HRD+K N+L+ G +AD GLA F D N RV T Y PPE+L
Sbjct: 160 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLD 219
Query: 173 GAT-----KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 227
+ + DM+S G I E+ E + E + V
Sbjct: 220 ESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIV 279
Query: 228 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281
+PS + E R +L+ + +P+ R++A +
Sbjct: 280 ----CIKKLRPSFPNRWSSDECLRQM----GKLMTECWAHNPASRLTALRVKKT 325
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-22
Identities = 56/195 (28%), Positives = 89/195 (45%), Gaps = 26/195 (13%)
Query: 6 KTGEIVALKKIRMD--NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGR 63
TGE+VA+KK++ F REI+ILK LQH+N++K K + S G
Sbjct: 37 NTGEVVAVKKLQHSTEEHLRDF----EREIEILKSLQHDNIVKYKGVCYSAGRR------ 86
Query: 64 PDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHR 122
+ ++ EY+ + L + R ++ Y Q+ G+ Y + +HR
Sbjct: 87 --------NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHR 138
Query: 123 DIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTLTNRVITL-WYRPPELLLGATKYGP 179
D+ N+L++NE +K+ DFGL + D + WY PE L +K+
Sbjct: 139 DLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY-APESLT-ESKFSV 196
Query: 180 AVDMWSVGCIFAELL 194
A D+WS G + EL
Sbjct: 197 ASDVWSFGVVLYELF 211
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 3e-22
Identities = 69/290 (23%), Positives = 109/290 (37%), Gaps = 65/290 (22%)
Query: 1 MAREIKTGEIVA---LKK--IRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 55
+ RE TG A L+K I +E + E ++L+ +H + LK +
Sbjct: 23 LVREKATGRYYAMKILRKEVIIAKDEVA----HTVTESRVLQNTRHPFLTALKYAFQTHD 78
Query: 56 PERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 114
V EY + +L R FT + + Y ++++ L Y
Sbjct: 79 ----------------RLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYL 121
Query: 115 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI--TLWYRPPELLL 172
H V++RDIK NL++D +G++K+ DFGL + D T T Y PE+L
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT---FCGTPEYLAPEVLE 178
Query: 173 GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 232
YG AVD W +G + E++ G+ ++ I +E +P
Sbjct: 179 D-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-----EEIRFP------- 225
Query: 233 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI--SAKDALD 280
R A LL +L DP QR+ DA +
Sbjct: 226 ------------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE 257
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 5e-22
Identities = 50/200 (25%), Positives = 81/200 (40%), Gaps = 22/200 (11%)
Query: 2 AREIKTGEIVALKKIRMD-NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
A + IVALK + + F RE + +LQ +V+ P D
Sbjct: 53 AEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV----------PIHD- 101
Query: 61 QGRPDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQV 119
G DG Y+ ++ DL + R G P+ ++Q+ + L H
Sbjct: 102 FGEIDG-----QLYVDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAHAAGA 155
Query: 120 LHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLGATKYG 178
HRD+K N+L+ + L DFG+A + + D T + TL+Y PE +
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFSESHA-T 213
Query: 179 PAVDMWSVGCIFAELLNGKP 198
D++++ C+ E L G P
Sbjct: 214 YRADIYALTCVLYECLTGSP 233
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 6e-22
Identities = 56/195 (28%), Positives = 89/195 (45%), Gaps = 26/195 (13%)
Query: 6 KTGEIVALKKIRMD--NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGR 63
TGE+VA+KK++ F REI+ILK LQH+N++K K + S G
Sbjct: 68 NTGEVVAVKKLQHSTEEHLRDF----EREIEILKSLQHDNIVKYKGVCYSAGRR------ 117
Query: 64 PDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHR 122
+ ++ EY+ + L + R ++ Y Q+ G+ Y + +HR
Sbjct: 118 --------NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHR 169
Query: 123 DIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTLTNRVITL-WYRPPELLLGATKYGP 179
D+ N+L++NE +K+ DFGL + D + WY PE L +K+
Sbjct: 170 DLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY-APESLT-ESKFSV 227
Query: 180 AVDMWSVGCIFAELL 194
A D+WS G + EL
Sbjct: 228 ASDVWSFGVVLYELF 242
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 7e-22
Identities = 48/201 (23%), Positives = 91/201 (45%), Gaps = 29/201 (14%)
Query: 74 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 132
+++ +Y++ +L + RFT +++ Y+ +++ L + H +++RDIK N+L+D
Sbjct: 135 HLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD 193
Query: 133 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK-YGPAVDMWSVGCIFA 191
+ G++ L DFGL++ F D + T+ Y P+++ G + AVD WS+G +
Sbjct: 194 SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMY 253
Query: 192 ELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFR 251
ELL G E ++I I P +
Sbjct: 254 ELLTGASPFTVDGEKNSQAEISRR-------ILKSEPPYP-------------------Q 287
Query: 252 HFDRHALELLEKMLMLDPSQR 272
A +L++++LM DP +R
Sbjct: 288 EMSALAKDLIQRLLMKDPKKR 308
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 34/205 (16%)
Query: 74 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 132
+ V EY++ DL +F + + Y +++ GL + H +++RD+K N+L+D
Sbjct: 94 FFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD 152
Query: 133 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 192
+G++K+ADFG+ + T T T Y PE+LLG KY +VD WS G + E
Sbjct: 153 KDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYE 210
Query: 193 LLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRH 252
+L G+ G++E E I D +P R
Sbjct: 211 MLIGQSPFHGQDEEELFHSIRM-----DNPFYP-------------------------RW 240
Query: 253 FDRHALELLEKMLMLDPSQRISAKD 277
++ A +LL K+ + +P +R+ +
Sbjct: 241 LEKEAKDLLVKLFVREPEKRLGVRG 265
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 3e-21
Identities = 63/277 (22%), Positives = 108/277 (38%), Gaps = 60/277 (21%)
Query: 1 MAREIKTGEIVALKKIRMDN---EKEGFPITAIR-EIKILKKLQHENVIKLKEIVTSPGP 56
+ R G A+K ++ + K+ + E +L + H +I++ G
Sbjct: 24 LIRSRHNGRYYAMKVLKKEIVVRLKQ---VEHTNDERLMLSIVTHPFIIRMW------GT 74
Query: 57 ERDEQGRPDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 115
+D Q +M+ +Y++ +L L + RF P K Y ++ L Y H
Sbjct: 75 FQDAQ----------QIFMIMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH 123
Query: 116 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT 175
+++RD+K N+L+D G++K+ DFG A+ D TL T Y PE++
Sbjct: 124 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-DVTYTLCG---TPDYIAPEVVST-K 178
Query: 176 KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235
Y ++D WS G + E+L G N + KI E +P
Sbjct: 179 PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN-----AELRFP---------- 223
Query: 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR 272
F+ +LL +++ D SQR
Sbjct: 224 ---------------PFFNEDVKDLLSRLITRDLSQR 245
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 4e-21
Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 18/201 (8%)
Query: 2 AREIKTGEIVALKKIRMD-NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
AR+++ VA+K +R D F + RE + L H ++ V G
Sbjct: 31 ARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA----VYDTGEAETP 86
Query: 61 QGRPDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQV 119
G Y+V EY+D L + G T + + L++ H N +
Sbjct: 87 AGP--------LPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNGI 137
Query: 120 LHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN-TLTNRVI-TLWYRPPELLLGATKY 177
+HRD+K +N++I +K+ DFG+AR+ + N+ T T VI T Y PE G +
Sbjct: 138 IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV- 196
Query: 178 GPAVDMWSVGCIFAELLNGKP 198
D++S+GC+ E+L G+P
Sbjct: 197 DARSDVYSLGCVLYEVLTGEP 217
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 4e-21
Identities = 53/285 (18%), Positives = 104/285 (36%), Gaps = 42/285 (14%)
Query: 8 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 67
GE VA+K E+ EI L+HEN++ +
Sbjct: 65 GEEVAVKIFSSREERS---WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ------- 114
Query: 68 KYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ-------- 118
++V +Y +H L +R + TV + +GL + H+
Sbjct: 115 -----LWLVSDYHEHGSLFDYLNRYTV--TVEGMIKLALSTASGLAHLHMEIVGTQGKPA 167
Query: 119 VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT---LTNRVITLWYRPPELLLGAT 175
+ HRD+K N+L+ G +AD GLA + +RV T Y PE+L +
Sbjct: 168 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI 227
Query: 176 -----KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 230
+ D++++G +F E+ I + + + D ++ + K+
Sbjct: 228 NMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP---YYDLVPSDPSVEE-MRKV 283
Query: 231 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA 275
+P+ + + E R +++ + + + R++A
Sbjct: 284 VCEQKLRPNIPNRWQSCEALRVM----AKIMRECWYANGAARLTA 324
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 5e-21
Identities = 52/189 (27%), Positives = 85/189 (44%), Gaps = 27/189 (14%)
Query: 6 KTGEIVALKKIR---MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQG 62
TGE VA+K ++ N +EI+IL+ L HEN++K K I T G
Sbjct: 48 NTGEQVAVKSLKPESGGNHIADL----KKEIEILRNLYHENIVKYKGICTEDGGN----- 98
Query: 63 RPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
++ E++ L + + + Q Y Q+ G+ Y Q +H
Sbjct: 99 ---------GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVH 149
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTLTNRVITL-WYRPPELLLGATKYG 178
RD+ N+L+++E +K+ DFGL ++ D +R + WY PE L+ +K+
Sbjct: 150 RDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY-APECLM-QSKFY 207
Query: 179 PAVDMWSVG 187
A D+WS G
Sbjct: 208 IASDVWSFG 216
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 5e-21
Identities = 54/295 (18%), Positives = 99/295 (33%), Gaps = 52/295 (17%)
Query: 8 GEIVALKKIRMDNEKEGFPITAIREIKI--LKKLQHENVIKLKEIVTSPGPERDEQGRPD 65
GE VA+K +EK RE ++ L+HEN++ + +
Sbjct: 31 GENVAVKIFSSRDEKS-----WFRETELYNTVMLRHENILGFIASDMTSRHSSTQ----- 80
Query: 66 GNKYRGSTYMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ--- 118
+++ Y + +D L + + +GL + H+
Sbjct: 81 -------LWLITHYHEMGSLYDY--LQLTT---LDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 119 -----VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN---NTLTNRVITLWYRPPEL 170
+ HRD+K N+L+ G +AD GLA S N RV T Y PE+
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188
Query: 171 LLGAT-----KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWP 225
L VD+W+ G + E+ + + F D +
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP---FYDVVPNDPSFED 245
Query: 226 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280
+ K+ + +P+ + +L+++ +PS R++A
Sbjct: 246 -MRKVVCVDQQRPNIPNRWFSDPTLTSL----AKLMKECWYQNPSARLTALRIKK 295
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 7e-21
Identities = 64/289 (22%), Positives = 113/289 (39%), Gaps = 62/289 (21%)
Query: 1 MAREIKTGEIVALKKIR-----MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG 55
+ +E TG A+K ++ +E + E ++L+ +H + LK +
Sbjct: 166 LVKEKATGRYYAMKILKKEVIVAKDEVA----HTLTENRVLQNSRHPFLTALKYSFQTHD 221
Query: 56 PERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 114
V EY + +L R F+ + + Y ++++ L Y
Sbjct: 222 ----------------RLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYL 264
Query: 115 HVNQ-VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG 173
H + V++RD+K NL++D +G++K+ DFGL + D T T Y PE+L
Sbjct: 265 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLED 323
Query: 174 ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 233
YG AVD W +G + E++ G+ ++ + I +E +P
Sbjct: 324 -NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-----EEIRFP-------- 369
Query: 234 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI--SAKDALD 280
R A LL +L DP QR+ ++DA +
Sbjct: 370 -----------------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKE 401
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 8e-21
Identities = 55/292 (18%), Positives = 94/292 (32%), Gaps = 45/292 (15%)
Query: 8 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 67
VA+K N + + I + ++H+N+ + IV D +
Sbjct: 36 ERPVAVKVFSFANRQN---FINEKNIYRVPLMEHDNIARF--IVGDERVTADGRMEY--- 87
Query: 68 KYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH---------VN 117
+V EY + L + GL Y H
Sbjct: 88 ------LLVMEYYPNGSLXKYLSLHTS--DWVSSCRLAHSVTRGLAYLHTELPRGDHYKP 139
Query: 118 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH-------NNTLTNRVITLWYRPPEL 170
+ HRD+ N+L+ N+G ++DFGL+ + + +N + V T+ Y PE+
Sbjct: 140 AISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEV 199
Query: 171 LLGA------TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 224
L GA VDM+++G I+ E+ L + F+
Sbjct: 200 LEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNH---- 255
Query: 225 PGVSKMPAYNHFKPSR-TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA 275
P M + R +E E +E D R++A
Sbjct: 256 PTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLK-ETIEDCWDQDAEARLTA 306
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 1e-20
Identities = 46/191 (24%), Positives = 87/191 (45%), Gaps = 38/191 (19%)
Query: 94 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 153
F Y+ ++ L + H +++RD+K N++++++G++KL DFGL + +D
Sbjct: 117 IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT 176
Query: 154 NTLTNRVI--TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSK 211
T T T+ Y PE+L+ + + AVD WS+G + ++L G P G+N + + K
Sbjct: 177 VTHT---FCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDK 232
Query: 212 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ 271
I + + P + + A +LL+K+L + +
Sbjct: 233 ILK-----CKLNLP-------------------------PYLTQEARDLLKKLLKRNAAS 262
Query: 272 RISA--KDALD 280
R+ A DA +
Sbjct: 263 RLGAGPGDAGE 273
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 40/212 (18%)
Query: 74 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 132
Y V EY++ DL + G RF P Y ++ GL + +++RD+K N+++D
Sbjct: 97 YFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD 155
Query: 133 NEGNLKLADFGLARSFSYDHNNTLTNRVI--TLWYRPPELLLGATKYGPAVDMWSVGCIF 190
+EG++K+ADFG+ + +D T T T Y PE++ YG +VD W+ G +
Sbjct: 156 SEGHIKIADFGMCKENIWDGVTTKT---FCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLL 211
Query: 191 AELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVF 250
E+L G+ G++E E I E +P
Sbjct: 212 YEMLAGQAPFEGEDEDELFQSIME-----HNVAYP------------------------- 241
Query: 251 RHFDRHALELLEKMLMLDPSQRI--SAKDALD 280
+ + A+ + + ++ P +R+ + D
Sbjct: 242 KSMSKEAVAICKGLMTKHPGKRLGCGPEGERD 273
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 51/202 (25%), Positives = 88/202 (43%), Gaps = 38/202 (18%)
Query: 74 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 132
+ V E+++ DL + RF + + Y ++++ L + H +++RD+K N+L+D
Sbjct: 100 FFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLD 158
Query: 133 NEGNLKLADFGLARSFSYDHNNTLTNRVI--TLWYRPPELLLGATKYGPAVDMWSVGCIF 190
+EG+ KLADFG+ + + T T T Y PE+L YGPAVD W++G +
Sbjct: 159 HEGHCKLADFGMCKEGICNGVTTAT---FCGTPDYIAPEILQE-MLYGPAVDWWAMGVLL 214
Query: 191 AELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVF 250
E+L G +NE + I DE ++P
Sbjct: 215 YEMLCGHAPFEAENEDDLFEAILN-----DEVVYP------------------------- 244
Query: 251 RHFDRHALELLEKMLMLDPSQR 272
A +L+ + +P+ R
Sbjct: 245 TWLHEDATGILKSFMTKNPTMR 266
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 2e-20
Identities = 44/181 (24%), Positives = 73/181 (40%), Gaps = 36/181 (19%)
Query: 94 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 153
FT +K Y+ +L L + H +++RD+K N+L+D EG++KL DFGL++
Sbjct: 122 MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 181
Query: 154 NTLTNRVI--TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSK 211
+ T+ Y PE++ + + D WS G + E+L G GK+ E ++
Sbjct: 182 KAYS---FCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTM 237
Query: 212 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ 271
I L MP + A LL + +P+
Sbjct: 238 I--LKAKL---------GMP-------------------QFLSPEAQSLLRMLFKRNPAN 267
Query: 272 R 272
R
Sbjct: 268 R 268
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 8e-20
Identities = 52/195 (26%), Positives = 89/195 (45%), Gaps = 26/195 (13%)
Query: 6 KTGEIVALKKIRMD--NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGR 63
TG +VA+K+++ +++ F REI+ILK L + ++K + + PG +
Sbjct: 50 NTGALVAVKQLQHSGPDQQRDF----QREIQILKALHSDFIVKYRGVSYGPGRQ------ 99
Query: 64 PDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHR 122
S +V EY+ L R R ++ Y Q+ G+ Y + +HR
Sbjct: 100 --------SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHR 151
Query: 123 DIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTLTNRVITL-WYRPPELLLGATKYGP 179
D+ N+L+++E ++K+ADFGLA+ D + + WY PE L +
Sbjct: 152 DLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY-APESLS-DNIFSR 209
Query: 180 AVDMWSVGCIFAELL 194
D+WS G + EL
Sbjct: 210 QSDVWSFGVVLYELF 224
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 1e-19
Identities = 41/188 (21%), Positives = 80/188 (42%), Gaps = 26/188 (13%)
Query: 11 VALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 69
VA+K ++ D E E F ++E ++K+++H N+++L + T P
Sbjct: 248 VAVKTLKEDTMEVEEF----LKEAAVMKEIKHPNLVQLLGVCTREPP------------- 290
Query: 70 RGSTYMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 127
Y++ E+M + +L L + + + Q+ + + Y +HR++
Sbjct: 291 ---FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAAR 347
Query: 128 NLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL-WYRPPELLLGATKYGPAVDMWSV 186
N L+ +K+ADFGL+R + D + W P L K+ D+W+
Sbjct: 348 NCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAF 405
Query: 187 GCIFAELL 194
G + E+
Sbjct: 406 GVLLWEIA 413
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 28/207 (13%)
Query: 11 VALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 69
VA+K ++ E F ++E +++KKL+HE +++L +V+ P
Sbjct: 211 VAIKTLKPGTMSPEAF----LQEAQVMKKLRHEKLVQLYAVVS---------EEP----- 252
Query: 70 RGSTYMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 127
Y+V EYM L L G +PQ+ Q+ +G+ Y +HRD++ +
Sbjct: 253 ---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 309
Query: 128 NLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL-WYRPPELLLGATKYGPAVDMWSV 186
N+L+ K+ADFGLAR + + W P L G ++ D+WS
Sbjct: 310 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSF 367
Query: 187 GCIFAELLN-GKPILPGKNEAEQLSKI 212
G + EL G+ PG E L ++
Sbjct: 368 GILLTELTTKGRVPYPGMVNREVLDQV 394
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 64/290 (22%), Positives = 107/290 (36%), Gaps = 72/290 (24%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
+AR A +K+L+K + ++K KE ER+
Sbjct: 56 LARHKAEEVFYA--------------------VKVLQK---KAILKKKE-EKHIMSERNV 91
Query: 61 QGRPDGN------KY----RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLT 109
+ + + Y V +Y++ +L R F P+ + Y ++ +
Sbjct: 92 LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER-CFLEPRARFYAAEIAS 150
Query: 110 GLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI--TLWYRP 167
L Y H +++RD+K N+L+D++G++ L DFGL + ++ T T T Y
Sbjct: 151 ALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST---FCGTPEYLA 207
Query: 168 PELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 227
PE+L Y VD W +G + E+L G P +N AE I
Sbjct: 208 PEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN-----KPLQLK-- 259
Query: 228 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKD 277
+ A LLE +L D ++R+ AKD
Sbjct: 260 -----------------------PNITNSARHLLEGLLQKDRTKRLGAKD 286
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-19
Identities = 54/190 (28%), Positives = 85/190 (44%), Gaps = 31/190 (16%)
Query: 6 KTGEIVALKKIR---MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQG 62
TGE+VA+K ++ + G+ +EI IL+ L HE++IK K G
Sbjct: 58 GTGEMVAVKALKADAGPQHRSGW----KQEIDILRTLYHEHIIKYKGCCEDAGAA----- 108
Query: 63 RPDGNKYRGSTYMVFEYMDH-DL-TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
S +V EY+ L L + Q+ + +Q+ G+ Y H +
Sbjct: 109 ---------SLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYI 156
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTLTNRVITL-WYRPPELLLGATKY 177
HRD+ N+L+DN+ +K+ DFGLA++ H + + WY PE L K+
Sbjct: 157 HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLK-EYKF 214
Query: 178 GPAVDMWSVG 187
A D+WS G
Sbjct: 215 YYASDVWSFG 224
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 90.5 bits (224), Expect = 2e-19
Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 34/200 (17%)
Query: 74 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 132
Y V EY++ DL + G RF P Y ++ GL + +++RD+K N+++D
Sbjct: 418 YFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD 476
Query: 133 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 192
+EG++K+ADFG+ + +D T T T Y PE++ YG +VD W+ G + E
Sbjct: 477 SEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYE 534
Query: 193 LLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRH 252
+L G+ G++E E I E +P +
Sbjct: 535 MLAGQAPFEGEDEDELFQSIME-----HNVAYP-------------------------KS 564
Query: 253 FDRHALELLEKMLMLDPSQR 272
+ A+ + + ++ P +R
Sbjct: 565 MSKEAVAICKGLMTKHPGKR 584
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-19
Identities = 42/182 (23%), Positives = 73/182 (40%), Gaps = 26/182 (14%)
Query: 8 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 67
G VA+K I+ D + F + E ++ +L+H N+++L ++
Sbjct: 44 GNKVAVKCIKNDATAQAF----LAEASVMTQLRHSNLVQLLGVIVEEKG----------- 88
Query: 68 KYRGSTYMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIK 125
Y+V EYM L L R + + + + Y N +HRD+
Sbjct: 89 ----GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA 144
Query: 126 GSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWS 185
N+L+ + K++DFGL + S + ++ W PE L K+ D+WS
Sbjct: 145 ARNVLVSEDNVAKVSDFGLTKEASSTQDTG---KLPVKWT-APEALR-EKKFSTKSDVWS 199
Query: 186 VG 187
G
Sbjct: 200 FG 201
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 5e-19
Identities = 41/182 (22%), Positives = 72/182 (39%), Gaps = 26/182 (14%)
Query: 8 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 67
G VA+K I+ D + F + E ++ +L+H N+++L ++
Sbjct: 216 GNKVAVKCIKNDATAQAF----LAEASVMTQLRHSNLVQLLGVIVEEKG----------- 260
Query: 68 KYRGSTYMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIK 125
Y+V EYM L L R + + + + Y N +HRD+
Sbjct: 261 ----GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA 316
Query: 126 GSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWS 185
N+L+ + K++DFGL + S + ++ W P L K+ D+WS
Sbjct: 317 ARNVLVSEDNVAKVSDFGLTKEASSTQDTG---KLPVKWTAPEALREK--KFSTKSDVWS 371
Query: 186 VG 187
G
Sbjct: 372 FG 373
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 9e-19
Identities = 43/184 (23%), Positives = 78/184 (42%), Gaps = 32/184 (17%)
Query: 11 VALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 69
VA+K ++ D E E F ++E ++K+++H N+++L + T P
Sbjct: 41 VAVKTLKEDTMEVEEF----LKEAAVMKEIKHPNLVQLLGVCTREPP------------- 83
Query: 70 RGSTYMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 127
Y++ E+M + +L L + + + Q+ + + Y +HRD+
Sbjct: 84 ---FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140
Query: 128 NLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL----WYRPPELLLGATKYGPAVDM 183
N L+ +K+ADFGL+R +T T W PE L K+ D+
Sbjct: 141 NCLVGENHLVKVADFGLSR---LMTGDTYTAHAGAKFPIKWT-APESLA-YNKFSIKSDV 195
Query: 184 WSVG 187
W+ G
Sbjct: 196 WAFG 199
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 46/184 (25%), Positives = 75/184 (40%), Gaps = 30/184 (16%)
Query: 11 VALKKIR---MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 67
VA+K R + K F ++E +ILK+ H N+++L + T Q +P
Sbjct: 142 VAVKSCRETLPPDLKAKF----LQEARILKQYSHPNIVRLIGVCT--------QKQP--- 186
Query: 68 KYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKG 126
Y+V E + D G R V + + G+ Y +HRD+
Sbjct: 187 -----IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAA 241
Query: 127 SNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL---WYRPPELLLGATKYGPAVDM 183
N L+ + LK++DFG++R D + + + W PE L +Y D+
Sbjct: 242 RNCLVTEKNVLKISDFGMSR-EEADGVYAASGGLRQVPVKWT-APEALN-YGRYSSESDV 298
Query: 184 WSVG 187
WS G
Sbjct: 299 WSFG 302
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 50/214 (23%), Positives = 92/214 (42%), Gaps = 34/214 (15%)
Query: 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 64
IKT LK + ++ F + E I+ + H N+I+L+ +VT + +P
Sbjct: 78 IKT-----LKVGYTEKQRRDF----LGEASIMGQFDHPNIIRLEGVVT--------KSKP 120
Query: 65 DGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 123
+V EYM++ L + +FTV Q+ ++ + +G+ Y +HRD
Sbjct: 121 --------VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRD 172
Query: 124 IKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL----WYRPPELLLGATKYGP 179
+ N+LI++ K++DFGL R D W PE + K+
Sbjct: 173 LAARNILINSNLVCKVSDFGLGR-VLEDDPEAAYTTRGGKIPIRWT-SPEAIA-YRKFTS 229
Query: 180 AVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKI 212
A D+WS G + E+++ G+ + + + +
Sbjct: 230 ASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 5e-18
Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 28/207 (13%)
Query: 11 VALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 69
VA+K ++ E F ++E +++KKL+HE +++L +V+ P
Sbjct: 294 VAIKTLKPGTMSPEAF----LQEAQVMKKLRHEKLVQLYAVVS---------EEP----- 335
Query: 70 RGSTYMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 127
Y+V EYM L L G +PQ+ Q+ +G+ Y +HRD++ +
Sbjct: 336 ---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 392
Query: 128 NLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL-WYRPPELLLGATKYGPAVDMWSV 186
N+L+ K+ADFGLAR + + W P L G ++ D+WS
Sbjct: 393 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSF 450
Query: 187 GCIFAELLN-GKPILPGKNEAEQLSKI 212
G + EL G+ PG E L ++
Sbjct: 451 GILLTELTTKGRVPYPGMVNREVLDQV 477
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-18
Identities = 48/185 (25%), Positives = 85/185 (45%), Gaps = 31/185 (16%)
Query: 11 VALKKIR---MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 67
VA+K ++ + ++ F + E I+ + H N+I+L+ +VT +GR
Sbjct: 80 VAIKALKAGYTERQRRDF----LSEASIMGQFDHPNIIRLEGVVT--------RGRL--- 124
Query: 68 KYRGSTYMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIK 125
+V EYM++ L L G +FT+ Q+ ++ + G+ Y +HRD+
Sbjct: 125 -----AMIVTEYMENGSLDTFLRTHDG-QFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLA 178
Query: 126 GSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL---WYRPPELLLGATKYGPAVD 182
N+L+D+ K++DFGL+R D + T + W PE + + A D
Sbjct: 179 ARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT-APEAIA-FRTFSSASD 236
Query: 183 MWSVG 187
+WS G
Sbjct: 237 VWSFG 241
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 5e-18
Identities = 43/193 (22%), Positives = 73/193 (37%), Gaps = 51/193 (26%)
Query: 94 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 153
+ + Y ++ L+Y H +++RD+K N+L+D+EG++KL D+G+ + +
Sbjct: 106 KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 165
Query: 154 NTLT-----NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKP---------I 199
T T N Y PE+L G YG +VD W++G + E++ G+
Sbjct: 166 TTSTFCGTPN------YIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 218
Query: 200 LPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALE 259
E I E + P R A
Sbjct: 219 PDQNTEDYLFQVILE-----KQIRIP-------------------------RSLSVKAAS 248
Query: 260 LLEKMLMLDPSQR 272
+L+ L DP +R
Sbjct: 249 VLKSFLNKDPKER 261
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 8e-18
Identities = 45/184 (24%), Positives = 77/184 (41%), Gaps = 33/184 (17%)
Query: 11 VALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 69
VA+K IR +E F I E +++ KL H +++L + P
Sbjct: 35 VAIKTIREGAMSEEDF----IEEAEVMMKLSHPKLVQLYGVCLEQAP------------- 77
Query: 70 RGSTYMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 127
+V E+M+H L+ L + G F + + G+ Y V+HRD+
Sbjct: 78 ---ICLVTEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAAR 133
Query: 128 NLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL----WYRPPELLLGATKYGPAVDM 183
N L+ +K++DFG+ R + ++ T+ T W PE+ ++Y D+
Sbjct: 134 NCLVGENQVIKVSDFGMTR---FVLDDQYTSSTGTKFPVKWA-SPEVFS-FSRYSSKSDV 188
Query: 184 WSVG 187
WS G
Sbjct: 189 WSFG 192
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 9e-18
Identities = 46/184 (25%), Positives = 85/184 (46%), Gaps = 33/184 (17%)
Query: 11 VALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 69
VA+K ++ + + F + E ++K+LQH+ +++L +VT P
Sbjct: 40 VAVKSLKQGSMSPDAF----LAEANLMKQLQHQRLVRLYAVVT---------QEP----- 81
Query: 70 RGSTYMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 127
Y++ EYM++ L L G++ T+ ++ Q+ G+ + +HRD++ +
Sbjct: 82 ---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAA 138
Query: 128 NLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL----WYRPPELLLGATKYGPAVDM 183
N+L+ + + K+ADFGLAR +N T R W PE + + D+
Sbjct: 139 NILVSDTLSCKIADFGLAR---LIEDNEYTAREGAKFPIKWT-APEAIN-YGTFTIKSDV 193
Query: 184 WSVG 187
WS G
Sbjct: 194 WSFG 197
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 43/193 (22%), Positives = 73/193 (37%), Gaps = 51/193 (26%)
Query: 94 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 153
+ + Y ++ L+Y H +++RD+K N+L+D+EG++KL D+G+ + +
Sbjct: 149 KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 208
Query: 154 NTLT-----NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKP---------I 199
T T N Y PE+L G YG +VD W++G + E++ G+
Sbjct: 209 TTSTFCGTPN------YIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 261
Query: 200 LPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALE 259
E I E + P R A
Sbjct: 262 PDQNTEDYLFQVILE-----KQIRIP-------------------------RSLSVKAAS 291
Query: 260 LLEKMLMLDPSQR 272
+L+ L DP +R
Sbjct: 292 VLKSFLNKDPKER 304
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 42/192 (21%), Positives = 84/192 (43%), Gaps = 31/192 (16%)
Query: 11 VALKKIR---MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGN 67
VA+K ++ + ++ F + E I+ + H N+I+L+ +++ + +P
Sbjct: 76 VAIKTLKAGYTEKQRVDF----LGEAGIMGQFSHHNIIRLEGVIS--------KYKP--- 120
Query: 68 KYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKG 126
++ EYM++ L F+V Q+ ++ + G+ Y +HRD+
Sbjct: 121 -----MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAA 175
Query: 127 SNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL----WYRPPELLLGATKYGPAVD 182
N+L+++ K++DFGL+R D W PE + K+ A D
Sbjct: 176 RNILVNSNLVCKVSDFGLSR-VLEDDPEATYTTSGGKIPIRWT-APEAIS-YRKFTSASD 232
Query: 183 MWSVGCIFAELL 194
+WS G + E++
Sbjct: 233 VWSFGIVMWEVM 244
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 91/496 (18%), Positives = 145/496 (29%), Gaps = 101/496 (20%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDE 60
I+T E VA+K + + E KI + LQ + ++ G E D
Sbjct: 26 GTNIQTNEEVAIKLENVKTKHPQLL----YESKIYRILQGGTGIPNVRWF----GVEGD- 76
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
+V + + L L + + ++ + Q++ + + H L
Sbjct: 77 -----------YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125
Query: 121 HRDIKGSNLLIDNEGN---LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 177
HRDIK N L+ + + DFGLA+ + D + T++ I YR + L G +Y
Sbjct: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKY-RDTS---THQHIP--YRENKNLTGTARY 179
Query: 178 -----------GPAVDMWSVGCIFAELLNGKPILP-----GKNEAEQLSKIFE------- 214
D+ S+G + L G LP + ++ KI E
Sbjct: 180 ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS--LPWQGLKAGTKKQKYEKISEKKVATSI 237
Query: 215 --LC-GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ 271
LC G P E F + + L
Sbjct: 238 EALCRGYPTE----------------------------FASYFHYCRSL----------- 258
Query: 272 RISAKDALDSEYFWTDPLPCDPKSLPKYESSHEYQTKKRRQQQRQHEEATKRQKLHHPQP 331
D D Y L D ++ + + + QQ Q A R H P
Sbjct: 259 --RFDDKPDYSYLKR--LFRDLFIREGFQFDYVFDWTILKYQQSQIASAPPRAVGHGAGP 314
Query: 332 HGRLPPIQHAGQSHHWSGPNHPMNNAPPPVPGGPGHHHYGKPRGPPGGANRYPSGNQSGG 391
G PP + ++ P G S ++
Sbjct: 315 SGLAPPALQNDRQSGVDEGRTSGWSSMDRRRAPPPIASVGTLAKQKAPVGNDASFSKEPV 374
Query: 392 YNNPNRGGQGGGYSNAPYPPQGRGPPYAGAGMPANGPRGPASGYGVGPQSYSQSGQYGNS 451
+ N G+ G S P R P+ AS S Q NS
Sbjct: 375 ISASNFLGRSSGSSRRPAVSSSRDVMPIDTSEPSRTRATDASPGAFRRTSGPQKSSPVNS 434
Query: 452 AAGRGPNQMGGSRNQQ 467
A + + S N +
Sbjct: 435 AEPKHSSSARHSSNVK 450
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 2e-17
Identities = 48/183 (26%), Positives = 85/183 (46%), Gaps = 31/183 (16%)
Query: 11 VALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 69
VA+K I+ + ++ F I E K++ L HE +++L + T P
Sbjct: 51 VAIKMIKEGSMSEDEF----IEEAKVMMNLSHEKLVQLYGVCTKQRP------------- 93
Query: 70 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 128
+++ EYM + L RF Q+ K + + Y Q LHRD+ N
Sbjct: 94 ---IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARN 150
Query: 129 LLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL----WYRPPELLLGATKYGPAVDMW 184
L++++G +K++DFGL+R ++ T+ V + W PPE+L+ +K+ D+W
Sbjct: 151 CLVNDQGVVKVSDFGLSRYV---LDDEYTSSVGSKFPVRWS-PPEVLM-YSKFSSKSDIW 205
Query: 185 SVG 187
+ G
Sbjct: 206 AFG 208
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 3e-17
Identities = 42/183 (22%), Positives = 77/183 (42%), Gaps = 31/183 (16%)
Query: 11 VALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 69
VA+K I+ + ++ F +E + + KL H ++K + + + P
Sbjct: 35 VAVKMIKEGSMSEDEF----FQEAQTMMKLSHPKLVKFYGVCS--------KEYP----- 77
Query: 70 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 128
Y+V EY+ + L G Q+ + G+ + +Q +HRD+ N
Sbjct: 78 ---IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARN 134
Query: 129 LLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL----WYRPPELLLGATKYGPAVDMW 184
L+D + +K++DFG+ R Y ++ + V T W PE+ KY D+W
Sbjct: 135 CLVDRDLCVKVSDFGMTR---YVLDDQYVSSVGTKFPVKWS-APEVFH-YFKYSSKSDVW 189
Query: 185 SVG 187
+ G
Sbjct: 190 AFG 192
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 4e-17
Identities = 36/143 (25%), Positives = 59/143 (41%), Gaps = 27/143 (18%)
Query: 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 64
+KT KK + KE F + E I+K L H +++KL I+
Sbjct: 45 VKT-----CKKDCTLDNKEKF----MSEAVIMKNLDHPHIVKLIGIIE------------ 83
Query: 65 DGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 123
T+++ E + +L +R V + Y Q+ + Y +HRD
Sbjct: 84 -----EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRD 138
Query: 124 IKGSNLLIDNEGNLKLADFGLAR 146
I N+L+ + +KL DFGL+R
Sbjct: 139 IAVRNILVASPECVKLGDFGLSR 161
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 5e-17
Identities = 38/188 (20%), Positives = 70/188 (37%), Gaps = 34/188 (18%)
Query: 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 64
IK LK+ + E +RE +I+ +L + +++L + +
Sbjct: 42 IKV-----LKQGTEKADTEEM----MREAQIMHQLDNPYIVRLIGVCQAE---------- 82
Query: 65 DGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 123
+ +V E L V + + Q+ G+ Y +HRD
Sbjct: 83 -------ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRD 135
Query: 124 IKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL----WYRPPELLLGATKYGP 179
+ N+L+ N K++DFGL+++ ++ T R WY P + K+
Sbjct: 136 LAARNVLLVNRHYAKISDFGLSKAL-GADDSYYTARSAGKWPLKWYAPECINFR--KFSS 192
Query: 180 AVDMWSVG 187
D+WS G
Sbjct: 193 RSDVWSYG 200
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 6e-17
Identities = 41/186 (22%), Positives = 73/186 (39%), Gaps = 32/186 (17%)
Query: 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 64
IKT K D+ +E F ++E +++ H +++KL ++T
Sbjct: 423 IKT-----CKNCTSDSVREKF----LQEALTMRQFDHPHIVKLIGVITEN---------- 463
Query: 65 DGNKYRGSTYMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHR 122
+++ E +L L R + + Y QL T L Y + +HR
Sbjct: 464 -------PVWIIMELCTLGELRSFLQVRKF-SLDLASLILYAYQLSTALAYLESKRFVHR 515
Query: 123 DIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL-WYRPPELLLGATKYGPAV 181
DI N+L+ + +KL DFGL+R + + + W P + ++ A
Sbjct: 516 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR--RFTSAS 573
Query: 182 DMWSVG 187
D+W G
Sbjct: 574 DVWMFG 579
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 7e-17
Identities = 46/184 (25%), Positives = 80/184 (43%), Gaps = 33/184 (17%)
Query: 11 VALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 69
VA+K ++ + E F + E ++K LQH+ ++KL +VT
Sbjct: 215 VAVKTMKPGSMSVEAF----LAEANVMKTLQHDKLVKLHAVVT----------------- 253
Query: 70 RGSTYMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 127
+ Y++ E+M L L G + +P++ + Q+ G+ + +HRD++ +
Sbjct: 254 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAA 313
Query: 128 NLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL----WYRPPELLLGATKYGPAVDM 183
N+L+ K+ADFGLAR +N T R W P + G + D+
Sbjct: 314 NILVSASLVCKIADFGLAR---VIEDNEYTAREGAKFPIKWTAPEAINFG--SFTIKSDV 368
Query: 184 WSVG 187
WS G
Sbjct: 369 WSFG 372
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 7e-17
Identities = 57/214 (26%), Positives = 91/214 (42%), Gaps = 58/214 (27%)
Query: 8 GEIVALKKIRMDNEKEG------FPITAIREIKILKKLQHENVIKL----KEIVTSPGPE 57
VA+KK+ + F +EIK++ K QHEN+++L + G +
Sbjct: 54 NTTVAVKKLAAMVDITTEELKQQF----DQEIKVMAKCQHENLVELLGFSSD-----GDD 104
Query: 58 RDEQGRPDGNKYRGSTYMVFEYM-----DHDLTGLADRPGL----RFTVPQIKCYMKQLL 108
+V+ YM L+ L P L R K
Sbjct: 105 L---------------CLVYVYMPNGSLLDRLSCLDGTPPLSWHMR---------CKIAQ 140
Query: 109 ---TGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLW 164
G+++ H N +HRDIK +N+L+D K++DFGLAR+ +T+R++ T
Sbjct: 141 GAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTA 200
Query: 165 YRPPELLLGATKYGPAVDMWSVGCIFAELLNGKP 198
Y PE L G + P D++S G + E++ G P
Sbjct: 201 YMAPEALRG--EITPKSDIYSFGVVLLEIITGLP 232
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 7e-17
Identities = 37/187 (19%), Positives = 73/187 (39%), Gaps = 36/187 (19%)
Query: 11 VALKKIRMD----NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDG 66
VA+K ++ + K+ + E ++++L + ++++ I +
Sbjct: 47 VAVKILKNEANDPALKDEL----LAEANVMQQLDNPYIVRMIGICEAE------------ 90
Query: 67 NKYRGSTYMVFEYMDHDLTG-LAD--RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 123
S +V E + G L + I + Q+ G+ Y + +HRD
Sbjct: 91 -----SWMLVMEMAEL---GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRD 142
Query: 124 IKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL---WYRPPELLLGATKYGPA 180
+ N+L+ + K++DFGL+++ D N WY PE + K+
Sbjct: 143 LAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECIN-YYKFSSK 200
Query: 181 VDMWSVG 187
D+WS G
Sbjct: 201 SDVWSFG 207
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 43/182 (23%), Positives = 72/182 (39%), Gaps = 24/182 (13%)
Query: 11 VALKKIRMDNEKEGFPITA-IREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 69
VA+K ++ D + + IRE+ + L H N+I+L +V +P
Sbjct: 49 VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--------------- 93
Query: 70 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 128
MV E L + F + + Y Q+ G+ Y + +HRD+ N
Sbjct: 94 --PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARN 151
Query: 129 LLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL---WYRPPELLLGATKYGPAVDMWS 185
LL+ +K+ DFGL R+ + ++ + + W PE L + A D W
Sbjct: 152 LLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC-APESLK-TRTFSHASDTWM 209
Query: 186 VG 187
G
Sbjct: 210 FG 211
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 32/186 (17%), Positives = 66/186 (35%), Gaps = 31/186 (16%)
Query: 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 64
IK L++ + + E ++ + + +V +L I +
Sbjct: 49 IKE-----LREATSPKANKEI----LDEAYVMASVDNPHVCRLLGICLTS---------- 89
Query: 65 DGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 123
+ ++ + M L + + Q+ G++Y +++HRD
Sbjct: 90 -------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRD 142
Query: 124 IKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN--RVITLWYRPPELLLGATKYGPAV 181
+ N+L+ ++K+ DFGLA+ + +V W E +L Y
Sbjct: 143 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM-ALESIL-HRIYTHQS 200
Query: 182 DMWSVG 187
D+WS G
Sbjct: 201 DVWSYG 206
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-16
Identities = 42/187 (22%), Positives = 74/187 (39%), Gaps = 34/187 (18%)
Query: 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 64
IKT K D+ +E F ++E +++ H +++KL ++T
Sbjct: 48 IKT-----CKNCTSDSVREKF----LQEALTMRQFDHPHIVKLIGVITEN---------- 88
Query: 65 DGNKYRGSTYMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHR 122
+++ E +L L R + + Y QL T L Y + +HR
Sbjct: 89 -------PVWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAYLESKRFVHR 140
Query: 123 DIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN--RVITLWYRPPELLLGATKYGPA 180
DI N+L+ + +KL DFGL+R D + ++ W P + ++ A
Sbjct: 141 DIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFR--RFTSA 197
Query: 181 VDMWSVG 187
D+W G
Sbjct: 198 SDVWMFG 204
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-16
Identities = 35/188 (18%), Positives = 64/188 (34%), Gaps = 36/188 (19%)
Query: 11 VALKKIRMD--NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 68
V LK + N E F ++ KL H++++ + G
Sbjct: 43 VLLKVLDKAHRNYSESF----FEAASMMSKLSHKHLVLNYGVCV--------CGDE---- 86
Query: 69 YRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 127
+V E++ L + + KQL +H+ N ++H ++
Sbjct: 87 ----NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAK 142
Query: 128 NLLIDNEGNL--------KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGP 179
N+L+ E + KL+D G++ + + + W PPE +
Sbjct: 143 NILLIREEDRKTGNPPFIKLSDPGISITV-LPKDIL---QERIPWV-PPECIENPKNLNL 197
Query: 180 AVDMWSVG 187
A D WS G
Sbjct: 198 ATDKWSFG 205
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 30/152 (19%), Positives = 63/152 (41%), Gaps = 35/152 (23%)
Query: 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 64
IKT + + E+ F + E ++K+ +V++L +V+ QG+P
Sbjct: 60 IKT-----VNEAASMRERIEF----LNEASVMKEFNCHHVVRLLGVVS--------QGQP 102
Query: 65 DGNKYRGSTYMVFEYMDH-DL---------TGLADRPGLRFTVPQIKCYMKQLLTGLHYC 114
T ++ E M DL + ++ ++ ++ G+ Y
Sbjct: 103 --------TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL 154
Query: 115 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 146
+ N+ +HRD+ N ++ + +K+ DFG+ R
Sbjct: 155 NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 4e-16
Identities = 39/143 (27%), Positives = 62/143 (43%), Gaps = 25/143 (17%)
Query: 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 64
IK+ L +I + E F +RE +++ L H NV+ L I+ P
Sbjct: 54 IKS-----LSRITEMQQVEAF----LREGLLMRGLNHPNVLALIGIMLPPEG-------- 96
Query: 65 DGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 123
+++ YM H DL P TV + + Q+ G+ Y + +HRD
Sbjct: 97 -------LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRD 149
Query: 124 IKGSNLLIDNEGNLKLADFGLAR 146
+ N ++D +K+ADFGLAR
Sbjct: 150 LAARNCMLDESFTVKVADFGLAR 172
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 5e-16
Identities = 31/146 (21%), Positives = 59/146 (40%), Gaps = 25/146 (17%)
Query: 11 VALKKIRMDN----EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDG 66
VA+K +++DN E E F + E +K H NVI+L + +
Sbjct: 65 VAVKTMKLDNSSQREIEEF----LSEAACMKDFSHPNVIRLLGVCIEMSSQG-------- 112
Query: 67 NKYRGSTYMVFEYMDH-DL-----TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
++ +M + DL + + + +M + G+ Y L
Sbjct: 113 ---IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFL 169
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLAR 146
HRD+ N ++ ++ + +ADFGL++
Sbjct: 170 HRDLAARNCMLRDDMTVCVADFGLSK 195
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 6e-16
Identities = 39/143 (27%), Positives = 59/143 (41%), Gaps = 25/143 (17%)
Query: 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 64
+K+ L +I E F + E I+K H NV+ L I
Sbjct: 58 VKS-----LNRITDIGEVSQF----LTEGIIMKDFSHPNVLSLLGICL------------ 96
Query: 65 DGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 123
+ GS +V YM H DL TV + + Q+ G+ Y + +HRD
Sbjct: 97 ---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRD 153
Query: 124 IKGSNLLIDNEGNLKLADFGLAR 146
+ N ++D + +K+ADFGLAR
Sbjct: 154 LAARNCMLDEKFTVKVADFGLAR 176
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 6e-16
Identities = 30/146 (20%), Positives = 57/146 (39%), Gaps = 24/146 (16%)
Query: 11 VALKKIRMD----NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDG 66
VA+K ++ D ++ E F +RE +K+ H +V KL + +
Sbjct: 54 VAVKMLKADIIASSDIEEF----LREAACMKEFDHPHVAKLVGVSLRSRAKGRL------ 103
Query: 67 NKYRGSTYMVFEYMDH-DL-----TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
++ +M H DL + + +M + G+ Y +
Sbjct: 104 ----PIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFI 159
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLAR 146
HRD+ N ++ + + +ADFGL+R
Sbjct: 160 HRDLAARNCMLAEDMTVCVADFGLSR 185
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 38/143 (26%), Positives = 59/143 (41%), Gaps = 25/143 (17%)
Query: 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 64
+K+ L +I E F + E I+K H NV+ L I
Sbjct: 122 VKS-----LNRITDIGEVSQF----LTEGIIMKDFSHPNVLSLLGICL------------ 160
Query: 65 DGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 123
+ GS +V YM H DL TV + + Q+ G+ + + +HRD
Sbjct: 161 ---RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRD 217
Query: 124 IKGSNLLIDNEGNLKLADFGLAR 146
+ N ++D + +K+ADFGLAR
Sbjct: 218 LAARNCMLDEKFTVKVADFGLAR 240
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 77.3 bits (190), Expect = 3e-15
Identities = 36/187 (19%), Positives = 68/187 (36%), Gaps = 32/187 (17%)
Query: 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 64
IK LK+ + E +RE +I+ +L + +++L + +
Sbjct: 368 IKV-----LKQGTEKADTEEM----MREAQIMHQLDNPYIVRLIGVCQAE---------- 408
Query: 65 DGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 123
+ +V E L V + + Q+ G+ Y +HR+
Sbjct: 409 -------ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRN 461
Query: 124 IKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL---WYRPPELLLGATKYGPA 180
+ N+L+ N K++DFGL+++ D + WY P + K+
Sbjct: 462 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR--KFSSR 519
Query: 181 VDMWSVG 187
D+WS G
Sbjct: 520 SDVWSYG 526
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 3e-15
Identities = 29/211 (13%), Positives = 55/211 (26%), Gaps = 50/211 (23%)
Query: 2 AREIKTGEIVALKKIRMD-NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
A + VAL + + + L ++ V ++ ++V
Sbjct: 50 ALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV-------HT 102
Query: 61 QGRPDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQV 119
+ +V E++ L +AD + M+ L H V
Sbjct: 103 RAGG---------LVVAEWIRGGSLQEVADTSPSPVGAIRA---MQSLAAAADAAHRAGV 150
Query: 120 LHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGP 179
S + + +G++ LA P P
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPA---------------------TMPDA--------NP 181
Query: 180 AVDMWSVGCIFAELLNGKPILPGKNEAEQLS 210
D+ +G LL + LP L+
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLA 212
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 32/186 (17%), Positives = 66/186 (35%), Gaps = 31/186 (16%)
Query: 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 64
IK L++ + + E ++ + + +V +L I +
Sbjct: 49 IKE-----LREATSPKANKEI----LDEAYVMASVDNPHVCRLLGICLTS---------- 89
Query: 65 DGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 123
+ ++ + M L + + Q+ G++Y +++HRD
Sbjct: 90 -------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRD 142
Query: 124 IKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN--RVITLWYRPPELLLGATKYGPAV 181
+ N+L+ ++K+ DFGLA+ + +V W E +L Y
Sbjct: 143 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM-ALESIL-HRIYTHQS 200
Query: 182 DMWSVG 187
D+WS G
Sbjct: 201 DVWSYG 206
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 50/224 (22%), Positives = 88/224 (39%), Gaps = 42/224 (18%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
+A E A ++++ ++ G E+K +++ ++ IK + D
Sbjct: 55 LAFPTNKPEKDARHVVKVEYQENG---PLFSELKFYQRVAKKDCIKKW----IERKQLDY 107
Query: 61 QGRP----------DGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTG 110
G P G YR +MV E + DL ++ + G F + ++L
Sbjct: 108 LGIPLFYGSGLTEFKGRSYR---FMVMERLGIDLQKISGQNG-TFKKSTVLQLGIRMLDV 163
Query: 111 LHYCHVNQVLHRDIKGSNLLID--NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPP 168
L Y H N+ +H DIK +NLL+ N + LAD+GL+ + ++ P
Sbjct: 164 LEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYC----PNGNHKQYQ--ENPR 217
Query: 169 ELLLGATKY-------GPAV----DMWSVGCIFAELLNGKPILP 201
+ G ++ G A+ D+ +G L GK LP
Sbjct: 218 KGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGK--LP 259
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 5e-15
Identities = 39/158 (24%), Positives = 61/158 (38%), Gaps = 41/158 (25%)
Query: 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 64
IKT LK +E F E + +LQH NV+ L +VT + +P
Sbjct: 44 IKT-----LKDKAEGPLREEF----RHEAMLRARLQHPNVVCLLGVVT--------KDQP 86
Query: 65 DGNKYRGSTYMVFEYMDH-DL---------------TGLADRPGLRFTVPQIKCYMKQLL 108
M+F Y H DL T P + Q+
Sbjct: 87 --------LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIA 138
Query: 109 TGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 146
G+ Y + V+H+D+ N+L+ ++ N+K++D GL R
Sbjct: 139 AGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 9e-15
Identities = 54/250 (21%), Positives = 91/250 (36%), Gaps = 58/250 (23%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQH-ENVIKLKEIVTSPGPERDE 60
+I GE VA+K + + E KI K +Q + ++ G E D
Sbjct: 28 GTDIAAGEEVAIKLECVKTKHPQLH----IESKIYKMMQGGVGIPTIRWC----GAEGD- 78
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
MV E + L L + +F++ + Q+++ + Y H +
Sbjct: 79 -----------YNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFI 127
Query: 121 HRDIKGSNLLI---DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 177
HRD+K N L+ + + DFGLA+ + + T++ I YR + L G +Y
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR----DARTHQHIP--YRENKNLTGTARY 181
Query: 178 -----------GPAVDMWSVGCIFAELLNGKPILP-----GKNEAEQLSKIFE------- 214
D+ S+G + G LP + ++ +I E
Sbjct: 182 ASINTHLGIEQSRRDDLESLGYVLMYFNLGS--LPWQGLKAATKRQKYERISEKKMSTPI 239
Query: 215 --LC-GSPDE 221
LC G P E
Sbjct: 240 EVLCKGYPSE 249
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 32/187 (17%), Positives = 67/187 (35%), Gaps = 33/187 (17%)
Query: 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 64
IK ++ + + + L H ++++L +
Sbjct: 47 IKV-----IEDKSGRQSFQAV----TDHMLAIGSLDHAHIVRLLGLCPGS---------- 87
Query: 65 DGNKYRGSTYMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHR 122
S +V +Y+ L + G + + Q+ G++Y + ++HR
Sbjct: 88 -------SLQLVTQYLPLGSLLDHVRQHRG-ALGPQLLLNWGVQIAKGMYYLEEHGMVHR 139
Query: 123 DIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN--RVITLWYRPPELLLGATKYGPA 180
++ N+L+ + +++ADFG+A D L + + W E + KY
Sbjct: 140 NLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM-ALESIH-FGKYTHQ 197
Query: 181 VDMWSVG 187
D+WS G
Sbjct: 198 SDVWSYG 204
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 52/237 (21%), Positives = 86/237 (36%), Gaps = 50/237 (21%)
Query: 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQH-ENVIKLKEIVTSPGPERD 59
+ + + T E VA+K M + E + K+L + + ++ GP
Sbjct: 27 LGKNLYTNEYVAIKLEPMKSRAPQLH----LEYRFYKQLGSGDGIPQVYYF----GPCGK 78
Query: 60 EQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQV 119
MV E + L L D F++ + QL++ + Y H +
Sbjct: 79 ------------YNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNL 126
Query: 120 LHRDIKGSNLLIDNEGNLK-----LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA 174
++RD+K N LI GN + DF LA+ + D T + I YR + L G
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY-IDPE---TKKHIP--YREHKSLTGT 180
Query: 175 TKY-----------GPAVDMWSVGCIFAELLNGKPILP-----GKNEAEQLSKIFEL 215
+Y D+ ++G +F L G LP E+ KI +
Sbjct: 181 ARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGS--LPWQGLKADTLKERYQKIGDT 235
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 4e-14
Identities = 33/166 (19%), Positives = 61/166 (36%), Gaps = 49/166 (29%)
Query: 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 64
+K LK+ +E + E +LK++ H +VIKL + GP
Sbjct: 58 VKM-----LKENASPSELRDL----LSEFNVLKQVNHPHVIKLYGACSQDGP-------- 100
Query: 65 DGNKYRGSTYMVFEYMDH-DL-----------------------TGLADRPGLRFTVPQI 100
++ EY + L + L T+ +
Sbjct: 101 --------LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDL 152
Query: 101 KCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 146
+ Q+ G+ Y +++HRD+ N+L+ +K++DFGL+R
Sbjct: 153 ISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 4e-14
Identities = 35/163 (21%), Positives = 58/163 (35%), Gaps = 42/163 (25%)
Query: 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGR 63
IK +K+ ++ F E+++L KL H N+I L G
Sbjct: 57 IKR-----MKEYASKDDHRDF----AGELEVLCKLGHHPNIINLLGACEHRGY------- 100
Query: 64 PDGNKYRGSTYMVFEYMDH-DL---------------TGLADRPGLRFTVPQIKCYMKQL 107
Y+ EY H +L +A+ + Q+ + +
Sbjct: 101 ---------LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 108 LTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 150
G+ Y Q +HRD+ N+L+ K+ADFGL+R
Sbjct: 152 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 194
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 6e-14
Identities = 38/154 (24%), Positives = 62/154 (40%), Gaps = 38/154 (24%)
Query: 11 VALKKIR--MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 68
VA+K ++ ++ F RE ++L LQHE+++K + G P
Sbjct: 48 VAVKALKDPTLAARKDF----QREAELLTNLQHEHIVKFYGVCG--------DGDP---- 91
Query: 69 YRGSTYMVFEYMDH-DL---------------TGLADRPGLRFTVPQIKCYMKQLLTGLH 112
MVFEYM H DL G + + Q+ Q+ +G+
Sbjct: 92 ----LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMV 147
Query: 113 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 146
Y +HRD+ N L+ +K+ DFG++R
Sbjct: 148 YLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 7e-14
Identities = 47/240 (19%), Positives = 81/240 (33%), Gaps = 49/240 (20%)
Query: 4 EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGR 63
+ + +K DN E+K ++ I+ G
Sbjct: 61 SVGSDAPCVVKVEPSDNGP------LFTELKFYQRAAKPEQIQKWIRTRKLKY----LGV 110
Query: 64 P----------DGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHY 113
P +G YR +M+ + DL + + RF+ + ++L L Y
Sbjct: 111 PKYWGSGLHDKNGKSYR---FMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEY 167
Query: 114 CHVNQVLHRDIKGSNLLID--NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELL 171
H ++ +H DIK SNLL++ N + L D+GLA + ++ P
Sbjct: 168 IHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY-CPEG---VHKAYA--ADPKRCH 221
Query: 172 LGATKY-------GPAV----DMWSVGCIFAELLNGKPILP-----GKNEAEQLSKIFEL 215
G ++ G A D+ +G + L G LP + + SKI
Sbjct: 222 DGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH--LPWEDNLKDPKYVRDSKIRYR 279
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 7e-14
Identities = 50/252 (19%), Positives = 87/252 (34%), Gaps = 60/252 (23%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQH-ENVIKLKEIVTSPGPERDE 60
+ + VA+K ++ E + K L + + G E
Sbjct: 29 GTNLLNNQQVAIKFEPRRSDAPQLR----DEYRTYKLLAGCTGIPNVYYF----GQEGL- 79
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
+V + + L L D G +F+V + KQ+L + H ++
Sbjct: 80 -----------HNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV 128
Query: 121 HRDIKGSNLLIDNEGNLK-----LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT 175
+RDIK N LI + + DFG+ + + + +T + I YR + L G
Sbjct: 129 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR----DPVTKQHIP--YREKKNLSGTA 182
Query: 176 KY-----------GPAVDMWSVGCIFAELLNGKPILP-----GKNEAEQLSKIFE----- 214
+Y D+ ++G +F L G LP ++ +I E
Sbjct: 183 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGS--LPWQGLKAATNKQKYERIGEKKQST 240
Query: 215 ----LC-GSPDE 221
LC G P+E
Sbjct: 241 PLRELCAGFPEE 252
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 8e-14
Identities = 35/159 (22%), Positives = 60/159 (37%), Gaps = 41/159 (25%)
Query: 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGR 63
+K LK+ +E + E+KIL + H NV+ L T + G
Sbjct: 62 VKM-----LKEGATHSEHRAL----MSELKILIHIGHHLNVVNLLGACT-------KPGG 105
Query: 64 PDGNKYRGSTYMVFEYMDH-DL---------------TGLADRPGLRFTVPQIKCYMKQL 107
P ++ E+ +L D T+ + CY Q+
Sbjct: 106 P--------LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQV 157
Query: 108 LTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 146
G+ + + +HRD+ N+L+ + +K+ DFGLAR
Sbjct: 158 AKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 37/157 (23%), Positives = 58/157 (36%), Gaps = 40/157 (25%)
Query: 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGR 63
+K LK +EKE + E+KI+ L QHEN++ L T GP
Sbjct: 81 VKM-----LKSTAHADEKEAL----MSELKIMSHLGQHENIVNLLGACTHGGP------- 124
Query: 64 PDGNKYRGSTYMVFEYMDH-DL-------------TGLADRPGLRFTVPQIKCYMKQLLT 109
++ EY + DL + + + Q+
Sbjct: 125 ---------VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQ 175
Query: 110 GLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 146
G+ + +HRD+ N+L+ N K+ DFGLAR
Sbjct: 176 GMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 34/159 (21%), Positives = 62/159 (38%), Gaps = 42/159 (26%)
Query: 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGR 63
+K LK + + I E++++K + +H+N+I L T GP
Sbjct: 106 VKM-----LKSDATEKDLSDL----ISEMEMMKMIGKHKNIINLLGACTQDGP------- 149
Query: 64 PDGNKYRGSTYMVFEYMDH-DL---------------TGLADRPGLRFTVPQIKCYMKQL 107
Y++ EY +L + P + + + Q+
Sbjct: 150 ---------LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQV 200
Query: 108 LTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 146
G+ Y + +HRD+ N+L+ + +K+ADFGLAR
Sbjct: 201 ARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 35/159 (22%), Positives = 61/159 (38%), Gaps = 42/159 (26%)
Query: 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGR 63
+K LK + + + E++++K + +H+N+I L T GP
Sbjct: 72 VKM-----LKDDATEKDLSDL----VSEMEMMKMIGKHKNIINLLGACTQDGP------- 115
Query: 64 PDGNKYRGSTYMVFEYMDH-DL---------------TGLADRPGLRFTVPQIKCYMKQL 107
Y++ EY +L + P + T + QL
Sbjct: 116 ---------LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQL 166
Query: 108 LTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 146
G+ Y + +HRD+ N+L+ +K+ADFGLAR
Sbjct: 167 ARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 39/153 (25%), Positives = 66/153 (43%), Gaps = 37/153 (24%)
Query: 11 VALKKIR--MDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK 68
VA+K ++ ++ ++ F RE ++L LQH+++++ + T +GRP
Sbjct: 74 VAVKALKEASESARQDF----QREAELLTMLQHQHIVRFFGVCT--------EGRP---- 117
Query: 69 YRGSTYMVFEYMDH-DL--------------TGLADRPGLRFTVPQIKCYMKQLLTGLHY 113
MVFEYM H DL G D + Q+ Q+ G+ Y
Sbjct: 118 ----LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVY 173
Query: 114 CHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 146
+HRD+ N L+ +K+ DFG++R
Sbjct: 174 LAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 206
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 33/152 (21%), Positives = 57/152 (37%), Gaps = 35/152 (23%)
Query: 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 64
+KT L ++ + ++ F + E I+ K H+N+++ + Q P
Sbjct: 65 VKT-----LPEVCSEQDELDF----LMEALIISKFNHQNIVRCIGVSL--------QSLP 107
Query: 65 DGNKYRGSTYMVFEYMDH-DLTG--LADRP----GLRFTVPQIKCYMKQLLTGLHYCHVN 117
+++ E M DL RP + + + + G Y N
Sbjct: 108 --------RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN 159
Query: 118 QVLHRDIKGSNLLIDNEGN---LKLADFGLAR 146
+HRDI N L+ G K+ DFG+AR
Sbjct: 160 HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 35/159 (22%), Positives = 61/159 (38%), Gaps = 42/159 (26%)
Query: 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGR 63
+K LK + + + E++++K + +H+N+I L T GP
Sbjct: 118 VKM-----LKDDATEKDLSDL----VSEMEMMKMIGKHKNIINLLGACTQDGP------- 161
Query: 64 PDGNKYRGSTYMVFEYMDH-DL---------------TGLADRPGLRFTVPQIKCYMKQL 107
Y++ EY +L + P + T + QL
Sbjct: 162 ---------LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQL 212
Query: 108 LTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 146
G+ Y + +HRD+ N+L+ +K+ADFGLAR
Sbjct: 213 ARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 3e-13
Identities = 47/180 (26%), Positives = 80/180 (44%), Gaps = 43/180 (23%)
Query: 5 IKTGEIVALKKIRMDN---EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPG--PERD 59
++ G VALK+ ++ +E F EI+ L +H +++ L G ER+
Sbjct: 60 LRDGAKVALKRRTPESSQGIEE-F----ETEIETLSFCRHPHLVSLI------GFCDERN 108
Query: 60 EQGRPDGNKYRGSTYMVFEYM------DHDLTGLADRPGLRFTVPQIKCYMKQLL---TG 110
E ++++YM H L G +D P + + Q ++ + G
Sbjct: 109 EMI------------LIYKYMENGNLKRH-LYG-SDLPTMSMSWEQ---RLEICIGAARG 151
Query: 111 LHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPE 169
LHY H ++HRD+K N+L+D K+ DFG+++ + L+ V TL Y PE
Sbjct: 152 LHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPE 211
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 33/166 (19%), Positives = 62/166 (37%), Gaps = 49/166 (29%)
Query: 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 64
+K LK+ + + F RE ++ + + N++KL + G+P
Sbjct: 82 VKM-----LKEEASADMQADF----QREAALMAEFDNPNIVKLLGVCA--------VGKP 124
Query: 65 DGNKYRGSTYMVFEYMDH-DL-----------------------TGLADRPGLRFTVPQI 100
++FEYM + DL ++ + +
Sbjct: 125 --------MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQ 176
Query: 101 KCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 146
C +Q+ G+ Y + +HRD+ N L+ +K+ADFGL+R
Sbjct: 177 LCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 4e-13
Identities = 35/161 (21%), Positives = 59/161 (36%), Gaps = 44/161 (27%)
Query: 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGR 63
+K LK E+E + E+K+L L H N++ L T GP
Sbjct: 58 VKM-----LKPSAHLTEREAL----MSELKVLSYLGNHMNIVNLLGACTIGGP------- 101
Query: 64 PDGNKYRGSTYMVFEYMDH-DL-----------------TGLADRPGLRFTVPQIKCYMK 105
T ++ EY + DL + + L + + +
Sbjct: 102 ---------TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSY 152
Query: 106 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 146
Q+ G+ + +HRD+ N+L+ + K+ DFGLAR
Sbjct: 153 QVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLAR 193
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 7e-13
Identities = 33/152 (21%), Positives = 57/152 (37%), Gaps = 35/152 (23%)
Query: 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 64
+KT L ++ + ++ F + E I+ K H+N+++ + Q P
Sbjct: 106 VKT-----LPEVCSEQDELDF----LMEALIISKFNHQNIVRCIGVSL--------QSLP 148
Query: 65 DGNKYRGSTYMVFEYMDH-DLTG--LADRP----GLRFTVPQIKCYMKQLLTGLHYCHVN 117
+++ E M DL RP + + + + G Y N
Sbjct: 149 --------RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN 200
Query: 118 QVLHRDIKGSNLLIDNEGN---LKLADFGLAR 146
+HRDI N L+ G K+ DFG+AR
Sbjct: 201 HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 1e-12
Identities = 52/234 (22%), Positives = 98/234 (41%), Gaps = 58/234 (24%)
Query: 5 IKTGEIVALKKIRMD----NEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
+ G +VA+K+++ + E + F E++++ H N+++L+ + ER
Sbjct: 51 LADGTLVAVKRLKEERTQGGELQ-F----QTEVEMISMAVHRNLLRLRGFCMT-PTER-- 102
Query: 61 QGRPDGNKYRGSTYMVFEYM-----DHDLTGLAD-RPGL----RFTVPQIKCYMKQLL-- 108
+V+ YM L + +P L R + L
Sbjct: 103 -------------LLVYPYMANGSVASCLRERPESQPPLDWPKR---------QRIALGS 140
Query: 109 -TGLHYCHVN---QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT-LTNRVI-T 162
GL Y H + +++HRD+K +N+L+D E + DFGLA+ D+ +T +T V T
Sbjct: 141 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGT 198
Query: 163 LWYRPPE-LLLGATKYGPAVDMWSVGCIFAELLNG-KPILPGKNEAEQLSKIFE 214
+ + PE L G K D++ G + EL+ G + + + + +
Sbjct: 199 IGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 9e-12
Identities = 37/166 (22%), Positives = 64/166 (38%), Gaps = 49/166 (29%)
Query: 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGR 63
+K LK+ +E+E + E+K++ +L HEN++ L T GP
Sbjct: 80 VKM-----LKEKADSSEREAL----MSELKMMTQLGSHENIVNLLGACTLSGP------- 123
Query: 64 PDGNKYRGSTYMVFEYMDH-DL----------------------TGLADRPGLRFTVPQI 100
Y++FEY + DL + T +
Sbjct: 124 ---------IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDL 174
Query: 101 KCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 146
C+ Q+ G+ + +HRD+ N+L+ + +K+ DFGLAR
Sbjct: 175 LCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 29/170 (17%), Positives = 58/170 (34%), Gaps = 30/170 (17%)
Query: 65 DGNKYRGSTYMVFEYMDHDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 123
+KYR ++V + L D P + + +LL L + H N+ +H +
Sbjct: 128 HQDKYR---FLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGN 184
Query: 124 IKGSNLLI--DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY---- 177
+ N+ + +++ + LA +G A + + + + G ++
Sbjct: 185 VTAENIFVDPEDQSQVTLAGYGFAFRY------CPSGKHVAYVEGSRSPHEGDLEFISMD 238
Query: 178 ---GPAV----DMWSVGCIFAELLNGKPILP-----GKNEAEQLSKIFEL 215
G D+ S+G + L G LP E K +
Sbjct: 239 LHKGCGPSRRSDLQSLGYCMLKWLYGF--LPWTNCLPNTEDIMKQKQKFV 286
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 59.5 bits (143), Expect = 2e-09
Identities = 21/134 (15%), Positives = 30/134 (22%), Gaps = 4/134 (2%)
Query: 327 HHPQPHGRLPPIQHAGQSHHWSGPNHPMNNAPPPVPGGPGHHHYGKPRGPPGGANRYPSG 386
HH + R+ P Q Q + P PP YG+ PP GA
Sbjct: 3 HHKK---RVYP-QAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQ 58
Query: 387 NQSGGYNNPNRGGQGGGYSNAPYPPQGRGPPYAGAGMPANGPRGPASGYGVGPQSYSQSG 446
Q Q + + P G + Q +
Sbjct: 59 QQFLTPAQEQLHQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAA 118
Query: 447 QYGNSAAGRGPNQM 460
+ M
Sbjct: 119 PAYGQPSAAMGQNM 132
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 51.8 bits (123), Expect = 4e-07
Identities = 11/148 (7%), Positives = 20/148 (13%)
Query: 322 KRQKLHHPQPHGRLPPIQHAGQSHHWSGPNHPMNNAPPPVPGGPGHHHYGKPRGPPGGAN 381
K++ Q + + G P
Sbjct: 5 KKRVYPQAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTP 64
Query: 382 RYPSGNQSGGYNNPNRGGQGGGYSNAPYPPQGRGPPYAGAGMPANGPRGPASGYGVGPQS 441
+Q + P P + Q
Sbjct: 65 AQEQLHQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQP 124
Query: 442 YSQSGQYGNSAAGRGPNQMGGSRNQQYG 469
+ GQ P +
Sbjct: 125 SAAMGQNMRPMNQLYPIDLLTELPPPIT 152
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 6e-07
Identities = 14/123 (11%), Positives = 20/123 (16%), Gaps = 3/123 (2%)
Query: 350 PNHPMNNAPPPVPGGPGHHHYGKPRGPPGGANRYPSGNQSGGYNNPNRGGQGGGYSNAPY 409
P + P + P+ P Y P+ G Q
Sbjct: 10 PQAQLQYGQNATPLQQP-AQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTPAQEQ 68
Query: 410 PPQGRGPPYAGAGMPANGPRGPASGYGVGPQSYSQSGQYGNSAAGRGPNQMGGSRNQQYG 469
Q A M Q G + + Q
Sbjct: 69 LHQ--QIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSA 126
Query: 470 WQQ 472
Sbjct: 127 AMG 129
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 4e-06
Identities = 38/193 (19%), Positives = 65/193 (33%), Gaps = 56/193 (29%)
Query: 13 LKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPE-------------- 57
LK+ +E + E+KIL + H NV+ L T PG
Sbjct: 60 LKEGATHSEHRAL----MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS 115
Query: 58 ---RDEQGRPDGNKYRGSTYMVF-EYMDHDLTGLADR----------------------- 90
R ++ K +G+ + +Y+ L R
Sbjct: 116 TYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175
Query: 91 ----------PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLA 140
T+ + CY Q+ G+ + + +HRD+ N+L+ + +K+
Sbjct: 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 235
Query: 141 DFGLARSFSYDHN 153
DFGLAR D +
Sbjct: 236 DFGLARDIYKDPD 248
|
| >1dx0_A Prion protein; brain, repeat; NMR {Bos taurus} SCOP: d.6.1.1 PDB: 1dx1_A 1qlx_A 1qlz_A Length = 219 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 3e-05
Identities = 31/131 (23%), Positives = 41/131 (31%), Gaps = 3/131 (2%)
Query: 341 AGQSHHWSGPNHPMNNAPPPVPGGPGHHHYGKPRGPPGGANRYPSGNQSGGYNNPNRGGQ 400
G S + + N PP GG G H G P GG P G GG+ P+ GG
Sbjct: 14 TGGSRYPGQGSPGGNRYPPQGGGGWGQPHGGGWGQPHGGGWGQPHG---GGWGQPHGGGW 70
Query: 401 GGGYSNAPYPPQGRGPPYAGAGMPANGPRGPASGYGVGPQSYSQSGQYGNSAAGRGPNQM 460
G + + G + P + A G G SA R
Sbjct: 71 GQPHGGGGWGQGGTHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSAMSRPLIHF 130
Query: 461 GGSRNQQYGWQ 471
G +Y +
Sbjct: 131 GSDYEDRYYRE 141
|
| >1dx0_A Prion protein; brain, repeat; NMR {Bos taurus} SCOP: d.6.1.1 PDB: 1dx1_A 1qlx_A 1qlz_A Length = 219 | Back alignment and structure |
|---|
Score = 39.8 bits (92), Expect = 8e-04
Identities = 26/140 (18%), Positives = 36/140 (25%), Gaps = 8/140 (5%)
Query: 336 PPIQHAGQSHHWSGPNHPMNNAPPPVPGGPGHHHYGKPRGPPGGANRYPSGNQSGGYNNP 395
++ Q G H P G H G + GG + + GG+
Sbjct: 26 GGNRYPPQGGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQPHGGG---WGQPHGGGGWGQG 82
Query: 396 NRGGQGGGYSNAPYPPQGRGPPYAGAGMPANGPRGPASGYGVGPQSYSQSG----QYGNS 451
+ P A AG G G G + +Y
Sbjct: 83 G-THGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSAMSRPLIHFGSDYEDRYYRE 141
Query: 452 AAGRGPNQMGGSRNQQYGWQ 471
R PNQ+ QY Q
Sbjct: 142 NMHRYPNQVYYRPVDQYSNQ 161
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 472 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.98 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.83 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.72 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.53 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.13 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.06 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.98 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.77 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.36 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.27 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.08 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.05 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.97 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.73 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.56 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.53 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.51 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.38 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.1 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.09 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.09 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.01 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.9 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.75 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.58 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.27 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.17 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.14 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.33 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 95.29 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 93.79 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 92.21 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 92.2 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-57 Score=448.70 Aligned_cols=238 Identities=26% Similarity=0.461 Sum_probs=205.3
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+++.||+.||||+++..... ....+.+|+++|++|+|||||+++++|++ ++.+|||||||
T Consensus 92 ~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~----------------~~~~~ivmEy~ 153 (346)
T 4fih_A 92 IATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLV----------------GDELWVVMEFL 153 (346)
T ss_dssp EEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEE----------------TTEEEEEECCC
T ss_pred EEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEE----------------CCEEEEEEeCC
Confidence 4789999999999999865433 34567899999999999999999999987 66899999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
++ +|.+++.+ .++++.+++.|++||+.||+|||++|||||||||+||||+.+++|||+|||+|+.+.... ......
T Consensus 154 ~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~ 230 (346)
T 4fih_A 154 EGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSL 230 (346)
T ss_dssp TTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCBCCC
T ss_pred CCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-Cccccc
Confidence 96 56666654 369999999999999999999999999999999999999999999999999998765432 344567
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
+||+.|||||++.+ ..|+.++||||||||||||++|+.||.+.+..+.+..|.+......
T Consensus 231 ~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~------------------- 290 (346)
T 4fih_A 231 VGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL------------------- 290 (346)
T ss_dssp CSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC-------------------
T ss_pred ccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC-------------------
Confidence 89999999999976 6789999999999999999999999999999988888865321110
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
..+..+++++++||.+||.+||++|+|++|||+|+||...
T Consensus 291 --------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 291 --------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp --------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred --------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence 0123578899999999999999999999999999999764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-57 Score=458.49 Aligned_cols=278 Identities=37% Similarity=0.594 Sum_probs=227.0
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+++.||+.||||+|+...........+++|+++|++|+|||||++++++..... ....+++|||||||
T Consensus 72 ~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~----------~~~~~~~~ivmE~~ 141 (398)
T 4b99_A 72 SARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVP----------YGEFKSVYVVLDLM 141 (398)
T ss_dssp EEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSC----------TTTCCCEEEEEECC
T ss_pred EEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccc----------cccCCEEEEEEeCC
Confidence 47899999999999998665444455678899999999999999999999976421 11256899999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccC---CCCccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD---HNNTLT 157 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~---~~~~~~ 157 (472)
+|+|.+++.+. ..+++.+++.|++||+.||+|||++|||||||||+||||+.++.+||+|||+|+.+... ......
T Consensus 142 ~g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~ 220 (398)
T 4b99_A 142 ESDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMT 220 (398)
T ss_dssp SEEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCC
T ss_pred CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccc
Confidence 99988888764 47999999999999999999999999999999999999999999999999999876432 223455
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccC-
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF- 236 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~- 236 (472)
+.+||+.|||||++.+...|+.++||||||||||||++|++||.+.+..+++..|++..+.+....|............
T Consensus 221 ~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~ 300 (398)
T 4b99_A 221 EYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQ 300 (398)
T ss_dssp SSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHH
T ss_pred cceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhh
Confidence 6799999999999988677899999999999999999999999999999999999999999887776654332110000
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCCCC
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL 289 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~~~ 289 (472)
.........+..++..++.+++|||.+||.+||++|+|++|+|+||||+....
T Consensus 301 ~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 301 SLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 353 (398)
T ss_dssp SSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred cCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence 00001122355667788999999999999999999999999999999976433
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-57 Score=436.50 Aligned_cols=237 Identities=29% Similarity=0.479 Sum_probs=195.1
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.||+.||||++++... .......+.+|+++|++|+|||||+++++|++ ++.+||||||
T Consensus 31 ~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~----------------~~~~~ivmEy 94 (275)
T 3hyh_A 31 LAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS----------------KDEIIMVIEY 94 (275)
T ss_dssp EEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC----------------SSEEEEEEEC
T ss_pred EEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE----------------CCEEEEEEeC
Confidence 478899999999999986643 33456678899999999999999999999987 6689999999
Q ss_pred CCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 80 MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 80 ~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
|+|+|.+++.+. ..+++.+++.|++||+.||+|||++||+||||||+||||+.++++||+|||+|+..... ....+.
T Consensus 95 ~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--~~~~~~ 171 (275)
T 3hyh_A 95 AGNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--NFLKTS 171 (275)
T ss_dssp CCEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------------
T ss_pred CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC--CccCCe
Confidence 999998887664 46999999999999999999999999999999999999999999999999999865432 234457
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
+||+.|||||++.+...++.++||||||||||+|++|+.||.+.+..+.+..+.+.....
T Consensus 172 ~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~-------------------- 231 (275)
T 3hyh_A 172 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTL-------------------- 231 (275)
T ss_dssp ---CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC--------------------
T ss_pred eECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC--------------------
Confidence 899999999999885556789999999999999999999999998888888776532211
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
+..+++++++||++||+.||++|+|++|+|+|+||+.
T Consensus 232 ----------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 232 ----------PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp ----------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred ----------CCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 1246788999999999999999999999999999964
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-57 Score=451.71 Aligned_cols=239 Identities=24% Similarity=0.439 Sum_probs=207.0
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+++.||+.||||+|++..........+.+|+++|++|+|||||+++++|++ ++.+|||||||
T Consensus 42 ~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~----------------~~~~yiVmEy~ 105 (350)
T 4b9d_A 42 LVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE----------------NGSLYIVMDYC 105 (350)
T ss_dssp EEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----------------TTEEEEEEECC
T ss_pred EEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE----------------CCEEEEEEeCC
Confidence 47899999999999998775554456778999999999999999999999987 66899999999
Q ss_pred CC-ChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 81 DH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 81 ~g-~l~~~~~~-~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
+| +|.+++.. ....+++.+++.|++||+.||+|||++|||||||||+||||+.+++|||+|||+|+.+... ......
T Consensus 106 ~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~~~~~~ 184 (350)
T 4b9d_A 106 EGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-VELARA 184 (350)
T ss_dssp TTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-HHHHHH
T ss_pred CCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC-cccccc
Confidence 85 78777754 3446899999999999999999999999999999999999999999999999999865422 122345
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
.+||+.|||||++.+ ..|+.++||||||||||||++|+.||.+.+..+++.++.+....+.
T Consensus 185 ~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~------------------ 245 (350)
T 4b9d_A 185 CIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPV------------------ 245 (350)
T ss_dssp HHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC------------------
T ss_pred cCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC------------------
Confidence 689999999999987 6789999999999999999999999999999999988876432111
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
+..++.++++||.+||++||++|||++|||+|+||..
T Consensus 246 -----------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 246 -----------SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp -----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred -----------CccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 1246789999999999999999999999999999954
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-56 Score=441.31 Aligned_cols=238 Identities=26% Similarity=0.432 Sum_probs=206.6
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.|++.||||+|++.. ..+.....+.+|+++|++|+|||||+++++|++ ++.+||||||
T Consensus 50 ~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----------------~~~~yivmEy 113 (311)
T 4aw0_A 50 LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD----------------DEKLYFGLSY 113 (311)
T ss_dssp EEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----------------SSEEEEEECC
T ss_pred EEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe----------------CCEEEEEEec
Confidence 58899999999999998653 233456678999999999999999999999987 6689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCC-CCccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH-NNTLT 157 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~ 157 (472)
|+| +|.+++.+. ..+++.+++.|++||+.||+|||+++|+||||||+||||+.++++||+|||+|+.+.... .....
T Consensus 114 ~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~ 192 (311)
T 4aw0_A 114 AKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 192 (311)
T ss_dssp CTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBC
T ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCccccc
Confidence 996 777777653 469999999999999999999999999999999999999999999999999999875433 23445
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
+.+||+.|||||++.+ ..|+.++||||||||||+|++|+.||.+.+..+.+.+|.+.....+
T Consensus 193 ~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p----------------- 254 (311)
T 4aw0_A 193 SFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP----------------- 254 (311)
T ss_dssp CCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-----------------
T ss_pred CcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-----------------
Confidence 6789999999999987 6789999999999999999999999999999999988876432111
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHH------HhcCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKD------ALDSEYFWT 286 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~e------lL~h~~f~~ 286 (472)
..+++++++||++||++||++|+|++| |++||||..
T Consensus 255 -------------~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 255 -------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296 (311)
T ss_dssp -------------TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred -------------cccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence 246788999999999999999999988 589999954
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-56 Score=451.58 Aligned_cols=238 Identities=26% Similarity=0.461 Sum_probs=205.2
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+++.||+.||||+++..... ..+.+.+|+++|++|+|||||+++++|++ .+.+|||||||
T Consensus 169 ~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~----------------~~~~~iVmEy~ 230 (423)
T 4fie_A 169 IATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLV----------------GDELWVVMEFL 230 (423)
T ss_dssp EEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEE----------------TTEEEEEEECC
T ss_pred EEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEE----------------CCEEEEEEeCC
Confidence 5889999999999999865433 35678899999999999999999999987 66899999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
+| +|.+++.. .++++.+++.|++||+.||+|||++|||||||||+||||+.+++|||+|||+|+.+... .......
T Consensus 231 ~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~-~~~~~~~ 307 (423)
T 4fie_A 231 EGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-VPRRKSL 307 (423)
T ss_dssp TTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS-CCCBCCC
T ss_pred CCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC-Ccccccc
Confidence 96 56666543 35999999999999999999999999999999999999999999999999999876543 2344567
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
+||+.|||||++.+ ..|+.++||||||||||||++|+.||.+.+..+.+..|....... ..
T Consensus 308 ~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~-~~----------------- 368 (423)
T 4fie_A 308 VGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR-LK----------------- 368 (423)
T ss_dssp EECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-CS-----------------
T ss_pred ccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC-Cc-----------------
Confidence 89999999999976 679999999999999999999999999999999888886532111 00
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
.+..+++++++||.+||.+||++|+|+.|||+|+||...
T Consensus 369 ---------~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 369 ---------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp ---------CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ---------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 112478899999999999999999999999999999764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-55 Score=429.53 Aligned_cols=233 Identities=24% Similarity=0.398 Sum_probs=192.9
Q ss_pred ccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-C
Q 012062 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-D 83 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~ 83 (472)
..+++.||||++++..........+.+|+++|++|+|||||+++++|++ ++.+|||||||+| +
T Consensus 49 ~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----------------~~~~~ivmEy~~gg~ 112 (304)
T 3ubd_A 49 SDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT----------------EGKLYLILDFLRGGD 112 (304)
T ss_dssp TTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE----------------TTEEEEEECCCTTCE
T ss_pred CCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE----------------CCEEEEEEEcCCCCC
Confidence 4578999999998664333334567899999999999999999999987 6689999999996 6
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccC
Q 012062 84 LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL 163 (472)
Q Consensus 84 l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~ 163 (472)
|.+++.+. ..+++.+++.|++||+.||+|||++||+||||||+||||+.++++||+|||+|+..... .....+.+||+
T Consensus 113 L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~~~~~~~~GT~ 190 (304)
T 3ubd_A 113 LFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH-EKKAYSFCGTV 190 (304)
T ss_dssp EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC------CCCCSCCCCG
T ss_pred HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC-CccccccccCc
Confidence 76766553 46999999999999999999999999999999999999999999999999999865432 23345578999
Q ss_pred CCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhh
Q 012062 164 WYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMK 243 (472)
Q Consensus 164 ~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (472)
.|||||++.+ ..|+.++||||||||||||++|+.||.+.+..+.+.+|.+.....
T Consensus 191 ~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~------------------------ 245 (304)
T 3ubd_A 191 EYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM------------------------ 245 (304)
T ss_dssp GGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC------------------------
T ss_pred ccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC------------------------
Confidence 9999999987 678999999999999999999999999999999998887642211
Q ss_pred hhHHHHhhhccHHHHHHHHHhhccCCCCCCC-----HHHHhcCCCCCC
Q 012062 244 RRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 286 (472)
Q Consensus 244 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t-----~~elL~h~~f~~ 286 (472)
+..+++++++||++||++||++|+| ++||++|+||..
T Consensus 246 ------p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 246 ------PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp ------CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred ------CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 1246789999999999999999998 589999999954
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-54 Score=422.86 Aligned_cols=241 Identities=22% Similarity=0.303 Sum_probs=196.1
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+++.|++.||||++............+.+|+++|++|+|||||+++++|++.. ..+..+|||||||
T Consensus 44 ~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~------------~~~~~~~lvmEy~ 111 (290)
T 3fpq_A 44 KGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV------------KGKKCIVLVTELM 111 (290)
T ss_dssp EEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE------------TTEEEEEEEEECC
T ss_pred EEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc------------CCCcEEEEEEeCC
Confidence 4788999999999999866544445567889999999999999999999997521 1145689999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEcC-CCCeEEeeccceeeeccCCCCcc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ--VLHRDIKGSNLLIDN-EGNLKLADFGLARSFSYDHNNTL 156 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~g--iiHrDLKp~NILl~~-~~~vkL~DFG~a~~~~~~~~~~~ 156 (472)
++ +|.+++.+ ...+++.+++.|++||+.||+|||+++ ||||||||+||||+. ++++||+|||+|+... ....
T Consensus 112 ~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~---~~~~ 187 (290)
T 3fpq_A 112 TSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFA 187 (290)
T ss_dssp CSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC---TTSB
T ss_pred CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC---CCcc
Confidence 96 66666654 346999999999999999999999998 999999999999985 7899999999997543 2334
Q ss_pred ccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccC
Q 012062 157 TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236 (472)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (472)
...+||+.|||||++.+ .|+.++||||||||||||++|+.||.+.+....+.+.+.....+
T Consensus 188 ~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~----------------- 248 (290)
T 3fpq_A 188 KAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP----------------- 248 (290)
T ss_dssp EESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC-----------------
T ss_pred CCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC-----------------
Confidence 55789999999998865 58999999999999999999999998776655544443211100
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
..+...+++++++||.+||..||++|||++|+|+||||+.
T Consensus 249 ----------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 249 ----------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ----------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ----------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 0112346678999999999999999999999999999964
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-54 Score=427.06 Aligned_cols=234 Identities=24% Similarity=0.310 Sum_probs=195.1
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+++.||+.||||+++.+.. ..+|+.+|++|+|||||+++++|++ .+.+|||||||
T Consensus 76 ~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~----------------~~~~~ivmEy~ 132 (336)
T 4g3f_A 76 RMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVRE----------------GPWVNIFMELL 132 (336)
T ss_dssp EEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEE----------------TTEEEEEECCC
T ss_pred EEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEE----------------CCEEEEEEecc
Confidence 478999999999999986432 2479999999999999999999987 66899999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC-CeEEeeccceeeeccCCCC----
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG-NLKLADFGLARSFSYDHNN---- 154 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~-~vkL~DFG~a~~~~~~~~~---- 154 (472)
+| +|.+++.+. ..+++.+++.|+.||+.||+|||+++||||||||+||||+.++ ++||+|||+|+.+......
T Consensus 133 ~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~ 211 (336)
T 4g3f_A 133 EGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211 (336)
T ss_dssp TTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----------
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccccee
Confidence 96 677776543 4699999999999999999999999999999999999999987 5999999999876543221
Q ss_pred ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 155 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
.....+||+.|||||++.+ ..|+.++||||||||||||++|+.||.+.+..+.+.+|.....
T Consensus 212 ~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~----------------- 273 (336)
T 4g3f_A 212 TGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPP----------------- 273 (336)
T ss_dssp --CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCC-----------------
T ss_pred cCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCC-----------------
Confidence 2234579999999999987 6799999999999999999999999999887777777755211
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHH-------------hcCCCCCC
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDA-------------LDSEYFWT 286 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~el-------------L~h~~f~~ 286 (472)
....++..+++++++||.+||.+||++|||+.|| |+|||+..
T Consensus 274 ----------~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~ 328 (336)
T 4g3f_A 274 ----------PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE 328 (336)
T ss_dssp ----------GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred ----------CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence 0112234678899999999999999999999997 57999854
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-52 Score=418.51 Aligned_cols=257 Identities=26% Similarity=0.437 Sum_probs=195.6
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-C
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-D 83 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~ 83 (472)
.+++.||||++.... ...++.+|+++|+.+ +|||||+++++|++ ++++|||||||++ +
T Consensus 47 ~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~----------------~~~~~lvmE~~~g~~ 106 (361)
T 4f9c_A 47 GPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRK----------------NDHVVIAMPYLEHES 106 (361)
T ss_dssp SCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE----------------TTEEEEEEECCCCCC
T ss_pred CCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEE----------------CCEEEEEEeCCCccc
Confidence 578899999986542 345678999999998 69999999999987 6689999999985 6
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC-CCeEEeeccceeeeccCC----------
Q 012062 84 LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE-GNLKLADFGLARSFSYDH---------- 152 (472)
Q Consensus 84 l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~-~~vkL~DFG~a~~~~~~~---------- 152 (472)
|.+++. .+++.+++.|++||+.||+|||++||+||||||+||||+.+ +.+||+|||+|+......
T Consensus 107 L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~ 182 (361)
T 4f9c_A 107 FLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSE 182 (361)
T ss_dssp HHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC---
T ss_pred HHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccccccccccc
Confidence 777663 48999999999999999999999999999999999999876 789999999998654321
Q ss_pred -----------------CCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCC-CCCChHHHHHHHHH
Q 012062 153 -----------------NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPIL-PGKNEAEQLSKIFE 214 (472)
Q Consensus 153 -----------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf-~~~~~~~~~~~i~~ 214 (472)
....+..+||+.|||||++.+...|+.++||||||||+|+|++|+.|| .+.++.+++..|+.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~ 262 (361)
T 4f9c_A 183 AQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMT 262 (361)
T ss_dssp -----------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
Confidence 112345689999999999988667999999999999999999999887 56678888998888
Q ss_pred hcCCCCCCCCccCC--------CCCcc------------cc----CCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCC
Q 012062 215 LCGSPDETIWPGVS--------KMPAY------------NH----FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPS 270 (472)
Q Consensus 215 ~~~~~~~~~~~~~~--------~~~~~------------~~----~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~ 270 (472)
.++.+....+.... ..+.. .. +.............+..++++++|||++||+.||+
T Consensus 263 ~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~ 342 (361)
T 4f9c_A 263 IRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPA 342 (361)
T ss_dssp HHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTT
T ss_pred hcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChh
Confidence 76643211111000 00000 00 00000001112234567899999999999999999
Q ss_pred CCCCHHHHhcCCCCCC
Q 012062 271 QRISAKDALDSEYFWT 286 (472)
Q Consensus 271 ~R~t~~elL~h~~f~~ 286 (472)
+|+|++|+|+||||+.
T Consensus 343 ~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 343 SRITAEEALLHPFFKD 358 (361)
T ss_dssp TSCCHHHHHTSGGGTT
T ss_pred HCcCHHHHhcCcccCC
Confidence 9999999999999954
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-51 Score=434.23 Aligned_cols=244 Identities=25% Similarity=0.400 Sum_probs=210.6
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+++.||+.||||+++..... ....+.+|+++|+.|+|||||+++++|++ .+.+|||||||
T Consensus 175 ~~~~~~tg~~~AiK~i~~~~~~--~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----------------~~~~~iv~E~~ 236 (573)
T 3uto_A 175 RVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHPTLVNLHDAFED----------------DNEMVMIYEFM 236 (573)
T ss_dssp EEEETTTCCEEEEEEEECCSHH--HHHHHHHHHHHHHHTCCTTBCCEEEEEEC----------------SSEEEEEEECC
T ss_pred EEEECCCCCEEEEEEEeccchh--hHHHHHHHHHHHHhCCCCCCCeEEEEEEE----------------CCEEEEEEeec
Confidence 4789999999999999865432 24567899999999999999999999987 67899999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC--CCeEEeeccceeeeccCCCCccc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE--GNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~--~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
+| +|.+++.+....|++.+++.|++||+.||+|||+++|+||||||+||||+.+ +.+||+|||+|+.+... ....
T Consensus 237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~--~~~~ 314 (573)
T 3uto_A 237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSVK 314 (573)
T ss_dssp CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--SEEE
T ss_pred CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC--Ccee
Confidence 85 7878777666679999999999999999999999999999999999999864 78999999999877532 3345
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..+||+.|||||++.+ ..|+.++||||||||||+|++|+.||.+.+..+.+..|......+....
T Consensus 315 ~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------------- 379 (573)
T 3uto_A 315 VTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA-------------- 379 (573)
T ss_dssp EECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGG--------------
T ss_pred eeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCccc--------------
Confidence 5689999999999987 6789999999999999999999999999999999998876544333222
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPC 291 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~~~~~ 291 (472)
+..+++++++||++||..||++|+|+.|+|+|+||+....+.
T Consensus 380 ------------~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~ 421 (573)
T 3uto_A 380 ------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 421 (573)
T ss_dssp ------------GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred ------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence 235788999999999999999999999999999997654443
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-51 Score=401.07 Aligned_cols=249 Identities=22% Similarity=0.315 Sum_probs=182.1
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+++.||+.||||+++.... +.....+.+|+++|++|+|||||+++++|.+.+.... ......+.++|||||||
T Consensus 23 ~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~----~~~~~~~~~l~ivmE~~ 97 (299)
T 4g31_A 23 EAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEK----LQPSSPKVYLYIQMQLC 97 (299)
T ss_dssp EEEETTTCCEEEEEEEEECSS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------------CEEEEEEEECC
T ss_pred EEEECCCCCEEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccc----ccccCCCcEEEEEEecC
Confidence 478999999999999986542 2244678899999999999999999999986432100 00111244689999999
Q ss_pred CC-ChhhhhcCCCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC----
Q 012062 81 DH-DLTGLADRPGL--RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN---- 153 (472)
Q Consensus 81 ~g-~l~~~~~~~~~--~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~---- 153 (472)
++ +|.+++..... ......++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 98 ~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~ 177 (299)
T 4g31_A 98 RKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177 (299)
T ss_dssp CSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC------------
T ss_pred CCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccceecCCCcccccc
Confidence 85 67776655321 245667899999999999999999999999999999999999999999999987654322
Q ss_pred -------CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 012062 154 -------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPG 226 (472)
Q Consensus 154 -------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 226 (472)
...+..+||+.|||||++.+ ..|+.++||||||||||||++ ||.+.. +....+.......
T Consensus 178 ~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~~~~~~~~~~------- 244 (299)
T 4g31_A 178 LTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQM--ERVRTLTDVRNLK------- 244 (299)
T ss_dssp --------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHHHHHHHHTTC-------
T ss_pred ccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHHHHHHHhcCC-------
Confidence 12344689999999999987 679999999999999999996 675432 3333222221100
Q ss_pred CCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 227 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
....+...++.+++||++||+.||++|||+.|||+|+||..
T Consensus 245 -------------------~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 245 -------------------FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285 (299)
T ss_dssp -------------------CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred -------------------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence 01223345667889999999999999999999999999964
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=391.95 Aligned_cols=232 Identities=18% Similarity=0.273 Sum_probs=185.1
Q ss_pred CCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chhh
Q 012062 8 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTG 86 (472)
Q Consensus 8 g~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~~ 86 (472)
...||||+++.........+.+.+|+++|++|+|||||++++++.. +.+|||||||++ +|.+
T Consensus 58 ~~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-----------------~~~~iVmEy~~gGsL~~ 120 (307)
T 3omv_A 58 HGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-----------------DNLAIVTQWCEGSSLYK 120 (307)
T ss_dssp SSEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----------------SSCEEEEECCSSCBHHH
T ss_pred CCcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-----------------CeEEEEEEcCCCCCHHH
Confidence 3469999998665444456678899999999999999999998853 357999999995 7778
Q ss_pred hhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCC-CCccccccccCCC
Q 012062 87 LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH-NNTLTNRVITLWY 165 (472)
Q Consensus 87 ~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~~~gt~~y 165 (472)
++......+++.++..|+.||+.||+|||+++||||||||+||||+.++++||+|||+|+...... .......+||+.|
T Consensus 121 ~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~y 200 (307)
T 3omv_A 121 HLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLW 200 (307)
T ss_dssp HHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTS
T ss_pred HHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCc
Confidence 777666689999999999999999999999999999999999999999999999999998654322 2334556899999
Q ss_pred CChhhhcCC--CCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhh
Q 012062 166 RPPELLLGA--TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMK 243 (472)
Q Consensus 166 ~aPE~l~~~--~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (472)
||||++.+. ..|+.++||||||||||||+||+.||.+.+....+..++......+. .
T Consensus 201 mAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~-----~---------------- 259 (307)
T 3omv_A 201 MAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPD-----L---------------- 259 (307)
T ss_dssp CCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCC-----S----------------
T ss_pred cCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCC-----c----------------
Confidence 999999752 35899999999999999999999999988776666655543221111 0
Q ss_pred hhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 244 RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 244 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...+..+++++.+||.+||+.||++|||+.||++
T Consensus 260 ---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 260 ---SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp ---TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred ---ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 0112346788999999999999999999998864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-49 Score=388.56 Aligned_cols=267 Identities=45% Similarity=0.844 Sum_probs=224.2
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++ .+++.||||+++...........+.+|+++|++++|+||+++++++.+ .+.+||||||++
T Consensus 40 ~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----------------~~~~~lv~e~~~ 102 (311)
T 3niz_A 40 AKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS----------------ERCLTLVFEFME 102 (311)
T ss_dssp EEE-TTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC----------------SSCEEEEEECCS
T ss_pred EEE-CCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc----------------CCEEEEEEcCCC
Confidence 555 369999999998776555566788899999999999999999999976 567999999999
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccc
Q 012062 82 HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 161 (472)
Q Consensus 82 g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 161 (472)
++|.+.+......+++.+++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+... .......++
T Consensus 103 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~ 181 (311)
T 3niz_A 103 KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP-VRSYTHEVV 181 (311)
T ss_dssp EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC-CC---CCCC
T ss_pred CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC-cccccCCcc
Confidence 9999888877777999999999999999999999999999999999999999999999999999876432 223344578
Q ss_pred cCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchh
Q 012062 162 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241 (472)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (472)
|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..++...+.+....|+....++.+........
T Consensus 182 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (311)
T 3niz_A 182 TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVF 261 (311)
T ss_dssp CCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCC
T ss_pred cCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccc
Confidence 99999999998766789999999999999999999999999999999999999999998888887766544332222222
Q ss_pred hhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
...........++.++++||++||..||++|||++|+|+|+||+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 306 (311)
T 3niz_A 262 EKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306 (311)
T ss_dssp CCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred cCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence 234455667788999999999999999999999999999999954
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-49 Score=390.94 Aligned_cols=229 Identities=24% Similarity=0.352 Sum_probs=182.4
Q ss_pred eccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-
Q 012062 4 EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH- 82 (472)
Q Consensus 4 ~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g- 82 (472)
+..+++.||||+++... ....+.+.+|+++|++|+|||||++++++.+ .+.+|||||||++
T Consensus 67 ~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~----------------~~~~~lV~Ey~~~G 128 (329)
T 4aoj_A 67 PEQDKMLVAVKALKEAS--ESARQDFQREAELLTMLQHQHIVRFFGVCTE----------------GRPLLMVFEYMRHG 128 (329)
T ss_dssp C---CEEEEEEEESCCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----------------SSSEEEEEECCTTC
T ss_pred cCCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----------------CCEEEEEEEcCCCC
Confidence 34678999999997543 2235678899999999999999999999986 5578999999995
Q ss_pred ChhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeee
Q 012062 83 DLTGLADRP--------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 148 (472)
Q Consensus 83 ~l~~~~~~~--------------~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 148 (472)
+|.+++.+. ...+++.++..|+.||+.||+|||+++||||||||+||||+.++++||+|||+|+.+
T Consensus 129 ~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~ 208 (329)
T 4aoj_A 129 DLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI 208 (329)
T ss_dssp BHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred cHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEcccccceec
Confidence 777766542 235899999999999999999999999999999999999999999999999999876
Q ss_pred ccCCC-CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 012062 149 SYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPG 226 (472)
Q Consensus 149 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 226 (472)
..... ...+..++|+.|||||++.+ ..|+.++||||||||||||+| |+.||.+.+..+.+..+.+......
T Consensus 209 ~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~~~------ 281 (329)
T 4aoj_A 209 YSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELER------ 281 (329)
T ss_dssp -----------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCCCCC------
T ss_pred cCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC------
Confidence 44322 23344678999999999986 678999999999999999998 8999999999888887765321110
Q ss_pred CCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 227 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...+++++.+||.+||+.||++|||+.||++
T Consensus 282 -----------------------p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 312 (329)
T 4aoj_A 282 -----------------------PRACPPEVYAIMRGCWQREPQQRHSIKDVHA 312 (329)
T ss_dssp -----------------------CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHH
T ss_pred -----------------------cccccHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 1246778999999999999999999999975
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=388.32 Aligned_cols=228 Identities=24% Similarity=0.360 Sum_probs=189.0
Q ss_pred ccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-C
Q 012062 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-D 83 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~ 83 (472)
..+++.||||+++... ....+.+.+|+++|++|+|||||++++++.+ .+.+|||||||++ +
T Consensus 40 ~~~~~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~----------------~~~~~lV~Ey~~~G~ 101 (299)
T 4asz_A 40 EQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVE----------------GDPLIMVFEYMKHGD 101 (299)
T ss_dssp ---CEEEEEEEECSCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----------------SSSEEEEEECCTTCB
T ss_pred CCCCEEEEEEEeCCCC--hHHHHHHHHHHHHHHhCCCCCCccEEEEEee----------------CCEEEEEEEcCCCCc
Confidence 3578899999997543 2235678899999999999999999999986 5578999999985 7
Q ss_pred hhhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccC
Q 012062 84 LTGLADRP------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 151 (472)
Q Consensus 84 l~~~~~~~------------~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 151 (472)
|.+++.+. ...+++.+++.|+.||+.||+|||+++||||||||+||||+.++++||+|||+|+.....
T Consensus 102 L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 181 (299)
T 4asz_A 102 LNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYST 181 (299)
T ss_dssp HHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGG
T ss_pred HHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCcccceecCCC
Confidence 77776532 346999999999999999999999999999999999999999999999999999865433
Q ss_pred CCC-ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 012062 152 HNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 229 (472)
Q Consensus 152 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (472)
... .....++|+.|||||++.+ ..|+.++||||||||||||+| |+.||.+.+..+.+..+.+....+.
T Consensus 182 ~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~--------- 251 (299)
T 4asz_A 182 DYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQR--------- 251 (299)
T ss_dssp GCEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCCC---------
T ss_pred CceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC---------
Confidence 222 2233468999999999987 679999999999999999998 8999999999888888765321110
Q ss_pred CCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 230 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
+..+++++.+||.+||+.||++|||++||++
T Consensus 252 --------------------p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~ 282 (299)
T 4asz_A 252 --------------------PRTCPQEVYELMLGCWQREPHMRKNIKGIHT 282 (299)
T ss_dssp --------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1246778999999999999999999999853
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=419.49 Aligned_cols=236 Identities=22% Similarity=0.360 Sum_probs=192.1
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHH---HHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEE
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIR---EIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMV 76 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~---Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iV 76 (472)
+|+++.||+.||||+|++... .......+.+ ++.+++.++|||||+++++|++ .+.+|||
T Consensus 207 la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~----------------~~~lylV 270 (689)
T 3v5w_A 207 GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT----------------PDKLSFI 270 (689)
T ss_dssp EEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC----------------SSEEEEE
T ss_pred EEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE----------------CCEEEEE
Confidence 588999999999999976531 1222233334 4666777899999999999997 6689999
Q ss_pred EecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCc
Q 012062 77 FEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT 155 (472)
Q Consensus 77 mEy~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 155 (472)
||||.| +|..++.+. ..|++..++.|++||+.||+|||++|||||||||+||||+.+|+|||+|||+|+.+... .
T Consensus 271 mEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~---~ 346 (689)
T 3v5w_A 271 LDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---K 346 (689)
T ss_dssp ECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---C
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCC---C
Confidence 999996 677766553 46999999999999999999999999999999999999999999999999999876533 2
Q ss_pred cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCCCCCCccCCCCCc
Q 012062 156 LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE---AEQLSKIFELCGSPDETIWPGVSKMPA 232 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (472)
..+.+||+.|||||++.+...|+.++||||||||||||++|+.||.+.+. .+....+......
T Consensus 347 ~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~-------------- 412 (689)
T 3v5w_A 347 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE-------------- 412 (689)
T ss_dssp CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCC--------------
T ss_pred CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCC--------------
Confidence 34568999999999997556799999999999999999999999986533 2333333321110
Q ss_pred cccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCC-----HHHHhcCCCCCC
Q 012062 233 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 286 (472)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t-----~~elL~h~~f~~ 286 (472)
++..++.++++||.+||.+||++|++ ++||++|+||..
T Consensus 413 ----------------~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 413 ----------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp ----------------CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred ----------------CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 11247889999999999999999998 799999999953
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=379.68 Aligned_cols=268 Identities=42% Similarity=0.785 Sum_probs=228.6
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+++...........+.+|++++++++|+||+++++++.+ .+.+||||||+
T Consensus 20 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~~ 83 (292)
T 3o0g_A 20 KAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS----------------DKKLTLVFEFC 83 (292)
T ss_dssp EEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE----------------TTEEEEEEECC
T ss_pred EEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe----------------CCEEEEEEecC
Confidence 47889999999999998776666666788899999999999999999999987 56899999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+++++..+......+++.+++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+... .......+
T Consensus 84 ~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 162 (292)
T 3o0g_A 84 DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEV 162 (292)
T ss_dssp SEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC-CSCCCSCC
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc-cccccCCc
Confidence 99998888776678999999999999999999999999999999999999999999999999999876532 23334557
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPI-LPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
+|..|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+++..+.+....|+.....+.+......
T Consensus 163 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (292)
T 3o0g_A 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242 (292)
T ss_dssp SCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCC
T ss_pred cccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccc
Confidence 899999999998766689999999999999999987655 7888889999999999999999888887776655433221
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
. ...........++.++++||++||+.||++|||++|+|+|+||..
T Consensus 243 ~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 288 (292)
T 3o0g_A 243 P-ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp C-TTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred c-CCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccccc
Confidence 1 122233344568899999999999999999999999999999954
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=385.17 Aligned_cols=284 Identities=51% Similarity=0.924 Sum_probs=233.2
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||++............+.+|+++|+.++|+||+++++++...... .....+.+||||||+
T Consensus 35 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~--------~~~~~~~~~lv~e~~ 106 (351)
T 3mi9_A 35 KARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASP--------YNRCKGSIYLVFDFC 106 (351)
T ss_dssp EEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC----------------CEEEEEEECC
T ss_pred EEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccc--------cccCCceEEEEEecc
Confidence 478889999999999987766666677888999999999999999999999874321 111256799999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCC---CCccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH---NNTLT 157 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~---~~~~~ 157 (472)
+++|...+......+++.+++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+.... .....
T Consensus 107 ~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 186 (351)
T 3mi9_A 107 EHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186 (351)
T ss_dssp SEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCC
T ss_pred CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccC
Confidence 999988888776779999999999999999999999999999999999999999999999999998765322 22334
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..++|+.|+|||++.+...++.++||||||||+|+|++|+.||.+.+..+.+..+...++......|+.......+....
T Consensus 187 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (351)
T 3mi9_A 187 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLE 266 (351)
T ss_dssp SSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSC
T ss_pred CcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccc
Confidence 56789999999999876678999999999999999999999999999999999999999999888888776554444333
Q ss_pred CchhhhhhHHHHhh--hccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 012062 238 PSRTMKRRVREVFR--HFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCD 292 (472)
Q Consensus 238 ~~~~~~~~~~~~~~--~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~~~~~~ 292 (472)
.............. ..+..+++||.+||..||++|+|++|+|+|+||+.++.+..
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 323 (351)
T 3mi9_A 267 LVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD 323 (351)
T ss_dssp CCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCCC
T ss_pred cccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCccc
Confidence 32222222222222 24788999999999999999999999999999988766543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=383.45 Aligned_cols=231 Identities=23% Similarity=0.326 Sum_probs=189.9
Q ss_pred eccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-
Q 012062 4 EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH- 82 (472)
Q Consensus 4 ~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g- 82 (472)
+..+++.||||+++.... ....+.+.+|+.+|++|+|||||++++++.. .+.+|||||||++
T Consensus 52 ~~~~~~~VAvK~l~~~~~-~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~----------------~~~~~lV~Ey~~~G 114 (308)
T 4gt4_A 52 PGEQTQAVAIKTLKDKAE-GPLREEFRHEAMLRARLQHPNVVCLLGVVTK----------------DQPLSMIFSYCSHG 114 (308)
T ss_dssp ----CEEEEEEECCC-CC-C-CHHHHHHHHHHHHHCCCTTBCCEEEEECS----------------SSSCEEEEECCSSC
T ss_pred cCCCCeEEEEEEECcccC-hHHHHHHHHHHHHHHhCCCCCCCCcceEEEE----------------CCEEEEEEEcCCCC
Confidence 346788999999975433 3345678999999999999999999999986 4568999999985
Q ss_pred ChhhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceee
Q 012062 83 DLTGLADRP---------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS 147 (472)
Q Consensus 83 ~l~~~~~~~---------------~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~ 147 (472)
+|.+++... ...+++.++..|+.||+.||+|||+++||||||||+||||++++++||+|||+|+.
T Consensus 115 ~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~ 194 (308)
T 4gt4_A 115 DLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE 194 (308)
T ss_dssp BHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCG
T ss_pred cHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEECCccccee
Confidence 777776432 23589999999999999999999999999999999999999999999999999986
Q ss_pred eccCC-CCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCc
Q 012062 148 FSYDH-NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWP 225 (472)
Q Consensus 148 ~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 225 (472)
..... ....+..++|+.|||||++.+ ..|+.++||||||||||||+| |..||.+.+..+.+..+.+....+.
T Consensus 195 ~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~----- 268 (308)
T 4gt4_A 195 VYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPC----- 268 (308)
T ss_dssp GGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCCCC-----
T ss_pred ccCCCceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-----
Confidence 64332 233445678999999999987 679999999999999999998 8999999998888877754321110
Q ss_pred cCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 226 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
...++..+.+||.+||+.||++|||+.||+++
T Consensus 269 ------------------------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 269 ------------------------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp ------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------cccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 12467789999999999999999999999864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-48 Score=376.14 Aligned_cols=266 Identities=45% Similarity=0.837 Sum_probs=220.5
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++ .+++.||||+++...........+.+|++++++++||||+++++++.. .+.+||||||++
T Consensus 21 ~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~~~ 83 (288)
T 1ob3_A 21 AQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT----------------KKRLVLVFEHLD 83 (288)
T ss_dssp EEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC----------------SSCEEEEEECCS
T ss_pred EEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc----------------CCeEEEEEEecC
Confidence 566 689999999998766555556778899999999999999999999986 557999999999
Q ss_pred CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccc
Q 012062 82 HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 161 (472)
Q Consensus 82 g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 161 (472)
++|.+++......+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+.... ......++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~ 162 (288)
T 1ob3_A 84 QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKYTHEIV 162 (288)
T ss_dssp EEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----------C
T ss_pred CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc-cccccccc
Confidence 99988888766679999999999999999999999999999999999999999999999999997654322 22344577
Q ss_pred cCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchh
Q 012062 162 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241 (472)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (472)
|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+++..+.+....|+.....+.+.......
T Consensus 163 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 241 (288)
T 1ob3_A 163 TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY- 241 (288)
T ss_dssp CCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCC-
T ss_pred cccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccc-
Confidence 9999999999875668999999999999999999999999999999999999999988888888766554432211110
Q ss_pred hhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
...........++.++++||++||..||++|||++|+|+|+||..
T Consensus 242 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp CCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 011223344568899999999999999999999999999999954
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-48 Score=383.19 Aligned_cols=269 Identities=44% Similarity=0.803 Sum_probs=217.0
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+++...........+.+|+++|++++|+||+++++++.. ...+||||||+
T Consensus 52 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~~ 115 (329)
T 3gbz_A 52 KAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH----------------NHRLHLIFEYA 115 (329)
T ss_dssp EEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE----------------TTEEEEEEECC
T ss_pred EEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec----------------CCEEEEEEecC
Confidence 46788999999999998776555556677899999999999999999999987 56899999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc-----CCCCeEEeeccceeeeccCCCCc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID-----NEGNLKLADFGLARSFSYDHNNT 155 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~-----~~~~vkL~DFG~a~~~~~~~~~~ 155 (472)
+++|.+++.... .+++.+++.|+.||+.||+|||+++|+||||||+||||+ .++.+||+|||+++.+... ...
T Consensus 116 ~~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~ 193 (329)
T 3gbz_A 116 ENDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP-IRQ 193 (329)
T ss_dssp SEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC------
T ss_pred CCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc-ccc
Confidence 998888876543 599999999999999999999999999999999999995 4445999999999765432 223
Q ss_pred cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcccc
Q 012062 156 LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (472)
....++|..|+|||++.+...++.++||||||||+|+|++|+.||.+.+..+.+.++++..+.+....|+.....+.+..
T Consensus 194 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (329)
T 3gbz_A 194 FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQ 273 (329)
T ss_dssp ------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhh
Confidence 34457799999999998756689999999999999999999999999999999999999999999988888776655444
Q ss_pred CCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
..+..............++.++++||++||..||++|||++|+|+|+||...
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 274 SFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp TCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 3333222233334445688999999999999999999999999999999653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=377.99 Aligned_cols=268 Identities=42% Similarity=0.825 Sum_probs=222.6
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+++..... .....+.+|+++|++++||||+++++++.. .+.+||||||+
T Consensus 23 ~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----------------~~~~~lv~e~~ 85 (317)
T 2pmi_A 23 KGLNKTTGVYVALKEVKLDSEE-GTPSTAIREISLMKELKHENIVRLYDVIHT----------------ENKLTLVFEFM 85 (317)
T ss_dssp EEECSSSCCEEEEEEEECCSTT-CSCHHHHHHHHHHTTCCBTTBCCEEEEECC----------------TTEEEEEEECC
T ss_pred EEEECCCCcEEEEEEeeccccc-ccHHHHHHHHHHHHhcCCCCcceEEEEEEE----------------CCeEEEEEEec
Confidence 3678899999999999866432 345678899999999999999999999976 56899999999
Q ss_pred CCChhhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCc
Q 012062 81 DHDLTGLADRP-----GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT 155 (472)
Q Consensus 81 ~g~l~~~~~~~-----~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 155 (472)
+++|.+++... ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+.... ..
T Consensus 86 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~ 164 (317)
T 2pmi_A 86 DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV-NT 164 (317)
T ss_dssp CCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC-CC
T ss_pred CCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc-cc
Confidence 99888766532 2358999999999999999999999999999999999999999999999999998764322 23
Q ss_pred cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcccc
Q 012062 156 LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (472)
....++|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+++..+.+....|+...+++.+..
T Consensus 165 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 244 (317)
T 2pmi_A 165 FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNP 244 (317)
T ss_dssp CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCT
T ss_pred CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhccc
Confidence 34457899999999998756789999999999999999999999999999999999999999999999988777665432
Q ss_pred CCCchh---hhhh-HHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 236 FKPSRT---MKRR-VREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 236 ~~~~~~---~~~~-~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
...... .... .......++.++++||++||..||++|||+.|+|+|+||..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 299 (317)
T 2pmi_A 245 NIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299 (317)
T ss_dssp TCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred ccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhc
Confidence 221111 1111 11112357889999999999999999999999999999954
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=379.08 Aligned_cols=273 Identities=43% Similarity=0.774 Sum_probs=228.5
Q ss_pred CceeccCCCEEEEEEeecCCcC---CCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEE
Q 012062 1 MAREIKTGEIVALKKIRMDNEK---EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVF 77 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVm 77 (472)
+|++..+++.||||+++..... ......+.+|+++++.++|+||+++++++.. .+.+||||
T Consensus 28 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~ 91 (346)
T 1ua2_A 28 KARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH----------------KSNISLVF 91 (346)
T ss_dssp EEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC----------------TTCCEEEE
T ss_pred EEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee----------------CCceEEEE
Confidence 3678889999999999864322 2334578899999999999999999999976 55789999
Q ss_pred ecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 78 EYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 78 Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
||++++|..++......+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+... .....
T Consensus 92 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-~~~~~ 170 (346)
T 1ua2_A 92 DFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-NRAYT 170 (346)
T ss_dssp ECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC-CCCCC
T ss_pred EcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC-cccCC
Confidence 99999988888777667999999999999999999999999999999999999999999999999999765432 22334
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..++|+.|+|||++.+...++.++||||||||+|+|++|.+||.+.+..+.+.++++..+.+....|+.....+.+..+.
T Consensus 171 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (346)
T 1ua2_A 171 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 250 (346)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred cccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCccccccc
Confidence 56789999999999775668899999999999999999999999999999999999999999999998887766654443
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCD 292 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~~~~~~ 292 (472)
... .......+..++.++++||++||..||++|||+.|+|+|+||...+.+..
T Consensus 251 ~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~ 303 (346)
T 1ua2_A 251 SFP--GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP 303 (346)
T ss_dssp CCC--CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCC
T ss_pred ccC--CCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCC
Confidence 221 12345566788999999999999999999999999999999987655443
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=382.44 Aligned_cols=268 Identities=42% Similarity=0.784 Sum_probs=218.5
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+++...... ....+.+|+++|++++|+||+++++++.. .+.+||||||+
T Consensus 20 ~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~~ 82 (324)
T 3mtl_A 20 KGKSKLTDNLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDIIHT----------------EKSLTLVFEYL 82 (324)
T ss_dssp EEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEEC----------------SSCEEEEEECC
T ss_pred EEEECCCCcEEEEEEEecccccc-cchhHHHHHHHHHhcCCCCCCeeeeEEee----------------CCEEEEEeccc
Confidence 36788899999999997654322 22344579999999999999999999986 56789999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+++|..++......+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++..... .......+
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~ 161 (324)
T 3mtl_A 83 DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP-TKTYDNEV 161 (324)
T ss_dssp SEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------------
T ss_pred ccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC-cccccccc
Confidence 99999888876667999999999999999999999999999999999999999999999999999765432 22334457
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (472)
+|..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+++..+.+....|+.......+..+....
T Consensus 162 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (324)
T 3mtl_A 162 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPK 241 (324)
T ss_dssp -CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCC
T ss_pred CcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccccccc
Confidence 79999999999876678999999999999999999999999999999999999999999998888765543332222222
Q ss_pred hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
............++.++++||++||..||++|||++|||+|+||..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 287 (324)
T 3mtl_A 242 YRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS 287 (324)
T ss_dssp CCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred ccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhh
Confidence 2233345556778999999999999999999999999999999964
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=398.26 Aligned_cols=274 Identities=37% Similarity=0.615 Sum_probs=209.4
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+++.+++.||||++............+++|+++|++|+|+|||++++++...+.+ ....+||||||+
T Consensus 71 ~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-----------~~~~~~lv~e~~ 139 (458)
T 3rp9_A 71 EAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVE-----------KFDELYVVLEIA 139 (458)
T ss_dssp EEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT-----------TCCCEEEEECCC
T ss_pred EEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcc-----------cCceEEEEEecc
Confidence 478899999999999976544444456788999999999999999999999763221 245799999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC-------
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN------- 153 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~------- 153 (472)
+++|..++... ..+++..++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 140 ~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 218 (458)
T 3rp9_A 140 DSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPI 218 (458)
T ss_dssp SEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC-
T ss_pred ccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCcccccccccc
Confidence 99988888664 4699999999999999999999999999999999999999999999999999987643211
Q ss_pred -------------------CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-----------CCCCCCCC
Q 012062 154 -------------------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-----------GKPILPGK 203 (472)
Q Consensus 154 -------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-----------G~~pf~~~ 203 (472)
...+..++|+.|+|||++.....++.++||||||||||||++ ++++|.+.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~ 298 (458)
T 3rp9_A 219 SPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGS 298 (458)
T ss_dssp --------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--
T ss_pred CccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCC
Confidence 234556789999999988665679999999999999999998 78888776
Q ss_pred C--------------------hHHHHHHHHHhcCCCCCCCCccCCCCCc--cccCCCchhhhhhHHHHhhhccHHHHHHH
Q 012062 204 N--------------------EAEQLSKIFELCGSPDETIWPGVSKMPA--YNHFKPSRTMKRRVREVFRHFDRHALELL 261 (472)
Q Consensus 204 ~--------------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ll 261 (472)
+ ..+++..|++.++.+....+........ +....+ ..........+..++.++++||
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~s~~~~dLl 377 (458)
T 3rp9_A 299 SCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFP-KREGTDLAERFPASSADAIHLL 377 (458)
T ss_dssp ------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSC-CCCCCCGGGGSTTSCHHHHHHH
T ss_pred ccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcC-CCCCCCHHHHCCCCCHHHHHHH
Confidence 5 3678888888888876554443322000 000000 0011223344566789999999
Q ss_pred HHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 262 EKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 262 ~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
++||..||++|+|++|||+||||...
T Consensus 378 ~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 378 KRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp HHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHhccCccccCCHHHHhcCHhhhhc
Confidence 99999999999999999999999654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=367.93 Aligned_cols=269 Identities=41% Similarity=0.730 Sum_probs=221.7
Q ss_pred CceeccCCCEEEEEEeecCC---cCCCchhhHHHHHHHHHhcC---CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEE
Q 012062 1 MAREIKTGEIVALKKIRMDN---EKEGFPITAIREIKILKKLQ---HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTY 74 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~---~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 74 (472)
+|++..+++.||||+++... ........+.+|+.+++.++ |+||+++++++..... .....+|
T Consensus 27 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~-----------~~~~~~~ 95 (308)
T 3g33_A 27 KARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT-----------DREIKVT 95 (308)
T ss_dssp EEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS-----------SSEEEEE
T ss_pred EEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC-----------CCceeEE
Confidence 47788999999999997543 22234456778888888775 9999999999986321 1123689
Q ss_pred EEEecCCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC
Q 012062 75 MVFEYMDHDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 153 (472)
Q Consensus 75 iVmEy~~g~l~~~~~~~~-~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~ 153 (472)
|||||++++|.+++.... ..+++.+++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+.. .
T Consensus 96 lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~--~ 173 (308)
T 3g33_A 96 LVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSY--Q 173 (308)
T ss_dssp EEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTT--C
T ss_pred EEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccccccCC--C
Confidence 999999999988877644 3499999999999999999999999999999999999999999999999999976542 2
Q ss_pred CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 012062 154 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 233 (472)
Q Consensus 154 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (472)
......++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+.++++..+.+....|+....++..
T Consensus 174 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 252 (308)
T 3g33_A 174 MALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRG 252 (308)
T ss_dssp CCSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGG
T ss_pred cccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 23345678999999999986 56899999999999999999999999999999999999999999988888876654432
Q ss_pred ccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 234 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.. ..............+++++.+||.+||..||++|||+.|+|+|+||..
T Consensus 253 ~~---~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~ 302 (308)
T 3g33_A 253 AF---PPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302 (308)
T ss_dssp GS---CCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC--
T ss_pred cc---CCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccC
Confidence 11 111233455667789999999999999999999999999999999965
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=382.74 Aligned_cols=270 Identities=36% Similarity=0.586 Sum_probs=210.6
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC-CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||++............+.+|+.+|+.+. |+|||++++++...+ ...+||||||
T Consensus 27 ~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~--------------~~~~~lv~e~ 92 (388)
T 3oz6_A 27 KSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN--------------DRDVYLVFDY 92 (388)
T ss_dssp EEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT--------------SSCEEEEEEC
T ss_pred EEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC--------------CCEEEEEecc
Confidence 4788999999999999765444445567789999999997 999999999998632 3478999999
Q ss_pred CCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccC--------
Q 012062 80 MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD-------- 151 (472)
Q Consensus 80 ~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-------- 151 (472)
|+++|..++... .+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.+...
T Consensus 93 ~~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 170 (388)
T 3oz6_A 93 METDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170 (388)
T ss_dssp CSEEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGG
T ss_pred cCcCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccccccccc
Confidence 999888877653 5899999999999999999999999999999999999999999999999999875421
Q ss_pred ------------CCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 012062 152 ------------HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSP 219 (472)
Q Consensus 152 ------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~ 219 (472)
.....+..++|+.|+|||++.+...++.++||||||||||+|++|+.||.+.+..+++.+++...+.+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p 250 (388)
T 3oz6_A 171 LSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFP 250 (388)
T ss_dssp GCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 11233456889999999999876678999999999999999999999999999999999999888877
Q ss_pred CCCCCccCCCCCc--------------cccCCCchhhhh-hHHH--HhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCC
Q 012062 220 DETIWPGVSKMPA--------------YNHFKPSRTMKR-RVRE--VFRHFDRHALELLEKMLMLDPSQRISAKDALDSE 282 (472)
Q Consensus 220 ~~~~~~~~~~~~~--------------~~~~~~~~~~~~-~~~~--~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~ 282 (472)
....+........ ...+........ .... ....++.++++||++||..||++|+|++|+|+||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp 330 (388)
T 3oz6_A 251 SNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHP 330 (388)
T ss_dssp CHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTST
T ss_pred CHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCH
Confidence 6544332211000 000000000000 0000 0125688999999999999999999999999999
Q ss_pred CCCC
Q 012062 283 YFWT 286 (472)
Q Consensus 283 ~f~~ 286 (472)
||..
T Consensus 331 ~~~~ 334 (388)
T 3oz6_A 331 FVSI 334 (388)
T ss_dssp TTTT
T ss_pred HHHH
Confidence 9954
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=373.82 Aligned_cols=238 Identities=28% Similarity=0.488 Sum_probs=202.9
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..||+.||||+++...........+.+|+++|+.++||||+++++++.. .+.+||||||+
T Consensus 33 ~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----------------~~~~~lv~e~~ 96 (328)
T 3fe3_A 33 LARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET----------------EKTLYLIMEYA 96 (328)
T ss_dssp EEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC----------------SSEEEEEECCC
T ss_pred EEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE----------------CCEEEEEEECC
Confidence 47888999999999998765444455678899999999999999999999987 56899999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
++ +|.+++... ..+++.+++.++.||+.||+|||+++|+||||||+||||+.++++||+|||++..+... ......
T Consensus 97 ~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--~~~~~~ 173 (328)
T 3fe3_A 97 SGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLDAF 173 (328)
T ss_dssp TTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS--CGGGTT
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC--Cccccc
Confidence 85 666666543 46999999999999999999999999999999999999999999999999999765432 334556
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
++|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+.......+
T Consensus 174 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p------------------- 234 (328)
T 3fe3_A 174 CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP------------------- 234 (328)
T ss_dssp SSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-------------------
T ss_pred cCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-------------------
Confidence 8899999999998754456899999999999999999999999998888887765322111
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
..++.++.+||++||..||++|||++|+|+|+||...
T Consensus 235 -----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 235 -----------FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp -----------TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred -----------CCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCC
Confidence 1357789999999999999999999999999999653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=394.64 Aligned_cols=270 Identities=31% Similarity=0.512 Sum_probs=209.3
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+++...........+.+|+++|+.++|+|||+++++|...... .....+||||||+
T Consensus 80 ~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~----------~~~~~~~lv~E~~ 149 (464)
T 3ttj_A 80 AAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL----------EEFQDVYLVMELM 149 (464)
T ss_dssp EEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST----------TTCCEEEEEEECC
T ss_pred EEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcc----------ccCCeEEEEEeCC
Confidence 478899999999999986644444566788999999999999999999999764311 1145789999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
++++...+.. .+++.+++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.... ....+..+
T Consensus 150 ~~~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~--~~~~~~~~ 224 (464)
T 3ttj_A 150 DANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYV 224 (464)
T ss_dssp SEEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-------CCCC----
T ss_pred CCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC--CcccCCCc
Confidence 9998887754 489999999999999999999999999999999999999999999999999986543 23345568
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC--------CCc
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK--------MPA 232 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--------~~~ 232 (472)
+|+.|+|||++.+ ..|+.++||||||||||+|++|+.||.+.+..+++.++++.++.+....|..... .+.
T Consensus 225 gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~ 303 (464)
T 3ttj_A 225 VTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 303 (464)
T ss_dssp CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCC
T ss_pred ccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccc
Confidence 8999999999987 5789999999999999999999999999999999999999988876544433211 000
Q ss_pred cccCCCchhh----hhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 233 YNHFKPSRTM----KRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 233 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
+......... ...........+.++++||++||..||++|+|++|+|+||||..
T Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 304 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp CCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred cCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 0000000000 00001111223678999999999999999999999999999964
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=387.45 Aligned_cols=274 Identities=33% Similarity=0.569 Sum_probs=214.3
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+++.+++.||||+++...........+++|+++|++|+|+|||++++++...... ....+||||||+
T Consensus 44 ~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~-----------~~~~~~lv~e~~ 112 (432)
T 3n9x_A 44 LAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLL-----------KFDELYIVLEIA 112 (432)
T ss_dssp EEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT-----------TCCCEEEEEECC
T ss_pred EEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCC-----------cCCeEEEEEecC
Confidence 478899999999999986544444456788999999999999999999999763211 135789999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC-------
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN------- 153 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~------- 153 (472)
+++|..++... ..+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.......
T Consensus 113 ~~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 191 (432)
T 3n9x_A 113 DSDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191 (432)
T ss_dssp SEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC------------
T ss_pred CcCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccc
Confidence 99988888664 4699999999999999999999999999999999999999999999999999987654321
Q ss_pred --------------CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-----------CCCCCCCCC----
Q 012062 154 --------------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-----------GKPILPGKN---- 204 (472)
Q Consensus 154 --------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-----------G~~pf~~~~---- 204 (472)
...+..++|+.|+|||++.....++.++||||||||||+|++ +.++|.+.+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~ 271 (432)
T 3n9x_A 192 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPL 271 (432)
T ss_dssp -------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC-
T ss_pred cccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCcccccc
Confidence 124667889999999998666779999999999999999998 566666654
Q ss_pred -------------hHHHHHHHHHhcCCCCCCCCccCCCCCcc--ccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCC
Q 012062 205 -------------EAEQLSKIFELCGSPDETIWPGVSKMPAY--NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDP 269 (472)
Q Consensus 205 -------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 269 (472)
..+++..+++.++.+....+......... .... ...........+..+++++++||++||..||
T Consensus 272 ~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP 350 (432)
T 3n9x_A 272 SPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLF-PHRKPINLKQKYPSISDDGINLLESMLKFNP 350 (432)
T ss_dssp ---------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTS-CCCCCCCHHHHSTTSCHHHHHHHHHHSCSST
T ss_pred CcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhC-CCCCCCCHHHHCCCCCHHHHHHHHHHhcCCc
Confidence 46788889999888876554433221000 0000 0011223445567789999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCC
Q 012062 270 SQRISAKDALDSEYFWTD 287 (472)
Q Consensus 270 ~~R~t~~elL~h~~f~~~ 287 (472)
++|+|++|||+||||...
T Consensus 351 ~~R~ta~e~L~Hp~f~~~ 368 (432)
T 3n9x_A 351 NKRITIDQALDHPYLKDV 368 (432)
T ss_dssp TTSCCHHHHHTCGGGTTT
T ss_pred ccCCCHHHHhcChhhhhc
Confidence 999999999999999654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=379.53 Aligned_cols=231 Identities=23% Similarity=0.374 Sum_probs=185.8
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCC-CCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-C
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQH-ENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-D 83 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~ 83 (472)
.+++.||||+++...... ....+++|+++|++|+| ||||+++++|... .+.+|||||||++ +
T Consensus 92 ~~~k~VAvK~l~~~~~~~-~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~---------------~~~~~iV~Ey~~~G~ 155 (353)
T 4ase_A 92 ATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNVVNLLGACTKP---------------GGPLMVIVEFCKFGN 155 (353)
T ss_dssp TCEEEEEEEEECTTCCHH-HHHHHHHHHHHHHHHCCCTTBCCEEEEECCT---------------TSCCEEEEECCTTEE
T ss_pred cCCeEEEEEEEccccChH-HHHHHHHHHHHHHHcCCCCcEEEEEEEEEec---------------CCEEEEEEEcCCCCC
Confidence 355789999997654322 34568899999999975 8999999998652 3468999999995 7
Q ss_pred hhhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeee
Q 012062 84 LTGLADRP---------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 148 (472)
Q Consensus 84 l~~~~~~~---------------~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 148 (472)
|.+++.+. ...+++.++..|+.||+.||+|||+++||||||||+||||++++++||+|||+|+.+
T Consensus 156 L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~ 235 (353)
T 4ase_A 156 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 235 (353)
T ss_dssp HHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCT
T ss_pred HHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCCEEECcchhhhhc
Confidence 77776432 234899999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCC-ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 012062 149 SYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPG 226 (472)
Q Consensus 149 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 226 (472)
...... .....++|+.|||||++.+ ..|+.++||||||||||||+| |+.||.+.+..+.+.+++.....+.
T Consensus 236 ~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~------ 308 (353)
T 4ase_A 236 YKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR------ 308 (353)
T ss_dssp TTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC------
T ss_pred ccCCCceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCC------
Confidence 543332 2344578999999999987 679999999999999999998 9999998775555544443221111
Q ss_pred CCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 227 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
....+++++.+||.+||+.||++|||+.||++|
T Consensus 309 ----------------------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 309 ----------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp ----------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 012367789999999999999999999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=379.13 Aligned_cols=270 Identities=36% Similarity=0.594 Sum_probs=217.4
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..||+.||||++............+.+|+++|+.++|+||+++++++...... .....+||||||+
T Consensus 43 ~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~----------~~~~~~~lv~e~~ 112 (367)
T 1cm8_A 43 SAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL----------DDFTDFYLVMPFM 112 (367)
T ss_dssp EEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST----------TTCCCCEEEEECC
T ss_pred EEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcc----------ccCceEEEEEecC
Confidence 367889999999999976554444566788999999999999999999999864211 1124679999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+++|..++.. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... ..+..+
T Consensus 113 ~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~----~~~~~~ 186 (367)
T 1cm8_A 113 GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS----EMTGYV 186 (367)
T ss_dssp SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS----SCCSSC
T ss_pred CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc----ccCcCc
Confidence 8788877765 3589999999999999999999999999999999999999999999999999987542 234567
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc--cccCCC
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA--YNHFKP 238 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~--~~~~~~ 238 (472)
+|+.|+|||++.+...++.++||||||||+|+|++|+.||.+.+..+++..+++..+.+....+..+..... +....+
T Consensus 187 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 266 (367)
T 1cm8_A 187 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLP 266 (367)
T ss_dssp SCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSC
T ss_pred CCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCC
Confidence 899999999998766789999999999999999999999999999999999999888876554433221000 000000
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
..........+..++..+++||++||..||++|+|++|+|+|+||..-
T Consensus 267 -~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 267 -ELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp -CCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred -CCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 000112233445678999999999999999999999999999999654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=371.79 Aligned_cols=240 Identities=26% Similarity=0.424 Sum_probs=203.8
Q ss_pred CceeccCCCEEEEEEeecCCcCC----CchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEE
Q 012062 1 MAREIKTGEIVALKKIRMDNEKE----GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMV 76 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iV 76 (472)
+|+++.||+.||||+++...... .....+.+|+.+|++|+||||++++++|++ ...+|||
T Consensus 30 ~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----------------~~~~~lv 93 (361)
T 2yab_A 30 KCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN----------------RTDVVLI 93 (361)
T ss_dssp EEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----------------SSEEEEE
T ss_pred EEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe----------------CCEEEEE
Confidence 47888999999999998764322 134678899999999999999999999987 5689999
Q ss_pred EecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC----CeEEeeccceeeeccC
Q 012062 77 FEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG----NLKLADFGLARSFSYD 151 (472)
Q Consensus 77 mEy~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~----~vkL~DFG~a~~~~~~ 151 (472)
|||+.+ +|.+++.. ...+++.+++.|+.||+.||+|||++||+||||||+||||+.++ .+||+|||+++.+...
T Consensus 94 ~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~ 172 (361)
T 2yab_A 94 LELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172 (361)
T ss_dssp EECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTT
T ss_pred EEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCC
Confidence 999975 66666654 44799999999999999999999999999999999999998877 7999999999876532
Q ss_pred CCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 012062 152 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 231 (472)
Q Consensus 152 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (472)
......++|+.|+|||++.+ ..++.++||||||||+|+|++|..||.+.+..+.+..+.......+
T Consensus 173 --~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----------- 238 (361)
T 2yab_A 173 --VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD----------- 238 (361)
T ss_dssp --CCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC-----------
T ss_pred --CccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-----------
Confidence 23345678999999999976 5789999999999999999999999999999888888765432211
Q ss_pred ccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 232 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
...+..++..+++||++||..||++|||+.|+|+||||..
T Consensus 239 ---------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 239 ---------------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp ---------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred ---------------chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 2345568889999999999999999999999999999953
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=379.87 Aligned_cols=269 Identities=38% Similarity=0.702 Sum_probs=206.7
Q ss_pred ccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCCh
Q 012062 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDL 84 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~l 84 (472)
..+++.||||+++... ....+.+|+.+|++|+|+|||+++++|.... ...+||||||++++|
T Consensus 45 ~~~~~~vaiK~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--------------~~~~~lv~e~~~~~l 106 (405)
T 3rgf_A 45 GKDDKDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHA--------------DRKVWLLFDYAEHDL 106 (405)
T ss_dssp SSCCCCEEEEECSSSS----CCHHHHHHHHHHHHCCCTTBCCCCEEEEETT--------------TTEEEEEEECCSEEH
T ss_pred CCCCeEEEEEEECCCC----CCHHHHHHHHHHHhcCCCCeeeEeeEEecCC--------------CCeEEEEEeCCCCCH
Confidence 3678999999997443 3346789999999999999999999996522 557999999999988
Q ss_pred hhhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE----cCCCCeEEeeccceeeeccCC
Q 012062 85 TGLADR--------PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI----DNEGNLKLADFGLARSFSYDH 152 (472)
Q Consensus 85 ~~~~~~--------~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl----~~~~~vkL~DFG~a~~~~~~~ 152 (472)
..++.. ....+++..++.|+.||+.||+|||+++|+||||||+|||| +.++.+||+|||+++.+....
T Consensus 107 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~ 186 (405)
T 3rgf_A 107 WHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 186 (405)
T ss_dssp HHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC------
T ss_pred HHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCC
Confidence 876652 12248999999999999999999999999999999999999 677899999999998765322
Q ss_pred C--CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHhcCCCCC
Q 012062 153 N--NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE---------AEQLSKIFELCGSPDE 221 (472)
Q Consensus 153 ~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~---------~~~~~~i~~~~~~~~~ 221 (472)
. ......++|+.|+|||++.+...++.++||||||||||+|++|+.||.+.+. .+++..+++.++.+..
T Consensus 187 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~ 266 (405)
T 3rgf_A 187 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPAD 266 (405)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCT
T ss_pred cccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCCh
Confidence 1 2334567899999999998756689999999999999999999999987665 4889999999999999
Q ss_pred CCCccCCCCCccccCC----Cch----hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCCCCCC
Q 012062 222 TIWPGVSKMPAYNHFK----PSR----TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPC 291 (472)
Q Consensus 222 ~~~~~~~~~~~~~~~~----~~~----~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~~~~~ 291 (472)
..|.....++...... ... .............+..+++||++||..||++|+|++|||+|+||...+.+.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~~~ 344 (405)
T 3rgf_A 267 KDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPT 344 (405)
T ss_dssp TTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSCCC
T ss_pred hhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCCCc
Confidence 9998877665432110 000 000011111122367899999999999999999999999999998776654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=375.54 Aligned_cols=271 Identities=37% Similarity=0.591 Sum_probs=206.5
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+++...........+.+|+++|+.|+|+||+++++++..... ......+||||||+
T Consensus 47 ~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~----------~~~~~~~~lv~e~~ 116 (367)
T 2fst_X 47 AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS----------LEEFNDVYLVTHLM 116 (367)
T ss_dssp EEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS----------GGGCCCCEEEEECC
T ss_pred EEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCc----------cccCCeEEEEeccc
Confidence 36788999999999997654443445677899999999999999999999976321 11135689999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+++|..++.. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... .....+
T Consensus 117 ~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~ 190 (367)
T 2fst_X 117 GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD----EMTGYV 190 (367)
T ss_dssp CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------------------
T ss_pred CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc----cCCCcC
Confidence 8888777765 3699999999999999999999999999999999999999999999999999976542 234467
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc--cccCCC
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA--YNHFKP 238 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~--~~~~~~ 238 (472)
+|..|+|||++.+...++.++||||||||+|+|++|+.||.+.+..+++..+++.++.+....+..+..... +.....
T Consensus 191 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~ 270 (367)
T 2fst_X 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 270 (367)
T ss_dssp CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSC
T ss_pred cCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccC
Confidence 899999999998756789999999999999999999999999999999999999988876655544332100 000000
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 288 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~~ 288 (472)
..........+..++..+++||++||..||++|+|+.|+|+|+||....
T Consensus 271 -~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 271 -QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp -CCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred -CCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 0011234455667889999999999999999999999999999997543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=368.92 Aligned_cols=240 Identities=27% Similarity=0.393 Sum_probs=202.4
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+++...........+.+|+.+|++|+|||||++++++.+ .+.+|||||||
T Consensus 47 ~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----------------~~~~~lv~e~~ 110 (362)
T 2bdw_A 47 RCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE----------------ESFHYLVFDLV 110 (362)
T ss_dssp EEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC----------------SSEEEEEECCC
T ss_pred EEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe----------------CCEEEEEEecC
Confidence 36788999999999998765443345678899999999999999999999987 56889999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC---CeEEeeccceeeeccCCCCcc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG---NLKLADFGLARSFSYDHNNTL 156 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~---~vkL~DFG~a~~~~~~~~~~~ 156 (472)
.+ +|.+.+... ..+++.+++.++.||+.||+|||+++|+||||||+||||+.++ .+||+|||++...... ...
T Consensus 111 ~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~--~~~ 187 (362)
T 2bdw_A 111 TGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAW 187 (362)
T ss_dssp CSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC--CSC
T ss_pred CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC--ccc
Confidence 96 666666543 4689999999999999999999999999999999999998654 4999999999766532 233
Q ss_pred ccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccC
Q 012062 157 TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236 (472)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (472)
...++|+.|+|||++.+ ..++.++||||||||+|+|++|..||.+.+..+.+..+.......+...
T Consensus 188 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~------------- 253 (362)
T 2bdw_A 188 HGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE------------- 253 (362)
T ss_dssp CCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTG-------------
T ss_pred ccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCccc-------------
Confidence 45678999999999976 5789999999999999999999999999998888887766433322211
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
+..++.++++||.+||..||++|||+.|+|+|+||..
T Consensus 254 -------------~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 254 -------------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp -------------GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred -------------ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 2357789999999999999999999999999999953
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=365.48 Aligned_cols=237 Identities=28% Similarity=0.431 Sum_probs=200.1
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.+++.||||+++... ........+.+|+.+|+.++||||++++++|.. .+.+||||||
T Consensus 23 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----------------~~~~~lv~E~ 86 (337)
T 1o6l_A 23 LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT----------------HDRLCFVMEY 86 (337)
T ss_dssp EEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC----------------SSEEEEEEEC
T ss_pred EEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe----------------CCEEEEEEeC
Confidence 47889999999999998653 123345678899999999999999999999987 5689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
+.+ +|..++.+ ...+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++..... ......
T Consensus 87 ~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~~~~~ 164 (337)
T 1o6l_A 87 ANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKT 164 (337)
T ss_dssp CTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-TCCBCC
T ss_pred CCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC-CCcccc
Confidence 986 56555544 346899999999999999999999999999999999999999999999999999754322 223445
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.......
T Consensus 165 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~------------------- 224 (337)
T 1o6l_A 165 FCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF------------------- 224 (337)
T ss_dssp CEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-------------------
T ss_pred cccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-------------------
Confidence 688999999999876 578999999999999999999999999998888777776432111
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 286 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----t~~elL~h~~f~~ 286 (472)
...++.++++||++||..||++|+ +++||++|+||..
T Consensus 225 -----------p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 225 -----------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp -----------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred -----------CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence 124678899999999999999999 9999999999954
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=377.30 Aligned_cols=240 Identities=26% Similarity=0.404 Sum_probs=204.4
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+++.+++.||+|+++...........+.+|+++|++|+|||||++++++.+ .+.+|||||||
T Consensus 29 ~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----------------~~~~~lv~E~~ 92 (444)
T 3soa_A 29 RCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE----------------EGHHYLIFDLV 92 (444)
T ss_dssp EEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC----------------SSEEEEEECCC
T ss_pred EEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE----------------CCEEEEEEEeC
Confidence 36788999999999998765444345668899999999999999999999987 66899999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC---CCCeEEeeccceeeeccCCCCcc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN---EGNLKLADFGLARSFSYDHNNTL 156 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~---~~~vkL~DFG~a~~~~~~~~~~~ 156 (472)
.+ +|.+.+... ..+++.+++.++.||+.||+|||++||+||||||+||||+. ++.+||+|||++....... ...
T Consensus 93 ~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~-~~~ 170 (444)
T 3soa_A 93 TGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAW 170 (444)
T ss_dssp BCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC-CBC
T ss_pred CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC-cee
Confidence 86 666666544 36999999999999999999999999999999999999984 5679999999997665332 233
Q ss_pred ccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccC
Q 012062 157 TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236 (472)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (472)
...++|+.|+|||++.+ ..++.++||||||||+|+|++|..||.+.+..+.+..+.......+...|
T Consensus 171 ~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~------------ 237 (444)
T 3soa_A 171 FGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEW------------ 237 (444)
T ss_dssp CCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTT------------
T ss_pred ecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcccc------------
Confidence 45688999999999976 57899999999999999999999999999999888888765444333222
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
..+++++++||.+||..||++|||+.|+|+|+||.
T Consensus 238 --------------~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~ 272 (444)
T 3soa_A 238 --------------DTVTPEAKDLINKMLTINPSKRITAAEALKHPWIS 272 (444)
T ss_dssp --------------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTH
T ss_pred --------------ccCCHHHHHHHHHHcCCChhHCCCHHHHhcCcccc
Confidence 24677899999999999999999999999999995
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=361.66 Aligned_cols=269 Identities=35% Similarity=0.593 Sum_probs=207.0
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||++............+.+|++++++++|+||+++++++.. .+.+||||||+
T Consensus 21 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~ 84 (311)
T 4agu_A 21 KCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR----------------KRRLHLVFEYC 84 (311)
T ss_dssp EEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----------------TTEEEEEEECC
T ss_pred EEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec----------------CCeEEEEEEeC
Confidence 36788999999999997665444445667899999999999999999999986 56899999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+++++..+......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++....... ......+
T Consensus 85 ~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 163 (311)
T 4agu_A 85 DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS-DYYDDEV 163 (311)
T ss_dssp SEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----------
T ss_pred CCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-cccCCCc
Confidence 987666555555579999999999999999999999999999999999999999999999999998765322 2334457
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC-Cc
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK-PS 239 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 239 (472)
+|..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+.........+........+.... +.
T Consensus 164 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (311)
T 4agu_A 164 ATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPD 243 (311)
T ss_dssp --GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCC
T ss_pred CCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCC
Confidence 89999999999876678999999999999999999999999999999888887765543321111100000000000 00
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
..........+..++..+.+||++||..||++|||++|||+|+||+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 290 (311)
T 4agu_A 244 PEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFEN 290 (311)
T ss_dssp CSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTT
T ss_pred ccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHh
Confidence 01112233445678899999999999999999999999999999954
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=354.97 Aligned_cols=237 Identities=26% Similarity=0.442 Sum_probs=200.3
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+++..... ....+.+|+.++++++||||+++++++.. .+.+||||||+
T Consensus 38 ~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----------------~~~~~lv~e~~ 99 (297)
T 3fxz_A 38 TAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV----------------GDELWVVMEYL 99 (297)
T ss_dssp EEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEE----------------TTEEEEEEECC
T ss_pred EEEECCCCcEEEEEEeeccccc--HHHHHHHHHHHHhcCCCCCCCeEeEEEEE----------------CCEEEEEEECC
Confidence 3678899999999999865433 35567899999999999999999999987 56799999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
++ +|.+++.+. .+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++....... ......
T Consensus 100 ~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 176 (297)
T 3fxz_A 100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTM 176 (297)
T ss_dssp TTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCBCCC
T ss_pred CCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc-cccCCc
Confidence 75 666666543 58999999999999999999999999999999999999999999999999998765433 233456
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+.........
T Consensus 177 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~------------------ 237 (297)
T 3fxz_A 177 VGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ------------------ 237 (297)
T ss_dssp CSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCS------------------
T ss_pred cCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC------------------
Confidence 78999999999987 57899999999999999999999999999888777766543221110
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
....++..+++||.+||..||++|||+.|+|+|+||..
T Consensus 238 ---------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~ 275 (297)
T 3fxz_A 238 ---------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKI 275 (297)
T ss_dssp ---------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred ---------CccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcc
Confidence 01246788999999999999999999999999999964
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=370.78 Aligned_cols=237 Identities=26% Similarity=0.421 Sum_probs=196.4
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
+|+++.+++.||||+++... ........+.+|+.+|+.+ +||||++++++|.. .+.+|||||
T Consensus 41 ~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~----------------~~~~~lv~E 104 (353)
T 3txo_A 41 LARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT----------------PDRLFFVME 104 (353)
T ss_dssp EEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----------------SSEEEEEEE
T ss_pred EEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe----------------CCEEEEEEe
Confidence 47889999999999998652 1223456678999999998 79999999999987 568999999
Q ss_pred cCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 79 YMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 79 y~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
||.+ +|..++.+. ..+++.+++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+|+..... .....
T Consensus 105 ~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~-~~~~~ 182 (353)
T 3txo_A 105 FVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN-GVTTA 182 (353)
T ss_dssp CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-------
T ss_pred CCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC-Ccccc
Confidence 9996 666665543 46999999999999999999999999999999999999999999999999999753322 22344
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+.++.......+
T Consensus 183 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----------------- 244 (353)
T 3txo_A 183 TFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP----------------- 244 (353)
T ss_dssp ---CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-----------------
T ss_pred ccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-----------------
Confidence 5689999999999986 5689999999999999999999999999999998888876322111
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCH------HHHhcCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA------KDALDSEYFWT 286 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~------~elL~h~~f~~ 286 (472)
..++.++++||++||..||++|+++ +||++|+||..
T Consensus 245 -------------~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 245 -------------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp -------------TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred -------------CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence 1367789999999999999999999 89999999954
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=356.91 Aligned_cols=240 Identities=28% Similarity=0.434 Sum_probs=202.2
Q ss_pred CceeccCCCEEEEEEeecCCcCC----CchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEE
Q 012062 1 MAREIKTGEIVALKKIRMDNEKE----GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMV 76 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iV 76 (472)
+|+++.+++.||||+++...... .....+.+|+.+|++|+||||+++++++.. ...+|||
T Consensus 29 ~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----------------~~~~~lv 92 (326)
T 2y0a_A 29 KCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN----------------KTDVILI 92 (326)
T ss_dssp EEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----------------SSEEEEE
T ss_pred EEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe----------------CCEEEEE
Confidence 37788999999999998654322 134568899999999999999999999986 5689999
Q ss_pred EecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC----CeEEeeccceeeeccC
Q 012062 77 FEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG----NLKLADFGLARSFSYD 151 (472)
Q Consensus 77 mEy~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~----~vkL~DFG~a~~~~~~ 151 (472)
|||+.+ +|.+++.. ...+++.+++.++.||+.||+|||+++|+||||||+||||+.++ .+||+|||+++.+...
T Consensus 93 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~ 171 (326)
T 2y0a_A 93 LELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 171 (326)
T ss_dssp EECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTT
T ss_pred EEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCC
Confidence 999986 66666654 44699999999999999999999999999999999999999887 7999999999876532
Q ss_pred CCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 012062 152 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 231 (472)
Q Consensus 152 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (472)
......++|+.|+|||++.+ ..++.++||||||||+|+|++|..||.+.+..+.+..+........
T Consensus 172 --~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~----------- 237 (326)
T 2y0a_A 172 --NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE----------- 237 (326)
T ss_dssp --SCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCC-----------
T ss_pred --CccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcC-----------
Confidence 23344678999999999876 5789999999999999999999999999988888877765422111
Q ss_pred ccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 232 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
...+..++..+++||++||..||++|||+.|+|+|+||..
T Consensus 238 ---------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 238 ---------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp ---------------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred ---------------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence 1334567889999999999999999999999999999954
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=366.46 Aligned_cols=239 Identities=21% Similarity=0.384 Sum_probs=204.3
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||+|+++.... ....+.+|+.+|+.++||||+++++++.+ .+.+|||||||
T Consensus 23 ~~~~~~~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----------------~~~~~lv~e~~ 83 (321)
T 1tki_A 23 RCVETSSKKTYMAKFVKVKGT---DQVLVKKEISILNIARHRNILHLHESFES----------------MEELVMIFEFI 83 (321)
T ss_dssp EEEETTTTEEEEEEEECCCTH---HHHHHHHHHHHHHHSCCTTBCCEEEEEEE----------------TTEEEEEECCC
T ss_pred EEEECCCCcEEEEEEEecCcc---cHHHHHHHHHHHHhCCCCCCCeEeEEEec----------------CCEEEEEEEeC
Confidence 367889999999999975432 24467899999999999999999999987 56899999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC--CCCeEEeeccceeeeccCCCCccc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN--EGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~--~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
++ +|.+.+......+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.+... ....
T Consensus 84 ~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~--~~~~ 161 (321)
T 1tki_A 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFR 161 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--CEEE
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC--Cccc
Confidence 86 777777766667999999999999999999999999999999999999987 788999999999876432 2334
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..++|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+........
T Consensus 162 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----------------- 223 (321)
T 1tki_A 162 LLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD----------------- 223 (321)
T ss_dssp EEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC-----------------
T ss_pred cccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCC-----------------
Confidence 4578999999999976 5678999999999999999999999999999888888866432221
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
...+..++.++++||++||..||++|||+.|+|+|+||...
T Consensus 224 ---------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 224 ---------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp ---------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred ---------hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 13345678899999999999999999999999999999754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=365.03 Aligned_cols=269 Identities=32% Similarity=0.624 Sum_probs=209.0
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||++............+.+|++++++++|+||+++++++.. .+.+||||||+
T Consensus 43 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~~ 106 (331)
T 4aaa_A 43 KCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK----------------KKRWYLVFEFV 106 (331)
T ss_dssp EEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----------------TTEEEEEEECC
T ss_pred EEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec----------------CCEEEEEEecC
Confidence 36788999999999997665444445667899999999999999999999986 56899999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+++++..+......+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+.... ......+
T Consensus 107 ~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 185 (331)
T 4aaa_A 107 DHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYDDEV 185 (331)
T ss_dssp SEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-------------CC
T ss_pred CcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc-cccCCCc
Confidence 987776665545579999999999999999999999999999999999999999999999999997654322 2334457
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC-Cc
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK-PS 239 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 239 (472)
+|..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+......+......+.+.... +.
T Consensus 186 ~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (331)
T 4aaa_A 186 ATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPE 265 (331)
T ss_dssp CCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCC
T ss_pred CCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCcc
Confidence 89999999999875578999999999999999999999999999999888887766554322111111111100000 01
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
..........+..+++.+.+||.+||..||++|||+.|||+|+||..
T Consensus 266 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 266 IKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp CSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred ccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 11122344555678999999999999999999999999999999943
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=356.87 Aligned_cols=242 Identities=31% Similarity=0.466 Sum_probs=194.0
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+++...... ....+.+|+.+++.++|+||+++++++.. .+.+|||||||
T Consensus 25 ~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----------------~~~~~lv~e~~ 87 (323)
T 3tki_A 25 LAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFYGHRRE----------------GNIQYLFLEYC 87 (323)
T ss_dssp EEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEEC----------------SSEEEEEEECC
T ss_pred EEEECCCCcEEEEEEEEcccccc-hHHHHHHHHHHHHhCCCCCCCeEEEEEec----------------CCeEEEEEEcC
Confidence 46788999999999997654322 34567899999999999999999999987 56889999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCC-CCcccc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH-NNTLTN 158 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~ 158 (472)
++ +|.+++. ....+++.+++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+.... ......
T Consensus 88 ~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 166 (323)
T 3tki_A 88 SGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166 (323)
T ss_dssp TTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCS
T ss_pred CCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCC
Confidence 86 5666554 44569999999999999999999999999999999999999999999999999998764332 223345
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
.++|+.|+|||++.+...++.++|||||||++|+|++|+.||...+...............
T Consensus 167 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------------------- 227 (323)
T 3tki_A 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY------------------- 227 (323)
T ss_dssp CCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT-------------------
T ss_pred CccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc-------------------
Confidence 6789999999999875545788999999999999999999998766543332222211100
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
...+..++..+++||.+||..||++|||+.|+|+|+||...
T Consensus 228 --------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 228 --------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp --------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred --------CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 01123578889999999999999999999999999999653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=358.24 Aligned_cols=234 Identities=24% Similarity=0.402 Sum_probs=200.0
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.+++.||||+++.... .......+.+|+.+|+.++||||+++++++.+ ...+||||||
T Consensus 24 ~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~----------------~~~~~lv~e~ 87 (318)
T 1fot_A 24 LIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD----------------AQQIFMIMDY 87 (318)
T ss_dssp EEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC----------------SSEEEEEECC
T ss_pred EEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe----------------CCEEEEEEeC
Confidence 478889999999999986532 22345667899999999999999999999987 5689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
+.+ +|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... ....
T Consensus 88 ~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~----~~~~ 162 (318)
T 1fot_A 88 IEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYT 162 (318)
T ss_dssp CCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----CBCC
T ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC----cccc
Confidence 986 666666543 4699999999999999999999999999999999999999999999999999986542 2234
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
.++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+.++.......
T Consensus 163 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~------------------- 222 (318)
T 1fot_A 163 LCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF------------------- 222 (318)
T ss_dssp CCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCC-------------------
T ss_pred ccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-------------------
Confidence 578999999999986 678999999999999999999999999999888888886532111
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 286 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----t~~elL~h~~f~~ 286 (472)
...++.++++||++||..||++|+ +++||++|+||..
T Consensus 223 -----------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 223 -----------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp -----------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred -----------CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence 123677899999999999999999 9999999999954
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=367.01 Aligned_cols=273 Identities=37% Similarity=0.619 Sum_probs=217.9
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+++.... ......+.+|+++|++++|+||+++++++.....+ ....+||||||+
T Consensus 45 ~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-----------~~~~~~iv~e~~ 112 (364)
T 3qyz_A 45 SAYDNLNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE-----------QMKDVYIVQDLM 112 (364)
T ss_dssp EEEETTTTEEEEEEEECCTTC-HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT-----------TCCCEEEEEECC
T ss_pred EEEECCCCeEEEEEEeccccC-cHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcc-----------ccceEEEEEccc
Confidence 467889999999999975432 22346778999999999999999999999764321 135689999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC--Ccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTLTN 158 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~--~~~~~ 158 (472)
+++|.+++... .+++.+++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++....... .....
T Consensus 113 ~~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 190 (364)
T 3qyz_A 113 ETDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190 (364)
T ss_dssp SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCC
T ss_pred CcCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccc
Confidence 99988877653 589999999999999999999999999999999999999999999999999987654322 22345
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcccc-CC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH-FK 237 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~ 237 (472)
.++|+.|+|||++.+...++.++||||||||+|+|++|+.||.+.+..+.+..+....+.+....+........... ..
T Consensus 191 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (364)
T 3qyz_A 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 270 (364)
T ss_dssp CCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHT
T ss_pred cccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHh
Confidence 67899999999987766689999999999999999999999999999999999998887776544433221100000 00
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
........+...+..++.++++||++||..||++|||+.|||+|+||...
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 271 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp SCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred cCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 00011122345556788999999999999999999999999999999654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=374.51 Aligned_cols=266 Identities=33% Similarity=0.569 Sum_probs=207.6
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||++..+.. ...+|+++|++|+|+|||+++++|...+.. .....++|||||+
T Consensus 72 ~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~----------~~~~~~~lv~e~~ 135 (420)
T 1j1b_A 72 QAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEK----------KDEVYLNLVLDYV 135 (420)
T ss_dssp EEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETT----------TTEEEEEEEEECC
T ss_pred EEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCC----------CcceeEEeehhcc
Confidence 467889999999999975432 123799999999999999999998653211 1133578999999
Q ss_pred CCChhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC-CCeEEeeccceeeeccCCCCcc
Q 012062 81 DHDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE-GNLKLADFGLARSFSYDHNNTL 156 (472)
Q Consensus 81 ~g~l~~~~~---~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~-~~vkL~DFG~a~~~~~~~~~~~ 156 (472)
.+++..++. .....+++..++.|+.||+.||+|||+++|+||||||+||||+.+ +.+||+|||+++.+... ...
T Consensus 136 ~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~--~~~ 213 (420)
T 1j1b_A 136 PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPN 213 (420)
T ss_dssp CEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT--CCC
T ss_pred cccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccC--CCc
Confidence 987766554 344579999999999999999999999999999999999999965 56899999999876432 223
Q ss_pred ccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccC
Q 012062 157 TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236 (472)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (472)
...++|+.|+|||++.+...++.++||||||||||||++|+.||.+.+..+++.++++.++.+....|.... +.+..+
T Consensus 214 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~--~~~~~~ 291 (420)
T 1j1b_A 214 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEF 291 (420)
T ss_dssp CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHC--SCCCCC
T ss_pred eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC--hhhhhh
Confidence 446789999999999875678999999999999999999999999999999999999888776544333221 111111
Q ss_pred CCchhhhhhHHH-HhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 237 KPSRTMKRRVRE-VFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 237 ~~~~~~~~~~~~-~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.........+.. +...++.++++||++||..||++|+|+.|+|+|+||..
T Consensus 292 ~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~ 342 (420)
T 1j1b_A 292 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 342 (420)
T ss_dssp CCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred ccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcc
Confidence 111111112222 23467889999999999999999999999999999953
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=352.69 Aligned_cols=241 Identities=28% Similarity=0.407 Sum_probs=192.9
Q ss_pred CceeccCCCEEEEEEeecCCcCC------------------------CchhhHHHHHHHHHhcCCCCccceeEEeeCCCC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKE------------------------GFPITAIREIKILKKLQHENVIKLKEIVTSPGP 56 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~------------------------~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 56 (472)
+|++..+++.||||+++...... .....+.+|+++|++|+|+||+++++++....
T Consensus 31 ~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 109 (298)
T 2zv2_A 31 LAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPN- 109 (298)
T ss_dssp EEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTTBCCEEEEEECSS-
T ss_pred EEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC-
Confidence 47788999999999997653211 12356789999999999999999999998632
Q ss_pred CCCCCCCCCCCCcCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC
Q 012062 57 ERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 136 (472)
Q Consensus 57 ~~~~~~~~~~~~~~~~~~iVmEy~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~ 136 (472)
...+||||||++++.+..+.. ...+++.+++.++.||+.||+|||+++|+||||||+||||+.++.
T Consensus 110 -------------~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~ 175 (298)
T 2zv2_A 110 -------------EDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGH 175 (298)
T ss_dssp -------------SSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC
T ss_pred -------------CCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCC
Confidence 457899999998644333332 236999999999999999999999999999999999999999999
Q ss_pred eEEeeccceeeeccCCCCccccccccCCCCChhhhcCCCC--CCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 012062 137 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK--YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 214 (472)
Q Consensus 137 vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~--~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~ 214 (472)
+||+|||+++.+.... ......++|+.|+|||++.+... ++.++|||||||++|+|++|+.||...+.......+..
T Consensus 176 ~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 254 (298)
T 2zv2_A 176 IKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKS 254 (298)
T ss_dssp EEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhc
Confidence 9999999998765332 22344578999999999876432 36789999999999999999999998887776666644
Q ss_pred hcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 215 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
.....+. ...+++++++||.+||..||++|||+.|||+|+||.
T Consensus 255 ~~~~~~~----------------------------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 255 QALEFPD----------------------------QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp CCCCCCS----------------------------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred ccCCCCC----------------------------ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 2211110 023677899999999999999999999999999984
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=371.78 Aligned_cols=270 Identities=30% Similarity=0.512 Sum_probs=200.9
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+++...........+.+|+.+++.++|+||+++++++...... .....+||||||+
T Consensus 43 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~----------~~~~~~~lv~e~~ 112 (371)
T 2xrw_A 43 AAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL----------EEFQDVYIVMELM 112 (371)
T ss_dssp EEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCST----------TTCCEEEEEEECC
T ss_pred EEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccc----------ccccceEEEEEcC
Confidence 367889999999999986544444456788999999999999999999999763211 1134789999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+++|.+.+.. .+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++..... ......+
T Consensus 113 ~~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~ 187 (371)
T 2xrw_A 113 DANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYV 187 (371)
T ss_dssp SEEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----------------
T ss_pred CCCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc--cccCCce
Confidence 9988887753 4899999999999999999999999999999999999999999999999999765432 2334467
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC--------CCc
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK--------MPA 232 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--------~~~ 232 (472)
+|+.|+|||++.+ ..++.++||||||||+|+|++|+.||.+.+..+.+..+++..+.+....+..... .+.
T Consensus 188 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (371)
T 2xrw_A 188 VTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPK 266 (371)
T ss_dssp --CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCC
T ss_pred ecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCcc
Confidence 8999999999987 5789999999999999999999999999999999999988776654333322110 000
Q ss_pred cccCCCchh----hhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 233 YNHFKPSRT----MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 233 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
+........ ............+.++++||++||..||++|||++|+|+|+||..
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 267 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp CCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred ccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 000000000 000001112234678999999999999999999999999999953
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=363.60 Aligned_cols=240 Identities=24% Similarity=0.405 Sum_probs=202.4
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+++.+++.||+|+++..... ....+.+|+++|+.|+|+|||++++++.+ ...+|||||||
T Consensus 69 ~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~~~~~~~~----------------~~~~~lv~E~~ 130 (387)
T 1kob_A 69 RCVEKATGRVFVAKFINTPYPL--DKYTVKNEISIMNQLHHPKLINLHDAFED----------------KYEMVLILEFL 130 (387)
T ss_dssp EEEETTTCCEEEEEEEECCSHH--HHHHHHHHHHHHTTCCSTTBCCEEEEEEC----------------SSEEEEEEECC
T ss_pred EEEECCCCCEEEEEEecccchh--hHHHHHHHHHHHHhCCCcCCCeEEEEEEe----------------CCEEEEEEEcC
Confidence 3678899999999999865322 23467899999999999999999999986 56899999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC--CCCeEEeeccceeeeccCCCCccc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN--EGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~--~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
.+ +|.+++......+++.+++.++.||+.||+|||++||+||||||+||||+. ++.+||+|||+++..... ....
T Consensus 131 ~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~--~~~~ 208 (387)
T 1kob_A 131 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVK 208 (387)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--SCEE
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC--ccee
Confidence 85 777777766667999999999999999999999999999999999999974 467999999999876532 2233
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..++|+.|+|||++.+ ..++.++||||||||+|+|++|..||.+.+..+.+..+...........
T Consensus 209 ~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------------- 273 (387)
T 1kob_A 209 VTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA-------------- 273 (387)
T ss_dssp EECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSST--------------
T ss_pred eeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccc--------------
Confidence 4578999999999976 5689999999999999999999999999998888887766433222211
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
+..++.++++||++||..||++|||+.|+|+|+||...
T Consensus 274 ------------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 274 ------------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp ------------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred ------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 12467889999999999999999999999999999764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=365.26 Aligned_cols=237 Identities=24% Similarity=0.393 Sum_probs=191.4
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
+|+++.+++.||||++++... .......+.+|+.+|+++ +|||||+++++|.+ .+.+|||||
T Consensus 70 ~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~----------------~~~~~lV~E 133 (396)
T 4dc2_A 70 LVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT----------------ESRLFFVIE 133 (396)
T ss_dssp EEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC----------------SSEEEEEEE
T ss_pred EEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE----------------CCEEEEEEE
Confidence 478899999999999987632 233445678999999887 89999999999987 668999999
Q ss_pred cCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 79 YMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 79 y~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
||.+ +|..++.+. ..+++..++.|+.||+.||+|||++||+||||||+||||+.++++||+|||+|+..... .....
T Consensus 134 ~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~-~~~~~ 211 (396)
T 4dc2_A 134 YVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTS 211 (396)
T ss_dssp CCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-TCCBC
T ss_pred cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC-CCccc
Confidence 9986 565555543 46999999999999999999999999999999999999999999999999999753322 23345
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCC---------hHHHHHHHHHhcCCCCCCCCccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN---------EAEQLSKIFELCGSPDETIWPGVS 228 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~---------~~~~~~~i~~~~~~~~~~~~~~~~ 228 (472)
..+||+.|+|||++.+ ..++.++||||||||+|+|++|+.||.... .......+......
T Consensus 212 ~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~---------- 280 (396)
T 4dc2_A 212 TFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR---------- 280 (396)
T ss_dssp CCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC----------
T ss_pred cccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC----------
Confidence 5789999999999987 678999999999999999999999996432 12233333221110
Q ss_pred CCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCH------HHHhcCCCCCC
Q 012062 229 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA------KDALDSEYFWT 286 (472)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~------~elL~h~~f~~ 286 (472)
+...++.++++||++||..||++|+++ +||++|+||..
T Consensus 281 --------------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 281 --------------------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp --------------------CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred --------------------CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 112467889999999999999999985 89999999954
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=361.81 Aligned_cols=241 Identities=30% Similarity=0.474 Sum_probs=196.0
Q ss_pred CceeccCCCEEEEEEeecCC---cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEE
Q 012062 1 MAREIKTGEIVALKKIRMDN---EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVF 77 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~---~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVm 77 (472)
+|+++.+++.||||+++... ........+.+|+.+++.|+||||+++++++.. .+.+||||
T Consensus 42 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----------------~~~~~lv~ 105 (351)
T 3c0i_A 42 RCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS----------------DGMLYMVF 105 (351)
T ss_dssp EEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE----------------TTEEEEEE
T ss_pred EEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe----------------CCEEEEEE
Confidence 36788999999999997542 112235678899999999999999999999987 56899999
Q ss_pred ecCCC-ChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC---eEEeeccceeeecc
Q 012062 78 EYMDH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN---LKLADFGLARSFSY 150 (472)
Q Consensus 78 Ey~~g-~l~~~~~~---~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~---vkL~DFG~a~~~~~ 150 (472)
|||++ +|.+.+.+ ....+++..++.++.||+.||+|||+++|+||||||+||||+.++. +||+|||++..+..
T Consensus 106 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 185 (351)
T 3c0i_A 106 EFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE 185 (351)
T ss_dssp ECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCT
T ss_pred eCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecC
Confidence 99995 66555543 2345899999999999999999999999999999999999987665 99999999987654
Q ss_pred CCCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 012062 151 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 230 (472)
Q Consensus 151 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 230 (472)
.. ......++|+.|+|||++.+ ..++.++||||||||+|+|++|..||.+.+ .+.+..+.......
T Consensus 186 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~----------- 251 (351)
T 3c0i_A 186 SG-LVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKM----------- 251 (351)
T ss_dssp TS-CBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCC-----------
T ss_pred CC-eeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCC-----------
Confidence 32 22345678999999999986 568999999999999999999999998754 34444444321111
Q ss_pred CccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 231 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
....+..++.++++||++||..||++|||+.|+|+|+||..
T Consensus 252 ---------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 252 ---------------NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp ---------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred ---------------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 11234567889999999999999999999999999999954
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=365.35 Aligned_cols=268 Identities=37% Similarity=0.615 Sum_probs=211.4
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+++.+++.||||+++.....+.....+.+|+.+++.++|+||+++++++...+... ....+||||||+
T Consensus 60 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~----------~~~~~~lv~e~~ 129 (371)
T 4exu_A 60 SAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR----------NFYDFYLVMPFM 129 (371)
T ss_dssp EEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSST----------TCCCCEEEEECC
T ss_pred EEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcc----------cceeEEEEEccc
Confidence 4788999999999999876555545677889999999999999999999998643211 122459999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
.++|...+.. .+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... .....+
T Consensus 130 ~~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~----~~~~~~ 202 (371)
T 4exu_A 130 QTDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA----EMTGYV 202 (371)
T ss_dssp CEEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC------------CTT
T ss_pred cccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc----CcCCcc
Confidence 9988777643 489999999999999999999999999999999999999999999999999976543 233457
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc--cccCCC
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA--YNHFKP 238 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~--~~~~~~ 238 (472)
+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+++..+.+....+........ +... .
T Consensus 203 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 281 (371)
T 4exu_A 203 VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQS-L 281 (371)
T ss_dssp CCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHH-S
T ss_pred cCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhc-c
Confidence 799999999998756789999999999999999999999999999999999998887765544332211000 0000 0
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
...........+..++..+++||++||..||++|||+.|+|+|+||..
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 329 (371)
T 4exu_A 282 PQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 329 (371)
T ss_dssp CCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred CCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccccc
Confidence 000112234455678999999999999999999999999999999964
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=366.40 Aligned_cols=270 Identities=21% Similarity=0.274 Sum_probs=196.8
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+++.+++.||||+++...........+.+|+.+|+.++|+|||+++++|.. .+.+|||||||
T Consensus 45 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----------------~~~~~lv~e~~ 108 (389)
T 3gni_B 45 LARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA----------------DNELWVVTSFM 108 (389)
T ss_dssp EEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----------------TTEEEEEEECC
T ss_pred EEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE----------------CCEEEEEEEcc
Confidence 47888999999999998765555456677889999999999999999999987 56899999999
Q ss_pred CC-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCC------
Q 012062 81 DH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH------ 152 (472)
Q Consensus 81 ~g-~l~~~~~~~-~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~------ 152 (472)
++ +|.+++... ...+++..++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||++.......
T Consensus 109 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~ 188 (389)
T 3gni_B 109 AYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVV 188 (389)
T ss_dssp TTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCB
T ss_pred CCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecccccccccc
Confidence 85 666665542 3469999999999999999999999999999999999999999999999999986543221
Q ss_pred CCccccccccCCCCChhhhcCC-CCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC--------CCCC
Q 012062 153 NNTLTNRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSP--------DETI 223 (472)
Q Consensus 153 ~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~--------~~~~ 223 (472)
.......++|+.|+|||++.+. ..++.++||||||||+|+|++|+.||.+.+..+.+..+....... ....
T Consensus 189 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (389)
T 3gni_B 189 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEEL 268 (389)
T ss_dssp CCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------------------
T ss_pred ccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccc
Confidence 1122234779999999999864 468999999999999999999999999877766655443221110 0000
Q ss_pred CccCCCCCcc----ccCC----CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 224 WPGVSKMPAY----NHFK----PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 224 ~~~~~~~~~~----~~~~----~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.......... .... ...............++.++++||++||+.||++|||+.|||+|+||..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~ 339 (389)
T 3gni_B 269 TMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 339 (389)
T ss_dssp -------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred cccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence 0000000000 0000 0000011122345668899999999999999999999999999999964
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=369.73 Aligned_cols=242 Identities=25% Similarity=0.297 Sum_probs=201.8
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.+++.||||++++.. ........+.+|+.+|+.++|||||+++++|.+ ...+||||||
T Consensus 87 ~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----------------~~~~~lV~E~ 150 (410)
T 3v8s_A 87 LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD----------------DRYLYMVMEY 150 (410)
T ss_dssp EEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC----------------SSEEEEEECC
T ss_pred EEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE----------------CCEEEEEEeC
Confidence 47889999999999997642 222334567899999999999999999999987 6689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
|.+ +|.+++... .+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.+..........
T Consensus 151 ~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~ 228 (410)
T 3v8s_A 151 MPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 228 (410)
T ss_dssp CTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCS
T ss_pred CCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccccC
Confidence 975 677766543 58999999999999999999999999999999999999999999999999998765443333446
Q ss_pred ccccCCCCChhhhcCCC---CCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcccc
Q 012062 159 RVITLWYRPPELLLGAT---KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~---~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (472)
.+||+.|+|||++.+.. .++.++||||||||||+|++|+.||.+.+..+.+.+|..........
T Consensus 229 ~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p------------- 295 (410)
T 3v8s_A 229 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP------------- 295 (410)
T ss_dssp CCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC-------------
T ss_pred CcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCC-------------
Confidence 78999999999997632 17889999999999999999999999999998888886532111000
Q ss_pred CCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCC--CCCHHHHhcCCCCCC
Q 012062 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ--RISAKDALDSEYFWT 286 (472)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~--R~t~~elL~h~~f~~ 286 (472)
....++.++++||++||..+|.+ |++++||++|+||..
T Consensus 296 -------------~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~ 335 (410)
T 3v8s_A 296 -------------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 335 (410)
T ss_dssp -------------TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred -------------CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence 01146789999999999999988 999999999999965
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=364.91 Aligned_cols=275 Identities=30% Similarity=0.537 Sum_probs=208.4
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCC-------------------
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ------------------- 61 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~------------------- 61 (472)
+|++..|++.||||++..+... ..+|+++|+.|+|+|||+++++|...+......
T Consensus 25 ~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (383)
T 3eb0_A 25 EVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNN 98 (383)
T ss_dssp EEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC--------------------------
T ss_pred EEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCccccccccccccccccccccccccc
Confidence 3788999999999999754322 237999999999999999999997643210000
Q ss_pred ---CCCCCCCcCCeEEEEEecCCCChhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc-CC
Q 012062 62 ---GRPDGNKYRGSTYMVFEYMDHDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID-NE 134 (472)
Q Consensus 62 ---~~~~~~~~~~~~~iVmEy~~g~l~~~~~---~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~-~~ 134 (472)
...........+||||||++++|.+.+. .....+++..++.|+.||+.||+|||++||+||||||+||||+ .+
T Consensus 99 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~ 178 (383)
T 3eb0_A 99 HHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKD 178 (383)
T ss_dssp -----------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTT
T ss_pred ccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCC
Confidence 0000012245689999999998666554 3455799999999999999999999999999999999999998 57
Q ss_pred CCeEEeeccceeeeccCCCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 012062 135 GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 214 (472)
Q Consensus 135 ~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~ 214 (472)
+.+||+|||+|+.+... ......++|..|+|||++.+...++.++||||||||+|+|++|+.||.+.+..+.+..+++
T Consensus 179 ~~~kl~Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 256 (383)
T 3eb0_A 179 NTLKLCDFGSAKKLIPS--EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQ 256 (383)
T ss_dssp TEEEECCCTTCEECCTT--SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CcEEEEECCCCcccCCC--CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 88999999999876433 2334457899999999998766689999999999999999999999999999999999998
Q ss_pred hcCCCCCCCCccCCCCCccccCCCchhhhhhH-HHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 215 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRV-REVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
.++.+....+..... .+............+ ..+...++.++++||.+||..||++|+|+.|+|+|+||.
T Consensus 257 ~~g~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 326 (383)
T 3eb0_A 257 IMGTPTKEQMIRMNP--HYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFD 326 (383)
T ss_dssp HHCCCCHHHHHHHCT--TC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGH
T ss_pred HhCCCCHHHHHHhCc--ccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHH
Confidence 888765433322111 111111111111122 223345888999999999999999999999999999993
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=361.81 Aligned_cols=237 Identities=26% Similarity=0.436 Sum_probs=199.3
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
+|+++.+++.||||+++... ........+.+|+.+|+.+ +||||++++++|.+ .+.+|||||
T Consensus 35 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~----------------~~~~~lv~E 98 (345)
T 1xjd_A 35 LAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT----------------KENLFFVME 98 (345)
T ss_dssp EEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC----------------SSEEEEEEE
T ss_pred EEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe----------------CCEEEEEEe
Confidence 47888999999999998653 1223455678899999987 89999999999987 568999999
Q ss_pred cCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 79 YMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 79 y~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
|+.+ +|..++.+. ..+++.+++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++..... .....
T Consensus 99 ~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~~~~ 176 (345)
T 1xjd_A 99 YLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-DAKTN 176 (345)
T ss_dssp CCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-TCCBC
T ss_pred CCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC-CCccc
Confidence 9986 666666543 36999999999999999999999999999999999999999999999999999754322 22344
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.......
T Consensus 177 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~------------------ 237 (345)
T 1xjd_A 177 TFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY------------------ 237 (345)
T ss_dssp CCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC------------------
T ss_pred CCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCC------------------
Confidence 5688999999999987 578999999999999999999999999999888888775432111
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHH-HHhcCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAK-DALDSEYFWT 286 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~-elL~h~~f~~ 286 (472)
...++.++++||++||..||++|+++. ||++|+||..
T Consensus 238 ------------p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~ 275 (345)
T 1xjd_A 238 ------------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 275 (345)
T ss_dssp ------------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred ------------CcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccC
Confidence 013677899999999999999999998 9999999954
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=368.14 Aligned_cols=238 Identities=30% Similarity=0.488 Sum_probs=194.7
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||+++... ........+.+|+++|+.++||||+++++++.. .+.+||||||
T Consensus 27 ~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----------------~~~~~lv~E~ 90 (336)
T 3h4j_B 27 LATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT----------------PTDIVMVIEY 90 (336)
T ss_dssp EEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC----------------SSEEEEEECC
T ss_pred EEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe----------------CCEEEEEEEC
Confidence 47888999999999997542 223345678899999999999999999999987 5679999999
Q ss_pred CCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 80 MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 80 ~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
++++|.+++... ..+++.+++.|+.||+.||+|||++||+||||||+||||+.++++||+|||++...... ......
T Consensus 91 ~~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~--~~~~~~ 167 (336)
T 3h4j_B 91 AGGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--NFLKTS 167 (336)
T ss_dssp CCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS--BTTCCC
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC--cccccc
Confidence 998888877654 36999999999999999999999999999999999999999999999999999765432 233456
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
++|+.|+|||++.+....+.++|||||||++|+|++|+.||.+....+.+.++ ...
T Consensus 168 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i---------------~~~--------- 223 (336)
T 3h4j_B 168 CGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV---------------NSC--------- 223 (336)
T ss_dssp TTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC---------------CSS---------
T ss_pred cCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH---------------HcC---------
Confidence 78999999999987544578999999999999999999999765432211100 000
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
.......++.++++||++||..||++|||++|+++|+||...
T Consensus 224 ------~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 224 ------VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp ------CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred ------CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 000112467889999999999999999999999999999653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=360.31 Aligned_cols=234 Identities=26% Similarity=0.399 Sum_probs=200.3
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.+++.||||+++... ........+.+|+.+|+.++||||+++++++.+ ...+||||||
T Consensus 59 ~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----------------~~~~~lv~e~ 122 (350)
T 1rdq_E 59 LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD----------------NSNLYMVMEY 122 (350)
T ss_dssp EEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----------------SSEEEEEEEC
T ss_pred EEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc----------------CCEEEEEEcC
Confidence 47888999999999997653 223345678899999999999999999999987 5689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
+.+ +|.+++.+. ..+++.+++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++..... ...
T Consensus 123 ~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~----~~~ 197 (350)
T 1rdq_E 123 VAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWT 197 (350)
T ss_dssp CTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----BCC
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC----ccc
Confidence 975 676666543 36999999999999999999999999999999999999999999999999999876432 234
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
.++|+.|+|||++.+ ..++.++||||||||+|+|++|+.||.+.+..+.+.++.......
T Consensus 198 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~------------------- 257 (350)
T 1rdq_E 198 LCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF------------------- 257 (350)
T ss_dssp CEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-------------------
T ss_pred ccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCC-------------------
Confidence 578999999999986 578999999999999999999999999999888888886532111
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCC-----HHHHhcCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 286 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t-----~~elL~h~~f~~ 286 (472)
...++.++++||++||..||++|++ ++||++|+||..
T Consensus 258 -----------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 258 -----------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp -----------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred -----------CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 1246778999999999999999998 999999999953
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=372.07 Aligned_cols=245 Identities=22% Similarity=0.334 Sum_probs=204.8
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.+++.||||+++... ........+.+|+.+|+.++|+||++++++|.+ .+.+||||||
T Consensus 92 ~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~----------------~~~~~lV~Ey 155 (437)
T 4aw2_A 92 VVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD----------------DNNLYLVMDY 155 (437)
T ss_dssp EEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC----------------SSEEEEEECC
T ss_pred EEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee----------------CCEEEEEEec
Confidence 47888999999999997642 222234457899999999999999999999987 6689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
|.+ +|.+++.+....+++..++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+............
T Consensus 156 ~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 235 (437)
T 4aw2_A 156 YVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV 235 (437)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECCS
T ss_pred CCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCccccc
Confidence 975 7878877756679999999999999999999999999999999999999999999999999998766544444455
Q ss_pred ccccCCCCChhhhcC----CCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 159 RVITLWYRPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
.+||+.|+|||++.. ...++.++||||||||+|||++|+.||.+.+..+.+.++........ ++
T Consensus 236 ~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~---------~p--- 303 (437)
T 4aw2_A 236 AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ---------FP--- 303 (437)
T ss_dssp CCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC---------CC---
T ss_pred ccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccccc---------CC---
Confidence 689999999999872 35689999999999999999999999999999998888865321110 00
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCC--CCCHHHHhcCCCCCC
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ--RISAKDALDSEYFWT 286 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~--R~t~~elL~h~~f~~ 286 (472)
..+..+++++++||++||..+|++ |++++|+++||||..
T Consensus 304 -------------~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 304 -------------TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp -------------SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred -------------cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence 001236789999999999999888 999999999999954
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=371.05 Aligned_cols=238 Identities=30% Similarity=0.478 Sum_probs=201.5
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..||+.||||+++.... .......+.+|+.+|+.++||||+++++++.. .+.+||||||
T Consensus 34 ~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~----------------~~~~~lv~E~ 97 (476)
T 2y94_A 34 VGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST----------------PSDIFMVMEY 97 (476)
T ss_dssp EEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC----------------SSEEEEEEEC
T ss_pred EEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----------------CCEEEEEEeC
Confidence 478889999999999976532 22345678899999999999999999999987 5679999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
|.+ +|.+++.+ ...+++.+++.++.||+.||+|||+++|+||||||+||||+.++++||+|||++...... .....
T Consensus 98 ~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~--~~~~~ 174 (476)
T 2y94_A 98 VSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRT 174 (476)
T ss_dssp CSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT--CCBCC
T ss_pred CCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc--ccccc
Confidence 975 66666654 457999999999999999999999999999999999999999999999999999876432 23445
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
.++|+.|+|||++.+....+.++||||||||+|+|++|+.||.+.+....+.++.......+
T Consensus 175 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p------------------ 236 (476)
T 2y94_A 175 SCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP------------------ 236 (476)
T ss_dssp CCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC------------------
T ss_pred cCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC------------------
Confidence 68899999999998754457899999999999999999999999888888877765321111
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
..++.++++||++||..||++|||+.||++|+||+..
T Consensus 237 ------------~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 237 ------------QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp ------------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred ------------ccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 1356789999999999999999999999999999754
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=357.61 Aligned_cols=237 Identities=24% Similarity=0.394 Sum_probs=192.3
Q ss_pred CceeccCCCEEEEEEeecCCcC-CCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 1 MAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~-~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
+|+++.|++.||||+++..... ......+.+|+.+|+++ +||||++++++|.+ .+.+|||||
T Consensus 27 ~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~----------------~~~~~lv~e 90 (345)
T 3a8x_A 27 LVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT----------------ESRLFFVIE 90 (345)
T ss_dssp EEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----------------SSEEEEEEC
T ss_pred EEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe----------------CCEEEEEEe
Confidence 4788899999999999866432 22345677899999988 89999999999987 568999999
Q ss_pred cCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 79 YMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 79 y~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
|+.+ +|..++.+. ..+++..++.|+.||+.||+|||+++|+||||||+||||+.++++||+|||+++..... .....
T Consensus 91 ~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~-~~~~~ 168 (345)
T 3a8x_A 91 YVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTS 168 (345)
T ss_dssp CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT-TCCBC
T ss_pred CCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC-CCccc
Confidence 9986 666665543 46999999999999999999999999999999999999999999999999999754322 22344
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCC---------ChHHHHHHHHHhcCCCCCCCCccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK---------NEAEQLSKIFELCGSPDETIWPGVS 228 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~~ 228 (472)
..++|+.|+|||++.+ ..++.++||||||||+|+|++|+.||... +.......+......
T Consensus 169 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~---------- 237 (345)
T 3a8x_A 169 TFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR---------- 237 (345)
T ss_dssp CCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC----------
T ss_pred ccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC----------
Confidence 5688999999999987 57899999999999999999999999752 222233333321100
Q ss_pred CCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCH------HHHhcCCCCCC
Q 012062 229 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA------KDALDSEYFWT 286 (472)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~------~elL~h~~f~~ 286 (472)
+...++.++++||++||..||++|+++ +|+++|+||..
T Consensus 238 --------------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 238 --------------------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp --------------------CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred --------------------CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 112467889999999999999999995 89999999953
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=364.24 Aligned_cols=238 Identities=30% Similarity=0.409 Sum_probs=201.6
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+++..... ....+.+|+++|++|+|+|||++++++.. .+.+|||||||
T Consensus 107 ~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----------------~~~~~lv~E~~ 168 (373)
T 2x4f_A 107 KCEETATGLKLAAKIIKTRGMK--DKEEVKNEISVMNQLDHANLIQLYDAFES----------------KNDIVLVMEYV 168 (373)
T ss_dssp EEEETTTCCEEEEEEEECCSHH--HHHHHHHHHHHHTTCCCTTBCCEEEEEEC----------------SSEEEEEEECC
T ss_pred EEEEcCCCcEEEEEEEcccccc--cHHHHHHHHHHHHhCCCCCCCeEEEEEEE----------------CCEEEEEEeCC
Confidence 3678899999999999865322 24567899999999999999999999987 56899999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE--cCCCCeEEeeccceeeeccCCCCccc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI--DNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl--~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
++ +|.+.+......+++.+++.|+.||+.||+|||+++|+||||||+|||| +.++.+||+|||+++.+.... ...
T Consensus 169 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~~ 246 (373)
T 2x4f_A 169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLK 246 (373)
T ss_dssp TTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BCC
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--ccc
Confidence 85 6777776555579999999999999999999999999999999999999 456789999999998765332 233
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..++|+.|+|||++.. ..++.++||||||||||+|++|+.||.+.+..+.+..+..........
T Consensus 247 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~--------------- 310 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDE--------------- 310 (373)
T ss_dssp CCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSG---------------
T ss_pred cccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChh---------------
Confidence 4578999999999876 568899999999999999999999999999999888887654322211
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
.+..++.++++||.+||..||++|||+.|+|+|+||.
T Consensus 311 -----------~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~ 347 (373)
T 2x4f_A 311 -----------EFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLS 347 (373)
T ss_dssp -----------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred -----------hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcC
Confidence 1235678999999999999999999999999999994
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=368.86 Aligned_cols=244 Identities=25% Similarity=0.374 Sum_probs=201.5
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.|++.||||++++.. ........+.+|+.+|+.++|+||++++++|.+ .+.+||||||
T Consensus 79 ~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~----------------~~~~~lVmE~ 142 (412)
T 2vd5_A 79 VVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD----------------ENYLYLVMEY 142 (412)
T ss_dssp EEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC----------------SSEEEEEECC
T ss_pred EEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee----------------CCEEEEEEcC
Confidence 47888999999999997542 122234567899999999999999999999987 5689999999
Q ss_pred CC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~-g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
|. ++|.+++.+....+++..++.|+.||+.||+|||+++|+||||||+||||+.++++||+|||+++............
T Consensus 143 ~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~ 222 (412)
T 2vd5_A 143 YVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV 222 (412)
T ss_dssp CCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECSS
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCccccce
Confidence 97 47777776654579999999999999999999999999999999999999999999999999998765443333445
Q ss_pred ccccCCCCChhhhcC------CCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 012062 159 RVITLWYRPPELLLG------ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 232 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~------~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (472)
.+||+.|+|||++.. ...++.++||||||||+|||++|+.||.+.+..+.+.+|........ .
T Consensus 223 ~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~---------~-- 291 (412)
T 2vd5_A 223 AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS---------L-- 291 (412)
T ss_dssp CCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC---------C--
T ss_pred eccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcC---------C--
Confidence 689999999999873 24689999999999999999999999999999888888864211000 0
Q ss_pred cccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCC---CHHHHhcCCCCCC
Q 012062 233 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI---SAKDALDSEYFWT 286 (472)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~---t~~elL~h~~f~~ 286 (472)
......++.++++||++||. ||++|+ +++||++|+||+.
T Consensus 292 --------------p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~ 333 (412)
T 2vd5_A 292 --------------PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333 (412)
T ss_dssp --------------C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred --------------CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence 01113578899999999999 999984 9999999999964
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=359.10 Aligned_cols=272 Identities=31% Similarity=0.491 Sum_probs=210.4
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||++..+.. ......+|++.++.++|+||++++++|...+.. ......+||||||+
T Consensus 41 ~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~---------~~~~~~~~lv~e~~ 108 (360)
T 3e3p_A 41 LGKEKSTGMSVAIKKVIQDPR---FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER---------DRRDIYLNVVMEYV 108 (360)
T ss_dssp EEEETTTCCEEEEEEEECCTT---CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS---------CTTCEEEEEEEECC
T ss_pred EEEECCCCCEEEEEEEecCcc---ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc---------cccceeEEEEeecc
Confidence 467889999999999975432 334667889999999999999999999763311 11133589999999
Q ss_pred CCChhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCCCcEEEcC-CCCeEEeeccceeeeccCCCC
Q 012062 81 DHDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCH--VNQVLHRDIKGSNLLIDN-EGNLKLADFGLARSFSYDHNN 154 (472)
Q Consensus 81 ~g~l~~~~~---~~~~~l~~~~i~~i~~Qll~aL~~LH--~~giiHrDLKp~NILl~~-~~~vkL~DFG~a~~~~~~~~~ 154 (472)
++++...+. .....+++..++.++.||+.||.||| +++|+||||||+||||+. ++.+||+|||+++.+....
T Consensus 109 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~-- 186 (360)
T 3e3p_A 109 PDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE-- 186 (360)
T ss_dssp SCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTS--
T ss_pred cccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCC--
Confidence 998765443 34556899999999999999999999 999999999999999996 8899999999998765322
Q ss_pred ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 155 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
.....++|+.|+|||++.+...++.++||||||||+|+|++|+.||.+.+..+.+..+.+..+.+....|..........
T Consensus 187 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (360)
T 3e3p_A 187 PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDV 266 (360)
T ss_dssp CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCG
T ss_pred CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhc
Confidence 33445789999999999776668999999999999999999999999999999999999887776654443322111000
Q ss_pred cCCCchhhhhhHHHHh----hhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCCC
Q 012062 235 HFKPSRTMKRRVREVF----RHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 288 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~----~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~~ 288 (472)
.+.. .....+...+ ..++.++++||.+||+.||++|||+.|||+|+||....
T Consensus 267 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 267 DLYN--SKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp GGGC--CCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred cccc--cccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 0000 0001112222 23678899999999999999999999999999996543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=369.00 Aligned_cols=262 Identities=31% Similarity=0.548 Sum_probs=207.7
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc------CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEE
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL------QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTY 74 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l------~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 74 (472)
+|++..+++.||||+++... .....+.+|+++++.+ +|+||+++++++.. .+.+|
T Consensus 115 ~a~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~----------------~~~~~ 175 (429)
T 3kvw_A 115 KAYDHKVHQHVALKMVRNEK---RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF----------------RNHIC 175 (429)
T ss_dssp EEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE----------------TTEEE
T ss_pred EEEECCCCcEEEEEEECCcc---chHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc----------------CCeEE
Confidence 46788999999999997532 2345677899998887 57799999999987 66899
Q ss_pred EEEecCCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC--eEEeeccceeeeccC
Q 012062 75 MVFEYMDHDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN--LKLADFGLARSFSYD 151 (472)
Q Consensus 75 iVmEy~~g~l~~~~~~~~-~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~--vkL~DFG~a~~~~~~ 151 (472)
|||||++++|.+++.... ..+++..++.|+.||+.||+|||+++|+||||||+||||+.++. +||+|||+++....
T Consensus 176 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~- 254 (429)
T 3kvw_A 176 MTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ- 254 (429)
T ss_dssp EEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC-
T ss_pred EEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCC-
Confidence 999999999988777543 35999999999999999999999999999999999999999887 99999999976432
Q ss_pred CCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 012062 152 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 231 (472)
Q Consensus 152 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (472)
.....++|+.|+|||++.+ ..++.++||||||||||+|++|+.||.+.++.+.+..+++..+.+....+.......
T Consensus 255 ---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~ 330 (429)
T 3kvw_A 255 ---RVYTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAK 330 (429)
T ss_dssp ---CCCSSCSCGGGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHH
T ss_pred ---cccccCCCCCccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhh
Confidence 2334578999999999987 568999999999999999999999999999999999999888776654332221100
Q ss_pred cccc------C------C----------------CchhhhhhH-HHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCC
Q 012062 232 AYNH------F------K----------------PSRTMKRRV-REVFRHFDRHALELLEKMLMLDPSQRISAKDALDSE 282 (472)
Q Consensus 232 ~~~~------~------~----------------~~~~~~~~~-~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~ 282 (472)
.+.. + . ........+ ..+....+..+++||++||..||++|||++|||+||
T Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hp 410 (429)
T 3kvw_A 331 NFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHP 410 (429)
T ss_dssp HHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTST
T ss_pred hccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCCh
Confidence 0000 0 0 000001111 222234578899999999999999999999999999
Q ss_pred CCCC
Q 012062 283 YFWT 286 (472)
Q Consensus 283 ~f~~ 286 (472)
||+.
T Consensus 411 w~~~ 414 (429)
T 3kvw_A 411 WLRR 414 (429)
T ss_dssp TTC-
T ss_pred hhcc
Confidence 9964
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=359.28 Aligned_cols=237 Identities=24% Similarity=0.427 Sum_probs=199.8
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
+|+++.+++.||||+++.... .......+.+|+.+|+.+ +|+||++++++|.. .+.+|||||
T Consensus 38 ~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~----------------~~~~~lv~E 101 (353)
T 2i0e_A 38 LSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT----------------MDRLYFVME 101 (353)
T ss_dssp EEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC----------------SSEEEEEEE
T ss_pred EEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc----------------CCEEEEEEe
Confidence 478888999999999986531 233456778999999988 79999999999987 568999999
Q ss_pred cCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 79 YMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 79 y~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
|+.+ +|..++.+. ..+++.+++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++..... .....
T Consensus 102 ~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~~~~ 179 (353)
T 2i0e_A 102 YVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD-GVTTK 179 (353)
T ss_dssp CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-TCCBC
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC-Ccccc
Confidence 9986 666666543 36999999999999999999999999999999999999999999999999999754322 22344
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+.++.......
T Consensus 180 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~------------------ 240 (353)
T 2i0e_A 180 TFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY------------------ 240 (353)
T ss_dssp CCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC------------------
T ss_pred cccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCC------------------
Confidence 5688999999999976 578999999999999999999999999999888888886532111
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 286 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----t~~elL~h~~f~~ 286 (472)
...++.++++||++||..||++|+ +++||++|+||..
T Consensus 241 ------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 241 ------------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp ------------CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred ------------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 124678899999999999999999 4799999999954
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=347.70 Aligned_cols=238 Identities=26% Similarity=0.464 Sum_probs=198.5
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+|+.||||+++..... ....+.+|+.++++++|+||+++++++.. .+.+||||||+
T Consensus 63 ~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~----------------~~~~~lv~e~~ 124 (321)
T 2c30_A 63 LAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLV----------------GEELWVLMEFL 124 (321)
T ss_dssp EEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCCCTTBCCEEEEEEE----------------TTEEEEEECCC
T ss_pred EEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCcceEEEEEEE----------------CCEEEEEEecC
Confidence 3678889999999999865432 35568899999999999999999999987 56799999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
++ +|.+++.. ..+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++....... ......
T Consensus 125 ~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 201 (321)
T 2c30_A 125 QGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSL 201 (321)
T ss_dssp CSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCBCCC
T ss_pred CCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc-cccccc
Confidence 86 55555543 359999999999999999999999999999999999999999999999999998765432 223456
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+........
T Consensus 202 ~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------------------- 261 (321)
T 2c30_A 202 VGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL------------------- 261 (321)
T ss_dssp CSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC-------------------
T ss_pred cCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCc-------------------
Confidence 78999999999976 5789999999999999999999999999888777776654321100
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
.....++..+++||.+||..||++|||+.|+|+|+||...
T Consensus 262 --------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 262 --------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp --------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred --------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 0012467789999999999999999999999999999653
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=351.29 Aligned_cols=237 Identities=29% Similarity=0.405 Sum_probs=180.2
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+++.... ...+.+|+++|++|+|+||+++++++.. .+.+||||||+
T Consensus 71 ~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~----------------~~~~~lv~e~~ 130 (349)
T 2w4o_A 71 RCKQKGTQKPYALKVLKKTVD----KKIVRTEIGVLLRLSHPNIIKLKEIFET----------------PTEISLVLELV 130 (349)
T ss_dssp EEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEEC----------------SSEEEEEECCC
T ss_pred EEEECCCCcEEEEEEeccchh----HHHHHHHHHHHHhCCCCCCcceeeeEec----------------CCeEEEEEEeC
Confidence 367888999999999986532 2356789999999999999999999986 56799999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC---CCCeEEeeccceeeeccCCCCcc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN---EGNLKLADFGLARSFSYDHNNTL 156 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~---~~~vkL~DFG~a~~~~~~~~~~~ 156 (472)
.+ +|.+.+... ..+++.+++.++.||+.||+|||+++|+||||||+||||+. ++.+||+|||+++..... ...
T Consensus 131 ~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~~~ 207 (349)
T 2w4o_A 131 TGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--VLM 207 (349)
T ss_dssp CSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------------
T ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc--ccc
Confidence 85 666666543 46999999999999999999999999999999999999975 788999999999765432 223
Q ss_pred ccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCCCCCccCCCCCcccc
Q 012062 157 TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAE-QLSKIFELCGSPDETIWPGVSKMPAYNH 235 (472)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (472)
...++|+.|+|||++.+ ..++.++||||||||+|+|++|..||...+..+ .+..+..........
T Consensus 208 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~------------- 273 (349)
T 2w4o_A 208 KTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISP------------- 273 (349)
T ss_dssp -----CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTT-------------
T ss_pred ccccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCc-------------
Confidence 34578999999999986 568999999999999999999999998776554 445554332211111
Q ss_pred CCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
.+..++.++++||++||..||++|||+.|+|+|+||...
T Consensus 274 -------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 312 (349)
T 2w4o_A 274 -------------WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312 (349)
T ss_dssp -------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred -------------hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 123467789999999999999999999999999999653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=349.24 Aligned_cols=268 Identities=40% Similarity=0.728 Sum_probs=215.7
Q ss_pred ceec-cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc---CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEE
Q 012062 2 AREI-KTGEIVALKKIRMDNEKEGFPITAIREIKILKKL---QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVF 77 (472)
Q Consensus 2 a~~~-~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVm 77 (472)
|++. .+++.||||+++...........+.+|+.+++.+ +|+||+++++++..... .....+||||
T Consensus 30 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~-----------~~~~~~~lv~ 98 (326)
T 1blx_A 30 ARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT-----------DRETKLTLVF 98 (326)
T ss_dssp EEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC-----------SSEEEEEEEE
T ss_pred EEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc-----------CCCceEEEEE
Confidence 5664 6789999999986654444455677888888877 89999999999873210 1155789999
Q ss_pred ecCCCChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcc
Q 012062 78 EYMDHDLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTL 156 (472)
Q Consensus 78 Ey~~g~l~~~~~~~-~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 156 (472)
||++++|.+++... ...+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++..... ...
T Consensus 99 e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~ 176 (326)
T 1blx_A 99 EHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MAL 176 (326)
T ss_dssp ECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG--GGG
T ss_pred ecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccccCC--CCc
Confidence 99999888877653 335899999999999999999999999999999999999999999999999999765432 233
Q ss_pred ccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccC
Q 012062 157 TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236 (472)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (472)
....+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+....|+.....+.....
T Consensus 177 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 1blx_A 177 TSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFH 255 (326)
T ss_dssp CCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSC
T ss_pred cccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhc
Confidence 44578999999999986 56899999999999999999999999999999999999988888777777654433321111
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.. .......+...++..+++||.+||..||++|||+.|+|+|+||..
T Consensus 256 ~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 302 (326)
T 1blx_A 256 SK---SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 302 (326)
T ss_dssp CC---CCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred cc---CcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccc
Confidence 10 011233445678899999999999999999999999999999964
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=353.76 Aligned_cols=274 Identities=35% Similarity=0.589 Sum_probs=211.7
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+++... .......+.+|+++|++++|+||+++++++..... .....+||||||+
T Consensus 29 ~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-----------~~~~~~~lv~e~~ 96 (353)
T 2b9h_A 29 SATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSF-----------ENFNEVYIIQELM 96 (353)
T ss_dssp EEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCS-----------TTCCCEEEEECCC
T ss_pred EEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeeccccc-----------CccceEEEEEecc
Confidence 36788899999999996432 22234567799999999999999999999875321 1245789999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC------
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN------ 154 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~------ 154 (472)
.++|..++... .+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+......
T Consensus 97 ~~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 174 (353)
T 2b9h_A 97 QTDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174 (353)
T ss_dssp SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-----------
T ss_pred CccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccc
Confidence 99888877653 5899999999999999999999999999999999999999999999999999876532211
Q ss_pred ---ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 012062 155 ---TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 231 (472)
Q Consensus 155 ---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (472)
.....++|..|+|||++.....++.++|||||||++|+|++|+.||.+.+..+.+..++...+.+............
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (353)
T 2b9h_A 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESP 254 (353)
T ss_dssp -----CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCH
T ss_pred cccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccc
Confidence 12335789999999998765678999999999999999999999999999999999998887766532211111000
Q ss_pred ccccC--CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCCC
Q 012062 232 AYNHF--KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 288 (472)
Q Consensus 232 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~~ 288 (472)
....+ .............+..++.++++||++||..||++|||+.|||+|+||....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 255 RAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 00000 0000001123445567899999999999999999999999999999996543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=356.01 Aligned_cols=272 Identities=31% Similarity=0.486 Sum_probs=206.1
Q ss_pred ceeccCCCEEEEEEeecCCcCCC---------chhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCe
Q 012062 2 AREIKTGEIVALKKIRMDNEKEG---------FPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 72 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~---------~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 72 (472)
|++. +++.||||++........ ....+.+|+++|++++|+||+++++++..... .....
T Consensus 41 ~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-----------~~~~~ 108 (362)
T 3pg1_A 41 GVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEE-----------PAMHK 108 (362)
T ss_dssp EECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCT-----------TTCCE
T ss_pred EECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccC-----------CCcce
Confidence 4454 489999999976533221 12567899999999999999999999875321 11457
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCC
Q 012062 73 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 152 (472)
Q Consensus 73 ~~iVmEy~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 152 (472)
+||||||++++|.+.+......+++.+++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||++......
T Consensus 109 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~- 187 (362)
T 3pg1_A 109 LYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD- 187 (362)
T ss_dssp EEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC--------
T ss_pred EEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCcccccccc-
Confidence 8999999999999988877777999999999999999999999999999999999999999999999999999754332
Q ss_pred CCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC--
Q 012062 153 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM-- 230 (472)
Q Consensus 153 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-- 230 (472)
......++|..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+....+......
T Consensus 188 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 266 (362)
T 3pg1_A 188 -ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSA 266 (362)
T ss_dssp ---------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHH
T ss_pred -cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhh
Confidence 22334577999999999987567899999999999999999999999999999999999887776543222111100
Q ss_pred CccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 231 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
..+...................++..+.+||.+||..||++|||+.|+|+|+||...
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 267 RDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp HHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 000000000011223445556788999999999999999999999999999999653
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=357.43 Aligned_cols=261 Identities=24% Similarity=0.362 Sum_probs=204.0
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC-----CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEE
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-----HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYM 75 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~-----hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i 75 (472)
+|++..+++.||||+++... .....+.+|+.+++.+. |+||+++++++.. .+.+||
T Consensus 53 ~~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~----------------~~~~~l 113 (360)
T 3llt_A 53 LCQHIDNKKYYAVKVVRNIK---KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY----------------YDHMCL 113 (360)
T ss_dssp EEEETTTCCEEEEEEECSCH---HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE----------------TTEEEE
T ss_pred EEEECCCCeEEEEEEeccch---hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE----------------CCeeEE
Confidence 47888999999999997432 23446678999999997 9999999999987 568999
Q ss_pred EEecCCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC---------------------
Q 012062 76 VFEYMDHDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN--------------------- 133 (472)
Q Consensus 76 VmEy~~g~l~~~~~~~~-~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~--------------------- 133 (472)
||||+.++|.+++.+.. ..+++.+++.|+.||+.||+|||+++|+||||||+||||+.
T Consensus 114 v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~ 193 (360)
T 3llt_A 114 IFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI 193 (360)
T ss_dssp EECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEE
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccc
Confidence 99999888888776543 35999999999999999999999999999999999999975
Q ss_pred ----CCCeEEeeccceeeeccCCCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHH
Q 012062 134 ----EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQL 209 (472)
Q Consensus 134 ----~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~ 209 (472)
++.+||+|||+++.... .....++|+.|+|||++.+ ..++.++||||||||+|+|++|+.||...+..+.+
T Consensus 194 ~~~~~~~~kl~DFG~a~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 268 (360)
T 3llt_A 194 YRTKSTGIKLIDFGCATFKSD----YHGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHL 268 (360)
T ss_dssp EEESCCCEEECCCTTCEETTS----CCCSCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred cccCCCCEEEEeccCceecCC----CCcCccCcccccCcHHHcC-CCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHH
Confidence 77899999999976432 2234578999999999987 57899999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCccCCCCCc--------c-ccCCCchhhh-------hhHHHHhhhccHHHHHHHHHhhccCCCCCC
Q 012062 210 SKIFELCGSPDETIWPGVSKMPA--------Y-NHFKPSRTMK-------RRVREVFRHFDRHALELLEKMLMLDPSQRI 273 (472)
Q Consensus 210 ~~i~~~~~~~~~~~~~~~~~~~~--------~-~~~~~~~~~~-------~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ 273 (472)
..+.......+...+........ . ..+....... ..........++.+.+||++||+.||++||
T Consensus 269 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 348 (360)
T 3llt_A 269 AMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRP 348 (360)
T ss_dssp HHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCC
Confidence 88888776655332221111000 0 0000000000 011111223457889999999999999999
Q ss_pred CHHHHhcCCCCC
Q 012062 274 SAKDALDSEYFW 285 (472)
Q Consensus 274 t~~elL~h~~f~ 285 (472)
|+.|||+|+||+
T Consensus 349 ta~elL~hp~f~ 360 (360)
T 3llt_A 349 SPAELLKHKFLE 360 (360)
T ss_dssp CHHHHTTSGGGC
T ss_pred CHHHHhcCcccC
Confidence 999999999983
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=363.05 Aligned_cols=264 Identities=33% Similarity=0.547 Sum_probs=204.6
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++ ||+|++..+... ..+|+++|+.++|+||++++++|...+.. .....+||||||+.
T Consensus 59 a~~~~~~~-~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~----------~~~~~~~lv~e~~~ 121 (394)
T 4e7w_A 59 AKLVESDE-VAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDK----------KDEVFLNLVLEYVP 121 (394)
T ss_dssp EEETTTEE-EEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSS----------SSCEEEEEEEECCS
T ss_pred EEECCCCe-EEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCC----------CCceEEEEEeeccC
Confidence 56666666 888888644321 13799999999999999999999763311 11345889999999
Q ss_pred CChhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc-CCCCeEEeeccceeeeccCCCCccc
Q 012062 82 HDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID-NEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 82 g~l~~~~~---~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~-~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
++++..+. .....+++..++.|+.||+.||+|||++||+||||||+||||+ .++.+||+|||+|+.+... ....
T Consensus 122 ~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~--~~~~ 199 (394)
T 4e7w_A 122 ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG--EPNV 199 (394)
T ss_dssp EEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT--CCCC
T ss_pred ccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC--CCCc
Confidence 87765443 2345699999999999999999999999999999999999999 7889999999999876432 2334
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..++|+.|+|||++.+...++.++||||||||+|+|++|+.||.+.+..+++..+++..+.+....+..... .+....
T Consensus 200 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~--~~~~~~ 277 (394)
T 4e7w_A 200 SYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP--NYMEHK 277 (394)
T ss_dssp SSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCG--GGSSSC
T ss_pred ccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh--hhhhhc
Confidence 567899999999998766789999999999999999999999999999999999998887765433322111 111111
Q ss_pred CchhhhhhHHH-HhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 238 PSRTMKRRVRE-VFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 238 ~~~~~~~~~~~-~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
........+.. +...++.++++||.+||..||++|+|+.|+|+|+||..
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (394)
T 4e7w_A 278 FPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE 327 (394)
T ss_dssp CCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGST
T ss_pred cccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhh
Confidence 11111112222 23458899999999999999999999999999999964
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=350.93 Aligned_cols=233 Identities=25% Similarity=0.421 Sum_probs=185.9
Q ss_pred ccCCCEEEEEEeecCCc--CCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC
Q 012062 5 IKTGEIVALKKIRMDNE--KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH 82 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g 82 (472)
..+++.||||+++.... .......+.+|+.+|+.++|+||+++++++.. .+.+||||||+++
T Consensus 42 ~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----------------~~~~~lv~e~~~~ 105 (327)
T 3a62_A 42 ANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT----------------GGKLYLILEYLSG 105 (327)
T ss_dssp TTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC----------------SSCEEEEEECCTT
T ss_pred CCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc----------------CCEEEEEEeCCCC
Confidence 37999999999986532 12234456789999999999999999999987 5679999999985
Q ss_pred -ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccc
Q 012062 83 -DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 161 (472)
Q Consensus 83 -~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 161 (472)
+|..++.+. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++...... ......++
T Consensus 106 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~g 183 (327)
T 3a62_A 106 GELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG-TVTHTFCG 183 (327)
T ss_dssp EEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-----------CTTSS
T ss_pred CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCC-ccccccCC
Confidence 666666543 368999999999999999999999999999999999999999999999999987543222 22344578
Q ss_pred cCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchh
Q 012062 162 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241 (472)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (472)
|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+.++.+.....+
T Consensus 184 t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p--------------------- 241 (327)
T 3a62_A 184 TIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP--------------------- 241 (327)
T ss_dssp CCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC---------------------
T ss_pred CcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC---------------------
Confidence 999999999976 5689999999999999999999999999998888888765422111
Q ss_pred hhhhHHHHhhhccHHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCCC
Q 012062 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 286 (472)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----t~~elL~h~~f~~ 286 (472)
..++.++++||.+||..||++|+ ++.|+++|+||..
T Consensus 242 ---------~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 242 ---------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp ---------TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred ---------CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence 13677899999999999999999 8999999999954
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=346.14 Aligned_cols=240 Identities=27% Similarity=0.429 Sum_probs=201.8
Q ss_pred CceeccCCCEEEEEEeecCCcCC----CchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEE
Q 012062 1 MAREIKTGEIVALKKIRMDNEKE----GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMV 76 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iV 76 (472)
+|++..+++.||||+++...... .....+.+|+.+|++++|+||+++++++.. ...+|||
T Consensus 30 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv 93 (321)
T 2a2a_A 30 KCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN----------------RTDVVLI 93 (321)
T ss_dssp EEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----------------SSEEEEE
T ss_pred EEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec----------------CCEEEEE
Confidence 37788999999999998664332 134568899999999999999999999986 5689999
Q ss_pred EecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC----CeEEeeccceeeeccC
Q 012062 77 FEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG----NLKLADFGLARSFSYD 151 (472)
Q Consensus 77 mEy~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~----~vkL~DFG~a~~~~~~ 151 (472)
|||+.+ +|.+++.. ...+++..++.++.||+.||+|||+++|+||||||+||||+.++ .+||+|||++......
T Consensus 94 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~ 172 (321)
T 2a2a_A 94 LELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172 (321)
T ss_dssp ECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCcc
Confidence 999975 67666654 34689999999999999999999999999999999999999887 7999999999876532
Q ss_pred CCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 012062 152 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 231 (472)
Q Consensus 152 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (472)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......+
T Consensus 173 --~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----------- 238 (321)
T 2a2a_A 173 --VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD----------- 238 (321)
T ss_dssp --CCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC-----------
T ss_pred --ccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccC-----------
Confidence 22344578999999999876 5789999999999999999999999999988888877754322111
Q ss_pred ccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 232 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
...+..++..+++||++||..||++|||+.|+|+|+||..
T Consensus 239 ---------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 239 ---------------EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp ---------------HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred ---------------hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence 1234567889999999999999999999999999999953
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=360.12 Aligned_cols=237 Identities=26% Similarity=0.395 Sum_probs=190.6
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHH-HHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKI-LKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
+|+++.+++.||||++++... .......+++|..+ ++.++||||++++++|.+ .+.+|||||
T Consensus 56 ~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~----------------~~~~~lv~E 119 (373)
T 2r5t_A 56 LARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT----------------ADKLYFVLD 119 (373)
T ss_dssp EEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC----------------SSEEEEEEE
T ss_pred EEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe----------------CCEEEEEEe
Confidence 478899999999999986642 22334456678777 577899999999999987 568999999
Q ss_pred cCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 79 YMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 79 y~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
|+.+ +|..++.+ ...+++..++.|+.||+.||+|||++||+||||||+||||+.++++||+|||+++..... .....
T Consensus 120 ~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~-~~~~~ 197 (373)
T 2r5t_A 120 YINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NSTTS 197 (373)
T ss_dssp CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC-CCCCC
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC-CCccc
Confidence 9986 56666554 346899999999999999999999999999999999999999999999999999753322 22344
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..+||+.|+|||++.+ ..++.++||||||||+|+|++|..||.+.+..+.+.++.......
T Consensus 198 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~------------------ 258 (373)
T 2r5t_A 198 TFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL------------------ 258 (373)
T ss_dssp SBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCC------------------
T ss_pred cccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCC------------------
Confidence 5689999999999986 678999999999999999999999999999988888886532111
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCH----HHHhcCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA----KDALDSEYFWT 286 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~----~elL~h~~f~~ 286 (472)
...++.++++||++||..||++|+++ .|+++|+||..
T Consensus 259 ------------~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 259 ------------KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp ------------CSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred ------------CCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 12467789999999999999999986 69999999954
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=350.53 Aligned_cols=235 Identities=23% Similarity=0.283 Sum_probs=189.8
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||++.............+.|+..+.++ +|+||+++++++.. .+.+||||||
T Consensus 75 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~----------------~~~~~lv~e~ 138 (311)
T 3p1a_A 75 KVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE----------------GGILYLQTEL 138 (311)
T ss_dssp EEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----------------TTEEEEEEEC
T ss_pred EEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe----------------CCEEEEEEec
Confidence 367889999999999876544433344556677666655 89999999999986 6689999999
Q ss_pred CCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 80 MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 80 ~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
+.++|..++......+++..++.|+.||+.||+|||+++|+||||||+||||+.++++||+|||++....... .....
T Consensus 139 ~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~ 216 (311)
T 3p1a_A 139 CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG--AGEVQ 216 (311)
T ss_dssp CCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC--------CC
T ss_pred cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC--CCccc
Confidence 9999988887766679999999999999999999999999999999999999999999999999997764322 23345
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
.+|+.|+|||++.+ .++.++|||||||++|+|++|..+|...+... .+....
T Consensus 217 ~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~~~----------------------- 268 (311)
T 3p1a_A 217 EGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QLRQGY----------------------- 268 (311)
T ss_dssp CCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTTTC-----------------------
T ss_pred CCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHhccC-----------------------
Confidence 68999999999875 58999999999999999999987766543322 221100
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
........++.++.+||.+||..||++|||++|||+||||+.
T Consensus 269 -----~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 269 -----LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp -----CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred -----CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 011334567889999999999999999999999999999953
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=355.77 Aligned_cols=237 Identities=26% Similarity=0.415 Sum_probs=199.6
Q ss_pred CceeccCCCEEEEEEeecCCcC-CCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||+++..... ......+.+|+++|++++|+|||++++++.. .+.+||||||
T Consensus 72 ~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----------------~~~~~lv~e~ 135 (348)
T 1u5q_A 72 FARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR----------------EHTAWLVMEY 135 (348)
T ss_dssp EEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----------------TTEEEEEEEC
T ss_pred EEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE----------------CCeEEEEEec
Confidence 3678899999999999865322 2234567899999999999999999999986 5689999999
Q ss_pred CCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 80 MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 80 ~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
+.+++.+++......+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++..... ....
T Consensus 136 ~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-----~~~~ 210 (348)
T 1u5q_A 136 CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSF 210 (348)
T ss_dssp CSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----BCCC
T ss_pred CCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-----CCcc
Confidence 99988887765556799999999999999999999999999999999999999999999999999976532 2345
Q ss_pred cccCCCCChhhhcC--CCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 160 VITLWYRPPELLLG--ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 160 ~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
++|+.|+|||++.+ ...++.++||||||||+|+|++|+.||...+..+.+..+.........
T Consensus 211 ~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------- 274 (348)
T 1u5q_A 211 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ---------------- 274 (348)
T ss_dssp CSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCC----------------
T ss_pred cCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC----------------
Confidence 78999999999863 356889999999999999999999999998887777766543211000
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
...+++.+++||.+||..||++|||++++|+|+||..
T Consensus 275 ------------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 275 ------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp ------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred ------------CCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 0135678999999999999999999999999999965
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=353.96 Aligned_cols=235 Identities=28% Similarity=0.405 Sum_probs=191.4
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.|++.||||+++.... ...+|+++|.++ +||||+++++++.+ ...+||||||
T Consensus 40 ~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~----------------~~~~~lv~E~ 97 (342)
T 2qr7_A 40 RCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDD----------------GKYVYVVTEL 97 (342)
T ss_dssp EEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEEC----------------SSEEEEEECC
T ss_pred EEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEc----------------CCEEEEEEeC
Confidence 478889999999999976532 235799999888 79999999999986 5689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC-C---CeEEeeccceeeeccCCCC
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE-G---NLKLADFGLARSFSYDHNN 154 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~-~---~vkL~DFG~a~~~~~~~~~ 154 (472)
|.+ +|.+.+.+. ..+++.+++.|+.||+.||+|||++||+||||||+||||.++ + .+||+|||+++.+.... .
T Consensus 98 ~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~-~ 175 (342)
T 2qr7_A 98 MKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN-G 175 (342)
T ss_dssp CCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT-C
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC-C
Confidence 986 677766554 469999999999999999999999999999999999998543 2 49999999998765432 2
Q ss_pred ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 012062 155 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK---NEAEQLSKIFELCGSPDETIWPGVSKMP 231 (472)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (472)
.....++|+.|+|||++.+ ..++.++|||||||++|+|++|..||... +..+.+..+...........
T Consensus 176 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~-------- 246 (342)
T 2qr7_A 176 LLMTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGY-------- 246 (342)
T ss_dssp CBCCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTT--------
T ss_pred ceeccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccc--------
Confidence 3345678999999999976 45788999999999999999999999863 44555555544322222111
Q ss_pred ccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 232 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
+..+++++++||++||..||++|+|+.|+|+|+||..
T Consensus 247 ------------------~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 247 ------------------WNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp ------------------TTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred ------------------cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 2357789999999999999999999999999999943
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=356.88 Aligned_cols=237 Identities=23% Similarity=0.384 Sum_probs=194.1
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||+++... ........+.+|+.+|+.++|||||+++++|.+ .+.+||||||
T Consensus 33 ~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----------------~~~~~lv~e~ 96 (384)
T 4fr4_A 33 IVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD----------------EEDMFMVVDL 96 (384)
T ss_dssp EEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----------------SSEEEEEECC
T ss_pred EEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe----------------CCEEEEEEec
Confidence 47889999999999997653 223345678899999999999999999999987 5689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
+.+ +|..++.. ...+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.. ......
T Consensus 97 ~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~~~~~~ 173 (384)
T 4fr4_A 97 LLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR--ETQITT 173 (384)
T ss_dssp CTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT--TCCBCC
T ss_pred CCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC--CCceec
Confidence 986 55555554 45699999999999999999999999999999999999999999999999999987643 233455
Q ss_pred ccccCCCCChhhhcCC--CCCCCCcchhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 012062 159 RVITLWYRPPELLLGA--TKYGPAVDMWSVGCIFAELLNGKPILPGKNE---AEQLSKIFELCGSPDETIWPGVSKMPAY 233 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~--~~~~~~~DiwSlG~il~ell~G~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (472)
.+||+.|+|||++... ..++.++||||||||+|+|++|+.||...+. .+.+..+......
T Consensus 174 ~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--------------- 238 (384)
T 4fr4_A 174 MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVT--------------- 238 (384)
T ss_dssp CCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCC---------------
T ss_pred cCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccC---------------
Confidence 7899999999998742 3588999999999999999999999985433 2333333221110
Q ss_pred ccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCC-HHHHhcCCCCCC
Q 012062 234 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-AKDALDSEYFWT 286 (472)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t-~~elL~h~~f~~ 286 (472)
....++..+.+||++||..||++|++ ++++++|+||..
T Consensus 239 ---------------~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 239 ---------------YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp ---------------CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred ---------------CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 01246778999999999999999998 999999999953
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=369.06 Aligned_cols=239 Identities=33% Similarity=0.542 Sum_probs=202.4
Q ss_pred CceeccCCCEEEEEEeecCCcC-CCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||++...... ......+.+|+.+|++|+|||||++++++.. .+.+||||||
T Consensus 44 ~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----------------~~~~~lv~e~ 107 (484)
T 3nyv_A 44 LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED----------------KGYFYLVGEV 107 (484)
T ss_dssp EEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----------------SSEEEEEECC
T ss_pred EEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe----------------CCEEEEEEec
Confidence 4788899999999999766432 3446678899999999999999999999987 6689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE---cCCCCeEEeeccceeeeccCCCCc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI---DNEGNLKLADFGLARSFSYDHNNT 155 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl---~~~~~vkL~DFG~a~~~~~~~~~~ 155 (472)
|.+ +|.+.+... ..+++.+++.|++||+.||+|||+++|+||||||+|||| +.++.+||+|||+++.+... ..
T Consensus 108 ~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~--~~ 184 (484)
T 3nyv_A 108 YTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS--KK 184 (484)
T ss_dssp CCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC--CS
T ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc--cc
Confidence 986 666666544 469999999999999999999999999999999999999 45678999999999766432 23
Q ss_pred cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcccc
Q 012062 156 LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (472)
....++|+.|+|||++.+ .++.++||||||||+|+|++|..||.+.+..+.+..+..........
T Consensus 185 ~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~------------- 249 (484)
T 3nyv_A 185 MKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELP------------- 249 (484)
T ss_dssp HHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSG-------------
T ss_pred cccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCc-------------
Confidence 445678999999999976 58999999999999999999999999999999888887643332221
Q ss_pred CCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.+..++.++++||++||..||++|||+.|+|+|+||..
T Consensus 250 -------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~ 287 (484)
T 3nyv_A 250 -------------QWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287 (484)
T ss_dssp -------------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred -------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcc
Confidence 22357889999999999999999999999999999954
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=351.40 Aligned_cols=236 Identities=22% Similarity=0.266 Sum_probs=168.8
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Ch
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL 84 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l 84 (472)
.+|+.||||+++..... ......|+.++.+|+|||||++++++...+. ....+|||||||++ +|
T Consensus 24 ~~g~~VAvK~l~~~~~~---~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~------------~~~~~~lV~Ey~~~gsL 88 (303)
T 3hmm_A 24 WRGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAADNKDNG------------TWTQLWLVSDYHEHGSL 88 (303)
T ss_dssp ETTEEEEEEEECGGGHH---HHHHHHHHHTSTTCCCTTBCCEEEEEEEECS------------SSEEEEEEEECCTTCBH
T ss_pred ECCEEEEEEEECccchh---hHHHHHHHHHHhcCCCCCCCcEEEEEEecCC------------CceEEEEEecCCCCCcH
Confidence 47999999999754321 1122346666678899999999999986321 12368999999995 77
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC--
Q 012062 85 TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN--------QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN-- 154 (472)
Q Consensus 85 ~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~--------giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~-- 154 (472)
.+++.+. .+++..+.+|+.|++.||+|||++ +||||||||+||||+.++++||+|||+|+........
T Consensus 89 ~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~ 166 (303)
T 3hmm_A 89 FDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 166 (303)
T ss_dssp HHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEES
T ss_pred HHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCcee
Confidence 7776543 589999999999999999999987 9999999999999999999999999999877543322
Q ss_pred -ccccccccCCCCChhhhcCCC-----CCCCCcchhhHHHHHHHHHhCCCCCCCCCh--------------HHHHHHHHH
Q 012062 155 -TLTNRVITLWYRPPELLLGAT-----KYGPAVDMWSVGCIFAELLNGKPILPGKNE--------------AEQLSKIFE 214 (472)
Q Consensus 155 -~~~~~~gt~~y~aPE~l~~~~-----~~~~~~DiwSlG~il~ell~G~~pf~~~~~--------------~~~~~~i~~ 214 (472)
.....+||+.|||||++.+.. .++.++||||||||||||+||..||..... .+.+.+...
T Consensus 167 ~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 246 (303)
T 3hmm_A 167 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246 (303)
T ss_dssp CC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHT
T ss_pred eecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHh
Confidence 223457999999999997532 256789999999999999999877643321 111111111
Q ss_pred hcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 215 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
... ..+..+.. .........+.+||.+||..||++|||+.||++
T Consensus 247 ~~~------------------~rp~~p~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 247 EQK------------------LRPNIPNR----WQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp TSC------------------CCCCCCGG----GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred ccc------------------CCCCCCcc----ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 000 00000000 000123457889999999999999999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=369.45 Aligned_cols=239 Identities=30% Similarity=0.498 Sum_probs=200.6
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+++.+++.||||+++...........+.+|+.+|+.|+|||||+++++|.. ...+|||||||
T Consensus 55 ~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----------------~~~~~lv~e~~ 118 (494)
T 3lij_A 55 LCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED----------------KRNYYLVMECY 118 (494)
T ss_dssp EEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC----------------SSEEEEEEECC
T ss_pred EEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe----------------CCEEEEEEecC
Confidence 47889999999999998765444456778899999999999999999999987 56899999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC---CCeEEeeccceeeeccCCCCcc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE---GNLKLADFGLARSFSYDHNNTL 156 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~---~~vkL~DFG~a~~~~~~~~~~~ 156 (472)
.+ +|.+.+... ..+++..++.|++||+.||+|||++||+||||||+||||+.. +.+||+|||++..+... ...
T Consensus 119 ~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~--~~~ 195 (494)
T 3lij_A 119 KGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ--KKM 195 (494)
T ss_dssp CSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT--BCB
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC--ccc
Confidence 86 666655443 469999999999999999999999999999999999999764 44999999999876533 234
Q ss_pred ccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccC
Q 012062 157 TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236 (472)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (472)
...++|+.|+|||++.+ .++.++||||||||+|+|++|..||.+.+..+.+..+...........
T Consensus 196 ~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------------- 260 (494)
T 3lij_A 196 KERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPE------------- 260 (494)
T ss_dssp CCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGG-------------
T ss_pred cccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchh-------------
Confidence 45678999999999864 589999999999999999999999999999998888876544333222
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
+..++..+++||++||..||++|||+.|+|+|+||..
T Consensus 261 -------------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 261 -------------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp -------------GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred -------------cccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 2356788999999999999999999999999999953
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=357.15 Aligned_cols=269 Identities=37% Similarity=0.616 Sum_probs=208.1
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+|+.||||+++.....+.....+.+|+.+|+.++|+||+++++++...... .....+||||||+
T Consensus 42 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~----------~~~~~~~lv~e~~ 111 (353)
T 3coi_A 42 SAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL----------RNFYDFYLVMPFM 111 (353)
T ss_dssp EEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSG----------GGCCCCEEEEECC
T ss_pred EEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccc----------ccceeEEEEeccc
Confidence 367889999999999986654444556788999999999999999999999863211 0123469999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
.++|..++.. .+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... .....+
T Consensus 112 ~~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~----~~~~~~ 184 (353)
T 3coi_A 112 QTDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA----EMTGYV 184 (353)
T ss_dssp SEEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC------------C
T ss_pred cCCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC----Cccccc
Confidence 9887776643 489999999999999999999999999999999999999999999999999876432 233457
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc--cccCCC
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA--YNHFKP 238 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~--~~~~~~ 238 (472)
+|..|+|||++.+...++.++||||||||+|+|++|+.||.+.+..+.+..+.+..+.+....+........ +....+
T Consensus 185 ~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (353)
T 3coi_A 185 VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLP 264 (353)
T ss_dssp CSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSC
T ss_pred cCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCc
Confidence 799999999998756789999999999999999999999999999999999988777665433322211000 000000
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
..........+..++.++++||.+||..||++|||+.|+|+|+||...
T Consensus 265 -~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 265 -QTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp -BCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred -CCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 000011122334678899999999999999999999999999999643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=356.10 Aligned_cols=241 Identities=27% Similarity=0.432 Sum_probs=180.6
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+++.... ....+.+|+.+++.|+|+||+++++++.. .+.+||||||+
T Consensus 38 ~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~----------------~~~~~lv~e~~ 98 (361)
T 3uc3_A 38 LMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVILT----------------PTHLAIIMEYA 98 (361)
T ss_dssp EEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------------SSEEEEEEECC
T ss_pred EEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEee----------------CCEEEEEEEeC
Confidence 478899999999999975432 23567899999999999999999999987 56899999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC--eEEeeccceeeeccCCCCccc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN--LKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~--vkL~DFG~a~~~~~~~~~~~~ 157 (472)
.+ +|..++... .++++..++.|+.||+.||+|||++||+||||||+||||+.++. +||+|||+++..... ....
T Consensus 99 ~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~--~~~~ 175 (361)
T 3uc3_A 99 SGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQPK 175 (361)
T ss_dssp CSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------------
T ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc--CCCC
Confidence 85 666665443 36999999999999999999999999999999999999987765 999999998743322 2233
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..++|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+..+......... ..+.
T Consensus 176 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~-------~~~~----- 243 (361)
T 3uc3_A 176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY-------SIPD----- 243 (361)
T ss_dssp -----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCC-------CCCT-----
T ss_pred CCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC-------CCCC-----
Confidence 4578999999999987444445589999999999999999999886553333333221111000 0000
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
...++.++++||++||..||++|||+.|||+|+||...
T Consensus 244 ------------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 244 ------------DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp ------------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred ------------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 01367789999999999999999999999999999543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=346.27 Aligned_cols=242 Identities=24% Similarity=0.364 Sum_probs=200.5
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC-CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.+++.||||+++...........+.+|+.+++.+. |+||+++++++.. .+.+||||||
T Consensus 47 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~----------------~~~~~lv~e~ 110 (327)
T 3lm5_A 47 QCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN----------------TSEIILILEY 110 (327)
T ss_dssp EEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----------------SSEEEEEEEC
T ss_pred EEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe----------------CCeEEEEEEe
Confidence 3678899999999999876555555677889999999995 6999999999986 5679999999
Q ss_pred CCC-ChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC---CCCeEEeeccceeeeccCCCC
Q 012062 80 MDH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN---EGNLKLADFGLARSFSYDHNN 154 (472)
Q Consensus 80 ~~g-~l~~~~~~-~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~---~~~vkL~DFG~a~~~~~~~~~ 154 (472)
+.+ +|.+++.. ....+++.+++.|+.||+.||+|||++||+||||||+||||+. ++.+||+|||+++......
T Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~-- 188 (327)
T 3lm5_A 111 AAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC-- 188 (327)
T ss_dssp CTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC------
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc--
Confidence 986 66666654 2356999999999999999999999999999999999999997 7889999999998764322
Q ss_pred ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 155 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
.....++|+.|+|||++.+ ..++.++||||||||+|+|++|+.||...+..+.+..+...........
T Consensus 189 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~----------- 256 (327)
T 3lm5_A 189 ELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEET----------- 256 (327)
T ss_dssp -----CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT-----------
T ss_pred ccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchh-----------
Confidence 2334578999999999976 5789999999999999999999999999999888888776543332221
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
+..++..+++||.+||..||++|||++|||+|+||...
T Consensus 257 ---------------~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~ 294 (327)
T 3lm5_A 257 ---------------FSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294 (327)
T ss_dssp ---------------TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred ---------------hcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence 12467789999999999999999999999999999653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=340.26 Aligned_cols=240 Identities=27% Similarity=0.394 Sum_probs=201.0
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+++...........+.+|+.++++++|+||+++++++.. .+..|+||||+
T Consensus 24 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~~v~e~~ 87 (284)
T 3kk8_A 24 RCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE----------------ESFHYLVFDLV 87 (284)
T ss_dssp EEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC----------------SSEEEEEECCC
T ss_pred EEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc----------------CCEEEEEEecC
Confidence 36788999999999998765444445677899999999999999999999986 56789999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC---eEEeeccceeeeccCCCCcc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN---LKLADFGLARSFSYDHNNTL 156 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~---vkL~DFG~a~~~~~~~~~~~ 156 (472)
.+ +|...+... ..+++..++.++.||+.||+|||+++|+||||||+||||+.++. +||+|||++...... ...
T Consensus 88 ~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~--~~~ 164 (284)
T 3kk8_A 88 TGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAW 164 (284)
T ss_dssp CSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS--CBC
T ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC--ccc
Confidence 86 565655543 36899999999999999999999999999999999999987665 999999999766432 223
Q ss_pred ccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccC
Q 012062 157 TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236 (472)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (472)
....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...........
T Consensus 165 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------------- 230 (284)
T 3kk8_A 165 HGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE------------- 230 (284)
T ss_dssp CCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT-------------
T ss_pred cCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchh-------------
Confidence 44578999999999986 5689999999999999999999999999998888887765443322211
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
+..+++++.+||.+||..||++|||+.|+|+|+||..
T Consensus 231 -------------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (284)
T 3kk8_A 231 -------------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 267 (284)
T ss_dssp -------------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHS
T ss_pred -------------hcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccC
Confidence 1246778999999999999999999999999999954
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=368.65 Aligned_cols=237 Identities=26% Similarity=0.408 Sum_probs=189.3
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||+++... ........+++|+.+|+.++|+||++++++|.. .+.+||||||
T Consensus 166 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~----------------~~~~~lv~e~ 229 (446)
T 4ejn_A 166 LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT----------------HDRLCFVMEY 229 (446)
T ss_dssp EEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE----------------TTEEEEEECC
T ss_pred EEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee----------------CCEEEEEEee
Confidence 47889999999999998652 222334567789999999999999999999987 5689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~-~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
|++ +|..++.+ ...+++..++.|+.||+.||+|||+ +||+||||||+||||+.++.+||+|||+|+..... .....
T Consensus 230 ~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~ 307 (446)
T 4ejn_A 230 ANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMK 307 (446)
T ss_dssp CSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC------C
T ss_pred CCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC-Ccccc
Confidence 987 55555543 3469999999999999999999998 99999999999999999999999999999753322 23344
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..++|+.|+|||++.+ ..++.++||||||||||+|++|+.||.+.+..+.+..+.......
T Consensus 308 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~------------------ 368 (446)
T 4ejn_A 308 TFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF------------------ 368 (446)
T ss_dssp CSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC------------------
T ss_pred cccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC------------------
Confidence 5688999999999986 678999999999999999999999999999888887776532111
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 286 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----t~~elL~h~~f~~ 286 (472)
...++.++++||.+||..||++|+ |++|||+|+||..
T Consensus 369 ------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 369 ------------PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp ------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred ------------CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 123677899999999999999999 9999999999953
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=349.36 Aligned_cols=237 Identities=28% Similarity=0.451 Sum_probs=175.0
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC-CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.+++.||||+++.. ....+.+|+.+++.+. |+||+++++++.+ ...+||||||
T Consensus 29 ~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~----------------~~~~~lv~e~ 87 (325)
T 3kn6_A 29 KCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHD----------------QLHTFLVMEL 87 (325)
T ss_dssp EEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----------------SSEEEEEECC
T ss_pred EEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc----------------CCEEEEEEEc
Confidence 3688899999999999743 2456779999999997 9999999999986 5689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC---CeEEeeccceeeeccCCCCc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG---NLKLADFGLARSFSYDHNNT 155 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~---~vkL~DFG~a~~~~~~~~~~ 155 (472)
+++ +|.+++.+. ..+++.+++.|+.||+.||+|||+++|+||||||+||||+.++ .+||+|||+++..... ...
T Consensus 88 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-~~~ 165 (325)
T 3kn6_A 88 LNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQP 165 (325)
T ss_dssp CCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC-CCc
Confidence 986 666666553 4699999999999999999999999999999999999998766 7999999999865432 223
Q ss_pred cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHHhcCCCCCCCCccCC
Q 012062 156 LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE-------AEQLSKIFELCGSPDETIWPGVS 228 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~~ 228 (472)
....++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+. .+.+..+.......
T Consensus 166 ~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~--------- 235 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF--------- 235 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC---------
T ss_pred ccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC---------
Confidence 345578999999999876 5789999999999999999999999987543 23333332211111
Q ss_pred CCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 229 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
....+..+++++++||++||..||++|||+.|+|+|+||...
T Consensus 236 -----------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 236 -----------------EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp -----------------CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred -----------------CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 112345688899999999999999999999999999999653
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=369.70 Aligned_cols=239 Identities=32% Similarity=0.523 Sum_probs=200.4
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+++...........+.+|+++|++|+|||||++++++.. ...+|||||||
T Consensus 40 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----------------~~~~~lv~e~~ 103 (486)
T 3mwu_A 40 KCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED----------------SSSFYIVGELY 103 (486)
T ss_dssp EEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----------------SSEEEEEECCC
T ss_pred EEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc----------------CCEEEEEEEcC
Confidence 47888999999999997654444456778899999999999999999999987 56899999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC---CCCeEEeeccceeeeccCCCCcc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN---EGNLKLADFGLARSFSYDHNNTL 156 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~---~~~vkL~DFG~a~~~~~~~~~~~ 156 (472)
.+ +|.+.+... ..+++.+++.|++||+.||.|||++||+||||||+||||+. ++.+||+|||+++.+... ...
T Consensus 104 ~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~--~~~ 180 (486)
T 3mwu_A 104 TGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKM 180 (486)
T ss_dssp CSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-----
T ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC--Ccc
Confidence 86 666655443 36999999999999999999999999999999999999954 457999999999765432 234
Q ss_pred ccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccC
Q 012062 157 TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236 (472)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (472)
...++|+.|+|||++.+ .++.++||||||||+|+|++|..||.+.+..+.+..+..........
T Consensus 181 ~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-------------- 244 (486)
T 3mwu_A 181 KDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP-------------- 244 (486)
T ss_dssp -CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSG--------------
T ss_pred CCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc--------------
Confidence 45678999999999976 48999999999999999999999999999998888886643332221
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.+..+++++++||++||..||++|||+.|+|+|+||..
T Consensus 245 ------------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 282 (486)
T 3mwu_A 245 ------------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (486)
T ss_dssp ------------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred ------------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence 13457889999999999999999999999999999964
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=351.29 Aligned_cols=283 Identities=34% Similarity=0.586 Sum_probs=209.5
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||++..... .....+.+|++++++++|+||+++++++...+..... ..........+||||||+
T Consensus 29 ~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~--~~~~~~~~~~~~lv~e~~ 104 (320)
T 2i6l_A 29 SAVDNDCDKRVAIKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD--DVGSLTELNSVYIVQEYM 104 (320)
T ss_dssp EEEETTTTEEEEEEEEECCSH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC------CCSCSEEEEEEECC
T ss_pred EEEECCCCeEEEEEEEecCCh--HHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc--ccccccccCceeEEeecc
Confidence 367888999999999975432 2356778999999999999999999999764321100 001112356899999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc-CCCCeEEeeccceeeeccCC--CCccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID-NEGNLKLADFGLARSFSYDH--NNTLT 157 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~-~~~~vkL~DFG~a~~~~~~~--~~~~~ 157 (472)
+++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||||+ .++.+||+|||+++...... .....
T Consensus 105 ~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 182 (320)
T 2i6l_A 105 ETDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182 (320)
T ss_dssp SEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCC
T ss_pred CCCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccc
Confidence 9988887764 3589999999999999999999999999999999999997 45689999999997654321 12233
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC-CCccccC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK-MPAYNHF 236 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~ 236 (472)
...+|..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+.........+..... ++.+...
T Consensus 183 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (320)
T 2i6l_A 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRN 262 (320)
T ss_dssp GGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHH
T ss_pred cccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccc
Confidence 446699999999987656789999999999999999999999999999888888877654433221111100 0000000
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCCCCC
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 290 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~~~~ 290 (472)
.. .............++.++++||++||..||++|||++|+|+|+||.....+
T Consensus 263 ~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 263 DM-TEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315 (320)
T ss_dssp HT-TSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred cc-cCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence 00 000112334556789999999999999999999999999999999754443
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=337.00 Aligned_cols=236 Identities=32% Similarity=0.444 Sum_probs=199.0
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||+|++...... ....+.+|++++++++|+||+++++++.. ...+||||||+
T Consensus 27 ~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~ 88 (277)
T 3f3z_A 27 IAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFED----------------NTDIYLVMELC 88 (277)
T ss_dssp EEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEEC----------------SSEEEEEEECC
T ss_pred EEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEec----------------CCeEEEEEecc
Confidence 3678899999999999865432 35678899999999999999999999986 56799999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE---cCCCCeEEeeccceeeeccCCCCcc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI---DNEGNLKLADFGLARSFSYDHNNTL 156 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl---~~~~~vkL~DFG~a~~~~~~~~~~~ 156 (472)
++ +|.+.+... ..+++.+++.++.||+.||+|||+++|+||||||+|||| +.++.+||+|||++..+... ...
T Consensus 89 ~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~--~~~ 165 (277)
T 3f3z_A 89 TGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMM 165 (277)
T ss_dssp CSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT--SCB
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc--cch
Confidence 86 665655443 458999999999999999999999999999999999999 77888999999999876532 233
Q ss_pred ccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccC
Q 012062 157 TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236 (472)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (472)
....+|+.|+|||++.+ .++.++|||||||++|+|++|+.||...+..+.+..+.+......
T Consensus 166 ~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------- 227 (277)
T 3f3z_A 166 RTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFP---------------- 227 (277)
T ss_dssp CCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----------------
T ss_pred hccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC----------------
Confidence 44578999999999875 489999999999999999999999999998888887765432211
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
...+..++..+.+||++||..||++|||+.|+|+|+||.
T Consensus 228 ----------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~ 266 (277)
T 3f3z_A 228 ----------EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFE 266 (277)
T ss_dssp ----------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred ----------chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHh
Confidence 122335788999999999999999999999999999994
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=345.59 Aligned_cols=241 Identities=24% Similarity=0.369 Sum_probs=186.5
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||+++... ......+.+|+++|+++ +|+||+++++++.. .+.+||||||
T Consensus 31 ~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~----------------~~~~~lv~e~ 92 (316)
T 2ac3_A 31 TCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEE----------------EDRFYLVFEK 92 (316)
T ss_dssp EEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE----------------TTEEEEEEEC
T ss_pred EEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEee----------------CCEEEEEEEc
Confidence 36788899999999997653 23456788999999985 79999999999987 5689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC---eEEeeccceeeeccCC---
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN---LKLADFGLARSFSYDH--- 152 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~---vkL~DFG~a~~~~~~~--- 152 (472)
+++ +|.+++.+. ..+++.+++.++.||+.||+|||+++|+||||||+||||+.++. +||+|||++..+....
T Consensus 93 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 171 (316)
T 2ac3_A 93 MRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171 (316)
T ss_dssp CTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---------
T ss_pred CCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccc
Confidence 985 676666543 36899999999999999999999999999999999999998776 9999999987654221
Q ss_pred ---CCccccccccCCCCChhhhcCC----CCCCCCcchhhHHHHHHHHHhCCCCCCCCChH---------------HHHH
Q 012062 153 ---NNTLTNRVITLWYRPPELLLGA----TKYGPAVDMWSVGCIFAELLNGKPILPGKNEA---------------EQLS 210 (472)
Q Consensus 153 ---~~~~~~~~gt~~y~aPE~l~~~----~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~---------------~~~~ 210 (472)
.......++|..|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+.. ..+.
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (316)
T 2ac3_A 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFE 251 (316)
T ss_dssp ----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHH
T ss_pred cccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHH
Confidence 1122345689999999998641 34788999999999999999999999876431 1222
Q ss_pred HHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 211 KIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 211 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.+....... ....+..++.++++||++||..||++|||+.|+|+|+||..
T Consensus 252 ~i~~~~~~~--------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 301 (316)
T 2ac3_A 252 SIQEGKYEF--------------------------PDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301 (316)
T ss_dssp HHHHCCCCC--------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-
T ss_pred HHhccCccc--------------------------CchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcC
Confidence 222211000 01223457889999999999999999999999999999954
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=337.92 Aligned_cols=238 Identities=29% Similarity=0.403 Sum_probs=191.2
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||++...... .....+.+|+++|++++|+||+++++++.. ...+||||||+
T Consensus 40 ~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----------------~~~~~lv~e~~ 102 (285)
T 3is5_A 40 LVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVFED----------------YHNMYIVMETC 102 (285)
T ss_dssp EEEETTTCCEEEEEEEEGGGCC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----------------SSEEEEEECCC
T ss_pred EEEEccCCceEEEEEeeccccc-hhHHHHHHHHHHHHhCCCchHHhHHHheec----------------CCeEEEEEEeC
Confidence 4678899999999999876433 235678899999999999999999999986 56799999999
Q ss_pred CC-ChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc---CCCCeEEeeccceeeeccCCC
Q 012062 81 DH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID---NEGNLKLADFGLARSFSYDHN 153 (472)
Q Consensus 81 ~g-~l~~~~~~---~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~---~~~~vkL~DFG~a~~~~~~~~ 153 (472)
++ +|.+.+.. ....+++..++.|+.||+.||+|||+++|+||||||+||||+ .++.+||+|||++..+...
T Consensus 103 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~-- 180 (285)
T 3is5_A 103 EGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-- 180 (285)
T ss_dssp SCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC------
T ss_pred CCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc--
Confidence 86 67666543 234699999999999999999999999999999999999994 4578999999999765432
Q ss_pred CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 012062 154 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 233 (472)
Q Consensus 154 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (472)
.......+|..|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+....+..........
T Consensus 181 ~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------- 247 (285)
T 3is5_A 181 EHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE----------- 247 (285)
T ss_dssp ------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC------------
T ss_pred ccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccc-----------
Confidence 22344578999999998864 57899999999999999999999999988777666654422111100
Q ss_pred ccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 234 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
...+++.+.+||++||..||++|||+.|||+|+||+.
T Consensus 248 ----------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 248 ----------------CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp -----------------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ----------------cCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 0125678999999999999999999999999999953
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=333.17 Aligned_cols=240 Identities=32% Similarity=0.462 Sum_probs=194.6
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+++..... .....+.+|+.+++.++|+||+++++++.. .+.+||||||+
T Consensus 25 ~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~ 87 (276)
T 2yex_A 25 LAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRRE----------------GNIQYLFLEYC 87 (276)
T ss_dssp EEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEE----------------TTEEEEEEECC
T ss_pred EEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEc----------------CCEEEEEEEec
Confidence 3678889999999999865432 345678899999999999999999999986 56889999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC-Ccccc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-NTLTN 158 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~~ 158 (472)
++ +|.+++.. ...+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++..+..... .....
T Consensus 88 ~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 166 (276)
T 2yex_A 88 SGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166 (276)
T ss_dssp TTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCC
T ss_pred CCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccC
Confidence 86 66666544 45699999999999999999999999999999999999999999999999999986643221 22344
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ-LSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
.++|..|+|||++.+...++.++|||||||++|+|++|+.||...+.... +..+......
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------------- 227 (276)
T 2yex_A 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY------------------- 227 (276)
T ss_dssp CCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT-------------------
T ss_pred CccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc-------------------
Confidence 57899999999998744457789999999999999999999987665432 2222211000
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
...+..++..+++||.+||..||++|||+.|+++|+||..
T Consensus 228 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 267 (276)
T 2yex_A 228 ---------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267 (276)
T ss_dssp ---------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred ---------cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccC
Confidence 0012357788999999999999999999999999999964
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=348.89 Aligned_cols=244 Identities=27% Similarity=0.417 Sum_probs=195.7
Q ss_pred CceeccCCCEEEEEEeecCC---cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEE
Q 012062 1 MAREIKTGEIVALKKIRMDN---EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVF 77 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~---~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVm 77 (472)
+|++..+++.||||+++... ........+.+|+++|++++||||+++++++.+ .+.+||||
T Consensus 44 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----------------~~~~~lv~ 107 (345)
T 3hko_A 44 VAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED----------------EQYICLVM 107 (345)
T ss_dssp EEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC----------------SSEEEEEE
T ss_pred EEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc----------------CCeEEEEE
Confidence 46788999999999997542 123455678899999999999999999999986 56899999
Q ss_pred ecCCC-ChhhhhcC---------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 012062 78 EYMDH-DLTGLADR---------------------------------------PGLRFTVPQIKCYMKQLLTGLHYCHVN 117 (472)
Q Consensus 78 Ey~~g-~l~~~~~~---------------------------------------~~~~l~~~~i~~i~~Qll~aL~~LH~~ 117 (472)
|||++ +|.+++.. ....+++..++.|+.||+.||+|||++
T Consensus 108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~ 187 (345)
T 3hko_A 108 ELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ 187 (345)
T ss_dssp ECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred eCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 99985 66665531 011246778999999999999999999
Q ss_pred CccccCCCCCcEEEcCCC--CeEEeeccceeeeccCCC---CccccccccCCCCChhhhcCC-CCCCCCcchhhHHHHHH
Q 012062 118 QVLHRDIKGSNLLIDNEG--NLKLADFGLARSFSYDHN---NTLTNRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIFA 191 (472)
Q Consensus 118 giiHrDLKp~NILl~~~~--~vkL~DFG~a~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ 191 (472)
+|+||||||+||||+.++ .+||+|||+++.+..... .......+|+.|+|||++.+. ..++.++||||||||+|
T Consensus 188 ~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~ 267 (345)
T 3hko_A 188 GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLH 267 (345)
T ss_dssp TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHH
T ss_pred CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHH
Confidence 999999999999998776 799999999987643222 123456789999999998642 56889999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCC
Q 012062 192 ELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ 271 (472)
Q Consensus 192 ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 271 (472)
+|++|+.||.+.+..+.+..+.......... .+..++.++++||.+||..||++
T Consensus 268 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~li~~~l~~~p~~ 321 (345)
T 3hko_A 268 LLLMGAVPFPGVNDADTISQVLNKKLCFENP--------------------------NYNVLSPLARDLLSNLLNRNVDE 321 (345)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHCCCCTTSG--------------------------GGGGSCHHHHHHHHHHSCSCTTT
T ss_pred HHHHCCCCCCCCChHHHHHHHHhcccccCCc--------------------------ccccCCHHHHHHHHHHcCCChhH
Confidence 9999999999999988888887643222111 12346788999999999999999
Q ss_pred CCCHHHHhcCCCCCC
Q 012062 272 RISAKDALDSEYFWT 286 (472)
Q Consensus 272 R~t~~elL~h~~f~~ 286 (472)
|||+.|+|+|+||..
T Consensus 322 Rps~~~~l~hp~~~~ 336 (345)
T 3hko_A 322 RFDAMRALQHPWISQ 336 (345)
T ss_dssp SCCHHHHHHSHHHHT
T ss_pred CCCHHHHhcChhhcc
Confidence 999999999999954
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=337.84 Aligned_cols=238 Identities=29% Similarity=0.473 Sum_probs=174.0
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||+++... ........+.+|++++++++|+||+++++++.. .+.+||||||
T Consensus 29 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~ 92 (278)
T 3cok_A 29 RAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED----------------SNYVYLVLEM 92 (278)
T ss_dssp EEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC----------------SSEEEEEEEC
T ss_pred EEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc----------------CCeEEEEEec
Confidence 36788899999999997543 223345678899999999999999999999986 5689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
+++ +|..++......+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++........ ....
T Consensus 93 ~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~ 171 (278)
T 3cok_A 93 CHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE-KHYT 171 (278)
T ss_dssp CTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---------
T ss_pred CCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC-ccee
Confidence 986 67777776656799999999999999999999999999999999999999999999999999987643222 2233
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
..+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+.... .
T Consensus 172 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------------~-- 229 (278)
T 3cok_A 172 LCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD-------------------Y-- 229 (278)
T ss_dssp ---------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSC-------------------C--
T ss_pred ccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcc-------------------c--
Confidence 568999999999876 567899999999999999999999998766544333221000 0
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.....++.++.+||.+||..||++|||+.|+|+|+||..
T Consensus 230 ---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 268 (278)
T 3cok_A 230 ---------EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268 (278)
T ss_dssp ---------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC-
T ss_pred ---------CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccC
Confidence 001236778999999999999999999999999999954
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=365.71 Aligned_cols=239 Identities=33% Similarity=0.503 Sum_probs=200.9
Q ss_pred CceeccCCCEEEEEEeecCCcC-----------CCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCc
Q 012062 1 MAREIKTGEIVALKKIRMDNEK-----------EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 69 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~-----------~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 69 (472)
+|+++.+++.||||+++..... +.....+.+|+.+|++|+|||||++++++..
T Consensus 54 ~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---------------- 117 (504)
T 3q5i_A 54 LCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFED---------------- 117 (504)
T ss_dssp EEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEEC----------------
T ss_pred EEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc----------------
Confidence 4788899999999999865322 1345678899999999999999999999987
Q ss_pred CCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC---CeEEeeccce
Q 012062 70 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG---NLKLADFGLA 145 (472)
Q Consensus 70 ~~~~~iVmEy~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~---~vkL~DFG~a 145 (472)
...+|||||||.+ +|.+.+... ..+++..++.|++||+.||+|||+++|+||||||+||||+.++ .+||+|||++
T Consensus 118 ~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 196 (504)
T 3q5i_A 118 KKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLS 196 (504)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTC
T ss_pred CCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCC
Confidence 6689999999986 666666543 3699999999999999999999999999999999999999876 6999999999
Q ss_pred eeeccCCCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCc
Q 012062 146 RSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWP 225 (472)
Q Consensus 146 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 225 (472)
+.+... ......++|+.|+|||++.+ .++.++||||||||+|+|++|..||.+.+..+.+..+........
T Consensus 197 ~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----- 267 (504)
T 3q5i_A 197 SFFSKD--YKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD----- 267 (504)
T ss_dssp EECCTT--SCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-----
T ss_pred EEcCCC--CccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-----
Confidence 876533 23445678999999999864 589999999999999999999999999999888888865322211
Q ss_pred cCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 226 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
...+..++.++++||++||..||++|||+.|+|+|+||..
T Consensus 268 ---------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 307 (504)
T 3q5i_A 268 ---------------------FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307 (504)
T ss_dssp ---------------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred ---------------------ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhh
Confidence 1234568889999999999999999999999999999964
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=356.64 Aligned_cols=239 Identities=25% Similarity=0.350 Sum_probs=184.2
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHH-hcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILK-KLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~-~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.|++.||||+++.. ..+.+|+.++. .++|+||++++++|.... ....++||||||
T Consensus 80 ~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~------------~~~~~~~lv~E~ 140 (400)
T 1nxk_A 80 QIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLY------------AGRKCLLIVMEC 140 (400)
T ss_dssp EEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE------------TTEEEEEEEEEC
T ss_pred EEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecc------------cCCcEEEEEEEe
Confidence 4788999999999999632 35678999874 558999999999986411 014578999999
Q ss_pred CCC-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC---CCCeEEeeccceeeeccCCCC
Q 012062 80 MDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN---EGNLKLADFGLARSFSYDHNN 154 (472)
Q Consensus 80 ~~g-~l~~~~~~~-~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~---~~~vkL~DFG~a~~~~~~~~~ 154 (472)
|++ +|.+++... ...+++.+++.|+.||+.||+|||+++|+||||||+||||+. ++.+||+|||+++..... .
T Consensus 141 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~--~ 218 (400)
T 1nxk_A 141 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--N 218 (400)
T ss_dssp CCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----
T ss_pred CCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCC--C
Confidence 986 787777654 346999999999999999999999999999999999999997 788999999999865432 2
Q ss_pred ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHH----HHHHHHHhcCCCCCCCCccCCCC
Q 012062 155 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAE----QLSKIFELCGSPDETIWPGVSKM 230 (472)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~ 230 (472)
.....++|+.|+|||++.+ ..++.++||||||||||+|++|+.||.+.+... ....+..........
T Consensus 219 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~-------- 289 (400)
T 1nxk_A 219 SLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP-------- 289 (400)
T ss_dssp --------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTT--------
T ss_pred ccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCc--------
Confidence 3445678999999999876 678999999999999999999999998765432 233333221111111
Q ss_pred CccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 231 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
.+..++.++++||++||..||++|||+.|||+|+||+..
T Consensus 290 ------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 290 ------------------EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp ------------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 123577899999999999999999999999999999653
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=349.97 Aligned_cols=240 Identities=26% Similarity=0.449 Sum_probs=198.7
Q ss_pred CceeccCCCEEEEEEeecCCcC------CCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeE
Q 012062 1 MAREIKTGEIVALKKIRMDNEK------EGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGST 73 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~------~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 73 (472)
+|++..+|+.||||+++..... +.....+.+|+.+++++ +|+||+++++++.. .+.+
T Consensus 112 ~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~----------------~~~~ 175 (365)
T 2y7j_A 112 RCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES----------------SSFM 175 (365)
T ss_dssp EEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB----------------SSEE
T ss_pred EEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee----------------CCEE
Confidence 3678889999999999865422 12245677899999999 79999999999986 5689
Q ss_pred EEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCC
Q 012062 74 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 152 (472)
Q Consensus 74 ~iVmEy~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 152 (472)
||||||+++ +|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 176 ~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~- 253 (365)
T 2y7j_A 176 FLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG- 253 (365)
T ss_dssp EEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT-
T ss_pred EEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCC-
Confidence 999999997 66666543 346999999999999999999999999999999999999999999999999999876532
Q ss_pred CCccccccccCCCCChhhhcCC-----CCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 012062 153 NNTLTNRVITLWYRPPELLLGA-----TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 227 (472)
Q Consensus 153 ~~~~~~~~gt~~y~aPE~l~~~-----~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 227 (472)
......++|+.|+|||++.+. ..++.++||||||||+|+|++|+.||...+....+..+........
T Consensus 254 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~------- 325 (365)
T 2y7j_A 254 -EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFS------- 325 (365)
T ss_dssp -CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-------
T ss_pred -cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC-------
Confidence 233456789999999998642 3578899999999999999999999999888877777755322111
Q ss_pred CCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 228 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
...+..++..+.+||++||..||++|||+.|+|+|+||.
T Consensus 326 -------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 326 -------------------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp -------------------HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred -------------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 122345778899999999999999999999999999994
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=338.30 Aligned_cols=235 Identities=30% Similarity=0.483 Sum_probs=194.8
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||++.... ........+.+|+.++++++|+||+++++++.. .+.+||||||
T Consensus 27 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~ 90 (279)
T 3fdn_A 27 LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD----------------ATRVYLILEY 90 (279)
T ss_dssp EEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----------------SSEEEEEECC
T ss_pred EEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec----------------CCEEEEEEec
Confidence 46788999999999997543 222345668899999999999999999999986 5679999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
+++ +|...+... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++...... ....
T Consensus 91 ~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~ 166 (279)
T 3fdn_A 91 APLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTD 166 (279)
T ss_dssp CTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----------
T ss_pred CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc---cccc
Confidence 996 566655443 36899999999999999999999999999999999999999999999999998654322 2334
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
..+|..|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+.......+
T Consensus 167 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------ 227 (279)
T 3fdn_A 167 LCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP------------------ 227 (279)
T ss_dssp -CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC------------------
T ss_pred cCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCC------------------
Confidence 578999999999876 5788999999999999999999999999988888777765332211
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
..++..+++||.+||..||++|||+.|||+|+||..
T Consensus 228 ------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~ 263 (279)
T 3fdn_A 228 ------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263 (279)
T ss_dssp ------------TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHH
T ss_pred ------------CcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccC
Confidence 135678999999999999999999999999999954
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=377.41 Aligned_cols=237 Identities=24% Similarity=0.424 Sum_probs=201.4
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
+|+++.+++.||||+++... ........++.|+.+|..+ +|+||++++++|++ .+.+|||||
T Consensus 359 ~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~----------------~~~~~lV~E 422 (674)
T 3pfq_A 359 LSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT----------------MDRLYFVME 422 (674)
T ss_dssp EEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC----------------SSEEEEEEE
T ss_pred EEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe----------------CCEEEEEEe
Confidence 47889999999999998652 2233456778999999988 79999999999986 568999999
Q ss_pred cCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 79 YMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 79 y~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
|+++ +|..++.+. ..+++.+++.|+.||+.||+|||+++|+||||||+||||+.++++||+|||+|+...... ....
T Consensus 423 ~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-~~~~ 500 (674)
T 3pfq_A 423 YVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-VTTK 500 (674)
T ss_dssp CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT-CCBC
T ss_pred CcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC-cccc
Confidence 9986 666665543 469999999999999999999999999999999999999999999999999998643322 3345
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..+||+.|+|||++.+ ..|+.++||||||||||||++|+.||.+.+..+++..|.+.....
T Consensus 501 ~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~------------------ 561 (674)
T 3pfq_A 501 TFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY------------------ 561 (674)
T ss_dssp CCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCC------------------
T ss_pred cccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCC------------------
Confidence 5689999999999976 678999999999999999999999999999999888886532111
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCH-----HHHhcCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA-----KDALDSEYFWT 286 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~-----~elL~h~~f~~ 286 (472)
...++.++++||++||..||++|+++ +||++|+||..
T Consensus 562 ------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 562 ------------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp ------------CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred ------------CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence 12467899999999999999999997 99999999964
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=344.91 Aligned_cols=240 Identities=30% Similarity=0.431 Sum_probs=199.7
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||+|++..... .......+.+|+.+++.++|+||+++++++.+ .+.+||||||
T Consensus 59 ~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~ 122 (335)
T 2owb_A 59 EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED----------------NDFVFVVLEL 122 (335)
T ss_dssp EEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC----------------SSEEEEEECC
T ss_pred EEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----------------CCeEEEEEec
Confidence 367889999999999986532 22345567889999999999999999999986 5689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
+++ +|.+++.. ...+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++....... .....
T Consensus 123 ~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 200 (335)
T 2owb_A 123 CRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-ERKKV 200 (335)
T ss_dssp CTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT-CCBCC
T ss_pred CCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc-ccccc
Confidence 996 56555543 3469999999999999999999999999999999999999999999999999998765332 22344
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
.++|..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+.......
T Consensus 201 ~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------------- 260 (335)
T 2owb_A 201 LCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI------------------- 260 (335)
T ss_dssp CCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC-------------------
T ss_pred cCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCC-------------------
Confidence 578999999999986 568899999999999999999999999988877776665432111
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL 289 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~~~ 289 (472)
...++..+.+||++||..||++|||+.|+|+|+||.....
T Consensus 261 -----------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 261 -----------PKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp -----------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred -----------CccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence 1135678999999999999999999999999999966433
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=348.13 Aligned_cols=231 Identities=25% Similarity=0.381 Sum_probs=189.0
Q ss_pred CceeccCCCEEEEEEeecCCcCCC------chhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEE
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEG------FPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTY 74 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~------~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 74 (472)
+|+++.+++.||||+++....... ....+.+|+.+|++++|+||++++++|.. .+.+|
T Consensus 42 ~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~----------------~~~~~ 105 (335)
T 3dls_A 42 TAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN----------------QGFFQ 105 (335)
T ss_dssp EEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC----------------SSEEE
T ss_pred EEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee----------------CCEEE
Confidence 367899999999999987643221 33456789999999999999999999986 66899
Q ss_pred EEEecCCC--ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCC
Q 012062 75 MVFEYMDH--DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 152 (472)
Q Consensus 75 iVmEy~~g--~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 152 (472)
|||||+.. +|..++... ..+++..++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.....
T Consensus 106 lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~- 183 (335)
T 3dls_A 106 LVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG- 183 (335)
T ss_dssp EEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred EEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCC-
Confidence 99999864 566666543 46999999999999999999999999999999999999999999999999999876532
Q ss_pred CCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 012062 153 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 232 (472)
Q Consensus 153 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (472)
......++|+.|+|||++.+...++.++|||||||++|+|++|+.||...... ... ...
T Consensus 184 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~-----------~~~--- 242 (335)
T 3dls_A 184 -KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VEA-----------AIH--- 242 (335)
T ss_dssp -CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TTT-----------CCC---
T ss_pred -CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hhh-----------ccC---
Confidence 23344578999999999987544588999999999999999999999653210 000 000
Q ss_pred cccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 233 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
....++.++.+||.+||..||++|||+.|||+|+||+.
T Consensus 243 ----------------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 243 ----------------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp ----------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred ----------------CCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 01136778999999999999999999999999999964
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=338.61 Aligned_cols=239 Identities=20% Similarity=0.289 Sum_probs=179.9
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+++...........+.+|..+++.++|+||+++++++.. .+.+||||||+
T Consensus 25 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~----------------~~~~~lv~e~~ 88 (290)
T 3fme_A 25 KMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR----------------EGDVWICMELM 88 (290)
T ss_dssp EEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC----------------SSSEEEEEECC
T ss_pred EEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec----------------cCCEEEEEehh
Confidence 36788999999999998654333333344455556888899999999999986 55789999999
Q ss_pred CCChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcc
Q 012062 81 DHDLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTL 156 (472)
Q Consensus 81 ~g~l~~~~~~---~~~~l~~~~i~~i~~Qll~aL~~LH~~-giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 156 (472)
+++|.+++.. ....+++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++...... ..
T Consensus 89 ~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 166 (290)
T 3fme_A 89 DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV--AK 166 (290)
T ss_dssp SEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--------------
T ss_pred ccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccccc--cc
Confidence 9987665543 455799999999999999999999998 99999999999999999999999999997664322 22
Q ss_pred ccccccCCCCChhhhc---CCCCCCCCcchhhHHHHHHHHHhCCCCCCC-CChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 012062 157 TNRVITLWYRPPELLL---GATKYGPAVDMWSVGCIFAELLNGKPILPG-KNEAEQLSKIFELCGSPDETIWPGVSKMPA 232 (472)
Q Consensus 157 ~~~~gt~~y~aPE~l~---~~~~~~~~~DiwSlG~il~ell~G~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (472)
....+|+.|+|||++. ....++.++|||||||++|+|++|+.||.. ......+..+.........
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 235 (290)
T 3fme_A 167 DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLP----------- 235 (290)
T ss_dssp ---CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCC-----------
T ss_pred cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcc-----------
Confidence 3346899999999972 335688899999999999999999999986 3444444444432111100
Q ss_pred cccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 233 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
...++.++.+||.+||..||++|||+.|+|+|+||.
T Consensus 236 -----------------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~ 271 (290)
T 3fme_A 236 -----------------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFT 271 (290)
T ss_dssp -----------------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred -----------------cccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccc
Confidence 023677899999999999999999999999999994
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=336.22 Aligned_cols=240 Identities=29% Similarity=0.423 Sum_probs=199.1
Q ss_pred CceeccCCCEEEEEEeecCCcC-CCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||+|++...... ......+.+|+.++++++|+||+++++++.. .+.+||||||
T Consensus 33 ~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~ 96 (294)
T 2rku_A 33 EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED----------------NDFVFVVLEL 96 (294)
T ss_dssp EEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC----------------SSEEEEEEEC
T ss_pred EEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc----------------CCEEEEEEec
Confidence 3678889999999999765322 2344567889999999999999999999986 5679999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
+++ +|.+++.. ...+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++....... .....
T Consensus 97 ~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~ 174 (294)
T 2rku_A 97 CRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-ERKKV 174 (294)
T ss_dssp CTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT-CCBCC
T ss_pred CCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc-ccccc
Confidence 996 55555543 3468999999999999999999999999999999999999999999999999998764322 22334
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
..+|..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+.......
T Consensus 175 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------------- 234 (294)
T 2rku_A 175 LCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI------------------- 234 (294)
T ss_dssp CCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC-------------------
T ss_pred ccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCC-------------------
Confidence 568999999999876 568899999999999999999999999988877766664321110
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL 289 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~~~ 289 (472)
...++..+.+||++||..||++|||+.|+|+|+||.....
T Consensus 235 -----------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 274 (294)
T 2rku_A 235 -----------PKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 274 (294)
T ss_dssp -----------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred -----------ccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCc
Confidence 1135678999999999999999999999999999976544
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=336.58 Aligned_cols=235 Identities=30% Similarity=0.486 Sum_probs=198.0
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||++.... ........+.+|++++++++|+||+++++++.. .+.+||||||
T Consensus 32 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~ 95 (284)
T 2vgo_A 32 LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD----------------RKRIYLMLEF 95 (284)
T ss_dssp EEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----------------SSEEEEEECC
T ss_pred EEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc----------------CCEEEEEEEe
Confidence 36788899999999997543 223345678899999999999999999999986 5689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
+++ +|.+++.+. ..+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++...... ....
T Consensus 96 ~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~ 171 (284)
T 2vgo_A 96 APRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL---RRRT 171 (284)
T ss_dssp CTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS---CBCC
T ss_pred CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc---cccc
Confidence 986 777766543 36899999999999999999999999999999999999999999999999998765432 2234
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
..+|..|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+.......
T Consensus 172 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------------- 231 (284)
T 2vgo_A 172 MCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKF------------------- 231 (284)
T ss_dssp CCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC-------------------
T ss_pred ccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCC-------------------
Confidence 568999999999986 568899999999999999999999999988887777665432110
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
...++..+++||.+||..||++|||+.|+|+|+||+.
T Consensus 232 -----------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~ 268 (284)
T 2vgo_A 232 -----------PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268 (284)
T ss_dssp -----------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHH
T ss_pred -----------CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHh
Confidence 1236778999999999999999999999999999964
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=340.48 Aligned_cols=252 Identities=24% Similarity=0.353 Sum_probs=187.5
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCC----------------------
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER---------------------- 58 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~---------------------- 58 (472)
+|++..+++.||||+++... .+.....+.+|+++|++|+|||||+++++|.+.....
T Consensus 24 ~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 102 (332)
T 3qd2_B 24 EAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSP 102 (332)
T ss_dssp EEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC---------------
T ss_pred EEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCC
Confidence 47888999999999998654 2335567889999999999999999999987643210
Q ss_pred -------------------CCCCCCCCCCcCCeEEEEEecCCC-ChhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHH
Q 012062 59 -------------------DEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPG--LRFTVPQIKCYMKQLLTGLHYCHV 116 (472)
Q Consensus 59 -------------------~~~~~~~~~~~~~~~~iVmEy~~g-~l~~~~~~~~--~~l~~~~i~~i~~Qll~aL~~LH~ 116 (472)
...........+..+|||||||++ +|.+++.+.. ...++..++.|+.||+.||+|||+
T Consensus 103 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~ 182 (332)
T 3qd2_B 103 SPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182 (332)
T ss_dssp -----------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH
T ss_pred CcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHh
Confidence 000000001223458999999996 6777666532 235666789999999999999999
Q ss_pred CCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC-----------CccccccccCCCCChhhhcCCCCCCCCcchhh
Q 012062 117 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-----------NTLTNRVITLWYRPPELLLGATKYGPAVDMWS 185 (472)
Q Consensus 117 ~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~-----------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwS 185 (472)
++|+||||||+||||+.++.+||+|||+++....... ......++|+.|+|||++.+ ..++.++||||
T Consensus 183 ~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s 261 (332)
T 3qd2_B 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG-NNYSHKVDIFS 261 (332)
T ss_dssp TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHC-CCCCTHHHHHH
T ss_pred CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcC-CCCcchhhHHH
Confidence 9999999999999999999999999999987654321 22344578999999999987 57899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhh
Q 012062 186 VGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKML 265 (472)
Q Consensus 186 lG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L 265 (472)
|||++|+|++|..++.. ....+..+... .....+...+..+++||.+||
T Consensus 262 lG~il~el~~~~~~~~~--~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~li~~~l 310 (332)
T 3qd2_B 262 LGLILFELLYSFSTQME--RVRIITDVRNL-----------------------------KFPLLFTQKYPQEHMMVQDML 310 (332)
T ss_dssp HHHHHHHHHSCCCCHHH--HHHHHHHHHTT-----------------------------CCCHHHHHHCHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhH--HHHHHHHhhcc-----------------------------CCCcccccCChhHHHHHHHHc
Confidence 99999999998655321 11111111110 011223455678899999999
Q ss_pred ccCCCCCCCHHHHhcCCCCC
Q 012062 266 MLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 266 ~~dP~~R~t~~elL~h~~f~ 285 (472)
..||++|||+.|+|+|+||.
T Consensus 311 ~~~p~~Rps~~~~l~~~~f~ 330 (332)
T 3qd2_B 311 SPSPTERPEATDIIENAIFE 330 (332)
T ss_dssp CSSGGGSCCHHHHHHSTTCC
T ss_pred cCCCCcCCCHHHHhhchhhh
Confidence 99999999999999999995
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=351.71 Aligned_cols=260 Identities=29% Similarity=0.506 Sum_probs=202.3
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC-CC-----CccceeEEeeCCCCCCCCCCCCCCCCcCCeEE
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HE-----NVIKLKEIVTSPGPERDEQGRPDGNKYRGSTY 74 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~-hp-----nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 74 (472)
+|++..+++.||||+++... .....+.+|+.+++.++ |+ +|+++++++.. .+.+|
T Consensus 72 ~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~----------------~~~~~ 132 (382)
T 2vx3_A 72 KAYDRVEQEWVAIKIIKNKK---AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF----------------RNHLC 132 (382)
T ss_dssp EEEETTTTEEEEEEEECSSH---HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE----------------TTEEE
T ss_pred EEEEcCCCcEEEEEEEeccH---HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc----------------CCceE
Confidence 36788999999999997432 23456678999998885 55 49999999986 56899
Q ss_pred EEEecCCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCCCcEEEc--CCCCeEEeeccceeeec
Q 012062 75 MVFEYMDHDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCH--VNQVLHRDIKGSNLLID--NEGNLKLADFGLARSFS 149 (472)
Q Consensus 75 iVmEy~~g~l~~~~~~~~-~~l~~~~i~~i~~Qll~aL~~LH--~~giiHrDLKp~NILl~--~~~~vkL~DFG~a~~~~ 149 (472)
|||||++++|.+++.... ..+++..++.|+.||+.||.||| +++|+||||||+||||+ .++.+||+|||+++...
T Consensus 133 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~ 212 (382)
T 2vx3_A 133 LVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 212 (382)
T ss_dssp EEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred EEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceecc
Confidence 999999999988877643 45899999999999999999999 57999999999999995 46789999999998764
Q ss_pred cCCCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 012062 150 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 229 (472)
Q Consensus 150 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (472)
. .....++|+.|+|||++.+ ..++.++||||||||||+|++|+.||.+.+..+.+..+.+..+.+....+.....
T Consensus 213 ~----~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 287 (382)
T 2vx3_A 213 Q----RIYQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPK 287 (382)
T ss_dssp C----CCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTT
T ss_pred c----ccccccCCccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHH
Confidence 2 2334678999999999987 5689999999999999999999999999999999999998877665443322111
Q ss_pred -------CCc-----------cccCCCchhhhhhHHHHh------------------hhccHHHHHHHHHhhccCCCCCC
Q 012062 230 -------MPA-----------YNHFKPSRTMKRRVREVF------------------RHFDRHALELLEKMLMLDPSQRI 273 (472)
Q Consensus 230 -------~~~-----------~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~ll~~~L~~dP~~R~ 273 (472)
++. ...+.+ .....+...+ ...+.++++||++||+.||++||
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rp 365 (382)
T 2vx3_A 288 ARKFFEKLPDGTWNLKKTKDGKREYKP--PGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRI 365 (382)
T ss_dssp HHHHEEECTTSCEEECCCCTTCCCSCC--TTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSC
T ss_pred HHHHHHhccccccccccccccccccCC--cchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCC
Confidence 000 000000 0001111111 01224789999999999999999
Q ss_pred CHHHHhcCCCCCC
Q 012062 274 SAKDALDSEYFWT 286 (472)
Q Consensus 274 t~~elL~h~~f~~ 286 (472)
|++|||+|+||..
T Consensus 366 ta~e~L~hp~f~~ 378 (382)
T 2vx3_A 366 QPYYALQHSFFKK 378 (382)
T ss_dssp CHHHHTTSGGGCC
T ss_pred CHHHHhcCccccc
Confidence 9999999999954
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=338.64 Aligned_cols=237 Identities=27% Similarity=0.417 Sum_probs=196.0
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+++..... ....+.+|+.++++++|+||+++++++.. .+.+||||||+
T Consensus 27 ~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~ 88 (304)
T 2jam_A 27 LVKQRLTGKLFALKCIKKSPAF--RDSSLENEIAVLKKIKHENIVTLEDIYES----------------TTHYYLVMQLV 88 (304)
T ss_dssp EEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEEC----------------SSEEEEEECCC
T ss_pred EEEECCCCCEEEEEEEeccccc--chHHHHHHHHHHHhCCCCCeeehhhhccc----------------CCEEEEEEEcC
Confidence 3678889999999999865322 23467899999999999999999999986 56899999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE---cCCCCeEEeeccceeeeccCCCCcc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI---DNEGNLKLADFGLARSFSYDHNNTL 156 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl---~~~~~vkL~DFG~a~~~~~~~~~~~ 156 (472)
++ +|.+.+... ..+++.+++.++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||++..... ...
T Consensus 89 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~---~~~ 164 (304)
T 2jam_A 89 SGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN---GIM 164 (304)
T ss_dssp CSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC---BTT
T ss_pred CCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC---Ccc
Confidence 85 676666543 358999999999999999999999999999999999999 6788899999999865432 123
Q ss_pred ccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccC
Q 012062 157 TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236 (472)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (472)
...++|..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+.+........
T Consensus 165 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~-------------- 229 (304)
T 2jam_A 165 STACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESP-------------- 229 (304)
T ss_dssp HHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTT--------------
T ss_pred ccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCcc--------------
Confidence 33468999999999876 568899999999999999999999999999888888776643322211
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.+..++.++++||.+||..||++|||+.|+|+|+||..
T Consensus 230 ------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (304)
T 2jam_A 230 ------------FWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267 (304)
T ss_dssp ------------TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred ------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence 12246778999999999999999999999999999964
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=353.15 Aligned_cols=264 Identities=26% Similarity=0.429 Sum_probs=201.5
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC--------CCCccceeEEeeCCCCCCCCCCCCCCCCcCCe
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ--------HENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 72 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~--------hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 72 (472)
+|++..+++.||||+++... .....+.+|+++|+.++ |+||++++++|...+. ....
T Consensus 55 ~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~------------~~~~ 119 (397)
T 1wak_A 55 LSWDIQGKKFVAMKVVKSAE---HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV------------NGTH 119 (397)
T ss_dssp EEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET------------TEEE
T ss_pred EEEecCCCeEEEEEEEecCC---cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC------------CCce
Confidence 47888999999999997432 23456789999999996 7889999999974211 1457
Q ss_pred EEEEEecCCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcCCC---------------
Q 012062 73 TYMVFEYMDHDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEG--------------- 135 (472)
Q Consensus 73 ~~iVmEy~~g~l~~~~~~~~-~~l~~~~i~~i~~Qll~aL~~LH~~-giiHrDLKp~NILl~~~~--------------- 135 (472)
+||||||+.++++..+.+.. ..+++.+++.|+.||+.||+|||++ ||+||||||+||||+.++
T Consensus 120 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~ 199 (397)
T 1wak_A 120 ICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQR 199 (397)
T ss_dssp EEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC----
T ss_pred EEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhh
Confidence 89999999998888776543 5699999999999999999999998 999999999999998775
Q ss_pred ----------------------------------CeEEeeccceeeeccCCCCccccccccCCCCChhhhcCCCCCCCCc
Q 012062 136 ----------------------------------NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 181 (472)
Q Consensus 136 ----------------------------------~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~ 181 (472)
.+||+|||+++.... .....++|+.|+|||++.+ ..++.++
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~ 274 (397)
T 1wak_A 200 SGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK----HFTEDIQTRQYRSLEVLIG-SGYNTPA 274 (397)
T ss_dssp -----------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB----CSCSCCSCGGGCCHHHHHT-SCCCTHH
T ss_pred cCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc----cCccCCCCCcccCChhhcC-CCCCcHH
Confidence 799999999987543 2344578999999999987 5689999
Q ss_pred chhhHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHhcCCCCCCCCc----------cCCCCCccccCCCchhhhhh
Q 012062 182 DMWSVGCIFAELLNGKPILPGKN------EAEQLSKIFELCGSPDETIWP----------GVSKMPAYNHFKPSRTMKRR 245 (472)
Q Consensus 182 DiwSlG~il~ell~G~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~ 245 (472)
||||||||||+|++|+.||...+ ..+.+..+.+..+.++...+. ............+.. ....
T Consensus 275 DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 353 (397)
T 1wak_A 275 DIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWG-LFEV 353 (397)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCC-HHHH
T ss_pred HHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcc-hhHh
Confidence 99999999999999999998765 566677777766665432211 111111111111100 0000
Q ss_pred HH---HHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 246 VR---EVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 246 ~~---~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
.. ......+..+++||.+||..||++|||+.|||+|+||.
T Consensus 354 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 354 LVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp HHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred hhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 11 11234567899999999999999999999999999994
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=362.55 Aligned_cols=238 Identities=24% Similarity=0.365 Sum_probs=195.7
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.||+.||||+++.... .......+.+|+++|++++|+||++++++|.. ...+||||||
T Consensus 203 ~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~----------------~~~l~lVmE~ 266 (543)
T 3c4z_A 203 ACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET----------------KTDLCLVMTI 266 (543)
T ss_dssp EEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----------------SSEEEEEECC
T ss_pred EEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee----------------CCEEEEEEEe
Confidence 478889999999999976532 22345678899999999999999999999987 5689999999
Q ss_pred CCC-ChhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCc
Q 012062 80 MDH-DLTGLADRP---GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT 155 (472)
Q Consensus 80 ~~g-~l~~~~~~~---~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 155 (472)
+++ +|..++... ...+++..++.|+.||+.||+|||++||+||||||+||||+.++++||+|||+++.+.... ..
T Consensus 267 ~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~-~~ 345 (543)
T 3c4z_A 267 MNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ-TK 345 (543)
T ss_dssp CTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC-CC
T ss_pred ccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC-cc
Confidence 996 666665442 3469999999999999999999999999999999999999999999999999998765332 22
Q ss_pred cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHhcCCCCCCCCccCCCCC
Q 012062 156 LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN----EAEQLSKIFELCGSPDETIWPGVSKMP 231 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (472)
....+||+.|+|||++.+ ..++.++||||||||+|+|++|+.||.+.+ ..+....+.......
T Consensus 346 ~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~------------ 412 (543)
T 3c4z_A 346 TKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTY------------ 412 (543)
T ss_dssp BCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCC------------
T ss_pred cccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCC------------
Confidence 334589999999999987 678999999999999999999999998764 234444443321110
Q ss_pred ccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCC-----HHHHhcCCCCCC
Q 012062 232 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 286 (472)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t-----~~elL~h~~f~~ 286 (472)
...++..+++||++||..||++|++ ++||++|+||..
T Consensus 413 ------------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 413 ------------------PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp ------------------CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred ------------------CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 1246788999999999999999995 589999999964
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=338.14 Aligned_cols=261 Identities=32% Similarity=0.530 Sum_probs=194.2
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC-CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||+++.. ....+.+|+++|++|+ |+||+++++++.... ...++|||||
T Consensus 54 ~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~--------------~~~~~lv~e~ 114 (330)
T 3nsz_A 54 EAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPV--------------SRTPALVFEH 114 (330)
T ss_dssp EEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT--------------TCCEEEEEEC
T ss_pred EEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCC--------------CCceEEEEec
Confidence 3678899999999999743 2456889999999997 999999999998632 4568999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC-CeEEeeccceeeeccCCCCccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG-NLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~-~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
+.+ +|..++. .+++.+++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||+++.+.... ...
T Consensus 115 ~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~ 188 (330)
T 3nsz_A 115 VNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYN 188 (330)
T ss_dssp CCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC--CCC
T ss_pred cCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC--ccc
Confidence 996 5555543 389999999999999999999999999999999999999777 79999999998764332 334
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCC-CCChHHHHHHHHHhcCCCCCCCCccCCC---CCcc
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILP-GKNEAEQLSKIFELCGSPDETIWPGVSK---MPAY 233 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~---~~~~ 233 (472)
..++|..|+|||++.+...++.++||||||||+|+|++|+.||. +.+..+.+..+.+..+......+-.... .+.+
T Consensus 189 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (330)
T 3nsz_A 189 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 268 (330)
T ss_dssp SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHH
T ss_pred cccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccch
Confidence 45789999999999875678999999999999999999998884 4555666665554433211000000000 0000
Q ss_pred c----cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 234 N----HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 234 ~----~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
. ..................++.++++||++||..||++|||++|||+|+||+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 325 (330)
T 3nsz_A 269 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 325 (330)
T ss_dssp HHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTT
T ss_pred hhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhh
Confidence 0 0000000000001112347889999999999999999999999999999964
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=353.78 Aligned_cols=241 Identities=29% Similarity=0.456 Sum_probs=183.7
Q ss_pred CceeccCCCEEEEEEeecCCcC------CCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEE
Q 012062 1 MAREIKTGEIVALKKIRMDNEK------EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTY 74 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~------~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 74 (472)
+|++..+++.||||++...... ......+.+|+++|++|+||||+++++++.. ..+|
T Consensus 153 ~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----------------~~~~ 215 (419)
T 3i6u_A 153 LAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-----------------EDYY 215 (419)
T ss_dssp EEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-----------------SEEE
T ss_pred EEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-----------------CceE
Confidence 4788999999999999764311 1223457899999999999999999999863 3579
Q ss_pred EEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC---CeEEeeccceeeecc
Q 012062 75 MVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG---NLKLADFGLARSFSY 150 (472)
Q Consensus 75 iVmEy~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~---~vkL~DFG~a~~~~~ 150 (472)
||||||.+ +|.+.+.. ...+++.+++.|+.||+.||+|||+++|+||||||+||||+.++ .+||+|||+++....
T Consensus 216 lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~ 294 (419)
T 3i6u_A 216 IVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 294 (419)
T ss_dssp EEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-
T ss_pred EEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCC
Confidence 99999986 56565554 44799999999999999999999999999999999999997654 499999999976543
Q ss_pred CCCCccccccccCCCCChhhhcC--CCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCC
Q 012062 151 DHNNTLTNRVITLWYRPPELLLG--ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 228 (472)
Q Consensus 151 ~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 228 (472)
. ......++|+.|+|||++.+ ...++.++|||||||++|+|++|+.||........+...+.....
T Consensus 295 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~---------- 362 (419)
T 3i6u_A 295 T--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY---------- 362 (419)
T ss_dssp ------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC----------
T ss_pred C--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC----------
Confidence 2 23345678999999999863 345788999999999999999999999876543333222211100
Q ss_pred CCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 229 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
......+..+++.+++||++||..||++|||++|+|+|+||..
T Consensus 363 ---------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 363 ---------------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp ---------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ---------------CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 0112345568889999999999999999999999999999943
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=368.33 Aligned_cols=237 Identities=25% Similarity=0.421 Sum_probs=194.9
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.|++.||||+++... ........+++|+.+|+.++|+|||+++++|.+ .+.+||||||
T Consensus 202 ~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~----------------~~~l~lVmEy 265 (576)
T 2acx_A 202 ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET----------------KDALCLVLTL 265 (576)
T ss_dssp EEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----------------SSEEEEEECC
T ss_pred EEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee----------------CCEEEEEEEc
Confidence 47788999999999997653 223345567899999999999999999999987 5689999999
Q ss_pred CCC-ChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 80 MDH-DLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 80 ~~g-~l~~~~~~~~-~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
+.+ +|..++.... ..+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+... ....
T Consensus 266 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~--~~~~ 343 (576)
T 2acx_A 266 MNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--QTIK 343 (576)
T ss_dssp CCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT--CCEE
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC--cccc
Confidence 985 6666665432 34999999999999999999999999999999999999999999999999999876432 2334
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE----AEQLSKIFELCGSPDETIWPGVSKMPAY 233 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (472)
..+||+.|+|||++.+ ..++.++||||||||+|+|++|+.||...+. ......+......
T Consensus 344 ~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~--------------- 407 (576)
T 2acx_A 344 GRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE--------------- 407 (576)
T ss_dssp CCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCC---------------
T ss_pred ccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccccc---------------
Confidence 4689999999999986 5689999999999999999999999987643 2233333221100
Q ss_pred ccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCCC
Q 012062 234 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 286 (472)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----t~~elL~h~~f~~ 286 (472)
+...++.++++||++||..||++|+ +++||++|+||..
T Consensus 408 ---------------~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 408 ---------------YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp ---------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred ---------------CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 0124678999999999999999999 8999999999964
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=338.49 Aligned_cols=237 Identities=24% Similarity=0.388 Sum_probs=197.1
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+++... ....+.+|++++++++|+||+++++++.. .+.+||||||+
T Consensus 47 ~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~ 106 (314)
T 3com_A 47 KAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFK----------------NTDLWIVMEYC 106 (314)
T ss_dssp EEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEE----------------TTEEEEEEECC
T ss_pred EEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEe----------------CCEEEEEeecC
Confidence 36788899999999998643 24568899999999999999999999986 56789999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
++ +|.+++......+++.+++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++....... ......
T Consensus 107 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~ 185 (314)
T 3com_A 107 GAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-AKRNTV 185 (314)
T ss_dssp TTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-SCBCCC
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-cccCcc
Confidence 87 6777665445579999999999999999999999999999999999999999999999999998765332 223345
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
.+|..|+|||++.+ ..++.++|||||||++|+|++|+.||...+....+..+........
T Consensus 186 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------- 245 (314)
T 3com_A 186 IGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTF------------------- 245 (314)
T ss_dssp CSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-------------------
T ss_pred CCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCccc-------------------
Confidence 78999999999876 5689999999999999999999999998887666554433211000
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.....++..+.+||.+||..||++|||+.|+|+|+||..
T Consensus 246 --------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~ 284 (314)
T 3com_A 246 --------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRS 284 (314)
T ss_dssp --------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHT
T ss_pred --------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhc
Confidence 001246778999999999999999999999999999964
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=350.70 Aligned_cols=239 Identities=28% Similarity=0.411 Sum_probs=187.2
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC--CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ--HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
|++. +++.||||+++...........+.+|+.+|++|+ |+|||++++++.. .+.+|||||+
T Consensus 75 ~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~----------------~~~~~lv~E~ 137 (390)
T 2zmd_A 75 VLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT----------------DQYIYMVMEC 137 (390)
T ss_dssp EECT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----------------SSEEEEEEEC
T ss_pred EEcC-CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec----------------CCEEEEEEec
Confidence 4454 4899999999876554445567889999999997 5999999999986 5579999997
Q ss_pred CCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC-Ccccc
Q 012062 80 MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-NTLTN 158 (472)
Q Consensus 80 ~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~~ 158 (472)
..++|.+++.+.. .+++.+++.|+.||+.||+|||+++|+||||||+||||+ ++.+||+|||+++.+..... .....
T Consensus 138 ~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~ 215 (390)
T 2zmd_A 138 GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDS 215 (390)
T ss_dssp CSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CC
T ss_pred CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCC
Confidence 7778888776543 689999999999999999999999999999999999996 57899999999987653322 12345
Q ss_pred ccccCCCCChhhhcCC----------CCCCCCcchhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCCCCCccC
Q 012062 159 RVITLWYRPPELLLGA----------TKYGPAVDMWSVGCIFAELLNGKPILPGKNE-AEQLSKIFELCGSPDETIWPGV 227 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~----------~~~~~~~DiwSlG~il~ell~G~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~ 227 (472)
.++|+.|+|||++.+. ..++.++||||||||||+|++|+.||..... ...+..+....... .++
T Consensus 216 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~---~~~-- 290 (390)
T 2zmd_A 216 QVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI---EFP-- 290 (390)
T ss_dssp SCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC---CCC--
T ss_pred CCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccC---CCC--
Confidence 6789999999998651 3578899999999999999999999987643 34444443211110 000
Q ss_pred CCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 228 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
...+.++++||++||..||++|||+.|||+|+||...
T Consensus 291 -----------------------~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 291 -----------------------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp -----------------------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred -----------------------ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 1235679999999999999999999999999999654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=344.70 Aligned_cols=239 Identities=28% Similarity=0.434 Sum_probs=185.6
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCC--CCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQH--ENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
|++ .+++.||||+++...........+.+|+.+|++|+| +||+++++++.. ...+|||||+
T Consensus 28 ~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~----------------~~~~~lv~e~ 90 (343)
T 3dbq_A 28 VLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT----------------DQYIYMVMEC 90 (343)
T ss_dssp EEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----------------SSEEEEEECC
T ss_pred EEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee----------------CCEEEEEEeC
Confidence 344 578999999998765544445678899999999986 999999999986 5689999998
Q ss_pred CCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC-cccc
Q 012062 80 MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN-TLTN 158 (472)
Q Consensus 80 ~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~ 158 (472)
..++|.+++... ..+++.+++.|+.||+.||+|||+++|+||||||+||||+ ++.+||+|||+++.+...... ....
T Consensus 91 ~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~ 168 (343)
T 3dbq_A 91 GNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDS 168 (343)
T ss_dssp CSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----------
T ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCC
Confidence 888888887664 3689999999999999999999999999999999999997 578999999999876533222 2334
Q ss_pred ccccCCCCChhhhcC----------CCCCCCCcchhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCCCCCccC
Q 012062 159 RVITLWYRPPELLLG----------ATKYGPAVDMWSVGCIFAELLNGKPILPGKNE-AEQLSKIFELCGSPDETIWPGV 227 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~----------~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~ 227 (472)
.++|+.|+|||++.+ ...++.++||||||||+|+|++|+.||..... ...+..+.... ....++
T Consensus 169 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~-- 243 (343)
T 3dbq_A 169 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN---HEIEFP-- 243 (343)
T ss_dssp -CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT---SCCCCC--
T ss_pred CcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCC---cccCCc--
Confidence 578999999999864 24578899999999999999999999987543 23333332211 110000
Q ss_pred CCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 228 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
...+.++.+||.+||..||++|||+.|+|+|+||...
T Consensus 244 -----------------------~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 244 -----------------------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp -----------------------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred -----------------------ccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 1235679999999999999999999999999999654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=334.74 Aligned_cols=241 Identities=22% Similarity=0.301 Sum_probs=193.6
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||+|+++...........+.+|+.+|++++|+||+++++++.... .....+||||||+
T Consensus 44 ~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------------~~~~~~~lv~e~~ 111 (290)
T 1t4h_A 44 KGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV------------KGKKCIVLVTELM 111 (290)
T ss_dssp EEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES------------SSCEEEEEEEECC
T ss_pred EeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc------------CCCceEEEEEEec
Confidence 3678899999999999866544445567889999999999999999999987521 1145789999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEc-CCCCeEEeeccceeeeccCCCCcc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ--VLHRDIKGSNLLID-NEGNLKLADFGLARSFSYDHNNTL 156 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~g--iiHrDLKp~NILl~-~~~~vkL~DFG~a~~~~~~~~~~~ 156 (472)
++ +|.+++.+. ..+++..++.|+.||+.||+|||+++ |+||||||+||||+ .++.+||+|||++..... ...
T Consensus 112 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~---~~~ 187 (290)
T 1t4h_A 112 TSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---SFA 187 (290)
T ss_dssp CSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT---TSB
T ss_pred CCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc---ccc
Confidence 86 666666543 46899999999999999999999999 99999999999998 788999999999865432 223
Q ss_pred ccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccC
Q 012062 157 TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236 (472)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (472)
....+|+.|+|||++.+ .++.++|||||||++|+|++|+.||........+.........+
T Consensus 188 ~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----------------- 248 (290)
T 1t4h_A 188 KAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP----------------- 248 (290)
T ss_dssp EESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC-----------------
T ss_pred ccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc-----------------
Confidence 34568999999998864 58999999999999999999999998866655544433211100
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.......+.++.+||.+||..||++|||+.|||+|+||..
T Consensus 249 ----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 249 ----------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ----------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ----------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 0112235678999999999999999999999999999964
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=331.84 Aligned_cols=239 Identities=26% Similarity=0.423 Sum_probs=196.1
Q ss_pred CceeccCCCEEEEEEeecCCcCC----CchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEE
Q 012062 1 MAREIKTGEIVALKKIRMDNEKE----GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMV 76 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iV 76 (472)
+|++..+++.||||+++...... .....+.+|+.++++++|+||+++++++.. ...+|||
T Consensus 23 ~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv 86 (283)
T 3bhy_A 23 KCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN----------------KTDVVLI 86 (283)
T ss_dssp EEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----------------SSEEEEE
T ss_pred EEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC----------------CCeEEEE
Confidence 36788899999999998654322 235678899999999999999999999986 5678999
Q ss_pred EecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC----CeEEeeccceeeeccC
Q 012062 77 FEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG----NLKLADFGLARSFSYD 151 (472)
Q Consensus 77 mEy~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~----~vkL~DFG~a~~~~~~ 151 (472)
|||+.+ +|.+++.. ...+++.+++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||++......
T Consensus 87 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~ 165 (283)
T 3bhy_A 87 LELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG 165 (283)
T ss_dssp EECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--
T ss_pred EeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCC
Confidence 999975 66666644 34689999999999999999999999999999999999998877 7999999999876432
Q ss_pred CCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 012062 152 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 231 (472)
Q Consensus 152 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (472)
. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......
T Consensus 166 ~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------ 230 (283)
T 3bhy_A 166 N--EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDF------------ 230 (283)
T ss_dssp --------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC------------
T ss_pred C--cccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCC------------
Confidence 2 2334568999999999876 568999999999999999999999999998887777665432111
Q ss_pred ccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 232 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
....+..++..+.+||++||..||++|||+.|+|+|+||.
T Consensus 231 --------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~ 270 (283)
T 3bhy_A 231 --------------DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIK 270 (283)
T ss_dssp --------------CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHH
T ss_pred --------------cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHH
Confidence 1233456788999999999999999999999999999993
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=333.74 Aligned_cols=240 Identities=25% Similarity=0.358 Sum_probs=191.6
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||++..... .....+.+|+++++.++|+||+++++++.. .+.+||||||+
T Consensus 37 ~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~ 98 (302)
T 2j7t_A 37 KAKNKETGALAAAKVIETKSE--EELEDYIVEIEILATCDHPYIVKLLGAYYH----------------DGKLWIMIEFC 98 (302)
T ss_dssp EEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----------------C-CEEEEEECC
T ss_pred EEEEcCCCcEEEEEEecCCCH--HHHHHHHHHHHHHhcCCCCCEeeeeeeeee----------------CCeEEEEEEeC
Confidence 367888999999999975532 235678899999999999999999999986 55789999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
++ +|..++......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++....... ......
T Consensus 99 ~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 177 (302)
T 2j7t_A 99 PGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-QKRDSF 177 (302)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-HC----
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-cccccc
Confidence 87 5555555445569999999999999999999999999999999999999999999999999875432111 112234
Q ss_pred cccCCCCChhhhc----CCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcccc
Q 012062 160 VITLWYRPPELLL----GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235 (472)
Q Consensus 160 ~gt~~y~aPE~l~----~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (472)
.+|..|+|||++. ....++.++|||||||++|+|++|..||...+..+.+..+........
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------- 242 (302)
T 2j7t_A 178 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL--------------- 242 (302)
T ss_dssp -CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC---------------
T ss_pred cCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc---------------
Confidence 6799999999984 235688999999999999999999999999888777766654321100
Q ss_pred CCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.....++..+.+||.+||..||++|||+.|+++|+||..
T Consensus 243 ------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 281 (302)
T 2j7t_A 243 ------------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSS 281 (302)
T ss_dssp ------------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTT
T ss_pred ------------CCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhh
Confidence 001246778999999999999999999999999999954
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=333.94 Aligned_cols=241 Identities=26% Similarity=0.428 Sum_probs=199.0
Q ss_pred CceeccCCCEEEEEEeecCCcCC-------CchhhHHHHHHHHHhcC-CCCccceeEEeeCCCCCCCCCCCCCCCCcCCe
Q 012062 1 MAREIKTGEIVALKKIRMDNEKE-------GFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 72 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~-------~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 72 (472)
+|+++.+++.||||+++...... .....+.+|+++++++. |+||+++++++.. .+.
T Consensus 35 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~----------------~~~ 98 (298)
T 1phk_A 35 RCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET----------------NTF 98 (298)
T ss_dssp EEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC----------------SSE
T ss_pred EEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc----------------CCe
Confidence 36788999999999998654211 22355678999999996 9999999999986 568
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccC
Q 012062 73 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 151 (472)
Q Consensus 73 ~~iVmEy~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 151 (472)
+||||||+++ +|.+++.. ...+++.+++.++.||+.||+|||++||+|+||||+|||++.++.+||+|||++..+...
T Consensus 99 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 177 (298)
T 1phk_A 99 FFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 177 (298)
T ss_dssp EEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcCCC
Confidence 9999999985 67666654 346899999999999999999999999999999999999999999999999999876532
Q ss_pred CCCccccccccCCCCChhhhcC-----CCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 012062 152 HNNTLTNRVITLWYRPPELLLG-----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPG 226 (472)
Q Consensus 152 ~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 226 (472)
.......+|..|+|||++.+ ...++.++|||||||++|+|++|+.||...+..+....+..........
T Consensus 178 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---- 251 (298)
T 1phk_A 178 --EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP---- 251 (298)
T ss_dssp --CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT----
T ss_pred --cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcc----
Confidence 23344578999999999852 3457889999999999999999999999988888777776543222111
Q ss_pred CCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 227 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.+..++..+.+||.+||..||++|||+.|+|+|+||..
T Consensus 252 ----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (298)
T 1phk_A 252 ----------------------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289 (298)
T ss_dssp ----------------------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred ----------------------cccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhh
Confidence 12356788999999999999999999999999999954
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=334.03 Aligned_cols=233 Identities=21% Similarity=0.229 Sum_probs=187.8
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||+++...........+++|+.++..+ +||||+++++++.. .+.+||||||
T Consensus 29 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~----------------~~~~~lv~e~ 92 (289)
T 1x8b_A 29 KCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE----------------DDHMLIQNEY 92 (289)
T ss_dssp EEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE----------------TTEEEEEEEC
T ss_pred EEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec----------------CCeEEEEEEe
Confidence 367888999999999987655554567788999999999 89999999999987 5689999999
Q ss_pred CCC-ChhhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC-------------------CC
Q 012062 80 MDH-DLTGLADRP---GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE-------------------GN 136 (472)
Q Consensus 80 ~~g-~l~~~~~~~---~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~-------------------~~ 136 (472)
+++ +|.+++... ...+++.+++.|+.||+.||+|||+++|+||||||+||||+.+ ..
T Consensus 93 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (289)
T 1x8b_A 93 CNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVM 172 (289)
T ss_dssp CTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CCC
T ss_pred cCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceE
Confidence 986 777776542 2458999999999999999999999999999999999999844 47
Q ss_pred eEEeeccceeeeccCCCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 012062 137 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 216 (472)
Q Consensus 137 vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~ 216 (472)
+||+|||++...... ....+|..|+|||++.+...++.++|||||||++|+|++|.+++...+. ...+....
T Consensus 173 ~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~~~~~ 244 (289)
T 1x8b_A 173 FKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEIRQGR 244 (289)
T ss_dssp EEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHHHHTTC
T ss_pred EEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHHHHcCC
Confidence 999999999876432 2235899999999998754667899999999999999999987755432 22222211
Q ss_pred CCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 217 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
. + .....++.++.+||.+||..||++|||+.|+|+|+||..
T Consensus 245 ~-------~----------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 245 L-------P----------------------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285 (289)
T ss_dssp C-------C----------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred C-------C----------------------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence 0 0 011246778999999999999999999999999999954
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=336.00 Aligned_cols=240 Identities=23% Similarity=0.356 Sum_probs=188.3
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||++..... .......+.+|+.++++++||||+++++++.. .+.+||||||
T Consensus 29 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~----------------~~~~~lv~e~ 92 (294)
T 4eqm_A 29 LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE----------------DDCYYLVMEY 92 (294)
T ss_dssp EEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC----------------SSEEEEEEEC
T ss_pred EEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee----------------CCeEEEEEeC
Confidence 478889999999999976533 23345677899999999999999999999986 6689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
+++ +|.+++.+. ..+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+..........
T Consensus 93 ~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 171 (294)
T 4eqm_A 93 IEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH 171 (294)
T ss_dssp CCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----------
T ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccccccCc
Confidence 986 666666543 369999999999999999999999999999999999999999999999999997665443334445
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
.++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+...+......
T Consensus 172 ~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~--------------------- 229 (294)
T 4eqm_A 172 VLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV--------------------- 229 (294)
T ss_dssp ---CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCC---------------------
T ss_pred cccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccC---------------------
Confidence 678999999999987 5689999999999999999999999999888776655543210
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 283 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~ 283 (472)
..........++..+.+||.+||..||++|++..+.+.+.|
T Consensus 230 ----~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l 270 (294)
T 4eqm_A 230 ----PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDL 270 (294)
T ss_dssp ----CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHH
T ss_pred ----CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHH
Confidence 00112233467889999999999999999995555444444
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=334.43 Aligned_cols=242 Identities=27% Similarity=0.404 Sum_probs=197.2
Q ss_pred ceeccCCCEEEEEEeecCCc--CCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 2 AREIKTGEIVALKKIRMDNE--KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
|++..+++.||||+++.... .......+.+|++++++++|+||+++++++.... ...+||||||
T Consensus 24 ~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--------------~~~~~lv~e~ 89 (305)
T 2wtk_C 24 VLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEE--------------KQKMYMVMEY 89 (305)
T ss_dssp EEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-----------------CEEEEEEC
T ss_pred EEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC--------------CCeEEEEehh
Confidence 67888999999999976531 1234567889999999999999999999986421 4578999999
Q ss_pred CCCChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCC-CCccc
Q 012062 80 MDHDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH-NNTLT 157 (472)
Q Consensus 80 ~~g~l~~~~~~-~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~ 157 (472)
+++++.+++.. ....+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++....... .....
T Consensus 90 ~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 169 (305)
T 2wtk_C 90 CVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR 169 (305)
T ss_dssp CSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEEC
T ss_pred ccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccccccccc
Confidence 99887766554 34569999999999999999999999999999999999999999999999999998764322 22333
Q ss_pred cccccCCCCChhhhcCCC-CCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccC
Q 012062 158 NRVITLWYRPPELLLGAT-KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~-~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (472)
...+|..|+|||++.+.. .++.++|||||||++|+|++|+.||.+.+..+.+..+.......
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~----------------- 232 (305)
T 2wtk_C 170 TSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAI----------------- 232 (305)
T ss_dssp CCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC-----------------
T ss_pred cCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCC-----------------
Confidence 456899999999987532 24678999999999999999999999988877777665432111
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
...++..+.+||++||..||++|||+.|+++|+||...
T Consensus 233 -------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 233 -------------PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp -------------CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred -------------CCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 11356789999999999999999999999999999653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=332.79 Aligned_cols=237 Identities=30% Similarity=0.441 Sum_probs=189.1
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||+++... ........+.+|+.+++.++|+||+++++++.. .+.+||||||
T Consensus 29 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~ 92 (276)
T 2h6d_A 29 IGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST----------------PTDFFMVMEY 92 (276)
T ss_dssp EEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----------------SSEEEEEEEC
T ss_pred EEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec----------------CCeEEEEEec
Confidence 36778899999999997643 223345678899999999999999999999986 5679999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
+.+ +|.+++... ..+++.+++.++.||+.||+|||+++|+|+||||+|||++.++.+||+|||++...... .....
T Consensus 93 ~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~ 169 (276)
T 2h6d_A 93 VSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRT 169 (276)
T ss_dssp CCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--------
T ss_pred cCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC--cceec
Confidence 985 676666543 36899999999999999999999999999999999999999999999999998765432 22234
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
..+|..|+|||++.+....+.++|||||||++|+|++|+.||...+....+..+.......
T Consensus 170 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------------- 230 (276)
T 2h6d_A 170 SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYI------------------- 230 (276)
T ss_dssp -------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-------------------
T ss_pred ccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccC-------------------
Confidence 5679999999999874444689999999999999999999999888777776665422111
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
...++..+.+||.+||..||++|||+.|+++|+||+.
T Consensus 231 -----------~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~ 267 (276)
T 2h6d_A 231 -----------PEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ 267 (276)
T ss_dssp -----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred -----------chhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhcc
Confidence 0135678999999999999999999999999999965
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=348.02 Aligned_cols=235 Identities=25% Similarity=0.424 Sum_probs=187.7
Q ss_pred ccCCCEEEEEEeecCCc--CCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 5 IKTGEIVALKKIRMDNE--KEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~~--~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
..+++.||||+++.... .......+.+|+++|+++ +|+||+++++++.. .+.+||||||++
T Consensus 79 ~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~----------------~~~~~lv~e~~~ 142 (355)
T 1vzo_A 79 HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT----------------ETKLHLILDYIN 142 (355)
T ss_dssp TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE----------------TTEEEEEECCCC
T ss_pred CCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee----------------CceEEEEeecCC
Confidence 36899999999975431 222345567899999999 69999999999986 568999999998
Q ss_pred C-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 82 H-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 82 g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+ +|.+++... ..+++.+++.++.||+.||+|||+++|+||||||+||||+.++++||+|||+++.+...........+
T Consensus 143 ~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 221 (355)
T 1vzo_A 143 GGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC 221 (355)
T ss_dssp SCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGG
T ss_pred CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcc
Confidence 6 666666543 36999999999999999999999999999999999999999999999999999876544444445567
Q ss_pred ccCCCCChhhhcCC-CCCCCCcchhhHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHhcCCCCCCCCccCCCCCcccc
Q 012062 161 ITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLNGKPILPGKNE----AEQLSKIFELCGSPDETIWPGVSKMPAYNH 235 (472)
Q Consensus 161 gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (472)
+|+.|+|||++.+. ..++.++||||||||||+|++|+.||...+. ......+......
T Consensus 222 gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------------- 284 (355)
T 1vzo_A 222 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP----------------- 284 (355)
T ss_dssp SCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC-----------------
T ss_pred cCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCC-----------------
Confidence 89999999999753 3478899999999999999999999975433 2222222221100
Q ss_pred CCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCCC
Q 012062 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 286 (472)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----t~~elL~h~~f~~ 286 (472)
....++..+++||.+||..||++|+ |++|+++|+||..
T Consensus 285 -------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 285 -------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp -------------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred -------------CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 0124677899999999999999999 9999999999953
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=335.53 Aligned_cols=233 Identities=21% Similarity=0.267 Sum_probs=189.2
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||+++..... ..+.+|+.++++| +|+||+++++++.. ...+||||||
T Consensus 27 ~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~----------------~~~~~lv~e~ 86 (330)
T 2izr_A 27 LGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPC----------------GKYNAMVLEL 86 (330)
T ss_dssp EEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEE----------------TTEEEEEEEC
T ss_pred EEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEec----------------CCccEEEEEe
Confidence 3678899999999999765432 3578999999999 99999999999987 5678999999
Q ss_pred CCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC-----eEEeeccceeeeccCCCC
Q 012062 80 MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN-----LKLADFGLARSFSYDHNN 154 (472)
Q Consensus 80 ~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~-----vkL~DFG~a~~~~~~~~~ 154 (472)
+.++|.+++......+++.+++.|+.||+.||+|||+++|+||||||+||||+.++. +||+|||+++.+......
T Consensus 87 ~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~ 166 (330)
T 2izr_A 87 LGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166 (330)
T ss_dssp CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTC
T ss_pred CCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCC
Confidence 977888888765567999999999999999999999999999999999999998887 999999999876543321
Q ss_pred ------ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhcCCCCCCCCc
Q 012062 155 ------TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA---EQLSKIFELCGSPDETIWP 225 (472)
Q Consensus 155 ------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~ 225 (472)
.....++|+.|+|||++.+ ..++.++||||||||+|+|++|+.||.+.+.. +.+..+.....
T Consensus 167 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~-------- 237 (330)
T 2izr_A 167 KHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR-------- 237 (330)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH--------
T ss_pred ccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc--------
Confidence 1245678999999999987 66899999999999999999999999885433 33333322110
Q ss_pred cCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 226 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
..........++ ++.+||.+||..||.+||++.+|++
T Consensus 238 -----------------~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 238 -----------------ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp -----------------HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred -----------------cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 001112223355 8999999999999999999988864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=344.53 Aligned_cols=245 Identities=22% Similarity=0.367 Sum_probs=192.5
Q ss_pred CceeccCCCEEEEEEeecCCcC-CCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||+++..... ......+.+|++++++++||||+++++++..... ....+||||||
T Consensus 30 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~------------~~~~~~lv~e~ 97 (311)
T 3ork_A 30 LARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP------------AGPLPYIVMEY 97 (311)
T ss_dssp EEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET------------TEEEEEEEEEC
T ss_pred EEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC------------CCcccEEEEec
Confidence 4788899999999999875432 2344567899999999999999999999876321 12356999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC--Ccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTL 156 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~--~~~ 156 (472)
+++ +|.+++... ..+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+..... ...
T Consensus 98 ~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 176 (311)
T 3ork_A 98 VDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176 (311)
T ss_dssp CCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-------------
T ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccc
Confidence 985 666666543 4699999999999999999999999999999999999999999999999999976643322 222
Q ss_pred ccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccC
Q 012062 157 TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236 (472)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (472)
...++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......+
T Consensus 177 ~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----------------- 238 (311)
T 3ork_A 177 AAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP----------------- 238 (311)
T ss_dssp -----CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC-----------------
T ss_pred cccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC-----------------
Confidence 34568999999999987 578999999999999999999999999998887776665432111
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
.......++.++.+||.+||..||++|+++.++|.|+|+.
T Consensus 239 ---------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 239 ---------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp ---------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ---------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 1223345788999999999999999999999999999873
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=339.33 Aligned_cols=261 Identities=25% Similarity=0.424 Sum_probs=201.4
Q ss_pred cee-ccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCC------ccceeEEeeCCCCCCCCCCCCCCCCcCCeEE
Q 012062 2 ARE-IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHEN------VIKLKEIVTSPGPERDEQGRPDGNKYRGSTY 74 (472)
Q Consensus 2 a~~-~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpn------Iv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 74 (472)
|++ ..+++.||||+++... .....+.+|+++++.++|++ |+++++++.. .+.+|
T Consensus 33 ~~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~----------------~~~~~ 93 (339)
T 1z57_A 33 CIDHKAGGRHVAVKIVKNVD---RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH----------------HGHIC 93 (339)
T ss_dssp EEETTTTTEEEEEEEECSSH---HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE----------------TTEEE
T ss_pred EEecCCCCcEEEEEEEecCC---chhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc----------------CCcEE
Confidence 556 5688999999997432 23456788999999997654 9999999986 56899
Q ss_pred EEEecCCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC-------------------C
Q 012062 75 MVFEYMDHDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN-------------------E 134 (472)
Q Consensus 75 iVmEy~~g~l~~~~~~~~-~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~-------------------~ 134 (472)
|||||++++|.+++.... ..+++.+++.++.||+.||+|||+++|+||||||+||||+. +
T Consensus 94 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~ 173 (339)
T 1z57_A 94 IVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLIN 173 (339)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESC
T ss_pred EEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccC
Confidence 999999889888776543 36899999999999999999999999999999999999987 5
Q ss_pred CCeEEeeccceeeeccCCCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 012062 135 GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 214 (472)
Q Consensus 135 ~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~ 214 (472)
+.+||+|||+++.... .....++|+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+.+..+..
T Consensus 174 ~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 248 (339)
T 1z57_A 174 PDIKVVDFGSATYDDE----HHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMER 248 (339)
T ss_dssp CCEEECCCSSCEETTS----CCCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHH
T ss_pred CCceEeeCcccccCcc----ccccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 6799999999976432 2234578999999999986 5789999999999999999999999999999888888877
Q ss_pred hcCCCCCCCCccCCCCCcc----ccCCCchhhhhhHHHH----------hhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 215 LCGSPDETIWPGVSKMPAY----NHFKPSRTMKRRVREV----------FRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~----------~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
..+..+...+........+ ..+............. ....++++.+||++||..||++|||+.|||+
T Consensus 249 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 249 ILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp HHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence 7765544332222111000 0011110001101110 1234678999999999999999999999999
Q ss_pred CCCCCC
Q 012062 281 SEYFWT 286 (472)
Q Consensus 281 h~~f~~ 286 (472)
|+||+.
T Consensus 329 hp~f~~ 334 (339)
T 1z57_A 329 HPFFDL 334 (339)
T ss_dssp SGGGGG
T ss_pred CHHHHH
Confidence 999953
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=331.08 Aligned_cols=238 Identities=32% Similarity=0.524 Sum_probs=197.7
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+++...........+.+|++++++++|+||+++++++.. .+.+||||||+
T Consensus 40 ~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~ 103 (287)
T 2wei_A 40 KCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED----------------SSSFYIVGELY 103 (287)
T ss_dssp EEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----------------SSEEEEEECCC
T ss_pred EEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC----------------CCeEEEEEEcc
Confidence 36788899999999998765555556788899999999999999999999986 56789999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC---CeEEeeccceeeeccCCCCcc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG---NLKLADFGLARSFSYDHNNTL 156 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~---~vkL~DFG~a~~~~~~~~~~~ 156 (472)
.+ +|.+.+... ..+++.+++.++.||+.||+|||+++|+||||||+||||+.++ .+||+|||++..+... ...
T Consensus 104 ~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~--~~~ 180 (287)
T 2wei_A 104 TGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKM 180 (287)
T ss_dssp CSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC--SSC
T ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC--Ccc
Confidence 85 666665443 3689999999999999999999999999999999999997644 6999999998765432 223
Q ss_pred ccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccC
Q 012062 157 TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236 (472)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (472)
....+|..|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+..........
T Consensus 181 ~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------- 244 (287)
T 2wei_A 181 KDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP-------------- 244 (287)
T ss_dssp SCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSG--------------
T ss_pred ccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCch--------------
Confidence 34467999999999875 48899999999999999999999999998888777775532221110
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
.+..++.++.+||++||..||++|||+.|+|+|+||.
T Consensus 245 ------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~ 281 (287)
T 2wei_A 245 ------------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281 (287)
T ss_dssp ------------GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHH
T ss_pred ------------hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHh
Confidence 1234678899999999999999999999999999994
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=336.11 Aligned_cols=248 Identities=21% Similarity=0.349 Sum_probs=178.2
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||+++..... .....+.+|+.++++++|+||+++++++.. .+.+||||||++
T Consensus 34 ~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~ 96 (303)
T 2vwi_A 34 AYCAPKKEKVAIKRINLEKCQ-TSMDELLKEIQAMSQCHHPNIVSYYTSFVV----------------KDELWLVMKLLS 96 (303)
T ss_dssp EEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEES----------------SSCEEEEEECCT
T ss_pred EEECCCCcEEEEEEEEhhhcc-hhHHHHHHHHHHHhhcCCCCEeeEEEEEee----------------cCCcEEEehhcc
Confidence 667789999999999765432 234567899999999999999999999987 557899999997
Q ss_pred C-ChhhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCC-
Q 012062 82 H-DLTGLADR-------PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH- 152 (472)
Q Consensus 82 g-~l~~~~~~-------~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~- 152 (472)
+ +|.+++.. ....+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++.......
T Consensus 97 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 176 (303)
T 2vwi_A 97 GGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGD 176 (303)
T ss_dssp TCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC----
T ss_pred CCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCC
Confidence 5 66666542 34468999999999999999999999999999999999999999999999999987654321
Q ss_pred ---CCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 012062 153 ---NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 229 (472)
Q Consensus 153 ---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (472)
........+|+.|+|||++.+...++.++|||||||++|+|++|+.||...+..+.+..............
T Consensus 177 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------ 250 (303)
T 2vwi_A 177 ITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG------ 250 (303)
T ss_dssp -----------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-------
T ss_pred ccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccc------
Confidence 11223456899999999987545688999999999999999999999998877766655443211110000
Q ss_pred CCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 230 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.........++.++.+||.+||..||++|||+.|+++|+||..
T Consensus 251 --------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 293 (303)
T 2vwi_A 251 --------------VQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293 (303)
T ss_dssp ------------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC--
T ss_pred --------------cccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhc
Confidence 0001122356788999999999999999999999999999953
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=334.93 Aligned_cols=239 Identities=31% Similarity=0.478 Sum_probs=187.2
Q ss_pred CceeccCCCEEEEEEeecCCc------CCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEE
Q 012062 1 MAREIKTGEIVALKKIRMDNE------KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTY 74 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~------~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 74 (472)
+|++..+++.||||+++.... .......+.+|+++|++|+|+||+++++++.. ..+|
T Consensus 28 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----------------~~~~ 90 (322)
T 2ycf_A 28 LAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-----------------EDYY 90 (322)
T ss_dssp EEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES-----------------SSEE
T ss_pred EEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC-----------------CceE
Confidence 367889999999999975431 11233457899999999999999999999874 2379
Q ss_pred EEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC---eEEeeccceeeecc
Q 012062 75 MVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN---LKLADFGLARSFSY 150 (472)
Q Consensus 75 iVmEy~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~---vkL~DFG~a~~~~~ 150 (472)
|||||+.+ +|.+.+.. ...+++.+++.++.||+.||+|||+++|+||||||+||||+.++. +||+|||++.....
T Consensus 91 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 169 (322)
T 2ycf_A 91 IVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169 (322)
T ss_dssp EEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCC
T ss_pred EEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceeccc
Confidence 99999986 66666654 347999999999999999999999999999999999999987665 99999999987542
Q ss_pred CCCCccccccccCCCCChhhhc--CCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHH-HHHHHhcCCCCCCCCccC
Q 012062 151 DHNNTLTNRVITLWYRPPELLL--GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQL-SKIFELCGSPDETIWPGV 227 (472)
Q Consensus 151 ~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~ 227 (472)
. .......+|..|+|||++. +...++.++|||||||++|+|++|..||........+ ..+......
T Consensus 170 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------- 238 (322)
T 2ycf_A 170 T--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN--------- 238 (322)
T ss_dssp C--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCC---------
T ss_pred c--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccc---------
Confidence 2 1223356799999999974 2356889999999999999999999999876543222 222221100
Q ss_pred CCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 228 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
.....+..++..+++||.+||..||++|||+.|+|+|+||.
T Consensus 239 -----------------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~ 279 (322)
T 2ycf_A 239 -----------------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279 (322)
T ss_dssp -----------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGC
T ss_pred -----------------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcC
Confidence 01233456788999999999999999999999999999994
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=357.34 Aligned_cols=244 Identities=16% Similarity=0.217 Sum_probs=179.3
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHH---HHHhcCCCCcccee-------EEeeCCCCCCCCCCCCC-CCC
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIK---ILKKLQHENVIKLK-------EIVTSPGPERDEQGRPD-GNK 68 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~---il~~l~hpnIv~l~-------~~~~~~~~~~~~~~~~~-~~~ 68 (472)
+|+++.+++.||||+++... ........+.+|++ +|+.++|||||+++ ++++..+.........+ ...
T Consensus 91 ~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (377)
T 3byv_A 91 EATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDM 170 (377)
T ss_dssp EEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------C
T ss_pred EEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCce
Confidence 36778899999999998653 23345567889995 55555799999998 67665321000000000 000
Q ss_pred cCCeEEEEEecCCCChhhhhcCCCCCCC-------HHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEee
Q 012062 69 YRGSTYMVFEYMDHDLTGLADRPGLRFT-------VPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLAD 141 (472)
Q Consensus 69 ~~~~~~iVmEy~~g~l~~~~~~~~~~l~-------~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~D 141 (472)
+--..||||||++|+|.+++.+.. .++ +..++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|
T Consensus 171 ~i~~~~lv~E~~~g~L~~~l~~~~-~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~D 249 (377)
T 3byv_A 171 WVLSRFFLYPRMQSNLQTFGEVLL-SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 249 (377)
T ss_dssp EEESEEEEEECCSEEHHHHHHHHH-HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECC
T ss_pred EEEEEEEEEeccCCCHHHHHHhcc-ccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEe
Confidence 001378999999988888776432 233 478888999999999999999999999999999999999999999
Q ss_pred ccceeeeccCCCCccccccccCCCCChhhhcCC----------CCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 012062 142 FGLARSFSYDHNNTLTNRVITLWYRPPELLLGA----------TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSK 211 (472)
Q Consensus 142 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----------~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~ 211 (472)
||+++.... .....++ +.|+|||++.+. ..++.++||||||||||+|++|+.||.+.+..+.+..
T Consensus 250 FG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~ 324 (377)
T 3byv_A 250 FEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEW 324 (377)
T ss_dssp GGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGG
T ss_pred chhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhh
Confidence 999985332 3344567 999999999863 2689999999999999999999999976553222111
Q ss_pred HHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 212 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 212 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
+. ..+..++.++++||.+||..||++|||+.|+|+|+||
T Consensus 325 ~~----------------------------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f 363 (377)
T 3byv_A 325 IF----------------------------------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY 363 (377)
T ss_dssp GG----------------------------------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHH
T ss_pred hh----------------------------------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHH
Confidence 11 0113567889999999999999999999999999999
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=340.39 Aligned_cols=261 Identities=26% Similarity=0.415 Sum_probs=201.1
Q ss_pred ceeccCC-CEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCC------ccceeEEeeCCCCCCCCCCCCCCCCcCCeEE
Q 012062 2 AREIKTG-EIVALKKIRMDNEKEGFPITAIREIKILKKLQHEN------VIKLKEIVTSPGPERDEQGRPDGNKYRGSTY 74 (472)
Q Consensus 2 a~~~~tg-~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpn------Iv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 74 (472)
|++..++ +.||||+++... .....+.+|+.++++++|++ |+.+++++.. .+.+|
T Consensus 38 ~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~----------------~~~~~ 98 (355)
T 2eu9_A 38 CLDHARGKSQVALKIIRNVG---KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF----------------HGHMC 98 (355)
T ss_dssp EEETTTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE----------------TTEEE
T ss_pred EEecCCCceEEEEEEEcccc---cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee----------------CCeEE
Confidence 6677777 689999997432 23456778999999997765 8999999876 56899
Q ss_pred EEEecCCCChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE-------------------cCC
Q 012062 75 MVFEYMDHDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI-------------------DNE 134 (472)
Q Consensus 75 iVmEy~~g~l~~~~~~~~-~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl-------------------~~~ 134 (472)
|||||++++++..+.... ..+++.+++.|+.||+.||+|||+++|+||||||+|||| +.+
T Consensus 99 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~ 178 (355)
T 2eu9_A 99 IAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKN 178 (355)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESC
T ss_pred EEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCC
Confidence 999999998888776543 469999999999999999999999999999999999999 567
Q ss_pred CCeEEeeccceeeeccCCCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 012062 135 GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 214 (472)
Q Consensus 135 ~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~ 214 (472)
+.+||+|||+++.... .....++|+.|+|||++.+ ..++.++||||||||+|+|++|+.||...+..+.+..+.+
T Consensus 179 ~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 253 (355)
T 2eu9_A 179 TSIRVADFGSATFDHE----HHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK 253 (355)
T ss_dssp CCEEECCCTTCEETTS----CCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CcEEEeecCccccccc----cccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 8899999999976432 2334578999999999986 5789999999999999999999999999999888888888
Q ss_pred hcCCCCCCCCccCCCCCcc----ccCCCchhhhhhHHHH----------hhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 215 LCGSPDETIWPGVSKMPAY----NHFKPSRTMKRRVREV----------FRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~----------~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
..+..+...+........+ ..+.......+..... ....+.++.+||++||..||++|||+.|+|+
T Consensus 254 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 254 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 7766554332222111000 0000000000001100 0123568999999999999999999999999
Q ss_pred CCCCCC
Q 012062 281 SEYFWT 286 (472)
Q Consensus 281 h~~f~~ 286 (472)
|+||..
T Consensus 334 hp~f~~ 339 (355)
T 2eu9_A 334 HPFFAG 339 (355)
T ss_dssp SGGGGG
T ss_pred ChhhcC
Confidence 999953
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=328.45 Aligned_cols=235 Identities=25% Similarity=0.390 Sum_probs=197.4
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||+++..... .....+.+|+.++++++|+||+++++++.. ...+||||||++
T Consensus 41 ~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~ 103 (303)
T 3a7i_A 41 GIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLK----------------DTKLWIIMEYLG 103 (303)
T ss_dssp EEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEE----------------TTEEEEEEECCT
T ss_pred EEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEec----------------CCeEEEEEEeCC
Confidence 678889999999999866433 345678899999999999999999999986 567999999998
Q ss_pred C-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 82 H-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 82 g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+ +|.+++.. ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.... .......
T Consensus 104 ~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 180 (303)
T 3a7i_A 104 GGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRNTFV 180 (303)
T ss_dssp TEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-CCBCCCC
T ss_pred CCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc-cccCccC
Confidence 6 66666644 368999999999999999999999999999999999999999999999999998765332 2234457
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (472)
+|..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+.......
T Consensus 181 ~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------------- 238 (303)
T 3a7i_A 181 GTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT--------------------- 238 (303)
T ss_dssp SCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC---------------------
T ss_pred CCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCC---------------------
Confidence 8999999999976 568899999999999999999999999888777666554321100
Q ss_pred hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
....++..+.+||.+||..||++|||+.|+|+|+||..
T Consensus 239 --------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 239 --------LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp --------CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred --------CccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence 01236678999999999999999999999999999965
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=334.20 Aligned_cols=259 Identities=23% Similarity=0.323 Sum_probs=193.5
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+++...... ....+.+|+++|++++|+||+++++++.... ...+||||||+
T Consensus 27 ~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--------------~~~~~lv~e~~ 91 (319)
T 4euu_A 27 RGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEETT--------------TRHKVLIMEFC 91 (319)
T ss_dssp EEEETTTCCEEEEEEECGGGGGS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECTT--------------TCCEEEEEECC
T ss_pred EEEECCCCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCCcceEEEEeecCC--------------CceEEEEEeCC
Confidence 47788999999999998654332 3556789999999999999999999997632 34789999999
Q ss_pred CC-ChhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE----cCCCCeEEeeccceeeeccCCC
Q 012062 81 DH-DLTGLADRPG--LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI----DNEGNLKLADFGLARSFSYDHN 153 (472)
Q Consensus 81 ~g-~l~~~~~~~~--~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl----~~~~~vkL~DFG~a~~~~~~~~ 153 (472)
++ +|.+++.... ..+++.+++.|+.||+.||+|||+++|+||||||+|||| +.++.+||+|||+++.+....
T Consensus 92 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~- 170 (319)
T 4euu_A 92 PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE- 170 (319)
T ss_dssp TTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTC-
T ss_pred CCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCC-
Confidence 85 6777766532 238999999999999999999999999999999999999 777789999999998765432
Q ss_pred CccccccccCCCCChhhhcC-------CCCCCCCcchhhHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHhcCCCCCC
Q 012062 154 NTLTNRVITLWYRPPELLLG-------ATKYGPAVDMWSVGCIFAELLNGKPILPGKN----EAEQLSKIFELCGSPDET 222 (472)
Q Consensus 154 ~~~~~~~gt~~y~aPE~l~~-------~~~~~~~~DiwSlG~il~ell~G~~pf~~~~----~~~~~~~i~~~~~~~~~~ 222 (472)
.....++|..|+|||++.. ...++.++||||||||+|+|++|+.||...+ ..+.+.++.... +..
T Consensus 171 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---p~~ 246 (319)
T 4euu_A 171 -QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK---PSG 246 (319)
T ss_dssp -CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC---CTT
T ss_pred -ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC---Ccc
Confidence 3344578999999999862 2568899999999999999999999997543 234444444332 222
Q ss_pred CCccCCCCCc-cccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCC
Q 012062 223 IWPGVSKMPA-YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSE 282 (472)
Q Consensus 223 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~ 282 (472)
.|........ ...+...... ...+...++..+.+||++||..||++|+|++|+|+|+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 247 AISGVQKAENGPIDWSGDMPV---SCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp CCEEEECSTTCCEEEESSCCT---TCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred cchhhhcccCCccccCccCCc---ccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 2222221110 0000000000 0012245677899999999999999999999999875
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=343.81 Aligned_cols=263 Identities=22% Similarity=0.326 Sum_probs=192.2
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||+|+++.... ......+.+|+.+|++++|+||+++++++.. .+.+||||||+
T Consensus 51 ~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~~ 113 (360)
T 3eqc_A 51 KVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYS----------------DGEISICMEHM 113 (360)
T ss_dssp EEEETTTCCEEEEEEEECCCC-HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE----------------TTEEEEEECCC
T ss_pred EEEECCCCcEEEEEEeccccC-HHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE----------------CCEEEEEEECC
Confidence 367889999999999986532 2345678899999999999999999999987 56899999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~-giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
++ +|.+++.+. ..+++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||++...... ....
T Consensus 114 ~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~ 189 (360)
T 3eqc_A 114 DGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 189 (360)
T ss_dssp TTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---C---
T ss_pred CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc---cccC
Confidence 86 666666543 3689999999999999999999996 9999999999999999999999999998655322 2234
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC-CCCCCCccCCCCCccccCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS-PDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~~~~~~~~ 237 (472)
.++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+...... .....+...........+.
T Consensus 190 ~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (360)
T 3eqc_A 190 FVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFG 268 (360)
T ss_dssp -CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------------
T ss_pred CCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccc
Confidence 578999999999986 57899999999999999999999999987766544333111111 1100000000000000000
Q ss_pred ----CchhhhhhHHHH---------hhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 238 ----PSRTMKRRVREV---------FRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 238 ----~~~~~~~~~~~~---------~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
............ ...++.++++||++||..||++|||++|+|+|+||.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 329 (360)
T 3eqc_A 269 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 329 (360)
T ss_dssp -----CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHH
T ss_pred cCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhh
Confidence 000000000100 123688999999999999999999999999999994
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=327.43 Aligned_cols=240 Identities=27% Similarity=0.431 Sum_probs=196.0
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||+++...........+.+|++++++++|+||+++++++.... ...+||||||++
T Consensus 25 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------------~~~~~lv~e~~~ 90 (279)
T 2w5a_A 25 IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT--------------NTTLYIVMEYCE 90 (279)
T ss_dssp EEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG--------------GTEEEEEEECCT
T ss_pred EEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC--------------CceEEEEEeCCC
Confidence 678889999999999876544445567889999999999999999999885421 457899999998
Q ss_pred C-ChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCCCcEEEcCCCCeEEeeccceeeeccCC
Q 012062 82 H-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQ-----VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 152 (472)
Q Consensus 82 g-~l~~~~~~---~~~~l~~~~i~~i~~Qll~aL~~LH~~g-----iiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 152 (472)
+ +|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~ 170 (279)
T 2w5a_A 91 GGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT 170 (279)
T ss_dssp TEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---C
T ss_pred CCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecccc
Confidence 6 77776653 2335899999999999999999999999 9999999999999999999999999987654321
Q ss_pred CCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 012062 153 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 232 (472)
Q Consensus 153 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (472)
.......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+.......
T Consensus 171 -~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~------------- 235 (279)
T 2w5a_A 171 -SFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR------------- 235 (279)
T ss_dssp -HHHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC-------------
T ss_pred -ccccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccccc-------------
Confidence 11223467999999999986 568899999999999999999999999988877777665432110
Q ss_pred cccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 233 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
+...++.++.+||.+||..||++|||+.|||+|+|+..
T Consensus 236 ----------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 236 ----------------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp ----------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred ----------------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 01136778999999999999999999999999999954
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=330.67 Aligned_cols=229 Identities=24% Similarity=0.323 Sum_probs=181.3
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Ch
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL 84 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l 84 (472)
.+++.||||++............+.+|+++|++++|+||+++++++.. .+.+||||||+++ +|
T Consensus 58 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----------------~~~~~lv~e~~~~~~L 121 (309)
T 3p86_A 58 WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ----------------PPNLSIVTEYLSRGSL 121 (309)
T ss_dssp ETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----------------TTCCEEEEECCTTCBH
T ss_pred ECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE----------------CCceEEEEecCCCCcH
Confidence 478899999998665444445678899999999999999999999976 4568999999986 67
Q ss_pred hhhhcCCCC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 85 TGLADRPGL--RFTVPQIKCYMKQLLTGLHYCHVNQ--VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 85 ~~~~~~~~~--~l~~~~i~~i~~Qll~aL~~LH~~g--iiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
.+++.+... .+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..... ........
T Consensus 122 ~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-~~~~~~~~ 200 (309)
T 3p86_A 122 YRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST-FLSSKSAA 200 (309)
T ss_dssp HHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----------------
T ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccc-ccccccCC
Confidence 777765432 3899999999999999999999999 999999999999999999999999999754332 22234457
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (472)
+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+........
T Consensus 201 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~-------------------- 259 (309)
T 3p86_A 201 GTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE-------------------- 259 (309)
T ss_dssp -CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCC--------------------
T ss_pred CCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--------------------
Confidence 8999999999986 5689999999999999999999999999888777766643221111
Q ss_pred hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....++..+.+||++||..||++|||+.|+++
T Consensus 260 --------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 260 --------IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp --------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------CCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 01246778999999999999999999999986
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=324.56 Aligned_cols=230 Identities=22% Similarity=0.345 Sum_probs=190.8
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++. +++.||||+++..... ...+.+|++++++++|+||+++++++.+ .+.+||||||++
T Consensus 29 ~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~ 88 (269)
T 4hcu_A 29 GYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLE----------------QAPICLVFEFME 88 (269)
T ss_dssp EEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECS----------------SSSEEEEEECCT
T ss_pred EEec-CCCeEEEEEecccccC---HHHHHHHHHHHHhCCCCCEeeEEEEEec----------------CCceEEEEEeCC
Confidence 3444 5778999999865432 3568899999999999999999999976 557899999998
Q ss_pred C-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 82 H-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 82 g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+ +|.+++......+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++...............
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 168 (269)
T 4hcu_A 89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK 168 (269)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTT
T ss_pred CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccccccCcc
Confidence 6 677777666667999999999999999999999999999999999999999999999999999765433323333445
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+........
T Consensus 169 ~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------- 228 (269)
T 4hcu_A 169 FPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK------------------- 228 (269)
T ss_dssp CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC-------------------
T ss_pred cccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC-------------------
Confidence 6788999999976 568999999999999999999 9999999988888777754321111
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
...++..+.+||.+||..||++|||+.|++++
T Consensus 229 ----------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 229 ----------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp ----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------CCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 01356789999999999999999999999874
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=334.54 Aligned_cols=253 Identities=23% Similarity=0.376 Sum_probs=194.5
Q ss_pred ceeccCCCEEEEEEeecCCcCCCch---------------hhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFP---------------ITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDG 66 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~---------------~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~ 66 (472)
|++ +++.||||+++......... ..+.+|+.++++|+|+||+++++++..
T Consensus 50 ~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------------- 114 (348)
T 2pml_X 50 CEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITN------------- 114 (348)
T ss_dssp EEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEES-------------
T ss_pred EEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEee-------------
Confidence 455 89999999998653322111 678899999999999999999999987
Q ss_pred CCcCCeEEEEEecCCC-Chhhh------hcCC-CCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCCe
Q 012062 67 NKYRGSTYMVFEYMDH-DLTGL------ADRP-GLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGNL 137 (472)
Q Consensus 67 ~~~~~~~~iVmEy~~g-~l~~~------~~~~-~~~l~~~~i~~i~~Qll~aL~~LH~-~giiHrDLKp~NILl~~~~~v 137 (472)
.+.+||||||+++ +|.++ +... ...+++..++.++.||+.||+|||+ +||+||||||+||||+.++.+
T Consensus 115 ---~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~~ 191 (348)
T 2pml_X 115 ---YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRV 191 (348)
T ss_dssp ---SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTSCE
T ss_pred ---CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCCcE
Confidence 5689999999997 67666 4332 4579999999999999999999999 999999999999999999999
Q ss_pred EEeeccceeeeccCCCCccccccccCCCCChhhhcCCCCCCC-CcchhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHh
Q 012062 138 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGP-AVDMWSVGCIFAELLNGKPILPGKNE-AEQLSKIFEL 215 (472)
Q Consensus 138 kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-~~DiwSlG~il~ell~G~~pf~~~~~-~~~~~~i~~~ 215 (472)
||+|||++...... ......+|..|+|||++.+...++. ++|||||||++|+|++|+.||...+. .+.+..+...
T Consensus 192 kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~ 268 (348)
T 2pml_X 192 KLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTK 268 (348)
T ss_dssp EECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSC
T ss_pred EEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhcc
Confidence 99999999876432 3344578999999999987435555 89999999999999999999998877 5555555332
Q ss_pred cCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 216 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
....+... .... ..............++.++.+||++||..||.+|||+.|+|+|+||..
T Consensus 269 ~~~~~~~~-~~~~----------~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 328 (348)
T 2pml_X 269 NIEYPLDR-NHFL----------YPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328 (348)
T ss_dssp CCCCCCSS-SSST----------TTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred CcCCccch-hhhh----------ccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence 11111100 0000 000011112233568889999999999999999999999999999954
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=333.89 Aligned_cols=232 Identities=24% Similarity=0.344 Sum_probs=188.7
Q ss_pred ceeccCCC---EEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 2 AREIKTGE---IVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 2 a~~~~tg~---~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
|++..+++ .||||+++..... .....+.+|+++|++|+|+||+++++++.. .+.+|||||
T Consensus 68 ~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e 130 (325)
T 3kul_A 68 GRLRVPGQRDVPVAIKALKAGYTE-RQRRDFLSEASIMGQFDHPNIIRLEGVVTR----------------GRLAMIVTE 130 (325)
T ss_dssp EEECCTTSCCEEEEEEEECTTCCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEECG----------------GGCCEEEEE
T ss_pred EEEecCCCCCceEEEEecCCCCCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEEe----------------CCccEEEee
Confidence 45665555 4999999854322 234568899999999999999999999976 557899999
Q ss_pred cCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCc--
Q 012062 79 YMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT-- 155 (472)
Q Consensus 79 y~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~-- 155 (472)
|+++ +|.+++......+++.+++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+.......
T Consensus 131 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 210 (325)
T 3kul_A 131 YMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT 210 (325)
T ss_dssp CCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEE
T ss_pred CCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccceee
Confidence 9986 7777776666679999999999999999999999999999999999999999999999999998765432222
Q ss_pred cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 156 LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
.....+|..|+|||++.+ ..++.++||||||||+|+|++ |..||...+..+.+..+......+.
T Consensus 211 ~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------- 275 (325)
T 3kul_A 211 TTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA-------------- 275 (325)
T ss_dssp CC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC--------------
T ss_pred ccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCC--------------
Confidence 222344778999999976 568899999999999999999 9999999998888877765322111
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...++..+.+||.+||..||++|||+.||++
T Consensus 276 ---------------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 276 ---------------PMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp ---------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1146778999999999999999999999985
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=347.14 Aligned_cols=237 Identities=25% Similarity=0.355 Sum_probs=181.1
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
++...+++.||||++.... ...+.+|+++|+++ +|||||++++++.+ ...+|||||||
T Consensus 42 ~~~~~~~~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~l~~~~~~----------------~~~~~lv~E~~ 100 (432)
T 3p23_A 42 YRGMFDNRDVAVKRILPEC-----FSFADREVQLLRESDEHPNVIRYFCTEKD----------------RQFQYIAIELC 100 (432)
T ss_dssp EEEESSSSEEEEEEECTTT-----EEECHHHHHHHHHSCCCTTBCCEEEEEEE----------------TTEEEEEEECC
T ss_pred EEEEeCCeEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEec----------------CCEEEEEEECC
Confidence 3566789999999997532 22456899999999 79999999999986 56889999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC-----CCeEEeeccceeeeccCCC--
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE-----GNLKLADFGLARSFSYDHN-- 153 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~-----~~vkL~DFG~a~~~~~~~~-- 153 (472)
.++|.+++......+.+.+++.|+.||+.||+|||+++|+||||||+||||+.+ ..+||+|||+++.......
T Consensus 101 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~ 180 (432)
T 3p23_A 101 AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSF 180 (432)
T ss_dssp SEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-------
T ss_pred CCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcce
Confidence 999999888776666766788999999999999999999999999999999532 2578999999987653321
Q ss_pred CccccccccCCCCChhhhcC--CCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 012062 154 NTLTNRVITLWYRPPELLLG--ATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 230 (472)
Q Consensus 154 ~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 230 (472)
......++|+.|+|||++.+ ...++.++||||||||+|+|++ |..||......... .+.. ......
T Consensus 181 ~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-~~~~---~~~~~~------- 249 (432)
T 3p23_A 181 SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-ILLG---ACSLDC------- 249 (432)
T ss_dssp -----CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-HHTT---CCCCTT-------
T ss_pred eeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-HHhc---cCCccc-------
Confidence 23344678999999999874 2456789999999999999999 89999665443322 2211 100000
Q ss_pred CccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 231 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.. .....+..+++||.+||..||++|||+.|||+|+|||.
T Consensus 250 -----~~-----------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 250 -----LH-----------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp -----SC-----------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred -----cC-----------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 00 00134566899999999999999999999999999974
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=324.07 Aligned_cols=234 Identities=19% Similarity=0.207 Sum_probs=191.7
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||+++.... ...+.+|+.+++.+ +|+||+++++++.. ...+||||||
T Consensus 28 ~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~----------------~~~~~lv~e~ 87 (298)
T 1csn_A 28 EGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQE----------------GLHNVLVIDL 87 (298)
T ss_dssp EEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEE----------------TTEEEEEEEC
T ss_pred EEEECCCCcEEEEEEeccCCc----cHHHHHHHHHHHHHhcCCCCCeEEeecCC----------------CceeEEEEEe
Confidence 367889999999999975433 23578999999999 79999999999976 5688999999
Q ss_pred CCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC-----eEEeeccceeeeccCCCC
Q 012062 80 MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN-----LKLADFGLARSFSYDHNN 154 (472)
Q Consensus 80 ~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~-----vkL~DFG~a~~~~~~~~~ 154 (472)
+.++|.+++......+++.+++.|+.||+.||+|||+++|+||||||+||||+.++. +||+|||+++........
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (298)
T 1csn_A 88 LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 167 (298)
T ss_dssp CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTC
T ss_pred cCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccccc
Confidence 977888888766667999999999999999999999999999999999999987776 999999999876543321
Q ss_pred ------ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCCCCCCc
Q 012062 155 ------TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN---EAEQLSKIFELCGSPDETIWP 225 (472)
Q Consensus 155 ------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~ 225 (472)
......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+ ..+.+..+....
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--------- 237 (298)
T 1csn_A 168 QHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK--------- 237 (298)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH---------
T ss_pred ccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc---------
Confidence 2345578999999999876 568999999999999999999999998854 333333332211
Q ss_pred cCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 226 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...........++.++.+||.+||..||++|||+.+|++
T Consensus 238 ----------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 238 ----------------QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp ----------------HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ----------------cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 011223344568889999999999999999999999875
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=330.01 Aligned_cols=244 Identities=23% Similarity=0.386 Sum_probs=189.9
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||+++.... ....+.+|+.+++++ +|+||+++++++...... ...+.+||||||
T Consensus 42 ~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~----------~~~~~~~lv~e~ 108 (326)
T 2x7f_A 42 KGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP----------GMDDQLWLVMEF 108 (326)
T ss_dssp EEEETTTCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC------------CCCCEEEEEEEC
T ss_pred EEEECCCCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc----------cccceEEEEEEc
Confidence 367888999999999975432 245788999999999 799999999999863211 114578999999
Q ss_pred CCC-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 80 MDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 80 ~~g-~l~~~~~~~-~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
+++ +|.+++... ...+++..++.++.||+.||+|||++||+|+||||+||||+.++.+||+|||++....... ....
T Consensus 109 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 187 (326)
T 2x7f_A 109 CGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV-GRRN 187 (326)
T ss_dssp CTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC-----------
T ss_pred CCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCc-cccc
Confidence 986 777776543 2468999999999999999999999999999999999999999999999999987654321 1233
Q ss_pred cccccCCCCChhhhcC----CCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 012062 158 NRVITLWYRPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 233 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (472)
...+|..|+|||++.. ...++.++|||||||++|+|++|..||...+....+..+........
T Consensus 188 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------- 254 (326)
T 2x7f_A 188 TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL------------- 254 (326)
T ss_dssp ---CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-------------
T ss_pred cccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccC-------------
Confidence 4568999999999863 24578999999999999999999999998887776665543211100
Q ss_pred ccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 234 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
....++..+++||.+||..||++|||+.|+|+|+||+.
T Consensus 255 ---------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 292 (326)
T 2x7f_A 255 ---------------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292 (326)
T ss_dssp ---------------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHC
T ss_pred ---------------CccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhh
Confidence 01235778999999999999999999999999999964
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=329.29 Aligned_cols=240 Identities=23% Similarity=0.307 Sum_probs=182.1
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+++...........+..+..+++.++|+||+++++++.. .+.+||||||+
T Consensus 43 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~----------------~~~~~lv~e~~ 106 (318)
T 2dyl_A 43 KMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT----------------NTDVFIAMELM 106 (318)
T ss_dssp EEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----------------SSEEEEEECCC
T ss_pred EEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec----------------CCcEEEEEecc
Confidence 36788899999999998664433333334455567888899999999999986 56899999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~-giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
++.+..+.......+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++..+.... .....
T Consensus 107 ~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~ 184 (318)
T 2dyl_A 107 GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK--AKDRS 184 (318)
T ss_dssp SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------------
T ss_pred CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc--ccccc
Confidence 6555555554455799999999999999999999995 99999999999999999999999999997654322 22345
Q ss_pred cccCCCCChhhhcC----CCCCCCCcchhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 160 VITLWYRPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPGK-NEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 160 ~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~G~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
.+|..|+|||++.. ...++.++||||||||+|+|++|+.||... +..+.+..+........ +.
T Consensus 185 ~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~-------- 252 (318)
T 2dyl_A 185 AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL----PG-------- 252 (318)
T ss_dssp --CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCC----CS--------
T ss_pred CCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCC----Cc--------
Confidence 68999999999852 345788999999999999999999999874 45555555544321100 00
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
...++.++.+||.+||..||.+|||+.|||+|+||.
T Consensus 253 ---------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~ 288 (318)
T 2dyl_A 253 ---------------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIK 288 (318)
T ss_dssp ---------------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred ---------------cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHH
Confidence 013677899999999999999999999999999994
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=339.44 Aligned_cols=265 Identities=27% Similarity=0.451 Sum_probs=198.3
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC-----------CCCccceeEEeeCCCCCCCCCCCCCCCCc
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-----------HENVIKLKEIVTSPGPERDEQGRPDGNKY 69 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~-----------hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 69 (472)
+|++..+++.||||+++.+. .....+.+|++++++++ |+||+++++++...+. .
T Consensus 37 ~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~------------~ 101 (373)
T 1q8y_A 37 LAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP------------N 101 (373)
T ss_dssp EEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEET------------T
T ss_pred EEEecCCCcEEEEEEecCCc---cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCC------------C
Confidence 47788999999999997432 13456778999999886 8899999999986221 1
Q ss_pred CCeEEEEEecCCCChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcC------CCCeEEee
Q 012062 70 RGSTYMVFEYMDHDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDN------EGNLKLAD 141 (472)
Q Consensus 70 ~~~~~iVmEy~~g~l~~~~~~-~~~~l~~~~i~~i~~Qll~aL~~LH~~-giiHrDLKp~NILl~~------~~~vkL~D 141 (472)
...++|||||+.++|.+++.. ....+++..++.|+.||+.||+|||++ ||+||||||+||||+. .+.+||+|
T Consensus 102 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~D 181 (373)
T 1q8y_A 102 GVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIAD 181 (373)
T ss_dssp EEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECC
T ss_pred CceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcc
Confidence 237899999998888887765 334599999999999999999999998 9999999999999953 33799999
Q ss_pred ccceeeeccCCCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHh
Q 012062 142 FGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN------EAEQLSKIFEL 215 (472)
Q Consensus 142 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~------~~~~~~~i~~~ 215 (472)
||+++.... .....++|+.|+|||++.+ ..++.++||||||||||+|++|+.||...+ ..+.+..+++.
T Consensus 182 fg~a~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (373)
T 1q8y_A 182 LGNACWYDE----HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 256 (373)
T ss_dssp CTTCEETTB----CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHH
T ss_pred cccccccCC----CCCCCCCCccccCcHHHhC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHh
Confidence 999987643 2334578999999999987 568999999999999999999999998764 56677777777
Q ss_pred cCCCCCCCCccCC-------------CCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCC
Q 012062 216 CGSPDETIWPGVS-------------KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSE 282 (472)
Q Consensus 216 ~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~ 282 (472)
++..+...+.... ....... .+..........+...++.++.+||++||..||++|||++|||+|+
T Consensus 257 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 335 (373)
T 1q8y_A 257 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKF-WPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHP 335 (373)
T ss_dssp HCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCB-CCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCG
T ss_pred cCCCCHHHHhccchhhhhcCCcchhcccccccc-cchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhCh
Confidence 7665432221110 0000000 0000001111112245678899999999999999999999999999
Q ss_pred CCCC
Q 012062 283 YFWT 286 (472)
Q Consensus 283 ~f~~ 286 (472)
||..
T Consensus 336 ~f~~ 339 (373)
T 1q8y_A 336 WLKD 339 (373)
T ss_dssp GGTT
T ss_pred hhhc
Confidence 9965
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=326.39 Aligned_cols=251 Identities=24% Similarity=0.351 Sum_probs=185.0
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+++... .....+.+|+.++++++|+||+++++++....... ...+.....+.+||||||+
T Consensus 24 ~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~---~~~~~~~~~~~~~lv~e~~ 97 (303)
T 1zy4_A 24 KARNALDSRYYAIKKIRHTE---EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFV---KPMTAVKKKSTLFIQMEYC 97 (303)
T ss_dssp EEEETTTCCEEEEEEEEEEH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCC---C------CEEEEEEEEECC
T ss_pred EEEEcCCCeEEEEEEEeccH---HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchh---hhhcccccCCceEEEEecC
Confidence 36788899999999997532 23456789999999999999999999987532100 0001122256789999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCC-------
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH------- 152 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~------- 152 (472)
++ +|.+++......+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++.......
T Consensus 98 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 177 (303)
T 1zy4_A 98 ENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177 (303)
T ss_dssp CSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC---------
T ss_pred CCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhcccc
Confidence 85 7888777665678899999999999999999999999999999999999999999999999987654221
Q ss_pred ------CCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCCCCCCc
Q 012062 153 ------NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK-NEAEQLSKIFELCGSPDETIWP 225 (472)
Q Consensus 153 ------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~ 225 (472)
........+|..|+|||++.+...++.++|||||||++|+|++ ||... +..+.+..+.......+..
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~--- 251 (303)
T 1zy4_A 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPD--- 251 (303)
T ss_dssp ----------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTT---
T ss_pred ccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCcc---
Confidence 1223345689999999999875578999999999999999998 45433 2333333333221111100
Q ss_pred cCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 226 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.....+..+++||++||..||++|||+.|+|+|+||..
T Consensus 252 -----------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 252 -----------------------FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp -----------------------CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred -----------------------ccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 01235567899999999999999999999999999953
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=323.50 Aligned_cols=240 Identities=29% Similarity=0.451 Sum_probs=187.9
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+++.... .....+.+|+.+++.++|+||+++++++.. .+.+||||||+
T Consensus 40 ~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~~ 101 (295)
T 2clq_A 40 AGRDLSNQVRIAIKEIPERDS--RYSQPLHEEIALHKHLKHKNIVQYLGSFSE----------------NGFIKIFMEQV 101 (295)
T ss_dssp EEEETTTCCEEEEEEEECCCC-----HHHHHHHHHHHTCCCTTBCCEEEEEEE----------------TTEEEEEEECC
T ss_pred EEEECCCCeEEEEEEccCCch--HHHHHHHHHHHHHHhCCCCCEeeEeeEEEe----------------CCcEEEEEEeC
Confidence 367889999999999986532 345678899999999999999999999986 56899999999
Q ss_pred CC-ChhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC-CCCeEEeeccceeeeccCCCCcc
Q 012062 81 DH-DLTGLADRP--GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN-EGNLKLADFGLARSFSYDHNNTL 156 (472)
Q Consensus 81 ~g-~l~~~~~~~--~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~-~~~vkL~DFG~a~~~~~~~~~~~ 156 (472)
.+ +|.+++... ...+++..++.++.||+.||+|||+++|+|+||||+||||+. ++.+||+|||++....... ...
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~~~ 180 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCT 180 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC-Ccc
Confidence 75 676666543 234678999999999999999999999999999999999987 8899999999998764322 222
Q ss_pred ccccccCCCCChhhhcCC-CCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcccc
Q 012062 157 TNRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235 (472)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (472)
....+|..|+|||++.+. ..++.++|||||||++|+|++|+.||...+................
T Consensus 181 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------- 245 (295)
T 2clq_A 181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP--------------- 245 (295)
T ss_dssp CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCC---------------
T ss_pred cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccc---------------
Confidence 345689999999998753 2378899999999999999999999976544332211111111000
Q ss_pred CCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.+...++.++.+||.+||..||++|||+.|+|+|+||..
T Consensus 246 ------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 284 (295)
T 2clq_A 246 ------------EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKV 284 (295)
T ss_dssp ------------CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC
T ss_pred ------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhh
Confidence 011246778999999999999999999999999999964
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=349.04 Aligned_cols=258 Identities=15% Similarity=0.144 Sum_probs=173.6
Q ss_pred CceeccCCCEEEEEEeecCCcC-CCchhhHHHHHHHHHhc--CCCCcccee-------EEeeCCCCCCCCCCC-CCCCCc
Q 012062 1 MAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKL--QHENVIKLK-------EIVTSPGPERDEQGR-PDGNKY 69 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~-~~~~~~~~~Ei~il~~l--~hpnIv~l~-------~~~~~~~~~~~~~~~-~~~~~~ 69 (472)
+|++..+++.||||+++..... ......+.+|+++++.| +||||++++ +++...+........ ......
T Consensus 80 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~ 159 (371)
T 3q60_A 80 LVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYA 159 (371)
T ss_dssp EEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CC
T ss_pred EEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccce
Confidence 4678899999999999876432 22344566775555555 699988755 555443211000000 000001
Q ss_pred CCeEEEEEecCCCChhhhhcCCCCCCCHHHH------HHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeecc
Q 012062 70 RGSTYMVFEYMDHDLTGLADRPGLRFTVPQI------KCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFG 143 (472)
Q Consensus 70 ~~~~~iVmEy~~g~l~~~~~~~~~~l~~~~i------~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG 143 (472)
...+|||||||+++|.+++......+....+ ..++.||+.||+|||+++|+||||||+||||+.++.+||+|||
T Consensus 160 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG 239 (371)
T 3q60_A 160 VANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVS 239 (371)
T ss_dssp EEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGG
T ss_pred eeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecc
Confidence 2458999999999998888754333444444 5667999999999999999999999999999999999999999
Q ss_pred ceeeeccCCCCccccccccCCCCChhhhcCC-CCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC
Q 012062 144 LARSFSYDHNNTLTNRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDET 222 (472)
Q Consensus 144 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~ 222 (472)
+++..... .....+|+.|+|||++.+. ..++.++|||||||+||+|++|+.||....... ..
T Consensus 240 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-------------~~ 302 (371)
T 3q60_A 240 ALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI-------------KG 302 (371)
T ss_dssp GEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTC-------------TT
T ss_pred eeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCccc-------------cc
Confidence 99865421 1144668999999999742 358999999999999999999999998764321 00
Q ss_pred CCccCCCCC-ccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 223 IWPGVSKMP-AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 223 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
.|....... ....+. ...+..++..+.+||.+||..||++|||+.|+|+|+||
T Consensus 303 ~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 356 (371)
T 3q60_A 303 SWKRPSLRVPGTDSLA---------FGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF 356 (371)
T ss_dssp CCCBCCTTSCCCCSCC---------CTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHH
T ss_pred chhhhhhhhccccccc---------hhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHH
Confidence 011000000 000000 01123578899999999999999999999999999999
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=320.44 Aligned_cols=227 Identities=21% Similarity=0.285 Sum_probs=188.8
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Ch
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL 84 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l 84 (472)
.++..||||+++..... ...+.+|++++++++|+||+++++++.. .+.+||||||+++ +|
T Consensus 30 ~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~~~~L 90 (268)
T 3sxs_A 30 KGQYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVCSK----------------EYPIYIVTEYISNGCL 90 (268)
T ss_dssp TTTEEEEEEEECBTTBC---HHHHHHHHHHHHHCCCTTBCCEEEEECS----------------SSSEEEEEECCTTCBH
T ss_pred cCceeEEEEEeccCCCc---HHHHHHHHHHHHhCCCCCEeeEEEEEcc----------------CCceEEEEEccCCCcH
Confidence 36678999999755332 3568899999999999999999999976 5578999999985 57
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccCC
Q 012062 85 TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLW 164 (472)
Q Consensus 85 ~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~ 164 (472)
.+++......+++.+++.|+.||+.||+|||+++|+||||||+|||++.++.+||+|||++...............+|..
T Consensus 91 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 170 (268)
T 3sxs_A 91 LNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK 170 (268)
T ss_dssp HHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGG
T ss_pred HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCCcCcc
Confidence 77776655569999999999999999999999999999999999999999999999999998765443333344455778
Q ss_pred CCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhh
Q 012062 165 YRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMK 243 (472)
Q Consensus 165 y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (472)
|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+.........
T Consensus 171 y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------- 227 (268)
T 3sxs_A 171 WSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP---------------------- 227 (268)
T ss_dssp GCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC----------------------
T ss_pred cCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCC----------------------
Confidence 999999976 568899999999999999999 99999998888877776543211110
Q ss_pred hhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 244 RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 244 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
..+++.+.+||.+||..||++|||+.|++++
T Consensus 228 -------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 228 -------HLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp -------TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -------CcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1246689999999999999999999999975
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=326.93 Aligned_cols=234 Identities=23% Similarity=0.343 Sum_probs=185.0
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||++.... ......+.+|+++|++|+|+||+++++++.+ .+.+||||||+
T Consensus 28 ~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----------------~~~~~lv~e~~ 89 (310)
T 3s95_A 28 KVTHRETGEVMVMKELIRFD--EETQRTFLKEVKVMRCLEHPNVLKFIGVLYK----------------DKRLNFITEYI 89 (310)
T ss_dssp EEEETTTCCEEEEEEESCCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE----------------TTEEEEEEECC
T ss_pred EEEECCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCcCcccEEEEEec----------------CCeeEEEEEec
Confidence 36788999999999986432 2345678899999999999999999999986 56899999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCc----
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT---- 155 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~---- 155 (472)
++ +|.+++......+++.+++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+.......
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 169 (310)
T 3s95_A 90 KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169 (310)
T ss_dssp TTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----------
T ss_pred CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccccc
Confidence 86 7777777656679999999999999999999999999999999999999999999999999998764332211
Q ss_pred ---------cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 012062 156 ---------LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPG 226 (472)
Q Consensus 156 ---------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 226 (472)
....++|+.|+|||++.+ ..++.++|||||||++|+|++|..+|.........
T Consensus 170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~----------------- 231 (310)
T 3s95_A 170 SLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD----------------- 231 (310)
T ss_dssp ----------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT-----------------
T ss_pred cccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH-----------------
Confidence 124578999999999986 67899999999999999999999888653221000
Q ss_pred CCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 227 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
... .............++..+.+||.+||..||++|||+.|+++
T Consensus 232 ---------~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 232 ---------FGL-NVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp ---------SSB-CHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------Hhh-hhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 000 00000011112456778999999999999999999999986
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=336.50 Aligned_cols=229 Identities=25% Similarity=0.386 Sum_probs=186.3
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-C
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-D 83 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~ 83 (472)
.++..||||+++.... ......+.+|+.+|+++ +|||||++++++.. .+.+||||||+.+ +
T Consensus 111 ~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~----------------~~~~~lv~e~~~~g~ 173 (370)
T 2psq_A 111 KEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ----------------DGPLYVIVEYASKGN 173 (370)
T ss_dssp TCEEEEEEEECCTTCB-HHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS----------------SSSCEEEEECCTTCB
T ss_pred CcceeEEEEEecCCcC-HHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc----------------CCCEEEEEEcCCCCC
Confidence 4566899999976532 22345688999999999 89999999999976 5578999999986 7
Q ss_pred hhhhhcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeee
Q 012062 84 LTGLADRPG---------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 148 (472)
Q Consensus 84 l~~~~~~~~---------------~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 148 (472)
|.+++.... ..+++.+++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+
T Consensus 174 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 253 (370)
T 2psq_A 174 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 253 (370)
T ss_dssp HHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred HHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCCCEEEccccCCccc
Confidence 777665432 35899999999999999999999999999999999999999999999999999876
Q ss_pred ccCCC-CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 012062 149 SYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPG 226 (472)
Q Consensus 149 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 226 (472)
..... .......+|+.|+|||++.+ ..++.++||||||||+|+|++ |..||.+.+..+.+..+.......
T Consensus 254 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~------- 325 (370)
T 2psq_A 254 NNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD------- 325 (370)
T ss_dssp TCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC-------
T ss_pred CcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC-------
Confidence 54322 22233456789999999986 578999999999999999999 999999988777666554321110
Q ss_pred CCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 227 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
....++..+.+||.+||..||++|||+.|++++
T Consensus 326 ----------------------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 326 ----------------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp ----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 012467789999999999999999999999863
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=323.41 Aligned_cols=227 Identities=23% Similarity=0.354 Sum_probs=189.1
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Ch
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL 84 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l 84 (472)
.++..||||+++..... ...+.+|++++++++|+||+++++++.. .+.+||||||+++ +|
T Consensus 46 ~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~~~~L 106 (283)
T 3gen_A 46 RGQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTK----------------QRPIFIITEYMANGCL 106 (283)
T ss_dssp TTTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECS----------------SSSEEEEECCCTTCBH
T ss_pred cCCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEEec----------------CCCeEEEEeccCCCcH
Confidence 36778999999855332 3568899999999999999999999976 5578999999975 77
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccCC
Q 012062 85 TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLW 164 (472)
Q Consensus 85 ~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~ 164 (472)
.+++......+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++..............+|..
T Consensus 107 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~ 186 (283)
T 3gen_A 107 LNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR 186 (283)
T ss_dssp HHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGG
T ss_pred HHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccccccCCccCcc
Confidence 77776655579999999999999999999999999999999999999999999999999997654332223333455788
Q ss_pred CCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhh
Q 012062 165 YRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMK 243 (472)
Q Consensus 165 y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (472)
|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+.........
T Consensus 187 y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------- 243 (283)
T 3gen_A 187 WSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---------------------- 243 (283)
T ss_dssp GCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC----------------------
T ss_pred cCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCC----------------------
Confidence 999999986 568999999999999999998 99999999988887777653221111
Q ss_pred hhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 244 RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 244 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
..+++.+.+||.+||..||++|||+.|+++|
T Consensus 244 -------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 244 -------HLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp -------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -------CcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 1346789999999999999999999999874
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=336.62 Aligned_cols=234 Identities=19% Similarity=0.291 Sum_probs=187.7
Q ss_pred eccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-
Q 012062 4 EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH- 82 (472)
Q Consensus 4 ~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g- 82 (472)
+..+++.||||+++..... .....+.+|+.++++++|+|||++++++.. ...+|||||||.+
T Consensus 97 ~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----------------~~~~~lv~e~~~~g 159 (367)
T 3l9p_A 97 NDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFNHQNIVRCIGVSLQ----------------SLPRFILLELMAGG 159 (367)
T ss_dssp ---CCEEEEEEECCSSCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEECS----------------SSSCEEEEECCTTE
T ss_pred CCCcceeEEEEecccccCh-hhHHHHHHHHHHHHhCCCCCCCeEEEEEec----------------CCCCEEEEEeCCCC
Confidence 5568889999999754322 234567899999999999999999999976 4567999999975
Q ss_pred ChhhhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC---CeEEeeccceeeeccCC-
Q 012062 83 DLTGLADRPG------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG---NLKLADFGLARSFSYDH- 152 (472)
Q Consensus 83 ~l~~~~~~~~------~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~---~vkL~DFG~a~~~~~~~- 152 (472)
+|.+++.... ..+++.+++.|+.||+.||+|||++||+||||||+||||+.++ .+||+|||+++.+....
T Consensus 160 ~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~ 239 (367)
T 3l9p_A 160 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY 239 (367)
T ss_dssp EHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSS
T ss_pred CHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccc
Confidence 7777665422 3589999999999999999999999999999999999999555 49999999997553322
Q ss_pred CCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 012062 153 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 231 (472)
Q Consensus 153 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (472)
........+|+.|+|||++.+ ..++.++||||||||+|+|++ |..||...+..+.+..+........
T Consensus 240 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~----------- 307 (367)
T 3l9p_A 240 YRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP----------- 307 (367)
T ss_dssp CTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC-----------
T ss_pred cccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-----------
Confidence 222333567899999999986 578999999999999999998 9999999998887777754321110
Q ss_pred ccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 232 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
...++..+.+||.+||..||++|||+.||+++-++
T Consensus 308 ------------------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 308 ------------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp ------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------------------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 12366789999999999999999999999987554
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=322.36 Aligned_cols=226 Identities=21% Similarity=0.345 Sum_probs=174.8
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chh
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLT 85 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~ 85 (472)
++..||||+++.... ......+.+|+.++++++||||+++++++.. +.+||||||+++ +|.
T Consensus 42 ~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----------------~~~~lv~e~~~~~~L~ 103 (281)
T 1mp8_A 42 PALAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVITE-----------------NPVWIIMELCTLGELR 103 (281)
T ss_dssp CCEEEEEEECTTTTS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----------------SSCEEEEECCTTEEHH
T ss_pred CceEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCccceEEEEEcc-----------------CccEEEEecCCCCCHH
Confidence 355799999875432 2245568899999999999999999999853 357999999996 777
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccCCC
Q 012062 86 GLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWY 165 (472)
Q Consensus 86 ~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y 165 (472)
+++......+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++..............+|+.|
T Consensus 104 ~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y 183 (281)
T 1mp8_A 104 SFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 183 (281)
T ss_dssp HHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------------CCGGG
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcccccccccCCCcccc
Confidence 77766655799999999999999999999999999999999999999999999999999987654333333334557889
Q ss_pred CChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhh
Q 012062 166 RPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 244 (472)
Q Consensus 166 ~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (472)
+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+......+
T Consensus 184 ~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~------------------------- 237 (281)
T 1mp8_A 184 MAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP------------------------- 237 (281)
T ss_dssp CCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC-------------------------
T ss_pred cChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCC-------------------------
Confidence 99999976 568899999999999999996 999999988877777665422111
Q ss_pred hHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 245 RVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 245 ~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....++..+.+||.+||..||++|||+.|+++
T Consensus 238 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 238 ----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 01246778999999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=341.41 Aligned_cols=238 Identities=28% Similarity=0.407 Sum_probs=178.1
Q ss_pred eeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 3 REIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 3 ~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
++..+|+.||||++..+. ...+.+|+++|+++ +|||||++++++.. .+.+|||||||+
T Consensus 34 ~~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~----------------~~~~~lv~E~~~ 92 (434)
T 2rio_A 34 QGSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETT----------------DRFLYIALELCN 92 (434)
T ss_dssp EEESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEEC----------------SSEEEEEECCCS
T ss_pred EEEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEec----------------CCeEEEEEecCC
Confidence 456789999999987532 34578999999876 89999999999986 568999999999
Q ss_pred CChhhhhcCCCCC------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC-------------CCeEEeec
Q 012062 82 HDLTGLADRPGLR------FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE-------------GNLKLADF 142 (472)
Q Consensus 82 g~l~~~~~~~~~~------l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~-------------~~vkL~DF 142 (472)
++|.+++...... .++..++.|+.||+.||+|||+++|+||||||+||||+.+ ..+||+||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF 172 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence 9888887654321 1233467899999999999999999999999999999754 37999999
Q ss_pred cceeeeccCCCC---ccccccccCCCCChhhhcC------CCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 012062 143 GLARSFSYDHNN---TLTNRVITLWYRPPELLLG------ATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKI 212 (472)
Q Consensus 143 G~a~~~~~~~~~---~~~~~~gt~~y~aPE~l~~------~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i 212 (472)
|+++........ .....++|+.|+|||++.+ ...++.++||||||||+|+|++ |..||......+ ..+
T Consensus 173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i 250 (434)
T 2rio_A 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNI 250 (434)
T ss_dssp TTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHH
T ss_pred ccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHH
Confidence 999876543221 2234578999999999965 2458899999999999999999 999997765443 223
Q ss_pred HHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 213 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.......... .. . ....++.++++||.+||..||++|||+.|||+|+|||.
T Consensus 251 ~~~~~~~~~~-----~~------~------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 251 IRGIFSLDEM-----KC------L------------HDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp HHTCCCCCCC-----TT------C------------CCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred hcCCCCcccc-----cc------c------------ccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 3221111100 00 0 01235678999999999999999999999999999974
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=328.93 Aligned_cols=245 Identities=19% Similarity=0.273 Sum_probs=176.0
Q ss_pred ceeccCCC---EEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 2 AREIKTGE---IVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 2 a~~~~tg~---~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
|++..+++ .||||+++...........+.+|++++++++|+||+++++++....... ....+|+|||
T Consensus 42 ~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~----------~~~~~~~v~e 111 (323)
T 3qup_A 42 AQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG----------RLPIPMVILP 111 (323)
T ss_dssp EEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----------------CEEEEEE
T ss_pred EEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc----------CCCccEEEEE
Confidence 45555654 8999999876544445677889999999999999999999998632110 0123599999
Q ss_pred cCCC-ChhhhhcC-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCC
Q 012062 79 YMDH-DLTGLADR-----PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 152 (472)
Q Consensus 79 y~~g-~l~~~~~~-----~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 152 (472)
|+.+ +|.+++.. ....+++.+++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 112 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~ 191 (323)
T 3qup_A 112 FMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191 (323)
T ss_dssp CCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred eccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeeccccccccccc
Confidence 9996 66665542 22258999999999999999999999999999999999999999999999999997654322
Q ss_pred C-CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 012062 153 N-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 230 (472)
Q Consensus 153 ~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 230 (472)
. .......+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+........
T Consensus 192 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 260 (323)
T 3qup_A 192 YYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQ---------- 260 (323)
T ss_dssp ---------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC----------
T ss_pred cccccccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCCC----------
Confidence 2 22223345778999999987 568999999999999999999 9999999888887777754321111
Q ss_pred CccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCC-------HHHHhcCCCCCC
Q 012062 231 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-------AKDALDSEYFWT 286 (472)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t-------~~elL~h~~f~~ 286 (472)
...++.++.+||.+||..||++||| ++++++|+|+..
T Consensus 261 -------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~ 304 (323)
T 3qup_A 261 -------------------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304 (323)
T ss_dssp -------------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred -------------------CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence 1236678999999999999999999 788889999854
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=331.95 Aligned_cols=233 Identities=22% Similarity=0.375 Sum_probs=186.2
Q ss_pred eccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC
Q 012062 4 EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH 82 (472)
Q Consensus 4 ~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g 82 (472)
+..+++.||||+++..... .....+.+|+++|+++ +|||||++++++... ...+|||||||.+
T Consensus 48 ~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~---------------~~~~~iv~e~~~~ 111 (359)
T 3vhe_A 48 KTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTKP---------------GGPLMVIVEFCKF 111 (359)
T ss_dssp STTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECST---------------TSCCEEEEECCTT
T ss_pred ccccceEEEEEEecCcCCH-HHHHHHHHHHHHHHhhcCCcceeeeeeeeecC---------------CCceEEEEEecCC
Confidence 5678899999999754322 2345688999999999 799999999999762 3357999999986
Q ss_pred -ChhhhhcCCCC-----------------------------------------------------------------CCC
Q 012062 83 -DLTGLADRPGL-----------------------------------------------------------------RFT 96 (472)
Q Consensus 83 -~l~~~~~~~~~-----------------------------------------------------------------~l~ 96 (472)
+|.+++..... .++
T Consensus 112 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 191 (359)
T 3vhe_A 112 GNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLT 191 (359)
T ss_dssp EEHHHHHHTTTTSBCSCC------------------------------------------------------CTTTTCBC
T ss_pred CcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhccccC
Confidence 77776654321 289
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC-CccccccccCCCCChhhhcCCC
Q 012062 97 VPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGAT 175 (472)
Q Consensus 97 ~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~ 175 (472)
+..++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+..... .......+|+.|+|||++.+ .
T Consensus 192 ~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~ 270 (359)
T 3vhe_A 192 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-R 270 (359)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHH-C
T ss_pred HHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcC-C
Confidence 999999999999999999999999999999999999999999999999976543222 22334567889999999986 6
Q ss_pred CCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhcc
Q 012062 176 KYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFD 254 (472)
Q Consensus 176 ~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (472)
.++.++||||||||+|+|++ |..||.+.+..+.+............ ...++
T Consensus 271 ~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~ 322 (359)
T 3vhe_A 271 VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA----------------------------PDYTT 322 (359)
T ss_dssp CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCC----------------------------CTTCC
T ss_pred CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCC----------------------------CCCCC
Confidence 78999999999999999998 99999988765555554443211110 11356
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 255 RHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 255 ~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
.++.+||.+||..||++|||+.||++|
T Consensus 323 ~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 323 PEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 789999999999999999999999975
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=315.94 Aligned_cols=230 Identities=20% Similarity=0.296 Sum_probs=184.8
Q ss_pred CceeccCCCEEEEEEeecCCcCCCc-----hhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEE
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGF-----PITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYM 75 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~-----~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i 75 (472)
+|++..+++.||||++......... ...+.+|++++++++|+||+++++++... .+|
T Consensus 37 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------------------~~l 98 (287)
T 4f0f_A 37 KGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP------------------PRM 98 (287)
T ss_dssp EEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT------------------TEE
T ss_pred EEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC------------------CeE
Confidence 3678899999999999765433221 25678999999999999999999999651 279
Q ss_pred EEecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEcCCCC-----eEEeeccceee
Q 012062 76 VFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ--VLHRDIKGSNLLIDNEGN-----LKLADFGLARS 147 (472)
Q Consensus 76 VmEy~~-g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~g--iiHrDLKp~NILl~~~~~-----vkL~DFG~a~~ 147 (472)
||||+. ++|.+.+......+++..++.++.||+.||+|||+++ |+||||||+||||+.++. +||+|||+++.
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~ 178 (287)
T 4f0f_A 99 VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ 178 (287)
T ss_dssp EEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBC
T ss_pred EEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcccc
Confidence 999998 5787877776667999999999999999999999999 999999999999988776 99999999975
Q ss_pred eccCCCCccccccccCCCCChhhhcC-CCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHH--HHHHHHhcCCCCCCCC
Q 012062 148 FSYDHNNTLTNRVITLWYRPPELLLG-ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ--LSKIFELCGSPDETIW 224 (472)
Q Consensus 148 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~--~~~i~~~~~~~~~~~~ 224 (472)
... ......+|+.|+|||++.. ...++.++|||||||++|+|++|+.||...+.... ...+......+.
T Consensus 179 ~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---- 250 (287)
T 4f0f_A 179 SVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT---- 250 (287)
T ss_dssp CSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCC----
T ss_pred ccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCC----
Confidence 432 3344678999999999843 24468899999999999999999999987654433 332222111000
Q ss_pred ccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 225 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....++..+.+||.+||..||++|||+.|+++
T Consensus 251 ------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 251 ------------------------IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp ------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------CCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 11246778999999999999999999999985
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=331.64 Aligned_cols=228 Identities=24% Similarity=0.378 Sum_probs=187.0
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Ch
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL 84 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l 84 (472)
+++.||||+++..... .....+.+|+++++++ +|+|||++++++.. .+.+||||||+++ +|
T Consensus 100 ~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~----------------~~~~~lv~e~~~~g~L 162 (382)
T 3tt0_A 100 RVTKVAVKMLKSDATE-KDLSDLISEMEMMKMIGKHKNIINLLGACTQ----------------DGPLYVIVEYASKGNL 162 (382)
T ss_dssp CEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----------------SSSCEEEEECCTTCBH
T ss_pred cceEEEEEeeccccCH-HHHHHHHHHHHHHHHhcCCchhhhheeeecc----------------CCceEEEEEecCCCcH
Confidence 4468999999865322 2346788999999999 89999999999976 5568999999986 77
Q ss_pred hhhhcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeec
Q 012062 85 TGLADRPG---------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 149 (472)
Q Consensus 85 ~~~~~~~~---------------~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~ 149 (472)
.+++.... ..+++.+++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++...
T Consensus 163 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 242 (382)
T 3tt0_A 163 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 242 (382)
T ss_dssp HHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSS
T ss_pred HHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCcccccc
Confidence 77665432 358999999999999999999999999999999999999999999999999998664
Q ss_pred cCCC-CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccC
Q 012062 150 YDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGV 227 (472)
Q Consensus 150 ~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 227 (472)
.... .......+|..|+|||++.+ ..++.++||||||||+|+|++ |..||.+.+..+.+..+........
T Consensus 243 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~------- 314 (382)
T 3tt0_A 243 HIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDK------- 314 (382)
T ss_dssp CCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC-------
T ss_pred cccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-------
Confidence 3322 22333456889999999986 678999999999999999999 9999999888777766654321110
Q ss_pred CCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 228 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
...++.++.+||++||..||++|||+.||+++
T Consensus 315 ----------------------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 315 ----------------------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp ----------------------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01367789999999999999999999999864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=336.36 Aligned_cols=232 Identities=22% Similarity=0.355 Sum_probs=188.0
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+++.||||+++.... ......+.+|+++|++++|||||++++++.. .+.+||||||++
T Consensus 133 ~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----------------~~~~~lv~e~~~ 195 (377)
T 3cbl_A 133 GRLRADNTLVAVKSCRETLP-PDLKAKFLQEARILKQYSHPNIVRLIGVCTQ----------------KQPIYIVMELVQ 195 (377)
T ss_dssp EEETTTCCEEEEEECCTTSC-HHHHTTTTHHHHHHTTCCCTTBCCEEEEECS----------------SSSCEEEEECCT
T ss_pred EEEecCCeEEEEEEccccCC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEec----------------CCCcEEEEEcCC
Confidence 67778999999999975432 2234467799999999999999999999976 456899999998
Q ss_pred -CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcc-ccc
Q 012062 82 -HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTL-TNR 159 (472)
Q Consensus 82 -g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~-~~~ 159 (472)
++|.+++......+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.......... ...
T Consensus 196 ~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~ 275 (377)
T 3cbl_A 196 GGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLR 275 (377)
T ss_dssp TCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCC
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCC
Confidence 477777766555699999999999999999999999999999999999999999999999999976433211111 122
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
.++..|+|||++.. ..++.++|||||||++|||++ |..||.+.+..+....+......+.
T Consensus 276 ~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~------------------ 336 (377)
T 3cbl_A 276 QVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPC------------------ 336 (377)
T ss_dssp EEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCC------------------
T ss_pred CCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC------------------
Confidence 34778999999976 568899999999999999998 9999999888776665543211110
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...+++++.+||.+||..||++|||+.+|++
T Consensus 337 -----------~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 337 -----------PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp -----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 1135678999999999999999999999985
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=319.47 Aligned_cols=231 Identities=20% Similarity=0.306 Sum_probs=192.0
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+++.+. .....+.+|++++++++|+||+++++++.. .+.+||||||+
T Consensus 31 ~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----------------~~~~~~v~e~~ 91 (288)
T 3kfa_A 31 EGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR----------------EPPFYIITEFM 91 (288)
T ss_dssp EEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECS----------------SSSEEEEEECC
T ss_pred EeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc----------------CCCEEEEEEcC
Confidence 36788899999999997543 235678899999999999999999999976 55789999999
Q ss_pred CC-ChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 81 DH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 81 ~g-~l~~~~~~-~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
++ +|.+++.. ....+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++.............
T Consensus 92 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 171 (288)
T 3kfa_A 92 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 171 (288)
T ss_dssp TTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETT
T ss_pred CCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccC
Confidence 95 77777754 33458999999999999999999999999999999999999999999999999997665444333444
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..+|..|+|||++.+ ..++.++|||||||++|+|++ |..||...+.......+........
T Consensus 172 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------- 233 (288)
T 3kfa_A 172 AKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER----------------- 233 (288)
T ss_dssp EEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCC-----------------
T ss_pred CccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCC-----------------
Confidence 456888999999976 568999999999999999999 9999998887776666543211110
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...+++.+.+||++||..||++|||+.|+++
T Consensus 234 ------------~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 234 ------------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp ------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------CCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 1246778999999999999999999999985
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=319.40 Aligned_cols=235 Identities=20% Similarity=0.239 Sum_probs=186.4
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||++...... ..+.+|+++++.++|++++..+..+... ...+||||||+
T Consensus 27 ~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~---------------~~~~~lv~e~~ 87 (296)
T 4hgt_A 27 LGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE---------------GDYNVMVMELL 87 (296)
T ss_dssp EEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEE---------------TTEEEEEEECC
T ss_pred EEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCC---------------CCceEEEEEcc
Confidence 3678899999999998765433 3577999999999998888777766431 55789999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE---cCCCCeEEeeccceeeeccCCC----
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI---DNEGNLKLADFGLARSFSYDHN---- 153 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl---~~~~~vkL~DFG~a~~~~~~~~---- 153 (472)
.++|.+++......+++.+++.++.||+.||+|||+++|+||||||+|||| +.++.+||+|||+++.......
T Consensus 88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~ 167 (296)
T 4hgt_A 88 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 167 (296)
T ss_dssp CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBC
T ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccC
Confidence 888888887655679999999999999999999999999999999999999 7888999999999987654332
Q ss_pred --CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhcCCCCCCCCccCC
Q 012062 154 --NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA---EQLSKIFELCGSPDETIWPGVS 228 (472)
Q Consensus 154 --~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~ 228 (472)
.......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.. ..+..+....
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------ 234 (296)
T 4hgt_A 168 PYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK------------ 234 (296)
T ss_dssp CCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH------------
T ss_pred CCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc------------
Confidence 12234578999999999987 56899999999999999999999999875432 1222221110
Q ss_pred CCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 229 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...........+++++.+||.+||..||++|||+.++++
T Consensus 235 -------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 235 -------------MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp -------------HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred -------------ccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 011122333567889999999999999999999999985
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=315.84 Aligned_cols=230 Identities=21% Similarity=0.331 Sum_probs=188.7
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++. +++.||||+++..... ...+.+|++++++++|+||+++++++.. .+.+||||||++
T Consensus 27 ~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~ 86 (267)
T 3t9t_A 27 GYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLE----------------QAPICLVTEFME 86 (267)
T ss_dssp EEET-TTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECS----------------SSSCEEEECCCT
T ss_pred EEec-CCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcc----------------CCCeEEEEeCCC
Confidence 3443 6788999999865432 3578899999999999999999999976 456899999998
Q ss_pred C-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 82 H-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 82 g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+ +|.+++......+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++...............
T Consensus 87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 166 (267)
T 3t9t_A 87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK 166 (267)
T ss_dssp TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTT
T ss_pred CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccccccccc
Confidence 5 777777666567999999999999999999999999999999999999999999999999998765432222223345
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+........
T Consensus 167 ~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~------------------- 226 (267)
T 3t9t_A 167 FPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK------------------- 226 (267)
T ss_dssp CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC-------------------
T ss_pred ccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCC-------------------
Confidence 6788999999976 568899999999999999999 8999999888877776654321110
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
...++..+.+||.+||..||++|||+.|++++
T Consensus 227 ----------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 227 ----------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp ----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------CccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 01356789999999999999999999999863
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=328.48 Aligned_cols=229 Identities=21% Similarity=0.327 Sum_probs=186.0
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Ch
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL 84 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l 84 (472)
.+++.||||+++.... ......+.+|++++++++|+||+++++++.. .+.+||||||+++ +|
T Consensus 75 ~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----------------~~~~~lv~e~~~~~~L 137 (343)
T 1luf_A 75 EPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDNPNIVKLLGVCAV----------------GKPMCLLFEYMAYGDL 137 (343)
T ss_dssp SSEEEEEEEECCTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----------------SSSCEEEEECCTTCBH
T ss_pred CCceeEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc----------------CCceEEEEecCCCCcH
Confidence 5668999999985532 2245567899999999999999999999976 4578999999986 77
Q ss_pred hhhhcCCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEee
Q 012062 85 TGLADRPG-----------------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLAD 141 (472)
Q Consensus 85 ~~~~~~~~-----------------------~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~D 141 (472)
.+++.... ..+++.+++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|
T Consensus 138 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~D 217 (343)
T 1luf_A 138 NEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIAD 217 (343)
T ss_dssp HHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECC
T ss_pred HHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEEee
Confidence 77665421 4689999999999999999999999999999999999999999999999
Q ss_pred ccceeeeccCCC-CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 012062 142 FGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSP 219 (472)
Q Consensus 142 FG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~ 219 (472)
||+++....... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+.+.....
T Consensus 218 fg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 296 (343)
T 1luf_A 218 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILA 296 (343)
T ss_dssp CSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred cCCCcccccCccccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcCC
Confidence 999976543221 22234466889999999886 568999999999999999999 999999988877777665421110
Q ss_pred CCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 220 DETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
....++..+.+||++||..||++|||+.|++++
T Consensus 297 -----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 297 -----------------------------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp -----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 012467789999999999999999999999863
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=315.40 Aligned_cols=235 Identities=20% Similarity=0.236 Sum_probs=187.6
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||++...... ..+.+|+.+++.++|++++..+..+... ...+||||||+
T Consensus 27 ~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~---------------~~~~~lv~e~~ 87 (296)
T 3uzp_A 27 LGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE---------------GDYNVMVMELL 87 (296)
T ss_dssp EEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEE---------------TTEEEEEEECC
T ss_pred EEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCC---------------CCceEEEEEec
Confidence 3678899999999998765432 3678999999999999887777666431 55789999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE---cCCCCeEEeeccceeeeccCCCC---
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI---DNEGNLKLADFGLARSFSYDHNN--- 154 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl---~~~~~vkL~DFG~a~~~~~~~~~--- 154 (472)
.++|.+++......+++.+++.++.||+.||+|||+++|+||||||+|||| +.++.+||+|||++.........
T Consensus 88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 167 (296)
T 3uzp_A 88 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 167 (296)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBC
T ss_pred CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccccc
Confidence 878888887555679999999999999999999999999999999999999 47888999999999876543321
Q ss_pred ---ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCCCCCCccCC
Q 012062 155 ---TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE---AEQLSKIFELCGSPDETIWPGVS 228 (472)
Q Consensus 155 ---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~ 228 (472)
......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||...+. ...+..+....
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------ 234 (296)
T 3uzp_A 168 PYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK------------ 234 (296)
T ss_dssp CCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH------------
T ss_pred ccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccc------------
Confidence 2244578999999999987 5689999999999999999999999986432 22222222110
Q ss_pred CCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 229 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...........++.++.+||++||+.||++|||+.++++
T Consensus 235 -------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 235 -------------MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp -------------HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred -------------cCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 011122333567889999999999999999999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=323.93 Aligned_cols=235 Identities=22% Similarity=0.313 Sum_probs=178.7
Q ss_pred CceeccCCCEEEEEEeecCCcC-CCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||+++..... ......+.+|+.++++++|+||+++++++.. .+.+||||||
T Consensus 52 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~----------------~~~~~lv~e~ 115 (309)
T 2h34_A 52 EAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI----------------DGQLYVDMRL 115 (309)
T ss_dssp EEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE----------------TTEEEEEEEC
T ss_pred EEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee----------------CCeEEEEEEe
Confidence 3678889999999999865432 2334677899999999999999999999986 5689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
+++ +|.+++... ..+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++.............
T Consensus 116 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 194 (309)
T 2h34_A 116 INGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN 194 (309)
T ss_dssp CCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC--------------
T ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccccccc
Confidence 996 676666543 368999999999999999999999999999999999999999999999999997765443344445
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
..+|..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+.. ....
T Consensus 195 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~------------------- 253 (309)
T 2h34_A 195 TVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQ-AIPR------------------- 253 (309)
T ss_dssp --CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHS-CCCC-------------------
T ss_pred cCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhcc-CCCC-------------------
Confidence 678999999999876 5788999999999999999999999988766533333321 1100
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCC-CHHHHhc
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-SAKDALD 280 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-t~~elL~ 280 (472)
.......++.++.+||.+||..||++|| |++++++
T Consensus 254 -------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 254 -------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp -------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred -------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 0011234677899999999999999999 8888875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=326.11 Aligned_cols=232 Identities=19% Similarity=0.248 Sum_probs=184.9
Q ss_pred ceeccCCCE----EEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEE
Q 012062 2 AREIKTGEI----VALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVF 77 (472)
Q Consensus 2 a~~~~tg~~----vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVm 77 (472)
|++..+++. ||+|++..... ......+.+|+.++++++|+||+++++++.. +.+|+||
T Consensus 32 ~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----------------~~~~~v~ 93 (325)
T 3kex_A 32 GVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-----------------SSLQLVT 93 (325)
T ss_dssp EEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-----------------SSEEEEE
T ss_pred EEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-----------------CccEEEE
Confidence 667778876 77777654432 2234566789999999999999999999853 3589999
Q ss_pred ecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC-c
Q 012062 78 EYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN-T 155 (472)
Q Consensus 78 Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~ 155 (472)
||+. ++|.+++......+++..++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+...... .
T Consensus 94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~ 173 (325)
T 3kex_A 94 QYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLL 173 (325)
T ss_dssp ECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC
T ss_pred EeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCccccccc
Confidence 9998 4787777766567999999999999999999999999999999999999999999999999999876543322 2
Q ss_pred cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 156 LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
.....+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+.........
T Consensus 174 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------- 239 (325)
T 3kex_A 174 YSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP------------- 239 (325)
T ss_dssp -----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCC-------------
T ss_pred ccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCC-------------
Confidence 334456889999999986 568999999999999999999 99999988877766666432211110
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
..++.++.+||.+||..||++|||+.|++++
T Consensus 240 ----------------~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 240 ----------------QICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp ----------------TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred ----------------CcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1244568899999999999999999999874
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=330.70 Aligned_cols=228 Identities=24% Similarity=0.365 Sum_probs=177.3
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC-CCh
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD-HDL 84 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~-g~l 84 (472)
.++..||||+++.... +.....+.+|+.+|++|+|+||+++++++.. .+.+||||||++ ++|
T Consensus 71 ~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----------------~~~~~lv~e~~~~~sL 133 (373)
T 2qol_A 71 KKEISVAIKTLKVGYT-EKQRRDFLGEASIMGQFDHPNIIRLEGVVTK----------------SKPVMIVTEYMENGSL 133 (373)
T ss_dssp SCBCCEEEEECCTTCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----------------SSSCEEEEECCTTCBH
T ss_pred CCceeEEEEEecCccC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEee----------------CCceEEEEeCCCCCcH
Confidence 5678899999986532 2234578899999999999999999999976 457899999997 478
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc--ccccc
Q 012062 85 TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT--NRVIT 162 (472)
Q Consensus 85 ~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~--~~~gt 162 (472)
.+++.+....+++.+++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++........... ...+|
T Consensus 134 ~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~ 213 (373)
T 2qol_A 134 DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIP 213 (373)
T ss_dssp HHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------------------
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcC
Confidence 8887776667999999999999999999999999999999999999999999999999999876543222211 22346
Q ss_pred CCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchh
Q 012062 163 LWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241 (472)
Q Consensus 163 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (472)
..|+|||++.+ ..++.++||||||||+|+|++ |+.||...+..+.+..+......+.
T Consensus 214 ~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~--------------------- 271 (373)
T 2qol_A 214 IRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP--------------------- 271 (373)
T ss_dssp CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCC---------------------
T ss_pred CCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---------------------
Confidence 78999999986 568999999999999999998 9999999888777766644321111
Q ss_pred hhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...++..+.+||.+||..||++|||+.||++
T Consensus 272 --------~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 272 --------PMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp --------CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------CccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 0135678999999999999999999999985
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=322.54 Aligned_cols=239 Identities=28% Similarity=0.400 Sum_probs=184.1
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC--CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ--HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
|++ .+++.||||+++...........+.+|++++++++ |+||+++++++.. ...+|||||+
T Consensus 47 ~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~----------------~~~~~lv~e~ 109 (313)
T 3cek_A 47 VLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT----------------DQYIYMVMEC 109 (313)
T ss_dssp EEC-TTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC----------------SSEEEEEECC
T ss_pred EEc-CCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec----------------CCEEEEEEec
Confidence 444 35899999999876544445567889999999997 5999999999986 5679999998
Q ss_pred CCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC-cccc
Q 012062 80 MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN-TLTN 158 (472)
Q Consensus 80 ~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~ 158 (472)
..++|.+++... ..+++.+++.|+.||+.||+|||+++|+||||||+||||++ +.+||+|||+++.+...... ....
T Consensus 110 ~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~ 187 (313)
T 3cek_A 110 GNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDS 187 (313)
T ss_dssp CSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC------------
T ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccCccccccccC
Confidence 778888887654 36899999999999999999999999999999999999965 78999999999766433221 2234
Q ss_pred ccccCCCCChhhhcCC----------CCCCCCcchhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCCCCCccC
Q 012062 159 RVITLWYRPPELLLGA----------TKYGPAVDMWSVGCIFAELLNGKPILPGKNE-AEQLSKIFELCGSPDETIWPGV 227 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~----------~~~~~~~DiwSlG~il~ell~G~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~ 227 (472)
.++|..|+|||++.+. ..++.++|||||||++|+|++|+.||..... ...+..+....... .
T Consensus 188 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---~---- 260 (313)
T 3cek_A 188 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI---E---- 260 (313)
T ss_dssp --CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC---C----
T ss_pred CCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccccc---C----
Confidence 5689999999998651 3578899999999999999999999987643 33333332211000 0
Q ss_pred CCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 228 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
+....+.++.+||++||..||++|||+.|+|+|+||...
T Consensus 261 ---------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 261 ---------------------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp ---------------------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred ---------------------CcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 001245689999999999999999999999999999654
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=325.76 Aligned_cols=230 Identities=25% Similarity=0.340 Sum_probs=187.2
Q ss_pred CceeccCCCEEEEEEeecCCcCC----CchhhHHHHHHHHHhcC--CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEE
Q 012062 1 MAREIKTGEIVALKKIRMDNEKE----GFPITAIREIKILKKLQ--HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTY 74 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~----~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 74 (472)
+|++..+++.||||+++...... .....+.+|+.++++++ |+||+++++++.. .+.++
T Consensus 61 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~----------------~~~~~ 124 (320)
T 3a99_A 61 SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER----------------PDSFV 124 (320)
T ss_dssp EEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC----------------SSEEE
T ss_pred EEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec----------------CCcEE
Confidence 36788999999999998664322 12345678999999996 5999999999986 56799
Q ss_pred EEEecCC--CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc-CCCCeEEeeccceeeeccC
Q 012062 75 MVFEYMD--HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID-NEGNLKLADFGLARSFSYD 151 (472)
Q Consensus 75 iVmEy~~--g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~-~~~~vkL~DFG~a~~~~~~ 151 (472)
+|||++. ++|.+++... ..+++.+++.|+.||+.||+|||+++|+||||||+||||+ +++.+||+|||+++.....
T Consensus 125 lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~ 203 (320)
T 3a99_A 125 LILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 203 (320)
T ss_dssp EEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSS
T ss_pred EEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccccc
Confidence 9999998 4677766543 4689999999999999999999999999999999999999 7789999999999876532
Q ss_pred CCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 012062 152 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 231 (472)
Q Consensus 152 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (472)
......+|..|+|||++.+...++.++|||||||++|+|++|+.||...+. +......
T Consensus 204 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~~~~------------- 261 (320)
T 3a99_A 204 ---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVF------------- 261 (320)
T ss_dssp ---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHCCCC-------------
T ss_pred ---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhccccc-------------
Confidence 233456899999999998754457889999999999999999999975421 1111000
Q ss_pred ccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 232 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
....++.++.+||++||..||++|||++||++|+||..
T Consensus 262 -----------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 299 (320)
T 3a99_A 262 -----------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 299 (320)
T ss_dssp -----------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred -----------------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcC
Confidence 01236778999999999999999999999999999954
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=316.61 Aligned_cols=233 Identities=19% Similarity=0.293 Sum_probs=176.5
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chh
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLT 85 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~ 85 (472)
....||||+++...........+.+|+++|++++|+||++++++.. ...++|||||+++ +|.
T Consensus 45 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----------------~~~~~lv~e~~~~~~L~ 107 (289)
T 3og7_A 45 WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-----------------APQLAIVTQWCEGSSLY 107 (289)
T ss_dssp SSSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----------------SSSCEEEEECCCEEEHH
T ss_pred EcCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-----------------CCccEEEEEecCCCcHH
Confidence 4456999999876555445567889999999999999999999764 3357999999985 777
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccC-CCCccccccccCC
Q 012062 86 GLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD-HNNTLTNRVITLW 164 (472)
Q Consensus 86 ~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~-~~~~~~~~~gt~~ 164 (472)
+++......+++.+++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++..... .........+|..
T Consensus 108 ~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 187 (289)
T 3og7_A 108 HHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187 (289)
T ss_dssp HHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------------------CCCT
T ss_pred HHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccccccccccCCCcc
Confidence 777666667999999999999999999999999999999999999999999999999999765432 2223344568999
Q ss_pred CCChhhhcC--CCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhh
Q 012062 165 YRPPELLLG--ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTM 242 (472)
Q Consensus 165 y~aPE~l~~--~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (472)
|+|||++.. ...++.++|||||||++|+|++|+.||...+..+.+..+......... .
T Consensus 188 y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----~--------------- 247 (289)
T 3og7_A 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD-----L--------------- 247 (289)
T ss_dssp TCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC-----T---------------
T ss_pred ccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc-----h---------------
Confidence 999999862 245788999999999999999999999987776666655543221111 0
Q ss_pred hhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 243 KRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 243 ~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
......++..+.+||.+||..||++|||+.|+++
T Consensus 248 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 248 ----SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp ----TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----hhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0011246778999999999999999999999985
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=321.89 Aligned_cols=247 Identities=24% Similarity=0.356 Sum_probs=178.2
Q ss_pred eccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-
Q 012062 4 EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH- 82 (472)
Q Consensus 4 ~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g- 82 (472)
+..+++.||||+++.... .....+.+|+++|++++|+||+++++++...+ ...+||||||+++
T Consensus 35 ~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--------------~~~~~lv~e~~~~~ 98 (295)
T 3ugc_A 35 QDNTGEVVAVKKLQHSTE--EHLRDFEREIEILKSLQHDNIVKYKGVCYSAG--------------RRNLKLIMEYLPYG 98 (295)
T ss_dssp CSSCCEEEEEEEESCCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH--------------HTSCEEEEECCTTC
T ss_pred cCCCCcEEEEEEcccCCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--------------CCceEEEEEeCCCC
Confidence 677999999999975432 23456789999999999999999999986521 3458999999975
Q ss_pred ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC--Ccccccc
Q 012062 83 DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTLTNRV 160 (472)
Q Consensus 83 ~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~--~~~~~~~ 160 (472)
+|.+++......+++.+++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+..... .......
T Consensus 99 ~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 178 (295)
T 3ugc_A 99 SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178 (295)
T ss_dssp BHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTT
T ss_pred CHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCC
Confidence 78777776655699999999999999999999999999999999999999999999999999987643322 1222334
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (472)
+|..|+|||++.+ ..++.++|||||||++|+|++|..||...... +..... ............. ..
T Consensus 179 ~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~~~~~~---~~~~~~~~~~~~~--------~~ 244 (295)
T 3ugc_A 179 SPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMRMIG---NDKQGQMIVFHLI--------EL 244 (295)
T ss_dssp CGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--HHHHHC---TTCCTHHHHHHHH--------HH
T ss_pred CccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccCCChHH--HHhhhc---CccccchhHHHHH--------HH
Confidence 6778999999986 56899999999999999999999888653221 111100 0000000000000 00
Q ss_pred hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
............+++++.+||++||..||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 245 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0000000011246788999999999999999999999985
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=324.48 Aligned_cols=232 Identities=19% Similarity=0.279 Sum_probs=180.0
Q ss_pred ceeccCCCEE----EEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEE
Q 012062 2 AREIKTGEIV----ALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVF 77 (472)
Q Consensus 2 a~~~~tg~~v----AlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVm 77 (472)
|++..+++.| |+|.++... .......+.+|+.++++++|+||+++++++.. +..++||
T Consensus 34 ~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----------------~~~~~v~ 95 (327)
T 3poz_A 34 GLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLT-----------------STVQLIT 95 (327)
T ss_dssp EEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEES-----------------SSEEEEE
T ss_pred EEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----------------CCeEEEE
Confidence 5667777765 777775433 22345678899999999999999999999975 2368899
Q ss_pred ecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC-c
Q 012062 78 EYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN-T 155 (472)
Q Consensus 78 Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~ 155 (472)
||+.+ +|.+++......+++..++.|+.||+.||+|||+++|+||||||+||||+.++++||+|||+++.+...... .
T Consensus 96 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 175 (327)
T 3poz_A 96 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175 (327)
T ss_dssp ECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC---
T ss_pred EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCccccc
Confidence 99884 777777766667999999999999999999999999999999999999999999999999999876543222 2
Q ss_pred cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 156 LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
.....+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+......+.
T Consensus 176 ~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-------------- 240 (327)
T 3poz_A 176 AEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ-------------- 240 (327)
T ss_dssp ----CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC--------------
T ss_pred ccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCC--------------
Confidence 223345789999999987 678999999999999999999 9999998887766555543221111
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
...++..+.+||.+||..||++|||+.|++++
T Consensus 241 ---------------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 241 ---------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp ---------------CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred ---------------CccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 11356789999999999999999999999864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=315.02 Aligned_cols=229 Identities=19% Similarity=0.261 Sum_probs=187.4
Q ss_pred ccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-C
Q 012062 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-D 83 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~ 83 (472)
..+++.||||+++.... ......+.+|++++++|+|+||+++++++.. +.+||||||+.+ +
T Consensus 34 ~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----------------~~~~lv~e~~~~~~ 95 (287)
T 1u59_A 34 RKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-----------------EALMLVMEMAGGGP 95 (287)
T ss_dssp --CCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-----------------SSEEEEEECCTTEE
T ss_pred CCCcceEEEEecCCccc-hhHHHHHHHHHHHHHhCCCCCEeEEEEEecC-----------------CCcEEEEEeCCCCC
Confidence 45788899999986532 2245668899999999999999999999953 358999999996 7
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC--Cccccccc
Q 012062 84 LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTLTNRVI 161 (472)
Q Consensus 84 l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~--~~~~~~~g 161 (472)
|.+++......+++.+++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||++........ .......+
T Consensus 96 L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 175 (287)
T 1u59_A 96 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 175 (287)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCC
T ss_pred HHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccc
Confidence 7777766666799999999999999999999999999999999999999999999999999987653322 11223345
Q ss_pred cCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 012062 162 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240 (472)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (472)
|..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+.......
T Consensus 176 ~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~--------------------- 233 (287)
T 1u59_A 176 PLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME--------------------- 233 (287)
T ss_dssp CGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC---------------------
T ss_pred cccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCC---------------------
Confidence 888999999976 568899999999999999998 999999988877776664421100
Q ss_pred hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
....++..+.+||.+||..||++|||+.|++++
T Consensus 234 --------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 266 (287)
T 1u59_A 234 --------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQR 266 (287)
T ss_dssp --------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --------CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 012467789999999999999999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=322.41 Aligned_cols=230 Identities=20% Similarity=0.328 Sum_probs=186.0
Q ss_pred ccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-C
Q 012062 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-D 83 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~ 83 (472)
..+++.||||+++.... ......+.+|+++|++|+||||+++++++.. .+.+||||||+.+ +
T Consensus 50 ~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----------------~~~~~lv~e~~~~~~ 112 (314)
T 2ivs_A 50 RAGYTTVAVKMLKENAS-PSELRDLLSEFNVLKQVNHPHVIKLYGACSQ----------------DGPLLLIVEYAKYGS 112 (314)
T ss_dssp CSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----------------SSSCEEEEECCTTCB
T ss_pred ccCcceEEEEeccCCCC-HHHHHHHHHHHHHHhhCCCCceeeEEEEEec----------------CCceEEEEeecCCCC
Confidence 35668999999985432 2234667899999999999999999999976 4568999999984 7
Q ss_pred hhhhhcCCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEe
Q 012062 84 LTGLADRPG-----------------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLA 140 (472)
Q Consensus 84 l~~~~~~~~-----------------------~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~ 140 (472)
|.+++.... ..+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+
T Consensus 113 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~ 192 (314)
T 2ivs_A 113 LRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKIS 192 (314)
T ss_dssp HHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEEC
T ss_pred HHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCCEEEc
Confidence 776665422 248999999999999999999999999999999999999999999999
Q ss_pred eccceeeeccCCCC-ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 012062 141 DFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGS 218 (472)
Q Consensus 141 DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~ 218 (472)
|||+++........ ......+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+......
T Consensus 193 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 271 (314)
T 2ivs_A 193 DFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRM 271 (314)
T ss_dssp CCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC
T ss_pred cccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcC
Confidence 99999876433221 2223355788999999986 568899999999999999999 99999988877766655432111
Q ss_pred CCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 219 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
. ....++..+.+||.+||..||++|||+.|++++
T Consensus 272 ~-----------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 272 E-----------------------------RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp C-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C-----------------------------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0 012467789999999999999999999999864
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=317.12 Aligned_cols=227 Identities=22% Similarity=0.282 Sum_probs=181.7
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chh
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLT 85 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~ 85 (472)
++..||||+++..... .....+.+|+.++++++|+||+++++++.. +..|+||||+.+ +|.
T Consensus 39 ~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----------------~~~~~v~e~~~~~~L~ 100 (281)
T 3cc6_A 39 EKINVAVKTCKKDCTL-DNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-----------------EPTWIIMELYPYGELG 100 (281)
T ss_dssp CEEEEEEEECCTTSCH-HHHHHHHHHHHHHHHHCCTTBCCEEEEECS-----------------SSCEEEEECCTTCBHH
T ss_pred CcceEEEEecccccCc-hHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----------------CCCEEEEecCCCCCHH
Confidence 4456999999865322 234678899999999999999999999864 245899999995 777
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccCCC
Q 012062 86 GLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWY 165 (472)
Q Consensus 86 ~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y 165 (472)
+++.+....+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++...............+|..|
T Consensus 101 ~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y 180 (281)
T 3cc6_A 101 HYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKW 180 (281)
T ss_dssp HHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGG
T ss_pred HHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccccccccccCCCCcce
Confidence 77766555699999999999999999999999999999999999999999999999999976654333333344568889
Q ss_pred CChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhh
Q 012062 166 RPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 244 (472)
Q Consensus 166 ~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (472)
+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+......+.
T Consensus 181 ~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~------------------------ 235 (281)
T 3cc6_A 181 MSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK------------------------ 235 (281)
T ss_dssp CCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCC------------------------
T ss_pred eCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCC------------------------
Confidence 99999976 568899999999999999998 9999988877776666544321111
Q ss_pred hHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 245 RVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 245 ~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
...+++.+.+||.+||..||++|||+.|++++
T Consensus 236 -----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 236 -----PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----CCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 01356789999999999999999999999863
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=318.98 Aligned_cols=226 Identities=18% Similarity=0.268 Sum_probs=179.6
Q ss_pred ceeccCC-------CEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEE
Q 012062 2 AREIKTG-------EIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTY 74 (472)
Q Consensus 2 a~~~~tg-------~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 74 (472)
|++..++ ..||||+++... ......+.+|++++++++|+||+++++++.. .+.+|
T Consensus 27 ~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~~ 88 (289)
T 4fvq_A 27 GVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVC----------------GDENI 88 (289)
T ss_dssp EEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECC----------------TTCCE
T ss_pred EEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe----------------CCCCE
Confidence 5566666 479999997543 2345678899999999999999999999986 45679
Q ss_pred EEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC--------eEEeeccce
Q 012062 75 MVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN--------LKLADFGLA 145 (472)
Q Consensus 75 iVmEy~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~--------vkL~DFG~a 145 (472)
|||||+++ +|.+++......+++..++.|+.||+.||+|||+++|+||||||+||||+.++. +||+|||++
T Consensus 89 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~ 168 (289)
T 4fvq_A 89 LVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168 (289)
T ss_dssp EEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSC
T ss_pred EEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCccc
Confidence 99999985 777777766555999999999999999999999999999999999999998887 999999998
Q ss_pred eeeccCCCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCC-CCCCCCChHHHHHHHHHhcCCCCCCCC
Q 012062 146 RSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK-PILPGKNEAEQLSKIFELCGSPDETIW 224 (472)
Q Consensus 146 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~-~pf~~~~~~~~~~~i~~~~~~~~~~~~ 224 (472)
.... ......+|..|+|||++.+...++.++|||||||++|+|++|. +||...+..... .+........
T Consensus 169 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~~~~~~~~~---- 238 (289)
T 4fvq_A 169 ITVL-----PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFYEDRHQLP---- 238 (289)
T ss_dssp TTTS-----CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHHTTCCCC----
T ss_pred cccc-----CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-HHhhccCCCC----
Confidence 5432 1223457899999999986566899999999999999999955 555554444433 3332211111
Q ss_pred ccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 225 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
..++.++.+||++||..||++|||+.|++++
T Consensus 239 --------------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 239 --------------------------APKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp --------------------------CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred --------------------------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1134468899999999999999999999975
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=341.84 Aligned_cols=230 Identities=20% Similarity=0.307 Sum_probs=190.2
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|+++.+++.||||+++.+.. ....+++|+.+|++|+|+|||++++++.. ...+|||||||.
T Consensus 239 ~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~----------------~~~~~lv~E~~~ 299 (495)
T 1opk_A 239 GVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTR----------------EPPFYIITEFMT 299 (495)
T ss_dssp EEEGGGTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS----------------SSSCEEEEECCT
T ss_pred EEEcCCCeEEEEEEecCccc---chHHHHHHHHHHHhcCCCCEeeEEEEEec----------------CCcEEEEEEccC
Confidence 67788899999999975432 35678899999999999999999999976 456899999998
Q ss_pred -CChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 82 -HDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 82 -g~l~~~~~~-~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
++|.+++.. ....+++..++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.............
T Consensus 300 ~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 379 (495)
T 1opk_A 300 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 379 (495)
T ss_dssp TCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTC
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCC
Confidence 577777764 334589999999999999999999999999999999999999999999999999987654332233334
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
.++..|+|||++.. ..++.++||||||||||+|++ |..||.+.+..+.+..+.......
T Consensus 380 ~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~------------------- 439 (495)
T 1opk_A 380 KFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME------------------- 439 (495)
T ss_dssp CCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC-------------------
T ss_pred cCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------------------
Confidence 45788999999976 568899999999999999999 999999988776666554321110
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....++..+.+||.+||..||++|||+.+|++
T Consensus 440 ----------~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 440 ----------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp ----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 01246778999999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=324.62 Aligned_cols=231 Identities=23% Similarity=0.367 Sum_probs=184.7
Q ss_pred ccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-
Q 012062 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH- 82 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g- 82 (472)
..+++.||||+++.... ......+.+|+.+|++| +||||+++++++.. .+.+||||||+++
T Consensus 72 ~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~----------------~~~~~lv~e~~~~g 134 (344)
T 1rjb_A 72 TGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGACTL----------------SGPIYLIFEYCCYG 134 (344)
T ss_dssp SSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS----------------SSSCEEEEECCTTC
T ss_pred CCcceEEEEEecccccC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee----------------CCccEEEEecCCCC
Confidence 34677899999985432 23456788999999999 89999999999976 4568999999985
Q ss_pred ChhhhhcCCCC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEe
Q 012062 83 DLTGLADRPGL----------------------RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLA 140 (472)
Q Consensus 83 ~l~~~~~~~~~----------------------~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~ 140 (472)
+|.+++..... .+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+
T Consensus 135 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~ 214 (344)
T 1rjb_A 135 DLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKIC 214 (344)
T ss_dssp BHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEEC
T ss_pred cHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeC
Confidence 78777765432 37899999999999999999999999999999999999999999999
Q ss_pred eccceeeeccCCCC-ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 012062 141 DFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGS 218 (472)
Q Consensus 141 DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~ 218 (472)
|||++..+...... ......+|+.|+|||++.+ ..++.++||||||||+|+|++ |..||.+.+....+..+......
T Consensus 215 Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 293 (344)
T 1rjb_A 215 DFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFK 293 (344)
T ss_dssp CCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCC
T ss_pred CCccCcccccCccceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCC
Confidence 99999866543322 2233456888999999876 568999999999999999998 99999988766665555443211
Q ss_pred CCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 219 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
... ...+++++.+||.+||..||.+|||+.||+++
T Consensus 294 ~~~----------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 294 MDQ----------------------------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp CCC----------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCC----------------------------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 110 01356789999999999999999999999975
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=325.87 Aligned_cols=242 Identities=21% Similarity=0.326 Sum_probs=168.7
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHH-HHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIK-ILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.+++.||||+++...... ....+.+|+. +++.++|+||+++++++.. .+.+||||||
T Consensus 40 ~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~h~niv~~~~~~~~----------------~~~~~lv~e~ 102 (327)
T 3aln_A 40 KMVHKPSGQIMAVKRIRSTVDEK-EQKQLLMDLDVVMRSSDCPYIVQFYGALFR----------------EGDCWICMEL 102 (327)
T ss_dssp EEEETTTTEEEEEEEEECCCCHH-HHHHHHHHHHHHHSSCCCTTBCCEEEEEEC----------------SSEEEEEECC
T ss_pred EEEEcCCCCEEEEEEeecccCch-HHHHHHHHHHHHHHcCCCCcEeeeeeEEEe----------------CCceEEEEee
Confidence 36788899999999998654322 2344556666 7778899999999999986 5678999999
Q ss_pred CCCChhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC
Q 012062 80 MDHDLTGLADR----PGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 154 (472)
Q Consensus 80 ~~g~l~~~~~~----~~~~l~~~~i~~i~~Qll~aL~~LH~~-giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 154 (472)
++++|.+++.. ....+++..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.+....
T Consensus 103 ~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-- 180 (327)
T 3aln_A 103 MSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI-- 180 (327)
T ss_dssp CSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-------
T ss_pred cCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc--
Confidence 99987766542 345689999999999999999999999 99999999999999999999999999997654322
Q ss_pred ccccccccCCCCChhhhc---CCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 012062 155 TLTNRVITLWYRPPELLL---GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 231 (472)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~---~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (472)
......+|..|+|||++. ....++.++|||||||++|+|++|+.||...+... ..+........ + .++
T Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~----~---~~~ 251 (327)
T 3aln_A 181 AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF--DQLTQVVKGDP----P---QLS 251 (327)
T ss_dssp -------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCCCCSCC----C---CCC
T ss_pred ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--HHHHHHhcCCC----C---CCC
Confidence 223346899999999984 22458899999999999999999999998654321 11111000000 0 000
Q ss_pred ccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 232 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
. .....++..+.+||++||..||++|||+.|||+|+||.
T Consensus 252 ~---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~ 290 (327)
T 3aln_A 252 N---------------SEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL 290 (327)
T ss_dssp C---------------CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred C---------------cccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHH
Confidence 0 01124677899999999999999999999999999994
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=311.32 Aligned_cols=226 Identities=25% Similarity=0.355 Sum_probs=173.3
Q ss_pred cCCCEEEEEEeecCCcC--CCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-
Q 012062 6 KTGEIVALKKIRMDNEK--EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH- 82 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g- 82 (472)
.+++.||||+++..... ......+.+|+++++.++|+||+++++++.. .+.+||||||+++
T Consensus 28 ~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~~~ 91 (271)
T 3dtc_A 28 WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK----------------EPNLCLVMEFARGG 91 (271)
T ss_dssp ETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC----------------C--CEEEEECCTTE
T ss_pred EcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec----------------CCceEEEEEcCCCC
Confidence 35889999999865322 2345678899999999999999999999976 4568999999986
Q ss_pred ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCCCcEEEcC--------CCCeEEeeccceeeeccC
Q 012062 83 DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ---VLHRDIKGSNLLIDN--------EGNLKLADFGLARSFSYD 151 (472)
Q Consensus 83 ~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~g---iiHrDLKp~NILl~~--------~~~vkL~DFG~a~~~~~~ 151 (472)
+|.+++.. ..+++.+++.++.||+.||+|||+++ |+||||||+||||+. ++.+||+|||++..+...
T Consensus 92 ~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~ 169 (271)
T 3dtc_A 92 PLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT 169 (271)
T ss_dssp EHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-------
T ss_pred CHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccccccc
Confidence 55555533 36999999999999999999999999 899999999999986 677999999999765432
Q ss_pred CCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 012062 152 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 231 (472)
Q Consensus 152 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (472)
. .....+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+........
T Consensus 170 ~---~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------- 234 (271)
T 3dtc_A 170 T---KMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP----------- 234 (271)
T ss_dssp ---------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCC-----------
T ss_pred c---ccCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCC-----------
Confidence 2 224568999999999986 5689999999999999999999999999888776666543211110
Q ss_pred ccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 232 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
....+++.+.+||.+||..||++|||+.|++++
T Consensus 235 -----------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 235 -----------------IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp -----------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 012467789999999999999999999999864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=320.77 Aligned_cols=225 Identities=22% Similarity=0.362 Sum_probs=179.1
Q ss_pred CEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chhhh
Q 012062 9 EIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGL 87 (472)
Q Consensus 9 ~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~~~ 87 (472)
..||||+++.... ......+.+|++++++++|+||+++++++.. .+.+||||||+++ +|.++
T Consensus 74 ~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~~~~~~L~~~ 136 (333)
T 1mqb_A 74 VPVAIKTLKAGYT-EKQRVDFLGEAGIMGQFSHHNIIRLEGVISK----------------YKPMMIITEYMENGALDKF 136 (333)
T ss_dssp EEEEEEEECTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----------------SSSEEEEEECCTTEEHHHH
T ss_pred ccEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEec----------------CCCcEEEEeCCCCCcHHHH
Confidence 4599999975532 2234567899999999999999999999976 5578999999986 77777
Q ss_pred hcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCc--cccccccCCC
Q 012062 88 ADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT--LTNRVITLWY 165 (472)
Q Consensus 88 ~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~--~~~~~gt~~y 165 (472)
+......+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++......... .....+|..|
T Consensus 137 l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y 216 (333)
T 1mqb_A 137 LREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 216 (333)
T ss_dssp HHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGG
T ss_pred HHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccc
Confidence 76665679999999999999999999999999999999999999999999999999998765432211 1223457789
Q ss_pred CChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhh
Q 012062 166 RPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 244 (472)
Q Consensus 166 ~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (472)
+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+.+..+......+.
T Consensus 217 ~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~------------------------ 271 (333)
T 1mqb_A 217 TAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT------------------------ 271 (333)
T ss_dssp SCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC------------------------
T ss_pred cCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCC------------------------
Confidence 99999976 568899999999999999998 9999999888777776654321110
Q ss_pred hHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 245 RVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 245 ~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...++..+.+||.+||..||++|||+.|+++
T Consensus 272 -----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 302 (333)
T 1mqb_A 272 -----PMDCPSAIYQLMMQCWQQERARRPKFADIVS 302 (333)
T ss_dssp -----CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----cccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0136778999999999999999999999985
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=319.16 Aligned_cols=232 Identities=23% Similarity=0.339 Sum_probs=187.8
Q ss_pred eccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC
Q 012062 4 EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH 82 (472)
Q Consensus 4 ~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g 82 (472)
+..+++.||||+++..... .....+.+|+++|++| +|+||+++++++.. .+.+||||||+++
T Consensus 49 ~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~----------------~~~~~lv~e~~~~ 111 (313)
T 1t46_A 49 KSDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYLGNHMNIVNLLGACTI----------------GGPTLVITEYCCY 111 (313)
T ss_dssp STTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----------------SSSCEEEEECCTT
T ss_pred ccchhhhhHHHhcCcchhH-HHHHHHHHHHHHHhhcccCCCeeeEEEEEec----------------CCCcEEEEecCCC
Confidence 4568899999999855322 2346788999999999 89999999999976 4567999999986
Q ss_pred -ChhhhhcCCCC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccc
Q 012062 83 -DLTGLADRPGL-----------------RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGL 144 (472)
Q Consensus 83 -~l~~~~~~~~~-----------------~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~ 144 (472)
+|.+++..... .+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+
T Consensus 112 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 191 (313)
T 1t46_A 112 GDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGL 191 (313)
T ss_dssp EEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGG
T ss_pred CCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEccccc
Confidence 77777654322 489999999999999999999999999999999999999999999999999
Q ss_pred eeeeccCCCC-ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCC
Q 012062 145 ARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDET 222 (472)
Q Consensus 145 a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~ 222 (472)
+......... ......+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+....+..+.........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~- 269 (313)
T 1t46_A 192 ARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLS- 269 (313)
T ss_dssp GSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCC-
T ss_pred cccccccccceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCCC-
Confidence 9776543322 1223456788999999876 578999999999999999998 99999988766655555443211110
Q ss_pred CCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 223 IWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
...++..+.+||.+||..||++|||+.|++++
T Consensus 270 ---------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 270 ---------------------------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp ---------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------------cccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 02356789999999999999999999999863
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=327.53 Aligned_cols=242 Identities=22% Similarity=0.341 Sum_probs=162.8
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHH-HHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIK-ILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||++.... ...+|+. .++.+.|+||+++++++..... ....+||||||
T Consensus 47 ~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~------------~~~~~~lv~e~ 107 (336)
T 3fhr_A 47 ECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYENMHH------------GKRCLLIIMEC 107 (336)
T ss_dssp EEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEEEET------------TEEEEEEEEEC
T ss_pred EEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhhccC------------CCceEEEEEec
Confidence 47888999999999997431 2333443 4677799999999999975211 13468999999
Q ss_pred CCC-ChhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC---CCeEEeeccceeeeccCCCC
Q 012062 80 MDH-DLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE---GNLKLADFGLARSFSYDHNN 154 (472)
Q Consensus 80 ~~g-~l~~~~~~~~-~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~---~~vkL~DFG~a~~~~~~~~~ 154 (472)
|++ +|.+++.+.. ..+++.+++.|+.||+.||+|||+++|+||||||+||||+.+ +.+||+|||+++.....
T Consensus 108 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~--- 184 (336)
T 3fhr_A 108 MEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN--- 184 (336)
T ss_dssp CTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC------
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecccc---
Confidence 986 7877776543 469999999999999999999999999999999999999864 45999999999765432
Q ss_pred ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 155 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
.....++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+......... ..
T Consensus 185 ~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------~~---- 252 (336)
T 3fhr_A 185 ALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY-------GF---- 252 (336)
T ss_dssp --------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------CC----
T ss_pred ccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccc-------cc----
Confidence 2334567999999999865 56788999999999999999999999876654432222111000000 00
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
....+..++.++++||++||..||++|||+.|+|+|+||...
T Consensus 253 -----------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 253 -----------PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp -----------CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred -----------CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 001123578899999999999999999999999999999653
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=321.68 Aligned_cols=230 Identities=25% Similarity=0.364 Sum_probs=181.2
Q ss_pred CceeccCCCEEEEEEeecCCcCC----CchhhHHHHHHHHHhc----CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCe
Q 012062 1 MAREIKTGEIVALKKIRMDNEKE----GFPITAIREIKILKKL----QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 72 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~----~~~~~~~~Ei~il~~l----~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 72 (472)
+|++..+++.||||+++...... .....+.+|+.+++++ +|+||+++++++.. .+.
T Consensus 49 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~----------------~~~ 112 (312)
T 2iwi_A 49 AGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET----------------QEG 112 (312)
T ss_dssp EEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---------------------
T ss_pred EEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec----------------CCe
Confidence 36788899999999997653321 1233456799999999 89999999999976 456
Q ss_pred EEEEEec-CC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc-CCCCeEEeeccceeeec
Q 012062 73 TYMVFEY-MD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID-NEGNLKLADFGLARSFS 149 (472)
Q Consensus 73 ~~iVmEy-~~-g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~-~~~~vkL~DFG~a~~~~ 149 (472)
+|+|||+ +. ++|.+++.+. ..+++.+++.++.||+.||+|||+++|+||||||+||||+ .++.+||+|||++....
T Consensus 113 ~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~ 191 (312)
T 2iwi_A 113 FMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH 191 (312)
T ss_dssp CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEECC
T ss_pred EEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhcc
Confidence 8999999 55 4777766543 3689999999999999999999999999999999999999 78899999999998765
Q ss_pred cCCCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 012062 150 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 229 (472)
Q Consensus 150 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (472)
.. ......+|..|+|||++.+....+.++|||||||++|+|++|+.||..... +......
T Consensus 192 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~----------- 251 (312)
T 2iwi_A 192 DE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAELH----------- 251 (312)
T ss_dssp SS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHTCCC-----------
T ss_pred cC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------HhhhccC-----------
Confidence 32 234456899999999987644445689999999999999999999975321 1111000
Q ss_pred CCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 230 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
+...++..+++||.+||..||++|||+.|+|+|+||..
T Consensus 252 -------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~ 289 (312)
T 2iwi_A 252 -------------------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQT 289 (312)
T ss_dssp -------------------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC
T ss_pred -------------------CcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcC
Confidence 01246778999999999999999999999999999964
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=324.93 Aligned_cols=239 Identities=23% Similarity=0.362 Sum_probs=168.1
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC-CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||++..... .....+.+|+.+++++. |+||+++++++....... ......+||||||
T Consensus 46 ~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~--------~~~~~~~~lv~e~ 115 (337)
T 3ll6_A 46 EAQDVGSGREYALKRLLSNEE--EKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES--------DTGQAEFLLLTEL 115 (337)
T ss_dssp EEEETTTCCEEEEEEEEESSH--HHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS--------TTSSEEEEEEEEC
T ss_pred EEEECCCCcEEEEEEecCCch--HHHHHHHHHHHHHHHhccCCChhhcccccccccccc--------ccCCceEEEEEEe
Confidence 467888999999999865432 23456789999999996 999999999996532211 1225578999999
Q ss_pred CCCChhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC-
Q 012062 80 MDHDLTGLADR--PGLRFTVPQIKCYMKQLLTGLHYCHVNQ--VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN- 154 (472)
Q Consensus 80 ~~g~l~~~~~~--~~~~l~~~~i~~i~~Qll~aL~~LH~~g--iiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~- 154 (472)
++++|.+++.. ....+++.+++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++........
T Consensus 116 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 195 (337)
T 3ll6_A 116 CKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYS 195 (337)
T ss_dssp CSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC---
T ss_pred cCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCccc
Confidence 99998887754 3456999999999999999999999999 999999999999999999999999999876432221
Q ss_pred ----------ccccccccCCCCChhhhc--CCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC
Q 012062 155 ----------TLTNRVITLWYRPPELLL--GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDET 222 (472)
Q Consensus 155 ----------~~~~~~gt~~y~aPE~l~--~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~ 222 (472)
.....++|+.|+|||++. ....++.++||||||||+|+|++|+.||........+...... +.
T Consensus 196 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~-- 270 (337)
T 3ll6_A 196 WSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSI---PP-- 270 (337)
T ss_dssp ----------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------CCC---CT--
T ss_pred ccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCcccC---Cc--
Confidence 112346799999999983 2356788999999999999999999999765544332221100 00
Q ss_pred CCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 223 IWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
....+..+.+||++||..||++|||+.|++++
T Consensus 271 ---------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 302 (337)
T 3ll6_A 271 ---------------------------HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ 302 (337)
T ss_dssp ---------------------------TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ---------------------------ccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 01234458899999999999999999999975
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=317.03 Aligned_cols=242 Identities=25% Similarity=0.404 Sum_probs=180.6
Q ss_pred eccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-
Q 012062 4 EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH- 82 (472)
Q Consensus 4 ~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g- 82 (472)
+..+++.||||+++..... .....+.+|+++|++++|+||+++++++...+ ...+||||||+++
T Consensus 46 ~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--------------~~~~~lv~e~~~~~ 110 (302)
T 4e5w_A 46 GDNTGEQVAVKSLKPESGG-NHIADLKKEIEILRNLYHENIVKYKGICTEDG--------------GNGIKLIMEFLPSG 110 (302)
T ss_dssp SSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----------------CCEEEEEECCTTC
T ss_pred cCccCeEEEEEEecccccc-hhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC--------------CceEEEEEEeCCCC
Confidence 6789999999999865432 34567889999999999999999999998632 3568999999986
Q ss_pred ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC--Ccccccc
Q 012062 83 DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTLTNRV 160 (472)
Q Consensus 83 ~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~--~~~~~~~ 160 (472)
+|.+++......+++.+++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||++..+..... .......
T Consensus 111 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 190 (302)
T 4e5w_A 111 SLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRD 190 (302)
T ss_dssp BHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTT
T ss_pred cHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCC
Confidence 77777755556799999999999999999999999999999999999999999999999999987654332 2233456
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (472)
+|..|+|||++.+ ..++.++|||||||++|+|++|..||.... ..+... ........ . ..
T Consensus 191 ~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~---~~~~~~~~-~-------------~~ 250 (302)
T 4e5w_A 191 SPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDSSPM--ALFLKM---IGPTHGQM-T-------------VT 250 (302)
T ss_dssp CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHH--HHHHHH---HCSCCGGG-H-------------HH
T ss_pred CCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCCcchh--hHHhhc---cCCccccc-C-------------HH
Confidence 7888999999976 567889999999999999999988754221 111111 00000000 0 00
Q ss_pred hhhhh-----HHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 241 TMKRR-----VREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 241 ~~~~~-----~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
..... .......+++.+.+||++||..||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 251 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 00000 00011356789999999999999999999999985
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=321.35 Aligned_cols=239 Identities=23% Similarity=0.283 Sum_probs=182.3
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Ch
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL 84 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l 84 (472)
.+++.||||++..... .....+.+|+++++.++|+||+++++++.. .+.+||||||+++ +|
T Consensus 61 ~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~~~~~~L 122 (321)
T 2qkw_B 61 RDGAKVALKRRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFCDE----------------RNEMILIYKYMENGNL 122 (321)
T ss_dssp TTCCEEEEEECCSCCS--SHHHHHHHHHHGGGSCCCTTBCCEEEECCC----------------TTCCEEEEECCTTCBT
T ss_pred CCCCEEEEEEecccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcC----------------CCeEEEEEEcCCCCcH
Confidence 4789999999875432 235678899999999999999999999876 5578999999985 67
Q ss_pred hhhhcCCC---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC-Ccccccc
Q 012062 85 TGLADRPG---LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-NTLTNRV 160 (472)
Q Consensus 85 ~~~~~~~~---~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~ 160 (472)
.+++.... ..+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++....... .......
T Consensus 123 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 202 (321)
T 2qkw_B 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK 202 (321)
T ss_dssp GGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCE
T ss_pred HHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccC
Confidence 66665432 3589999999999999999999999999999999999999999999999999986543222 2233456
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHH---HH--hcCCCCCCCCccCCCCCcccc
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI---FE--LCGSPDETIWPGVSKMPAYNH 235 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i---~~--~~~~~~~~~~~~~~~~~~~~~ 235 (472)
+|..|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+ .. ..........+..
T Consensus 203 gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 273 (321)
T 2qkw_B 203 GTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL-------- 273 (321)
T ss_dssp EETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSC--------
T ss_pred CCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhh--------
Confidence 8999999999976 56899999999999999999999999865432211111 00 0000000000000
Q ss_pred CCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
.......++..+.+||.+||..||++|||+.|++++
T Consensus 274 ----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 274 ----------ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp ----------TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 001112456789999999999999999999999864
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=333.70 Aligned_cols=234 Identities=20% Similarity=0.257 Sum_probs=187.5
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeE-EeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKE-IVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||+++..... ..+.+|+++++.|+|.+++..+. ++.. ....||||||
T Consensus 25 ~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~----------------~~~~~lvme~ 84 (483)
T 3sv0_A 25 LGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVE----------------GDYNVLVMDL 84 (483)
T ss_dssp EEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEE----------------TTEEEEEEEC
T ss_pred EEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEee----------------CCEEEEEEEC
Confidence 4678899999999998765433 35789999999998765554444 4433 5578999999
Q ss_pred CCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE---cCCCCeEEeeccceeeeccCCCC--
Q 012062 80 MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI---DNEGNLKLADFGLARSFSYDHNN-- 154 (472)
Q Consensus 80 ~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl---~~~~~vkL~DFG~a~~~~~~~~~-- 154 (472)
+.++|.+++......+++.+++.|+.||+.||+|||+++|+||||||+|||| +.++.+||+|||+++.+......
T Consensus 85 ~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (483)
T 3sv0_A 85 LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (483)
T ss_dssp CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCB
T ss_pred CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccc
Confidence 9888988887666679999999999999999999999999999999999999 68889999999999877643321
Q ss_pred ----ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhcCCCCCCCCccC
Q 012062 155 ----TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA---EQLSKIFELCGSPDETIWPGV 227 (472)
Q Consensus 155 ----~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~ 227 (472)
.....++|..|+|||++.+ ..++.++||||||||||+|++|+.||.+.... +.+.++...
T Consensus 165 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~------------ 231 (483)
T 3sv0_A 165 IPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK------------ 231 (483)
T ss_dssp CCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH------------
T ss_pred cccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc------------
Confidence 1235678999999999987 56899999999999999999999999875543 333333221
Q ss_pred CCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 228 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
........+...++.++.+||.+||..||++||++.+|++
T Consensus 232 -------------~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 232 -------------KVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp -------------HHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred -------------cccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0112233445678899999999999999999999998864
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=315.74 Aligned_cols=230 Identities=19% Similarity=0.263 Sum_probs=183.9
Q ss_pred eeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC
Q 012062 3 REIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH 82 (472)
Q Consensus 3 ~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g 82 (472)
++..+++.||||+++...........+.+|+++++.++|+||+++++++. .+.+||||||+.+
T Consensus 39 ~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----------------~~~~~lv~e~~~~ 101 (291)
T 1xbb_A 39 QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-----------------AESWMLVMEMAEL 101 (291)
T ss_dssp ECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----------------SSSEEEEEECCTT
T ss_pred cCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC-----------------CCCcEEEEEeCCC
Confidence 34567889999999876544445667889999999999999999999994 3468999999985
Q ss_pred -ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCc--cccc
Q 012062 83 -DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT--LTNR 159 (472)
Q Consensus 83 -~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~--~~~~ 159 (472)
+|.+++... ..+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++.......... ....
T Consensus 102 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 180 (291)
T 1xbb_A 102 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 180 (291)
T ss_dssp EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred CCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccC
Confidence 666666543 469999999999999999999999999999999999999999999999999998765433211 1223
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
.+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+.......
T Consensus 181 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~------------------- 240 (291)
T 1xbb_A 181 KWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG------------------- 240 (291)
T ss_dssp CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-------------------
T ss_pred CCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-------------------
Confidence 45688999999976 467889999999999999999 999999988877666654321100
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....++..+.+||.+||..||++|||+.|+++
T Consensus 241 ----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 241 ----------CPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp ----------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01246778999999999999999999999985
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=319.84 Aligned_cols=232 Identities=25% Similarity=0.336 Sum_probs=184.9
Q ss_pred CceeccCCCEE--EEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEE
Q 012062 1 MAREIKTGEIV--ALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVF 77 (472)
Q Consensus 1 La~~~~tg~~v--AlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVm 77 (472)
+|++..+++.+ |||+++..... .....+.+|+++|+++ +|+||+++++++.. .+.+||||
T Consensus 43 ~~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~----------------~~~~~lv~ 105 (327)
T 1fvr_A 43 KARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLGHHPNIINLLGACEH----------------RGYLYLAI 105 (327)
T ss_dssp EEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEE----------------TTEEEEEE
T ss_pred EEEEccCCcccceeeeeeccccch-HHHHHHHHHHHHHHhccCCCchhhhceeeee----------------CCceEEEE
Confidence 36778888865 99998754322 2455788999999999 89999999999986 56899999
Q ss_pred ecCCC-ChhhhhcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEee
Q 012062 78 EYMDH-DLTGLADRPG---------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLAD 141 (472)
Q Consensus 78 Ey~~g-~l~~~~~~~~---------------~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~D 141 (472)
||+++ +|.+++.... ..+++.+++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|
T Consensus 106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~D 185 (327)
T 1fvr_A 106 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIAD 185 (327)
T ss_dssp CCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECC
T ss_pred ecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEcc
Confidence 99975 7777776543 3689999999999999999999999999999999999999999999999
Q ss_pred ccceeeeccCCCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCC
Q 012062 142 FGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPD 220 (472)
Q Consensus 142 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~ 220 (472)
||+++..... .......++..|+|||++.+ ..++.++||||||||+|+|++ |..||.+.+..+....+.......
T Consensus 186 fg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~- 261 (327)
T 1fvr_A 186 FGLSRGQEVY--VKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE- 261 (327)
T ss_dssp TTCEESSCEE--CCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCC-
T ss_pred cCcCcccccc--ccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCCC-
Confidence 9998743221 12223355889999999876 567899999999999999998 999999988877666553321100
Q ss_pred CCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 221 ETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
....++..+.+||.+||..||++|||+.|++++
T Consensus 262 ----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 262 ----------------------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp ----------------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 011467789999999999999999999999864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=320.40 Aligned_cols=232 Identities=19% Similarity=0.277 Sum_probs=181.1
Q ss_pred CceeccCCCEE----EEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEE
Q 012062 1 MAREIKTGEIV----ALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMV 76 (472)
Q Consensus 1 La~~~~tg~~v----AlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iV 76 (472)
+|++..+++.| |+|.++... .......+.+|+.++++++|+||+++++++.. +..++|
T Consensus 33 ~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----------------~~~~~v 94 (327)
T 3lzb_A 33 KGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLT-----------------STVQLI 94 (327)
T ss_dssp EEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES-----------------SSEEEE
T ss_pred EEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec-----------------CCceEE
Confidence 36677788766 556554332 23356678899999999999999999999975 237889
Q ss_pred EecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC-C
Q 012062 77 FEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-N 154 (472)
Q Consensus 77 mEy~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~-~ 154 (472)
|||+.+ +|.+++......+++..++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+..... .
T Consensus 95 ~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~ 174 (327)
T 3lzb_A 95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174 (327)
T ss_dssp ECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----------
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccc
Confidence 999885 77777776666799999999999999999999999999999999999999999999999999987643322 1
Q ss_pred ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 012062 155 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 233 (472)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (472)
......+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+......+.
T Consensus 175 ~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~------------- 240 (327)
T 3lzb_A 175 HAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ------------- 240 (327)
T ss_dssp -----CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC-------------
T ss_pred cccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC-------------
Confidence 2223345788999999986 678999999999999999999 9999998887776665543221111
Q ss_pred ccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 234 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...++.++.+||++||..||++|||+.|+++
T Consensus 241 ----------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 241 ----------------PPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp ----------------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1236678999999999999999999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=318.98 Aligned_cols=229 Identities=25% Similarity=0.389 Sum_probs=184.5
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-C
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-D 83 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~ 83 (472)
.+++.||||+++.... ......+.+|+++++++ +|+||+++++++.. .+.+||||||+++ +
T Consensus 65 ~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~----------------~~~~~lv~e~~~~~~ 127 (334)
T 2pvf_A 65 KEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ----------------DGPLYVIVEYASKGN 127 (334)
T ss_dssp ---CEEEEEECCTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----------------SSCCEEEEECCTTCB
T ss_pred ccceEEEEeeeccCCc-HHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc----------------CCceEEEEECCCCCc
Confidence 5778999999985532 22345678999999999 89999999999976 5578999999986 7
Q ss_pred hhhhhcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeee
Q 012062 84 LTGLADRPG---------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 148 (472)
Q Consensus 84 l~~~~~~~~---------------~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~ 148 (472)
|.+++.... ..+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++..
T Consensus 128 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 207 (334)
T 2pvf_A 128 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 207 (334)
T ss_dssp HHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred HHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEccccccccc
Confidence 777766532 24899999999999999999999999999999999999999999999999999876
Q ss_pred ccCCC-CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 012062 149 SYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPG 226 (472)
Q Consensus 149 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 226 (472)
..... .......+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+........
T Consensus 208 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~------ 280 (334)
T 2pvf_A 208 NNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDK------ 280 (334)
T ss_dssp TTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC------
T ss_pred cccccccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCCCCC------
Confidence 54322 12223355788999999976 568899999999999999999 9999999888777766654321110
Q ss_pred CCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 227 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
...++..+.+||.+||..||++|||+.|++++
T Consensus 281 -----------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 281 -----------------------PANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp -----------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------CccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 11366789999999999999999999999863
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=308.23 Aligned_cols=226 Identities=16% Similarity=0.206 Sum_probs=185.4
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chh
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLT 85 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~ 85 (472)
+++.||||+++...........+.+|+.++++++|+||+++++++.... .+.+||||||+++ +|.
T Consensus 32 ~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--------------~~~~~lv~e~~~~~~L~ 97 (271)
T 3kmu_A 32 QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP--------------APHPTLITHWMPYGSLY 97 (271)
T ss_dssp TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT--------------SSSCEEEEECCTTCBHH
T ss_pred CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC--------------CCCeEeeecccCCCcHH
Confidence 5889999999876544445567889999999999999999999997632 3578999999985 787
Q ss_pred hhhcCCCC-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccccc
Q 012062 86 GLADRPGL-RFTVPQIKCYMKQLLTGLHYCHVNQ--VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVIT 162 (472)
Q Consensus 86 ~~~~~~~~-~l~~~~i~~i~~Qll~aL~~LH~~g--iiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt 162 (472)
+++..... .+++.+++.|+.||+.||+|||+++ |+||||||+|||++.++.++|+||+++.... .....+|
T Consensus 98 ~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~------~~~~~~t 171 (271)
T 3kmu_A 98 NVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYA 171 (271)
T ss_dssp HHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS------CTTCBSC
T ss_pred HHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec------ccCccCC
Confidence 77766433 5899999999999999999999999 9999999999999999999999999875422 2335679
Q ss_pred CCCCChhhhcCCCC--CCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 012062 163 LWYRPPELLLGATK--YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240 (472)
Q Consensus 163 ~~y~aPE~l~~~~~--~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (472)
+.|+|||++.+... ++.++|||||||++|+|++|+.||...+..+....+......+.
T Consensus 172 ~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------- 231 (271)
T 3kmu_A 172 PAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT-------------------- 231 (271)
T ss_dssp GGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC--------------------
T ss_pred ccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC--------------------
Confidence 99999999986322 23379999999999999999999999888887766654322111
Q ss_pred hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....++.++.+||.+||..||++|||+.|+++
T Consensus 232 --------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 232 --------IPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp --------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01246778999999999999999999999985
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=333.15 Aligned_cols=257 Identities=23% Similarity=0.331 Sum_probs=189.8
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+++...... ....+.+|+++|++++|+||+++++++.... ...+|||||||
T Consensus 27 ~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--------------~~~~~lv~e~~ 91 (396)
T 4eut_A 27 RGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEETT--------------TRHKVLIMEFC 91 (396)
T ss_dssp EEEETTTCCEEEEEEECGGGGGS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECTT--------------TCCEEEEECCC
T ss_pred EEEECCCCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCCCCeEEEeeccCC--------------CCeeEEEEecC
Confidence 47889999999999998654322 3456789999999999999999999998632 34789999999
Q ss_pred CC-ChhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE----cCCCCeEEeeccceeeeccCCC
Q 012062 81 DH-DLTGLADRPG--LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI----DNEGNLKLADFGLARSFSYDHN 153 (472)
Q Consensus 81 ~g-~l~~~~~~~~--~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl----~~~~~vkL~DFG~a~~~~~~~~ 153 (472)
++ +|.+++.... ..+++.+++.|+.||+.||+|||+++|+||||||+|||| +.++.+||+|||+++......
T Consensus 92 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~- 170 (396)
T 4eut_A 92 PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE- 170 (396)
T ss_dssp TTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGG-
T ss_pred CCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCC-
Confidence 85 6777666532 238999999999999999999999999999999999999 777779999999998764322
Q ss_pred CccccccccCCCCChhhhcCC-------CCCCCCcchhhHHHHHHHHHhCCCCCCCC----ChHHHHHHHHHhcCCCCCC
Q 012062 154 NTLTNRVITLWYRPPELLLGA-------TKYGPAVDMWSVGCIFAELLNGKPILPGK----NEAEQLSKIFELCGSPDET 222 (472)
Q Consensus 154 ~~~~~~~gt~~y~aPE~l~~~-------~~~~~~~DiwSlG~il~ell~G~~pf~~~----~~~~~~~~i~~~~~~~~~~ 222 (472)
.....++|..|+|||++.+. ..++.++|||||||++|+|++|+.||... ...+.+.++... .+..
T Consensus 171 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~---~p~~ 246 (396)
T 4eut_A 171 -QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG---KPSG 246 (396)
T ss_dssp -GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS---CCTT
T ss_pred -ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC---CCcc
Confidence 33445789999999998641 34677999999999999999999999743 334444444432 2222
Q ss_pred CCccCCCCCc-cccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 223 IWPGVSKMPA-YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 223 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
.|........ ...|...... ...+...++..+.+||++||..||++|+|+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~---~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 247 AISGVQKAENGPIDWSGDMPV---SCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp CCEEEECSTTCCEEEESSCCT---TCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred cchhheeccCCCcccCccCCc---ccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 2222211110 0000000000 00122356778999999999999999999999854
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=348.04 Aligned_cols=229 Identities=19% Similarity=0.268 Sum_probs=186.1
Q ss_pred eccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-
Q 012062 4 EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH- 82 (472)
Q Consensus 4 ~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g- 82 (472)
+..+++.||||+++...........+++|+++|++|+|+|||++++++.. ..+|||||||.+
T Consensus 392 ~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----------------~~~~lv~E~~~~g 454 (635)
T 4fl3_A 392 MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-----------------ESWMLVMEMAELG 454 (635)
T ss_dssp CSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-----------------SSEEEEEECCTTE
T ss_pred CCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----------------CCEEEEEEccCCC
Confidence 45677899999998765555556788999999999999999999999964 347999999986
Q ss_pred ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC--Ccccccc
Q 012062 83 DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTLTNRV 160 (472)
Q Consensus 83 ~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~--~~~~~~~ 160 (472)
+|.+++.. ...+++.+++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+..... .......
T Consensus 455 ~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~ 533 (635)
T 4fl3_A 455 PLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 533 (635)
T ss_dssp EHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------------
T ss_pred CHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCC
Confidence 66666654 34699999999999999999999999999999999999999999999999999986643322 2223334
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
+|..|+|||++.+ ..++.++||||||||||+|++ |+.||.+.+..+....+........
T Consensus 534 ~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~------------------- 593 (635)
T 4fl3_A 534 WPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC------------------- 593 (635)
T ss_dssp -CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC-------------------
T ss_pred CceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-------------------
Confidence 5788999999976 578999999999999999998 9999999998887777654321110
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...++.++.+||.+||..||++|||+.+|++
T Consensus 594 ----------p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 594 ----------PAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp ----------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 1246778999999999999999999999975
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=324.37 Aligned_cols=240 Identities=18% Similarity=0.183 Sum_probs=179.9
Q ss_pred CCCEEEEEEeecCCcCC---------CchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEE
Q 012062 7 TGEIVALKKIRMDNEKE---------GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVF 77 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~---------~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVm 77 (472)
+++.||||++....... ......+.|+.+++.++|+||+++++++..... ....+||||
T Consensus 64 ~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~------------~~~~~~lv~ 131 (364)
T 3op5_A 64 SDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKN------------GKSYRFMIM 131 (364)
T ss_dssp TTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEET------------TEEEEEEEE
T ss_pred cccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeeccC------------CcceEEEEE
Confidence 46899999987653210 011233456667778889999999999876210 134689999
Q ss_pred ecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc--CCCCeEEeeccceeeeccCCCC-
Q 012062 78 EYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID--NEGNLKLADFGLARSFSYDHNN- 154 (472)
Q Consensus 78 Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~--~~~~vkL~DFG~a~~~~~~~~~- 154 (472)
|||.++|.+++......+++.+++.|+.||+.||+|||+++|+||||||+||||+ .++.+||+|||+++.+......
T Consensus 132 e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~ 211 (364)
T 3op5_A 132 DRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211 (364)
T ss_dssp ECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCC
T ss_pred eCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCccc
Confidence 9996688888877666799999999999999999999999999999999999999 8889999999999876543221
Q ss_pred -----ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 012062 155 -----TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 229 (472)
Q Consensus 155 -----~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (472)
.....++|+.|+|||++.+ ..++.++||||||||||+|++|+.||.+......+.........
T Consensus 212 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~----------- 279 (364)
T 3op5_A 212 AYAADPKRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYR----------- 279 (364)
T ss_dssp CSSCCSSCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHH-----------
T ss_pred ccccCcccccCCCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhh-----------
Confidence 1233458999999999987 56899999999999999999999999864433332222111000
Q ss_pred CCccccCCCchhhhhhHHHHh--hhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 230 MPAYNHFKPSRTMKRRVREVF--RHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
..........+ ..++.++.+||.+||..||++|||+.+|++
T Consensus 280 ----------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 280 ----------ENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp ----------HCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ----------hhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 00000011111 356889999999999999999999999874
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=316.03 Aligned_cols=234 Identities=19% Similarity=0.248 Sum_probs=178.3
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chh
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLT 85 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~ 85 (472)
+++.||||+++...........+.+|+.++++++|+||+++++++...+.. ....+|+||||+.+ +|.
T Consensus 61 ~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-----------~~~~~~~v~e~~~~~~L~ 129 (313)
T 3brb_A 61 TSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ-----------GIPKPMVILPFMKYGDLH 129 (313)
T ss_dssp CEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------------------CEEEEEECCTTCBHH
T ss_pred ceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc-----------CCcccEEEEecccCCCHH
Confidence 666899999987654444456788999999999999999999999863211 12357999999996 666
Q ss_pred hhhc-----CCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC-Cccccc
Q 012062 86 GLAD-----RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-NTLTNR 159 (472)
Q Consensus 86 ~~~~-----~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~~~ 159 (472)
.++. .....+++.+++.|+.||+.||.|||+++|+||||||+||||+.++.+||+|||++..+..... ......
T Consensus 130 ~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 209 (313)
T 3brb_A 130 TYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIA 209 (313)
T ss_dssp HHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC---------------
T ss_pred HHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcceecccccccCccccc
Confidence 6552 2335699999999999999999999999999999999999999999999999999976543221 122233
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
.+++.|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+.......
T Consensus 210 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~------------------- 269 (313)
T 3brb_A 210 KMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLK------------------- 269 (313)
T ss_dssp -CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC-------------------
T ss_pred CCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCC-------------------
Confidence 45788999999986 678999999999999999999 899999988877776665432110
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
....++..+.+||.+||..||++|||+.+++++
T Consensus 270 ----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 270 ----------QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp ----------CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----------CCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 012466789999999999999999999999863
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=310.98 Aligned_cols=233 Identities=22% Similarity=0.315 Sum_probs=184.0
Q ss_pred ceeccCCC---EEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 2 AREIKTGE---IVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 2 a~~~~tg~---~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
|++..+++ .||||+++..... .....+.+|+.++++++|+||+++++++... +...|+|||
T Consensus 40 ~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---------------~~~~~~v~e 103 (298)
T 3pls_A 40 GEYIDQAQNRIQCAIKSLSRITEM-QQVEAFLREGLLMRGLNHPNVLALIGIMLPP---------------EGLPHVLLP 103 (298)
T ss_dssp EEEECSSSCEEEEEEEEETTCCSH-HHHHHHHHHHHHHHTCCCTTBCCCCEEECCS---------------SSCCEEEEC
T ss_pred EEEecCCCceeeeeeeeccccccH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEecC---------------CCCcEEEEe
Confidence 44444444 7999998754322 2345678999999999999999999999752 234589999
Q ss_pred cCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCC---CC
Q 012062 79 YMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH---NN 154 (472)
Q Consensus 79 y~~-g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~---~~ 154 (472)
|+. ++|.+++......+++.+++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.... ..
T Consensus 104 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 183 (298)
T 3pls_A 104 YMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQ 183 (298)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSC
T ss_pred cccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccc
Confidence 997 57888887766679999999999999999999999999999999999999999999999999997553321 12
Q ss_pred ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 012062 155 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 233 (472)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (472)
......+|..|+|||++.+ ..++.++|||||||++|+|++ +.++|...+..+....+........
T Consensus 184 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~------------- 249 (298)
T 3pls_A 184 QHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ------------- 249 (298)
T ss_dssp CSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCC-------------
T ss_pred cCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCC-------------
Confidence 2233456889999999976 568899999999999999999 5566666666666555543321111
Q ss_pred ccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 234 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...+++.+.+||++||..||.+|||+.++++
T Consensus 250 ----------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 250 ----------------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp ----------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1135678999999999999999999999985
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=317.90 Aligned_cols=233 Identities=22% Similarity=0.376 Sum_probs=185.3
Q ss_pred eccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC
Q 012062 4 EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH 82 (472)
Q Consensus 4 ~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g 82 (472)
+..+++.||||+++..... .....+.+|+++++++ +|+||+++++++... ...+||||||+.+
T Consensus 53 ~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~---------------~~~~~lv~e~~~~ 116 (316)
T 2xir_A 53 KTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTKP---------------GGPLMVIVEFCKF 116 (316)
T ss_dssp STTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT---------------TSCCEEEEECCTT
T ss_pred ccccceEEEEEecccCCCc-HHHHHHHHHHHHHHhcccCCCeeeEEEEEecC---------------CCceEEEEEcCCC
Confidence 3568899999999865322 2345678999999999 699999999998752 3358999999986
Q ss_pred -ChhhhhcCCCC---------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeecccee
Q 012062 83 -DLTGLADRPGL---------------RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 146 (472)
Q Consensus 83 -~l~~~~~~~~~---------------~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 146 (472)
+|.+++..... .+++..++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++
T Consensus 117 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 196 (316)
T 2xir_A 117 GNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196 (316)
T ss_dssp EEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGS
T ss_pred CcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEECCCcccc
Confidence 77777765432 28899999999999999999999999999999999999999999999999997
Q ss_pred eeccCCC-CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 012062 147 SFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIW 224 (472)
Q Consensus 147 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 224 (472)
....... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+...........
T Consensus 197 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---- 271 (316)
T 2xir_A 197 DIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR---- 271 (316)
T ss_dssp CTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCC----
T ss_pred ccccCccceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCC----
Confidence 6543322 12233456889999999986 568999999999999999998 9999988775554444433221110
Q ss_pred ccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 225 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
....++..+.+||.+||..||++|||+.|+++|
T Consensus 272 ------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 272 ------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp ------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 011356789999999999999999999999975
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=319.15 Aligned_cols=244 Identities=18% Similarity=0.273 Sum_probs=182.4
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Ch
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL 84 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l 84 (472)
.+++.||||+++...... ....+.+|++++++++|+||+++++++.. .+.+||||||+.+ +|
T Consensus 52 ~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~~~~~~L 114 (326)
T 3uim_A 52 ADGTLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMT----------------PTERLLVYPYMANGSV 114 (326)
T ss_dssp SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECC----------------SSCCEEEEECCTTCBH
T ss_pred cCCCEEEEEEeccccCch-HHHHHHHHHHHHHhccCCCccceEEEEec----------------CCceEEEEEeccCCCH
Confidence 478999999998654332 23468899999999999999999999976 4567999999986 67
Q ss_pred hhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 85 TGLADRP---GLRFTVPQIKCYMKQLLTGLHYCHVN---QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 85 ~~~~~~~---~~~l~~~~i~~i~~Qll~aL~~LH~~---giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
.+++... ...+++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++............
T Consensus 115 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 194 (326)
T 3uim_A 115 ASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 194 (326)
T ss_dssp HHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECC
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCccccccccc
Confidence 6666543 23489999999999999999999999 99999999999999999999999999998776555555555
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCC----ChHHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK----NEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
..+|+.|+|||++.+ ..++.++||||||||+|+|++|+.||... .....+......... .........
T Consensus 195 ~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~----- 266 (326)
T 3uim_A 195 VRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK--EKKLEALVD----- 266 (326)
T ss_dssp CCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS--SCCSTTSSC-----
T ss_pred ccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh--chhhhhhcC-----
Confidence 678999999999976 56889999999999999999999999621 111111111111000 000000000
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCC
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSE 282 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~ 282 (472)
.. .........+..+.+||.+||..||++|||+.||++|-
T Consensus 267 -~~-------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 306 (326)
T 3uim_A 267 -VD-------LQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306 (326)
T ss_dssp -TT-------CTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred -hh-------hccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence 00 00011123557899999999999999999999999863
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=307.91 Aligned_cols=225 Identities=21% Similarity=0.392 Sum_probs=184.1
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Ch
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL 84 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l 84 (472)
.+++.||||+++.... ....+.+|+++|++++|+||+++++++.. +.+||||||+.+ +|
T Consensus 35 ~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----------------~~~~~v~e~~~~~~L 94 (279)
T 1qpc_A 35 NGHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-----------------EPIYIITEYMENGSL 94 (279)
T ss_dssp TTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-----------------SSCEEEEECCTTCBH
T ss_pred cCCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEcC-----------------CCcEEEEecCCCCCH
Confidence 3567899999975432 34578899999999999999999999863 347999999975 77
Q ss_pred hhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccC
Q 012062 85 TGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL 163 (472)
Q Consensus 85 ~~~~~~~~-~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~ 163 (472)
.+++.... ..+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++...............+|.
T Consensus 95 ~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 174 (279)
T 1qpc_A 95 VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI 174 (279)
T ss_dssp HHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCT
T ss_pred HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCcc
Confidence 77665432 25899999999999999999999999999999999999999999999999999876544333333445688
Q ss_pred CCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhh
Q 012062 164 WYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTM 242 (472)
Q Consensus 164 ~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (472)
.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+.+..+........
T Consensus 175 ~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------- 231 (279)
T 1qpc_A 175 KWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR---------------------- 231 (279)
T ss_dssp TTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC----------------------
T ss_pred CccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCC----------------------
Confidence 8999999976 567889999999999999999 9999999888777766643211100
Q ss_pred hhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 243 KRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 243 ~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...++..+.+||.+||..||++|||+.++++
T Consensus 232 -------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 232 -------PDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp -------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------cccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1246778999999999999999999999985
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=318.97 Aligned_cols=229 Identities=19% Similarity=0.298 Sum_probs=185.6
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Ch
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL 84 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l 84 (472)
.+++.||||+++..... .....+.+|++++++++|+||+++++++.. .+.+||||||+++ +|
T Consensus 53 ~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~~~~L 115 (322)
T 1p4o_A 53 EPETRVAIKTVNEAASM-RERIEFLNEASVMKEFNCHHVVRLLGVVSQ----------------GQPTLVIMELMTRGDL 115 (322)
T ss_dssp EEEEEEEEEECCTTSCH-HHHHHHHHHHHHGGGCCCTTBCCEEEEECS----------------SSSCEEEEECCTTCBH
T ss_pred CCceEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCEeeeEEEEcc----------------CCccEEEEEeCCCCcH
Confidence 56789999999754322 234467899999999999999999999976 4568999999985 77
Q ss_pred hhhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC-C
Q 012062 85 TGLADRP---------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-N 154 (472)
Q Consensus 85 ~~~~~~~---------~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~-~ 154 (472)
.+++... ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++....... .
T Consensus 116 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~ 195 (322)
T 1p4o_A 116 KSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 195 (322)
T ss_dssp HHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEE
T ss_pred HHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCccccccccccccc
Confidence 7766531 13578999999999999999999999999999999999999999999999999976543221 1
Q ss_pred ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 012062 155 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 233 (472)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (472)
......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+........
T Consensus 196 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~------------- 261 (322)
T 1p4o_A 196 KGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK------------- 261 (322)
T ss_dssp GGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCC-------------
T ss_pred cccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcCCC-------------
Confidence 2223456889999999876 568899999999999999999 8999999888777776654211100
Q ss_pred ccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 234 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
...++..+.+||.+||..||++|||+.|++++
T Consensus 262 ----------------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 262 ----------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp ----------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 12467789999999999999999999999875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=311.98 Aligned_cols=233 Identities=29% Similarity=0.399 Sum_probs=175.3
Q ss_pred ceeccCCCEEEEEEeecCCc-CCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 2 AREIKTGEIVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
|++..+++.||||+++.... .......+.+|+.++++++|+||+++++++.. .+.+||||||+
T Consensus 51 ~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~ 114 (310)
T 2wqm_A 51 AACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE----------------DNELNIVLELA 114 (310)
T ss_dssp EEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE----------------TTEEEEEEECC
T ss_pred EEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc----------------CCcEEEEEecC
Confidence 67788999999999986432 22345567899999999999999999999986 56899999999
Q ss_pred CC-ChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcc
Q 012062 81 DH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTL 156 (472)
Q Consensus 81 ~g-~l~~~~~~---~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~ 156 (472)
++ +|.+++.. ....+++..++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||++..+.... ...
T Consensus 115 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~ 193 (310)
T 2wqm_A 115 DAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-TAA 193 (310)
T ss_dssp CSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------------
T ss_pred CCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC-ccc
Confidence 96 66665543 34568999999999999999999999999999999999999999999999999987654322 222
Q ss_pred ccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 157 TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE--AEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
....+|..|+|||++.+ ..++.++|||||||++|+|++|..||.+... ......+... ..+..
T Consensus 194 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~------------- 258 (310)
T 2wqm_A 194 HSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-DYPPL------------- 258 (310)
T ss_dssp -----CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT-CSCCC-------------
T ss_pred cccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc-cCCCC-------------
Confidence 34567999999999876 5688999999999999999999999976532 2333333221 11000
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....++.++.+||.+||..||++|||+.++++
T Consensus 259 --------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 259 --------------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp --------------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------cccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 01246778999999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=312.19 Aligned_cols=227 Identities=24% Similarity=0.321 Sum_probs=182.0
Q ss_pred CCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chhh
Q 012062 8 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTG 86 (472)
Q Consensus 8 g~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~~ 86 (472)
...||||+++.... ......+.+|+.++++++|+||+++++++... ++.+||||||+++ +|.+
T Consensus 53 ~~~~avk~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---------------~~~~~~v~e~~~~~~L~~ 116 (298)
T 3f66_A 53 KIHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS---------------EGSPLVVLPYMKHGDLRN 116 (298)
T ss_dssp CEEEEEEEETTCCS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS---------------SSCCEEEEECCTTCBHHH
T ss_pred eeEEEEEecccCCC-HHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC---------------CCceEEEEeCCCCCCHHH
Confidence 34689999875432 22345678999999999999999999986542 4567999999986 7878
Q ss_pred hhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC---CccccccccC
Q 012062 87 LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN---NTLTNRVITL 163 (472)
Q Consensus 87 ~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~---~~~~~~~gt~ 163 (472)
++......+++..++.|+.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....... .......+|+
T Consensus 117 ~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~ 196 (298)
T 3f66_A 117 FIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 196 (298)
T ss_dssp HHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCG
T ss_pred HHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCc
Confidence 8777666799999999999999999999999999999999999999999999999999976543221 2223345678
Q ss_pred CCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhh
Q 012062 164 WYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTM 242 (472)
Q Consensus 164 ~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (472)
.|+|||++.+ ..++.++|||||||++|+|++ +.+||...+..+....+........
T Consensus 197 ~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------- 253 (298)
T 3f66_A 197 KWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ---------------------- 253 (298)
T ss_dssp GGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCC----------------------
T ss_pred cccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCC----------------------
Confidence 8999999976 568899999999999999999 6788888777776666654321111
Q ss_pred hhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 243 KRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 243 ~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...++..+.+||.+||..||++|||+.|+++
T Consensus 254 -------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 254 -------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp -------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------CccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0135678999999999999999999999985
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=316.94 Aligned_cols=236 Identities=25% Similarity=0.375 Sum_probs=181.2
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
+++..+++.||||+++.... ......+.+|+++|++|+|+||+++++++...+ ...+||||||++
T Consensus 54 ~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--------------~~~~~lv~e~~~ 118 (318)
T 3lxp_A 54 PTNDGTGEMVAVKALKADAG-PQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG--------------AASLQLVMEYVP 118 (318)
T ss_dssp SCC--CCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--------------TTEEEEEECCCT
T ss_pred cCCCCCCcEEEEEEeccccC-hHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC--------------CceEEEEEeccc
Confidence 45677999999999986532 223556789999999999999999999998632 457899999998
Q ss_pred C-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC--Ccccc
Q 012062 82 H-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTLTN 158 (472)
Q Consensus 82 g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~--~~~~~ 158 (472)
+ +|.+++.+. .+++.+++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||++........ .....
T Consensus 119 ~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 196 (318)
T 3lxp_A 119 LGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 196 (318)
T ss_dssp TCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---
T ss_pred CCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccccccccccC
Confidence 6 777776554 389999999999999999999999999999999999999999999999999987654322 12233
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHH-----------HHHHHHHhcCCCCCCCCccC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAE-----------QLSKIFELCGSPDETIWPGV 227 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~-----------~~~~i~~~~~~~~~~~~~~~ 227 (472)
..+|..|+|||++.+ ..++.++|||||||++|+|++|..||....... ....+.+.......
T Consensus 197 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 269 (318)
T 3lxp_A 197 GDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER------ 269 (318)
T ss_dssp CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCC------
T ss_pred CCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccC------
Confidence 456888999999986 567889999999999999999999987543211 01111111000000
Q ss_pred CCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 228 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
......++.++.+||++||..||++|||+.|+++
T Consensus 270 -------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 270 -------------------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp -------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0011246788999999999999999999999985
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=320.10 Aligned_cols=234 Identities=19% Similarity=0.285 Sum_probs=184.7
Q ss_pred eccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-
Q 012062 4 EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH- 82 (472)
Q Consensus 4 ~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g- 82 (472)
+..+++.||||+++.... ......+.+|+.++++++|+||+++++++.. ...+||||||+++
T Consensus 56 ~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~~~~~ 118 (327)
T 2yfx_A 56 NDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKFNHQNIVRCIGVSLQ----------------SLPRFILMELMAGG 118 (327)
T ss_dssp ----CCEEEEEECCSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----------------SSSCEEEEECCTTE
T ss_pred CCCccceEEEEEeccccc-hhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC----------------CCCcEEEEecCCCC
Confidence 567889999999974432 2234567899999999999999999999976 4567999999975
Q ss_pred ChhhhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC---CCeEEeeccceeeeccCCC
Q 012062 83 DLTGLADRPG------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE---GNLKLADFGLARSFSYDHN 153 (472)
Q Consensus 83 ~l~~~~~~~~------~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~---~~vkL~DFG~a~~~~~~~~ 153 (472)
+|.+++.... ..+++.+++.++.||+.||.|||+++|+||||||+||||+.+ ..+||+|||++........
T Consensus 119 ~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~ 198 (327)
T 2yfx_A 119 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 198 (327)
T ss_dssp EHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC---
T ss_pred cHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccc
Confidence 7777765432 348999999999999999999999999999999999999944 4599999999875533221
Q ss_pred -CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 012062 154 -NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 231 (472)
Q Consensus 154 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (472)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+.+..+........
T Consensus 199 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~----------- 266 (327)
T 2yfx_A 199 YRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP----------- 266 (327)
T ss_dssp ---CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC-----------
T ss_pred cccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCCC-----------
Confidence 22233456889999999976 568999999999999999998 9999999888777766654321100
Q ss_pred ccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 232 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
...++..+.+||.+||..||++|||+.||+++.|+
T Consensus 267 ------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 267 ------------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp ------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------------------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 12467789999999999999999999999998765
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=320.85 Aligned_cols=236 Identities=25% Similarity=0.374 Sum_probs=183.8
Q ss_pred eccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-
Q 012062 4 EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH- 82 (472)
Q Consensus 4 ~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g- 82 (472)
+..+++.||||+++.... .....+.+|++++++++|+||+++++++...+ ...+||||||+++
T Consensus 48 ~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--------------~~~~~lv~e~~~~~ 111 (327)
T 3lxl_A 48 GDNTGALVAVKQLQHSGP--DQQRDFQREIQILKALHSDFIVKYRGVSYGPG--------------RQSLRLVMEYLPSG 111 (327)
T ss_dssp SSSCSEEEEEEEESSCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--------------SCEEEEEEECCTTC
T ss_pred CCCcceEEEEEEeccCCH--HHHHHHHHHHHHHHhcCCCceeEEEEEEecCC--------------CceEEEEEeecCCC
Confidence 678999999999975532 23456789999999999999999999987522 5678999999975
Q ss_pred ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC--cccccc
Q 012062 83 DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN--TLTNRV 160 (472)
Q Consensus 83 ~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~--~~~~~~ 160 (472)
+|.+++......+++.+++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||++......... ......
T Consensus 112 ~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 191 (327)
T 3lxl_A 112 CLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQ 191 (327)
T ss_dssp BHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCC
T ss_pred CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCC
Confidence 677777654456999999999999999999999999999999999999999999999999999876543221 223345
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHH-----------HHHHHhcCCCCCCCCccCCC
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQL-----------SKIFELCGSPDETIWPGVSK 229 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~-----------~~i~~~~~~~~~~~~~~~~~ 229 (472)
+|..|+|||++.+ ..++.++|||||||++|+|++|..||......... ..+.+......
T Consensus 192 ~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 261 (327)
T 3lxl_A 192 SPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQ--------- 261 (327)
T ss_dssp SCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTC---------
T ss_pred ccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhccc---------
Confidence 6888999999976 56789999999999999999999998754332111 00100000000
Q ss_pred CCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 230 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
.......++..+.+||++||..||++|||+.||+++
T Consensus 262 ----------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 262 ----------------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp ----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000113567899999999999999999999999753
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=319.91 Aligned_cols=242 Identities=19% Similarity=0.147 Sum_probs=184.1
Q ss_pred ceecc---CCCEEEEEEeecCCcCC---------CchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCc
Q 012062 2 AREIK---TGEIVALKKIRMDNEKE---------GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKY 69 (472)
Q Consensus 2 a~~~~---tg~~vAlK~i~~~~~~~---------~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 69 (472)
|++.. ++..||||++....... .....+.+|+.+++.++|+||+++++++.... ..
T Consensus 56 ~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~------------~~ 123 (345)
T 2v62_A 56 AFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEF------------KG 123 (345)
T ss_dssp EEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEES------------SS
T ss_pred EEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccccccc------------CC
Confidence 55655 88999999998653210 11234568899999999999999999987621 11
Q ss_pred CCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC--CeEEeeccceee
Q 012062 70 RGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG--NLKLADFGLARS 147 (472)
Q Consensus 70 ~~~~~iVmEy~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~--~vkL~DFG~a~~ 147 (472)
...+||||||+.++|.+++.... .+++.+++.|+.||+.||+|||+++|+||||||+||||+.++ .+||+|||+++.
T Consensus 124 ~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~ 202 (345)
T 2v62_A 124 RSYRFMVMERLGIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202 (345)
T ss_dssp CEEEEEEEECEEEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEE
T ss_pred CcEEEEEEeccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCcee
Confidence 45789999999667877776544 799999999999999999999999999999999999999877 999999999987
Q ss_pred eccCCC------CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCC--ChHHHHHHHHHhcCCC
Q 012062 148 FSYDHN------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK--NEAEQLSKIFELCGSP 219 (472)
Q Consensus 148 ~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~--~~~~~~~~i~~~~~~~ 219 (472)
+..... .......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||... +...............
T Consensus 203 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 281 (345)
T 2v62_A 203 YCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDEL 281 (345)
T ss_dssp SSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTT
T ss_pred cccccccccchhccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccc
Confidence 643221 11244578999999999987 57899999999999999999999999653 2222222221111000
Q ss_pred CCCCCccCCCCCccccCCCchhhhhhHHHHhh--hccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 220 DETIWPGVSKMPAYNHFKPSRTMKRRVREVFR--HFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
......... .++.++.+||.+||..||++|||+++|++
T Consensus 282 -----------------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 282 -----------------------PQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp -----------------------THHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred -----------------------cHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 011111111 57889999999999999999999999975
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=333.19 Aligned_cols=224 Identities=21% Similarity=0.367 Sum_probs=184.5
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chh
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLT 85 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~ 85 (472)
+++.||||+++.... ....+++|+.+|++|+|+|||++++++.. ..+|||||||.+ +|.
T Consensus 211 ~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-----------------~~~~lv~e~~~~g~L~ 270 (454)
T 1qcf_A 211 KHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVTK-----------------EPIYIITEFMAKGSLL 270 (454)
T ss_dssp TTEEEEEEEECTTSB---CHHHHHHHHHHHTTCCCTTBCCEEEEECS-----------------SSCEEEECCCTTCBHH
T ss_pred CccEEEEEEecCCCc---cHHHHHHHHHHHhhCCCCCEeeEEEEEeC-----------------CccEEEEeecCCCcHH
Confidence 567899999986432 35678899999999999999999999853 357999999985 777
Q ss_pred hhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccCC
Q 012062 86 GLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLW 164 (472)
Q Consensus 86 ~~~~~~~-~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~ 164 (472)
+++.... ..+++..++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++..............+|..
T Consensus 271 ~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~ 350 (454)
T 1qcf_A 271 DFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK 350 (454)
T ss_dssp HHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGG
T ss_pred HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCccccc
Confidence 7776532 358899999999999999999999999999999999999999999999999997654322222233345788
Q ss_pred CCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhh
Q 012062 165 YRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMK 243 (472)
Q Consensus 165 y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (472)
|+|||++.. ..++.++|||||||+||||++ |+.||.+.+..+.+..+......+.
T Consensus 351 y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~----------------------- 406 (454)
T 1qcf_A 351 WTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR----------------------- 406 (454)
T ss_dssp GSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC-----------------------
T ss_pred ccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-----------------------
Confidence 999999976 568999999999999999999 9999999988888777755322111
Q ss_pred hhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 244 RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 244 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...+++++.+||.+||..||++|||+++|++
T Consensus 407 ------~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 407 ------PENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp ------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------CCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 1136778999999999999999999999975
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=318.73 Aligned_cols=233 Identities=23% Similarity=0.363 Sum_probs=185.8
Q ss_pred ceeccCC-----CEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEE
Q 012062 2 AREIKTG-----EIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYM 75 (472)
Q Consensus 2 a~~~~tg-----~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i 75 (472)
|++..++ +.||||+++..... .....+.+|+++|++| +|+||+++++++.. .+.+||
T Consensus 65 ~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~----------------~~~~~l 127 (333)
T 2i1m_A 65 ATAFGLGKEDAVLKVAVKMLKSTAHA-DEKEALMSELKIMSHLGQHENIVNLLGACTH----------------GGPVLV 127 (333)
T ss_dssp EEETTCSSSCCCCEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----------------SSSCEE
T ss_pred EEecCCCcccchhHHHHHhcccccCh-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEec----------------CCceEE
Confidence 4455554 47999999765322 2345688999999999 89999999999976 456899
Q ss_pred EEecCCC-ChhhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEee
Q 012062 76 VFEYMDH-DLTGLADRP-------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLAD 141 (472)
Q Consensus 76 VmEy~~g-~l~~~~~~~-------------~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~D 141 (472)
||||+++ +|.+++... ...+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|
T Consensus 128 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 207 (333)
T 2i1m_A 128 ITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGD 207 (333)
T ss_dssp EEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCC
T ss_pred EEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEECc
Confidence 9999986 777766532 33589999999999999999999999999999999999999999999999
Q ss_pred ccceeeeccCCCC-ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 012062 142 FGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSP 219 (472)
Q Consensus 142 FG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~ 219 (472)
||++......... ......+|..|+|||++.+ ..++.++||||||||+|+|++ |..||.+......+..+.......
T Consensus 208 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 286 (333)
T 2i1m_A 208 FGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM 286 (333)
T ss_dssp CGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCC
T ss_pred cccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCC
Confidence 9999866443222 2233456788999999886 568999999999999999998 999999877666665555432211
Q ss_pred CCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 220 DETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
.. ...++..+.+||.+||..||.+|||+.|+++
T Consensus 287 ~~----------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 287 AQ----------------------------PAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp CC----------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC----------------------------CCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 10 0124678999999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=322.18 Aligned_cols=244 Identities=14% Similarity=0.116 Sum_probs=176.2
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCC-cCCeEEEEEecCCCChh
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNK-YRGSTYMVFEYMDHDLT 85 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~iVmEy~~g~l~ 85 (472)
+++.||||+++.. ..+.+|++++++++|+|||++++.+........ ....+... ....+||||||+.++|.
T Consensus 74 ~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i-~~~~~~~~~~~~~~~lv~e~~~~~L~ 145 (352)
T 2jii_A 74 QKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAI-PTCMGFGVHQDKYRFLVLPSLGRSLQ 145 (352)
T ss_dssp ---CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSC-CCCCEEEEETTTEEEEEEECCCEEHH
T ss_pred cCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhccCCccCc-cchhhccccCCcEEEEEecCCCcCHH
Confidence 4899999999744 357899999999999999984433221100000 00000000 14678999999977888
Q ss_pred hhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC--CeEEeeccceeeeccCCCC------cc
Q 012062 86 GLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG--NLKLADFGLARSFSYDHNN------TL 156 (472)
Q Consensus 86 ~~~~~~-~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~--~vkL~DFG~a~~~~~~~~~------~~ 156 (472)
+++... ...+++.+++.|+.||+.||+|||+++|+||||||+||||+.++ .+||+|||+++.+...... ..
T Consensus 146 ~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 225 (352)
T 2jii_A 146 SALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSR 225 (352)
T ss_dssp HHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSS
T ss_pred HHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCcccccccccc
Confidence 887654 34699999999999999999999999999999999999999988 8999999999776532211 22
Q ss_pred ccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCC-hHH-HHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 157 TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN-EAE-QLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~-~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
....+|+.|+|||++.+ ..++.++||||||||||+|++|+.||.... ..+ ...........+.... ...
T Consensus 226 ~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~------- 296 (352)
T 2jii_A 226 SPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFV-GPC------- 296 (352)
T ss_dssp CTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEE-CTT-------
T ss_pred ccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhh-hhc-------
Confidence 34478999999999986 568999999999999999999999998764 223 3322222211111100 000
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
..+..++.++.+||.+||..||++|||+++|++
T Consensus 297 -------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 297 -------------GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp -------------SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred -------------cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 001246788999999999999999999999975
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=319.42 Aligned_cols=250 Identities=22% Similarity=0.239 Sum_probs=176.4
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chh
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLT 85 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~ 85 (472)
+++.||||+++.... ......+|+.+|++++|+|||++++++..... ....+||||||+++ +|.
T Consensus 46 ~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~------------~~~~~~lv~e~~~~g~L~ 110 (322)
T 3soc_A 46 LNEYVAVKIFPIQDK---QSWQNEYEVYSLPGMKHENILQFIGAEKRGTS------------VDVDLWLITAFHEKGSLS 110 (322)
T ss_dssp TTEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS------------SSEEEEEEEECCTTCBHH
T ss_pred CCCEEEEEEeecCch---HHHHHHHHHHHHhcCCCCCchhhcceeccCCC------------CCceEEEEEecCCCCCHH
Confidence 478999999975432 23345679999999999999999999986321 13458999999986 777
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC----------CccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC-
Q 012062 86 GLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN----------QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN- 154 (472)
Q Consensus 86 ~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~----------giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~- 154 (472)
+++... .+++.+++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.+......
T Consensus 111 ~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~ 188 (322)
T 3soc_A 111 DFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188 (322)
T ss_dssp HHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCC
T ss_pred HHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCcc
Confidence 777553 489999999999999999999999 9999999999999999999999999999876543322
Q ss_pred ccccccccCCCCChhhhcCC----CCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 012062 155 TLTNRVITLWYRPPELLLGA----TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 230 (472)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~----~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 230 (472)
.....++|+.|+|||++.+. ..++.++||||||||+|+|++|+.||.+..+...+.........+....+......
T Consensus 189 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (322)
T 3soc_A 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVH 268 (322)
T ss_dssp CCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTT
T ss_pred ccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhc
Confidence 23345789999999999763 23456789999999999999999999865431110000000000000000000000
Q ss_pred CccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 231 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....+.. ... ......+.++.+||++||..||++|||+.||++
T Consensus 269 ---~~~~~~~--~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 269 ---KKKRPVL--RDY--WQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp ---SCCCCCC--CGG--GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---ccCCCCc--ccc--ccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0000000 000 000123456999999999999999999999985
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=340.49 Aligned_cols=227 Identities=19% Similarity=0.261 Sum_probs=183.4
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Ch
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL 84 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l 84 (472)
.++..||||+++.... ......+++|+++|++|+|+|||++++++.. +.+|||||||.+ +|
T Consensus 361 ~~~~~vAvK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-----------------~~~~lv~E~~~~g~L 422 (613)
T 2ozo_A 361 KKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-----------------EALMLVMEMAGGGPL 422 (613)
T ss_dssp SCEEEEEEEECCCCCS-STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-----------------SSEEEEEECCTTCBH
T ss_pred CCcEEEEEEEcCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-----------------CCeEEEEEeCCCCcH
Confidence 4566799999986533 2345678999999999999999999999974 248999999986 67
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC--cccccccc
Q 012062 85 TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN--TLTNRVIT 162 (472)
Q Consensus 85 ~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~--~~~~~~gt 162 (472)
.+++......+++.+++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+...... ......+|
T Consensus 423 ~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~ 502 (613)
T 2ozo_A 423 HKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 502 (613)
T ss_dssp HHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------C
T ss_pred HHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCc
Confidence 7777666667999999999999999999999999999999999999999999999999999765432221 11222346
Q ss_pred CCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchh
Q 012062 163 LWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241 (472)
Q Consensus 163 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (472)
+.|+|||++.. ..++.++||||||||||||++ |+.||.+.+..+.+..+.......
T Consensus 503 ~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~---------------------- 559 (613)
T 2ozo_A 503 LKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME---------------------- 559 (613)
T ss_dssp CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCC----------------------
T ss_pred cceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC----------------------
Confidence 88999999976 578999999999999999998 999999998888777765432110
Q ss_pred hhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....++.++.+||.+||..||++|||+.+|++
T Consensus 560 -------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 560 -------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp -------CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred -------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 01246778999999999999999999999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=309.28 Aligned_cols=243 Identities=24% Similarity=0.410 Sum_probs=185.4
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+++... ..+.+|++++++++|+||+++++++.....................+||||||+
T Consensus 29 ~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~ 102 (284)
T 2a19_B 29 KAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFC 102 (284)
T ss_dssp EEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCC
T ss_pred EEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEecc
Confidence 36788899999999998543 256789999999999999999999864211000000001112245689999999
Q ss_pred CC-ChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 81 DH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 81 ~g-~l~~~~~~-~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
++ +|.+++.. ....+++..++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||++....... ....
T Consensus 103 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~ 180 (284)
T 2a19_B 103 DKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG--KRTR 180 (284)
T ss_dssp CSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCS--CCCC
T ss_pred CCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheeccccc--cccc
Confidence 96 77777653 23468999999999999999999999999999999999999999999999999998765432 2334
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
..+|..|+|||++.+ ..++.++|||||||++|+|++|..+|... ......+....
T Consensus 181 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~~---------------------- 235 (284)
T 2a19_B 181 SKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDGI---------------------- 235 (284)
T ss_dssp CCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTTC----------------------
T ss_pred cCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhccc----------------------
Confidence 568999999999986 56899999999999999999998876421 11111111100
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
....++..+++||.+||..||++|||+.|++++.+.+.
T Consensus 236 ----------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 236 ----------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp ----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred ----------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 01236678999999999999999999999999876643
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=323.28 Aligned_cols=227 Identities=24% Similarity=0.315 Sum_probs=174.3
Q ss_pred CEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chhhh
Q 012062 9 EIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGL 87 (472)
Q Consensus 9 ~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~~~ 87 (472)
..||||+++... .......+.+|+.++++++||||+++++++... ++.+||||||+++ +|.++
T Consensus 118 ~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~---------------~~~~~lv~e~~~~g~L~~~ 181 (373)
T 3c1x_A 118 IHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS---------------EGSPLVVLPYMKHGDLRNF 181 (373)
T ss_dssp EEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC---------------SSCCEEEEECCTTCBHHHH
T ss_pred EEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC---------------CCCeEEEEECCCCCCHHHH
Confidence 468999987533 223456788999999999999999999987541 3467999999986 78888
Q ss_pred hcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC---ccccccccCC
Q 012062 88 ADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN---TLTNRVITLW 164 (472)
Q Consensus 88 ~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~---~~~~~~gt~~ 164 (472)
+......+++.+++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+...... ......+|..
T Consensus 182 l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~ 261 (373)
T 3c1x_A 182 IRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 261 (373)
T ss_dssp HHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------------------CCGG
T ss_pred HhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCccc
Confidence 8776667899999999999999999999999999999999999999999999999999765432211 1233456788
Q ss_pred CCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhh
Q 012062 165 YRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMK 243 (472)
Q Consensus 165 y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (472)
|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+........
T Consensus 262 y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~----------------------- 317 (373)
T 3c1x_A 262 WMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ----------------------- 317 (373)
T ss_dssp GSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCC-----------------------
T ss_pred ccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCC-----------------------
Confidence 999999986 578999999999999999999 7888988777666555543211100
Q ss_pred hhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 244 RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 244 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
...++..+.+||.+||..||++|||+.|++++
T Consensus 318 ------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 318 ------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 12366789999999999999999999999853
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=325.99 Aligned_cols=222 Identities=21% Similarity=0.354 Sum_probs=181.8
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Ch
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL 84 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l 84 (472)
.+++.||||+++.+. ....+.+|+.+|++|+|+|||++++++... .+.+|||||||.+ +|
T Consensus 214 ~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---------------~~~~~iv~e~~~~g~L 274 (450)
T 1k9a_A 214 YRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE---------------KGGLYIVTEYMAKGSL 274 (450)
T ss_dssp ETTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECT---------------TSCEEEEEECCTTCBH
T ss_pred ecCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcC---------------CCceEEEEEecCCCcH
Confidence 357899999997543 345788999999999999999999998652 3368999999985 77
Q ss_pred hhhhcCCCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccC
Q 012062 85 TGLADRPGL-RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL 163 (472)
Q Consensus 85 ~~~~~~~~~-~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~ 163 (472)
.+++.+... .+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++..... .....++.
T Consensus 275 ~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~~~~~~~ 350 (450)
T 1k9a_A 275 VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPV 350 (450)
T ss_dssp HHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----------CCCT
T ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc----ccCCCCCc
Confidence 777765432 3799999999999999999999999999999999999999999999999999854322 12235688
Q ss_pred CCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhh
Q 012062 164 WYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTM 242 (472)
Q Consensus 164 ~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (472)
.|+|||++.+ ..++.++|||||||+||+|++ |+.||...+..+.+..+.......
T Consensus 351 ~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~----------------------- 406 (450)
T 1k9a_A 351 KWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD----------------------- 406 (450)
T ss_dssp TTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCC-----------------------
T ss_pred ceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-----------------------
Confidence 9999999986 578999999999999999998 999999888777766664321110
Q ss_pred hhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 243 KRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 243 ~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....++..+.+||.+||..||++|||+.+|++
T Consensus 407 ------~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 407 ------APDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 01246778999999999999999999999974
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=313.30 Aligned_cols=228 Identities=17% Similarity=0.241 Sum_probs=181.5
Q ss_pred CEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chhhh
Q 012062 9 EIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGL 87 (472)
Q Consensus 9 ~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~~~ 87 (472)
..||||+++...........+.+|+.++++++|+||+++++++.. ...+||||||+++ +|.++
T Consensus 56 ~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----------------~~~~~iv~e~~~~~~L~~~ 119 (319)
T 2y4i_B 56 GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS----------------PPHLAIITSLCKGRTLYSV 119 (319)
T ss_dssp SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC----------------SSCEEEECBCCCSEEHHHH
T ss_pred CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec----------------CCceEEEeecccCCcHHHH
Confidence 359999998765555455667789999999999999999999986 4578999999985 77777
Q ss_pred hcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccC----CCCccccccccC
Q 012062 88 ADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD----HNNTLTNRVITL 163 (472)
Q Consensus 88 ~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~----~~~~~~~~~gt~ 163 (472)
+......+++.+++.++.||+.||+|||+++|+||||||+||||+ ++.+||+|||+++..... .........+|.
T Consensus 120 l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~ 198 (319)
T 2y4i_B 120 VRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWL 198 (319)
T ss_dssp TTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGG
T ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcc
Confidence 776666799999999999999999999999999999999999998 678999999998654321 112233346799
Q ss_pred CCCChhhhcC--------CCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcccc
Q 012062 164 WYRPPELLLG--------ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235 (472)
Q Consensus 164 ~y~aPE~l~~--------~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (472)
.|+|||++.. ...++.++|||||||++|+|++|+.||...+.......+.........
T Consensus 199 ~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------- 264 (319)
T 2y4i_B 199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLS-------------- 264 (319)
T ss_dssp GTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCC--------------
T ss_pred cccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCC--------------
Confidence 9999999874 234788999999999999999999999998887777666443211100
Q ss_pred CCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
...++.++.+||.+||..||++|||+.++++.
T Consensus 265 --------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 265 --------------QIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp --------------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred --------------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 01245578999999999999999999999863
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=316.09 Aligned_cols=238 Identities=22% Similarity=0.332 Sum_probs=181.9
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||++..... .....+.+|++++++++|+||+++++++..... ....+||||||+
T Consensus 47 ~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------------~~~~~~lv~e~~ 112 (317)
T 2buj_A 47 LVEGLHDGHFYALKRILCHEQ--QDREEAQREADMHRLFNHPNILRLVAYCLRERG------------AKHEAWLLLPFF 112 (317)
T ss_dssp EEEETTTCCEEEEEEEEESSH--HHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEET------------TEEEEEEEEECC
T ss_pred EEEecCCCcEEEEEEEecCCH--HHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccC------------CCceeEEEEEeC
Confidence 367889999999999975432 235567899999999999999999999874210 145789999999
Q ss_pred CC-ChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC--
Q 012062 81 DH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN-- 154 (472)
Q Consensus 81 ~g-~l~~~~~~---~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~-- 154 (472)
.+ +|.+++.+ ....+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++.........
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~ 192 (317)
T 2buj_A 113 KRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSR 192 (317)
T ss_dssp TTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHH
T ss_pred CCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhccccccccc
Confidence 96 77666654 3457999999999999999999999999999999999999999999999999998764321111
Q ss_pred ------ccccccccCCCCChhhhcCCC--CCCCCcchhhHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCCCCCC
Q 012062 155 ------TLTNRVITLWYRPPELLLGAT--KYGPAVDMWSVGCIFAELLNGKPILPGKNE--AEQLSKIFELCGSPDETIW 224 (472)
Q Consensus 155 ------~~~~~~gt~~y~aPE~l~~~~--~~~~~~DiwSlG~il~ell~G~~pf~~~~~--~~~~~~i~~~~~~~~~~~~ 224 (472)
......+|..|+|||++.+.. .++.++||||||||+|+|++|+.||..... ......+.... ..
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~----- 266 (317)
T 2buj_A 193 QALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL-SI----- 266 (317)
T ss_dssp HHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC---C-----
T ss_pred ccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccC-CC-----
Confidence 112235699999999987532 268899999999999999999999953211 01111111100 00
Q ss_pred ccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 225 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
+ ....++..+.+||.+||..||.+|||+.|++++
T Consensus 267 ~-----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 267 P-----------------------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp C-----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C-----------------------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 0 012467789999999999999999999999975
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=329.10 Aligned_cols=227 Identities=25% Similarity=0.416 Sum_probs=179.9
Q ss_pred CCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chhh
Q 012062 8 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTG 86 (472)
Q Consensus 8 g~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~~ 86 (472)
+..||||+++.... ....+.+|+++|++|+|+||+++++++.. +.+||||||+.+ +|.+
T Consensus 208 ~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----------------~~~~iv~e~~~~gsL~~ 267 (452)
T 1fmk_A 208 TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-----------------EPIYIVTEYMSKGSLLD 267 (452)
T ss_dssp TEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-----------------SSCEEEECCCTTCBHHH
T ss_pred CceEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----------------CceEEEehhhcCCCHHH
Confidence 46799999986432 24578899999999999999999999853 357999999985 7777
Q ss_pred hhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccCCC
Q 012062 87 LADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWY 165 (472)
Q Consensus 87 ~~~~-~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y 165 (472)
++.. ....+++.++..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++..............+|..|
T Consensus 268 ~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y 347 (452)
T 1fmk_A 268 FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347 (452)
T ss_dssp HHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGG
T ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCcccccc
Confidence 7754 223589999999999999999999999999999999999999999999999999987654333333334567889
Q ss_pred CChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhh
Q 012062 166 RPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 244 (472)
Q Consensus 166 ~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (472)
+|||++.. ..++.++|||||||+||+|++ |+.||.+.+..+.+..+......+.
T Consensus 348 ~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~------------------------ 402 (452)
T 1fmk_A 348 TAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC------------------------ 402 (452)
T ss_dssp SCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC------------------------
T ss_pred cCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC------------------------
Confidence 99999986 568999999999999999999 9999999988887777654321110
Q ss_pred hHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC--CCC
Q 012062 245 RVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS--EYF 284 (472)
Q Consensus 245 ~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h--~~f 284 (472)
...+++.+.+||.+||..||++|||+++|++. .+|
T Consensus 403 -----~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 403 -----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp -----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred -----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 12467789999999999999999999999863 454
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=309.82 Aligned_cols=225 Identities=23% Similarity=0.331 Sum_probs=178.6
Q ss_pred EEEEEEeecCCc-CCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chhhh
Q 012062 10 IVALKKIRMDNE-KEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGL 87 (472)
Q Consensus 10 ~vAlK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~~~ 87 (472)
.||||+++.... .......+.+|++++++++|+||+++++++.. ..+++||||+.+ +|.++
T Consensus 48 ~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----------------~~~~~v~e~~~~~~L~~~ 110 (291)
T 1u46_A 48 SVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-----------------PPMKMVTELAPLGSLLDR 110 (291)
T ss_dssp EEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----------------SSCEEEEECCTTCBHHHH
T ss_pred EEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc-----------------CCceeeEecccCCCHHHH
Confidence 689999986532 23345678899999999999999999999975 137899999984 77777
Q ss_pred hcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC--ccccccccCCC
Q 012062 88 ADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN--TLTNRVITLWY 165 (472)
Q Consensus 88 ~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~--~~~~~~gt~~y 165 (472)
+......+++.+++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++......... ......+|..|
T Consensus 111 l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y 190 (291)
T 1u46_A 111 LRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190 (291)
T ss_dssp HHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGG
T ss_pred HHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCcee
Confidence 7665556999999999999999999999999999999999999999999999999999876543221 12234567889
Q ss_pred CChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhh
Q 012062 166 RPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 244 (472)
Q Consensus 166 ~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (472)
+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+.+..+.........
T Consensus 191 ~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------------------- 246 (291)
T 1u46_A 191 CAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR----------------------- 246 (291)
T ss_dssp CCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC-----------------------
T ss_pred eCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCC-----------------------
Confidence 99999976 567889999999999999999 99999999888877776543211110
Q ss_pred hHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 245 RVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 245 ~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...++..+.+||.+||..||++|||+.++++
T Consensus 247 -----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 247 -----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----CcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1246778999999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=307.35 Aligned_cols=234 Identities=23% Similarity=0.292 Sum_probs=175.4
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHh--cCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKK--LQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH- 82 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g- 82 (472)
.+++.||||+++... .....+|.+++.. ++|+||+++++++.... .....+||||||+++
T Consensus 29 ~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~------------~~~~~~~lv~e~~~~g 91 (301)
T 3q4u_A 29 WQGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHENILGFIASDMTSR------------HSSTQLWLITHYHEMG 91 (301)
T ss_dssp ETTEEEEEEEECGGG-----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE------------TTEEEEEEEECCCTTC
T ss_pred ECCEEEEEEEecccc-----chhhHHHHHHHHHhhccCcCeeeEEEeecccc------------CCCceeEEehhhccCC
Confidence 478999999987532 3455677777777 79999999999876421 114568999999986
Q ss_pred ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC
Q 012062 83 DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH--------VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 154 (472)
Q Consensus 83 ~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH--------~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 154 (472)
+|.+++.. ..+++..++.|+.||+.||+||| +++|+||||||+||||+.++.+||+|||+++........
T Consensus 92 ~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 169 (301)
T 3q4u_A 92 SLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 169 (301)
T ss_dssp BHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTE
T ss_pred CHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeeccccccc
Confidence 77777744 35899999999999999999999 999999999999999999999999999999876543322
Q ss_pred ---ccccccccCCCCChhhhcCCC-----CCCCCcchhhHHHHHHHHHhC----------CCCCCCCC----hHHHHHHH
Q 012062 155 ---TLTNRVITLWYRPPELLLGAT-----KYGPAVDMWSVGCIFAELLNG----------KPILPGKN----EAEQLSKI 212 (472)
Q Consensus 155 ---~~~~~~gt~~y~aPE~l~~~~-----~~~~~~DiwSlG~il~ell~G----------~~pf~~~~----~~~~~~~i 212 (472)
.....++|+.|+|||++.+.. .++.++|||||||++|+|++| ..||.... ....+..+
T Consensus 170 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~ 249 (301)
T 3q4u_A 170 LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKV 249 (301)
T ss_dssp EECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHH
T ss_pred ccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHH
Confidence 123347899999999997642 234689999999999999999 88886532 22333333
Q ss_pred HHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 213 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
......... .+ .......++..+.+||++||..||++|||+.||++
T Consensus 250 ~~~~~~~~~--------~~--------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 250 VCVDQQRPN--------IP--------------NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp HTTSCCCCC--------CC--------------GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HhccCCCCC--------CC--------------hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 221111100 00 00011235678999999999999999999999985
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=310.60 Aligned_cols=243 Identities=25% Similarity=0.313 Sum_probs=184.0
Q ss_pred cCCCEEEEEEeecCC--cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-
Q 012062 6 KTGEIVALKKIRMDN--EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH- 82 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g- 82 (472)
.+++.||||++.... ..+.....+.+|++++++++|+||+++++++.. .+.+||||||+.+
T Consensus 52 ~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~~~ 115 (307)
T 2nru_A 52 VNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD----------------GDDLCLVYVYMPNG 115 (307)
T ss_dssp SSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS----------------SSSCEEEEECCTTC
T ss_pred ECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec----------------CCceEEEEEecCCC
Confidence 478899999997543 233455678899999999999999999999976 4578999999975
Q ss_pred ChhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC-ccccc
Q 012062 83 DLTGLADR--PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN-TLTNR 159 (472)
Q Consensus 83 ~l~~~~~~--~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~ 159 (472)
+|.+++.. ....+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++......... .....
T Consensus 116 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 195 (307)
T 2nru_A 116 SLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRI 195 (307)
T ss_dssp BHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSC
T ss_pred cHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccccccccc
Confidence 67666653 2345899999999999999999999999999999999999999999999999999876543222 22334
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
.+|..|+|||++.+ .++.++|||||||++|+|++|..||...+....+..+.+...............
T Consensus 196 ~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------- 263 (307)
T 2nru_A 196 VGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDK---------- 263 (307)
T ss_dssp CSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCS----------
T ss_pred CCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccc----------
Confidence 68999999999875 478999999999999999999999987655433333322211110000000000
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
.........+..+.+||.+||..||++|||+.+++++
T Consensus 264 -----~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 264 -----KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp -----SCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred -----cccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0000112356779999999999999999999999863
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=336.04 Aligned_cols=227 Identities=25% Similarity=0.415 Sum_probs=184.7
Q ss_pred CCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chhh
Q 012062 8 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTG 86 (472)
Q Consensus 8 g~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~~ 86 (472)
+..||||+++.... ..+.+++|+++|++|+|+|||++++++.. +.+|||||||.+ +|.+
T Consensus 291 ~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----------------~~~~lv~e~~~~gsL~~ 350 (535)
T 2h8h_A 291 TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-----------------EPIYIVTEYMSKGSLLD 350 (535)
T ss_dssp TEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-----------------SSCEEEECCCTTEEHHH
T ss_pred CceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEee-----------------ccceEeeehhcCCcHHH
Confidence 46799999986532 24578899999999999999999999853 357999999986 7777
Q ss_pred hhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccCCC
Q 012062 87 LADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWY 165 (472)
Q Consensus 87 ~~~~~-~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y 165 (472)
++... ...+++.+++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+............++..|
T Consensus 351 ~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y 430 (535)
T 2h8h_A 351 FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 430 (535)
T ss_dssp HHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGG
T ss_pred HHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccc
Confidence 77542 23589999999999999999999999999999999999999999999999999976543221222233457889
Q ss_pred CChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhh
Q 012062 166 RPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 244 (472)
Q Consensus 166 ~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (472)
+|||++.. ..++.++||||||||||||++ |+.||.+.+..+.+..+......+.
T Consensus 431 ~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~------------------------ 485 (535)
T 2h8h_A 431 TAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC------------------------ 485 (535)
T ss_dssp SCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCC------------------------
T ss_pred cCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC------------------------
Confidence 99999986 568999999999999999999 9999999988887777654321110
Q ss_pred hHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC--CCC
Q 012062 245 RVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS--EYF 284 (472)
Q Consensus 245 ~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h--~~f 284 (472)
...++..+.+||.+||..||++|||+++|++. .+|
T Consensus 486 -----~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 486 -----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred -----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 12467789999999999999999999999864 444
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=327.73 Aligned_cols=245 Identities=16% Similarity=0.173 Sum_probs=178.5
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhcCC-CC---------ccceeEEeeCCCCCCCCCC-CCCCCC
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQH-EN---------VIKLKEIVTSPGPERDEQG-RPDGNK 68 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l~h-pn---------Iv~l~~~~~~~~~~~~~~~-~~~~~~ 68 (472)
+|++..+|+.||||+++... ........+.+|+.+++.|+| .| ++...++....+....... ......
T Consensus 96 ~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (413)
T 3dzo_A 96 EATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDM 175 (413)
T ss_dssp EEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC--------------
T ss_pred EEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccc
Confidence 47889999999999998543 223345678899999999987 32 2222233322111000000 000001
Q ss_pred cCCeEEEEEecCCCChhhhhc------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeec
Q 012062 69 YRGSTYMVFEYMDHDLTGLAD------RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADF 142 (472)
Q Consensus 69 ~~~~~~iVmEy~~g~l~~~~~------~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DF 142 (472)
....++++|+++.++|.+++. .....+++..++.|+.||+.||+|||+++|+||||||+||||+.++.+||+||
T Consensus 176 ~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DF 255 (413)
T 3dzo_A 176 WVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGF 255 (413)
T ss_dssp -CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCG
T ss_pred cccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEec
Confidence 123578999999999888773 33445778889999999999999999999999999999999999999999999
Q ss_pred cceeeeccCCCCccccccccCCCCChhhhc---------CCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 012062 143 GLARSFSYDHNNTLTNRVITLWYRPPELLL---------GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 213 (472)
Q Consensus 143 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~---------~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~ 213 (472)
|+++..... ....++ +.|+|||++. ....++.++||||||||||+|++|+.||...+..+....++
T Consensus 256 G~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~ 330 (413)
T 3dzo_A 256 EHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIF 330 (413)
T ss_dssp GGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGG
T ss_pred cceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHH
Confidence 998765432 344567 9999999983 23457889999999999999999999998765432211111
Q ss_pred HhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 214 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
. ....+++.+++||.+||..||++|||+.|+|+|+||
T Consensus 331 ~----------------------------------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~ 367 (413)
T 3dzo_A 331 R----------------------------------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY 367 (413)
T ss_dssp S----------------------------------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred h----------------------------------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHH
Confidence 0 012467789999999999999999999999999999
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=309.86 Aligned_cols=222 Identities=23% Similarity=0.351 Sum_probs=170.3
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHH-HhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKIL-KKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||+++. ...+.+|+.++ +.++|+||+++++++.... .....+||||||
T Consensus 36 ~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~------------~~~~~~~lv~e~ 96 (299)
T 3m2w_A 36 QIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLY------------AGRKCLLIVMEC 96 (299)
T ss_dssp EEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE------------TTEEEEEEEECC
T ss_pred EEEEcCCCcEEEEEEecc-------cHHHHHHHHHHHHhccCCCchhHHhhhhhhc------------CCCceEEEEEee
Confidence 367889999999999963 23567899988 6668999999999987411 014578999999
Q ss_pred CCC-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC---CCCeEEeeccceeeeccCCCC
Q 012062 80 MDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN---EGNLKLADFGLARSFSYDHNN 154 (472)
Q Consensus 80 ~~g-~l~~~~~~~-~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~---~~~vkL~DFG~a~~~~~~~~~ 154 (472)
+++ +|.+++... ...+++.+++.|+.||+.||+|||+++|+||||||+||||+. ++.+||+|||++....
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~----- 171 (299)
T 3m2w_A 97 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT----- 171 (299)
T ss_dssp CCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-----
T ss_pred cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc-----
Confidence 986 777777653 346999999999999999999999999999999999999998 7789999999986432
Q ss_pred ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 155 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
...++.++|||||||++|+|++|+.||...+.......+.. .. . ..
T Consensus 172 -------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~-------~~----~----~~ 217 (299)
T 3m2w_A 172 -------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT-------RI----R----MG 217 (299)
T ss_dssp -------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC-------SS----C----TT
T ss_pred -------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH-------HH----h----hc
Confidence 13467889999999999999999999987654332111100 00 0 00
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
. .......+..++.++++||.+||..||++|||+.|+|+|+||...
T Consensus 218 ~-------~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 218 Q-------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp C-------CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred c-------ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 0 001122345688999999999999999999999999999999653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=304.08 Aligned_cols=222 Identities=22% Similarity=0.355 Sum_probs=174.3
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Ch
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL 84 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l 84 (472)
.+++.||||+++.+. ....+.+|++++++++|+||+++++++... .+.+||||||+++ +|
T Consensus 42 ~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---------------~~~~~lv~e~~~~~~L 102 (278)
T 1byg_A 42 YRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE---------------KGGLYIVTEYMAKGSL 102 (278)
T ss_dssp ETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC-----------------CCEEEECCCTTEEH
T ss_pred EcCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC---------------CCceEEEEecCCCCCH
Confidence 368899999997543 345788999999999999999999997542 3468999999986 77
Q ss_pred hhhhcCCCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccC
Q 012062 85 TGLADRPGL-RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL 163 (472)
Q Consensus 85 ~~~~~~~~~-~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~ 163 (472)
.+++.+... .+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++...... .....++.
T Consensus 103 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~ 178 (278)
T 1byg_A 103 VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPV 178 (278)
T ss_dssp HHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----------------CCT
T ss_pred HHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc----ccCCCccc
Confidence 777654321 2789999999999999999999999999999999999999999999999998765432 12235688
Q ss_pred CCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhh
Q 012062 164 WYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTM 242 (472)
Q Consensus 164 ~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (472)
.|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+.......
T Consensus 179 ~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~----------------------- 234 (278)
T 1byg_A 179 KWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD----------------------- 234 (278)
T ss_dssp TTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCC-----------------------
T ss_pred cccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC-----------------------
Confidence 9999999976 568899999999999999998 999999887766665553211000
Q ss_pred hhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 243 KRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 243 ~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....++..+.+||++||..||++|||+.|+++
T Consensus 235 ------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 235 ------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------CcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 01246778999999999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=338.75 Aligned_cols=265 Identities=23% Similarity=0.292 Sum_probs=190.9
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..+++.||||+++.... ......+.+|+++|++++||||+++++++..... ....+.+|||||||
T Consensus 32 la~~~~tg~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~----------~~~~~~~~LVmEy~ 100 (676)
T 3qa8_A 32 RWIHQDTGEQVAIKQCRQELS-PKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQK----------LAPNDLPLLAMEYC 100 (676)
T ss_dssp CCCCTTTTCCEEECCCCSCCC-HHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCC----------CCTTSSCCCEEECC
T ss_pred EEEECCCCcEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCCCCceeeeeccccc----------ccCCCeEEEEEEeC
Confidence 477889999999999976432 2234567899999999999999999999865221 11145679999999
Q ss_pred CC-ChhhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC---eEEeeccceeeeccCCCC
Q 012062 81 DH-DLTGLADRPG--LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN---LKLADFGLARSFSYDHNN 154 (472)
Q Consensus 81 ~g-~l~~~~~~~~--~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~---vkL~DFG~a~~~~~~~~~ 154 (472)
++ +|.+++.... ..+++..++.|+.||+.||+|||++||+||||||+||||+.++. +||+|||++...... .
T Consensus 101 ~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~--~ 178 (676)
T 3qa8_A 101 EGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--E 178 (676)
T ss_dssp SSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSC--C
T ss_pred CCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccccccc--c
Confidence 75 7777766532 25889999999999999999999999999999999999997765 999999999865432 2
Q ss_pred ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 155 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
......+|..|+|||++.+ ..++.++|||||||++|+|++|..||........+..............+........+.
T Consensus 179 ~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~ 257 (676)
T 3qa8_A 179 LCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFS 257 (676)
T ss_dssp CCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCC
T ss_pred ccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccc
Confidence 3344678999999999876 678999999999999999999999998765543322111111111001111110000000
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
...+ ........++..+.+||++||..||++|||+.|+|+|+||.
T Consensus 258 ~~lp------~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~ 302 (676)
T 3qa8_A 258 SVLP------TPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ 302 (676)
T ss_dssp SSSC------CSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHH
T ss_pred cccC------CchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHH
Confidence 0000 01112335778899999999999999999999999999983
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=311.47 Aligned_cols=235 Identities=26% Similarity=0.389 Sum_probs=180.6
Q ss_pred eccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-
Q 012062 4 EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH- 82 (472)
Q Consensus 4 ~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g- 82 (472)
+..+++.||||+++... ......+.+|++++++++|+||+++++++...+ ...+||||||+++
T Consensus 66 ~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--------------~~~~~lv~e~~~~~ 129 (326)
T 2w1i_A 66 QDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG--------------RRNLKLIMEYLPYG 129 (326)
T ss_dssp SSSCCEEEEEEEESSCC--SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC------------------CCEEEECCCTTC
T ss_pred cCCCceEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC--------------CCceEEEEECCCCC
Confidence 56789999999997542 234567889999999999999999999987532 3468999999985
Q ss_pred ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC--cccccc
Q 012062 83 DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN--TLTNRV 160 (472)
Q Consensus 83 ~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~--~~~~~~ 160 (472)
+|.+++......+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||++......... ......
T Consensus 130 ~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~ 209 (326)
T 2w1i_A 130 SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGE 209 (326)
T ss_dssp BHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCS
T ss_pred CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCC
Confidence 788877766567999999999999999999999999999999999999999999999999999876543221 122334
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChH------------HHHHHHHHhcCCCCCCCCccCC
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA------------EQLSKIFELCGSPDETIWPGVS 228 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~------------~~~~~i~~~~~~~~~~~~~~~~ 228 (472)
++..|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+.+.......
T Consensus 210 ~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 281 (326)
T 2w1i_A 210 SPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR------- 281 (326)
T ss_dssp CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCC-------
T ss_pred CceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCC-------
Confidence 5778999999976 46788999999999999999999887643110 000011110000000
Q ss_pred CCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 229 KMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
......++.++.+||++||..||++|||+.||++
T Consensus 282 ------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 282 ------------------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp ------------------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ------------------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0011246788999999999999999999999985
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=303.98 Aligned_cols=219 Identities=24% Similarity=0.374 Sum_probs=169.0
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Ch
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL 84 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l 84 (472)
.+++.||||+++... ....+.+|+++|++++||||+++++++.+ .+||||||+++ +|
T Consensus 29 ~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------------------~~~lv~e~~~~~~L 86 (307)
T 2eva_A 29 WRAKDVAIKQIESES----ERKAFIVELRQLSRVNHPNIVKLYGACLN------------------PVCLVMEYAEGGSL 86 (307)
T ss_dssp ETTEEEEEEECSSTT----HHHHHHHHHHHHHHCCCTTBCCEEEBCTT------------------TTEEEEECCTTCBH
T ss_pred ECCeeEEEEEecChh----HHHHHHHHHHHHhcCCCCCcCeEEEEEcC------------------CcEEEEEcCCCCCH
Confidence 357899999986432 34578899999999999999999998753 36999999985 77
Q ss_pred hhhhcCCCC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCCCcEEEcCCCC-eEEeeccceeeeccCCCCcccc
Q 012062 85 TGLADRPGL--RFTVPQIKCYMKQLLTGLHYCHV---NQVLHRDIKGSNLLIDNEGN-LKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 85 ~~~~~~~~~--~l~~~~i~~i~~Qll~aL~~LH~---~giiHrDLKp~NILl~~~~~-vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
.+++..... .+++..++.++.||+.||+|||+ ++|+||||||+||||+.++. +||+|||++...... ...
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----~~~ 162 (307)
T 2eva_A 87 YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTN 162 (307)
T ss_dssp HHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------------
T ss_pred HHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----ccc
Confidence 777665332 47899999999999999999999 89999999999999998887 799999999765322 233
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCCCCCCCCccCCCCCccccC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA--EQLSKIFELCGSPDETIWPGVSKMPAYNHF 236 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (472)
..+|..|+|||++.+ ..++.++|||||||++|+|++|+.||...... .....+... ...
T Consensus 163 ~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~---------------- 223 (307)
T 2eva_A 163 NKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG--TRP---------------- 223 (307)
T ss_dssp --CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTT--CCC----------------
T ss_pred CCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcC--CCC----------------
Confidence 468999999999986 57899999999999999999999999865432 222222111 000
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
.....++..+.+||.+||..||++|||+.|+++
T Consensus 224 -----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 224 -----------PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp -----------CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------CcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 011246778999999999999999999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=308.51 Aligned_cols=243 Identities=17% Similarity=0.135 Sum_probs=174.5
Q ss_pred ceeccCCCEEEEEEeecCCc------CCCchhhHHHHHHHHHhcC---------CCCccceeEEeeCCCCC---------
Q 012062 2 AREIKTGEIVALKKIRMDNE------KEGFPITAIREIKILKKLQ---------HENVIKLKEIVTSPGPE--------- 57 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~------~~~~~~~~~~Ei~il~~l~---------hpnIv~l~~~~~~~~~~--------- 57 (472)
|++ +++.||||+++.... .......+.+|+.+|+.|+ |+|||++++++...+..
T Consensus 39 ~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~ 116 (336)
T 2vuw_A 39 TIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWD 116 (336)
T ss_dssp EEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHH
T ss_pred EEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHH
Confidence 444 789999999987642 2233467889999999986 66666666654321000
Q ss_pred ------CCCCCCCCCCCcCCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCCCcE
Q 012062 58 ------RDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH-VNQVLHRDIKGSNL 129 (472)
Q Consensus 58 ------~~~~~~~~~~~~~~~~~iVmEy~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH-~~giiHrDLKp~NI 129 (472)
...... ......+.+|||||||.+ ++++.+.+ ..+++.+++.|++||+.||+||| +++|+||||||+||
T Consensus 117 ~~~~~~~~~~~~-~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NI 193 (336)
T 2vuw_A 117 HYNSTKGSANDR-PDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNV 193 (336)
T ss_dssp HHHHHTCCSSCC-SCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGE
T ss_pred HHhhhccccccC-ccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHE
Confidence 000000 001115689999999986 46666654 35899999999999999999999 99999999999999
Q ss_pred EEcCCC--------------------CeEEeeccceeeeccCCCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHH
Q 012062 130 LIDNEG--------------------NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCI 189 (472)
Q Consensus 130 Ll~~~~--------------------~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~i 189 (472)
||+.++ .+||+|||+|+..... ..++|+.|+|||++.+. . +.++|||||+++
T Consensus 194 Ll~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE~~~g~-~-~~~~Diwsl~~~ 265 (336)
T 2vuw_A 194 LLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDEDLFTGD-G-DYQFDIYRLMKK 265 (336)
T ss_dssp EEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSGGGCCC-S-SHHHHHHHHHHH
T ss_pred EEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChhhhcCC-C-ccceehhhhhCC
Confidence 999887 8999999999876532 34789999999999874 3 789999998777
Q ss_pred -HHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhcc
Q 012062 190 -FAELLNGKPILPGKNE-AEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLML 267 (472)
Q Consensus 190 -l~ell~G~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~ 267 (472)
++++++|..||..... ......+........ ......+..+++++++||++||+.
T Consensus 266 ~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~s~~~~dli~~~L~~ 322 (336)
T 2vuw_A 266 ENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKT-----------------------KCNTPAMKQIKRKIQEFHRTMLNF 322 (336)
T ss_dssp HHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSS-----------------------CCCSHHHHHHHHHHHHHHHHGGGS
T ss_pred CCcccccccCCCcchhhhhHHHHhhhhhhccCc-----------------------ccchhhhhhcCHHHHHHHHHHhcc
Confidence 7778889988854221 112223322111000 001124456888999999999998
Q ss_pred CCCCCCCHHHHh-cCCCCC
Q 012062 268 DPSQRISAKDAL-DSEYFW 285 (472)
Q Consensus 268 dP~~R~t~~elL-~h~~f~ 285 (472)
| |++|+| +||||+
T Consensus 323 d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 323 S-----SATDLLCQHSLFK 336 (336)
T ss_dssp S-----SHHHHHHHCGGGC
T ss_pred C-----CHHHHHhcCCCcC
Confidence 8 999999 999983
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=313.35 Aligned_cols=222 Identities=17% Similarity=0.206 Sum_probs=172.6
Q ss_pred eeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC---CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 3 REIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ---HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 3 ~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
++..+++.||||+++... ...+.+|+++++.|+ |+||+++++++.. .+.+||||||
T Consensus 90 ~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~----------------~~~~~lv~e~ 148 (365)
T 3e7e_A 90 NDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF----------------QNGSVLVGEL 148 (365)
T ss_dssp ----CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC----------------SSCEEEEECC
T ss_pred cccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhheeeec----------------CCCcEEEEec
Confidence 467899999999997542 446778888888887 9999999999987 5678999999
Q ss_pred CCC-ChhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC-----------CCCeEEeecc
Q 012062 80 MDH-DLTGLADR----PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN-----------EGNLKLADFG 143 (472)
Q Consensus 80 ~~g-~l~~~~~~----~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~-----------~~~vkL~DFG 143 (472)
|++ +|.+++.. ....+++.+++.|+.||+.||+|||+++|+||||||+||||+. ++.+||+|||
T Consensus 149 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG 228 (365)
T 3e7e_A 149 YSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLG 228 (365)
T ss_dssp CCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCT
T ss_pred cCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCc
Confidence 985 77776653 3456999999999999999999999999999999999999998 8899999999
Q ss_pred ceeeeccC-CCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC
Q 012062 144 LARSFSYD-HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDET 222 (472)
Q Consensus 144 ~a~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~ 222 (472)
+|+.+... ........+||..|+|||++.+ ..++.++||||||||+|+|++|+.||...+...
T Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--------------- 292 (365)
T 3e7e_A 229 QSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--------------- 292 (365)
T ss_dssp TCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---------------
T ss_pred hhhhhhccCCCceeeeecCCCCCCChHHhcC-CCCCccccHHHHHHHHHHHHhCCCccccCCCCc---------------
Confidence 99765422 2334455678999999999987 568999999999999999999999986543210
Q ss_pred CCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 223 IWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
|.....+.. . ..++.+.+|+.+||..+|.+|++..+.|.
T Consensus 293 -~~~~~~~~~---~---------------~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 293 -CKPEGLFRR---L---------------PHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp -EEECSCCTT---C---------------SSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred -eeechhccc---c---------------CcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 000000000 0 13456889999999999999975544443
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=332.80 Aligned_cols=226 Identities=21% Similarity=0.342 Sum_probs=182.6
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chh
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLT 85 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~ 85 (472)
++..||||+++.... ......+.+|+.+|++++||||+++++++.. +.+||||||+++ +|.
T Consensus 417 ~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-----------------~~~~lv~E~~~~g~L~ 478 (656)
T 2j0j_A 417 PAMAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVITE-----------------NPVWIIMELCTLGELR 478 (656)
T ss_dssp CCEEEEEEECSSTTC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----------------SSCEEEEECCTTCBHH
T ss_pred ccEEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-----------------CceEEEEEcCCCCcHH
Confidence 356799999875432 2244678899999999999999999999853 357999999984 777
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccCCC
Q 012062 86 GLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWY 165 (472)
Q Consensus 86 ~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y 165 (472)
+++......+++..++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++..............+|+.|
T Consensus 479 ~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y 558 (656)
T 2j0j_A 479 SFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 558 (656)
T ss_dssp HHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGG
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcce
Confidence 77766656799999999999999999999999999999999999999999999999999987654333333334567899
Q ss_pred CChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhh
Q 012062 166 RPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 244 (472)
Q Consensus 166 ~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (472)
+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+......+.
T Consensus 559 ~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~------------------------ 613 (656)
T 2j0j_A 559 MAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM------------------------ 613 (656)
T ss_dssp CCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCC------------------------
T ss_pred eCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC------------------------
Confidence 99999976 578999999999999999997 9999999998888777755321110
Q ss_pred hHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 245 RVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 245 ~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...++..+.+||.+||..||++|||+.||++
T Consensus 614 -----~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 614 -----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----CccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1246778999999999999999999999985
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=301.99 Aligned_cols=234 Identities=24% Similarity=0.304 Sum_probs=170.9
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc--CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKL--QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH- 82 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l--~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g- 82 (472)
.+++.||||++.... .....+|.+++..+ +|+||+++++++..... ....+||||||+++
T Consensus 58 ~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~------------~~~~~~lv~e~~~~g 120 (337)
T 3mdy_A 58 WRGEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTG------------SWTQLYLITDYHENG 120 (337)
T ss_dssp ETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG------------GGCEEEEEECCCTTC
T ss_pred ECCceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC------------CCCceEEEEeccCCC
Confidence 358999999996432 23445666666655 89999999999886321 12578999999986
Q ss_pred ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC
Q 012062 83 DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN--------QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 154 (472)
Q Consensus 83 ~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~--------giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 154 (472)
+|.+++... .+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.+......
T Consensus 121 ~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 198 (337)
T 3mdy_A 121 SLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNE 198 (337)
T ss_dssp BHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeecccccc
Confidence 777777543 589999999999999999999999 9999999999999999999999999999776433222
Q ss_pred ---ccccccccCCCCChhhhcCCCCCCCC------cchhhHHHHHHHHHhC----------CCCCCCCC----hHHHHHH
Q 012062 155 ---TLTNRVITLWYRPPELLLGATKYGPA------VDMWSVGCIFAELLNG----------KPILPGKN----EAEQLSK 211 (472)
Q Consensus 155 ---~~~~~~gt~~y~aPE~l~~~~~~~~~------~DiwSlG~il~ell~G----------~~pf~~~~----~~~~~~~ 211 (472)
.....++|..|+|||++.+. .+... +||||||||+|+|++| ..||.... ....+..
T Consensus 199 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 277 (337)
T 3mdy_A 199 VDIPPNTRVGTKRYMPPEVLDES-LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMRE 277 (337)
T ss_dssp ----CCSSCSCGGGCCHHHHTTC-CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHH
T ss_pred ccCCCCCCccCcceeChhhcccc-cCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHH
Confidence 12245789999999999763 34444 8999999999999999 66665432 1222222
Q ss_pred HHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 212 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 212 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
.......... .+ .......++.++.+||.+||..||++|||+.||+++
T Consensus 278 ~~~~~~~~~~--------~~--------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 278 IVCIKKLRPS--------FP--------------NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp HHTTSCCCCC--------CC--------------GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHhhhccCcc--------cc--------------ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 2211110000 00 000112466789999999999999999999999864
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=300.25 Aligned_cols=235 Identities=22% Similarity=0.270 Sum_probs=176.8
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHh--cCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKK--LQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH- 82 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g- 82 (472)
.+++.||||+++... ...+.+|+++++. ++|+||+++++++..... ....+||||||+.+
T Consensus 63 ~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~------------~~~~~~lv~e~~~~g 125 (342)
T 1b6c_B 63 WRGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNG------------TWTQLWLVSDYHEHG 125 (342)
T ss_dssp ETTEEEEEEEECGGG-----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS------------SCCCEEEEECCCTTC
T ss_pred EcCccEEEEEeCchh-----HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC------------ccceeEEEEeecCCC
Confidence 368999999996432 3467789999988 789999999999986321 12378999999996
Q ss_pred ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC
Q 012062 83 DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH--------VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 154 (472)
Q Consensus 83 ~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH--------~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 154 (472)
+|.+++.+. .+++.+++.++.||+.||+||| +++|+||||||+||||+.++++||+|||++.........
T Consensus 126 ~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 203 (342)
T 1b6c_B 126 SLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 203 (342)
T ss_dssp BHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTE
T ss_pred cHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccccccc
Confidence 777777553 5899999999999999999999 899999999999999999999999999999876543322
Q ss_pred ---ccccccccCCCCChhhhcCCCC-----CCCCcchhhHHHHHHHHHhC----------CCCCCCCCh----HHHHHHH
Q 012062 155 ---TLTNRVITLWYRPPELLLGATK-----YGPAVDMWSVGCIFAELLNG----------KPILPGKNE----AEQLSKI 212 (472)
Q Consensus 155 ---~~~~~~gt~~y~aPE~l~~~~~-----~~~~~DiwSlG~il~ell~G----------~~pf~~~~~----~~~~~~i 212 (472)
......+|..|+|||++.+... ++.++||||||||+|+|++| ..||..... .+.+...
T Consensus 204 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 283 (342)
T 1b6c_B 204 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 283 (342)
T ss_dssp EEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHH
T ss_pred cccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHH
Confidence 2344578999999999976322 22579999999999999999 778865422 2222222
Q ss_pred HHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 213 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
......... ++. . .....+++.+.+||.+||..||++|||+.||+++
T Consensus 284 ~~~~~~~~~--------~~~------------~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 284 VCEQKLRPN--------IPN------------R--WQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp HTTSCCCCC--------CCG------------G--GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred HHHHHhCCC--------Ccc------------c--ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 211000000 000 0 0012345679999999999999999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=302.90 Aligned_cols=237 Identities=24% Similarity=0.303 Sum_probs=166.6
Q ss_pred ccCCCEEEEEEeecCCcCCCchhhHHHHHHH--HHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC
Q 012062 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKI--LKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH 82 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~i--l~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g 82 (472)
..+++.||||+++... ......|.++ ++.++|+||+++++.+..... .....+|||||||++
T Consensus 33 ~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~-----------~~~~~~~lv~e~~~~ 96 (336)
T 3g2f_A 33 SLDERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTA-----------DGRMEYLLVMEYYPN 96 (336)
T ss_dssp EETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECT-----------TSCEEEEEEECCCTT
T ss_pred EECCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheeccccccc-----------CCCceEEEEEecCCC
Confidence 3478999999997543 2233444444 456899999999987654211 114468999999975
Q ss_pred -ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CccccCCCCCcEEEcCCCCeEEeeccceeeeccCC
Q 012062 83 -DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN---------QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 152 (472)
Q Consensus 83 -~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~---------giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~ 152 (472)
+|.+++... .+++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.+....
T Consensus 97 g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~ 174 (336)
T 3g2f_A 97 GSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174 (336)
T ss_dssp CBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSS
T ss_pred CcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeeccccc
Confidence 777777554 358889999999999999999999 99999999999999999999999999998765322
Q ss_pred -------CCccccccccCCCCChhhhcCC------CCCCCCcchhhHHHHHHHHHhCCCCCC-CCChH------------
Q 012062 153 -------NNTLTNRVITLWYRPPELLLGA------TKYGPAVDMWSVGCIFAELLNGKPILP-GKNEA------------ 206 (472)
Q Consensus 153 -------~~~~~~~~gt~~y~aPE~l~~~------~~~~~~~DiwSlG~il~ell~G~~pf~-~~~~~------------ 206 (472)
.......++|+.|+|||++.+. ..++.++||||||||+|+|++|..||. +....
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 254 (336)
T 3g2f_A 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGN 254 (336)
T ss_dssp CC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCS
T ss_pred ccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCC
Confidence 1223345789999999998752 235568999999999999999965543 32211
Q ss_pred ----HHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 207 ----EQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 207 ----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
+.+..+........ .++. .+. ....++.++.+||.+||..||++|||+.||++
T Consensus 255 ~~~~~~~~~~~~~~~~~~--------~~~~--~~~-----------~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 255 HPTFEDMQVLVSREKQRP--------KFPE--AWK-----------ENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp SCCHHHHHHHHTTSCCCC--------CCCT--TCC-----------CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CchHHHHHhhhcccccCC--------CCCc--ccc-----------cccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 11111111000000 0000 000 01135567999999999999999999999964
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-36 Score=290.89 Aligned_cols=208 Identities=17% Similarity=0.152 Sum_probs=164.4
Q ss_pred CceeccCCCEEEEEEeecCCcC-CCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|++..+++.||||+++..... ......+.+|+.++++++|+||+++++++.. .+.+||||||
T Consensus 49 ~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~----------------~~~~~lv~e~ 112 (286)
T 3uqc_A 49 QALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT----------------RAGGLVVAEW 112 (286)
T ss_dssp EEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE----------------TTEEEEEEEC
T ss_pred EEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE----------------CCcEEEEEEe
Confidence 4788899999999999866433 2344678899999999999999999999987 5679999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
+++ +|.+++.+ .....++..|+.||+.||+|||++||+||||||+||||+.++.+||++++.
T Consensus 113 ~~g~~L~~~l~~---~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~-------------- 175 (286)
T 3uqc_A 113 IRGGSLQEVADT---SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT-------------- 175 (286)
T ss_dssp CCEEEHHHHHTT---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC--------------
T ss_pred cCCCCHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc--------------
Confidence 986 66666643 246668899999999999999999999999999999999999999985542
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
++ .++.++|||||||+||+|++|+.||.+.+..+.+.... ...
T Consensus 176 -------~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~--------------------~~~-- 218 (286)
T 3uqc_A 176 -------MP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE--------------------RDT-- 218 (286)
T ss_dssp -------CT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC--------------------BCT--
T ss_pred -------cC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH--------------------HHh--
Confidence 22 36789999999999999999999998765422110000 000
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
.............+++++.+||.+||..||++| |+.|+++
T Consensus 219 -~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 219 -AGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp -TSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred -ccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 000112334556788999999999999999999 9999985
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=330.43 Aligned_cols=224 Identities=21% Similarity=0.324 Sum_probs=173.5
Q ss_pred ceecc-CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 2 AREIK-TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 2 a~~~~-tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
|++.. +++.||||++..... ......+.+|+++|++|+|||||++++++...+.. ....+||||||+
T Consensus 99 a~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~-----------~~~~~~lv~E~~ 166 (681)
T 2pzi_A 99 ALDRNVNGRPVVLKGLVHSGD-AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH-----------GDPVGYIVMEYV 166 (681)
T ss_dssp EEEGGGTTEEEEEEESCSSCC-HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT-----------SCEEEEEEEECC
T ss_pred EEEcCCCCcEEEEEEeCccCC-HHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC-----------CCceeEEEEEeC
Confidence 56665 789999999875432 22345678999999999999999999999863211 012369999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
++ +|.+.+.. .+++.+++.|+.||+.+|.|||++||+||||||+||||+.+ .+||+|||+++..... ...
T Consensus 167 ~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~-----~~~ 237 (681)
T 2pzi_A 167 GGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF-----GYL 237 (681)
T ss_dssp CCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC-----SCC
T ss_pred CCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC-----Ccc
Confidence 97 44444333 69999999999999999999999999999999999999985 8999999999875432 445
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
++|+.|+|||++.+ .++.++||||||||||+|++|..+|.+.... .++ .
T Consensus 238 ~gt~~y~aPE~~~~--~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------------------~~~-------~ 286 (681)
T 2pzi_A 238 YGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRNGRYVD----------------------GLP-------E 286 (681)
T ss_dssp CCCTTTSCTTHHHH--CSCHHHHHHHHHHHHHHHHSCCCEETTEECS----------------------SCC-------T
T ss_pred CCCccccCHHHHcC--CCCCceehhhhHHHHHHHHhCCCCCcccccc----------------------ccc-------c
Confidence 78999999999876 3488999999999999999998887642100 000 0
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
. .....+++.+.+||.+||..||++|+++.+++.|+|+
T Consensus 287 ---~----~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 287 ---D----DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp ---T----CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ---c----ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 0 0011245789999999999999999998888887665
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.1e-34 Score=302.79 Aligned_cols=173 Identities=19% Similarity=0.107 Sum_probs=127.0
Q ss_pred ceeccCCCEEEEEEeecCCcC--------CCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCe
Q 012062 2 AREIKTGEIVALKKIRMDNEK--------EGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 72 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~--------~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 72 (472)
|++.-+|+.||||++.++... +.....+.+|+++|+++ .|+||+++++++++ ++.
T Consensus 253 ~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed----------------~~~ 316 (569)
T 4azs_A 253 SRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN----------------AQS 316 (569)
T ss_dssp CEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC----------------SSE
T ss_pred cccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE----------------CCE
Confidence 466778999999999865321 12234578899999999 69999999999997 678
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccC
Q 012062 73 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 151 (472)
Q Consensus 73 ~~iVmEy~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 151 (472)
+|||||||+| +|.+++.+ ...+++. .|++||+.||+|||++|||||||||+||||+.+++|||+|||+|+.+...
T Consensus 317 ~yLVMEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 317 GWLVMEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EEEEEECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EEEEEecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 9999999998 56666654 4467654 57899999999999999999999999999999999999999999876543
Q ss_pred CCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCC
Q 012062 152 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK 197 (472)
Q Consensus 152 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~ 197 (472)
. ....+.+||+.|||||++.+ .+..++|+||+|+++++|+++.
T Consensus 393 ~-~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 393 C-SWPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp --CCSHHHHHHHHHHHHHHC-------------------CCCCTTH
T ss_pred C-ccccCceechhhccHHHhCC--CCCCcccccccccchhhhcccc
Confidence 2 33455689999999999976 3567899999999988876653
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.9e-24 Score=228.75 Aligned_cols=169 Identities=15% Similarity=0.142 Sum_probs=128.9
Q ss_pred ccCCCEEEEEEeecCCcCCC------chhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 5 IKTGEIVALKKIRMDNEKEG------FPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~~~~~------~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
...++.+|+|++........ ....+.+|+++|++++|+||+++..++.. .+..|||||
T Consensus 356 ~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~----------------~~~~~lVmE 419 (540)
T 3en9_A 356 SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD----------------LDNKRIMMS 419 (540)
T ss_dssp ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE----------------TTTTEEEEE
T ss_pred EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe----------------CCccEEEEE
Confidence 34678899998754322211 13346899999999999999944444333 335699999
Q ss_pred cCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC---
Q 012062 79 YMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN--- 154 (472)
Q Consensus 79 y~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~--- 154 (472)
||++ +|.+++.. +..|+.||+.+|+|||+++|+||||||+||||+. ++||+|||+++........
T Consensus 420 ~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~ 488 (540)
T 3en9_A 420 YINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVD 488 (540)
T ss_dssp CCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHH
T ss_pred CCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccc
Confidence 9984 77776654 5689999999999999999999999999999999 8999999999876542211
Q ss_pred ---ccccccccCCCCChhhhcCC-CCCCCCcchhhHHHHHHHHHhCCCCC
Q 012062 155 ---TLTNRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLNGKPIL 200 (472)
Q Consensus 155 ---~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ell~G~~pf 200 (472)
.....++|+.|||||++... ..|+..+|+||..+-..+.+..+..|
T Consensus 489 ~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 489 LIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred hhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 12346789999999998641 24677889999998888887766544
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=2.5e-21 Score=188.21 Aligned_cols=127 Identities=16% Similarity=0.130 Sum_probs=98.5
Q ss_pred ceeccCCCEEEEEEeecCCcCC----------------CchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKE----------------GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPD 65 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~----------------~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~ 65 (472)
|++ .+|+.||||+++...... .....+.+|+.+|++++ | +++.+++..
T Consensus 109 ~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~------------ 172 (282)
T 1zar_A 109 CYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAW------------ 172 (282)
T ss_dssp EEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEE------------
T ss_pred EEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEec------------
Confidence 566 789999999997543211 02345789999999999 5 677666542
Q ss_pred CCCcCCeEEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccc
Q 012062 66 GNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGL 144 (472)
Q Consensus 66 ~~~~~~~~~iVmEy~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~ 144 (472)
+..|||||||++ +|.+ +.. ..+..++.||+.||.|||++||+||||||+||||+ ++.+||+|||+
T Consensus 173 -----~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~ 238 (282)
T 1zar_A 173 -----EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQ 238 (282)
T ss_dssp -----ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred -----cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCC
Confidence 245999999987 6665 321 23567999999999999999999999999999999 99999999999
Q ss_pred eeeeccCCCCccccccccCCCCChhhhc
Q 012062 145 ARSFSYDHNNTLTNRVITLWYRPPELLL 172 (472)
Q Consensus 145 a~~~~~~~~~~~~~~~gt~~y~aPE~l~ 172 (472)
|+. +..++|||++.
T Consensus 239 a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 239 SVE--------------VGEEGWREILE 252 (282)
T ss_dssp CEE--------------TTSTTHHHHHH
T ss_pred CeE--------------CCCCCHHHHHH
Confidence 863 44578999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=3.5e-18 Score=163.78 Aligned_cols=121 Identities=15% Similarity=0.267 Sum_probs=88.9
Q ss_pred ceeccCCCE--EEEEEeecCCcCC----C------------------chhhHHHHHHHHHhcCCCCc--cceeEEeeCCC
Q 012062 2 AREIKTGEI--VALKKIRMDNEKE----G------------------FPITAIREIKILKKLQHENV--IKLKEIVTSPG 55 (472)
Q Consensus 2 a~~~~tg~~--vAlK~i~~~~~~~----~------------------~~~~~~~Ei~il~~l~hpnI--v~l~~~~~~~~ 55 (472)
|++..+|+. ||||+++...... . ....+.+|+.+|++|.|++| ..++++.
T Consensus 66 a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~---- 141 (258)
T 1zth_A 66 ADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGVSVPQPYTYM---- 141 (258)
T ss_dssp EEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTCCCCCEEEEE----
T ss_pred EEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCCCCCeEEEcC----
Confidence 566678999 9999986542110 0 01257789999999998864 3333321
Q ss_pred CCCCCCCCCCCCCcCCeEEEEEecCCC------ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCCCc
Q 012062 56 PERDEQGRPDGNKYRGSTYMVFEYMDH------DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH-VNQVLHRDIKGSN 128 (472)
Q Consensus 56 ~~~~~~~~~~~~~~~~~~~iVmEy~~g------~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH-~~giiHrDLKp~N 128 (472)
..||||||+++ .|.+.... +++..+..++.||+.+|.||| ++||+||||||+|
T Consensus 142 ----------------~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N 201 (258)
T 1zth_A 142 ----------------KNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN 201 (258)
T ss_dssp ----------------TTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred ----------------CCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence 34899999952 33333221 234568899999999999999 9999999999999
Q ss_pred EEEcCCCCeEEeeccceeee
Q 012062 129 LLIDNEGNLKLADFGLARSF 148 (472)
Q Consensus 129 ILl~~~~~vkL~DFG~a~~~ 148 (472)
|||+. .++|+|||+|...
T Consensus 202 ILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 202 IMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp EEESS--SEEECCCTTCEET
T ss_pred EEEcC--cEEEEECcccccC
Confidence 99998 8999999999653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.53 E-value=1.1e-14 Score=146.29 Aligned_cols=69 Identities=19% Similarity=0.220 Sum_probs=55.9
Q ss_pred EEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCC----------eEEeecc
Q 012062 74 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN----------LKLADFG 143 (472)
Q Consensus 74 ~iVmEy~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~----------vkL~DFG 143 (472)
+|||||++|..+..+.. ...+..++.||+.+|.+||++|||||||||+||||+.++. +.||||+
T Consensus 187 ~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~ 260 (397)
T 4gyi_A 187 TIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFP 260 (397)
T ss_dssp EEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCT
T ss_pred eEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeC
Confidence 79999999844332222 1245678999999999999999999999999999988763 8999999
Q ss_pred ceeee
Q 012062 144 LARSF 148 (472)
Q Consensus 144 ~a~~~ 148 (472)
.+...
T Consensus 261 Q~V~~ 265 (397)
T 4gyi_A 261 QMVSM 265 (397)
T ss_dssp TCEET
T ss_pred CcccC
Confidence 87653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.13 E-value=1.7e-10 Score=109.83 Aligned_cols=117 Identities=15% Similarity=0.118 Sum_probs=87.6
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC-CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCChh
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLT 85 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~l~ 85 (472)
.++.++||+....... ....+.+|+.+|+.|. +..+.++++++.. .+..||||||++|..+
T Consensus 36 ~~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~----------------~~~~~lv~e~i~G~~l 97 (263)
T 3tm0_A 36 ENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERH----------------DGWSNLLMSEADGVLC 97 (263)
T ss_dssp SSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEE----------------TTEEEEEEECCSSEEH
T ss_pred CCCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEec----------------CCceEEEEEecCCeeh
Confidence 4688999998753211 1335789999999995 6677889988865 4578999999998543
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------------
Q 012062 86 GLADRPGLRFTVPQIKCYMKQLLTGLHYCHV------------------------------------------------- 116 (472)
Q Consensus 86 ~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~------------------------------------------------- 116 (472)
..... +......++.++..+|+.||+
T Consensus 98 ~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 172 (263)
T 3tm0_A 98 SEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYD 172 (263)
T ss_dssp HHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHH
T ss_pred hhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHH
Confidence 32211 112345778899999999998
Q ss_pred ----------CCccccCCCCCcEEEcCCCCeEEeecccee
Q 012062 117 ----------NQVLHRDIKGSNLLIDNEGNLKLADFGLAR 146 (472)
Q Consensus 117 ----------~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 146 (472)
..++|+|+++.|||+++...+.|+||+.+.
T Consensus 173 ~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 173 FLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 448999999999999876556799999764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.06 E-value=5.9e-10 Score=105.40 Aligned_cols=112 Identities=13% Similarity=0.097 Sum_probs=82.2
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCC--ccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCC
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHEN--VIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHD 83 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~ 83 (472)
.+|+.|+||+.... ....+.+|+.+++.|.+.+ |.+++.+... .+..|+||||++|.
T Consensus 42 ~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~----------------~~~~~~v~e~i~G~ 100 (264)
T 1nd4_A 42 QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTE----------------AGRDWLLLGEVPGQ 100 (264)
T ss_dssp TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC----------------SSCEEEEEECCSSE
T ss_pred CCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccC----------------CCCCEEEEEecCCc
Confidence 45678999987643 1245779999999996545 4568887765 34679999999985
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---------------------------------------------
Q 012062 84 LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ--------------------------------------------- 118 (472)
Q Consensus 84 l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~g--------------------------------------------- 118 (472)
.+. ... .+ ...++.++...|..||+..
T Consensus 101 ~l~-~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (264)
T 1nd4_A 101 DLL-SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 172 (264)
T ss_dssp ETT-TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred ccC-cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence 443 211 22 2356778888888888753
Q ss_pred -------------ccccCCCCCcEEEcCCCCeEEeecccee
Q 012062 119 -------------VLHRDIKGSNLLIDNEGNLKLADFGLAR 146 (472)
Q Consensus 119 -------------iiHrDLKp~NILl~~~~~vkL~DFG~a~ 146 (472)
++|+||+|.|||++.+..+.|+||+.+.
T Consensus 173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999876656799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.98 E-value=2.3e-09 Score=107.01 Aligned_cols=124 Identities=13% Similarity=0.191 Sum_probs=88.6
Q ss_pred CCEEEEEEee--cCCcCCCchhhHHHHHHHHHhcC--CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCC
Q 012062 8 GEIVALKKIR--MDNEKEGFPITAIREIKILKKLQ--HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHD 83 (472)
Q Consensus 8 g~~vAlK~i~--~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~ 83 (472)
+..++||+.. ..... .....+.+|+.+|+.|. +..+.+++.++.+.. ..+..|+||||++|.
T Consensus 61 ~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~-------------~~g~~~~vme~v~G~ 126 (359)
T 3dxp_A 61 GQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDES-------------VIGRAFYIMEFVSGR 126 (359)
T ss_dssp SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT-------------TTSSCEEEEECCCCB
T ss_pred CceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC-------------ccCCeEEEEEecCCe
Confidence 4567888765 32211 12346778999999997 445788888876521 124579999999984
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q 012062 84 LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV----------------------------------------------- 116 (472)
Q Consensus 84 l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~----------------------------------------------- 116 (472)
.+... ....++..+...++.+++..|+.||+
T Consensus 127 ~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 204 (359)
T 3dxp_A 127 VLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWL 204 (359)
T ss_dssp CCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHG
T ss_pred ecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHH
Confidence 33211 11236788889999999999999997
Q ss_pred -----------CCccccCCCCCcEEEcCCCC--eEEeeccceee
Q 012062 117 -----------NQVLHRDIKGSNLLIDNEGN--LKLADFGLARS 147 (472)
Q Consensus 117 -----------~giiHrDLKp~NILl~~~~~--vkL~DFG~a~~ 147 (472)
..++|+|+++.|||++.++. +.|+||+.+..
T Consensus 205 ~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 205 PQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp GGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36999999999999997753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.77 E-value=6.6e-09 Score=101.20 Aligned_cols=167 Identities=16% Similarity=0.085 Sum_probs=103.0
Q ss_pred CEEEEEEeecCCcCCCchhhHHHHHHHHHhcC-CCC--ccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCChh
Q 012062 9 EIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HEN--VIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLT 85 (472)
Q Consensus 9 ~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpn--Iv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~l~ 85 (472)
+.++||+.+.. .....+.+|+.+|+.|. +.. +.+++...... ......|+|||+++|..+
T Consensus 41 ~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~-------------~~~~~~~~vm~~i~G~~l 103 (304)
T 3sg8_A 41 RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPS-------------ETYQMSFAGFTKIKGVPL 103 (304)
T ss_dssp TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCC-------------SSCSCSCEEEECCCCEEC
T ss_pred CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCC-------------CCCCcceEEEcccCCeEC
Confidence 45778875422 23456789999999884 333 23443332211 011234899999998433
Q ss_pred h-hhcCCCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------------
Q 012062 86 G-LADRPGLRFTVPQIKCYMKQLLTGLHYCHV------------------------------------------------ 116 (472)
Q Consensus 86 ~-~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~------------------------------------------------ 116 (472)
. ... ..++..+...++.++...|+.||+
T Consensus 104 ~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 180 (304)
T 3sg8_A 104 TPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDI 180 (304)
T ss_dssp CHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHH
T ss_pred Ccccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHH
Confidence 2 222 136777888888999998888886
Q ss_pred ----------CCccccCCCCCcEEEcC--CCCeEEeeccceeeeccCCCCccccccccCCC---CChhhhcCC-CCC---
Q 012062 117 ----------NQVLHRDIKGSNLLIDN--EGNLKLADFGLARSFSYDHNNTLTNRVITLWY---RPPELLLGA-TKY--- 177 (472)
Q Consensus 117 ----------~giiHrDLKp~NILl~~--~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y---~aPE~l~~~-~~~--- 177 (472)
..++|+|+++.|||++. ...+.|+||+.+....... ... ....+ ..++.+... ..|
T Consensus 181 l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~--Dl~---~~~~~~~~~~~~~~~~~l~~Y~~~ 255 (304)
T 3sg8_A 181 LENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN--DFI---SLMEDDEEYGMEFVSKILNHYKHK 255 (304)
T ss_dssp HTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH--HHH---TTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred HhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH--HHH---HHHhhccccCHHHHHHHHHHcCCC
Confidence 13799999999999998 4557899999986532110 000 01111 233321100 001
Q ss_pred ---------CCCcchhhHHHHHHHHHhCCCCC
Q 012062 178 ---------GPAVDMWSVGCIFAELLNGKPIL 200 (472)
Q Consensus 178 ---------~~~~DiwSlG~il~ell~G~~pf 200 (472)
....++|+++.++|.+.+|..+|
T Consensus 256 ~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 256 DIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 12258999999999999997544
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=4.4e-06 Score=81.32 Aligned_cols=118 Identities=15% Similarity=0.129 Sum_probs=77.6
Q ss_pred CCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCC---CccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCCh
Q 012062 8 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHE---NVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDL 84 (472)
Q Consensus 8 g~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hp---nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~l 84 (472)
++.++||+.+. ......+.+|+.+|+.|.+. .|.+++.+.... .+..|+|||+++|..
T Consensus 39 g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~---------------~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 39 NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRS---------------DGNPFVGYRKVQGQI 99 (306)
T ss_dssp TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECT---------------TSCEEEEEECCCSEE
T ss_pred CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccC---------------CCceEEEEeccCCeE
Confidence 45677887432 12345678999999999753 244555555321 345689999999853
Q ss_pred hhh-hcCCCCCCCHHHHHHHHHHHHHHHHHHHHC----------------------------------------------
Q 012062 85 TGL-ADRPGLRFTVPQIKCYMKQLLTGLHYCHVN---------------------------------------------- 117 (472)
Q Consensus 85 ~~~-~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~---------------------------------------------- 117 (472)
+.. ... .++..+...++.+|...|+.||+.
T Consensus 100 l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~ 176 (306)
T 3tdw_A 100 LGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRF 176 (306)
T ss_dssp CHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHH
T ss_pred Cchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHH
Confidence 322 111 245555666666666666666643
Q ss_pred --------------CccccCCCCCcEEEcC---CCCe-EEeeccceee
Q 012062 118 --------------QVLHRDIKGSNLLIDN---EGNL-KLADFGLARS 147 (472)
Q Consensus 118 --------------giiHrDLKp~NILl~~---~~~v-kL~DFG~a~~ 147 (472)
.++|+|+++.|||++. ++.+ .|+||+.+..
T Consensus 177 ~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 177 QSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3589999999999987 4554 8999998754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.08 E-value=1.2e-05 Score=76.33 Aligned_cols=115 Identities=15% Similarity=0.106 Sum_probs=77.6
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC-CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCCh-
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDL- 84 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~l- 84 (472)
.+..++||+-... ....+.+|..+|+.|. +--|.+++.++.+ .+..|||||+++|..
T Consensus 49 ~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~----------------~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 49 NAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRT----------------PDDAWLLTTAIPGKTA 107 (272)
T ss_dssp TCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEE----------------TTEEEEEEECCCSEEH
T ss_pred CCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEE----------------CCeEEEEEEeeCCccc
Confidence 4556888876532 2445778999999885 3235677777765 456799999999843
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------------------
Q 012062 85 TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN----------------------------------------------- 117 (472)
Q Consensus 85 ~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~----------------------------------------------- 117 (472)
...... .......+..++...|..||..
T Consensus 108 ~~~~~~-----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 108 FQVLEE-----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp HHHHHH-----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred cccccC-----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 222211 1122344556666666666641
Q ss_pred -----------CccccCCCCCcEEEcCCCCeEEeeccceee
Q 012062 118 -----------QVLHRDIKGSNLLIDNEGNLKLADFGLARS 147 (472)
Q Consensus 118 -----------giiHrDLKp~NILl~~~~~vkL~DFG~a~~ 147 (472)
.++|+|+.+.|||++..+.+-|+||+.+..
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 268999999999999877677999998743
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.97 E-value=9.6e-06 Score=80.37 Aligned_cols=31 Identities=16% Similarity=0.217 Sum_probs=25.9
Q ss_pred CCccccCCCCCcEEEcCCCCeEEeeccceee
Q 012062 117 NQVLHRDIKGSNLLIDNEGNLKLADFGLARS 147 (472)
Q Consensus 117 ~giiHrDLKp~NILl~~~~~vkL~DFG~a~~ 147 (472)
..++|+|+++.|||+++...+.|+||..+..
T Consensus 222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred ceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 4699999999999999644579999998753
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00015 Score=70.81 Aligned_cols=30 Identities=17% Similarity=0.297 Sum_probs=27.0
Q ss_pred CCccccCCCCCcEEEcCCCCeEEeecccee
Q 012062 117 NQVLHRDIKGSNLLIDNEGNLKLADFGLAR 146 (472)
Q Consensus 117 ~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 146 (472)
..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999877889999999763
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00028 Score=64.37 Aligned_cols=97 Identities=15% Similarity=0.020 Sum_probs=64.8
Q ss_pred ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccc
Q 012062 83 DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 161 (472)
Q Consensus 83 ~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~-~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g 161 (472)
+|.+++...+.+++++++|.++.|.+..|.-+-. +.-..+=+.+..|+|..+|+|.+.+ ..+. ..
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------~~ 99 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------AG 99 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-------------cc
Confidence 4677777777789999999999999999887722 2222444557899999999887764 1110 11
Q ss_pred cCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh
Q 012062 162 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN 195 (472)
Q Consensus 162 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~ 195 (472)
...+.+||++. ...+.+.=|||||++||.-+-
T Consensus 100 ~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 100 EPPPVAGKLGY--SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -------CCSS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred ccCCCChhhcc--ccchHHHHHHHHHHHHHHHhh
Confidence 33567888653 344567789999999999985
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00033 Score=70.34 Aligned_cols=30 Identities=17% Similarity=0.314 Sum_probs=25.6
Q ss_pred HCCccccCCCCCcEEEcCCCCeEEeecccee
Q 012062 116 VNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 146 (472)
Q Consensus 116 ~~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 146 (472)
...++|+|+.+.|||++.++ ++|+||.++.
T Consensus 226 ~~~L~HGDl~~~Nil~~~~~-~~lID~e~a~ 255 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEHE-TKVIDPEFAF 255 (397)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCE
T ss_pred CCceeeCCCCcCcEEEeCCC-eEEEeCcccc
Confidence 35799999999999998764 9999998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00042 Score=66.82 Aligned_cols=29 Identities=21% Similarity=0.260 Sum_probs=24.5
Q ss_pred CccccCCCCCcEEEcCCCCeEEeeccceee
Q 012062 118 QVLHRDIKGSNLLIDNEGNLKLADFGLARS 147 (472)
Q Consensus 118 giiHrDLKp~NILl~~~~~vkL~DFG~a~~ 147 (472)
.++|+|+.+.||| ..++.+.|+||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 4899999999999 5566799999998753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0012 Score=65.54 Aligned_cols=28 Identities=29% Similarity=0.513 Sum_probs=24.2
Q ss_pred CccccCCCCCcEEEcCCCCeEEeecccee
Q 012062 118 QVLHRDIKGSNLLIDNEGNLKLADFGLAR 146 (472)
Q Consensus 118 giiHrDLKp~NILl~~~~~vkL~DFG~a~ 146 (472)
.++|+|+++.|||++.+. +.|+||..+.
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 599999999999998654 9999998875
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0014 Score=66.72 Aligned_cols=51 Identities=20% Similarity=0.122 Sum_probs=34.2
Q ss_pred CCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCc-cceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC
Q 012062 8 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENV-IKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH 82 (472)
Q Consensus 8 g~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g 82 (472)
++.|+||+.... .....+++|+.+++.|...+| .+++.++.. .+||||++|
T Consensus 105 ~~~~vlRi~~~~----~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~--------------------g~v~e~l~G 156 (429)
T 1nw1_A 105 PNKVLLRVYFNP----ETESHLVAESVIFTLLSERHLGPKLYGIFSG--------------------GRLEEYIPS 156 (429)
T ss_dssp CSEEEEEEECSC----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT--------------------EEEECCCCE
T ss_pred CceEEEEEeCCC----CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC--------------------CEEEEEeCC
Confidence 578889987421 112456689999999864444 567666532 389999986
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.09 E-value=0.002 Score=64.35 Aligned_cols=116 Identities=17% Similarity=0.124 Sum_probs=70.8
Q ss_pred CCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCC-ccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCChhh
Q 012062 8 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHEN-VIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTG 86 (472)
Q Consensus 8 g~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~l~~ 86 (472)
++.|+||+.... ........+|..+++.|.--+ ..+++.++.+ .+||||++|..+.
T Consensus 82 ~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~--------------------g~v~e~i~G~~l~ 138 (379)
T 3feg_A 82 PREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVFPE--------------------GRLEQYIPSRPLK 138 (379)
T ss_dssp CSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT--------------------EEEEECCSEEECC
T ss_pred CCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC--------------------ccEEEEecCccCC
Confidence 467888885321 112455678999999885333 3566666532 3899999872211
Q ss_pred ---hh---------------cCCC----CCCC--HHHHHHHHHHHHH-------------------HHHHHH----H---
Q 012062 87 ---LA---------------DRPG----LRFT--VPQIKCYMKQLLT-------------------GLHYCH----V--- 116 (472)
Q Consensus 87 ---~~---------------~~~~----~~l~--~~~i~~i~~Qll~-------------------aL~~LH----~--- 116 (472)
+. .... .... ..++..|+.++.. .+..|. .
T Consensus 139 ~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~ 218 (379)
T 3feg_A 139 TQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPS 218 (379)
T ss_dssp GGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCC
T ss_pred hhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCC
Confidence 00 0011 1112 3456666655422 233332 2
Q ss_pred -CCccccCCCCCcEEEcCC----CCeEEeecccee
Q 012062 117 -NQVLHRDIKGSNLLIDNE----GNLKLADFGLAR 146 (472)
Q Consensus 117 -~giiHrDLKp~NILl~~~----~~vkL~DFG~a~ 146 (472)
..++|+|+.+.|||++.+ +.+.|+||..|.
T Consensus 219 ~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 219 PVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp CEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred CcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 259999999999999876 689999999874
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0012 Score=63.88 Aligned_cols=30 Identities=27% Similarity=0.310 Sum_probs=25.6
Q ss_pred CCccccCCCCCcEEEcCCCCeEEeecccee
Q 012062 117 NQVLHRDIKGSNLLIDNEGNLKLADFGLAR 146 (472)
Q Consensus 117 ~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 146 (472)
.+++|+|+++.|||++.+..+.|+||+.+.
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 369999999999999887656899999774
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0028 Score=61.76 Aligned_cols=31 Identities=32% Similarity=0.397 Sum_probs=27.0
Q ss_pred CCccccCCCCCcEEEcCC----CCeEEeeccceee
Q 012062 117 NQVLHRDIKGSNLLIDNE----GNLKLADFGLARS 147 (472)
Q Consensus 117 ~giiHrDLKp~NILl~~~----~~vkL~DFG~a~~ 147 (472)
..++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 479999999999999874 6799999998854
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0074 Score=58.55 Aligned_cols=56 Identities=20% Similarity=0.191 Sum_probs=40.1
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC---CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCC
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ---HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHD 83 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~ 83 (472)
++..++||+.... ....+..|+.+|+.|. ...|.+++.+... .+..|+|||++++.
T Consensus 58 ~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~----------------~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 58 EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNS----------------QGHSFLLLEALNKS 116 (312)
T ss_dssp SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC----------------SSEEEEEEECCCCC
T ss_pred CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec----------------CCceEEEEEeccCC
Confidence 4567888876532 2445778999999884 2557778777654 35689999999874
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.58 E-value=0.013 Score=59.89 Aligned_cols=52 Identities=23% Similarity=0.159 Sum_probs=33.6
Q ss_pred CCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCc-cceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC
Q 012062 8 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENV-IKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH 82 (472)
Q Consensus 8 g~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g 82 (472)
++.|+||+..... + ......+|+.+|+.|...+| .+++.++.. .+||||++|
T Consensus 133 ~~~~vLRi~g~~~--~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~~--------------------G~v~e~I~G 185 (458)
T 2qg7_A 133 QAKYLIRLYGPKT--D-EIINREREKKISCILYNKNIAKKIYVFFTN--------------------GRIEEFMDG 185 (458)
T ss_dssp TEEEEEEEECC-C--C-SCSCHHHHHHHHHHHTTSSSBCCEEEEETT--------------------EEEEECCCS
T ss_pred CceEEEEECCCCh--h-hhcCHHHHHHHHHHHHhcCCCCCEEEEeCC--------------------eEEEEeeCC
Confidence 3678888774321 1 12233589999999976555 467766631 369999987
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.27 E-value=0.027 Score=53.52 Aligned_cols=56 Identities=16% Similarity=0.115 Sum_probs=36.0
Q ss_pred ccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCC---CccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHE---NVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hp---nIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
..+|+.|.||+...... .....+..|+..|+.|..- -+.+++.+-. -++||||++
T Consensus 36 l~DG~~~~vK~~~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~--------------------~~lv~e~l~ 93 (288)
T 3f7w_A 36 LADGTPLFVKALPDDAP--ALDGLFRAEALGLDWLGRSFGSPVPQVAGWDD--------------------RTLAMEWVD 93 (288)
T ss_dssp ETTSCEEEEEECCTTCC--CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEET--------------------TEEEEECCC
T ss_pred ECCCCEEEEEEeCCCCc--chhhHHHHHHHHHHHHHhhCCCCcceEEeccC--------------------ceEEEEeec
Confidence 46789999998654322 1233567899999998532 2344444321 279999997
Q ss_pred C
Q 012062 82 H 82 (472)
Q Consensus 82 g 82 (472)
+
T Consensus 94 ~ 94 (288)
T 3f7w_A 94 E 94 (288)
T ss_dssp C
T ss_pred c
Confidence 5
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.17 E-value=0.013 Score=59.29 Aligned_cols=29 Identities=24% Similarity=0.542 Sum_probs=25.6
Q ss_pred CccccCCCCCcEEEcCCCCeEEeeccceee
Q 012062 118 QVLHRDIKGSNLLIDNEGNLKLADFGLARS 147 (472)
Q Consensus 118 giiHrDLKp~NILl~~~~~vkL~DFG~a~~ 147 (472)
.++|+|+.+.||| +.++.+.|+||..|..
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 5899999999999 7778899999998753
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.33 E-value=0.033 Score=55.87 Aligned_cols=29 Identities=28% Similarity=0.473 Sum_probs=24.5
Q ss_pred ccccCCCCCcEEE------cCCCCeEEeeccceee
Q 012062 119 VLHRDIKGSNLLI------DNEGNLKLADFGLARS 147 (472)
Q Consensus 119 iiHrDLKp~NILl------~~~~~vkL~DFG~a~~ 147 (472)
++|+|+.+.|||+ +++..|+|+||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 3456799999998853
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=95.29 E-value=0.012 Score=59.32 Aligned_cols=32 Identities=9% Similarity=0.313 Sum_probs=28.2
Q ss_pred HHCCccccCCCCCcEEEcCCCCeEEeeccceee
Q 012062 115 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS 147 (472)
Q Consensus 115 H~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~ 147 (472)
+...++|+|+++.|||++.++ ++|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 456899999999999999876 99999998864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=93.79 E-value=0.047 Score=52.66 Aligned_cols=28 Identities=29% Similarity=0.337 Sum_probs=24.5
Q ss_pred CCccccCCCCCcEEEcCCCCeEEeecccee
Q 012062 117 NQVLHRDIKGSNLLIDNEGNLKLADFGLAR 146 (472)
Q Consensus 117 ~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 146 (472)
..++|+|+++.|||++ + .+.|+||+.+.
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 4689999999999999 4 79999998764
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=92.21 E-value=0.085 Score=51.49 Aligned_cols=31 Identities=26% Similarity=0.415 Sum_probs=27.5
Q ss_pred CCccccCCCCCcEEEcCCCCeEEeeccceee
Q 012062 117 NQVLHRDIKGSNLLIDNEGNLKLADFGLARS 147 (472)
Q Consensus 117 ~giiHrDLKp~NILl~~~~~vkL~DFG~a~~ 147 (472)
..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4699999999999999878899999987754
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* | Back alignment and structure |
|---|
Probab=92.20 E-value=0.026 Score=56.96 Aligned_cols=7 Identities=14% Similarity=0.116 Sum_probs=2.6
Q ss_pred HHHHHHH
Q 012062 257 ALELLEK 263 (472)
Q Consensus 257 ~~~ll~~ 263 (472)
+++-+++
T Consensus 322 fR~~~~~ 328 (448)
T 2z73_A 322 FREAISQ 328 (448)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 3333333
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 472 | ||||
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-90 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-79 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-72 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-71 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-70 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-69 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-68 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-66 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-66 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-65 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-65 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-64 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-64 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-61 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-60 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-60 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-60 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-60 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-60 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-58 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-57 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-57 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-56 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-56 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-53 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-52 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-50 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-48 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-48 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-45 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-44 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-44 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-44 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-44 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-43 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-43 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-43 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-42 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-42 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-41 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-41 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-40 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-40 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-40 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-39 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-38 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-38 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-37 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-34 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-34 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-34 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-32 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-32 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-30 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-20 |
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 276 bits (706), Expect = 2e-90
Identities = 145/298 (48%), Positives = 200/298 (67%), Gaps = 13/298 (4%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
AR KTG+ VALKK+ M+NEKEGFPITA+REIKIL+ L+HENV+ L EI + +
Sbjct: 29 ARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR- 87
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
+GS Y+VF++ +HDL GL ++FT+ +IK M+ LL GL+Y H N++LH
Sbjct: 88 -------CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILH 140
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFS---YDHNNTLTNRVITLWYRPPELLLGATKYG 178
RD+K +N+LI +G LKLADFGLAR+FS N TNRV+TLWYRPPELLLG YG
Sbjct: 141 RDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYG 200
Query: 179 PAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238
P +D+W GCI AE+ PI+ G E QL+ I +LCGS +WP V Y +
Sbjct: 201 PPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLEL 260
Query: 239 SRTMKRRVREVFRHF--DRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPK 294
+ KR+V++ + + D +AL+L++K+L+LDP+QRI + DAL+ ++FW+DP+P D K
Sbjct: 261 VKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLK 318
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 246 bits (628), Expect = 4e-79
Identities = 119/300 (39%), Positives = 168/300 (56%), Gaps = 22/300 (7%)
Query: 2 AREIKTGEIVALKKIRMDN---EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPER 58
AR+ T +IVA+KKI++ + K+G TA+REIK+L++L H N+I L +
Sbjct: 17 ARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS--- 73
Query: 59 DEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 118
+ +VF++M+ DL + L T IK YM L GL Y H +
Sbjct: 74 -------------NISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 119 VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYG 178
+LHRD+K +NLL+D G LKLADFGLA+SF + T++V+T WYR PELL GA YG
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYTHQVVTRWYRAPELLFGARMYG 179
Query: 179 PAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238
VDMW+VGCI AELL P LPG ++ +QL++IFE G+P E WP + +P Y FK
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239
Query: 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPK 298
+ +F L+L++ + + +P RI+A AL +YF P P LP+
Sbjct: 240 FP--GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPR 297
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (585), Expect = 1e-72
Identities = 132/292 (45%), Positives = 178/292 (60%), Gaps = 21/292 (7%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
AR TGE+VALKKIR+D E EG P TAIREI +LK+L H N++KL +++ +
Sbjct: 21 ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN------ 74
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLAD-RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
Y+VFE++ DL D +P IK Y+ QLL GL +CH ++VL
Sbjct: 75 ----------KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 180
HRD+K NLLI+ EG +KLADFGLAR+F T+ V+TLWYR PE+LLG Y A
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILLGCKYYSTA 183
Query: 181 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240
VD+WS+GCIFAE++ + + PG +E +QL +IF G+PDE +WPGV+ MP Y P +
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP-K 242
Query: 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW--TDPLP 290
++ +V D LL +ML DP++RISAK AL +F T P+P
Sbjct: 243 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (580), Expect = 2e-71
Identities = 111/331 (33%), Positives = 169/331 (51%), Gaps = 19/331 (5%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A + VA+KKI E + + +REIKIL + +HEN+I + +I+ +P E+ +
Sbjct: 27 AYDNVNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
Y+V M DL L + I ++ Q+L GL Y H VLH
Sbjct: 86 V-----------YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLH 132
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN--TLTNRVITLWYRPPELLLGATKYGP 179
RD+K SNLL++ +LK+ DFGLAR DH++ LT V T WYR PE++L + Y
Sbjct: 133 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 192
Query: 180 AVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH-FKP 238
++D+WSVGCI AE+L+ +PI PGK+ +QL+ I + GSP + + + A N+
Sbjct: 193 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL 252
Query: 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCD-PKSLP 297
K +F + D AL+LL+KML +P +RI + AL Y P D P +
Sbjct: 253 PHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA 312
Query: 298 KYESSHEYQT-KKRRQQQRQHEEATKRQKLH 327
++ E K + ++ EE + Q +
Sbjct: 313 PFKFDMELDDLPKEKLKELIFEETARFQPGY 343
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 223 bits (570), Expect = 1e-70
Identities = 120/279 (43%), Positives = 170/279 (60%), Gaps = 18/279 (6%)
Query: 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPD 65
GE ALKKIR++ E EG P T IREI ILK+L+H N++KL +++ +
Sbjct: 24 NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK---------- 73
Query: 66 GNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIK 125
+VFE++D DL L D K ++ QLL G+ YCH +VLHRD+K
Sbjct: 74 ------RLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127
Query: 126 GSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWS 185
NLLI+ EG LK+ADFGLAR+F T+ ++TLWYR P++L+G+ KY +D+WS
Sbjct: 128 PQNLLINREGELKIADFGLARAFG-IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWS 186
Query: 186 VGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRR 245
VGCIFAE++NG P+ PG +EA+QL +IF + G+P+ WP V+++P Y+ +
Sbjct: 187 VGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD-PNFTVYEPLP 245
Query: 246 VREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
+ D ++LL KML LDP+QRI+AK AL+ YF
Sbjct: 246 WESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (568), Expect = 2e-69
Identities = 101/315 (32%), Positives = 164/315 (52%), Gaps = 17/315 (5%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A + +TG VA+KK+ + E F A RE+++LK ++HENVI L ++ T D
Sbjct: 37 AVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD-- 94
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
Y+V +M DL L + +I+ + Q+L GL Y H ++H
Sbjct: 95 --------FTDFYLVMPFMGTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAAGIIH 144
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 181
RD+K NL ++ + LK+ DFGLAR ++ +T V+T WYR PE++L +Y V
Sbjct: 145 RDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVVTRWYRAPEVILNWMRYTQTV 200
Query: 182 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241
D+WSVGCI AE++ GK + G + +QL +I ++ G+P + A N+ K
Sbjct: 201 DIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPE 260
Query: 242 MKRR-VREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYE 300
++++ + + A+ LLEKML+LD QR++A +AL YF + D + KY+
Sbjct: 261 LEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYD 320
Query: 301 SSHEYQTKKRRQQQR 315
S + + + +R
Sbjct: 321 DSFDDVDRTLDEWKR 335
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (560), Expect = 3e-68
Identities = 99/339 (29%), Positives = 158/339 (46%), Gaps = 32/339 (9%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A+ +GE+VA+KK+ D + RE++I++KL H N+++L+ S G ++DE
Sbjct: 39 AKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 118
+V +Y+ + +A R V +K YM QL L Y H
Sbjct: 93 ----------YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 119 VLHRDIKGSNLLIDNEGNL-KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 177
+ HRDIK NLL+D + + KL DFG A+ + + + +YR PEL+ GAT Y
Sbjct: 143 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRAPELIFGATDY 200
Query: 178 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237
++D+WS GC+ AELL G+PI PG + +QL +I ++ G+P ++ P Y FK
Sbjct: 201 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFK 258
Query: 238 PSRTMKRRVREVFR-HFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSL 296
+ +VFR A+ L ++L P+ R++ +A +F D L L
Sbjct: 259 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF--DELRDPNVKL 316
Query: 297 PKYESSHEYQTKKRRQQQRQHEEATKRQKLHHPQPHGRL 335
P + ++ AT PH R+
Sbjct: 317 PNGRDTPALFNFTTQELSSNPPLATILI-----PPHARI 350
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (544), Expect = 1e-66
Identities = 116/290 (40%), Positives = 169/290 (58%), Gaps = 21/290 (7%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A+ +T EIVALK++R+D++ EG P +A+REI +LK+L+H+N+++L +++ S
Sbjct: 21 AKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK----- 75
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
+VFE+ D DL D +K ++ QLL GL +CH VLH
Sbjct: 76 -----------LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLH 124
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 181
RD+K NLLI+ G LKLA+FGLAR+F + V+TLWYRPP++L GA Y ++
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 182 DMWSVGCIFAELLNGK-PILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240
DMWS GCIFAEL N P+ PG + +QL +IF L G+P E WP ++K+P Y + P
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY-PMY 242
Query: 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDP 288
+ V + +LL+ +L +P QRISA++AL YF + P
Sbjct: 243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 1e-66
Identities = 61/298 (20%), Positives = 114/298 (38%), Gaps = 36/298 (12%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
+G ++A K I ++ K IRE+++L + ++ S G
Sbjct: 25 VSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG------ 77
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH-VNQVL 120
+ E+MD + R + ++ GL Y ++++
Sbjct: 78 ----------EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 127
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 180
HRD+K SN+L+++ G +KL DFG++ ++ + V T Y PE L G T Y
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPERLQG-THYSVQ 183
Query: 181 VDMWSVGCIFAELLNGKPILPGKNEAE-QLSKIFELCGSPDET----IWPGVSKMPAYNH 235
D+WS+G E+ G+ +P + E +L ++ G ET PG
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243
Query: 236 FKPSRTMKRRVREVFRH---------FDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
+P + + + F + + K L+ +P++R K + +
Sbjct: 244 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 2e-65
Identities = 106/331 (32%), Positives = 158/331 (47%), Gaps = 20/331 (6%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A + KTG VA+KK+ + RE+++LK ++HENVI L ++ T +
Sbjct: 37 AFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
Y+V M DL + + T ++ + Q+L GL Y H ++H
Sbjct: 97 ----------DVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIH 144
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 181
RD+K SNL ++ + LK+ DFGLAR + T V T WYR PE++L Y V
Sbjct: 145 RDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTV 200
Query: 182 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK-PSR 240
D+WSVGCI AELL G+ + PG + +QL I L G+P + +S A N+ + ++
Sbjct: 201 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 260
Query: 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYE 300
K VF + A++LLEKML+LD +RI+A AL YF P D Y+
Sbjct: 261 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYD 320
Query: 301 SSHEYQTKKRRQQQRQHEEATKRQKLHHPQP 331
S E + + + + P P
Sbjct: 321 QSFESRDLLIDEWKSLTYDEVIS---FVPPP 348
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 212 bits (540), Expect = 2e-65
Identities = 68/350 (19%), Positives = 130/350 (37%), Gaps = 51/350 (14%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
E TG A K + +E + T +EI+ + L+H ++ L +
Sbjct: 45 VTERATGNNFAAKFVMTPHESD--KETVRKEIQTMSVLRHPTLVNLHDAFEDDN------ 96
Query: 62 GRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
M++E+M +L + + + YM+Q+ GL + H N +
Sbjct: 97 ----------EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 146
Query: 121 HRDIKGSNLLIDNE--GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYG 178
H D+K N++ + LKL DFGL D ++ T + PE+ G G
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTTGTAEFAAPEVAEG-KPVG 203
Query: 179 PAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238
DMWSVG + LL+G G+N+ E L + + D++ + G+S+
Sbjct: 204 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE--------- 254
Query: 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPK 298
+ + K+L+ DP+ R++ AL+ + P +P
Sbjct: 255 -----------------DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPS 297
Query: 299 YESSHEYQTKKRRQQQRQHEEATKRQKLHHPQPHGRLPPIQHAGQSHHWS 348
+ + + + E ++ + + P +++ + W
Sbjct: 298 -SRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKHRPQEYSIRDAFWD 346
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 1e-64
Identities = 109/288 (37%), Positives = 161/288 (55%), Gaps = 22/288 (7%)
Query: 2 AREIKT-GEIVALKKIRMDNEKEGFPITAIREIKILKKL---QHENVIKLKEIVTSPGPE 57
AR++K G VALK++R+ +EG P++ IRE+ +L+ L +H NV++L ++ T +
Sbjct: 26 ARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85
Query: 58 RDEQGRPDGNKYRGSTYMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 116
R+ +VFE++D D T L P IK M QLL GL + H
Sbjct: 86 RE-----------TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 134
Query: 117 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK 176
++V+HRD+K N+L+ + G +KLADFGLAR +S+ T + V+TLWYR PE+LL +
Sbjct: 135 HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT--SVVVTLWYRAPEVLLQ-SS 191
Query: 177 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236
Y VD+WSVGCIFAE+ KP+ G ++ +QL KI ++ G P E WP +P
Sbjct: 192 YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFH 251
Query: 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
S + + + D +LL K L +P++RISA AL YF
Sbjct: 252 SKS---AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 9e-64
Identities = 78/290 (26%), Positives = 115/290 (39%), Gaps = 46/290 (15%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A T E VA+K + M + P +EI I K L HENV+K
Sbjct: 24 AVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFYGHRREGN------ 76
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
Y+ EY P + P + + QL+ G+ Y H + H
Sbjct: 77 ----------IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITH 126
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLGATKYGPA 180
RDIK NLL+D NLK++DFGLA F Y++ L N++ TL Y PELL +
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 186
Query: 181 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240
VD+WS G + +L G+ +++ Q +
Sbjct: 187 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW--------------------------- 219
Query: 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 290
K+ ++ D L LL K+L+ +PS RI+ D ++ PL
Sbjct: 220 KEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY-NKPLK 268
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 4e-61
Identities = 56/314 (17%), Positives = 111/314 (35%), Gaps = 51/314 (16%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
E + + K +++ + + +EI IL +H N++ L E S
Sbjct: 24 CVETSSKKTYMAKFVKVKGTDQ---VLVKKEISILNIARHRNILHLHESFESMEE----- 75
Query: 62 GRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
M+FE++ D+ + +I Y+ Q+ L + H + +
Sbjct: 76 -----------LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 121 HRDIKGSNLLIDNEGN--LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYG 178
H DI+ N++ + +K+ +FG AR N L Y PE+
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQH-DVVS 181
Query: 179 PAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238
A DMWS+G + LL+G + + + I + DE + +S
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI--------- 232
Query: 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPK 298
A++ ++++L+ + R++A +AL + K +
Sbjct: 233 -----------------EAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRT 275
Query: 299 YESSHEYQTKKRRQ 312
+ Y T ++
Sbjct: 276 LKHRRYYHTLIKKD 289
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 200 bits (509), Expect = 1e-60
Identities = 61/328 (18%), Positives = 123/328 (37%), Gaps = 55/328 (16%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
E TG + K I + + T EI I+ +L H +I L +
Sbjct: 48 CVEKATGRVFVAKFINTPYPLDKY--TVKNEISIMNQLHHPKLINLHDAFEDKY------ 99
Query: 62 GRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
++ E++ +L + + ++ YM+Q GL + H + ++
Sbjct: 100 ----------EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIV 149
Query: 121 HRDIKGSNLLID--NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYG 178
H DIK N++ + ++K+ DFGLA + + + T + PE++ G
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEIVDR-EPVG 206
Query: 179 PAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238
DMW++G + LL+G G+++ E L + DE + VS
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP--------- 257
Query: 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPK 298
A + ++ +L +P +R++ DAL+ + D +L
Sbjct: 258 -----------------EAKDFIKNLLQKEPRKRLTVHDALEHPWL-----KGDHSNLTS 295
Query: 299 YESSHEYQTKKRRQQQRQHEEATKRQKL 326
S Y +++ +++ + + +
Sbjct: 296 RIPSSRYNKIRQKIKEKYADWPAPQPAI 323
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 198 bits (504), Expect = 2e-60
Identities = 66/319 (20%), Positives = 117/319 (36%), Gaps = 54/319 (16%)
Query: 2 AREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
AR+++ E+VA+KK+ + I+E++ L+KL+H N I+ +
Sbjct: 34 ARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH----- 88
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
+ ++V EY + L + +I L GL Y H + ++
Sbjct: 89 -----------TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 137
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT--KYG 178
HRD+K N+L+ G +KL DFG A + V T ++ PE++L +Y
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIM-----APANSFVGTPYWMAPEVILAMDEGQYD 192
Query: 179 PAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238
VD+WS+G EL KP L N L I + S+
Sbjct: 193 GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--NESPALQSGHWSEY-------- 242
Query: 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPK 298
++ L P R +++ L + + P L +
Sbjct: 243 ------------------FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQ 284
Query: 299 Y--ESSHEYQTKKRRQQQR 315
++ E + R+ ++
Sbjct: 285 RTKDAVRELDNLQYRKMKK 303
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (505), Expect = 3e-60
Identities = 87/325 (26%), Positives = 150/325 (46%), Gaps = 28/325 (8%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A + VA+KK+ + + A RE+ ++K + H+N+I L + T + Q
Sbjct: 36 AYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
Y+V E MD L + ++ + Q+L G+ + H ++H
Sbjct: 96 ----------DVYLVMELMDA---NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIH 142
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 181
RD+K SN+++ ++ LK+ DFGLAR+ + +T V+T +YR PE++LG Y V
Sbjct: 143 RDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILG-MGYKENV 199
Query: 182 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPG--------VSKMPAY 233
D+WSVGCI E++ K + PG++ +Q +K+ E G+P V P Y
Sbjct: 200 DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKY 259
Query: 234 NHFKPSRTMKRRV----REVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL 289
+ + E + A +LL KML++DP++RIS DAL Y
Sbjct: 260 AGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 319
Query: 290 PCDPKSLPKYESSHEYQTKKRRQQQ 314
P + ++ P + ++ ++
Sbjct: 320 PAEVEAPPPQIYDKQLDEREHTIEE 344
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 8e-60
Identities = 72/285 (25%), Positives = 115/285 (40%), Gaps = 51/285 (17%)
Query: 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERD 59
+ARE ++ I+ALK + EK G RE++I L+H N+++L
Sbjct: 24 LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT---- 79
Query: 60 EQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQV 119
Y++ EY + +F + Y+ +L L YCH +V
Sbjct: 80 ------------RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 127
Query: 120 LHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGP 179
+HRDIK NLL+ + G LK+ADFG + TL TL Y PPE++ G +
Sbjct: 128 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL---CGTLDYLPPEMIEG-RMHDE 183
Query: 180 AVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239
VD+WS+G + E L GKP E +I + + +
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD------------------ 225
Query: 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
A +L+ ++L +PSQR ++ L+ +
Sbjct: 226 ------------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 9e-60
Identities = 61/288 (21%), Positives = 108/288 (37%), Gaps = 51/288 (17%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A+ +T + A K I +E+E + EI IL H N++KL +
Sbjct: 31 AQNKETSVLAAAKVIDTKSEEE--LEDYMVEIDILASCDHPNIVKLLDAFYYEN------ 82
Query: 62 GRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
+ +++ E+ + + T QI+ KQ L L+Y H N+++
Sbjct: 83 ----------NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKII 132
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT----K 176
HRD+K N+L +G++KLADFG++ + + + T ++ PE+++ T
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNT-RTIQRRDSFIGTPYWMAPEVVMCETSKDRP 191
Query: 177 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236
Y D+WS+G E+ +P N L KI + P S
Sbjct: 192 YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK-SEPPTLAQPSRWSS------- 243
Query: 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
+ + L+K L + R + L +
Sbjct: 244 -------------------NFKDFLKKCLEKNVDARWTTSQLLQHPFV 272
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 9e-59
Identities = 65/284 (22%), Positives = 121/284 (42%), Gaps = 50/284 (17%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A ++ TG+ VA++++ + + + I I EI ++++ ++ N++ +
Sbjct: 39 AMDVATGQEVAIRQMNLQQQPKKELI--INEILVMRENKNPNIVNYLDSYLVGD------ 90
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLAD-RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
++V EY+ L D QI ++ L L + H NQV+
Sbjct: 91 ----------ELWVVMEYLAGGS--LTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVI 138
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 180
HRDIK N+L+ +G++KL DFG + + + + V T ++ PE++ YGP
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTR-KAYGPK 196
Query: 181 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240
VD+WS+G + E++ G+P +N L I G+P+ +S
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNPEKLSA----------- 244
Query: 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
+ L + L +D +R SAK+ L ++
Sbjct: 245 ---------------IFRDFLNRCLDMDVEKRGSAKELLQHQFL 273
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 4e-58
Identities = 62/291 (21%), Positives = 111/291 (38%), Gaps = 54/291 (18%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
R G+I+ K++ + E + E+ +L++L+H N+++ + +
Sbjct: 23 IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN----- 77
Query: 62 GRPDGNKYRGSTYMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH-- 115
+ Y+V EY + + + + M QL L CH
Sbjct: 78 ---------TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 128
Query: 116 ---VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL 172
+ VLHRD+K +N+ +D + N+KL DFGLAR + + V T +Y PE +
Sbjct: 129 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKAFVGTPYYMSPEQMN 187
Query: 173 GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 232
Y D+WS+GC+ EL P ++ E KI
Sbjct: 188 R-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-------------------- 226
Query: 233 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 283
+ + R + + E++ +ML L R S ++ L++
Sbjct: 227 ---------REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 191 bits (485), Expect = 2e-57
Identities = 83/295 (28%), Positives = 140/295 (47%), Gaps = 34/295 (11%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDE 60
A I E V +K ++ +K+ REIKIL+ L+ N+I L +IV P
Sbjct: 54 AINITNNEKVVVKILKPVKKKK-----IKREIKILENLRGGPNIITLADIVKDPV----- 103
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
+ +VFE++++ + T I+ YM ++L L YCH ++
Sbjct: 104 ---------SRTPALVFEHVNN---TDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIM 151
Query: 121 HRDIKGSNLLIDNEGN-LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGP 179
HRD+K N++ID+E L+L D+GLA + RV + +++ PELL+ Y
Sbjct: 152 HRDVKPHNVMIDHEHRKLRLIDWGLAEFY--HPGQEYNVRVASRYFKGPELLVDYQMYDY 209
Query: 180 AVDMWSVGCIFAELLNGK-PILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238
++DMWS+GC+ A ++ K P G + +QL +I ++ G+ D + + F
Sbjct: 210 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 269
Query: 239 SRTMKRRVR-------EVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286
R R E AL+ L+K+L D R++A++A++ YF+T
Sbjct: 270 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 189 bits (480), Expect = 5e-57
Identities = 73/326 (22%), Positives = 125/326 (38%), Gaps = 51/326 (15%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A + +T ++VA+K I EG + EI +L K++H N++ L +I S G
Sbjct: 28 AEDKRTQKLVAIKCIAKKA-LEGKEGSMENEIAVLHKIKHPNIVALDDIYESGG------ 80
Query: 62 GRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
Y++ + + +L G +T + Q+L + Y H ++
Sbjct: 81 ----------HLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLHDLGIV 129
Query: 121 HRDIKGSNLLI---DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 177
HRD+K NLL D + + ++DFGL++ D + L+ T Y PE+L Y
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYVAPEVLAQ-KPY 186
Query: 178 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237
AVD WS+G I LL G P +N+A+ +I + D W +S
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD-------- 238
Query: 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLP 297
A + + ++ DP +R + + AL + D
Sbjct: 239 ------------------SAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQS 280
Query: 298 KYESSHEYQTKKRRQQQRQHEEATKR 323
E + K + +Q +
Sbjct: 281 VSEQIKKNFAKSKWKQAFNATAVVRH 306
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 1e-56
Identities = 64/289 (22%), Positives = 109/289 (37%), Gaps = 49/289 (16%)
Query: 2 AREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
ARE+ T A+K + + KE RE ++ +L H +KL
Sbjct: 27 ARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE----- 81
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
Y Y + R F + Y ++++ L Y H ++
Sbjct: 82 -----------KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGII 130
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLGATKYGP 179
HRD+K N+L++ + ++++ DFG A+ S + N + T Y PELL
Sbjct: 131 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-KSACK 189
Query: 180 AVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239
+ D+W++GCI +L+ G P NE KI +L E +P
Sbjct: 190 SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP-------------- 235
Query: 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 288
A +L+EK+L+LD ++R+ ++ P
Sbjct: 236 ----------------KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHP 268
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 186 bits (473), Expect = 3e-56
Identities = 66/297 (22%), Positives = 112/297 (37%), Gaps = 59/297 (19%)
Query: 2 AREIKTGEIVALKKIRMDN-------EKEGFPITAIREIKILKKLQ-HENVIKLKEIVTS 53
T + A+K I + E + ++E+ IL+K+ H N+I+LK+ +
Sbjct: 22 CIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81
Query: 54 PGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLH 112
++VF+ M +L + + + M+ LL +
Sbjct: 82 NT----------------FFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVIC 124
Query: 113 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL 172
H ++HRD+K N+L+D++ N+KL DFG + D L T Y PE++
Sbjct: 125 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSYLAPEIIE 182
Query: 173 GAT-----KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 227
+ YG VDMWS G I LL G P + + L I W
Sbjct: 183 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY 242
Query: 228 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
S +L+ + L++ P +R +A++AL +F
Sbjct: 243 SD--------------------------TVKDLVSRFLVVQPQKRYTAEEALAHPFF 273
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 1e-53
Identities = 71/311 (22%), Positives = 122/311 (39%), Gaps = 58/311 (18%)
Query: 2 AREIKTGEIVALKKIR---MDNEKEGFPITAI-REIKILKKLQHENVIKLKEIVTSPGPE 57
RE TG A K I+ + + G I RE+ ILK++QH NVI L E+ +
Sbjct: 29 CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT-- 86
Query: 58 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 117
++ E + T + ++KQ+L G++Y H
Sbjct: 87 --------------DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL 132
Query: 118 QVLHRDIKGSNLLIDNEG----NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG 173
Q+ H D+K N+++ + +K+ DFGLA D N N T + PE++
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPEIVNY 190
Query: 174 ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 233
G DMWS+G I LL+G G + E L+ + + ++ + S +
Sbjct: 191 -EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL--- 246
Query: 234 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF----WTDPL 289
A + + ++L+ DP +R++ +D+L + L
Sbjct: 247 -----------------------AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQAL 283
Query: 290 PCDPKSLPKYE 300
S P++E
Sbjct: 284 S-SAWSHPQFE 293
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 9e-53
Identities = 51/286 (17%), Positives = 100/286 (34%), Gaps = 47/286 (16%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
+ +T VA +++ + E ++LK LQH N+++ + S +
Sbjct: 28 GLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK-- 85
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN--QV 119
+V E M + + ++ + +Q+L GL + H +
Sbjct: 86 ----------CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPI 135
Query: 120 LHRDIKGSNLLIDNE-GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYG 178
+HRD+K N+ I G++K+ D GLA + + T + PE+ KY
Sbjct: 136 IHRDLKCDNIFITGPTGSVKIGDLGLAT---LKRASFAKAVIGTPEFMAPEMYEE--KYD 190
Query: 179 PAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238
+VD+++ G E+ + A Q+ + G +
Sbjct: 191 ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV-TSGVKPASFDKVAIP--------- 240
Query: 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284
E++E + + +R S KD L+ +F
Sbjct: 241 -----------------EVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 3e-52
Identities = 52/297 (17%), Positives = 109/297 (36%), Gaps = 52/297 (17%)
Query: 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPD 65
K VA+K + + E+ +L+K +H N++ T+P
Sbjct: 28 KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL--------- 78
Query: 66 GNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 124
+V ++ + L +F + ++ +Q G+ Y H ++HRD+
Sbjct: 79 --------AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 130
Query: 125 KGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLG--ATKYGPAV 181
K +N+ + + +K+ DFGLA S + ++ ++ + PE++ Y
Sbjct: 131 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 190
Query: 182 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241
D+++ G + EL+ G+ N +Q+ + + P +SK+ +
Sbjct: 191 DVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG-----RGYLSPDLSKVRS--------- 236
Query: 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPK 298
+ + L+ + L +R L S + +SLPK
Sbjct: 237 ----------NCPKAMKRLMAECLKKKRDERPLFPQILAS-------IELLARSLPK 276
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 1e-50
Identities = 71/345 (20%), Positives = 128/345 (37%), Gaps = 56/345 (16%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDE 60
+T E ALK ++ + A RE+++ + Q +++++ ++ + R
Sbjct: 31 IFNKRTQEKFALKMLQDCPK-------ARREVELHWRASQCPHIVRIVDVYENLYAGRK- 82
Query: 61 QGRPDGNKYRGSTYMVFEYMDH-DL-TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 118
+V E +D +L + + DR FT + MK + + Y H
Sbjct: 83 -----------CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 131
Query: 119 VLHRDIKGSNLLID---NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT 175
+ HRD+K NLL LKL DFG A+ +N+LT T +Y PE+L
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET--TSHNSLTTPCYTPYYVAPEVLGP-E 188
Query: 176 KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235
KY + DMWS+G I LL G P + + I G + P
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR-------IRMGQYEFP---- 237
Query: 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD-PLPCDPK 294
+ L+ +L +P+QR++ + ++ + +P P
Sbjct: 238 -----------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP- 285
Query: 295 SLPKYESSHEYQTKKRRQQQRQHEEATKRQKLHHPQPHGRLPPIQ 339
+S + K R + + E + + ++ I+
Sbjct: 286 ----LHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIE 326
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 168 bits (426), Expect = 2e-48
Identities = 52/293 (17%), Positives = 107/293 (36%), Gaps = 55/293 (18%)
Query: 2 AREIKTGEIVALKKIRM----DNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 57
R+ TG++ A+K + + E + + ++ ++ + +P
Sbjct: 23 CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD-- 80
Query: 58 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 117
+ + M+ F+ ++ Y +++ GL + H
Sbjct: 81 --------------KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 126
Query: 118 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY 177
V++RD+K +N+L+D G+++++D GLA FS V T Y PE+L Y
Sbjct: 127 FVVYRDLKPANILLDEHGHVRISDLGLACDFS---KKKPHASVGTHGYMAPEVLQKGVAY 183
Query: 178 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237
+ D +S+GC+ +LL G ++ +I + + + S
Sbjct: 184 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSP-------- 234
Query: 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFW 285
LLE +L D ++R+ A++ +S +F
Sbjct: 235 ------------------ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 269
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 165 bits (419), Expect = 2e-48
Identities = 56/281 (19%), Positives = 100/281 (35%), Gaps = 42/281 (14%)
Query: 2 AREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
AR+++ VA+K +R D F + RE + L H ++ + + + P
Sbjct: 26 ARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
Y+V EY+D T + + L++ H N ++
Sbjct: 86 P------------YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGII 133
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN--TLTNRVITLWYRPPELLLGATKYG 178
HRD+K +N++I +K+ DFG+AR+ + N+ + T Y PE G
Sbjct: 134 HRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVD 192
Query: 179 PAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238
D++S+GC+ E+L G+P G + + P G+S
Sbjct: 193 ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA--------- 243
Query: 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 279
++ K L +P R +
Sbjct: 244 -----------------DLDAVVLKALAKNPENRYQTAAEM 267
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 1e-45
Identities = 51/279 (18%), Positives = 98/279 (35%), Gaps = 56/279 (20%)
Query: 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 64
G VA+K I+ D + F + E ++ +L+H N+++L ++
Sbjct: 27 DYRGNKVAVKCIKNDATAQAF----LAEASVMTQLRHSNLVQLLGVIVEE---------- 72
Query: 65 DGNKYRGSTYMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHR 122
+G Y+V EYM + L R + + + + Y N +HR
Sbjct: 73 -----KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR 127
Query: 123 DIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVD 182
D+ N+L+ + K++DFGL + S +T + + + PE L K+ D
Sbjct: 128 DLAARNVLVSEDNVAKVSDFGLTKEAS----STQDTGKLPVKWTAPEALRE-KKFSTKSD 182
Query: 183 MWSVGCIFAELL-NGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241
+WS G + E+ G+ P + + ++
Sbjct: 183 VWSFGILLWEIYSFGRVPYPRIPLKDVVPRV----------------------------- 213
Query: 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280
K + E+++ LD + R S +
Sbjct: 214 EKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 4e-45
Identities = 58/280 (20%), Positives = 113/280 (40%), Gaps = 50/280 (17%)
Query: 2 AREIKTGEIVALKKIRMDN--EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERD 59
A KT + A+K ++ D + T + + + +H + + +
Sbjct: 21 AEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE---- 76
Query: 60 EQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQV 119
+ + V EY++ + +F + + Y +++ GL + H +
Sbjct: 77 ------------NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGI 124
Query: 120 LHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGP 179
++RD+K N+L+D +G++K+ADFG+ + + T Y PE+LLG KY
Sbjct: 125 VYRDLKLDNILLDKDGHIKIADFGMCKENM-LGDAKTNTFCGTPDYIAPEILLGQ-KYNH 182
Query: 180 AVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239
+VD WS G + E+L G+ G++E E I D +P
Sbjct: 183 SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-----DNPFYP-------------- 223
Query: 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 279
R ++ A +LL K+ + +P +R+ + +
Sbjct: 224 -----------RWLEKEAKDLLVKLFVREPEKRLGVRGDI 252
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 157 bits (398), Expect = 7e-45
Identities = 55/290 (18%), Positives = 102/290 (35%), Gaps = 57/290 (19%)
Query: 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERD 59
+ R G A+K ++ + + E +L + H +I++
Sbjct: 22 LIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ---- 77
Query: 60 EQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQV 119
+M+ +Y++ R RF P K Y ++ L Y H +
Sbjct: 78 ------------QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125
Query: 120 LHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGP 179
++RD+K N+L+D G++K+ DFG A+ + T Y PE++ Y
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEVVST-KPYNK 180
Query: 180 AVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239
++D WS G + E+L G N + KI + P ++
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----AELRFPPFFNE---------- 226
Query: 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYF 284
+LL +++ D SQR+ +D + +F
Sbjct: 227 ----------------DVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 157 bits (396), Expect = 3e-44
Identities = 70/324 (21%), Positives = 128/324 (39%), Gaps = 34/324 (10%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
A+++ VA+K +R D + + A EIK+L+++ + K + + + +
Sbjct: 32 AKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ-VL 120
G + ++ L + + +K KQLL GL Y H ++
Sbjct: 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGII 148
Query: 121 HRDIKGSNLLIDNEG------NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA 174
H DIK N+L++ +K+AD G A + + N++ R YR PE+LLGA
Sbjct: 149 HTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR----EYRSPEVLLGA 204
Query: 175 TKYGPAVDMWSVGCIFAELLNGKPILPGK------NEAEQLSKIFELCGSPDETIWPGVS 228
+G D+WS C+ EL+ G + + + +++I EL G +
Sbjct: 205 -PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGK 263
Query: 229 KMPAYNH------------FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAK 276
+ + F P + + + + + L ML LDP +R A
Sbjct: 264 YTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323
Query: 277 DALDSEYFWTDPLPCDPKSLPKYE 300
++ + D L + +P E
Sbjct: 324 GLVNHPWL-KDTLGMEEIRVPDRE 346
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 3e-44
Identities = 61/304 (20%), Positives = 101/304 (33%), Gaps = 65/304 (21%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPIT----AIREIKILKKLQ--HENVIKLKEIVTSPG 55
+ VA+K + D + + E+ +LKK+ VI+L + P
Sbjct: 23 GIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82
Query: 56 PERDEQGRPDGNKYRGSTYMVFEYMD--HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHY 113
S ++ E + DL G + + Q+L + +
Sbjct: 83 ----------------SFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRH 125
Query: 114 CHVNQVLHRDIKGSNLLID-NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL 172
CH VLHRDIK N+LID N G LKL DFG + T+ T Y PPE +
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA---LLKDTVYTDFDGTRVYSPPEWIR 182
Query: 173 GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 232
+G + +WS+G + +++ G E + F
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR------------------ 224
Query: 233 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCD 292
+ L+ L L PS R + ++ + + LP +
Sbjct: 225 ------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQE 266
Query: 293 PKSL 296
+
Sbjct: 267 TAEI 270
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 7e-44
Identities = 50/286 (17%), Positives = 104/286 (36%), Gaps = 55/286 (19%)
Query: 4 EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGR 63
VA+K ++ + + E ++K+LQH+ +++L +VT
Sbjct: 33 YYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRLYAVVTQEPI------- 82
Query: 64 PDGNKYRGSTYMVFEYMDHDLTG--LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
Y++ EYM++ L G++ T+ ++ Q+ G+ + +H
Sbjct: 83 ----------YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 132
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 181
RD++ +N+L+ + + K+ADFGLAR + + + PE + +
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG-TFTIKS 191
Query: 182 DMWSVGCIFAELL-NGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240
D+WS G + E++ +G+ PG E + + Y +P
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-----------------GYRMVRPD- 233
Query: 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD--SEYF 284
+ +L+ P R + ++F
Sbjct: 234 -----------NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 9e-44
Identities = 42/288 (14%), Positives = 94/288 (32%), Gaps = 53/288 (18%)
Query: 3 REIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQG 62
+ K + VA+K ++ + + E ++++L + ++++ I +
Sbjct: 29 QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESW------ 82
Query: 63 RPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHR 122
+V E + + I + Q+ G+ Y + +HR
Sbjct: 83 -----------MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 131
Query: 123 DIKGSNLLIDNEGNLKLADFGLARSFS--YDHNNTLTNRVITLWYRPPELLLGATKYGPA 180
D+ N+L+ + K++DFGL+++ ++ T+ + + PE + K+
Sbjct: 132 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSK 190
Query: 181 VDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239
D+WS G + E + G+ G +E + +
Sbjct: 191 SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML--------------------------- 223
Query: 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKD---ALDSEYF 284
K R +L+ D R L + Y+
Sbjct: 224 --EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-43
Identities = 63/289 (21%), Positives = 107/289 (37%), Gaps = 54/289 (18%)
Query: 2 AREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
RE TG A+K +R + + + E ++L+ +H + LK +
Sbjct: 24 VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD----- 78
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
V EY + FT + + Y ++++ L Y H V+
Sbjct: 79 -----------RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 180
+RDIK NL++D +G++K+ DFGL + T+ T Y PE+L YG A
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKTFCGTPEYLAPEVLED-NDYGRA 185
Query: 181 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240
VD W +G + E++ G+ ++ I + +S
Sbjct: 186 VDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL----MEEIRFPRTLSP----------- 230
Query: 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYF 284
A LL +L DP QR+ AK+ ++ +F
Sbjct: 231 ---------------EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-43
Identities = 54/279 (19%), Positives = 99/279 (35%), Gaps = 51/279 (18%)
Query: 4 EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGR 63
+ + VA+K I+ + E I E K++ L HE +++L + T P
Sbjct: 24 KWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGVCTKQRP------- 73
Query: 64 PDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHR 122
+++ EYM + L RF Q+ K + + Y Q LHR
Sbjct: 74 ---------IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 124
Query: 123 DIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVD 182
D+ N L++++G +K++DFGL+R D + + + PPE+L+ +K+ D
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKFSSKSD 183
Query: 183 MWSVGCIFAELL-NGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241
+W+ G + E+ GK +E I + +
Sbjct: 184 IWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS---------------- 227
Query: 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280
++ +R + K L
Sbjct: 228 -------------EKVYTIMYSCWHEKADERPTFKILLS 253
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 5e-43
Identities = 58/294 (19%), Positives = 105/294 (35%), Gaps = 57/294 (19%)
Query: 6 KTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 64
VA+K ++ E F ++E +++KKL+HE +++L +V+
Sbjct: 39 NGTTRVAIKTLKPGTMSPEAF----LQEAQVMKKLRHEKLVQLYAVVSEEPI-------- 86
Query: 65 DGNKYRGSTYMVFEYMDHDLTGLA--DRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHR 122
Y+V EYM G +PQ+ Q+ +G+ Y +HR
Sbjct: 87 ---------YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 137
Query: 123 DIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVD 182
D++ +N+L+ K+ADFGLAR + + + PE L ++ D
Sbjct: 138 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSD 196
Query: 183 MWSVGCIFAELL-NGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241
+WS G + EL G+ PG E L ++ P +
Sbjct: 197 VWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMPCPPECPE------------ 241
Query: 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD--SEYFWTDPLPCDP 293
+L+ + +P +R + + +YF + P
Sbjct: 242 --------------SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 1e-42
Identities = 54/276 (19%), Positives = 97/276 (35%), Gaps = 51/276 (18%)
Query: 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPD 65
+ VA+K IR E I E +++ KL H +++L + P
Sbjct: 27 LNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGVCLEQAP--------- 74
Query: 66 GNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 124
+VFE+M+H L+ F + + G+ Y V+HRD+
Sbjct: 75 -------ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 127
Query: 125 KGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMW 184
N L+ +K++DFG+ R D + T + + PE+ ++Y D+W
Sbjct: 128 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVW 186
Query: 185 SVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMK 243
S G + E+ + GK ++ +E + I + +KP
Sbjct: 187 SFGVLMWEVFSEGKIPYENRSNSEVVEDI-----------------STGFRLYKP----- 224
Query: 244 RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 279
R H +++ P R + L
Sbjct: 225 -------RLASTHVYQIMNHCWKERPEDRPAFSRLL 253
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 4e-42
Identities = 53/280 (18%), Positives = 92/280 (32%), Gaps = 51/280 (18%)
Query: 6 KTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRP 64
VA+K ++ D + IRE+ + L H N+I+L +V +P
Sbjct: 34 GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPM-------- 85
Query: 65 DGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 123
MV E L + F + + Y Q+ G+ Y + +HRD
Sbjct: 86 ---------KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRD 136
Query: 124 IKGSNLLIDNEGNLKLADFGLARSFSYDHNNTL--TNRVITLWYRPPELLLGATKYGPAV 181
+ NLL+ +K+ DFGL R+ + ++ + +R + + PE L + A
Sbjct: 137 LAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHAS 195
Query: 182 DMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240
D W G E+ G+ G N ++ L KI +
Sbjct: 196 DTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI--DKEGERLPRPEDCPQ----------- 242
Query: 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280
++ + P R + D
Sbjct: 243 ---------------DIYNVMVQCWAHKPEDRPTFVALRD 267
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 2e-41
Identities = 53/288 (18%), Positives = 113/288 (39%), Gaps = 51/288 (17%)
Query: 6 KTGEIVALKKIRMDN--EKEGFPITAIREIKILKKLQHE-NVIKLKEIVTSPGPERDEQG 62
TG++ A+K ++ +K E ++L+ ++ ++ L +
Sbjct: 50 DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET------- 102
Query: 63 RPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHR 122
+++ +Y++ RFT +++ Y+ +++ L + H +++R
Sbjct: 103 ---------KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYR 153
Query: 123 DIKGSNLLIDNEGNLKLADFGLARSF-SYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 181
DIK N+L+D+ G++ L DFGL++ F + + + P + G + + AV
Sbjct: 154 DIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAV 213
Query: 182 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241
D WS+G + ELL G E ++I + +S
Sbjct: 214 DWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA------------ 261
Query: 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYF 284
A +L++++LM DP +R+ A + + +F
Sbjct: 262 --------------LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 6e-41
Identities = 58/291 (19%), Positives = 101/291 (34%), Gaps = 42/291 (14%)
Query: 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDG 66
GE VA+K E+ F EI L+HEN++ +
Sbjct: 25 RGEEVAVKIFSSREERSWF---REAEIYQTVMLRHENILGFIAADNKDNGTWTQ------ 75
Query: 67 NKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV--------N 117
++V +Y +H L +R + TV + +GL + H+
Sbjct: 76 ------LWLVSDYHEHGSLFDYLNRYTV--TVEGMIKLALSTASGLAHLHMEIVGTQGKP 127
Query: 118 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT---LTNRVITLWYRPPELLLGA 174
+ HRD+K N+L+ G +AD GLA + +RV T Y PE+L +
Sbjct: 128 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 187
Query: 175 -----TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 229
+ D++++G +F E+ I G +E QL + P V
Sbjct: 188 INMKHFESFKRADIYAMGLVFWEIARRCSI-GGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246
Query: 230 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280
P+R V +++ + + + R++A
Sbjct: 247 EQKLRPNIPNRWQSCEALRVMA-------KIMRECWYANGAARLTALRIKK 290
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 7e-41
Identities = 46/277 (16%), Positives = 91/277 (32%), Gaps = 50/277 (18%)
Query: 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPD 65
VA+K + + + ++E +++ H +++KL ++T
Sbjct: 33 NPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------------- 78
Query: 66 GNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 124
+++ E +L + + Y QL T L Y + +HRDI
Sbjct: 79 ----ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDI 134
Query: 125 KGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMW 184
N+L+ + +KL DFGL+R + + + + PE + ++ A D+W
Sbjct: 135 AARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVW 193
Query: 185 SVGCIFAELL-NGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMK 243
G E+L +G G + + +I
Sbjct: 194 MFGVCMWEILMHGVKPFQGVKNNDVIGRI-----------------------------EN 224
Query: 244 RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280
+ + L+ K DPS+R +
Sbjct: 225 GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 261
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (367), Expect = 1e-40
Identities = 48/288 (16%), Positives = 84/288 (29%), Gaps = 51/288 (17%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
+I GE VA+K + + E KI K +Q I + G
Sbjct: 26 GTDIAAGEEVAIKLECVKTKHPQL----HIESKIYKMMQGGVGIPTIRWCGAEG------ 75
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
MV E + L L + +F++ + Q+++ + Y H +H
Sbjct: 76 ---------DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIH 126
Query: 122 RDIKGSNLLI---DNEGNLKLADFGLARSF------SYDHNNTLTNRVITLWYRPPELLL 172
RD+K N L+ + + DFGLA+ + + N T Y L
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 173 GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 232
G + D+ S+G + G G A + K +
Sbjct: 187 G-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE--------------- 230
Query: 233 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280
+ M + + + + L L +
Sbjct: 231 -------KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 271
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 1e-40
Identities = 47/282 (16%), Positives = 88/282 (31%), Gaps = 52/282 (18%)
Query: 3 REIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQG 62
R K VA+K ++ EK +RE +I+ +L + +++L + +
Sbjct: 31 RMRKKQIDVAIKVLKQGTEKADTE-EMMREAQIMHQLDNPYIVRLIGVCQAEAL------ 83
Query: 63 RPDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
+V E L V + + Q+ G+ Y +H
Sbjct: 84 -----------MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 132
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYD--HNNTLTNRVITLWYRPPELLLGATKYGP 179
RD+ N+L+ N K++DFGL+++ D + + L + PE + K+
Sbjct: 133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSS 191
Query: 180 AVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238
D+WS G E L+ G+ E ++ I
Sbjct: 192 RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-------------------------- 225
Query: 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280
+ + E L+ + R
Sbjct: 226 ---EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 264
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 143 bits (362), Expect = 5e-40
Identities = 52/282 (18%), Positives = 98/282 (34%), Gaps = 52/282 (18%)
Query: 2 AREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
K VA+K ++ D E E F ++E ++K+++H N+++L + T P
Sbjct: 36 GVWKKYSLTVAVKTLKEDTMEVEEF----LKEAAVMKEIKHPNLVQLLGVCTREPP---- 87
Query: 61 QGRPDGNKYRGSTYMVFEYMDH--DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 118
Y++ E+M + L L + + + Q+ + + Y
Sbjct: 88 ------------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 135
Query: 119 VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYG 178
+HRD+ N L+ +K+ADFGL+R + D + + PE L K+
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFS 194
Query: 179 PAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238
D+W+ G + E+ + Q+ ++ L G +
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL--LEKDYRMERPEGCPE--------- 243
Query: 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280
EL+ +PS R S +
Sbjct: 244 -----------------KVYELMRACWQWNPSDRPSFAEIHQ 268
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 143 bits (361), Expect = 7e-40
Identities = 54/297 (18%), Positives = 109/297 (36%), Gaps = 57/297 (19%)
Query: 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPD 65
K VA+K ++ ++ + E I+ + H NVI L+ +VT P
Sbjct: 52 KREIFVAIKTLKSGYTEKQR-RDFLSEASIMGQFDHPNVIHLEGVVTKSTP--------- 101
Query: 66 GNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 124
++ E+M++ L + +FTV Q+ ++ + G+ Y +HRD+
Sbjct: 102 -------VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDL 154
Query: 125 KGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV----ITLWYRPPELLLGATKYGPA 180
N+L+++ K++DFGL+R D ++ I + + PE + K+ A
Sbjct: 155 AARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSA 213
Query: 181 VDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239
D+WS G + E+++ G+ + ++ I
Sbjct: 214 SDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI--------------------------- 246
Query: 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSL 296
+ +L+ D + R +++ D + +P SL
Sbjct: 247 --EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT----LDKMIRNPNSL 297
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 142 bits (359), Expect = 1e-39
Identities = 46/282 (16%), Positives = 80/282 (28%), Gaps = 53/282 (18%)
Query: 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQ 61
+ + VA+K ++ E + K L I
Sbjct: 24 GTNLLNNQQVAIKFEPRRSDAPQL----RDEYRTYKLLAGCTGIPNVYYFGQ-------- 71
Query: 62 GRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
+G +V + + L L D G +F+V + KQ+L + H +++
Sbjct: 72 ---EGLHN----VLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 124
Query: 122 RDIKGSNLLIDN-----EGNLKLADFGLARSFSYD------HNNTLTNRVITLWYRPPEL 170
RDIK N LI + + DFG+ + + N T Y
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 171 LLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 230
LG + D+ ++G +F L G G A K +
Sbjct: 185 HLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG-------------- 229
Query: 231 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR 272
+ +RE+ F + + L
Sbjct: 230 --------EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (350), Expect = 2e-38
Identities = 50/302 (16%), Positives = 95/302 (31%), Gaps = 73/302 (24%)
Query: 4 EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGR 63
+ +VA+K ++ + RE ++ + + N++KL + P
Sbjct: 39 PYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP------- 90
Query: 64 PDGNKYRGSTYMVFEYMDH-DLTGLADRPGLR-----------------------FTVPQ 99
++FEYM + DL + +
Sbjct: 91 ---------MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAE 141
Query: 100 IKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF-SYDHNNTLTN 158
C +Q+ G+ Y + +HRD+ N L+ +K+ADFGL+R+ S D+ N
Sbjct: 142 QLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGN 201
Query: 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCG 217
I + + PPE + +Y D+W+ G + E+ + G G E + +
Sbjct: 202 DAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYV----- 255
Query: 218 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKD 277
+ + L+ P+ R S
Sbjct: 256 ------------------------RDGNILACPENCPLELYNLMRLCWSKLPADRPSFCS 291
Query: 278 AL 279
Sbjct: 292 IH 293
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 3e-38
Identities = 56/280 (20%), Positives = 92/280 (32%), Gaps = 51/280 (18%)
Query: 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPD 65
A+K + + G + E I+K H NV+ L I
Sbjct: 53 GKKIHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----------- 100
Query: 66 GNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 124
GS +V YM H DL TV + + Q+ G+ + + +HRD+
Sbjct: 101 ----EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDL 156
Query: 125 KGSNLLIDNEGNLKLADFGLARSF---SYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 181
N ++D + +K+ADFGLAR +D + T + + + E L K+
Sbjct: 157 AARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKS 215
Query: 182 DMWSVGCIFAELL-NGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240
D+WS G + EL+ G P P N + + + P
Sbjct: 216 DVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP--------------- 260
Query: 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280
E++ K R S + +
Sbjct: 261 --------------DPLYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 5e-38
Identities = 53/310 (17%), Positives = 110/310 (35%), Gaps = 28/310 (9%)
Query: 2 AREIKTGE----IVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPE 57
I GE VA+K++R + + E ++ + + +V +L I + +
Sbjct: 28 GLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGICLTSTVQ 86
Query: 58 RDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 117
+ L + + Q+ G++Y
Sbjct: 87 ----------------LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 118 QVLHRDIKGSNLLIDNEGNLKLADFGLARSF-SYDHNNTLTNRVITLWYRPPELLLGATK 176
+++HRD+ N+L+ ++K+ DFGLA+ + + + + + E +L
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RI 189
Query: 177 YGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235
Y D+WS G EL+ G G +E S + + P I M
Sbjct: 190 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 249
Query: 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKS 295
+ + + RE+ F + A + ++ L++ +R+ DS ++ D +
Sbjct: 250 WMIDADSRPKFRELIIEFSKMARD-PQRYLVIQGDERMHLPSPTDSNFY---RALMDEED 305
Query: 296 LPKYESSHEY 305
+ + EY
Sbjct: 306 MDDVVDADEY 315
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (351), Expect = 6e-38
Identities = 56/311 (18%), Positives = 105/311 (33%), Gaps = 31/311 (9%)
Query: 2 AREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDE 60
+ ++G A+K + K + E +IL+ + ++KL+
Sbjct: 60 VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF----------- 108
Query: 61 QGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 120
+ M + + L RF+ P + Y Q++ Y H ++
Sbjct: 109 ---SFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 121 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 180
+RD+K NLLID +G +++ DFG A+ T PE++L Y A
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWTLCGTPEALAPEIILS-KGYNKA 218
Query: 181 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPG----VSKMPAYNHF 236
VD W++G + E+ G P + KI + + +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 237 KPSRTMKRRVREVFRH--FDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPK 294
K +K V ++ H F + + ++ K D+ F D +
Sbjct: 279 KRFGNLKNGVNDIKNHKWFATTDWIAIYQR-KVEAPFIPKFKGPGDTSNF--DDYEEEEI 335
Query: 295 SLPKYESSHEY 305
+ E +
Sbjct: 336 RVSINEKCGKE 346
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 1e-37
Identities = 55/304 (18%), Positives = 100/304 (32%), Gaps = 72/304 (23%)
Query: 3 REIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQ 61
+ VA+K ++ + + E+K++ +L HEN++ L T GP
Sbjct: 62 SKTGVSIQVAVKMLK-EKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP----- 115
Query: 62 GRPDGNKYRGSTYMVFEYMDH-----------------------DLTGLADRPGLRFTVP 98
Y++FEY + + T
Sbjct: 116 -----------IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 164
Query: 99 QIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTL-T 157
+ C+ Q+ G+ + +HRD+ N+L+ + +K+ DFGLAR D N +
Sbjct: 165 DLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRG 224
Query: 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELC 216
N + + + PE L Y D+WS G + E+ + G PG K+ +
Sbjct: 225 NARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ-- 281
Query: 217 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAK 276
N FK + + +++ D +R S
Sbjct: 282 -----------------NGFKMDQP---------FYATEEIYIIMQSCWAFDSRKRPSFP 315
Query: 277 DALD 280
+
Sbjct: 316 NLTS 319
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 1e-34
Identities = 48/279 (17%), Positives = 100/279 (35%), Gaps = 51/279 (18%)
Query: 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPD 65
K VA+K ++ E + + E I+ + H N+I+L+ +++ P
Sbjct: 34 KKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP--------- 83
Query: 66 GNKYRGSTYMVFEYMDHDLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 124
++ EYM++ F+V Q+ ++ + G+ Y +HRD+
Sbjct: 84 -------MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDL 136
Query: 125 KGSNLLIDNEGNLKLADFGLARSF--SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVD 182
N+L+++ K++DFGL+R + T + I + + PE + K+ A D
Sbjct: 137 AARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASD 195
Query: 183 MWSVGCIFAELL-NGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241
+WS G + E++ G+ + E + I
Sbjct: 196 VWSFGIVMWEVMTYGERPYWELSNHEVMKAI----------------------------- 226
Query: 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280
+L+ + + ++R D +
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 3e-34
Identities = 60/300 (20%), Positives = 100/300 (33%), Gaps = 69/300 (23%)
Query: 2 AREIKTGEI--VALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPER 58
AR K G A+K+++ K+ E+++L KL H N+I L
Sbjct: 29 ARIKKDGLRMDAAIKRMKEYASKDDHRDF-AGELEVLCKLGHHPNIINLLGACE------ 81
Query: 59 DEQGRPDGNKYRGSTYMVFEYMDH----------------DLTGLADRPGLRFTVPQIKC 102
+RG Y+ EY H +A+ + Q+
Sbjct: 82 ----------HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 103 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVIT 162
+ + G+ Y Q +HRD+ N+L+ K+ADFGL+R + T +
Sbjct: 132 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG--QEVYVKKTMGRLP 189
Query: 163 LWYRPPELLLGATKYGPAVDMWSVGCIFAELL-NGKPILPGKNEAEQLSKIFELCGSPDE 221
+ + E L + Y D+WS G + E++ G G AE K+
Sbjct: 190 VRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL--------- 239
Query: 222 TIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281
+ E + D +L+ + P +R S L S
Sbjct: 240 --------------------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 5e-34
Identities = 54/296 (18%), Positives = 97/296 (32%), Gaps = 69/296 (23%)
Query: 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRP 64
VA+K ++ + E+K+L L H N++ L T GP
Sbjct: 51 DAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP-------- 101
Query: 65 DGNKYRGSTYMVFEYMDH------------------DLTGLADRPGLRFTVPQIKCYMKQ 106
T ++ EY + + + L + + + Q
Sbjct: 102 --------TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQ 153
Query: 107 LLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTL-TNRVITLWY 165
+ G+ + +HRD+ N+L+ + K+ DFGLAR D N + N + + +
Sbjct: 154 VAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKW 213
Query: 166 RPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIW 224
PE + Y D+WS G EL + G PG + K+
Sbjct: 214 MAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM------------ 260
Query: 225 PGVSKMPAYNHFKPSRTMKRRVREVF-RHFDRHALELLEKMLMLDPSQRISAKDAL 279
+K R + H ++++ DP +R + K +
Sbjct: 261 -----------------IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 1e-32
Identities = 46/281 (16%), Positives = 85/281 (30%), Gaps = 32/281 (11%)
Query: 3 REIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQG 62
+ T VA+K ++ ++ H NV+ L T PG
Sbjct: 38 DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 97
Query: 63 RP-DGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 121
D T+ + CY Q+ G+ + + +H
Sbjct: 98 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIH 157
Query: 122 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLGATKYGPA 180
RD+ N+L+ + +K+ DFGLAR D + L + PE + Y
Sbjct: 158 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQ 216
Query: 181 VDMWSVGCIFAELLNG-KPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239
D+WS G + E+ + PG E+ + +
Sbjct: 217 SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK------------------------- 251
Query: 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280
+ + + + +PSQR + + ++
Sbjct: 252 ---EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 9e-32
Identities = 54/294 (18%), Positives = 99/294 (33%), Gaps = 66/294 (22%)
Query: 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRP 64
VA+K ++ D ++ I E++++K + +H+N+I L T GP
Sbjct: 43 NRVTKVAVKMLKSDATEKDL-SDLISEMEMMKMIGKHKNIINLLGACTQDGP-------- 93
Query: 65 DGNKYRGSTYMVFEYMDH----------------DLTGLADRPGLRFTVPQIKCYMKQLL 108
Y++ EY + P + + + Q+
Sbjct: 94 --------LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVA 145
Query: 109 TGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT-NRVITLWYRP 167
G+ Y + +HRD+ N+L+ + +K+ADFGLAR + T N + + +
Sbjct: 146 RGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMA 205
Query: 168 PELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPG 226
PE L Y D+WS G + E+ G PG E +
Sbjct: 206 PEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-------------- 250
Query: 227 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280
+ + + ++ PSQR + K ++
Sbjct: 251 ---------------KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 1e-30
Identities = 44/303 (14%), Positives = 101/303 (33%), Gaps = 59/303 (19%)
Query: 3 REIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQG 62
+ + VA+K + + I + E ++K+ +V++L +V+ P
Sbjct: 45 VKDEPETRVAIKTVN-EAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP------ 97
Query: 63 RPDGNKYRGSTYMVFEYMD----------HDLTGLADRPGLRFTVPQIKCYMKQLLTGLH 112
T ++ E M + ++ ++ ++ G+
Sbjct: 98 ----------TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 147
Query: 113 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF-SYDHNNTLTNRVITLWYRPPELL 171
Y + N+ +HRD+ N ++ + +K+ DFG+ R D+ ++ + + PE L
Sbjct: 148 YLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL 207
Query: 172 LGATKYGPAVDMWSVGCIFAELLNG-KPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 230
+ D+WS G + E+ + G + + L +
Sbjct: 208 KDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV------------------ 248
Query: 231 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 290
M+ + + + EL+ +P R S + + S +P
Sbjct: 249 -----------MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 297
Query: 291 CDP 293
+
Sbjct: 298 REV 300
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 86.4 bits (213), Expect = 3e-20
Identities = 27/201 (13%), Positives = 56/201 (27%), Gaps = 55/201 (27%)
Query: 6 KTGEIVALKKIRMDNE----------------KEGFPITAIREIKILKKLQHENVIKLKE 49
+ +K ++ + +A E + L+KLQ V K+
Sbjct: 22 EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81
Query: 50 IVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLT 109
++ E +D R V + +L
Sbjct: 82 W--------------------EGNAVLMELIDAKELY-------RVRVENPDEVLDMILE 114
Query: 110 GLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLWYR 166
+ + ++H D+ N+L+ EG + + DF + + + R I ++
Sbjct: 115 EVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRNIITYFS 173
Query: 167 PPELLLGATKYGPAVDMWSVG 187
Y D+ S
Sbjct: 174 --------RTYRTEKDINSAI 186
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 472 | |||
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.84 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.09 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.94 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.27 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.24 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.07 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.49 |
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-56 Score=435.00 Aligned_cols=278 Identities=42% Similarity=0.766 Sum_probs=234.7
Q ss_pred CceeccCCCEEEEEEeecCCcC---CCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEE
Q 012062 1 MAREIKTGEIVALKKIRMDNEK---EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVF 77 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVm 77 (472)
+|+++.||+.||||+++..... +.....+++|+++|++++|||||+++++|.. ++++||||
T Consensus 16 ~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~----------------~~~~~ivm 79 (299)
T d1ua2a_ 16 KARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH----------------KSNISLVF 79 (299)
T ss_dssp EEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC----------------TTCCEEEE
T ss_pred EEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc----------------CCceeehh
Confidence 4789999999999999765322 2345678899999999999999999999987 56789999
Q ss_pred ecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 78 EYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 78 Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
|||.++++..+......+++.+++.|++||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+.... ....
T Consensus 80 E~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-~~~~ 158 (299)
T d1ua2a_ 80 DFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYT 158 (299)
T ss_dssp ECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-CCCC
T ss_pred hhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCc-cccc
Confidence 999998877777777789999999999999999999999999999999999999999999999999997655432 2334
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..++|+.|+|||++.....|+.++||||||||+|+|++|..||.+.++.+++.+|++.++.+....|+..........+.
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 46789999999999876678999999999999999999999999999999999999999999998888877765554443
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLP 297 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~~~~~~~~~~~ 297 (472)
... .......+..+++++++||++||+.||++|+|++|+|+|+||+..+.++....+|
T Consensus 239 ~~~--~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~~~~p 296 (299)
T d1ua2a_ 239 SFP--GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLP 296 (299)
T ss_dssp CCC--CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSSC
T ss_pred cCC--CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCCCCCC
Confidence 221 2334566678899999999999999999999999999999999887776665554
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-54 Score=416.76 Aligned_cols=241 Identities=31% Similarity=0.458 Sum_probs=197.4
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+++.||+.||||+++.....+ ..+.+.+|+++|++|+|||||++++++.+ .+.+|||||||
T Consensus 23 ~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~----------------~~~~~ivmEy~ 85 (271)
T d1nvra_ 23 LAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFYGHRRE----------------GNIQYLFLEYC 85 (271)
T ss_dssp EEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEE----------------TTEEEEEEECC
T ss_pred EEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHhCCCCCEeeEeeeecc----------------CceeEEEEecc
Confidence 47899999999999998664332 34578899999999999999999999987 66899999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCC-CCcccc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH-NNTLTN 158 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~ 158 (472)
++ +|.+++.+ ...+++.+++.|++||+.||+|||++||+||||||+||||+.++++||+|||+|+.+.... ......
T Consensus 86 ~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~ 164 (271)
T d1nvra_ 86 SGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 164 (271)
T ss_dssp TTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCC
T ss_pred CCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccc
Confidence 96 67776654 4579999999999999999999999999999999999999999999999999998765433 233455
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
.+||+.|||||++.+...++.++||||||||||+|++|+.||...++..............
T Consensus 165 ~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~------------------- 225 (271)
T d1nvra_ 165 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY------------------- 225 (271)
T ss_dssp CCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT-------------------
T ss_pred eeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------------------
Confidence 7899999999999875555788999999999999999999998776544443333221110
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
...+..+++++++||++||+.||++|||++|+|+||||+.
T Consensus 226 --------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 226 --------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp --------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred --------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 0112357889999999999999999999999999999964
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-53 Score=413.53 Aligned_cols=237 Identities=26% Similarity=0.439 Sum_probs=202.5
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+++.||+.||||+++..... ..+.+.+|+++|++++|||||+++++|.+ .+.+|||||||
T Consensus 38 ~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~----------------~~~~~ivmEy~ 99 (293)
T d1yhwa1 38 TAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV----------------GDELWVVMEYL 99 (293)
T ss_dssp EEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEE----------------TTEEEEEEECC
T ss_pred EEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEE----------------CCEEEEEEEec
Confidence 4788999999999999865433 34678899999999999999999999987 56899999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
++ +|..++.+ ..+++.+++.|++||+.||+|||++||+||||||+||||+.++++||+|||+|+.+.... ......
T Consensus 100 ~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~~~ 176 (293)
T d1yhwa1 100 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTM 176 (293)
T ss_dssp TTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCBCCC
T ss_pred CCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc-cccccc
Confidence 96 55555543 359999999999999999999999999999999999999999999999999998765432 334556
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..+........
T Consensus 177 ~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~------------------- 236 (293)
T d1yhwa1 177 VGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL------------------- 236 (293)
T ss_dssp CSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC-------------------
T ss_pred ccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC-------------------
Confidence 89999999999987 6789999999999999999999999999998888877765421110
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
..+..+++++++||++||..||++|+|++|+|+|+||+.
T Consensus 237 --------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 237 --------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp --------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred --------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 012357889999999999999999999999999999964
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-53 Score=413.28 Aligned_cols=269 Identities=48% Similarity=0.862 Sum_probs=227.0
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+++.|++.||||+++.....+.....+.+|+++|++++|||||+++++|.+ .+++|||||||
T Consensus 20 ~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~----------------~~~~~iv~e~~ 83 (298)
T d1gz8a_ 20 KARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT----------------ENKLYLVFEFL 83 (298)
T ss_dssp EEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE----------------TTEEEEEEECC
T ss_pred EEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc----------------ccceeEEEeec
Confidence 47899999999999998776555566788999999999999999999999987 66899999999
Q ss_pred CCChhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 81 DHDLTGLAD-RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 81 ~g~l~~~~~-~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
++++..++. .....+++.+++.|+.||+.||+|||+++||||||||+|||++.++++||+|||+|+..... .......
T Consensus 84 ~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~-~~~~~~~ 162 (298)
T d1gz8a_ 84 HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHE 162 (298)
T ss_dssp SEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC-SBCTTCC
T ss_pred CCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCC-cccceee
Confidence 988766554 44556999999999999999999999999999999999999999999999999999766432 3344556
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
++|+.|+|||++.....++.++|||||||++|+|++|+.||.+.+..+.+.++++..+.+....|+.....+.+....+.
T Consensus 163 ~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (298)
T d1gz8a_ 163 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 242 (298)
T ss_dssp BCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCC
T ss_pred cccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccccccc
Confidence 88999999999887666789999999999999999999999999999999999999999999988877665554333322
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
............++.++++||++||..||++|+|++|||+|+||..-
T Consensus 243 -~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 243 -WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp -CCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred -ccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 22234456667889999999999999999999999999999999643
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-54 Score=411.91 Aligned_cols=234 Identities=30% Similarity=0.478 Sum_probs=201.5
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.|++.||||++++.. ........+.+|+++|++++|||||++++++.+ ++.+||||||
T Consensus 24 ~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----------------~~~~~ivmEy 87 (263)
T d2j4za1 24 LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD----------------ATRVYLILEY 87 (263)
T ss_dssp EEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----------------SSEEEEEEEC
T ss_pred EEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE----------------CCEEEEEEee
Confidence 47899999999999997653 234456678899999999999999999999987 6689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
|++ +|.+++.+. ..+++.+++.|+.||+.||+|||+++|+||||||+||||+.++++||+|||+|+..... ....
T Consensus 88 ~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~---~~~~ 163 (263)
T d2j4za1 88 APLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTT 163 (263)
T ss_dssp CTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---CCEE
T ss_pred cCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC---cccc
Confidence 996 666666543 46999999999999999999999999999999999999999999999999999765432 2345
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
.+||+.|||||++.+ ..|+.++|||||||+||+|++|+.||.+.+..+.+.++.+.....
T Consensus 164 ~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~------------------- 223 (263)
T d2j4za1 164 LCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF------------------- 223 (263)
T ss_dssp TTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC-------------------
T ss_pred cCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-------------------
Confidence 678999999999987 678999999999999999999999999999888888776532111
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
...+++++++||.+||+.||++|||++|+|+||||.
T Consensus 224 -----------p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~ 259 (263)
T d2j4za1 224 -----------PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 259 (263)
T ss_dssp -----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHH
T ss_pred -----------CccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcC
Confidence 123678899999999999999999999999999994
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-52 Score=411.59 Aligned_cols=284 Identities=51% Similarity=0.924 Sum_probs=226.5
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+++.+|+.||||+++.....+.....+++|+++|++|+|+||+++++++...... ....++++|||||||
T Consensus 28 ~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~--------~~~~~~~~~iv~e~~ 99 (318)
T d3blha1 28 KARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASP--------YNRCKGSIYLVFDFC 99 (318)
T ss_dssp EEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------------------CEEEEEECC
T ss_pred EEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccc--------ccccCceEEEEEecc
Confidence 478999999999999988776666778899999999999999999999999764321 122356799999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC---Cccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN---NTLT 157 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~---~~~~ 157 (472)
.++++.........+++.+++.|++||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..... ....
T Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 179 (318)
T d3blha1 100 EHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 179 (318)
T ss_dssp CEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCC
T ss_pred CCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeeccccccccccccc
Confidence 9988887777777899999999999999999999999999999999999999999999999999987653222 2333
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..++|+.|+|||++.+...|+.++|||||||++|+|++|+.||.+.++.+.+..+.+..+.+....+.............
T Consensus 180 ~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (318)
T d3blha1 180 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLE 259 (318)
T ss_dssp SCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------
T ss_pred ceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhc
Confidence 45789999999999876779999999999999999999999999999999999999999998888777766544433333
Q ss_pred CchhhhhhHHHHh--hhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 012062 238 PSRTMKRRVREVF--RHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCD 292 (472)
Q Consensus 238 ~~~~~~~~~~~~~--~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~~~~~~ 292 (472)
............+ ...+.+++|||.+||+.||++|+|++|||+||||+.++.|++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p~~ 316 (318)
T d3blha1 260 LVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD 316 (318)
T ss_dssp CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCCCC
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCCCC
Confidence 2222222232222 235778999999999999999999999999999998877654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-53 Score=411.42 Aligned_cols=240 Identities=24% Similarity=0.327 Sum_probs=202.1
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+++.|++.||||+++.... ...+.+.+|+++|++|+|||||++++++.+ .+.+|||||||
T Consensus 30 ~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----------------~~~~~lvmEy~ 91 (288)
T d2jfla1 30 KAQNKETSVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVKLLDAFYY----------------ENNLWILIEFC 91 (288)
T ss_dssp EEEETTTCCEEEEEEEECSSS--GGGGGTHHHHHHHHHCCCTTBCCEEEEEEE----------------TTEEEEEEECC
T ss_pred EEEECCCCeEEEEEEECcCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEee----------------CCeEEEEEecC
Confidence 478999999999999986533 235678899999999999999999999987 66899999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
++ +|..++.+....+++.+++.|+.||+.||+|||++||+||||||+||||+.++++||+|||+|+...... ......
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~~~~ 170 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSF 170 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HHHTCC
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc-cccccc
Confidence 96 5666655555579999999999999999999999999999999999999999999999999997654321 223456
Q ss_pred cccCCCCChhhhcC----CCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcccc
Q 012062 160 VITLWYRPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235 (472)
Q Consensus 160 ~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (472)
+||+.|+|||++.. ...|+.++|||||||+||+|++|+.||.+.+..+.+.++........
T Consensus 171 ~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~--------------- 235 (288)
T d2jfla1 171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL--------------- 235 (288)
T ss_dssp CSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC---------------
T ss_pred ccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC---------------
Confidence 78999999999853 34588999999999999999999999999999888888765321100
Q ss_pred CCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.....+++++++||++||+.||++|||++|||+|+||..
T Consensus 236 ------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 236 ------------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp ------------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred ------------CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 011357889999999999999999999999999999954
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.3e-52 Score=417.12 Aligned_cols=245 Identities=25% Similarity=0.398 Sum_probs=209.0
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+++.||+.||||+++..... ..+.+.+|+++|++|+|||||+++++|++ ++.+|||||||
T Consensus 44 ~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~----------------~~~~~ivmE~~ 105 (350)
T d1koaa2 44 RVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHPTLVNLHDAFED----------------DNEMVMIYEFM 105 (350)
T ss_dssp EEEETTTTEEEEEEEECCCSHH--HHHHHHHHHHHHHHTCCTTBCCEEEEEEE----------------TTEEEEEECCC
T ss_pred EEEECCCCCEEEEEEEcccchh--hHHHHHHHHHHHHhCCCCCCCcEEEEEEE----------------CCEEEEEEEcC
Confidence 4789999999999999765432 24567899999999999999999999987 66899999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC--CCCeEEeeccceeeeccCCCCccc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN--EGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~--~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
++ +|.+++.+....+++.+++.|++||+.||+|||++|||||||||+||||+. ++.+||+|||+|+.+... ....
T Consensus 106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~--~~~~ 183 (350)
T d1koaa2 106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSVK 183 (350)
T ss_dssp CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT--SCEE
T ss_pred CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc--cccc
Confidence 85 777777666667999999999999999999999999999999999999964 578999999999876532 3334
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..+||+.|||||++.+ ..|+.++||||||||+|+|++|+.||.+.+..+.+..+..........
T Consensus 184 ~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~--------------- 247 (350)
T d1koaa2 184 VTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS--------------- 247 (350)
T ss_dssp EECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCG---------------
T ss_pred eecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc---------------
Confidence 5688999999999987 678999999999999999999999999999999998887654433221
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCD 292 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~~~~~~ 292 (472)
.+..+++++++||++||+.||++|||++|||+||||.....+..
T Consensus 248 -----------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~ 291 (350)
T d1koaa2 248 -----------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR 291 (350)
T ss_dssp -----------GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCSC
T ss_pred -----------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCCc
Confidence 22357889999999999999999999999999999976544433
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.8e-52 Score=407.80 Aligned_cols=239 Identities=26% Similarity=0.403 Sum_probs=187.4
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+++.|++.||||+++...... ....+.+|+++|++|+|||||+++++|++ .+.+|||||||
T Consensus 27 ~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----------------~~~~~lvmE~~ 89 (307)
T d1a06a_ 27 LAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYES----------------GGHLYLIMQLV 89 (307)
T ss_dssp EEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEEC----------------SSEEEEEECCC
T ss_pred EEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEE----------------CCEEEEEEecc
Confidence 47899999999999998654332 23467799999999999999999999987 66899999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc---CCCCeEEeeccceeeeccCCCCcc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID---NEGNLKLADFGLARSFSYDHNNTL 156 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~---~~~~vkL~DFG~a~~~~~~~~~~~ 156 (472)
++ +|.+++.+. ..+++.+++.|+.||+.||+|||+++|+||||||+|||+. .++.+||+|||+|+..... ...
T Consensus 90 ~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~--~~~ 166 (307)
T d1a06a_ 90 SGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVL 166 (307)
T ss_dssp CSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------------
T ss_pred CCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC--Cee
Confidence 95 777777654 4699999999999999999999999999999999999995 4678999999999865432 233
Q ss_pred ccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccC
Q 012062 157 TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236 (472)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (472)
...+||+.|||||++.+ ..|+.++|||||||+||+|++|+.||.+.+..+....+.+........
T Consensus 167 ~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-------------- 231 (307)
T d1a06a_ 167 STACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP-------------- 231 (307)
T ss_dssp ------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTT--------------
T ss_pred eeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCc--------------
Confidence 45689999999999987 678999999999999999999999999999988888887643332221
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.+..+++++++||.+||..||++|||++|+|+||||..
T Consensus 232 ------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 232 ------------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp ------------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred ------------cccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 12357789999999999999999999999999999964
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.1e-52 Score=416.55 Aligned_cols=240 Identities=24% Similarity=0.400 Sum_probs=207.0
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+++.||+.||||+++..... ....+.+|+++|++|+|||||+++++|++ ++.+|||||||
T Consensus 47 ~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIv~~~~~~~~----------------~~~~~ivmE~~ 108 (352)
T d1koba_ 47 RCVEKATGRVFVAKFINTPYPL--DKYTVKNEISIMNQLHHPKLINLHDAFED----------------KYEMVLILEFL 108 (352)
T ss_dssp EEEETTTCCEEEEEEEECCSHH--HHHHHHHHHHHHTTCCSTTBCCEEEEEEC----------------SSEEEEEEECC
T ss_pred EEEECCCCCEEEEEEECCcchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEE----------------CCEEEEEEEcC
Confidence 4789999999999999865432 24567899999999999999999999987 66899999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc--CCCCeEEeeccceeeeccCCCCccc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID--NEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~--~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
++ +|.+.+.+...++++.+++.|+.||+.||+|||++||+||||||+||||+ .++.|||+|||+|+.+... ....
T Consensus 109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~--~~~~ 186 (352)
T d1koba_ 109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVK 186 (352)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--SCEE
T ss_pred CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC--Ccee
Confidence 95 67677776666799999999999999999999999999999999999998 5678999999999877533 2344
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..++|+.|+|||++.+ ..|+.++|||||||+||+|++|+.||.+.+..+.+.++......++...|
T Consensus 187 ~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~------------- 252 (352)
T d1koba_ 187 VTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF------------- 252 (352)
T ss_dssp EECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTT-------------
T ss_pred eccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccc-------------
Confidence 5678999999999986 67899999999999999999999999999999999888775544333222
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
..+++++++||++||+.||++|+|++|||+|+||..+
T Consensus 253 -------------~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 253 -------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp -------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred -------------cCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 2467899999999999999999999999999999754
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-53 Score=409.57 Aligned_cols=238 Identities=26% Similarity=0.423 Sum_probs=199.4
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.|++.||||++++.. ..+.....+.+|+++|++|+|||||+++++|++ ++.+||||||
T Consensus 26 ~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----------------~~~~~ivmEy 89 (288)
T d1uu3a_ 26 LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD----------------DEKLYFGLSY 89 (288)
T ss_dssp EEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC----------------SSEEEEEECC
T ss_pred EEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE----------------CCEEEEEEEc
Confidence 47899999999999998653 233455678899999999999999999999987 6689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCC-CCccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH-NNTLT 157 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~ 157 (472)
|++ +|.+++... ..+++.+++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.+.... .....
T Consensus 90 ~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~ 168 (288)
T d1uu3a_ 90 AKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 168 (288)
T ss_dssp CTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---------
T ss_pred cCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcccccc
Confidence 996 666665543 469999999999999999999999999999999999999999999999999998775433 23344
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..+||+.|+|||++.+ ..|+.++||||||||||+|++|+.||.+.+..+.+.++.+.....
T Consensus 169 ~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~------------------ 229 (288)
T d1uu3a_ 169 SFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF------------------ 229 (288)
T ss_dssp -CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC------------------
T ss_pred cccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCC------------------
Confidence 5689999999999987 578999999999999999999999999999988888886532111
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHH------HhcCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKD------ALDSEYFWT 286 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~e------lL~h~~f~~ 286 (472)
...+++++++||++||+.||++|+|++| +++||||..
T Consensus 230 ------------p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 230 ------------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp ------------CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred ------------CccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 1246788999999999999999999988 578999954
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-52 Score=403.40 Aligned_cols=239 Identities=27% Similarity=0.431 Sum_probs=190.7
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+++.||+.||||+++.....+.....+.+|+++|++|+|||||++++++.+.. .+.+|||||||
T Consensus 22 ~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--------------~~~~~ivmEy~ 87 (269)
T d2java1 22 KIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT--------------NTTLYIVMEYC 87 (269)
T ss_dssp EEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC------------------CEEEEEECC
T ss_pred EEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC--------------CCEEEEEEecC
Confidence 4789999999999999877555545567889999999999999999999987521 45689999999
Q ss_pred CC-ChhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCCCcEEEcCCCCeEEeeccceeeeccC
Q 012062 81 DH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQ-----VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 151 (472)
Q Consensus 81 ~g-~l~~~~~~---~~~~l~~~~i~~i~~Qll~aL~~LH~~g-----iiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 151 (472)
++ +|.+++.+ ....+++.+++.|+.||+.||+|||+++ |+||||||+||||+.++++||+|||+|+.+...
T Consensus 88 ~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 167 (269)
T d2java1 88 EGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD 167 (269)
T ss_dssp TTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC---
T ss_pred CCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccC
Confidence 85 77776643 3456999999999999999999999876 999999999999999999999999999876532
Q ss_pred CCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 012062 152 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 231 (472)
Q Consensus 152 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (472)
. ......++|+.|||||++.+ ..|+.++||||||||||+|++|+.||.+.+..+.+.++.+.....
T Consensus 168 ~-~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~------------ 233 (269)
T d2java1 168 T-SFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR------------ 233 (269)
T ss_dssp ---------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC------------
T ss_pred C-CccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence 2 23345688999999999976 678999999999999999999999999999888888776532111
Q ss_pred ccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 012062 232 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 284 (472)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f 284 (472)
+...+++++++||++||+.||++|||++|||+|||+
T Consensus 234 -----------------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 234 -----------------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp -----------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -----------------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 012467889999999999999999999999999995
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-52 Score=410.58 Aligned_cols=237 Identities=26% Similarity=0.414 Sum_probs=201.6
Q ss_pred CceeccCCCEEEEEEeecCCcC-CCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.|++.||||+++..... ......+.+|+++|++|+|||||+++++|.+ .+.+||||||
T Consensus 33 ~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~----------------~~~~~iv~E~ 96 (309)
T d1u5ra_ 33 FARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR----------------EHTAWLVMEY 96 (309)
T ss_dssp EEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE----------------TTEEEEEEEC
T ss_pred EEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE----------------CCEEEEEEEe
Confidence 4788999999999999866432 2334568899999999999999999999987 5689999999
Q ss_pred CCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 80 MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 80 ~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
|.++++..+......+++.+++.|++||+.||.|||++||+||||||+||||+.++++||+|||+|+.... ....
T Consensus 97 ~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-----~~~~ 171 (309)
T d1u5ra_ 97 CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSF 171 (309)
T ss_dssp CSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----BCCC
T ss_pred cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC-----CCcc
Confidence 99877665555555799999999999999999999999999999999999999999999999999976432 3346
Q ss_pred cccCCCCChhhhcCC--CCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 160 VITLWYRPPELLLGA--TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~--~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
+||+.|||||++.+. ..|+.++|||||||++|+|++|+.||.+.+..+.+.++.........
T Consensus 172 ~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~---------------- 235 (309)
T d1u5ra_ 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ---------------- 235 (309)
T ss_dssp CSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS----------------
T ss_pred ccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC----------------
Confidence 799999999998752 35889999999999999999999999999988888877653221110
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
...+++++++||++||..||++|||++|||+|+||..
T Consensus 236 ------------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 236 ------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp ------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred ------------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 0146788999999999999999999999999999964
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.9e-52 Score=402.89 Aligned_cols=266 Identities=45% Similarity=0.831 Sum_probs=224.9
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+++ +++.||||+++.....+.....+.+|+++|++++|||||+++++|.. .+.+||||||+
T Consensus 20 ~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----------------~~~~~i~~e~~ 82 (286)
T d1ob3a_ 20 KAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT----------------KKRLVLVFEHL 82 (286)
T ss_dssp EEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC----------------SSCEEEEEECC
T ss_pred EEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc----------------CCceeEEEEee
Confidence 36664 88999999998776666667889999999999999999999999987 66799999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
.++++..+......+++.+++.|++||+.||+|||+++|+||||||+||||+.++.+||+|||+|....... ......+
T Consensus 83 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~ 161 (286)
T d1ob3a_ 83 DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKYTHEI 161 (286)
T ss_dssp SEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----------
T ss_pred hhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc-cccceec
Confidence 998888887777789999999999999999999999999999999999999999999999999997764332 2334456
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCch
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 240 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (472)
+++.|+|||++.+...++.++|||||||++|+|++|+.||.+.++.+++.++++..+.+....|........+......
T Consensus 162 ~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~- 240 (286)
T d1ob3a_ 162 VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV- 240 (286)
T ss_dssp CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCC-
T ss_pred ccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccccc-
Confidence 8999999999987777899999999999999999999999999999999999999999988888877665543322211
Q ss_pred hhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 241 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
............++.+++|||++||+.||++|+|++|||+||||+
T Consensus 241 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~ 285 (286)
T d1ob3a_ 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285 (286)
T ss_dssp CCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred ccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 112234455567889999999999999999999999999999995
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-52 Score=411.23 Aligned_cols=237 Identities=28% Similarity=0.431 Sum_probs=203.3
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.||+.||||++++.. ........+++|+++|++++|||||+++++|++ .+.+||||||
T Consensus 23 ~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----------------~~~~~iv~ey 86 (337)
T d1o6la_ 23 LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT----------------HDRLCFVMEY 86 (337)
T ss_dssp EEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC----------------SSEEEEEEEC
T ss_pred EEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc----------------ccccccceec
Confidence 47899999999999998653 233456778899999999999999999999997 6689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
|.+ +|..++.+ ...+++.+++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+|+..... ......
T Consensus 87 ~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~-~~~~~~ 164 (337)
T d1o6la_ 87 ANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKT 164 (337)
T ss_dssp CTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-TCCBCC
T ss_pred cCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC-Cccccc
Confidence 996 55555544 447999999999999999999999999999999999999999999999999999865432 234455
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
.+||+.|+|||++.+ ..|+.++||||||||||+|++|+.||.+.+..+.+..+.......
T Consensus 165 ~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~------------------- 224 (337)
T d1o6la_ 165 FCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF------------------- 224 (337)
T ss_dssp CEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-------------------
T ss_pred ceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCC-------------------
Confidence 789999999999987 678999999999999999999999999999988888776532111
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 286 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----t~~elL~h~~f~~ 286 (472)
+..+++++++||++||++||++|+ +++||++|+||..
T Consensus 225 -----------p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 225 -----------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp -----------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred -----------CccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCccccc
Confidence 124678999999999999999999 4999999999954
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-52 Score=401.20 Aligned_cols=240 Identities=23% Similarity=0.302 Sum_probs=194.3
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|++..|++.||||+++.....+.....+.+|+++|++|+|||||+++++|++.. ..+..+|||||||
T Consensus 27 ~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~------------~~~~~~~ivmE~~ 94 (270)
T d1t4ha_ 27 KGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV------------KGKKCIVLVTELM 94 (270)
T ss_dssp EEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES------------SSCEEEEEEEECC
T ss_pred EEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc------------ccCCEEEEEEeCC
Confidence 4788999999999999876544444567889999999999999999999997521 1145789999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEcC-CCCeEEeeccceeeeccCCCCcc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ--VLHRDIKGSNLLIDN-EGNLKLADFGLARSFSYDHNNTL 156 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~g--iiHrDLKp~NILl~~-~~~vkL~DFG~a~~~~~~~~~~~ 156 (472)
++ +|.+++.+ ...+++.+++.|++||+.||+|||+++ |+||||||+||||+. ++.+||+|||+|+.... ...
T Consensus 95 ~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~---~~~ 170 (270)
T d1t4ha_ 95 TSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---SFA 170 (270)
T ss_dssp CSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT---TSB
T ss_pred CCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC---Ccc
Confidence 96 56666554 346999999999999999999999998 999999999999974 78999999999975432 233
Q ss_pred ccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccC
Q 012062 157 TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236 (472)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (472)
...+||+.|||||++.+ .++.++||||||||||+|++|+.||.+.+....+.+.+.....+
T Consensus 171 ~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~----------------- 231 (270)
T d1t4ha_ 171 KAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP----------------- 231 (270)
T ss_dssp EESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC-----------------
T ss_pred CCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCC-----------------
Confidence 45689999999999875 58999999999999999999999998766555444333211000
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
..+...+++++++||++||+.||++|||++|||+||||+
T Consensus 232 ----------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 232 ----------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp ----------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ----------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 011234677899999999999999999999999999994
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=414.85 Aligned_cols=263 Identities=23% Similarity=0.344 Sum_probs=194.0
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+++.||+.||||+++.+.. ......+.+|+++|++|+|||||+++++|.+ .+++|||||||
T Consensus 24 ~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----------------~~~~~iVmEy~ 86 (322)
T d1s9ja_ 24 KVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYS----------------DGEISICMEHM 86 (322)
T ss_dssp EEEETTTTEEEEEEEEECCCC-TTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC----------------SSEEEEEEECC
T ss_pred EEEECCCCcEEEEEEEChhhC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----------------CCEEEEEEEcC
Confidence 478899999999999986543 3455678899999999999999999999987 66899999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~-~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
++ +|.+++.+. ..+++.+++.++.||+.||+|||+ ++|+||||||+||||+.++++||+|||+|+.+... ....
T Consensus 87 ~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~---~~~~ 162 (322)
T d1s9ja_ 87 DGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 162 (322)
T ss_dssp TTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---TC--
T ss_pred CCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC---cccc
Confidence 96 666666543 469999999999999999999997 59999999999999999999999999999876432 2345
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHH-HHHHHhcCCCCCCC----CccCCCCCcc
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQL-SKIFELCGSPDETI----WPGVSKMPAY 233 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~-~~i~~~~~~~~~~~----~~~~~~~~~~ 233 (472)
.+||+.|||||++.+ ..|+.++||||||||+|||++|+.||.+.+..+.. ..+....+...... +.........
T Consensus 163 ~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (322)
T d1s9ja_ 163 FVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241 (322)
T ss_dssp -CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------------
T ss_pred ccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccc
Confidence 689999999999987 67999999999999999999999999887654322 21222211111110 0000000000
Q ss_pred ccCCCchhhhhhHHHHh---------hhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 234 NHFKPSRTMKRRVREVF---------RHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 234 ~~~~~~~~~~~~~~~~~---------~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
....+............ ..++.+++|||.+||..||++|||++|+|+||||+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~ 302 (322)
T d1s9ja_ 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 302 (322)
T ss_dssp ----CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred cccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhC
Confidence 00011111111111111 13678999999999999999999999999999994
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.6e-51 Score=404.21 Aligned_cols=235 Identities=23% Similarity=0.373 Sum_probs=203.1
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.||+.||||+++... ........+.+|+.+|++++|||||++++++.+ .+.+||||||
T Consensus 22 ~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~----------------~~~~~ivmE~ 85 (316)
T d1fota_ 22 LIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD----------------AQQIFMIMDY 85 (316)
T ss_dssp EEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC----------------SSEEEEEECC
T ss_pred EEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee----------------CCeeeeEeee
Confidence 47899999999999998653 233456678899999999999999999999987 6689999999
Q ss_pred CCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 80 MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 80 ~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
|.++.+..+......+++.+++.|+.||+.||+|||++||+||||||+||||+.++++||+|||+|+.... .....
T Consensus 86 ~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~----~~~~~ 161 (316)
T d1fota_ 86 IEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTL 161 (316)
T ss_dssp CCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----CBCCC
T ss_pred cCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc----ccccc
Confidence 99866555555555789999999999999999999999999999999999999999999999999987643 23456
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
+||+.|||||++.+ ..|+.++||||||||||+|++|+.||.+.+..+.+.++.......+
T Consensus 162 ~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p------------------- 221 (316)
T d1fota_ 162 CGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP------------------- 221 (316)
T ss_dssp CSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC-------------------
T ss_pred cCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC-------------------
Confidence 89999999999986 6789999999999999999999999999999998888865422111
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 286 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----t~~elL~h~~f~~ 286 (472)
..+++++++||++||..||++|+ |++|||+||||+.
T Consensus 222 -----------~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 222 -----------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp -----------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred -----------CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCccccc
Confidence 24677899999999999999997 9999999999954
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-51 Score=402.34 Aligned_cols=269 Identities=41% Similarity=0.733 Sum_probs=220.0
Q ss_pred CceeccC-CCEEEEEEeecCCcCCCchhhHHHHHHHHHhc---CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEE
Q 012062 1 MAREIKT-GEIVALKKIRMDNEKEGFPITAIREIKILKKL---QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMV 76 (472)
Q Consensus 1 La~~~~t-g~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iV 76 (472)
+|++..| ++.||||+++.....+.....+++|+.+|+.| +|||||+++++|..... .....+||+
T Consensus 25 ~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~-----------~~~~~~~~~ 93 (305)
T d1blxa_ 25 KARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT-----------DRETKLTLV 93 (305)
T ss_dssp EEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC-----------SSEEEEEEE
T ss_pred EEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc-----------ccCceEEEE
Confidence 4778766 56799999987765555566778899888877 79999999999975321 124578999
Q ss_pred EecCCCChhhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCc
Q 012062 77 FEYMDHDLTGLA-DRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT 155 (472)
Q Consensus 77 mEy~~g~l~~~~-~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 155 (472)
||||+++++.+. ......+++..++.|++||+.||+|||+++|+||||||+|||++.++.+||+|||+++.... ...
T Consensus 94 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~--~~~ 171 (305)
T d1blxa_ 94 FEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMA 171 (305)
T ss_dssp EECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCG--GGG
T ss_pred EEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhhcc--ccc
Confidence 999998766543 34555699999999999999999999999999999999999999999999999999876543 233
Q ss_pred cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcccc
Q 012062 156 LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (472)
....+||+.|+|||++.+ ..|+.++||||||||+|||++|+.||.+.+..+++.++++..+.+....|+.....+....
T Consensus 172 ~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 250 (305)
T d1blxa_ 172 LTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF 250 (305)
T ss_dssp GCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGS
T ss_pred CCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhh
Confidence 455688999999999987 6799999999999999999999999999999999999999999888877776555443222
Q ss_pred CCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.... ..........+++.+++||++||+.||++|||++|||+||||+.
T Consensus 251 ~~~~---~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 251 HSKS---AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298 (305)
T ss_dssp CCCC---CCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred cccc---ccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence 1111 11233445678899999999999999999999999999999964
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-51 Score=398.78 Aligned_cols=240 Identities=28% Similarity=0.428 Sum_probs=203.9
Q ss_pred CceeccCCCEEEEEEeecCCcCC----CchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEE
Q 012062 1 MAREIKTGEIVALKKIRMDNEKE----GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMV 76 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iV 76 (472)
+|+++.||+.||||++++..... .....+.+|+++|++|+|||||+++++|++ .+.+|||
T Consensus 28 ~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~----------------~~~~~iv 91 (293)
T d1jksa_ 28 KCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN----------------KTDVILI 91 (293)
T ss_dssp EEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----------------SSEEEEE
T ss_pred EEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----------------CCEEEEE
Confidence 47889999999999998653222 235678899999999999999999999987 6689999
Q ss_pred EecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC----CeEEeeccceeeeccC
Q 012062 77 FEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG----NLKLADFGLARSFSYD 151 (472)
Q Consensus 77 mEy~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~----~vkL~DFG~a~~~~~~ 151 (472)
||||++ +|.+++.+. ..+++.+++.|++||+.||+|||+++|+||||||+||||+.++ .+||+|||+|+.....
T Consensus 92 ~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~ 170 (293)
T d1jksa_ 92 LELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 170 (293)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTS
T ss_pred EEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCC
Confidence 999996 666666543 4699999999999999999999999999999999999998776 4999999999876533
Q ss_pred CCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 012062 152 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 231 (472)
Q Consensus 152 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (472)
......++|+.|+|||++.+ ..++.++||||||||||+|++|+.||.+.+..+.+..+.......
T Consensus 171 --~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~------------ 235 (293)
T d1jksa_ 171 --NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF------------ 235 (293)
T ss_dssp --CBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC------------
T ss_pred --ccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC------------
Confidence 23445678999999999986 678999999999999999999999999999998888886542211
Q ss_pred ccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 232 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
....+..++.++++||++||..||++|||++|+|+|+||+.
T Consensus 236 --------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 236 --------------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp --------------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred --------------CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 12344568889999999999999999999999999999954
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-51 Score=407.42 Aligned_cols=271 Identities=35% Similarity=0.576 Sum_probs=217.9
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+++.||+.||||+++.....+.....+++|+++|++|+|||||+++++|...+.. ....++|||||||
T Consensus 36 ~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~----------~~~~~~~lv~e~~ 105 (346)
T d1cm8a_ 36 SAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL----------DDFTDFYLVMPFM 105 (346)
T ss_dssp EEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST----------TTCCCCEEEEECC
T ss_pred EEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccc----------cccceEEEEEecc
Confidence 478999999999999987655555567788999999999999999999999874321 1244689999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+.+|..+... .++++..++.|++||+.||+|||++||+||||||+|||++.++.+||+|||+|+.... ..+..+
T Consensus 106 ~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~----~~~~~~ 179 (346)
T d1cm8a_ 106 GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS----EMTGYV 179 (346)
T ss_dssp SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS----SCCSSC
T ss_pred cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC----cccccc
Confidence 7777666654 3599999999999999999999999999999999999999999999999999987643 334567
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcccc-CCCc
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH-FKPS 239 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 239 (472)
+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+....+........... ....
T Consensus 180 ~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (346)
T d1cm8a_ 180 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLP 259 (346)
T ss_dssp SCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSC
T ss_pred ccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCC
Confidence 899999999998767789999999999999999999999999999999999988887766544432221000000 0000
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
..........+..++++++|||++||..||++|||++|||+||||+.-
T Consensus 260 ~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 260 ELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp CCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred cccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 000112233445678999999999999999999999999999999753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.5e-50 Score=389.81 Aligned_cols=241 Identities=26% Similarity=0.422 Sum_probs=204.0
Q ss_pred CceeccCCCEEEEEEeecCCcCCC-------chhhHHHHHHHHHhcC-CCCccceeEEeeCCCCCCCCCCCCCCCCcCCe
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEG-------FPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGS 72 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~-------~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~ 72 (472)
+|+++.+++.||||++++...... ....+++|+.+|++|+ |||||+++++|++ ++.
T Consensus 21 ~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~----------------~~~ 84 (277)
T d1phka_ 21 RCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET----------------NTF 84 (277)
T ss_dssp EEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC----------------SSE
T ss_pred EEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc----------------Ccc
Confidence 478999999999999987643321 2345779999999997 9999999999987 678
Q ss_pred EEEEEecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccC
Q 012062 73 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 151 (472)
Q Consensus 73 ~~iVmEy~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 151 (472)
+|||||||++ +|.+++... ..+++.+++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus 85 ~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 163 (277)
T d1phka_ 85 FFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 163 (277)
T ss_dssp EEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred eEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccCC
Confidence 9999999985 777777553 47999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCccccccccCCCCChhhhcC-----CCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCcc
Q 012062 152 HNNTLTNRVITLWYRPPELLLG-----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPG 226 (472)
Q Consensus 152 ~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 226 (472)
. .....+||..|+|||++.+ ...++.++||||||||||+|++|+.||.+.+..+.+..+.+........
T Consensus 164 ~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~---- 237 (277)
T d1phka_ 164 E--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP---- 237 (277)
T ss_dssp C--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT----
T ss_pred C--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc----
Confidence 2 3345678999999999863 2457889999999999999999999999999988888887643222111
Q ss_pred CCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 227 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.+..+++++++||.+||+.||++|||++|||+|+||+.
T Consensus 238 ----------------------~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 238 ----------------------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp ----------------------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred ----------------------ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 12357889999999999999999999999999999953
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-50 Score=405.00 Aligned_cols=234 Identities=26% Similarity=0.403 Sum_probs=201.5
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.||+.||||++++.. ........+++|+++|+.++|||||+++++|.. ...+|+||||
T Consensus 59 ~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----------------~~~~~~v~e~ 122 (350)
T d1rdqe_ 59 LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD----------------NSNLYMVMEY 122 (350)
T ss_dssp EEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----------------SSEEEEEEEC
T ss_pred EEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc----------------cccccccccc
Confidence 47899999999999997653 233455678899999999999999999999987 6689999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
+.+ +|...+.+. ..+++.+++.|+.||+.||.|||+++||||||||+||||+.++++||+|||+|+.+... ...
T Consensus 123 ~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~----~~~ 197 (350)
T d1rdqe_ 123 VAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWT 197 (350)
T ss_dssp CTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----BCC
T ss_pred ccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc----ccc
Confidence 996 455555443 46999999999999999999999999999999999999999999999999999876532 334
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
.+||+.|||||++.+ ..++.++||||||||||+|++|+.||.+.+....+.++.......+
T Consensus 198 ~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p------------------ 258 (350)
T d1rdqe_ 198 LCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP------------------ 258 (350)
T ss_dssp CEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC------------------
T ss_pred ccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCC------------------
Confidence 678999999999987 6789999999999999999999999999999888888866432211
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 286 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----t~~elL~h~~f~~ 286 (472)
..+++++.+||++||..||++|+ |++|||+|+||..
T Consensus 259 ------------~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 259 ------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp ------------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred ------------ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccC
Confidence 24678899999999999999995 9999999999954
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=399.58 Aligned_cols=239 Identities=21% Similarity=0.391 Sum_probs=205.3
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+++.|++.||||+++..... ...+.+|+++|++++|||||+++++|++ .+.+|||||||
T Consensus 23 ~~~~~~~~~~~AiK~i~~~~~~---~~~~~~Ei~il~~l~HpnIv~~~~~~~~----------------~~~~~lvmE~~ 83 (321)
T d1tkia_ 23 RCVETSSKKTYMAKFVKVKGTD---QVLVKKEISILNIARHRNILHLHESFES----------------MEELVMIFEFI 83 (321)
T ss_dssp EEEETTTTEEEEEEEECCCTHH---HHHHHHHHHHHHHSCCTTBCCEEEEEEE----------------TTEEEEEECCC
T ss_pred EEEECCCCcEEEEEEEcCCccc---HHHHHHHHHHHHhCCCCCCCeEEEEEEE----------------CCEEEEEEecC
Confidence 4789999999999999865322 3457799999999999999999999987 66899999999
Q ss_pred CC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC--CCeEEeeccceeeeccCCCCccc
Q 012062 81 DH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE--GNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 81 ~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~--~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
++ +|.+++.+....+++.+++.|+.||+.||+|||++||+||||||+||||+.+ ..+||+|||+++..... ....
T Consensus 84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~--~~~~ 161 (321)
T d1tkia_ 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFR 161 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--CEEE
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC--Cccc
Confidence 96 7877777666679999999999999999999999999999999999999854 47999999999876432 2334
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..++|+.|+|||++.+ ..|+.++||||||||||+|++|..||.+.+..+.+.+|.+....++
T Consensus 162 ~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----------------- 223 (321)
T d1tkia_ 162 LLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD----------------- 223 (321)
T ss_dssp EEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC-----------------
T ss_pred ccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-----------------
Confidence 4578999999999876 5789999999999999999999999999999999988876433222
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
...+..+++++++||++||..||++|+|++|+|+||||...
T Consensus 224 ---------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 224 ---------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp ---------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred ---------hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 23445678899999999999999999999999999999653
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=385.23 Aligned_cols=267 Identities=42% Similarity=0.788 Sum_probs=226.3
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+++.|++.||||+++.....+.....+.+|+.+|+.++|+|||+++++|.. ...++||||++
T Consensus 20 ~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~----------------~~~~~iv~~~~ 83 (292)
T d1unla_ 20 KAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS----------------DKKLTLVFEFC 83 (292)
T ss_dssp EEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC----------------SSEEEEEEECC
T ss_pred EEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc----------------ccceeEEeeec
Confidence 58899999999999998877666677888999999999999999999999987 66889999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
.++++..+......+++.+++.+++||+.||+|||+++|+||||||+||||+.++++||+|||+|+...... .......
T Consensus 84 ~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~-~~~~~~~ 162 (292)
T d1unla_ 84 DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCYSAEV 162 (292)
T ss_dssp SEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-SCCCSCC
T ss_pred cccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC-ccceeec
Confidence 987776666666789999999999999999999999999999999999999999999999999998765432 2333446
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPI-LPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
++..|+|||++.....++.++|||||||++|+|++|+.| |.+.+..+.+.++....+.+....|+.......+......
T Consensus 163 ~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (292)
T d1unla_ 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242 (292)
T ss_dssp SCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCC
T ss_pred cccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccc
Confidence 688999999998766689999999999999999999876 6677888889999999998888888777665554333222
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 285 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~ 285 (472)
. ...........++..+++||++||+.||++|+|++|||+||||.
T Consensus 243 ~-~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~ 287 (292)
T d1unla_ 243 P-ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287 (292)
T ss_dssp C-TTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGS
T ss_pred c-ccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhc
Confidence 1 12233344557889999999999999999999999999999995
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=397.97 Aligned_cols=267 Identities=31% Similarity=0.529 Sum_probs=210.4
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+++.||+.||||+++.+... ..+|+++|++|+|+|||+++++|...... ....++|||||||
T Consensus 38 ~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~----------~~~~~~~lv~Ey~ 101 (350)
T d1q5ka_ 38 QAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEK----------KDEVYLNLVLDYV 101 (350)
T ss_dssp EEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--C----------CSCCEEEEEEECC
T ss_pred EEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCcc----------CCceEEEEEEecc
Confidence 5889999999999999865322 23799999999999999999999763321 1245789999999
Q ss_pred CCChhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC-CeEEeeccceeeeccCCCCcc
Q 012062 81 DHDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG-NLKLADFGLARSFSYDHNNTL 156 (472)
Q Consensus 81 ~g~l~~~~~---~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~-~vkL~DFG~a~~~~~~~~~~~ 156 (472)
++++...+. .....+++.+++.|++||+.||+|||++||+||||||+||||+.++ .+||+|||+++.+... ...
T Consensus 102 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~--~~~ 179 (350)
T d1q5ka_ 102 PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPN 179 (350)
T ss_dssp SEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT--SCC
T ss_pred CCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCC--ccc
Confidence 987655443 3455799999999999999999999999999999999999999775 7999999999876432 234
Q ss_pred ccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccC
Q 012062 157 TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236 (472)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (472)
...++|..|+|||++.+...++.++||||||||+|||++|+.||...+..+++.++++.++.+....|...........+
T Consensus 180 ~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~ 259 (350)
T d1q5ka_ 180 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 259 (350)
T ss_dssp CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCC
T ss_pred ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccc
Confidence 45688999999999987677999999999999999999999999999999999999988887765544433221100000
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
.. .............+++++++||.+||..||++|+|+.|+|+|+||..
T Consensus 260 ~~-~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 308 (350)
T d1q5ka_ 260 PQ-IKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308 (350)
T ss_dssp CC-CCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred cc-cccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 00 00000111223457889999999999999999999999999999954
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.3e-49 Score=399.30 Aligned_cols=239 Identities=22% Similarity=0.335 Sum_probs=191.7
Q ss_pred CceeccCCCEEEEEEeecCCc-CCCchhhHH---HHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEE
Q 012062 1 MAREIKTGEIVALKKIRMDNE-KEGFPITAI---REIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMV 76 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~-~~~~~~~~~---~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iV 76 (472)
+|+++.||+.||||++++... .......++ +|+++++.++|||||+++++|.+ .+.+|||
T Consensus 22 ~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~----------------~~~~~iv 85 (364)
T d1omwa3 22 GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT----------------PDKLSFI 85 (364)
T ss_dssp EEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC----------------SSEEEEE
T ss_pred EEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE----------------CCEEEEE
Confidence 478999999999999975421 111222333 44677777889999999999987 6689999
Q ss_pred EecCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCc
Q 012062 77 FEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT 155 (472)
Q Consensus 77 mEy~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~ 155 (472)
||||++ +|..++.+ ...+++.+++.|++||+.||+|||+++||||||||+||||+.++.+||+|||+|+.+... .
T Consensus 86 mE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~---~ 161 (364)
T d1omwa3 86 LDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---K 161 (364)
T ss_dssp ECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS---C
T ss_pred EEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC---c
Confidence 999995 66666654 346899999999999999999999999999999999999999999999999999876533 2
Q ss_pred cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcccc
Q 012062 156 LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 235 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (472)
....+||+.|+|||++.....|+.++||||||||||+|++|+.||.+.+..+......... .....
T Consensus 162 ~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~-~~~~~------------- 227 (364)
T d1omwa3 162 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-TMAVE------------- 227 (364)
T ss_dssp CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSS-SCCCC-------------
T ss_pred ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-cCCCC-------------
Confidence 3446799999999999765678999999999999999999999998766544333222211 11111
Q ss_pred CCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCC-----HHHHhcCCCCCC
Q 012062 236 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 286 (472)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t-----~~elL~h~~f~~ 286 (472)
.+..+++++++||.+||..||++|+| ++||++|+||+.
T Consensus 228 -------------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 228 -------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp -------------CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred -------------CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 11247789999999999999999999 799999999964
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=393.07 Aligned_cols=237 Identities=26% Similarity=0.441 Sum_probs=199.8
Q ss_pred CceeccCCCEEEEEEeecCC-cCCCchhhHHHHHHHHH-hcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 1 MAREIKTGEIVALKKIRMDN-EKEGFPITAIREIKILK-KLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~-~~~~~~~~~~~Ei~il~-~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
+|+++.|++.||||+++++. ..+.....+++|+.++. .++|||||++++++++ ++.+|||||
T Consensus 20 ~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~----------------~~~~yivmE 83 (320)
T d1xjda_ 20 LAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT----------------KENLFFVME 83 (320)
T ss_dssp EEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC----------------SSEEEEEEE
T ss_pred EEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc----------------CCceeEEEe
Confidence 47899999999999998653 22334556677777765 6899999999999987 668999999
Q ss_pred cCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 79 YMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 79 y~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
||++ +|..++.. ...+++.+++.|+.||+.||+|||+++|+||||||+|||++.++++||+|||+|+..... .....
T Consensus 84 y~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~-~~~~~ 161 (320)
T d1xjda_ 84 YLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-DAKTN 161 (320)
T ss_dssp CCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-TCCBC
T ss_pred ecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc-ccccc
Confidence 9996 56665543 447999999999999999999999999999999999999999999999999999865433 23344
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..+||+.|+|||++.+ ..|+.++||||||||+|+|++|+.||.+.+..+++.++.......
T Consensus 162 ~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~------------------ 222 (320)
T d1xjda_ 162 TFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY------------------ 222 (320)
T ss_dssp CCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC------------------
T ss_pred ccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC------------------
Confidence 5688999999999987 678999999999999999999999999999988888875432110
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHH-HHhcCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAK-DALDSEYFWT 286 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~-elL~h~~f~~ 286 (472)
.+.+++++++||++||..||++|+|+. |+++||||+.
T Consensus 223 ------------p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 223 ------------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp ------------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred ------------CccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence 124678999999999999999999996 8999999954
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-49 Score=394.53 Aligned_cols=274 Identities=37% Similarity=0.603 Sum_probs=215.3
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+++.||+.||||+++.... ....+.+++|+.+|++|+|+|||++++++..... .....+||+|+++
T Consensus 26 ~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~-----------~~~~~~~l~~~~~ 93 (345)
T d1pmea_ 26 SAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDIIRAPTI-----------EQMKDVYLVTHLM 93 (345)
T ss_dssp EEEETTTCSEEEEEEECCTTC-HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST-----------TTCCCEEEEEECC
T ss_pred EEEECCCCcEEEEEEEehhcC-hHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc-----------cccceEEEEEeec
Confidence 478999999999999975442 2345678899999999999999999999976321 2245678888888
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCC--CCcccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH--NNTLTN 158 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~--~~~~~~ 158 (472)
.++|.+++... ++++.+++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+...... ......
T Consensus 94 ~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 171 (345)
T d1pmea_ 94 GADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 171 (345)
T ss_dssp CEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCC
T ss_pred CCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeecc
Confidence 88998887653 59999999999999999999999999999999999999999999999999998764432 223455
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccc-cCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN-HFK 237 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-~~~ 237 (472)
.++|+.|+|||++.....++.++||||+|||+|+|++|+.||.+.+..++...+......+............... ...
T Consensus 172 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (345)
T d1pmea_ 172 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 251 (345)
T ss_dssp CCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHT
T ss_pred ccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhccccc
Confidence 6789999999998766678999999999999999999999999999988888887776655432211111100000 000
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCCC
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 288 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~~ 288 (472)
............+..++.++++||.+||+.||++|||++|||+||||+...
T Consensus 252 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 252 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp SCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred CCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 000111223456677889999999999999999999999999999997543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-49 Score=390.15 Aligned_cols=242 Identities=24% Similarity=0.351 Sum_probs=191.6
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.|++.||||+++.. ..+.+|++++.++ +|||||+++++|++.. ..+.++||||||
T Consensus 30 ~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~------------~~~~~~~ivmEy 90 (335)
T d2ozaa1 30 QIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLY------------AGRKCLLIVMEC 90 (335)
T ss_dssp EEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE------------TTEEEEEEEEEC
T ss_pred EEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecc------------cCCCEEEEEEEC
Confidence 5889999999999999732 3567899987654 8999999999997521 114579999999
Q ss_pred CCC-ChhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC---CCCeEEeeccceeeeccCCCC
Q 012062 80 MDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN---EGNLKLADFGLARSFSYDHNN 154 (472)
Q Consensus 80 ~~g-~l~~~~~~~-~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~---~~~vkL~DFG~a~~~~~~~~~ 154 (472)
|++ +|.+++.+. ...|++.+++.|++||+.||+|||++||+||||||+|||++. ++.+||+|||+|+..... .
T Consensus 91 ~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~--~ 168 (335)
T d2ozaa1 91 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--N 168 (335)
T ss_dssp CCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC--C
T ss_pred CCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCC--C
Confidence 985 888877654 346999999999999999999999999999999999999986 456999999999876543 2
Q ss_pred ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 155 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
.....+||+.|||||++.+ ..|+.++||||||||||+|++|+.||.+.+..+....+......... ..
T Consensus 169 ~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~-------~~---- 236 (335)
T d2ozaa1 169 SLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-------EF---- 236 (335)
T ss_dssp CCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSS-------SC----
T ss_pred ccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCC-------CC----
Confidence 3445689999999999876 57899999999999999999999999988766655544332211100 00
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
....+..+++++++||++||+.||++|+|+.|||+|+||..
T Consensus 237 -----------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 237 -----------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp -----------CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred -----------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence 01123468899999999999999999999999999999964
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=390.33 Aligned_cols=271 Identities=37% Similarity=0.586 Sum_probs=211.3
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+++.||+.||||++++..........+.+|+++|++|+|+|||+++++|...... .....+||+|+++
T Consensus 36 ~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~----------~~~~~~~i~~~~~ 105 (348)
T d2gfsa1 36 AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL----------EEFNDVYLVTHLM 105 (348)
T ss_dssp EEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSST----------TTCCCCEEEEECC
T ss_pred EEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccc----------ccCceEEEEEeec
Confidence 588999999999999987654444556788999999999999999999999764321 1134566666666
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
.++|.+++.. .++++.+++.|++||+.||+|||++||+||||||+|||++.++.+||+|||++..... ......
T Consensus 106 gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~----~~~~~~ 179 (348)
T d2gfsa1 106 GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYV 179 (348)
T ss_dssp SEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG----GGSSSC
T ss_pred CCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc----cccccc
Confidence 6788877754 3699999999999999999999999999999999999999999999999999876432 334467
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccc-cCCCc
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN-HFKPS 239 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 239 (472)
+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+.......+.+..+.+....+.......... .....
T Consensus 180 g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (348)
T d2gfsa1 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 259 (348)
T ss_dssp HHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSC
T ss_pred ccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcc
Confidence 89999999998876678999999999999999999999999999999999998887765543333222100000 00000
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
..........+..++++++|||++||..||++|+|++|||+||||..-
T Consensus 260 ~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 260 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp CCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred cCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 111223445566789999999999999999999999999999999754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-49 Score=379.90 Aligned_cols=230 Identities=24% Similarity=0.325 Sum_probs=187.6
Q ss_pred CceeccCCCEEEEEEeecCCcCC----CchhhHHHHHHHHHhcC--CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEE
Q 012062 1 MAREIKTGEIVALKKIRMDNEKE----GFPITAIREIKILKKLQ--HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTY 74 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~----~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 74 (472)
+|+++.||+.||||+++...... .....+.+|+.+|++++ |||||+++++|++ .+.+|
T Consensus 22 ~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~----------------~~~~~ 85 (273)
T d1xwsa_ 22 SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER----------------PDSFV 85 (273)
T ss_dssp EEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC----------------SSEEE
T ss_pred EEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee----------------CCeEE
Confidence 47899999999999998653221 12234668999999997 8999999999987 66899
Q ss_pred EEEecCCC--ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC-CCeEEeeccceeeeccC
Q 012062 75 MVFEYMDH--DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE-GNLKLADFGLARSFSYD 151 (472)
Q Consensus 75 iVmEy~~g--~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~-~~vkL~DFG~a~~~~~~ 151 (472)
|||||+.+ ++..++.+ ...+++.+++.|++||+.||+|||+++|+||||||+||||+.+ +.+||+|||+|+....
T Consensus 86 lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~- 163 (273)
T d1xwsa_ 86 LILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD- 163 (273)
T ss_dssp EEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS-
T ss_pred EEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccc-
Confidence 99999985 44444443 3469999999999999999999999999999999999999854 6899999999986543
Q ss_pred CCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCC
Q 012062 152 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 231 (472)
Q Consensus 152 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (472)
...+..+||+.|+|||++.+...++.++|||||||+||+|++|+.||...+ .+......
T Consensus 164 --~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~------------- 222 (273)
T d1xwsa_ 164 --TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVF------------- 222 (273)
T ss_dssp --SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCC-------------
T ss_pred --ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccC-------------
Confidence 234556899999999999875556788999999999999999999997632 12221100
Q ss_pred ccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 232 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
+...+++++++||++||+.||++|||++|+|+||||+.
T Consensus 223 -----------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 260 (273)
T d1xwsa_ 223 -----------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260 (273)
T ss_dssp -----------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred -----------------CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 01246789999999999999999999999999999954
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-49 Score=393.46 Aligned_cols=271 Identities=31% Similarity=0.506 Sum_probs=208.4
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+|+.||+.||||+++...........+.+|+.+|++++|||||+++++|...+.. ....++|||||||
T Consensus 35 ~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~----------~~~~~~~iv~Ey~ 104 (355)
T d2b1pa1 35 AAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL----------EEFQDVYLVMELM 104 (355)
T ss_dssp EEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST----------TTCCEEEEEEECC
T ss_pred EEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccc----------ccCceeEEEEecc
Confidence 578999999999999987655544556788999999999999999999999864321 1256899999999
Q ss_pred CCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 81 DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 81 ~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
.++++..+.. .+++.+++.|++||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ......+
T Consensus 105 ~~~l~~~~~~---~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~--~~~~~~~ 179 (355)
T d2b1pa1 105 DANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYV 179 (355)
T ss_dssp SEEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------------
T ss_pred chHHHHhhhc---CCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc--ccccccc
Confidence 9988877653 5899999999999999999999999999999999999999999999999998765432 2334557
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC--------Cc
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM--------PA 232 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--------~~ 232 (472)
+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+.++......+....|...... ..
T Consensus 180 ~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (355)
T d2b1pa1 180 VTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 258 (355)
T ss_dssp -CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCC
T ss_pred ccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCcc
Confidence 8999999999987 67899999999999999999999999999999999999887776655444332210 00
Q ss_pred cccCCCc----hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCCC
Q 012062 233 YNHFKPS----RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 287 (472)
Q Consensus 233 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~~ 287 (472)
....... .............++.++++||++||..||++||||+|||+||||...
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 259 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp CCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred ccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 0000000 000011112234567889999999999999999999999999999653
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-48 Score=374.62 Aligned_cols=234 Identities=19% Similarity=0.262 Sum_probs=188.4
Q ss_pred CCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC-CChh
Q 012062 7 TGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD-HDLT 85 (472)
Q Consensus 7 tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~-g~l~ 85 (472)
.+..||||+++.........+.+.+|+++|++++|||||++++++.. ..+|||||||+ ++|.
T Consensus 29 ~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-----------------~~~~lv~Ey~~~g~L~ 91 (276)
T d1uwha_ 29 WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-----------------PQLAIVTQWCEGSSLY 91 (276)
T ss_dssp SSSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----------------SSCEEEEECCCEEEHH
T ss_pred ECCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-----------------cEEEEEEecCCCCCHH
Confidence 44579999998776555566788899999999999999999998753 35799999999 5788
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCC-CCccccccccCC
Q 012062 86 GLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH-NNTLTNRVITLW 164 (472)
Q Consensus 86 ~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~~~gt~~ 164 (472)
+++......+++.++..|+.||+.||+|||+++||||||||+||||+.++++||+|||+|+...... ........+|+.
T Consensus 92 ~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~ 171 (276)
T d1uwha_ 92 HHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171 (276)
T ss_dssp HHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGG
T ss_pred HHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcc
Confidence 8887766679999999999999999999999999999999999999999999999999997765332 233445678999
Q ss_pred CCChhhhcCC--CCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhh
Q 012062 165 YRPPELLLGA--TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTM 242 (472)
Q Consensus 165 y~aPE~l~~~--~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (472)
|||||++... ..|+.++|||||||+||||++|+.||.+.+....+..+.......+.
T Consensus 172 y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~--------------------- 230 (276)
T d1uwha_ 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD--------------------- 230 (276)
T ss_dssp GCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC---------------------
T ss_pred cCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc---------------------
Confidence 9999998642 35788999999999999999999999998877766655543222111
Q ss_pred hhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 243 KRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 243 ~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
.......+++++.+||.+||..||++|||+.||+++
T Consensus 231 ---~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 231 ---LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp ---GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 111223577899999999999999999999999864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1e-47 Score=380.58 Aligned_cols=262 Identities=31% Similarity=0.495 Sum_probs=197.9
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC-CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.|++.||||+++... ...+.+|+++|+.|+ |+||++++++|.... ...+||||||
T Consensus 53 ~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~--------------~~~~~~v~e~ 113 (328)
T d3bqca1 53 EAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPV--------------SRTPALVFEH 113 (328)
T ss_dssp EEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTT--------------TCSEEEEEEC
T ss_pred EEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecC--------------CCceeEEEee
Confidence 48899999999999997432 456789999999996 999999999998632 4578999999
Q ss_pred CCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC-CeEEeeccceeeeccCCCCcccc
Q 012062 80 MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG-NLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 80 ~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~-~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
|+++.+..+. ..+++.+++.|++||+.||+|||++||+||||||+||||+.++ .+||+|||+|+..... .....
T Consensus 114 ~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~--~~~~~ 188 (328)
T d3bqca1 114 VNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--QEYNV 188 (328)
T ss_dssp CCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT--CCCCS
T ss_pred cCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC--Ccccc
Confidence 9975544333 3599999999999999999999999999999999999999766 5999999999876533 23445
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCCCCCCccCCCC---Cccc
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK-NEAEQLSKIFELCGSPDETIWPGVSKM---PAYN 234 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~---~~~~ 234 (472)
.++|+.|+|||++.+...++.++|||||||++|+|++|+.||... +..++...+.+.++.+....|...... ..+.
T Consensus 189 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 268 (328)
T d3bqca1 189 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 268 (328)
T ss_dssp CCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGG
T ss_pred cccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccc
Confidence 678999999999988677899999999999999999999998755 455555666555443211111100000 0000
Q ss_pred cCCCc----hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcCCCCCC
Q 012062 235 HFKPS----RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 286 (472)
Q Consensus 235 ~~~~~----~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h~~f~~ 286 (472)
..... .............++++++|||++||..||++|+|++|||+||||+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~ 324 (328)
T d3bqca1 269 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324 (328)
T ss_dssp GTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred hhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 00000 00000111223457889999999999999999999999999999975
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=367.25 Aligned_cols=230 Identities=22% Similarity=0.341 Sum_probs=180.4
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|+++ +++.||||+++.+.. ....+.+|++++++++|||||++++++.. .+.+|||||||.
T Consensus 24 ~~~~-~~~~vAvK~i~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----------------~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 24 GYWL-NKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLE----------------QAPICLVFEFME 83 (263)
T ss_dssp EEET-TTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS----------------SSSCEEEEECCT
T ss_pred EEEC-CCCEEEEEEECCCcC---cHHHHHHHHHHHHhcCCCCcccccceecc----------------CCceEEEEEecC
Confidence 3443 677899999975432 34578899999999999999999999986 457899999998
Q ss_pred C-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 82 H-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 82 g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+ +|.+++......+++..++.|+.||+.||+|||+++|+||||||+||||+.++++||+|||+++.+............
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~ 163 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK 163 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------------
T ss_pred CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeeccee
Confidence 5 677777776667999999999999999999999999999999999999999999999999999877654444445567
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
+|..|+|||++.+ ..|+.++|||||||+||||++ |.++|...+..+.+..+........
T Consensus 164 gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~------------------- 223 (263)
T d1sm2a_ 164 FPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK------------------- 223 (263)
T ss_dssp -CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC-------------------
T ss_pred cCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC-------------------
Confidence 8999999999986 578999999999999999999 5777887777777777655321111
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
...+++++.+||.+||..||++|||++|||++
T Consensus 224 ----------p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 224 ----------PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp ----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------ccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 01356789999999999999999999999874
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.7e-48 Score=373.49 Aligned_cols=239 Identities=23% Similarity=0.365 Sum_probs=187.7
Q ss_pred CceeccCCCEEEEEEeecCCcC-CCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.||+.||||+++..... ......+.+|+++|+.++|||||++++++...+. ....+||||||
T Consensus 25 ~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~------------~~~~~~lvmE~ 92 (277)
T d1o6ya_ 25 LARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP------------AGPLPYIVMEY 92 (277)
T ss_dssp EEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS------------SSEEEEEEEEC
T ss_pred EEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccC------------CCceEEEEEEC
Confidence 4789999999999999876433 2345568899999999999999999999986321 13458999999
Q ss_pred CCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCC--CCcc
Q 012062 80 MDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH--NNTL 156 (472)
Q Consensus 80 ~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~--~~~~ 156 (472)
|++ +|...+.. ...+++.+++.|++||+.||+|||++||+||||||+||||+.++.++|+|||++....... ....
T Consensus 93 ~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~ 171 (277)
T d1o6ya_ 93 VDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 171 (277)
T ss_dssp CCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---------
T ss_pred CCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccccccccc
Confidence 996 45544443 3479999999999999999999999999999999999999999999999999987654322 2234
Q ss_pred ccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccC
Q 012062 157 TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236 (472)
Q Consensus 157 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (472)
...+||+.|+|||++.+ ..++.++||||||||||+|++|+.||.+.+..+.+.++......+..
T Consensus 172 ~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~--------------- 235 (277)
T d1o6ya_ 172 AAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS--------------- 235 (277)
T ss_dssp -------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGG---------------
T ss_pred ccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCc---------------
Confidence 45678999999999986 57899999999999999999999999999998888877654322211
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCC-CHHHHh
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-SAKDAL 279 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-t~~elL 279 (472)
.....+++++++||++||+.||++|| |+++++
T Consensus 236 -----------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~ 268 (277)
T d1o6ya_ 236 -----------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 268 (277)
T ss_dssp -----------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred -----------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHH
Confidence 11235788999999999999999999 566654
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-47 Score=372.76 Aligned_cols=231 Identities=20% Similarity=0.284 Sum_probs=188.0
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecC
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYM 80 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~ 80 (472)
+|+++.|++.||||+++.+.. ..+.+++|+++|++|+|||||+++++|.+ .+.+|||||||
T Consensus 35 ~a~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~----------------~~~~~iv~E~~ 95 (287)
T d1opja_ 35 EGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTR----------------EPPFYIITEFM 95 (287)
T ss_dssp EEEEGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS----------------SSSCEEEEECC
T ss_pred EEEECCCCeEEEEEEECCccc---hHHHHHHHHHHHHhCCCCCEecCCccEee----------------CCeeEEEeecc
Confidence 478889999999999975432 34578899999999999999999999986 55789999999
Q ss_pred CC-ChhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccc
Q 012062 81 DH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 158 (472)
Q Consensus 81 ~g-~l~~~~~~-~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~ 158 (472)
++ +|..++.+ ....+++..++.|+.||+.||+|||+++|+||||||+||||+.++++||+|||+|+............
T Consensus 96 ~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~ 175 (287)
T d1opja_ 96 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 175 (287)
T ss_dssp TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETT
T ss_pred cCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCceeecc
Confidence 95 66666543 44568999999999999999999999999999999999999999999999999998765544444444
Q ss_pred ccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCC-CCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCC
Q 012062 159 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPIL-PGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 237 (472)
Q Consensus 159 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (472)
..+|+.|+|||++.+ ..|+.++|||||||++|||+++..|| .+.+....+..+... ..+.
T Consensus 176 ~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~-~~~~----------------- 236 (287)
T d1opja_ 176 AKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRME----------------- 236 (287)
T ss_dssp EEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CCCC-----------------
T ss_pred ccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC-CCCC-----------------
Confidence 567899999999987 57899999999999999999966554 444544444333221 1110
Q ss_pred CchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 238 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....+++++++||.+||+.||++|||+.||++
T Consensus 237 -----------~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 237 -----------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp -----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 11246788999999999999999999999976
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-48 Score=372.53 Aligned_cols=229 Identities=19% Similarity=0.269 Sum_probs=184.2
Q ss_pred eccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-
Q 012062 4 EIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH- 82 (472)
Q Consensus 4 ~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g- 82 (472)
+..+++.||||+++...........+++|+++|++|+|||||+++++++. +.+|||||||++
T Consensus 30 ~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-----------------~~~~lvmE~~~~g 92 (277)
T d1xbba_ 30 MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-----------------ESWMLVMEMAELG 92 (277)
T ss_dssp CSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-----------------SSEEEEEECCTTE
T ss_pred cCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-----------------CCEEEEEEcCCCC
Confidence 34567889999998665555556678999999999999999999999864 247899999996
Q ss_pred ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC--cccccc
Q 012062 83 DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN--TLTNRV 160 (472)
Q Consensus 83 ~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~--~~~~~~ 160 (472)
+|.+++.+ ...+++.+++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.+...... ......
T Consensus 93 ~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~ 171 (277)
T d1xbba_ 93 PLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 171 (277)
T ss_dssp EHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----C
T ss_pred cHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccC
Confidence 56666554 346999999999999999999999999999999999999999999999999999876543322 223346
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
+|+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+....+.+.....
T Consensus 172 gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~-------------------- 230 (277)
T d1xbba_ 172 WPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG-------------------- 230 (277)
T ss_dssp CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC--------------------
T ss_pred CCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCC--------------------
Confidence 7999999999986 568999999999999999997 899999998887776664321110
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
....+++++.+||.+||..||++|||+++|++
T Consensus 231 ---------~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~ 262 (277)
T d1xbba_ 231 ---------CPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 262 (277)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---------CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 01246778999999999999999999999853
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=360.74 Aligned_cols=230 Identities=23% Similarity=0.343 Sum_probs=195.9
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++ .+++.||||+++.+.. ....+++|++++++++|||||++++++.+ ++.+||||||++
T Consensus 23 ~~~-~~~~~vAvK~l~~~~~---~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~----------------~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 23 GKW-RGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTK----------------QRPIFIITEYMA 82 (258)
T ss_dssp EEE-TTTEEEEEEEEESSSS---CHHHHHHHHHHHHTCCCTTBCCEEEEECC----------------SSSEEEEEECCT
T ss_pred EEE-CCCCEEEEEEECcCcC---CHHHHHHHHHHHHhcCCCceeeEEEEEee----------------CCceEEEEEccC
Confidence 454 4788999999986543 24578999999999999999999999976 567999999998
Q ss_pred C-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 82 H-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 82 g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+ ++..++......+++..++.|+.||++||+|||++||+||||||+||||++++.+||+|||+++.+............
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 162 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK 162 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSC
T ss_pred CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeecccC
Confidence 5 666776666667999999999999999999999999999999999999999999999999999876655555555677
Q ss_pred ccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 161 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 161 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
+|..|+|||++.+ ..++.++|||||||++|||+| |+.||.+.+..+...++.+....+..
T Consensus 163 ~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p------------------ 223 (258)
T d1k2pa_ 163 FPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP------------------ 223 (258)
T ss_dssp CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCC------------------
T ss_pred CCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc------------------
Confidence 8999999999986 568999999999999999998 89999999998888877653221111
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
..+++++.+||++||+.||++|||++|||+|
T Consensus 224 -----------~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 224 -----------HLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp -----------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -----------ccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 1356789999999999999999999999976
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.5e-47 Score=369.07 Aligned_cols=232 Identities=22% Similarity=0.344 Sum_probs=179.5
Q ss_pred ceeccCCC---EEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 2 AREIKTGE---IVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 2 a~~~~tg~---~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
|+++.+++ .||||+++..... ...+.+++|+++|++|+|||||++++++.. .+.+|||||
T Consensus 45 ~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~----------------~~~~~iv~E 107 (299)
T d1jpaa_ 45 GHLKLPGKREIFVAIKTLKSGYTE-KQRRDFLSEASIMGQFDHPNVIHLEGVVTK----------------STPVMIITE 107 (299)
T ss_dssp EEECC---CCEEEEEEECCSSCCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEECS----------------SSSCEEEEE
T ss_pred EEEeCCCCEEEEEEEEEECcccCH-HHHHHHHHHHHHHHhCCCCCCccEEEEEee----------------CCEEEEEEE
Confidence 55666655 5889988754332 234578899999999999999999999976 557899999
Q ss_pred cCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC---
Q 012062 79 YMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN--- 154 (472)
Q Consensus 79 y~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~--- 154 (472)
||++ +|.+++......+++.++..|+.||+.||+|||+++|+||||||+||||+.++++||+|||+|+.+......
T Consensus 108 y~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~ 187 (299)
T d1jpaa_ 108 FMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 187 (299)
T ss_dssp CCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------------
T ss_pred ecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCccee
Confidence 9996 566667666667999999999999999999999999999999999999999999999999999876543221
Q ss_pred -ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCc
Q 012062 155 -TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 232 (472)
Q Consensus 155 -~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (472)
......+|+.|||||++.. ..++.++||||||||||||++ |+.||.+.+..+.+..+.+....+.
T Consensus 188 ~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~------------ 254 (299)
T d1jpaa_ 188 TSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP------------ 254 (299)
T ss_dssp --------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC------------
T ss_pred eecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC------------
Confidence 1222456899999999986 578999999999999999998 8999999998888877754322111
Q ss_pred cccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 233 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...++.++.+||.+||+.||++|||+.||++
T Consensus 255 -----------------~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~ 285 (299)
T d1jpaa_ 255 -----------------PMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285 (299)
T ss_dssp -----------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----------------CccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 1236778999999999999999999999985
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=372.96 Aligned_cols=234 Identities=24% Similarity=0.370 Sum_probs=187.6
Q ss_pred ceeccCCC-----EEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEE
Q 012062 2 AREIKTGE-----IVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYM 75 (472)
Q Consensus 2 a~~~~tg~-----~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i 75 (472)
|++..+++ .||||++...... .....+++|+.+|+++ +|||||++++++.+ .+.+||
T Consensus 56 a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~----------------~~~~~l 118 (325)
T d1rjba_ 56 ATAYGISKTGVSIQVAVKMLKEKADS-SEREALMSELKMMTQLGSHENIVNLLGACTL----------------SGPIYL 118 (325)
T ss_dssp EEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS----------------SSSCEE
T ss_pred EEEcCCCcccceeEEEEEEeccccCH-HHHHHHHHHHHHHHHhcCCCcEeEEEEEEee----------------CCeEEE
Confidence 44544443 6999998755332 3456788999999998 89999999999987 557899
Q ss_pred EEecCCC-ChhhhhcCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc
Q 012062 76 VFEYMDH-DLTGLADRPG----------------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 132 (472)
Q Consensus 76 VmEy~~g-~l~~~~~~~~----------------------~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~ 132 (472)
|||||++ +|.+++.... ..+++.+++.|+.||+.||+|||+++||||||||+|||++
T Consensus 119 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~ 198 (325)
T d1rjba_ 119 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT 198 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEE
T ss_pred EEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccc
Confidence 9999985 7777765432 2478999999999999999999999999999999999999
Q ss_pred CCCCeEEeeccceeeeccCCCC-ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 012062 133 NEGNLKLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLS 210 (472)
Q Consensus 133 ~~~~vkL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~ 210 (472)
.++++||+|||+|+........ ......+|+.|||||++.+ ..++.++||||||||||||++ |+.||.+.+..+.+.
T Consensus 199 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~ 277 (325)
T d1rjba_ 199 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY 277 (325)
T ss_dssp TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999876544332 2334567999999999986 678999999999999999997 899999988777777
Q ss_pred HHHHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 211 KIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 211 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
++++....++. ...+++++++||.+||+.||++|||++||++|
T Consensus 278 ~~~~~~~~~~~----------------------------p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 278 KLIQNGFKMDQ----------------------------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHTTCCCCC----------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCCCC----------------------------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 76653322111 12467789999999999999999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=364.20 Aligned_cols=226 Identities=20% Similarity=0.270 Sum_probs=187.1
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Ch
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL 84 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l 84 (472)
.++..||||+++..... .....+++|+++|++|+|||||+++++++. +.+|||||||++ +|
T Consensus 34 ~~~~~vAvK~l~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-----------------~~~~lvmE~~~~g~L 95 (285)
T d1u59a_ 34 KKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-----------------EALMLVMEMAGGGPL 95 (285)
T ss_dssp -CCEEEEEEEECSSCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEES-----------------SSEEEEEECCTTEEH
T ss_pred CCcEEEEEEEEChhcCH-HHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----------------CeEEEEEEeCCCCcH
Confidence 44557999999765432 245678899999999999999999999864 257999999996 67
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC--Ccccccccc
Q 012062 85 TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTLTNRVIT 162 (472)
Q Consensus 85 ~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~--~~~~~~~gt 162 (472)
.+++......+++.+++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.+..... .......+|
T Consensus 96 ~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt 175 (285)
T d1u59a_ 96 HKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175 (285)
T ss_dssp HHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCC
T ss_pred HHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccC
Confidence 777666666799999999999999999999999999999999999999999999999999987754332 222344678
Q ss_pred CCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchh
Q 012062 163 LWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 241 (472)
Q Consensus 163 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (472)
+.|+|||++.. ..++.++|||||||++|||+| |+.||.+.+..+.+..+.+.....
T Consensus 176 ~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~---------------------- 232 (285)
T d1u59a_ 176 LKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME---------------------- 232 (285)
T ss_dssp GGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC----------------------
T ss_pred ccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC----------------------
Confidence 99999999976 578999999999999999998 899999988887777665422110
Q ss_pred hhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHh
Q 012062 242 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 279 (472)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL 279 (472)
....+++++.+||.+||..||++|||+.+|+
T Consensus 233 -------~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~ 263 (285)
T d1u59a_ 233 -------CPPECPPELYALMSDCWIYKWEDRPDFLTVE 263 (285)
T ss_dssp -------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHH
T ss_pred -------CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 1124677899999999999999999999885
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-47 Score=364.38 Aligned_cols=229 Identities=21% Similarity=0.404 Sum_probs=187.1
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Ch
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL 84 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l 84 (472)
.+++.||||+++.+.. ..+.+.+|+++|++|+|||||++++++.+ +.+|||||||++ +|
T Consensus 35 ~~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-----------------~~~~iv~Ey~~~g~L 94 (272)
T d1qpca_ 35 NGHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-----------------EPIYIITEYMENGSL 94 (272)
T ss_dssp TTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-----------------SSCEEEEECCTTCBH
T ss_pred CCCCEEEEEEEccCcC---CHHHHHHHHHHHHhCCCCCEeEEEeeecc-----------------CCeEEEEEeCCCCcH
Confidence 3678899999975432 34578999999999999999999998853 357999999996 55
Q ss_pred hhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccC
Q 012062 85 TGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL 163 (472)
Q Consensus 85 ~~~~~~~-~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~ 163 (472)
.+++... ...+++.+++.|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.+............+|+
T Consensus 95 ~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~ 174 (272)
T d1qpca_ 95 VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI 174 (272)
T ss_dssp HHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCT
T ss_pred HHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCccccccccCCcc
Confidence 5554432 235899999999999999999999999999999999999999999999999999887654444445567899
Q ss_pred CCCChhhhcCCCCCCCCcchhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhh
Q 012062 164 WYRPPELLLGATKYGPAVDMWSVGCIFAELLNG-KPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTM 242 (472)
Q Consensus 164 ~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (472)
.|+|||++.. ..++.++||||||||||||+|| .++|...+..+.+..+........
T Consensus 175 ~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~---------------------- 231 (272)
T d1qpca_ 175 KWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR---------------------- 231 (272)
T ss_dssp TTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC----------------------
T ss_pred cccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC----------------------
Confidence 9999999986 5689999999999999999995 567777777777766644221110
Q ss_pred hhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc--CCCC
Q 012062 243 KRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD--SEYF 284 (472)
Q Consensus 243 ~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~--h~~f 284 (472)
...+++++.+||++||+.||++|||++||++ ++||
T Consensus 232 -------p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 232 -------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp -------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 1246778999999999999999999999987 6676
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-46 Score=360.73 Aligned_cols=232 Identities=20% Similarity=0.333 Sum_probs=178.9
Q ss_pred ceeccC---CCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 2 AREIKT---GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 2 a~~~~t---g~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
|++..+ +..||||+++.... +.....+.+|+++|++++|||||++++++.+ +.+|||||
T Consensus 26 a~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-----------------~~~~iv~E 87 (273)
T d1mp8a_ 26 GIYMSPENPALAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVITE-----------------NPVWIIME 87 (273)
T ss_dssp EEECCC--CCEEEEEEECTTTTS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----------------SSCEEEEE
T ss_pred EEEecCCceeEEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----------------CeEEEEEE
Confidence 445443 34688998865432 2235678899999999999999999999853 35799999
Q ss_pred cCCC-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccc
Q 012062 79 YMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 157 (472)
Q Consensus 79 y~~g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~ 157 (472)
||++ ++..++......+++.+++.++.||+.||+|||+++|+||||||+|||++.++++||+|||+|+.+.........
T Consensus 88 ~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~ 167 (273)
T d1mp8a_ 88 LCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS 167 (273)
T ss_dssp CCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------------
T ss_pred eccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcceecc
Confidence 9996 566666666667999999999999999999999999999999999999999999999999999876654444445
Q ss_pred cccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccC
Q 012062 158 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 236 (472)
Q Consensus 158 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (472)
...+|+.|+|||++.+ ..++.++|||||||+||||++ |.+||.+.+..+.+.++.+....+
T Consensus 168 ~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~----------------- 229 (273)
T d1mp8a_ 168 KGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP----------------- 229 (273)
T ss_dssp ---CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC-----------------
T ss_pred ceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-----------------
Confidence 5567999999999986 578999999999999999998 899999999888888775432111
Q ss_pred CCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 237 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
.+..+++++.+||.+||..||++|||+.||+++
T Consensus 230 ------------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 230 ------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp ------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 112467889999999999999999999999864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=370.97 Aligned_cols=239 Identities=23% Similarity=0.411 Sum_probs=194.6
Q ss_pred ccCCCEEEEEEeecCC--cCCCchhhHHHHHHHHHhcCC-CCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 5 IKTGEIVALKKIRMDN--EKEGFPITAIREIKILKKLQH-ENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~--~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
..||+.||||++++.. .+......+.+|+++|++++| +||+++++++++ ...+|+||||+.
T Consensus 49 ~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~----------------~~~~~~v~e~~~ 112 (322)
T d1vzoa_ 49 HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT----------------ETKLHLILDYIN 112 (322)
T ss_dssp TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE----------------TTEEEEEECCCC
T ss_pred CCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc----------------CCceeeeeeccc
Confidence 5689999999997653 223345667899999999976 899999999987 568999999999
Q ss_pred C-ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCcccccc
Q 012062 82 H-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV 160 (472)
Q Consensus 82 g-~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 160 (472)
+ +|...+... ..+.+..++.+++||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.+............
T Consensus 113 ~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~ 191 (322)
T d1vzoa_ 113 GGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC 191 (322)
T ss_dssp SCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGG
T ss_pred ccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcccccccccccc
Confidence 6 565555443 46889999999999999999999999999999999999999999999999999877655555556678
Q ss_pred ccCCCCChhhhcCCC-CCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCc
Q 012062 161 ITLWYRPPELLLGAT-KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 239 (472)
Q Consensus 161 gt~~y~aPE~l~~~~-~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (472)
+|+.|+|||++.+.. .++.++|||||||+||+|++|+.||.+.+..+....+.+........
T Consensus 192 g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~----------------- 254 (322)
T d1vzoa_ 192 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP----------------- 254 (322)
T ss_dssp SCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC-----------------
T ss_pred cccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCC-----------------
Confidence 899999999997643 46889999999999999999999998877666555554432111110
Q ss_pred hhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCCC
Q 012062 240 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 286 (472)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-----t~~elL~h~~f~~ 286 (472)
+...++.++++||++||..||++|+ |++|+|+||||..
T Consensus 255 ---------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 255 ---------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp ---------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred ---------CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 1124788999999999999999999 5899999999953
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=355.46 Aligned_cols=234 Identities=24% Similarity=0.392 Sum_probs=182.4
Q ss_pred ceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCC
Q 012062 2 AREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMD 81 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~ 81 (472)
|++..+ +.||||+++.+... .+.+++|+.+|++++|+|||++++++.+ +.+|||||||.
T Consensus 36 ~~~~~~-~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~-----------------~~~~lv~Ey~~ 94 (285)
T d1fmka3 36 GTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-----------------EPIYIVTEYMS 94 (285)
T ss_dssp EEETTT-EEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-----------------SSCEEEECCCT
T ss_pred EEECCC-CEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEec-----------------CCeEEEEEecC
Confidence 555544 57999999755432 4578899999999999999999999853 34799999999
Q ss_pred CC-hhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccc
Q 012062 82 HD-LTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 159 (472)
Q Consensus 82 g~-l~~~~~~-~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 159 (472)
++ |..++.. ....+++.+++.|+.||+.||+|||+++|+||||||+||||+.++++||+|||+|+.+...........
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 174 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 174 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------------
T ss_pred CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCceeeccc
Confidence 64 5555443 234599999999999999999999999999999999999999999999999999987654444445556
Q ss_pred cccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCC
Q 012062 160 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNG-KPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 238 (472)
Q Consensus 160 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (472)
.+|+.|+|||++.. ..++.++||||||||||||++| .++|...+..+.+..+.+....+.
T Consensus 175 ~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~------------------ 235 (285)
T d1fmka3 175 KFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC------------------ 235 (285)
T ss_dssp -CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC------------------
T ss_pred cccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC------------------
Confidence 78999999999986 6789999999999999999995 566677777777766654321111
Q ss_pred chhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc--CCCCCC
Q 012062 239 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD--SEYFWT 286 (472)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~--h~~f~~ 286 (472)
...+++++++||.+||+.||++|||+++|++ ++||..
T Consensus 236 -----------~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 236 -----------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp -----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred -----------CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 1246778999999999999999999999988 888854
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-45 Score=352.29 Aligned_cols=225 Identities=21% Similarity=0.345 Sum_probs=174.8
Q ss_pred CEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCC-hhhh
Q 012062 9 EIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHD-LTGL 87 (472)
Q Consensus 9 ~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~-l~~~ 87 (472)
..||||+++...... ....+++|+++|++|+|||||++++++.+ .+.+++|||||.++ +...
T Consensus 37 ~~vAvK~~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~~~g~~~~----------------~~~~~~v~e~~~~~~l~~~ 99 (283)
T d1mqba_ 37 VPVAIKTLKAGYTEK-QRVDFLGEAGIMGQFSHHNIIRLEGVISK----------------YKPMMIITEYMENGALDKF 99 (283)
T ss_dssp EEEEEEEECTTCCHH-HHHHHHHHHHHHHTCCCTTBCCEEEEECS----------------SSSEEEEEECCTTEEHHHH
T ss_pred EEEEEEEECcccChH-HHHHHHHHHHHHHhcCCCCEeeeeEEEec----------------CCceEEEEEecccCcchhh
Confidence 479999997654332 34567899999999999999999999976 55789999999975 4555
Q ss_pred hcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC--CccccccccCCC
Q 012062 88 ADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTLTNRVITLWY 165 (472)
Q Consensus 88 ~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~--~~~~~~~gt~~y 165 (472)
+......+++.++..|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+....... .......+|..|
T Consensus 100 ~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y 179 (283)
T d1mqba_ 100 LREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179 (283)
T ss_dssp HHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGG
T ss_pred hhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccc
Confidence 555556799999999999999999999999999999999999999999999999999987644322 222334679999
Q ss_pred CChhhhcCCCCCCCCcchhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhhh
Q 012062 166 RPPELLLGATKYGPAVDMWSVGCIFAELLNG-KPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 244 (472)
Q Consensus 166 ~aPE~l~~~~~~~~~~DiwSlG~il~ell~G-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (472)
+|||++.+ ..++.++|||||||+||||+++ .++|...+..+.+..+.+....+.
T Consensus 180 ~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~------------------------ 234 (283)
T d1mqba_ 180 TAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT------------------------ 234 (283)
T ss_dssp SCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC------------------------
T ss_pred cCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCC------------------------
Confidence 99999986 6789999999999999999995 555666666666655543211110
Q ss_pred hHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 245 RVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 245 ~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...++.++.+||.+||..||++|||+.||++
T Consensus 235 -----~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 235 -----PMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp -----CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----chhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 1236678999999999999999999999985
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=356.36 Aligned_cols=232 Identities=19% Similarity=0.276 Sum_probs=183.8
Q ss_pred ceeccCCC----EEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEE
Q 012062 2 AREIKTGE----IVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVF 77 (472)
Q Consensus 2 a~~~~tg~----~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVm 77 (472)
|++..+|+ .||||+++.... ....+.+++|+++|++|+|||||++++++.+ +..++||
T Consensus 28 ~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-----------------~~~~~v~ 89 (317)
T d1xkka_ 28 GLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLT-----------------STVQLIT 89 (317)
T ss_dssp EEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-----------------SSEEEEE
T ss_pred EEEcCCCCEEEEEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----------------CCeeEEE
Confidence 56667776 588888865433 2346678999999999999999999999975 2457777
Q ss_pred ecCC-CChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC-c
Q 012062 78 EYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN-T 155 (472)
Q Consensus 78 Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~ 155 (472)
||+. ++|.+.+......+++..++.|+.||+.||+|||+++|+||||||+||||+.++++||+|||+|+.+...... .
T Consensus 90 e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 169 (317)
T d1xkka_ 90 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 169 (317)
T ss_dssp ECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC---
T ss_pred EeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccccccc
Confidence 8777 5787777777778999999999999999999999999999999999999999999999999999876543322 2
Q ss_pred cccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccc
Q 012062 156 LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 234 (472)
Q Consensus 156 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (472)
.....+|+.|+|||++.+ ..|+.++|||||||+||||+| |..||.+.+..+....+.+....+.
T Consensus 170 ~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~-------------- 234 (317)
T d1xkka_ 170 AEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ-------------- 234 (317)
T ss_dssp -----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCC--------------
T ss_pred ccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC--------------
Confidence 233467999999999987 578999999999999999998 8899998887776666644321111
Q ss_pred cCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 235 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
...++.++.+||.+||..||++|||+.||++|
T Consensus 235 ---------------p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 235 ---------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp ---------------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 12467789999999999999999999999976
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-45 Score=350.21 Aligned_cols=226 Identities=23% Similarity=0.324 Sum_probs=181.0
Q ss_pred CEEEEEEeecCCcC-CCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chhh
Q 012062 9 EIVALKKIRMDNEK-EGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTG 86 (472)
Q Consensus 9 ~~vAlK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~~ 86 (472)
..||||+++.+... +...+.+.+|+++|++|+|||||++++++.+ ..+|||||||++ ++.+
T Consensus 37 ~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-----------------~~~~lv~e~~~~~~l~~ 99 (273)
T d1u46a_ 37 VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-----------------PPMKMVTELAPLGSLLD 99 (273)
T ss_dssp EEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----------------SSCEEEEECCTTCBHHH
T ss_pred EEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----------------cchheeeeeecCcchhh
Confidence 36899999876433 3345678899999999999999999999964 246899999985 6666
Q ss_pred hhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC--ccccccccCC
Q 012062 87 LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN--TLTNRVITLW 164 (472)
Q Consensus 87 ~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~--~~~~~~gt~~ 164 (472)
.+......+++..++.++.||+.||.|||+++|+||||||+||||+.++++||+|||+++.+...... ......+|..
T Consensus 100 ~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~ 179 (273)
T d1u46a_ 100 RLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179 (273)
T ss_dssp HHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGG
T ss_pred hhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcc
Confidence 66655557999999999999999999999999999999999999999999999999999887543322 2223456889
Q ss_pred CCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhh
Q 012062 165 YRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMK 243 (472)
Q Consensus 165 y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (472)
|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+.+..+.+....++.
T Consensus 180 ~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~---------------------- 236 (273)
T d1u46a_ 180 WCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR---------------------- 236 (273)
T ss_dssp GCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC----------------------
T ss_pred cCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCC----------------------
Confidence 999999987 678999999999999999998 89999999999988888654322111
Q ss_pred hhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 244 RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 244 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...++.++++||.+||..||++|||+.||++
T Consensus 237 ------~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 237 ------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------cccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1246778999999999999999999999874
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-44 Score=348.20 Aligned_cols=232 Identities=22% Similarity=0.358 Sum_probs=175.5
Q ss_pred ccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-
Q 012062 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH- 82 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g- 82 (472)
..+++.||||+++...... ....+++|+.++.++ +|+|||.+++++... ...+|||||||++
T Consensus 40 ~~~~~~vAvK~l~~~~~~~-~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~---------------~~~~~iv~E~~~~g 103 (299)
T d1ywna1 40 TATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNVVNLLGACTKP---------------GGPLMVIVEFCKFG 103 (299)
T ss_dssp SSCEEEEEEEEC----CHH-HHHHHHHHHHHHHHHCCCTTBCCEEEEECST---------------TSCCEEEEECCTTC
T ss_pred ccCCeEEEEEEEccccCcH-HHHHHHHHHHHHHhhcCCCeEEEeeeeeccC---------------CCeEEEEEEecCCC
Confidence 3466789999997554332 345677888888777 689999999988652 3468999999995
Q ss_pred ChhhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceee
Q 012062 83 DLTGLADRP---------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS 147 (472)
Q Consensus 83 ~l~~~~~~~---------------~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~ 147 (472)
+|.+++... ...+++.+++.|+.||+.||+|||+++|+||||||+||||+.++++||+|||+|+.
T Consensus 104 ~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~ 183 (299)
T d1ywna1 104 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 183 (299)
T ss_dssp BHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC------
T ss_pred cHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEccCcchhh
Confidence 666665432 23488999999999999999999999999999999999999999999999999987
Q ss_pred eccCCC-CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCCCCCCc
Q 012062 148 FSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNG-KPILPGKNEAEQLSKIFELCGSPDETIWP 225 (472)
Q Consensus 148 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 225 (472)
...... ......+||+.|+|||++.+ ..++.++||||||||+|||+++ ..||.+.+..+.+..++.....+.
T Consensus 184 ~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~----- 257 (299)
T d1ywna1 184 IYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR----- 257 (299)
T ss_dssp CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCC-----
T ss_pred ccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC-----
Confidence 654333 23344578999999999987 6789999999999999999986 578888776666655544322111
Q ss_pred cCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 226 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
....+++++++||.+||+.||++|||+.||++|
T Consensus 258 -----------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 258 -----------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp -----------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 012467789999999999999999999999975
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-43 Score=346.51 Aligned_cols=229 Identities=20% Similarity=0.311 Sum_probs=186.2
Q ss_pred ccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-C
Q 012062 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-D 83 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~ 83 (472)
..+++.||||+++..... .....+.+|+++|++++|+||+++++++.. .+.+++||||+.+ +
T Consensus 40 ~~~~~~vAvK~i~~~~~~-~~~~~~~~E~~il~~l~h~niv~~~~~~~~----------------~~~~~~v~e~~~~g~ 102 (301)
T d1lufa_ 40 YEPFTMVAVKMLKEEASA-DMQADFQREAALMAEFDNPNIVKLLGVCAV----------------GKPMCLLFEYMAYGD 102 (301)
T ss_dssp TSSEEEEEEEECCTTCCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEECS----------------SSSCEEEEECCTTCB
T ss_pred CCCCeEEEEEEEChhcCh-HHHHHHHHHHHHHHhcCCCCcccceeeecc----------------CCceEEEEEecCCCc
Confidence 356789999999765432 245678899999999999999999999986 5578999999985 6
Q ss_pred hhhhhcCC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEe
Q 012062 84 LTGLADRP-----------------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLA 140 (472)
Q Consensus 84 l~~~~~~~-----------------------~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~ 140 (472)
|.+++... ...+++.+++.|++||+.||+|||+++||||||||+||||+.++++||+
T Consensus 103 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~ 182 (301)
T d1lufa_ 103 LNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIA 182 (301)
T ss_dssp HHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred HHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCcEEEc
Confidence 66665421 1248899999999999999999999999999999999999999999999
Q ss_pred eccceeeeccCCC-CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCC-CCCCCCChHHHHHHHHHhcCC
Q 012062 141 DFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK-PILPGKNEAEQLSKIFELCGS 218 (472)
Q Consensus 141 DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~-~pf~~~~~~~~~~~i~~~~~~ 218 (472)
|||+|+.+..... ...+...+|+.|+|||++.+ ..|+.++||||||||||||+++. +||.+.+..+.+..+.+....
T Consensus 183 DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~ 261 (301)
T d1lufa_ 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL 261 (301)
T ss_dssp CCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC
T ss_pred cchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9999976543322 23334567899999999987 67899999999999999999985 789999988888777543211
Q ss_pred CCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 219 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
. ....++.++.+||.+||+.||++|||+.||++
T Consensus 262 ~-----------------------------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 262 A-----------------------------CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp C-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C-----------------------------CCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0 11246778999999999999999999999975
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-43 Score=342.69 Aligned_cols=225 Identities=24% Similarity=0.397 Sum_probs=184.9
Q ss_pred CEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chhh
Q 012062 9 EIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTG 86 (472)
Q Consensus 9 ~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~~ 86 (472)
..||||+++.+.... ....+.+|+.+++++ +|||||+++++|.+ ++.+|+|||||++ +|.+
T Consensus 46 ~~vAvK~~~~~~~~~-~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~----------------~~~~~~v~e~~~~g~l~~ 108 (299)
T d1fgka_ 46 TKVAVKMLKSDATEK-DLSDLISEMEMMKMIGKHKNIINLLGACTQ----------------DGPLYVIVEYASKGNLRE 108 (299)
T ss_dssp EEEEEECCCTTCCHH-HHHHHHHHHHHHHHHCCCTTBCCEEEEECS----------------SSSCEEEECCCTTCBHHH
T ss_pred eEEEEEEECcccChH-HHHHHHHHHHHHHHhcCCCeEEeccccccc----------------CCeEEEEEEccCCCcHHH
Confidence 479999998654332 345678899999888 79999999999986 5578999999995 6666
Q ss_pred hhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccC
Q 012062 87 LADRP---------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 151 (472)
Q Consensus 87 ~~~~~---------------~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~ 151 (472)
++... ...+++.+++.|+.||+.||+|||+++||||||||+|||++.++.+||+|||+++.....
T Consensus 109 ~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~ 188 (299)
T d1fgka_ 109 YLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188 (299)
T ss_dssp HHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGC
T ss_pred HHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCCeEeccchhhcccccc
Confidence 66433 235899999999999999999999999999999999999999999999999999877554
Q ss_pred CCC-ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCC
Q 012062 152 HNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 229 (472)
Q Consensus 152 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (472)
... ......+|+.|+|||++.+ ..|+.++||||||||+|||++ |..||.+.+..+.+..+.+.. .+..
T Consensus 189 ~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~-~~~~-------- 258 (299)
T d1fgka_ 189 DYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH-RMDK-------- 258 (299)
T ss_dssp CTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-CCCC--------
T ss_pred ccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCC-CCCC--------
Confidence 332 3344567999999999986 679999999999999999998 789999888877666554321 1110
Q ss_pred CCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 230 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...+++++++||.+||+.||++|||+.|||+
T Consensus 259 --------------------p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 259 --------------------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp --------------------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 1246778999999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.4e-43 Score=340.62 Aligned_cols=241 Identities=20% Similarity=0.229 Sum_probs=186.8
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEE-eeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEI-VTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.||+.||||+++..... ..+.+|+++++.++|+|+|.++.. +.. ....+|||||
T Consensus 25 ~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~----------------~~~~~ivme~ 84 (299)
T d1ckia_ 25 LGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE----------------GDYNVMVMEL 84 (299)
T ss_dssp EEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEE----------------TTEEEEEEEC
T ss_pred EEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEec----------------CCEEEEEEEE
Confidence 4789999999999998865432 357789999999988776655544 443 5678999999
Q ss_pred CCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC---CCCeEEeeccceeeeccCCC---
Q 012062 80 MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN---EGNLKLADFGLARSFSYDHN--- 153 (472)
Q Consensus 80 ~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~---~~~vkL~DFG~a~~~~~~~~--- 153 (472)
+++++...+......+++..+..++.||+.||+|||++||+||||||+|||++. +..+||+|||+|+.+.....
T Consensus 85 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~ 164 (299)
T d1ckia_ 85 LGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 164 (299)
T ss_dssp CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCB
T ss_pred cCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccc
Confidence 999988887776778999999999999999999999999999999999999864 44699999999988754332
Q ss_pred ---CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCC
Q 012062 154 ---NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 230 (472)
Q Consensus 154 ---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 230 (472)
......+||+.|||||++.+ ..++.++|||||||++|||++|+.||......+....+.....
T Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~------------- 230 (299)
T d1ckia_ 165 IPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE------------- 230 (299)
T ss_dssp CCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH-------------
T ss_pred eeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc-------------
Confidence 22345578999999999987 5689999999999999999999999988766554443322110
Q ss_pred CccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHH---hcCCCC
Q 012062 231 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDA---LDSEYF 284 (472)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~el---L~h~~f 284 (472)
.............+++++.+||.+||..||++||++.+| |++.|.
T Consensus 231 ---------~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 231 ---------KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp ---------HHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred ---------ccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 000112334456788999999999999999999998755 555443
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-43 Score=343.89 Aligned_cols=231 Identities=25% Similarity=0.327 Sum_probs=184.1
Q ss_pred ceeccCCCE--EEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEe
Q 012062 2 AREIKTGEI--VALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFE 78 (472)
Q Consensus 2 a~~~~tg~~--vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmE 78 (472)
|+++.|+.. ||||+++.....+ ....+.+|+++|+++ +|||||++++++.. ++.+|||||
T Consensus 29 ~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~----------------~~~~~iV~e 91 (309)
T d1fvra_ 29 ARIKKDGLRMDAAIKRMKEYASKD-DHRDFAGELEVLCKLGHHPNIINLLGACEH----------------RGYLYLAIE 91 (309)
T ss_dssp EEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEE----------------TTEEEEEEC
T ss_pred EEECCCCeEEEEEEEEECcccChH-HHHHHHHHHHHHHhccCCCCEeeEEEEEec----------------CCeeEEEEE
Confidence 677778875 6777776443332 355788999999999 79999999999987 668999999
Q ss_pred cCCC-ChhhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeec
Q 012062 79 YMDH-DLTGLADRP---------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADF 142 (472)
Q Consensus 79 y~~g-~l~~~~~~~---------------~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DF 142 (472)
|+++ +|.+++.+. ...+++.++..++.||+.||.|||+++|+||||||+|||++.++.+||+||
T Consensus 92 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~Df 171 (309)
T d1fvra_ 92 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF 171 (309)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCT
T ss_pred ecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEccc
Confidence 9995 777766432 356899999999999999999999999999999999999999999999999
Q ss_pred cceeeeccCCCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCC-CCCCCCChHHHHHHHHHhcCCCCC
Q 012062 143 GLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK-PILPGKNEAEQLSKIFELCGSPDE 221 (472)
Q Consensus 143 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~-~pf~~~~~~~~~~~i~~~~~~~~~ 221 (472)
|+|+...... ......+|..|+|||++.+ ..++.++||||||||+|||++|. +||.+.+..+.+..+.+.....
T Consensus 172 G~a~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~-- 246 (309)
T d1fvra_ 172 GLSRGQEVYV--KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE-- 246 (309)
T ss_dssp TCEESSCEEC--CC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCC--
T ss_pred cccccccccc--cccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCC--
Confidence 9997654322 2223467999999999986 57899999999999999999965 6788888877777664321110
Q ss_pred CCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 222 TIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
.+..+++++++||.+||+.||++|||++||+++
T Consensus 247 ---------------------------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 247 ---------------------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp ---------------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 112467899999999999999999999999975
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=339.08 Aligned_cols=222 Identities=21% Similarity=0.343 Sum_probs=175.6
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Ch
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL 84 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l 84 (472)
.+|+.||||+++.+. ..+.+.+|+++|++++|||||++++++.+. ++.+||||||+++ +|
T Consensus 28 ~~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~---------------~~~~~lv~ey~~~g~L 88 (262)
T d1byga_ 28 YRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE---------------KGGLYIVTEYMAKGSL 88 (262)
T ss_dssp ETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC-----------------CCEEEECCCTTEEH
T ss_pred ECCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEec---------------CCcEEEEEeccCCCCH
Confidence 368899999997543 345788999999999999999999998541 3458999999985 67
Q ss_pred hhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCCccccccccC
Q 012062 85 TGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL 163 (472)
Q Consensus 85 ~~~~~~~-~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~ 163 (472)
.+++.+. ...+++..++.|+.||+.||.|||+++|+||||||+|||++.++.+||+|||+++..... .....+|.
T Consensus 89 ~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----~~~~~~~~ 164 (262)
T d1byga_ 89 VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPV 164 (262)
T ss_dssp HHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----------------CCT
T ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC----Cccccccc
Confidence 7766442 234899999999999999999999999999999999999999999999999999765432 22345689
Q ss_pred CCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhh
Q 012062 164 WYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTM 242 (472)
Q Consensus 164 ~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (472)
.|+|||++.+ ..++.++|||||||++|||++ |+.||...+..+.+..+.+.....
T Consensus 165 ~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~----------------------- 220 (262)
T d1byga_ 165 KWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD----------------------- 220 (262)
T ss_dssp TTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCC-----------------------
T ss_pred cCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-----------------------
Confidence 9999999986 578999999999999999998 789999888877777764321110
Q ss_pred hhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 243 KRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 243 ~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
+...+++++++||++||..||++|||+.||++
T Consensus 221 ------~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 252 (262)
T d1byga_ 221 ------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252 (262)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------CCccCCHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 11246678999999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-42 Score=339.70 Aligned_cols=227 Identities=22% Similarity=0.273 Sum_probs=178.7
Q ss_pred CEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Chhhh
Q 012062 9 EIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DLTGL 87 (472)
Q Consensus 9 ~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l~~~ 87 (472)
..||||+++.... ......+++|+++|++|+|||||++++++... ++.+|||||||++ +|.++
T Consensus 56 ~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~---------------~~~~~lv~E~~~~g~l~~~ 119 (311)
T d1r0pa_ 56 IHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS---------------EGSPLVVLPYMKHGDLRNF 119 (311)
T ss_dssp EEEEEEEECCCCC-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET---------------TTEEEEEEECCTTCBHHHH
T ss_pred EEEEEEEECcccC-HHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec---------------CCceEEEEEEeecCchhhh
Confidence 3699999975432 23456789999999999999999999997642 4578999999996 55666
Q ss_pred hcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC---ccccccccCC
Q 012062 88 ADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN---TLTNRVITLW 164 (472)
Q Consensus 88 ~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~---~~~~~~gt~~ 164 (472)
+......+++..+..++.||+.||.|||+++|+||||||+||||++++.+||+|||+++........ ......+|..
T Consensus 120 ~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~ 199 (311)
T d1r0pa_ 120 IRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 199 (311)
T ss_dssp HHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGG
T ss_pred hccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccceeccccccccc
Confidence 6666667888999999999999999999999999999999999999999999999999876543222 2233467999
Q ss_pred CCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCCCCCCccCCCCCccccCCCchhhh
Q 012062 165 YRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK-NEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMK 243 (472)
Q Consensus 165 y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (472)
|+|||++.. ..++.++|||||||+||||+++..||... +..+....+.+.....
T Consensus 200 y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~------------------------ 254 (311)
T d1r0pa_ 200 WMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL------------------------ 254 (311)
T ss_dssp GSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCC------------------------
T ss_pred ccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC------------------------
Confidence 999999886 57899999999999999999977666544 3333444443221110
Q ss_pred hhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 244 RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 244 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
....+++++.+||.+||..||++|||+.||+++
T Consensus 255 -----~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 255 -----QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 012467789999999999999999999999976
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-43 Score=342.53 Aligned_cols=230 Identities=23% Similarity=0.354 Sum_probs=187.8
Q ss_pred ccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhc-CCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-
Q 012062 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKL-QHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH- 82 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g- 82 (472)
..+++.||||+++..... .....+++|+.+++++ +|||||++++++.+ ...+|||||||++
T Consensus 50 ~~~~~~vAvK~i~~~~~~-~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~----------------~~~~~lvmE~~~~g 112 (311)
T d1t46a_ 50 SDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYLGNHMNIVNLLGACTI----------------GGPTLVITEYCCYG 112 (311)
T ss_dssp TTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----------------SSSCEEEEECCTTE
T ss_pred CCCCeEEEEEEECcccCH-HHHHHHHHHHHHHHhccCCCCEEEEEEEEee----------------CCEEEEEEEcCCCC
Confidence 467889999999865432 2345678999999999 69999999999987 4568999999986
Q ss_pred ChhhhhcCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccce
Q 012062 83 DLTGLADRP-----------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLA 145 (472)
Q Consensus 83 ~l~~~~~~~-----------------~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a 145 (472)
+|..++.+. ...+++..++.|+.||+.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 113 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~ 192 (311)
T d1t46a_ 113 DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192 (311)
T ss_dssp EHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGG
T ss_pred CHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccCcccccccchh
Confidence 566655432 235899999999999999999999999999999999999999999999999999
Q ss_pred eeeccCCC-CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 012062 146 RSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETI 223 (472)
Q Consensus 146 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 223 (472)
+....... ......++|+.|+|||++.. ..++.++|||||||++|||++ |.++|...+..+.+.++++....+..
T Consensus 193 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~-- 269 (311)
T d1t46a_ 193 RDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLS-- 269 (311)
T ss_dssp SCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCC--
T ss_pred eeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCC--
Confidence 87654332 23344577999999999986 678999999999999999998 77788888777777776654322111
Q ss_pred CccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 224 WPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...+++++.+||.+||..||++|||++||++
T Consensus 270 --------------------------~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 270 --------------------------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp --------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------------cccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1236778999999999999999999999985
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.8e-42 Score=333.25 Aligned_cols=233 Identities=19% Similarity=0.202 Sum_probs=189.9
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCC-CCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEec
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQH-ENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEY 79 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy 79 (472)
+|+++.||+.||||+++..... ..+.+|+++++.|+| +||+.+++++.. ....|+||||
T Consensus 23 ~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~----------------~~~~~~vme~ 82 (293)
T d1csna_ 23 EGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQE----------------GLHNVLVIDL 82 (293)
T ss_dssp EEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEE----------------TTEEEEEEEC
T ss_pred EEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeec----------------CCccEEEEEe
Confidence 4789999999999998765432 356789999999975 899999999976 6688999999
Q ss_pred CCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC-----CCCeEEeeccceeeeccCCC-
Q 012062 80 MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN-----EGNLKLADFGLARSFSYDHN- 153 (472)
Q Consensus 80 ~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~-----~~~vkL~DFG~a~~~~~~~~- 153 (472)
++++|.+++......+++..+..|+.|++.||+|||++||+||||||+||||+. ++.+||+|||+|+.+.....
T Consensus 83 ~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (293)
T d1csna_ 83 LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 162 (293)
T ss_dssp CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTC
T ss_pred cCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccc
Confidence 999998888777667999999999999999999999999999999999999974 56799999999988654322
Q ss_pred -----CccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCChHHH---HHHHHHhcCCCCCCCCc
Q 012062 154 -----NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ---LSKIFELCGSPDETIWP 225 (472)
Q Consensus 154 -----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~ 225 (472)
......+||+.|||||++.+ ..++.++|||||||++|+|++|+.||.+.+.... +.++....
T Consensus 163 ~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~--------- 232 (293)
T d1csna_ 163 QHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK--------- 232 (293)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH---------
T ss_pred cceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc---------
Confidence 12344678999999999987 6789999999999999999999999986544332 23332210
Q ss_pred cCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHh
Q 012062 226 GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 279 (472)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL 279 (472)
......+....+++++.+||..|+..+|++||+.+.+.
T Consensus 233 ----------------~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 233 ----------------QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp ----------------HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred ----------------CCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 01123344567888999999999999999999876654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-42 Score=338.90 Aligned_cols=228 Identities=18% Similarity=0.290 Sum_probs=186.0
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-Ch
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH-DL 84 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g-~l 84 (472)
.+++.||||+++..... .....+++|++++++++|+|||++++++.. +..++||||||.+ +|
T Consensus 48 ~~~~~VAvK~~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~----------------~~~~~lv~e~~~~g~l 110 (308)
T d1p4oa_ 48 EPETRVAIKTVNEAASM-RERIEFLNEASVMKEFNCHHVVRLLGVVSQ----------------GQPTLVIMELMTRGDL 110 (308)
T ss_dssp EEEEEEEEEECCTTSCH-HHHHHHHHHHHHGGGCCCTTBCCEEEEECS----------------SSSCEEEEECCTTCBH
T ss_pred CCCcEEEEEEECcccCh-HHHHHHHHHHHHHHHcCCCCEeeeeeEEec----------------CCceeEEEeecCCCCH
Confidence 45678999999754322 234567899999999999999999999976 5578999999985 56
Q ss_pred hhhhcC---------CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCC-C
Q 012062 85 TGLADR---------PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-N 154 (472)
Q Consensus 85 ~~~~~~---------~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~-~ 154 (472)
.+++.. ....+++..+..|+.||+.||.|||+++|+||||||+||||+.++++||+|||+|+.+..... .
T Consensus 111 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~ 190 (308)
T d1p4oa_ 111 KSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190 (308)
T ss_dssp HHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEE
T ss_pred HHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeecccceeccCCccee
Confidence 555432 123478899999999999999999999999999999999999999999999999986644322 2
Q ss_pred ccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCCCCCCccCCCCCcc
Q 012062 155 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNG-KPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 233 (472)
Q Consensus 155 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (472)
......+|+.|+|||++.+ ..++.++|||||||+||||+++ .+||.+.+..+.+..+.+......
T Consensus 191 ~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~------------- 256 (308)
T d1p4oa_ 191 KGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK------------- 256 (308)
T ss_dssp GGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCC-------------
T ss_pred eccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCCC-------------
Confidence 2333467999999999987 6788999999999999999998 588999988888887754321110
Q ss_pred ccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 234 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
...++..+.+||.+||+.||++|||++||++
T Consensus 257 ----------------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 257 ----------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp ----------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------cccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1236678999999999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.8e-41 Score=338.12 Aligned_cols=264 Identities=26% Similarity=0.420 Sum_probs=191.7
Q ss_pred CceeccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC-----------CCCccceeEEeeCCCCCCCCCCCCCCCCc
Q 012062 1 MAREIKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-----------HENVIKLKEIVTSPGPERDEQGRPDGNKY 69 (472)
Q Consensus 1 La~~~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~-----------hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 69 (472)
+|+++.||+.||||+++.+.. ....+.+|+++|+.++ |+|||++++++...+
T Consensus 31 ~~~~~~~g~~vAvKvi~~~~~---~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~-------------- 93 (362)
T d1q8ya_ 31 LAKDMVNNTHVAMKIVRGDKV---YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG-------------- 93 (362)
T ss_dssp EEEETTTTEEEEEEEECSCHH---HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE--------------
T ss_pred EEEECCCCCEEEEEEEecccc---chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc--------------
Confidence 478999999999999985432 2346678999998885 478999999987522
Q ss_pred CCeEEEEEecCCC--Chh-hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCC------eEE
Q 012062 70 RGSTYMVFEYMDH--DLT-GLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGN------LKL 139 (472)
Q Consensus 70 ~~~~~iVmEy~~g--~l~-~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~-~giiHrDLKp~NILl~~~~~------vkL 139 (472)
....++||+++.. +.. .........+++..++.+++||+.||+|||+ .||+||||||+||||+.++. +||
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl 173 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKI 173 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEE
T ss_pred ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeE
Confidence 3456667766653 222 2333455578999999999999999999998 89999999999999987654 999
Q ss_pred eeccceeeeccCCCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHHHHHHHhCCCCCCCCC------hHHHHHHHH
Q 012062 140 ADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN------EAEQLSKIF 213 (472)
Q Consensus 140 ~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~------~~~~~~~i~ 213 (472)
+|||.+..... .....++|+.|+|||++.. ..++.++|||||||++++|++|+.||...+ ..+.+.+++
T Consensus 174 ~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~ 248 (362)
T d1q8ya_ 174 ADLGNACWYDE----HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248 (362)
T ss_dssp CCCTTCEETTB----CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHH
T ss_pred eeccccccccc----ccccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHH
Confidence 99999976543 2344578999999999986 678999999999999999999999997543 445666666
Q ss_pred HhcCCCCCCCCccCCCCC-------cccc-----CCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhcC
Q 012062 214 ELCGSPDETIWPGVSKMP-------AYNH-----FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 281 (472)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~-------~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~h 281 (472)
..++..+...+....... .... ..................+.+++|||.+||..||.+|||++|||+|
T Consensus 249 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred HHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 776665433322111100 0000 0011111111112234577899999999999999999999999999
Q ss_pred CCCCC
Q 012062 282 EYFWT 286 (472)
Q Consensus 282 ~~f~~ 286 (472)
|||+.
T Consensus 329 p~f~~ 333 (362)
T d1q8ya_ 329 PWLKD 333 (362)
T ss_dssp GGGTT
T ss_pred cccCC
Confidence 99973
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-40 Score=322.47 Aligned_cols=234 Identities=23% Similarity=0.275 Sum_probs=168.3
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHH--HHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC-
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIR--EIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH- 82 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~--Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g- 82 (472)
.+|+.||||+++.+. .....+ |+..+++++|||||++++++...+. ....+|||||||++
T Consensus 24 ~~g~~vAvK~~~~~~-----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~------------~~~~~~lv~Ey~~~g 86 (303)
T d1vjya_ 24 WRGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNG------------TWTQLWLVSDYHEHG 86 (303)
T ss_dssp ETTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS------------SSEEEEEEEECCTTC
T ss_pred ECCEEEEEEEECccc-----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCC------------cceEEEEEEecccCC
Confidence 478999999997543 223334 5555567899999999999986321 12368999999985
Q ss_pred ChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCccccCCCCCcEEEcCCCCeEEeeccceeeeccCCCC
Q 012062 83 DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV--------NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 154 (472)
Q Consensus 83 ~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~--------~giiHrDLKp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 154 (472)
+|.+++.+. .+++.+++.++.|++.||+|||+ ++|+||||||+||||+.++++||+|||+++........
T Consensus 87 ~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~ 164 (303)
T d1vjya_ 87 SLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 164 (303)
T ss_dssp BHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTE
T ss_pred CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcc
Confidence 676777653 58999999999999999999996 59999999999999999999999999999877543321
Q ss_pred ---ccccccccCCCCChhhhcCCC-----CCCCCcchhhHHHHHHHHHhCCCCCCCCCh--------------HHHHHHH
Q 012062 155 ---TLTNRVITLWYRPPELLLGAT-----KYGPAVDMWSVGCIFAELLNGKPILPGKNE--------------AEQLSKI 212 (472)
Q Consensus 155 ---~~~~~~gt~~y~aPE~l~~~~-----~~~~~~DiwSlG~il~ell~G~~pf~~~~~--------------~~~~~~i 212 (472)
.....+||+.|+|||++.+.. .++.++||||||||||||++|..||..... .+.+...
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (303)
T d1vjya_ 165 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244 (303)
T ss_dssp ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHH
T ss_pred eeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHH
Confidence 234567899999999987532 146689999999999999999887743221 1111111
Q ss_pred HHhcCCCCCCCCccCCCCCccccCCCchhhhhhHHHHhhhccHHHHHHHHHhhccCCCCCCCHHHHhc
Q 012062 213 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 280 (472)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t~~elL~ 280 (472)
..... .++... . ..........+.+||.+||+.||++|||+.||++
T Consensus 245 ~~~~~------------------~~p~~~--~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 245 VCEQK------------------LRPNIP--N--RWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp HTTSC------------------CCCCCC--G--GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred Hhccc------------------cCCCCC--c--ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 11000 000000 0 0001123456889999999999999999999975
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.84 E-value=7.6e-22 Score=178.42 Aligned_cols=154 Identities=17% Similarity=0.119 Sum_probs=105.3
Q ss_pred ceeccCCCEEEEEEeecCCcC-----C-----------CchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCC
Q 012062 2 AREIKTGEIVALKKIRMDNEK-----E-----------GFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPD 65 (472)
Q Consensus 2 a~~~~tg~~vAlK~i~~~~~~-----~-----------~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~ 65 (472)
|++ .+|+.||||+++..... . .....+.+|+.++.++.|.+++..+++...
T Consensus 19 a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~~~------------ 85 (191)
T d1zara2 19 CYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEGN------------ 85 (191)
T ss_dssp EEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEETT------------
T ss_pred EEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEecCC------------
Confidence 455 47999999998743211 0 011233568999999999999998876432
Q ss_pred CCCcCCeEEEEEecCCCChhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCCeEEeeccce
Q 012062 66 GNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLA 145 (472)
Q Consensus 66 ~~~~~~~~~iVmEy~~g~l~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~~giiHrDLKp~NILl~~~~~vkL~DFG~a 145 (472)
+|||||+++..... ++...+..++.||+.+|+|||++||+||||||+|||+++++ ++|+|||+|
T Consensus 86 --------~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~a 149 (191)
T d1zara2 86 --------AVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQS 149 (191)
T ss_dssp --------EEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTTC
T ss_pred --------EEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCCc
Confidence 79999999854432 33445678999999999999999999999999999999765 999999999
Q ss_pred eeeccCCCCccccccccCCCCChhhhcCCCCCCCCcchhhHHHH
Q 012062 146 RSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCI 189 (472)
Q Consensus 146 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~i 189 (472)
+............+-.+ . --|.+. +.|+.++|+||+.--
T Consensus 150 ~~~~~~~~~~~l~rd~~--~-~~~~f~--r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 150 VEVGEEGWREILERDVR--N-IITYFS--RTYRTEKDINSAIDR 188 (191)
T ss_dssp EETTSTTHHHHHHHHHH--H-HHHHHH--HHHCCCCCHHHHHHH
T ss_pred ccCCCCCcHHHHHHHHH--H-HHHHHc--CCCCCcccHHHHHHH
Confidence 76542221111000000 0 012222 457889999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.09 E-value=8.3e-06 Score=74.65 Aligned_cols=118 Identities=15% Similarity=0.119 Sum_probs=74.6
Q ss_pred cCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcC-CCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCCh
Q 012062 6 KTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQ-HENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDL 84 (472)
Q Consensus 6 ~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~l 84 (472)
.+++.++||+....... ....+.+|+.+|+.|. +--+.+++.+... .+..||||++++|..
T Consensus 35 ~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~----------------~~~~~lv~~~l~G~~ 96 (263)
T d1j7la_ 35 GENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERH----------------DGWSNLLMSEADGVL 96 (263)
T ss_dssp CSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEE----------------TTEEEEEEECCSSEE
T ss_pred eCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEec----------------CCceEEEEEeccccc
Confidence 35666788877644322 2345678999988875 3335667776665 457799999999854
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------------
Q 012062 85 TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV------------------------------------------------ 116 (472)
Q Consensus 85 ~~~~~~~~~~l~~~~i~~i~~Qll~aL~~LH~------------------------------------------------ 116 (472)
........ . ....++.++...|+.||+
T Consensus 97 ~~~~~~~~--~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (263)
T d1j7la_ 97 CSEEYEDE--Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELY 171 (263)
T ss_dssp HHHHTTTC--S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHH
T ss_pred cccccccc--c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHH
Confidence 32221111 1 122233444444444443
Q ss_pred -----C------CccccCCCCCcEEEcCCCCeEEeecccee
Q 012062 117 -----N------QVLHRDIKGSNLLIDNEGNLKLADFGLAR 146 (472)
Q Consensus 117 -----~------giiHrDLKp~NILl~~~~~vkL~DFG~a~ 146 (472)
. .++|+|+.+.|||+++++.+-|+||+.+.
T Consensus 172 ~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 172 DFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1 26999999999999977656799999774
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.94 E-value=2.6e-05 Score=70.90 Aligned_cols=28 Identities=25% Similarity=0.268 Sum_probs=24.6
Q ss_pred ccccCCCCCcEEEcCCCCeEEeecccee
Q 012062 119 VLHRDIKGSNLLIDNEGNLKLADFGLAR 146 (472)
Q Consensus 119 iiHrDLKp~NILl~~~~~vkL~DFG~a~ 146 (472)
++|+|+.+.|||++++..+-|+||+.+.
T Consensus 177 liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 177 VTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred EEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 7999999999999987667899999764
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.27 E-value=0.00033 Score=66.14 Aligned_cols=128 Identities=13% Similarity=0.071 Sum_probs=70.5
Q ss_pred ccCCCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCccceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCCCh
Q 012062 5 IKTGEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENVIKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDHDL 84 (472)
Q Consensus 5 ~~tg~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g~l 84 (472)
.++|+.|++|+.+.... ....+..|+..+..|....|.-..-+....+ ......+..+.|++++.|..
T Consensus 43 ~~dg~~~VlK~~rp~~~---s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~---------~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 43 DEDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQ---------TLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp CTTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTB---------SCEEETTEEEEEEECCCCEE
T ss_pred cCCCCEEEEEEeCCCCC---CHHHHHHHHHHHHHHHhcCCCCCCceecCCC---------eeeeeeeEEEEEEeecCCcC
Confidence 35788899999875422 2456778999998886433321111111111 11123667899999998621
Q ss_pred hhh-----h--------------cC----CCCCCCH----------------------HHHHHHHHHHHHHHHHHH----
Q 012062 85 TGL-----A--------------DR----PGLRFTV----------------------PQIKCYMKQLLTGLHYCH---- 115 (472)
Q Consensus 85 ~~~-----~--------------~~----~~~~l~~----------------------~~i~~i~~Qll~aL~~LH---- 115 (472)
... . .. ....++. ......+..++..+.-+-
T Consensus 111 ~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~ 190 (325)
T d1zyla1 111 FEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDF 190 (325)
T ss_dssp CCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCS
T ss_pred CCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccC
Confidence 110 0 00 0011111 112223333443333321
Q ss_pred HCCccccCCCCCcEEEcCCCCeEEeecccee
Q 012062 116 VNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 146 (472)
Q Consensus 116 ~~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 146 (472)
..++||+|+.+.|||++++ ..|+||+.+.
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred CceeecCCCCcccEEEeCC--ceEEechhcc
Confidence 1369999999999999743 5689999774
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.24 E-value=0.00025 Score=68.99 Aligned_cols=28 Identities=18% Similarity=0.324 Sum_probs=25.0
Q ss_pred CccccCCCCCcEEEcCCCCeEEeecccee
Q 012062 118 QVLHRDIKGSNLLIDNEGNLKLADFGLAR 146 (472)
Q Consensus 118 giiHrDLKp~NILl~~~~~vkL~DFG~a~ 146 (472)
.++|+|+++.|||++.+. ++|+||.+|.
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~ 251 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAF 251 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhcc
Confidence 589999999999998765 9999998874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.07 E-value=0.0009 Score=64.81 Aligned_cols=51 Identities=22% Similarity=0.151 Sum_probs=33.7
Q ss_pred CCEEEEEEeecCCcCCCchhhHHHHHHHHHhcCCCCc-cceeEEeeCCCCCCCCCCCCCCCCcCCeEEEEEecCCC
Q 012062 8 GEIVALKKIRMDNEKEGFPITAIREIKILKKLQHENV-IKLKEIVTSPGPERDEQGRPDGNKYRGSTYMVFEYMDH 82 (472)
Q Consensus 8 g~~vAlK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~~~~~~~~~~~~~~~~~iVmEy~~g 82 (472)
.+.|.|++.-. .. ......+|..+++.+.--+| .+++.++.. .+||||++|
T Consensus 74 ~~~vllRi~g~---~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~--------------------g~I~efi~g 125 (395)
T d1nw1a_ 74 PNKVLLRVYFN---PE-TESHLVAESVIFTLLSERHLGPKLYGIFSG--------------------GRLEEYIPS 125 (395)
T ss_dssp CSEEEEEEECS---CC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT--------------------EEEECCCCE
T ss_pred CCcEEEEecCC---cc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC--------------------ceEEEEecc
Confidence 34566666541 11 23456689999999864444 488887743 689999987
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.49 E-value=0.0012 Score=61.56 Aligned_cols=30 Identities=27% Similarity=0.310 Sum_probs=26.6
Q ss_pred CCccccCCCCCcEEEcCCCCeEEeecccee
Q 012062 117 NQVLHRDIKGSNLLIDNEGNLKLADFGLAR 146 (472)
Q Consensus 117 ~giiHrDLKp~NILl~~~~~vkL~DFG~a~ 146 (472)
.||||+|+.++||+++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 379999999999999988767899999874
|